PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jiang, ZG; Mukamal, K; Tapper, E; Robson, SC; Tsugawa, Y				Jiang, Zhenghui Gordon; Mukamal, Kenneth; Tapper, Elliot; Robson, Simon C.; Tsugawa, Yusuke			Low LDL-C and High HDL-C Levels Are Associated with Elevated Serum Transaminases amongst Adults in the United States: A Cross-sectional Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ALANINE AMINOTRANSFERASE; FAMILIAL HYPOBETALIPOPROTEINEMIA; METABOLIC SYNDROME; APO-B; ALCOHOL-CONSUMPTION; PREVALENCE; CHOLESTEROL; POPULATION; INDIVIDUALS	Background: Dyslipidemia, typically recognized as high serum triglyceride, high low-density lipoprotein cholesterol (LDL-C) or low high-density lipoprotein cholesterol (HDL-C) levels, are associated with nonalcoholic fatty liver disease (NAFLD). However, low LDL-C levels could result from defects in lipoprotein metabolism or impaired liver synthetic function, and may serve as ab initio markers for unrecognized liver diseases. Whether such relationships exist in the general population has not been investigated. We hypothesized that despite common conception that low LDL-C is desirable, it might be associated with elevated liver enzymes due to metabolic liver diseases. Methods and Findings: We examined the associations between alanine aminotransferase (ALT), aspartate aminotransferase (AST) and major components of serum lipid profiles in a nationally representative sample of 23,073 individuals, who had no chronic viral hepatitis and were not taking lipid-lowering medications, from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2010. ALT and AST exhibited non-linear U-shaped associations with LDL-C and HDL-C, but not with triglyceride. After adjusting for potential confounders, individuals with LDL-C less than 40 and 41-70 mg/dL were associated with 4.2 (95% CI 1.5-11.7, p = 0.007) and 1.6 (95% CI 1.1-2.5, p = 0.03) times higher odds of abnormal liver enzymes respectively, when compared with those with LDL-C values 71-100 mg/dL (reference group). Surprisingly, those with HDL-C levels above 100 mg/dL was associated with 3.2 (95% CI 2.1-5.0, p < 0.001) times higher odds of abnormal liver enzymes, compared with HDL-C values of 61-80 mg/dL. Conclusions: Both low LDL-C and high HDL-C, often viewed as desirable, were associated with significantly higher odds of elevated transaminases in the general U. S. adult population. Our findings underscore an underestimated biological link between lipoprotein metabolism and liver diseases, and raise a potential need for liver evaluation among over 10 million people with particularly low LDL-C or high HDL-C in the United States.	[Jiang, Zhenghui Gordon; Tapper, Elliot; Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med,Dept Med, Boston, MA 02215 USA; [Mukamal, Kenneth; Tsugawa, Yusuke] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Sch Med,Dept Med, Boston, MA 02215 USA; [Tsugawa, Yusuke] Harvard Univ, Harvard Univ Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Jiang, ZG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med,Dept Med, Boston, MA 02215 USA.	zgjiang@bidmc.harvard.edu	Jiang, Z. Gordon/U-5256-2017; Robson, Simon C./AAA-8537-2021; Mukamal, Kenneth/GVR-7978-2022	Jiang, Z. Gordon/0000-0003-0495-9940; Tsugawa, Yusuke/0000-0002-1937-4833	National Institute of Health [P01 HL087203]; Honjo International Scholarship Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087203] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Simon was supported in part by National Institute of Health Grant P01 HL087203. Dr. Yusuke Tsugawa was supported in part by Honjo International Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Burnett JR, 2003, J BIOL CHEM, V278, P13442, DOI 10.1074/jbc.M300235200; Burnett JR, 2007, J BIOL CHEM; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COLLINS JC, 1989, GASTROENTEROLOGY, V97, P766, DOI 10.1016/0016-5085(89)90651-3; Curtin Lester R, 2012, Vital Health Stat 2, P1; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Higuchi N, 2011, EXP THER MED, V2, P1077, DOI 10.3892/etm.2011.328; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Ioannou GN, 2005, GASTROENTEROLOGY, V128, P627, DOI 10.1053/j.gastro.2004.12.004; Jiang ZG, 2013, J BIOMED RES, V27, P1, DOI 10.7555/JBR.27.20120077; Kelishadi R, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-29; Korn EL, 1999, WILEY SERIES SURVEY; Liangpunsakul S, 2005, AM J MED SCI, V329, P111, DOI 10.1097/00000441-200503000-00001; LINN S, 1993, AM J PUBLIC HEALTH, V83, P811, DOI 10.2105/AJPH.83.6.811; LINTON MF, 1993, J LIPID RES, V34, P521; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Mukamal KJ, 2008, CURR ATHEROSCLER REP, V10, P536, DOI 10.1007/s11883-008-0083-2; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Prevention CfDC, NAT HLTH NUTR EX SUR; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Schonfeld G, 2005, CELL MOL LIFE SCI, V62, P1372, DOI 10.1007/s00018-005-4473-0; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Tanoli T, 2004, J LIPID RES, V45, P941, DOI 10.1194/jlr.M300508-JLR200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; WETTERAU JR, 1992, SCIENCE, V258, P999; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; WITTE DL, 1988, CLIN CHEM, V34, P1447; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020	40	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85366	10.1371/journal.pone.0085366	http://dx.doi.org/10.1371/journal.pone.0085366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454851	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100075
J	Kelly, RP; Port, JA; Yamahara, KM; Crowder, LB				Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Crowder, Larry B.			Using Environmental DNA to Census Marine Fishes in a Large Mesocosm	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; ANIMAL DNA; REGION; ATLANTIC; BARCODE; DIET	The ocean is a soup of its resident species' genetic material, cast off in the forms of metabolic waste, shed skin cells, or damaged tissue. Sampling this environmental DNA (eDNA) is a potentially powerful means of assessing whole biological communities, a significant advance over the manual methods of environmental sampling that have historically dominated marine ecology and related fields. Here, we estimate the vertebrate fauna in a 4.5-million-liter mesocosm aquarium tank at the Monterey Bay Aquarium of known species composition by sequencing the eDNA from its constituent seawater. We find that it is generally possible to detect mitochondrial DNA of bony fishes sufficient to identify organisms to taxonomic family-or genus-level using a 106 bp fragment of the 12S ribosomal gene. Within bony fishes, we observe a low false-negative detection rate, although we did not detect the cartilaginous fishes or sea turtles present with this fragment. We find that the rank abundance of recovered eDNA sequences correlates with the abundance of corresponding species' biomass in the mesocosm, but the data in hand do not allow us to develop a quantitative relationship between biomass and eDNA abundance. Finally, we find a low false-positive rate for detection of exogenous eDNA, and we were able to diagnose non-native species' tissue in the food used to maintain the mesocosm, underscoring the sensitivity of eDNA as a technique for community-level ecological surveys. We conclude that eDNA has substantial potential to become a core tool for environmental monitoring, but that a variety of challenges remain before reliable quantitative assessments of ecological communities in the field become possible.	[Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Woods Inst Environm, Palo Alto, CA 94304 USA; [Kelly, Ryan P.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	Stanford University; University of Washington; University of Washington Seattle	Kelly, RP (corresponding author), Stanford Univ, Ctr Ocean Solut, Woods Inst Environm, Palo Alto, CA 94304 USA.	rpkelly@uw.edu		Kelly, Ryan/0000-0001-5037-2441	David and Lucile Packard Foundation [2013-38473]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was funded by the David and Lucile Packard Foundation #2013-38473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; BIBER E, 2011, U COLO L REV, V83, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Encalada SE, 1996, MOL ECOL, V5, P473; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Machida RJ, 2012, PLOS ONE, V7; Magurran A.E., 1998, J APPL ECOL, DOI DOI 10.2307/2403731; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; MPA Monitoring Enterprise, 2010, N CENTR COAST MPA MO; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	43	235	257	8	248	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86175	10.1371/journal.pone.0086175	http://dx.doi.org/10.1371/journal.pone.0086175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454960	gold, Green Published			2022-12-27	WOS:000330235100148
J	Lin, LG; Chen, KY; Khalek, WA; Ward, JL; Yang, H; Chabi, B; Wrutniak-Cabello, C; Tong, Q				Lin, Ligen; Chen, Keyun; Khalek, Waed Abdel; Ward, Jack Lee, III; Yang, Henry; Chabi, Beatrice; Wrutniak-Cabello, Chantal; Tong, Qiang			Regulation of Skeletal Muscle Oxidative Capacity and Muscle Mass by SIRT3	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; MYOSIN HEAVY-CHAIN; CALORIC RESTRICTION; TRANSGENIC MICE; SIRT3-MEDIATED DEACETYLATION; MITOCHONDRIAL-FUNCTION; LYSINE ACETYLATION; UBIQUITIN LIGASES; GENE-EXPRESSION	We have previously reported that the expression of mitochondrial deacetylase SIRT3 is high in the slow oxidative muscle and that the expression of muscle SIRT3 level is increased by dietary restriction or exercise training. To explore the function of SIRT3 in skeletal muscle, we report here the establishment of a transgenic mouse model with muscle-specific expression of the murine SIRT3 short isoform (SIRT3M3). Calorimetry study revealed that the transgenic mice had increased energy expenditure and lower respiratory exchange rate (RER), indicating a shift towards lipid oxidation for fuel usage, compared to control mice. The transgenic mice exhibited better exercise performance on treadmills, running 45% further than control animals. Moreover, the transgenic mice displayed higher proportion of slow oxidative muscle fibers, with increased muscle AMPK activation and PPARd expression, both of which are known regulators promoting type I muscle fiber specification. Surprisingly, transgenic expression of SIRT3M3 reduced muscle mass up to 30%, likely through an up-regulation of FOXO1 transcription factor and its downstream atrophy gene MuRF-1. In summary, these results suggest that SIRT3 regulates the formation of oxidative muscle fiber, improves muscle metabolic function, and reduces muscle mass, changes that mimic the effects of caloric restriction.	[Lin, Ligen; Chen, Keyun; Ward, Jack Lee, III; Yang, Henry; Tong, Qiang] Baylor Coll Med, Dept Pediat, USDA ARS Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Khalek, Waed Abdel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] INRA, UMR Dynam Musculaire & Metab 866, F-34060 Montpellier, France; [Tong, Qiang] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Tong, Qiang] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); INRAE; Universite de Montpellier; Baylor College of Medicine; Baylor College of Medicine	Tong, Q (corresponding author), Baylor Coll Med, Dept Pediat, USDA ARS Childrens Nutr Res Ctr, Houston, TX 77030 USA.	qtong@bcm.tmc.edu	Lin, Ligen/ABC-1078-2020; Chabi, Beatrice/AAI-6545-2020	Lin, Ligen/0000-0002-6799-5327; Chabi, Beatrice/0000-0002-5604-5668	American Heart Association [0665162Y]; U.S. Department of Agriculture [6250-51000-055]; Baylor Diabetes Endocrinology Research Center-Pilot & Feasibility Grant [P30 DK079638]; NIH [DK075978]; USDA ARS; PHS [DK 56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, P30DK056338, R01DK075978] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Baylor Diabetes Endocrinology Research Center-Pilot & Feasibility Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association (0665162Y), a U.S. Department of Agriculture (6250-51000-055), Baylor Diabetes Endocrinology Research Center-Pilot & Feasibility Grant (P30 DK079638), and NIH (DK075978) to Q. T. Measurements of energy balance and food intake were performed in the Mouse Metabolic Research Unit at the USDA/ARS Children's Nutrition Research Center, which is supported by funds from the USDA ARS (www.bcm.edu/cnrc/mmru). The services provided by the Molecular Morphology Core Laboratory was sponsored by PHS grant DK 56338. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen BL, 2010, ACTA PHARMACOL SIN, V31, P798, DOI 10.1038/aps.2010.73; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dixit M, 2008, CARDIOVASC RES, V77, P160, DOI 10.1093/cvr/cvm017; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340, DOI 10.1152/ajpendo.1997.272.3.E340; FERNANDES G, 1976, NATURE, V263, P504, DOI 10.1038/263504b0; Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Kregel, 2006, RESOURCE BOOK DESIGN; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; McKiernan SH, 2011, EXP GERONTOL, V46, P23, DOI 10.1016/j.exger.2010.09.011; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Yang YJ, 2011, GENE, V488, P46, DOI 10.1016/j.gene.2011.07.029; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	71	37	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85636	10.1371/journal.pone.0085636	http://dx.doi.org/10.1371/journal.pone.0085636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454908	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100111
J	Li, L; Wang, JY; Zhang, Z; Wang, YL; Liu, MX; Jiang, H; Chai, RY; Mao, XQ; Qiu, HP; Liu, FQ; Sun, GC				Li, Ling; Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Liu, Maoxin; Jiang, Hua; Chai, Rongyao; Mao, Xueqin; Qiu, Haiping; Liu, Fengquan; Sun, Guochang			MoPex19, which Is Essential for Maintenance of Peroxisomal Structure and Woronin Bodies, Is Required for Metabolism and Development in the Rice Blast Fungus	PLOS ONE			English	Article							MEDIATED PLANT INFECTION; MITOCHONDRIAL BETA-OXIDATION; INTEGRAL MEMBRANE-PROTEINS; MAGNAPORTHE-GRISEA; ASPERGILLUS-NIDULANS; PATHOGENIC FUNGUS; FATTY-ACIDS; COLLETOTRICHUM-LAGENARIUM; BIOGENESIS DISORDERS; NEUROSPORA-CRASSA	Peroxisomes are present ubiquitously and make important contributions to cellular metabolism in eukaryotes. They play crucial roles in pathogenicity of plant fungal pathogens. The peroxisomal matrix proteins and peroxisomal membrane proteins (PMPs) are synthesized in the cytosol and imported post-translationally. Although the peroxisomal import machineries are generally conserved, some species-specific features were found in different types of organisms. In phytopathogenic fungi, the pathways of the matrix proteins have been elucidated, while the import machinery of PMPs remains obscure. Here, we report that MoPEX19, an ortholog of ScPEX19, was required for PMPs import and peroxisomal maintenance, and played crucial roles in metabolism and pathogenicity of the rice blast fungus Magnaporthe oryzae. MoPEX19 was expressed in a low level and Mopex19p was distributed in the cytoplasm and newly formed peroxisomes. MoPEX19 deletion led to mislocalization of peroxisomal membrane proteins (PMPs), as well peroxisomal matrix proteins. Peroxisomal structures were totally absent in Delta mopex19 mutants and woronin bodies also vanished. Delta mopex19 exhibited metabolic deficiency typical in peroxisomal disorders and also abnormality in glyoxylate cycle which was undetected in the known mopex mutants. The Delta mopex19 mutants performed multiple disorders in fungal development and pathogenicity-related morphogenesis, and lost completely the pathogenicity on its hosts. These data demonstrate that MoPEX19 plays crucial roles in maintenance of peroxisomal and peroxisome-derived structures and makes more contributions to fungal development and pathogenicity than the known MoPEX genes in the rice blast fungus.	[Li, Ling; Liu, Maoxin; Liu, Fengquan] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Li, Ling; Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Liu, Maoxin; Jiang, Hua; Chai, Rongyao; Mao, Xueqin; Qiu, Haiping; Sun, Guochang] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect Microbiol, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences	Liu, FQ (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	fqliu@njau.edu.cn; sungc01@sina.com		Li, Ling/0000-0003-4921-0423	National Natural Science Foundation of China [30900933, 31170136, 30970082]; National Basic Research Program (973) from the Ministry of Science and Technology of China [2012CB722504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) from the Ministry of Science and Technology of China(National Basic Research Program of China)	This work was supported by the grants (No. 30900933 and 31170136 to J.-Y. Wang and 30970082 to G.-C. Sun) from National Natural Science Foundation of China and the National Basic Research Program (973) (No. 2012CB722504) from the Ministry of Science and Technology of China (http://www.nsfc.gov.cn/Portal0/default152.htm) (http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; BEEVERS H, 1982, ANN NY ACAD SCI, V386, P243, DOI 10.1111/j.1749-6632.1982.tb21420.x; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; CRAWFORD MS, 1986, GENETICS, V114, P1111; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dodt G, 1996, ANN NY ACAD SCI, V804, P516, DOI 10.1111/j.1749-6632.1996.tb18641.x; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Faust PL, 2005, J INHERIT METAB DIS, V28, P369, DOI 10.1007/s10545-005-7059-y; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujihara N, 2010, MOL PLANT MICROBE IN, V23, P436, DOI 10.1094/MPMI-23-4-0436; Girzalsky W, 2010, BIOCH BIOPHYSICA ACT, V1803; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Gotte K, 1998, MOL CELL BIOL, V18, P616; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jones AB, 2001, MED RES REV, V21, P540, DOI 10.1002/med.1025; Jungwirth H, 2008, FEBS LETT, V582, P2882, DOI 10.1016/j.febslet.2008.07.023; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kim KH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000653; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Lambkin GR, 2001, MOL BIOL CELL, V12, P3353, DOI 10.1091/mbc.12.11.3353; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Managadze D, 2007, TRAFFIC, V8, P687, DOI 10.1111/j.1600-0854.2007.00560.x; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Money NP, 1996, FUNGAL GENET BIOL, V20, P217, DOI 10.1006/fgbi.1996.0037; NOTTEGHEM JL, 1992, PHYTOPATHOLOGY, V82, P421, DOI 10.1094/Phyto-82-421; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Otzen M, 2004, J BIOL CHEM, V279, P19181, DOI 10.1074/jbc.M314275200; Patkar RN, 2012, MOL MICROBIOL, V86, P1345, DOI 10.1111/mmi.12060; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Rehling P, 1996, ANN NY ACAD SCI, V804, P34, DOI 10.1111/j.1749-6632.1996.tb18606.x; REISS J, 1971, PROTOPLASMA, V72, P43, DOI 10.1007/BF01281009; Rho HS, 2001, MOL CELLS, V12, P407; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Shibata N, 2004, MOL REPROD DEV, V67, P1, DOI 10.1002/mrd.20009; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Titorenko VI, 2004, J CELL BIOL, V164, P641, DOI 10.1083/jcb.200312081; Titorenko VI, 2001, TRENDS CELL BIOL, V11, P22, DOI 10.1016/S0962-8924(00)01865-1; Valenciano S, 1996, ARCH MICROBIOL, V166, P336, DOI 10.1007/s002030050392; VALENT B, 1990, PHYTOPATHOLOGY, V80, P33, DOI 10.1094/Phyto-80-33; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P802, DOI 10.1631/jzus.B0860001; Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055554; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x	71	31	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85252	10.1371/journal.pone.0085252	http://dx.doi.org/10.1371/journal.pone.0085252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454828	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800030
J	Phillips, CJ; Phillips, CD; Goecks, J; Lessa, EP; Sotero-Caio, CG; Tandler, B; Gannon, MR; Baker, RJ				Phillips, Carleton J.; Phillips, Caleb D.; Goecks, Jeremy; Lessa, Enrique P.; Sotero-Caio, Cibele G.; Tandler, Bernard; Gannon, Michael R.; Baker, Robert J.			Dietary and Flight Energetic Adaptations in a Salivary Gland Transcriptome of an Insectivorous Bat	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; DNA TRANSPOSON ACTIVITY; CARBOXYL ESTER LIPASE; MYOTIS-LUCIFUGUS; COMPLEMENT COMPONENT-3; INSULIN-RESISTANCE; FAT-ABSORPTION; BROWN BAT; EVOLUTION; MORPHOLOGY	We hypothesized that evolution of salivary gland secretory proteome has been important in adaptation to insectivory, the most common dietary strategy among Chiroptera. A submandibular salivary gland (SMG) transcriptome was sequenced for the little brown bat, Myotis lucifugus. The likely secretory proteome of 23 genes included seven (RETNLB, PSAP, CLU, APOE, LCN2, C3, CEL) related to M. lucifugus insectivorous diet and metabolism. Six of the secretory proteins probably are endocrine, whereas one (CEL) most likely is exocrine. The encoded proteins are associated with lipid hydrolysis, regulation of lipid metabolism, lipid transport, and insulin resistance. They are capable of processing exogenous lipids for flight metabolism while foraging. Salivary carboxyl ester lipase (CEL) is thought to hydrolyze insect lipophorins, which probably are absorbed across the gastric mucosa during feeding. The other six proteins are predicted either to maintain these lipids at high blood concentrations or to facilitate transport and uptake by flight muscles. Expression of these seven genes and coordinated secretion from a single organ is novel to this insectivorous bat, and apparently has evolved through instances of gene duplication, gene recruitment, and nucleotide selection. Four of the recruited genes are single-copy in the Myotis genome, whereas three have undergone duplication(s) with two of these genes exhibiting evolutionary 'bursts' of duplication resulting in multiple paralogs. Evidence for episodic directional selection was found for six of seven genes, reinforcing the conclusion that the recruited genes have important roles in adaptation to insectivory and the metabolic demands of flight. Intragenic frequencies of mobile-element-like sequences differed from frequencies in the whole M. lucifugus genome. Differences among recruited genes imply separate evolutionary trajectories and that adaptation was not a single, coordinated event.	[Phillips, Carleton J.; Phillips, Caleb D.; Sotero-Caio, Cibele G.; Baker, Robert J.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Goecks, Jeremy] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Goecks, Jeremy] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Lessa, Enrique P.] Univ Republica, Dept Ecol & Evoluc, Fac Ciencias, Montevideo, Uruguay; [Tandler, Bernard] Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH 44106 USA; [Gannon, Michael R.] Penn State Univ, Dept Biol, Altoona Coll, Altoona, PA USA	Texas Tech University System; Texas Tech University; Emory University; Emory University; Universidad de la Republica, Uruguay; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Phillips, CJ (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	carl.phillips@ttu.edu	Lessa, Enrique/D-8894-2011	Lessa, Enrique/0000-0001-9750-4093; Sotero-Caio, Cibele/0000-0002-3112-0000	Texas Biological Database Program; Natural Science Research Laboratory and Genetic Resources Center at The Museum of Texas Tech University	Texas Biological Database Program; Natural Science Research Laboratory and Genetic Resources Center at The Museum of Texas Tech University	Financial and curatorial support was provided by the Texas Biological Database Program and the Natural Science Research Laboratory and Genetic Resources Center at The Museum of Texas Tech University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL KJ, 1992, MAMM GENOME, V2, P32, DOI 10.1007/BF00570438; ALOE L, 1986, P NATL ACAD SCI USA, V83, P6184, DOI 10.1073/pnas.83.16.6184; Altenberg J.S., 1987, P100; Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; AW TY, 1980, J NUTR, V110, P2133, DOI 10.1093/jn/110.11.2133; Bailey R, 1999, MOL CELL ENDOCRINOL, V151, P17, DOI 10.1016/S0303-7207(99)00016-7; BAKER RJ, 1986, P NATL ACAD SCI USA, V83, P8245, DOI 10.1073/pnas.83.21.8245; BAKER RJ, 2006, ATLAS MAMMALIAN CHRO, P378; Baker Robert J., 2003, Occasional Papers Museum of Texas Tech University, V229, P1; Baker RJ, 2012, CAM STUD MORPHOL MOL, P385; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Cabej NR, 2010, DEVEL DYNAMICS, V240, P1; Calero M, 1999, BIOCHEM J, V344, P375, DOI 10.1042/0264-6021:3440375; CAPORALE LH, 1980, J BIOL CHEM, V255, P758; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Chapman M John, 2007, Diab Vasc Dis Res, V4 Suppl 3, pS5; CHAPPELL MA, 1990, RESP PHYSIOL, V81, P401, DOI 10.1016/0034-5687(90)90120-N; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Cianflone K, 2004, J LIPID RES, V45, P124, DOI 10.1194/jlr.M300214-JLR200; Cianflone K, 1997, J ENDOCRINOL, V155, P203, DOI 10.1677/joe.0.1550203; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; DOWNER RGH, 1976, AM ZOOL, V16, P733; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; FOEHRING RC, 1984, J MAMMAL, V65, P388, DOI 10.2307/1381084; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; FREEMAN PW, 1981, J MAMMAL, V62, P166, DOI 10.2307/1380489; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; HAMOSH M, 1989, PEDIATRICS, V83, P86; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Isenman L, 1999, AM J PHYSIOL-ENDOC M, V276, pE223, DOI 10.1152/ajpendo.1999.276.2.E223; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; KARMEN A, 1963, J LIPID RES, V4, P312; LIN HH, 1991, GENOMICS, V10, P102, DOI 10.1016/0888-7543(91)90490-6; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MEISLER MH, 1993, CRIT REV ORAL BIOL M, V4, P503, DOI 10.1177/10454411930040033501; Mitra R, 2013, P NATL ACAD SCI USA, V110, P234, DOI 10.1073/pnas.1217548110; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Ozyildirim AM, 2005, INVEST OPHTH VIS SCI, V46, P1572, DOI 10.1167/iovs.04-1380; Pagan HJT, 2012, GENOME BIOL EVOL, V4, P575, DOI 10.1093/gbe/evs038; Phillips CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057649; Phillips Carleton J., 2000, P247, DOI 10.1017/CBO9780511541872.008; Phillips CJ, 1998, EUR J MORPHOL, V36, P19; Phillips CJ, 1996, CONTRIBUTIONS MAMMAL, P1; Phillips CJ, 1993, BIOL SALIVARY GLANDS, P39; PINKSTAFF CA, 1982, J MORPHOL, V172, P271, DOI 10.1002/jmor.1051720303; Poorkhalkali N, 1998, HISTOCHEM CELL BIOL, V110, P367, DOI 10.1007/s004180050297; POWERS LV, 1991, J COMP PHYSIOL A, V168, P675; Proctor GB, 1998, FRONT ORAL BIOL, V10, P73; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Ratcliffe JM, 2003, ANIM BEHAV, V66, P847, DOI 10.1006/anbe.2003.2297; Ray DA, 2008, GENOME RES, V18, P717, DOI 10.1101/gr.071886.107; Ray DA, 2007, MOL BIOL EVOL, V24, P632, DOI 10.1093/molbev/msl192; Raybould HE, 1998, AM J PHYSIOL-REG I, V274, pR1834, DOI 10.1152/ajpregu.1998.274.6.R1834; Roberts A, 2011, BIOINFORMATICS, V9, DOI 10.1093; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SAMUELSON LC, 1990, MOL CELL BIOL, V10, P2513, DOI 10.1128/MCB.10.6.2513; SAMUELSON LC, 1988, NUCLEIC ACIDS RES, V16, P8261, DOI 10.1093/nar/16.17.8261; Santana SE, 2011, FUNCTIONAL ECOL, DOI 10.1111; Shamir R, 1996, J CLIN INVEST, V97, P1696, DOI 10.1172/JCI118596; Shen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033197; Soulages JL, 1996, BIOCHEMISTRY-US, V35, P5191, DOI 10.1021/bi952794d; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tandler B, 2006, ANAT REC PART A, V288A, P498, DOI 10.1002/ar.a.20319; Tandler B, 2001, ANAT RECORD, V264, P121, DOI 10.1002/ar.1108; TANDLER B, 1993, MICROSC RES TECHNIQ, V26, P32, DOI 10.1002/jemt.1070260105; Thai CT, 2003, J IMMUNOL, V171, P6565, DOI 10.4049/jimmunol.171.12.6565; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Verseyden C, 2003, J LIPID RES, V44, P2100, DOI 10.1194/jlr.M300201-JLR200; Voigt CC, 2010, ECOLOGY, V91, P2908, DOI 10.1890/09-2232.1; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wilson MR, 2000, CLUSTERIN IS SECRETE; Winter Y, 1998, J COMP PHYSIOL B, V168, P105, DOI 10.1007/s003600050126; YACOE ME, 1982, AM J PHYSIOL, V242, pR189, DOI 10.1152/ajpregu.1982.242.3.R189; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zwiner J, 1998, EUR J IMMUNOL, V28, P1570	99	10	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83512	10.1371/journal.pone.0083512	http://dx.doi.org/10.1371/journal.pone.0083512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454705	gold, Green Published, Green Submitted			2022-12-27	WOS:000329925800009
J	Zhang, C; Kho, YS; Wang, Z; Chiang, YT; Ng, GKH; Shaw, PC; Wang, YZ; Qi, RZ				Zhang, Chao; Kho, Yik-Shing; Wang, Zhe; Chiang, Yan Ting; Ng, Gary K. H.; Shaw, Pang-Chui; Wang, Yuzhuo; Qi, Robert Z.			Transmembrane and Coiled-Coil Domain Family 1 Is a Novel Protein of the Endoplasmic Reticulum	PLOS ONE			English	Article							MEMBRANE-PROTEINS; CANDIDATE GENES; ER; KINECTIN; CELLS; TRANSLOCATION; DYNAMICS; TUBULES; PHOSPHORYLATION; IDENTIFICATION	The endoplasmic reticulum (ER) is a continuous membrane network in eukaryotic cells comprising the nuclear envelope, the rough ER, and the smooth ER. The ER has multiple critical functions and a characteristic structure. In this study, we identified a new protein of the ER, TMCC1 (transmembrane and coiled-coil domain family 1). The TMCC family consists of at least 3 putative proteins (TMCC1-3) that are conserved from nematode to human. We show that TMCC1 is an ER protein that is expressed in diverse human cell lines. TMCC1 contains 2 adjacent transmembrane domains near the C-terminus, in addition to coiled-coil domains. TMCC1 was targeted to the rough ER through the transmembrane domains, whereas the N-terminal region and C-terminal tail of TMCC1 were found to reside in the cytoplasm. Moreover, the cytosolic region of TMCC1 formed homo-or hetero-dimers or oligomers with other TMCC proteins and interacted with ribosomal proteins. Notably, overexpression of TMCC1 or its transmembrane domains caused defects in ER morphology. Our results suggest roles of TMCC1 in ER organization.	[Zhang, Chao; Kho, Yik-Shing; Wang, Zhe; Chiang, Yan Ting; Ng, Gary K. H.; Qi, Robert Z.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Chao; Kho, Yik-Shing; Wang, Zhe; Chiang, Yan Ting; Ng, Gary K. H.; Qi, Robert Z.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Chiang, Yan Ting; Wang, Yuzhuo] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Shaw, Pang-Chui] Chinese Univ Hong Kong, Biochem Programme, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Shaw, Pang-Chui] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; British Columbia Cancer Agency; Chinese University of Hong Kong; Chinese University of Hong Kong	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		Zhang, Chao/0000-0002-7174-044X; Wang, Yuzhuo/0000-0002-9749-8591; Qi, Robert Zhong/0000-0001-5596-8172	Research Grants Council of Hong Kong; National Key Basic Research Program of China [2013CB530900]; University Grants Committee of Hong Kong [SEG_HKUST05]; TUYF Charitable Trust; Hong Kong University of Science and Technology	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Key Basic Research Program of China(National Basic Research Program of China); University Grants Committee of Hong Kong; TUYF Charitable Trust; Hong Kong University of Science and Technology	This work was supported by grants from the Research Grants Council (General Research Fund and Theme-based Research Scheme) of Hong Kong, the National Key Basic Research Program (2013CB530900) of China, the University Grants Committee (Area of Excellence Scheme and Special Equipment Grant SEG_HKUST05) of Hong Kong, the TUYF Charitable Trust, and by funds from the Hong Kong University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2007, NEUROSCI LETT, V413, P238, DOI 10.1016/j.neulet.2006.11.064; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Dudek J, 2013, METHODS MOL BIOL, V1033, P285, DOI 10.1007/978-1-62703-487-6_18; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hong WJ, 1998, J CELL SCI, V111, P2831; Hopkins PCR, 2011, J ALZHEIMERS DIS, V26, P239, DOI 10.3233/JAD-2011-102115; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Ivanova AV, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-91; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; McMaster CR, 2001, BIOCHEM CELL BIOL, V79, P681, DOI 10.1139/bcb-79-6-681; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MICHALIK J, 1981, LIFE SCI, V28, P1371, DOI 10.1016/0024-3205(81)90411-2; Michielse CB, 2006, EUR J HUM GENET, V14, P1306, DOI 10.1038/sj.ejhg.5201706; Murtazina DA, 2011, BIOL REPROD, V85, P315, DOI 10.1095/biolreprod.111.091082; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong LL, 2006, J BIOL CHEM, V281, P33621, DOI 10.1074/jbc.M607555200; Ong LL, 2003, J BIOL CHEM, V278, P32115, DOI 10.1074/jbc.M210917200; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schwernmers S, 2007, EXP HEMATOL, V35, P1695, DOI 10.1016/j.exphem.2007.07.004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, EXP CELL RES, V316, P329, DOI 10.1016/j.yexcr.2009.11.009; van der Zwaag B, 2005, GENOMICS, V86, P55, DOI 10.1016/j.ygeno.2005.03.007; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Volkova EG, 2012, BIOL OPEN, V1, P802, DOI 10.1242/bio.20121537; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; ZENGEL JM, 1990, P NATL ACAD SCI USA, V87, P2675, DOI 10.1073/pnas.87.7.2675; Zhang X, 2010, J CELL SCI, V123, P3901, DOI 10.1242/jcs.069153	52	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85206	10.1371/journal.pone.0085206	http://dx.doi.org/10.1371/journal.pone.0085206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454821	Green Published, gold			2022-12-27	WOS:000329925800026
J	Howe, PDL; Webb, ME				Howe, Piers D. L.; Webb, Margaret E.			Detecting Unidentified Changes	PLOS ONE			English	Article							COMPARATIVE VISUAL-SEARCH; FUSIFORM FACE AREA; CHANGE-BLINDNESS; WORKING-MEMORY; AWARENESS; REPRESENTATION; PERCEPTION; ATTENTION; DISCRIMINATION; BLINDSIGHT	Does becoming aware of a change to a purely visual stimulus necessarily cause the observer to be able to identify or localise the change or can change detection occur in the absence of identification or localisation? Several theories of visual awareness stress that we are aware of more than just the few objects to which we attend. In particular, it is clear that to some extent we are also aware of the global properties of the scene, such as the mean luminance or the distribution of spatial frequencies. It follows that we may be able to detect a change to a visual scene by detecting a change to one or more of these global properties. However, detecting a change to global property may not supply us with enough information to accurately identify or localise which object in the scene has been changed. Thus, it may be possible to reliably detect the occurrence of changes without being able to identify or localise what has changed. Previous attempts to show that this can occur with natural images have produced mixed results. Here we use a novel analysis technique to provide additional evidence that changes can be detected in natural images without also being identified or localised. It is likely that this occurs by the observers monitoring the global properties of the scene.	[Howe, Piers D. L.; Webb, Margaret E.] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia	University of Melbourne	Howe, PDL (corresponding author), Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia.	pdhowe@unimelb.edu.au		Howe, Piers/0000-0001-6171-1381	University of Melbourne	University of Melbourne(University of Melbourne)	The work has been funded by internal grants from the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi P, 1998, CONSCIOUS COGN, V7, P292, DOI 10.1006/ccog.1998.0358; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bridgeman B, 1975, VISION RES, V15, P183; Burmester A, 2012, PERCEPTION, V41, P505, DOI 10.1068/p7176; Busch NA, 2010, J COGNITIVE NEUROSCI, V22, P1852, DOI 10.1162/jocn.2009.21294; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; Fernandez-Duque D, 2000, VIS COGN, V7, P323, DOI 10.1080/135062800394838; Fernandez-Duque D, 2003, J EXP PSYCHOL HUMAN, V29, P846, DOI 10.1037/0096-1523.29.5.846; Fernandez-Duque D, 2003, J COGNITIVE NEUROSCI, V15, P491, DOI 10.1162/089892903321662895; Galpin A, 2008, CONSCIOUS COGN, V17, P672, DOI 10.1016/j.concog.2007.10.004; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; KOLB FC, 1995, NATURE, V377, P336, DOI 10.1038/377336a0; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mack A., 1998, INATTENTIONAL BLINDN; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Mitroff SR, 2004, PERCEPT PSYCHOPHYS, V66, P1268, DOI 10.3758/BF03194997; Mitroff SR, 2002, J EXP PSYCHOL HUMAN, V28, P798, DOI 10.1037//0096-1523.28.4.798; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; NAKAYAMA K, 1985, J OPT SOC AM A, V2, P267, DOI 10.1364/JOSAA.2.000267; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; O'Regan JK, 1992, CAN J PSYCHOL, V46; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Pomplun M, 2001, COGNITIVE SCI, V25, P3, DOI 10.1016/S0364-0213(00)00037-9; Rensink RA, 2004, PSYCHOL SCI, V15, P27, DOI 10.1111/j.0963-7214.2004.01501005.x; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Rensink RA, 2000, VIS COGN, V7, P345, DOI 10.1080/135062800394847; Rensink RA, 1997, PSYCHOL SCI, V8; Simons DJ, 2005, PSYCHOL SCI, V16, P520, DOI 10.1111/j.0956-7976.2005.01568.x; Simons DJ, 2000, VIS COGN, V7, P1, DOI 10.1080/135062800394658; Sokal R. R., 1981, BIOMETRY, P859; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Thornton IM, 2002, PROG BRAIN RES, V140, P99; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; WEISKRANTZ L, 1995, P NATL ACAD SCI USA, V92, P6122, DOI 10.1073/pnas.92.13.6122; Weiskrantz L., 1999, CONSCIOUSNESS LOST F; WEISKRANTZ L, 1986, CASE STUDY IMPLICATI; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001	44	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84490	10.1371/journal.pone.0084490	http://dx.doi.org/10.1371/journal.pone.0084490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292SL	24454727	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500011
J	Yin, AA; Zhang, LH; Cheng, JX; Dong, Y; Liu, BL; Han, N; Zhang, X				Yin, An-an; Zhang, Lu-hua; Cheng, Jin-xiang; Dong, Yu; Liu, Bo-lin; Han, Ning; Zhang, Xiang			The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis	PLOS ONE			English	Article							RADIOTHERAPY PLUS CONCOMITANT; PHASE-II; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMAS; PATIENTS OLDER; TIME	Background: The clinical implication of O6-methylguanine-DNA methyltransferase (MGMT) promoter status is ill-defined in elderly glioblastoma patients. Here we report a meta-analysis to seek valid evidence for its clinical relevance in this subpopulation. Methods: Literature were searched and reviewed in a systematic manner using the PubMed, EMBASE and Cochrane databases. Studies investigating the association between MGMT promoter status and survival data of elderly patients (>= 65 years) were eligible for inclusion. Results: Totally 16 studies were identified, with 13 studies included in the final analyses. The aggregate proportion of MGMT promoter methylation in elderly patients was 47% (95% confidence interval [CI]: 42-52%), which was similar to the value for younger patients. The analyses showed differential effects of MGMT status on overall survival (OS) of elderly patients according to assigned treatments: methylated vs. unmethylated: (1) temozolomide (TMZ)-containing therapies: hazard ratio [HR] 0.49, 95% CI 0.41-0.58; (2) TMZ-free therapies: HR 0.97, 95% CI 0.77-1.21. More importantly, a useful predictive value was observed by an interaction analysis: TMZ-containing therapies vs. RT alone: (1) methylated tumors: HR 0.48, 95% CI 0.36-0.65; (2) unmethylated tumors: HR 1.14; 95% CI 0.90-1.44. Conclusion: The meta-analysis reports an age-independent presence of MGMT promoter methylation. More importantly, the study encouraged routine testing of MGMT promoter status especially in elderly glioblastoma patients by indicating a direct linkage between biomarker test and individual treatment decision. Future studies are needed to justify the mandatory testing in younger patients.	[Yin, An-an; Zhang, Lu-hua; Cheng, Jin-xiang; Liu, Bo-lin; Han, Ning; Zhang, Xiang] Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China; [Dong, Yu] Fourth Mil Med Univ, Dept Prosthodont, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhang, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China.	xzhang@fmmu.edu.cn	Cheng, Jin-xiang/GRX-3942-2022; Han, Ning/K-3220-2017	Han, Ning/0000-0001-9177-6792; Yin, An-An/0000-0002-1888-5551	National Natural Science Foundation of China [81171087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (No: 81171087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinav K, 2013, CLIN NEUROL NEUROSUR, V115, P1375, DOI 10.1016/j.clineuro.2012.12.023; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Berghoff AS, 2012, CLIN NEUROPATHOL, V31, P405, DOI 10.5414/NP300576; Brandes AA, 2006, BRIT J CANCER, V95, P1155, DOI 10.1038/sj.bjc.6603376; Brandes AA, 2009, CANCER-AM CANCER SOC, V115, P3512, DOI 10.1002/cncr.24406; Christians A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033449; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fiorentino A, 2013, AM J CLIN ONCOL; Franceschi E, 2013, J CLIN ONCOL, V15, P1; Gerstner ER, 2009, NEUROLOGY, V73, P1509, DOI 10.1212/WNL.0b013e3181bf9907; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Italiano A, 2011, J CLIN ONCOL, V29, P4718, DOI 10.1200/JCO.2011.38.3729; Iwamoto FM, 2008, ANN NEUROL, V64, P628, DOI 10.1002/ana.21521; Kagan Jacob, 2007, Cancer Res, V67, P4545, DOI 10.1158/0008-5472.CAN-06-2888; Kita D, 2009, NEUROEPIDEMIOLOGY, V33, P17, DOI 10.1159/000210017; Laperriere N, 2013, CANCER TREAT REV, V39, P350, DOI 10.1016/j.ctrv.2012.05.008; Lombardi G, 2013, J CLIN ONCOL, V15, P1; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Minniti G, 2012, INT J RADIAT ONCOL, V83, P93, DOI 10.1016/j.ijrobp.2011.06.1992; Minniti G, 2011, J NEURO-ONCOL, V102, P311, DOI 10.1007/s11060-010-0324-4; Mishima K, 2010, NEURO-ONCOLOGY, V12, P46; Perez-Larraya JG, 2011, J CLIN ONCOL, V29, P3050, DOI 10.1200/JCO.2011.34.8086; Petretta M, 2011, AM J CARDIOL, V108, P1171, DOI 10.1016/j.amjcard.2011.06.022; Philippe M, 2011, NEURO-ONCOLOGY, V13, P56; Piccirilli M, 2006, TUMORI J, V92, P98, DOI 10.1177/030089160609200203; Reifenberger G, 2012, INT J CANCER, V131, P1342, DOI 10.1002/ijc.27385; Sijben AE, 2008, J NEURO-ONCOL, V89, P97, DOI 10.1007/s11060-008-9593-6; Siu LL, 2007, NEW ENGL J MED, V356, P1575, DOI 10.1056/NEJMe078023; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Weiler M, 2010, INT J RADIAT ONCOL, V77, P670, DOI 10.1016/j.ijrobp.2009.05.031; Weller M, 2012, NEURO-ONCOLOGY, V14, P100, DOI 10.1093/neuonc/nos206; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wells G.A., NEWCASTLE OTTAWA SCA; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Yin AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074242; Yin AA, 2013, CRIT REV ONCOL HEMAT, V87, P265, DOI 10.1016/j.critrevonc.2013.01.007	43	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85102	10.1371/journal.pone.0085102	http://dx.doi.org/10.1371/journal.pone.0085102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454798	Green Published, gold			2022-12-27	WOS:000329922500042
J	Ascioglu, S; Chan, KA				Ascioglu, Sibel; Chan, K. Arnold			Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the US	PLOS ONE			English	Article							EMPIRICAL ANTIFUNGAL THERAPY; LIPOSOMAL AMPHOTERICIN-B; OFF-LABEL; FUNGAL-INFECTIONS; PROPENSITY SCORE; ASPERGILLOSIS	Objectives: Both caspofungin and voriconazole were initially approved by the FDA with very narrow indications. Our aim was to evaluate the utilization patterns and comparative effectiveness of these agents early after marketing before any labeling change occurred. Methods: This was a retrospective cohort study utilizing a large healthcare database in the United States. Patients who received at least one dose of systemic antifungal agent between the years 2001 and 2003 were included. Information was available for each hospital-day including underlying conditions, medications, procedures and disease severity scores. Tests for proportions, trend tests and logistic regression were used for evaluation of utilization. Propensity score analysis was used in comparison of mortality. Results: The study cohort included 381,245 patients with serious underlying conditions. In just two years after marketing, caspofungin and voriconazole use increased to 40% of the total systemic antifungal consumption. However, only 3.4% of caspofungin and 12.5% of voriconazole were used as indicated in labeling. In the propensity score analyses, caspofungin was associated with 7% decrease in mortality (OR: 0.93 95% CI: 0.85-0.98). Voriconazole use was not found to be associated with mortality (OR: 1.95% CI: 0.89-1.12) Conclusions: Caspofungin and voriconazole were mostly used of unapproved indications immediately after their marketing. Although unapproved drug use might be due to a crucial need by clinicians, this may create problems in further antifungal drug development. Our results suggest a survival benefit with caspofungin; however, similar comparative effectiveness studies must be repeated using more recent data.	[Ascioglu, Sibel; Chan, K. Arnold] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Ascioglu, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	ascioglu@hacettepe.edu.tr		Chan, Kinwei/0000-0001-8161-1986	Pharmacoepidemiology Program at Harvard School of Public Health; Pfizer; Novartis; Aventis; Weyth	Pharmacoepidemiology Program at Harvard School of Public Health; Pfizer(Pfizer); Novartis(Novartis); Aventis(Sanofi-Aventis); Weyth	The study was supported by the Pharmacoepidemiology Program at Harvard School of Public Health, which received unrestricted donations from the following pharmaceutical companies for education and training purpose (Pfizer, Novartis, Aventis and Weyth). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averill R, 2003, WHAT ARE APR DRGS IN; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; BINDSCHADLER DD, 1969, J INFECT DIS, V120, P427, DOI 10.1093/infdis/120.4.427; Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; Dasbach EJ, 2000, CLIN INFECT DIS, V31, P1524, DOI 10.1086/317487; de With Katja, 2005, BMC Clin Pharmacol, V5, P1; Fanaroff AA, 2006, PEDIATRICS, V117, P214, DOI 10.1542/peds.2005-2183; GRASELA TH, 1994, ANN PHARMACOTHER, V28, P252, DOI 10.1177/106002809402800219; Gutierrez F, 1996, J ANTIMICROB CHEMOTH, V37, P175, DOI 10.1093/jac/37.1.175; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Largent EA, 2009, ARCH INTERN MED, V169, P1745, DOI 10.1001/archinternmed.2009.314; Lortholary O, 2004, J ANTIMICROB CHEMOTH, V54, P456, DOI 10.1093/jac/dkh348; Maertens J, 2006, INT J ANTIMICROB AG, V27, P457, DOI 10.1016/j.ijantimicag.2006.03.019; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Prasad PA, 2008, PEDIATR INFECT DIS J, V27, P1083, DOI 10.1097/INF.0b013e31817eeee5; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rex JH, 2001, CLIN INFECT DIS, V33, P95, DOI 10.1086/320876; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; Sobel JD, 2007, NEW ENGL J MED, V356, P2525, DOI 10.1056/NEJMe078078; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Walsh TJ, 2002, NEW ENGL J MED, V346, P1499; Walsh TJ, 2004, NEW ENGL J MED, V351, P1391, DOI 10.1056/NEJMoa040446; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Westreich D, 2010, PHARMACOEPIDEM DR S; Wynn BO, 2007, RAND HLTH WORKING PA	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83658	10.1371/journal.pone.0083658	http://dx.doi.org/10.1371/journal.pone.0083658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427277	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200017
J	Minami, A; Otsubo, T; Ieno, D; Ikeda, K; Kanazawa, H; Shimizu, K; Ohata, K; Yokochi, T; Horii, Y; Fukumoto, H; Taguchi, R; Takahashi, T; Oku, N; Suzuki, T				Minami, Akira; Otsubo, Tadamune; Ieno, Daisuke; Ikeda, Kiyoshi; Kanazawa, Hiroaki; Shimizu, Kosuke; Ohata, Ko; Yokochi, Tsunehiro; Horii, Yuuki; Fukumoto, Hokuto; Taguchi, Risa; Takahashi, Tadanobu; Oku, Naoto; Suzuki, Takashi			Visualization of Sialidase Activity in Mammalian Tissues and Cancer Detection with a Novel Fluorescent Sialidase Substrate	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; PLASMA-MEMBRANE; LYSOSOMAL SIALIDASE; COLON-CANCER; EXPRESSION; CELLS; BRAIN; ACID; NEU3; 2-ARYLBENZOTHIAZOLES	Sialidase removes sialic acid from sialoglycoconjugates and plays crucial roles in many physiological and pathological processes. Various human cancers express an abnormally high level of the plasma membrane-associated sialidase isoform. Visualization of sialidase activity in living mammalian tissues would be useful not only for understanding sialidase functions but also for cancer diagnosis. However, since enzyme activity of mammalian sialidase is remarkably weak compared with that of bacterial and viral sialidases, it has been difficult to detect sialidase activity in mammalian tissues. We synthesized a novel benzothiazolylphenol-based sialic acid derivative (BTP-Neu5Ac) as a fluorescent sialidase substrate. BTP-Neu5Ac can visualize sialidase activities sensitively and selectively in acute rat brain slices. Cancer cells implanted orthotopically in mouse colons and human colon cancers (stages T3-T4) were also clearly detected with BTP-Neu5Ac. The results suggest that BTP-Neu5Ac is useful for histochemical imaging of sialidase activities.	[Minami, Akira; Ieno, Daisuke; Horii, Yuuki; Fukumoto, Hokuto; Taguchi, Risa; Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Hiroshima, Japan; [Kanazawa, Hiroaki] Univ Shizuoka, Sch Nursing, Dept Funct Anat, Shizuoka 4228526, Japan; [Shimizu, Kosuke; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan; [Ohata, Ko] Shizuoka Prefectural Gen Hosp, Dept Gastroenterol Surg, Shizuoka, Japan; [Yokochi, Tsunehiro] Shizuoka Prefectural Gen Hosp, Dept Med Technol, Shizuoka, Japan	University of Shizuoka; University of Shizuoka; University of Shizuoka; Shizuoka General Hospital; Shizuoka General Hospital	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp		Otsubo, Tadamune/0000-0003-1949-9780; Shimizu, Kosuke/0000-0003-3789-2447	KAKENHI [24790080]; Sasakawa Scientific Research Grant from the Japan Science Society; Naito Foundation; Grants-in-Aid for Scientific Research [23590549, 24790080] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sasakawa Scientific Research Grant from the Japan Science Society; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientists (B) (KAKENHI; no. 24790080), The Sasakawa Scientific Research Grant from the Japan Science Society and The Naito Foundation Subsidy for Promotion of Specific Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY K, 1984, J CHEM SOC PERK T 2, P2111, DOI 10.1039/p29840002111; Azarifar D, 2009, PHOSPHORUS SULFUR, V184, P2097, DOI 10.1080/10426500802423933; Deligeorgiev TG, 2010, PHOSPHORUS SULFUR, V185, P2292, DOI 10.1080/10426501003598648; Du ZY, 2010, BBA-MOL CELL BIOL L, V1801, P526, DOI 10.1016/j.bbalip.2010.01.002; Friedland S, 2005, GASTROINTEST ENDOSC, V61, P395, DOI 10.1016/S0016-5107(04)02775-0; Fujii I, 1993, Bioorg Med Chem, V1, P147, DOI 10.1016/S0968-0896(00)82112-4; Ha KT, 2004, MOL CELLS, V17, P267; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kiernan JA, 2007, BIOTECH HISTOCHEM, V82, P73, DOI 10.1080/10520290701375278; Koda T, 2009, BIOCHEM BIOPH RES CO, V387, P729, DOI 10.1016/j.bbrc.2009.07.100; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Marmillot P, 1999, ALCOHOL CLIN EXP RES, V23, P376, DOI 10.1097/00000374-199902000-00027; Minami A, 2012, TRENDS GLYCOSCI GLYC, V24, P112, DOI 10.4052/tigg.24.112; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; MIYAGI T, 1984, EUR J BIOCHEM, V141, P75, DOI 10.1111/j.1432-1033.1984.tb08159.x; Miyagi T, 2012, ADV EXP MED BIOL, V749, P257, DOI 10.1007/978-1-4614-3381-1_17; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Oku N, 2011, INT J PHARMACEUT, V403, P170, DOI 10.1016/j.ijpharm.2010.10.001; Otsubo T, 2013, BIOORG MED CHEM LETT, V23, P2245, DOI 10.1016/j.bmcl.2013.01.043; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Saito M, 2002, HISTOCHEM CELL BIOL, V117, P453, DOI 10.1007/s00418-002-0399-x; SAITO M, 1993, J NEUROSCI RES, V36, P127, DOI 10.1002/jnr.490360203; Santra M, 2011, ORG LETT, V13, P3422, DOI 10.1021/ol2011693; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Sun W, 2012, TETRAHEDRON LETT, V53, P2332, DOI 10.1016/j.tetlet.2012.02.098; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Takahashi T, 2004, CANCER SCI, V95, P514, DOI 10.1111/j.1349-7006.2004.tb03242.x; Urano Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002823; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854	31	42	42	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e81941	10.1371/journal.pone.0081941	http://dx.doi.org/10.1371/journal.pone.0081941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427265	Green Submitted, Green Published, gold			2022-12-27	WOS:000329868200005
J	Molnar, PK; Lewis, MA; Derocher, AE				Molnar, Peter K.; Lewis, Mark A.; Derocher, Andrew E.			Estimating Allee Dynamics before They Can Be Observed: Polar Bears as a Case Study	PLOS ONE			English	Article							URSUS-MARITIMUS; POPULATION-DYNAMICS; EXTINCTION RISK; MATING SYSTEM; BODY-SIZE; VIABILITY; ECOLOGY; CONSEQUENCES; CONSERVATION; ERADICATION	Allee effects are an important component in the population dynamics of numerous species. Accounting for these Allee effects in population viability analyses generally requires estimates of low-density population growth rates, but such data are unavailable for most species and particularly difficult to obtain for large mammals. Here, we present a mechanistic modeling framework that allows estimating the expected low-density growth rates under a mate-finding Allee effect before the Allee effect occurs or can be observed. The approach relies on representing the mechanisms causing the Allee effect in a process-based model, which can be parameterized and validated from data on the mechanisms rather than data on population growth. We illustrate the approach using polar bears (Ursus maritimus), and estimate their expected low-density growth by linking a mating dynamics model to a matrix projection model. The Allee threshold, defined as the population density below which growth becomes negative, is shown to depend on age-structure, sex ratio, and the life history parameters determining reproduction and survival. The Allee threshold is thus both density-and frequency-dependent. Sensitivity analyses of the Allee threshold show that different combinations of the parameters determining reproduction and survival can lead to differing Allee thresholds, even if these differing combinations imply the same stable-stage population growth rate. The approach further shows how mate-limitation can induce long transient dynamics, even in populations that eventually grow to carrying capacity. Applying the models to the overharvested low-density polar bear population of Viscount Melville Sound, Canada, shows that a mate-finding Allee effect is a plausible mechanism for slow recovery of this population. Our approach is generalizable to any mating system and life cycle, and could aid proactive management and conservation strategies, for example, by providing a priori estimates of minimum conservation targets for rare species or minimum eradication targets for pests and invasive species.	[Molnar, Peter K.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Lewis, Mark A.] Univ Alberta, Dept Math & Stat Sci, Ctr Math Biol, Edmonton, AB, Canada; [Lewis, Mark A.; Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Princeton University; University of Alberta; University of Alberta	Molnar, PK (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pmolnar@princeton.edu	Lewis, Mark/A-2659-2014; Lewis, Mark A/C-5015-2008; Derocher, Andrew/J-4469-2012	Lewis, Mark A/0000-0002-7155-7426; Derocher, Andrew/0000-0002-1104-7774	Aquarium du Quebec; ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Canadian Circumpolar Institute's Boreal Alberta Research; Environment Canada; Hauser Bears; Natural Sciences and Engineering Research Council of Canada; Scientific Training Program of Aboriginal Affairs and Northern Development Canada; Polar Continental Shelf Project; Polar Bears International; Quark Expeditions; World Wildlife Fund (Canada International); NSERC; Killam Foundation	Aquarium du Quebec; ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Canadian Circumpolar Institute's Boreal Alberta Research; Environment Canada(CGIAR); Hauser Bears; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Scientific Training Program of Aboriginal Affairs and Northern Development Canada; Polar Continental Shelf Project(Natural Resources Canada); Polar Bears International; Quark Expeditions; World Wildlife Fund (Canada International); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Foundation	The authors gratefully acknowledge the financial and logistic support from the Aquarium du Quebec, ArcticNet, Canadian Association of Zoos and Aquariums, Canadian Wildlife Federation, Canadian Circumpolar Institute's Boreal Alberta Research, Environment Canada, Hauser Bears, Natural Sciences and Engineering Research Council of Canada, Northern Scientific Training Program of Aboriginal Affairs and Northern Development Canada, Polar Continental Shelf Project, Polar Bears International, Quark Expeditions, and World Wildlife Fund (Canada & International). MAL gratefully acknowledges a Canada Research Chair, NSERC Discovery and Accelerator Grants, and a Research Fellowship from the Killam Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P23; Allee W.C, 1931, ANIMAL AGGREGATION S; Angulo E, 2007, CONSERV BIOL, V21, P1082, DOI 10.1111/j.1523-1739.2007.00721.x; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Bethke R, 1996, ECOL APPL, V6, P311, DOI 10.2307/2269574; Blackwood JC, 2012, P ROY SOC B-BIOL SCI, V279, P2807, DOI 10.1098/rspb.2012.0255; Boukal DS, 2009, POPUL ECOL, V51, P445, DOI 10.1007/s10144-009-0154-4; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Buhnerkempe MG, 2011, BIOL CONSERV, V144, P1808, DOI 10.1016/j.biocon.2011.03.012; Calabrese JM, 2008, J ANIM ECOL, V77, P746, DOI 10.1111/j.1365-2656.2008.01385.x; Caswell, 2000, MATRIX POPULATION MO; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Courchamp F, 2002, BEHAV ECOL, V13, P20, DOI 10.1093/beheco/13.1.20; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; DEMASTER D P, 1981, Mammalian Species, P1, DOI 10.2307/3503828; Dennis B, 2002, OIKOS, V96, P389, DOI 10.1034/j.1600-0706.2002.960301.x; Deredec A, 2007, ECOSCIENCE, V14, P440, DOI 10.2980/1195-6860(2007)14[440:IOTAEF]2.0.CO;2; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Derocher AE, 1997, J WILDLIFE MANAGE, V61, P1075, DOI 10.2307/3802104; DEROCHER AE, 1992, CAN J ZOOL, V70, P561, DOI 10.1139/z92-084; Derocher AE, 2010, BEHAV ECOL SOCIOBIOL, V64, P939, DOI 10.1007/s00265-010-0909-0; Ferguson SH, 1998, J BIOGEOGR, V25, P1081; Gilroy JJ, 2012, CONSERV LETT, V5, P313, DOI 10.1111/j.1755-263X.2012.00245.x; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gregory SD, 2010, ECOLOGY, V91, P2151, DOI 10.1890/09-1128.1; Gusset Markus, 2012, BMC Research Notes, V5, P313, DOI 10.1186/1756-0500-5-313; Gusset M, 2009, BIOL CONSERV, V142, P2774, DOI 10.1016/j.biocon.2009.07.007; Hackney EE, 2001, CONSERV BIOL, V15, P129, DOI 10.1046/j.1523-1739.2001.98546.x; Henle K, 2004, BIODIVERS CONSERV, V13, P9, DOI 10.1023/B:BIOC.0000004312.41575.83; Hunter C. M., 2007, POLAR BEARS SO BEAUF; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Kokko H, 2005, EVOLUTION, V59, P1876; Koons DN, 2005, ECOL MODEL, V185, P283, DOI 10.1016/j.ecolmodel.2004.12.011; Kovach AI, 2003, CAN J ZOOL, V81, P1257, DOI 10.1139/Z03-111; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Laidre KL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2371; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Molnar PK, 2008, P R SOC B, V275, P217, DOI 10.1098/rspb.2007.1307; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Molnar PK, 2009, J EXP BIOL, V212, P2313, DOI 10.1242/jeb.026146; Morris DW, 2002, ECOLOGY, V83, P14; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Obbard M.E., 2010, P 15 WORK M IUCN SSC; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; RAMSAY MA, 1986, CAN J ZOOL, V64, P2142, DOI 10.1139/z86-329; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Rosing-Asvid A, 2002, POLAR BIOL, V25, P878, DOI 10.1007/s00300-002-0430-7; Schreiber SJ, 2004, P AM MATH SOC, V132, P3047, DOI 10.1090/S0002-9939-04-07406-4; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Stephens PA, 2002, J APPL ECOL, V39, P629, DOI 10.1046/j.1365-2664.2002.00740.x; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STIRLING I, 1978, CAN J ZOOL, V56, P1768, DOI 10.1139/z78-242; TAYLOR M, 1995, ARCTIC, V48, P147; Taylor MK, 2008, WILDLIFE BIOL, V14, P52, DOI 10.2981/0909-6396(2008)14[52:SHOPBU]2.0.CO;2; Taylor MK, 2002, URSUS, V13, P185; Taylor MK, 2005, ARCTIC, V58, P203; Taylor MK, 2001, CAN J ZOOL, V79, P690, DOI 10.1139/cjz-79-4-690; TAYLOR MK, 1987, J WILDLIFE MANAGE, V51, P811, DOI 10.2307/3801746; TAYLOR MK, 2001, RISKMAN STOCHASTIC D; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Veit RR, 1996, AM NAT, V148, P255, DOI 10.1086/285924; WIIG O, 1992, Polar Record, V28, P157	73	14	14	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85410	10.1371/journal.pone.0085410	http://dx.doi.org/10.1371/journal.pone.0085410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427306	gold, Green Published, Green Submitted			2022-12-27	WOS:000329868200047
J	Gorman, JL; Liu, STK; Slopack, D; Shariati, K; Hasanee, A; Olenich, S; Olfert, IM; Haas, TL				Gorman, Jennifer L.; Liu, Sammy T. K.; Slopack, Dara; Shariati, Khashayar; Hasanee, Adam; Olenich, Sara; Olfert, I. Mark; Haas, Tara L.			Angiotensin II Evokes Angiogenic Signals within Skeletal Muscle through Co-ordinated Effects on Skeletal Myocytes and Endothelial Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; STRESS-INDUCED ANGIOGENESIS; GROWTH-FACTOR EXPRESSION; MATRIX METALLOPROTEINASES; IN-VITRO; EXTRACELLULAR-MATRIX; CAPILLARY GROWTH; TYPE-1 RECEPTOR; GENE-EXPRESSION; PROTEIN-KINASE	Skeletal muscle overload induces the expression of angiogenic factors such as vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-2, leading to new capillary growth. We found that the overload-induced increase in angiogenesis, as well as increases in VEGF, MMP-2 and MT1-MMP transcripts were abrogated in muscle VEGF KO mice, highlighting the critical role of myocyte-derived VEGF in controlling this process. The upstream mediators that contribute to overload-induced expression of VEGF have yet to be ascertained. We found that muscle overload increased angiotensinogen expression, a precursor of angiotensin (Ang) II, and that Ang II signaling played an important role in basal VEGF production in C2C12 cells. Furthermore, matrix-bound VEGF released from myoblasts induced the activation of endothelial cells, as evidenced by elevated endothelial cell phospho-p38 levels. We also found that exogenous Ang II elevates VEGF expression, as well as MMP-2 transcript levels in C2C12 myotubes. Interestingly, these responses also were observed in skeletal muscle endothelial cells in response to Ang II treatment, indicating that these cells also can respond directly to the stimulus. The involvement of Ang II in muscle overload-induced angiogenesis was assessed. We found that blockade of AT1R-dependent Ang II signaling using losartan did not attenuate capillary growth. Surprisingly, increased levels of VEGF protein were detected in overloaded muscle from losartan-treated rats. Similarly, we observed elevated VEGF production in cultured endothelial cells treated with losartan alone or in combination with Ang II. These studies conclusively establish the requirement for muscle derived VEGF in overload-induced angiogenesis and highlight a role for Ang II in basal VEGF production in skeletal muscle. However, while Ang II signaling is activated following overload and plays a role in muscle VEGF production, inhibition of this pathway is not sufficient to halt overload-induced angiogenesis, indicating that AT1-independent signals maintain VEGF production in losartan-treated muscle.	[Gorman, Jennifer L.; Liu, Sammy T. K.; Slopack, Dara; Shariati, Khashayar; Hasanee, Adam; Haas, Tara L.] York Univ, Angiogenesis Res Grp, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Gorman, Jennifer L.; Liu, Sammy T. K.; Slopack, Dara; Shariati, Khashayar; Hasanee, Adam; Haas, Tara L.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Olenich, Sara; Olfert, I. Mark] W Virginia Univ, Sch Med, Ctr Cardiovasc & Resp Sci, Div Exercise Physiol, Morgantown, WV 26506 USA	York University - Canada; York University - Canada; West Virginia University	Haas, TL (corresponding author), York Univ, Angiogenesis Res Grp, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	thaas@yorku.ca	Haas, Tara/F-6788-2013	Haas, Tara/0000-0001-8559-9574	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this project to TLH from Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoudemos MM, 2005, MICROCIRCULATION, V12, P627, DOI 10.1080/10739680500301664; Amaral SL, 2001, MICROCIRCULATION, V8, P57, DOI 10.1038/sj.mn.7300142; Amaral SL, 2001, AM J PHYSIOL-HEART C, V281, pH1163, DOI 10.1152/ajpheart.2001.281.3.H1163; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; Baumann M, 2007, HYPERTENS RES, V30, P853, DOI 10.1291/hypres.30.853; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bellamy LM, 2010, AM J PHYSIOL-CELL PH, V299, pC1402, DOI 10.1152/ajpcell.00306.2010; Benndorf R, 2003, CIRC RES, V93, P438, DOI 10.1161/01.RES.0000088358.99466.04; Brassard P, 2005, HYPERTENSION, V46, P598, DOI 10.1161/01.HYP.0000176744.15592.7d; BROWN LF, 1997, EXS, V79, P233; Bryan BA, 2008, MOL BIOL CELL, V19, P994, DOI 10.1091/mbc.E07-09-0856; Carbajo-Lozoya J, 2012, CELL SIGNAL; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Chua CC, 1998, BBA-MOL CELL RES, V1401, P187, DOI 10.1016/S0167-4889(97)00129-8; Clapp C, 2009, PHYSIOL REV, V89, P1177, DOI 10.1152/physrev.00024.2009; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Day RT, 2010, CELL SIGNAL, V22, P1849, DOI 10.1016/j.cellsig.2010.07.012; Doyle JL, 2009, J CELL BIOCHEM, V107, P272, DOI 10.1002/jcb.22123; Egginton S, 1998, J APPL PHYSIOL, V85, P2025, DOI 10.1152/jappl.1998.85.6.2025; Failli P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-32; FERRARA N, 1995, ANN NY ACAD SCI, V752, P246, DOI 10.1111/j.1749-6632.1995.tb17435.x; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Fujiyama S, 2001, CIRC RES, V88, P22, DOI 10.1161/01.RES.88.1.22; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Haas TL, 2000, AM J PHYSIOL-HEART C, V279, pH1540, DOI 10.1152/ajpheart.2000.279.4.H1540; Han XY, 2003, J BIOL CHEM, V278, P47785, DOI 10.1074/jbc.M309482200; Hoier B, 2010, AM J PHYSIOL-HEART C, V299, pH857, DOI 10.1152/ajpheart.00082.2010; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Johnston APW, 2011, J RENIN-ANGIO-ALDO S, V12, P75, DOI 10.1177/1470320310381795; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Linderman JR, 2001, MICROCIRCULATION, V8, P275, DOI 10.1038/sj.mn.7800097; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Madsen K, 2010, J AM SOC NEPHROL, V21, P448, DOI 10.1681/ASN.2009010045; Masuda T, 2012, AM J PHYSIOL-HEART C, V302, pH1871, DOI 10.1152/ajpheart.00663.2011; Milkiewicz M, 2005, AM J PHYSIOL-HEART C, V289, pH1315, DOI 10.1152/ajpheart.00284.2005; Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325; Munk VC, 2007, HYPERTENSION, V49, P1178, DOI 10.1161/HYPERTENSIONAHA.106.080242; Olfert IM, 2010, AM J PHYSIOL-REG I, V299, pR1059, DOI 10.1152/ajpregu.00347.2010; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Otani A, 1998, CIRC RES, V82, P619, DOI 10.1161/01.RES.82.5.619; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Rhoads RP, 2009, AM J PHYSIOL-CELL PH, V296, pC1321, DOI 10.1152/ajpcell.00391.2008; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Rocha FL, 2007, AM J PHYSIOL-HEART C, V293, pH3575, DOI 10.1152/ajpheart.01251.2006; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Rullman E, 2007, J APPL PHYSIOL, V102, P2346, DOI 10.1152/japplphysiol.00822.2006; Rullman E, 2009, J APPL PHYSIOL, V106, P804, DOI 10.1152/japplphysiol.90872.2008; Sasaki K, 2002, J CLIN INVEST, V109, P603, DOI 10.1172/JCI200213055; SCHUNKERT H, 1990, J CLIN INVEST, V86, P1913, DOI 10.1172/JCI114924; SUZUKI J, 1993, CIRC RES, V73, P439, DOI 10.1161/01.RES.73.3.439; Wang JW, 2004, BBA-MOL BASIS DIS, V1690, P177, DOI 10.1016/j.bbadis.2004.06.004; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; WILLIAMS B, 1995, HYPERTENSION, V25, P913, DOI 10.1161/01.HYP.25.5.913; Williams JL, 2006, MICROCIRCULATION, V13, P499, DOI 10.1080/10739680600785717; Williams JL, 2006, CLIN SCI, V110, P587, DOI 10.1042/CS20050185; Yamagishi S, 2003, DRUG EXP CLIN RES, V29, P75; Zhou AL, 1998, ANAT REC, V252, P49, DOI 10.1002/(SICI)1097-0185(199809)252:1<49::AID-AR6>3.0.CO;2-9	66	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85537	10.1371/journal.pone.0085537	http://dx.doi.org/10.1371/journal.pone.0085537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416421	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300085
J	Quintanilla, RH; Asprer, JST; Vaz, C; Tanavde, V; Lakshmipathy, U				Quintanilla, Rene H., Jr.; Asprer, Joanna S. T.; Vaz, Candida; Tanavde, Vivek; Lakshmipathy, Uma			CD44 Is a Negative Cell Surface Marker for Pluripotent Stem Cell Identification during Human Fibroblast Reprogramming	PLOS ONE			English	Article							GENE-EXPRESSION; INDUCTION; TRANSCRIPTOME; RECEPTOR; VECTOR; NANOG	Induced pluripotent stem cells (iPSCs) are promising tools for disease research and cell therapy. One of the critical steps in establishing iPSC lines is the early identification of fully reprogrammed colonies among unreprogrammed fibroblasts and partially reprogrammed intermediates. Currently, colony morphology and pluripotent stem cell surface markers are used to identify iPSC colonies. Through additional clonal characterization, we show that these tools fail to distinguish partially reprogrammed intermediates from fully reprogrammed iPSCs. Thus, they can lead to the selection of suboptimal clones for expansion. A subsequent global transcriptome analysis revealed that the cell adhesion protein CD44 is a marker that differentiates between partially and fully reprogrammed cells. Immunohistochemistry and flow cytometry confirmed that CD44 is highly expressed in the human parental fibroblasts used for the reprogramming experiments. It is gradually lost throughout the reprogramming process and is absent in fully established iPSCs. When used in conjunction with pluripotent cell markers, CD44 staining results in the clear identification of fully reprogrammed cells. This combination of positive and negative surface markers allows for easier and more accurate iPSC detection and selection, thus reducing the effort spent on suboptimal iPSC clones.	[Quintanilla, Rene H., Jr.; Asprer, Joanna S. T.; Lakshmipathy, Uma] Life Technol, Cell Biol & Stem Cell Sci, Carlsbad, CA USA; [Vaz, Candida; Tanavde, Vivek] ASTAR, Bioinformat Inst, Singapore, Singapore; [Tanavde, Vivek] ASTAR, Inst Med Biol, Singapore, Singapore	Thermo Fisher Scientific; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Lakshmipathy, U (corresponding author), Life Technol, Cell Biol & Stem Cell Sci, Carlsbad, CA USA.	uma.lakshmipathy@lifetech.com	Tanavde, Vivek/B-4758-2011; Lakshmipathy, Uma/L-4706-2013; Vaz, Candida/HHZ-7196-2022	Tanavde, Vivek/0000-0001-7404-5568; Lakshmipathy, Uma/0000-0003-4004-8212; Vaz, Candida/0000-0002-6650-7889	Life Technologies	Life Technologies	Please note that authors RHQ, JSTA and UL are employed by Life Technologies and receive financial compensation. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Kahler DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059867; KENNEL SJ, 1993, J CELL SCI, V104, P373; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schwartz DR, 2003, CANCER RES, V63, P2913; Singh U, 2012, STEM CELL REV REP, V8, P1021, DOI 10.1007/s12015-012-9359-6; Sorrell JM, 2003, EXP DERMATOL, V12, P315, DOI 10.1034/j.1600-0625.2003.120312.x; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	38	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85419	10.1371/journal.pone.0085419	http://dx.doi.org/10.1371/journal.pone.0085419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416407	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300078
J	Hoffmann, CJ; Chaisson, RE; Martinson, NA				Hoffmann, Christopher J.; Chaisson, Richard E.; Martinson, Neil A.			Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV	PLOS ONE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; MYCOBACTERIUM-TUBERCULOSIS; INFECTED ADULTS; COTE-DIVOIRE; MORTALITY; TRIAL; SUSCEPTIBILITY; COMBINATION; MORBIDITY; ABIDJAN	Objectives: Many randomized and cohort studies have reported a survival benefit with cotrimoxazole prophylaxis without detecting a difference in tuberculosis (TB) incidence by cotrimoxazole status. However, several in vitro studies have reported that cotrimoxazole possesses anti-TB activity. We sought to compare TB incidence and TB diagnostic yield by cotrimoxazole use among participants in a well characterized cohort of HIV-infected adults living in a high TB prevalence region. Methods: We analyzed prospective data from a long-term longitudinal cohort of adults receiving HIV care and TB investigations in Soweto, South Africa. Using longitudinal analysis, we compared total and laboratory confirmed TB incidence by cotrimoxazole status as well as all-cause mortality. In addition, we compared TB culture results by cotrimoxazole status. Results: In a multivariable analysis, adjusted for sex, body mass index, WHO clinical stage, time-updated CD4 count, and antiretroviral therapy status, we observed an association between cotrimoxazole and an increase in TB incidence (hazard ratio 1.7, 95% CI: 1.2, 2.2). However, when restricted to laboratory-confirmed TB, there was no association between cotrimoxazole and TB incidence (hazard ratio: 0.97, 95% CI: 0.39, 2.4). In TB cases, we found no difference in the proportion of positive sputum cultures or days to culture positivity by cotrimoxazole status. Cotrimoxazole was associated with a reduction in mortality. Conclusions: In this cohort with a mortality benefit from cotrimoxazole, we found an increased risk of all TB among individuals using cotrimoxazole, likely a result of residual confounding, but no association between use of cotrimoxazole and laboratory-confirmed TB. Cotrimoxazole did not compromise TB diagnosis.	[Hoffmann, Christopher J.; Chaisson, Richard E.; Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Hoffmann, Christopher J.; Chaisson, Richard E.; Martinson, Neil A.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Martinson, Neil A.] Perinatal HIV Res Unit, Johannesburg, South Africa	Johns Hopkins University; Johns Hopkins University	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	choffmann@jhmi.edu		Hoffmann, Christopher/0000-0002-9422-0519	National Heart, Lung, and Blood Institute Lung Health [R01 HL90312]; Johns Hopkins University Center for AIDS Research [P30-AI094189-01A1]; National Institutes of Health [AI083099]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K23AI083099] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Lung Health; Johns Hopkins University Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a National Heart, Lung, and Blood Institute Lung Health research grant [R01 HL90312]. REC is partly supported by the Johns Hopkins University Center for AIDS Research [P30-AI094189-01A1]. CJH is supported by a National Institutes of Health K23 research grant [AI083099]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; DUBAR V, 1990, J ANTIMICROB CHEMOTH, V26, P791, DOI 10.1093/jac/26.6.791; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Huang TS, 2012, J ANTIMICROB CHEMOTH, V67, P633, DOI 10.1093/jac/dkr501; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; Omar T, 2011, AIDS, V25, P87, DOI 10.1097/QAD.0b013e328340fd99; Ong W, 2010, ANTIMICROB AGENTS CH, V54, P2748, DOI 10.1128/AAC.00029-10; Rubin DB, 2004, MULTIPLE IMPUTATION; Sesay M, 2006, GUIDELINES COTRIMOXA; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	19	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83750	10.1371/journal.pone.0083750	http://dx.doi.org/10.1371/journal.pone.0083750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421903	Green Published, gold			2022-12-27	WOS:000329862500070
J	Morita, S; Horii, T; Kimura, M; Arai, Y; Kamei, Y; Ogawa, Y; Hatada, I				Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Arai, Yuji; Kamei, Yasutomi; Ogawa, Yoshihiro; Hatada, Izuho			Paternal Allele Influences High Fat Diet-Induced Obesity	PLOS ONE			English	Article							GROWTH-FACTOR-II; INSULIN SECRETORY FUNCTION; ALTERED BODY-COMPOSITION; GLUCOSE-HOMEOSTASIS; HORMONE ADIPONECTIN; MICE; RESISTANCE; IGF2; METHYLATION; REGION	C57BL/6J (B6) mice are susceptible to high-fat diet (HFD)-induced obesity and have been used in metabolism research for many decades. However, the genetic component of HFD-induced obesity has not yet been elucidated. This study reports evidence for a paternal transmission of HFD-induced obesity and a correlated expression of Igf2 and Peg3 (paternal expressed gene 3) imprinted genes. We found that PWK mice are resistant to HFD-induced obesity compared to C57BL/6J mice. Therefore, we generated and analyzed reciprocal crosses between these mice, namely; (PWK6B6) F1 progeny with B6 father and (B66PWK) F1 progeny with PWK father. The (PWK6B6) F1 mice were more sensitive to diet-induced obesity compared to (B66PWK) F1 mice, suggesting a paternal transmission of diet-induced obesity. Expression analysis of imprinted genes in adipocytes revealed that HFD influences the expression of some of the imprinted genes in adipose tissue in B6 and PWK mice. Interestingly, Igf2 and Peg3, which are paternally expressed imprinted genes involved in the regulation of body fat accumulation, were down-regulated in B6 and (PWK6B6) F1 mice, which are susceptible to HFD-induced obesity, but not in PWK and (B66PWK) F1 mice, which are resistant. Furthermore, in vitro analysis showed that Igf2, but not Peg3, had an anti-inflammatory effect on TNF-alpha induced MCP-1 expression in adipocytes. Taken together, our findings suggest that the down-regulation of Igf2 and Peg3 imprinted genes in adipocytes may be involved in the paternal transmission of HFD-induced obesity.	[Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Hatada, Izuho] Gunma Univ, Lab Genome Sci, Biosignal Genome Resource Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Arai, Yuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biosci & Genet, Div Dev Biotechnol, Suita, Osaka, Japan; [Kamei, Yasutomi] Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Sakyo Ku, Kyoto 606, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Gunma University; National Cerebral & Cardiovascular Center - Japan; Kyoto Prefectural University; Tokyo Medical & Dental University (TMDU)	Hatada, I (corresponding author), Gunma Univ, Lab Genome Sci, Biosignal Genome Resource Ctr, Inst Mol & Cellular Regulat, Showa Machi, Maebashi, Gunma 371, Japan.	hatada@gunma-u.ac.jp		Ogawa, Yoshihiro/0000-0002-0834-2836	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; National Institute of Biomedical Innovation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; the National Institute of Biomedical Innovation; and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2002, AM J PHYSIOL-ENDOC M, V283, pE738, DOI 10.1152/ajpendo.00199.2002; Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; FEIL R, 1994, DEVELOPMENT, V120, P2933; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Kooptiwut S, 2002, ENDOCRINOLOGY, V143, P2085, DOI 10.1210/en.143.6.2085; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; O'Dell SD, 1999, EUR J HUM GENET, V7, P821, DOI 10.1038/sj.ejhg.5200381; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Ravussin E., 2002, Pharmacogenomics Journal, V2, P4, DOI 10.1038/sj.tpj.6500068; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Rossetti L, 1996, J BIOL CHEM, V271, P203, DOI 10.1074/jbc.271.1.203; Sandhu MJS, 2003, DIABETES, V52, P1403, DOI 10.2337/diabetes.52.6.1403; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smas CM, 1996, INT J OBESITY, V20, pS65; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	38	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85477	10.1371/journal.pone.0085477	http://dx.doi.org/10.1371/journal.pone.0085477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416415	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500252
J	Zhou, B; Zhao, B				Zhou, Bin; Zhao, Bin			Analysis of Intervention Strategies for Inhalation Exposure to Polycyclic Aromatic Hydrocarbons and Associated Lung Cancer Risk Based on a Monte Carlo Population Exposure Assessment Model	PLOS ONE			English	Article							PARTICULATE MATTER; INDOOR; POLLUTANTS; IMPACT; STOVE	It is difficult to evaluate and compare interventions for reducing exposure to air pollutants, including polycyclic aromatic hydrocarbons (PAHs), a widely found air pollutant in both indoor and outdoor air. This study presents the first application of the Monte Carlo population exposure assessment model to quantify the effects of different intervention strategies on inhalation exposure to PAHs and the associated lung cancer risk. The method was applied to the population in Beijing, China, in the year 2006. Several intervention strategies were designed and studied, including atmospheric cleaning, smoking prohibition indoors, use of clean fuel for cooking, enhancing ventilation while cooking and use of indoor cleaners. Their performances were quantified by population attributable fraction (PAF) and potential impact fraction (PIF) of lung cancer risk, and the changes in indoor PAH concentrations and annual inhalation doses were also calculated and compared. The results showed that atmospheric cleaning and use of indoor cleaners were the two most effective interventions. The sensitivity analysis showed that several input parameters had major influence on the modeled PAH inhalation exposure and the rankings of different interventions. The ranking was reasonably robust for the remaining majority of parameters. The method itself can be extended to other pollutants and in different places. It enables the quantitative comparison of different intervention strategies and would benefit intervention design and relevant policy making.	[Zhou, Bin; Zhao, Bin] Tsinghua Univ, Dept Bldg Sci, Sch Architecture, Beijing 100084, Peoples R China	Tsinghua University	Zhao, B (corresponding author), Tsinghua Univ, Dept Bldg Sci, Sch Architecture, Beijing 100084, Peoples R China.	binzhao@tsinghua.edu.cn	Zhao, Bin/B-5158-2012; Zhou, Bin/E-4102-2017	Zhao, Bin/0000-0003-1325-6091; Zhou, Bin/0000-0002-1741-8628	National Natural Science Foundation of China [51136002]; 12th Five-year National Key Technology RD Program [2012BAJ02B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year National Key Technology RD Program(Chinese Academy of Sciences)	Financial support was provided by the National Natural Science Foundation of China (Grant No. 51136002) and the 12th Five-year National Key Technology R&D Program (Grant No. 2012BAJ02B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Armstrong B, 2004, ENVIRON HEALTH PERSP, V112, P970, DOI 10.1289/ehp.6895; Batterman S, 2012, INDOOR AIR, V22, P235, DOI 10.1111/j.1600-0668.2011.00761.x; Beijing Municipal Bureau of Statistics, 2007, BEIJ STAT YB; Burke JM, 2001, J EXPO ANAL ENV EPID, V11, P470, DOI 10.1038/sj.jea.7500188; Cho SH, 2000, J OCCUP HEALTH, V42, P138, DOI 10.1539/joh.42.138; Ezzati M, 2004, COMP QUANTIFICATION; HE XZ, 1989, INT CONGR SER, V860, P227; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Kruize H, 2003, J EXPO ANAL ENV EPID, V13, P87, DOI 10.1038/sj.jea.7500258; Lan Q, 1999, CHINESE J PUBLIC HLT, V15; Li Q, 2011, CHARACTERIZING COMMU; Li Z, 2011, ENVIRON INT, V37, P1157, DOI 10.1016/j.envint.2011.03.024; Liu L, 2007, J SAFETY ENV, P35; Liu Y, 2011, J ENV HLTH, P240; Loh MM, 2007, ENVIRON HEALTH PERSP, V115, P1160, DOI 10.1289/ehp.9884; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; Riojas-Rodriguez H, 2011, ENVIRON HEALTH PERSP, V119, P1301, DOI 10.1289/ehp.1002927; Shi SS, 2012, ATMOS ENVIRON, V59, P93, DOI 10.1016/j.atmosenv.2012.05.007; Vardoulakis S, 2008, SCI TOTAL ENVIRON, V394, P244, DOI 10.1016/j.scitotenv.2008.01.037; World Health Organization, 2000, AIR QUALITY GUIDELIN, V2nd; Zartarian V, 2008, 600R08118 EPA OFF RE; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P21063, DOI 10.1073/pnas.0905756106; Zhou B, 2012, ATMOS ENVIRON, V62, P472, DOI 10.1016/j.atmosenv.2012.08.059; Zidek JV, 2005, ENVIRONMETRICS, V16, P481, DOI 10.1002/env.716	27	16	16	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85676	10.1371/journal.pone.0085676	http://dx.doi.org/10.1371/journal.pone.0085676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416436	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500260
J	Greene, MW; Burrington, CM; Lynch, DT; Davenport, SK; Johnson, AK; Horsman, MJ; Chowdhry, S; Zhang, J; Sparks, JD; Tirrell, PC				Greene, Michael W.; Burrington, Christine M.; Lynch, Darin T.; Davenport, Samantha K.; Johnson, Andrew K.; Horsman, Melissa J.; Chowdhry, Saleem; Zhang, Jian; Sparks, Janet D.; Tirrell, Paul C.			Lipid Metabolism, Oxidative Stress and Cell Death Are Regulated by PKC Delta in a Dietary Model of Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							PROTEIN-KINASE-C; FATTY LIVER-DISEASE; INDUCED INSULIN-RESISTANCE; MICE; MECHANISMS; STEATOSIS; INFLAMMATION; FIBROSIS; PROGRESSION; DEFICIENCY	Steatosis, oxidative stress, and apoptosis underlie the development of nonalcoholic steatohepatitis (NASH). Protein kinase C delta (PKCd) has been implicated in fatty liver disease and is activated in the methionine and choline-deficient (MCD) diet model of NASH, yet its pathophysiological importance towards steatohepatitis progression is uncertain. We therefore addressed the role of PKCd in the development of steatosis, inflammation, oxidative stress, apoptosis, and fibrosis in an animal model of NASH. We fed PKCd 2/2 mice and wildtype littermates a control or MCD diet. PKCd 2/2 primary hepatocytes were used to evaluate the direct effects of fatty acids on hepatocyte lipid metabolism gene expression. A reduction in hepatic steatosis and triglyceride levels were observed between wildtype and PKCd 2/2 mice fed the MCD diet. The hepatic expression of key regulators of beta-oxidation and plasma triglyceride metabolism was significantly reduced in PKCd 2/2 mice and changes in serum triglyceride were blocked in PKCd 2/2 mice. MCD diet-induced hepatic oxidative stress and hepatocyte apoptosis were reduced in PKCd 2/2 mice. MCD diet-induced NADPH oxidase activity and p47 phox membrane translocation were blunted and blocked, respectively, in PKCd 2/2 mice. Expression of pro-apoptotic genes and caspase 3 and 9 cleavage in the liver of MCD diet fed PKCd 2/2 mice were blunted and blocked, respectively. Surprisingly, no differences in MCD diet-induced fibrosis or pro-fibrotic gene expression were observed in 8 week MCD diet fed PKCd 2/2 mice. Our results suggest that PKCd plays a role in key pathological features of fatty liver disease but not ultimately in fibrosis in the MCD diet model of NASH.	[Greene, Michael W.] Auburn Univ, Boshell Diabet & Metab Dis Res Program, Auburn, AL 36849 USA; [Greene, Michael W.; Zhang, Jian] Auburn Univ, Coll Human Sci, Auburn, AL 36849 USA; [Greene, Michael W.; Burrington, Christine M.; Lynch, Darin T.; Johnson, Andrew K.; Horsman, Melissa J.] Bassett Healthcare Network, Bassett Res Inst, Bassett Med Ctr, Cooperstown, NY USA; [Davenport, Samantha K.] Bassett Healthcare Network, Dept Pathol, Bassett Med Ctr, Cooperstown, NY USA; [Chowdhry, Saleem; Tirrell, Paul C.] Bassett Healthcare Network, Dept Internal Med, Bassett Med Ctr, Cooperstown, NY USA; [Sparks, Janet D.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Rochester	Greene, MW (corresponding author), Auburn Univ, Boshell Diabet & Metab Dis Res Program, Auburn, AL 36849 USA.	mwgreene@auburn.edu	Greene, Michael/L-6174-2019; Chowdhry, Saleem/AAS-7396-2020	Sparks, Janet/0000-0002-0072-766X; Greene, Michael/0000-0002-6443-8269; Horsman, Melissa/0000-0001-5660-5242	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2010, J HEPATOL, V53, P542, DOI 10.1016/j.jhep.2010.03.016; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Bokoch GM, 2009, ANTIOXID REDOX SIGN, V11, P2429, DOI [10.1089/ars.2009.2590, 10.1089/ARS.2009.2590]; Charatcharoenwitthaya P, 2012, DIGEST DIS SCI, V57, P1925, DOI 10.1007/s10620-012-2098-3; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Csak T, 2011, AM J PHYSIOL-GASTR L, V300, pG433, DOI 10.1152/ajpgi.00163.2009; Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein A, 2004, AM J GASTROENTEROL, V99, P1718, DOI 10.1111/j.1572-0241.2004.40573.x; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Greene MW, 2010, J BIOL CHEM, V285, P42115, DOI 10.1074/jbc.M110.168575; Greene MW, 2010, CELL SIGNAL, V22, P274, DOI 10.1016/j.cellsig.2009.09.029; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lee GS, 2007, J LIPID RES, V48, P1885, DOI 10.1194/jlr.M700181-JLR200; Lee JS, 2009, CYTOKINE, V48, P186, DOI 10.1016/j.cyto.2009.07.008; Lee SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055979; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; PICKENS MK, 2009, J LIPID RES; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rombouts K, 2010, DIGEST DIS, V28, P229, DOI 10.1159/000282094; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49	48	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85848	10.1371/journal.pone.0085848	http://dx.doi.org/10.1371/journal.pone.0085848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454937	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100136
J	Hutchinson, RN; Shin, S				Hutchinson, Rebecca Newlin; Shin, Sonya			Systematic Review of Health Disparities for Cardiovascular Diseases and Associated Factors among American Indian and Alaska Native Populations	PLOS ONE			English	Review							LIFE-STYLE BEHAVIORS; RISK-FACTORS; METABOLIC SYNDROME; UNITED-STATES; HEART-DISEASE; PREVALENCE; WOMEN; COMMUNITIES; MORTALITY; STROKE	Background: American Indians and Alaska Native (AI/AN) populations experience significant health disparities compared to non-Hispanic white populations. Cardiovascular disease and related risk factors are increasingly recognized as growing indicators of global health disparities. However, comparative reports on disparities among this constellation of diseases for AI/AN populations have not been systematically reviewed. Objectives: We performed a literature review on the prevalence of diabetes, metabolic syndrome, dyslipidemia, obesity, hypertension, and cardiovascular disease; and associated morbidity and mortality among AI/AN. Data sources: A total of 203 articles were reviewed, of which 31 met study criteria for inclusion. Searches were performed on PUBMED, MEDLINE, the CDC MMWR, and the Indian Health Services. Study eligibility criteria: Published literature that were published within the last fifteen years and provided direct comparisons between AI/AN to non-AI/AN populations were included. Study appraisal and synthesis methods: We abstracted data on study design, data source, AI/AN population, comparison group, and. outcome measures. A descriptive synthesis of primary findings is included. Results: Rates of obesity, diabetes, cardiovascular disease, and metabolic syndrome are clearly higher for AI/AN populations. Hypertension and hyperlipidemia differences are more equivocal. Our analysis also revealed that there are likely regional and gender differences in the degree of disparities observed. Limitations: Studies using BRFSS telephone surveys administered in English may underestimate disparities. Many AI/AN do not have telephones and/or speak English. Regional variability makes national surveys difficult to interpret. Finally, studies using self-reported data may not be accurate. Conclusions and implications of key findings: Profound health disparities in cardiovascular diseases and associated risk factors for AI/AN populations persist, perhaps due to low socioeconomic status and access to quality healthcare. Successful programs will address social determinants and increase healthcare access. Community-based outreach to bring health services to the most vulnerable may also be very helpful in this effort.	[Hutchinson, Rebecca Newlin] Lankenau Med Ctr, Wynnewood, PA USA; [Shin, Sonya] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Lankenau Medical Center; Harvard University; Brigham & Women's Hospital	Shin, S (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	ahartnelson@partners.org		Hutchinson, Rebecca/0000-0002-9121-6426				Acton KJ, 2002, AM J PUBLIC HEALTH, V92, P1485, DOI 10.2105/AJPH.92.9.1485; Amparo P, 2011, PREV CHRONIC DIS, V8; [Anonymous], 2013, OBS NOV AM IND AL NA; [Anonymous], 2013, AM IND AL NAT PROF; Ayala CN, 2002, STROKE, V33, P1197, DOI 10.1161/01.STR.0000015028.52771.D1; Ballew C, 1997, J NUTR, V127, pS2085, DOI 10.1093/jn/127.10.2085S; Balluz LS, 2008, ETHNIC DIS, V18, P450; BARNES PM, 2010, NATL HLTH STAT REPOR, V20, P1; Beckles Gloria L., 2011, Morbidity and Mortality Weekly Report, V60, P13; Bloom DE, 2011, GLOBAL EC BURDEN NON; Burrows NR, 2000, DIABETES CARE, V23, P1786, DOI 10.2337/diacare.23.12.1786; *CDC, 2012, NAT HLTH INT SURV; CDC (Centers for Disease Control and Prevention), 2012, BEHAV RISK FACT SURV; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P702; Compher C, 2006, J TRANSCULT NURS, V17, P217, DOI 10.1177/1043659606288376; Denny CH, 2005, AM J PUBLIC HEALTH, V95, P825, DOI 10.2105/AJPH.2004.043489; Denny Clark H, 2003, MMWR Surveill Summ, V52, P1; Devi S, 2011, LANCET, V377, P1481, DOI 10.1016/S0140-6736(11)60586-2; Doshi SR, 2006, J WOMENS HEALTH, V15, P919, DOI 10.1089/jwh.2006.15.919; Duran BM, 2005, AM J PUBLIC HEALTH, V95, P758, DOI 10.2105/AJPH.95.5.758; Finkelstein EA, 2004, J WOMENS HEALTH, V13, P503, DOI 10.1089/1540999041280963; Gittelsohn J, 2011, AM J CLIN NUTR, V93, p1179S, DOI 10.3945/ajcn.110.003509; Gittelsohn J, 2009, AM J PREV MED, V36, pS161, DOI 10.1016/j.amepre.2009.01.007; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harwell TS, 2005, CIRCULATION, V112, P2263, DOI 10.1161/CIRCULATIONAHA.105.560607; Harwell TS, 2001, AM J PREV MED, V20, P196, DOI 10.1016/S0749-3797(00)00312-3; Hodge FS, 2011, ETHNIC DIS, V21, P52; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; Hsia J, 2007, CIRCULATION, V115, P855, DOI 10.1161/CIRCULATIONAHA.106.656850; Jernigan VBB, 2010, AM J PUBLIC HEALTH, V100, P677, DOI 10.2105/AJPH.2009.164285; Jones DS, 2006, AM J PUBLIC HEALTH, V96, P2122, DOI 10.2105/AJPH.2004.054262; Jones DE, 2012, PATIENT EDUC COUNS, V89, P57, DOI 10.1016/j.pec.2012.06.003; Lee ET, 2004, ANN EPIDEMIOL, V14, P696, DOI 10.1016/j.annepidem.2003.10.013; Lee ET, 1998, AM J EPIDEMIOL, V147, P995, DOI 10.1093/oxfordjournals.aje.a009406; Levin S, 2002, ETHNIC HEALTH, V7, P57, DOI 10.1080/13557850220146993; Liao Youlian, 2004, Morbidity and Mortality Weekly Report, V53, P1; Liao Youlian, 2011, Morbidity and Mortality Weekly Report, V60, P1; O'Connell J, 2010, DIABETES CARE, V33, P1463, DOI 10.2337/dc09-1652; OUHSC, 2012, LARG EP STUD CARD DI; Ray EB, 2012, J HUNGER ENVIRON NUT, V7, P91, DOI 10.1080/19320248.2012.649670; Raymond Jaime, 2011, Morbidity and Mortality Weekly Report, V60, P21; Redwood DG, 2010, PREV CHRONIC DIS, V7; Rhoades DA, 2005, CIRCULATION, V111, P1250, DOI 10.1161/01.CIR.0000157735.25005.3F; Rith-Najarian SJ, 2002, DIABETES CARE, V25, P279, DOI 10.2337/diacare.25.2.279; Schumacher Catherine, 2008, Metabolic Syndrome and Related Disorders, V6, P267, DOI 10.1089/met.2008.0021; Setala A, 2011, PUBLIC HEALTH NUTR, V14, P1658, DOI 10.1017/S1368980011000334; Sinclair KA, 2011, DIABETES CARE, V34, P118, DOI 10.2337/dc10-0221; Steele CB, 2008, CANCER-AM CANCER SOC, V113, P1131, DOI 10.1002/cncr.23727; Story M, 1999, AM J CLIN NUTR, V69, p747S, DOI 10.1093/ajcn/69.4.747S; United States. Agency for Healthcare Research and Quality, AHRQ PUBLICATION, pv; Van Ploeg M, 2009, USDA ADM PUBLICATION, V160; Viswanathan M, 2009, EVID REP TECHNOL ASS; Will JC, 1997, J NUTR, V127, pS2106, DOI 10.1093/jn/127.10.2106S; Zhang Y, 2008, CIRCULATION, V118, P1577, DOI 10.1161/CIRCULATIONAHA.108.772285; Zhao G, 2008, J HUM HYPERTENS, V22, P608, DOI 10.1038/jhh.2008.52	55	102	106	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e80973	10.1371/journal.pone.0080973	http://dx.doi.org/10.1371/journal.pone.0080973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454685	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100001
J	Liu, AP; Yang, Y; Liu, L; Meng, ZF; Li, LZ; Qiu, C; Xu, JQ; Zhang, XY				Liu, Aiping; Yang, Yu; Liu, Lu; Meng, Zhefeng; Li, Liangzhu; Qiu, Chao; Xu, Jianqing; Zhang, Xiaoyan			Differential Compartmentalization of HIV-Targeting Immune Cells in Inner and Outer Foreskin Tissue	PLOS ONE			English	Article							MALE CIRCUMCISION; LANGERHANS CELLS; INTEGRIN ALPHA(4)BETA(7); T-CELLS; INFECTION; TRANSMISSION; MEN; EXPRESSION; PREVENTION; UGANDA	Ex vivo foreskin models have demonstrated that inner foreskin is more susceptible to HIV-1 infection than outer foreskin. In the present study we characterized the compartition of HIV-1 target cells and quantified these cells in the epidermis and dermis of inner and outer foreskins using immunohistochemistry and flow cytometry. Our data showed that the epidermis of the inner foreskin was more enriched with CD4(+) T cells and Langerhans cells (LCs), with the co-expression of CCR5 and alpha 4b7 receptors, than the outer foreskin. Interestingly, the vast majority of CD4(+) T cells and LCs expressed CCR5, but not CXCR4, indicating that the inner foreskin might capture and transmit R5-tropic HIV strains more efficiently. In addition, lymphoid aggregates, composed of T cells, macrophages and dendritic cells (DCs) in the dermis, were closer to the epithelial surface in the inner foreskin than in the outer foreskin. As dendritic cells are able to capture and pass HIV particles to susceptible target cells, HIV may be able to more efficiently infect the inner foreskin by hijacking the augmented immune communication pathways in this tissue. After the inoculation of HIV-1 particles in a foreskin explant culture model, the level of p24 antigen in the supernatant from the inner foreskin was slightly higher than that from the outer foreskin, although this difference was not significant. The present study is the first to employ both CCR5 and a4b7 to identify HIV target cells in the foreskin. Our data demonstrated that the inner foreskin was more enriched with HIV target immune cells than the outer foreskin, and this tissue was structured for efficient communication among immune cells that may promote HIV transmission and replication. In addition, our data suggests the R5-tropism of HIV sexual transmission is likely shaped through the inherent receptor composition on HIV target cells in the mucosa.	[Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xu, JQ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhangxy066@gmail.com	Qiu, Chao/M-6702-2014	Qiu, Chao/0000-0001-9401-5219; meng, zhefeng/0000-0001-9396-0673	973 Program [2012CB519001]; NSFC [81171553, 812111038]; Fundamental Research Funds for the Central Universities [10FX111]; Chinese National Grand Program on Key Infectious Disease Control and Prevention [2012ZX10001-007-008, 2013ZX10001006]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese National Grand Program on Key Infectious Disease Control and Prevention	This work was supported by 973 Program (2012CB519001), NSFC (81171553; 812111038), Fundamental Research Funds for the Central Universities (10FX111) and Chinese National Grand Program on Key Infectious Disease Control and Prevention (2012ZX10001-007-008; 2013ZX10001006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2011, AM J REPROD IMMUNOL; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Bohler T, 1999, EUR J PEDIATR, V158, P638, DOI 10.1007/s004310051167; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; CHARM SE, 1992, VOX SANG, V62, P12, DOI 10.1111/j.1423-0410.1992.tb01160.x; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; de Jong MAWP, 2010, METHODS MOL BIOL, V595, P55, DOI 10.1007/978-1-60761-421-0_4; Dinh MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041271; Dinh MH, 2010, AIDS, V24, P899, DOI 10.1097/QAD.0b013e3283367779; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32; Ganor Yonatan, 2011, Am J Reprod Immunol, V65, P284, DOI 10.1111/j.1600-0897.2010.00933.x; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hirbod T, 2010, AM J PATHOL, V176, P2798, DOI 10.2353/ajpath.2010.090926; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lynch GW, 2003, EXP DERMATOL, V12, P700, DOI 10.1034/j.1600-0625.2003.00078.x; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; MILLER CJ, 1992, LAB INVEST, V67, P628; Nie JH, 2010, JAIDS-J ACQ IMM DEF, V53, P440, DOI 10.1097/QAI.0b013e3181cb8300; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Prodger JL, 2012, MUCOSAL IMMUNOL, V5, P121, DOI 10.1038/mi.2011.56; Qin Q, 2009, INT UROL NEPHROL, V41, P747, DOI 10.1007/s11255-008-9521-x; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Uthman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009628; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Zhou ZC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002100	41	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85176	10.1371/journal.pone.0085176	http://dx.doi.org/10.1371/journal.pone.0085176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454812	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100059
J	Lux, RL; Sower, CT; Allen, N; Etheridge, SP; Tristani-Firouzi, M; Saarel, EV				Lux, Robert L.; Sower, Christopher Todd; Allen, Nancy; Etheridge, Susan P.; Tristani-Firouzi, Martin; Saarel, Elizabeth V.			The Application of Root Mean Square Electrocardiography (RMS ECG) for the Detection of Acquired and Congenital Long QT Syndrome	PLOS ONE			English	Article							POTASSIUM CHANNEL; REPOLARIZATION; DISPERSION; HERG; INTERVALS; HEART	Background: Precise measurement of the QT interval is often hampered by difficulty determining the end of the low amplitude T wave. Root mean square electrocardiography (RMS ECG) provides a novel alternative measure of ventricular repolarization. Experimental data have shown that the interval between the RMS ECG QRS and T wave peaks (RTPK) closely reflects the mean ventricular action potential duration while the RMS T wave width (TW) tracks the dispersion of repolarization timing. Here, we tested the precision of RMS ECG to assess ventricular repolarization in humans in the setting of drug-induced and congenital Long QT Syndrome (LQTS). Methods: RMS ECG signals were derived from high-resolution 24 hour Holter monitor recordings from 68 subjects after receiving placebo and moxifloxacin and from standard 12 lead ECGs obtained in 97 subjects with LQTS and 97 age-and sex-matched controls. RTPK, QT(RMS) and RMS TW intervals were automatically measured using custom software and compared to traditional QT measures using lead II. Results: All measures of repolarization were prolonged during moxifloxacin administration and in LQTS subjects, but the variance of RMS intervals was significantly smaller than traditional lead II measurements. TW was prolonged during moxifloxacin and in subjects with LQT-2, but not LQT-1 or LQT-3. Conclusion: These data validate the application of RMS ECG for the detection of drug-induced and congenital LQTS. RMS ECG measurements are more precise than the current standard of care lead II measurements.	[Lux, Robert L.; Sower, Christopher Todd; Allen, Nancy; Tristani-Firouzi, Martin] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Etheridge, Susan P.; Tristani-Firouzi, Martin; Saarel, Elizabeth V.] Univ Utah, Div Pediat Cardiol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Tristani-Firouzi, M (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.	mfirouzi@cvrti.utah.edu			Nora Eccles Treadwell Foundation	Nora Eccles Treadwell Foundation	This work was supported by the Nora Eccles Treadwell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum NW, 2010, PACE, V33, P1198, DOI 10.1111/j.1540-8159.2010.02788.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Couderc JP, 2011, ANN NONINVAS ELECTRO, V16, P13, DOI 10.1111/j.1542-474X.2010.00402.x; Couderc JP, 2010, IEEE ENG MED BIO, P6252, DOI 10.1109/IEMBS.2010.5628067; Darpo B, 2011, CARDIOL J, V18, P401; Fuller MS, 2000, J ELECTROCARDIOL, V33, P171, DOI 10.1016/S0022-0736(00)80073-4; Fuller MS, 2000, CIRCULATION, V102, P685, DOI 10.1161/01.CIR.102.6.685; HAWS CW, 1990, CIRCULATION, V81, P281, DOI 10.1161/01.CIR.81.1.281; Holzgrefe Jr HH, 2011, J CLIN PHARM; Kang JS, 2001, MOL PHARMACOL, V59, P122, DOI 10.1124/mol.59.1.122; Lux RL, 1999, J ELECTROCARDIOL, V32, P153, DOI 10.1016/S0022-0736(99)90073-0; Lux RL, 2006, J ELECTROCARDIOL, V39, pS161, DOI 10.1016/j.jelectrocard.2006.05.020; Malik M, 2002, HEART, V87, P220, DOI 10.1136/heart.87.3.220; Malik M, 2009, ANN NONINVAS ELECTRO, V14, P242, DOI 10.1111/j.1542-474X.2009.00304.x; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Segerson NM, 2008, HEART RHYTHM, V5, P208, DOI 10.1016/j.hrthm.2007.10.006; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285	17	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85689	10.1371/journal.pone.0085689	http://dx.doi.org/10.1371/journal.pone.0085689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454918	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100120
J	Guest, J; Grant, R; Mori, TA; Croft, KD				Guest, Jade; Grant, Ross; Mori, Trevor A.; Croft, Kevin D.			Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age in Cerebrospinal Fluid	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; ALCOHOL INTAKE; COGNITIVE FUNCTION; CELL-DEATH; BRAIN; STRESS; POLY(ADP-RIBOSE); ALZHEIMERS; DNA; DEPLETION	An extensive body of evidence indicates that oxidative stress and inflammation play a central role in the degenerative changes of systemic tissues in aging. However a comparatively limited amount of data is available to verify whether these processes also contribute to normal aging within the brain. High levels of oxidative damage results in key cellular changes including a reduction in available nicotinamide adenine dinucleotide (NAD(+)), an essential molecule required for a number of vital cellular processes including DNA repair, immune signaling and epigenetic processing. In this study we quantified changes in [NAD(H)] and markers of inflammation and oxidative damage (F2-isoprostanes, 8-OHdG, total antioxidant capacity) in the cerebrospinal fluid (CSF) of healthy humans across a wide age range (24-91 years). CSF was collected from consenting patients who required a spinal tap for the administration of anesthetic. CSF of participants aged >45 years was found to contain increased levels of lipid peroxidation (F2-isoprostanes) (p = 0.04) and inflammation (IL-6) (p = 0.00) and decreased levels of both total antioxidant capacity (p = 0.00) and NAD(H) (p = 0.05), compared to their younger counterparts. A positive association was also observed between plasma [NAD(H)] and CSF NAD(H) levels (p = 0.03). Further analysis of the data identified a relationship between alcohol intake and CSF [NAD(H)] and markers of inflammation. The CSF of participants who consumed >1 standard drink of alcohol per day contained lower levels of NAD(H) compared to those who consumed no alcohol (p<0.05). An increase in CSF IL-6 was observed in participants who reported drinking >0-1 (p<0.05) and >1 (p<0.05) standard alcoholic drinks per day compared to those who did not drink alcohol. Taken together these data suggest a progressive age associated increase in oxidative damage, inflammation and reduced [NAD(H)] in the brain which may be exacerbated by alcohol intake.	[Guest, Jade] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia; [Guest, Jade; Grant, Ross] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Fac Med, Sydney, NSW, Australia; [Grant, Ross] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Mori, Trevor A.; Croft, Kevin D.] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp Unit, Perth, WA 6009, Australia	Sydney Adventist Hospital; University of New South Wales Sydney; University of Sydney; Royal Perth Hospital; University of Western Australia	Grant, R (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Fac Med, Sydney, NSW, Australia.	ross.grant@unsw.edu.au	Mori, Trevor/H-5485-2014; Grant, Ross/H-1805-2015	Mori, Trevor/0000-0002-5264-9229; Croft, Kevin/0000-0003-1596-4913	BUPA Health Foundation [219]	BUPA Health Foundation	This study was supported by a grant (#219) from the BUPA Health Foundation www.bupa.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7; Athilingam Ponrathi, 2013, Congest Heart Fail, V19, P92, DOI 10.1111/chf.12007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Cakatay U, 2001, EXP GERONTOL, V36, P221, DOI 10.1016/S0531-5565(00)00197-2; CARSON DA, 1986, EXP CELL RES, V164, P273, DOI 10.1016/0014-4827(86)90028-5; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEGUCHI T, 1968, BIOCHIM BIOPHYS ACTA, V158, P382, DOI 10.1016/0304-4165(68)90292-4; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Ding JZ, 2004, STROKE, V35, P16, DOI 10.1161/01.STR.0000105929.88691.8E; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Espeland MA, 2005, AM J EPIDEMIOL, V161, P228, DOI 10.1093/aje/kwi043; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Fernandez-Lizarbe S, 2008, MOL IMMUNOL, V45, P2007, DOI 10.1016/j.molimm.2007.10.025; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Grant R, 2010, INT J TRYPTOPHAN RES, V3, P151; Grant RS, 1998, J NEUROCHEM, V70, P1759; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; Ji C, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/216450; Kesse-Guyot E, 2012, J NUTR, V142, P76, DOI 10.3945/jn.111.144428; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Martinez E, 2013, J ALZHEIMERS DIS, V36, P129, DOI 10.3233/JAD-130215; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCELFRESH KC, 1983, BIOCHEM GENET, V21, P365, DOI 10.1007/BF00499145; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Minana R, 2000, J NEUROCHEM, V75, P954, DOI 10.1046/j.1471-4159.2000.0750954.x; MOGHAL S, 1994, NEUROEPIDEMIOLOGY, V13, P175, DOI 10.1159/000110376; Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; OGURA K, 1994, NEUROREPORT, V5, P1224, DOI 10.1097/00001756-199406020-00016; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Reddy VD, 2013, MOL CELL BIOCHEM, V375, P39, DOI 10.1007/s11010-012-1526-1; Rex A, 2002, PHARMACOL TOXICOL, V90, P220, DOI 10.1034/j.1600-0773.2002.900409.x; REYES E, 1993, ALCOHOL CLIN EXP RES, V17, P877, DOI 10.1111/j.1530-0277.1993.tb00857.x; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rubio M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023690; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Sattarova EA, 2013, BBA-GEN SUBJECTS, V1830, P3542, DOI 10.1016/j.bbagen.2013.01.027; Schenck JF, 2004, NMR BIOMED, V17, P433, DOI 10.1002/nbm.922; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; SZARKOWSKA L, 1965, ACTA BIOCHIM POL, V12, P179; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Verbaten MN, 2009, HUM PSYCHOPHARM CLIN, V24, P199, DOI 10.1002/hup.1022; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y	71	39	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85335	10.1371/journal.pone.0085335	http://dx.doi.org/10.1371/journal.pone.0085335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454842	gold, Green Published			2022-12-27	WOS:000329925800037
J	Meslec, N; Curseu, PL; Meeus, MTH; Fodor, OCI				Meslec, Nicoleta; Curseu, Petru Lucian; Meeus, Marius T. H.; Fodor, Oana C. Iederan			When None of Us Perform Better than All of Us Together: The Role of Analogical Decision Rules in Groups	PLOS ONE			English	Article							BASE-RATE; INFORMATION; COGNITION; INTERVENTION; ENVIRONMENTS; RATIONALITY; VARIABILITY; IMPACT; BIASES; TEAMS	During social interactions, groups develop collective competencies that (ideally) should assist groups to outperform average standalone individual members (weak cognitive synergy) or the best performing member in the group (strong cognitive synergy). In two experimental studies we manipulate the type of decision rule used in group decision-making (identify the best vs. collaborative), and the way in which the decision rules are induced (direct vs. analogical) and we test the effect of these two manipulations on the emergence of strong and weak cognitive synergy. Our most important results indicate that an analogically induced decision rule (imitate-the-successful heuristic) in which groups have to identify the best member and build on his/her performance (take-the-best heuristic) is the most conducive for strong cognitive synergy. Our studies bring evidence for the role of analogy-making in groups as well as the role of fast-and-frugal heuristics for group decision-making.	[Meslec, Nicoleta; Curseu, Petru Lucian; Meeus, Marius T. H.] Tilburg Univ, Dept Org Studies, NL-5000 LE Tilburg, Netherlands; [Meslec, Nicoleta; Curseu, Petru Lucian; Meeus, Marius T. H.] Tilburg Univ, Ctr Innovat Res, NL-5000 LE Tilburg, Netherlands; [Fodor, Oana C. Iederan] Cognitrom, Cluj Napoca, Romania; [Fodor, Oana C. Iederan] Univ Babes Bolyai, Dept Psychol, R-3400 Cluj Napoca, Romania	Tilburg University; Tilburg University; Babes Bolyai University from Cluj	Meslec, N (corresponding author), Tilburg Univ, Dept Org Studies, NL-5000 LE Tilburg, Netherlands.	m.n.meslec@uvt.nl	Curseu, Petru Lucian/H-7620-2012; Meeus, Marius T.H./E-8648-2011; Fodor, Oana/ABB-2731-2020; Curseu, Petru Lucian/AAD-5084-2019	Curseu, Petru Lucian/0000-0003-0067-6310; Fodor, Oana/0000-0002-4381-4309; Curseu, Petru Lucian/0000-0003-0067-6310	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [II-ID-PCE-2011-3-0482]	Romanian National Authority for Scientific Research, CNCS - UEFISCDI	Oana C. Iederan Fodor was supported by a grant of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project number PN-II-ID-PCE-2011-3-0482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOTE L, 1990, ORGAN BEHAV HUM DEC, V46, P296, DOI 10.1016/0749-5978(90)90034-7; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Buehler R, 2005, ORGAN BEHAV HUM DEC, V97, P47, DOI 10.1016/j.obhdp.2005.02.004; Choi HS, 2004, J EXP SOC PSYCHOL, V40, P273, DOI 10.1016/S0022-1031(03)00101-X; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; COOPER J, 1984, ADV EXP SOC PSYCHOL, V17, P229, DOI 10.1016/S0065-2601(08)60121-5; Curseu P, 2012, MANAGE DECIS, V50, P1062, DOI 10.1108/00251741211238337; Curseu PL, 2007, GROUP DYN-THEOR RES, V11, P187, DOI 10.1037/1089-2699.11.3.187; Curseu PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056454; Czerlinski Jean, 1999, SIMPLE HEURISTICS MA, P97, DOI DOI 10.1002/(SICI)1099-0771(200004/06)13:2<161::AID-BDM348>3.0.CO;2-P; DEBISEAU JC, 1994, J INSECT BEHAV, V7, P767, DOI 10.1007/BF01997125; Edwards SC, 2009, P ROY SOC B-BIOL SCI, V276, P3655, DOI 10.1098/rspb.2009.0981; Fausing MS, 2013, TEAM PERFORM MANAG, V19, P244, DOI 10.1108/TPM-11-2012-0038; FISCHER GW, 1981, ORGAN BEHAV HUM PERF, V28, P96, DOI 10.1016/0030-5073(81)90017-9; Forbes DP, 1999, ACAD MANAGE REV, V24, P489, DOI 10.2307/259138; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; HALL J, 1970, HUM RELAT, V23, P299, DOI 10.1177/001872677002300404; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Haunschild PR, 1997, ADMIN SCI QUART, V42, P472, DOI 10.2307/2393735; HINSZ VB, 1990, J PERS SOC PSYCHOL, V59, P705, DOI 10.1037/0022-3514.59.4.705; Hinsz VB, 2008, J EXP SOC PSYCHOL, V44, P116, DOI 10.1016/j.jesp.2007.02.013; Johnson DW, 1987, JOINING TOGETHER GRO; Katsikopoulos KV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015505; Kirkman BL, 1999, ACAD MANAGE J, V42, P58, DOI 10.2307/256874; Kouchaki M, 2012, GROUP ORGAN MANAGE, V37, P171, DOI 10.1177/1059601112443850; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Larson JR, 2007, SMALL GR RES, V38, P413, DOI 10.1177/1046496407301972; Laughlin PR, 2003, GROUP DYN-THEOR RES, V7, P55, DOI 10.1037/1089-2699.7.1.55; Malhotra A, 2001, MIS QUART, V25, P229, DOI 10.2307/3250930; Meslec N, 2013, SMALL GR RES, V44, P471, DOI 10.1177/1046496413491988; Paletz SBF, 2013, COGNITION, V126, P1, DOI 10.1016/j.cognition.2012.07.020; REAGANCIRINCIONE P, 1994, ORGAN BEHAV HUM DEC, V58, P246, DOI 10.1006/obhd.1994.1036; ROGELBERG SG, 1992, J APPL PSYCHOL, V77, P730, DOI 10.1037/0021-9010.77.5.730; Rolfsen M, 2013, TEAM PERFORM MANAG, V19, P292, DOI 10.1108/TPM-12-2012-0045; Sasaki T, 2012, CURR BIOL, V22, pR827, DOI 10.1016/j.cub.2012.07.058; Schein EH, 1996, SYST PRACTICE, V9, P27, DOI 10.1007/BF02173417; Schuster S, 2006, CURR BIOL, V16, P378, DOI 10.1016/j.cub.2005.12.037; SNIEZEK JA, 1990, GROUP ORGAN STUD, V15, P5, DOI 10.1177/105960119001500102; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Tannenbaum SI, 2012, IND ORGAN PSYCHOL-US, V5, P2, DOI 10.1111/j.1754-9434.2011.01396.x; Toelch U, 2010, EVOL HUM BEHAV, V31, P326, DOI 10.1016/j.evolhumbehav.2010.03.002; Toelch U, 2009, EVOL HUM BEHAV, V30, P32, DOI 10.1016/j.evolhumbehav.2008.07.003; VOLLRATH DA, 1989, ORGAN BEHAV HUM DEC, V43, P289, DOI 10.1016/0749-5978(89)90040-X; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	45	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85232	10.1371/journal.pone.0085232	http://dx.doi.org/10.1371/journal.pone.0085232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292TQ	24454824	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800027
J	Pesciotta, EN; Sriswasdi, S; Tang, HY; Speicher, DW; Mason, PJ; Bessler, M				Pesciotta, Esther N.; Sriswasdi, Sira; Tang, Hsin-Yao; Speicher, David W.; Mason, Philip J.; Bessler, Monica			Dysferlin and Other Non-Red Cell Proteins Accumulate in the Red Cell Membrane of Diamond-Blackfan Anemia Patients	PLOS ONE			English	Article							ERYTHROID FAILURE; S19 DEFICIENCY; EXPRESSION; GENE; ERYTHROPOIESIS; PROTEOME; MYOPATHY; MUTATION; MODEL	Diamond Blackfan Anemia (DBA) is a congenital anemia usually caused by diverse mutations in ribosomal proteins. Although the genetics of DBA are well characterized, the mechanisms that lead to macrocytic anemia remain unclear. We systematically analyzed the proteomes of red blood cell membranes from multiple DBA patients to determine whether abnormalities in protein translation or erythropoiesis contribute to the observed macrocytosis or alterations in the mature red blood cell membrane. In depth proteome analysis of red cell membranes enabled highly reproducible identification and quantitative comparisons of 1100 or more proteins. These comparisons revealed clear differences between red cell membrane proteomes in DBA patients and healthy controls that were consistent across DBA patients with different ribosomal gene mutations. Proteins exhibiting changes in abundance included those known to be increased in DBA such as fetal hemoglobin and a number of proteins not normally found in mature red cell membranes, including proteins involved in the major histocompatibility complex class I pathway. Most striking was the presence of dysferlin in the red blood cell membranes of DBA patients but absent in healthy controls. Immunoblot validation using red cell membranes isolated from additional DBA patients and healthy controls confirmed a distinct membrane protein signature specific to patients with DBA.	[Pesciotta, Esther N.; Mason, Philip J.; Bessler, Monica] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Sriswasdi, Sira; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Sriswasdi, Sira; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Sriswasdi, Sira; Speicher, David W.] Univ Penn, Genom & Computat Biol Grad Grp, Philadelphia, PA 19104 USA; [Bessler, Monica] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; The Wistar Institute; The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Bessler, M (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.	besslerm@email.chop.edu		Tang, Hsin-Yao/0000-0003-1838-018X	National Institutes of Health [RO1-DK084188, HL038794]; National Institutes of Health (National Cancer Institute) [CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084188, T32DK007780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (http://grants1.nih.gov) grants RO1-DK084188 (to MB), HL038794 (to DWS), and CA010815 (National Cancer Institute core grant to the Wistar Institute (http://www.cancer.gov/researchandfunding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegretti AP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/725684; ALTER BP, 1979, EXP HEMATOL, V7, P200; An HJ, 2009, CELL BIOCHEM FUNCT, V27, P289, DOI 10.1002/cbf.1571; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Ball S, 2011, HEMATOL-AM SOC HEMAT, P487, DOI 10.1182/asheducation-2011.1.487; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beer LA, 2011, J PROTEOME RES, V10, P1126, DOI 10.1021/pr1008866; BOTTO M, 1990, BRIT J HAEMATOL, V75, P106, DOI 10.1111/j.1365-2141.1990.tb02624.x; Burton NM, 2011, BIOCHEM CELL BIOL, V89, P200, DOI [10.1139/o10-154, 10.1139/O10-154]; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; de Morree A, 2013, J BIOL CHEM; De Palma A, 2010, J CHROMATOGR A, V1217, P5328, DOI 10.1016/j.chroma.2010.06.045; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; EVERETT ET, 1990, HUM IMMUNOL, V29, P14, DOI 10.1016/0198-8859(90)90065-W; Franco RS, 2013, AM J HEMATOL, V88, P44, DOI 10.1002/ajh.23344; Gazda HT, 2006, STEM CELLS, V24, P2034, DOI 10.1634/stemcells.2005-0554; GILES CM, 1987, CLIN EXP IMMUNOL, V69, P368; HOFFMAN JF, 1958, J GEN PHYSIOL, V42, P9, DOI 10.1085/jgp.42.1.9; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; MORTON JA, 1977, VOX SANG, V32, P26, DOI 10.1111/j.1423-0410.1977.tb00600.x; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; NATHAN DG, 1978, J CLIN INVEST, V61, P489, DOI 10.1172/JCI108960; Neubert H, 2008, J PROTEOME RES, V7, P2270, DOI 10.1021/pr700705u; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; PERDAHL EB, 1994, BLOOD, V83, P645; Pesciotta EN, 2012, J PROTEOMICS; SHARMA R, 1991, BIOCHEM MED METAB B, V46, P33, DOI 10.1016/0885-4505(91)90048-P; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; van Gestel RA, 2010, J PROTEOMICS, V73, P456, DOI 10.1016/j.jprot.2009.08.010; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vlachos A, 2013, EUR J HUM GENET, V21, DOI 10.1038/ejhg.2013.34; Weiss MJ, 2012, J CLIN INVEST, V122, P2346, DOI 10.1172/JCI63989; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; YURCHENCO PD, 1982, J BIOL CHEM, V257, P9102	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85504	10.1371/journal.pone.0085504	http://dx.doi.org/10.1371/journal.pone.0085504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454878	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800048
J	Collier, JL; Fitzgerald, SP; Hice, LA; Frisk, MG; McElroy, AE				Collier, Jackie L.; Fitzgerald, Sean P.; Hice, Lyndie A.; Frisk, Michael G.; McElroy, Anne E.			A New PCR-Based Method Shows That Blue Crabs (Callinectes sapidus (Rathbun)) Consume Winter Flounder (Pseudopleuronectes americanus (Walbaum))	PLOS ONE			English	Article							SAND SHRIMP; STOMACH CONTENTS; FEEDING-HABITS; GUT CONTENTS; PREDATION; MORTALITY; DNA; ESTUARY; SIZE; IDENTIFICATION	Winter flounder (Pseudopleuronectes americanus) once supported robust commercial and recreational fisheries in the New York (USA) region, but since the 1990s populations have been in decline. Available data show that settlement of young-of-the-year winter flounder has not declined as sharply as adult abundance, suggesting that juveniles are experiencing higher mortality following settlement. The recent increase of blue crab (Callinectes sapidus) abundance in the New York region raises the possibility that new sources of predation may be contributing to juvenile winter flounder mortality. To investigate this possibility we developed and validated a method to specifically detect winter flounder mitochondrial control region DNA sequences in the gut contents of blue crabs. A survey of 55 crabs collected from Shinnecock Bay (along the south shore of Long Island, New York) in July, August, and September of 2011 showed that 12 of 42 blue crabs (28.6%) from which PCR-amplifiable DNA was recovered had consumed winter flounder in the wild, empirically supporting the trophic link between these species that has been widely speculated to exist. This technique overcomes difficulties with visual identification of the often unrecognizable gut contents of decapod crustaceans, and modifications of this approach offer valuable tools to more broadly address their feeding habits on a wide variety of species.	[Collier, Jackie L.; Fitzgerald, Sean P.; Hice, Lyndie A.; Frisk, Michael G.; McElroy, Anne E.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Collier, JL (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	jackie.collier@stonybrook.edu		Collier, Jackie/0000-0001-8774-5715	Saltonstall Kennedy Program of the National Marine Fisheries Service of NOAA [NA101NMF4270202]; Stony Brook University's Undergraduate Research and Creative Activities program; Laurie Landau and Jim Foundation; Marilyn Simons Foundation	Saltonstall Kennedy Program of the National Marine Fisheries Service of NOAA; Stony Brook University's Undergraduate Research and Creative Activities program; Laurie Landau and Jim Foundation; Marilyn Simons Foundation	This project was funded by the Saltonstall Kennedy Program of the National Marine Fisheries Service of NOAA (http://www.nmfs.noaa.gov/mb/financial_services/skhome.htm) in grant NA101NMF4270202 to M. Frisk, M. Fast and A. McElroy. S. Fitzgerald was partially supported by Stony Brook University's Undergraduate Research and Creative Activities program (http://www.stonybrook.edu/ureca/). The Shinnecock Bay Restoration Program received major funding from the Laurie Landau and Jim and Marilyn Simons Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina A, 2010, J EXP MAR BIOL ECOL, V391, P178, DOI 10.1016/j.jembe.2010.06.029; Asahida T, 1997, J EXP MAR BIOL ECOL, V217, P153, DOI 10.1016/S0022-0981(97)00039-7; ASMFC (Atlantic States Marine Fisheries Commission), 2006, ATLANTIC STATES MARI, V15, P4; Bauer LJ, 2010, ESTUAR COAST, V33, P678, DOI 10.1007/s12237-009-9237-x; Bauer LJ, 2010, ESTUAR COAST, V33, P668, DOI 10.1007/s12237-010-9277-2; Briggs PT, 1998, J SHELLFISH RES, V17, P487; Colton AR, 2011, EVALUATION SYNCHRONI; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; CT DEEP, 2011, STUD MAR RECR FISH C; DeLong AK, 2001, CAN J FISH AQUAT SCI, V58, P2233, DOI 10.1139/cjfas-58-11-2233; Fairchild EA, 2000, J SEA RES, V44, P81, DOI 10.1016/S1385-1101(00)00037-X; FITZ HC, 1991, MAR ECOL PROG SER, V76, P249, DOI 10.3354/meps076249; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hines A.H., 2010, BIOL MANAGEMENT EXPL, P109, DOI DOI 10.4027/BMECPCC.2010.22; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; LAUGHLIN RA, 1982, B MAR SCI, V32, P807; LEE WJ, 1995, J MOL EVOL, V41, P54; McGaw IJ, 2000, J EXP BIOL, V203, P359; Meise CJ, 2003, ESTUARIES, V26, P731, DOI 10.1007/BF02711984; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; NEFSC, 2011, 1102 NEFSC; Nuttal MA, 2010, HIST RECOUNT GREAT S; Nuttall MA, 2011, ECOL MODEL, V222, P3335, DOI 10.1016/j.ecolmodel.2011.07.004; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; PAUL RKG, 1981, MAR ECOL PROG SER, V6, P91, DOI 10.3354/meps006091; REICHERT MJM, 1991, NETH J SEA RES, V27, P375, DOI 10.1016/0077-7579(91)90040-8; ROPES JW, 1989, FISH B-NOAA, V87, P197; RYER CH, 1987, ESTUARIES, V10, P136, DOI 10.2307/1352178; Saitoh K, 2003, FISHERIES SCI, V69, P473, DOI 10.1046/j.1444-2906.2003.00647.x; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Socrates J.B., 2006, STUDY STRIPED BASS M; Stehlik LL, 2004, FISH B-NOAA, V102, P693; Sudo H, 2008, FISH RES, V89, P49, DOI 10.1016/j.fishres.2007.08.012; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taylor DL, 2005, J EXP MAR BIOL ECOL, V324, P112, DOI 10.1016/j.jembe.2005.04.014; Taylor DL, 2005, CAN J FISH AQUAT SCI, V62, P1611, DOI [10.1139/f05-047, 10.1139/F05-047]; Taylor DL, 2004, J EXP MAR BIOL ECOL, V301, P55, DOI 10.1016/j.jembe.2003.09.013; VANDERVEER HW, 1987, MAR ECOL PROG SER, V35, P203, DOI 10.3354/meps035203; WILCOX JR, 1974, BIOL BULL, V146, P424, DOI 10.2307/1540416; WITTING DA, 1993, FISH B-NOAA, V91, P577; Yencho MA, 2009, ABUNDANCE MORTALITY	42	16	16	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85101	10.1371/journal.pone.0085101	http://dx.doi.org/10.1371/journal.pone.0085101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454797	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500041
J	Wang, W; Wu, XG; Liu, ZJ; Zheng, HJ; Cheng, YX				Wang, Wei; Wu, Xugan; Liu, Zhijun; Zheng, Huajun; Cheng, Yongxu			Insights into Hepatopancreatic Functions for Nutrition Metabolism and Ovarian Development in the Crab Portunus trituberculatus: Gene Discovery in the Comparative Transcriptome of Different Hepatopancreas Stages	PLOS ONE			English	Article							CHINESE MITTEN CRAB; FATTY-ACID-COMPOSITION; BINDING PROTEIN; SWIMMING CRAB; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; LITOPENAEUS-VANNAMEI; METHYL FARNESOATE; TISSUE EXPRESSION; LIPID-COMPOSITION	The crustacean hepatopancreas has different functions including absorption, storage of nutrients and vitellogenesis during growth, and ovarian development. However, genetic information on the biological functions of the crustacean hepatopancreas during such processes is limited. The swimming crab, Portunus trituberculatus, is a commercially important species for both aquaculture and fisheries in the Asia-Pacific region. This study compared the transcriptome in the hepatopancreas of female P. trituberculatus during the growth and ovarian maturation stages by 454 high-throughput pyrosequencing and bioinformatics. The goal was to discover genes in the hepatopancreas involved in food digestion, nutrition metabolism and ovarian development, and to identify patterns of gene expression during growth and ovarian maturation. Our transcriptome produced 303,450 reads with an average length of 351 bp, and the high quality reads were assembled into 21,635 contigs and 31,844 singlets. Based on BLASTP searches of the deduced protein sequences, there were 7,762 contigs and 4,098 singlets with functional annotation. Further analysis revealed 33,427 unigenes with ORFs, including 17,388 contigs and 16,039 singlets in the hepatopancreas, while only 7,954 unigenes (5,691 contigs and 2,263 singlets) with the predicted protein sequences were annotated with biological functions. The deduced protein sequences were assigned to 3,734 GO terms, 25 COG categories and 294 specific pathways. Furthermore, there were 14, 534, and 22 identified unigenes involved in food digestion, nutrition metabolism and ovarian development, respectively. 212 differentially expressed genes (DEGs) were found between the growth and endogenous stage of the hepatopancreas, while there were 382 DEGs between the endogenous and exogenous stage hepatopancreas. Our results not only enhance the understanding of crustacean hepatopancreatic functions during growth and ovarian development, but also represent a basis for further research on new genes and functional genomics of P. trituberculatus or closely related species.	[Wang, Wei; Wu, Xugan; Liu, Zhijun; Cheng, Yongxu] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Shanghai Ocean University	Cheng, YX (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.	chengyongxucrablab@hotmail.com			Natural Science Foundation of China [41276158]; National High Technology Research R & D Program of China [2012AA10A409]; Shanghai Municipal Natural Science Foundation [12ZR1413000]; second batch innovation research group developing project in the universities of Shanghai [2009-026]; Shanghai Universities First-class Disciplines Project of Fisheries	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research R & D Program of China; Shanghai Municipal Natural Science Foundation; second batch innovation research group developing project in the universities of Shanghai; Shanghai Universities First-class Disciplines Project of Fisheries	This study was supported by the grants from the Natural Science Foundation of China (No. 41276158), the National High Technology Research R & D Program of China (No. 2012AA10A409), Shanghai Municipal Natural Science Foundation project (No. 12ZR1413000), the second batch innovation research group developing project in the universities of Shanghai (No. 2009-026) and Shanghai Universities First-class Disciplines Project of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Borst DW, 2001, AM ZOOL, V41, P430, DOI 10.1668/0003-1569(2001)041[0430:ROTCMO]2.0.CO;2; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Chan SM, 2005, ANN NY ACAD SCI, V1040, P74, DOI 10.1196/annals.1327.008; Chavez-Rios R, 2003, MOL BIOCHEM PARASIT, V127, P151, DOI 10.1016/S0166-6851(02)00332-8; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheng Yong-Xu, 1998, Acta Zoologica Sinica, V44, P420; Cheng Yongxu, 2000, Journal of Fisheries of China, V24, P113; Coccia E, 2010, BIOL BULL-US, V218, P36, DOI 10.1086/BBLv218n1p36; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Ding XueYan, 2010, Chinese Journal of Animal Nutrition, V22, P492; Du XJ, 2006, MOL IMMUNOL, V43, P1633, DOI 10.1016/j.molimm.2005.09.018; French SS, 2008, GEN COMP ENDOCR, V155, P148, DOI 10.1016/j.ygcen.2007.04.007; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; GHOSH D, 1993, GEN COMP ENDOCR, V89, P248, DOI 10.1006/gcen.1993.1030; Gibson R., 1979, Oceanography and Marine Biology an Annual Review, V17, P285; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gong YN, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-71; Gunawardene YINS, 2002, EUR J BIOCHEM, V269, P3587, DOI 10.1046/j.1432-1033.2002.03048.x; Gunawardene YINS, 2001, INSECT BIOCHEM MOLEC, V31, P1115, DOI 10.1016/S0965-1748(01)00060-1; Harrison S, 1999, GEN PHARMACOL-VASC S, V32, P287, DOI 10.1016/S0306-3623(98)00204-3; Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40; Holford KC, 2004, INSECT BIOCHEM MOLEC, V34, P785, DOI 10.1016/j.ibmb.2004.04.003; Homola E, 1997, COMP BIOCHEM PHYS B, V117, P347, DOI 10.1016/S0305-0491(96)00337-9; Hu KJ, 2007, COMP BIOCHEM PHYS B, V146, P69, DOI 10.1016/j.cbpb.2006.09.010; Huang QS, 2010, FISH SHELLFISH IMMUN, V29, P75, DOI 10.1016/j.fsi.2010.02.014; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kuballa AV, 2007, GEN COMP ENDOCR, V150, P48, DOI 10.1016/j.ygcen.2006.07.020; Kuballa AV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-575; Kung SY, 2004, BIOL REPROD, V71, P863, DOI 10.1095/biolreprod.103.022905; Lea PJ, 2003, PLANT PHYSIOL BIOCH, V41, P555, DOI 10.1016/S0981-9428(03)00060-3; Lee SO, 2011, COMP BIOCHEM PHYS B, V159, P148, DOI 10.1016/j.cbpb.2011.03.004; Lee SY, 2004, BIOCHEM BIOPH RES CO, V322, P490, DOI 10.1016/j.bbrc.2004.07.145; Li K, 2006, COMP BIOCHEM PHYS B, V143, P453, DOI 10.1016/j.cbpb.2005.12.019; Li Taiwu, 1996, Oceanologia et Limnologia Sinica, V27, P471; Liu Y, 2011, FISH SHELLFISH IMMUN, V31, P29, DOI 10.1016/j.fsi.2011.02.016; Liu ZJ, 2010, THESIS SHANGHAI OCEA; Lubzens E, 1997, J EXP ZOOL, V278, P339, DOI 10.1002/(SICI)1097-010X(19970815)278:6&lt;339::AID-JEZ1&gt;3.0.CO;2-P; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; McKenna MC, 2000, NEUROCHEM INT, V37, P229, DOI 10.1016/S0197-0186(00)00042-5; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miled N, 2000, BIOCHIMIE, V82, P973, DOI 10.1016/S0300-9084(00)01179-2; Minde DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046147; Mitic N, 2005, ARCH BIOCHEM BIOPHYS, V439, P154, DOI 10.1016/j.abb.2005.05.013; Mitoma J, 2004, GENE, V334, P15, DOI 10.1016/j.gene.2004.03.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Ots I, 1996, P ROY SOC B-BIOL SCI, V263, P1443, DOI 10.1098/rspb.1996.0210; Pan LQ, 2009, PERIODICAL OCEAN U C, V5; Pasquevich MY, 2011, COMP BIOCHEM PHYS B, V160, P201, DOI 10.1016/j.cbpb.2011.08.006; Perera E, 2008, COMP BIOCHEM PHYS B, V150, P247, DOI 10.1016/j.cbpb.2008.03.009; Peterfy M, 2012, BBA-MOL CELL BIOL L, V1821, P790, DOI 10.1016/j.bbalip.2011.10.006; Qiu GF, 2008, COMP BIOCHEM PHYS B, V150, P320, DOI 10.1016/j.cbpb.2008.03.016; RAINER J, 1993, COMP BIOCHEM PHYS B, V104, P69, DOI 10.1016/0305-0491(93)90339-7; Reddy PS, 2004, GEN COMP ENDOCR, V135, P35, DOI 10.1016/j.ygcen.2003.08.002; Rharrabe K, 2007, ARCH INSECT BIOCHEM, V65, P65, DOI 10.1002/arch.20191; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivera-Perez C, 2011, MAR GENOM, V4, P273, DOI 10.1016/j.margen.2011.07.002; Rocha J, 2012, AQUACULTURE, V330, P111, DOI 10.1016/j.aquaculture.2011.12.024; Rodriguez EM, 2002, J EXP ZOOL, V292, P82, DOI 10.1002/jez.1144; Ruan YH, 2010, FISH SHELLFISH IMMUN, V28, P542, DOI 10.1016/j.fsi.2009.12.013; Schenk G, 2013, COORDIN CHEM REV, V257, P473, DOI 10.1016/j.ccr.2012.03.020; Schroeder F, 2007, BBA-MOL CELL BIOL L, V1771, P700, DOI 10.1016/j.bbalip.2007.04.005; Seedorf U, 2000, BBA-MOL CELL BIOL L, V1486, P45, DOI 10.1016/S1388-1981(00)00047-0; Shen Jie, 2011, Journal of Fisheries of China, V35, P1481; SNYDER MJ, 1991, BIOL BULL, V180, P475, DOI 10.2307/1542348; Song H.T., 1989, MAR SCI B, V8, P66; Sricharoen S, 2005, DEV COMP IMMUNOL, V29, P1017, DOI 10.1016/j.dci.2005.03.010; Sun SM, 2012, FISH SHELLFISH IMMUN, V33, P1222, DOI 10.1016/j.fsi.2012.09.023; SWEVERS L, 1991, COMP BIOCHEM PHYS B, V99, P35, DOI 10.1016/0305-0491(91)90004-W; Terwilliger NB, 2005, J EXP BIOL, V208, P2467, DOI 10.1242/jeb.01667; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Vianey-Saban C, 1998, CLIN CHIM ACTA, V269, P43, DOI 10.1016/S0009-8981(97)00185-X; VOGT G, 1994, ZOOMORPHOLOGY, V114, P83, DOI 10.1007/BF00396642; VOGT G, 1989, HISTOCHEMISTRY, V91, P373, DOI 10.1007/BF00493824; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wen XB, 2006, AQUACULTURE, V252, P598, DOI 10.1016/j.aquaculture.2005.07.027; Wouters R, 2001, AQUACULTURE, V198, P307, DOI 10.1016/S0044-8486(01)00522-1; [吴静 Wu Jing], 2012, [食品与生物技术学报, Journal of Food Science and Biotechnology], V31, P793; Wu X, 2010, AQUACULT NUTR, V16, P25, DOI 10.1111/j.1365-2095.2008.00637.x; Wu XG, 2011, AQUAC RES, V42, P457, DOI 10.1111/j.1365-2109.2010.02643.x; Wu XG, 2010, AQUACULTURE, V301, P78, DOI 10.1016/j.aquaculture.2010.01.016; [吴旭干 WU Xugan], 2007, [海洋学报, Acta Oceanologica Sinica], V29, P120; Xie ZM, 2002, PORTUNUS TRITUBERCUL, P1; Xu QH, 2010, J EXP MAR BIOL ECOL, V394, P105, DOI 10.1016/j.jembe.2010.08.002; Yang F, 2005, COMP BIOCHEM PHYS B, V142, P456, DOI 10.1016/j.cbpb.2005.09.011; Yang PY, 2002, ANAL BIOCHEM, V308, P168, DOI 10.1016/S0003-2697(02)00218-X; [姚桂桂 YAO Guigui], 2008, [海洋学报, Acta Oceanologica Sinica], V30, P122; Yoshinari K, 2012, TOXICOL LETT, V208, P185, DOI 10.1016/j.toxlet.2011.11.003; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Zhang XM, 2012, PLOS ONE, V7; Zhang Y, 2011, THESIS SHANGHAI OCEA; Zhang YL, 2009, FISH SHELLFISH IMMUN, V27, P330, DOI 10.1016/j.fsi.2009.05.017	107	113	123	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84921	10.1371/journal.pone.0084921	http://dx.doi.org/10.1371/journal.pone.0084921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454766	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500025
J	Ding, H; Zhao, CJ; Cui, X; Gu, YF; Jia, WT; Rahaman, MN; Wang, Y; Huang, WH; Zhang, CQ				Ding, Hao; Zhao, Cun-Ju; Cui, Xu; Gu, Yi-Fei; Jia, Wei-Tao; Rahaman, Mohamed N.; Wang, Yang; Huang, Wen-Hai; Zhang, Chang-Qing			A Novel Injectable Borate Bioactive Glass Cement as an Antibiotic Delivery Vehicle for Treating Osteomyelitis	PLOS ONE			English	Article							CONTROLLABLE DEGRADATION BEHAVIOR; RESISTANT STAPHYLOCOCCUS-AUREUS; BONE SUBSTITUTE MATERIALS; CALCIUM-PHOSPHATE CEMENT; IN-VITRO; GLASS/CHITOSAN COMPOSITE; ADULT OSTEOMYELITIS; CARRIER MATERIAL; LOCAL-DELIVERY; DRUG-RELEASE	Background: A novel injectable cement composed of chitosan-bonded borate bioactive glass (BG) particles was evaluated as a carrier for local delivery of vancomycin in the treatment of osteomyelitis in a rabbit tibial model. Materials and Methods: The setting time, injectability, and compressive strength of the borate BG cement, and the release profile of vancomycin from the cement were measured in vitro. The capacity of the vancomycin-loaded BG cement to eradicate methicillin-resistant Staphylococcus aureus (MRSA)-induced osteomyelitis in rabbit tibiae in vivo was evaluated and compared with that for a vancomycin-loaded calcium sulfate (CS) cement and for intravenous injection of vancomycin. Results: The BG cement had an injectability of >90% during the first 3 minutes after mixing, hardened within 30 minutes and, after hardening, had a compressive strength of 18+/-2 MPa. Vancomycin was released from the BG cement into phosphate-buffered saline for up to 36 days, and the cumulative amount of vancomycin released was 86% of the amount initially loaded into the cement. In comparison, vancomycin was released from the CS cement for up 28 days and the cumulative amount released was 89%. Two months post-surgery, radiography and microbiological tests showed that the BG and CS cements had a better ability to eradicate osteomyelitis when compared to intravenous injection of vancomycin, but there was no significant difference between the BG and CS cements in eradicating the infection. Histological examination showed that the BG cement was biocompatible and had a good capacity for regenerating bone in the tibial defects. Conclusions: These results indicate that borate BG cement is a promising material both as an injectable carrier for vancomycin in the eradication of osteomyelitis and as an osteoconductive matrix to regenerate bone after the infection is cured.	[Jia, Wei-Tao; Wang, Yang; Zhang, Chang-Qing] Shanghai Jiao Tong Univ, Dept Orthoped Surg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Zhao, Cun-Ju] Liaocheng Peoples Hosp, Dept Orthoped Surg, Liaocheng, Shandong, Peoples R China; [Cui, Xu; Gu, Yi-Fei; Huang, Wen-Hai] Tongji Univ, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China; [Rahaman, Mohamed N.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO USA	Shanghai Jiao Tong University; Tongji University; University of Missouri System; Missouri University of Science & Technology	Huang, WH (corresponding author), Tongji Univ, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China.	whhuang@tongji.edu.cn; zcqgk@hotmail.com	Cui, Xu/P-1610-2015	zhang, changqing/0000-0002-7408-4126	National Natural Science Foundation of China [51072133, 81000788, 81201377]; Shanghai Science Committee [12JC1408500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science Committee	This work was supported by the National Natural Science Foundation of China through the project 51072133, 81000788 and 81201377, and by the Shanghai Science Committee through the project 12JC1408500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866; Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7; ASTM International C26699, 2007, C26699 ASTM INT; Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679; Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1; Cevher E, 2006, INT J PHARMACEUT, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014; Chang W, 2007, ACTA ORTHOP BELG, V73, P238; Cierny G, 2003, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000088564.81746.62; Englert C, 2007, UNFALLCHIRURG, V110, P408, DOI 10.1007/s00113-007-1229-3; Ginebra MP, 2001, J BIOMED MATER RES, V57, P113, DOI 10.1002/1097-4636(200110)57:1<113::AID-JBM1149>3.0.CO;2-5; GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6; Haleem AA, 2004, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.blo.0000144477.43661.59; Hanssen AD, 2005, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000175713.30506.77; Jia WT, 2010, INT J PHARMACEUT, V387, P184, DOI 10.1016/j.ijpharm.2009.12.002; Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011; Jia WT, 2010, ANTIMICROB AGENTS CH, V54, P170, DOI 10.1128/AAC.01122-09; Jiang JL, 2012, INFLAMM RES, V61, P207, DOI 10.1007/s00011-011-0402-x; Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083; Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008; Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371; Liu H, 2006, ACTA BIOMATER, V2, P557, DOI 10.1016/j.actbio.2006.03.007; Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615; McCann SJ, 2002, J ANTIMICROB CHEMOTH, V50, P107, DOI 10.1093/jac/dkf067; McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; National Committee for Clinical Laboratory Standards NCCLS, 2000, M7A5 NCCLS; NORDEN CW, 1980, BRIT J EXP PATHOL, V61, P451; Patwardhan S, 2013, J BONE JOINT SURG AM, V95A, DOI 10.2106/JBJS.K.01338; Phaechamud T, 2008, AAPS PHARMSCITECH, V9, P829, DOI 10.1208/s12249-008-9117-x; Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045; Sanicola Shawn M, 2005, J Foot Ankle Surg, V44, P121, DOI 10.1053/j.jfas.2005.01.006; Simpson AHRW, 2001, J BONE JOINT SURG BR, V83B, P403, DOI 10.1302/0301-620X.83B3.10727; Smeltzer MS, 1997, J ORTHOPAED RES, V15, P414, DOI 10.1002/jor.1100150314; Tang H, 2009, ARCH ORTHOP TRAUM SU, V129, P1301, DOI 10.1007/s00402-008-0782-8; Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012; Yao AH, 2007, CHINESE SCI BULL, V52, P272, DOI 10.1007/s11434-007-0023-5; Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x; Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6; Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312	39	35	40	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85472	10.1371/journal.pone.0085472	http://dx.doi.org/10.1371/journal.pone.0085472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427311	Green Submitted, gold, Green Published			2022-12-27	WOS:000329868200052
J	Mullerova, H; Lu, C; Li, H; Tabberer, M				Muellerova, Hana; Lu, Chao; Li, Hao; Tabberer, Maggie			Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care	PLOS ONE			English	Article							REPORTED OUTCOMES; DYSPNEA; COPD; SEVERITY; MECHANISMS; SYMPTOMS; HYPERINFLATION; EXACERBATION; POPULATION; SPIROMETRY	Background & Aims: Breathlessness is a primary clinical feature of chronic obstructive pulmonary disease (COPD). We aimed to describe the frequency of and factors associated with breathlessness in a cohort of COPD patients identified from the Clinical Practice Research Datalink (CPRD), a general practice electronic medical records database. Methods: Patients with a record of COPD diagnosis after January 1 2008 were identified in the CPRD. Breathlessness was assessed using the Medical Research Council (MRC) dyspnoea scale, with scoring ranging from 1-5, which has been routinely administered as a part of the regular assessment of patients with COPD in the general practice since April 2009. Stepwise multivariate logistic regression estimated independent associations with dyspnoea. Negative binomial regression evaluated a relationship between breathlessness and exacerbation rate during follow-up. Results: The total cohort comprised 49,438 patients diagnosed with COPD; 40,425 (82%) had any MRC dyspnoea grade recorded. Of those, 22,770 (46%) had moderate-to-severe dyspnoea (MRC >= 3). Breathlessness increased with increasing airflow limitation; however, moderate-to-severe dyspnoea was also observed in 32% of patients with mild airflow obstruction. Other factors associated with increased dyspnoea grade included female gender, older age (>= 70 years), obesity (BMI >= 30), history of moderate-to-severe COPD exacerbations, and frequent visits to the general practitioner. Patients with worse breathlessness were at higher risk of COPD exacerbations during follow-up. Conclusions: Moderate-to-severe dyspnoea was reported by >40% of patients diagnosed with COPD in primary care. Presence of dyspnoea, including even a perception of mild dyspnoea (MRC = 2), was associated with increased disease severity and a higher risk of COPD exacerbations during follow-up.	[Muellerova, Hana] GlaxoSmithKline R&D, Resp Epidemiol, Uxbridge, Middx, England; [Lu, Chao; Li, Hao] GlaxoSmithKline R&D, Observat Data Analyt, Res Triangle Pk, NC USA; [Tabberer, Maggie] GlaxoSmithKline R&D, Global Hlth Outcomes, Uxbridge, Middx, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Mullerova, H (corresponding author), GlaxoSmithKline R&D, Resp Epidemiol, Uxbridge, Middx, England.	hana.x.muellerova@gsk.com		Mullerova, Hana/0000-0002-0949-0101	GlaxoSmithKline Plc.	GlaxoSmithKline Plc.(GlaxoSmithKline)	Editorial support (in the form of development of a draft outline in consultation with the authors, development of a manuscript first draft in consultation with the authors, editorial suggestions to draft versions of this paper, analyses of key data to provide test statistics, assembling tables and figures, collating author comments, copyediting, fact checking, referencing and graphic services) was provided by Jane Davies and Carol Cooper of Caudex Medical and was funded by GlaxoSmithKline Plc. The open-access charge was paid for by GlaxoSmithKline Plc.	Bausewein C, 2007, RESP MED, V101, P399, DOI 10.1016/j.rmed.2006.07.003; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; BMA & NHS Employers, 2009, QUALITY OUTCOMES FRA; Booth Sara, 2009, Expert Rev Respir Med, V3, P21, DOI 10.1586/17476348.3.1.21; Burgel PR, 2012, RESP MED; Chronic Obstructive Pulmonary Disease, 2004, THORAX S1, V59; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dransfield MT, 2011, PRIM CARE RESP J, V20, P46, DOI 10.4104/pcrj.2010.00059; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Gold Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Howard K, 2012, VALUE HEALTH, V15, P1042, DOI 10.1016/j.jval.2012.06.018; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jolley CJ, 2009, EUR RESPIR REV, V18, P66, DOI 10.1183/09059180.00000809; Jones PW, 2011, EUR RESPIR J, V38, P29, DOI 10.1183/09031936.00177210; Jones PW, 2011, RESP MED, V105, P57, DOI 10.1016/j.rmed.2010.09.004; Jones P, 2012, INT J CHRONIC OBSTR, V7, P697, DOI 10.2147/COPD.S32675; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Laveneziana P, 2009, EUR J APPL PHYSIOL, V107, P633, DOI 10.1007/s00421-009-1169-4; Mahler DA, 2012, COPD, V9, P522, DOI 10.3109/15412555.2012.701678; NICE, 2007, MRC DYSPN SCAL; NICE, 2011, MAN CHRON OBSTR PULM; O'Donnell DE, 2006, EUR RESPIR REV, V15, P61, DOI 10.1183/09059180.00010002; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; O'Donnell Denis E, 2007, COPD, V4, P225, DOI 10.1080/15412550701480455; O'Donnell Denis E, 2007, Proc Am Thorac Soc, V4, P145, DOI 10.1513/pats.200611-159CC; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010; Oga T, 2007, RESP MED, V101, P146, DOI 10.1016/j.rmed.2006.04.001; Ora J, 2010, CURR OPIN PULM MED, V16, P144, DOI 10.1097/MCP.0b013e328334a728; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Redelmeier DA, 1996, CHEST, V109, P1163, DOI 10.1378/chest.109.5.1163; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Sahebjami H, 2000, AM J RESP CRIT CARE, V161, P886, DOI 10.1164/ajrccm.161.3.9905023; Sarkar S, 2006, PRIMARY CARE, V33, P643, DOI 10.1016/j.pop.2006.06.007; Sheel AW, 2011, CURR OPIN PHARMACOL, V11, P195, DOI 10.1016/j.coph.2011.04.004; Soriano JB, 2001, EUR J EPIDEMIOL, V17, P1075, DOI 10.1023/A:1021235123382; Strong M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-108; Uzaslan E, 2012, RESP MED, V106, pS45, DOI 10.1016/S0954-6111(12)70014-8; Walke LM, 2007, ARCH INTERN MED, V167, P2503, DOI 10.1001/archinte.167.22.2503; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	42	74	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85540	10.1371/journal.pone.0085540	http://dx.doi.org/10.1371/journal.pone.0085540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427316	Green Submitted, gold, Green Published			2022-12-27	WOS:000329868200057
J	Ye, TH; Xiong, Y; Yan, YP; Xia, Y; Song, XJ; Liu, L; Li, DL; Wang, NY; Zhang, LD; Zhu, YX; Zeng, J; Wei, YQ; Yu, LT				Ye, Tinghong; Xiong, Ying; Yan, Yupeng; Xia, Yong; Song, Xuejiao; Liu, Li; Li, Deliang; Wang, Ningyu; Zhang, Lidan; Zhu, Yongxia; Zeng, Jun; Wei, Yuquan; Yu, Luoting			The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; SUPPRESSOR-CELLS; STEM-CELLS; STAT3; EXPRESSION; CARCINOMA; SURVIVAL; GROWTH; PHOSPHORYLATION; DIFFERENTIATION	Breast carcinoma is the most common female cancer with considerable metastatic potential. Discovery of new therapeutic approaches for treatment of metastatic breast cancer is still needed. Here, we reported our finding with niclosamide, an FDA approved anthelmintic drug. The potency of niclosamide on breast cancer was assessed in vitro and in vivo. In this investigation, we found that niclosamide showed a dramatic growth inhibition against breast cancer cell lines and induced apoptosis of 4T1 cells in a dose-dependent manner. Further, Western blot analysis demonstrated the occurrence of its apoptosis was associated with activation of Cleaved caspases-3, down-regulation of Bcl-2, Mcl-1 and Survivin. Moreover, niclosamide blocked breast cancer cells migration and invasion, and the reduction of phosphorylated STAT3(Tyr705), phosphorylated FAK(Tyr925) and phosphorylated Src(Tyr416) were also observed. Furthermore, in our animal experiments, intraperitoneal administration of 20 mg/kg/d niclosamide suppressed 4T1 tumor growth without detectable toxicity. Histological and immunohistochemical analyses revealed a decrease in Ki67-positive cells, VEGF-positive cells and microvessel density (MVD) and an increase in Cleaved caspase-3-positive cells upon niclosamide. Notably, niclosamide reduced the number of myeloid-derived suppressor cells (MDSCs) in tumor tissues and blocked formation of pulmonary metastases. Taken together, these results demonstrated that niclosamide may be a promising candidate for breast cancer.	[Ye, Tinghong; Xiong, Ying; Yan, Yupeng; Xia, Yong; Song, Xuejiao; Liu, Li; Li, Deliang; Wang, Ningyu; Zhang, Lidan; Zhu, Yongxia; Zeng, Jun; Wei, Yuquan; Yu, Luoting] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Ye, Tinghong; Xiong, Ying; Yan, Yupeng; Xia, Yong; Song, Xuejiao; Liu, Li; Li, Deliang; Wang, Ningyu; Zhang, Lidan; Zhu, Yongxia; Zeng, Jun; Wei, Yuquan; Yu, Luoting] Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610064, Peoples R China; [Yan, Yupeng] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Liu, Li; Zhang, Lidan] Sichuan Univ, Coll Chem Engn, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wei, YQ (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	yuquawei@vip.sina.com; yuluot@scu.edu.cn		Wang, Ning-Yu/0000-0003-3571-4903	National Key Basic Research Program of China [2010 CB 529900]; National Natural Science Foundation of China [81123003]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Key Basic Research Program of China (2010 CB 529900) and the National Natural Science Foundation of China (81123003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BO, 2006, BREAST J, V12, pS54, DOI 10.1111/j.1075-122X.2006.00203.x; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brennan K, 2003, BREAST CANCER RES, V5, P69, DOI 10.1186/bcr559; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Cataldo L, 2000, INT J ONCOL, V17, P1179; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; GARIN J P, 1964, Lyon Med, V212, P1581; Hao H, 2011, CANCER LETT, V309, P85, DOI 10.1016/j.canlet.2011.05.020; Harrison H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3396; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Khan S, 2013, CANCER LETT, V337, P90, DOI 10.1016/j.canlet.2013.05.020; Kodumudi KN, 2010, CLIN CANCER RES, V16, P4583, DOI 10.1158/1078-0432.CCR-10-0733; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074670; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Page C, 2000, INT J ONCOL, V17, P23; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pulaski BA, 1998, CANCER RES, V58, P1486; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Saunders MM, 2001, CANCER RES, V61, P1765; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063900; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Wang AM, 2009, J CELL BIOCHEM, V106, P682, DOI 10.1002/jcb.22065; Wang YS, 2009, CLIN CANCER RES, V15, P6901, DOI 10.1158/1078-0432.CCR-09-0484; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074538; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wiebe JP, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3422; Xin H, 2011, CANCER RES, V71, P6601, DOI 10.1158/0008-5472.CAN-11-1217; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yo YT, 2012, MOL CANCER THER, V11, P1703, DOI 10.1158/1535-7163.MCT-12-0002; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	46	86	90	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85887	10.1371/journal.pone.0085887	http://dx.doi.org/10.1371/journal.pone.0085887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416452	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500267
J	Li, K; Precup, D; Perkins, TJ				Li, Kyle; Precup, Doina; Perkins, Theodore J.			Pooled Screening for Synergistic Interactions Subject to Blocking and Noise	PLOS ONE			English	Article							SHIFTED TRANSVERSAL DESIGN; PLURIPOTENT STEM-CELLS; POOLING STRATEGY; MULTICOMPONENT THERAPEUTICS; INTERACTION NETWORK; SYSTEMS; GENE; IDENTIFICATION; ALGORITHMS; INHIBITORS	The complex molecular networks in the cell can give rise to surprising interactions: gene deletions that are synthetically lethal, gene overexpressions that promote stemness or differentiation, synergistic drug interactions that heighten potency. Yet, the number of actual interactions is dwarfed by the number of potential interactions, and discovering them remains a major problem. Pooled screening, in which multiple factors are simultaneously tested for possible interactions, has the potential to increase the efficiency of searching for interactions among a large set of factors. However, pooling also carries with it the risk of masking genuine interactions due to antagonistic influence from other factors in the pool. Here, we explore several theoretical models of pooled screening, allowing for synergy and antagonism between factors, noisy measurements, and other forms of uncertainty. We investigate randomized sequential designs, deriving formulae for the expected number of tests that need to be performed to discover a synergistic interaction, and the optimal size of pools to test. We find that even in the presence of significant antagonistic interactions and testing noise, randomized pooled designs can significantly outperform exhaustive testing of all possible combinations. We also find that testing noise does not affect optimal pool size, and that mitigating noise by a selective approach to retesting outperforms naive replication of all tests. Finally, we show that a Bayesian approach can be used to handle uncertainty in problem parameters, such as the extent of synergistic and antagonistic interactions, resulting in schedules for adapting pool size during the course of testing.	[Li, Kyle; Precup, Doina; Perkins, Theodore J.] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Perkins, Theodore J.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Perkins, Theodore J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Perkins, TJ (corresponding author), McGill Univ, Sch Comp Sci, Montreal, PQ, Canada.	tperkins@ohri.ca		Perkins, Theodore J./0000-0002-6622-8003	National Sciences and Engineering Research Council of Canada; Ottawa Hospital Research Institute	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ottawa Hospital Research Institute	This work was supported by grants from the National Sciences and Engineering Research Council of Canada (to DP and to TJP) and the Ottawa Hospital Research Institute (TJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1999, Pac Symp Biocomput, P17; Akutsu T., 1998, P 9 ANN ACM SIAM S D, P695; Akutsu T, 1996, LECT NOTES COMPUTER, V1090, P290; Arpe J, 2003, LECT NOTES ARTIF INT, V2842, P99; Balding D.J., 1996, GENETIC MAPPING DNA, V81, P133; Bar-Lev SK, 2006, APPL STOCH MODEL BUS, V22, P281, DOI 10.1002/asmb.616; BARILLOT E, 1991, NUCLEIC ACIDS RES, V19, P6241, DOI 10.1093/nar/19.22.6241; Baxter Karen, 2008, Adverse Drug Reaction Bulletin, P951; Bertsekas D.P., 2005, DYNAMIC PROGRAMMING, VI; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Bshouty NH, 2005, J COMPUT SYST SCI, V71, P250, DOI 10.1016/j.jcss.2004.10.010; Chang FH, 2011, J COMB OPTIM, V22, P145, DOI 10.1007/s10878-009-9279-9; Chang H, 2010, J COMPUT BIOL, V17, P927, DOI 10.1089/cmb.2009.0138; Chen HB, 2011, J COMPUT BIOL, V18, P851, DOI 10.1089/cmb.2010.0030; Chen HB, 2009, DISCRETE APPL MATH, V157, P1581, DOI 10.1016/j.dam.2008.06.003; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'yachkov A, 2005, J COMPUT BIOL, V12, P1129, DOI 10.1089/cmb.2005.12.1129; Damaschke P, 2006, LECT NOTES COMPUT SC, V4123, P707; De Bonis A, 1998, INFORM PROCESS LETT, V67, P57, DOI 10.1016/S0020-0190(98)00088-X; De Bonis A, 2008, J COMB OPTIM, V15, P77, DOI 10.1007/s10878-007-9085-1; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Du D.Z., 2000, COMBINATORIAL GROUP; Farah MJ, 1997, CARN S COGN, P357; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Fukagawa D, 2005, INFORM PROCESS LETT, V93, P7, DOI 10.1016/j.ipl.2004.09.017; Hughes-Oliver J.M, 2006, POOLING EXPT BLOOD S; Kainkaryam RM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-256; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Krupa B, 2002, J THEOR BIOL, V219, P257, DOI 10.1006/jtbi.2002.3119; Langfeldt SA, 1997, I STAT MIMEOGRAPH SE, V2297; Macula AJ, 2004, DISCRETE APPL MATH, V137, P97, DOI 10.1016/S0166-218X(03)00191-4; Macula AJ., 1999, ANN COMB, V3, P61, DOI DOI 10.1007/BF01609876; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perkins TJ, 2010, IEEE ACM T COMPUT BI, V7, P118, DOI 10.1109/TCBB.2008.38; Perkins TJ, 2004, J THEOR BIOL, V230, P289, DOI 10.1016/j.jtbi.2004.05.022; Puri MC, 2012, STEM CELLS, V30, P10, DOI 10.1002/stem.788; Rais Y, 2013, NATURE IN PRESS; Remlinger KS, 2006, TECHNOMETRICS, V48, P133, DOI 10.1198/004017005000000481; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thai My T, 2007, Int J Bioinform Res Appl, V3, P145, DOI 10.1504/IJBRA.2007.013599; Thierry-Mieg N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-28; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Xie M, 2001, J AM STAT ASSOC, V96, P92, DOI 10.1198/016214501750333009; Xin XF, 2009, GENOME RES, V19, P1262, DOI 10.1101/gr.090019.108; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	52	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85864	10.1371/journal.pone.0085864	http://dx.doi.org/10.1371/journal.pone.0085864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454940	Green Published, gold, Green Submitted			2022-12-27	WOS:000330236000018
J	Dodo, K; Chono, H; Saito, N; Tanaka, Y; Tahara, K; Nukaya, I; Mineno, J				Dodo, Katsuyuki; Chono, Hideto; Saito, Naoki; Tanaka, Yoshinori; Tahara, Kenichi; Nukaya, Ikuei; Mineno, Junichi			An Efficient Large-Scale Retroviral Transduction Method Involving Preloading the Vector into a RetroNectin-Coated Bag with Low-Temperature Shaking	PLOS ONE			English	Article							HUMAN T-LYMPHOCYTES; GENE-TRANSFER; LEUKEMIA-VIRUS; TARGET-CELLS; HELPER-FREE; HIGH-TITER; FIBRONECTIN; THERAPY; CONSTRUCTION; OPTIMIZATION	In retroviral vector-mediated gene transfer, transduction efficiency can be hampered by inhibitory molecules derived from the culture fluid of virus producer cell lines. To remove these inhibitory molecules to enable better gene transduction, we had previously developed a transduction method using a fibronectin fragment-coated vessel (i.e., the RetroNectin-bound virus transduction method). In the present study, we developed a method that combined RetroNectin-bound virus transduction with low-temperature shaking and applied this method in manufacturing autologous retroviral-engineered T cells for adoptive transfer gene therapy in a large-scale closed system. Retroviral vector was preloaded into a RetroNectin-coated bag and incubated at 4 degrees C for 16 h on a reciprocating shaker at 50 rounds per minute. After the supernatant was removed, activated T cells were added to the bag. The bag transduction method has the advantage of increasing transduction efficiency, as simply flipping over the bag during gene transduction facilitates more efficient utilization of the retroviral vector adsorbed on the top and bottom surfaces of the bag. Finally, we performed validation runs of endoribonuclease MazF-modified CD4(+) T cell manufacturing for HIV-1 gene therapy and T cell receptor-modified T cell manufacturing for MAGE-A4 antigen-expressing cancer gene therapy and achieved over 200-fold (>= 10(10)) and 100-fold (>= 5x10(9)) expansion, respectively. In conclusion, we demonstrated that the large-scale closed transduction system is highly efficient for retroviral vector-based T cell manufacturing for adoptive transfer gene therapy, and this technology is expected to be amenable to automation and improve current clinical gene therapy protocols.	[Dodo, Katsuyuki; Chono, Hideto; Saito, Naoki; Tanaka, Yoshinori; Tahara, Kenichi; Nukaya, Ikuei; Mineno, Junichi] Takara Bio Inc Seta, Ctr Cell & Gene Therapy, Otsu, Shiga, Japan		Chono, H (corresponding author), Takara Bio Inc Seta, Ctr Cell & Gene Therapy, Otsu, Shiga, Japan.	chonoh@takara-bio.co.jp						Andreadis ST, 1997, J VIROL, V71, P7541, DOI 10.1128/JVI.71.10.7541-7548.1997; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Bowles NE, 1996, HUM GENE THER, V7, P1735, DOI 10.1089/hum.1996.7.14-1735; Brentjens RJ, 2012, HEMATOL-AM SOC HEMAT, P143, DOI 10.1182/asheducation-2012.1.143; Chono H, 2001, J BIOCHEM, V130, P331, DOI 10.1093/oxfordjournals.jbchem.a002990; Chono H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023585; Chono H, 2011, HUM GENE THER, V22, P35, DOI 10.1089/hum.2010.001; Chono H, 2011, J BIOCHEM, V149, P285, DOI 10.1093/jb/mvq135; Chuck AS, 1996, HUM GENE THER, V7, P743, DOI 10.1089/hum.1996.7.6-743; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Dardalhon V, 1999, HUM GENE THER, V10, P5, DOI 10.1089/10430349950019147; Davis JL, 1997, HUM GENE THER, V8, P1459, DOI 10.1089/hum.1997.8.12-1459; Forestell SP, 1995, GENE THER, V2, P723; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hoxie JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007179; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; June C, 2012, NAT BIOTECHNOL, V30, P611, DOI 10.1038/nbt.2305; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kildebeck E, 2012, CURR OPIN PEDIATR, V24, P731, DOI 10.1097/MOP.0b013e328359e480; KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572; Lamers CHJ, 2008, CYTOTHERAPY, V10, P406, DOI 10.1080/14653240801982961; LeDoux JM, 1996, J VIROL, V70, P6468, DOI 10.1128/JVI.70.9.6468-6473.1996; Lee JT, 2004, GENE THER, V11, P94, DOI 10.1038/sj.gt.3302138; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MILLER AD, 1991, J VIROL, V65, P2220, DOI 10.1128/JVI.65.5.2220-2224.1991; Moritz T, 1996, BLOOD, V88, P855, DOI 10.1182/blood.V88.3.855.bloodjournal883855; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Okamoto M, 2013, HUM GENE THER METHOD, V24, P94, DOI 10.1089/hgtb.2012.131; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; OLAH Z, 1994, J BIOL CHEM, V269, P25426; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pollok KE, 1998, J VIROL, V72, P4882, DOI 10.1128/JVI.72.6.4882-4892.1998; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Quintas-Cardama A, 2007, HUM GENE THER, V18, P1253, DOI 10.1089/hum.2007.088; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Seppen J, 1997, BIOTECHNIQUES, V23, P788, DOI 10.2144/97235bm04; Tebas P, 2013, BLOOD, V121, P1524, DOI 10.1182/blood-2012-07-447250; Tonks A, 2005, BIOTECHNOL PROGR, V21, P953, DOI 10.1021/bp0500314; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Yang SL, 1999, HUM GENE THER, V10, P123, DOI 10.1089/10430349950019255; YODER MC, 1995, EXP HEMATOL, V23, P961; Yu S, 2008, CANCER GENE THER, V15, P508, DOI 10.1038/cgt.2008.21; Zhou P, 2001, HUM GENE THER, V12, P1843, DOI 10.1089/104303401753153901	48	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86275	10.1371/journal.pone.0086275	http://dx.doi.org/10.1371/journal.pone.0086275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454964	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100150
J	Greenhill, SD; Chamberlain, SEL; Lench, A; Massey, PV; Yuill, KH; Woodhall, GL; Jones, RSG				Greenhill, Stuart David; Chamberlain, Sophie Elizabeth Lyn; Lench, Alex; Massey, Peter Vernon; Yuill, Kathryn Heather; Woodhall, Gavin Lawrence; Jones, Roland Spencer Gwynne			Background Synaptic Activity in Rat Entorhinal Cortex Shows a Progressively Greater Dominance of Inhibition over Excitation from Deep to Superficial Layers	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; TEMPORAL-LOBE EPILEPSY; PARVALBUMIN-IMMUNOREACTIVE NEURONS; MEMBRANE-POTENTIAL FLUCTUATIONS; COMPLEX PARTIAL SEIZURES; AMINO-ACID RECEPTORS; IN-VITRO; GAMMA-OSCILLATIONS; EPILEPTIFORM DISCHARGES; DIFFERENTIAL ELECTRORESPONSIVENESS	The entorhinal cortex (EC) controls hippocampal input and output, playing major roles in memory and spatial navigation. Different layers of the EC subserve different functions and a number of studies have compared properties of neurones across layers. We have studied synaptic inhibition and excitation in EC neurones, and we have previously compared spontaneous synaptic release of glutamate and GABA using patch clamp recordings of synaptic currents in principal neurones of layers II (L2) and V (L5). Here, we add comparative studies in layer III (L3). Such studies essentially look at neuronal activity from a presynaptic viewpoint. To correlate this with the postsynaptic consequences of spontaneous transmitter release, we have determined global postsynaptic conductances mediated by the two transmitters, using a method to estimate conductances from membrane potential fluctuations. We have previously presented some of this data for L3 and now extend to L2 and L5. Inhibition dominates excitation in all layers but the ratio follows a clear rank order (highest to lowest) of L2 > L3 > L5. The variance of the background conductances was markedly higher for excitation and inhibition in L2 compared to L3 or L5. We also show that induction of synchronized network epileptiform activity by blockade of GABA inhibition reveals a relative reluctance of L2 to participate in such activity. This was associated with maintenance of a dominant background inhibition in L2, whereas in L3 and L5 the absolute level of inhibition fell below that of excitation, coincident with the appearance of synchronized discharges. Further experiments identified potential roles for competition for bicuculline by ambient GABA at the GABA(A) receptor, and strychnine-sensitive glycine receptors in residual inhibition in L2. We discuss our results in terms of control of excitability in neuronal subpopulations of EC neurones and what these may suggest for their functional roles.	[Greenhill, Stuart David; Chamberlain, Sophie Elizabeth Lyn; Lench, Alex; Massey, Peter Vernon; Jones, Roland Spencer Gwynne] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Woodhall, Gavin Lawrence] Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England; [Yuill, Kathryn Heather] Univ Plymouth, Sch Biomed & Healthcare Sci, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Yuill, Kathryn Heather] Univ Plymouth, Sch Biomed & Healthcare Sci, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England	University of Bath; Aston University; University of Plymouth; University of Plymouth	Jones, RSG (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Claverton Down, Bath BA2 7AY, Avon, England.	r.s.g.jones@bath.ac.uk	Greenhill, Stuart D./N-9412-2019; Jones, Roland/K-1539-2016	Jones, Roland/0000-0002-3072-7505; woodhall, gavin/0000-0003-1281-9008; Greenhill, Stuart/0000-0002-5038-5258	NC3Rs [G1000059]; University of Bath; BBSRC; Medical Research Council [1096590] Funding Source: researchfish	NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); University of Bath; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Peter Massey is supported by the NC3Rs (Grant Number G1000059; http://www.nc3rs.org.uk/). Alex Lench is an MRC student. Stuart Greenhill received a studentship from the University of Bath. Sophie Chamberlain received a studentship from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Arellano JL, 2002, CEREB CORTEX, V12, P617, DOI 10.1093/cercor/12.6.617; Avoli M, 1996, J NEUROSCI, V16, P3912; Bailey SJ, 2004, NEUROPHARMACOLOGY, V46, P31, DOI 10.1016/j.neuropharm.2003.07.001; BEAR J, 1993, EPILEPSY RES, V14, P183, DOI 10.1016/0920-1211(93)90043-7; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Berretta N, 1996, J NEUROPHYSIOL, V76, P1089, DOI 10.1152/jn.1996.76.2.1089; Breustedt J, 2004, EUR J NEUROSCI, V19, P1987, DOI 10.1111/j.1460-9568.2004.03266.x; Buchheim K, 2002, EXP NEUROL, V175, P76, DOI 10.1006/exnr.2002.7893; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Cunningham MO, 2006, J NEUROSCI, V26, P2767, DOI 10.1523/JNEUROSCI.5054-05.2006; Cunningham MO, 2004, J PHYSIOL-LONDON, V559, P347, DOI 10.1113/jphysiol.2004.068973; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Cunningham MO, 2003, J NEUROSCI, V23, P9761; D'Arcangelo G, 2001, NEUROBIOL DIS, V8, P993, DOI 10.1006/nbdi.2001.0445; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2010, FRONT CELL NEUROSCI, V4, P1; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; DU F, 1993, EPILEPSY RES, V16, P223, DOI 10.1016/0920-1211(93)90083-J; Eichenbaum H, 2001, NAT NEUROSCI, V4, P1057, DOI 10.1038/nn1101-1057; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; GOLDRING S, 1992, J NEUROSURG, V77, P185, DOI 10.3171/jns.1992.77.2.0185; Greenhill SD, 2007, NEUROSCIENCE, V147, P884, DOI 10.1016/j.neuroscience.2007.05.016; Greenhill SD, 2010, NEUROSCIENCE, V167, P456, DOI 10.1016/j.neuroscience.2010.02.021; Greenhill SD, 2012, NEUROPHARMACOLOGY, V62, P807, DOI 10.1016/j.neuropharm.2011.09.006; Hamam BN, 2000, J COMP NEUROL, V418, P457; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; JONES RSG, 1994, HIPPOCAMPUS, V4, P335, DOI 10.1002/hipo.450040317; JONES RSG, 1990, EXP BRAIN RES, V80, P310; JONES RSG, 1990, NEUROSCIENCE, V34, P657, DOI 10.1016/0306-4522(90)90172-Z; JONES RSG, 1988, BRAIN RES, V457, P113, DOI 10.1016/0006-8993(88)90062-5; JONES RSG, 1988, J NEUROPHYSIOL, V59, P1476, DOI 10.1152/jn.1988.59.5.1476; Jones RSG, 2005, J PHYSIOL-LONDON, V562, P107, DOI 10.1113/jphysiol.2004.076133; Jones RSG, 1993, NEUROSCI LETT, V149, P5; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; KOHLER C, 1982, J COMP NEUROL, V210, P136, DOI 10.1002/cne.902100204; KOHLER C, 1983, ANAT EMBRYOL, V167, P151, DOI 10.1007/BF00298508; Kohler C, 1985, ANAT EMBRYOL, V173, P335; Lopantsev V, 1996, NEUROSCI LETT, V210, P5, DOI 10.1016/0304-3940(96)12656-2; LOTHMAN EW, 1990, EPILEPSY RES, V6, P110, DOI 10.1016/0920-1211(90)90085-A; LOTSTRA F, 1987, NEUROSCI LETT, V80, P191, DOI 10.1016/0304-3940(87)90652-5; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Miettinen M, 1997, J COMP NEUROL, V378, P363; Miettinen M, 1996, BRAIN RES, V706, P113, DOI 10.1016/0006-8993(95)01203-6; Mikkonen M, 1997, J COMP NEUROL, V388, P64; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; RAFIQ A, 1993, J NEUROPHYSIOL, V70, P1962, DOI 10.1152/jn.1993.70.5.1962; ROGERS JH, 1992, BRAIN RES, V587, P147, DOI 10.1016/0006-8993(92)91439-L; Rudolph M, 2004, J PHYSIOL-PARIS, V98, P452, DOI 10.1016/j.jphysparis.2005.09.015; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; RUTECKI PA, 1989, J NEUROSURG, V70, P667, DOI 10.3171/jns.1989.70.5.0667; Schmitz D, 1998, NEUROSCIENCE, V85, P999, DOI 10.1016/S0306-4522(98)00113-4; Shu YS, 2003, J NEUROSCI, V23, P10388; Siegel AN, 1990, EPILEPSY RES, V63, P56; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Sperling MR, 1996, JAMA-J AM MED ASSOC, V276, P470, DOI 10.1001/jama.276.6.470; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; Traub RD, 2005, J PHYSIOL-LONDON, V562, P3, DOI 10.1113/jphysiol.2004.074641; Traub RD, 2003, P NATL ACAD SCI USA, V100, P11047, DOI 10.1073/pnas.1934854100; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Weissinger F, 2000, NEUROBIOL DIS, V7, P286, DOI 10.1006/nbdi.2000.0298; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Woodhall GL, 2005, HIPPOCAMPUS, V15, P232, DOI 10.1002/hipo.20047; Wouterlood FG, 2000, HIPPOCAMPUS, V10, P77, DOI 10.1002/(SICI)1098-1063(2000)10:1<77::AID-HIPO8>3.3.CO;2-G; Wouterlood FG, 2000, J COMP NEUROL, V425, P177, DOI 10.1002/1096-9861(20000918)425:2<177::AID-CNE2>3.0.CO;2-G; WOUTERLOOD FG, 1995, J NEUROCYTOL, V24, P135, DOI 10.1007/BF01181556	79	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85125	10.1371/journal.pone.0085125	http://dx.doi.org/10.1371/journal.pone.0085125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454801	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100055
J	Qureshi, NK; Yin, SH; Boyle-Vavra, S				Qureshi, Nadia K.; Yin, Shaohui; Boyle-Vavra, Susan			The Role of the Staphylococcal VraTSR Regulatory System on Vancomycin Resistance and vanA Operon Expression in Vancomycin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							CELL-WALL; GLYCOPEPTIDE RESISTANCE; METHICILLIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CLINICAL STRAINS; VRASR; SUSCEPTIBILITY; ACTIVATION; PLASMID	Vancomycin is often the preferred treatment for invasive methicillin-resistant Staphylococcus aureus (MRSA) infection. With the increase in incidence of MRSA infections, the use of vancomycin has increased and, as feared, isolates of vancomycin-resistant Staphylococcus aureus (VRSA) have emerged. VRSA isolates have acquired the entercoccal vanA operon contained on transposon (Tn) 1546 residing on a conjugal plasmid. VraTSR is a vancomycin and beta-lactam-inducible three-component regulatory system encoded on the S. aureus chromosome that modulates the cell-wall stress response to cell-wall acting antibiotics. Mutation in vraTSR has shown to increase susceptibility to beta-lactams and vancomycin in clinical VISA strains and in recombinant strain COLVA-200 which expresses a plasmid borne vanA operon. To date, the role of VraTSR in vanA operon expression in VRSA has not been demonstrated. In this study, the vraTSR operon was deleted from the first clinical VRSA strain (VRS1) by transduction with phage harvested from a USA300 vraTSR operon deletion strain. The absence of the vraTSR operon and presence of the vanA operon were confirmed in the transductant (VRS1 Delta vra) by PCR. Broth MIC determinations, demonstrated that the vancomycin MIC of VRS1 Delta vra (64 mg/ml) decreased by 16-fold compared with VRS1 (1024 mg/ml). The effect of the vraTSR operon deletion on expression of the van gene cluster (vanA, vanX and vanR) was examined by quantitative RT-PCR using relative quantification. A 2-5-fold decreased expression of the vanA operon genes occured in strain VRS1 Delta vra at stationary growth phase compared with the parent strain, VRS1. Both vancomycin resistance and vancomycin-induced expression of vanA and vanR were restored by complementation with a plasmid harboring the vraTSR operon. These findings demonstrate that expression in S. aureus of the horizontally acquired enterococcal vanA gene cluster is enhanced by the staphylococcal three-component cell wall stress regulatory system VraTSR, that is present in all S. aureus strains.	[Qureshi, Nadia K.; Yin, Shaohui; Boyle-Vavra, Susan] Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA	University of Chicago	Boyle-Vavra, S (corresponding author), Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA.	sboyleva@uchicago.edu		Qureshi, Nadia/0000-0003-2629-4986	National Center for Research Resources [UL1RR02499]; Grant Health Care Foundation; National Institutes of Health [NIAID R56 AI04048]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Grant Health Care Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Nadia K. Qureshi was supported by the National Center for Research Resources (grant number UL1RR024999). Susan Boyle-Vavra was supported by the Grant Health Care Foundation and the National Institutes of Health (NIAID R56 AI04048). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum PC, 2007, INT J ANTIMICROB AG, V30, P398, DOI 10.1016/j.ijantimicag.2007.07.011; Arthur M, 1997, J BACTERIOL, V179, P97, DOI 10.1128/jb.179.1.97-106.1997; Arthur M, 2001, ANTIMICROB AGENTS CH, V45, P375, DOI 10.1128/AAC.45.2.375-381.2001; Berger-Bachi B, 1998, DRUG RESIST UPDATE, V1, P325, DOI 10.1016/S1368-7646(98)80048-4; Boyle-Vavra S, 2001, J ANTIMICROB CHEMOTH, V48, P617, DOI 10.1093/jac/48.5.617; Boyle-Vavra S, 2001, ANTIMICROB AGENTS CH, V45, P280, DOI 10.1128/AAC.45.1.280-287.2001; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Boyle-Vavra S, 2013, ANTIMICROB AGENTS CH, V57, P83, DOI 10.1128/AAC.01651-12; Bozdogan B, 2004, ANTIMICROB AGENTS CH, V48, P4762, DOI 10.1128/AAC.48.12.4762-4765.2004; BRISSONNOEL A, 1990, ANTIMICROB AGENTS CH, V34, P924, DOI 10.1128/AAC.34.5.924; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Clinical and Laboratory Standards Institute (CLSI), 2006, METH DIL ANT SUSC TE; COHEN S, 1973, J BACTERIOL, V116, P803, DOI 10.1128/JB.116.2.803-811.1973; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Depardieu F, 2003, MOL MICROBIOL, V50, P1069, DOI 10.1046/j.1365-2958.2003.03771.x; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Gardete S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002505; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P199, DOI 10.1093/jac/42.2.199; HANDWERGER S, 1992, J BACTERIOL, V174, P5982, DOI 10.1128/jb.174.18.5982-5984.1992; Jo DS, 2011, ANTIMICROB AGENTS CH, V55, P2818, DOI 10.1128/AAC.01704-10; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livermore DM, 2000, INT J ANTIMICROB AG, V16, pS3; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Perichon B, 2006, ANTIMICROB AGENTS CH, V50, P3622, DOI 10.1128/AAC.00410-06; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Yin SH, 2006, ANTIMICROB AGENTS CH, V50, P336, DOI 10.1128/AAC.50.1.336-343.2006	33	20	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85873	10.1371/journal.pone.0085873	http://dx.doi.org/10.1371/journal.pone.0085873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454941	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100138
J	Caldas, GFR; Oliveira, ARD; Araujo, AV; Quixabeira, DCA; Silva-Neto, JD; Costa-Silva, JH; de Menezes, IRA; Ferreira, F; Leite, ACL; da Costa, JGM; Wanderley, AG				Rocha Caldas, Germana Freire; da Silva Oliveira, Alisson Rodrigo; Araujo, Alice Valenca; Alves Quixabeira, Dafne Carolina; Silva-Neto, Jacinto da Costa; Costa-Silva, Joao Henrique; Alencar de Menezes, Irwin Rose; Ferreira, Fabiano; Lima Leite, Ana Cristina; Martins da Costa, Jose Galberto; Wanderley, Almir Goncalves			Gastroprotective and Ulcer Healing Effects of Essential Oil of Hyptis martiusii Benth. (Lamiaceae)	PLOS ONE			English	Article							NEUTROPHIL INFILTRATION; ANTIOXIDANT CAPACITY; GASTRIC-ULCER; NITRIC-OXIDE; PLANTS; RATS; PROSTAGLANDINS; SULFHYDRYLS; EXTRACT; FOOD	Hyptis martiusii Benth. is an aromatic plant found in abundance in northeastern Brazil that is used in ethnomedicine to treat gastric disorders. The aim of this study was to elucidate the mechanisms of action involved in the gastroprotection of the essential oil of Hyptis martiusii (EOHM) and to evaluate its healing capacity. Wistar rats were exposed to different protocols and subsequently were treated with 1% Tween-80 aqueous solution (negative control), pantoprazole, carbenoxolone, N-acetylcysteine (depending on the specificity of each model) or EOHM. The antisecretory activity (basal or stimulated) was determined using the pyloric ligature method. The gastroprotective action of nitric oxide and sulphydryl groups (-SH groups), as well as the quantification of adherent mucus and the levels of malondialdehyde and -SH groups in gastric mucosa, were evaluated using ethanol-induced gastric ulcer model. The healing ability was evaluated using the acetic acidinduced gastric ulcer model and histological and immunohistochemical analysis (HE, PAS and PCNA). EOHM (400 mg/ kg) reduced the volume and acidity of gastric secretion stimulated by histamine and pentagastrin. The gastroprotective effect of EOHM involves the participation of endogenous sulfhydryl groups. EOHM increased mucus production (54.8%), reduced levels of MDA (72.5%) and prevented the depletion of -SH groups (73.8%) in the gastric mucosa. The treatment with EOHM reduced in 70.3% the gastric lesion area, promoting significant regeneration of the gastric mucosa, as confirmed by histological analysis and analysis of proliferating cell nuclear antigen. The results show that gastroprotective effect of EOHM is mediated by cytoprotective and antioxidant mechanisms and by their antisecretory activity, and suggest that the essential oil of Hyptis martiusii is a promising candidate for the treatment of gastric ulcers.	[Rocha Caldas, Germana Freire; Lima Leite, Ana Cristina; Wanderley, Almir Goncalves] Univ Fed Pernambuco, Dept Pharmaceut Sci, Recife, PE, Brazil; [da Silva Oliveira, Alisson Rodrigo; Araujo, Alice Valenca; Ferreira, Fabiano; Wanderley, Almir Goncalves] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil; [Alves Quixabeira, Dafne Carolina; Silva-Neto, Jacinto da Costa] Univ Fed Pernambuco, Dept Histol & Embryol, Recife, PE, Brazil; [Costa-Silva, Joao Henrique] Univ Fed Pernambuco, Dept Phys Educ & Sport Sci, Vitoria De Santo Antao, PE, Brazil; [Alencar de Menezes, Irwin Rose; Martins da Costa, Jose Galberto] Reg Univ Cariri, Dept Biol Chem, Crato, Ceara, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Regional do Cariri	Wanderley, AG (corresponding author), Univ Fed Pernambuco, Dept Pharmaceut Sci, Recife, PE, Brazil.	almirgw@globo.com	Costa, Jose Galberto/L-6022-2016; WANDERLEY, ALMIR GONÇALVES/T-3087-2019; Silva Neto, Jacinto da Costa/R-5602-2017; Costa-Silva, João Henrique/D-1372-2014; de Menezes, Irwin Rose Alencar/A-6777-2012; Araújo, Alice V/S-2346-2018; Costa, Jose Galberto Martins/AFP-6381-2022; CALDAS, GERMANA/O-7180-2014; Lima Leite, Ana/C-5430-2013	Costa, Jose Galberto/0000-0002-0730-7246; WANDERLEY, ALMIR GONÇALVES/0000-0001-5193-1153; Silva Neto, Jacinto da Costa/0000-0003-4418-801X; Costa-Silva, João Henrique/0000-0002-9794-1418; de Menezes, Irwin Rose Alencar/0000-0003-1065-9581; Costa, Jose Galberto Martins/0000-0003-4268-663X; CALDAS, GERMANA/0000-0002-7655-2974; Quixabeira, Dafne/0000-0003-2614-3942; Lima Leite, Ana/0000-0002-9346-2292	CNPq [483470/2009-0, 305256/2009-2]; GFRC [554207/2010-9]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GFRC	CNPq (projects no.: 483470/2009-0 and 305256/2009-2) Grants doctoral scholarship from GFRC (process no.: 554207/2010-9) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Agra MD, 2008, REV BRAS FARMACOGN, V18, P472, DOI 10.1590/S0102-695X2008000300023; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; Amakura Y, 2002, FOOD CHEM, V77, P47, DOI 10.1016/S0308-8146(01)00321-1; Arrieta J, 2003, PLANTA MED, V69, P905, DOI 10.1055/s-2003-45098; Avila JR, 1996, INFLAMM RES, V45, P83, DOI 10.1007/BF02265120; Araujo ECD, 2006, Z NATURFORSCH C, V61, P177; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Chow DKL, 2009, BEST PRACT RES CL GA, V23, P3, DOI 10.1016/j.bpg.2008.11.010; Corne S.J., 1974, J PHYSL, V242, P116; Costa J. G. M., 2005, REV BRAS FARMACOGN, V15, P304, DOI DOI 10.1590/S0102-695X2005000400008; Costa-Lotufo LV, 2004, PHARMAZIE, V59, P78; Coutinho HDM, 2008, REV BRAS FARMACOGN, V18, P670, DOI 10.1590/S0102-695X2008000500005; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Diniz LRL, 2013, J ETHNOPHARMACOL, V149, P694, DOI 10.1016/j.jep.2013.07.026; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Matsuda H, 1999, LIFE SCI, V65, pPL27, DOI 10.1016/S0024-3205(99)00241-6; McNeil M, 2011, NAT PROD COMMUN, V6, P1775; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ojeda-Sana AM, 2013, FOOD CONTROL, V31, P189, DOI 10.1016/j.foodcont.2012.09.022; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; Park S, 2004, DIGEST DIS SCI, V49, P384, DOI 10.1023/B:DDAS.0000020490.34220.6d; Sobrinho TJSP, 2011, AFR J PHARM PHARMACO, V5, P2310, DOI 10.5897/AJPP11.608; Rebelo MM, 2009, REV BRAS FARMACOGN, V19, P230, DOI 10.1590/S0102-695X2009000200009; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; Caldas GFR, 2011, J ETHNOPHARMACOL, V137, P886, DOI 10.1016/j.jep.2011.07.005; Rozza AL, 2013, FUND CLIN PHARMACOL, V27, P51, DOI 10.1111/j.1472-8206.2012.01067.x; Samonina G.E., 2004, Pathophysiology, V11, P1, DOI 10.1016/j.pathophys.2003.10.008; Santos AKL, 2010, PHARMACOGN MAG, V6, P335, DOI 10.4103/0973-1296.71789; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; TAKAGI K, 1969, JPN J PHARMACOL, V19, P418, DOI 10.1254/jjp.19.418; Takayama C, 2011, J ETHNOPHARMACOL, V135, P147, DOI 10.1016/j.jep.2011.03.002; Wang L, 2008, CAN J PHYSIOL PHARM, V86, P97, DOI [10.1139/Y08-003, 10.1139/y08-003]; Yanishlieva NV, 1999, FOOD CHEM, V64, P59, DOI 10.1016/S0308-8146(98)00086-7	36	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84400	10.1371/journal.pone.0084400	http://dx.doi.org/10.1371/journal.pone.0084400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454726	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100022
J	Shuryak, I; Bryan, RA; Nosanchuk, JD; Dadachova, E				Shuryak, Igor; Bryan, Ruth A.; Nosanchuk, Joshua D.; Dadachova, Ekaterina			Mathematical Modeling Predicts Enhanced Growth of X-Ray Irradiated Pigmented Fungi	PLOS ONE			English	Article							IONIZING-RADIATION; GAMMA-RADIATION; MELANIN; MICROFUNGI	Ionizing radiation is known for its cytotoxic and mutagenic properties. However, recent evidence suggests that chronic sublethal irradiation stimulates the growth of melanin-pigmented (melanized) fungi, supporting the hypothesis that interactions between melanin and ionizing photons generate energy useful for fungal growth, and/or regulate growth-promoting genes. There are no quantitative models of how fungal proliferation is affected by ionizing photon energy, dose rate, and presence versus absence of melanin on the same genetic background. Here we present such a model, which we test using experimental data on melanin-modulated radiation-induced proliferation enhancement in the fungus Cryptococcus neoformans, exposed to two different peak energies (150 and 320 kVp) over a wide range of X-ray dose rates. Our analysis demonstrates that radiation-induced proliferation enhancement in C. neoformans behaves as a binary "on/off'' phenomenon, which is triggered by dose rates <0.002 mGy/h, and stays in the "on'' position. A competing dose rate-dependent growth inhibition becomes apparent at dose rates <5000 mGy/h. Proliferation enhancement of irradiated cells compared with unirradiated controls occurs at both X-ray peak energies, but its magnitude is modulated by X-ray peak energy and cell melanization. At dose rates <5000 mGy/h, both melanized and non-melanized cells exposed to 150 kVp Xrays, and non-melanized cells exposed to 320 kVp X-rays, all exhibit the same proliferation enhancement: on average, chronic irradiation stimulates each founder cell to produce 100 (95% CI: 83, 116) extra descendants over 48 hours. Interactions between melanin and 320 kVp X-rays result in a significant (2-tailed p-value = 4.8x10(-5)) additional increase in the number of radiation-induced descendants per founder cell: by 55 (95% CI: 29, 81). These results show that both melanin-dependent and melanin-independent mechanisms are involved in radiation-induced fungal growth enhancement, and implicate direct and/or indirect interactions of melanin with high energy ionizing photons as an important pro-proliferative factor.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; [Bryan, Ruth A.; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@columbia.edu	Dadachova, Ekaterina/I-7838-2013; Nosanchuk, Joshua/AAS-7801-2021		NIAID [U19-AI67773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through NIAID grant U19-AI67773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan R, 2011, FUNGAL BIOL-UK, V115, P945, DOI 10.1016/j.funbio.2011.04.003; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; DURRELL LW, 1960, MYCOLOGIA, V52, P636, DOI 10.2307/3756096; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; GOCHENAU.SE, 1974, ECOLOGY, V55, P1004, DOI 10.2307/1940351; Myers R., 1990, CLASSICAL MODERN REG; National Research Council, 2006, HLTH RISKS EXPOSURE, P311; Robertson KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048674; Rosas AL, 2000, J IMMUNOL METHODS, V244, P69, DOI 10.1016/S0022-1759(00)00255-6; Tugay T, 2006, MYCOLOGIA, V98, P521, DOI 10.3852/mycologia.98.4.521; Tugay TI, 2011, HEALTH PHYS, V101, P375, DOI 10.1097/HP.0b013e3181f56bf8; Turick CE, 2011, BIOELECTROCHEMISTRY, V82, P69, DOI 10.1016/j.bioelechem.2011.04.009; Zaragoza O, 2011, ANTIMICROB AGENTS CH, V55, P1563, DOI 10.1128/AAC.01631-10; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966; ZHDANOVA NN, 1995, MYCOL RES, V98, P789	18	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85561	10.1371/journal.pone.0085561	http://dx.doi.org/10.1371/journal.pone.0085561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454887	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100098
J	Yang, XJ; Cui, W; Yu, SC; Xu, C; Chen, GL; Gu, A; Li, TT; Cui, YH; Zhang, X; Bian, XW				Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu			A Synthetic dl-Nordihydroguaiaretic acid (Nordy), Inhibits Angiogenesis, Invasion and Proliferation of Glioma Stem Cells within a Zebrafish Xenotransplantation Model	PLOS ONE			English	Article							PHASE-II; LIPOXYGENASE INHIBITOR; MALIGNANT GLIOMA; ARACHIDONIC-ACID; IN-VIVO; CANCER; VATALANIB; AXITINIB; RECEPTOR; DIFFERENTIATION	The zebrafish (Danio rerio) and their transparent embryos represent a promising model system in cancer research. Compared with other vertebrate model systems, we had previously shown that the zebrafish model provides many advantages over mouse or chicken models to study tumor invasion, angiogenesis, and tumorigenesis. In this study, we systematically investigated the biological features of glioma stem cells (GSCs) in a zebrafish model, such as tumor angiogenesis, invasion, and proliferation. We demonstrated that several verified anti-angiogenic agents inhibited angiogenesis that was induced by xenografted-GSCs. We next evaluated the effects of a synthetic dl-nordihydroguaiaretic acid compound (dl-NDGA or "Nordy''), which revealed anti-tumor activity against human GSCs in vitro by establishing parameters through studying its ability to suppress angiogenesis, tumor invasion, and proliferation. Furthermore, our results indicated that Nordy might inhibit GSCs invasion and proliferation through regulation of the arachidonate 5-lipoxygenase (Alox-5) pathway. Moreover, the combination of Nordy and a VEGF inhibitor exhibited an enhanced ability to suppress angiogenesis that was induced by GSCs. By contrast, even following treatment with 50 mM Nordy, there was no discernible effect on zebrafish embryonic development. Together, these results suggested efficacy and safety of using Nordy in vivo, and further demonstrated that this model should be suitable for studying GSCs and anti-GSC drug evaluation.	[Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Army Medical University; Ministry of Education, China; Army Medical University; Army Medical University	Yang, XJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China.	xiaojunyang.cn@gmail.com; bianxiuwu@263.net	Bian, Xiu-Wu/D-4736-2017; Zhang, Xia/B-8152-2008	Bian, Xiu-Wu/0000-0003-4383-0197; Zhang, Xia/0000-0002-9040-1486	National Basic Research Program of China (973 Program) [2010CB529403]; National Natural Science Fundation of China [81101632, 81272598]; Liaoning Science and Technology Program [201225109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Science and Technology Program	This work was supported by grants from the National Basic Research Program of China (973 Program, Grant No. 2010CB529403), The National Natural Science Fundation of China (Grant No. 81101632 and 81272598), and Liaoning Science and Technology Program (No. 201225109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2009, ZEBRAFISH, V6, P329, DOI 10.1089/zeb.2009.0626; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bian XW, 2008, PROTEOMICS, V8, P484, DOI 10.1002/pmic.200700054; Chang NW, 2013, J NUTR BIOCHEM, V24, P274, DOI 10.1016/j.jnutbio.2012.06.005; Chen JH, 2006, BIOCHEM BIOPH RES CO, V342, P1368, DOI 10.1016/j.bbrc.2006.02.113; Chen JH, 2007, J NEURO-ONCOL, V84, P223, DOI 10.1007/s11060-007-9369-4; Cohen EEW, 2008, J CLIN ONCOL, V26, P4708, DOI 10.1200/JCO.2007.15.9566; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Geiger GA, 2008, CANCER RES, V68, P3396, DOI 10.1158/0008-5472.CAN-07-6396; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Paesler J, 2010, CLIN CANCER RES, V16, P3390, DOI 10.1158/1078-0432.CCR-10-0232; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Ping YF, 2007, J NEURO-ONCOL, V84, P21, DOI 10.1007/s11060-007-9349-8; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rixe O, 2007, LANCET ONCOL, V8, P975, DOI 10.1016/S1470-2045(07)70285-1; Schiller JH, 2009, J CLIN ONCOL, V27, P3836, DOI 10.1200/JCO.2008.20.8355; Scott EN, 2007, EXPERT OPIN INV DRUG, V16, P367, DOI 10.1517/13543784.16.3.367; Sobrero AF, 2011, J CLIN ONCOL, V29, P1938, DOI 10.1200/JCO.2010.33.2429; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Visted T, 2003, FRONT BIOSCI-LANDMRK, V8, pE289, DOI 10.2741/1026; Wang B, 2011, STEM CELL REV REP, V7, P458, DOI 10.1007/s12015-010-9175-9; Yang XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061801, 10.1371/journal.pone.0062181]; Yang XJ, 2013, INT IMMUNOPHARMACOL, V15, P191, DOI 10.1016/j.intimp.2012.12.002; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	35	73	76	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85759	10.1371/journal.pone.0085759	http://dx.doi.org/10.1371/journal.pone.0085759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454929	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100131
J	Srivastava, SK; Huang, XQ; Brar, HK; Fakhoury, AM; Bluhm, BH; Bhattacharyya, MK				Srivastava, Subodh K.; Huang, Xiaoqiu; Brar, Hargeet K.; Fakhoury, Ahmad M.; Bluhm, Burton H.; Bhattacharyya, Madan K.			The Genome Sequence of the Fungal Pathogen Fusarium virguliforme That Cause Sudden Death Syndrome in Soybean	PLOS ONE			English	Article							MAGNAPORTHE-GRISEA; DNA; ALIGNMENT; DATABASE; TOXIN; EXPRESSION; TUCUMANIAE; REVEALS; BLAST; RICE	Fusarium virguliforme causes sudden death syndrome (SDS) of soybean, a disease of serious concern throughout most of the soybean producing regions of the world. Despite the global importance, little is known about the pathogenesis mechanisms of F. virguliforme. Thus, we applied Next-Generation DNA Sequencing to reveal the draft F. virguliforme genome sequence and identified putative pathogenicity genes to facilitate discovering the mechanisms used by the pathogen to cause this disease. Methodology/Principal Findings: We have generated the draft genome sequence of F. virguliforme by conducting whole-genome shotgun sequencing on a 454 GS-FLX Titanium sequencer. Initially, single-end reads of a 400-bp shotgun library were assembled using the PCAP program. Paired end sequences from 3 and 20 Kb DNA fragments and approximately 100 Kb inserts of 1,400 BAC clones were used to generate the assembled genome. The assembled genome sequence was 51 Mb. The N50 scaffold number was 11 with an N50 Scaffold length of 1,263 Kb. The AUGUSTUS gene prediction program predicted 14,845 putative genes, which were annotated with Pfam and GO databases. Gene distributions were uniform in all but one of the major scaffolds. Phylogenic analyses revealed that F. virguliforme was closely related to the pea pathogen, Nectria haematococca. Of the 14,845 F. virguliforme genes, 11,043 were conserved among five Fusarium species: F. virguliforme, F. graminearum, F. verticillioides, F. oxysporum and N. haematococca; and 1,332 F. virguliforme-specific genes, which may include pathogenicity genes. Additionally, searches for candidate F. virguliforme pathogenicity genes using gene sequences of the pathogen-host interaction database identified 358 genes. Conclusions: The F. virguliforme genome sequence and putative pathogenicity genes presented here will facilitate identification of pathogenicity mechanisms involved in SDS development. Together, these resources will expedite our efforts towards discovering pathogenicity mechanisms in F. virguliforme. This will ultimately lead to improvement of SDS resistance in soybean.	[Srivastava, Subodh K.; Brar, Hargeet K.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Fakhoury, Ahmad M.] So Illinois Univ, Dept Plant Soil Sci & Agr Syst, Carbondale, IL 62901 USA; [Bluhm, Burton H.] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA	Iowa State University; Iowa State University; Southern Illinois University System; Southern Illinois University; University of Arkansas System; University of Arkansas Fayetteville	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	mbhattac@iastate.edu			Soybean Research Development Council & Iowa Soybean Association	Soybean Research Development Council & Iowa Soybean Association	The authors are thankful to Soybean Research Development Council & Iowa Soybean Association for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Covert SF, 2007, FUNGAL GENET BIOL, V44, P799, DOI 10.1016/j.fgb.2006.12.009; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Doyle J. J., 1987, PHYTOCHEM B, P11; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Huang XQ, 2004, BIOINFORMATICS, V20, P2529, DOI 10.1093/bioinformatics/bth279; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Innocenti A, 2010, BIOORGAN MED CHEM, V18, P1034, DOI 10.1016/j.bmc.2009.12.058; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2009, J PLANT PATHOL, V91, P77; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Mar JC, 2011, BIOINFORMATICS, V27, P1094, DOI 10.1093/bioinformatics/btr074; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Osoegawa K, 2007, GENOMICS, V89, P291, DOI 10.1016/j.ygeno.2006.10.002; Pal K, 2007, STUD MYCOL, P19, DOI 10.3114/sim.2007.59.03; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; RUPE JC, 1989, PLANT DIS, V73, P581, DOI 10.1094/PD-73-0581; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Wrather JA, 2006, J NEMATOL, V38, P173	45	38	39	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e81832	10.1371/journal.pone.0081832	http://dx.doi.org/10.1371/journal.pone.0081832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454689	gold, Green Published, Green Submitted			2022-12-27	WOS:000329925800005
J	Gai, XH; Lu, ZT; Tu, KS; Liang, ZY; Zheng, X				Gai, Xiaohong; Lu, Zhongtang; Tu, Kangsheng; Liang, Zheyong; Zheng, Xin			Caveolin-1 Is Up-Regulated by GLI1 and Contributes to GLI1-Driven EMT in Hepatocellular Carcinoma	PLOS ONE			English	Article							POOR-PROGNOSIS; EXPRESSION; METASTASIS; CANCER; OVEREXPRESSION; ADENOCARCINOMA; PROSTATE; SURVIVAL; INVASION; GROWTH	Caveolin-1 (Cav-1) has been recently identified to be over-expressed in hepatocellular carcinoma (HCC) and promote HCC cell motility and invasion ability via inducing epithelial-mesenchymal transition (EMT). However, the mechanism of aberrant overexpression of Cav-1 remains vague. Here, we observed that Cav-1 expression was positively associated with GLI1 expression in HCC tissues. Forced expression of GLI1 up-regulated Cav-1 in Huh7 cells, while knockdown of GLI1 decreased expression of Cav-1 in SNU449 cells. Additionally, silencing Cav-1 abolished GLI1-induced EMT of Huh7 cells. The correlation between GLI1 and Cav-1 was confirmed in tumor specimens from HCC patients and Cav-1 was found to be associated with poor prognosis after hepatic resection. The relationship between protein expression of GLI1 and Cav-1 was also established in HCC xenografts of nude mice. These results suggest that GLI1 may be attributed to Cav-1 up-regulation which plays an important role in GLI1-driven EMT phenotype in HCC.	[Gai, Xiaohong; Lu, Zhongtang; Tu, Kangsheng; Liang, Zheyong; Zheng, Xin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Zheng, X (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China.	xin.zheng.xjtu@gmail.com	Tu, Kangsheng/N-1544-2019; ZHENG, XIN/H-2342-2016; Zheng, Xin/AAX-4333-2021	Tu, Kangsheng/0000-0002-0032-1459; ZHENG, XIN/0000-0002-6328-0834; 	Research Fund for the doctoral Program of High Education of China from Ministry of Education [20120201120090]	Research Fund for the doctoral Program of High Education of China from Ministry of Education	This study was supported by Research Fund for the doctoral Program of High Education of China from Ministry of Education (No. 20120201120090 to Xin Zheng). The URL of Research Fund for the doctoral Program of High Education of China from Ministry of Education is http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2013/02/1354173488080563.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2003, CANCER RES, V63, P2864; Bender FC, 2000, CANCER RES, V60, P5870; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Collin G, 2007, MOL CELL BIOL, V27, P7631, DOI 10.1128/MCB.00543-07; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Fong A, 2003, AM J CLIN PATHOL, V120, P93, DOI 10.1309/292NHAYNWAVREJ37; Hatanaka M, 1998, BIOCHEM BIOPH RES CO, V253, P382, DOI 10.1006/bbrc.1998.9744; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Joo HJ, 2004, BJU INT, V93, P291, DOI 10.1111/j.1464-410X.2004.04604.x; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Razani B, 2000, BIOCHEMISTRY-US, V39, P13916, DOI 10.1021/bi001489b; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sato M, 2012, RESPIROLOGY, V17, P1048, DOI 10.1111/j.1440-1843.2012.02173.x; Tahir SA, 2001, CANCER RES, V61, P3882; Tang Y, 2012, MED ONCOL, V29, P977, DOI 10.1007/s12032-011-9900-5; Tse EYT, 2012, J PATHOL, V226, P645, DOI 10.1002/path.3957; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P617, DOI 10.1016/j.cgh.2011.03.027; Yang SF, 2010, PATHOLOGY, V42, P438, DOI 10.3109/00313025.2010.494293; Zhang ZB, 2009, PATHOL ONCOL RES, V15, P495, DOI 10.1007/s12253-008-9144-7; Zheng X, 2013, ONCOL REP, V29, P1811, DOI 10.3892/or.2013.2341; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zheng X, 2010, MOL MED REP, V3, P965, DOI 10.3892/mmr.2010.375	30	31	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84551	10.1371/journal.pone.0084551	http://dx.doi.org/10.1371/journal.pone.0084551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454730	gold, Green Submitted, Green Published			2022-12-27	WOS:000329922500012
J	Trebbien, R; Chriel, M; Struve, T; Hjulsager, CK; Larsen, G; Larsen, LE				Trebbien, Ramona; Chriel, Mariann; Struve, Tina; Hjulsager, Charlotte Kristiane; Larsen, Gitte; Larsen, Lars Erik			Wildlife Reservoirs of Canine Distemper Virus Resulted in a Major Outbreak in Danish Farmed Mink (Neovison vison)	PLOS ONE			English	Article							TRANSPLACENTAL TRANSMISSION; RED FOXES; HEMAGGLUTININ; PREVALENCE; ANTIBODIES; CARNIVORES; PARVOVIRUS; INFECTION; EMERGENCE; STRAINS	A major outbreak of canine distemper virus (CDV) in Danish farmed mink (Neovison vison) started in the late summer period of 2012. At the same time, a high number of diseased and dead wildlife species such as foxes, raccoon dogs, and ferrets were observed. To track the origin of the outbreak virus full-length sequencing of the receptor binding surface protein hemagglutinin (H) was performed on 26 CDV's collected from mink and 10 CDV's collected from wildlife species. Subsequent phylogenetic analyses showed that the virus circulating in the mink farms and wildlife were highly identical with an identity at the nucleotide level of 99.45% to 100%. The sequences could be grouped by single nucleotide polymorphisms according to geographical distribution of mink farms and wildlife. The signaling lymphocytic activation molecule (SLAM) receptor binding region in most viruses from both mink and wildlife contained G at position 530 and Y at position 549; however, three mink viruses had an Y549H substitution. The outbreak viruses clustered phylogenetically in the European lineage and were highly identical to wildlife viruses from Germany and Hungary (99.29% - 99.62%). The study furthermore revealed that fleas (Ceratophyllus sciurorum) contained CDV and that vertical transmission of CDV occurred in a wild ferret. The study provides evidence that wildlife species, such as foxes, play an important role in the transmission of CDV to farmed mink and that the virus may be maintained in the wild animal reservoir between outbreaks.	[Trebbien, Ramona; Chriel, Mariann; Hjulsager, Charlotte Kristiane; Larsen, Gitte; Larsen, Lars Erik] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Struve, Tina] Kopenhagen Diagnost, Glostrup, Denmark	Technical University of Denmark	Larsen, LE (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	lael@vet.dtu.dk	Larsen, Lars E/G-3827-2015	Larsen, Lars E/0000-0003-0730-5555; Trebbien, Ramona/0000-0003-2352-5726	Kopenhagen Fur	Kopenhagen Fur	The project was supported financial by Kopenhagen Fur www.kopenhagenfur.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL MJG, 1995, VET MICROBIOL, V44, P187, DOI 10.1016/0378-1135(95)00011-X; Bolt G, 1997, J GEN VIROL, V78, P367, DOI 10.1099/0022-1317-78-2-367; Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020; Cha SY, 2012, COMP IMMUNOL MICROB, V35, P497, DOI 10.1016/j.cimid.2012.04.006; Damien BC, 2002, J WILDLIFE DIS, V38, P856, DOI 10.7589/0090-3558-38.4.856; Denzin N, 2013, VET MICROBIOL, V162, P214, DOI 10.1016/j.vetmic.2012.08.031; Frolich K, 2000, VET MICROBIOL, V74, P283, DOI 10.1016/S0378-1135(00)00192-9; Guo L, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-109; Kameo Y, 2012, VET MICROBIOL, V154, P222, DOI 10.1016/j.vetmic.2011.07.006; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; KRAKOWKA S, 1974, AM J VET RES, V35, P1251; KRAKOWKA S, 1977, AM J VET RES, V38, P919; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martella V, 2011, VACCINE, V29, P1222, DOI 10.1016/j.vaccine.2010.12.001; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Nikolin VM, 2012, VET MICROBIOL, V156, P45, DOI 10.1016/j.vetmic.2011.10.009; Perpinan D, 2008, VET REC, V163, P248; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Santos N, 2009, J WILDLIFE DIS, V45, P221, DOI 10.7589/0090-3558-45.1.221; Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029; Sobrino R, 2008, VET MICROBIOL, V126, P251, DOI 10.1016/j.vetmic.2007.06.014; Tan B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-520; van de Bildt MWG, 2002, EMERG INFECT DIS, V8, P211; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; Woma TY, 2010, VET MICROBIOL, V143, P126, DOI 10.1016/j.vetmic.2009.11.013; Zhao JJ, 2010, VET MICROBIOL, V140, P34, DOI 10.1016/j.vetmic.2009.07.010	26	38	39	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85598	10.1371/journal.pone.0085598	http://dx.doi.org/10.1371/journal.pone.0085598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454897	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500057
J	Mulder, KA; King, DJ; Innis, SM				Mulder, Kelly A.; King, D. Janette; Innis, Sheila M.			Omega-3 Fatty Acid Deficiency in Infants before Birth Identified Using a Randomized Trial of Maternal DHA Supplementation in Pregnancy	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; PLASMA PHOSPHOLIPIDS; CHILDRENS IQ; HUMAN-MILK; FISH-OIL; N-3; BRAIN; AGE; NEURODEVELOPMENT	Background: DHA is accumulated in the central nervous system (CNS) before birth and is involved in early developmental processes, such as neurite outgrowth and gene expression. Objective: To determine whether fetal DHA insufficiency occurs and constrains CNS development in term gestation infants. Design: A risk reduction model using a randomized prospective study of term gestation single birth healthy infants born to women (n = 270) given a placebo or 400 mg/day DHA from 16 wk gestation to delivery. Fetal DHA deficiency sufficient to constrain CNS development was assessed based on increased risk that infants in the placebo group would not achieve neurodevelopment scores in the top quartile of all infants in the study. Results: Infants in the placebo group were at increased risk of lower language development assessed as words understood (OR 3.22, CL 1.49-6.94, P = 0.002) and produced (OR 2.61, CL 1.22-5.58, P = 0.01) at 14 mo, and words understood (OR 2.77, CL 1.23-6.28, P=0.03) and sentences produced (OR 2.60, CL 1.15-5.89, P = 0.02) at 18 mo using the McArthur Communicative Developmental Inventory; receptive (OR 2.23, CL 1.08-4.60, P=0.02) and expressive language (OR 1.89, CL 0.94-3.83, P=0.05) at 18 mo using the Bayley Scales of Infant Development III; and visual acuity (OR 2.69, CL 1.10-6.54, P=0.03) at 2 mo.	[Mulder, Kelly A.; King, D. Janette; Innis, Sheila M.] Univ British Columbia, Dept Pediat, Fac Med, Nutr & Metab Program,Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	Child & Family Research Institute; University of British Columbia	Innis, SM (corresponding author), Univ British Columbia, Dept Pediat, Fac Med, Nutr & Metab Program,Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada.	sinnis@mail.ubc.ca			Canadian Institutes for Health Research (CIHR) [MOP 84248]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes for Health Research (CIHR) grant number MOP 84248. The funders had no role in study design, data collection and analysis, decision to publish, or pepartion of the manuscript.	ARBUCKLE LD, 1994, J NUTR, V124, P289, DOI 10.1093/jn/124.2.289; ARBUCKLE LD, 1993, J NUTR, V123, P1668, DOI 10.1093/jn/123.10.1668; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Auestad N, 2003, NUTR NEUROSCI, V6, P335, DOI 10.1080/10284150310001624183; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Bazan NG, 2009, PROSTAG LEUKOTR ESS, V81, P205, DOI 10.1016/j.plefa.2009.05.024; Bertrand PC, 2006, J NUTR, V136, P1570, DOI 10.1093/jn/136.6.1570; Boucher O, 2011, AM J CLIN NUTR, V93, P1025, DOI 10.3945/ajcn.110.000323; Brown L., 1997, TEST NONVERBAL INTEL; Browning LM, 2012, AM J CLIN NUTR, V96, P748, DOI 10.3945/ajcn.112.041343; Campoy C, 2011, AM J CLIN NUTR, V94, p1880S, DOI 10.3945/ajcn.110.001107; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; Childs CE, 2012, PROSTAG LEUKOTR ESS, V86, P141, DOI 10.1016/j.plefa.2012.03.007; CLANDININ MT, 1981, EARLY HUM DEV, V5, P355, DOI 10.1016/0378-3782(81)90016-5; de Velasco PC, 2012, EXP NEUROL, V234, P220, DOI 10.1016/j.expneurol.2011.12.032; Dunstan JA, 2008, ARCH DIS CHILD-FETAL, V93, pF45, DOI 10.1136/adc.2006.099085; Elias SL, 2001, AM J CLIN NUTR, V73, P807; FARQUHARSON J, 1995, ARCH DIS CHILD, V72, P198, DOI 10.1136/adc.72.3.198; Georgieff MK, 2005, PEDIATR RES, V57, p99R, DOI 10.1203/01.PDR.0000160542.69840.0F; Gil-Sanchez A, 2010, AM J CLIN NUTR, V92, P115, DOI 10.3945/ajcn.2010.29589; Greiner RCS, 1997, PEDIATR RES, V42, P826, DOI 10.1203/00006450-199712000-00018; Harbeby E, 2012, PROSTAG LEUKOTR ESS, V86, P211, DOI 10.1016/j.plefa.2012.04.008; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Helland IB, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e82; Helland IB, 2008, PEDIATRICS, V122, pE472, DOI 10.1542/peds.2007-2762; Helland IB, 2006, J MATERN-FETAL NEO M, V19, P397, DOI 10.1080/14767050600738396; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Innis S. M., 2013, Current Nutrition Reports, V2, P151; Innis SM, 2008, AM J CLIN NUTR, V87, P548, DOI 10.1093/ajcn/87.3.548; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Innis SM, 2001, J NUTR, V131, P118, DOI 10.1093/jn/131.1.118; Innis SM, 2001, J PEDIATR-US, V139, P532, DOI 10.1067/mpd.2001.118429; Innis SM, 2004, ADV EXP MED BIOL, V554, P27; Judge MP, 2007, AM J CLIN NUTR, V85, P1572, DOI 10.1093/ajcn/85.6.1572; Katakura M, 2009, NEUROSCIENCE, V160, P651, DOI 10.1016/j.neuroscience.2009.02.057; Katakura M, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/490476; Kothapalli KSD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000370; Kuipers RS, 2012, PROSTAG LEUKOTR ESS, V86, P13, DOI 10.1016/j.plefa.2011.10.012; Liou YA, 2007, J NUTR, V137, P945, DOI 10.1093/jn/137.4.945; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Mendez MA, 2009, PUBLIC HEALTH NUTR, V12, P1702, DOI 10.1017/S1368980008003947; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; Novak EM, 2008, BRAIN RES, V1237, P136, DOI 10.1016/j.brainres.2008.07.107; O'Connor DL, 2001, PEDIATRICS, V108, P359, DOI 10.1542/peds.108.2.359; Oken E, 2008, AM J CLIN NUTR, V88, P789, DOI 10.1093/ajcn/88.3.789; POPPSNIJDERS C, 1986, BIOCHIM BIOPHYS ACTA, V854, P31, DOI 10.1016/0005-2736(86)90061-1; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; SANDERS TAB, 1992, J PEDIATR-US, V120, pS71, DOI 10.1016/S0022-3476(05)81239-9; Smithers LG, 2011, AM J CLIN NUTR, V93, P1293, DOI 10.3945/ajcn.110.009647; Stein AD, 2012, J NUTR, V142, P1577, DOI 10.3945/jn.112.162461; Su HM, 1999, PEDIATR RES, V45, P87, DOI 10.1203/00006450-199901000-00015; van Goor SA, 2011, PROSTAG LEUKOTR ESS, V84, P139, DOI 10.1016/j.plefa.2011.01.002; Escolano-Margarit MV, 2013, BRIT J NUTR, V109, P1647, DOI 10.1017/S0007114512003716; Escolano-Margarit MV, 2011, J NUTR, V141, P1216, DOI 10.3945/jn.110.129635; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Willatts P, 1999, DEV PSYCHOL, V35, P651, DOI 10.1037/0012-1649.35.3.651; Yavin E, 2006, PROSTAG LEUKOTR ESS, V75, P203, DOI 10.1016/j.plefa.2006.05.014	58	51	53	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83764	10.1371/journal.pone.0083764	http://dx.doi.org/10.1371/journal.pone.0083764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427279	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200019
J	Zouine, M; Fu, YY; Chateigner-Boutin, AL; Mila, I; Frasse, P; Wang, H; Audran, C; Roustan, JP; Bouzayen, M				Zouine, Mohamed; Fu, Yongyao; Chateigner-Boutin, Anne-Laure; Mila, Isabelle; Frasse, Pierre; Wang, Hua; Audran, Corinne; Roustan, Jean-Paul; Bouzayen, Mondher			Characterization of the Tomato ARF Gene Family Uncovers a Multi-Levels Post-Transcriptional Regulation Including Alternative Splicing	PLOS ONE			English	Article							AUXIN-RESPONSE-FACTOR; GENOME-WIDE IDENTIFICATION; FRUIT-SET; DOWN-REGULATION; ARABIDOPSIS; EXPRESSION; AUX/IAA; TRANSCRIPTION; INTEGRATION; PROTEINS	Background: The phytohormone auxin is involved in a wide range of developmental processes and auxin signaling is known to modulate the expression of target genes via two types of transcriptional regulators, namely, Aux/IAA and Auxin Response Factors (ARF). ARFs play a major role in transcriptional activation or repression through direct binding to the promoter of auxin-responsive genes. The present study aims at gaining better insight on distinctive structural and functional features among ARF proteins. Results: Building on the most updated tomato (Solanum lycopersicon) reference genome sequence, a comprehensive set of ARF genes was identified, extending the total number of family members to 22. Upon correction of structural annotation inconsistencies, renaming the tomato ARF family members provided a consensus nomenclature for all ARF genes across plant species. In silico search predicted the presence of putative target site for small interfering RNAs within twelve Sl-ARFs while sequence analysis of the 5'-leader sequences revealed the presence of potential small uORF regulatory elements. Functional characterization carried out by transactivation assay partitioned tomato ARFs into repressors and activators of auxin-dependent gene transcription. Expression studies identified tomato ARFs potentially involved in the fruit set process. Genome-wide expression profiling using RNA-seq revealed that at least one third of the gene family members display alternative splicing mode of regulation during the flower to fruit transition. Moreover, the regulation of several tomato ARF genes by both ethylene and auxin, suggests their potential contribution to the convergence mechanism between the signaling pathways of these two hormones. Conclusion: All together, the data bring new insight on the complexity of the expression control of Sl-ARF genes at the transcriptional and post-transcriptional levels supporting the hypothesis that these transcriptional mediators might represent one of the main components that enable auxin to regulate a wide range of physiological processes in a highly specific and coordinated manner.	[Zouine, Mohamed; Fu, Yongyao; Chateigner-Boutin, Anne-Laure; Mila, Isabelle; Frasse, Pierre; Wang, Hua; Audran, Corinne; Roustan, Jean-Paul; Bouzayen, Mondher] Univ Toulouse, INP ENSA Toulouse, Castanet Tolosan, France; [Zouine, Mohamed; Fu, Yongyao; Chateigner-Boutin, Anne-Laure; Mila, Isabelle; Frasse, Pierre; Wang, Hua; Audran, Corinne; Roustan, Jean-Paul; Bouzayen, Mondher] INRA, Genom & Biotechnol Fruits, Auzeville, France	Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE	Zouine, M (corresponding author), Univ Toulouse, INP ENSA Toulouse, Castanet Tolosan, France.	mohamed.zouine@ensat.fr; bouzayen@ensat.fr	Wang, Hua Cassan/AAF-5966-2021; Bouzayen, Mondher/AFQ-0802-2022	Wang, Hua Cassan/0000-0002-7395-9285; Audran, Corinne/0000-0002-3083-8088; FU, YONGYAO/0000-0001-9524-1234; Isabelle, Mila/0000-0002-8878-0018	Laboratoire d'Excellence (LABEX) [TULIP ANR-10-LABX-41]	Laboratoire d'Excellence (LABEX)	This work was supported by the Laboratoire d'Excellence (LABEX, TULIP ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Causier B, 2012, PLANT SIGNAL BEHAV, V7, P325, DOI 10.4161/psb.19283; Cole M, 2009, DEVELOPMENT, V136, P1643, DOI 10.1242/dev.032177; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; de Jong M, 2011, J EXP BOT, V62, P617, DOI 10.1093/jxb/erq293; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; Devoghalaere F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-7; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Guilfoyle TJ, 2001, J PLANT GROWTH REGUL, V20, P281, DOI 10.1007/s003440010026; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guillon F, 2008, J EXP BOT, V59, P273, DOI 10.1093/jxb/erm323; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Hayashi K, 2012, PLANT CELL PHYSIOL, V53, P965, DOI 10.1093/pcp/pcs035; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jones B, 2002, PLANT J, V32, P603, DOI 10.1046/j.1365-313X.2002.01450.x; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liu Zhen-Hua, 2011, Yichuan, V33, P1335, DOI 10.3724/SP.J.1005.2011.01335; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Maza Elie, 2013, Commun Integr Biol, V6, pe25849, DOI 10.4161/cib.25849; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Rademacher EH, 2012, DEV CELL, V22, P211, DOI 10.1016/j.devcel.2011.10.026; Rosado A, 2012, P NATL ACAD SCI USA, V109, P19537, DOI 10.1073/pnas.1214774109; Sagar M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25647; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Teale WD, 2008, MOL PLANT, V1, P229, DOI 10.1093/mp/ssn006; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Vert G, 2008, P NATL ACAD SCI USA, V105, P9829, DOI 10.1073/pnas.0803996105; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang L, 2013, P NATL ACAD SCI USA, V110, P761, DOI 10.1073/pnas.1215010110; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Yoon EK, 2010, J PLANT BIOL, V53, P150, DOI 10.1007/s12374-010-9100-4; Zhou F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-193	57	115	121	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84203	10.1371/journal.pone.0084203	http://dx.doi.org/10.1371/journal.pone.0084203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427281	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200021
J	Filardy, AA; Costa-da-Silva, AC; Koeller, CM; Guimaraes-Pinto, K; Ribeiro-Gomes, FL; Lopes, MF; Heise, N; Freire-de-Lima, CG; Nunes, MP; DosReis, GA				Filardy, Alessandra A.; Costa-da-Silva, Ana Caroline; Koeller, Carolina M.; Guimaraes-Pinto, Kamila; Ribeiro-Gomes, Flavia L.; Lopes, Marcela F.; Heise, Norton; Freire-de-Lima, Celio G.; Nunes, Marise P.; DosReis, George A.			Infection with Leishmania major Induces a Cellular Stress Response in Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; FAS LIGAND; TNF-ALPHA; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; T-LYMPHOCYTES; MAP KINASES; EXPRESSION; MICE	We investigated early cellular responses induced by infection with Leishmania major in macrophages from resistant C57/BL6 mice. Infection increased production of reactive oxygen species by resident, but not inflammatory peritoneal macrophages. In addition, infection increased activation of stress-activated protein kinases/c-Jun N-terminal kinases (SAPK/JNK) in resident, but not in inflammatory peritoneal macrophages. Infection also increased expression of membrane and soluble FasL, but infected macrophages remained viable after 48 h. Infection increased secretion of cytokines/chemokines TNF-alpha, IL-6, TIMP-1, IL-1RA, G-CSF, TREM, KC, MIP-1 alpha, MIP-1 beta, MCP-1, and MIP-2 in resident macrophages. Addition of antioxidants deferoxamine and N-acetylcysteine reduced ROS generation and JNK activation. Addition of antioxidants or JNK inhibitor SP600125 reduced secretion of KC. Furthermore, treatment with antioxidants or JNK inhibitor also reduced intracellular parasite replication. These results indicated that infection triggers a rapid cellular stress response in resident macrophages which induces proinflammatory signals, but is also involved in parasite survival and replication in host macrophages.	[Filardy, Alessandra A.; Costa-da-Silva, Ana Caroline; Koeller, Carolina M.; Guimaraes-Pinto, Kamila; Lopes, Marcela F.; Heise, Norton; Freire-de-Lima, Celio G.; DosReis, George A.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Ribeiro-Gomes, Flavia L.] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA; [Nunes, Marise P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; Fundacao Oswaldo Cruz	DosReis, GA (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil.	gdosreis@biof.ufrj.br	Filardy, Alessandra/AAH-6034-2020; Ribeiro-Gomes, Flávia L/F-7609-2015; de Lima, Celio Geraldo Freire/A-9057-2012; Lopes, Marcela Freitas/E-2201-2012; Koeller, Carolina/ABB-1968-2021; Heise, Norton/I-4098-2013	Filardy, Alessandra/0000-0003-4098-3235; Ribeiro-Gomes, Flávia L/0000-0003-0297-6341; Lopes, Marcela Freitas/0000-0002-4508-0505; Koeller, Carolina/0000-0002-1919-7582; Heise, Norton/0000-0003-0154-7406; Guimaraes Pinto, Kamila/0000-0003-2642-5229; Costa da silva, Ana Caroline/0000-0002-2729-5836; DosReis, George/0000-0002-8924-4727	Brazilian National Research Council (CNPq); Rio de Janeiro State Science Foundation (FAPERJ); Programa Institutos Nacionais de Ciencia e Tecnologia (INCT), CNPq, Brazil	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Institutos Nacionais de Ciencia e Tecnologia (INCT), CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian National Research Council (CNPq), Rio de Janeiro State Science Foundation (FAPERJ), and Programa Institutos Nacionais de Ciencia e Tecnologia (INCT), CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 1998, EUR J IMMUNOL, V28, P1389, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1389::AID-IMMU1389&gt;3.0.CO;2-1; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Chakour R, 2003, INFECT IMMUN, V71, P5287, DOI 10.1128/IAI.71.9.5287-5295.2003; Choudhury R, 2013, IMMUNOBIOLOGY, V218, P114, DOI 10.1016/j.imbio.2012.02.008; Conceicao-Silva F, 1998, EUR J IMMUNOL, V28, P237, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;237::AID-IMMU237&gt;3.0.CO;2-O; Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Faris M, 1998, J IMMUNOL, V160, P134; Feng GJ, 1999, J IMMUNOL, V163, P6403; Filardy AA, 2010, J IMMUNOL, V185, P2044, DOI 10.4049/jimmunol.1000017; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; FORTIER AH, 1982, INFECT IMMUN, V38, P1304, DOI 10.1128/IAI.38.3.1304-1308.1982; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; GORDON S, 1974, J EXP MED, V139, P1228, DOI 10.1084/jem.139.5.1228; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Hojo Y, 2002, CIRC RES, V91, P712, DOI 10.1161/01.RES.0000037981.97541.25; Huang FP, 1998, J IMMUNOL, V160, P4143; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kautz-Neu K, 2011, EXP DERMATOL, V20, P77, DOI 10.1111/j.1600-0625.2010.01172.x; Kavurma MM, 2003, CELL DEATH DIFFER, V10, P36, DOI 10.1038/sj.cdd.4401179; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; LOUIS J, 1979, EUR J IMMUNOL, V9, P841, DOI 10.1002/eji.1830091103; Majumder S, 2012, J INFECT DIS, V205, P1607, DOI 10.1093/infdis/jis229; MALLINSON DJ, 1989, INT J PARASITOL, V19, P647, DOI 10.1016/0020-7519(89)90043-X; Maretti-Mira AC, 2011, CLIN EXP IMMUNOL, V163, P207, DOI 10.1111/j.1365-2249.2010.04285.x; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Ribeiro-Gomes FL, 2005, J INFECT DIS, V192, P1127, DOI 10.1086/432764; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Sardar AH, 2013, J PROTEOMICS, V81, P185, DOI 10.1016/j.jprot.2013.01.011; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wiese M, 2003, INT J PARASITOL, V33, P1577, DOI 10.1016/S0020-7519(03)00252-2; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75	47	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85715	10.1371/journal.pone.0085715	http://dx.doi.org/10.1371/journal.pone.0085715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416445	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300100
J	Geenes, V; Lovgren-Sandblom, A; Benthin, L; Lawrance, D; Chambers, J; Gurung, V; Thornton, J; Chappell, L; Khan, E; Dixon, P; Marschall, HU; Williamson, C				Geenes, Victoria; Lovgren-Sandblom, Anita; Benthin, Lisbet; Lawrance, Dominic; Chambers, Jenny; Gurung, Vinita; Thornton, Jim; Chappell, Lucy; Khan, Erum; Dixon, Peter; Marschall, Hanns-Ulrich; Williamson, Catherine			The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid	PLOS ONE			English	Article							MATERNAL LIVER TANDEM; HUMAN PLACENTA; OBSTETRIC CHOLESTASIS; SALT METABOLISM; OATP-C; FETAL; EXPRESSION; DIAGNOSIS; TRANSPORT; PROFILES	Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disorder associated with an increased risk of adverse fetal outcomes. It is characterised by raised maternal serum bile acids, which are believed to cause the adverse outcomes. ICP is commonly treated with ursodeoxycholic acid (UDCA). This study aimed to determine the fetal and maternal bile acid profiles in normal and ICP pregnancies, and to examine the effect of UDCA treatment. Matched maternal and umbilical cord serum samples were collected from untreated ICP (n = 18), UDCA-treated ICP (n = 46) and uncomplicated pregnancy (n = 15) cases at the time of delivery. Nineteen individual bile acids were measured using HPLC-MS/MS. Maternal and fetal serum bile acids are significantly raised in ICP compared with normal pregnancy (p = <0.0001 and <0.05, respectively), predominantly due to increased levels of conjugated cholic and chenodeoxycholic acid. There are no differences between the umbilical cord artery and cord vein levels of the major bile acid species. The feto-maternal gradient of bile acids is reversed in ICP. Treatment with UDCA significantly reduces serum bile acids in the maternal compartment (p = <0.0001), thereby reducing the feto-maternal transplacental gradient. UDCA-treatment does not cause a clinically important increase in lithocholic acid (LCA) concentrations. ICP is associated with significant quantitative and qualitative changes in the maternal and fetal bile acid pools. Treatment with UDCA reduces the level of bile acids in both compartments and reverses the qualitative changes. We have not found evidence to support the suggestion that UDCA treatment increases fetal LCA concentrations to deleterious levels.	[Geenes, Victoria; Lawrance, Dominic; Chambers, Jenny; Khan, Erum; Dixon, Peter; Williamson, Catherine] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Lovgren-Sandblom, Anita; Benthin, Lisbet] Karolinska Inst, Dept Clin Chem, Stockholm, Sweden; [Lovgren-Sandblom, Anita; Benthin, Lisbet] Karolinska Inst, Dept Med, Stockholm, Sweden; [Gurung, Vinita; Thornton, Jim] Univ Nottingham, Sch Human Dev, Nottingham NG7 2RD, England; [Chappell, Lucy; Dixon, Peter; Williamson, Catherine] Kings Coll London, Womens Hlth Acad Ctr, London WC2R 2LS, England; [Chappell, Lucy; Dixon, Peter; Williamson, Catherine] Kings Hlth Partners, London, England; [Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	Imperial College London; Karolinska Institutet; Karolinska Institutet; University of Nottingham; University of London; King's College London; University of London; King's College London; University of Gothenburg	Williamson, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England.	catherine.williamson@kcl.ac.uk	Marschall, Hanns-Ulrich/K-8842-2017; Thornton, Jim/B-8336-2008	Marschall, Hanns-Ulrich/0000-0001-7347-3085; Thornton, Jim/0000-0001-9764-6876; Dixon, Peter/0000-0002-0197-2632; Williamson, Catherine/0000-0002-6226-7611	MRC; National Institute for Health Research (NIHR) Biomedical Research Centres bile acidsed at Imperial College Healthcare NHS Trust, Imperial College London; NIHR [PB-PG-0107-12037]; National Institute for Health Research [PB-PG-0107-12037] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centres bile acidsed at Imperial College Healthcare NHS Trust, Imperial College London; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by an MRC PhD Studentship (VG). The research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centres bile acidsed at Imperial College Healthcare NHS Trust, Imperial College London and the NIHR Research for Patient Benefit programme (grant number PB-PG-0107-12037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Brites D, 1998, EUR J OBSTET GYN R B, V80, P31, DOI 10.1016/S0301-2115(98)00086-4; Briz O, 2003, BIOCHEM J, V371, P897, DOI 10.1042/BJ20030034; Chappell LC, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3799; COLOMBO C, 1985, PEDIATR RES, V19, P227, DOI 10.1203/00006450-198502000-00018; Cui T, 2009, SAUDI MED J, V30, P1406; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes VL, 2011, PLACENTA, V32, P535, DOI 10.1016/j.placenta.2011.04.014; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; HEIKKINEN J, 1981, BRIT J OBSTET GYNAEC, V88, P240, DOI 10.1111/j.1471-0528.1981.tb00975.x; HEIKKINEN J, 1983, OBSTET GYNECOL, V61, P581; ITOH S, 1982, BIOCHEM J, V204, P141, DOI 10.1042/bj2040141; LAATIKAINEN T, 1977, OBSTET GYNECOL, V50, P313; LAATIKAINEN TJ, 1975, AM J OBSTET GYNECOL, V122, P852, DOI 10.1016/0002-9378(75)90727-9; Lucangioli SE, 2009, ANN CLIN BIOCHEM, V46, P44, DOI 10.1258/acb.2008.008130; LUNZER M, 1986, GASTROENTEROLOGY, V91, P825, DOI 10.1016/0016-5085(86)90682-7; Macias RIR, 2000, HEPATOLOGY, V31, P975, DOI 10.1053/he.2000.5921; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; Patel P, 2003, PLACENTA, V24, P39, DOI 10.1053/plac.2002.0879; Reyes H, 2000, ANN MED, V32, P94, DOI 10.3109/07853890009011758; Serrano MA, 2007, PLACENTA, V28, P107, DOI 10.1016/j.placenta.2006.03.009; Serrano MA, 1998, J HEPATOL, V28, P829, DOI 10.1016/S0168-8278(98)80234-1; SEWELL RB, 1980, AM J PHYSIOL, V239, pG354, DOI 10.1152/ajpgi.1980.239.5.G354; SEWELL RB, 1982, AM J PHYSIOL, V243, pG172, DOI 10.1152/ajpgi.1982.243.2.G172; SHAW D, 1982, AM J OBSTET GYNECOL, V142, P621, DOI 10.1016/S0002-9378(16)32430-9; Sinakos E, 2010, HEPATOLOGY, V52, P197, DOI 10.1002/hep.23631; Sinakos E, 2010, AM J GASTROENTEROL, V105, P596, DOI 10.1038/ajg.2009.639; SJOVALL K, 1966, CLIN CHIM ACTA, V13, P207, DOI 10.1016/0009-8981(66)90294-4; St-Pierre MV, 2000, AM J PHYSIOL-REG I, V279, pR1495, DOI 10.1152/ajpregu.2000.279.4.R1495; Tribe RM, 2010, AM J GASTROENTEROL, V105, P585, DOI 10.1038/ajg.2009.633; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x; Xu Zhou, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P430	32	61	66	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83828	10.1371/journal.pone.0083828	http://dx.doi.org/10.1371/journal.pone.0083828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421907	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500076
J	Kowalewski, M; Domenech, R; Martinell, J				Kowalewski, Michal; Domenech, Rosa; Martinell, Jordi			Vanishing Clams on an Iberian Beach: Local Consequences and Global Implications of Accelerating Loss of Shells to Tourism	PLOS ONE			English	Article							MOLLUSCAN DEATH ASSEMBLAGES; HERMIT-CRABS; SANDY BEACH; SEA; REPRODUCTION; NOURISHMENT; TRANSPORT; OYSTERS; IMPACT; FISH	Multi-decadal increase in shell removal by tourists, a process that may accelerate degradation of natural habitats, was quantified via two series of monthly surveys, conducted thirty years apart (1978-1981 and 2008-2010) in one small embayment on the Mediterranean coast of the Iberian Peninsula. Over the last three decades, the local tourist arrivals have increased almost three-fold (2.74), while the area has remained unaffected by urban encroachment and commercial fisheries. During the same time interval the abundance of mollusk shells along the shoreline decreased by a comparable factor (2.62) and was significantly and negatively correlated with tourist arrivals (r = -0.52). The strength of the correlation increased when data were restricted to months with high tourist arrivals (r = -0.72). In contrast, the maximum monthly wave energy (an indirect proxy for changes in rate of onshore shell transport) was not significantly correlated with shell abundance (r = 0.10). Similarly, rank dominance of common species, drilling predation intensity, and body size-frequency distribution patterns have all remained stable over recent decades. A four-fold increase in global tourist arrivals over the last 30 years may have induced a comparable worldwide acceleration in shell removal from marine shorelines, resulting in multiple, currently unquantifiable, habitat changes such as increased beach erosion, changes in calcium carbonate recycling, and declines in diversity and abundance of organisms, which are dependent on shell availability.	[Kowalewski, Michal] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Domenech, Rosa; Martinell, Jordi] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; [Domenech, Rosa; Martinell, Jordi] Univ Barcelona, Dept Estratig Paleontol & Geociencies Marines, Fac Geol, Barcelona, Spain	State University System of Florida; University of Florida; University of Barcelona; University of Barcelona	Kowalewski, M (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	kowalewski@ufl.edu	Domènech, Rosa/X-5080-2019; Kowalewski, Michal/B-4263-2008; Domènech, Rosa/M-6195-2013; Martinell, Jordi/K-2981-2014; Martinell, Jordi/X-4501-2019	Domènech, Rosa/0000-0002-4174-8942; Kowalewski, Michal/0000-0002-8575-4711; Domènech, Rosa/0000-0002-4174-8942; Martinell, Jordi/0000-0003-2638-8106; Martinell, Jordi/0000-0003-2638-8106	Spanish Science and Innovation Ministry [CGL2010-15047]; Jon A. and Beverly L. Thompson Foundation (University of Florida)	Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Jon A. and Beverly L. Thompson Foundation (University of Florida)	The study was supported by the research project CGL2010-15047 (Spanish Science and Innovation Ministry) and by the Jon A. and Beverly L. Thompson Foundation (University of Florida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 1983, SENCKENBERG MARIT, V15, P87; CARTER RWG, 1976, J SEDIMENT PETROL, V46, P418, DOI 10.1306/212F6F8C-2B24-11D7-8648000102C1865D; Carver CE, 2010, J SHELLFISH RES, V29, P905, DOI 10.2983/035.029.0423; Chauvaud L, 2003, LIMNOL OCEANOGR, V48, P2086, DOI 10.4319/lo.2003.48.6.2086; Dalgic G, 2009, J ANIM VET ADV, V8, P2009; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; DAVIES DJ, 1989, PALAEOGEOGR PALAEOCL, V72, P317, DOI 10.1016/0031-0182(89)90150-8; de la Rua A. Rodriguez, 2003, Boletin Instituto Espanol de Oceanografia, V19, P57; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; den Hollander J., 1974, Entomologische Berichten, V34, P155; Dias TLP, 2011, BIODIVERS CONSERV, V20, P2393, DOI 10.1007/s10531-011-9991-5; Dietl GP, 2011, TRENDS ECOL EVOL, V26, P30, DOI 10.1016/j.tree.2010.09.010; EVANS JW, 1969, AM ZOOL, V9, P775; Fanini L, 2005, OCEANOLOGIA, V47, P93; Flessa KW, 1998, GEOLOGY, V26, P187, DOI 10.1130/0091-7613(1998)026<0187:WTCSTD>2.3.CO;2; Gossling S, 2004, BIODIVERS CONSERV, V13, P2623, DOI 10.1007/s10531-004-2139-0; Gossling S, 2002, GLOBAL ENVIRON CHANG, V12, P283, DOI 10.1016/S0959-3780(02)00044-4; Grey M, 2005, ORYX, V39, P413, DOI 10.1017/S0030605305000967; Griffiths J, 2006, MAR BIOL, V149, P1489, DOI 10.1007/s00227-006-0289-1; Guo HY, 2012, OECOLOGIA, V170, P789, DOI 10.1007/s00442-012-2356-2; Hofrichter R., 2004, MAR MEDITERRANEO FAU; Hunter C., 1995, TOURISM ENV SUSTAINA; Jimenez H, 2011, FISH RES, V108, P195, DOI 10.1016/j.fishres.2010.12.021; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; Kidwell SM, 2008, LETHAIA, V41, P199, DOI 10.1111/j.1502-3931.2007.00050.x; Kidwell SM, 2007, P NATL ACAD SCI USA, V104, P17701, DOI 10.1073/pnas.0707194104; Kinzelman JL, 2003, LAKE RESERV MANAGE, V19, P349, DOI 10.1080/07438140309353944; Kowalewski M, 2000, GEOLOGY, V28, P1059, DOI 10.1130/0091-7613(2000)28<1059:DDFPTT>2.0.CO;2; Kowalewski Michal, 2009, Paleontological Society Papers, V15, P1; Kyle R, 1997, BIOL CONSERV, V82, P183, DOI 10.1016/S0006-3207(97)00022-0; Laidre ME, 2011, J EXP MAR BIOL ECOL, V397, P65, DOI 10.1016/j.jembe.2010.10.024; Lebrato M, 2010, ECOL MONOGR, V80, P441, DOI 10.1890/09-0553.1; Lenu║ek Lena., 1999, BEACH HIST PARADISE; Lescinsky HL, 2002, PALAIOS, V17, P171, DOI 10.1669/0883-1351(2002)017<0171:MSEABR>2.0.CO;2; MARTINELL J, 1982, MALACOLOGIA, V22, P587; Masio B, 2011, RESTOR ECOL, V19, P194; Mathieson A, 1982, TOURISM EC SOCIAL PH; McLachlan A, 1996, OCEANOGR MAR BIOL, V34, P163; Murray SN, 1999, CAL COOP OCEAN FISH, V40, P100; Olszewski TD, 2012, BIOL LETTERS, V8, P131, DOI 10.1098/rsbl.2011.0337; Pawlowska AM, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P109, DOI 10.1007/978-3-540-77598-0_6; Peres J. M., 1964, RECUEIL TRAVAUX STAT, V47, P5; Peter Dance S., 1986, HIST SHELL COLLECTIN, P99; Peterson CH, 2000, J COASTAL RES, V16, P368; Poppe G. T., 1991, EUROPEAN SEASHELLS, V1; POWELL EN, 1992, J MAR RES, V50, P229, DOI 10.1357/002224092784797665; Preston-Whyte R., 2004, COMPANION TOURISM, P349, DOI DOI 10.1002/9780470752272; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Rodland DL, 2004, PALAIOS, V19, P381, DOI 10.1669/0883-1351(2004)019<0381:COALWE>2.0.CO;2; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Seung-Woo L, 2010, MICRON, V41, P273; Smith Stephen A., 2004, COMPANION TOURISM, P25; Spanish Government, 2007, B OFIC ESTADO, V299, P51275; Speybroeck J, 2006, AQUAT CONSERV, V16, P419, DOI 10.1002/aqc.733; Terry RC, 2010, P ROY SOC B-BIOL SCI, V277, P1193, DOI 10.1098/rspb.2009.1984; Tirado C, 1999, MAR ECOL-P S Z N I, V20, P111, DOI 10.1046/j.1439-0485.1999.00068.x; Tlili S, 2011, CHEMOSPHERE, V84, P1362, DOI 10.1016/j.chemosphere.2011.05.009; Tomasovych A, 2006, PALEOBIOLOGY, V32, P278, DOI 10.1666/0094-8373(2006)32[278:MSAAIS]2.0.CO;2; van der Meij SET, 2009, MAR POLLUT BULL, V59, P101, DOI 10.1016/j.marpolbul.2009.02.021; van der Wal D, 1998, J COASTAL RES, V14, P620; Warwick RM, 2002, J MAR BIOL ASSOC UK, V82, P847, DOI 10.1017/S0025315402006227; Warwick RM, 2002, BIODIVERS CONSERV, V11, P99, DOI 10.1023/A:1014094829984; Wells SM, 1989, MARINE INVERTEBRATE; Wilson SK, 2005, MAR BIOL, V147, P179, DOI 10.1007/s00227-005-1556-2; Wong P.P., 2004, COMPANION TOURISM, P450, DOI [10.1002/9780470752272, DOI 10.1002/9780470752272]; Yanes Y, 2012, PALAIOS, V27, P373, DOI 10.2110/palo.2011.p11-089r; Zuschin M, 2007, FACIES, V53, P319, DOI 10.1007/s10347-007-0110-8	69	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83615	10.1371/journal.pone.0083615	http://dx.doi.org/10.1371/journal.pone.0083615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421895	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500059
J	Thorstensson, R; Trollfors, B; Al-Tawil, N; Jahnmatz, M; Bergstrom, J; Ljungman, M; Torner, A; Wehlin, L; Van Broekhoven, A; Bosman, F; Debrie, AS; Mielcarek, N; Locht, C				Thorstensson, Rigmor; Trollfors, Birger; Al-Tawil, Nabil; Jahnmatz, Maja; Bergstrom, Jakob; Ljungman, Margaretha; Torner, Anna; Wehlin, Lena; Van Broekhoven, Annie; Bosman, Fons; Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille			A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine-BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers	PLOS ONE			English	Article							VACCINATION; INFECTION; IMMUNITY; PATHOGENESIS; PROTECTION; ANTIBODIES; INFLUENZA; INFANTS; DISEASE; COUGH	Background: Acellular pertussis vaccines do not control pertussis. A new approach to offer protection to infants is necessary. BPZE1, a genetically modified Bordetella pertussis strain, was developed as a live attenuated nasal pertussis vaccine by genetically eliminating or detoxifying 3 toxins. Methods: We performed a double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally for the first time to human volunteers, the first trial of a live attenuated bacterial vaccine specifically designed for the respiratory tract. 12 subjects per dose group received 10 3, 10 5 or 10 7 colony-forming units as droplets with half of the dose in each nostril. 12 controls received the diluent. Local and systemic safety and immune responses were assessed during 6 months, and nasopharyngeal colonization with BPZE1 was determined with repeated cultures during the first 4 weeks after vaccination. Results: Colonization was seen in one subject in the low dose, one in the medium dose and five in the high dose group. Significant increases in immune responses against pertussis antigens were seen in all colonized subjects. There was one serious adverse event not related to the vaccine. Other adverse events were trivial and occurred with similar frequency in the placebo and vaccine groups. Conclusions: BPZE1 is safe in healthy adults and able to transiently colonize the nasopharynx. It induces immune responses in all colonized individuals. BPZE1 can thus undergo further clinical development, including dose optimization and trials in younger age groups.	[Thorstensson, Rigmor; Trollfors, Birger; Jahnmatz, Maja; Bergstrom, Jakob; Ljungman, Margaretha; Torner, Anna; Wehlin, Lena] Swedish Inst Communicable Dis Control, Solna, Sweden; [Al-Tawil, Nabil] Karolinska Univ Hosp, Karolinska Trial Alliance, Stockholm, Sweden; [Jahnmatz, Maja] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Van Broekhoven, Annie; Bosman, Fons] BioIncubator, Q Biol, Zwijnaarde, Belgium; [Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] INSERM, F-59045 Lille, France; [Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] Natl Ctr Sci Res, Lille, France; [Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] Univ Lille Nord France, Lille, France; [Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Thorstensson, R (corresponding author), Swedish Inst Communicable Dis Control, Solna, Sweden.	Rigmor.thorstensson@smi.se	Locht, Camille/L-3516-2018	Debrie, Anne-Sophie/0000-0003-0570-4413; Locht, Camille/0000-0001-7295-7336; Mielcarek, Nathalie/0000-0002-5968-9442	European Commission Framework Program 7 (Child-Innovac project) [201502]	European Commission Framework Program 7 (Child-Innovac project)	This work was supported by the European Commission Framework Program 7 (Child-Innovac project, grant agreement number 201502). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P509; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2010, CLIN VACCINE IMMUNOL, V17, P741, DOI 10.1128/CVI.00469-09; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Clark TA, 2012, TRENDS MICROBIOL, V20, P211, DOI 10.1016/j.tim.2012.03.003; Feunou PF, 2008, VACCINE, V26, P5722, DOI 10.1016/j.vaccine.2008.08.018; Feunou PF, 2010, VACCINE, V28, P7047, DOI 10.1016/j.vaccine.2010.08.017; GRUBER WC, 1993, J INFECT DIS, V168, P1282, DOI 10.1093/infdis/168.5.1282; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Hallander HO, 2009, APMIS, V117, P660, DOI 10.1111/j.1600-0463.2009.02521.x; Hodgins DC, 2012, VACCINE, V30, P1541, DOI 10.1016/j.vaccine.2011.12.047; HUANG CC, 1962, NEW ENGL J MED, V266, P105, DOI 10.1056/NEJM196201182660301; Keitel WA, 2001, J INFECT DIS, V183, P329, DOI 10.1086/317926; Lehar Craig, 2008, Vet Ther, V9, P257; Levine MM, 2007, CLIN INFECT DIS, V45, pS24, DOI 10.1086/518141; Locht C, 2012, FEMS IMMUNOL MED MIC, V66, P121, DOI 10.1111/j.1574-695X.2012.00988.x; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mielcarek N, 2001, ADV DRUG DELIVER REV, V51, P55, DOI 10.1016/S0169-409X(01)00168-5; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Mielcarek N, 2010, CLIN VACCINE IMMUNOL, V17, P317, DOI 10.1128/CVI.00322-09; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; R Core Team, 2012, R LANG ENV STAT COMP; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; Skerry CM, 2011, CLIN VACCINE IMMUNOL, V18, P187, DOI 10.1128/CVI.00371-10; Skerry CM, 2009, CLIN VACCINE IMMUNOL, V16, P1344, DOI 10.1128/CVI.00082-09; Storsaeter J, 2003, VACCINE, V21, P3542, DOI 10.1016/S0264-410X(03)00407-9; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; World Health Organization, VACC PREV DIS MON SY	30	101	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83449	10.1371/journal.pone.0083449	http://dx.doi.org/10.1371/journal.pone.0083449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421886	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500048
J	Chen, X; Wang, Z; Yan, YL; Li, P; Yang, Z; Qin, LY; Mo, WN				Chen, Xu; Wang, Zhe; Yan, Yulan; Li, Ping; Yang, Zheng; Qin, Lingyan; Mo, Wuning			XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis	PLOS ONE			English	Article							REPAIR GENE XRCC3; SINGLE-NUCLEOTIDE POLYMORPHISMS; HOMOLOGOUS RECOMBINATION REPAIR; SKIN-CANCER RISK; DNA-REPAIR; T241M POLYMORPHISM; CUTANEOUS MELANOMA; GENOTYPING ERRORS; SUSCEPTIBILITY; VARIANT	Background: The X-ray repair cross-complementing group 3 (XRCC3) in homologous recombination repair (HRR) pathway plays a very important role in DNA double-strand break repair (DSBR). Variations in the XRCC3 gene might lead to altered protein structure or function which may change DSBR efficiency and result in cancer. The XRCC3 C18067T polymorphism has been reported to be associated with skin cancer susceptibility, yet the results of these previous results have been inconsistent or controversial. To derive a more precise estimation of the association, we conducted a meta-analysis. Methods: The quality of the studies was assessed according to a predefined scale. The association between the XRCC3 C18067T polymorphism and skin cancer risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). Results: Overall, no significant association was observed between XRCC3 C18067T polymorphism and skin cancer risk in any genetic model. Stratified analyses according to tumor type, significant association was found in the relationship between XRCC3 C18067T polymorphism and nonmelanoma skin cancer risk (homozygote comparison TT versus CC: OR = 0.74, 95% CI = 0.61-0.90, P = 0.003; recessive model TT versus TC/CC: OR = 0.81, 95% CI = 0.68-0.95, P = 0.01). Furthermore, significant association was also observed in XRCC3 C18067T polymorphism with both basal cell carcinoma risk (homozygote comparison TT versus CC: OR = 0.70, 95% CI = 0.53-0.92, P = 0.011; recessive model TT versus. TC/CC: OR = 0.74, 95% CI = 0.600.92, P = 0.007) and squamous cell carcinoma risk (heterozygote comparison TT versus. CC: OR = 0.81, 95% CI = 0.67-0.99, P = 0.04; dominant model TT/TC versus. CC: OR = 0.81, 95% CI = 0.68-0.98, P = 0.029). Conclusion: The present meta-analysis demonstrates that XRCC3 C18067T polymorphism was not associated with risk of cutaneous melanoma but contributed a decreased risk to both basal cell carcinoma and squamous cell carcinoma.	[Chen, Xu; Yan, Yulan; Li, Ping; Yang, Zheng; Qin, Lingyan; Mo, Wuning] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Wang, Zhe] Guangxi Med Univ, Affiliated Hosp 1, Div Spine & Osteopathy Surg, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Mo, WN (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	mown16300@126.com	Wang, Zhe/K-1663-2016					BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bertram CG, 2004, J INVEST DERMATOL, V122, P429, DOI 10.1046/j.0022-202X.2003.12541.x; Brenneman MA, 2000, MUTAT RES-DNA REPAIR, V459, P89, DOI 10.1016/S0921-8777(00)00002-1; Capell BC, 2009, J INVEST DERMATOL, V129, P2340, DOI 10.1038/jid.2009.103; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan ZG, 2002, CANCER EPIDEM BIOMAR, V11, P1142; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Festa F, 2005, MUTAT RES-FUND MOL M, V574, P105, DOI 10.1016/j.mrfmmm.2005.01.026; Figl A, 2010, MUTAT RES-GEN TOX EN, V702, P8, DOI 10.1016/j.mrgentox.2010.06.011; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Goncalves FT, 2011, J DERMATOL SCI, V64, P59, DOI 10.1016/j.jdermsci.2011.06.003; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Griffin CS, 2002, MUTAT RES-FUND MOL M, V504, P149, DOI 10.1016/S0027-5107(02)00088-X; Han JL, 2004, CANCER RES, V64, P3009, DOI 10.1158/0008-5472.CAN-04-0246; Han JL, 2004, CANCER EPIDEM BIOMAR, V13, P330, DOI 10.1158/1055-9965.EPI-03-0332; Han SZ, 2006, EUR J HUM GENET, V14, P1136, DOI 10.1038/sj.ejhg.5201681; He XF, 2013, GENE, V523, P10, DOI 10.1016/j.gene.2013.03.071; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035220; Jacobsen NR, 2003, CANCER EPIDEM BIOMAR, V12, P584; Jiang DK, 2011, J INVEST DERMATOL, V131, P220, DOI 10.1038/jid.2010.270; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Lin JS, 2011, ANN INTERN MED, V154, P190, DOI 10.7326/0003-4819-154-3-201102010-00009; MANTEL N, 1959, J NATL CANCER I, V22, P719; Manuguerra M, 2006, AM J EPIDEMIOL, V164, P297, DOI 10.1093/aje/kwj189; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Romanowicz-Makowska H, 2012, J OBSTET GYNAECOL RE, V38, P918, DOI 10.1111/j.1447-0756.2011.01811.x; Scherer D, 2008, INT J CANCER, V122, P1787, DOI 10.1002/ijc.23257; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thirumaran RK, 2006, CARCINOGENESIS, V27, P1676, DOI 10.1093/carcin/bgi381; Thompson JF, 2009, LANCET, V374, P362, DOI 10.1016/S0140-6736(09)61397-0; Ulrich C, 2008, AM J TRANSPLANT, V8, P2192, DOI 10.1111/j.1600-6143.2008.02386.x; Wang YG, 2012, ASIAN PAC J CANCER P, V13, P111, DOI 10.7314/APJCP.2012.13.1.111; Winsey SL, 2000, CANCER RES, V60, P5612; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Young C, 2009, OCCUP MED-OXFORD, V59, P82, DOI 10.1093/occmed/kqn170; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L; Zhang LQ, 2012, MUTAGENESIS, V27, P67, DOI 10.1093/mutage/ger062	42	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84195	10.1371/journal.pone.0084195	http://dx.doi.org/10.1371/journal.pone.0084195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454720	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100019
J	Epelbaum, M				Epelbaum, Michael			Lifespan and Aggregate Size Variables in Specifications of Mortality or Survivorship	PLOS ONE			English	Article							POWER-LAW; HETEROGENEITY; MODEL; SURVIVAL; VITALITY; AGE; DISTRIBUTIONS; LONGEVITY; FRAILTY; THERMODYNAMICS	A specification of mortality or survivorship provides respective explicit details about mortality's or survivorship's relationships with one or more other variables (e.g., age, sex, etc.). Previous studies have discovered and analyzed diverse specifications of mortality or survivorship; these discoveries and analyses suggest that additional specifications of mortality or survivorship have yet to be discovered and analyzed. In consistency with previous research, multivariable limited powered polynomials regression analyses of mortality and survivorship of selected humans (Swedes, 1760-2008) and selected insects (caged medflies) show age-specific, historical-time-specific, environmental-context-specific, and sex-specific mortality and survivorship. These analyses also present discoveries of hitherto unknown lifespan-specific, contemporary-aggregate-size-specific, and lifespan-aggregate-size-specific mortality and survivorship. The results of this investigation and results of previous research help identify variables for inclusion in regression models of mortality or survivorship. Moreover, these results and results of previous research strengthen the suggestion that additional specifications of mortality or survivorship have yet to be discovered and analyzed, and they also suggest that specifications of mortality and survivorship indicate corresponding specifications of frailty and vitality. Furthermore, the present analyses reveal the usefulness of a multivariable limited powered polynomials regression model-building approach. This article shows that much has yet to be learned about specifications of mortality or survivorship of diverse kinds of individuals in diverse times and places.				mepelbaum3@gmail.com		Epelbaum, Michael/0000-0002-1786-6391				Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson JJ, 2008, AM NAT, V171, pE20, DOI 10.1086/524199; ANDERSON JJ, 1992, INDIVIDUAL-BASED MODELS AND APPROACHES IN ECOLOGY, P256; Anderson JJ, 2000, ECOL MONOGR, V70, P445, DOI 10.1890/0012-9615(2000)070[0445:AVBMRS]2.0.CO;2; [Anonymous], 1939, HUM BIOL, DOI DOI 10.2307/41447403; ATLAN H, 1976, MECH AGEING DEV, V5, P371, DOI 10.1016/0047-6374(76)90035-X; ATLAN H, 1968, J GERONTOL, V23, P196, DOI 10.1093/geronj/23.2.196; Beard R.E., 1959, CIBA FDN C AGEING, P302; Beard R. E., 1971, BIOL ASPECTS DEMOGRA, V999, P57; Beard RE, 1964, INT C ACTUARIES, V3, P463; Bebbington M, 2011, MATH POPUL STUD, V18, P18, DOI 10.1080/08898480.2011.540173; Becerra O, 2006, ANN C AM POL SCI ASS; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Bevacqua D, 2011, OECOLOGIA, V165, P333, DOI 10.1007/s00442-010-1727-9; Bigger JT, 1996, CIRCULATION, V93, P2142, DOI 10.1161/01.CIR.93.12.2142; Brody S, 1923, J GEN PHYSIOL, V6, P245; Brown J., 2000, SCALING BIOL; CALDER WA, 1983, J THEOR BIOL, V102, P135, DOI 10.1016/0022-5193(83)90266-7; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Carnes BA, 2001, EXP GERONTOL, V36, P419, DOI 10.1016/S0531-5565(00)00254-0; Carnes BA, 1996, POPUL DEV REV, V22, P231, DOI 10.2307/2137434; Carnes BA, 2011, BIOGERONTOLOGY, V12, P367, DOI 10.1007/s10522-011-9338-3; Charnov Eric L., 1993, P1; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2010, J CONFLICT RESOLUT, V54, P179, DOI 10.1177/0022002709352452; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CLAYTON DG, 1978, BIOMETRIKA, V65, P141, DOI 10.2307/2335289; Cohen M.N., 1989, HLTH RISE CIVILIZATI; Comfort A, 1957, CIBA FDN C AGEING, P2; Corbaux F, 1833, NATURAL MATH LAWS PO; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; Duchateau L, 2008, STAT BIOL HEALTH, P1; Economos A C, 1982, Arch Gerontol Geriatr, V1, P3; ECONOMOS AC, 1981, GERONTOLOGY, V27, P258, DOI 10.1159/000212481; EPELBAUM M, 1990, SOC SCI RES, V19, P322, DOI 10.1016/0049-089X(90)90002-Z; FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb54674.x; Fienberg S.E., 1985, COHORT ANAL SOCIAL R, DOI DOI 10.1007/978-1-4613-8536-3; Finch CE, 1990, LONGEVITY SENESCENCE; GILLIS DM, 1986, J THEOR BIOL, V123, P281, DOI 10.1016/S0022-5193(86)80243-0; Golubev A, 2009, J THEOR BIOL, V258, P1, DOI 10.1016/j.jtbi.2009.01.009; Gompertz B, 1862, PHILOS T ROY SOC LON, V152, P511; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; GREENBERG BG, 1950, J AM STAT ASSOC, V45, P373, DOI 10.2307/2280294; Greene W. H., 2012, ECONOMETRIC ANAL, V7th; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Heckman J.J., 1981, STUDIES LABOR MARKET, P91; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Heckman JJ, 1986, HDB ECONOMETRICS, P1690; HOBCRAFT J, 1982, POPUL INDEX, V48, P4, DOI 10.2307/2736356; Hooker P. F, 1965, J I ACTUARIES, V91, P203; HOUGAARD P, 1984, BIOMETRIKA, V71, P75, DOI 10.2307/2336399; Jenkins SP, 2008, SURVIVAL ANAL STAT M; Johnson SE, 2009, TREE PHYSIOL, V29, P1317, DOI 10.1093/treephys/tpp068; JONES H B, 1956, Adv Biol Med Phys, V4, P281; JUCKETT DA, 1982, MECH AGEING DEV, V18, P33, DOI 10.1016/0047-6374(82)90027-6; Kannisto V, 1991, Genus, V47, P101; Kermack WO, 1934, LANCET, V1, P698; Kirkwood TBL, 1996, BIOESSAYS, V18, P1009, DOI 10.1002/bies.950181211; Koenker R, 2001, J AM STAT ASSOC, V96, P458, DOI 10.1198/016214501753168172; LEE RD, 1987, DEMOGRAPHY, V24, P443, DOI 10.2307/2061385; Lenski R.E., 2011, MICROBE, V6, P30; Li T, 2009, THEOR POPUL BIOL, V76, P118, DOI 10.1016/j.tpb.2009.05.004; LINDHEIM R, 1983, ANNU REV PUBL HEALTH, V4, P335, DOI 10.1146/annurev.pu.04.050183.002003; LINTS FA, 1989, GERONTOLOGY, V35, P36, DOI 10.1159/000212998; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, V2nd; Macunovich DJ, 1999, RELATIVE COHORT SIZE, V139; Makeham W.M., 1867, J I ACTUARIES 1866 1, V13, P325, DOI [DOI 10.1017/S2046166600003238, 10.1017/s2046166600003238]; Makeham WM, 1889, J I ACTUARIES, V28, P185; Makeham WM, 1889, J I ACTUARIES, V28, P152; Malthus T.R., 1992, ESSAY PRINCIPLE POPU; Manton GK, 1984, METHODOLOGIES COLLEC, P265; Manton GK, 1984, RECENT TRENDS MORTAL; MANTON KG, 1986, J AM STAT ASSOC, V81, P635, DOI 10.2307/2288991; MASON KO, 1973, AM SOCIOL REV, V38, P242, DOI 10.2307/2094398; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Medawar PB, 1946, UNIQUENESS INDIVIDUA, P17; Milne EMG, 2008, J THEOR BIOL, V255, P223, DOI 10.1016/j.jtbi.2008.07.021; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Novozhilov AS, 2006, BRIEF BIOINFORM, V7, P70, DOI 10.1093/bib/bbk006; O'Brien RM, 2011, QUAL QUANT, P1; O'Brien RM, 2008, SOCIOL METHOD RES, V36, P402, DOI 10.1177/0049124106290392; Olivola CY, 2009, P NATL ACAD SCI USA, V106, P22151, DOI 10.1073/pnas.0908980106; Olshansky SJ, 1997, DEMOGRAPHY, V34, P1, DOI 10.2307/2061656; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; Pearl R., 1928, RATE LIVING; Perks W., 1932, J I ACTUARIES, V63, P12, DOI DOI 10.1017/S0020268100046680; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; RASMUSSEN S, 2009, PROTOCELLS BRIDGING; Richardson L. F., 1960, STAT DEADLY QUARRELS; Riley J, 2001, RISING LIFE EXPECTAN; Riley J.C., 2008, LOW INCOME SOCIAL GR; ROSENBERG B, 1973, Mechanisms of Ageing and Development, V2, P275, DOI 10.1016/0047-6374(73)90023-7; Rossetto M, 2012, OECOLOGIA, V168, P989, DOI 10.1007/s00442-011-2163-1; Rossolini G, 2001, EXP GERONTOL, V36, P1277, DOI 10.1016/S0531-5565(01)00092-4; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Royston P., 2008, MULTIVARIABLE MODEL; Ruggiero C, 2008, J GERONTOL A-BIOL, V63, P698, DOI 10.1093/gerona/63.7.698; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Service PM, 2000, AM NAT, V156, P1, DOI 10.1086/303371; Service PM, 2004, EXP GERONTOL, V39, P25, DOI 10.1016/j.exger.2003.09.014; SIMMS HS, 1946, J GERONTOL, V1, P13; SINCLAIR ARE, 1988, ECOLOGICAL CONCEPTS, P197; StataCorp, 2021, STATA STAT SOFTWARE; Steinsaltz D, 2005, EXP GERONTOL, V40, P101, DOI 10.1016/j.exger.2004.11.010; Steinsaltz DR, 2006, MATH POPUL STUD, V13, P19, DOI 10.1080/08898480500452117; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; STREHLER BL, 1977, TIME CELLS AGING; Swinne C, 1998, AGE AGEING, V27, P411, DOI 10.1093/ageing/27.3.411-a; Theil H., 1957, REV INT STATISTICAL, V25, P41, DOI 10.2307/1401673; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wong ES, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-175; World Health Organization, INT CLASS DIS WEBS; Wrigley E. A., 1997, ENGLISH POPULATION H; Wu DQ, 2009, EXP GERONTOL, V44, P607, DOI 10.1016/j.exger.2009.06.007; Wu DQ, 2006, EXP GERONTOL, V41, P261, DOI 10.1016/j.exger.2006.01.003; Yashin A. I., 2000, MATH POPUL STUD, V8, P305, DOI DOI 10.1080/08898480009525489; Zheng H, 2011, DEMOGRAPHY, V48, P267, DOI 10.1007/s13524-011-0013-8; Zuev SM, 2000, J GERONTOL A-BIOL, V55, pB10	125	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84156	10.1371/journal.pone.0084156	http://dx.doi.org/10.1371/journal.pone.0084156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454719	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100018
J	Ishtiaq, M; Campos-Melo, D; Volkening, K; Strong, MJ				Ishtiaq, Muhammad; Campos-Melo, Danae; Volkening, Kathryn; Strong, Michael J.			Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; SELECTIVE LOSS; WEB SERVER; CELL FATE; EXPRESSION; PROTEIN; MIRNA; GENE; PREDICTION; TDP-43	Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by progressive motor neuron degeneration and neurofilament aggregate formation. Spinal motor neurons in ALS also show a selective suppression in the levels of low molecular weight neurofilament (NEFL) mRNA. We have been interested in investigating the role of microRNAs (miRNAs) in NEFL transcript stability. MiRNAs are small, 20-25 nucleotide, non-coding RNAs that act as post-transcriptional gene regulators by targeting the 3' untranslated region (3'UTR) of mRNA resulting in mRNA decay or translational silencing. In this study, we characterized putative novel miRNAs from a small RNA library derived from control and sporadic ALS (sALS) spinal cords. We detected 80 putative novel miRNAs, 24 of which have miRNA response elements (MREs) within the NEFL mRNA 3'UTR. From this group, we determined by real-time PCR that 10 miRNAs were differentially expressed in sALS compared to controls. Functional analysis by reporter gene assay and relative quantitative RT-PCR showed that two novel miRNAs, miR-b1336 and miR-b2403, were downregulated in ALS spinal cord and that both stabilize NEFL mRNA. We confirmed the direct effect of these latter miRNAs using anit-miR-b1336 and anti-miR-b2403. These results demonstrate that the expression of two miRNAs (miRNAs miR-b1336 and miR-b2403) whose effect is to stabilize NEFL mRNA are down regulated in ALS, the net effect of which is predicted to contribute directly to the loss of NEFL steady state mRNA which is pathognomic of spinal motor neurons in ALS.	[Ishtiaq, Muhammad; Campos-Melo, Danae; Volkening, Kathryn; Strong, Michael J.] Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, London, ON, Canada; [Volkening, Kathryn; Strong, Michael J.] Univ Western Ontario, Dept Clin Neurol Sci, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Strong, MJ (corresponding author), Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, London, ON, Canada.	Michael.Strong@schulich.uwo.ca	Strong, Michael/AAU-5699-2020; Strong, Michael J/H-9689-2012; Ishtiaq, Muhammad/GSN-4278-2022	Strong, Michael/0000-0003-1988-6262; 	ALS Society of Canada; Canadian Institutes of Health Research (CIHR)	ALS Society of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Research was funded by the ALS Society of Canada (Senior Scientist Bridge Funding) and the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhattacharyya SN, 2007, CELL, V128, P1027, DOI 10.1016/j.cell.2007.02.033; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Buchan JR, 2007, SCIENCE, V318, P1877, DOI 10.1126/science.1152623; Campos-Melo D, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-26; Cerutti H, 2011, EUKARYOT CELL, V10, P1164, DOI 10.1128/EC.05106-11; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crippa S, 2012, CURR PHARM DESIGN, V18, P1718, DOI 10.2174/138161212799859620; De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058; Droppelmann CA, 2013, NEUROBIOL AGING, V34, P248, DOI 10.1016/j.neurobiolaging.2012.06.021; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge WW, 2007, MOL CELL NEUROSCI, V34, P80, DOI 10.1016/j.mcn.2006.10.001; Ge WW, 2005, J BIOL CHEM, V280, P118, DOI 10.1074/jbc.M405065200; Ge WW, 2003, J BIOL CHEM, V278, P26558, DOI 10.1074/jbc.M302886200; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Iwasaki S, 2009, FLY, V3, P204; KONDO A, 1986, JPN J PSYCHIAT NEUR, V40, P677; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee S, 2013, ADV EXP MED BIOL, V768, P97, DOI 10.1007/978-1-4614-5107-5_7; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Menzies FM, 2002, J NEUROCHEM, V82, P1118, DOI 10.1046/j.1471-4159.2002.01045.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Carroll Donal, 2013, Neuropsychopharmacology, V38, P39, DOI 10.1038/npp.2012.87; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Saraiya AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055672; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Tyagi S, 2008, BIOCHEM BIOPH RES CO, V372, P831, DOI 10.1016/j.bbrc.2008.05.134; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volkening K, 2010, AMYOTROPH LATERAL SC, V11, P97, DOI 10.3109/17482960902995584; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wong NKY, 2000, J NEUROPATH EXP NEUR, V59, P972, DOI 10.1093/jnen/59.11.972; Zeller John L, 2007, JAMA, V298, P248, DOI 10.1001/jama.298.2.248; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85653	10.1371/journal.pone.0085653	http://dx.doi.org/10.1371/journal.pone.0085653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454911	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100114
J	Liu, SQ; Miriyala, S; Keaton, MA; Jordan, CT; Wiedl, C; St Clair, DK; Moscow, JA				Liu, Shuqian; Miriyala, Sumitra; Keaton, Mignon A.; Jordan, Craig T.; Wiedl, Christina; St Clair, Daret K.; Moscow, Jeffrey A.			Metabolic Effects of Acute Thiamine Depletion Are Reversed by Rapamycin in Breast and Leukemia Cells	PLOS ONE			English	Article							ENZYME; IDENTIFICATION; INHIBITORS	Thiamine-dependent enzymes (TDEs) control metabolic pathways that are frequently altered in cancer and therefore present cancer-relevant targets. We have previously shown that the recombinant enzyme thiaminase cleaves and depletes intracellular thiamine, has growth inhibitory activity against leukemia and breast cancer cell lines, and that its growth inhibitory effects were reversed in leukemia cell lines by rapamycin. Now, we first show further evidence of thiaminase therapeutic potential by demonstrating its activity against breast and leukemia xenografts, and against a primary leukemia xenograft. We therefore further explored the metabolic effects of thiaminase in combination with rapamycin in leukemia and breast cell lines. Thiaminase decreased oxygen consumption rate and increased extracellular acidification rate, consistent with the inhibitory effect of acute thiamine depletion on the activity of the TDEs pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes; these effects were reversed by rapamycin. Metabolomic studies demonstrated intracellular thiamine depletion and the presence of the thiazole cleavage product in thiaminase-treated cells, providing validation of the experimental procedures. Accumulation of ribose and ribulose in both cell lines support the thiaminase-mediated suppression of the TDE transketolase. Interestingly, thiaminase suppression of another TDE, branched chain amino ketoacid dehydrogenase (BCKDH), showed very different patterns in the two cell lines: in RS4 leukemia cells it led to an increase in BCKDH substrates, and in MCF-7 breast cancer cells it led to a decrease in BCKDH products. Immunoblot analyses showed corresponding differences in expression of BCKDH pathway enzymes, and partial protection of thiaminase growth inhibition by gabapentin indicated that BCKDH inhibition may be a mechanism of thiaminase-mediated toxicity. Surprisingly, most of thiaminase-mediated metabolomic effects were also reversed by rapamycin. Thus, these studies demonstrate that acute intracellular thiamine depletion by recombinant thiaminase results in metabolic changes in thiamine-dependent metabolism, and demonstrate a previously unrecognized role of mTOR signaling in the regulation of thiamine-dependent metabolism.	[Liu, Shuqian; Moscow, Jeffrey A.] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Miriyala, Sumitra; St Clair, Daret K.] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY USA; [Keaton, Mignon A.] Metabolon Inc, Durham, NC USA; [Jordan, Craig T.] Univ Colorado, Div Hematol Hematol Malignancies & Stem Cell Tran, Denver, CO 80202 USA; [Wiedl, Christina] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA USA	University of Kentucky; University of Kentucky; Metabolon; University of Colorado System; University of Colorado Denver; Virginia Commonwealth University	Moscow, JA (corresponding author), Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA.	jmoscow@uky.edu	jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465; Miriyala, Sumitra/0000-0001-7158-9295	DanceBlue, an effort of the University of Kentucky student community	DanceBlue, an effort of the University of Kentucky student community	The authors thank the Research Communication Office of the Markey Cancer Center at the University of Kentucky for editorial and graphics assistance. This work was supported by DanceBlue, an effort of the University of Kentucky student community to support pediatric oncology care and research.	Casteels M, 2007, BIOCHEM SOC T, V35, P876, DOI 10.1042/BST0350876; Costello CA, 1996, J BIOL CHEM, V271, P3445, DOI 10.1074/jbc.271.7.3445; Daily A, 2013, INT J VITAM IN PRESS; Daily A, 2011, MOL CANCER THER, V10, P1563, DOI 10.1158/1535-7163.MCT-11-0003; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Hassane DC, 2010, BLOOD, V116, P5983, DOI 10.1182/blood-2010-04-278044; Hutson SM, 1998, J NEUROCHEM, V71, P863; Le Huerou Y, 2008, BIOORG MED CHEM LETT, V18, P505, DOI 10.1016/j.bmcl.2007.11.100; Liu SQ, 2012, J PHARMACOL EXP THER, V341, P775, DOI 10.1124/jpet.112.191817; Liu SQ, 2010, CANCER CHEMOTH PHARM, V66, P171, DOI 10.1007/s00280-009-1148-9; Liu SQ, 2004, MOL CANCER RES, V2, P477; Liu SQ, 2003, MOL CANCER RES, V1, P665; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Santra S, 2008, EXPERT OPIN PHARMACO, V9, P1229, DOI 10.1517/146565608D2042343; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P2206, DOI 10.1016/j.bmcl.2007.11.101; Zastre JA, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-16	17	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85702	10.1371/journal.pone.0085702	http://dx.doi.org/10.1371/journal.pone.0085702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454921	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100123
J	Loebel, M; Strohschein, K; Giannini, C; Koelsch, U; Bauer, S; Doebis, C; Thomas, S; Unterwalder, N; von Baehr, V; Reinke, P; Knops, M; Hanitsch, LG; Meisel, C; Volk, HD; Scheibenbogen, C				Loebel, Madlen; Strohschein, Kristin; Giannini, Carolin; Koelsch, Uwe; Bauer, Sandra; Doebis, Cornelia; Thomas, Sybill; Unterwalder, Nadine; von Baehr, Volker; Reinke, Petra; Knops, Michael; Hanitsch, Leif G.; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen			Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IGM SERUM ANTIBODIES; GENE-PRODUCTS P52; HUMAN HERPESVIRUS-6; IMMUNOLOGICAL ABNORMALITIES; HHV-6 REACTIVATION; UNIQUELY PRESENT; CROSS-REACT; INFECTION; REPLICATION	Epstein-Barr virus (EBV) has long been discussed as a possible cause or trigger of Chronic Fatigue Syndrome (CFS). In a subset of patients the disease starts with infectious mononucleosis and both enhanced and diminished EBV-specific antibody titers have been reported. In this study, we comprehensively analyzed the EBV-specific memory B-and T-cell response in patients with CFS. While we observed no difference in viral capsid antigen (VCA)-IgG antibodies, EBV nuclear antigen (EBNA)-IgG titers were low or absent in 10% of CFS patients. Remarkably, when analyzing the EBV-specific memory B-cell reservoir in vitro a diminished or absent number of EBNA-1- and VCA-antibody secreting cells was found in up to 76% of patients. Moreover, the ex vivo EBV-induced secretion of TNF-alpha and IFN-gamma was significantly lower in patients. Multicolor flow cytometry revealed that the frequencies of EBNA-1-specific triple TNF-alpha/IFN-gamma/IL-2 producing CD4(+) and CD8(+) T-cell subsets were significantly diminished whereas no difference could be detected for HCMV-specific T-cell responses. When comparing EBV load in blood immune cells, we found more frequently EBER-DNA but not BZLF-1 RNA in CFS patients compared to healthy controls suggesting more frequent latent replication. Taken together, our findings give evidence for a deficient EBV-specific B-and T-cell memory response in CFS patients and suggest an impaired ability to control early steps of EBV reactivation. In addition the diminished EBV response might be suitable to develop diagnostic marker in CFS.	[Loebel, Madlen; Strohschein, Kristin; Giannini, Carolin; Bauer, Sandra; Thomas, Sybill; Knops, Michael; Hanitsch, Leif G.; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Strohschein, Kristin] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Koelsch, Uwe; Unterwalder, Nadine; Meisel, Christian] Charite, Dept Immunol, Lab Berlin GmbH, D-13353 Berlin, Germany; [Doebis, Cornelia; von Baehr, Volker] Inst Med Diagnost, Berlin, Germany; [Reinke, Petra; Volk, Hans-Dieter; Scheibenbogen, Carmen] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Reinke, Petra] Charite, Dept Nephrol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Loebel, M (corresponding author), Charite, Inst Med Immunol, Campus Virchow, D-13353 Berlin, Germany.	Madlen.loebel@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Hanitsch, Leif G./0000-0002-8181-0093; Reinke, Petra/0000-0003-0771-4375; Scheibenbogen, Carmen/0000-0002-8554-9638; Meisel, Christian/0000-0003-0222-991X	Fatigatio e.V. Bundesverband Chronisches Erschopfungssyndrom; "Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union	Fatigatio e.V. Bundesverband Chronisches Erschopfungssyndrom; "Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union	This work was supported by a grant from the "Fatigatio e.V. Bundesverband Chronisches Erschopfungssyndrom" and the "Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union grant "Investition in Ihre Zukunft''. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi DV, 2000, J CLIN VIROL, V16, P179, DOI 10.1016/S1386-6532(99)00079-7; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bansal AS, 2012, BRAIN BEHAV IMMUN, V26, P24, DOI 10.1016/j.bbi.2011.06.016; Beqaj SH, 2008, J CLIN PATHOL, V61, P623, DOI 10.1136/jcp.2007.050633; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; Broderick G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-191; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Burbelo PD, 2012, AM J TRANSL RES, V4, P443; Cameron B, 2010, J MED VIROL, V82, P1684, DOI 10.1002/jmv.21873; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Chang CM, 2012, CANCER-AM CANCER SOC, V118, P5929, DOI 10.1002/cncr.27612; Chapenko S, 2006, J CLIN VIROL, V37, pS47, DOI 10.1016/S1386-6532(06)70011-7; Chapenko S, 2012, ADV VIROL, V2012, DOI 10.1155/2012/205085; Christley Y, 2012, J EVAL CLIN PRACT, V18, P25, DOI 10.1111/j.1365-2753.2010.01512.x; Cohen JI, 1999, CURR OPIN IMMUNOL, V11, P365, DOI 10.1016/S0952-7915(99)80062-4; Colmenares M, 2002, INFECT IMMUN, V70, P6597, DOI 10.1128/IAI.70.12.6597-6605.2002; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Curriu M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-68; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Draborg AH, 2012, SCAND J RHEUMATOL, V41, P280, DOI 10.3109/03009742.2012.665944; Dreyfus DH, 2011, AUTOIMMUN REV, V11, P88, DOI 10.1016/j.autrev.2011.08.005; El-Far Mohamed, 2008, Curr HIV/AIDS Rep, V5, P13, DOI 10.1007/s11904-008-0003-7; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; Fremont M, 2009, IN VIVO, V23, P209; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gabibov AG, 2011, FASEB J, V25, P4211, DOI 10.1096/fj.11-190769; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; Guerreiro M, 2010, EUR J IMMUNOL, V40, P1566, DOI 10.1002/eji.200940000; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Iwakiri D, 2010, ADV CANCER RES, V107, P119, DOI 10.1016/S0065-230X(10)07004-1; Jason LA, 2002, BIOL PSYCHOL, V59, P15, DOI 10.1016/S0301-0511(01)00120-X; Jason LA, 2000, J CLIN PSYCHOL, V56, P1497, DOI 10.1002/1097-4679(200012)56:12<1497::AID-2>3.0.CO;2-Z; Jilek S, 2008, BRAIN, V131, P1712, DOI 10.1093/brain/awn108; JOSEPHS SF, 1991, LANCET, V337, P1346, DOI 10.1016/0140-6736(91)93018-5; KAWAI K, 1992, INTERNAL MED, V31, P313, DOI 10.2169/internalmedicine.31.313; Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874; Klein G, 2010, BIOCHEM BIOPH RES CO, V396, P67, DOI 10.1016/j.bbrc.2010.02.146; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Komaroff AL, 2011, SEMIN NEUROL, V31, P325, DOI 10.1055/s-0031-1287654; Krueger GRF, 2001, IN VIVO, V15, P461; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Lerner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047891; Lerner AM, 2004, IN VIVO, V18, P101; Lerner AM, 2002, IN VIVO, V16, P153; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Ling PD, 2003, CLIN INFECT DIS, V37, P1244, DOI 10.1086/378808; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; MANIAN FA, 1994, CLIN INFECT DIS, V19, P448, DOI 10.1093/clinids/19.3.448; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; MILLER G, 1985, NEW ENGL J MED, V312, P750, DOI 10.1056/NEJM198503213121204; Niller HH, 2008, AUTOIMMUNITY, V41, P298, DOI 10.1080/08916930802024772; Niller HH, 2011, ADV EXP MED BIOL, V711, P82; NILSSON K, 1971, INT J CANCER, V8, P443, DOI 10.1002/ijc.2910080312; Ortega-Hernandez OD, 2009, ANN NY ACAD SCI, V1173, P600, DOI 10.1111/j.1749-6632.2009.04799.x; Patarca R, 2001, ANN NY ACAD SCI, V933, P185; PATNAIK M, 1995, J INFECT DIS, V172, P1364, DOI 10.1093/infdis/172.5.1364; Piriou E, 2005, BLOOD, V106, P3166, DOI 10.1182/blood-2005-01-0432; Piriou ER, 2005, EUR J IMMUNOL, V35, P796, DOI 10.1002/eji.200425792; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Sairenji T, 1995, INTERVIROLOGY, V38, P269, DOI 10.1159/000150450; SCHLUEDERBERG A, 1992, ANN INTERN MED, V117, P325, DOI 10.7326/0003-4819-117-4-325; SECCHIERO P, 1995, J CLIN MICROBIOL, V33, P2124, DOI 10.1128/JCM.33.8.2124-2130.1995; Shepherd C, 2002, BRIT MED J, V324, P914, DOI 10.1136/bmj.324.7342.914; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Skowera A, 2004, CLIN EXP IMMUNOL, V135, P294, DOI 10.1111/j.1365-2249.2004.02354.x; Soto Norberto E, 2000, Herpes, V7, P46; STRAUS SE, 1993, J CLIN IMMUNOL, V13, P30, DOI 10.1007/BF00920633; Tanaka Yoshihide, 2012, Nihon Rinsho, V70, P880; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; van Baarle D, 2008, J INFECT DIS, V198, P1353, DOI 10.1086/592170; van Kuppeveld FJM, 2012, LANCET, V379, pE27, DOI 10.1016/S0140-6736(11)60899-4; Wallace HL, 1999, CLIN DIAGN LAB IMMUN, V6, P216, DOI 10.1128/CDLI.6.2.216-223.1999; WHELTON CL, 1992, J RHEUMATOL, V19, P939; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806	84	53	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85387	10.1371/journal.pone.0085387	http://dx.doi.org/10.1371/journal.pone.0085387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454857	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100078
J	Montgomery, AL; Ram, U; Kumar, R; Jha, P				Montgomery, Ann L.; Ram, Usha; Kumar, Rajesh; Jha, Prabhat		Million Death Study Collaborators	Maternal Mortality in India: Causes and Healthcare Service Use Based on a Nationally Representative Survey	PLOS ONE			English	Article							DEATH	Background: Data on cause-specific mortality, skilled birth attendance, and emergency obstetric care access are essential to plan maternity services. We present the distribution of India's 2001-2003 maternal mortality by cause and uptake of emergency obstetric care, in poorer and richer states. Methods and Findings: The Registrar General of India surveyed all deaths occurring in 2001-2003 in 1.1 million nationally representative homes. Field staff interviewed household members about events that preceded the death. Two physicians independently assigned a cause of death. Narratives for all maternal deaths were coded for variables on healthcare uptake. Distribution of number of maternal deaths, cause-specific mortality and uptake of healthcare indicators were compared for poorer and richer states. There were 10 041 all-cause deaths in women age 15-49 years, of which 1096 (11.1%) were maternal deaths. Based on 2004-2006 SRS national MMR estimates of 254 deaths per 100 000 live births, we estimated rural areas of poorer states had the highest MMR (397, 95% CI 385-410) compared to the lowest MMR in urban areas of richer states (115, 95% CI 85-146). We estimated 69 400 maternal deaths in India in 2005. Three-quarters of maternal deaths were clustered in rural areas of poorer states, although these regions have only half the estimated live births in India. Most maternal deaths were attributed to direct obstetric causes (82%). There was no difference in the major causes of maternal deaths between poorer and richer states. Two-thirds of women died seeking some form of healthcare, most seeking care in a critical medical condition. Rural areas of poorer states had proportionately lower access and utilization to healthcare services than the urban areas; however this rural-urban difference was not seen in richer states. Conclusions: Maternal mortality and poor access to healthcare is disproportionately higher in rural populations of the poorer states of India.	[Montgomery, Ann L.; Ram, Usha; Jha, Prabhat] St Michael Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON, Canada; [Ram, Usha] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; [Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; International Institute for Population Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Toronto	Montgomery, AL (corresponding author), St Michael Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON, Canada.	cghr@smh.ca	Ram, Usha/AAS-4140-2020	Ram, Usha/0000-0001-6722-7347				Barnett S, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI DOI 10.1186/1471-2393-8-6; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bartlett LA, 2005, LANCET, V365, P864, DOI 10.1016/S0140-6736(05)71044-8; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; BHATIA JC, 1993, STUD FAMILY PLANN, V24, P310, DOI 10.2307/2939224; Campbell O, 1990, MEASURING MATERNAL M; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cunningham F, 2009, WILLIAMS OBSTET, V23rd; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Faveau V, 1988, B WORLD HEALTH ORGAN, V66, P643; Heeringa A, 2010, APPL SURVEY DATA ANA; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS) Government of India., 2006, REPR CHILD HLTH DIST; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Khatun F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-84; Khosla AH, 2000, INT J GYNECOL OBSTET, V68, P163, DOI 10.1016/S0020-7292(99)00185-X; Leitao J, 2013, BMC MED IN PRESS; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Montgomery AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033075; Montgomery AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014637; Nisar N, 2010, J PAK MED ASSOC, V60, P20; RGI, 2011, SPEC B MAT MORT IND; RGI, 2009, SPEC B MAT MORT IND; RGI, 2011, SAMPL REG SYST STAT; Sinha D, 2006, 7 CTR GLOB HLTH RES; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Swain S, 1993, Indian Pediatr, V30, P771; UNFPA, 2009, CONC ASS JAN SUR YOJ; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO United Nations Population Fund Unicef World Bank, 2003, MAN COMPL PREGN CHIL; World Health Organization, 1994, INT STAT CLASS DIS R; World Health Organization, 2012, WHO APPL ICD 10 DEAT; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	38	98	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83331	10.1371/journal.pone.0083331	http://dx.doi.org/10.1371/journal.pone.0083331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454701	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100008
J	Nir, O; Gruber, DF; Shemesh, E; Glasser, E; Tchernov, D				Nir, Orit; Gruber, David F.; Shemesh, Eli; Glasser, Eliezra; Tchernov, Dan			Seasonal Mesophotic Coral Bleaching of Stylophora pistillata in the Northern Red Sea	PLOS ONE			English	Article							SYMBIOTIC ALGAE; REEF CORALS; LIGHT; EVOLUTION; DENSITIES	Coral bleaching occurs when environmental stress induces breakdown of the coral-algae symbiosis and the host initiates algae expulsion. Two types of coral bleaching had been thoroughly discussed in the scientific literature; the first is primarily associated with mass coral bleaching events; the second is a seasonal loss of algae and/or pigments. Here, we describe a phenomenon that has been witnessed for repeated summers in the mesophotic zone (40-63 m) in the northern Red Sea: seasonal bleaching and recovery of several hermatypic coral species. In this study, we followed the recurring bleaching process of the common coral Stylophora pistillata. Bleaching occurred from April to September with a 66% decline in chlorophyll a concentration, while recovery began in October. Using aquarium and transplantation experiments, we explored environmental factors such as temperature, photon flux density and heterotrophic food availability. Our experiments and observations did not yield one single factor, alone, responsible for the seasonal bleaching. The dinoflagellate symbionts (of the genus Symbiodinium) in shallow (5 m) Stylophora pistillata were found to have a net photosynthetic rate of 56.98-92.19 mu mol O-2 cm(-2) day(-1). However, those from mesophotic depth (60 m) during months when they are not bleached are net consumers of oxygen having a net photosynthetic rate between -12.86 -(-10.24) mu mol O-2 cm(-2) day(-1). But during months when these mesophotic corals are partially-bleached, they yielded higher net production, between -2.83-0.76 mu mol O-2 cm(-2) day(-1). This study opens research questions as to why mesophotic zooxanthellae are more successfully meeting the corals metabolic requirements when Chl a concentration decreases by over 60% during summer and early fall.	[Nir, Orit; Shemesh, Eli; Glasser, Eliezra; Tchernov, Dan] Univ Haifa, Dept Marine Biol, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel; [Gruber, David F.] CUNY Bernard M Baruch Coll, Dept Nat Sci, New York, NY 10010 USA; [Gruber, David F.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	University of Haifa; City University of New York (CUNY) System; Baruch College (CUNY); American Museum of Natural History (AMNH)	Nir, O (corresponding author), Univ Haifa, Dept Marine Biol, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel.	oritnir.eco@gmail.com	Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270	Israeli Science Foundation [981/05]; United States National Science Foundation [0920572]	Israeli Science Foundation(Israel Science Foundation); United States National Science Foundation(National Science Foundation (NSF))	Funding provided by Israeli Science Foundation Grant No. 981/05 to DT and United States National Science Foundation grant No. 0920572 to DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; Dimond JL, 2011, LIMNOL OCEANOGR, V56, P2233, DOI 10.4319/lo.2011.56.6.2233; Dishon G, 2012, INT J REMOTE SENS, V33, P2683, DOI 10.1080/01431161.2011.619209; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Einbinder S, 2009, MAR ECOL PROG SER, V381, P167, DOI 10.3354/meps07908; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GHIOLD J, 1990, Caribbean Journal of Science, V26, P52; GLYNN PW, 1991, TRENDS ECOL EVOL, V6, P175, DOI 10.1016/0169-5347(91)90208-F; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; LaJeunesse TC, 2007, CORAL REEFS, V26, P265, DOI 10.1007/s00338-006-0189-3; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; PEARSE VB, 1971, BIOL BULL, V141, P350, DOI 10.2307/1540123; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Sunagawa S, 2008, CIENC MAR, V34, P113, DOI 10.7773/cm.v34i2.1230; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tchernov D, 2012, TRENDS ECOL EVOL, V27, P194, DOI 10.1016/j.tree.2011.11.002; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V263, P211, DOI 10.1016/S0022-0981(01)00309-4; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Wagner D, 2011, P ROY SOC B-BIOL SCI, V278, P1323, DOI 10.1098/rspb.2010.1681; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182	35	34	36	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84968	10.1371/journal.pone.0084968	http://dx.doi.org/10.1371/journal.pone.0084968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454772	Green Published, gold			2022-12-27	WOS:000330235100045
J	Hoopes, LA; Rea, LD; Christ, A; Worthy, GAJ				Hoopes, Lisa A.; Rea, Lorrie D.; Christ, Aaron; Worthy, Graham A. J.			No Evidence of Metabolic Depression in Western Alaskan Juvenile Steller Sea Lions (Eumetopias jubatus)	PLOS ONE			English	Article							NORTHERN ELEPHANT SEAL; FUR-SEAL; BODY-COMPOSITION; CALLORHINUS-URSINUS; PHOCA-VITULINA; MATERNAL INVESTMENT; NUTRITIONAL STRESS; THYROID-HORMONES; MASS-LOSS; PUPS	Steller sea lion (Eumetopias jubatus) populations have undergone precipitous declines through their western Alaskan range over the last four decades with the leading hypothesis to explain this decline centering around changing prey quality, quantity, or availability for this species (i.e., nutritional stress hypothesis). Under chronic conditions of reduced food intake sea lions would conserve energy by limiting energy expenditures through lowering of metabolic rate known as metabolic depression. To examine the potential for nutritional stress, resting metabolic rate (RMR) and body composition were measured in free-ranging juvenile Steller sea lions (N = 91) at three distinct geographical locations (Southeast Alaska, Prince William Sound, Central Aleutian Islands) using open-flow respirometry and deuterium isotope dilution, respectively. Average sea lion RMR ranged from 6.7 to 36.2 MJ d(-1) and was influenced by body mass, total body lipid, and to a lesser extent, ambient air temperature and age. Sea lion pups captured in the Aleutian Islands (region of decline) had significantly greater body mass and total body lipid stores when compared to pups from Prince William Sound (region of decline) and Southeast Alaska (stable region). Along with evidence of robust body condition in Aleutian Island pups, no definitive differences were detected in RMR between sea lions sampled between eastern and western populations that could not be accounted for by higher percent total body lipid content, suggesting that that at the time of this study, Steller sea lions were not experiencing metabolic depression in the locations studied.	[Hoopes, Lisa A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Rea, Lorrie D.; Christ, Aaron] Alaska Dept Fish & Game, Div Wildlife Conservat, Anchorage, AK 99518 USA; [Worthy, Graham A. J.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	Texas A&M University System; Texas A&M University College Station; Alaska Department of Fish & Game; State University System of Florida; University of Central Florida	Hoopes, LA (corresponding author), Georgia Aquarium, Atlanta, GA 30313 USA.	lhoopes@georgiaaquarium.org			National Oceanic and Atmospheric Administration (NOAA) [NA17FX1079, NA04NMF4390170]; University of Central Florida; Texas A&M University at Galveston; Hubbs-SeaWorld Research Institute	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); University of Central Florida; Texas A&M University at Galveston; Hubbs-SeaWorld Research Institute	Financial support for this project was provided to Alaska Department of Fish and Game under National Oceanic and Atmospheric Administration (NOAA) cooperative agreements NA17FX1079 and NA04NMF4390170 and through a Research Enhancement Award from University of Central Florida to GAJW. Graduate support to LAH was provided by Texas A&M University at Galveston, University of Central Florida, and Hubbs-SeaWorld Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B. M., 2013, NMFSAFSC245 NOAA US; [Anonymous], 2000, MAR FISH REV; Arnould JPY, 2002, J ZOOL, V256, P351, DOI 10.1017/S0952836902000389; Arnould JPY, 1996, PHYSIOL ZOOL, V69, P93, DOI 10.1086/physzool.69.1.30164202; Ashwell-Erickson S., 1981, E BERING SEA SHELF O, P869; ASHWELLERICKSON S, 1986, CAN J ZOOL, V64, P1086, DOI 10.1139/z86-163; Atkinson S, 2008, MAMMAL REV, V38, P1, DOI 10.1111/j.1365-2907.2008.00128.x; Baker JD, 2000, CAN J ZOOL, V78, P100, DOI 10.1139/cjz-78-1-100; Beauplet G, 2003, PHYSIOL BIOCHEM ZOOL, V76, P262, DOI 10.1086/367951; Boily P, 1996, AM J PHYSIOL-REG I, V270, pR1051, DOI 10.1152/ajpregu.1996.270.5.R1051; BOILY P, 1995, PHYSIOL ZOOL, V68, P1181, DOI 10.1086/physzool.68.6.30163799; Boltnev AI, 2001, J ZOOL, V254, P219, DOI 10.1017/S0952836901000735; Bowen WD, 1998, PHYSIOL ZOOL, V71, P329, DOI 10.1086/515921; Brandon EAA, 2005, FISH B-NOAA, V103, P246; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CORNISH ER, 1965, ANIM BEHAV, V13, P242, DOI 10.1016/0003-3472(65)90042-4; Craig MP, 1999, MAR MAMMAL SCI, V15, P786, DOI 10.1111/j.1748-7692.1999.tb00843.x; Donohue MJ, 2000, J EXP BIOL, V203, P1003; du Dot TJ, 2009, PHYSIOL BIOCHEM ZOOL, V82, P516, DOI 10.1086/603637; du Dot TJ, 2009, COMP BIOCHEM PHYS A, V152, P524, DOI 10.1016/j.cbpa.2008.12.010; Fadely BS, 2004, SEA LIONS WORLD CONS, P21; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; Fritz L, 2005, NMFSAFSC183 NOAA US; Fritz LW, 2003, NMFSAFSC153 NOAA US; Fuglei E, 1999, J COMP PHYSIOL B, V169, P361, DOI 10.1007/s003600050232; GALLIVAN GJ, 1986, PHYSIOL ZOOL, V59, P552, DOI 10.1086/physzool.59.5.30156119; Guinet C, 1999, BEHAV ECOL SOCIOBIOL, V46, P157, DOI 10.1007/s002650050605; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Harrell FE, 2001, REGRESSION MODELING; HEATH ME, 1977, COMP BIOCHEM PHYS A, V57, P203, DOI 10.1016/0300-9629(77)90456-X; Heath RB, 1997, J WILDLIFE DIS, V33, P206, DOI 10.7589/0090-3558-33.2.206; Hoopes LA, 2007, METABOLIC THERMOREGU; IRVING LAURENCE, 1957, CANADIAN JOUR ZOOL, V35, P497, DOI 10.1139/z57-041; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; King JC, 2007, MAR MAMMAL SCI, V23, P262, DOI 10.1111/j.1748-7692.2007.00108.x; Kleiber M., 1975, FIRE LIFE INTRO ANIM; KOVACS KM, 1992, CAN J ZOOL, V70, P1953, DOI 10.1139/z92-265; Kumagai S, 2006, J COMP PHYSIOL B, V176, P589, DOI 10.1007/s00360-006-0082-y; Markussen NH, 1995, DEV MAR BIO, V4, P383; Mellish JAE, 2007, J MAMMAL, V88, P408, DOI 10.1644/06-MAMM-A-157R2.1; MERRICK RL, 1995, FISH B-NOAA, V93, P753; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Myers MJ, 2006, COMP BIOCHEM PHYS A, V145, P90, DOI 10.1016/j.cbpa.2006.05.004; NORDOY ES, 1990, ACTA PHYSIOL SCAND, V139, P361, DOI 10.1111/j.1748-1716.1990.tb08935.x; OFTEDAL OT, 1987, PHYSIOL ZOOL, V60, P560, DOI 10.1086/physzool.60.5.30156130; Pitcher KW, 2007, FISH B-NOAA, V105, P102; Pitcher KW, 2000, MAR MAMMAL SCI, V16, P427, DOI 10.1111/j.1748-7692.2000.tb00934.x; Pitcher KW, 2001, J MAMMAL, V82, P1047, DOI 10.1644/1545-1542(2001)082<1047:SATVIT>2.0.CO;2; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Rea LD, 2007, CAN J ZOOL, V85, P190, DOI 10.1139/Z06-204; REA LD, 1992, PHYSIOL ZOOL, V65, P97, DOI 10.1086/physzool.65.1.30158241; Rea LD, 2013, SCI TOTAL ENVIRON, V454, P277, DOI 10.1016/j.scitotenv.2013.02.095; ROBIN JP, 1988, AM J PHYSIOL, V254, pR61, DOI 10.1152/ajpregu.1988.254.1.R61; Rosen DAS, 2002, COMP BIOCHEM PHYS B, V132, P389, DOI 10.1016/S1096-4959(02)00048-9; Rosen DAS, 1998, CAN J ZOOL, V76, P1520, DOI 10.1139/cjz-76-8-1520; Rosen DAS, 1999, PHYSIOL BIOCHEM ZOOL, V72, P723, DOI 10.1086/316705; Rutishauser MR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P669, DOI 10.1086/421749; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; THOMPSON SD, 1987, PHYSIOL ZOOL, V60, P730, DOI 10.1086/physzool.60.6.30159989; TRITES AW, 1992, CAN J ZOOL, V70, P2125, DOI 10.1139/z92-286; WESTERTERP K, 1977, PHYSIOL ZOOL, V50, P331, DOI 10.1086/physzool.50.4.30155736; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; WORTHY GAJ, 1987, PHYSIOL ZOOL, V60, P352, DOI 10.1086/physzool.60.3.30162289; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x; York AE, 1991, PINNIPEDS EL NINO RE, P94	66	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85339	10.1371/journal.pone.0085339	http://dx.doi.org/10.1371/journal.pone.0085339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416394	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300072
J	Kendall, CJ; Virani, MZ; Hopcraft, JGC; Bildstein, KL; Rubenstein, DI				Kendall, Corinne J.; Virani, Munir Z.; Hopcraft, J. Grant C.; Bildstein, Keith L.; Rubenstein, Daniel I.			African Vultures Don't Follow Migratory Herds: Scavenger Habitat Use Is Not Mediated by Prey Abundance	PLOS ONE			English	Article							MARA NATIONAL RESERVE; GYPS-AFRICANUS; SERENGETI WILDEBEEST; GRIFFON VULTURES; POPULATION; FACILITATION; COEXISTENCE; YELLOWSTONE; COMPETITION; CARCASSES	The ongoing global decline in vulture populations raises major conservation concerns, but little is known about the factors that mediate scavenger habitat use, in particular the importance of abundance of live prey versus prey mortality. We test this using data from the Serengeti-Mara ecosystem in East Africa. The two hypotheses that prey abundance or prey mortality are the main drivers of vulture habitat use provide alternative predictions. If vultures select areas based only on prey abundance, we expect tracked vultures to remain close to herds of migratory wildebeest regardless of season. However, if vultures select areas where mortality rates are greatest then we expect vultures to select the driest regions, where animals are more likely to die of starvation, and to be attracted to migratory wildebeest only during the dry season when wildebeest mortality is greatest. We used data from GSM-GPS transmitters to assess the relationship between three vulture species and migratory wildebeest in the Mara-Serengeti ecosystem. Results indicate that vultures preferentially cluster around migratory herds only during the dry season, when herds experience their highest mortality. Additionally during the wet season, Ruppell's and Lappet-faced vultures select relatively dry areas, based on Normalized Difference Vegetation Index, whereas White-backed vultures preferred wetter areas during the wet season. Differences in habitat use among species may mediate coexistence in this scavenger guild. In general, our results suggest that prey abundance is not the primary driver of avian scavenger habitat use. The apparent reliance of vultures on non-migratory ungulates during the wet season has important conservation implications for vultures in light of on-going declines in non-migratory ungulate species and use of poisons in unprotected areas.	[Kendall, Corinne J.; Rubenstein, Daniel I.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Kendall, Corinne J.; Virani, Munir Z.] Natl Museums Kenya, Dept Zool, Ornithol Sect, Nairobi, Kenya; [Virani, Munir Z.] Peregrine Fund, Boise, ID USA; [Hopcraft, J. Grant C.] Frankfurt Zool Soc, Arusha, Tanzania; [Bildstein, Keith L.] Hawk Mt Sanctuary, Acopian Ctr Conservat Learning, Orwigsburg, PA USA	Princeton University	Kendall, CJ (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	cjk2113@columbia.edu			Hawk Mountain Sanctuary; Peregrine Fund; Explorer's Club; SeaWorld and Busch Gardens Conservation Fund; Pompeo M. Maresi Memorial Fund from Princeton University's Department of Ecology and Evolutionary Biology; PEI's Development Grand Challenge; National Science Foundation [IBN-9874523, CNS-025214, IOB-9874523]	Hawk Mountain Sanctuary; Peregrine Fund; Explorer's Club; SeaWorld and Busch Gardens Conservation Fund; Pompeo M. Maresi Memorial Fund from Princeton University's Department of Ecology and Evolutionary Biology; PEI's Development Grand Challenge; National Science Foundation(National Science Foundation (NSF))	Funds were provided by Hawk Mountain Sanctuary, The Peregrine Fund, The Explorer's Club, and SeaWorld and Busch Gardens Conservation Fund. Funds were also provided by Pompeo M. Maresi Memorial Fund from Princeton University's Department of Ecology and Evolutionary Biology. DIR was funded by PEI's Development Grand Challenge and National Science Foundation (IBN-9874523, CNS-025214, and IOB-9874523). While individuals from funding institutions were involved in this study, the funding institutions themselves had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dobson A, 2010, NATURE, V467, P272, DOI 10.1038/467272a; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Fryxell J.M., 1997, INDIVIDUAL BEHAV COM; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; FRYXELL JM, 1988, AFR J ECOL, V26, P17, DOI 10.1111/j.1365-2028.1988.tb01125.x; Guan K, REMOTE SENS IN PRESS; HILLS RC, 1979, T I BRIT GEOGR, V4, P329, DOI 10.2307/622055; Hopcraft G, 2011, J ANIM ECOL; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Hopcraft JGC, SERENGETI IN PRESS; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOUSTON DC, 1974, J ZOOL, V172, P35; HOUSTON DC, 1976, IBIS, V118, P14, DOI 10.1111/j.1474-919X.1976.tb02008.x; Houston DC, 2001, VULTURES CONDORS; Jackson AL, 2008, BIOL LETTERS, V4, P311, DOI 10.1098/rsbl.2008.0038; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kendall C, 2012, CONDOR, V114, P523, DOI 10.1525/cond.2012.100196; Kendall CJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P383, DOI 10.1007/s00265-012-1458-5; Kendall CJ, 2012, J RAPTOR RES, V46, P135, DOI 10.3356/JRR-10-87.1; KRUUK H, 1967, ARDEA, V55, P171; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MAYHEW P, 1989, IBIS, V131, P1, DOI 10.1111/j.1474-919X.1989.tb02736.x; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Mundy P., 1992, VULTURES AFRICA; NORTON-GRIFFITHS M, 1975, East African Wildlife Journal, V13, P347, DOI 10.1111/j.1365-2028.1975.tb00144.x; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Pennycuick C.J., 1983, P172; Pennycuick C.J., 1979, SERENGETI; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Phipps WL, 2013, PLOSONE, V8; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Shivik JA, 2006, BIOSCIENCE, V56, P819, DOI 10.1641/0006-3568(2006)56[819:AVBADS]2.0.CO;2; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Spiegel O, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-5; Thiollay JM, 2007, OSTRICH, V78, P405, DOI 10.2989/OSTRICH.2007.78.2.46.126; Virani M, 2010, OSTRICH, V81, P205, DOI 10.2989/00306525.2010.519894; Virani MZ, 2012, BIRD CONSERV INT, V22, P260, DOI 10.1017/S0959270911000505; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; WALLACE MP, 1980, J FIELD ORNITHOL, V51, P309; WATSON RT, 1985, S AFR J WILDL RES, V15, P63; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x	57	31	33	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83470	10.1371/journal.pone.0083470	http://dx.doi.org/10.1371/journal.pone.0083470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421887	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000329862500049
J	Rose, S; Frye, RE; Slattery, J; Wynne, R; Tippett, M; Pavliv, O; Melnyk, S; James, SJ				Rose, Shannon; Frye, Richard E.; Slattery, John; Wynne, Rebecca; Tippett, Marie; Pavliv, Oleksandra; Melnyk, Stepan; James, S. Jill			Oxidative Stress Induces Mitochondrial Dysfunction in a Subset of Autism Lymphoblastoid Cell Lines in a Well-Matched Case Control Cohort	PLOS ONE			English	Article							SPARE RESPIRATORY CAPACITY; NECROSIS-FACTOR-ALPHA; COMPLEX-I; SPECTRUM DISORDERS; METHYL MERCURY; CYTOCHROME-C; CHILDREN; GLUTATHIONE; DNA; TRANSPORT	There is increasing recognition that mitochondrial dysfunction is associated with the autism spectrum disorders. However, little attention has been given to the etiology of mitochondrial dysfunction or how mitochondrial abnormalities might interact with other physiological disturbances associated with autism, such as oxidative stress. In the current study we used respirometry to examine reserve capacity, a measure of the mitochondrial ability to respond to physiological stress, in lymphoblastoid cell lines (LCLs) derived from children with autistic disorder (AD) as well as age and gender-matched control LCLs. We demonstrate, for the first time, that LCLs derived from children with AD have an abnormal mitochondrial reserve capacity before and after exposure to increasingly higher concentrations of 2,3-dimethoxy-1,4-napthoquinone (DMNQ), an agent that increases intracellular reactive oxygen species (ROS). Specifically, the AD LCLs exhibit a higher reserve capacity at baseline and a sharper depletion of reserve capacity when ROS exposure is increased, as compared to control LCLs. Detailed investigation indicated that reserve capacity abnormalities seen in AD LCLs were the result of higher ATP-linked respiration and maximal respiratory capacity at baseline combined with a marked increase in proton leak respiration as ROS was increased. We further demonstrate that these reserve capacity abnormalities are driven by a subgroup of eight (32%) of 25 AD LCLs. Additional investigation of this subgroup of AD LCLs with reserve capacity abnormalities revealed that it demonstrated a greater reliance on glycolysis and on uncoupling protein 2 to regulate oxidative stress at the inner mitochondria membrane. This study suggests that a significant subgroup of AD children may have alterations in mitochondrial function which could render them more vulnerable to a pro-oxidant microenvironment derived from intrinsic and extrinsic sources of ROS such as immune activation and pro-oxidant environmental toxicants. These findings are consistent with the notion that AD is caused by a combination of genetic and environmental factors.	[Rose, Shannon; Frye, Richard E.; Slattery, John; Wynne, Rebecca; Tippett, Marie; Pavliv, Oleksandra; Melnyk, Stepan; James, S. Jill] Arkansas Childrens Hosp, Res Inst, Dept Pediat, Little Rock, AR 72202 USA	Arkansas Children's Hospital	Frye, RE (corresponding author), Arkansas Childrens Hosp, Res Inst, Dept Pediat, 800 Marshall St, Little Rock, AR 72202 USA.	REFrye@uams.edu	Frye, Richard/AAB-5543-2020	Rose, Shannon/0000-0003-0595-4367	National Institute for Child Health and Development; Arkansas Biosciences Institute; Jane Botsford Johnson Foundation	National Institute for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Arkansas Biosciences Institute; Jane Botsford Johnson Foundation	This research was funded by the National Institute for Child Health and Development (SJJ), the Arkansas Biosciences Institute (REF, SJJ), and the Jane Botsford Johnson Foundation (REF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg M. R., 1973, CLUSTER ANAL APPL; Anitha A, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-12; APA, 1994, DIAGN STAT MAN MENT; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P840, DOI 10.1016/j.bbi.2010.09.002; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501; FernandezCheca JC, 1997, AM J PHYSIOL-GASTR L, V273, pG7, DOI 10.1152/ajpgi.1997.273.1.G7; FOWLER BA, 1977, EXP MOL PATHOL, V27, P403, DOI 10.1016/0014-4800(77)90010-7; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Frye RE, 2012, N AM J MED SCI, V5, P141; Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530; Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Goyer RA, 1997, ANNU REV NUTR, V17, P37, DOI 10.1146/annurev.nutr.17.1.37; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Gu F, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.68; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Melnyk S, 2000, CLIN CHEM, V46, P265; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nickles D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-477; Oh JH, 2013, J HUM GENET, V58, P16, DOI 10.1038/jhg.2012.123; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Pourahmad J, 2001, ADV EXP MED BIOL, V500, P249; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Rose Shannon, 2012, Autism Res Treat, V2012, P986519, DOI 10.1155/2012/986519; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Shenker BJ, 1999, TOXICOL APPL PHARM, V157, P23, DOI 10.1006/taap.1999.8652; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; STUBBS EG, 1977, J AUTISM CHILD SCHIZ, V7, P49, DOI 10.1007/BF01531114; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Vali S, 2007, NEUROSCIENCE, V149, P917, DOI 10.1016/j.neuroscience.2007.08.028; Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06; Ward J. H., 1963, J AM STAT SOC, V77, P841; Wong PW, 2001, J NEUROCHEM, V76, P450, DOI 10.1046/j.1471-4159.2001.00022.x; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; YAMANO T, 1995, ARCH ENVIRON CON TOX, V28, P1, DOI 10.1007/BF00213961	59	102	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85436	10.1371/journal.pone.0085436	http://dx.doi.org/10.1371/journal.pone.0085436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416410	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500249
J	Siciliano, P; Scolari, F; Gomulski, LM; Falchetto, M; Manni, M; Gabrieli, P; Field, LM; Zhou, JJ; Gasperi, G; Malacrida, AR				Siciliano, Paolo; Scolari, Francesca; Gomulski, Ludvik M.; Falchetto, Marco; Manni, Mose; Gabrieli, Paolo; Field, Linda M.; Zhou, Jing-Jiang; Gasperi, Giuliano; Malacrida, Anna R.			Sniffing Out Chemosensory Genes from the Mediterranean Fruit Fly, Ceratitis capitata	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; SEMINAL FLUID PROTEINS; PHEROMONE-BINDING; MATING-BEHAVIOR; FLIES DIPTERA; CIRCADIAN-RHYTHMS; AEDES-AEGYPTI; DROSOPHILA; TEPHRITIDAE; IDENTIFICATION	The Mediterranean fruit fly, Ceratitis capitata (medfly), is an extremely invasive agricultural pest due to its extremely wide host range and its ability to adapt to a broad range of climatic conditions and habitats. Chemosensory behaviour plays an important role in many crucial stages in the life of this insect, such as the detection of pheromone cues during mate pursuit and odorants during host plant localisation. Thus, the analysis of the chemosensory gene repertoire is an important step for the interpretation of the biology of this species and consequently its invasive potential. Moreover, these genes may represent ideal targets for the development of novel, effective control methods and pest population monitoring systems. Expressed sequence tag libraries from C. capitata adult heads, embryos, male accessory glands and testes were screened for sequences encoding putative odorant binding proteins (OBPs). A total of seventeen putative OBP transcripts were identified, corresponding to 13 Classic, three Minus-C and one Plus-C subfamily OBPs. The tissue distributions of the OBP transcripts were assessed by RT-PCR and a subset of five genes with predicted proteins sharing high sequence similarities and close phylogenetic affinities to Drosophila melanogaster pheromone binding protein related proteins (PBPRPs) were characterised in greater detail. Real Time quantitative PCR was used to assess the effects of maturation, mating and time of day on the transcript abundances of the putative PBPRP genes in the principal olfactory organs, the antennae, in males and females. The results of the present study have facilitated the annotation of OBP genes in the recently released medfly genome sequence and represent a significant contribution to the characterisation of the medfly chemosensory repertoire. The identification of these medfly OBPs/PBPRPs permitted evolutionary and functional comparisons with homologous sequences from other tephritids of the genera Bactrocera and Rhagoletis.	[Siciliano, Paolo; Scolari, Francesca; Gomulski, Ludvik M.; Falchetto, Marco; Manni, Mose; Gabrieli, Paolo; Gasperi, Giuliano; Malacrida, Anna R.] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Field, Linda M.; Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	University of Pavia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Malacrida, AR (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, Italy.	malacrid@unipv.it	Gabrieli, Paolo/A-3206-2016; Scolari, Francesca/ABC-2285-2020; Gomulski, Ludvik/AAG-2709-2022; Gasperi, Giuliano/Y-1894-2019; Gomulski, Ludvik/AFK-3930-2022	Gabrieli, Paolo/0000-0002-4996-2468; Scolari, Francesca/0000-0003-3085-9038; Gasperi, Giuliano/0000-0001-6972-8591; Field, Linda/0000-0002-3328-2513; GOMULSKI, LUDVIK/0000-0002-1506-7051; malacrida, anna/0000-0003-4566-8795	Italian Ministry of education, University and Research PRIN [20077RCHRW]; FAO/IAEA(Food and Agriculture Organization of the United Nations (FAO)/International Atomic Energy Agency (IAEA)) [16966]; UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BBS/E/C/00005194, BBS/E/C/00004947] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004947, BBS/E/C/00005194] Funding Source: researchfish	Italian Ministry of education, University and Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FAO/IAEA(Food and Agriculture Organization of the United Nations (FAO)/International Atomic Energy Agency (IAEA)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially funded by Italian Ministry of education, University and Research PRIN grant 20077RCHRW (LMG, ARM, GG), and a FAO/IAEA(Food and Agriculture Organization of the United Nations (FAO)/International Atomic Energy Agency (IAEA)) Technical Contract No. 16966 (GG). The work was also carried out within the FAO/IAEA research CRP programme "Identification of molecular and transgenic tools for sexing strategies and development of strain and sperm marking systems for fruitfly pests" - "Development and evaluation of improved strains of insect pests for SIT" (GG). Rothamsted Research receives grant-aided support from the UK Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2011, J AGR FOOD CHEM, V59, P298, DOI 10.1021/jf104183c; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anholt RRH, 2010, CHEM SENSES, V35, P21, DOI 10.1093/chemse/bjp073; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Ashburner M, 1998, BIOESSAYS, V20, P949, DOI 10.1002/(SICI)1521-1878(199811)20:11&lt;949::AID-BIES10&gt;3.0.CO;2-0; Ayala FJ, 1996, P NATL ACAD SCI USA, V93, P11729, DOI 10.1073/pnas.93.21.11729; BAKER R, 1985, J CHEM SOC CHEM COMM, P824, DOI 10.1039/c39850000824; BARUFFI L, 1995, HEREDITY, V74, P425, DOI 10.1038/hdy.1995.60; Briceno RD, 2002, FLA ENTOMOL, V85, P32, DOI 10.1653/0015-4040(2002)085[0032:VITIBS]2.0.CO;2; Diaz-Fleischer F, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P811; Drew RAI, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P731; Dyck V.A., 2006, STERILE INSECT TECHN; Emery P, 2008, CURR BIOL, V18, pR569, DOI 10.1016/j.cub.2008.05.011; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; FLATH RA, 1993, J AGR FOOD CHEM, V41, P830, DOI 10.1021/jf00029a029; FLETCHER BS, 1989, FRUIT FLIES THEIR B, V3, P209; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; LANDOLT PJ, 1992, ENTOMOL EXP APPL, V65, P259, DOI 10.1007/BF02343859; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Levinson H, 2003, J APPL ENTOMOL, V127, P269, DOI 10.1046/j.1439-0418.2003.00750.x; Light DM, 1999, J CHEM ECOL, V25, P2757, DOI 10.1023/A:1020855625244; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; MCDONALD PT, 1987, ANN ENTOMOL SOC AM, V80, P17, DOI 10.1093/aesa/80.1.17; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; NAKAGAWA S, 1973, J ECON ENTOMOL, V66, P583, DOI 10.1093/jee/66.2.583; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Papadopoulos NT, 2006, J INSECT BEHAV, V19, P403, DOI 10.1007/s10905-006-9031-6; Papadopoulos NT, 2010, J INSECT PHYSIOL, V56, P283, DOI 10.1016/j.jinsphys.2009.10.014; Papadopoulos NT, 1998, ENTOMOL EXP APPL, V89, P175, DOI 10.1023/A:1003580814122; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; PROKOPY RJ, 1979, ANN ENTOMOL SOC AM, V72, P642, DOI 10.1093/aesa/72.5.642; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; SAUL SH, 1982, ANN ENTOMOL SOC AM, V75, P480, DOI 10.1093/aesa/75.4.480; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Scolari F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046812; Shelly TE, 2002, FLA ENTOMOL, V85, P150, DOI 10.1653/0015-4040(2002)085[0150:EOADOS]2.0.CO;2; Shelly T, 2012, ANN ENTOMOL SOC AM, V105, P368, DOI 10.1603/AN11125; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Sivinski J, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P751; South A, 2011, INSECT MOL BIOL, V20, P447, DOI 10.1111/j.1365-2583.2011.01083.x; Takemori N, 2009, PROTEOMICS, V9, P2484, DOI 10.1002/pmic.200800795; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor PW, 1999, ANIM BEHAV, V58, P247, DOI 10.1006/anbe.1999.1137; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanickova L, 2012, J AGR FOOD CHEM, V60, P7168, DOI 10.1021/jf301474d; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WHITTIER TS, 1992, ANN ENTOMOL SOC AM, V85, P214, DOI 10.1093/aesa/85.2.214; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yuval B, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P429; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681; Zucoloto FS, 1990, J PHYSL ENTOMOL, V37, P21	85	33	34	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85523	10.1371/journal.pone.0085523	http://dx.doi.org/10.1371/journal.pone.0085523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416419	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500254
J	Kelaher, BP; Coleman, MA; Broad, A; Rees, MJ; Jordan, A; Davis, AR				Kelaher, Brendan P.; Coleman, Melinda A.; Broad, Allison; Rees, Matthew J.; Jordan, Alan; Davis, Andrew R.			Changes in Fish Assemblages following the Establishment of a Network of No-Take Marine Reserves and Partially-Protected Areas	PLOS ONE			English	Article							CONSERVATION BENEFITS; REEF; POPULATIONS; ENFORCEMENT; COMMUNITIES; CONNECTIVITY; RECRUITMENT; MANAGEMENT; FISHERIES; RESPONSES	Networks of no-take marine reserves and partially-protected areas (with limited fishing) are being increasingly promoted as a means of conserving biodiversity. We examined changes in fish assemblages across a network of marine reserves and two different types of partially-protected areas within a marine park over the first 5 years of its establishment. We used Baited Remote Underwater Video (BRUV) to quantify fish communities on rocky reefs at 20-40 m depth between 2008-2011. Each year, we sampled 12 sites in 6 no-take marine reserves and 12 sites in two types of partially-protected areas with contrasting levels of protection (n = 4 BRUV stations per site). Fish abundances were 38% greater across the network of marine reserves compared to the partially-protected areas, although not all individual reserves performed equally. Compliance actions were positively associated with marine reserve responses, while reserve size had no apparent relationship with reserve performance after 5 years. The richness and abundance of fishes did not consistently differ between the two types of partially-protected areas. There was, therefore, no evidence that the more regulated partially-protected areas had additional conservation benefits for reef fish assemblages. Overall, our results demonstrate conservation benefits to fish assemblages from a newly established network of temperate marine reserves. They also show that ecological monitoring can contribute to adaptive management of newly established marine reserve networks, but the extent of this contribution is limited by the rate of change in marine communities in response to protection.	[Kelaher, Brendan P.; Coleman, Melinda A.; Jordan, Alan] New South Wales Fisheries, Dept Primary Ind, Coffs Harbour, NSW 2450, Australia; [Kelaher, Brendan P.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Kelaher, Brendan P.] So Cross Univ, Ctr Coastal Biogeochem Res, Sch Environm Sci & Engn, Coffs Harbour, NSW, Australia; [Broad, Allison; Rees, Matthew J.; Davis, Andrew R.] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW 2522, Australia	NSW Department of Primary Industries; Southern Cross University; Southern Cross University; University of Wollongong	Kelaher, BP (corresponding author), New South Wales Fisheries, Dept Primary Ind, POB 4321, Coffs Harbour, NSW 2450, Australia.	brendan.kelaher@scu.edu.au	Davis, Andy/H-3607-2011; Rees, Matthew J/I-9177-2012; Broad, Allison/AAY-5852-2021; Coleman, Melinda A/R-5563-2016; Kelaher, Brendan/P-3647-2017	Davis, Andy/0000-0002-8146-7424; Broad, Allison/0000-0002-1402-6098; Coleman, Melinda A/0000-0003-2623-633X; Kelaher, Brendan/0000-0002-7505-4412; Rees, Matthew/0000-0002-2472-6215	NSW Government	NSW Government	The study was funded by the NSW Government. Independent university-based scientists and NSW Fisheries scientists were responsible for the data collection and analysis, decision to publish, and preparation of the manuscript.	Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], SOL ISL MAR PARK ZON; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Banks SA, 2010, MAR POLICY, V34, P197, DOI 10.1016/j.marpol.2009.06.006; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Botsford LW, 2005, B MAR SCI, V76, P245; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burfeind DD, 2013, BIOL INVASIONS, V15, P17, DOI 10.1007/s10530-012-0265-2; Byers JE, 2007, ECOL APPL, V17, P1851, DOI 10.1890/07-0067.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coleman MA, 2013, BIOL CONSERV, V167, P257, DOI 10.1016/j.biocon.2013.08.033; Coleman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020168; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Coleman MA, 2009, MAR ECOL PROG SER, V381, P63, DOI 10.3354/meps07977; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Curley BG, 2013, REV FISH BIOL FISHER; Davis BC, 2005, ENFORCING US MARINE; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Edgar GJ, 2012, ENVIRON CONSERV, V39, P271, DOI 10.1017/S0376892912000185; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; GRAY CA, 1994, AUST J MAR FRESH RES, V45, P665; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hastings A, 2003, ECOL APPL, V13, pS65; Jordan A, 2010, NSW DEP ENV CLIMATE; Kelaher BP, 2003, OECOLOGIA, V135, P431, DOI 10.1007/s00442-003-1196-5; Klages J, 2014, ENVIRON BIOL FISH, V97, P215, DOI 10.1007/s10641-013-0138-2; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lowry M, 2012, J EXP MAR BIOL ECOL, V416, P243, DOI 10.1016/j.jembe.2012.01.013; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2010, AQUAT CONSERV, V20, P83, DOI 10.1002/aqc.1055; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Read AD, 2011, J ENVIRON MANAGE, V92, P2558, DOI 10.1016/j.jenvman.2011.05.022; Read AD, 2010, OCEAN COAST MANAGE, V53, P636, DOI 10.1016/j.ocecoaman.2010.08.003; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts Callum M., 2005, P265; Roberts CM, 2003, ECOL APPL, V13, pS199; Rowling K, 2010, STATUS FISHERIES RES; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Steffe AS, 2005, ASSESSMENT CHANGES; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Tuya FC, 2000, ICES J MAR SCI, V57, P1218, DOI 10.1006/jmsc.2000.0808; UNDERWOOD AJ, 1993, AUST J ECOL, V18, P99, DOI 10.1111/j.1442-9993.1993.tb00437.x; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	63	47	49	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85825	10.1371/journal.pone.0085825	http://dx.doi.org/10.1371/journal.pone.0085825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454934	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100135
J	Lin, WY; Lou, XY; Gao, GM; Liu, NJ				Lin, Wan-Yu; Lou, Xiang-Yang; Gao, Guimin; Liu, Nianjun			Rare Variant Association Testing by Adaptive Combination of P-values	PLOS ONE			English	Article							DISEASE ASSOCIATION; SEQUENCING DATA; COMMON; HAPLOTYPE; SUSCEPTIBILITY; ALLELES	With the development of next-generation sequencing technology, there is a great demand for powerful statistical methods to detect rare variants (minor allele frequencies (MAFs), 1%) associated with diseases. Testing for each variant site individually is known to be underpowered, and therefore many methods have been proposed to test for the association of a group of variants with phenotypes, by pooling signals of the variants in a chromosomal region. However, this pooling strategy inevitably leads to the inclusion of a large proportion of neutral variants, which may compromise the power of association tests. To address this issue, we extend the sigma-MidP method (Cheung et al., 2012, Genet Epidemiol 36:675-685) and propose an approach (named 'adaptive combination of P-values for rare variant association testing', abbreviated as 'ADA') that adaptively combines per-site P-values with the weights based on MAFs. Before combining P-values, we first imposed a truncation threshold upon the per-site P-values, to guard against the noise caused by the inclusion of neutral variants. This ADA method is shown to outperform popular burden tests and non-burden tests under many scenarios. ADA is recommended for next-generation sequencing data analysis where many neutral variants may be included in a functional region.	[Lin, Wan-Yu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lou, Xiang-Yang; Liu, Nianjun] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Gao, Guimin] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	National Taiwan University; University of Alabama System; University of Alabama Birmingham; Virginia Commonwealth University	Lin, WY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	linwy@ntu.edu.tw; nliu@uab.edu		LIN, WAN-YU/0000-0002-3385-4702	National Science Council of Taiwan [NSC 102-2628-B-002-039-MY3, NSC 102-2314-B-002-001-MY2]; National Taiwan University [NTU-CESRP-101R7622-8, NTU-CESRP-102R7622-8, NTU-CDP-102R7769]; NIH [R01GM081488, R01HL092173, P01AR049084, P60AR048095, R01DA095025, R01GM073766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048095, P01AR049084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081488, R01GM073766] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants NSC 102-2628-B-002-039-MY3 and NSC 102-2314-B-002-001-MY2 from the National Science Council of Taiwan, and NTU-CESRP-101R7622-8, NTU-CESRP-102R7622-8, and NTU-CDP-102R7769 from National Taiwan University (W-Y.L.), and NIH grants R01GM081488, R01HL092173, P01AR049084, P60AR048095 (N.L.), R01DA095025 (X. L.), and R01GM073766 (G. G.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 1932, STAT METHODS RES WOR; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Cheung YH, 2012, GENET EPIDEMIOL, V36, P675, DOI 10.1002/gepi.21662; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lee S, 2013, PACKAGE SKAT; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Lin WY, 2013, GENET EPIDEMIOL, V37, P560, DOI 10.1002/gepi.21740; Lin WY, 2012, GENET EPIDEMIOL, V36, P572, DOI 10.1002/gepi.21650; Lin Wan-Yu, 2011, BMC Proc, V5 Suppl 9, pS118, DOI 10.1186/1753-6561-5-S9-S118; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen B.E., 2009, PLOS GENET, V5; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang Hsin-Chou, 2011, BMC Proc, V5 Suppl 9, pS43, DOI 10.1186/1753-6561-5-S9-S43; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	45	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85728	10.1371/journal.pone.0085728	http://dx.doi.org/10.1371/journal.pone.0085728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454922	Green Published, gold			2022-12-27	WOS:000330235100124
J	Zhang, FQ; Liu, CX; Xu, Y; Qi, GY; Yuan, GZ; Cheng, ZH; Wang, JD; Wang, GQ; Wang, ZQ; Zhu, W; Zhou, ZH; Zhao, XF; Tian, L; Jin, CH; Yuan, JM; Zhang, GF; Chen, YG; Wang, LF; Lu, TL; Yan, H; Ruan, YY; Yue, WH; Zhang, D				Zhang, Fuquan; Liu, Chenxing; Xu, Yong; Qi, Guoyang; Yuan, Guozhen; Cheng, Zaohuo; Wang, Jidong; Wang, Guoqiang; Wang, Zhiqiang; Zhu, Wei; Zhou, Zhenhe; Zhao, Xingfu; Tian, Lin; Jin, Chunhui; Yuan, Janmin; Zhang, Guofu; Chen, Yaguang; Wang, Lifang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Yue, Weihua; Zhang, Dai			A Two-Stage Association Study Suggests BRAP as a Susceptibility Gene for Schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROTEIN; RISK; DISEASE; SNPS; POLYMORPHISMS; VISUALIZATION; NEUROBIOLOGY; CHINESE; SAMPLE	Schizophrenia (SZ) is a neurodevelopmental disorder in which altered immune function typically plays an important role in mediating the effect of environmental insults and regulation of inflammation. The breast cancer suppressor protein associated protein (BRAP) is suggested to exert vital effects in neurodevelopment by modulating the mitogen-activated protein kinase cascade and inflammation signaling. To explore the possible role of BRAP in SZ, we conducted a two-stage study to examine the association of BRAP polymorphisms with SZ in the Han Chinese population. In stage one, we screened SNPs in BRAP from our GWAS data, which detected three associated SNPs, with rs3782886 being the most significant one (P = 2.31E-6, OR = 0.67). In stage two, we validated these three SNPs in an independently collected population including 1957 patients and 1509 controls, supporting the association of rs3782886 with SZ (P = 1.43E-6, OR = 0.73). Furthermore, cis-eQTL analysis indicates that rs3782886 genotypes are associated with mRNA levels of aldehyde dehydrogenase 2 family (ALDH2) (P = 0.0039) and myosin regulatory light chain 2 (MYL2) (P < 1.0E-4). Our data suggest that the BRAP gene may confer vulnerability for SZ in Han Chinese population, adding further evidence for the involvement of developmental and/or neuroinflammatory cascades in the illness.	[Zhang, Fuquan; Qi, Guoyang; Yuan, Guozhen; Cheng, Zaohuo; Wang, Jidong; Wang, Guoqiang; Wang, Zhiqiang; Zhu, Wei; Zhou, Zhenhe; Zhao, Xingfu; Tian, Lin; Jin, Chunhui; Yuan, Janmin; Zhang, Guofu] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Zhang, Fuquan; Liu, Chenxing; Chen, Yaguang; Wang, Lifang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Yue, Weihua; Zhang, Dai] Peking Univ, Key Lab Mental Hlth, Minist Hlth, Inst Mental Hlth,Hosp 6, Beijing 100871, Peoples R China; [Xu, Yong] Shanxi Med Univ, Dept Psychiat, Hosp 1, Taiyuan, Peoples R China; [Zhang, Dai] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Nanjing Medical University; Peking University; Shanxi Medical University; Peking University	Yue, WH (corresponding author), Peking Univ, Key Lab Mental Hlth, Minist Hlth, Inst Mental Hlth,Hosp 6, Beijing 100871, Peoples R China.	dyue@bjmu.edu.cn; daizhang@bjmu.edu.cn	Yan, Hao/U-1330-2017	Yan, Hao/0000-0003-0376-9037; Zhang, Fuquan/0000-0003-3204-8191	National High-Tech Research and Development Program of China [2009AA022702]; National Natural Science Foundation of China [81000578, 81071087, 81071088]; Science Fund for Creative Research Groups of the National Natural Science Foundation of China [81221002]; National Basic Research Program of China [2011CB707805]; International Science & Technology Cooperation Program of China [2010DFB30820]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International Science & Technology Cooperation Program of China	This work was supported by research grants from the National High-Tech Research and Development Program of China (2009AA022702), the National Natural Science Foundation of China (81000578, 81071087 and 81071088), Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81221002), the National Basic Research Program of China (2011CB707805), and the International Science & Technology Cooperation Program of China (2010DFB30820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Demirhan O, 2006, Genetika, V42, P985; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Hinohara K, 2009, J HUM GENET, V54, P642, DOI 10.1038/jhg.2009.87; Kneeland RE, 2013, PROG NEURO-PSYCHOPH, V42, P35, DOI 10.1016/j.pnpbp.2012.02.001; Lanctot AA, 2013, DEV CELL, V25, P241, DOI 10.1016/j.devcel.2013.04.006; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lee SA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S20; Lee SY, 2012, PROG NEURO-PSYCHOPH, V38, P247, DOI 10.1016/j.pnpbp.2012.04.005; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liao YC, 2011, MOL MED, V17, P1065, DOI 10.2119/molmed.2011.00043; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Mehler MF, 1997, TRENDS NEUROSCI, V20, P357, DOI 10.1016/S0166-2236(96)01045-4; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Meyer U, 2013, PROG NEURO-PSYCHOPH, V42, P20, DOI 10.1016/j.pnpbp.2011.11.003; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Takashima O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058911; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; WADGAONKAR R, 1993, CELL MOL BIOL RES, V39, P13; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Weterman MAJ, 2013, BRAIN, V136, P282, DOI 10.1093/brain/aws293; Wood SJ, 2009, ANN ACAD MED SINGAP, V38, P396; Wu LJ, 2013, DIABETES VASC DIS RE, V10, P202, DOI 10.1177/1479164112455535; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yang XL, 2013, AM J CLIN NUTR, V97, P545, DOI 10.3945/ajcn.112.046482; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang YM, 2011, PHARMACOL THERAPEUT, V132, P86, DOI 10.1016/j.pharmthera.2011.05.008	44	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86037	10.1371/journal.pone.0086037	http://dx.doi.org/10.1371/journal.pone.0086037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454952	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100144
J	Desai, AJ; Roberts, DJ; Richards, GO; Skerry, TM				Desai, Aditya J.; Roberts, David J.; Richards, Gareth O.; Skerry, Timothy M.			Role of Receptor Activity Modifying Protein 1 in Function of the Calcium Sensing Receptor in the Human TT Thyroid Carcinoma Cell Line	PLOS ONE			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; CALCITONIN-RECEPTOR; INTRACELLULAR CALCIUM; LIGAND SPECIFICITY; CA2+; CATION; TRAFFICKING; KINASE; FRET; ADRENOMEDULLIN	The Calcium Sensing Receptor (CaSR) plays a role in calcium homeostasis by sensing minute changes in serum Ca2+ and modulating secretion of calciotropic hormones. It has been shown in transfected cells that accessory proteins known as Receptor Activity Modifying Proteins (RAMPs), specifically RAMPs 1 and 3, are required for cell-surface trafficking of the CaSR. These effects have only been demonstrated in transfected cells, so their physiological relevance is unclear. Here we explored CaSR/RAMP interactions in detail, and showed that in thyroid human carcinoma cells, RAMP1 is required for trafficking of the CaSR. Furthermore, we show that normal RAMP1 function is required for intracellular responses to ligands. Specifically, to confirm earlier studies with tagged constructs, and to provide the additional benefit of quantitative stoichiometric analysis, we used fluorescence resonance energy transfer to show equal abilities of RAMP1 and 3 to chaperone CaSR to the cell surface, though RAMP3 interacted more efficiently with the receptor. Furthermore, a higher fraction of RAMP3 than RAMP1 was observed in CaSR-complexes on the cell-surface, suggesting different ratios of RAMPs to CaSR. In order to determine relevance of these findings in an endogenous expression system we assessed the effect of RAMP1 siRNA knock-down in medullary thyroid carcinoma TT cells, (which express RAMP1, but not RAMP3 constitutively) and measured a significant 50% attenuation of signalling in response to CaSR ligands Cinacalcet and neomycin. Blockade of RAMP1 using specific antibodies induced a concentration-dependent reduction in CaSR-mediated signalling in response to Cinacalcet in TT cells, suggesting a novel functional role for RAMP1 in regulation of CaSR signalling in addition to its known role in receptor trafficking. These data provide evidence that RAMPs traffic the CaSR as higher-level oligomers and play a role in CaSR signalling even after cell surface localisation has occurred.	[Desai, Aditya J.; Roberts, David J.; Richards, Gareth O.; Skerry, Timothy M.] Univ Sheffield, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield, S Yorkshire, England	University of Sheffield	Skerry, TM (corresponding author), Univ Sheffield, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield, S Yorkshire, England.	t.skerry@sheffield.ac.uk		Richards, Gareth Owain/0000-0001-7984-6882; Skerry, Timothy/0000-0003-1319-5575	BBRSC [117120]; BBSRC; Prostate Cancer UK [PA12-12] Funding Source: researchfish	BBRSC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prostate Cancer UK	Support for DJR provided by BBRSC Industrial Partnership Award 117120 PI TMS, and support for AJD provided by BBSRC Dorothy Hodgkin Studentship PI TMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Arthur JM, 1997, AM J PHYSIOL-RENAL, V273, pF129, DOI 10.1152/ajprenal.1997.273.1.F129; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bogazzi F, 2011, J ENDOCRINOL INVEST, V34, pE200, DOI 10.3275/7228; Bomberger JM, 2005, J BIOL CHEM, V280, P23926, DOI 10.1074/jbc.M501751200; Bomberger JM, 2005, J BIOL CHEM, V280, P9297, DOI 10.1074/jbc.M413786200; Bonner K, 2010, J ALLERGY CLIN IMMUN, V126, P1277, DOI 10.1016/j.jaci.2010.08.013; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Bouschet T, 2012, ADV EXP MED BIOL, V744, P39, DOI 10.1007/978-1-4614-2364-5_4; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Bu L, 2008, PROTEINS, V71, P215, DOI 10.1002/prot.21685; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; COLE DEC, 1990, J CRAN GENET DEV BIO, V10, P205; Corbetta S, 2002, J CLIN ENDOCR METAB, V87, P2201, DOI 10.1210/jc.87.5.2201; DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946; Faurskov B, 2002, PFLUG ARCH EUR J PHY, V445, P40, DOI 10.1007/s00424-002-0912-z; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; GARRETT JE, 1995, ENDOCRINOLOGY, V136, P5202, DOI 10.1210/en.136.11.5202; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Handlogten ME, 2000, AM J PHYSIOL-RENAL, V279, pF1083, DOI 10.1152/ajprenal.2000.279.6.F1083; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hsu YJ, 2010, NEPHROL DIAL TRANSPL, V25, P1428, DOI 10.1093/ndt/gfp645; Huang CF, 2004, AM J PHYSIOL-CELL PH, V286, pC22, DOI 10.1152/ajpcell.00229.2003; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Kawase T, 2003, EUR J PHARMACOL, V470, P125, DOI 10.1016/S0014-2999(03)01763-1; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kraenzlin ME, 2011, NAT REV ENDOCRINOL, V7, P647, DOI 10.1038/nrendo.2011.108; Kumar GN, 2004, DRUG METAB DISPOS, V32, P1491, DOI 10.1124/dmd.104.000604; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Quinn SJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1315, DOI 10.1152/ajpcell.1997.273.4.C1315; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8	45	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85237	10.1371/journal.pone.0085237	http://dx.doi.org/10.1371/journal.pone.0085237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454825	gold, Green Published, Green Accepted			2022-12-27	WOS:000329922500050
J	Huang, A; Zhao, HC; Quan, YJ; Jin, RS; Feng, B; Zheng, MH				Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua			E2A Predicts Prognosis of Colorectal Cancer Patients and Regulates Cancer Cell Growth by Targeting miR-320a	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2A; CONFERS RESISTANCE; CYCLE PROGRESSION; LIVER METASTASIS; GENE E2A; EXPRESSION; PROTEINS; PROLIFERATION; E47; PROMOTES	Background and objective: Transcriptional factor E2A is crucial for the normal development and differentiation of B and T lymphocytes. Dysregulation of E2A leads to leukemia and tumorigenesis of some solid tumors. The expression and clinical significance of E2A as well as its role in colorectal cancer (CRC) are still unknown. This study aims to assess E2A expression in CRC tissues, evaluate its prognosis value, and investigate its role in colon cancer cell growth. Methods: E2A expression in CRC tissues and normal mucosa was detected by immunohistochemical staining; Kaplan-Meier survival curve and Cox regression model were used to evaluate the prognostic value of E2A. Lentivirus was used to construct E2A stably knocked-down cells. MTT assay was employed to detect cell proliferation change; cell cycle was analyzed by flow cytometry; and chromatin immunoprecipitation (ChIP) assay was used to validate the predicted binding target of E2A. Results: Expression of E2A was lower in CRC tissues than normal mucosa; low E2A expression correlated with advanced TNM stage and larger tumor size, and predicted poor prognosis of CRC patients. E2A knockdown resulted in increased cell proliferation rate and cell cycle acceleration. ChIP assay showed miR-320a was a direct target of E2A and upregulation of miR-320a in E2A downregulated cells could reverse cell proliferation and cell cycle changes caused by E2A deficiency. Conclusions: E2A is an independent prognostic factor for CRC patients and targets miR-320a to regulate cell proliferation of colon cancer cells.	[Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua] Shanghai Jiao Tong Univ, Dept Surg, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua] Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua] Shanghai Minimally Invas Surg Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zheng, MH (corresponding author), Shanghai Jiao Tong Univ, Dept Surg, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	strongao123@163.com			National Natural Science Foundation of China (NSFC) [30873000]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Natural Science Foundation of China (NSFC, 30873000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrysik Z, 2013, CELL REP, V3, P1346, DOI 10.1016/j.celrep.2013.04.014; Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feng Biao, 2012, ISRN Endocrinol, V2012, P549875, DOI 10.5402/2012/549875; Herblot S, 2002, MOL CELL BIOL, V22, P886, DOI 10.1128/MCB.22.3.886-900.2002; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Hwang-Verslues WW, 2011, ONCOGENE, V30, P2463, DOI 10.1038/onc.2010.618; Kardava L, 2011, INT IMMUNOL, V23, P375, DOI 10.1093/intimm/dxr027; Knosel T, 2004, NEOPLASIA, V6, P23, DOI 10.1016/s1476-5586(04)80050-2; LeBrun DP, 2003, FRONT BIOSCI, V8, pS206, DOI 10.2741/1030; Lietz A, 2007, BRIT J HAEMATOL, V137, P342, DOI 10.1111/j.1365-2141.2007.06583.x; Liu TY, 2010, MODERN PATHOL, V23, P1507, DOI 10.1038/modpathol.2010.139; Mao Z, 2013, PLOS ONE, DOI [10.1371/journal.pone.0068206, DOI 10.1371/J0URNAL.P0NE.0068206]; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Mo ML, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-29; Park ST, 1999, J EXP MED, V189, P501, DOI 10.1084/jem.189.3.501; Patel D, 2012, BIOCHEM BIOPH RES CO, V422, P146, DOI 10.1016/j.bbrc.2012.04.126; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Seidel MG, 2001, ONCOGENE, V20, P5718, DOI 10.1038/sj.onc.1204591; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Slattery C, 2006, FEBS LETT, V580, P4021, DOI 10.1016/j.febslet.2006.06.039; Slyper M, 2012, CANCER RES, V72, P5613, DOI 10.1158/0008-5472.CAN-12-0119; Steininger A, 2011, J EXP MED, V208, P1585, DOI 10.1084/jem.20101785; Sun JY, 2012, BIOCHEM BIOPH RES CO, V420, P787, DOI 10.1016/j.bbrc.2012.03.075; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wilson JW, 2001, CANCER RES, V61, P8803; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; Yang Q, 2011, BLOOD, V117, P3529, DOI 10.1182/blood-2010-07-297689; Zhang YJ, 2012, ONCOL REP, V27, P685, DOI 10.3892/or.2011.1561; Zhao F, 2001, MOL CELL BIOL, V21, P6346, DOI 10.1128/MCB.21.18.6346-6357.2001; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; ZHUANG Y, 1992, P NATL ACAD SCI USA, V89, P12132, DOI 10.1073/pnas.89.24.12132	44	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85201	10.1371/journal.pone.0085201	http://dx.doi.org/10.1371/journal.pone.0085201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454819	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500047
J	Janotova, T; Jalovecka, M; Auerova, M; Svecova, I; Bruzlova, P; Maierova, V; Kumzakova, Z; Cunatova, S; Vlckova, Z; Caisova, V; Rozsypalova, P; Lukacova, K; Vacova, N; Wachtlova, M; Salat, J; Lieskovska, J; Kopecky, J; Zenka, J				Janotova, Tereza; Jalovecka, Marie; Auerova, Marie; Svecova, Ivana; Bruzlova, Pavlina; Maierova, Veronika; Kumzakova, Zuzana; Cunatova, Stepanka; Vlckova, Zuzana; Caisova, Veronika; Rozsypalova, Petra; Lukacova, Katarina; Vacova, Nikol; Wachtlova, Marketa; Salat, Jiri; Lieskovska, Jaroslava; Kopecky, Jan; Zenka, Jan			The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; INNATE IMMUNE; EXPRESSION; LIPOPOLYSACCHARIDE; GROWTH; MACROPHAGES; CELLS; BETA; ACTIVATION; REGRESSION	The application of the phagocytic receptor agonists in cancer immunotherapy was studied. Agonists (laminarin, molecules with terminal mannose, N-Formyl-methioninyl-leucyl-phenylalanine) were firmly anchored to the tumor cell surface. When particular agonists of phagocytic receptors were used together with LPS (Toll-like receptor agonist), high synergy causing tumour shrinkage and a temporary or permanent disappearance was observed. Methods of anchoring phagocytic receptor agonists (charge interactions, anchoring based on hydrophobic chains, covalent bonds) and various regimes of phagocytic agonist/LPS mixture applications were tested to achieve maximum therapeutic effect. Combinations of mannan/LPS and fMLF/LPS (hydrophobic anchors) in appropriate (pulse) regimes resulted in an 80% and 60% recovery for mice, respectively. We propose that substantial synergy between agonists of phagocytic and Toll-like receptors (TLR) is based on two events. The TLR ligand induces early and massive inflammatory infiltration of tumors. The effect of this cell infiltrate is directed towards tumor cells, bearing agonists of phagocytic receptors on their surface. The result of these processes was effective killing of tumor cells. This novel approach represents exploitation of innate immunity mechanisms for treating cancer.	[Janotova, Tereza; Jalovecka, Marie; Auerova, Marie; Svecova, Ivana; Bruzlova, Pavlina; Maierova, Veronika; Kumzakova, Zuzana; Cunatova, Stepanka; Vlckova, Zuzana; Caisova, Veronika; Rozsypalova, Petra; Vacova, Nikol; Wachtlova, Marketa; Lieskovska, Jaroslava; Kopecky, Jan; Zenka, Jan] Univ South Bohemia, Fac Sci, Dept Med Biol, Ceske Budejovice, Czech Republic; [Lukacova, Katarina] Reg Hosp, Dept Pathol, Ceske Budejovice, Czech Republic; [Salat, Jiri] Vet Res Inst, Dept Virol, CS-62132 Brno, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Veterinary Research Institute	Zenka, J (corresponding author), Univ South Bohemia, Fac Sci, Dept Med Biol, Ceske Budejovice, Czech Republic.	jzenka@gmail.com	Lieskovska, Jaroslava/G-9309-2014; JaloveckÃ, MaruÅka/AAU-5086-2020; Jalovecka, Marie/R-3549-2018; Kopecky, Jan/G-9347-2014; Salát, Jiří/F-6295-2019	JaloveckÃ, MaruÅka/0000-0003-4681-116X; Jalovecka, Marie/0000-0003-4681-116X; Salát, Jiří/0000-0002-9915-8953; Lieskovska, Jaroslava/0000-0001-6626-4912	European Social Fund [CZ.1.07/2.2.00/15.0361]; Czech State Budget; company POLAK CZ s.r.o.	European Social Fund(European Social Fund (ESF)); Czech State Budget; company POLAK CZ s.r.o.	This work was supported by the project no. CZ.1.07/2.2.00/15.0361 funded by European Social Fund and Czech State Budget. Further it was supported by the company POLAK CZ s.r.o. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2009, IMMUNOTHERAPY-UK, V1, P949, DOI [10.2217/imt.09.70, 10.2217/IMT.09.70]; Algarra I, 1997, INT J CLIN LAB RES, V27, P95, DOI 10.1007/BF02912442; Blanks MJ, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-26; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chicoine MR, 2001, NEUROSURGERY, V48, P607, DOI 10.1097/00006123-200103000-00032; CHRISTIAANSEN JE, 1984, J IMMUNOL METHODS, V74, P229, DOI 10.1016/0022-1759(84)90290-4; Cui Z, 2003, P NATL ACAD SCI USA, V100, P6682, DOI 10.1073/pnas.1031601100; deVries TJ, 1997, CANCER RES, V57, P3223; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Frasnelli ME, 2005, ARTHRITIS RES THER, V7, pR370, DOI 10.1186/ar1494; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Guha M, 2012, NAT REV DRUG DISCOV, V11, P503, DOI 10.1038/nrd3775; Hamai A, 2010, TISSUE ANTIGENS, V75, P1, DOI 10.1111/j.1399-0039.2009.01401.x; Hayakawa Y, 2006, ADV CANCER RES, V95, P293, DOI 10.1016/S0065-230X(06)95008-8; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Jager E, 1996, INT J CANCER, V66, P470, DOI 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C; Jinushi M, 2012, ONCOIMMUNOLOGY, V1, P189, DOI 10.4161/onci.1.2.18495; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kato K, 2004, BIOTECHNOL PROGR, V20, P897, DOI 10.1021/bp0342093; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Langers I, 2012, BIOL-TARGETS THER, V6, P73, DOI 10.2147/BTT.S23976; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Li J, 2009, WORLD J GASTROENTERO, V15, P2602, DOI 10.3748/wjg.15.2602; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Mariani CL, 2007, J NEURO-ONCOL, V85, P231, DOI 10.1007/s11060-007-9415-2; Marquez M, 2004, ANTICANCER RES, V24, P1347; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; SHEPHERD VL, 1990, J IMMUNOL, V145, P1530; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Tripathi P, 2006, CANCER INVEST, V24, P178, DOI 10.1080/07357900500524579; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Vetvicka V, 2011, WORLD J CLIN ONCOL, V2, P115, DOI 10.5306/wjco.v2.i2.115; Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157	41	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85222	10.1371/journal.pone.0085222	http://dx.doi.org/10.1371/journal.pone.0085222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454822	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500048
J	Chang, HC; Lee, HJ; Tzeng, OJL; Kuo, WJ				Chang, Hui-Chuan; Lee, Hsin-Ju; Tzeng, Ovid J. L.; Kuo, Wen-Jui			Implicit Target Substitution and Sequencing for Lexical Tone Production in Chinese: An fMRI Study	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; LANGUAGE LATERALITY; MANDARIN CHINESE; WORD PRODUCTION; FUNCTIONAL MRI; SPEECH; PERCEPTION; DOMINANCE; BRAIN; AREAS	In this study, we examine the neural substrates underlying Tone 3 sandhi and tone sequencing in Mandarin Chinese using fMRI. Tone 3 sandhi is traditionally described as the substitution of Tone 3 with Tone 2 when followed by another Tone 3 (i.e., 33 -> 23). According to current speech production models, target substitution is expected to engage the posterior inferior frontal gyrus. Since Tone 3 sandhi is, to some extent, independent of segments, which makes it more similar to singing, right-lateralized activation in this region was predicted. As for tone sequencing, based on studies in sequencing, we expected the involvement of the supplementary motor area. In the experiments, participants were asked to produce twelve four-syllable sequences with the same tone assignment (the repeated sequences) or a different tone assignment (the mixed sequences). We found right-lateralized posterior inferior frontal gyrus activation for the sequence 3333 (Tone 3 sandhi) and left-lateralized activation in the supplementary motor area for the mixed sequences (tone sequencing). We proposed that tones and segments could be processed in parallel in the left and right hemispheres, but their integration, or the product of their integration, is hosted in the left hemisphere.	[Chang, Hui-Chuan; Lee, Hsin-Ju; Tzeng, Ovid J. L.; Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Tzeng, Ovid J. L.] Acad Sinica, Inst Linguist, Taipei 115, Taiwan; [Kuo, Wen-Jui] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Kuo, WJ (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	wjkuo@ym.edu.tw		Tzeng, Ovid J. L./0000-0002-0844-7865; Lee, Hsin-Ju/0000-0003-3358-8720; CHANG, CLAIRE H. C./0000-0002-3773-1777	National Science Council of Taiwan [97-2752-H-010-002-PAE, 96-2752-H-010-002-PAE, 95-2752-H-010-002-PAE, 94-2752-H-010-002-PAE]; thematic research program of Academia Sinica, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); thematic research program of Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This study was supported by the grants from the National Science Council of Taiwan (97-2752-H-010-002-PAE, 96-2752-H-010-002-PAE, 95-2752-H-010-002-PAE, 94-2752-H-010-002-PAE) and the thematic research program of Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2004, BRAIN LANG, V89, P320, DOI 10.1016/S0093-934X(03)00347-X; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Boersma P., 2013, PRAAT DOING PHONETIC; Boersma Paul, 2002, GLOT INT, V5, P341; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Bortoletto M, 2010, NEUROIMAGE, V49, P3338, DOI 10.1016/j.neuroimage.2009.11.048; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Chao Y. R., 1948, MANDARIN PRIMER; Chen JY, 1999, APPL PSYCHOLINGUIST, V20, P289, DOI 10.1017/S0142716499002064; Chen M.Y., 2000, TONE SANDHI PATTERNS; Fon J, 1997, WHAT ARE TONES REALL; FOWLER CA, 1993, LANG SPEECH, V36, P171, DOI 10.1177/002383099303600304; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gandour J, 2003, HUM BRAIN MAPP, V20, P185, DOI 10.1002/hbm.10137; Garraux G, 2005, J NEUROSCI, V25, P5290, DOI 10.1523/JNEUROSCI.0340-05.2005; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Huang T, 2010, PHONETICA, V67, P243, DOI 10.1159/000327392; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Keating P. A., 1990, PAPERS LAB PHONOLOGY, VI, P451, DOI [DOI 10.1017/CBO9780511627736, 10.1017/CBO9780511627736.026, DOI 10.1017/CBO9780511627736.026]; Kell CA, 2011, CEREB CORTEX, V21, P932, DOI 10.1093/cercor/bhq167; Klein D, 2001, NEUROIMAGE, V13, P646, DOI 10.1006/nimg.2000.0738; Kochanski G, 2003, SPEECH COMMUN, V41, P625, DOI 10.1016/S0167-6393(03)00100-6; Kochanski G, 2006, P SPEECH PROSODY, P5; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; LI CN, 1977, J CHILD LANG, V4, P185, DOI 10.1017/S0305000900001598; Li XJ, 2010, NEUROREPORT, V21, P690, DOI 10.1097/WNR.0b013e32833b0a10; Liu L, 2006, NEUROIMAGE, V29, P515, DOI 10.1016/j.neuroimage.2005.07.046; Loui P, 2011, NEUROIMAGE, V55, P500, DOI 10.1016/j.neuroimage.2010.12.022; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Munhall KK, 2000, LAB PHONOLOGY, P9; Myers J., 2003, TAIWAN J LINGUISTICS, V1, P29; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; OHALA JJ, 1993, LANG SPEECH, V36, P155, DOI 10.1177/002383099303600303; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Peng S.-H., 2000, PAPERS LAB PHONOLOGY, P152; Peretz I, 2011, 13 BIOL FDN MUS INS, DOI DOI 10.1016/B978-0-12-381460-9.00013-4; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Prom-on S, 2009, J ACOUST SOC AM, V125, P405, DOI 10.1121/1.3037222; Pulvermuller F, 2012, CORTEX, V48, P871, DOI 10.1016/j.cortex.2011.02.006; Reimold M, 2006, J CEREBR BLOOD F MET, V26, P751, DOI 10.1038/sj.jcbfm.9600231; Riecker A, 2000, NEUROREPORT, V11, P1997, DOI 10.1097/00001756-200006260-00038; Riecker A, 2000, NEUROIMAGE, V11, pS315; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Shih C.-l., 1986, PROSODIC DOMAIN TONE; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Shtyrov Y, 2000, NEUROIMAGE, V12, P657, DOI 10.1006/nimg.2000.0646; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Speer S, 1989, LANGUAGE SPEECH; Talairach I., 1988, COPLANAR STEREOTACTI; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van der Merwe A, 1997, THEORETICAL FRAMEWOR, P1; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Wan I.P., 1998, PHONOLOGY, V15, P417, DOI [10.1017/S0952675799003668, DOI 10.1017/S0952675799003668]; WANG WSY, 1967, J SPEECH HEAR RES, V10, P629, DOI 10.1044/jshr.1003.629; Wang Y, 2003, J ACOUSTICAL SOC; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Wong PCM, 2002, BRAIN RES BULL, V59, P83, DOI 10.1016/S0361-9230(02)00860-2; Wong PS, 2005, J SPEECH LANG HEAR R, V48, P1065, DOI 10.1044/1092-4388(2005/074); Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; Xu Y, 1999, J PHONETICS, V27, P55, DOI 10.1006/jpho.1999.0086; Xu Y, 2005, J PHONETICS, V33, P159, DOI 10.1016/j.wocn.2004.11.001; Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034; Zatorre R, 1994, J NEUROSCIENCE; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; Zhang J, 2006, TESTING ROLE PHONETI, V28, P65; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	80	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83126	10.1371/journal.pone.0083126	http://dx.doi.org/10.1371/journal.pone.0083126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427269	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200009
J	Mao, XG; Chen, SS; Li, A; Zhai, CC; Jing, RL				Mao, Xinguo; Chen, Shuangshuang; Li, Ang; Zhai, Chaochao; Jing, Ruilian			Novel NAC Transcription Factor TaNAC67 Confers Enhanced Multi-Abiotic Stress Tolerances in Arabidopsis	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; SECONDARY WALL SYNTHESIS; ABSCISIC-ACID; SALT TOLERANCE; DROUGHT TOLERANCE; COMPREHENSIVE ANALYSIS; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; LOW-TEMPERATURE; PROTEIN-KINASE	Abiotic stresses are major environmental factors that affect agricultural productivity worldwide. NAC transcription factors play pivotal roles in abiotic stress signaling in plants. As a staple crop, wheat production is severely constrained by abiotic stresses whereas only a few NAC transcription factors have been characterized functionally. To promote the application of NAC genes in wheat improvement by biotechnology, a novel NAC gene designated TaNAC67 was characterized in common wheat. To determine its role, transgenic Arabidopsis overexpressing TaNAC67-GFP controlled by the CaMV-35S promoter was generated and subjected to various abiotic stresses for morphological and physiological assays. Gene expression showed that TaNAC67 was involved in response to drought, salt, cold and ABA treatments. Localization assays revealed that TaNAC67 localized in the nucleus. Morphological analysis indicated the transgenics had enhanced tolerances to drought, salt and freezing stresses, simultaneously supported by enhanced expression of multiple abiotic stress responsive genes and improved physiological traits, including strengthened cell membrane stability, retention of higher chlorophyll contents and Na+ efflux rates, improved photosynthetic potential, and enhanced water retention capability. Overexpression of TaNAC67 resulted in pronounced enhanced tolerances to drought, salt and freezing stresses, therefore it has potential for utilization in transgenic breeding to improve abiotic stress tolerance in crops.	[Mao, Xinguo; Chen, Shuangshuang; Li, Ang; Zhai, Chaochao; Jing, Ruilian] Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Jing, RL (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China.	jingrl@caas.net.cn	Xinguo, Mao/AAF-3195-2020	Xinguo, Mao/0000-0003-4712-437X	National High-tech R&D Project (863 Project) [2012AA10A308]; National Basic Research Program of China (973 Program) [2010CB951501]; Beijing Natural Science Foundation [6132030]	National High-tech R&D Project (863 Project); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National High-tech R&D Project (863 Project, 2012AA10A308), National Basic Research Program of China (973 Program, 2010CB951501) and Beijing Natural Science Foundation (6132030). The funders had no role in study design, data collection and analysis, desision to publish, or prepare of the manuscript.	Baloglu MC, 2012, PLANT MOL BIOL REP, V30, P1246, DOI 10.1007/s11105-012-0445-3; Bent A, 2006, METH MOL B, V343, P87; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Christianson JA, 2009, PLANT PHYSIOL, V149, P1724, DOI 10.1104/pp.108.131912; Cuin TA, 2012, PLANT BIOLOGY, V14, P438, DOI 10.1111/j.1438-8677.2011.00526.x; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Farooq S, 2006, J PLANT PHYSIOL, V163, P629, DOI 10.1016/j.jplph.2005.06.006; FINKELSTEIN RR, 1990, PLANT PHYSIOL, V94, P1172, DOI 10.1104/pp.94.3.1172; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gao F, 2010, PLANT CELL TISS ORG, V100, P255, DOI 10.1007/s11240-009-9640-9; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Hao YJ, 2010, PLANTA, V232, P1033, DOI 10.1007/s00425-010-1238-2; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Levitt J., 1980, WATER RAD SALT OTHER, V1; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Mao Xin-Guo, 2005, Acta Genetica Sinica, V32, P811; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Mao XG, 2011, FUNCT INTEGR GENOMIC, V11, P445, DOI 10.1007/s10142-011-0218-3; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Meng CM, 2009, PLANT SCI, V176, P352, DOI 10.1016/j.plantsci.2008.12.003; Mitsuda N, 2008, PLANT J, V56, P768, DOI 10.1111/j.1365-313X.2008.03633.x; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Pang XiaoBin, 2007, Acta Agronomica Sinica, V33, P333; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shabala S., 2006, PLANT ELECTROPHYSIOL, P35; Shen HS, 2012, PLANT MOL BIOL, V80, P241, DOI 10.1007/s11103-012-9941-y; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Strasser A, 2002, PROBING PHOTOSYNTHES, P443; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tang YM, 2012, PHYSIOL PLANTARUM, V144, P210, DOI 10.1111/j.1399-3054.2011.01539.x; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wakeel A, 2011, PLANT PHYSIOL BIOCH, V49, P341, DOI 10.1016/j.plaphy.2011.01.006; Wang CX, 2011, J EXP BOT, V62, P1299, DOI 10.1093/jxb/erq377; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xia N, 2010, MOL BIOL REP, V37, P3703, DOI 10.1007/s11033-010-0023-4; Xia N, 2010, PHYSIOL MOL PLANT P, V74, P394, DOI 10.1016/j.pmpp.2010.06.005; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Xiong LM, 1999, PLANT PHYSIOL, V119, P205, DOI 10.1104/pp.119.1.205; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Xue GP, 2006, FUNCT PLANT BIOL, V33, P43, DOI 10.1071/FP05161; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yokotani N, 2009, PLANTA, V229, P1065, DOI 10.1007/s00425-009-0895-5; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	77	92	114	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84359	10.1371/journal.pone.0084359	http://dx.doi.org/10.1371/journal.pone.0084359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427285	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200025
J	Amaral, AR; Lovewell, G; Coelho, MM; Amato, G; Rosenbaum, HC				Amaral, Ana R.; Lovewell, Gretchen; Coelho, Maria M.; Amato, George; Rosenbaum, Howard C.			Hybrid Speciation in a Marine Mammal: The Clymene Dolphin (Stenella clymene)	PLOS ONE			English	Article							NATURAL HYBRIDIZATION; PHYLOGENETIC-RELATIONSHIPS; HAPLOTYPE RECONSTRUCTION; POPULATION-STRUCTURE; DELPHININAE CETACEA; ORIGIN; MODEL; SEQUENCES; INFERENCE; GENETICS	Natural hybridization may result in the exchange of genetic material between divergent lineages and even the formation of new taxa. Many of the Neo-Darwinian architects argued that, particularly for animal clades, natural hybridization was maladaptive. Recent evidence, however, has falsified this hypothesis, instead indicating that this process may lead to increased biodiversity through the formation of new species. Although such cases of hybrid speciation have been described in plants, fish and insects, they are considered exceptionally rare in mammals. Here we present evidence for a marine mammal, Stenella clymene, arising through natural hybridization. We found phylogenetic discordance between mitochondrial and nuclear markers, which, coupled with a pattern of transgressive segregation seen in the morphometric variation of some characters, support a case of hybrid speciation. S. clymene is currently genetically differentiated from its putative parental species, Stenella coerueloalba and Stenella longisrostris, although low levels of introgressive hybridization may be occurring. Although non-reticulate forms of evolution, such as incomplete lineage sorting, could explain our genetic results, we consider that the genetic and morphological evidence taken together argue more convincingly towards a case of hybrid speciation. We anticipate that our study will bring attention to this important aspect of reticulate evolution in non-model mammal species. The study of speciation through hybridization is an excellent opportunity to understand the mechanisms leading to speciation in the context of gene flow.	[Amaral, Ana R.; Coelho, Maria M.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Amaral, Ana R.; Amato, George; Rosenbaum, Howard C.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Lovewell, Gretchen] Mote Marine Lab, Sarasota, FL 34236 USA; [Rosenbaum, Howard C.] Wildlife Conservat Soc, Ocean Giants Program, New York, NY USA	Universidade de Lisboa; American Museum of Natural History (AMNH); Mote Marine Laboratory & Aquarium; Wildlife Conservation Society	Amaral, AR (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	aramaral@fc.ul.pt	Amaral, Ana Rita/ABG-4271-2021; Coelho, Maria M/B-8672-2009; Amaral, Ana/D-1060-2010	Amaral, Ana Rita/0000-0002-0595-0086; Coelho, Maria M/0000-0003-3288-1693; Amaral, Ana/0000-0002-0595-0086	Portuguese Foundation for Science and Technology [SFRH/BPD/79002/2011]; NOAA Fisheries	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA)	AR Amaral was funded by a grant from the Portuguese Foundation for Science and Technology (SFRH/BPD/79002/2011). The authors thank NOAA Fisheries for funding to initiate this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Amaral AR, 2010, CONSERV GENET, V11, P1143, DOI 10.1007/s10592-009-9903-3; Amaral AR, 2012, MOL ECOL, V21, P4854, DOI 10.1111/j.1365-294X.2012.05728.x; Amaral AR, 2012, MOL PHYLOGENET EVOL, V64, P243, DOI 10.1016/j.ympev.2012.04.004; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; ARNASON U, 1980, HEREDITAS, V92, P179, DOI 10.1111/j.1601-5223.1980.tb01693.x; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Baskett ML, 2011, THEOR ECOL-NETH, V4, P223, DOI 10.1007/s12080-011-0118-0; Bergman TJ, 2003, SEXUAL SELECTION PRI, P500; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Berube M., 2002, ENCY MARINE MAMMALS, P596; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Dittrich-Reed DR, 2013, EVOL BIOL, V40, P310, DOI 10.1007/s11692-012-9209-0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Jackson JA, 2009, MOL BIOL EVOL, V26, P2427, DOI 10.1093/molbev/msp169; Jefferson Thomas A., 2003, Mammalian Species, V726, P1, DOI 10.1644/726; Kingston SE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-245; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lyons LA, 1999, J HERED, V90, P15, DOI 10.1093/jhered/90.1.15; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mavarez J, 2008, MOL ECOL, V17, P4181, DOI 10.1111/j.1365-294X.2008.03898.x; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; PERRIN WF, 1981, J MAMMAL, V62, P583, DOI 10.2307/1380405; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Shurtliff QR, 2013, MAMMAL REV, V43, P1, DOI 10.1111/j.1365-2907.2011.00205.x; Silva-Jr JM, 2005, AQUATIC MAMMALS, V31; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tobler M, 2010, J EVOLUTION BIOL, V23, P1475, DOI 10.1111/j.1420-9101.2010.02014.x; Tosi AJ, 2003, EVOLUTION, V57, P1419; Willis PM, 2004, CAN J ZOOL, V82, P828, DOI 10.1139/Z04-059; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Zornetzer HR, 2003, CAN J ZOOL, V81, P1755, DOI 10.1139/Z03-150	52	64	66	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83645	10.1371/journal.pone.0083645	http://dx.doi.org/10.1371/journal.pone.0083645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421898	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500062
J	Hernandez, I; Preston, JL; Hepler, J				Hernandez, Ivan; Preston, Jesse Lee; Hepler, Justin			Timescale Halo: Average-Speed Targets Elicit More Positive and Less Negative Attributions than Slow or Fast Targets	PLOS ONE			English	Article							POINT-LIGHT DISPLAYS; INTERPERSONAL-ATTRACTION; PERCEPTION; JUDGMENT; EMOTION; MOTION; MODELS; BEAUTY; CUES; MIND	Research on the timescale bias has found that observers perceive more capacity for mind in targets moving at an average speed, relative to slow or fast moving targets. The present research revisited the timescale bias as a type of halo effect, where normal-speed people elicit positive evaluations and abnormal-speed (slow and fast) people elicit negative evaluations. In two studies, participants viewed videos of people walking at a slow, average, or fast speed. We find evidence for a timescale halo effect: people walking at an average-speed were attributed more positive mental traits, but fewer negative mental traits, relative to slow or fast moving people. These effects held across both cognitive and emotional dimensions of mind and were mediated by overall positive/negative ratings of the person. These results suggest that, rather than eliciting greater perceptions of general mind, the timescale bias may reflect a generalized positivity toward average speed people relative to slow or fast moving people.	[Hernandez, Ivan; Preston, Jesse Lee; Hepler, Justin] Univ Illinois, Dept Psychol, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Hernandez, I (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL USA.	hernan27@illinois.edu		Preston, Jesse/0000-0003-1708-221X				ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Barrett HC, 2005, EVOL HUM BEHAV, V26, P313, DOI 10.1016/j.evolhumbehav.2004.08.015; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bobko P, 2007, ORGAN RES METHODS, V10, P689, DOI 10.1177/1094428106294734; BYRNE D, 1961, J ABNORM SOC PSYCH, V62, P713, DOI 10.1037/h0044721; BYRNE D, 1967, J PERS SOC PSYCHOL, V5, P82, DOI 10.1037/h0021198; Cikara M, 2011, CURR DIR PSYCHOL SCI, V20, P149, DOI 10.1177/0963721411408713; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; EFRAN MG, 1974, J RES PERS, V8, P45, DOI 10.1016/0092-6566(74)90044-0; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; FISKE ST, 1980, J PERS SOC PSYCHOL, V38, P889, DOI 10.1037/0022-3514.38.6.889; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Koenig MA, 2011, CHILD DEV, V82, P1634, DOI 10.1111/j.1467-8624.2011.01618.x; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; LANDY D, 1974, J PERS SOC PSYCHOL, V29, P299, DOI 10.1037/h0036018; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Morewedge CK, 2007, J PERS SOC PSYCHOL, V93, P1, DOI 10.1037/0022-3514.93.1.1; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Prentice DA, 2010, MIND CONTEXT, P259; Roese NJ, 2007, PERSPECT PSYCHOL SCI, V2, P124, DOI 10.1111/j.1745-6916.2007.00033.x; ROSENBER.S, 1968, J PERS SOC PSYCHOL, V9, P283, DOI 10.1037/h0026086; SCHACHTER S, 1951, J ABNORM SOC PSYCH, V46, P190, DOI 10.1037/h0062326; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Tremoulet PD, 2000, PERCEPTION, V29, P943, DOI 10.1068/p3101; Waytz A, 2010, J PERS SOC PSYCHOL, V99, P410, DOI 10.1037/a0020240	31	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83320	10.1371/journal.pone.0083320	http://dx.doi.org/10.1371/journal.pone.0083320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421882	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500042
J	Jang, JY; Choi, YW; Kim, HN; Kim, YR; Hong, JW; Bae, DW; Park, SJ; Shin, HK; Choi, BT				Jang, Ji Yeon; Choi, Young Whan; Kim, Ha Neui; Kim, Yu Ri; Hong, Jin Woo; Bae, Dong Won; Park, Se Jin; Shin, Hwa Kyoung; Choi, Byung Tae			Neuroprotective Effects of a Novel Single Compound 1-Methoxyoctadecan-1-ol Isolated from Uncaria sinensis in Primary Cortical Neurons and a Photothrombotic Ischemia Model	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE STEP; EXTRASYNAPTIC NMDA RECEPTORS; CEREBRAL-ISCHEMIA; NITRIC-OXIDE; MOUSE MODEL; CELL-DEATH; P38 MAPK; ACTIVATION; EXCITOTOXICITY; DISORDERS	We identified a novel neuroprotective compound, 1-methoxyoctadecan-1-ol, from Uncaria sinensis (Oliv.) Havil and investigated its effects and mechanisms in primary cortical neurons and in a photothrombotic ischemic model. In primary rat cortical neurons against glutamate-induced neurotoxicity, pretreatment with 1-methoxyoctadecan-1-ol resulted in significantly reduced neuronal death in a dose-dependent manner. In addition, treatment with 1-methoxyoctadecan-1-ol resulted in decreased neuronal apoptotic death, as assessed by nuclear morphological approaches. To clarify the neuroprotective mechanism of 1-methoxyoctadecan-1-ol, we explored the downstream signaling pathways of N-methyl-D-aspartate receptor (NMDAR) with calpain activation. Treatment with glutamate leads to early activation of NMDAR, which in turn leads to calpain-mediated cleavage of striatal-enriched protein tyrosine phosphatase (STEP) and subsequent activation of p38 mitogen activated protein kinase (MAPK). However, pretreatment with 1-methoxyoctadecan-1-ol resulted in significantly attenuated activation of GluN2B-NMDAR and a decrease in calpain-mediated STEP cleavage, leading to subsequent attenuation of p38 MAPK activation. We confirmed the critical role of p38 MAPK in neuroprotective effects of 1-methoxyoctadecan-1-ol using specific inhibitor SB203580. In the photothrombotic ischemic injury in mice, treatment with 1-methoxyoctadecan-1-ol resulted in significantly reduced infarct volume, edema size, and improved neurological function. 1-methoxyoctadecan-1-ol effectively prevents cerebral ischemic damage through down-regulation of calpain-mediated STEP cleavage and activation of p38 MAPK. These results suggest that 1-methoxyoctadecan-1-ol showed neuroprotective effects through down-regulation of calpain-mediated STEP cleavage with activation of GluN2B-NMDAR, and subsequent alleviation of p38 MAPK activation. In addition, 1-methoxyoctadecan-1-ol might be a useful therapeutic agent for brain disorder such as ischemic stroke.	[Jang, Ji Yeon; Shin, Hwa Kyoung; Choi, Byung Tae] Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea; [Choi, Young Whan; Park, Se Jin] Pusan Natl Univ, Coll Nat Resource & Life Sci, Dept Hort Biosci, Miryang, Gyeongnam, South Korea; [Kim, Ha Neui; Kim, Yu Ri; Choi, Byung Tae] Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, Gyeongnam, South Korea; [Hong, Jin Woo] Pusan Natl Univ, Sch Korean Med, Div Clin Med 1, Yangsan, Gyeongnam, South Korea; [Bae, Dong Won] Gyeongsang Natl Univ, Biomat Analyt Lab, Cent Instrument Facil, Jinju, Gyeongnam, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University; Gyeongsang National University	Shin, HK (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea.	julie@pusan.ac.kr; choibt@pusan.ac.kr	Choi, Young-Whan/AAO-4826-2021	Kim, Haneui/0000-0002-5651-4727	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0022151]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0022151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asomugha CO, 2010, J NEUROCHEM, V112, P214, DOI 10.1111/j.1471-4159.2009.06447.x; Braithwaite SP, 2008, EUR J NEUROSCI, V27, P2444, DOI 10.1111/j.1460-9568.2008.06209.x; Bult A, 1997, EUR J CELL BIOL, V72, P337; CHOI DW, 1987, J NEUROSCI, V7, P369; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Fan J, 2012, NEUROBIOL DIS, V45, P999, DOI 10.1016/j.nbd.2011.12.019; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Gladding CM, 2012, HUM MOL GENET, V21, P3739, DOI 10.1093/hmg/dds154; Goebel-Goody SM, 2012, PHARMACOL REV, V64, P65, DOI 10.1124/pr.110.003053; Gurd JW, 1999, J NEUROCHEM, V73, P1990; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Jang JY, 2012, INT J MOL MED, V30, P1465, DOI 10.3892/ijmm.2012.1134; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Lin YW, 2011, J ETHNOPHARMACOL, V135, P313, DOI 10.1016/j.jep.2011.03.018; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1999, METH MOL B, V128, P121; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Mulholland PJ, 2008, NEUROSCIENCE, V151, P419, DOI 10.1016/j.neuroscience.2007.11.001; Nguyen TH, 1999, J NEUROCHEM, V73, P1995; Nicotera P, 1997, Adv Neurol, V72, P95; Park SH, 2011, J ETHNOPHARMACOL, V138, P774, DOI 10.1016/j.jep.2011.10.026; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2010, J NEUROCHEM, V114, P1107, DOI 10.1111/j.1471-4159.2010.06835.x; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Qiu S, 2011, SEMIN CELL DEV BIOL, V22, P521, DOI 10.1016/j.semcdb.2011.06.003; Shimada Y, 1999, J PHARM PHARMACOL, V51, P715, DOI 10.1211/0022357991772853; Shimada Y, 2001, AM J CHINESE MED, V29, P173, DOI 10.1142/S0192415X01000198; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soriano FX, 2007, J PHYSIOL-LONDON, V584, P381, DOI 10.1113/jphysiol.2007.138875; Suk K, 2002, LIFE SCI, V70, P2467, DOI 10.1016/S0024-3205(02)01534-5; Tan SN, 2011, TALANTA, V83, P891, DOI 10.1016/j.talanta.2010.10.048; Tu HJ, 2010, J NEUROSCI, V30, P749, DOI 10.1523/JNEUROSCI.2343-09.2010; Volbracht C, 2005, J NEUROCHEM, V93, P1280, DOI 10.1111/j.1471-4159.2005.03122.x; Watanabe H, 2003, PHARMACOL BIOCHEM BE, V75, P635, DOI 10.1016/S0091-3057(03)00109-6; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yang JL, 2011, MECH AGEING DEV, V132, P405, DOI 10.1016/j.mad.2011.06.005; Zhou JY, 2010, J ETHNOPHARMACOL, V132, P15, DOI 10.1016/j.jep.2010.08.041	41	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85322	10.1371/journal.pone.0085322	http://dx.doi.org/10.1371/journal.pone.0085322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416390	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500239
J	Zhao, DY; Han, LS; He, ZJ; Zhang, J; Zhang, YJ				Zhao, Dongying; Han, Lianshu; He, Zhengjuan; Zhang, Jun; Zhang, Yongjun			Identification of the Plasma Metabolomics as Early Diagnostic Markers between Biliary Atresia and Neonatal Hepatitis Syndrome	PLOS ONE			English	Article							CHOLESTATIC JAUNDICE; INFANTS; BIOMARKERS; ACCURACY; CHILDREN; DISEASE; AMINO	Early detection is the most effective way to improve the clinical outcome of biliary atresia (BA). Emerging metabolomics provides a powerful platform for discovering novel biomarkers and biochemical pathways to improve early diagnosis. The aim of this study is to find the potential biomarkers to distinguish BA from neonatal hepatitis syndrome (NHS) by using a metabolomics method. We comprehensively analyzed the serum metabolites in a total of 124 blood samples from patients with BA or neonatal hepatitis syndrome (NHS) and from normal individuals using advanced metabolomic approaches, and found that the levels of glutarylcarnitine (C5DC) significantly increased in the BA group while the levels of threonine (Thr) significantly rose in the NHS group comparing with the other groups. The levels of glutamic acid (Glu) in the BA group were significantly elevated compared to those in the NHS group, but still lower than the hyperbilirubinemia and normal controls. The levels of propionyl carnitine (C3), isovaleryl carnitine (C5) and glutamine (Gln) were reduced in the BA group compared to those in the NHS group, but still higher than the hyperbilirubinemia and normal controls. This study demonstrates the possibility of metabolomics as non-invasive biomarkers for the early detection of BA and also provides new insight into pathophysiologic mechanisms for BA.	[Zhao, Dongying; Han, Lianshu; He, Zhengjuan; Zhang, Jun; Zhang, Yongjun] Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Jun; Zhang, Yongjun] MOE, Shanghai, Peoples R China; [Zhang, Jun; Zhang, Yongjun] Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhang, YJ (corresponding author), Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Shanghai 200030, Peoples R China.	zhangyongjun@sjtu.edu.cn	Zhao, Doreen/HHN-5678-2022		Shanghai Natural Science Foundation [11ZR1423800]; Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine; Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine; Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	This work was supported by the Shanghai Natural Science Foundation (No. 11ZR1423800), the Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital (to Y. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Baumann U, 2012, CLIN RES HEPATOL GAS, V36, P257, DOI 10.1016/j.clinre.2012.03.017; BYRD DJ, 1993, EUR J CLIN CHEM CLIN, V31, P197; Chardot C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-28; Dutta M, 2012, MOL BIOSYST, V8, P3281, DOI 10.1039/c2mb25353d; Esmaili J, 2007, ABDOM IMAGING, V32, P243, DOI 10.1007/s00261-006-9049-4; Feldman AG, 2012, SEMIN PEDIATR SURG, V21, P192, DOI 10.1053/j.sempedsurg.2012.05.003; Fleming KE, 2013, LIVER INT, V33, P525, DOI 10.1111/liv.12099; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Jimenez-Rivera C, 2013, J PEDIATR GASTR NUTR, V56, P344, DOI 10.1097/MPG.0b013e318282a913; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kianifar HR, 2013, PEDIATR RADIOL, V43, P905, DOI 10.1007/s00247-013-2623-3; Krahenbuhl S, 2000, HEPATOLOGY, V31, P1217, DOI 10.1053/jhep.2000.8105; Couce ML, 2013, EUR J PAEDIATR NEURO, V17, P383, DOI 10.1016/j.ejpn.2013.01.003; Mack CL, 2012, SEMIN LIVER DIS, V32, P307, DOI 10.1055/s-0032-1329899; Moyer V, 2004, J PEDIATR GASTR NUTR, V39, P115, DOI 10.1097/00005176-200408000-00001; Mushtaq I, 1999, BRIT MED J, V319, P471, DOI 10.1136/bmj.319.7208.471; Noto A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/612032; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013; Selimoglu MA, 2001, PEDIATR INT, V43, P391, DOI 10.1046/j.1442-200X.2001.01423.x; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Szavay PO, 2002, EUR J PEDIATR SURG, V12, P248, DOI 10.1055/s-2002-34477; Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130; Xu FG, 2011, MASS SPECTROM REV, V30, P1143, DOI 10.1002/mas.20316; Yang JG, 2009, CLIN IMAG, V33, P439, DOI 10.1016/j.clinimag.2009.01.003; Zabiegaj-Zwick C, 2012, SAMJ S AFR MED J, V102, P890, DOI 10.7196/SAMJ.6163; Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhou KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049270; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	33	15	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85694	10.1371/journal.pone.0085694	http://dx.doi.org/10.1371/journal.pone.0085694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416443	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500263
J	de Vries, G; Hees, HL; Koeter, MWJ; Lagerveld, SE; Schene, AH				de Vries, Gabe; Hees, Hiske L.; Koeter, Maarten W. J.; Lagerveld, Suzanne E.; Schene, Aart H.			Perceived Impeding Factors for Return-to-Work after Long-Term Sickness Absence Due to Major Depressive Disorder: A Concept Mapping Approach	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; SUPPORTED EMPLOYMENT; INDIVIDUAL PLACEMENT; LISTED EMPLOYEES; LOW-BACK; HEALTH; DISABILITY; PREDICTORS; GENERALIZABILITY; REHABILITATION	Objective: The purpose of the present study was to explore various stakeholder perspectives regarding factors that impede return-to-work (RTW) after long-term sickness absence related to major depressive disorder (MDD). Methods: Concept mapping was used to explore employees', supervisors' and occupational physicians' perspectives on these impeding factors. Results: Nine perceived themes, grouped in three meta-clusters were found that might impede RTW: Person, (personality / coping problems, symptoms of depression and comorbid (health) problems, employee feels misunderstood, and resuming work too soon), Work (troublesome work situation, too little support at work, and too little guidance at work) and Healthcare (insufficient mental healthcare and insufficient care from occupational physician). All stakeholders regarded personality/coping problems and symptoms of depression as the most important impeding theme. In addition, supervisors emphasized the importance of mental healthcare underestimating the importance of the work environment, while occupational physicians stressed the importance of the lack of safety and support in the work environment. Conclusions: In addition to the reduction of symptoms, more attention is needed on coping with depressive symptoms and personality problems in the work environment support in the work environment and for RTW in mental healthcare, to prevent long term sickness absence.	[de Vries, Gabe; Koeter, Maarten W. J.; Schene, Aart H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, NL-1105 AZ Amsterdam, Netherlands; [Hees, Hiske L.] Pro Persona, Program Mood Disorders, Arnhem, Netherlands; [Lagerveld, Suzanne E.] TNO Work & Employment, Hoofddorp, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Organization Applied Science Research	de Vries, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	Gabe.deVries@amc.uva.nl	Schene, A.H./H-8085-2014	Schene, A.H./0000-0002-1756-3235				Ajitha EA, 2017, THESIS KARNATAK U; Andersen MF, 2012, SCAND J WORK ENV HEA, V38, P93, DOI 10.5271/sjweh.3257; Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; [Anonymous], 2012, OECD SICK JOB MYTHS, DOI DOI 10.1787/9789264124523-EN; Blank L, 2008, J OCCUP REHABIL, V18, P27, DOI 10.1007/s10926-008-9121-8; Bond GR, 2012, WORLD PSYCHIATRY, V11, P32, DOI 10.1016/j.wpsyc.2012.01.005; Bonde JP, 2008, OCCUP ENVIRON MED, V65, P38; Briand C, 2008, J OCCUP REHABIL, V18, P207, DOI 10.1007/s10926-008-9128-1; Bultmann U, 2008, EUR J PUBLIC HEALTH, V18, P232, DOI 10.1093/eurpub/ckm132; Cornelius LR, 2011, J OCCUP REHABIL, V21, P259, DOI 10.1007/s10926-010-9261-5; D'Amato A, 2010, J OCCUP ENVIRON MED, V52, P67, DOI 10.1097/JOM.0b013e3181c75291; de Vries G, 2012, J AFFECT DISORDERS, V136, P1017, DOI 10.1016/j.jad.2011.06.035; Dekkers-Sanchez PM, 2011, SCAND J WORK ENV HEA, V37, P481, DOI 10.5271/sjweh.3173; Elinson L, 2004, PSYCHIAT SERV, V55, P29, DOI 10.1176/appi.ps.55.1.29; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; Franche RL, 2002, J OCCUP REHABIL, V12, P233, DOI 10.1023/A:1020270407044; Glozier N, 2002, OCCUP ENVIRON MED, V59, P714, DOI 10.1136/oem.59.10.714; Goetzel RZ, 2002, J OCCUP ENVIRON MED, V44, P320, DOI 10.1097/00043764-200204000-00012; Hansson E, 2006, EUR SPINE J, V15, P780, DOI 10.1007/s00586-004-0863-5; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Hees HL, 2013, OCCUP ENVIRON MED, V70, P252, DOI 10.1136/oemed-2012-100789; Hees Hiske L, 2012, J Clin Psychiatry, V73, pe1048, DOI 10.4088/JCP.12m07699; Hees HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039947; Hensing G, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-19; Huijs JJJM, 2012, J OCCUP REHABIL, V22, P301, DOI 10.1007/s10926-011-9351-z; International Classification of Functioning Disability and Health, 2001, ICF FULL VERS; Kane M, 2007, CONCEPT MAPPING PLAN; Koopmans PC, 2008, INT ARCH OCC ENV HEA, V81, P711, DOI 10.1007/s00420-007-0243-7; Lagerveld SE, 2010, J OCCUP REHABIL, V20, P275, DOI 10.1007/s10926-009-9224-x; Lagerveld SE, 2012, J OCCUP HEALTH PSYCH, V17, P220, DOI 10.1037/a0027049; Latimer EA, 2006, BRIT J PSYCHIAT, V189, P65, DOI 10.1192/bjp.bp.105.012641; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Lerner D, 2008, J OCCUP ENVIRON MED, V50, P401, DOI 10.1097/JOM.0b013e31816bae50; MacEachen E, 2006, SCAND J WORK ENV HEA, V32, P257, DOI 10.5271/sjweh.1009; Michon HWC, 2008, PSYCHOL MED, V38, P1627, DOI 10.1017/S0033291707002449; Nabitz U, 2005, INT J QUAL HEALTH C, V17, P193, DOI 10.1093/intqhc/mzi037; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Nielsen MBD, 2012, DISABIL REHABIL, V34, P1311, DOI 10.3109/09638288.2011.641664; Nielsen MBD, 2011, EUR J PUBLIC HEALTH, V21, P806, DOI 10.1093/eurpub/ckq171; Nieuwenhuijsen K, 2006, SCAND J WORK ENV HEA, V32, P67, DOI 10.5271/sjweh.978; Nieuwenhuijsen K, 2008, Cochrane Database Syst Rev, pCD006237, DOI 10.1002/14651858.CD006237.pub2; Noordik E, 2011, DISABIL REHABIL, V33, P1625, DOI 10.3109/09638288.2010.541547; O'Neil A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-95; Roelen CAM, 2012, J OCCUP REHABIL, V22, P409, DOI 10.1007/s10926-012-9363-3; Rosas SR, 2012, EVAL PROGRAM PLANN, V35, P236, DOI 10.1016/j.evalprogplan.2011.10.003; Schuring M, 2011, J EPIDEMIOL COMMUN H, V65, P639, DOI 10.1136/jech.2009.103838; Severens P., 1995, HDB CONCEPT MAPPING; Southern DM, 1998, AUST FAM PHYSICIAN, V28, pS35; Spijker J, 2004, ACTA PSYCHIAT SCAND, V110, P208, DOI 10.1111/j.1600-0447.2004.00335.x; van der Werff E, 2010, J AFFECT DISORDERS, V127, P203, DOI 10.1016/j.jad.2010.05.024; Vlasveld MC, 2012, J OCCUP REHABIL, V22, P118, DOI 10.1007/s10926-011-9326-0; Vlasveld MC, 2013, J OCCUP REHABIL, V23, P309, DOI 10.1007/s10926-012-9406-9; Waddell G, 2005, BEST PRACT RES CL RH, V19, P655, DOI 10.1016/j.berh.2005.03.008; Wang PS, 2004, AM J PSYCHIAT, V161, P1885, DOI 10.1176/appi.ajp.161.10.1885; Williams Renee M, 2002, Work, V19, P87	55	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85038	10.1371/journal.pone.0085038	http://dx.doi.org/10.1371/journal.pone.0085038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454786	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100051
J	Hu, KD; Wang, Q; Hu, LY; Gao, SP; Wu, J; Li, YH; Zheng, JL; Han, Y; Liu, YS; Zhang, H				Hu, Kang-Di; Wang, Qian; Hu, Lan-Ying; Gao, Shuai-Ping; Wu, Jun; Li, Yan-Hong; Zheng, Ji-Lian; Han, Yi; Liu, Yong-Sheng; Zhang, Hua			Hydrogen Sulfide Prolongs Postharvest Storage of Fresh-Cut Pears (Pyrus pyrifolia) by Alleviation of Oxidative Damage and Inhibition of Fungal Growth	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; SHORT-TERM EXPOSURE; NITRIC-OXIDE; ANTIOXIDANT ACTIVITY; POLYPHENOL OXIDASE; STRAWBERRY FRUIT; GENE-EXPRESSION; SALICYLIC-ACID; ASCORBIC-ACID; APPLE SLICES	Hydrogen sulfide (H2S) has proved to be a multifunctional signaling molecule in plants and animals. Here, we investigated the role of H2S in the decay of fresh-cut pears (Pyrus pyrifolia). H2S gas released by sodium hydrosulfide (NaHS) prolonged the shelf life of fresh-cut pear slices in a dose-dependent manner. Moreover, H2S maintained higher levels of reducing sugar and soluble protein in pear slices. H2S significantly reduced the accumulation of hydrogen peroxide (H2O2), superoxide radicals (center dot O-2(-)) and malondialdehyde (MDA). Further investigation showed that H2S fumigation up-regulated the activities of antioxidant enzymes ascorbate peroxidase (APX), catalase (CAT), and guaiacol peroxidase (POD), while it down-regulated those of lipoxygenase (LOX), phenylalanine ammonia lyase (PAL) and polyphenol oxidase (PPO). Furthermore, H2S fumigation effectively inhibited the growth of two fungal pathogens of pear, Aspergillus niger and Penicillium expansum, suggesting that H2S can be developed as an effective fungicide for postharvest storage. The present study implies that H2S is involved in prolonging postharvest storage of pears by acting as an antioxidant and fungicide.	[Hu, Kang-Di; Wang, Qian; Hu, Lan-Ying; Gao, Shuai-Ping; Li, Yan-Hong; Zheng, Ji-Lian; Han, Yi; Liu, Yong-Sheng; Zhang, Hua] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China; [Wu, Jun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Hefei University of Technology; Nanjing Agricultural University	Zhang, H (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China.	hzhanglab@gmail.com	li, yan/GTI-4638-2022; Han, Yi/AAS-8007-2021; Han, Yi/GQP-5513-2022; Han, Yi/AAV-8691-2021	Han, Yi/0000-0002-4424-1485; Han, Yi/0000-0002-4424-1485	National Natural Science Foundation of China [31271803, 31301820, 31300133]; Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, SEM); Natural Science Foundations of Anhui Province [11040606M85]; Anhui Provincial Education Department [2012AJZR0028, ZD200910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, SEM)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundations of Anhui Province; Anhui Provincial Education Department	This work was financially supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm, project number 31271803, 31301820, 31300133), the Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, SEM), the Natural Science Foundations of Anhui Province (11040606M85), and the Anhui Provincial Education Department (2012AJZR0028, ZD200910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo E, 2010, POSTHARVEST BIOL TEC, V57, P52, DOI 10.1016/j.postharvbio.2010.03.001; Alvarez C, 2012, PLANT CELL, V24, P4621, DOI 10.1105/tpc.112.105403; Ayala-Zavala JF, 2004, LEBENSM-WISS TECHNOL, V37, P687, DOI 10.1016/j.lwt.2004.03.002; BEAUDOINEAGAN LD, 1985, PLANT PHYSIOL, V78, P438, DOI 10.1104/pp.78.3.438; BENJAMIN ND, 1973, J FOOD SCI, V38, P799, DOI 10.1111/j.1365-2621.1973.tb02079.x; Bloem E, 2004, J EXP BOT, V55, P2305, DOI 10.1093/jxb/erh236; Bonghi C, 1999, POSTHARVEST BIOL TEC, V16, P213, DOI 10.1016/S0925-5214(99)00028-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng GP, 2009, J AGR FOOD CHEM, V57, P5799, DOI 10.1021/jf901173n; Ding ZS, 2007, PHYSIOL PLANTARUM, V130, P112, DOI 10.1111/j.1399-3054.2007.00893.x; Duan XW, 2007, J HORTIC SCI BIOTECH, V82, P467, DOI 10.1080/14620316.2007.11512260; Flores FB, 2008, EUR FOOD RES TECHNOL, V227, P1599, DOI 10.1007/s00217-008-0884-0; Fonseca S, 2004, PLANT SCI, V167, P457, DOI 10.1016/j.plantsci.2004.03.033; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Gupta SM, 2006, POSTHARVEST BIOL TEC, V42, P16, DOI 10.1016/j.postharvbio.2006.05.002; Haneklaus S, 2007, MINERAL ELEMENTS PLA; Hernandez-Munoz P, 2008, FOOD CHEM, V110, P428, DOI 10.1016/j.foodchem.2008.02.020; Hodges DM, 2008, POSTHARVEST BIOL TEC, V48, P155, DOI 10.1016/j.postharvbio.2007.10.016; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; Lana MM, 2006, FOOD CHEM, V97, P203, DOI 10.1016/j.foodchem.2005.03.037; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; MARSH R. W., 1929, JOUR POMOLOGY & HORT SCI, V7, P237; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mishra BB, 2013, FOOD CHEM, V139, P105, DOI 10.1016/j.foodchem.2013.01.074; Nguyen TBT, 2003, POSTHARVEST BIOL TEC, V30, P187, DOI 10.1016/S0925-5214(03)00103-0; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Oms-Oliu G, 2008, POSTHARVEST BIOL TEC, V50, P87, DOI 10.1016/j.postharvbio.2008.03.005; Oms-Oliu G, 2008, FOOD CHEM, V106, P1085, DOI 10.1016/j.foodchem.2007.07.040; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Pristijono P, 2006, POSTHARVEST BIOL TEC, V42, P256, DOI 10.1016/j.postharvbio.2006.07.006; Raseetha S, 2013, FOOD CHEM, V138, P1360, DOI 10.1016/j.foodchem.2012.09.126; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Reyes LF, 2007, FOOD CHEM, V101, P1254, DOI 10.1016/j.foodchem.2006.03.032; Riemenschneider A, 2005, PLANT PHYSIOL BIOCH, V43, P473, DOI 10.1016/j.plaphy.2005.04.001; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; Singh R, 2008, FOOD CHEM, V111, P951, DOI 10.1016/j.foodchem.2008.05.011; SURREY K, 1964, PLANT PHYSIOL, V39, P65, DOI 10.1104/pp.39.1.65; Vicente AR, 2006, POSTHARVEST BIOL TEC, V40, P116, DOI 10.1016/j.postharvbio.2005.12.012; Villalobos-Acuna M, 2008, POSTHARVEST BIOL TEC, V49, P187, DOI 10.1016/j.postharvbio.2008.03.003; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2009, J INTEGR PLANT BIOL, V51, P1086, DOI 10.1111/j.1744-7909.2009.00885.x; Zheng XD, 2007, POSTHARVEST BIOL TEC, V45, P221, DOI 10.1016/j.postharvbio.2007.03.001; Zhu LQ, 2009, FOOD CHEM, V114, P174, DOI 10.1016/j.foodchem.2008.09.036; Zhu SH, 2007, FOOD CHEM, V100, P1517, DOI 10.1016/j.foodchem.2005.12.022	52	54	63	6	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85524	10.1371/journal.pone.0085524	http://dx.doi.org/10.1371/journal.pone.0085524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454881	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100095
J	Lee, CG; McCarthy, S; Gruidl, M; Timme, C; Yeatman, TJ				Lee, Chang Gong; McCarthy, Susan; Gruidl, Mike; Timme, Cindy; Yeatman, Timothy J.			MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; E-CADHERIN; MIR-200 FAMILY; GEFITINIB RESISTANCE; TARGETED THERAPY; REPRESSORS ZEB1; EMT; PATHWAY; PROGRESSION	Background: The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer progression and may promote resistance to therapy. An analysis of patients (n = 71) profiled with both gene expression and a global microRNA assessment (similar to 415 miRs) identified miR-147 as highly anti-correlated with an EMT gene expression signature score and postulated to reverse EMT (MET). Methods and Findings: miR-147 was transfected into colon cancer cells (HCT116, SW480) as well as lung cancer cells (A-549). The cells were assessed for morphological changes, and evaluated for effects on invasion, motility, and the expression of key EMT markers. Resistance to chemotherapy was evaluated by treating cells with gefitinib, an EGFR inhibitor. The downstream genes regulated by miR-147 were assayed using the Affymetrix GeneChip U133 Plus2.0 platform. miR-147 was identified to: 1. cause MET primarily by increasing the expression of CDH1 and decreasing that of ZEB1; 2. inhibit the invasion and motility of cells; 3. cause G1 arrest by up-regulating p27 and down-regulating cyclin D1. miR-147 also dramatically reversed the native drug resistance of the colon cancer cell line HCT116 to gefitinib. miR-147 significantly repressed Akt phosphorylation, and knockdown of Akt with siRNA induced MET. The morphologic effects of miR-147 on cells appear to be attenuated by TGF-B1, promoting a plastic and reversible transition between MET and EMT. Conclusion: miR-147 induced cancer cells to undergo MET and induced cell cycle arrest, suggesting a potential tumor suppressor role. miR-147 strikingly increased the sensitivity to EGFR inhibitor, gefitinib in cell with native resistance. We conclude that miR-147 might have therapeutic potential given its ability to inhibit proliferation, induce MET, as well as reverse drug sensitivity.	[Lee, Chang Gong; Yeatman, Timothy J.] Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA; [McCarthy, Susan; Gruidl, Mike; Timme, Cindy] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Yeatman, TJ (corresponding author), Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA.	jharvey@gibbscc.org			 [1U01CA157960-01A1]; NATIONAL CANCER INSTITUTE [U01CA157960] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant 1U01CA157960-01A1, www.cancer.gov http://report.nih.gov/award/index.cfm?ot=&fy=2012&state=FL&ic=N-CI&fm=&orgid=3736101&distr=&rfa=&pid=6418154#tab5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri RR, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-143; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birnbaum Ariel, 2005, Curr Treat Options Oncol, V6, P75, DOI 10.1007/s11864-005-0015-0; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bullock MD, 2012, BIOL CELL, V104, P3, DOI 10.1111/boc.201100115; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harazono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062757; Jain A, 2005, P NATL ACAD SCI USA, V102, P11858, DOI 10.1073/pnas.0502113102; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Koizumi F, 2004, INT J CANCER, V108, P464, DOI 10.1002/ijc.11539; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosaka T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165214; Kwon TK, 1997, BIOCHEM BIOPH RES CO, V238, P534, DOI 10.1006/bbrc.1997.7335; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Li J, 2000, WORLD J GASTROENTERO, V6, P513; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Maseki S, 2012, BRIT J CANCER, V106, P1196, DOI 10.1038/bjc.2012.24; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Semb H, 1998, AM J HUM GENET, V63, P1588, DOI 10.1086/302173; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; UMBAS R, 1994, CANCER RES, V54, P3929; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xia H, 2012, CANCER GENE THER, V19, P723, DOI 10.1038/cgt.2012.58; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107	43	76	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84597	10.1371/journal.pone.0084597	http://dx.doi.org/10.1371/journal.pone.0084597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454732	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100026
J	Untawale, S; Odegaard, AO; Koh, WP; Jin, AZ; Yuan, JM; Anderson, KE				Untawale, Seema; Odegaard, Andrew O.; Koh, Woon-Puay; Jin, Ai Zhen; Yuan, Jian-Min; Anderson, Kristin E.			Body Mass Index and Risk of Pancreatic Cancer in a Chinese Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SMOKING STATUS; OLDER CHINESE; OBESITY; SINGAPORE; HEALTH; DIETARY; WEIGHT; COHORT; METAANALYSIS	Few studies have examined the association between body mass index (BMI: kg/m(2)) and pancreatic cancer risk in Asian populations. We examined this relationship in 51,251 Chinese men and women aged 45-74 who enrolled between 1993 and 1998 in the population based, prospective Singapore Chinese Health Study. Data were collected through in-person interviews. By December 31, 2011, 194 cohort participants had developed pancreatic cancer. A Cox proportional hazards model was used to estimate hazard ratios (HR) and their 95% confidence intervals (95% CI). We hypothesized the association between BMI and pancreatic cancer risk may vary by smoking status (ever v. never) and there was evidence for this as the interaction between BMI and smoking status was significant (p = 0.018). Among ever smokers, being classified as underweight (BMI < 18.5 kg/m(2)), was associated with a significantly elevated risk of pancreatic cancer relative to smokers with a BMI of 21.5-24.4 kg/m(2) (HR = 1.99, 95% CI = 1.03-3.84). This association was strengthened after exclusion of the first three years of follow-up time. Among never smokers, there was no association between BMI and pancreatic cancer risk. However, after excluding pancreatic cancer cases and person-years in the first three years of follow-up, never smokers with a BMI >= 27.5 kg/m(2) showed a suggestive increased risk of pancreatic cancer relative to never smokers with a BMI of 21.5-24.4 kg/m(2) (HR = 1.75, 95% CI = 0.93-3.3). In conclusion, Singaporean Chinese who were underweight with a history of smoking had an increased risk of developing pancreatic cancer, whereas there was no significant association between BMI and pancreatic cancer in never smokers.	[Untawale, Seema; Odegaard, Andrew O.; Anderson, Kristin E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Jin, Ai Zhen] Hlth Promot Board, Natl Registry Dis Off, Singapore, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Untawale, Seema] Tacoma Pierce Cty Hlth Dept, Tacoma, WA USA; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Anderson, Kristin E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities	Odegaard, AO (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	odeg0025@umn.edu		Yuan, Jian-Min/0000-0002-4620-3108	NIH, USA [NCI RO1 CA055069, R35 CA053890, R01 CA080205, R01 CA098497, R01 CA144034]; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA080205, R35CA053890, R01CA055069, R01CA098497] Funding Source: NIH RePORTER	NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by 'NIH, USA (NCI RO1 CA055069, R35 CA053890, R01 CA080205, R01 CA098497 and R01 CA144034).' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berrington de Gonzalez A, 2003, NEW ENGL J MED, V348, P1625; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; CONOVER CA, 1992, J CLIN ENDOCR METAB, V74, P1355, DOI 10.1210/jc.74.6.1355; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Durazo-Arvizu RA, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.86; Edwards B. K., 2013, CANCER; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hart AR, 2008, CLIN GASTROENTEROL H, V6, P275, DOI 10.1016/j.cgh.2007.12.041; Hu FB, 2008, OBESITY EPIDEMIOLOGY, V1; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Jiao L, 2010, CANCER CAUSE CONTROL, V21, P1305, DOI 10.1007/s10552-010-9558-x; KLESGES RC, 1991, J CONSULT CLIN PSYCH, V59, P899, DOI 10.1037/0022-006X.59.6.899; Koh WP, 2005, J NUTR, V135, P2473, DOI 10.1093/jn/135.10.2473; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; Larsson SC, 2005, BRIT J CANCER, V93, P1310, DOI 10.1038/sj.bjc.6602868; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Lin Y, 2013, EUROPEAN J CANC PREV, V22, P244; Lin YS, 2007, INT J CANCER, V120, P2665, DOI 10.1002/ijc.22614; Lu XH, 2006, WORLD J GASTROENTERO, V12, P2229, DOI 10.3748/wjg.v12.i4.2229; Luo J, 2008, BRIT J CANCER, V99, P527, DOI 10.1038/sj.bjc.6604487; Luo JH, 2007, CANCER CAUSE CONTROL, V18, P603, DOI 10.1007/s10552-007-9002-z; Ma J, 2000, AM J CLIN NUTR, V71, P774, DOI 10.1093/ajcn/71.3.774; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Nothlings U, 2007, CANCER CAUSE CONTROL, V18, P165, DOI 10.1007/s10552-006-0100-0; Odegaard AO, 2011, DIABETES CARE, V34, P880, DOI 10.2337/dc10-2350; Olusi SO, 2002, INT J OBESITY, V26, P1159, DOI 10.1038/sj.ijo.0802066; Parkin D, 2002, CANC INCIDENCE 5 CON, VVIII, P155; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P459, DOI 10.1158/1055-9965.EPI-04-0583; PERKINS KA, 1989, NEW ENGL J MED, V320, P898, DOI 10.1056/NEJM198904063201404; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P135; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P775; Stevens RJ, 2009, INT J CANCER, V124, P2400, DOI 10.1002/ijc.24196; Stolzenberg-Solomon RZ, 2008, AM J EPIDEMIOL, V167, P586, DOI 10.1093/aje/kwm361; Stolzenberg-Solomon RZ, 2002, CANCER CAUSE CONTROL, V13, P417, DOI 10.1023/A:1015729615148; Stolzenberg-Solomon RZ, 2002, AM J EPIDEMIOL, V155, P783, DOI 10.1093/aje/155.9.783; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Wang MY, 1998, CANCER RES, V58, P38; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	50	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85149	10.1371/journal.pone.0085149	http://dx.doi.org/10.1371/journal.pone.0085149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454807	Green Published, gold			2022-12-27	WOS:000330235100057
J	Glazier, RH; Creatore, MI; Weyman, JT; Fazli, G; Matheson, FI; Gozdyra, P; Moineddin, R; Shriqui, VK; Booth, GL				Glazier, Richard H.; Creatore, Maria I.; Weyman, Jonathan T.; Fazli, Ghazal; Matheson, Flora I.; Gozdyra, Peter; Moineddin, Rahim; Shriqui, Vered Kaufman; Booth, Gillian L.			Density, Destinations or Both? A Comparison of Measures of Walkability in Relation to Transportation Behaviors, Obesity and Diabetes in Toronto, Canada	PLOS ONE			English	Article							BUILT ENVIRONMENT; PHYSICAL-ACTIVITY; LAND-USE; NEIGHBORHOOD WALKABILITY; RESIDENTIAL DENSITY; URBAN FORM; WALKING; PREVALENCE; ONTARIO; DESIGN	The design of suburban communities encourages car dependency and discourages walking, characteristics that have been implicated in the rise of obesity. Walkability measures have been developed to capture these features of urban built environments. Our objective was to examine the individual and combined associations of residential density and the presence of walkable destinations, two of the most commonly used and potentially modifiable components of walkability measures, with transportation, overweight, obesity, and diabetes. We examined associations between a previously published walkability measure and transportation behaviors and health outcomes in Toronto, Canada, a city of 2.6 million people in 2011. Data sources included the Canada census, a transportation survey, a national health survey and a validated administrative diabetes database. We depicted interactions between residential density and the availability of walkable destinations graphically and examined them statistically using general linear modeling. Individuals living in more walkable areas were more than twice as likely to walk, bicycle or use public transit and were significantly less likely to drive or own a vehicle compared with those living in less walkable areas. Individuals in less walkable areas were up to one-third more likely to be obese or to have diabetes. Residential density and the availability of walkable destinations were each significantly associated with transportation and health outcomes. The combination of high levels of both measures was associated with the highest levels of walking or bicycling (p<0.0001) and public transit use (p<0.0026) and the lowest levels of automobile trips (p<0.0001), and diabetes prevalence (p<0.0001). We conclude that both residential density and the availability of walkable destinations are good measures of urban walkability and can be recommended for use by policy-makers, planners and public health officials. In our setting, the combination of both factors provided additional explanatory power.	[Glazier, Richard H.; Creatore, Maria I.; Weyman, Jonathan T.; Fazli, Ghazal; Matheson, Flora I.; Gozdyra, Peter; Shriqui, Vered Kaufman; Booth, Gillian L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Glazier, Richard H.; Creatore, Maria I.; Matheson, Flora I.; Gozdyra, Peter; Moineddin, Rahim; Booth, Gillian L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Glazier, Richard H.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Glazier, Richard H.; Matheson, Flora I.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Glazier, Richard H.; Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Booth, Gillian L.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Glazier, RH (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	rick.glazier@ices.on.ca	Shriqui, Vered Kaufman/R-8657-2019	Shriqui, Vered Kaufman/0000-0003-3190-4187	Canadian Institutes of Health Research; Centre for Research on Inner City Health (CRICH) at St. Michael's Hospital; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for Research on Inner City Health (CRICH) at St. Michael's Hospital; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was funded by a research grant from the Canadian Institutes of Health Research. This study was supported by the Centre for Research on Inner City Health (CRICH) at St. Michael's Hospital and by the Institute for Clinical Evaluative Sciences (ICES), which are funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Booth GL, 2013, DIABETES CARE, V36, P302, DOI 10.2337/dc12-0777; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Data Management Group, 2013, INT DAT RETR SYST OV; Dygryn J, 2010, J HUM KINET, V24, P93, DOI 10.2478/v10078-010-0025-2; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Forsyth A, 2008, URBAN STUD, V45, P1973, DOI 10.1177/0042098008093386; Forsyth A, 2007, URBAN STUD, V44, P679, DOI 10.1080/00420980601184729; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Frank LD, 2008, PREV MED, V47, P172, DOI 10.1016/j.ypmed.2008.04.004; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Glazier RH, 2012, DEV VALIDATION URB W; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Institute for Clinical Evaluative Sciences, 2011, DO I ACC ICES DAT RE; Lee C, 2006, TRANSPORT RES D-TR E, V11, P204, DOI 10.1016/j.trd.2006.02.003; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; McCormack GR, 2008, PREV MED, V46, P33, DOI 10.1016/j.ypmed.2007.01.013; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Owen N, 2007, AM J PREV MED, V33, P387, DOI 10.1016/j.amepre.2007.07.025; Owen N, 2010, J URBAN HEALTH, V87, P189, DOI 10.1007/s11524-009-9424-x; Panter J, 2007, TACKLING OBESITIES F; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rodriguez DA, 2009, AM J PREV MED, V37, P397, DOI 10.1016/j.amepre.2009.07.008; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017; Statistics Canada, 2013, PUBL US MICR FIL PUM; Sugiyama T, 2012, MED SCI SPORT EXER, V44, P1275, DOI 10.1249/MSS.0b013e318247d286; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wilkins R, 2011, PCCF VERSION 5G USER; World Health Organization, 2013, URB POP GROWTH GLOB	42	113	113	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85295	10.1371/journal.pone.0085295	http://dx.doi.org/10.1371/journal.pone.0085295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292TQ	24454837	gold, Green Published			2022-12-27	WOS:000329925800035
J	Ju, L; Zhang, GL; Zhang, X; Jia, ZY; Gao, XJ; Jiang, Y; Yan, CL; Duerksen-Hughes, PJ; Chen, FF; Li, HJ; Zhu, XQ; Yang, J				Ju, Li; Zhang, Guanglin; Zhang, Xing; Jia, Zhenyu; Gao, Xiangjing; Jiang, Ying; Yan, Chunlan; Duerksen-Hughes, Penelope J.; Chen, Fanqing Frank; Li, Hongjuan; Zhu, Xinqiang; Yang, Jun			Proteomic Analysis of Cellular Response Induced by Multi-Walled Carbon Nanotubes Exposure in A549 Cells	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; DNA-DAMAGE; IN-VITRO; INTRATRACHEAL INSTILLATION; INFLAMMATORY RESPONSE; ACTIN CYTOSKELETON; OXIDATIVE STRESS; EPITHELIAL-CELLS; IMMUNE FUNCTION; HEAT-SHOCK	The wide application of multi-walled carbon nanotubes (MWCNT) has raised serious concerns about their safety on human health and the environment. However, the potential harmful effects of MWCNT remain unclear and contradictory. To clarify the potentially toxic effects of MWCNT and to elucidate the associated underlying mechanisms, the effects of MWCNT on human lung adenocarcinoma A549 cells were examined at both the cellular and the protein level. Cytotoxicity and genotoxicity were examined, followed by a proteomic analysis (2-DE coupled with LC-MS/MS) of the cellular response to MWCNT. Our results demonstrate that MWCNT induces cytotoxicity in A549 cells only at relatively high concentrations and longer exposure time. Within a relatively low dosage range (30 mg/ml) and short time period (24 h), MWCNT treatment does not induce significant cytotoxicity, cell cycle changes, apoptosis, or DNA damage. However, at these low doses and times, MWCNT treatment causes significant changes in protein expression. A total of 106 proteins show altered expression at various time points and dosages, and of these, 52 proteins were further identified by MS. Identified proteins are involved in several cellular processes including proliferation, stress, and cellular skeleton organization. In particular, MWCNT treatment causes increases in actin expression. This increase has the potential to contribute to increased migration capacity and may be mediated by reactive oxygen species (ROS).	[Ju, Li; Zhang, Guanglin; Gao, Xiangjing; Jiang, Ying; Yan, Chunlan; Yang, Jun] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Diag & Therapy,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ju, Li; Zhang, Guanglin; Gao, Xiangjing; Jiang, Ying; Yan, Chunlan; Zhu, Xinqiang] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Ju, Li; Zhang, Xing; Jia, Zhenyu] Zhejiang Acad Med Sci, Hangzhou, Zhejiang, Peoples R China; [Duerksen-Hughes, Penelope J.] Loma Linda Univ, Div Biochem, Dept Basic Sci, Sch Med, Loma Linda, CA USA; [Chen, Fanqing Frank] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Li, Hongjuan] Hangzhou Normal Univ, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Yang, Jun] Zhejiang Agr & Forestry Univ, Coll Biotechnol, Hangzhou, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang Academy of Medical Sciences; Loma Linda University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Hangzhou Normal University; Zhejiang A&F University	Zhu, XQ (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China.	zhuxq@zju.edu.cn; gastate@zju.edu.cn		Duerksen-Hughes, Penelope/0000-0002-0998-2157	National Natural Science Foundation of China [81172692, 81202241, 81373036, 81302398]; Provincial Natural Science Foundation [LY12H26006]; Zhejiang Provincial Department of Science and Technology [2013C14016]; Zhejiang Medical Support Plan in Discipline Construction [11ZC02]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation; Zhejiang Provincial Department of Science and Technology; Zhejiang Medical Support Plan in Discipline Construction; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by grants from the National Natural Science Foundation of China (No. 81172692, 81202241, 81373036 and 81302398; http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list); Zhejiang Provincial Natural Science Foundation (No. LY12H26006; http://www.zjnsf.gov.cn/); Zhejiang Provincial Department of Science and Technology (No. 2013C14016; http://www.zjkjt.gov.cn); and Zhejiang Medical Support Plan in Discipline Construction (11ZC02; http://www.zjwst.gov.cn/). JY is a recipient of the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (http://www.zjwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Chandel N, 2013, AM J PHYSIOL-RENAL, V304, pF1347, DOI 10.1152/ajprenal.00717.2012; Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Elgrabli D, 2008, TOXICOLOGY, V253, P131, DOI 10.1016/j.tox.2008.09.004; ENDO M, 1988, CHEMTECH, V18, P568; Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; Ghosh M, 2011, J HAZARD MATER, V197, P327, DOI 10.1016/j.jhazmat.2011.09.090; Gladwin KM, 2013, ADV HEALTHC MATER, V2, P728, DOI 10.1002/adhm.201200233; GOTLIEB AI, 1990, TOXICOL PATHOL, V18, P603; Guo YY, 2011, MUTAT RES-GEN TOX EN, V721, P184, DOI 10.1016/j.mrgentox.2011.01.014; Hamilton RF, 2007, NANOTOXICOLOGY, V1, P104, DOI 10.1080/17435390600926939; Haniu H, 2010, TOXICOL APPL PHARM, V242, P256, DOI 10.1016/j.taap.2009.10.015; He L, 2006, ANAL CHIM ACTA, V556, P1, DOI 10.1016/j.aca.2005.08.042; Hsieh HL, 2013, MOL NEUROBIOL; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Inoue K, 2009, TOXICOL APPL PHARM, V237, P306, DOI 10.1016/j.taap.2009.04.003; Ju L, 2013, MUTAT RES-GEN TOX EN, V753, P54, DOI 10.1016/j.mrgentox.2013.01.006; Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078; Kermanizadeh A, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-28; Kim JS, 2012, TOXICOL SCI, V128, P439, DOI 10.1093/toxsci/kfs161; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Lee JSY, 2003, HISTOL HISTOPATHOL, V18, P879, DOI 10.14670/HH-18.879; Liu D, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-361; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; McShan D, 2012, TOXICOL IND HEALTH; MEHLEN P, 1993, EUR J BIOCHEM, V215, P277, DOI 10.1111/j.1432-1033.1993.tb18032.x; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053633; Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21; Mercer RR, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-28; Mezencev R, 2013, ANTI-CANCER DRUG, V24, P504, DOI 10.1097/CAD.0b013e32836009d7; Mitchell LA, 2009, NAT NANOTECHNOL, V4, P451, DOI [10.1038/nnano.2009.151, 10.1038/NNANO.2009.151]; Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V53, P1123, DOI 10.1016/j.freeradbiomed.2012.05.036; Muller J, 2008, CARCINOGENESIS, V29, P427, DOI 10.1093/carcin/bgm243; Muller J, 2009, TOXICOL SCI, V110, P442, DOI 10.1093/toxsci/kfp100; Murr LE, 2004, J NANOPART RES, V6, P241, DOI 10.1023/B:NANO.0000034651.91325.40; Ni JX, 2013, FREE RADICAL BIO MED, V61, P26, DOI 10.1016/j.freeradbiomed.2013.03.012; Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057; Pacurari M, 2012, J TOXICOL ENV HEAL A, V75, P112, DOI [10.1080/15287394.2011.615110, 10.1080/15287394.2012.625549]; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Patel H, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-22; Patlolla A, 2010, ETHNIC DIS, V20; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Qian Y, 2010, J TOXICOL ENV HEAL A, V73, P819, DOI 10.1080/15287391003689317; Raffa V, 2010, NANOSCALE RES LETT, V5, P257, DOI 10.1007/s11671-009-9463-y; Ravichandran P, 2010, APOPTOSIS, V15, P1507, DOI 10.1007/s10495-010-0532-6; Reddy ARN, 2010, TOXICOLOGY, V272, P11, DOI 10.1016/j.tox.2010.03.017; Ryman-Rasmussen JP, 2009, AM J RESP CELL MOL, V40, P349, DOI 10.1165/rcmb.2008-0276OC; SHASBY DM, 1982, CIRC RES, V51, P657, DOI 10.1161/01.RES.51.5.657; Shen Zhen-zhou, 2010, Clinical Oncology and Cancer Research, V7, P7, DOI 10.1007/s11805-010-0007-0; Shibata A, 2013, BIOCHEM BIOPH RES CO, V433, P317, DOI 10.1016/j.bbrc.2013.02.100; Sneh A, 2013, BREAST CANCER RES TR, V138, P727, DOI 10.1007/s10549-013-2491-4; Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105; Tian FR, 2013, EUR J PHARM BIOPHARM, V84, P412, DOI 10.1016/j.ejpb.2013.03.008; Tretyakov YD, 2009, RUSS CHEM REV+, V78, P801, DOI 10.1070/RC2009v078n09ABEH004029; Ursini CL, 2012, TOXICOL IN VITRO, V26, P831, DOI 10.1016/j.tiv.2012.05.001; Vankoningsloo S, 2010, NANOTOXICOLOGY, V4, P84, DOI 10.3109/17435390903428869; Veetil JV, 2009, BIOTECHNOL PROGR, V25, P709, DOI 10.1002/btpr.165; Walker VG, 2009, TOXICOL APPL PHARM, V236, P319, DOI 10.1016/j.taap.2009.02.018; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048247; Wang JY, 2011, TOXICOL IN VITRO, V25, P242, DOI 10.1016/j.tiv.2010.11.010; Witzmann FA, 2006, NANOMED-NANOTECHNOL, V2, P158, DOI 10.1016/j.nano.2006.07.005; Wu D, 2012, NEUROSCI LETT, V507, P72, DOI 10.1016/j.neulet.2011.11.056; Yamashita K, 2010, INFLAMMATION, V33, P276, DOI 10.1007/s10753-010-9182-7; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137; Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zhang GL, 2012, MUTAT RES-GEN TOX EN, V746, P66, DOI 10.1016/j.mrgentox.2012.03.004; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004; Zhu L, 2013, PLANT CELL, V25, P851, DOI 10.1105/tpc.113.110528	76	34	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84974	10.1371/journal.pone.0084974	http://dx.doi.org/10.1371/journal.pone.0084974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454774	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800019
J	van Twillert, I; van Gaans-van den Brink, JAM; Poelen, MCM; Helm, K; Kuipers, B; Schipper, M; Boog, CJP; Verheij, TJM; Versteegh, FGA; van Els, CACM				van Twillert, Inonge; van Gaans-van den Brink, Jacqueline A. M.; Poelen, Martien C. M.; Helm, Kina; Kuipers, Betsy; Schipper, Maarten; Boog, Claire J. P.; Verheij, Theo J. M.; Versteegh, Florens G. A.; van Els, Cecile A. C. M.			Age Related Differences in Dynamics of Specific Memory B Cell Populations after Clinical Pertussis Infection	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; IMMUNE-RESPONSES; SERUM ANTIBODIES; IGG ANTIBODIES; FILAMENTOUS HEMAGGLUTININ; BOOSTER VACCINATION; REFERENCE VALUES; GENOMIC CONTENT; DISEASE BURDEN; PERTACTIN	For a better understanding of the maintenance of immune mechanisms to Bordetella pertussis (Bp) in relation to age, we investigated the dynamic range of specific B cell responses in various age-groups at different time points after a laboratory confirmed pertussis infection. Blood samples were obtained in a Dutch cross sectional observational study from symptomatic pertussis cases. Lymphocyte subpopulations were phenotyped by flowcytometry before and after culture. Memory B (B-mem) cells were differentiated into IgG antibody secreting cells (ASC) by polyclonal stimulation and detected by an ELISPOT assay specific for pertussis antigens pertussis toxin (Ptx), filamentous haemagglutinin (FHA) and pertactin (Prn). Bp antigen specific IgG concentrations in plasma were determined using multiplex technology. The majority of subjects having experienced a clinical pertussis episode demonstrated high levels of both Bp specific IgG and B-mem cell levels within the first 6 weeks after diagnosis. Significantly lower levels were observed thereafter. Waning of cellular and humoral immunity to maintenance levels occurred within 9 months after antigen encounter. Age was found to determine the maximum but not base-line frequencies of B-mem cell populations; higher levels of B-mem cells specific for Ptx and FHA were reached in adults and (pre-) elderly compared to under-fours and schoolchildren in the first 6 weeks after Bp exposure, whereas not in later phases. This age effect was less obvious for specific IgG levels. Nonetheless, subjects' levels of specific B-mem cells and specific IgG were weakly correlated. This is the first study to show that both age and closeness to last Bp encounter impacts the size of Bp specific B-mem cell and plasma IgG levels.	[van Twillert, Inonge; van Gaans-van den Brink, Jacqueline A. M.; Poelen, Martien C. M.; Helm, Kina; Kuipers, Betsy; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Immunol Infect Dis & Vaccines, Bilthoven, Netherlands; [Schipper, Maarten] Natl Inst Publ Hlth & Environm RIVM, Dept Stat Math Modelling & Data Logist, Bilthoven, Netherlands; [Boog, Claire J. P.] InTraVacc, Bilthoven, Netherlands; [Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Versteegh, Florens G. A.] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	van Els, CACM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Immunol Infect Dis & Vaccines, Bilthoven, Netherlands.	Cecile.van.Els@rivm.nl		Versteegh, Florens G.A./0000-0003-4773-5592	European Commission [201502]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission under the grant agreement #201502 (ChildINNOVAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, CLIN VACCINE IMMUNOL, V18, P844, DOI 10.1128/CVI.00562-10; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 1988, Lancet, V1, P955; Barkoff AM, 2012, CLIN VACCINE IMMUNOL, V19, P1703, DOI 10.1128/CVI.00367-12; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Buisman AM, 2009, VACCINE, V28, P179, DOI 10.1016/j.vaccine.2009.09.102; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Colonna-Romano G, 2006, REJUV RES, V9, P149, DOI 10.1089/rej.2006.9.149; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Dalby T, 2010, J MED MICROBIOL, V59, P1029, DOI 10.1099/jmm.0.020826-0; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Frasca D, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-14; Gaayeb L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048684; Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x; Hegerle N, 2012, CLIN MICROBIOL INFEC, V18, pE340, DOI 10.1111/j.1469-0691.2012.03925.x; Hendrikx LH, 2011, VACCINE, V30, P51, DOI 10.1016/j.vaccine.2011.10.048; Hendrikx LH, 2011, VACCINE, V29, P5725, DOI 10.1016/j.vaccine.2011.05.094; Hendrikx LH, 2011, VACCINE, V29, P1431, DOI 10.1016/j.vaccine.2010.12.033; Hendrikx LH, 2009, VACCINE, V27, P6530, DOI 10.1016/j.vaccine.2009.08.052; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hviid A, 2006, EXPERT REV VACCINES, V5, P641, DOI 10.1586/14760584.5.5.641; ISACSON J, 1995, PEDIATR INFECT DIS J, V14, P517, DOI 10.1097/00006454-199506000-00009; ISACSON J, 1995, SCAND J INFECT DIS, V27, P273, DOI 10.3109/00365549509019021; Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; Kallonen T, 2011, INFECT GENET EVOL, V11, P2034, DOI 10.1016/j.meegid.2011.09.012; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; Khurana S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002920; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Luijkx TA, 2008, CLIN VACCINE IMMUNOL, V15, P1598, DOI 10.1128/CVI.00192-08; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McGuiness CB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-32; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Ndungu FM, 2013, EUR J IMMUNOL; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270; Queenan AM, 2013, NEW ENGL J MED, V368, P583, DOI 10.1056/NEJMc1209369; Rashid H, 2012, CURR OPIN INFECT DIS, V25, P243, DOI 10.1097/QCO.0b013e328352f727; Rosado MM, 2011, EUR J IMMUNOL, V41, P1800, DOI 10.1002/eji.201041187; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Salmaso S, 1998, VACCINE, V16, P1270, DOI 10.1016/S0264-410X(98)00040-1; Schure RM, 2013, CLIN VACCINE IMMUNOL; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Slifka M K, 1998, Dev Biol Stand, V95, P105; Storsaeter J, 2003, VACCINE, V21, P3542, DOI 10.1016/S0264-410X(03)00407-9; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Taranger J, 2000, J INFECT DIS, V181, P1010, DOI 10.1086/315318; Taranger J, 2001, CLIN INFECT DIS, V33, P1004, DOI 10.1086/322639; TOMODA T, 1991, J INFECT DIS, V163, P559, DOI 10.1093/infdis/163.3.559; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gent R, 2009, CLIN IMMUNOL, V133, P95, DOI 10.1016/j.clim.2009.05.020; Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; Vincent JM, 2000, CLIN INFECT DIS, V30, P534, DOI 10.1086/313707; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	73	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85227	10.1371/journal.pone.0085227	http://dx.doi.org/10.1371/journal.pone.0085227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454823	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500049
J	Takaya, J; Yamanouchi, S; Kaneko, K				Takaya, Junji; Yamanouchi, Sohsaku; Kaneko, Kazunari			A Calcium-Deficient Diet in Rat Dams during Gestation and Nursing Affects Hepatic 11 beta-hydroxysteroid dehydrogenase-1 Expression in the Offspring	PLOS ONE			English	Article							DEHYDROGENASE TYPE-1 ACTIVITY; INSULIN-RESISTANCE SYNDROME; METABOLIC SYNDROME; GLUCOCORTICOID METABOLISM; PROTEIN RESTRICTION; GENE-EXPRESSION; ADIPOSE-TISSUE; BLOOD-PRESSURE; OBESE-PATIENTS; CELL FUNCTION	Background: Prenatal malnutrition can affect the phenotype of offspring by changing epigenetic regulation of specific genes. Several lines of evidence demonstrate that calcium (Ca) plays an important role in the pathogenesis of insulin resistance syndrome. We hypothesized that pregnant female rats fed a Ca-deficient diet would have offspring with altered hepatic glucocorticoid-related gene expression and that lactation would modify these alterations. Methodology: We determined the effects of Ca deficiency during pregnancy and/or lactation on hepatic 11 beta-hydroxysteroid dehydrogenase-1 (Hsd11b1) expression in offspring. Female Wistar rats consumed either a Ca-deficient (D: 0.008% Ca) or control (C: 0.90% Ca) diet ad libitum from 3 weeks preconception to 21 days postparturition. On postnatal day 1, pups were cross-fostered to the same or opposite dams and divided into the following four groups: CC, DD, CD, and DC (first letter: original mother's diet; second letter: nursing mother's diet). All offspring were fed a control diet beginning at weaning (day 21) and were killed on day 200 +/- 7. Serum insulin and adipokines in offspring were measured using ELISA kits. Principal Findings: In males, mean levels of insulin, glucose, and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) were higher in the DD and DC groups than in the CC group. We found no difference in HOMA-IR between the CC and CD groups in either males or females. Expression of Hsd11b1 was lower in male DD rats than in CC rats. Hsd11b1 expression in male offspring nursed by cross-fostered dams was higher than that in those nursed by dams fed the same diet; CC vs. CD and DD vs. DC. In females, Hsd11b1 expression in DC rats was higher than that in CC rats. Conclusions: These findings indicated that maternal Ca restriction during pregnancy and/or lactation alters postnatal growth, Hsd11b1 expression, and insulin resistance in a sex-specific manner.	[Takaya, Junji; Yamanouchi, Sohsaku; Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, Moriguchi, Osaka 570, Japan	Kansai Medical University	Takaya, J (corresponding author), Kansai Med Univ, Dept Pediat, Moriguchi, Osaka 570, Japan.	takaya@takii.kmu.ac.jp			Mami Mizutani Foundation; Japanese Society for the Promotion of Science [24591614]	Mami Mizutani Foundation; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Mami Mizutani Foundation and by a Grant-in-Aid for Scientific research (C) from the Japanese Society for the Promotion of Science (No. 24591614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2008, AM J EPIDEMIOL, V168, P1374, DOI 10.1093/aje/kwn258; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Belizan JM, 2004, CIRCULATION, V110, P1990; Bergel E, 2002, BJOG-INT J OBSTET GY, V109, P540; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Drouillet P, 2007, NUTR METAB CARDIOVAS, V17, P486, DOI 10.1016/j.numecd.2007.01.006; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gong L, 2010, EPIGENETICS-US, V5, P619, DOI 10.4161/epi.5.7.12882; Goodwin JE, 2012, PEDIATR NEPHROL, V27, P1059, DOI 10.1007/s00467-011-1928-4; Heaney RP, 2002, J AM COLL NUTR, V21, p152S, DOI 10.1080/07315724.2002.10719213; Hemanowski-Vosatka A, 2005, J EXP MED, V202, P517; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; LAX ER, 1978, ACTA ENDOCRINOL-COP, V89, P352, DOI 10.1530/acta.0.0890352; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Liu YJ, 2003, DIABETES, V52, P1409, DOI 10.2337/diabetes.52.6.1409; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; LOW SC, 1994, J MOL ENDOCRINOL, V13, P167, DOI 10.1677/jme.0.0130167; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matthews PA, 2011, J PHYSIOL-LONDON, V589, P3969, DOI 10.1113/jphysiol.2011.212324; Morley R, 2004, INT J EPIDEMIOL, V33, P1304, DOI 10.1093/ije/dyh284; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Patel MS, 2011, ANN NUTR METAB, V58, P18, DOI 10.1159/000328040; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Peixoto-Silva N, 2011, BRIT J NUTR, V106, P1364, DOI 10.1017/S0007114511001735; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Srinivasan M, 2013, AM J PHYSIOL-ENDOC M, V304, pE486, DOI 10.1152/ajpendo.00519.2012; Stimson RH, 2011, DIABETES, V60, P720, DOI 10.2337/db10-0726; Takaya J, 2013, NUTR RES, V33, P961, DOI 10.1016/j.nutres.2013.07.015; Takaya J, 2011, ANN NUTR METAB, V59, P73, DOI 10.1159/000332915; Torrecilla E, 2012, OBES SURG, V22, P478, DOI 10.1007/s11695-011-0524-9; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Valsamakis G, 2004, J CLIN ENDOCR METAB, V89, P4755, DOI 10.1210/jc.2003-032240; Voice MW, 1996, BIOCHEM J, V317, P621, DOI 10.1042/bj3170621; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Weaver ICG, 2009, SEMIN FETAL NEONAT M, V14, P143, DOI 10.1016/j.siny.2008.12.002; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84125	10.1371/journal.pone.0084125	http://dx.doi.org/10.1371/journal.pone.0084125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427280	gold, Green Submitted, Green Published			2022-12-27	WOS:000329868200020
J	Wang, M; Chen, D; Cheng, H; Li, B; Yan, FG; Su, JJ; Peng, C; Sun, ML; Hu, YW; Wang, XS; Wang, GH; Chen, ZW; Li, QL				Wang Mei; Chen Dong; Cheng Hui; Li Bin; Yan Fenggen; Su Jingjing; Peng Cheng; Sun Meiling; Hu Yawen; Wang Xiaoshan; Wang Guanghui; Chen Zhiwu; Li Qinglin			Gambogenic Acid Kills Lung Cancer Cells through Aberrant Autophagy	PLOS ONE			English	Article							ENHANCES PEMETREXED CYTOTOXICITY; MALIGNANT GLIOMA-CELLS; DEPENDENT MECHANISM; TARGETING AUTOPHAGY; APOPTOSIS; INHIBITION; DEATH; DIFFERENTIATION; DEGRADATION; MDA-7/IL-24	Lung cancer is one of the most common types of cancer and causes 1.38 million deaths annually, as of 2008 worldwide. Identifying natural anti-lung cancer agents has become very important. Gambogenic acid (GNA) is one of the active compounds of Gamboge, a traditional medicine that was used as a drastic purgative, emetic, or vermifuge for treating tapeworm. Recently, increasing evidence has indicated that GNA exerts promising anti-tumor effects; however, the underlying mechanism remains unclear. In the present paper, we found that GNA could induce the formation of vacuoles, which was linked with autophagy in A549 and HeLa cells. Further studies revealed that GNA triggers the initiation of autophagy based on the results of MDC staining, AO staining, accumulation of LC3 II, activation of Beclin 1 and phosphorylation of P70S6K. However, degradation of p62 was disrupted and free GFP could not be released in GNA treated cells, which indicated a block in the autophagy flux. Further studies demonstrated that GNA blocks the fusion between autophagosomes and lysosomes by inhibiting acidification in lysosomes. This dysfunctional autophagy plays a pro-death role in GNA-treated cells by activating p53, Bax and cleaved caspase-3 while decreasing Bcl-2. Beclin 1 knockdown greatly decreased GNA-induced cell death and the effects on p53, Bax, cleaved caspase-3 and Bcl-2. Similar results were obtained using a xenograft model. Our findings show, for the first time, that GNA can cause aberrant autophagy to induce cell death and may suggest the potential application of GNA as a tool or viable drug in anticancer therapies.	[Wang Mei; Chen Zhiwu] Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China; [Wang Mei; Cheng Hui; Yan Fenggen; Su Jingjing; Peng Cheng; Sun Meiling; Hu Yawen; Wang Xiaoshan; Li Qinglin] Anhui Univ Tradit Chinese Med, Minist Educ, Key Lab Xinan Med, Hefei, Anhui, Peoples R China; [Chen Dong; Li Bin; Wang Guanghui] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Lab Mol Neuropathol, Suzhou, Jiangsu, Peoples R China	Anhui Medical University; Anhui University of Chinese Medicine; Soochow University - China	Chen, ZW (corresponding author), Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China.	kuller_chen@163.com; qinglin_lee@hotmail.com		Li, Bin/0000-0001-9341-4672; Yan, Fenggen/0000-0001-5832-6597	National Natural Science Foundation of China [81173600]; National Natural Science Foundation of Anhui Province, China [11040606M190]; Key Project in the National Science&Technology Pillar Program [2009ZX09103-399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Anhui Province, China; Key Project in the National Science&Technology Pillar Program	This work was supported by the National Natural Science Foundation of China, No. 81173600 (Q.-L. Li); the National Natural Science Foundation of Anhui Province, China, No. 11040606M190 (Q.-L. Li) and Key Project in the National Science&Technology Pillar Program 2009ZX09103-399 (Q.-L. Li, Co-PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Asano J, 1996, PHYTOCHEMISTRY, V41, P815, DOI 10.1016/0031-9422(95)00682-6; Bareford MD, 2011, AUTOPHAGY, V7, P1261, DOI 10.4161/auto.7.10.17029; Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bhutia SK, 2011, AUTOPHAGY, V7, P1076, DOI 10.4161/auto.7.9.16163; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Cheng H, 2011, J ASIAN NAT PROD RES, V13, P993, DOI 10.1080/10286020.2011.605062; Cooper S, 2006, RESPIROLOGY, V11, P241, DOI 10.1111/j.1440-1843.2006.00850.x; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dent P, 2010, PHARMACOL THERAPEUT, V128, P375, DOI 10.1016/j.pharmthera.2010.08.001; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo QL, 2004, ACTA PHARMACOL SIN, V25, P769; Hwang SH, 2013, EUROPEAN RADIOLOGY; Kanematsu S, 2010, ANTICANCER RES, V30, P3381; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882; LEI QM, 1985, CHIN J TUMOR, V7, P282; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Li QL, 2010, BIOL PHARM BULL, V33, P415, DOI 10.1248/bpb.33.415; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIU Jing-bing QS-k, 2005, CHINESE CLIN ONCOLOG, V10; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Martin AP, 2009, CANCER BIOL THER, V8, P2084; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Munafo DB, 2001, J CELL SCI, V114, P3619; QU BX, 1991, CHIN J CLIN ONCOL, V18, P53; QU BX, 1991, CHIN J CLIN ONCOL, V18, P50; Sesen M Berkan, 2012, AMIA Annu Symp Proc, V2012, P838; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Yan F, EUR J PHARM, V652, P23; Yan F, ENV TOXICOL PHARM, V33, P181; Yang Li, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1217; Yu XJ, 2012, CANCER LETT, V322, P185, DOI 10.1016/j.canlet.2012.03.004; Zhuang WZ, 2009, ACTA BIOCH BIOPH SIN, V41, P341, DOI 10.1093/abbs/gmp028	41	19	20	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83604	10.1371/journal.pone.0083604	http://dx.doi.org/10.1371/journal.pone.0083604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427275	Green Submitted, Green Published, gold			2022-12-27	WOS:000329868200015
J	Pages, N; Breard, E; Urien, C; Talavera, S; Viarouge, C; Lorca-Oro, C; Jouneau, L; Charley, B; Zientara, S; Bensaid, A; Solanes, D; Pujols, J; Schwartz-Cornil, I				Pages, Nonito; Breard, Emmanuel; Urien, Celine; Talavera, Sandra; Viarouge, Cyril; Lorca-Oro, Cristina; Jouneau, Luc; Charley, Bernard; Zientara, Stephan; Bensaid, Albert; Solanes, David; Pujols, Joan; Schwartz-Cornil, Isabelle			Culicoides Midge Bites Modulate the Host Response and Impact on Bluetongue Virus Infection in Sheep	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; SALIVARY-GLANDS; SEROTYPE 8; TRANSMISSION; VECTOR; SONORENSIS; ENCEPHALITIS; ENHANCEMENT; PARTICLES; DYNAMICS	Many haematophagous insects produce factors that help their blood meal and coincidently favor pathogen transmission. However nothing is known about the ability of Culicoides midges to interfere with the infectivity of the viruses they transmit. Among these, Bluetongue Virus (BTV) induces a hemorrhagic fever-type disease and its recent emergence in Europe had a major economical impact. We observed that needle inoculation of BTV8 in the site of uninfected C. nubeculosus feeding reduced viraemia and clinical disease intensity compared to plain needle inoculation. The sheep that developed the highest local inflammatory reaction had the lowest viral load, suggesting that the inflammatory response to midge bites may participate in the individual sensitivity to BTV viraemia development. Conversely compared to needle inoculation, inoculation of BTV8 by infected C. nubeculosus bites promoted viraemia and clinical symptom expression, in association with delayed IFN-induced gene expression and retarded neutralizing antibody responses. The effects of uninfected and infected midge bites on BTV viraemia and on the host response indicate that BTV transmission by infected midges is the most reliable experimental method to study the physio-pathological events relevant to a natural infection and to pertinent vaccine evaluation in the target species. It also leads the way to identify the promoting viral infectivity factors of infected Culicoides in order to possibly develop new control strategies against BTV and other Culicoides transmitted viruses.	[Pages, Nonito; Talavera, Sandra; Lorca-Oro, Cristina; Bensaid, Albert; Solanes, David; Pujols, Joan] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, Inst Recerca & Tecnol Agroalimentaries, Bellaterra, Spain; [Breard, Emmanuel; Viarouge, Cyril; Zientara, Stephan] Ecole Natl Vet Alfort, Agence Natl Securite Sanitaire Alimentat Environm, Inst Natl Rech Agron, Unite Mixte Rech UMR1161, Maisons Alfort, France; [Urien, Celine; Jouneau, Luc; Charley, Bernard; Schwartz-Cornil, Isabelle] INRA, Unite Rech UR892, Jouy En Josas, France	Autonomous University of Barcelona; IRTA; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Schwartz-Cornil, I (corresponding author), INRA, Unite Rech UR892, Jouy En Josas, France.	isabelle.schwartz@jouy.inra.fr	Pujols, Joan/K-9693-2015; Bensaid, Albert/K-1960-2017; Zientara, Stephan/A-5336-2016; Pages, Nonito/Q-1274-2016; breard, emmanuel/E-2123-2011; Zientara, Stephan/AAA-7661-2021; schwartz-cornil, isabelle/D-8547-2011; Pujols, Joan/S-1141-2018; Pujols, Joan/AAV-6427-2020; Talavera, Sandra/ABG-8759-2020; Lorca-Oró, Cristina/ABE-7268-2021; Jouneau, Luc/AAC-4711-2020	Pujols, Joan/0000-0002-6940-1529; Bensaid, Albert/0000-0001-6493-3756; Zientara, Stephan/0000-0003-0089-8175; Pages, Nonito/0000-0001-6020-7175; Zientara, Stephan/0000-0002-6733-8503; Pujols, Joan/0000-0002-6940-1529; Lorca-Oró, Cristina/0000-0001-5351-4169; 	European Community [FP7-228394]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001701] Funding Source: researchfish; BBSRC [BBS/E/I/00001701] Funding Source: UKRI	European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7, 2007-2013), Research Infrastructures action, under the grant agreement No. FP7-228394 (NADIR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Andrade BB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00121; Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Baylis M, 2008, MED VET ENTOMOL, V22, P228, DOI 10.1111/j.1365-2915.2008.00732.x; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; Bishop JV, 2006, AM J TROP MED HYG, V75, P532, DOI 10.4269/ajtmh.2006.75.532; BOORMAN J, 1974, B ENTOMOL RES, V64, P371, DOI 10.1017/S0007485300031254; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Darpel KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017545; de Leon AAP, 1998, EXP PARASITOL, V88, P121, DOI 10.1006/expr.1998.4210; deLeon AAP, 1997, AM J TROP MED HYG, V57, P375, DOI 10.4269/ajtmh.1997.57.375; Di Gialleonardo L, 2011, RES VET SCI, V91, P316, DOI 10.1016/j.rvsc.2010.12.017; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Eschbaumer M, 2010, VET MICROBIOL, V146, P150, DOI 10.1016/j.vetmic.2010.05.004; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118; Girard YA, 2010, J MED ENTOMOL, V47, P421, DOI 10.1603/ME09249; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; Howey R, 2009, J R SOC INTERFACE, V6, P835, DOI 10.1098/rsif.2008.0434; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; JENNINGS DM, 1988, VET MICROBIOL, V17, P1, DOI 10.1016/0378-1135(88)90074-0; Langner KFA, 2008, VET IMMUNOL IMMUNOP, V122, P126, DOI 10.1016/j.vetimm.2007.11.001; Limesand KH, 2003, J MED ENTOMOL, V40, P199, DOI 10.1603/0022-2585-40.2.199; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Martinelle L, 2011, VACCINE, V29, P3600, DOI 10.1016/j.vaccine.2011.02.055; Mercer DR, 2005, J MED ENTOMOL, V42, P554, DOI 10.1603/0022-2585(2005)042[0554:CIRSCO]2.0.CO;2; Moulin V, 2012, VACCINE, V30, P2228, DOI 10.1016/j.vaccine.2011.11.100; Quan M, 2004, J COMP PATHOL, V131, P294, DOI 10.1016/j.jcpa.2004.05.002; Reisen WK, 2000, J MED ENTOMOL, V37, P250, DOI 10.1603/0022-2585-37.2.250; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Stewart M, 2010, VACCINE, V28, P3047, DOI 10.1016/j.vaccine.2009.10.072; Stewart M, 2013, VACCINE, V31, P553, DOI 10.1016/j.vaccine.2012.11.016; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091	37	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83683	10.1371/journal.pone.0083683	http://dx.doi.org/10.1371/journal.pone.0083683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421899	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500065
J	Samartzis, EP; Noske, A; Meisel, A; Varga, Z; Fink, D; Imesch, P				Samartzis, Eleftherios P.; Noske, Aurelia; Meisel, Alexander; Varga, Zsuzsanna; Fink, Daniel; Imesch, Patrick			The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer	PLOS ONE			English	Article							GPR30; 17-BETA-ESTRADIOL; MEMBRANE; CELLS; PROLIFERATION; ASSOCIATION; MIGRATION	Introduction: The G protein-coupled estrogen receptor (GPER) is a novel estrogen receptor that mediates proliferative effects induced by estrogen but also by tamoxifen. The aim of our study was to analyze the frequency of GPER in a large collective of primary invasive breast carcinomas, with special emphasis on the subcellular expression and to evaluate the association with clinicopathological parameters and patient overall survival. Methods: The tissue microarrays from formalin-fixed, paraffin embedded samples of primary invasive breast carcinomas (n = 981) were analyzed for GPER expression using immunohistochemistry. Expression data were compared to the clinicopathological parameters and overall survival. GPER localization was also analyzed in two immortalized breast cancer cell lines T47D and MCF7 by confocal immunofluorescence microscopy. Results: A predominantly cytoplasmic GPER expression was found in 189 carcinomas (19.3%), whereas a predominantly nuclear expression was observed in 529 cases (53.9%). A simultaneous comparable positive expression of both patterns was found in 32 of 981 cases (3.2%), and negative staining was detected in 295 cases (30%). Confocal microscopy confirmed the occurrence of cytoplasmic and nuclear GPER expression in T47D and MCF7. Cytoplasmic GPER expression was significantly associated with non-ductal histologic subtypes, low tumor stage, better histologic differentiation, as well as Luminal A and B subtypes. In contrast, nuclear GPER expression was significantly associated with poorly differentiated carcinomas and the triple-negative subtype. In univariate analysis, cytoplasmic GPER expression was associated with better overall survival (p = 0.012). Conclusion: Our data suggest that predominantly cytoplasmic and/or nuclear GPER expression are two distinct immunohistochemical patterns in breast carcinomas and may reflect different biological features, reason why these patterns should be clearly distinguished in histological evaluations. Prospective studies will be needed to assess whether the expression status of GPER in breast carcinomas should be routinely observed by clinicians, for instance, before implementing endocrine breast cancer treatment.	[Samartzis, Eleftherios P.; Fink, Daniel; Imesch, Patrick] Univ Zurich Hosp, Dept Gynecol, CH-8091 Zurich, Switzerland; [Noske, Aurelia; Varga, Zsuzsanna] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Meisel, Alexander] Univ Zurich Hosp, Dept Med Oncol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Imesch, P (corresponding author), Univ Zurich Hosp, Dept Gynecol, CH-8091 Zurich, Switzerland.	patrick.imesch@usz.ch	Samartzis, Eleftherios P./AAJ-5650-2020	Samartzis, Eleftherios P./0000-0002-8246-5842	Center for Clinical Research, University and University Hospital of Zurich; EMDO foundation; Hartmann-Mueller foundation	Center for Clinical Research, University and University Hospital of Zurich; EMDO foundation; Hartmann-Mueller foundation	This project was supported by grants from the Center for Clinical Research, University and University Hospital of Zurich, and by grants from the EMDO and the Hartmann-Mueller foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; Cheng SB, 2011, STEROIDS, V76, P892, DOI 10.1016/j.steroids.2011.02.018; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Du GQ, 2012, BIOCHEM BIOPH RES CO, V420, P343, DOI 10.1016/j.bbrc.2012.02.161; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Filardo EJ, 2008, STEROIDS, V73, P870, DOI 10.1016/j.steroids.2007.12.025; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Han GC, 2013, PHARMACOL RES, V71, P53, DOI 10.1016/j.phrs.2013.02.008; Ignatov A, 2011, BREAST CANCER RES TR, V128, P457, DOI 10.1007/s10549-011-1584-1; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Ignatov T, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.034; Kleuser B, 2008, MOL PHARMACOL, V74, P1533, DOI 10.1124/mol.108.046854; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Luo HJ, 2011, J BREAST CANCER, V14, P185, DOI 10.4048/jbc.2011.14.3.185; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Samartzis N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-30; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344	23	35	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83296	10.1371/journal.pone.0083296	http://dx.doi.org/10.1371/journal.pone.0083296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421881	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500041
J	Sarker, S; Patterson, EI; Peters, A; Baker, GB; Forwood, JK; Ghorashi, SA; Holdsworth, M; Baker, R; Murray, N; Raidal, SR				Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Baker, G. Barry; Forwood, Jade K.; Ghorashi, Seyed A.; Holdsworth, Mark; Baker, Rupert; Murray, Neil; Raidal, Shane R.			Mutability Dynamics of an Emergent Single Stranded DNA Virus in a Naive Host	PLOS ONE			English	Article							FEATHER-DISEASE-VIRUS; POLYMERASE-CHAIN-REACTION; PSITTACINE BEAK; PHYLOGENETIC EVIDENCE; MOLECULAR EVOLUTION; POSITIVE SELECTION; GENETIC DIVERSITY; VIRAL EVOLUTION; HIGH-RATES; RECOMBINATION	Quasispecies variants and recombination were studied longitudinally in an emergent outbreak of beak and feather disease virus (BFDV) infection in the orange-bellied parrot (Neophema chrysogaster). Detailed health monitoring and the small population size (<300 individuals) of this critically endangered bird provided an opportunity to longitudinally track viral replication and mutation events occurring in a circular, single-stranded DNA virus over a period of four years within a novel bottleneck population. Optimized PCR was used with different combinations of primers, primer walking, direct amplicon sequencing and sequencing of cloned amplicons to analyze BFDV genome variants. Analysis of complete viral genomes (n = 16) and Rep gene sequences (n = 35) revealed that the outbreak was associated with mutations in functionally important regions of the normally conserved Rep gene and immunogenic capsid (Cap) gene with a high evolutionary rate (3.41610 23 subs/site/year) approaching that for RNA viruses; simultaneously we observed significant evidence of recombination hotspots between two distinct progenitor genotypes within orange-bellied parrots indicating early cross-transmission of BFDV in the population. Multiple quasispecies variants were also demonstrated with at least 13 genotypic variants identified in four different individual birds, with one containing up to seven genetic variants. Preferential PCR amplification of variants was also detected. Our findings suggest that the high degree of genetic variation within the BFDV species as a whole is reflected in evolutionary dynamics within individually infected birds as quasispecies variation, particularly when BFDV jumps from one host species to another.	[Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Ghorashi, Seyed A.; Raidal, Shane R.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia; [Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Forwood, Jade K.; Ghorashi, Seyed A.; Raidal, Shane R.] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Forwood, Jade K.; Ghorashi, Seyed A.; Raidal, Shane R.] Charles Sturt Univ, Wagga Wagga, NSW, Australia; [Baker, G. Barry] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Holdsworth, Mark] Dept Primary Ind Pk Water & Environm, Biodivers Conservat Branch, Hobart, Tas, Australia; [Murray, Neil] La Trobe Univ, Dept Genet, Bundoora, Vic, Australia	Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University; University of Tasmania; La Trobe University	Raidal, SR (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.	shraidal@csu.edu.au	Forwood, Jade K/K-4123-2014; Sarker, Subir/U-8444-2019; Raidal, Shane/C-4632-2008; Ghorashi, Seyed/C-1529-2016	Forwood, Jade K/0000-0003-3267-9997; Sarker, Subir/0000-0002-2685-8377; Baker, G. Barry/0000-0003-4766-8182; Patterson, Edward/0000-0003-3465-0848; Raidal, Shane/0000-0001-7917-8976; Ghorashi, Seyed/0000-0002-9820-5308; Peters, Andrew/0000-0003-4938-2823	Australian Research Council [DP1095408]	Australian Research Council(Australian Research Council)	This research was supported by Australian Research Council's Discovery Projects funding scheme (grant number DP1095408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Andersson M, 2013, AM NAT, V181, P545, DOI 10.1086/669905; Andrew R, 2009, FIGTREE V1 4 COMPUTE; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; Bassami MR, 2001, VIROLOGY, V279, P392, DOI 10.1006/viro.2000.0847; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; Bonne N, 2008, J VET DIAGN INVEST, V20, P60, DOI 10.1177/104063870802000111; Brown P., 1988, Australian Aviculture, V42, P165; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Ge LM, 2007, J VIROL, V81, P5902, DOI 10.1128/JVI.02431-06; Gerlach H., 1994, AVIAN MED PRINCIPLES, P894; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Grasland B, 2005, VET RES, V36, P685, DOI 10.1051/vetres:2005024; Harris J, 2006, P AUSTR COMM ASS AV, P143; Hatwell JN, 2000, J GEN VIROL, V81, P1191, DOI 10.1099/0022-1317-81-5-1191; Heath L, 2004, J VIROL, V78, P9277, DOI 10.1128/JVI.78.17.9277-9284.2004; Higgins PJ, 1999, HDB AUSTR NZ ANTARCT, V4; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; IUCN, 2013, IUCN RED LIST THREAT; Julian L, 2013, J GEN VIROL, V94, P1086, DOI 10.1099/vir.0.050179-0; Khalesi B, 2005, J GEN VIROL, V86, P3039, DOI 10.1099/vir.0.81275-0; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Kondiah K, 2006, ARCH VIROL, V151, P2539, DOI 10.1007/s00705-006-0800-5; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kundu S, 2012, J VIROL, V86, P5221, DOI 10.1128/JVI.06504-11; Latimer K S, 1990, J Vet Diagn Invest, V2, P204; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2011, VIRUSES-BASEL, V3, P1699, DOI 10.3390/v3091699; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Massaro M, 2012, ARCH VIROL, V157, P1651, DOI 10.1007/s00705-012-1336-5; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Niagro FD, 1998, ARCH VIROL, V143, P1723, DOI 10.1007/s007050050412; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PASS DA, 1984, AUST VET J, V61, P69, DOI 10.1111/j.1751-0813.1984.tb15520.x; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; Perry RA, 1981, P REFR COURS AV CAG, P81; Peters A, 2013, J WILDL DIS IN PRESS; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Pritchard R, 2012, UPDATE ORGANCE BELLI; Rahaus M, 2008, VET MED-CZECH, V53, P53, DOI 10.17221/1932-VETMED; RAIDAL SR, 1993, AUST VET J, V70, P137, DOI 10.1111/j.1751-0813.1993.tb06105.x; Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093; Ritchie B.W, 1995, CIRCOVIRIDAE AVIAN V, P223; RITCHIE BW, 1989, VIROLOGY, V171, P83, DOI 10.1016/0042-6822(89)90513-8; RITCHIE BW, 1990, J WILDLIFE DIS, V26, P196, DOI 10.7589/0090-3558-26.2.196; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2006, J VIROL, V80, P9928, DOI 10.1128/JVI.00441-06; Shearer PL, 2008, AVIAN PATHOL, V37, P75, DOI 10.1080/03079450701802206; Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd D, 2004, VET MICROBIOL, V98, P169, DOI 10.1016/j.vetmic.2003.10.010; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; Umemura T, 2002, FEBS LETT, V510, P171, DOI 10.1016/S0014-5793(01)03258-6; van der Walt E, 2009, J GEN VIROL, V90, P734, DOI 10.1099/vir.0.007724-0; Varsani A, 2011, J GEN VIROL, V92, P752, DOI 10.1099/vir.0.028126-0; Walsh P S, 1992, PCR Methods Appl, V1, P241, DOI 10.1101/gr.1.4.241; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Ypelaar I, 1999, VET MICROBIOL, V68, P141, DOI 10.1016/S0378-1135(99)00070-X	78	48	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85370	10.1371/journal.pone.0085370	http://dx.doi.org/10.1371/journal.pone.0085370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416396	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500242
J	Li, CM; Meng, S; Yang, XH; Wang, J; Hu, JN				Li, Chuanming; Meng, Shan; Yang, Xinhua; Wang, Jian; Hu, Jiani			The Value of T2*in Differentiating Metastatic from Benign Axillary Lymph Nodes in Patients with Breast Cancer - A Preliminary In Vivo Study	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; SENTINEL NODE; RECURRENCE; BIOPSY; WOMEN; DISSECTION; ULTRASONOGRAPHY; SURVIVAL; TRIAL	Background: Accurate detection and determination of axillary lymph node metastasis are crucial for the clinical management of patients with breast cancer. Noninvasive imaging methods including ultrasound (US), computed tomography (CT), or conventional magnetic resonance imaging (MRI) are not yet accurate enough. The purpose of this study was to investigate the value of in vivo T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer. Methodology/Principal Findings: In this institutional review board approved study, 35 women with breast cancer underwent multi-echo T2* weighted imaging (T2* WI) of the axillary area on a 3.0 T clinical magnetic resonance (MR) imaging system. T2* values of pathologically proven benign and metastatic axillary lymph nodes were calculated and compared. Receiver operating characteristics (ROC) analysis was conducted to evaluate the diagnostic ability. The areas under the ROC curve (AUCs) and the confidence intervals (CIs) were assessed. In total, 56 metastatic and 65 benign axillary lymph nodes were identified in this study. For metastatic lymph nodes, the average T2* value (55.96 +/- 11.87 ms) was significantly longer than that of the benign lymph nodes (26.00 +/- 5.51 ms, P<0.05). The AUC of T2* in differentiating benign from metastatic lymph nodes was 0.993. The cut-off value of 37.5 milliseconds (ms) gave a sensitivity of 94.6%, a specificity of 98.5%, a positive predictive value of 98.17 and a negative predictive value 95.54. Conclusions: In vivo T2* can differentiate benign from metastatic axillary lymph nodes in patients with breast cancer. The high sensitivity and specificity as well as the easiness suggest its high potential for use in clinical practice.	[Li, Chuanming; Meng, Shan; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Yang, Xinhua] Third Mil Med Univ, Southwest Hosp, Dept Breast Surg, Chongqing, Peoples R China; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	Army Medical University; Army Medical University; Wayne State University	Wang, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	wangjian_1964@sohu.com; jiani_hu@sohu.com						Atahan IL, 2008, ACTA ONCOL, V47, P232, DOI 10.1080/02841860701678761; Bahri S, 2008, ANN ONCOL, V19, P822, DOI 10.1093/annonc/mdn043; Beenken SW, 2003, ANN SURG, V237, P732, DOI 10.1097/00000658-200305000-00016; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Cooper KL, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15040; DOOMS GC, 1984, RADIOLOGY, V153, P719, DOI 10.1148/radiology.153.3.6093190; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Harada T, 2007, EUR J RADIOL, V63, P401, DOI 10.1016/j.ejrad.2007.02.010; He N, 2012, EUR J RADIOL, V81, P2602, DOI 10.1016/j.ejrad.2012.03.019; Heusner TA, 2010, EUR J NUCL MED MOL I, V37, P1077, DOI 10.1007/s00259-010-1399-z; Hildebrandt MG, 2011, DAN MED BULL, V58; IVENS D, 1992, BRIT J CANCER, V66, P136, DOI 10.1038/bjc.1992.230; Korteweg MA, 2011, RADIOLOGY, V261, P127, DOI 10.1148/radiol.11103535; Kvistad KA, 2000, EUR RADIOL, V10, P1464, DOI 10.1007/s003300000370; Kwee TC, 2010, EUR J RADIOL, V75, P215, DOI 10.1016/j.ejrad.2009.03.026; Le Bouedec G, 2008, PRESSE MED, V37, P1685, DOI 10.1016/j.lpm.2007.10.020; Lim SW, 2011, ACAD RADIOL, V18, P504, DOI 10.1016/j.acra.2010.10.017; Luciani A, 2009, EUR J RADIOL, V69, P59, DOI 10.1016/j.ejrad.2008.07.040; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Martin RCG, 2005, ANN SURG, V241, P1005, DOI 10.1097/01.sla.0000165200.32722.02; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5213, DOI 10.1200/JCO.2008.16.3725; Mortellaro VE, 2009, J MAGN RESON IMAGING, V30, P309, DOI 10.1002/jmri.21802; Murray AD, 2002, BRIT J RADIOL, V75, P220, DOI 10.1259/bjr.75.891.750220; Scaranelo AM, 2012, RADIOLOGY, V262, P425, DOI 10.1148/radiol.11110639; Strnad P, 2005, Ceska Gynekol, V70, P291; Tolaney SM, 2007, BREAST, V16, pS45, DOI 10.1016/j.breast.2007.07.005; Ueda S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-165; VASSALLO P, 1993, INVEST RADIOL, V28, P698, DOI 10.1097/00004424-199308000-00009; Zuo CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049337	29	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e84038	10.1371/journal.pone.0084038	http://dx.doi.org/10.1371/journal.pone.0084038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454715	Green Published, gold, Green Submitted			2022-12-27	WOS:000330236000005
J	Carrette, T; Straehler-Pohl, I; Seymour, J				Carrette, Teresa; Straehler-Pohl, Ilka; Seymour, Jamie			Early Life History of Alatina cf. moseri Populations from Australia and Hawaii with Implications for Taxonomy (Cubozoa: Carybdeida, Alatinidae)	PLOS ONE			English	Article							TRIPEDALIA-CYSTOPHORA CUBOZOA; MARSUPIALIS LINNAEUS; SIVICKISI CNIDARIA; JELLYFISH; SCYPHOZOA; BEHAVIOR; CYCLE; METAMORPHOSIS; CUBOPOLYP; POLYP	The early life stages of the cubomedusa Alatina cf. moseri from Osprey Reef (North Queensland, Australia) and Waikiki (Oahu, Hawaii) were studied using laboratory-based culturing conditions. Spawning populations from both regions were observed with reliable periodicity allowing polyp cultures from these locations to be collected and established under laboratory conditions. The polyps of this species were successfully reared from spawning adults. Polyps of Alatina cf. moseri were cultured at temperatures of 23-28 degrees C, developed up to 19 tentacles and reached up to 1.70 mm in height. The balloonshaped hypostomes possessed 4 well-defined lips. The polyps increased their numbers by means of formation of either sedentary polyp buds or creeping-polyp buds, which attached after 2-3 days. Metamorphosis occurred at temperatures of 25-28 degrees C. Development of polyps and medusae were achieved for the first time within the genus Alatina and allowed comparisons of early life history between these and other species of the Carybdeida families. The metamorphosis and young medusa of this genus showed characters that differed distinctly from those noted for other Carybdeida species, but are very similar to the one described from Puerto Rico by Arneson and Cutress in 1976 for Alatina sp. (named by them Carybdea alata). Based on this evidence, the discrepancies in original specimen descriptions and the previous genetic comparisons, we support the suggestion that the two previously described species of Alatina from Australia and Hawaii (Alatina mordens and Alatina moseri) appear to represent artificial taxonomic units and may in fact be the same as the original Carybdea alata species named from Puerto Rico. Further taxonomic studies are desperately needed in order to clarify the various species and description discrepancies that exist within this newly proposed genus.	[Carrette, Teresa] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Straehler-Pohl, Ilka] Univ Hamburg, Museum & Inst Zool, Bioctr Grindel, Hamburg, Germany; [Seymour, Jamie] Queensland Trop Hlth Alliance, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia; [Seymour, Jamie] James Cook Univ, Cairns, Qld, Australia	James Cook University; University of Hamburg; James Cook University	Carrette, T (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia.	Teresa.Carrette@my.jcu.edu.au		Straehler-Pohl, Ilka/0000-0001-5831-4967	Lions Foundation of Australia; Queensland Emergency Medical Research Foundation, Brisbane, Queensland	Lions Foundation of Australia; Queensland Emergency Medical Research Foundation, Brisbane, Queensland	The Lions Foundation of Australia provided a grant that partially supported this research. J.S. acknowledges the financial support of the Queensland Emergency Medical Research Foundation, Brisbane, Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson A, 1976, THESIS U PUERTO RICO; Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; Bentlage B, 2012, THESIS U KANSAS; Bentlage B, 2012, J NAT HIST, V46, P2595, DOI 10.1080/00222933.2012.717645; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; BERGER EW, 1900, MEM BIOL LAB J HOPKI, V4, P1; Berger EW, 1900, MEMOIRS BIOL LAB J H, V4, P1; BREWER RH, 1976, BIOL BULL-US, V150, P183, DOI 10.2307/1540467; BREWER RH, 1978, ESTUARIES, V1, P120, DOI 10.2307/1351601; CALDER DR, 1982, BIOL BULL, V162, P149, DOI 10.2307/1540810; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; Carrette TJ, 2012, DIVING HYPERB MED, V42, P214; CHAPMAN DM, 1978, HELGOLAND WISS MEER, V31, P128, DOI 10.1007/BF02296994; Conant FS, 1897, NOTES CUBOMEDUSAE, P132; CONANT FS, 1898, MEM BIOL LAB J HOPKI, V4, P1; Courtney R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069369; Cutress C. E., 1973, P ASS ISLAND MARINE, V9, P25; Edwards A, 2010, CORAL REEF TARGETED, Vii, P166; Fischer AB, 2004, HYDROBIOLOGIA, V530, P331, DOI 10.1007/s10750-004-2658-4; Fuentes V, 2011, MAR BIOL, V158, P2247, DOI 10.1007/s00227-011-1730-7; Gershwin L., 2005, Memoirs of the Queensland Museum, V51, P501; GOLZ R, 1993, PROTOPLASMA, V173, P13, DOI 10.1007/BF01378858; Haacke W, 1887, JENAISCHE Z NATURWIS, V20, P588; Haeckel E., 1880, DENKSCHRIFTEN MED NA, V2, P361, DOI DOI 10.5962/BHL.TITLE.46856; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P171, DOI 10.1007/BF00026459; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; HOLST S, 2006, J MAR BIOL ASSOC UK, V151, P863; Holst S, 2007, MAR BIOL, V151, P1695, DOI 10.1007/s00227-006-0594-8; Kawahara M, 2006, MAR ECOL PROG SER, V307, P161, DOI 10.3354/meps307161; LASKAMEHNERT G, 1985, HELGOLANDER MEERESUN, V39, P129, DOI 10.1007/BF01997447; Lesson R-P, 1843, ACALEPHES; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Lewis Cheryl, 2008, Publications of the Seto Marine Biological Laboratory, V40, P1; Mayer A. G., 1900, B MUS COMP ZOOL HARV, V37, P1; Mehnert G, 1984, THESIS RHEINESCHEN F; Okada Y. K., 1927, Bulletin Biologique de la France et de la Belgique, V61, P241; Omori M, 2010, MAR BIOL RES, V7, P3, DOI 10.1080/17451001003642317; Pitt KA, 2000, MAR BIOL, V136, P269, DOI 10.1007/s002270050685; Reynaud AAM, 1830, CARYBDEE MEDUSE AILE; Schiariti A, 2008, MAR BIOL, V156, P1, DOI 10.1007/s00227-008-1050-8; SPANGENBERG D B, 1968, Oceanography and Marine Biology an Annual Review, V6, P231; Stangl K, 2002, VIE MILIEU, V52, P131; Stangl K, 1997, THESIS U WIEN; STIASNY G., 1926, ZOOL MEDEDEEL, V9, P239; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I., 2001, VERWANDTSCHAFT DREIE; Straehler-Pohl I, 2009, THESIS U HAMBURG; Straehler-Pohl I, 2011, ZOOTAXA, P36; Straehler-Pohl I, 2011, ZOOTAXA, P1; Straehler-Pohl Ilka, 2011, Midoriishi, V22, P8; Studebaker JP, 1972, THESIS U PUERTO RICO; Thomas C S, 2001, Hawaii Med J, V60, P205; Thomas C S, 2001, Hawaii Med J, V60, P100; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; Uchida T., 1970, Publs Seto mar. biol. Lab., V17, P289; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; WERNER B, 1973, MAR BIOL, V18, P212, DOI 10.1007/BF00367987; WERNER B, 1975, HELGOLAND WISS MEER, V27, P461, DOI 10.1007/BF01611150; WERNER B, 1983, HELGOLANDER MEERESUN, V36, P257, DOI 10.1007/BF01983630; WERNER B, 1976, EXPERIENTIA, V32, P1047, DOI 10.1007/BF01933964; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Werner B., 1976, Umschau, V76, P80; Werner B, 1993, LEHBUCH SPEZIELLEN Z, P11; Yamaguchi M., 1980, P11; Yamaguchi M., 1982, Aquabiology (Tokyo), V4, P248; Yoshimoto CM, 2002, T ROY SOC TROP MED H, V96, P300, DOI 10.1016/S0035-9203(02)90105-7	66	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84377	10.1371/journal.pone.0084377	http://dx.doi.org/10.1371/journal.pone.0084377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454725	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000330235100021
J	Schauer, C; Thompson, C; Brune, A				Schauer, Christine; Thompson, Claire; Brune, Andreas			Pyrotag Sequencing of the Gut Microbiota of the Cockroach Shelfordella lateralis Reveals a Highly Dynamic Core but Only Limited Effects of Diet on Community Structure	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; AMERICAN COCKROACH; PERIPLANETA-AMERICANA; BACTERIAL COMMUNITY; GERMAN-COCKROACH; REPRODUCTION; TERMITES; HINDGUT; FOOD; ENVIRONMENT	Although blattid cockroaches and termites share a common ancestor, their diets are distinctly different. While termites consume a highly specialized diet of lignocellulose, cockroaches are omnivorous and opportunistic feeders. The role of the termite gut microbiota has been studied intensively, but little is known about the cockroach gut microbiota and its function in digestion and nutrition, particularly the adaptation to different diets. Our analyses of the bacterial gut microbiota of the blattid cockroach Shelfordella lateralis combining terminal restriction fragment length polymorphism of their 16S rRNA genes with physiological parameters (microbial metabolites, hydrogen and methane emission) indicated substantial variation between individuals but failed to identify any diet-related response. Subsequent deep-sequencing of the 16S rRNA genes of the colonic gut microbiota of S. lateralis fed either a high-or a low-fiber diet confirmed the absence of bacterial taxa that responded to diet. Instead, we found a small number of abundant phylotypes that were consistently present in all samples and made up half of the community in both diet groups. They varied strongly in abundance between individual samples at the genus but not at the family level. The remaining phylotypes were inconsistently present among replicate batches. Our findings suggest that S. lateralis harbors a highly dynamic core gut microbiota that is maintained even after fundamental dietary shifts, and that any dietary effects on the gut community are likely to be masked by strong individual variations.	[Schauer, Christine; Thompson, Claire; Brune, Andreas] Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany; [Schauer, Christine; Thompson, Claire; Brune, Andreas] Univ Marburg, LOEWE Ctr Synthet Microbiol, SYNMIKRO, Marburg, Germany; [Thompson, Claire] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	Max Planck Society; Philipps University Marburg; University of Sydney	Brune, A (corresponding author), Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany.	brune@mpi-marburg.mpg.de	Brune, Andreas/C-6944-2011	Brune, Andreas/0000-0002-2667-4391; allnutt, theo/0000-0002-1347-3777	LOEWE program of the State of Hesse (Center for Synthetic Microbiology); Max Planck Society; Alexander von Humboldt Foundation	LOEWE program of the State of Hesse (Center for Synthetic Microbiology); Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported within the LOEWE program of the State of Hesse (Center for Synthetic Microbiology) and by the Max Planck Society. CLT received a postdoctoral fellowship of the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bignell D.E., 1981, P57; BIGNELL DE, 1977, CAN J ZOOL, V55, P579, DOI 10.1139/z77-073; BIGNELL DE, 1977, CAN J ZOOL, V55, P1100, DOI 10.1139/z77-142; BIGNELL DE, 1977, J INVERTEBR PATHOL, V29, P338, DOI 10.1016/S0022-2011(77)80040-2; BRACKE JW, 1978, ANTIMICROB AGENTS CH, V13, P115, DOI 10.1128/AAC.13.1.115; Brune A, 2007, NATURE, V450, P487, DOI 10.1038/450487a; Brune A, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P439, DOI 10.1007/978-90-481-3977-4_16; COCHRAN DG, 1979, ANN ENTOMOL SOC AM, V72, P197, DOI 10.1093/aesa/72.2.197; COOPER RA, 1992, ENTOMOL EXP APPL, V63, P123, DOI 10.1007/BF00343572; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; DURBIN EJ, 1985, ENTOMOL EXP APPL, V37, P77, DOI 10.1007/BF00366811; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; HAMILTON RL, 1990, ENTOMOL EXP APPL, V55, P23, DOI 10.1007/BF00188224; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; Hongoh Y, 2010, MICROBIOL MONOGR, V19, P55, DOI 10.1007/978-3-642-13615-3_5; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Ikeda-Ohtsubo W, 2007, MICROBIOL-SGM, V153, P3458, DOI 10.1099/mic.0.2007/009217-0; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; KANE MD, 1991, APPL ENVIRON MICROB, V57, P2628, DOI 10.1128/AEM.57.9.2628-2634.1991; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; KUNKEL JG, 1966, J INSECT PHYSIOL, V12, P227, DOI 10.1016/0022-1910(66)90137-5; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Noda S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-158; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Core Team, 2021, R LANGUAGE ENV STAT; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Sabree ZL, 2012, APPL ENVIRON MICROB, V78, P204, DOI 10.1128/AEM.06540-11; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6018, DOI 10.1128/AEM.69.10.6018-6024.2003; Simpson JM, 1999, J MICROBIOL METH, V36, P167, DOI 10.1016/S0167-7012(99)00029-9; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WILLIS ER, 1957, J ECON ENTOMOL, V50, P438, DOI 10.1093/jee/50.4.438; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854; Zurek L, 1996, J INSECT PHYSIOL, V42, P743, DOI 10.1016/0022-1910(96)00028-5; Zurek L, 1998, J INSECT PHYSIOL, V44, P645, DOI 10.1016/S0022-1910(98)00024-9	46	51	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85861	10.1371/journal.pone.0085861	http://dx.doi.org/10.1371/journal.pone.0085861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454939	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100137
J	Witzmann, F; Schwarz-Wings, D; Hampe, O; Fritsch, G; Asbach, P				Witzmann, Florian; Schwarz-Wings, Daniela; Hampe, Oliver; Fritsch, Guido; Asbach, Patrick			Evidence of Spondyloarthropathy in the Spine of a Phytosaur (Reptilia: Archosauriformes) from the Late Triassic of Halberstadt, Germany	PLOS ONE			English	Article							OSSEOUS PATHOLOGY; CROCODILIANS	Pathologies in the skeleton of phytosaurs, extinct archosauriform reptiles restricted to the Late Triassic, have only been rarely described. The only known postcranial pathologies of a phytosaur are two pairs of fused vertebrae of "Angistorhinopsis ruetimeyeri'' from Halberstadt, Germany, as initially described by the paleontologist Friedrich von Huene. These pathologic vertebrae are redescribed in more detail in this study in the light of modern paleopathologic methods. Four different pathologic observations can be made in the vertebral column of this individual: 1) fusion of two thoracic vertebral bodies by new bone formation within the synovial membrane and articular capsule of the intervertebral joint; 2) fusion and conspicuous antero-posterior shortening of last presacral and first sacral vertebral bodies; 3) destruction and erosion of the anterior articular surface of the last presacral vertebra; and 4) a smooth depression on the ventral surface of the fused last presacral and first sacral vertebral bodies. Observations 1-3 can most plausibly and parsimoniously be attributed to one disease: spondyloarthropathy, an aseptic inflammatory process in which affected vertebrae show typical types of reactive new bone formation and erosion of subchondral bone. The kind of vertebral shortening present in the fused lumbosacral vertebrae suggests that the phytosaur acquired this disease in its early life. Observation 4, the smooth ventral depression in the fused lumbosacral vertebrae, is most probably not connected to the spondyloarthropathy, and can be regarded as a separate abnormality. It remains of uncertain origin, but may be the result of pressure, perhaps caused by a benign mass such as an aneurysm or cyst of unknown type. Reports of spondyloarthropathy in Paleozoic and Mesozoic reptiles are still exceptional, and our report of spondyloarthropathy in fossil material from Halberstadt is the first unequivocal occurrence of this disease in a Triassic tetrapod and in a phytosaur.	[Witzmann, Florian; Schwarz-Wings, Daniela; Hampe, Oliver] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Fritsch, Guido] Forschungsverbund Berlin eV, Leibniz Inst Zoo & Wildtierforsch IZW, Berlin, Germany; [Asbach, Patrick] Charite, Inst Radiol, D-13353 Berlin, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Leibniz Institut fur Zoo und Wildtierforschung; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Witzmann, F (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany.	florian.witzmann@mfn-berlin.de		Schwarz, Daniela/0000-0003-4017-8914; Asbach, Patrick/0000-0002-6885-3283	Museum fur Naturkunde, Leibniz Institute for Research on Evolution and Biodiversity, Berlin; Deutsche Forschungsgemeinschaft (DFG) [SCHW 1452/2-1, HA 1776/13-1]	Museum fur Naturkunde, Leibniz Institute for Research on Evolution and Biodiversity, Berlin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding is provided by the Museum fur Naturkunde, Leibniz Institute for Research on Evolution and Biodiversity, Berlin, and by the Deutsche Forschungsgemeinschaft (DFG) to DSW (SCHW 1452/2-1) and OH (HA 1776/13-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1922, Palaeontologische Zeitschrift Berlin, V5, P26; Adler CP, 2005, DIAGNOSTIK MAKROSKOP; Anonymous, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P1; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P133; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Bruggeman BJ, 2012, DEV DYNAM, V241, P675, DOI 10.1002/dvdy.23750; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; CAMP CHARLES L., 1930, MEM UNIV CALIFORNIA, V10, P1; Case C. E., 1932, Contributions from the Museum of Paleontology University of Michigan, V4, P57; Castriota-Scanderbeg A, 2005, ABNORMAL SKELETAL PH; CHATTERJEE S, 1978, Palaeontology (Oxford), V21, P83; Cisneros JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013425; Dawes B, 1930, PHILOS T R SOC LON B, V218, P115, DOI 10.1098/rstb.1930.0004; Eysel P, 1997, BAKTERIELLE INFEKTIO, P52; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Gozzi E, 2003, RIV ITAL PALEONTOL S, V109, P475, DOI 10.13130/2039-4942/5518; GREGORY J T, 1969, Palaeontologische Zeitschrift, V43, P37; GREGORY JOSEPH T., 1962, AMER MUS NOVITATES, V2095, P1; Hoffstetter R., 1969, P201; Huene F.von., 1921, Jahrbuch der Preussischen Geologischen Landes-Anstalt, V42, P59; Hungerbuhler A, 2002, PALAEONTOLOGY, V45, P377, DOI 10.1111/1475-4983.00242; Hunt A.P., 1989, P349; Hurlburt Grant R., 2003, Bulletin of the New Mexico Museum of Natural History and Science, V24, P105; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jaeger G.F., 1828, FOSSILEN REPTILIEN W; Jaekel O., 1914, Palaeontologische Zeitschrift Berlin, V1, P155; Lautenschlager S, 2011, PALAEONTOL Z, V85, P357, DOI 10.1007/s12542-011-0105-1; Leivseth G, 2005, CLIN BIOMECH, V20, P669, DOI 10.1016/j.clinbiomech.2005.04.006; Lucas S.G., 2012, NEW MEX MUS NAT HIST, V55, P1; McGregor J. H., 1906, MEMOIRS AM MUSEUM NA, V9, P27; Moodie R. L., 1917, ANN MED HIST, V1917, P374; Moodie RL, 1923, ANTIQUITY DIS; Moodie RL, 1918, SCI MON, V7, P265; Moore R. I., 1922, Science New York, V56, P417; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Resnick D., 1988, DIAGNOSIS BONE JOINT; Rothschild B, 2002, LANCET, V360, P1454, DOI 10.1016/S0140-6736(02)11471-1; Rothschild BM, ANAT HISTOL EMBRYOL; Rothschild B, 2010, J HERPETOL, V44, P13, DOI 10.1670/08-243.1; Rothschild B, 2009, APPL HERPETOL, V6, P47, DOI 10.1163/157075409X413842; Rothschild Bruce M., 2012, P1, DOI 10.1007/978-1-4614-0824-6_1; Rothschild BM, 2005, CURR RHEUMATOL REV, V1, P57, DOI 10.2174/1573397052954145; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Stocker MR, 2013, GEOL SOC SPEC PUBL, V379, P91, DOI 10.1144/SP379.5; Stocker MR, 2012, J VERTEBR PALEONTOL, V32, P573, DOI 10.1080/02724634.2012.649815; Tsuihiji T, 2004, J VERTEBR PALEONTOL, V24, P165, DOI 10.1671/A1129-12; Vega CS, 2014, VERTEBR PALEOBIOL PA, P151, DOI 10.1007/978-94-007-6841-3_9; von Huene F, 1913, B AM MUS NAT HIST, V32, P275; von Huene F, 1911, GEOLOGISCHE PALAONTO, V10, P67, DOI DOI 10.1086/621900; VONWETTSTEIN O, 1937, HDB ZOOLOGIE, P236; Westphal F., 1976, HDB PALAOHERPETOLOGI, V13, P99; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; WINCHESTER L, 1977, J ZOOL, V181, P495	56	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85511	10.1371/journal.pone.0085511	http://dx.doi.org/10.1371/journal.pone.0085511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454880	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100094
J	Bingle, LEH; Constantinidou, C; Shaw, RK; Islam, MS; Patel, M; Snyder, LAS; Lee, DJ; Penn, CW; Busby, SJW; Pallen, MJ				Bingle, Lewis E. H.; Constantinidou, Chrystala; Shaw, Robert K.; Islam, Md. Shahidul; Patel, Mala; Snyder, Lori A. S.; Lee, David J.; Penn, Charles W.; Busby, Stephen J. W.; Pallen, Mark J.			Microarray Analysis of the Ler Regulon in Enteropathogenic and Enterohaemorrhagic Escherichia coli Strains	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT; H-NS; CONTROLS EXPRESSION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; SUBVERSIVE ELEMENTS; PROTEIN SECRETION; REGULATORY REGION; EPITHELIAL-CELLS	The type III protein secretion system is an important pathogenicity factor of enteropathogenic and enterohaemorrhagic Escherichia coli pathotypes. The genes encoding this apparatus are located on a pathogenicity island (the locus of enterocyte effacement) and are transcriptionally activated by the master regulator Ler. In each pathotype Ler is also known to regulate genes located elsewhere on the chromosome, but the full extent of the Ler regulon is unclear, especially for enteropathogenic E. coli. The Ler regulon was defined for two strains of E. coli: E2348/69 (enteropathogenic) and EDL933 (enterohaemorrhagic) in mid and late log phases of growth by DNA microarray analysis of the transcriptomes of wild-type and ler mutant versions of each strain. In both strains the Ler regulon is focused on the locus of enterocyte effacement - all major transcriptional units of which are activated by Ler, with the sole exception of the LEE1 operon during mid-log phase growth in E2348/69. However, the Ler regulon does extend more widely and also includes unlinked pathogenicity genes: in E2348/69 more than 50 genes outside of this locus were regulated, including a number of known or potential pathogenicity determinants; in EDL933 only 4 extra-LEE genes, again including known pathogenicity factors, were activated. In E2348/69, where the Ler regulon is clearly growth phase dependent, a number of genes including the plasmid-encoded regulator operon perABC, were found to be negatively regulated by Ler. Negative regulation by Ler of PerC, itself a positive regulator of the ler promoter, suggests a negative feedback loop involving these proteins.	[Bingle, Lewis E. H.; Constantinidou, Chrystala; Shaw, Robert K.; Islam, Md. Shahidul; Patel, Mala; Snyder, Lori A. S.; Lee, David J.; Penn, Charles W.; Busby, Stephen J. W.; Pallen, Mark J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Pallen, MJ (corresponding author), Univ Warwick, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England.	m.pallen@warwick.ac.uk	Bingle, Lewis E.H./A-7591-2012; Busby, Stephen/C-2712-2015	Bingle, Lewis E.H./0000-0001-5168-5167; Pallen, Mark/0000-0003-1807-3657; Snyder, Lori/0000-0003-3172-3984; Lee, David/0000-0003-2395-351X; Busby, Stephen/0000-0003-2148-1758; Islam, Md Shahidul/0000-0003-4712-4046	BBSRC; BBSRC [BB/E020860/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C516701/1, BB/E020860/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant from the BBSRC (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bishop RE, 2005, J ENDOTOXIN RES, V11, P174, DOI 10.1179/096805105X35242; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Bustamante VH, 2011, MOL MICROBIOL, V82, P398, DOI 10.1111/j.1365-2958.2011.07819.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Garcia-Angulo VA, 2008, J BACTERIOL, V190, P2388, DOI 10.1128/JB.01602-07; Garmendia J, 2005, FEMS MICROBIOL LETT, V247, P137, DOI 10.1016/j.femsle.2005.04.035; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Islam MS, 2011, MOL MICROBIOL, V79, P468, DOI 10.1111/j.1365-2958.2010.07460.x; Islam MS, 2011, THESIS U BIRMINGHAM; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KEENLEYSIDE WJ, 1992, J BACTERIOL, V174, P8, DOI 10.1128/jb.174.1.8-16.1992; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Lathem WW, 2004, J EXP MED, V199, P1077, DOI 10.1084/jem.20030255; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Leverton LQ, 2005, INFECT IMMUN, V73, P1034, DOI 10.1128/IAI.73.2.1034-1043.2005; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 2011, MICROBIOL-SGM, V157, P1123, DOI 10.1099/mic.0.046094-0; Mellies JL, 2008, MICROBIOL-SGM, V154, P3624, DOI 10.1099/mic.0.2008/023382-0; Mellies JL, 2006, INFECT IMMUN, V74, P64, DOI 10.1128/IAI.74.1.64-72.2006; Mellies JL, 2001, INFECT IMMUN, V69, P315, DOI 10.1128/IAI.69.1.315-324.2001; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Mildiner-Earley S, 2006, INFECT IMMUN, V74, P4361, DOI 10.1128/IAI.00154-06; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Roe AJ, 2007, MICROBIOL-SGM, V153, P1350, DOI 10.1099/mic.0.2006/003707-0; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Salinger N, 2009, APPL ENVIRON MICROB, V75, P275, DOI 10.1128/AEM.01734-08; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Sperandio V, 2002, INFECT IMMUN, V70, P3085, DOI 10.1128/IAI.70.6.3085-3093.2002; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Tobe T, 1996, MOL MICROBIOL, V21, P963, DOI 10.1046/j.1365-2958.1996.531415.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Torres AG, 2007, J BACTERIOL, V189, P5916, DOI 10.1128/JB.00245-07; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; Vidal JE, 2006, INFECT IMMUN, V74, P2293, DOI 10.1128/IAI.74.4.2293-2303.2006; Wade JT, 2000, MOL MICROBIOL, V36, P223, DOI 10.1046/j.1365-2958.2000.01850.x; Wieler LH, 1997, FEMS MICROBIOL LETT, V156, P49, DOI 10.1016/S0378-1097(97)00403-5; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Xicohtencatl-Cortes J, 2010, J BIOL CHEM, V285, P32336, DOI 10.1074/jbc.M110.162248	60	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e80160	10.1371/journal.pone.0080160	http://dx.doi.org/10.1371/journal.pone.0080160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454682	Green Published, Green Accepted, gold			2022-12-27	WOS:000329925800003
J	Bordean, DM; Nica, DV; Harmanescu, M; Banatean-Dunea, I; Gergen, II				Bordean, Despina-Maria; Nica, Dragos V.; Harmanescu, Monica; Banatean-Dunea, Ionut; Gergen, Iosif I.			Soil Manganese Enrichment from Industrial Inputs: A Gastropod Perspective	PLOS ONE			English	Article							SNAIL HELIX-ASPERSA; METAL TRANSFER; GARDEN SNAIL; LAND SNAILS; HEAVY-METAL; TOXICITY; CADMIUM; GROWTH; LEAD; BIOAVAILABILITY	Manganese is one of the most abundant metal in natural environments and serves as an essential microelement for all living systems. However, the enrichment of soil with manganese resulting from industrial inputs may threaten terrestrial ecosystems. Several studies have demonstrated harmful effects of manganese exposure by cutaneous contact and/or by soil ingestion to a wide range of soil invertebrates. The link between soil manganese and land snails has never been made although these invertebrates routinely come in contact with the upper soil horizons through cutaneous contact, egg-laying, and feeding activities in soil. Therefore, we have investigated the direct transfer of manganese from soils to snails and assessed its toxicity at background concentrations in the soil. Juvenile Cantareus aspersus snails were caged under semi-field conditions and exposed first, for a period of 30 days, to a series of soil manganese concentrations, and then, for a second period of 30 days, to soils with higher manganese concentrations. Manganese levels were measured in the snail hepatopancreas, foot, and shell. The snail survival and shell growth were used to assess the lethal and sublethal effects of manganese exposure. The transfer of manganese from soil to snails occurred independently of food ingestion, but had no consistent effect on either the snail survival or shell growth. The hepatopancreas was the best biomarker of manganese exposure, whereas the shell did not serve as a long-term sink for this metal. The kinetics of manganese retention in the hepatopancreas of snails previously exposed to manganese-spiked soils was significantly influenced by a new exposure event. The results of this study reveal the importance of land snails for manganese cycling in terrestrial biotopes and suggest that the direct transfer from soils to snails should be considered when precisely assessing the impact of anthropogenic Mn releases on soil ecosystems.	[Bordean, Despina-Maria; Gergen, Iosif I.] Banats Univ Agr Sci & Vet Med Timisoara, Fac Food Proc Technol, Timisoara, Romania; [Nica, Dragos V.; Banatean-Dunea, Ionut] Banats Univ Agr Sci & Vet Med Timisoara, Fac Anim Sci & Biotechnol, Timisoara, Romania; [Harmanescu, Monica] Banats Univ Agr Sci & Vet Med Timisoara, Fac Agr, Timisoara, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine	Nica, DV (corresponding author), Banats Univ Agr Sci & Vet Med Timisoara, Fac Anim Sci & Biotechnol, Timisoara, Romania.	nicadragos@gmail.com	Harmanescu, Monica/AAQ-4906-2020; Bordean, Despina Maria/N-8613-2014; Gergen, Iosif I/O-3321-2014	Bordean, Despina Maria/0000-0002-1647-7992; Gergen, Iosif I/0000-0002-8144-1961	project Post-doctoral School Of Agriculture And Veterinary Medicine" [POSDRU/89/1.5/S/62371]; European Social Fund through the Sectorial Operational Programme for the Human Resources Development	project Post-doctoral School Of Agriculture And Veterinary Medicine"; European Social Fund through the Sectorial Operational Programme for the Human Resources Development	The present work was funded by the project "Post-doctoral School Of Agriculture And Veterinary Medicine POSDRU/89/1.5/S/62371'', co-financed by the European Social Fund through the Sectorial Operational Programme for the Human Resources Development 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway B.J., 2012, HEAVY METALS SOILS T, V22; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF MA IN PRESS; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; BEEBY A, 1989, ARCH ENVIRON CON TOX, V18, P623, DOI 10.1007/BF01055031; BERGER B, 1995, ENVIRON TOXICOL CHEM, V14, P781, DOI 10.1002/etc.5620140507; Bradley MD, 1996, BCPC SYMP SER, P353; Bura M, 2004, CRESTEREA MELCILOR A; CICAD, 2004, 63 CICAD WHO; Coeurdassier M, 2002, ECOTOX ENVIRON SAFE, V53, P425, DOI 10.1016/S0147-6513(02)00004-0; COPPOLINO ML, 2009, THESIS SO ILLINOIS U; DALLINGER R, 1993, SETAC SP P, P245; Dallinger R., 2001, P489, DOI 10.1079/9780851993188.0489; De Grisse A., 1996, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V61, P129; Dahm KCD, 2006, COMP BIOCHEM PHYS C, V143, P316, DOI 10.1016/j.cbpc.2006.03.005; De Vaufleury A, 2006, ENVIRON TOXICOL CHEM, V25, P797, DOI 10.1897/04-560R.1; DECALVENTI IB, 1965, ANN NY ACAD SCI, V118, P1015; Elmslie LJ, 1998, J MOLLUS STUD, V64, P400, DOI 10.1093/mollus/64.3.400; GOMOT A, 1989, J MOLLUS STUD, V55, P1, DOI 10.1093/mollus/55.1.1-a; Gomot-De Vaufleury A, 2002, ENVIRON TOXICOL CHEM, V21, P820, DOI [10.1897/1551-5028(2002)021<0820:MFTAOC>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;0820:MFTAOC&gt;2.0.CO;2]; Gomot-De Vaufleury A, 2000, ENVIRON SCI TECHNOL, V34, P1865, DOI 10.1021/es9907212; HARTENSTEIN R, 1981, J ENVIRON QUAL, V10, P372, DOI 10.2134/jeq1981.00472425001000030026x; Heller J., 2001, P413, DOI 10.1079/9780851993188.0413; Itziou A, 2011, ARCH ENVIRON CON TOX, V60, P697, DOI 10.1007/s00244-010-9583-5; Kerney M.P., 1979, FIELD GUIDE LAND SNA; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kuperman RG, 2004, ECOTOX ENVIRON SAFE, V57, P48, DOI 10.1016/j.ecoenv.2003.08.010; Laskowski R, 1996, ENVIRON POLLUT, V91, P289, DOI 10.1016/0269-7491(95)00070-4; Law NA, 1999, ADV INORG CHEM, V46, P305; Locher R, 2000, INVERTEBR REPROD DEV, V38, P53, DOI 10.1080/07924259.2000.9652436; Mensink PJ, 2011, J MOLLUS STUD, V77, P241, DOI 10.1093/mollus/eyr011; Menta C, 2001, ENVIRON POLLUT, V115, P205, DOI 10.1016/S0269-7491(01)00110-5; Millaleo R, 2010, J SOIL SCI PLANT NUT, V10, P476, DOI 10.4067/S0718-95162010000200008; Mourier B, 2011, CHEMOSPHERE, V85, P1057, DOI 10.1016/j.chemosphere.2011.07.035; Nica DV, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-145; Nica DV, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-55; Pauget B, 2012, SCI TOTAL ENVIRON, V431, P413, DOI 10.1016/j.scitotenv.2012.05.048; Pauget B, 2011, J HAZARD MATER, V192, P1804, DOI 10.1016/j.jhazmat.2011.07.016; Pihan F, 2000, ECOTOX ENVIRON SAFE, V46, P137, DOI 10.1006/eesa.1999.1891; Pinsino A, 2012, ENV CONTAMINATION, P17, DOI DOI 10.5772/31438; Post JE, 1999, P NATL ACAD SCI USA, V96, P3447, DOI 10.1073/pnas.96.7.3447; Rabitsch WB, 1996, B ENVIRON CONTAM TOX, V56, P734, DOI 10.1007/s001289900108; Regoli F, 2006, ENVIRON HEALTH PERSP, V114, P63, DOI 10.1289/ehp.8397; Salway J., 2012, MED BIOCH GLANCE; Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5; SPEEG KV, 1968, AM J PHYSIOL, V214, P1392; Tatara CP, 1998, AQUAT TOXICOL, V42, P255, DOI 10.1016/S0166-445X(97)00104-5; TAYLOR MG, 1988, PROC R SOC SER B-BIO, V234, P463, DOI 10.1098/rspb.1988.0059; WHO, 2004, WHOSDEWSH0304104REV1; WILLIAMSON P, 1980, OECOLOGIA, V44, P213, DOI 10.1007/BF00572682	49	10	10	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85384	10.1371/journal.pone.0085384	http://dx.doi.org/10.1371/journal.pone.0085384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454856	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800044
J	Jung, K; Molinari, J; Kalko, EKV				Jung, Kirsten; Molinari, Jesus; Kalko, Elisabeth K. V.			Driving Factors for the Evolution of Species-Specific Echolocation Call Design in New World Free-Tailed Bats (Molossidae)	PLOS ONE			English	Article							AERIAL-HAWKING; MOLECULAR PHYLOGENY; INSECTIVOROUS BATS; EMBALLONURID BATS; SIGNAL-DESIGN; MORPHOLOGY; BEHAVIOR; VARIABILITY; CHIROPTERA; WINGBEAT	Phylogeny, ecology, and sensorial constraints are thought to be the most important factors influencing echolocation call design in bats. The Molossidae is a diverse bat family with a majority of species restricted to tropical and subtropical regions. Most molossids are specialized to forage for insects in open space, and thus share similar navigational challenges. We use an unprecedented dataset on the echolocation calls of 8 genera and 18 species of New World molossids to explore how habitat, phylogenetic relatedness, body mass, and prey perception contribute to echolocation call design. Our results confirm that, with the exception of the genus Molossops, echolocation calls of these bats show a typical design for open space foraging. Two lines of evidence point to echolocation call structure of molossids reflecting phylogenetic relatedness. First, such structure is significantly more similar within than among genera. Second, except for allometric scaling, such structure is nearly the same in congeneric species. Despite contrasting body masses, 12 of 18 species call within a relatively narrow frequency range of 20 to 35 kHz, a finding that we explain by using a modeling approach whose results suggest this frequency range to be an adaptation optimizing prey perception in open space. To conclude, we argue that the high variability in echolocation call design of molossids is an advanced evolutionary trait allowing the flexible adjustment of echolocation systems to various sensorial challenges, while conserving sender identity for social communication. Unraveling evolutionary drivers for echolocation call design in bats has so far been hampered by the lack of adequate model organisms sharing a phylogenetic origin and facing similar sensorial challenges. We thus believe that knowledge of the echolocation call diversity of New World molossid bats may prove to be landmark to understand the evolution and functionality of species-specific signal design in bats.	[Jung, Kirsten; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Molinari, Jesus] Univ Los Andes, Fac Ciencias, Dept Biol, Merida 5101, Venezuela; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; University of Los Andes Venezuela; Smithsonian Institution; Smithsonian Tropical Research Institute	Jung, K (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	kirsten.jung@uni-ulm.de	caputo, carlo/N-3747-2014	Molinari, Jesus/0000-0002-9393-5483	German Academic Exchange Program (DAAD); DFG Schwerpunktprogramm; International Foundation for Science (Sweden) [B/2637]	German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG Schwerpunktprogramm(German Research Foundation (DFG)); International Foundation for Science (Sweden)(International Foundation for Science)	This work has partly been funded by the German Academic Exchange Program (DAAD) with a PhD-scholarship to K. Jung. Field work of E. Kalko was financed by the DFG Schwerpunktprogramm "Mechanismen der Aufrechterhaltung tropischer Diversitat". Field work by J. Molinari in Venezuela was partly funded by project B/2637 of the International Foundation for Science (Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Ammerman LK, 2012, J MAMMAL, V93, P12, DOI 10.1644/11-MAMM-A-103.1; Barquez RM, 2013, MAMMALIA, V77, P119, DOI 10.1515/mammalia-2012-0053; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Denzinger A., 2004, ECHOLOCATION BATS DO, P311; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Freeman P.W., 1981, FIELDIANA ZOOL CHICA, V7, P1, DOI DOI 10.5962/BHL.TITLE.3128; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; Gillam EH, 2007, ANIM BEHAV, V74, P277, DOI 10.1016/j.anbehav.2006.12.006; Gillam EH, 2009, BEHAV ECOL SOCIOBIOL, V64, P69, DOI 10.1007/s00265-009-0819-1; Guillen-Servent A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1599, DOI 10.1007/s00265-007-0392-4; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Holderied MW, 2008, INTEGR COMP BIOL, V48, P74, DOI 10.1093/icb/icn035; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Jakobsen L, 2013, NATURE, V493, P93, DOI 10.1038/nature11664; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 1999, J EXP BIOL, V202, P3359; JONES G, 1994, FUNCT ECOL, V8, P450, DOI 10.2307/2390068; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kingston T, 2003, J MAMMAL, V84, P205, DOI 10.1644/1545-1542(2003)084<0205:AOECIS>2.0.CO;2; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; Lim BK, 2008, J MAMM EVOL, V15, P79, DOI 10.1007/s10914-007-9068-0; Macswiney G. M. C., 2006, REV MEXICANA MASTOZO, V10, P102; Mohl B., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P435; Mora EC, 2004, J COMP PHYSIOL A, V190, P561, DOI 10.1007/s00359-004-0519-2; Mora EC, 2011, ACTA CHIROPTEROL, V13, P179, DOI 10.3161/150811011X578723; NEUWEILER G, 1984, NATURWISSENSCHAFTEN, V71, P446, DOI 10.1007/BF00455897; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Peters SL, 2002, J MAMMAL, V83, P1097, DOI 10.1644/1545-1542(2002)083<1097:SODFBC>2.0.CO;2; PYE JD, 1979, ENDEAVOUR, V3, P57, DOI 10.1016/0160-9327(79)90067-X; Ruczynski I, 2007, J EXP BIOL, V210, P3607, DOI 10.1242/jeb.009837; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Safi K, 2010, EVOL ECOL, V24, P703, DOI 10.1007/s10682-009-9326-0; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sparks DW, 2003, SOUTHWEST NAT, V48, P132, DOI 10.1894/0038-4909(2003)048<0132:FHONMA>2.0.CO;2; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Ubernickel K, 2013, ETHOLOGY, V119, P66, DOI 10.1111/eth.12038; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Voigt CC, 2012, J COMP PHYSIOL B, V182, P415, DOI 10.1007/s00360-011-0627-6; Voigt-Heucke SL, 2010, ANIM BEHAV, V80, P59, DOI 10.1016/j.anbehav.2010.03.025; WILKINS K T, 1989, Mammalian Species, P1, DOI 10.2307/3504148; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	54	69	81	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85279	10.1371/journal.pone.0085279	http://dx.doi.org/10.1371/journal.pone.0085279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454833	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800033
J	Terletzky, P; Ramsey, RD				Terletzky, Pat; Ramsey, Robert Douglas			A Semi-Automated Single Day Image Differencing Technique to Identify Animals in Aerial Imagery	PLOS ONE			English	Article							OBSERVER VARIABILITY; SIGHTABILITY MODEL; COUNTS; ABUNDANCE; PHOTOGRAPHS; ACCURACY; WALRUSES; SVALBARD; SEALS; PUPS	Our research presents a proof-of-concept that explores a new and innovative method to identify large animals in aerial imagery with single day image differencing. We acquired two aerial images of eight fenced pastures and conducted a principal component analysis of each image. We then subtracted the first principal component of the two pasture images followed by heuristic thresholding to generate polygons. The number of polygons represented the number of potential cattle (Bos taurus) and horses (Equus caballus) in the pasture. The process was considered semi-automated because we were not able to automate the identification of spatial or spectral thresholding values. Imagery was acquired concurrently with ground counts of animal numbers. Across the eight pastures, 82% of the animals were correctly identified, mean percent commission was 53%, and mean percent omission was 18%. The high commission error was due to small mis-alignments generated from image-to-image registration, misidentified shadows, and grouping behavior of animals. The high probability of correctly identifying animals suggests short time interval image differencing could provide a new technique to enumerate wild ungulates occupying grassland ecosystems, especially in isolated or difficult to access areas. To our knowledge, this was the first attempt to use standard change detection techniques to identify and enumerate large ungulates.	[Terletzky, Pat; Ramsey, Robert Douglas] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Terletzky, P (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	pat.terletzky@usu.edu			Ecology Center at Utah State University; Remote Sensing and GIS laboratory at Utah State University; Utah Division of Wildlife Resources	Ecology Center at Utah State University; Remote Sensing and GIS laboratory at Utah State University; Utah Division of Wildlife Resources	The research was funded by the Ecology Center and the Remote Sensing and GIS laboratory at Utah State University and the Utah Division of Wildlife Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agarwal C, 2002, NE297 USDA NE RES ST; Anderson CR, 1996, WILDLIFE SOC B, V24, P247; BAYLISS P, 1989, J APPL ECOL, V26, P925, DOI 10.2307/2403702; Bernatas S, 2004, WILDLIFE SOC B, V32, P638, DOI 10.2193/0091-7648(2004)032[0638:SMFCBS]2.0.CO;2; Brockett BH, 2002, S AFR J WILDL RES, V32, P121; Cai B, 1999, P 17 BIENN WORKSH CO, P231; CHAVEZ PS, 1989, PHOTOGRAMM ENG REM S, V55, P339; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; Coudray N, 2010, PATTERN RECOGN LETT, V31, P1010, DOI 10.1016/j.patrec.2009.12.025; Couturier S., 1994, P 6 N AM CAR WORKSH, V1994, P283; DEYOUNG CA, 1985, WILDLIFE SOC B, V13, P146; Easson G, 2010, REMOTE SENS-BASEL, V2, P1331, DOI 10.3390/rs2051331; Endsley M.R, 1996, HUM FAC TRANSP, V20, P163; ERWIN RM, 1982, J FIELD ORNITHOL, V53, P159; Fleming PJS, 2008, WILDLIFE RES, V35, P258, DOI 10.1071/WR07081; Freddy DJ, 2004, WILDLIFE SOC B, V32, P916, DOI 10.2193/0091-7648(2004)032[0916:HMMDAT]2.0.CO;2; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; GILMER DS, 1988, WILDLIFE SOC B, V16, P204; HARRIS MP, 1977, BRIT BIRDS, V70, P200; Heide-Jorgensen MP, 2004, MAR MAMMAL SCI, V20, P246, DOI 10.1111/j.1748-7692.2004.tb01154.x; Hess S. C., 2002, THESIS MONTANA STATE; HIBY AR, 1988, PHOTOGRAMM REC, V12, P589; Huang CQ, 2002, REMOTE SENS ENVIRON, V80, P203, DOI 10.1016/S0034-4257(02)00068-8; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jensen J. R., 2005, INTRO DIGITAL IMAGE; Koski W. R., 2010, Journal of Cetacean Research and Management, V11, P89; Krafft BA, 2006, MAR MAMMAL SCI, V22, P394, DOI 10.1111/j.1748-7692.2006.00035.x; Laliberte AS, 2003, WILDLIFE SOC B, V31, P362; Laube P, 2005, INT J GEOGR INF SCI, V19, P639, DOI 10.1080/13658810500105572; Linklater WL, 2002, WILDLIFE RES, V29, P221, DOI 10.1071/WR01063; Lowry MS, 1999, MAR MAMMAL SCI, V15, P143, DOI 10.1111/j.1748-7692.1999.tb00786.x; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Lu D, 2005, INT J REMOTE SENS, V26, P101, DOI 10.1080/01431160410001720748; Lubow BC, 2009, J WILDLIFE MANAGE, V73, P1420, DOI 10.2193/2008-538; Lydersen C, 2008, ARCTIC, V61, P119; Martinez B, 2009, REMOTE SENS ENVIRON, V113, P1823, DOI 10.1016/j.rse.2009.04.016; Medina-Carnicer R, 2010, PATTERN RECOGN, V43, P1224, DOI 10.1016/j.patcog.2009.10.019; Moller A.L., 2008, UTAH CLIMATE; NEALE CMU, 1994, REMOTE SENS ENVIRON, V49, P187, DOI 10.1016/0034-4257(94)90014-0; Patil R., 2004, 2004 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) (IEEE Cat. No.04CH37566), P1323; Rivest LP, 1998, BIOMETRICS, V54, P865, DOI 10.2307/2533841; Rosin PL, 2005, INT J REMOTE SENS, V26, P1075, DOI 10.1080/01431160512331330481; Russ J. C., 2006, IMAGE PROCESSING HDB; Russell J, 1994, 6 N AM CAR WORKSH PR, P319; SINCLAIR A R E, 1973, East African Wildlife Journal, V11, P93; Skelsey C, 2004, PHOTOGRAMM ENG REM S, V70, P341, DOI 10.14358/PERS.70.3.341; Snyder GM, 2001, MAR MAMMAL SCI, V17, P136, DOI 10.1111/j.1748-7692.2001.tb00984.x; Song DZ, 2010, IEEE T IMAGE PROCESS, V19, P2321, DOI 10.1109/TIP.2010.2048151; Stow D, 2002, ANAL MULTITEMPORAL R, V2, P59; Terletzky P., 2013, THESIS UTAH STATE U; TRIVEDI MM, 1982, PHOTOGRAMM ENG REM S, V48, P1879; Udevitz MS, 2005, MAR MAMMAL SCI, V21, P108, DOI 10.1111/j.1748-7692.2005.tb01211.x; Walter V, 2011, ISPRS J PHOTOGRAMM, V66, P519, DOI 10.1016/j.isprsjprs.2011.02.010; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WOLFE ML, 1989, J WILDLIFE MANAGE, V53, P593, DOI 10.2307/3809181; WYATT CL, 1985, PHOTOGRAMM ENG REM S, V51, P245; Young Robert F., 1999, Journal of Cetacean Research and Management, V1, P279	57	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85239	10.1371/journal.pone.0085239	http://dx.doi.org/10.1371/journal.pone.0085239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454827	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800029
J	Fulton, EA; Smith, ADM; Smith, DC; Johnson, P				Fulton, Elizabeth A.; Smith, Anthony D. M.; Smith, David C.; Johnson, Penelope			An Integrated Approach Is Needed for Ecosystem Based Fisheries Management: Insights from Ecosystem-Level Management Strategy Evaluation	PLOS ONE			English	Article							MANAGING FISHERIES; STOCK ASSESSMENT; CATCH SHARES; MARINE; LESSONS; CONSEQUENCES; BENEFITS; BEHAVIOR; IMPACT; FISH	An ecosystem approach is widely seen as a desirable goal for fisheries management but there is little consensus on what strategies or measures are needed to achieve it. Management strategy evaluation (MSE) is a tool that has been widely used to develop and test single species fisheries management strategies and is now being extended to support ecosystem based fisheries management (EBFM). We describe the application of MSE to investigate alternative strategies for achieving EBFM goals for a complex multispecies fishery in southeastern Australia. The study was undertaken as part of a stakeholder driven process to review and improve the ecological, economic and social performance of the fishery. An integrated management strategy, involving combinations of measures including quotas, gear controls and spatial management, performed best against a wide range of objectives and this strategy was subsequently adopted in the fishery, leading to marked improvements in performance. Although particular to one fishery, the conclusion that an integrated package of measures outperforms single focus measures we argue is likely to apply widely in fisheries that aim to achieve EBFM goals.	[Fulton, Elizabeth A.; Smith, Anthony D. M.; Smith, David C.] Commonwealth Sci & Ind Res Org, Wealth Oceans Flagship, Hobart, Tas, Australia; [Johnson, Penelope] Australian Bur Stat, Rural Environm & Agr Stat Branch, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Fulton, EA (corresponding author), Commonwealth Sci & Ind Res Org, Wealth Oceans Flagship, Hobart, Tas, Australia.	beth.fulton@csiro.au	Fulton, Beth/AAJ-1398-2021; Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917	Fisheries Research and Development Corporation (FRDC); CSIRO	Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was funded by the Fisheries Research and Development Corporation (FRDC) and CSIRO on behalf of the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Branch T, 2008, FISH FISH, V9, P1, DOI DOI 10.1111/J.1467-2979.2007.00266.X; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Brown K, 2008, ECOL ECON, V37, P417; CATON A, 2004, FISHERY STATUS REPOR; Charles A. T., 2001, SUSTAINABLE FISHERY; Chu C, 2009, FISH FISH, V10, P217, DOI 10.1111/j.1467-2979.2008.00313.x; Constable A, 2001, CCAMLR SCI, V8, P37; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Dinmore TA, 2003, ICES J MAR SCI, V60, P371, DOI 10.1016/S1054-3139(03)00010-9; DIXON JA, 1993, OCEANUS, V36, P35; Essington TE, 2012, CONSERV LETT, V5, P186, DOI 10.1111/j.1755-263X.2012.00226.x; Fulton E. A., 2005, ECOLOGICAL INDICATOR; Fulton EA, 2007, ALTERNATIVE MANAGEME; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Garcia SM, 2012, SCIENCE, V335, P1045, DOI 10.1126/science.1214594; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Grafton RQ, 2008, MAR POLICY, V32, P630, DOI 10.1016/j.marpol.2007.11.003; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Grafton RQ, 2005, EEN0505 AUSTR NAT U; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Kaiser MJ, 2005, CAN J FISH AQUAT SCI, V62, P1194, DOI 10.1139/F05-056; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P132, DOI 10.1093/icesjms/fsn201; Maurstad A, 2000, HUM ORGAN, V59, P37, DOI 10.17730/humo.59.1.q0242m112x223862; McLeod K., 2009, ECOSYSTEM BASED MANA; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Polacheck T, 2008, 023 CSIRO MAR ATM; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Rice J, 2011, FISH FISH, V12, P209, DOI 10.1111/j.1467-2979.2011.00416.x; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Rudd MA, 2002, COAST MANAGE, V30, P133, DOI 10.1080/089207502753504670; Sainsbury K, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P343, DOI 10.1079/9780851996332.0343; Smith A., 2004, ALTERNATIVE MANAGEME; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Smith ADM, 1999, ICES J MAR SCI, V56, P967, DOI 10.1006/jmsc.1999.0540; Smith ADM, 2001, MAR FRESHWATER RES, V52, P353, DOI 10.1071/MF01029; Smith ADM, 2008, FISH RES, V94, P373, DOI 10.1016/j.fishres.2008.06.006; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Ward T, 2002, POLICY PROPOSALS OPE, P80; Weninger Q, 2000, CAN J ECON, V33, P394, DOI 10.1111/0008-4085.00021; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	46	182	182	5	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84242	10.1371/journal.pone.0084242	http://dx.doi.org/10.1371/journal.pone.0084242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454722	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500008
J	Suckling, DM; Sforza, RFH				Suckling, David Maxwell; Sforza, Rene Francois Henri			What Magnitude Are Observed Non-Target Impacts from Weed Biocontrol?	PLOS ONE			English	Article							CLASSICAL BIOLOGICAL-CONTROL; CACTOBLASTIS-CACTORUM LEPIDOPTERA; FIELD HOST-RANGE; INVASIVE ALIEN PLANTS; GORSE POD MOTH; NEW-ZEALAND; TRICHOSIROCALUS-HORRIDUS; RISK-ASSESSMENT; COLEOPTERA; INSECTS	A systematic review focused by plant on non-target impacts from agents deliberately introduced for the biological control of weeds found significant non-target impacts to be rare. The magnitude of direct impact of 43 biocontrol agents on 140 non-target plants was retrospectively categorized using a risk management framework for ecological impacts of invasive species (minimal, minor, moderate, major, massive). The vast majority of agents introduced for classical biological control of weeds (>99% of 512 agents released) have had no known significant adverse effects on non-target plants thus far; major effects suppressing non-target plant populations could be expected to be detectable. Most direct non-target impacts on plants (91.6%) were categorized as minimal or minor in magnitude with no known adverse long-term impact on non-target plant populations, but a few cacti and thistles are affected at moderate (n = 3), major (n = 7) to massive (n = 1) scale. The largest direct impacts are from two agents (Cactoblastis cactorum on native cacti and Rhinocyllus conicus on native thistles), but these introductions would not be permitted today as more balanced attitudes exist to plant biodiversity, driven by both society and the scientific community. Our analysis shows (as far as is known), weed biological control agents have a biosafety track record of >99% of cases avoiding significant non-target impacts on plant populations. Some impacts could have been overlooked, but this seems unlikely to change the basic distribution of very limited adverse effects. Fewer nontarget impacts can be expected in future because of improved science and incorporation of wider values. Failure to use biological control represents a significant opportunity cost from the certainty of ongoing adverse impacts from invasive weeds. It is recommended that a simple five-step scale be used to better communicate the risk of consequences from both action (classical biological control) and no action (ongoing impacts from invasive weeds).	[Suckling, David Maxwell] New Zealand Inst Plant & Food Res Ltd, Biosecur Grp, Christchurch, New Zealand; [Suckling, David Maxwell] Better Border Biosecur, Christchurch, New Zealand; [Sforza, Rene Francois Henri] USDA ARS, European Biol Control Lab, Montferrier Sur Lez, France	New Zealand Institute for Plant & Food Research Ltd	Suckling, DM (corresponding author), New Zealand Inst Plant & Food Res Ltd, Biosecur Grp, Christchurch, New Zealand.	Max.Suckling@plantandfood.co.nz	Suckling, David Maxwell/M-7730-2019; Suckling, David M/F-7005-2010	Suckling, David Maxwell/0000-0001-7216-9348; Suckling, David M/0000-0001-7216-9348; sforza, Rene/0000-0002-1737-2033	New Zealand Ministry of Business, Innovation and Employment [CO2X0501]; Organisation for Economic Cooperation and Development (Cooperative Research Programme: Biological Resource Management for Sustainable Agricultural Systems) at the European Biological Control Laboratory (USDA ARS), Montpellier	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Organisation for Economic Cooperation and Development (Cooperative Research Programme: Biological Resource Management for Sustainable Agricultural Systems) at the European Biological Control Laboratory (USDA ARS), Montpellier	This project was partially funded by the New Zealand Ministry of Business, Innovation and Employment (CO2X0501 Better Border Biosecurity, www.b3nz.org), and completed during a fellowship to DMS supported by the Organisation for Economic Cooperation and Development (Cooperative Research Programme: Biological Resource Management for Sustainable Agricultural Systems) at the European Biological Control Laboratory (USDA ARS), Montpellier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres L. A., 1985, Proceedings of the VI International Symposium on Biological Control of Weeds., P235; APHIS, 2012, TECHN ADV GROUP BIOL; Barton J, 2004, BIOL CONTROL, V31, P99, DOI 10.1016/j.biocontrol.2004.04.008; Bourdot GW, 2007, NEW ZEAL J AGR RES, V50, P139, DOI 10.1080/00288230709510288; Briese DT, 2004, AUST J ENTOMOL, V43, P304, DOI 10.1111/j.1326-6756.2004.00442.x; Callaway RM, 1999, ECOLOGY, V80, P1196, DOI 10.1890/0012-9658(1999)080[1196:BCHMIC]2.0.CO;2; CAMPBELL CL, 1991, ENVIRON ENTOMOL, V20, P303, DOI 10.1093/ee/20.1.303; Clewley GD, 2012, J APPL ECOL, V49, P1287, DOI 10.1111/j.1365-2664.2012.02209.x; Corcket E, 2013, INTERACTIONS INSECTS, P443; Coulson JR, 2000, 110 YEARS BIOL CONTR; CRC, 2001, COOP RES CTR CRC WEE, P27; Cronk Q.C.B., 1995, PLANT INVADERS, V79, P313, DOI DOI 10.1023/A:1017152906274; De Clerck-Floate Rosemarie, 2011, P291; Denslow JS, 2005, BIOL CONTROL, V35, P307, DOI 10.1016/j.biocontrol.2005.02.008; DODD ALAN P., 1940; Dodge G, 2005, APPENDICES COLONIZAT; EPA, 2012, BIOL CONTR AG APPR U; EPA, 2011, DEC MAK TECHN GUID I; Ferguson CM, 2007, BCANZ BIOL CONTROL A; Fowler S. V., 2010, 17th Australasian weeds conference. New frontiers in New Zealand: together we can beat the weeds. Christchurch, New Zealand, 26-30 September, 2010, P211; Fowler SV, 2006, ECOL STU AN, V186, P355; Fowler SV, 2012, J APPL ECOL, V49, P307, DOI 10.1111/j.1365-2664.2011.02106.x; Fowler SV, 2000, AUSTRAL ECOL, V25, P553, DOI 10.1046/j.1442-9993.2000.01075.x; Gaskin JF, 2011, BIOL CONTROL, V58, P1, DOI 10.1016/j.biocontrol.2011.03.015; Gassmann A, 2001, EVALUATING INDIRECT ECOLOGICAL EFFECTS OF BIOLOGICAL CONTROL, P147, DOI 10.1079/9780851994536.0147; Gerard P. J., 2006, New Zealand Plant Protection, V59, P285; GREATHEAD D. J., 1968, PANS (C), V14, P167; Groenteman R, 2011, BIOL CONTROL, V57, P50, DOI 10.1016/j.biocontrol.2011.01.005; Habeck DH, 1990, 333 FLOR DEP AGR CON; Havens K, 2012, BIOL CONSERV, V155, P202, DOI 10.1016/j.biocon.2012.06.010; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; JAYANTH KP, 1993, B ENTOMOL RES, V83, P595, DOI 10.1017/S0007485300040013; Jezorek HA, 2010, ENVIRON ENTOMOL, V39, P1884, DOI 10.1603/EN10022; Johnson DM, 1998, FLA ENTOMOL, V81, P12, DOI 10.2307/3495992; Julien M. H., 1998, BIOL CONTROL WEEDS W; Julien M, 2012, BIOLOGICAL CONTROL OF WEEDS IN AUSTRALIA, P518; Klein H, 2011, AFR ENTOMOL, V19, P515, DOI 10.4001/003.019.0214; Lawton J. H., 1990, FRI Bulletin, P3; Le Bourgeois T, 2011, P 13 INT S BIOC WEED; Louda SM, 2003, CONSERV BIOL, V17, P73, DOI 10.1046/j.1523-1739.2003.02020.x; Louda SM, 2005, BIOL CONTROL, V35, P253, DOI 10.1016/j.biocontrol.2005.07.022; Louda SM, 1997, SCIENCE, V277, P1088, DOI 10.1126/science.277.5329.1088; Mantyla E, 2011, OECOLOGIA, V165, P143, DOI 10.1007/s00442-010-1774-2; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; McFadyen R. E. C., 2012, Pakistan Journal of Weed Science Research, V18, P333; McFadyen REC, 1998, ANNU REV ENTOMOL, V43, P369, DOI 10.1146/annurev.ento.43.1.369; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nordblum T, 2001, COOPERATIVE RES CTR, P35; Page AR, 2006, TECHNICAL SERIES CRC, V10; Palmer WA, 2010, BIOL CONTROL, V52, P271, DOI 10.1016/j.biocontrol.2009.07.011; Palmer W. A., 2004, Weed management: balancing people, planet, profit. 14th Australian Weeds Conference, Wagga Wagga, New South Wales, Australia, 6-9 September 2004: papers and proceedings, P341; Paraiso O, 2011, FLA ENTOMOL, V94, P81, DOI 10.1653/024.094.0111; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Paxton EH, 2011, CONDOR, V113, P255, DOI 10.1525/cond.2011.090226; Paynter Q, 2008, BIOL CONTROL, V46, P453, DOI 10.1016/j.biocontrol.2008.05.004; Paynter QE, 2004, N Z PLANT PROTECT-SE, P102, DOI 10.30843/nzpp.2004.57.6979; Paynter Q, 2008, BIOL CONTROL, V44, P248, DOI 10.1016/j.biocontrol.2007.08.003; Pearson DE, 2003, TRENDS ECOL EVOL, V18, P456, DOI 10.1016/S0169-5347(03)00188-5; Pearson DE, 2008, ECOL APPL, V18, P1489, DOI 10.1890/07-1789.1; Pemberton RW, 2007, BIOL CONTROL, V41, P272, DOI 10.1016/j.biocontrol.2007.02.002; Pemberton RW, 2000, OECOLOGIA, V125, P489, DOI 10.1007/s004420000477; PEMBERTON RW, 1990, ENTOMOPHAGA, V35, P71, DOI 10.1007/BF02374303; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; Pratt PD, 2009, BIOL CONTROL, V49, P146, DOI 10.1016/j.biocontrol.2009.01.014; Shaw RH, 2011, WEED RES, V51, P552, DOI 10.1111/j.1365-3180.2011.00880.x; SHEPPARD AW, 2003, BIOCONTROL NEWS INFO, V24, P91; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Simberloff D, 2012, BIOCONTROL, V57, P263, DOI 10.1007/s10526-011-9392-4; Sogge MK, 2008, RESTOR ECOL, V16, P146, DOI 10.1111/j.1526-100X.2008.00357.x; Stephens AEA, 2007, AUST J ENTOMOL, V46, P152, DOI 10.1111/j.1440-6055.2007.00571.x; Suckling DM, 2013, BIOL CONTROL, V66, P27, DOI 10.1016/j.biocontrol.2013.02.009; Suckling DM, 2013, AGR ENTOMOL EARLY VI, DOI [10.1111/afe.12028, DOI 10.1111/AFE.12028]; Takahashi M, 2009, ENVIRON ENTOMOL, V38, P731, DOI 10.1603/022.038.0325; Tryon H, 1910, QUEENSLAND AGR J, V25, P188; TURNER CE, 1987, ENVIRON ENTOMOL, V16, P111, DOI 10.1093/ee/16.1.111; Van Lenteren JC, 2003, BIOCONTROL, V48, P3, DOI 10.1023/A:1021262931608; van Wilgen BW, 2004, S AFR J SCI, V100, P113; Waipara N. W., 2009, New Zealand Plant Protection, V62, P41; WAPSHERE AJ, 1974, ANN APPL BIOL, V77, P201, DOI 10.1111/j.1744-7348.1974.tb06886.x; Wiggins GJ, 2009, BIOCONTROL SCI TECHN, V19, P993, DOI 10.1080/09583150903191343; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Willis AJ, 2003, CRC AUST WEED MANAGE, P35; Willis AJ, 1998, AUST J BOT, V46, P707, DOI 10.1071/BT97025; Withers Toni M., 2008, New Zealand Entomologist, V31, P67; Zimmermann H. G., 2000, Diversity and Distributions, V6, P259, DOI 10.1046/j.1472-4642.2000.00088.x; Zimmermann HG, 2004, CACTOBLASTIS CACTORU	86	89	90	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84847	10.1371/journal.pone.0084847	http://dx.doi.org/10.1371/journal.pone.0084847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454755	gold, Green Published			2022-12-27	WOS:000329922500023
J	Wang, XW; Han, XP; Wang, BH				Wang, Xiang-Wen; Han, Xiao-Pu; Wang, Bing-Hong			Correlations and Scaling Laws in Human Mobility	PLOS ONE			English	Article							MODEL	Background: In recent years, several path-breaking findings on human mobility patterns point out a novel issue which is of important theoretical significance and great application prospects. The empirical analysis of the data which can reflect the real-world human mobility provides the basic cognition and verification of the theoretical models and predictive results on human mobility. One of the most noticeable findings in previous studies on human mobility is the wide-spread scaling anomalies, e. g. the power-law-like displacement distributions. Understanding the origin of these scaling anomalies is of central importance to this issue and therefore is the focus of our discussion. Methodology/Principal Findings: In this paper, we empirically analyze the real-world human movements which are based on GPS records, and observe rich scaling properties in the temporal-spatial patterns as well as an abnormal transition in the speed-displacement patterns together with an evidence to the real-world traffic jams. In addition, we notice that the displacements at the population level show a significant positive correlation, indicating a cascading-like nature in human movements. Furthermore, our analysis at the individual level finds that the displacement distributions of users with stronger correlations usually are closer to the power law, suggesting a correlation between the positive correlation of the displacement series and the form of an individual's displacement distribution. Conclusions/Significance: These empirical findings make connections between the two basic properties of human mobility, the scaling anomalies on displacement distributions and the positive correlations on displacement series, implying the cascading-like dynamics which is exhibited by the positive correlations would cause the emergence of scaling properties on human mobility patterns. Our findings would inspire further researches on mechanisms and predictions of human mobility.	[Wang, Xiang-Wen; Han, Xiao-Pu] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Xiang-Wen] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Wang, Xiang-Wen; Wang, Bing-Hong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Wang, Bing-Hong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China; [Wang, Bing-Hong] Shanghai Univ Sci & Technol, Res Ctr Complex Syst Sci, Shanghai 201800, Peoples R China	Hangzhou Normal University; Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wenzhou University; University of Shanghai for Science & Technology	Han, XP (corresponding author), Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Zhejiang, Peoples R China.	xp@hznu.edu.cn	Wang, Xiangwen/AAR-6326-2021; Han, Xiao-Pu/E-8401-2010	Wang, Xiangwen/0000-0002-4755-4639	National Natural Science Foundation of China [11205040, 11105024, 70971089, 10635040]; Zhejiang Provincial Natural Science Foundation of China [LY12A05003]; start-up foundation and Pandeng project of Hangzhou Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); start-up foundation and Pandeng project of Hangzhou Normal University	This work was supported by the National Natural Science Foundation of China Grants Nos. 11205040, 11105024, 70971089 and 10635040. XPH acknowledges the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY12A05003), the start-up foundation and Pandeng project of Hangzhou Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Clements M., ARXIV11065213; Feder J, 1988, FRACTALS PHYS SOLIDS; Gallotti R, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113920010; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Han XP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036117; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Lee K, 2009, IEEE INFOCOM SER, P855, DOI 10.1109/INFCOM.2009.5061995; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Ni SJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016111; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Rhee I., 2008, IEEE INFOCOM, V9, P630; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rybski D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00560; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Scellato S, 2011, P 17 ACM SIGKDD INT, P1046, DOI DOI 10.1145/2020408.2020575; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Veneziano D, ARXIV11013719; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Yan XY, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/12/120506; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677	37	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84954	10.1371/journal.pone.0084954	http://dx.doi.org/10.1371/journal.pone.0084954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454769	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500027
J	Shin, HJ; Joo, J; Yoon, JH; Yoo, CW; Kim, JY				Shin, Hye-Jin; Joo, Jungnam; Yoon, Ji Hyun; Yoo, Chong Woo; Kim, Joo-Young			Physical Status of Human Papillomavirus Integration in Cervical Cancer Is Associated with Treatment Outcome of the Patients Treated with Radiotherapy	PLOS ONE			English	Article							DISEASE-FREE SURVIVAL; TYPE-16 DNA; INFECTION	Integration of human papillomavirus (HPV) DNA into the host genome is a critical aetiological event in the progression from normal cervix to intraepithelial neoplasm, and finally to invasive cervical cancer. However, there has been little work on how HPV integration status relates to treatment outcome for cervical carcinomas. In the current study, HPV E2 and E6 gene copy numbers were measured in 111 cervical cancer tissues using real-time QPCR. Integration patterns were divided into four groups: single copy-integrated with episomal components (group 1), single copy-integrated without episomal components (group 2), multicopy tandem repetition-integrated (group 3), and low HPV (group 4) groups. A relapse-predicting model was constructed using multivariable Cox proportional hazards model to classify patients into different risk groups for disease-free survival (DFS). The model was internally validated using bootstrap resampling. Oligonucleotide microarray analysis was performed to evaluate gene expression patterns in relation to the different integration groups. DFS rate was inferior in the order of the patients in group 4, group 2/3, and group 1. Multivariate analysis showed that histologic grade, clinical stage group, and integration pattern were significant prognostic factors for poor DFS. The current prognostic model accurately predicted the risk of relapse, with an area under the receiver operating characteristic curve (AUC) of 0.74 (bootstrap corrected, 0.71). In conclusion, these data suggest that HPV integration pattern is a potent prognostic factor for tailored treatment of cervical cancer.	[Shin, Hye-Jin; Kim, Joo-Young] Natl Canc Ctr, Radiat Med Branch, Res Inst & Hosp, Goyang, South Korea; [Joo, Jungnam] Natl Canc Ctr, Biometr Res Branch, Res Inst & Hosp, Goyang, South Korea; [Yoo, Chong Woo] Natl Canc Ctr, Ctr Uterine Canc, Res Inst & Hosp, Goyang, South Korea; [Yoon, Ji Hyun] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); McGill University	Kim, JY (corresponding author), Natl Canc Ctr, Radiat Med Branch, Res Inst & Hosp, Goyang, South Korea.	jooyoungcasa@ncc.re.kr			National Cancer Center, Goyang, Korea [1310300, 1110033]	National Cancer Center, Goyang, Korea	This work was supported by the National Cancer Center, Goyang, Korea (Grant 1310300 and 1110033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kim JY, 2009, J CLIN ONCOL, V27, P5088, DOI 10.1200/JCO.2009.22.4659; Kusumoto-Matsuo R, 2011, GENES CELLS, V16, P23, DOI 10.1111/j.1365-2443.2010.01458.x; Li W, 2008, J CANCER RES CLIN, V134, P1355, DOI 10.1007/s00432-008-0413-3; Lindel K, 2006, INT J RADIAT ONCOL, V65, P760, DOI 10.1016/j.ijrobp.2006.01.023; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett MR, 2006, P NATL ACAD SCI USA, V103, P3822, DOI 10.1073/pnas.0600078103; Sell S, 2011, CURR PHARM BIOTECHNO, V12, P182, DOI 10.2174/138920111794295675; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; UNGER ER, 1995, J INFECT DIS, V172, P1184, DOI 10.1093/infdis/172.5.1184; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; WAGATSUMA M, 1990, J VIROL, V64, P813, DOI 10.1128/JVI.64.2.813-821.1990	14	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e78995	10.1371/journal.pone.0078995	http://dx.doi.org/10.1371/journal.pone.0078995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427262	gold, Green Published, Green Submitted			2022-12-27	WOS:000329868200002
J	Zhao, J; Wan, SZ; Zhang, CL; Liu, ZF; Zhou, LX; Fu, SL				Zhao, Jie; Wan, Songze; Zhang, Chenlu; Liu, Zhanfeng; Zhou, Lixia; Fu, Shenglei			Contributions of Understory and/or Overstory Vegetations to Soil Microbial PLFA and Nematode Diversities in Eucalyptus Monocultures	PLOS ONE			English	Article							PLANT DIVERSITY; ECOSYSTEM; BIODIVERSITY; FOREST; COMMUNITIES; PRODUCTIVITY; GRASSLAND; IDENTITY; PLANTATIONS; DYNAMICS	Ecological interactions between aboveground and belowground biodiversity have received many attentions in the recent decades. Although soil biodiversity declined with the decrease of plant diversity, many previous studies found plant species identities were more important than plant diversity in controlling soil biodiversity. This study focused on the responses of soil biodiversity to the altering of plant functional groups, namely overstory and understory vegetations, rather than plant diversity gradient. We conducted an experiment by removing overstory and/or understory vegetation to compare their effects on soil microbial phospholipid fatty acid (PLFA) and nematode diversities in eucalyptus monocultures. Our results indicated that both overstory and understory vegetations could affect soil microbial PLFA and nematode diversities, which manifested as the decrease in Shannon-Wiener diversity index (H') and Pielou evenness index (J) and the increase in Simpson dominance index (lambda) after vegetation removal. Soil microclimate change explained part of variance of soil biodiversity indices. Both overstory and understory vegetations positively correlated with soil microbial PLFA and nematode diversities. In addition, the alteration of soil biodiversity might be due to a mixing effect of bottom-up control and soil microclimate change after vegetation removal in the studied plantations. Given the studied ecosystem is common in humid subtropical and tropical region of the world, our findings might have great potential to extrapolate to large scales and could be conducive to ecosystem management and service.	[Zhao, Jie; Wan, Songze; Liu, Zhanfeng; Zhou, Lixia; Fu, Shenglei] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhang, Chenlu] Henan Univ, Coll Life Sci, State Key Lab Cotton Biol, Key Lab Plant Stress Biol, Kaifeng, Peoples R China; [Zhao, Jie] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Henan University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Fu, SL (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	sfu@scbg.ac.cn	Liu, Zhanfeng/ABD-3933-2021; Zhou, Li/GSE-4531-2022; Fu, Shenglei/B-2729-2012	Liu, Zhanfeng/0000-0002-6602-6196; 	Chinese Academy of Sciences [KSCZ2-EW-Z-6]; Natural Science Fund of China [31210103920]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCZ2-EW-Z-6) and Natural Science Fund of China (31210103920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell RC, 2008, FOREST ECOL MANAG, V255, P3621, DOI 10.1016/j.foreco.2008.02.049; Bardgett R.D., 2005, Biological Diversity and Function in Soil; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; BIRD GA, 1988, CAN J SOIL SCI, V68, P29, DOI 10.4141/cjss88-003; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Brussaard L, 1997, AMBIO, V26, P563; Busse MD, 1996, SOIL SCI SOC AM J, V60, P1614, DOI 10.2136/sssaj1996.03615995006000060004x; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; FAO, 2006, 103 FAO WORLD SOIL R; Forge TA, 2001, BIOL FERT SOILS, V34, P170, DOI 10.1007/s003740100390; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Hartmann M, 2012, ISME J; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Konneke M, 2003, ENVIRON MICROBIOL, V5, P1064, DOI 10.1046/j.1462-2920.2003.00499.x; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lopez G, 1997, J APPL ECOL, V34, P1257, DOI 10.2307/2405236; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Neher DA, 1994, APPL SOIL ECOL, V1, P17, DOI 10.1016/0929-1393(94)90020-5; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Panesar TS, 2000, PEDOBIOLOGIA, V44, P641, DOI 10.1078/S0031-4056(04)70079-7; SEASTEDT TR, 1981, ECOLOGY, V62, P126, DOI 10.2307/1936676; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Viketoft M, 2005, APPL SOIL ECOL, V30, P90, DOI 10.1016/j.apsoil.2005.02.007; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Woodward FI, 1996, J VEG SCI, V7, P306, DOI 10.1111/j.1654-1103.1996.tb00489.x; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Zhao J, 2014, APPL SOIL ECOL, V75, P134, DOI 10.1016/j.apsoil.2013.10.011; Zhao J, 2013, FOREST ECOL MANAG, V310, P80, DOI 10.1016/j.foreco.2013.08.013; Zhao J, 2013, ECOL INDIC, V24, P236, DOI 10.1016/j.ecolind.2012.06.012; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020; Zhao J, 2011, SOIL BIOL BIOCHEM, V43, P954, DOI 10.1016/j.soilbio.2011.01.010	46	16	21	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85513	10.1371/journal.pone.0085513	http://dx.doi.org/10.1371/journal.pone.0085513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427315	Green Published, gold			2022-12-27	WOS:000329868200056
J	Werden, L; Barker, IK; Bowman, J; Gonzales, EK; Leighton, PA; Lindsay, LR; Jardine, CM				Werden, Lisa; Barker, Ian K.; Bowman, Jeff; Gonzales, Emily K.; Leighton, Patrick A.; Lindsay, L. Robbin; Jardine, Claire M.			Geography, Deer, and Host Biodiversity Shape the Pattern of Lyme Disease Emergence in the Thousand Islands Archipelago of Ontario, Canada	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; BLACKLEGGED TICK ACARI; BORRELIA-BURGDORFERI; RANGE EXPANSION; COMMUNITY COMPOSITION; RESERVOIR COMPETENCE; PASSIVE SURVEILLANCE; FOREST FRAGMENTATION; HABITAT DISTRIBUTION; PEROMYSCUS-LEUCOPUS	In the Thousand Islands region of eastern Ontario, Canada, Lyme disease is emerging as a serious health risk. The factors that influence Lyme disease risk, as measured by the number of blacklegged tick (Ixodes scapularis) vectors infected with Borrelia burgdorferi, are complex and vary across eastern North America. Despite study sites in the Thousand Islands being in close geographic proximity, host communities differed and both the abundance of ticks and the prevalence of B. burgdorferi infection in them varied among sites. Using this archipelago in a natural experiment, we examined the relative importance of various biotic and abiotic factors, including air temperature, vegetation, and host communities on Lyme disease risk in this zone of recent invasion. Deer abundance and temperature at ground level were positively associated with tick abundance, whereas the number of ticks in the environment, the prevalence of B. burgdorferi infection, and the number of infected nymphs all decreased with increasing distance from the United States, the presumed source of this new endemic population of ticks. Higher species richness was associated with a lower number of infected nymphs. However, the relative abundance of Peromyscus leucopus was an important factor in modulating the effects of species richness such that high biodiversity did not always reduce the number of nymphs or the prevalence of B. burgdorferi infection. Our study is one of the first to consider the interaction between the relative abundance of small mammal hosts and species richness in the analysis of the effects of biodiversity on disease risk, providing validation for theoretical models showing both dilution and amplification effects. Insights into the B. burgdorferi transmission cycle in this zone of recent invasion will also help in devising management strategies as this important vector-borne disease expands its range in North America.	[Werden, Lisa; Barker, Ian K.; Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Werden, Lisa] Pk Canada Agcy, Mallorytown, ON, Canada; [Barker, Ian K.; Jardine, Claire M.] Canadian Cooperat Wildlife Hlth Ctr, Guelph, ON, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Peterborough, ON, Canada; [Gonzales, Emily K.] Univ Victoria, Victoria, BC, Canada; [Leighton, Patrick A.] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	University of Guelph; Ministry of Natural Resources & Forestry; University of Victoria; Universite de Montreal; Public Health Agency of Canada	Jardine, CM (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	cjardi01@uoguelph.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Lindsay, Robbin/0000-0001-7236-2930	University of Guelph; Canadian Cooperative Wildlife Health Centre; Ontario Ministry of Natural Resources; Parks Canada Agency; Public Health Agency of Canada; Natural Sciences and Engineering and Research Council of Canada; Ontario Graduate Scholarship	University of Guelph; Canadian Cooperative Wildlife Health Centre; Ontario Ministry of Natural Resources; Parks Canada Agency; Public Health Agency of Canada; Natural Sciences and Engineering and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Funding for this study was provided by the University of Guelph (CJ), Canadian Cooperative Wildlife Health Centre (IKB), Ontario Ministry of Natural Resources (JB), Parks Canada Agency (EKG), Public Health Agency of Canada (LRL), Natural Sciences and Engineering and Research Council of Canada (CJ; www.nserc.ca), and an Ontario Graduate Scholarship (LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Employees and/or students with all funding agencies assisted with data collection.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Anderson JM, 2006, APPL ENVIRON MICROB, V72, P5331, DOI 10.1128/AEM.00014-06; [Anonymous], [No title captured]; Bertrand MR, 1996, J MED ENTOMOL, V33, P619, DOI 10.1093/jmedent/33.4.619; Bouchard C, 2013, J MED ENTOMOL, V50, P384, DOI 10.1603/ME12093; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Bowman J, 2002, CONSERV ECOL, V6; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; DANIELS TJ, 1995, J MED ENTOMOL, V32, P5, DOI 10.1093/jmedent/32.1.5; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Durden LA., 1996, NYMPHS GENUS IXODES; Eder T., 2002, MAMMALS ONTARIO; Eisen Lars, 2002, P91, DOI 10.1079/9780851996325.0091; Giardina AR, 2000, CAN J ZOOL, V78, P2184, DOI 10.1139/cjz-78-12-2184; Ginsberg HS, 2005, J MED ENTOMOL, V42, P445, DOI 10.1603/0022-2585(2005)042[0445:RCONNA]2.0.CO;2; Ginsberg HS, 1996, EXP APPL ACAROL, V20, P533, DOI 10.1007/BF00048285; Glavanakov S, 2001, AM J TROP MED HYG, V65, P538, DOI 10.4269/ajtmh.2001.65.538; Gray JS, 1998, ZBL BAKT-INT J MED M, V287, P211, DOI 10.1016/S0934-8840(98)80123-0; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Jackson CA, 2002, J CLIN MICROBIOL, V40, P2070, DOI 10.1128/JCM.40.6.2070-2073.2002; Jordan RA, 2005, ENVIRON ENTOMOL, V34, P801, DOI 10.1603/0046-225X-34.4.801; Jordan RA, 2007, J MED ENTOMOL, V44, P752, DOI 10.1603/0022-2585(2007)44[752:EORDDO]2.0.CO;2; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Krohne DT, 1999, CAN J ZOOL, V77, P1247, DOI 10.1139/cjz-77-8-1247; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; LINDSAY LR, 1995, J MED ENTOMOL, V32, P143, DOI 10.1093/jmedent/32.2.143; Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Madhav NK, 2004, J MED ENTOMOL, V41, P842, DOI 10.1603/0022-2585-41.5.842; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; Nupp TE, 1998, J MAMMAL, V79, P1234, DOI 10.2307/1383014; Ogden N H, 2008, Can Commun Dis Rep, V34, P1; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden NH, 2009, EPIDEMICS-NETH, V1, P196, DOI 10.1016/j.epidem.2009.06.002; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2001, VECTOR-BORNE ZOONOT, V1, P55, DOI 10.1089/153036601750137688; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2002, CONSERVATION MEDICINE, P207; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Piesman Joseph, 2002, P223, DOI 10.1079/9780851996325.0223; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Rand PW, 2004, J MED ENTOMOL, V41, P779, DOI 10.1603/0022-2585-41.4.779; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Schulze TL, 2009, J MED ENTOMOL, V46, P1025, DOI 10.1603/033.046.0508; SCHULZE TL, 1995, J MED ENTOMOL, V32, P730, DOI 10.1093/jmedent/32.5.730; SPIELMAN A, 1984, YALE J BIOL MED, V57, P507; STAFFORD KC, 1993, J MED ENTOMOL, V30, P986, DOI 10.1093/jmedent/30.6.986; Swei A, 2011, P ROY SOC B-BIOL SCI, V278, P2970, DOI 10.1098/rspb.2010.2402; Talleklint L, 1996, J MED ENTOMOL, V33, P805, DOI 10.1093/jmedent/33.5.805; TELFORD SR, 1988, AM J TROP MED HYG, V39, P105, DOI 10.4269/ajtmh.1988.39.105; Thompson L, 2010, THESIS TRENT U PETER; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Van Wieren J, 2008, ST LAWRENCE ISLANDS; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360; Werden L, 2012, THESIS U GUELPH GUEL; WHITE DJ, 1991, JAMA-J AM MED ASSOC, V266, P1230, DOI 10.1001/jama.266.9.1230; YUVAL B, 1990, J MED ENTOMOL, V27, P196, DOI 10.1093/jmedent/27.2.196; Zuur Alain F., 2009, P1	80	70	70	0	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85640	10.1371/journal.pone.0085640	http://dx.doi.org/10.1371/journal.pone.0085640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416435	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300094
J	Bai, X; Lee, JY; Kim, TI; Dai, F; Lee, TJ; Hong, SJ				Bai, Xuelian; Lee, Ji-Yun; Kim, Tae Im; Dai, Fuhong; Lee, Tae-Jin; Hong, Sung-Jong			Molecular Cloning and Characterization of Growth Factor Receptor Bound-Protein in Clonorchis sinensis	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GRB2 ADAPTER PROTEIN; SH3 DOMAINS; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; GENE-EXPRESSION; TYROSINE KINASE; RAS; SOS; DYNAMIN	Background: Clonorchis sinensis causes clonorchiasis, a potentially serious disease. Growth factor receptor-bound protein 2 (Grb2) is a cytosolic protein conserved among animals and plays roles in cellular functions such as meiosis, organogenesis and energy metabolism. In the present study, we report first molecular characters of growth factor receptor bound-protein (CsGrb2) from C. sinensis as counter part of Grb2 from animals and its possible functions in development and organogenesis of C. sinensis. Methodology/Principal Findings: A CsGrb2 cDNA clone retrieved from the C. sinensis transcriptome encoded a polypeptide with a SH3-SH2-SH3 structure. Recombinant CsGrb2 was bacterially produced and purified to homogeneity. Native CsGrb2 with estimated molecular weight was identified from C. sinensis adult extract by western blotting using a mouse immune serum to recombinant CsGrb2. CsGrb2 transcripts was more abundant in the metacercariae than in the adults. Immunohistochemical staining showed that CsGrb2 was localized to the suckers, mesenchymal tissues, sperms in seminal receptacle and ovary in the adults, and abundantly expressed in most organs of the metacercariae. Recombinant CsGrb2 was evaluated to be little useful as a serodiagnostic reagent for C. sinesis human infections. Conclusion: Grb2 protein found in C. sinensis was conserved among animals and suggested to play a role in the organogenesis, energy metabolism and mitotic spermatogenesis of C. sinensis. These findings from C. sinensis provide wider understanding on diverse function of Grb2 in lower animals such as platyhelminths.	[Bai, Xuelian; Lee, Ji-Yun; Kim, Tae Im; Dai, Fuhong; Hong, Sung-Jong] Chung Ang Univ, Coll Med, Dept Med Environm Biol, Seoul 156756, South Korea; [Lee, Tae-Jin] Chung Ang Univ, Coll Med, Dept Pathol, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Hong, SJ (corresponding author), Chung Ang Univ, Coll Med, Dept Med Environm Biol, Seoul 156756, South Korea.	hongsj@cau.ac.kr		Lee, Ji-Yun/0000-0002-4053-6577	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A080681]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A080681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; BONINI JA, 1995, AM J PHYSIOL-ENDOC M, V269, pE759, DOI 10.1152/ajpendo.1995.269.4.E759; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Cailliau K, 2001, CELL SIGNAL, V13, P51, DOI 10.1016/S0898-6568(00)00138-8; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; Denkinger DJ, 2000, BBA-GENE STRUCT EXPR, V1491, P253, DOI 10.1016/S0167-4781(00)00008-7; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Kim TI, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001414; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kondo A, 2008, J BIOL CHEM, V283, P1428, DOI 10.1074/jbc.M704999200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MATUOKA K, 1993, EMBO J, V12, P3467, DOI 10.1002/j.1460-2075.1993.tb06021.x; MATUOKA K, 1992, P NATL ACAD SCI USA, V89, P9015, DOI 10.1073/pnas.89.19.9015; Mur C, 2002, DIABETES, V51, P743, DOI 10.2337/diabetes.51.3.743; Nema V, 2013, BIOINFORMATION, V9, P796, DOI 10.6026/97320630009796; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Paez-Espinosa V, 2001, ENDOCRINE, V14, P295, DOI 10.1385/ENDO:14:3:295; Pan Z, 2008, MOL CELL BIOCHEM, V307, P121, DOI 10.1007/s11010-007-9591-6; SCAIFE R, 1994, EMBO J, V13, P2574, DOI 10.1002/j.1460-2075.1994.tb06547.x; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUEN KL, 1993, MOL CELL BIOL, V13, P5500, DOI 10.1128/MCB.13.9.5500; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vidal M, 1998, J BIOL CHEM, V273, P5343, DOI 10.1074/jbc.273.9.5343; Vidal M, 1999, J MOL BIOL, V290, P717, DOI 10.1006/jmbi.1999.2899; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Yoo WG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001208; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Yoon SY, 2002, J CELL BIOCHEM, V84, P150, DOI 10.1002/jcb.1275; Yu GZ, 2009, J CANCER RES CLIN, V135, P1331, DOI 10.1007/s00432-009-0574-8; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	44	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85577	10.1371/journal.pone.0085577	http://dx.doi.org/10.1371/journal.pone.0085577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454892	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000013
J	Donnelly, JE; Herrmann, SD; Lambourne, K; Szabo, AN; Honas, JJ; Washburn, RA				Donnelly, Joseph E.; Herrmann, Stephen D.; Lambourne, Kate; Szabo, Amanda N.; Honas, Jeffery J.; Washburn, Richard A.			Does Increased Exercise or Physical Activity Alter Ad-Libitum Daily Energy Intake or Macronutrient Composition in Healthy Adults? A Systematic Review	PLOS ONE			English	Review							RESTING METABOLIC-RATE; MODERATE INTENSITY EXERCISE; GUT HORMONE-LEVELS; BODY-COMPOSITION; WEIGHT-LOSS; LONG-TERM; AEROBIC EXERCISE; OVERWEIGHT MEN; FOOD-INTAKE; COMPENSATORY RESPONSES	Background: The magnitude of the negative energy balance induced by exercise may be reduced due to compensatory increases in energy intake. Objective: To address the question: Does increased exercise or physical activity alter ad-libitum daily energy intake or macronutrient composition in healthy adults? Data Sources: PubMed and Embase were searched (January 1990-January 2013) for studies that presented data on energy and/or macronutrient intake by level of exercise, physical activity or change in response to exercise. Ninety-nine articles (103 studies) were included. Study Eligibility Criteria: Primary source articles published in English in peer-reviewed journals. Articles that presented data on energy and/or macronutrient intake by level of exercise or physical activity or changes in energy or macronutrient intake in response to acute exercise or exercise training in healthy (non-athlete) adults (mean age 18-64 years). Study Appraisal and Synthesis Methods: Articles were grouped by study design: cross-sectional, acute/short term, nonrandomized, and randomized trials. Considerable heterogeneity existed within study groups for several important study parameters, therefore a meta-analysis was considered inappropriate. Results were synthesized and presented by study design. Results: No effect of physical activity, exercise or exercise training on energy intake was shown in 59% of cross-sectional studies (n = 17), 69% of acute (n = 40), 50% of short-term (n = 10), 92% of non-randomized (n = 12) and 75% of randomized trials (n = 24). Ninety-four percent of acute, 57% of short-term, 100% of non-randomized and 74% of randomized trials found no effect of exercise on macronutrient intake. Forty-six percent of cross-sectional trials found lower fat intake with increased physical activity. Limitations: The literature is limited by the lack of adequately powered trials of sufficient duration, which have prescribed and measured exercise energy expenditure, or employed adequate assessment methods for energy and macronutrient intake. Conclusions: We found no consistent evidence that increased physical activity or exercise effects energy or macronutrient intake.	[Donnelly, Joseph E.; Herrmann, Stephen D.; Lambourne, Kate; Szabo, Amanda N.; Honas, Jeffery J.; Washburn, Richard A.] Univ Kansas, Med Ctr, Cardiovasc Res Inst, Ctr Phys Act & Weight Management, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Donnelly, JE (corresponding author), Univ Kansas, Med Ctr, Cardiovasc Res Inst, Ctr Phys Act & Weight Management, Kansas City, KS 66103 USA.	jdonnelly@ku.edu	Herrmann, Stephen/HCI-3993-2022	Herrmann, Stephen/0000-0003-1933-5938; Szabo-Reed, Amanda/0000-0002-4927-1501	International Life Sciences Institute	International Life Sciences Institute	This review was funded by the International Life Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON B, 1991, INT J OBESITY, V15, P75; [Anonymous], HLTH PEOPL 2020; [Anonymous], 2008, 2008 PHYS ACTIVITY G; [Anonymous], 2005, DIET REF INT EN CARB; Balaguera-Cortes L, 2011, APPL PHYSIOL NUTR ME, V36, P958, DOI [10.1139/H11-121, 10.1139/h11-121]; Bales CW, 2012, MED SCI SPORT EXER, V44, P2033, DOI 10.1249/MSS.0b013e318259479a; Blundell JE, 2003, P NUTR SOC, V62, P651, DOI 10.1079/PNS2003286; Brandon LJ, 2006, ETHNIC DIS, V16, P675; BROEDER CE, 1992, AM J CLIN NUTR, V55, P802, DOI 10.1093/ajcn/55.4.802; Bryant EJ, 2012, APPETITE, V58, P234, DOI 10.1016/j.appet.2011.09.006; Bryner RW, 1997, J AM COLL NUTR, V16, P68, DOI 10.1080/07315724.1997.10718651; BUTTERWORTH DE, 1994, INT J SPORT NUTR, V4, P289, DOI 10.1123/ijsn.4.3.289; Camoes M, 2008, PUBLIC HEALTH NUTR, V11, P841, DOI 10.1017/S1368980007001309; Caudwell P, 2013, MED SCI SPORT EXER, V45, P351, DOI 10.1249/MSS.0b013e31826ced79; Church TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004515; Cox KL, 2010, METABOLISM, V59, P1562, DOI 10.1016/j.metabol.2010.02.001; Cox KL, 2003, METABOLISM, V52, P107, DOI 10.1053/meta.2003.50017; D'Angelo E, 2010, J SPORT MED PHYS FIT, V50, P311; Deighton K, 2012, APPETITE, V58, P946, DOI 10.1016/j.appet.2012.02.041; Di Blasio A, 2012, MENOPAUSE, V19, P23, DOI 10.1097/gme.0b013e318223e6b3; Donnelly JE, 2003, AM J CLIN NUTR, V78, P950, DOI 10.1093/ajcn/78.5.950; Donnelly JE, 2003, ARCH INTERN MED, V163, P1343, DOI 10.1001/archinte.163.11.1343; Donnelly JE, 2000, INT J OBESITY, V24, P566, DOI 10.1038/sj.ijo.0801198; Donnelly JE, 2013, OBESITY, V21, pE219, DOI 10.1002/oby.20145; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Duvigneaud N, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-26; EATON CB, 1995, AM J PREV MED, V11, P238, DOI 10.1016/S0749-3797(18)30452-5; Erdmann J, 2007, REGUL PEPTIDES, V143, P127, DOI 10.1016/j.regpep.2007.05.002; Farah NMF, 2010, MED SCI SPORT EXER, V42, P2015, DOI 10.1249/MSS.0b013e3181e0d186; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finlayson G, 2009, PHYSIOL BEHAV, V97, P62, DOI 10.1016/j.physbeh.2009.02.002; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; George VA, 2003, APPETITE, V40, P43, DOI 10.1016/S0195-6663(02)00146-0; Gilliat-Wimberly M, 2001, J AM DIET ASSOC, V101, P1181, DOI 10.1016/S0002-8223(01)00289-9; GREDIAGIN MA, 1995, J AM DIET ASSOC, V95, P661, DOI 10.1016/S0002-8223(95)00181-6; Harris Cristen L, 2008, Eat Behav, V9, P415, DOI 10.1016/j.eatbeh.2008.06.004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hopkins M, 2010, CURR OPIN CLIN NUTR, V13, P635, DOI 10.1097/MCO.0b013e32833e343b; Hornbuckle LM, 2005, MED SCI SPORT EXER, V37, P1069, DOI 10.1249/01.mss.0000166575.35311.07; Imbeault P, 1997, BRIT J NUTR, V77, P511, DOI 10.1079/BJN19970053; Jago R, 2005, PREV MED, V41, P194, DOI 10.1016/j.ypmed.2004.09.045; Jakicic JM, 2011, OBESITY, V19, P100, DOI 10.1038/oby.2010.122; Jokisch E, 2012, APPETITE, V58, P722, DOI 10.1016/j.appet.2011.11.024; Keim NL, 1996, APPETITE, V26, P55, DOI 10.1006/appe.1996.0005; KEIM NL, 1990, INT J OBESITY, V14, P335; Kelly PJ, 2012, MED SCI SPORT EXER, V44, P516, DOI 10.1249/MSS.0b013e318231c176; Keytel LR, 2001, INT J SPORT NUTR EXE, V11, P226, DOI 10.1123/ijsnem.11.2.226; King JA, 2011, J OBES, V2011, DOI 10.1155/2011/351628; King JA, 2011, J CLIN ENDOCR METAB, V96, P1114, DOI 10.1210/jc.2010-2735; King JA, 2010, APPETITE, V54, P492, DOI 10.1016/j.appet.2010.02.002; King JA, 2010, MED SCI SPORT EXER, V42, P485, DOI 10.1249/MSS.0b013e3181ba10c4; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; King NA, 1997, EUR J CLIN NUTR, V51, P478, DOI 10.1038/sj.ejcn.1600432; KING NA, 1995, EUR J CLIN NUTR, V49, P114; KING NA, 1994, EUR J CLIN NUTR, V48, P715; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; Kirk EP, 2003, INT J OBESITY, V27, P912, DOI 10.1038/sj.ijo.0802317; Kirkwood L, 2007, INT J FOOD SCI NUTR, V58, P383, DOI 10.1080/09637480701252336; KISSILEFF HR, 1990, AM J CLIN NUTR, V52, P240, DOI 10.1093/ajcn/52.2.240; Koulouri AA, 2006, J HUM NUTR DIET, V19, P263, DOI 10.1111/j.1365-277X.2006.00703.x; Laan DJ, 2010, APPL PHYSIOL NUTR ME, V35, P842, DOI 10.1139/H10-072; Lake AA, 2009, J HUM NUTR DIET, V22, P444, DOI 10.1111/j.1365-277X.2009.00982.x; Larson-Meyer DE, 2012, J OBES, V2012, DOI 10.1155/2012/730409; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lissner L, 1997, OBES RES, V5, P43, DOI 10.1002/j.1550-8528.1997.tb00282.x; Lluch A, 1998, EUR J CLIN NUTR, V52, P300, DOI 10.1038/sj.ejcn.1600555; Lluch A, 2000, BRIT J NUTR, V84, P219; Manthou E, 2010, MED SCI SPORT EXER, V42, P1221, DOI 10.1249/MSS.0b013e3181c524b7; Maraki M, 2005, APPETITE, V45, P272, DOI 10.1016/j.appet.2005.07.005; Martins C, 2008, INT J OBESITY, V32, P1337, DOI 10.1038/ijo.2008.98; Martins C, 2010, J CLIN ENDOCR METAB, V95, P1609, DOI 10.1210/jc.2009-2082; Martins C, 2008, P NUTR SOC, V67, P28, DOI 10.1017/S0029665108005995; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; Matthews CE, 1997, MED SCI SPORT EXER, V29, P1199, DOI 10.1097/00005768-199709000-00013; Melby CL, 2002, INT J SPORT NUTR EXE, V12, P294, DOI 10.1123/ijsnem.12.3.294; Melzer K, 2005, CLIN NUTR, V24, P885, DOI 10.1016/j.clnu.2005.06.003; Miyashita M, 2010, J ATHEROSCLER THROMB, V17, P21, DOI 10.5551/jat.2337; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; MULLIGAN K, 1990, BRIT J NUTR, V64, P23, DOI 10.1079/BJN19900006; NIEMAN DC, 1990, AM J CLIN NUTR, V52, P640, DOI 10.1093/ajcn/52.4.640; Nordby P, 2012, OBESITY, V20, P2202, DOI 10.1038/oby.2012.70; O'Donoghue KJM, 2010, INT J SPORT NUTR EXE, V20, P350, DOI 10.1123/ijsnem.20.4.350; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; PERRY AC, 1992, INT J SPORTS MED, V13, P210, DOI 10.1055/s-2007-1021255; Pomerleau M, 2004, AM J CLIN NUTR, V80, P1230, DOI 10.1093/ajcn/80.5.1230; Potteiger JA, 2008, INT J SPORT NUTR EXE, V18, P79, DOI 10.1123/ijsnem.18.1.79; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Pritchard JE, 1997, J AM DIET ASSOC, V97, P37, DOI 10.1016/S0002-8223(97)00015-1; Ready AE, 1996, MED SCI SPORT EXER, V28, P1097, DOI 10.1097/00005768-199609000-00004; READY AE, 1995, CAN J CARDIOL, V11, P905; Reseland JE, 2001, AM J CLIN NUTR, V73, P240; Rintala M, 2011, PUBLIC HEALTH NUTR, V14, P846, DOI 10.1017/S136898001000090X; Rosenkilde M, 2012, AM J PHYSIOL-REG I, V303, pR571, DOI 10.1152/ajpregu.00141.2012; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Schneider KL, 2009, EAT BEHAV, V10, P29, DOI 10.1016/j.eatbeh.2008.10.009; Schubert MM, 2013, APPETITE, V63, P92, DOI 10.1016/j.appet.2012.12.010; Shaw BS, 2010, J SPORT MED PHYS FIT, V50, P207; Shorten AL, 2009, AM J CLIN NUTR, V90, P1215, DOI 10.3945/ajcn.2009.28162; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Snyder KA, 1997, INT J OBESITY, V21, P1180, DOI 10.1038/sj.ijo.0800533; Stensel D, 2010, ANN NUTR METAB, V57, P36, DOI 10.1159/000322702; Stiegler P, 2006, SPORTS MED, V36, P239, DOI 10.2165/00007256-200636030-00005; Stubbs RJ, 2004, AM J CLIN NUTR, V79, P62; Stubbs RJ, 2004, AM J PHYSIOL-REG I, V286, pR350, DOI 10.1152/ajpregu.00196.2003; Stubbs RJ, 2002, EUR J CLIN NUTR, V56, P129, DOI 10.1038/sj.ejcn.1601295; Stubbs RJ, 2002, INT J OBESITY, V26, P866, DOI 10.1038/sj.ijo.0801874; Suzuki Shihoko, 1998, Applied Human Science, V17, P259, DOI 10.2114/jpa.17.259; TREMBLAY A, 1994, AM J CLIN NUTR, V59, P975, DOI 10.1093/ajcn/59.5.975; Tsofliou F, 2003, INT J OBESITY, V27, P1332, DOI 10.1038/sj.ijo.0802406; Ueda SY, 2009, J ENDOCRINOL, V203, P357, DOI 10.1677/JOE-09-0190; Ueda S, 2009, J ENDOCRINOL, V201, P151, DOI 10.1677/JOE-08-0500; Unick JL, 2010, APPETITE, V55, P413, DOI 10.1016/j.appet.2010.07.012; Van Pelt RE, 2001, AM J PHYSIOL-ENDOC M, V281, pE633, DOI 10.1152/ajpendo.2001.281.3.E633; Van Walleghen EL, 2007, INT J OBESITY, V31, P1277, DOI 10.1038/sj.ijo.0803579; VanEtten LMLA, 1997, J APPL PHYSIOL, V82, P298, DOI 10.1152/jappl.1997.82.1.298; Vatansever-Ozen S, 2011, J SPORT SCI MED, V10, P283; VERGER P, 1992, APPETITE, V18, P93, DOI 10.1016/0195-6663(92)90186-A; VERGER P, 1994, APPETITE, V22, P159, DOI 10.1006/appe.1994.1015; Visona C, 2002, OBES RES, V10, P1251, DOI 10.1038/oby.2002.170; Washburn RA, 2012, J SPORT MED PHYS FIT, V52, P273; WESTERTERP KR, 1992, BRIT J NUTR, V68, P21, DOI 10.1079/BJN19920063; Westerterp KR, 2001, NATURE, V410, P539, DOI 10.1038/35069142; Whybrow S, 2008, BRIT J NUTR, V100, P1109, DOI 10.1017/S0007114508968240; Wilmore JH, 1998, AM J CLIN NUTR, V68, P66, DOI 10.1093/ajcn/68.1.66; Yaemsiri S, 2011, INT J OBESITY, V35, P1063, DOI 10.1038/ijo.2010.229	128	77	77	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83498	10.1371/journal.pone.0083498	http://dx.doi.org/10.1371/journal.pone.0083498			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454704	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100010
J	Li, MH; Holmes, V; Zhou, Y; Ni, HP; Sanzari, JK; Kennedy, AR; Weissman, D				Li, Minghong; Holmes, Veronica; Zhou, Yu; Ni, Houping; Sanzari, Jenine K.; Kennedy, Ann R.; Weissman, Drew			Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections	PLOS ONE			English	Article							SOLAR PARTICLE EVENTS; SPACE-FLIGHT; IMMUNE-SYSTEM; DNA-PKCS; ANTIORTHOSTATIC SUSPENSION; SPACEFLIGHT CONDITIONS; UNLOADING MODEL; RESPONSES; MICE; ASTRONAUTS	A major risk of extended space travel is the combined effects of weightlessness and radiation exposure on the immune system. In this study, we used the hindlimb suspension model of microgravity that includes the other space stressors, situational and confinement stress and alterations in food intake, and solar particle event (SPE)-like radiation to measure the combined effects on the ability to control bacterial infections. A massive increase in morbidity and decrease in the ability to control bacterial growth was observed using 2 different types of bacteria delivered by systemic and pulmonary routes in 3 different strains of mice. These data suggest that an astronaut exposed to a strong SPE during extended space travel is at increased risk for the development of infections that could potentially be severe and interfere with mission success and astronaut health.	[Li, Minghong; Holmes, Veronica; Zhou, Yu; Ni, Houping; Weissman, Drew] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Kennedy, Ann R.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Weissman, D (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.	dreww@mail.med.upenn.edu			National Space Biomedical Research Institute (NSBRI) through NASA NCC [9-58]	National Space Biomedical Research Institute (NSBRI) through NASA NCC	This work was supported by a grant from the National Space Biomedical Research Institute (NSBRI) through NASA NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; ARMSTRONG JW, 1993, J APPL PHYSIOL, V75, P2734, DOI 10.1152/jappl.1993.75.6.2734; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2003, J APPL PHYSIOL, V95, P491, DOI 10.1152/japplphysiol.00259.2003; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baillie SE, 2012, CHEM COMMUN, V48, P1985, DOI 10.1039/c2cc16959b; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Cena H, 2003, EUR J NUTR, V42, P99, DOI 10.1007/s00394-003-0392-8; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; CHOI KH, 1994, J ANTIMICROB CHEMOTH, V33, P1233, DOI 10.1093/jac/33.6.1233; Clegg W, 2013, DALTON T, V42, P2512, DOI 10.1039/c2dt32176a; Crucian B., 2009, RISK CREW ADVERSE HL; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Drake B., 2009, NASASP2009566 JOHNS; Fabre KM, 2011, RADIAT RES, V175, P493, DOI 10.1667/RR2431.1; Fischer JC, 2011, TRANSFUSION, V51, P1431, DOI 10.1111/j.1537-2995.2010.02998.x; FLEMING SD, 1990, AVIAT SPACE ENVIR MD, V61, P327; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Fu YP, 2003, CANCER RES, V63, P2440; Gridley DS, 2008, IN VIVO, V22, P159; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hu LH, 2009, J CHROMATOGR A, V1216, P5377, DOI 10.1016/j.chroma.2009.05.030; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Kahler SW, 2012, ASTROPHYS J, P1; Kantemiris I, 2011, MED PHYS, V38, P6585, DOI 10.1118/1.3662911; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Kita M, 2004, J GRAVIT PHYSL, V11, pP67; LANE HW, 1994, AM J CLIN NUTR, V60, p801S, DOI 10.1093/ajcn/60.5.801S; Lee EH, 2005, AVIAT SPACE ENVIR MD, V76, P536; Levine DS, 1998, AVIAT SPACE ENVIR MD, V69, P172; Maks CJ, 2011, RADIAT RES, V176, P170, DOI 10.1667/RR2413.1; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Mermel LA, 2013, CLIN INFECT DIS, V56, P123, DOI 10.1093/cid/cis861; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Mori N, 2001, ONCOGENE, V20, P3609, DOI 10.1038/sj.onc.1204497; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; Ohmori Sachiko, 1997, Environmental Medicine (Nagoya), V41, P9; Okayasu R, 2000, CANCER RES, V60, P4342; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Romero-Weaver AL, 2013, RAD RES; Romero-Weaver AL, 2013, ASTROBIOLOG IN PRESS; Romero-Weaver Ana L, 2012, Int J Biomed Sci, V8, P7; Sastry KJ, 2001, IN VITRO CELL DEV-AN, V37, P203; Setlow RB, 2003, EMBO REP, V4, P1013, DOI 10.1038/sj.embor.7400016; Shearer WT, 2005, J ALLERGY CLIN IMMUN, V115, P1297, DOI 10.1016/j.jaci.2005.03.003; Sonnenfeld G, 2003, ADV SPACE RES-SERIES, V32, P1473, DOI 10.1016/S0273-1177(03)90383-8; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; STEFFEN JM, 1986, AVIAT SPACE ENVIR MD, V57, P162; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Townsend L. W., 2006, INFORM NEEDED MAKE R; Townsend LW, 2005, RADIAT PROT DOSIM, V115, P44, DOI 10.1093/rpd/nci141; Uri JJ, 2005, ACTA ASTRONAUT, V56, P883, DOI 10.1016/j.actaastro.2005.01.014; Walker C, 2006, J P ROBINSON; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wei LX, 2003, CELL RES, V13, P465, DOI 10.1038/sj.cr.7290189; Wimalawansa SM, 1999, ENDOCRINE, V10, P253, DOI 10.1007/BF02738624	60	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85665	10.1371/journal.pone.0085665	http://dx.doi.org/10.1371/journal.pone.0085665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454913	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100116
J	Tachinardi, P; Bicudo, JEW; Oda, GA; Valentinuzzi, VS				Tachinardi, Patricia; Wilken Bicudo, Jose Eduardo; Oda, Gisele Akemi; Sandra Valentinuzzi, Veronica			Rhythmic 24 h Variation of Core Body Temperature and Locomotor Activity in a Subterranean Rodent (Ctenomys aff. knighti), the Tuco-Tuco	PLOS ONE			English	Article							WHEEL-RUNNING ACTIVITY; CIRCADIAN-RHYTHMS; DIURNAL RHYTHMS; METABOLIC-RATE; ENERGETICS; THERMOREGULATION; ENTRAINMENT; AMPLITUDE; TALARUM; ACCESS	The tuco-tuco Ctenomys aff. knighti is a subterranean rodent which inhabits a semi-arid area in Northwestern Argentina. Although they live in underground burrows where environmental cycles are attenuated, they display robust, 24 h locomotor activity rhythms that are synchronized by light/dark cycles, both in laboratory and field conditions. The underground environment also poses energetic challenges (e. g. high-energy demands of digging, hypoxia, high humidity, low food availability) that have motivated thermoregulation studies in several subterranean rodent species. By using chronobiological protocols, the present work aims to contribute towards these studies by exploring day-night variations of thermoregulatory functions in tuco-tucos, starting with body temperature and its temporal relationship to locomotor activity. Animals showed daily, 24 h body temperature rhythms that persisted even in constant darkness and temperature, synchronizing to a daily light/dark cycle, with highest values occurring during darkness hours. The range of oscillation of body temperature was slightly lower than those reported for similar-sized and dark-active rodents. Most rhythmic parameters, such as period and phase, did not change upon removal of the running wheel. Body temperature and locomotor activity rhythms were robustly associated in time. The former persisted even after removal of the acute effects of intense activity on body temperature by a statistical method. Finally, regression gradients between body temperature and activity were higher in the beginning of the night, suggesting day-night variation in thermal conductance and heat production. Consideration of these day-night variations in thermoregulatory processes is beneficial for further studies on thermoregulation and energetics of subterranean rodents.	[Tachinardi, Patricia; Wilken Bicudo, Jose Eduardo; Oda, Gisele Akemi] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Sandra Valentinuzzi, Veronica] Ctr Reg Invest Cient & Transferencia Tecnol La Ri, La Rioja, Argentina	Universidade de Sao Paulo	Oda, GA (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	gaoda@ib.usp.br; vvalentinuzzi@crilar-conicet.gob.ar	oda, gisele a/F-4283-2012	oda, gisele a/0000-0001-7776-5368	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011/1979]; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas; Brazilian Agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/55035-5, 2010/50222-1, 2012/15767-2]; FAPESP [2008/58687-3, 2010/03565-0]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [130127/2010-08];  [PIP-11420090100252]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Brazilian Agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, grant PICT 2011/1979, and by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas; http://www.conicet.gov.ar/), grant PIP-11420090100252, from Argentina. Also by the Brazilian Agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; www.fapesp.br) grant # 2008/55035-5, 2010/50222-1 and 2012/15767-2. PT received two fellowships from FAPESP 2008/58687-3 and 2010/03565-0 as well as from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; www.cnpq.br) (130127/2010-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends A., 2002, COMP BIOCH PHYSL A, V131, P105; ASCHOFF J, 1973, J COMP PHYSIOL PSYCH, V85, P20, DOI 10.1037/h0034849; Aschoff J., 1982, COMPANION ANIMAL PHY, P173; Aschoff Jurgen, 1972, ADV CLIMATIC PHYSL, P334; Begall S., 2007, SUBTERRANEAN RODENTS; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Buffenstein R, 2000, LIFE UNDERGROUND, P62; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Burda H, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P21, DOI 10.1007/978-3-540-69276-8_3; BUSCH C, 1989, COMP BIOCHEM PHYS A, V93, P345, DOI 10.1016/0300-9629(89)90048-0; Busch C, 2000, LIFE UNDERGROUND, P183; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; Cook JA, 1998, EVOLUTION, V52, P1521, DOI 10.1111/j.1558-5646.1998.tb02035.x; DECASTRO JM, 1978, PHYSIOL BEHAV, V21, P883, DOI 10.1016/0031-9384(78)90160-9; Decoursey PJ, 1998, PHYSIOL BEHAV, V65, P457, DOI 10.1016/S0031-9384(98)00187-5; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Flores DEFL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068243; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; GOLOMBEK DA, 1993, PHYSIOL BEHAV, V53, P1049, DOI 10.1016/0031-9384(93)90358-M; Gordon CJ, 1997, J THERM BIOL, V22, P59, DOI 10.1016/S0306-4565(96)00035-6; Harri M, 1999, LAB ANIM SCI, V49, P401; HONMA K, 1978, JPN J PHYSIOL, V28, P159; Kas MJH, 1999, J NEUROSCI, V19, P328, DOI 10.1523/JNEUROSCI.19-01-00328.1999; Lacey EA, 1998, J MAMMAL, V79, P986, DOI 10.2307/1383106; Lacey EA, 2000, LIFE UNDERGROUND BIO; LOVEGROVE BG, 1994, AUST J ZOOL, V42, P65, DOI 10.1071/ZO9940065; Lovegrove BG, 1996, PHYSIOL BEHAV, V60, P991; LOVEGROVE BG, 1991, J THERM BIOL, V16, P185, DOI 10.1016/0306-4565(91)90025-W; Luna F, 2002, CAN J ZOOL, V80, P2144, DOI 10.1139/Z02-201; Luna F, 2007, COMP BIOCHEM PHYS A, V146, P559, DOI 10.1016/j.cbpa.2005.12.025; Luna F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P226, DOI 10.1086/597526; MATHER JG, 1981, MAMMAL REV, V11, P41, DOI 10.1111/j.1365-2907.1981.tb00246.x; MCNAB BK, 1966, ECOLOGY, V47, P712, DOI 10.2307/1934259; Moore-Ede M., 1984, CLOCKS TIME US PHYSL; NEVO E, 1979, ANNU REV ECOL SYST, V10, P269, DOI 10.1146/annurev.es.10.110179.001413; Perissinotti PP, 2009, COMP BIOCHEM PHYS A, V154, P298, DOI 10.1016/j.cbpa.2009.05.013; R Development Core Team, 2010, R LANG ENV STAT COMP; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Refinetti R, 1997, BIOL RHYTHM RES, V28, P19, DOI 10.1076/brhm.28.3.5.19.13127; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Refinetti R, 1999, J THERM BIOL, V24, P477, DOI 10.1016/S0306-4565(99)00077-7; Refinetti R, 2010, FRONT BIOSCI-LANDMRK, V15, P564, DOI 10.2741/3634; Riccio AP, 2000, PHYSIOL BEHAV, V71, P15, DOI 10.1016/S0031-9384(00)00280-8; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Schleich CE, 2010, J COMP NEUROL, V518, P4001, DOI 10.1002/cne.22440; Sedlacek F, 2007, SUBTERRANEAN RODENTS, P21; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Tachinardi P, 2012, THESIS U SAO PAULO; Tomotani BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037918; VASSALLO AI, 1994, J MAMMAL, V75, P725, DOI 10.2307/1382522; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5	54	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85674	10.1371/journal.pone.0085674	http://dx.doi.org/10.1371/journal.pone.0085674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454916	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100118
J	Nishimura, M; Satoh, M; Nishimura, S; Kakinuma, S; Sato, K; Sawai, S; Tsuchida, S; Kazama, T; Matsushita, K; Kado, S; Kodera, Y; Nomura, F				Nishimura, Motoi; Satoh, Mamoru; Nishimura, Satomi; Kakinuma, Shoko; Sato, Kenichi; Sawai, Setsu; Tsuchida, Sachio; Kazama, Takeshi; Matsushita, Kazuyuki; Kado, Sayaka; Kodera, Yoshio; Nomura, Fumio			Human Apolipoprotein E Resequencing by Proteomic Analysis and Its Application to Serotyping	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; E ISOFORMS; PROTEINS; PLASMA; SERUM	Background: Apolipoprotein E (ApoE) typing is considered important because of the association between ApoE and Alzheimer's disease and familial dyslipidemia and is currently performed by genetic testing (APOE genotyping). ApoE levels in plasma and serum are clinically determined by immunoassay. Methods: Combining an ApoE immunoassay reagent with proteomic analysis using an Orbitrap mass spectrometer, we attempted to resequence ApoE from trace amounts of serum for typing (serotyping). Most (24 of 33) ApoE mutant proteins registered to date with Online Mendelian Inheritance in Man, such as ApoE2 and ApoE4, involve lysine and arginine mutations. Digestion of mutant ApoE with trypsin will thus result in fragments that differ substantially from wild-type ApoE3 in terms of mass, making serotyping ideally suited to mass spectrometry analysis. Results: The mean coverage of the amino acid sequence of full-length ApoE was 91.6% in the protein resequence. Residues 112 and 158 (which are mutated in ApoE2 and ApoE4) were covered in all samples, and the protein sequences were used for serotyping. Serotypes including all heterozygous combinations (ApoE2/E3, E2/E4, E3/E4) corresponded exactly to the APOE genotyping results in each of the subjects. Conclusion: Our novel ApoE serotyping method with protein resequencing requires no synthesis of stable isotope-labeled peptides or genome analysis. The method can use residual blood from samples collected for routine clinical tests, thus enabling retrospective studies with preserved body fluids. The test could be applied to samples from subjects whose DNA is unavailable. In future studies, we hope to demonstrate the capability of our method to detect rare ApoE mutations.	[Nishimura, Motoi; Satoh, Mamoru; Nishimura, Satomi; Kakinuma, Shoko; Sawai, Setsu; Tsuchida, Sachio; Matsushita, Kazuyuki; Nomura, Fumio] Chiba Univ, Dept Mol Diag, Grad Sch Med, Chiba, Japan; [Nishimura, Motoi; Sato, Kenichi; Sawai, Setsu; Kazama, Takeshi; Matsushita, Kazuyuki; Nomura, Fumio] Chiba Univ Hosp, Div Lab Med & Clin Genet, Chiba, Japan; [Nishimura, Motoi; Satoh, Mamoru; Matsushita, Kazuyuki; Kodera, Yoshio; Nomura, Fumio] Chiba Univ Hosp, Clin Prote Res Ctr, Chiba, Japan; [Kado, Sayaka] Chiba Univ, Ctr Chem Anal, Chiba 260, Japan; [Kodera, Yoshio] Kitasato Univ, Lab Biomol Dynam, Dept Phys, Sch Sci, Sagamihara, Kanagawa 228, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Kitasato University	Nishimura, M (corresponding author), Chiba Univ, Dept Mol Diag, Grad Sch Med, Chiba, Japan.	ZXA03460@nifty.ne.jp	Matsushita, Kazuyuki/AAJ-5380-2020	Matsushita, Kazuyuki/0000-0001-6742-0761	JSPS KAKENHI [13059483]; Grants-in-Aid for Scientific Research [25670266] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Our work is supported by JSPS KAKENHI (Grant-in-Aid for Young Scientists (B)) Grant Number 13059483). The funder has no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ait-Ghezala G, 2008, CYTOKINE, V44, P283, DOI 10.1016/j.cyto.2008.08.013; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luis CA, 2009, AGING NEUROPSYCHOL C, V16, P203, DOI 10.1080/13825580802411766; Oikawa S, 1997, J AM SOC NEPHROL, V8, P820; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Satoh M, 2005, PROTEOMICS, V5, P1113, DOI 10.1002/pmic.200401117; Uchida Y, 2000, J CLIN LAB ANAL, V14, P260, DOI 10.1002/1098-2825(20001212)14:6<260::AID-JCLA2>3.0.CO;2-I; Wang MY, 2012, ANAL CHEM, V84, P8340, DOI 10.1021/ac3018873; Wildsmith KR, 2009, ANAL BIOCHEM, V395, P116, DOI 10.1016/j.ab.2009.07.049	13	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85356	10.1371/journal.pone.0085356	http://dx.doi.org/10.1371/journal.pone.0085356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454848	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800041
J	Gulia, KK; Patel, N; Radhakrishnan, A; Kumar, VM				Gulia, Kamalesh K.; Patel, Niraj; Radhakrishnan, Arathi; Kumar, Velayudhan Mohan			Reduction in Ultrasonic Vocalizations in Pups Born to Rapid Eye Movement Sleep Restricted Mothers in Rat Model	PLOS ONE			English	Article							ANXIETY-RELATED BEHAVIOR; PRENATAL STRESS; ANIMAL-MODELS; INFANT RATS; PREGNANCY; DEPRIVATION; RISK; CONSEQUENCES; PATTERNS; GROWTH	The effects of rapid eye movement sleep restriction (REMSR) in rats during late pregnancy were studied on the ultrasonic vocalizations (USVs) made by the pups. USVs are distress calls inaudible to human ears. Rapid eye movement (REM) sleep was restricted in one group of pregnant rats for 22 hours, starting from gestational day 14 to 20, using standard single platform method. The USVs of male pups were recorded after a brief isolation from their mother for two minutes on alternate post-natal days, from day one till weaning. The USVs were recorded using microphones and were analysed qualitatively and quantitatively using SASPro software. Control pups produced maximum vocalization on post-natal days 9 to 11. In comparison, the pups born to REMSR mothers showed not only a reduction in vocalization but also a delay in peak call making days. The experimental group showed variations in the types and characteristics of call types, and alteration in temporal profile. The blunting of distress call making response in these pups indicates that maternal sleep plays a role in regulating the neural development involved in vocalizations and possibly in shaping the emotional behaviour in neonates. It is suggested that the reduced ultrasonic vocalizations can be utilized as a reliable early marker for affective state in rat pups. Such impaired vocalization responses could provide an important lead in understanding mother-child bonding for an optimal cognitive development during post-partum life. This is the first report showing a potential link between maternal REM sleep deprivation and the vocalization in neonates and infants.	[Gulia, Kamalesh K.; Patel, Niraj; Radhakrishnan, Arathi; Kumar, Velayudhan Mohan] Sree Chitra Tirunal Inst Med Sci & Technol, Comprehens Ctr Sleep Disorders, Sleep Res Lab, Trivandrum, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Gulia, KK (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Comprehens Ctr Sleep Disorders, Sleep Res Lab, Trivandrum, Kerala, India.	kkguliak@hotmail.com	Gulia, Kamalesh/AAC-2011-2022	Gulia, Kamalesh/0000-0002-2253-2644; Kumar, Velayudhan Mohan/0000-0002-8477-6679	Department of Science and Technology, India [SR/WOS-A/LS-59/2008, SR/CSI/110/2012]	Department of Science and Technology, India(Department of Science & Technology (India))	The study was supported by the Research Grant from Department of Science and Technology, India (SR/WOS-A/LS-59/2008 & SR/CSI/110/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; Blumberg MS, 2001, PSYCHOL REV, V108, P83, DOI 10.1037//0033-295X.108.1.83; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Braw Y, 2008, BEHAV BRAIN RES, V193, P94, DOI 10.1016/j.bbr.2008.04.026; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Brunelli SA, 2001, DEV PSYCHOBIOL, V38, P221, DOI 10.1002/dev.1016; BRUNELLI SA, 1994, J COMP PSYCHOL, V108, P298, DOI 10.1037/0735-7036.108.3.298; Chang JJ, 2010, SLEEP MED REV, V14, P107, DOI 10.1016/j.smrv.2009.05.001; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; DRIVER HS, 1992, SLEEP, V15, P449, DOI 10.1093/sleep/15.5.449; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28; Groenink Lucianne, 2008, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0518s43; Hedman C, 2002, SLEEP MED, V3, P37, DOI 10.1016/S1389-9457(01)00130-7; HERTZ G, 1992, SLEEP, V15, P246, DOI 10.1093/sleep/15.3.246; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kimura M, 1996, AM J PHYSIOL-REG I, V271, pR1063, DOI 10.1152/ajpregu.1996.271.4.R1063; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; LaGasse LL, 2005, MENT RETARD DEV D R, V11, P83, DOI 10.1002/mrdd.20050; Micheli K, 2011, EPIDEMIOLOGY, V22, P738, DOI 10.1097/EDE.0b013e31822546fd; Morgan KN, 1999, DEV PSYCHOBIOL, V34, P205, DOI 10.1002/(SICI)1098-2302(199904)34:3<205::AID-DEV5>3.0.CO;2-V; Naito H, 2000, EXP ANIM TOKYO, V49, P289, DOI 10.1538/expanim.49.289; Nishina H, 1996, NEUROSCI LETT, V203, P5, DOI 10.1016/0304-3940(95)12249-4; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; O'Neil MF, 2003, HUM PSYCHOPHARM CLIN, V18, P239, DOI 10.1002/hup.496; OKON EE, 1972, J ZOOL, V68, P139; Okun ML, 2009, OBSTET GYNECOL SURV, V64, P273, DOI 10.1097/OGX.0b013e318195160e; Pertsov SS, 2012, B EXP BIOL MED+, V153, P805, DOI 10.1007/s10517-012-1831-4; Pires GN, 2010, MED HYPOTHESES, V75, P578, DOI 10.1016/j.mehy.2010.07.036; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Ratcliff R, 2009, PSYCHON B REV, V16, P742, DOI 10.3758/PBR.16.4.742; RYCHLIK L, 1990, J ETHOL, V8, P69, DOI 10.1007/BF02350276; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schwarting RKW, 2012, BRAZ J MED BIOL RES, V45, P337, DOI 10.1590/S0100-879X2012007500038; Shair HN, 2003, DEV PSYCHOBIOL, V42, P206, DOI 10.1002/dev.10087; Soltis J, 2004, BEHAV BRAIN SCI, V27, P443, DOI 10.1017/S0140525X0400010X; Tonkiss J, 2003, DEV PSYCHOBIOL, V43, P90, DOI 10.1002/dev.10124; VERMA S, 1989, INDIAN J EXP BIOL, V27, P892; Walker MP, 2008, SLEEP MED, V9, pS29, DOI 10.1016/S1389-9457(08)70014-5; Wilson DL, 2011, AUST NZ J OBSTET GYN, V51, P38, DOI 10.1111/j.1479-828X.2010.01252.x; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310; Zeskind Philip Sanford, 2011, Front Psychiatry, V2, P56, DOI 10.3389/fpsyt.2011.00056	46	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84948	10.1371/journal.pone.0084948	http://dx.doi.org/10.1371/journal.pone.0084948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454768	Green Submitted, gold, Green Published			2022-12-27	WOS:000329922500026
J	Jannig, PR; Moreira, JBN; Bechara, LRG; Bozi, LHM; Bacurau, AV; Monteiro, AWA; Dourado, PM; Wisloff, U; Brum, PC				Jannig, Paulo R.; Moreira, Jose B. N.; Bechara, Luiz R. G.; Bozi, Luiz H. M.; Bacurau, Aline V.; Monteiro, Alex W. A.; Dourado, Paulo M.; Wisloff, Ulrik; Brum, Patricia C.			Autophagy Signaling in Skeletal Muscle of Infarcted Rats	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; EXERCISE CAPACITY; ATROPHY; HYPERTROPHY; DEGRADATION; PATHWAYS; PROTEINS; FISSION; UPDATE; MICE	Background: Heart failure (HF)-induced skeletal muscle atrophy is often associated to exercise intolerance and poor prognosis. Better understanding of the molecular mechanisms underlying HF-induced muscle atrophy may contribute to the development of pharmacological strategies to prevent or treat such condition. It has been shown that autophagy-lysosome system is an important mechanism for maintenance of muscle mass. However, its role in HF-induced myopathy has not been addressed yet. Therefore, the aim of the present study was to evaluate autophagy signaling in myocardial infarction (MI)-induced muscle atrophy in rats. Methods/Principal Findings: Wistar rats underwent MI or Sham surgeries, and after 12 weeks were submitted to echocardiography, exercise tolerance and histology evaluations. Cathepsin L activity and expression of autophagy-related genes and proteins were assessed in soleus and plantaris muscles by fluorimetric assay, qRT-PCR and immunoblotting, respectively. MI rats displayed exercise intolerance, left ventricular dysfunction and dilation, thereby suggesting the presence of HF. The key findings of the present study were: a) upregulation of autophagy-related genes (GABARAPL1, ATG7, BNIP3, CTSL1 and LAMP2) was observed only in plantaris while muscle atrophy was observed in both soleus and plantaris muscles, and b) Cathepsin L activity, Bnip3 and Fis1 protein levels, and levels of lipid hydroperoxides were increased specifically in plantaris muscle of MI rats. Conclusions: Altogether our results provide evidence for autophagy signaling regulation in HF-induced plantaris atrophy but not soleus atrophy. Therefore, autophagy-lysosome system is differentially regulated in atrophic muscles comprising different fiber-types and metabolic characteristics.	[Jannig, Paulo R.; Brum, Patricia C.] Univ Sao Paulo, Expt Physiopathol Med Sch, Sao Paulo, Brazil; [Jannig, Paulo R.; Moreira, Jose B. N.; Bechara, Luiz R. G.; Bozi, Luiz H. M.; Bacurau, Aline V.; Monteiro, Alex W. A.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Dourado, Paulo M.] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil; [Moreira, Jose B. N.; Wisloff, Ulrik] Norwegian Univ Sci & Technol, KG Jensen Ctr Exercise Med, N-7034 Trondheim, Norway	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Norwegian University of Science & Technology (NTNU)	Brum, PC (corresponding author), Univ Sao Paulo, Expt Physiopathol Med Sch, Sao Paulo, Brazil.	pcbrum@usp.br	Bozi, Luiz H M/K-5259-2012; Brum, Patricia C/E-6605-2011; Bechara, Luiz R G/K-4095-2012; Bacurau, Aline/F-3293-2012; Bacurau, Aline Villa Nova/AAK-7446-2021; Moreira, Jose/G-1556-2014; Jannig, Paulo Roberto/E-9482-2013; Wisloff, Ulrik/K-2899-2012; Bozi, Luiz/AAT-6126-2020	Bozi, Luiz H M/0000-0002-5698-1181; Brum, Patricia C/0000-0002-4750-6506; Bacurau, Aline/0000-0002-5129-5115; Bacurau, Aline Villa Nova/0000-0002-5129-5115; Jannig, Paulo Roberto/0000-0002-2569-4091; Bechara, Luiz/0000-0002-1642-1008	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) [2010/14567-4]; FAPESP [2010/50048-1]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [302201/2011-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	PRJ held a master degree scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP #2010/14567-4). PCB holds grants from FAPESP (#2010/50048-1) and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq #302201/2011-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Attaix Didier, 2008, Curr Opin Support Palliat Care, V2, P262, DOI 10.1097/SPC.0b013e3283196ac2; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Bechet D, 2005, INT J BIOCHEM CELL B, V37, P2098, DOI 10.1016/j.biocel.2005.02.029; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; Deval C, 2001, BIOCHEM J, V360, P143, DOI 10.1042/0264-6021:3600143; Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; JONDEAU G, 1992, CIRCULATION, V86, P1351, DOI 10.1161/01.CIR.86.5.1351; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Krum H, 2009, LANCET, V373, P941, DOI 10.1016/S0140-6736(09)60236-1; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mendes S., 2011, GLOBAL ATLAS CARDIOV; Middlekauff HR, 2010, CIRC-HEART FAIL, V3, P537, DOI 10.1161/CIRCHEARTFAILURE.109.903773; MINOTTI JR, 1993, J APPL PHYSIOL, V75, P373, DOI 10.1152/jappl.1993.75.1.373; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; Musaro A, 2010, CURR OPIN CLIN NUTR, V13, P236, DOI 10.1097/MCO.0b013e3283368188; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012; Ogata T, 2010, BIOCHEM BIOPH RES CO, V394, P136, DOI 10.1016/j.bbrc.2010.02.130; Picard MH, 2011, J AM SOC ECHOCARDIOG, V24, P1, DOI 10.1016/j.echo.2010.11.006; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Thomas RL, 2011, AUTOPHAGY, V7, P775, DOI 10.4161/auto.7.7.15536; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	45	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85820	10.1371/journal.pone.0085820	http://dx.doi.org/10.1371/journal.pone.0085820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427319	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200060
J	Pereira-Fernandes, A; Dirinck, E; Dirtu, AC; Malarvannan, G; Covaci, A; Van Gaal, L; Vanparys, C; Jorens, PG; Blust, R				Pereira-Fernandes, Anna; Dirinck, Eveline; Dirtu, Alin C.; Malarvannan, Govindan; Covaci, Adrian; Van Gaal, Luc; Vanparys, Caroline; Jorens, Philippe G.; Blust, Ronny			Expression of Obesity Markers and Persistent Organic Pollutants Levels in Adipose Tissue of Obese Patients: Reinforcing the Obesogen Hypothesis?	PLOS ONE			English	Article							GENE-EXPRESSION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPONECTIN EXPRESSION; ENDOCRINE DISRUPTORS; PERINATAL EXPOSURE; MESSENGER-RNA; ETHER PBDE-99; FACTOR-ALPHA; LEPTIN	Introduction: Persistent Organic Pollutants (POPs) accumulate in adipose tissue and some are described to possess endocrine disrupting capacities. Therefore, it is important to evaluate their effects on key endocrine pathways in adipose tissue (AT), to further evaluate their potential role in metabolic pathologies such as obesity. Objectives: The aim is twofold: (i) evaluate gene expression levels of obesity marker genes, i. e. the adipokines leptin (LEP), adiponectin (ADIPOQ) and Tumor Necrosis Factor alpha (TNF alpha) and the nuclear receptor, Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) in paired subcutaneous (SAT) and visceral (VAT) AT of obese subjects (n = 50) and to relate these values to serum concentrations of LEP and ADIPOQ (ii) evaluate the association of expression levels of marker genes in AT and serum with POP concentrations in AT. Results and Conclusions: Leptin and adiponectin levels in serum were positively correlated to respectively expression levels of leptin in SAT and adiponectin in VAT. Our study shows more significant correlations between gene expression of obesity marker genes and POP concentrations in VAT compared to SAT. Since VAT is more important than SAT in pathologies associated with obesity, this suggests that POPs are able to influence the association between obesity and the development of associated pathologies. Moreover, this finding reveals the importance of VAT when investigating the obesogen hypothesis. Concerning PPAR gamma expression in VAT, negative correlations with polychlorinated biphenyls (PCBs) concentrations were found in non T2D patients. LEP serum concentrations correlated with several PCBs in women whereas in men no correlations were found. This strengthens the potential importance of gender differences in obesity and within the obesogen hypothesis.	[Pereira-Fernandes, Anna; Vanparys, Caroline; Blust, Ronny] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium; [Dirinck, Eveline; Van Gaal, Luc] Univ Antwerp, Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Edegem, Belgium; [Dirtu, Alin C.; Malarvannan, Govindan; Covaci, Adrian] Univ Antwerp, Toxicol Ctr, B-2020 Antwerp, Belgium; [Jorens, Philippe G.] Univ Antwerp, Univ Antwerp Hosp, Dept Clin Pharmacol, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	Pereira-Fernandes, A (corresponding author), Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium.	Anna.Pereira-Fernandes@ua.ac.be	Covaci, Adrian/A-9058-2008; Malarvannan, Govindan/A-6264-2014; DIRTU, Alin Constantin/P-1525-2014	Covaci, Adrian/0000-0003-0527-1136; Malarvannan, Govindan/0000-0002-2212-8617; DIRTU, Alin Constantin/0000-0002-8144-5807	University of Antwerp (UA) through a GOA project [FA020000/2/3565]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); UA; Research Scientific Foundation-Flanders (FWO)	University of Antwerp (UA) through a GOA project; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); UA; Research Scientific Foundation-Flanders (FWO)(FWO)	This study was funded by the University of Antwerp (UA) through a GOA project (Endocrine disrupting environmental chemicals: from accumulation to their role in the global 'neuro-endocrine' epidemic of obesity and its metabolic consequences; FA020000/2/3565). APF thanks the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) for her doctoral scholarship. GM and ACD acknowledge respectively the UA and the Research Scientific Foundation-Flanders (FWO) for their postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Baker NA, 2013, ENVIRON HEALTH PERSP, V121, P105, DOI 10.1289/ehp.1205421; Branchi I, 2002, NEUROTOXICOLOGY, V23, P375, DOI 10.1016/S0161-813X(02)00078-5; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elobeid MA, 2010, INT J ENV RES PUB HE, V7, P2988, DOI 10.3390/ijerph7072988; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garaulet M, 2000, EUR J ENDOCRINOL, V143, P657, DOI 10.1530/eje.0.1430657; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Giusti V, 2003, DIABETES, V52, P1673, DOI 10.2337/diabetes.52.7.1673; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Hoppe AA, 2007, OBESITY, V15, P2942, DOI 10.1038/oby.2007.351; Janesick A, 2011, J STEROID BIOCHEM, V127, P4, DOI 10.1016/j.jsbmb.2011.01.005; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Kim MJ, 2011, ENVIRON HEALTH PERSP, V119, P377, DOI 10.1289/ehp.1002848; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kouidhi S, 2011, J ENDOCRINOL INVEST, V34, pE16, DOI [10.1007/BF03347056, 10.3275/7204]; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Lee DH, 2006, DIABETES CARE, V29, P2568, DOI 10.2337/dc06-1720; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; Lilienthal H, 2006, ENVIRON HEALTH PERSP, V114, P194, DOI 10.1289/ehp.8391; Lyche JL, 2010, J TOXICOL ENV HEAL A, V73, P1032, DOI 10.1080/15287394.2010.481618; Malarvannan G, 2013, ENVIRON INT, V55, P33, DOI 10.1016/j.envint.2013.02.012; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Mullerova D, 2007, PHYSIOL RES, V56, P375, DOI 10.33549/physiolres.931022; Mullerova D, 2008, INT J OBESITY, V32, P1875, DOI 10.1038/ijo.2008.169; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pereira-Fernandes A, 2013, MOL CELL ENDOCRINOL, V370, P52, DOI 10.1016/j.mce.2013.02.011; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Suvorov A, 2009, TOXICOLOGY, V260, P126, DOI 10.1016/j.tox.2009.03.018; Tang-Peronard JL, 2011, OBES REV, V12, P622, DOI 10.1111/j.1467-789X.2011.00871.x; Taxvig C, 2012, MOL CELL ENDOCRINOL, V361, P106, DOI 10.1016/j.mce.2012.03.021; Teijeira-Fernandez E, 2011, CYTOKINE, V54, P185, DOI 10.1016/j.cyto.2011.01.016; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256	44	35	36	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84816	10.1371/journal.pone.0084816	http://dx.doi.org/10.1371/journal.pone.0084816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427296	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200036
J	Aza-Carmona, M; Barca-Tierno, V; Hisado-Oliva, A; Belinchon, A; Gorbenko-del Blanco, D; Rodriguez, JI; Benito-Sanz, S; Campos-Barros, A; Heath, KE				Aza-Carmona, Miriam; Barca-Tierno, Veronica; Hisado-Oliva, Alfonso; Belinchon, Alberta; Gorbenko-del Blanco, Darya; Ignacio Rodriguez, Jose; Benito-Sanz, Sara; Campos-Barros, Angel; Heath, Karen E.			NPPB and ACAN, Two Novel SHOX2 Transcription Targets Implicated in Skeletal Development	PLOS ONE			English	Article							HOMEOBOX GENE SHOX; LERI-WEILL DYSCHONDROSTEOSIS; IDIOPATHIC SHORT STATURE; SINOATRIAL NODE; PAR1 DELETION; EXPRESSION; SOX6; REVEALS; L-SOX5; DIFFERENTIATION	SHOX and SHOX2 transcription factors are highly homologous, with even identical homeodomains. Genetic alterations in SHOX result in two skeletal dysplasias; Leri-Weill dyschondrosteosis (LWD) and Langer mesomelic dysplasia (LMD), while no human genetic disease has been linked to date with SHOX2. SHOX2 is, though, involved in skeletal development, as shown by different knockout mice models. Due to the high homology between SHOX and SHOX2, and their functional redundancy during heart development, we postulated that SHOX2 might have the same transcriptional targets and cofactors as SHOX in limb development. We selected two SHOX transcription targets regulated by different mechanisms: 1) the natriuretic peptide precursor B gene (NPPB) involved in the endochondral ossification signalling and directly activated by SHOX; and 2) Aggrecan (ACAN), a major component of cartilage extracellular matrix, regulated by the cooperation of SHOX with the SOX trio (SOX5, SOX6 and SOX9) via the protein interaction between SOX5/SOX6 and SHOX. Using the luciferase assay we have demonstrated that SHOX2, like SHOX, regulates NPPB directly whilst activates ACAN via its cooperation with the SOX trio. Subsequently, we have identified and characterized the protein domains implicated in the SHOX2 dimerization and also its protein interaction with SOX5/SOX6 and SHOX using the yeast-two hybrid and co-immunoprecipitation assays. Immunohistochemistry of human fetal growth plates from different time points demonstrated that SHOX2 is coexpressed with SHOX and the members of the SOX trio. Despite these findings, no mutation was identified in SHOX2 in a cohort of 83 LWD patients with no known molecular defect, suggesting that SHOX2 alterations do not cause LWD. In conclusion, our work has identified the first cofactors and two new transcription targets of SHOX2 in limb development, and we hypothesize a time-and tissue-specific functional redundancy between SHOX and SHOX2.	[Aza-Carmona, Miriam; Barca-Tierno, Veronica; Hisado-Oliva, Alfonso; Belinchon, Alberta; Benito-Sanz, Sara; Campos-Barros, Angel; Heath, Karen E.] Univ Autonoma Madrid, IdiPAZ, Hosp Univ La Paz, Inst Med & Mol Genet INGEMM, Madrid, Spain; [Aza-Carmona, Miriam; Barca-Tierno, Veronica; Hisado-Oliva, Alfonso; Belinchon, Alberta; Benito-Sanz, Sara; Campos-Barros, Angel; Heath, Karen E.] Inst Salud Carlos III, Ctr Invest Biomed Enfermedades Raras CIBERER, Madrid, Spain; [Gorbenko-del Blanco, Darya] Univ Barcelona, Fac Med, Dept Celular Biol Immunol & Neurosci, Barcelona 7, Spain; [Ignacio Rodriguez, Jose] Hosp Univ La Paz, Dept Pathol, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Hospital Universitario La Paz	Heath, KE (corresponding author), Univ Autonoma Madrid, IdiPAZ, Hosp Univ La Paz, Inst Med & Mol Genet INGEMM, Madrid, Spain.	karen.heath@salud.madrid.org	Benito-Sanz, Sara/ABB-4188-2021; Heath, Karen Elise/K-7760-2014; Heath, K. E./ABG-4658-2020; del Blanco, Darya Gorbenko/N-6069-2018; Barros, Angel Campos/E-6427-2018	Heath, Karen Elise/0000-0002-5816-7044; Heath, K. E./0000-0002-5816-7044; del Blanco, Darya Gorbenko/0000-0002-9674-2388; Barros, Angel Campos/0000-0003-4649-2971; BENITO-SANZ, SARA/0000-0002-6101-9413; Aza-Carmona, Miriam/0000-0003-4448-9541; Barca Tierno, Veronica/0000-0001-7339-3974	Ministerio de Innovacion y Ciencia [MINECO SAF2012-30871, MICINN SAF2009-08230]; MICINN ("Juan de la Cierva"); CIBERER; Ministerio de Educacion (FPI); Basque Country; MICINN [SAF2009-08230]	Ministerio de Innovacion y Ciencia(Spanish Government); MICINN ("Juan de la Cierva")(Ministry of Science and Innovation, Spain (MICINN)); CIBERER; Ministerio de Educacion (FPI)(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG)); Basque Country(Basque Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by the: Ministerio de Innovacion y Ciencia [MINECO SAF2012-30871 y MICINN SAF2009-08230]. Postdoctoral fellowships were awarded from MICINN ("Juan de la Cierva", M. A-C) and CIBERER [S. B-S]. Predoctoral fellowships were awarded from the Ministerio de Educacion (FPI, V. B-T), Basque Country (A. H-S) and MICINN SAF2009-08230 (A. B-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Benito-Sanz S, 2005, AM J HUM GENET, V77, P533, DOI 10.1086/449313; Benito-Sanz S, 2011, J CLIN ENDOCR METAB, V96, pE404, DOI 10.1210/jc.2010-1689; Benito-Sanz Sara, 2006, Hum Mutat, V27, P1062, DOI 10.1002/humu.9456; Benito-Sanz S, 2012, J MED GENET, V49, P442, DOI 10.1136/jmedgenet-2011-100678; Benito-Sanz S, 2012, EUR J HUM GENET, V20, P125, DOI 10.1038/ejhg.2011.210; Benito-Sanz S, 2006, AM J HUM GENET, V79, P409, DOI 10.1086/506390; Bertorelli R, 2007, CLIN GENET, V72, P490, DOI 10.1111/j.1399-0004.2007.00875.x; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Bobick BE, 2012, J CELL SCI, V125, P6071, DOI 10.1242/jcs.111997; Campos-Barros A, 2007, AM J MED GENET A, V143A, P933, DOI 10.1002/ajmg.a.31676; Chen J, 2009, J MED GENET, V46, P834, DOI 10.1136/jmg.2009.067785; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Decker E, 2011, HUM MOL GENET, V20, P1524, DOI 10.1093/hmg/ddr030; Durand C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045369; Espinoza-Lewis RA, 2011, DEV BIOL, V356, P359, DOI 10.1016/j.ydbio.2011.05.663; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Huber C, 2006, J MED GENET, V43, P735, DOI 10.1136/jmg.2006.040998; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; Liu HB, 2011, J BIOL CHEM, V286, P17029, DOI 10.1074/jbc.M111.234252; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Marchini A, 2007, HUM MOL GENET, V16, P3081, DOI 10.1093/hmg/ddm266; Munns CJF, 2004, J CLIN ENDOCR METAB, V89, P4130, DOI 10.1210/jc.2003-032230; NICOLAIDES NC, 1990, BIOTECHNIQUES, V8, P154; Nicolosi A, 2011, J ENDOCRINOL INVES S, V33, P7; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Schneider KU, 2005, HUM MUTAT, V26, P44, DOI 10.1002/humu.20187; Semina EV, 1998, HUM MOL GENET, V7, P415, DOI 10.1093/hmg/7.3.415; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sobradillo B, 2002, CURVAS TABLAS CRECIM, P1; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	48	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83104	10.1371/journal.pone.0083104	http://dx.doi.org/10.1371/journal.pone.0083104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421874	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500027
J	Kovjazin, R; Horn, G; Smorodinsky, NI; Shapira, MY; Carmon, L				Kovjazin, Riva; Horn, Galit; Smorodinsky, Nechama I.; Shapira, Michael Y.; Carmon, Lior			Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies: Implications for Cancer Diagnostics and Therapy	PLOS ONE			English	Article							POLYMORPHIC EPITHELIAL MUCIN; TUMOR-ANTIGEN MUC1; MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODIES; OVARIAN-CANCER; BREAST-CANCER; EXPRESSION; PROTEIN; SEQUENCE; VACCINE	The MUC1 tumor associated antigen is highly expressed on a range of tumors. Its broad distribution on primary tumors and metastases renders it an attractive target for immunotherapy. After synthesis MUC1 is cleaved, yielding a large soluble extracellular alpha subunit containing the tandem repeats array (TRA) domain specifically bound, via non-covalent interaction, to a smaller beta subunit containing the transmembrane and cytoplasmic domains. Thus far, inconclusive efficacy has been reported for anti-MUC1 antibodies directed against the soluble alpha subunit. Targeting the cell bound beta subunit, may bypass limitations posed by circulating TRA domains. MUC1's signal peptide (SP) domain promiscuously binds multiple MHC class II and Class I alleles, which upon vaccination, generated robust T-cell immunity against MUC1-positive tumors. This is a first demonstration of non-MHC associated, MUC1 specific, cell surfaces presence for MUC1 SP domain. Polyclonal and monoclonal antibodies generated against MUC1 SP domain specifically bind a large variety of MUC1-positive human solid and haematological tumor cell lines; MUC1-positive bone marrow derived plasma cells obtained from multiple myeloma (MM)-patients, but not MUC1 negative tumors cells, and normal naive primary blood and epithelial cells. Membranal MUC1 SP appears mainly as an independent entity but also co-localized with the full MUC1 molecule. MUC1-SP specific binding in BM-derived plasma cells can assist in selecting patients to be treated with anti-MUC1 SP therapeutic vaccine, ImMucin. A therapeutic potential of the anti-MUC1 SP antibodies was suggested by their ability to support of complement-mediated lysis of MUC1-positive tumor cells but not MUC1 negative tumor cells and normal naive primary epithelial cells. These findings suggest a novel cell surface presence of MUC1 SP domain, a potential therapeutic benefit for anti-MUC1 SP antibodies in MUC1-positive tumors and a selection tool for MM patients to be treated with the anti-MUC1 SP vaccine, ImMucin.	[Kovjazin, Riva; Carmon, Lior] Vaxil BioTherapeut Ltd, Ness Ziona, Israel; [Horn, Galit; Smorodinsky, Nechama I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Smorodinsky, Nechama I.] Tel Aviv Univ, George S Wise Fac Life Sci, Alec & Myra Marmot Hybridoma Unit, IL-69978 Tel Aviv, Israel; [Shapira, Michael Y.] Hadassah Hebrew Univ Med Ctr, Dept Bone Marrow Transplantat & Canc Immunotherap, Jerusalem, Israel	Tel Aviv University; Tel Aviv University; Hebrew University of Jerusalem	Carmon, L (corresponding author), Vaxil BioTherapeut Ltd, Weizmann Sci Pk, Ness Ziona, Israel.	lior.carmon@vaxilbio.com			Ministry of Industry Trade and Labor [48447]	Ministry of Industry Trade and Labor	This work was supported by a grant No. 48447 from the Israeli Chief Scientist of the Ministry of Industry Trade and Labor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal B, 1998, NAT MED, V4, P43, DOI 10.1038/nm0198-043; ALAUSA OK, 1975, J IMMUNOL METHODS, V8, P117, DOI 10.1016/0022-1759(75)90088-5; APOSTOLOPOULOS V, 1994, CRIT REV IMMUNOL, V14, P293, DOI 10.1615/CritRevImmunol.v14.i3-4.40; Baruch A, 1997, INT J CANCER, V71, P741; Brossart P, 1999, BLOOD, V93, P4309, DOI 10.1182/blood.V93.12.4309.412k19_4309_4317; Brossart P, 2001, CANCER RES, V61, P6846; Carmon L, 2000, INT J CANCER, V85, P391; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; CHEUNG NKV, 1988, J CLIN INVEST, V81, P1122, DOI 10.1172/JCI113426; Correa I, 2005, INT J CANCER, V115, P760, DOI 10.1002/ijc.20949; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fan XN, 2010, PATHOL RES PRACT, V206, P585, DOI 10.1016/j.prp.2010.03.006; Flanders A, 2013, BLOOD, V122, P1088, DOI 10.1182/blood-2013-05-506170; FUNG PYS, 1991, CANCER RES, V51, P1170; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gillespie AM, 2000, ANN ONCOL, V11, P735, DOI 10.1023/A:1008349300781; Graham RA, 1996, CANCER IMMUNOL IMMUN, V42, P71, DOI 10.1007/s002620050254; HAREUVENI M, 1990, EUR J BIOCHEM, V189, P475, DOI 10.1111/j.1432-1033.1990.tb15512.x; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HO SB, 1993, CANCER RES, V53, P641; KEYDAR I, 1989, P NATL ACAD SCI USA, V86, P1362, DOI 10.1073/pnas.86.4.1362; Kovjazin R, 2012, EXP THER MED, V3, P1092, DOI 10.3892/etm.2012.538; Kovjazin R, 2011, VACCINE, V29, P4676, DOI 10.1016/j.vaccine.2011.04.103; Kovjazin R, 2011, MOL IMMUNOL, V48, P1009, DOI 10.1016/j.molimm.2011.01.006; Lacunza E, 2010, CANCER GENET CYTOGEN, V201, P102, DOI 10.1016/j.cancergencyto.2010.05.015; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; LYKO F, 1995, J BIOL CHEM, V270, P19873, DOI 10.1074/jbc.270.34.19873; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; MCGUCKIN MA, 1995, HUM PATHOL, V26, P432, DOI 10.1016/0046-8177(95)90146-9; Nakayama S, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-131; PALMITER RD, 1978, P NATL ACAD SCI USA, V75, P94, DOI 10.1073/pnas.75.1.94; Pichinuk E, 2012, CANCER RES, V72, P3324, DOI 10.1158/0008-5472.CAN-12-0067; Prinssen HM, 1998, CANCER IMMUNOL IMMUN, V47, P39, DOI 10.1007/s002620050502; Rubinstein DB, 2006, CANCER RES, V66, P11247, DOI 10.1158/0008-5472.CAN-06-1486; Schrempf S, 2007, J VIROL, V81, P12515, DOI 10.1128/JVI.01481-07; SEGEV N, 1985, P NATL ACAD SCI USA, V82, P1531, DOI 10.1073/pnas.82.5.1531; Strome SE, 2007, ONCOLOGIST, V12, P1084, DOI 10.1634/theoncologist.12-9-1084; Tang CK, 2008, EXPERT REV VACCINES, V7, P963, DOI 10.1586/14760584.7.7.963; Thie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015921; Treon SP, 2000, SEMIN ONCOL, V27, P598; VANDEWIELVANKEMENADE E, 1993, J IMMUNOL, V151, P767; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; YE RD, 1988, J BIOL CHEM, V263, P4869	46	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85400	10.1371/journal.pone.0085400	http://dx.doi.org/10.1371/journal.pone.0085400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416403	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500245
J	Davison, JM; Yee, M; Krill-Burger, JM; Lyons-Weiler, MA; Kelly, LA; Sciulli, CM; Nason, KS; Luketich, JD; Michalopoulos, GK; LaFramboise, WA				Davison, Jon M.; Yee, Melissa; Krill-Burger, J. Michael; Lyons-Weiler, Maureen A.; Kelly, Lori A.; Sciulli, Christin M.; Nason, Katie S.; Luketich, James D.; Michalopoulos, George K.; LaFramboise, William A.			The Degree of Segmental Aneuploidy Measured by Total Copy Number Abnormalities Predicts Survival and Recurrence in Superficial Gastroesophageal Adenocarcinoma	PLOS ONE			English	Article							LONG-TERM SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; CHROMOSOMAL INSTABILITY; DNA-PLOIDY; BARRETTS-ESOPHAGUS; CANCER; ABERRATIONS; EVENT; GENE; OVEREXPRESSION	Background: Prognostic biomarkers are needed for superficial gastroesophageal adenocarcinoma (EAC) to predict clinical outcomes and select therapy. Although recurrent mutations have been characterized in EAC, little is known about their clinical and prognostic significance. Aneuploidy is predictive of clinical outcome in many malignancies but has not been evaluated in superficial EAC. Methods: We quantified copy number changes in 41 superficial EAC using Affymetrix SNP 6.0 arrays. We identified recurrent chromosomal gains and losses and calculated the total copy number abnormality (CNA) count for each tumor as a measure of aneuploidy. We correlated CNA count with overall survival and time to first recurrence in univariate and multivariate analyses. Results: Recurrent segmental gains and losses involved multiple genes, including: HER2, EGFR, MET, CDK6, KRAS (recurrent gains); and FHIT, WWOX, CDKN2A/B, SMAD4, RUNX1 (recurrent losses). There was a 40-fold variation in CNA count across all cases. Tumors with the lowest and highest quartile CNA count had significantly better overall survival (p = 0.032) and time to first recurrence (p = 0.010) compared to those with intermediate CNA counts. These associations persisted when controlling for other prognostic variables. Significance: SNP arrays facilitate the assessment of recurrent chromosomal gain and loss and allow high resolution, quantitative assessment of segmental aneuploidy (total CNA count). The non-monotonic association of segmental aneuploidy with survival has been described in other tumors. The degree of aneuploidy is a promising prognostic biomarker in a potentially curable form of EAC.	[Davison, Jon M.; Krill-Burger, J. Michael; Lyons-Weiler, Maureen A.; Kelly, Lori A.; Sciulli, Christin M.; Michalopoulos, George K.; LaFramboise, William A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Yee, Melissa] Univ Pittsburgh, Sch Med, Dept Internal Med, Pittsburgh, PA USA; [Nason, Katie S.; Luketich, James D.] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Davison, JM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	davisonjm@upmc.edu	luketich, james/AAY-6230-2020		National Cancer Institute Cancer Center [P30 CA47904]; NATIONAL CANCER INSTITUTE [K07CA151613, P30CA047904] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Cancer Center Support Grant P30 CA47904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Araujo SEA, 2007, DIS COLON RECTUM, V50, P1800, DOI 10.1007/s10350-007-9013-6; Bang YJ, 2010, LANCET, V376, P1302; Baumbusch LO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054356; Bayraktar S, 2012, BREAST CANCER RES TR, V135, P355, DOI 10.1007/s10549-012-2158-6; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Choma D, 2001, BRIT J CANCER, V85, P14, DOI 10.1054/bjoc.2001.1892; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gu JA, 2010, CANCER PREV RES, V3, P1176, DOI 10.1158/1940-6207.CAPR-09-0265; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirsch D, 2013, CANCER RES, V73, P1454, DOI 10.1158/0008-5472.CAN-12-0928; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Lai LA, 2010, MOL CANCER RES, V8, P1084, DOI 10.1158/1541-7786.MCR-09-0529; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Li Shuangwei, 2012, Front Med, V6, P275, DOI 10.1007/s11684-012-0216-4; Lin L, 2012, P NATL ACAD SCI USA, V109, P4251, DOI 10.1073/pnas.1011989109; Marx AH, 2010, HISTOPATHOLOGY, V57, P418, DOI 10.1111/j.1365-2559.2010.03643.x; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; MenkePluymers MBE, 1995, HEPATO-GASTROENTEROL, V42, P786; NAKAMURA T, 1994, CANCER-AM CANCER SOC, V73, P1785, DOI 10.1002/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Ng G, 2006, J MOL DIAGN, V8, P449, DOI 10.2353/jmoldx.2006.060033; Ong CA, 2013, J CLIN ONCOL; Pech O, 2011, ANN SURG, V254, P67, DOI 10.1097/SLA.0b013e31821d4bf6; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Prasad GA, 2009, GASTROENTEROLOGY, V137, P815, DOI 10.1053/j.gastro.2009.05.059; Radu OM, 2012, AM J CLIN PATHOL, V137, P583, DOI 10.1309/AJCPXQVS6YGHPDCY; Reid BJ, 2011, CANCER BIOMARK, V9, P307, DOI 10.3233/CBM-2011-0162; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Rice TW, 2001, J THORAC CARDIOV SUR, V122, P1077, DOI 10.1067/mtc.2001.113749; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Saldiyar JC, 2010, J CELL BIOCHEM, V109, P858, DOI 10.1002/jcb.22481; Sarbia M, 1996, J CANCER RES CLIN, V122, P186, DOI 10.1007/BF01366961; Schweigert M, 2013, NAT REV GASTROENTERO; Schweighofer CD, 2013, J MOL DIAGN, V15, P196, DOI 10.1016/j.jmoldx.2012.09.006; Stein HJ, 2005, ANN SURG, V242, P566, DOI 10.1097/01.sla.0000184211.75970.85; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Theisen J, 2007, Adv Surg, V41, P229, DOI 10.1016/j.yasu.2007.05.016; Thompson ER, 2005, HUM MUTAT, V26, P384, DOI 10.1002/humu.20220; Tuefferd M, 2008, GENE CHROMOSOME CANC, V47, P957, DOI 10.1002/gcc.20599	57	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e79079	10.1371/journal.pone.0079079	http://dx.doi.org/10.1371/journal.pone.0079079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454681	Green Accepted, Green Published, gold			2022-12-27	WOS:000330236000003
J	Hu, ZS; Murakami, T; Suzuki, K; Tamura, H; Kuwahara-Arai, K; Iba, T; Nagaoka, I				Hu, Zhongshuang; Murakami, Taisuke; Suzuki, Kaori; Tamura, Hiroshi; Kuwahara-Arai, Kyoko; Iba, Toshiaki; Nagaoka, Isao			Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism	PLOS ONE			English	Article							P2X(7) RECEPTOR; CELL-DEATH; PROINFLAMMATORY CYTOKINES; MAMMALIAN DEFENSINS; P2X7 RECEPTOR; SEPSIS; ATP; LPS; APOPTOSIS; SUPPRESSES	Pyroptosis is a caspase-1 dependent cell death, associated with proinflammatory cytokine production, and is considered to play a crucial role in sepsis. Pyroptosis is induced by the two distinct stimuli, microbial PAMPs (pathogen associated molecular patterns) and endogenous DAMPs (damage associated molecular patterns). Importantly, cathelicidin-related AMPs (antimicrobial peptides) have a role in innate immune defense. Notably, human cathelicidin LL-37 exhibits the protective effect on the septic animal models. Thus, in this study, to elucidate the mechanism for the protective action of LL-37 on sepsis, we utilized LPS (lipopolysaccharide) and ATP (adenosine triphosphate) as a PAMP and a DAMP, respectively, and examined the effect of LL-37 on the LPS/ATP-induced pyroptosis of macrophage-like J774 cells. The data indicated that the stimulation of J774 cells with LPS and ATP induces the features of pyroptosis, including the expression of IL-1 beta mRNA and protein, activation of caspase-1, inflammasome formation and cell death. Moreover, LL-37 inhibits the LPS/ATP-induced IL-1 beta expression, caspase-1 activation, inflammasome formation, as well as cell death. Notably, LL-37 suppressed the LPS binding to target cells and ATP-induced/P2X(7)-mediated caspase-1 activation. Together these observations suggest that LL-37 potently inhibits the LPS/ATP-induced pyroptosis by both neutralizing the action of LPS and inhibiting the response of P2X(7) to ATP. Thus, the present finding may provide a novel insight into the modulation of sepsis utilizing LL-37 with a dual action on the LPS binding and P2X(7) activation.	[Hu, Zhongshuang; Murakami, Taisuke; Suzuki, Kaori; Tamura, Hiroshi; Nagaoka, Isao] Juntendo Univ, Grad Sch Med, Dept Host Def & Biochem Res, Tokyo, Japan; [Kuwahara-Arai, Kyoko] Juntendo Univ, Grad Sch Med, Dept Bacteriol, Tokyo, Japan; [Iba, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Emergency & Disaster Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University	Nagaoka, I (corresponding author), Juntendo Univ, Grad Sch Med, Dept Host Def & Biochem Res, Tokyo, Japan.	nagaokai@juntendo.ac.jp	Iba, Toshiaki/H-5314-2013; Iba, Toshiaki/AAP-7141-2021	Iba, Toshiaki/0000-0002-0255-4088; Iba, Toshiaki/0000-0002-0255-4088; Tamura, Hiroshi/0000-0003-0077-1801	Japan Society for the Promotion of Science [23590519]; Ministry of Education, Culture, Sports, Science and Technology, Japan [S1201013]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid (Grant number 23590519; http://www.jsps.go.jp/j-grantsinaid/index.html) for Scientific Research from Japan Society for the Promotion of Science, and a Grants-in-Aid (Grant number S1201013; http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; da Silva F, 2009, APOPTOSIS, V14, P509, DOI 10.1007/s10495-009-0320-3; Dinarello CA, 2002, AM J RESP CRIT CARE, V166, P1156, DOI 10.1164/rccm.2208006; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matsuda A, 2012, J NIPPON MED SCH, V79, P4, DOI 10.1272/jnms.79.4; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Moore SF, 2009, J IMMUNOL, V183, P3302, DOI 10.4049/jimmunol.0900394; Murakami T, 2009, INT IMMUNOL, V21, P905, DOI 10.1093/intimm/dxp057; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; Pinsky MR, 2004, AM J MED SCI, V328, P220, DOI 10.1097/00000441-200410000-00005; Pochet S, 2006, MOL PHARMACOL, V69, P2037, DOI 10.1124/mol.105.021444; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Seil M, 2010, BBA-BIOMEMBRANES, V1798, P569, DOI 10.1016/j.bbamem.2009.11.002; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sperlagh B, 1998, NEUROCHEM INT, V33, P209, DOI 10.1016/S0197-0186(98)00025-4; Suzuki K, 2011, INT IMMUNOL, V23, P185, DOI 10.1093/intimm/dxq471; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Wewers MD, 2009, PURINERG SIGNAL, V5, P189, DOI 10.1007/s11302-009-9131-9; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang D, 2001, J LEUKOCYTE BIOL, V69, P691	58	56	64	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85765	10.1371/journal.pone.0085765	http://dx.doi.org/10.1371/journal.pone.0085765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454930	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000015
J	Kodavali, PK; Dudkiewicz, M; Pikula, S; Pawlowski, K				Kodavali, Praveen Kumar; Dudkiewicz, Malgorzata; Pikula, Slawomir; Pawlowski, Krzysztof			Bioinformatics Analysis of Bacterial Annexins - Putative Ancestral Relatives of Eukaryotic Annexins	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; PROTEIN HOMOLOGY DETECTION; MEMBRANE-BINDING PROTEINS; HORIZONTAL GENE-TRANSFER; SP-NOV.; PREDICTION; ALIGNMENT; CALCIUM; EVOLUTION; DATABASE	Annexins are Ca2+-binding, membrane-interacting proteins, widespread among eukaryotes, consisting usually of four structurally similar repeated domains. It is accepted that vertebrate annexins derive from a double genome duplication event. It has been postulated that a single domain annexin, if found, might represent a molecule related to the hypothetical ancestral annexin. The recent discovery of a single-domain annexin in a bacterium, Cytophaga hutchinsonii, apparently confirmed this hypothesis. Here, we present a more complex picture. Using remote sequence similarity detection tools, a survey of bacterial genomes was performed in search of annexin-like proteins. In total, we identified about thirty annexin homologues, including single-domain and multi-domain annexins, in seventeen bacterial species. The thorough search yielded, besides the known annexin homologue from C. hutchinsonii, homologues from the Bacteroidetes/Chlorobi phylum, from Gemmatimonadetes, from beta-and delta-Proteobacteria, and from Actinobacteria. The sequences of bacterial annexins exhibited remote but statistically significant similarity to sequence profiles built of the eukaryotic ones. Some bacterial annexins are equipped with additional, different domains, for example those characteristic for toxins. The variation in bacterial annexin sequences, much wider than that observed in eukaryotes, and different domain architectures suggest that annexins found in bacteria may actually descend from an ancestral bacterial annexin, from which eukaryotic annexins also originate. The hypothesis of an ancient origin of bacterial annexins has to be reconciled with the fact that remarkably few bacterial strains possess annexin genes compared to the thousands of known bacterial genomes and with the patchy, anomalous phylogenetic distribution of bacterial annexins. Thus, a massive annexin gene loss in several bacterial lineages or very divergent evolution would appear a likely explanation. Alternative evolutionary scenarios, involving horizontal gene transfer between bacteria and protozoan eukaryotes, in either direction, appear much less likely. Altogether, current evidence does not allow unequivocal judgement as to the origin of bacterial annexins.	[Kodavali, Praveen Kumar; Pikula, Slawomir] Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Life Sciences	Pawlowski, K (corresponding author), Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland.	krzysztof_pawlowski@sggw.pll	Pawłowski, Krzysztof/C-2949-2013; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Pikula, Slawomir/0000-0003-4640-3094; Dudkiewicz, Malgorzata/0000-0003-4432-2530	NODPERCEPTION contract from European Community's Marie Curie Research Training Network Program [MRTN-CT-2006-035546]; Nencki Institute of Experimental Biology, Warsaw, Poland; EC NODPERCEPTION contract [ESR7]	NODPERCEPTION contract from European Community's Marie Curie Research Training Network Program; Nencki Institute of Experimental Biology, Warsaw, Poland; EC NODPERCEPTION contract	This work was supported by the NODPERCEPTION contract (MRTN-CT-2006-035546) from the European Community's Marie Curie Research Training Network Program and by the Nencki Institute of Experimental Biology, Warsaw, Poland. PKK acknowledges a fellowship from the EC NODPERCEPTION contract No ESR7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bandorowicz-Pikula J, 2012, MOL MEMBR BIOL, V29, P229, DOI 10.3109/09687688.2012.693210; BARTON GJ, 1991, EUR J BIOCHEM, V198, P749, DOI 10.1111/j.1432-1033.1991.tb16076.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Cantacessi C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02893; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; CLARK GB, 1995, PLANT PHYSIOL, V109, P1133, DOI 10.1104/pp.109.4.1133; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dana CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031643; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Du ZJ, 2011, J BACTERIOL, V193, P4557, DOI 10.1128/JB.05513-11; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Filippini M, 2012, J BACTERIOL, V194, P4445, DOI 10.1128/JB.00869-12; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; Hall T, 2012, BIOEDIT; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Hofmann A, 2000, BIOCHEMISTRY-US, V39, P7712, DOI 10.1021/bi992359+; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Huang RJ, 2011, VIRULENCE, V2, P435, DOI 10.4161/viru.2.5.16140; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; Huntley S, 2012, J BACTERIOL, V194, P3012, DOI 10.1128/JB.00397-12; Ivanova N, 2010, STAND GENOMIC SCI, V2, P96, DOI 10.4056/sigs.69.1277; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Kumar S, 2012, J BACTERIOL, V194, P3746, DOI 10.1128/JB.00649-12; Lail K, 2010, STAND GENOMIC SCI, V2, P176, DOI 10.4056/sigs.741334; Lang E, 2009, INT J SYST EVOL MICR, V59, P2122, DOI 10.1099/ijs.0.003566-0; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; LEADBETTER ER, 1979, ARCH MICROBIOL, V122, P9, DOI 10.1007/BF00408040; Lee HS, 2011, J BACTERIOL, V193, P4031, DOI 10.1128/JB.05241-11; Lenart A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062272; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin BK, 2012, INT J SYST EVOL MICR, V62, P869, DOI 10.1099/ijs.0.027136-0; Liu HQ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-276; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McDaniel LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043506; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morgan RO, 2006, BBA-MOL CELL RES, V1763, P1238, DOI 10.1016/j.bbamcr.2006.09.028; MORGAN RO, 1995, MOL BIOL EVOL, V12, P967; Morgan RO, 2004, BBA-MOL CELL RES, V1742, P133, DOI 10.1016/j.bbamcr.2004.09.010; Morgan RO, 1997, J MOL EVOL, V44, P178, DOI 10.1007/PL00006134; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nakagawa Y, 2002, J GEN APPL MICROBIOL, V48, P155, DOI 10.2323/jgam.48.155; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Nupur, 2012, INT J SYST EVOL MICR, V62, P2213, DOI 10.1099/ijs.0.036608-0; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Podell S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-419; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Schoenfeld TW, 2013, MOL BIOL EVOL, V30, P1653, DOI 10.1093/molbev/mst078; Smith J, 2007, BACTERIALLY MEDIATED; SMITH PD, 1994, TRENDS GENET, V10, P241, DOI 10.1016/0168-9525(94)90171-6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; SWAIRJO MA, 1994, ANNU REV BIOPH BIOM, V23, P193, DOI 10.1146/annurev.bb.23.060194.001205; Talukdar T, 2009, ACTA BIOCHIM POL, V56, P199; Teles FR, 2012, J PERIODONTAL RES, V47, P95, DOI 10.1111/j.1600-0765.2011.01409.x; Tice H, 2010, STAND GENOMIC SCI, V2, P168, DOI 10.4056/sigs.721316; Vikram S, 2012, J BACTERIOL, V194, P3543, DOI 10.1128/JB.00532-12; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Yajima S, 2004, BIOCHEM BIOPH RES CO, V322, P966, DOI 10.1016/j.bbrc.2004.07.206; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0	89	8	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85428	10.1371/journal.pone.0085428	http://dx.doi.org/10.1371/journal.pone.0085428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454864	gold, Green Published, Green Submitted			2022-12-27	WOS:000330236000009
J	Karczewski, KJ; Fernald, GH; Martin, AR; Snyder, M; Tatonetti, NP; Dudley, JT				Karczewski, Konrad J.; Fernald, Guy Haskin; Martin, Alicia R.; Snyder, Michael; Tatonetti, Nicholas P.; Dudley, Joel T.			STORMSeq: An Open-Source, User-Friendly Pipeline for Processing Personal Genomics Data in the Cloud	PLOS ONE			English	Article								The increasing public availability of personal complete genome sequencing data has ushered in an era of democratized genomics. However, read mapping and variant calling software is constantly improving and individuals with personal genomic data may prefer to customize and update their variant calls. Here, we describe STORMSeq (Scalable Tools for Open-Source Read Mapping), a graphical interface cloud computing solution that does not require a parallel computing environment or extensive technical experience. This customizable and modular system performs read mapping, read cleaning, and variant calling and annotation. At present, STORMSeq costs approximately $2 and 5-10 hours to process a full exome sequence and $30 and 3-8 days to process a whole genome sequence. We provide this open-access and open-source resource as a user-friendly interface in Amazon EC2.	[Karczewski, Konrad J.; Fernald, Guy Haskin; Martin, Alicia R.] Stanford Univ, Sch Med, Biomed Informat Training Program, Stanford, CA 94305 USA; [Karczewski, Konrad J.; Fernald, Guy Haskin; Martin, Alicia R.; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Tatonetti, Nicholas P.] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Dudley, Joel T.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Stanford University; Stanford University; Columbia University; Icahn School of Medicine at Mount Sinai	Karczewski, KJ (corresponding author), Stanford Univ, Sch Med, Biomed Informat Training Program, Stanford, CA 94305 USA.	konradjkarczewski@gmail.com; joel.dudley@mssm.edu	; Karczewski, Jakub/L-7326-2018	Karczewski, Konrad/0000-0003-2878-4671; Tatonetti, Nicholas/0000-0002-2700-2597; Snyder, Michael/0000-0003-0784-7987; Martin, Alicia/0000-0003-0241-3522; Karczewski, Jakub/0000-0001-9322-7842	National Science Foundation (NSF); National Institutes of Health (NIH) [LM007033, GM007790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	KJK is funded by the National Science Foundation (NSF) Graduate Research Fellowship. KJK and GHF are funded by National Institutes of Health (NIH) Training Grant LM007033. ARM is funded by NIH Training Grant GM007790. MS is funded by grants from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Faster and More Accurate Sequence Alignment with SNAP, 2011, FASTER MORE ACCURAT; Fischer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041948; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Karczewski KJ, 2012, BIOCOMPUT-PAC SYM, P339; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77	11	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84860	10.1371/journal.pone.0084860	http://dx.doi.org/10.1371/journal.pone.0084860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454756	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100037
J	Kellner, AWA; Pinheiro, AEP; Campos, DA				Kellner, Alexander W. A.; Pinheiro, Andre E. P.; Campos, Diogenes A.			A New Sebecid from the Paleogene of Brazil and the Crocodyliform Radiation after the K-Pg Boundary	PLOS ONE			English	Article							SNOUTED DYROSAURID CROCODYLIFORMES; PALEOCENE; MESOEUCROCODYLIA; BASIN; OSTEOLOGY	A new crocodyliform, Sahitisuchus fluminensis gen. et sp. nov., is described based on a complete skull, lower jaw and anterior cervical vertebrae collected in the Sao Jose de Itaborai Basin of Rio de Janeiro, Brazil. The specimen is one of the best preserved crocodyliforms from Paleocene deposits recovered so far and represents a sebecosuchian, one of the few clades that survived the Cretaceous-Paleogene biotic crisis. The new taxon is found in the same deposit as an alligatoroid, a group that experienced large diversification in the Paleogene. The sebecosuchian record suggests that after the Cretaceous-Paleogene biotic crisis, the less specialized members of this clade characterized by a higher number of teeth compared to the baurusuchid sebecosuchians survived, some having terrestrial habits while others developed a semi-aquatic life style (e.g., Lorosuchus). Starting in the Eocene, sebecid sebecosuchians became specialized with a more accentuated oreinirostry as observed in Sebecus and in Langstonia, but not showing the typical reduced dentition developed by the Cretaceous baurusuchid sebecosuchians. The basal position of Barinasuchus arveloi, a high-snouted Miocene sebecid, indicates the occurrence of an independent lineage sometime after the K-Pg biotic crisis that developed accentuated oreinirostry, suggesting a more complex history of the post-K-Pg crocodyliform radiation.	[Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Lab Sistemat & Tafon Vertebrados Fosseis, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil; [Pinheiro, Andre E. P.] Univ Fed Rio de Janeiro, Dept Geol, Lab Macrofosseis, Rio De Janeiro, Brazil; [Campos, Diogenes A.] Co Pesquisa Recursos Minerais, Serv Geol Brasil, Museu Ciencias Terra, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Kellner, AWA (corresponding author), Univ Fed Rio de Janeiro, Lab Sistemat & Tafon Vertebrados Fosseis, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil.	kellner@mn.ufrj.br	Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.779/2008, E-26/111.273/2010]; Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq) [307276/2009-0]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AWAK acknowledges the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ nos. E-26/102.779/2008 and E-26/111.273/2010) and the Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq no. 307276/2009-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa JA, 2008, P ROY SOC B-BIOL SCI, V275, P1385, DOI 10.1098/rspb.2008.0110; BARTELS WS, 1984, J PALEONTOL, V58, P1347; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Bergqvist LP, 2011, REV BRAS PALEONTOLOG, V14, P75, DOI 10.4072/rbp.2011.1.08; Bergqvist LP, 2005, BASICA SAO JOSE ITAB, P1; Bona P, 2011, J MORPHOL, P1, DOI 10.1002/jmor.10894; Bona P, 2007, AMEGHINIANA, V44, P435; Brochu CA, 2004, J VERTEBR PALEONTOL, V24, P857, DOI 10.1671/0272-4634(2004)024[0857:APATSO]2.0.CO;2; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; BUFFETAUT E, 1975, CR ACAD SCI D NAT, V280, P2741; BUFFETAUT E, 1990, TECTONOPHYSICS, V171, P337, DOI 10.1016/0040-1951(90)90108-K; Buffetaut Eric, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P545; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Campos DA, 2011, AN ACAD BRAS CIENC, V83, P317, DOI 10.1590/S0001-37652011000100020; Carvalho ID, 2004, GONDWANA RES, V7, P975, DOI 10.1016/S1342-937X(05)71079-0; Carvalho ID, 2007, ZOOTAXA, P35; Chiasson R. B., 1962, LAB ANATOMY ALLIGATO, P1; Colbert Edwin Harris, 1946, BULL AMER MUS NAT HIST, V87, P217; De Muizon Christian, 1993, Annales de Paleontologie, V79, P233; Gasparini Z., 1991, Journal of Vertebrate Paleontology, V11, P316; Gasparini Zulma, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P159; Gasparini Zulma, 1993, Historical Biology, V7, P1; Gelfo JN, 2009, PALAEONTOLOGY, V52, P251, DOI 10.1111/j.1475-4983.2008.00835.x; Goloboff P.A., 2008, TNT TREE ANAL USING; Hecht MK, 1983, KONSTRUKTIONSMORPHOL, V152, P657; Hekkala E, 2011, MOL ECOL, V20, P4199, DOI 10.1111/j.1365-294X.2011.05245.x; Iordansky N.N., 1973, P201; Iordansky Nikolai N., 2000, Russian Journal of Herpetology, V7, P41; Jouve S, 2005, PALAEONTOLOGY, V48, P359, DOI 10.1111/j.1475-4983.2005.00442.x; Jouve S, 2008, PALAEONTOLOGY, V51, P281, DOI 10.1111/j.1475-4983.2007.00747.x; KELLNER AWA, 1987, AN ACAD BRAS CIENC, V59, P219; Kellner AWA, 1999, EPISODES, V22, P238; Klein Victor De Carvalho, 2002, Arquivos do Museu Nacional Rio de Janeiro, V60, P245; Langston W, 1997, VERTEBRATE PALEONTOL; LANGSTON W JR, 1975, Fieldiana Geology, V33, P291; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Larsson HCE, 2000, NEUES JAHRB GEOL P-A, V217, P131, DOI 10.1127/njgpa/217/2000/131; Marshall L.G., 1985, Topics in Geobiology, V4, P49; Marshall LG, 1997, J S AM EARTH SCI, V10, P49, DOI 10.1016/S0895-9811(97)00005-9; Medeiros R. A., 1999, ACTA GEOLOGICA LEOPO, V22, P3; Montefeltro FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021916; Paolillo A., 2007, PALEOBIOLOGIA NEOTRO, V3, P1; Paula Couto de C., 1952, AM MUS NOVIT, V1559; Paula-Couto C, 1953, NOTAS PRELIMINARES E, V75, P1; Piacentini Pinheiro Andre Eduardo, 2008, Revista Brasileira de Paleontologia, V11, P37; Pinheiro AEP, 2012, HIST BIOL, P1, DOI [10.1080/08912963.2012.705838, DOI 10.1080/08912963.2012.705838)]; Pol D, 2012, J VERTEBR PALEONTOL, V32, P328, DOI 10.1080/02724634.2012.646833; Pol D, 2011, ZOOL J LINN SOC-LOND, V163, pS7, DOI 10.1111/j.1096-3642.2011.00714.x; Powell JE, 2011, EOCENE VERTEBRATES N, P49; Price LI, 1946, B 2 C PANAMERICANO E, V3, P149; Rage Jean-Claude, 1998, Palaeovertebrata (Montpellier), V27, P109; Riccomini C, 2004, GEOLOGIA CONTINENTE, P393; Riff D, 2011, ZOOL J LINN SOC-LOND, V163, pS37, DOI 10.1111/j.1096-3642.2011.00713.x; Rodrigues-Francisco BH, 1985, DNPM SERIE GEOLOGIA, V2, P651; Simpson G. G., 1937, American Museum Novitates, P1; Whetstone K.N., 1983, OCCASIONAL PAPERS MU, V106, P1, DOI DOI 10.1017/CBO9781107415324.004	60	31	31	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e81386	10.1371/journal.pone.0081386	http://dx.doi.org/10.1371/journal.pone.0081386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454686	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100002
J	Kim, S; Kim, JY; Lee, DC; Lee, HS; Lee, JW; Jeon, JY				Kim, Sue; Kim, Ji-Young; Lee, Duk-Chul; Lee, Hye-Sun; Lee, Ji-Won; Jeon, Justin Y.			Combined Impact of Cardiorespiratory Fitness and Visceral Adiposity on Metabolic Syndrome in Overweight and Obese Adults in Korea	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE MORTALITY; HOMEOSTASIS MODEL ASSESSMENT; TYPE-2 DIABETIC-PATIENTS; BODY-FAT DISTRIBUTION; HEART-RATE RECOVERY; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; ALL-CAUSE; OXYGEN-UPTAKE; RISK-FACTORS	Background: Obesity, especially visceral obesity, is known to be an important correlate for cardiovascular disease and increased mortality. On the other hand, high cardiorespiratory fitness is suggested to be an effective contributor for reducing this risk. This study was conducted to determine the combined impact of cardiorespiratory fitness and visceral adiposity, otherwise known as fitness and fatness, on metabolic syndrome in overweight and obese adults. Methods: A total of 232 overweight and obese individuals were grouped into four subtypes according to their fitness level. This was measured by recovery heart rate from a step test in addition to visceral adiposity defined as the visceral adipose tissue area to subcutaneous adipose tissue area ratio (VAT/SAT ratio). Associations of fitness and visceral fatness were analyzed in comparison with the prevalence of metabolic syndrome. Results: The high visceral fat and low fitness group had the highest prevalence of metabolic syndrome [Odds Ratio (OR) 5.02; 95% Confidence Interval (CI) 1.85-13.61] compared with the reference group, which was the low visceral adiposity and high fitness group, after adjustments for confounding factors. Viscerally lean but unfit subjects were associated with a higher prevalence of metabolic syndrome than more viscerally obese but fit subjects (OR 3.42; 95% CI 1.27-9.19, and OR 2.70; 95% CI 1.01-7.25, respectively). Conclusions: Our study shows that visceral obesity and fitness levels are cumulatively associated with a higher prevalence of metabolic syndrome in healthy overweight and obese adults. This suggests that cardiorespiratory fitness is a significant modifier in the relation of visceral adiposity to adverse metabolic outcomes in overweight and obese individuals.	[Kim, Sue; Lee, Duk-Chul; Lee, Ji-Won] Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Seoul, South Korea; [Kim, Ji-Young; Jeon, Justin Y.] Yonsei Univ, Dept Sport & Leisure Studies, Seoul 120749, South Korea; [Lee, Hye-Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Units, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System	Lee, JW (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Seoul, South Korea.	indi5645@yuhs.ac; jjeon@yonsei.ac.kr	; Lee, Hye Sun/J-2154-2015	LEE, JI WON/0000-0002-2666-4249; Lee, Duk Chul/0000-0001-9166-1813; Lee, Hye Sun/0000-0001-6328-6948; Jeon, Justin/0000-0001-7978-4271	Biomedical Technology Development Research Program through the National Research Foundation of Korea(NRF); Ministry of Science, ICT and Future Planning [NRF-2013M3A9B6046413]	Biomedical Technology Development Research Program through the National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Biomedical Technology Development Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013M3A9B6046413). The funders had no role in study design, data collection and anlalysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2007, ARCH INTERN MED, V167, P1518, DOI 10.1001/archinte.167.14.1518; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Clark JE, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-19; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; HOUMARD JA, 1993, AM J PHYSIOL, V264, pE896, DOI 10.1152/ajpendo.1993.264.6.E896; Izquierdo M, 2009, EUR J APPL PHYSIOL, V107, P397, DOI 10.1007/s00421-009-1139-x; Jekal Yoonsuk, 2010, Korean Diabetes J, V34, P182, DOI 10.4093/kdj.2010.34.3.182; Jones TE, 2009, OBESITY, V17, P1189, DOI 10.1038/oby.2009.11; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; Katzmarzyk PT, 2004, ARCH INTERN MED, V164, P1092, DOI 10.1001/archinte.164.10.1092; Kelley DE, 1999, MED SCI SPORT EXER, V31, pS619, DOI 10.1097/00005768-199911001-00021; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Lee JW, 2007, CLIN ENDOCRINOL, V66, P572, DOI 10.1111/j.1365-2265.2007.02780.x; Lentner C, 1982, GEIGY SCI TABLES; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McArdle WD, 2000, ESSENTIALS EXERCISE; McAuley PA, 2012, J OBES, V2012, DOI 10.1155/2012/951582; McAuley PA, 2009, AM J HYPERTENS, V22, P1062, DOI 10.1038/ajh.2009.122; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Morshedi-Meibodi A, 2002, AM J CARDIOL, V90, P848, DOI 10.1016/S0002-9149(02)02706-6; Nannipieri M, 2007, INT J OBESITY, V31, P1843, DOI 10.1038/sj.ijo.0803676; Nilsson G, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.06.025; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rheaume C, 2011, J CLIN ENDOCR METAB, V96, P1462, DOI 10.1210/jc.2010-2432; Santo AS, 2003, RES Q EXERCISE SPORT, V74, P110, DOI 10.1080/02701367.2003.10609070; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; SICONOLFI SF, 1985, AM J EPIDEMIOL, V121, P382, DOI 10.1093/oxfordjournals.aje.a114010; Sieverdes JC, 2010, BRIT J SPORT MED, V44, P238, DOI 10.1136/bjsm.2009.062117; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Stevens J, 2004, INT J OBESITY, V28, P1463, DOI 10.1038/sj.ijo.0802770; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; WENER J, 1953, CAN MED ASSOC J, V68, P368; Yokoyama H, 2004, J CLIN ENDOCR METAB, V89, P1481, DOI 10.1210/jc.2003-031374	48	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85742	10.1371/journal.pone.0085742	http://dx.doi.org/10.1371/journal.pone.0085742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454926	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100128
J	Minamoto, T; Osaka, M; Yaoi, K; Osaka, N				Minamoto, Takehiro; Osaka, Mariko; Yaoi, Ken; Osaka, Naoyuki			Extrapunitive and Intropunitive Individuals Activate Different Parts of the Prefrontal Cortex under an Ego-Blocking Frustration	PLOS ONE			English	Article							WORKING-MEMORY; NEURAL BASIS; REACTIVE AGGRESSION; FMRI; ANGER; INVOLVEMENT; MECHANISMS; EXPRESSION; DEPRESSION; RESPONSES	Different people make different responses when they face a frustrating situation: some punish others (extrapunitive), while others punish themselves (intropunitive). Few studies have investigated the neural structures that differentiate extrapunitive and intropunitive individuals. The present fMRI study explored these neural structures using two different frustrating situations: an ego-blocking situation which blocks a desire or goal, and a superego-blocking situation which blocks self-esteem. In the ego-blocking condition, the extrapunitive group (n = 9) showed greater activation in the bilateral ventrolateral prefrontal cortex, indicating that these individuals prefer emotional processing. On the other hand, the intropunitive group (n = 9) showed greater activation in the left dorsolateral prefrontal cortex, possibly reflecting an effortful control for anger reduction. Such patterns were not observed in the superego-blocking condition. These results indicate that the prefrontal cortex is the source of individual differences in aggression direction in the ego-blocking situation.	[Minamoto, Takehiro; Osaka, Mariko] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan; [Yaoi, Ken; Osaka, Naoyuki] Kyoto Univ, Grad Sch Letters, Sakyo Ku, Kyoto, Japan	Osaka University; Kyoto University	Minamoto, T (corresponding author), Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan.	txminamoto@hus.osaka-u.ac.jp			Japan Society for the Promotion of Science [23800034, 22220003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), grant numbers 23800034 to TM and 22220003 to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Abler B, 2005, NEUROREPORT, V16, P669, DOI 10.1097/00001756-200505120-00003; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59; Berkowitz L, 2004, EMOTION, V4, P107, DOI 10.1037/1528-3542.4.2.107; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Blair RJR, 2003, CONT NEUROS, P21; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; BRUTUS M, 1989, EXP NEUROL, V104, P55, DOI 10.1016/0014-4886(89)90008-3; BUTTER CM, 1970, J COMP PHYSIOL PSYCH, V72, P132, DOI 10.1037/h0029303; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; David N, 2008, SOC COGN AFFECT NEUR, V3, P279, DOI 10.1093/scan/nsn023; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dollard J, 1939, FRUSTRATION AGGRESSI, DOI 10.1037/10022-000; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; FUCHS SAG, 1985, BRAIN RES, V330, P93, DOI 10.1016/0006-8993(85)90010-1; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Giancola PR, 1995, AGGRESSIVE BEHAV, V21, P431, DOI 10.1002/1098-2337(1995)21:6<431::AID-AB2480210604>3.0.CO;2-Q; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gregg TR, 2001, PROG NEURO-PSYCHOPH, V25, P91, DOI 10.1016/S0278-5846(00)00150-0; Gregg TR, 2003, CONT NEUROS, P1; Hata K, 2006, MANUAL PF STUDY; JONIDES J, 1995, INVITATION COGNITIVE; Kahn-Greene ET, 2006, PERS INDIV DIFFER, V41, P1433, DOI 10.1016/j.paid.2006.06.002; KAMBACK MC, 1973, BIOL PSYCHIAT, V7, P173; Kane MJ, 2006, J EXP PSYCHOL LEARN, V32, P749, DOI 10.1037/0278-7393.32.4.749; Kopper BA, 1996, J COUNS PSYCHOL, V43, P158, DOI 10.1037/0022-0167.43.2.158; Kramer UM, 2007, NEUROIMAGE, V38, P203, DOI 10.1016/j.neuroimage.2007.07.029; Lotze M, 2007, NEUROIMAGE, V34, P470, DOI 10.1016/j.neuroimage.2006.09.028; Mass R, 1975, PRIMATES, V16; Miller M, 1977, PRIMATES, V18; Norman M, 2008, J INTERPERS VIOLENCE, V23, P561, DOI 10.1177/0886260507312948; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; ROSENZWEIG S, 1945, J PERS, V14, P3, DOI 10.1111/j.1467-6494.1945.tb01036.x; Rosenzweig S, 1934, J ABNORM SOC PSYCH, V29, P298, DOI 10.1037/h0073674; Rosenzweig S, 1944, PERS BEHAV, P379; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Shih JH, 2006, PERS SOC PSYCHOL B, V32, P434, DOI 10.1177/0146167205282739; SIEGEL A, 1983, NEUROSCI BIOBEHAV R, V7, P395, DOI 10.1016/0149-7634(83)90045-3; Siegel A, 1990, PROGR PSYCHOBIOLOGY, V14, P135; STEER RA, 1982, PSYCHOL REP, V50, P723, DOI 10.2466/pr0.1982.50.3.723; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; Wilkowski BM, 2008, PERS SOC PSYCHOL REV, V12, P3, DOI 10.1177/1088868307309874	57	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86036	10.1371/journal.pone.0086036	http://dx.doi.org/10.1371/journal.pone.0086036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454951	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100143
J	Takehana, Y; Yamada, A; Tamori, M; Motokawa, T				Takehana, Yasuhiro; Yamada, Akira; Tamori, Masaki; Motokawa, Tatsuo			Softenin, a Novel Protein That Softens the Connective Tissue of Sea Cucumbers through Inhibiting Interaction between Collagen Fibrils	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; STICHOPUS-JAPONICUS; IONIC ENVIRONMENT; STIFFEST STATE; BODY-WALL; CATCH; STIFFNESS; DERMIS; MORPHOLOGY; VISCOSITY	The dermis in the holothurian body wall is a typical catch connective tissue or mutable collagenous tissue that shows rapid changes in stiffness. Some chemical factors that change the stiffness of the tissue were found in previous studies, but the molecular mechanisms of the changes are not yet fully understood. Detection of factors that change the stiffness by working directly on the extracellular matrix was vital to clarify the mechanisms of the change. We isolated from the body wall of the sea cucumber Stichopus chloronotus a novel protein, softenin, that softened the body-wall dermis. The apparent molecular mass was 20 kDa. The N-terminal sequence of 17 amino acids had low homology to that of known proteins. We performed sequential chemical and physical dissections of the dermis and tested the effects of softenin on each dissection stage by dynamic mechanical tests. Softenin softened Triton-treated dermis whose cells had been disrupted by detergent. The Triton-treated dermis was subjected to repetitive freeze-and-thawing to make Triton-Freeze-Thaw (TFT) dermis that was softer than the Triton-treated dermis, implying that some force-bearing structure had been disrupted by this treatment. TFT dermis was stiffened by tensilin, a stiffening protein of sea cucumbers. Softenin softened the tensilin-stiffened TFT dermis while it had no effect on the TFT dermis without tensilin treatment. We isolated collagen from the dermis. When tensilin was applied to the suspending solution of collagen fibrils, they made a large compact aggregate that was dissolved by the application of softenin or by repetitive freeze-and-thawing. These results strongly suggested that softenin decreased dermal stiffness through inhibiting cross-bridge formation between collagen fibrils; the formation was augmented by tensilin and the bridges were broken by the freeze-thaw treatment. Softenin is thus the first softener of catch connective tissue shown to work on the cross-bridges between extracellular materials.	[Takehana, Yasuhiro; Tamori, Masaki; Motokawa, Tatsuo] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Yamada, Akira] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo, Japan	Tokyo Institute of Technology; National Institute of Information & Communications Technology (NICT) - Japan	Takehana, Y (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan.	takehana.y.aa@m.titech.ac.jp			JSPS KAKENHI [21570075, 23570092]; Grants-in-Aid for Scientific Research [21570075] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 21570075 to T. M. and 23570092 to M. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; HAYASHI Y, 1986, J EXP BIOL, V125, P71; HILL RB, 1976, J INVERTEBR PATHOL, V28, P131, DOI 10.1016/0022-2011(76)90079-3; Inoue M, 1999, P ROY SOC B-BIOL SCI, V266, P993, DOI 10.1098/rspb.1999.0735; JUNQUEIRA LCU, 1980, REV CAN BIOL EXPTL, V39, P157; Koob TJ, 1999, J EXP BIOL, V202, P2291; MATSUMURA T, 1974, CONNECT TISSUE RES, V2, P117, DOI 10.3109/03008207409152097; MOTOKAWA T, 1994, COMP BIOCHEM PHYS B, V109, P613, DOI 10.1016/0305-0491(94)90124-4; Motokawa T., 1988, P39; Motokawa T, 2003, BIOL BULL-US, V205, P261, DOI 10.2307/1543290; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; MOTOKAWA T, 1981, COMP BIOCHEM PHYS C, V70, P41, DOI 10.1016/0306-4492(81)90076-9; MOTOKAWA T, 1982, J EXP BIOL, V99, P29; Quinn KP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004205; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIBAYAMA R, 1994, ZOOL SCI, V11, P511; Slatter DA, 2012, PEPTIDES, V36, P86, DOI 10.1016/j.peptides.2012.04.013; SMITH GN, 1973, BIOL BULL-US, V144, P421, DOI 10.2307/1540018; Szulgit G, 2007, BIOESSAYS, V29, P645, DOI 10.1002/bies.20597; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Wilkie IC, 2005, PROG MOLEC, V39, P221; Wilkie IC, 2002, J EXP BIOL, V205, P159; Wu HL, 2013, PROCESS BIOCHEM, V48, P871, DOI 10.1016/j.procbio.2013.04.011; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149	30	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85644	10.1371/journal.pone.0085644	http://dx.doi.org/10.1371/journal.pone.0085644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454910	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100113
J	Terragni, R; Gardini, AC; Sabattini, S; Bettini, G; Amadori, D; Talamonti, C; Vignoli, M; Capelli, L; Saunders, JH; Ricci, M; Ulivi, P				Terragni, Rossella; Gardini, Andrea Casadei; Sabattini, Silvia; Bettini, Giuliano; Amadori, Dino; Talamonti, Chiara; Vignoli, Massimo; Capelli, Laura; Saunders, Jimmy H.; Ricci, Marianna; Ulivi, Paola			EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model?	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; CELL LUNG-CANCER; COLORECTAL-CANCER; CARCINOMA; EXPRESSION; ADENOCARCINOMA; DOG; CETUXIMAB; IMMUNOHISTOCHEMISTRY	Epidermal growth factor receptor (EGFR or HER-1) and its analog c-erbB-2 (HER-2) are protein tyrosine kinases correlated with prognosis and response to therapy in a variety of human cancers. KRAS mediates the transduction of signals between EGFR and the nucleus, and its mutation has been identified as a predictor of resistance to anti-EGFR drugs. In human oncology, the importance of the EGFR/HER-2/KRAS signalling pathway in gastric cancer is well established, and HER-2 testing is required before initiating therapy. Conversely, this pathway has never been investigated in canine gastric tumours. A total of 19 canine gastric epithelial neoplasms (5 adenomas and 14 carcinomas) were retrospectively evaluated for EGFR/HER-2 immunohistochemical expression and KRAS mutational status. Five (35.7%) carcinomas were classified as intestinal-type and 9 (64.3%) as diffuse-type. EGFR was overexpressed (>= 1+) in 8 (42.1%) cases and HER-2 (3+) in 11 (57.9%) cases, regardless of tumour location or biological behaviour. The percentage of EGFR-positive tumours was significantly higher in the intestinal-type (80%) than in the diffuse-type (11.1%, p = 0.023). KRAS gene was wild type in 18 cases, whereas one mucinous carcinoma harboured a point mutation at codon 12 (G12R). EGFR and HER-2 may be promising prognostic and therapeutic targets in canine gastric epithelial neoplasms. The potential presence of KRAS mutation should be taken into account as a possible mechanism of drug resistance. Further studies are necessary to evaluate the role of dog as a model for human gastric cancer.	[Terragni, Rossella] Vet Oncol Ctr, Sasso Marconi, Italy; [Terragni, Rossella; Saunders, Jimmy H.; Ricci, Marianna; Ulivi, Paola] Univ Ghent, Fac Vet Med, B-9000 Ghent, Belgium; [Gardini, Andrea Casadei; Amadori, Dino; Capelli, Laura] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy; [Sabattini, Silvia; Bettini, Giuliano; Talamonti, Chiara] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Vignoli, Massimo] Petcare Vet Assoc, Marzabotto, Italy	Ghent University; IRCCS Meldola (IRST); University of Bologna	Gardini, AC (corresponding author), Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy.	casadeigardini@gmail.com	Vignoli, Massimo/R-5134-2019; Bettini, Giuliano/L-5907-2016; Gardini, Andrea/AAA-6985-2022; Capelli, Laura/AAB-9682-2019; Gardini, Andrea Casadei/F-1830-2016; gardini, Andrea Casadei/L-4859-2019; Sabattini, Silvia/AAN-3233-2020	Vignoli, Massimo/0000-0002-4981-4051; Gardini, Andrea Casadei/0000-0001-6289-7202; gardini, Andrea Casadei/0000-0001-6289-7202; Sabattini, Silvia/0000-0001-7005-2736; Ulivi, Paola/0000-0002-4334-9662; Bettini, Giuliano/0000-0003-1857-7329				Bang YJ, 2010, LANCET, V376, P1302; Bergkvist GT, 2011, VET COMP ONCOL, V9, P81, DOI 10.1111/j.1476-5829.2010.00237.x; Buskens CJ, 2006, J SURG RES, V135, P337, DOI 10.1016/j.jss.2006.04.023; Chen HC, 2011, TUMOR BIOL, V32, P367, DOI 10.1007/s13277-010-0129-2; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de las Mulas JM, 2003, BREAST CANCER RES TR, V80, P363, DOI 10.1023/A:1024929730165; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; FONDA D, 1989, J SMALL ANIM PRACT, V30, P353, DOI 10.1111/j.1748-5827.1989.tb01579.x; Gama A, 2009, RES VET SCI, V87, P432, DOI 10.1016/j.rvsc.2009.04.016; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Head K. W., 2003, WHO INT HISTOLOGICAL, VX; Hicks DG, 2011, APPL IMMUNOHISTO M M, V19, P1506, DOI 10.1097/PAI.0b013e31822c3a0f; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Hsu WL, 2009, VET J, V180, P116, DOI 10.1016/j.tvjl.2007.10.013; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; KRAEGEL SA, 1992, CANCER RES, V52, P4724; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee HR, 1996, ONCOLOGY-BASEL, V53, P192; Lee S, 2011, HISTOPATHOLOGY, V59, P832, DOI 10.1111/j.1365-2559.2011.04017.x; Liu C, 2005, PATHOLOGIC BASIS DIS, P804; Lorenzen S, 2011, CURR OPIN ONCOL, V23, P396, DOI 10.1097/CCO.0b013e3283469567; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Okines AFC, 2010, EUR J CANCER, V46, P1949, DOI 10.1016/j.ejca.2010.05.003; PATNAIK AK, 1978, VET PATHOL, V15, P600, DOI 10.1177/030098587801500503; Pinto C, 2009, BRIT J CANCER, V101, P1261, DOI 10.1038/sj.bjc.6605319; Ressel L, 2013, RES VET SCI, V94, P299, DOI 10.1016/j.rvsc.2012.09.016; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Sabattini S, 2012, VET COMP ON IN PRESS; Sassi F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-5; SAUTTER JH, 1975, J AM VET MED ASSOC, V166, P691; SCANZIANI E, 1991, J SMALL ANIM PRACT, V32, P465, DOI 10.1111/j.1748-5827.1991.tb00991.x; Shiomitsu K, 2009, VET COMP ONCOL, V7, P106, DOI 10.1111/j.1476-5829.2009.00178.x; Singer J, 2012, MOL IMMUNOL, V50, P200, DOI 10.1016/j.molimm.2012.01.002; SULLIVAN M, 1987, VET REC, V120, P79, DOI 10.1136/vr.120.4.79; Swann HM, 2002, J AM ANIM HOSP ASSOC, V38, P157, DOI 10.5326/0380157; Takehana T, 2003, CLIN GASTROENTEROL H, V1, P438, DOI 10.1016/S1542-3565(03)00219-2; TOKUNAGA A, 1995, CANCER, V75, P1418, DOI 10.1002/1097-0142(19950315)75:6+<1418::AID-CNCR2820751505>3.0.CO;2-Y; Wang JF, 2013, CANCER BIOMARK, V13, P89, DOI 10.3233/CBM-130334; Wang YK, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-14; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Withrow S.J., 2007, SMALL ANIMAL CLIN ON, P480	43	29	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85388	10.1371/journal.pone.0085388	http://dx.doi.org/10.1371/journal.pone.0085388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454858	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100079
J	Knapp, RT; Wong, MJH; Kollmannsberger, LK; Gassen, NC; Kretzschmar, A; Zschocke, J; Hafner, K; Young, JC; Rein, T				Knapp, Regina T.; Wong, Michael J. H.; Kollmannsberger, Lorenz K.; Gassen, Nils C.; Kretzschmar, Anja; Zschocke, Juergen; Hafner, Kathrin; Young, Jason C.; Rein, Theo			Hsp70 Cochaperones HspBP1 and BAG-1M Differentially Regulate Steroid Hormone Receptor Function	PLOS ONE			English	Article							ENHANCES ANDROGEN RECEPTOR; NUCLEOTIDE EXCHANGE FACTOR; GLUCOCORTICOID-RECEPTOR; MOLECULAR CHAPERONES; NEGATIVE REGULATOR; ATP HYDROLYSIS; CO-CHAPERONE; PROTEIN; COMPLEX; BINDING	Hsp70 binding protein 1 (HspBP1) and Bcl2-associated athanogene 1 (BAG-1), the functional orthologous nucleotide exchange factors of the heat shock protein 70 kilodalton (Hsc70/Hsp70) chaperones, catalyze the release of ADP from Hsp70 while inducing different conformational changes of the ATPase domain of Hsp70. An appropriate exchange rate of ADP/ATP is crucial for chaperone-dependent protein folding processes. Among Hsp70 client proteins are steroid receptors such as the glucocorticoid receptor (GR), the mineralocorticoid receptor (MR), and the androgen receptor (AR). BAG-1 diversely affects steroid receptor activity, while to date the influence of HspBP1 on steroid receptor function is mostly unknown. Here, we compared the influence of HspBP1 and BAG-1M on Hsp70-mediated steroid receptor folding complexes and steroid receptor activity. Coimmunoprecipitation studies indicated preferential binding of Hsp40 and the steroid receptors to BAG-1M as compared to HspBP1. Furthermore, Hsp70 binding to the ligand-binding domain of GR was reduced in the presence of HspBP1 but not in the presence of BAG-1M as shown by pull-down assays. Reporter gene experiments revealed an inhibitory effect on GR, MR, and AR at a wide range of HspBP1 protein levels and at hormone concentrations at or approaching saturation. BAG-1M exhibited a transition from stimulatory effects at low BAG-1M levels to inhibitory effects at higher BAG-1M levels. Overall, BAG-1M and HspBP1 had differential impacts on the dynamic composition of steroid receptor folding complexes and on receptor function with important implications for steroid receptor physiology.	[Knapp, Regina T.; Kollmannsberger, Lorenz K.; Gassen, Nils C.; Kretzschmar, Anja; Zschocke, Juergen; Hafner, Kathrin; Rein, Theo] Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany; [Wong, Michael J. H.; Young, Jason C.] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada	Max Planck Society; McGill University	Rein, T (corresponding author), Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany.	theorein@mpipsykl.mpg.de	Gassen, Nils/AAZ-2504-2021	Rein, Theo/0000-0003-2850-4289	Canadian Institutes of Health Research; Canada Research Chair in Molecular Chaperones	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Molecular Chaperones	J.C.Y. is supported by the Canadian Institutes of Health Research, and a Canada Research Chair in Molecular Chaperones, Tier II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel A, 2002, MOL ENDOCRINOL, V16, P1352; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Cutress RI, 2003, ONCOGENE, V22, P4973, DOI 10.1038/sj.onc.1206688; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Gebauer M, 1998, MOL CELL BIOL, V18, P6238, DOI 10.1128/MCB.18.11.6238; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; HOHFELD J, 1995, CELL, V83, P589; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hong W, 2008, J MOL BIOL, V384, P22, DOI 10.1016/j.jmb.2008.09.010; Hong W, 2009, FEBS LETT, V583, P2451, DOI 10.1016/j.febslet.2009.07.010; Kanelakis KC, 2000, BIOCHEMISTRY-US, V39, P14314, DOI 10.1021/bi001671c; Knapp RT, 2012, BIOCHEM J, V441, P297, DOI 10.1042/BJ20111456; Knee DA, 2001, J BIOL CHEM, V276, P12718, DOI 10.1074/jbc.M010841200; Kullmann M, 1998, J BIOL CHEM, V273, P14620, DOI 10.1074/jbc.273.23.14620; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Maeng SH, 2008, P NATL ACAD SCI USA, V105, P8766, DOI 10.1073/pnas.0803736105; Oh WK, 2003, MOL CELLS, V16, P84; Pratt W B, 1996, EXS, V77, P79; Raynes DA, 2003, TUMOR BIOL, V24, P281, DOI 10.1159/000076459; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Schneikert J, 1999, J CELL BIOL, V146, P929, DOI 10.1083/jcb.146.5.929; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zheng HC, 2010, HUM PATHOL, V41, P724, DOI 10.1016/j.humpath.2009.10.017; Zhou R, 2005, J NEUROSCI, V25, P4493, DOI 10.1523/JNEUROSCI.4530-04.2005	51	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85415	10.1371/journal.pone.0085415	http://dx.doi.org/10.1371/journal.pone.0085415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454860	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800045
J	Lippert, J; Halfter, H; Heidbreder, A; Rohr, D; Gess, B; Boentert, M; Osada, N; Young, P				Lippert, Julian; Halfter, Hartmut; Heidbreder, Anna; Roehr, Dominik; Gess, Burkhard; Boentert, Mathias; Osada, Nani; Young, Peter			Altered Dynamics in the Circadian Oscillation of Clock Genes in Dermal Fibroblasts of Patients Suffering from Idiopathic Hypersomnia	PLOS ONE			English	Article							BIPOLAR-I-DISORDER; SCHIZOAFFECTIVE DISORDER; SUPRACHIASMATIC NUCLEUS; INDIVIDUAL FIBROBLASTS; BODY-TEMPERATURE; SLEEP DISORDERS; RHYTHMS; TIME; ASSOCIATION; EXPRESSION	From single cell organisms to the most complex life forms, the 24-hour circadian rhythm is important for numerous aspects of physiology and behavior such as daily periodic fluctuations in body temperature and sleep-wake cycles. Influenced by environmental cues - mainly by light input -, the central pacemaker in the thalamic suprachiasmatic nuclei (SCN) controls and regulates the internal clock mechanisms which are present in peripheral tissues. In order to correlate modifications in the molecular mechanisms of circadian rhythm with the pathophysiology of idiopathic hypersomnia, this study aimed to investigate the dynamics of the expression of circadian clock genes in dermal fibroblasts of idiopathic hypersomniacs (IH) in comparison to those of healthy controls (HC). Ten clinically and polysomnographically proven IH patients were recruited from the department of sleep medicine of the University Hospital of Muenster. Clinical diagnosis was done by two consecutive polysomnographies (PSG) and Multiple Sleep Latency Test (MSLT). Fourteen clinical healthy volunteers served as control group. Dermal fibroblasts were obtained via punch biopsy and grown in cell culture. The expression of circadian clock genes was investigated by semiquantitative Reverse Transcriptase-PCR qRT-PCR analysis, confirming periodical oscillation of expression of the core circadian clock genes BMAL1, PER1/2 and CRY1/2. The amplitude of the rhythmically expressed BMAL1, PER1 and PER2 was significantly dampened in dermal fibroblasts of IH compared to HC over two circadian periods whereas the overall expression of only the key transcriptional factor BMAL1 was significantly reduced in IH. Our study suggests for the first time an aberrant dynamics in the circadian clock in IH. These findings may serve to better understand some clinical features of the pathophysiology in sleep - wake rhythms in IH.	[Lippert, Julian; Halfter, Hartmut; Heidbreder, Anna; Roehr, Dominik; Gess, Burkhard; Boentert, Mathias; Young, Peter] Univ Hosp Muenster, Dept Neurol Sleepmed & Neuromuscular Dis, Munster, Germany; [Osada, Nani] Inst Med Informat, Munster, Germany	University of Munster	Young, P (corresponding author), Univ Hosp Muenster, Dept Neurol Sleepmed & Neuromuscular Dis, Albert Schweitzer Campus 1, Munster, Germany.	Peter.Young@ukmuenster.de	Heidbreder, Anna/GLR-3355-2022	Heidbreder, Anna/0000-0002-9552-7619				Achermann P, 2004, AVIAT SPACE ENVIR MD, V75, pA37; Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; American Academy of Sleep Medicine, 2005, DIAGN COD MAN; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Bellet MM, 2013, PROCNATLACADSCIUSA; Billiard M, 2001, Sleep Med Rev, V5, P349, DOI 10.1053/smrv.2001.0168; Billiard M., 2003, SLEEP PHYSL INVESTIG, P333; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Brown S, 2005, AM POETRY REV, V34, P3; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Coelho FMS, 2011, J CLIN NEUROPHYSIOL, V28, P412, DOI 10.1097/WNP.0b013e31822734a3; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Dauvilliers Yves, 2005, Dialogues Clin Neurosci, V7, P347; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fernandez JR, 2009, PHILOS T R SOC A, V367, P431, DOI 10.1098/rsta.2008.0231; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; Harvey AG, 2006, DEV PSYCHOPATHOL, V18, P1147, DOI 10.1017/S095457940606055X; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; Hida A, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-7; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Mansour HA, 2005, CHRONOBIOL INT, V22, P571, DOI 10.1081/CBI-200062413; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Moller-Levet CS, 2013, PROCNATLACADSCIUSA; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nevsimalova S, 2000, Suppl Clin Neurophysiol, V53, P366, DOI 10.1016/S1567-424X(09)70183-7; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raizen DM, 2011, CHEST, V139, P446, DOI 10.1378/chest.10-1313; Reid KJ, 2009, SEMIN NEUROL, V29, P393, DOI 10.1055/s-0029-1237120; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Schirmacher A, 2011, BIOL RHYTHM RES, V42, P407, DOI 10.1080/09291016.2010.525382; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Teclemariam-Mesbah R, 1999, J COMP NEUROL, V406, P171, DOI 10.1002/(SICI)1096-9861(19990405)406:2<171::AID-CNE3>3.0.CO;2-U; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; Vernet C, 2009, SLEEP, V32, P753, DOI 10.1093/sleep/32.6.753; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9	63	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85255	10.1371/journal.pone.0085255	http://dx.doi.org/10.1371/journal.pone.0085255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454829	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800031
J	Liao, YY; Yang, YR; Wu, YR; Wang, RY				Liao, Ying-Yi; Yang, Yea-Ru; Wu, Yih-Ru; Wang, Ray-Yau			Factors Influencing Obstacle Crossing Performance in Patients with Parkinson's Disease	PLOS ONE			English	Article							POSTURAL STABILITY; OLDER-ADULTS; GAIT; STRENGTH; RELIABILITY; BALANCE; VALIDATION; VALIDITY; STROKE; FALLS	Background: Tripping over obstacles is the major cause of falls in community-dwelling patients with Parkinson's disease (PD). Understanding the factors associated with the obstacle crossing behavior may help to develop possible training programs for crossing performance. This study aimed to identify the relationships and important factors determining obstacle crossing performance in patients with PD. Methods: Forty-two idiopathic patients with PD (Hoehn and Yahr stages I to III) participated in this study. Obstacle crossing performance was recorded by the Liberty system, a three-dimensional motion capture device. Maximal isometric strength of the lower extremity was measured by a handheld dynamometer. Dynamic balance and sensory integration ability were assessed using the Balance Master system. Movement velocity (MV), maximal excursion (ME), and directional control (DC) were obtained during the limits of stability test to quantify dynamic balance. The sum of sensory organization test (SOT) scores was used to quantify sensory organization ability. Results: Both crossing stride length and stride velocity correlated significantly with lower extremity muscle strength, dynamic balance control (forward and sideward), and sum of SOT scores. From the regression model, forward DC and ankle dorsiflexor strength were identified as two major determinants for crossing performance (R-2 = .37 to. 41 for the crossing stride length, R-2 = .43 to. 44 for the crossing stride velocity). Conclusions: Lower extremity muscle strength, dynamic balance control and sensory integration ability significantly influence obstacle crossing performance. We suggest an emphasis on muscle strengthening exercises (especially ankle dorsiflexors), balance training (especially forward DC), and sensory integration training to improve obstacle crossing performance in patients with PD.	[Liao, Ying-Yi; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Liao, Ying-Yi] Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil, Miaoli, Taiwan; [Wu, Yih-Ru] Chang Guan Mem Hosp, Dept Neuromuscular Disorders, Linkou, Taiwan	National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Wang, RY (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	rywang@ym.edu.tw			Cheng Hsin General Hospital [102F218C10]; National Science Council of the Republic of China [NSC100-2314-B-010-022-MY2]	Cheng Hsin General Hospital; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported partly by grants from the Cheng Hsin General Hospital (Grant No. 102F218C10), and partly by grants from the National Science Council of the Republic of China (grant no. NSC100-2314-B-010-022-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn A, 2001, AGE AGEING, V30, P47, DOI 10.1093/ageing/30.1.47; Azulay JP, 2006, J NEUROL SCI, V248, P192, DOI 10.1016/j.jns.2006.05.008; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bohannon RW, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-30; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; Brauer SG, 2000, J GERONTOL A-BIOL, V55, pM469, DOI 10.1093/gerona/55.8.M469; Earhart GM, 2007, NEUROREHAB NEURAL RE, V21, P116, DOI 10.1177/1545968306290674; Galna B, 2010, HUM MOVEMENT SCI, V29, P843, DOI 10.1016/j.humov.2009.09.006; Hagell P, 2007, J NEUROL NEUROSUR PS, V78, P1191, DOI 10.1136/jnnp.2006.111161; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; Helbostad JL, 2010, AGE AGEING, V39, P256, DOI 10.1093/ageing/afp224; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Kempen GIJM, 2007, DISABIL REHABIL, V29, P155, DOI 10.1080/09638280600747637; Kim JW, 2012, GERIATR GERONTOL INT, V12, P257, DOI 10.1111/j.1447-0594.2011.00761.x; Lamoureux E, 2003, GAIT POSTURE, V17, P273, DOI 10.1016/S0966-6362(02)00101-7; Lamoureux EL, 2002, J AM GERIATR SOC, V50, P468, DOI 10.1046/j.1532-5415.2002.50112.x; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Nallegowda M, 2004, AM J PHYS MED REHAB, V83, P898, DOI 10.1097/01.PHM.0000146505.18244.43; Nocera JR, 2010, ARCH PHYS MED REHAB, V91, P589, DOI 10.1016/j.apmr.2009.11.026; Oliveira CB, 2011, CLINICS, V66, P2043, DOI 10.1590/S1807-59322011001200008; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; Stegemoller EL, 2012, ARCH PHYS MED REHAB, V93, P703, DOI 10.1016/j.apmr.2011.11.004; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; Vitale C, 2011, MOVEMENT DISORD, V26, P1458, DOI 10.1002/mds.23657; WATERSTON JA, 1993, J NEUROL NEUROSUR PS, V56, P1276, DOI 10.1136/jnnp.56.12.1276; Yang YR, 2008, GAIT POSTURE, V27, P611, DOI 10.1016/j.gaitpost.2007.08.003; Zhang JL, 2012, QUAL LIFE RES, V21, P1217, DOI 10.1007/s11136-011-0026-1	28	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84245	10.1371/journal.pone.0084245	http://dx.doi.org/10.1371/journal.pone.0084245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454723	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500009
J	Mirkovic-Hosle, M; Forstemann, K				Mirkovic-Hoesle, Milijana; Foerstemann, Klaus			Transposon Defense by Endo-siRNAs, piRNAs and Somatic pilRNAs in Drosophila: Contributions of Loqs-PD and R2D2	PLOS ONE			English	Article							RNA PATHWAY; DISTINCT ROLES; PIWI; EXPRESSION; CHROMATIN; MICRORNAS; INTERACTS; COMPONENT; HOMOLOG; DICER-2	Transposable elements are a serious threat for genome integrity and their control via small RNA mediated silencing pathways is an ancient strategy. The fruit fly Drosophila melanogaster has two silencing activities that target transposons: endogenous siRNAs (esiRNAs or endo-siRNAs) and Piwi-interacting small RNAs (piRNAs). The biogenesis of endo-siRNAs involves the Dicer-2 co-factors Loqs-PD, which acts predominantly during processing of dsRNA by Dcr-2, and R2D2, which primarily helps to direct siRNAs into the RNA interference effector Ago2. Nonetheless, loss of either protein is not sufficient to produce a phenotype comparable with a dcr-2 mutation. We provide further deep sequencing evidence supporting the notion that R2D2 and Loqs-PD have partially overlapping function. Certain transposons display a preference for either dsRBD-protein during production or loading; this appeared to correlate neither with overall abundance, classification of the transposon or a specific site of genomic origin. The endo-siRNA biogenesis pathway in germline operates according to the same principles as the existing model for the soma, and its impairment does not significantly affect piRNAs. Expanding the analysis, we confirmed the occurrence of somatic piRNA-like RNAs (pilRNAs) that show a ping-pong signature. We detected expression of the Piwi-family protein mRNAs only barely above background, indicating that the somatic pilRNAs may arise from a small sub-population of somatic cells that express a functional piRNA pathway.	[Foerstemann, Klaus] Univ Munich, Gene Ctr, Munich, Germany; Univ Munich, Dept Biochem, Munich, Germany	University of Munich; University of Munich	Forstemann, K (corresponding author), Univ Munich, Gene Ctr, Munich, Germany.	Foerstemann@lmb.uni-muenchen.de			DFG [FO360-2]; DFG collaborative research center [SFB646]; Fonds der Chemischen Industrie	DFG(German Research Foundation (DFG)); DFG collaborative research center(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by a DFG grant to KF (FO360-2) and the DFG collaborative research center, SFB646. MMH was the recipient of a PhD fellowship awarded by the "Fonds der Chemischen Industrie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Cichocki F, 2010, J IMMUNOL, V185, P2009, DOI 10.4049/jimmunol.1000855; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Gerbasi VR, 2011, P NATL ACAD SCI USA, V108, P3204, DOI 10.1073/pnas.1009781108; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Karthik A, 2008, PAK J PHARM SCI, V21, P421; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Matranga C, 2007, CURR BIOL, V17, pR789, DOI 10.1016/j.cub.2007.07.014; Miyoshi K, 2010, RNA; Nishida KM, 2013, MOL CELL, V49, P680, DOI 10.1016/j.molcel.2012.12.024; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2010, MOL CELL BIOL; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Perrat PN, 2013, SCIENCE, V340, P91, DOI 10.1126/science.1231965; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; SCHUPBACH T, 1991, GENETICS, V129, P1119; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Smulders-Srinivasan TK, 2003, GENETICS, V165, P1971; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309	51	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84994	10.1371/journal.pone.0084994	http://dx.doi.org/10.1371/journal.pone.0084994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454776	gold, Green Submitted, Green Published			2022-12-27	WOS:000329922500030
J	Ricankova, VP; Robovsky, J; Riegert, J				Ricankova, Vera Pavelkova; Robovsky, Jan; Riegert, Jan			Ecological Structure of Recent and Last Glacial Mammalian Faunas in Northern Eurasia: The Case of Altai-Sayan Refugium	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PLANT-COMMUNITIES; FOREST-STEPPE; VEGETATION; EUROPE; POLLEN; PATTERNS; CLIMATE; SIBERIA; ORIGIN	Pleistocene mammalian communities display unique features which differ from present-day faunas. The paleocommunities were characterized by the extraordinarily large body size of herbivores and predators and by their unique structure consisting of species now inhabiting geographically and ecologically distinct natural zones. These features were probably the result of the unique environmental conditions of ice age ecosystems. To analyze the ecological structure of Last Glacial and Recent mammal communities we classified the species into biome and trophic-size categories, using Principal Component analysis. We found a marked similarity in ecological structure between Recent eastern Altai-Sayan mammalian assemblages and comparable Pleistocene faunas. The composition of Last Glacial and Recent eastern Altai-Sayan assemblages were characterized by the occurrence of large herbivore and predator species associated with steppe, desert and alpine biomes. These three modern biomes harbor most of the surviving Pleistocene mammals. None of the analyzed Palearctic Last Glacial faunas showed affinity to the temperate forest, taiga, or tundra biome. The Eastern part of the Altai-Sayan region could be considered a refugium of the Last Glacial-like mammalian assemblages. Glacial fauna seems to persist up to present in those areas where the forest belt does not separate alpine vegetation from the steppes and deserts.	[Ricankova, Vera Pavelkova; Robovsky, Jan; Riegert, Jan] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Ricankova, VP (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	ricankova@seznam.cz	Riegert, Jan/D-9070-2016; Robovsky, Jan/AAL-3362-2020; Riegert, Jan/AAQ-5136-2021	Riegert, Jan/0000-0003-4195-1278; Robovsky, Jan/0000-0001-8720-9314; Riegert, Jan/0000-0003-4195-1278; Ricankova, Vera/0000-0002-6475-4894	Czech Ministry of Education [MSM 6007665801]; Czech Science Foundation [P504/11/0454]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by Czech Ministry of Education (MSM 6007665801) http://www.msmt.cz/index.php?lang = 2 and Czech Science Foundation (# P504/11/0454) http://www.gacr.cz/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian A.K., 2005, PALEONTOL J+, V39, P645; Alberdi Maria Teresa, 1998, Geologija (Vilnius), V25, P8; Allen JRM, 2010, QUATERNARY SCI REV, V29, P19; Blinnikov MS, 2011, QUATERNARY SCI REV, V30, P2906, DOI 10.1016/j.quascirev.2011.07.002; Boeskorov GG, 2006, QUATERN INT, V142, P119, DOI 10.1016/j.quaint.2005.03.009; Brugal JP, 2007, QUATERNAIRE, V18, P129; Duff A, 2004, MAMMALS WORLD CHECKL; Dulamsuren C, 2005, APPL VEG SCI, V8, P149, DOI 10.1111/j.1654-109X.2005.tb00640.x; Faith JT, 2011, QUATERNARY SCI REV, V30, P13; Frenzel B, 1992, ATLAS PALEOCLIMATES; Guthrie R.D., 1984, P259; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; HIBBARD CW, 1949, GEOL SOC AM BULL, V60, P1417, DOI 10.1130/0016-7606(1949)60[1417:PVPINA]2.0.CO;2; Hoffmann MH, 2011, J MOLLUS STUD, V77, P76, DOI 10.1093/mollus/eyq039; Hoffmann MH, 2001, PHYTOCOENOLOGIA, V31, P401; HORACEK I, 1988, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V98, P1; Horsak M, 2010, J BIOGEOGR, V37, P1450, DOI 10.1111/j.1365-2699.2010.02280.x; Huntley B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061963; Jankovska V., 2002, ACTA PALAEOBOT, V42, P29; Jankovska V, 2008, PRESLIA, V80, P307; Kunes P, 2008, J BIOGEOGR, V35, P2223, DOI 10.1111/j.1365-2699.2008.01974.x; KurtUn B., 1968, PLEISTOCENE MAMMALS; Le Fur S, 2011, PALAEOGEOGR PALAEOCL, V305, P295, DOI 10.1016/j.palaeo.2011.03.011; Louys J, 2011, GLOBAL ECOL BIOGEOGR, V20, P717, DOI 10.1111/j.1466-8238.2010.00643.x; Markova AK, 2009, QUATERN INT, V201, P53, DOI 10.1016/j.quaint.2008.05.020; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Meloro C, 2012, PALAIOS, V27, P90, DOI 10.2110/palo.2011.p11-048r; Mendoza M, 2005, EVOL ECOL RES, V7, P505; Mendoza M, 2004, J THEOR BIOL, V230, P203, DOI 10.1016/j.jtbi.2004.05.002; Musil R., 1999, ACTA MUSEI MORAVIAE, V64, P161; Pelankova B, 2009, REV PALAEOBOT PALYNO, V157, P253, DOI 10.1016/j.revpalbo.2009.05.005; Potapkina AF., 1979, MAMMALS ALTAI SAYAN; Rodriguez J, 2006, J BIOGEOGR, V33, P291, DOI 10.1111/j.1365-2699.2005.01397.x; Rodriguez J, 2006, PALAEOGEOGR PALAEOCL, V239, P355, DOI 10.1016/j.palaeo.2006.02.001; Rodriguez JS, 2004, PALAEOGEOGR PALAEOCL, V207, P1, DOI 10.1016/j.palaeo.2003.12.016; Romer AS, 1933, AM ABORIGINES THEIR, P47; Shackleton N.J., 1969, P ROY SOC LOND B BIO, V174, P135, DOI DOI 10.1098/RSPB.1969.0085; Simakova AN, 2006, QUATERN INT, V149, P110, DOI 10.1016/j.quaint.2005.11.024; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Smidt S, 2002, HYDROBIOLOGIA, V468, P95, DOI 10.1023/A:1015237411606; Smith R.L., 1986, ELEMENTS ECOLOGY; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2008, QUATERNARY SCI REV, V27, P2499, DOI 10.1016/j.quascirev.2008.08.003; Tarasov PE, 1999, EARTH PLANET SC LETT, V171, P635, DOI 10.1016/S0012-821X(99)00171-5; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Van Kolfschoten Thijs, 1995, Acta Zoologica Cracoviensia, V38, P73; VERESHCHAGIN NK, 1991, ANN ZOOL FENN, V28, P253; Wells AG, 2012, APPL VEG SCI, V15, P560, DOI 10.1111/j.1654-109X.2012.01193.x; WILLIAMS DF, 1988, PALAEOGEOGR PALAEOCL, V64, P221, DOI 10.1016/0031-0182(88)90008-9; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Willis KJ, 2004, QUATERNARY SCI REV, V53, P203; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson JS, 2010, PROG PHYS GEOG, V34, P419, DOI 10.1177/0309133310363991; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824	57	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85056	10.1371/journal.pone.0085056	http://dx.doi.org/10.1371/journal.pone.0085056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454791	Green Published, gold			2022-12-27	WOS:000329922500038
J	Crevecoeur, I; Skinner, MM; Bailey, SE; Gunz, P; Bortoluzzi, S; Brooks, AS; Burlet, C; Cornelissen, E; De Clerck, N; Maureille, B; Semal, P; Vanbrabant, Y; Wood, B				Crevecoeur, Isabelle; Skinner, Matthew M.; Bailey, Shara E.; Gunz, Philipp; Bortoluzzi, Silvia; Brooks, Alison S.; Burlet, Christian; Cornelissen, Els; De Clerck, Nora; Maureille, Bruno; Semal, Patrick; Vanbrabant, Yves; Wood, Bernard			First Early Hominin from Central Africa (Ishango, Democratic Republic of Congo)	PLOS ONE			English	Article							UPPER SEMLIKI VALLEY; ENAMEL THICKNESS; TISSUE PROPORTIONS; MOLARS; AUSTRALOPITHECUS; MORPHOLOGY; EVOLUTION; HOMO; CHALLENGES; FOSSILS	Despite uncontested evidence for fossils belonging to the early hominin genus Australopithecus in East Africa from at least 4.2 million years ago (Ma), and from Chad by 3.5 Ma, thus far there has been no convincing evidence of Australopithecus, Paranthropus or early Homo from the western (Albertine) branch of the Rift Valley. Here we report the discovery of an isolated upper molar (#Ish25) from the Western Rift Valley site of Ishango in Central Africa in a derived context, overlying beds dated to between ca. 2.6 to 2.0 Ma. We used mu CT imaging to compare its external and internal macro-morphology to upper molars of australopiths, and fossil and recent Homo. We show that the size and shape of the enamel-dentine junction (EDJ) surface discriminate between Plio-Pleistocene and post-Lower Pleistocene hominins, and that the Ishango molar clusters with australopiths and early Homo from East and southern Africa. A reassessment of the archaeological context of the specimen is consistent with the morphological evidence and suggest that early hominins were occupying this region by at least 2 Ma.	[Crevecoeur, Isabelle; Maureille, Bruno] Univ Bordeaux, CNRS, Prehist Actuel Culture Environm & Anthropol UMR P, UMR 5199, Talence, France; [Skinner, Matthew M.] UCL, Dept Anthropol, London, England; [Bailey, Shara E.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Skinner, Matthew M.; Bailey, Shara E.; Gunz, Philipp] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Bortoluzzi, Silvia] Univ Florence, Dipartimento Biol Evoluzionist Leo Pardi, Lab Antropol, Florence, Italy; [Brooks, Alison S.; Wood, Bernard] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Burlet, Christian; Vanbrabant, Yves] Royal Belgian Inst Nat Sci, Geol Survey Belgium, Brussels, Belgium; [Cornelissen, Els] Royal Museum Cent Africa, Sect Prehist & Archaeol, Tervuren, Belgium; [De Clerck, Nora] Univ Antwerp, Microtomog CT Res Grp, Antwerp, Belgium; [Semal, Patrick] Royal Belgian Inst Nat Sci, Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of London; University College London; New York University; Max Planck Society; University of Florence; George Washington University; Royal Belgian Institute of Natural Sciences; Royal Museum for Central Africa; University of Antwerp; Royal Belgian Institute of Natural Sciences	Crevecoeur, I (corresponding author), Univ Bordeaux, CNRS, Prehist Actuel Culture Environm & Anthropol UMR P, UMR 5199, Talence, France.	i.crevecoeur@pacea.u-bordeaux1.fr	Skinner, Matthew/D-1104-2010; Gunz, Philipp/C-7748-2009	Skinner, Matthew/0000-0001-8321-3543; Gunz, Philipp/0000-0002-2350-4450; Burlet, Christian/0000-0002-2134-1969; Semal, Patrick/0000-0002-4048-7728; Bailey, Shara/0000-0002-4626-9262; Maureille, Bruno/0000-0002-7616-0073	Brussels Institute for Research and Innovation (IRSIB) [PRFB 2006/CM/IV/52]; Franco-American Commission for Educational Exchange (Fulbright Foreign Scholarship); Centre national de la recherche scientifique (CNRS); Programma Vigoni; Max Planck Society	Brussels Institute for Research and Innovation (IRSIB)(Innoviris); Franco-American Commission for Educational Exchange (Fulbright Foreign Scholarship); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Programma Vigoni; Max Planck Society(Max Planck Society)	Support was provided by the Brussels Institute for Research and Innovation (IRSIB, program Prospective Research for Brussels 2007-2009; PRFB 2006/CM/IV/52; http://www.innoviris.be/site/), the Franco-American Commission for Educational Exchange (Fulbright Foreign Scholarship 2010; http://www.fulbright-france.org/gene/main.php), The Centre national de la recherche scientifique (CNRS; http://www.cnrs.fr/), the Programma Vigoni (bilateral exchange program between Italy and Germany) and the Max Planck Society (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam W, 1957, MOLLUSQUES QUATERNAI; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Berger LR, 2013, SCIENCE, V340, P163, DOI 10.1126/science.340.6129.163; Boaz N.T., 1990, Virginia Museum of Natural History Memoir, P3; BOAZ NT, 1992, J HUM EVOL, V22, P505, DOI 10.1016/0047-2484(92)90083-L; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Brooks A. S., 1990, WORLD 18000 BP, V2, P121; Brooks A. S., 1987, AFRICAN ARCHAEOL REV, V5, P65, DOI DOI 10.1007/BF01117083; BROOKS AS, 1995, SCIENCE, V268, P548, DOI 10.1126/science.7725099; BROWN FH, 1985, ANCESTORS HARD EVIDE, P82; Clarke RJ, 2012, J HUM EVOL, V63, P418, DOI 10.1016/j.jhevol.2011.11.007; Cleuvenot Emmanuel, 1993, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V5, P245, DOI 10.3406/bmsap.1993.2354; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; Cooke H.B.S., 1990, Virginia Museum of Natural History Memoir, P197; Damas H., 1940, Revue de Zoologie et de Botanique Africaines, V33, P265; de Heinzelin J., 1957, FOUILLES ISHANGO; de Heinzelin J., 1996, REALM UPPER SEMLIKI; de Heinzelin J, 1955, FOSSE TECTONIQUE PAR; de Heinzelin J., 1961, PALEOLITHIQUE ABORDS; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dechamps R, 1990, VA MUS NAT, P71; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; Fuchs V., 1934, GEOL MAG, V71, P97; Fuchs V., 1934, GEOL MAG, V72, P145; Gautier A, 1970, GEOLOGISCHE WETENSCH, V67, P5; Greenwood P. H., 1959, QUATERNARY FISH FOSS; Grine F.E., 1988, P3; Grine FE, 2005, AM J PHYS ANTHROPOL, V126, P14, DOI 10.1002/ajpa.10277; Guatelli-Steinberg D, 2005, AM J PHYS ANTHROPOL, V128, P477, DOI 10.1002/ajpa.20194; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Harris J.W.K., 1990, Virginia Museum of Natural History Memoir, P237; HILLSON S, 1996, DENT ANTHR; Hopwood A. T., 1959, MAMMIFERES FOSSILES; KANAZAWA E, 1990, AM J PHYS ANTHROPOL, V83, P173, DOI 10.1002/ajpa.1330830205; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel William H., 2007, P1539, DOI 10.1007/978-3-540-33761-4_50; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kirchner MT, 1997, J RAMAN SPECTROSC, V28, P171; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Korenhof C. A. W., 1960, MORPHOGENETICAL ASPE; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lepersonne J., 1970, Annls Mus r. Afr. cent 8[degrees] Sci. geol., VNo. 67, P171; MACHO GA, 1993, AM J PHYS ANTHROPOL, V92, P189, DOI 10.1002/ajpa.1330920208; Martin, 1983, RELATIONSHIPS LATER; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin Rudolf, 1914, LEHRBUCH ANTHR SYSTE; Mercader J, 2001, J ANTHROPOL RES, V57, P197, DOI 10.1086/jar.57.2.3631567; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak A.J., 2006, MICROCOMPUTED TOMOGR; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; Orban Rosine, 2001, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V13, P97; Peters J., 1990, Revue de Paleobiologie, V9, P73; Pickford M., 1993, GEOLOGY PALAEOBIOLOG, V24, P1; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Quam R, 2009, J ANAT, V214, P655, DOI 10.1111/j.1469-7580.2009.01064.x; Robinson JT, 1956, DENTITION AUSTRALOPI; SCOTT GR, 1980, HUM BIOL, V52, P63; SENUT B, 1987, CR ACAD SCI II, V305, P819; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2005, J HUM EVOL, V48, P575, DOI 10.1016/j.jhevol.2005.02.004; Stanley SM, 1995, STUDIES GEOPHYSICS E, P233; Stewart K. M., 1989, BAR INT SERIES; SUZUKI M, 1991, J DENT RES, V70, P1092, DOI 10.1177/00220345910700071501; Tafforeau P, 2004, ASPECTS PHYLOGENETIQ; Tsuda H, 1996, EUR J ORAL SCI, V104, P123, DOI 10.1111/j.1600-0722.1996.tb00056.x; Twiesselmann F, 1958, EXPLORATION PARC NAT; ULLRICH CG, 1980, RADIOLOGY, V134, P137, DOI 10.1148/radiology.134.1.7350593; Van Damme D., 1994, GEOLOGY PALAEOBIOLOG, V2, P71; VANNEER W, 1994, GEOLOGY PALAEOBIOLOG, V2, P89; Verheyen W., 1959, OISEAUX FOSSILES; Vrba E.S., 1988, P405; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1988, J ANAT, V161, P1; Wood B, 2010, P NATL ACAD SCI USA, V107, P8902, DOI 10.1073/pnas.1001649107; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; Zanolli C, 2010, CR PALEVOL, V9, P341, DOI 10.1016/j.crpv.2010.07.019	85	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84652	10.1371/journal.pone.0084652	http://dx.doi.org/10.1371/journal.pone.0084652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427292	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329868200032
J	Torgersen, JS; Koppang, EO; Stien, LH; Kohler, A; Pedersen, ME; Morkore, T				Torgersen, Jacob S.; Koppang, Erling Olaf; Stien, Lars H.; Kohler, Achim; Pedersen, Mona E.; Morkore, Turid			Soft Texture of Atlantic Salmon Fillets Is Associated with Glycogen Accumulation	PLOS ONE			English	Article							CONNECTIVE TISSUES; MUSCLE; COLLAGEN; FISH; EXPRESSION; PERLECAN; FLESH; COLOR	Atlantic salmon (Salmo salar L.) with soft fillets are not suited for manufacturing high quality products. Therefore fillets with insufficient firmness are downgraded, leading to severe economic losses to the farming and processing industries. In the current study, morphological characteristics of salmon fillets ranging from soft to hard were analysed. Different microscopic techniques were applied, including novel methods in this field of research: morphometric image analysis, periodic acid Schiff staining, immunofluorescence microscopy, transmission electron microscopy and fourier transform infrared microscopy. The results showed that the myocytes of soft muscle had detached cells with mitochondrial dysfunctions, large glycogen aggregates and enlarged inter cellular areas, void of extracellular matrix proteins, including lower amounts of sulfated glycoproteins. Myofibre-myofibre detachment and disappearance of the endomysium in soft muscles coincided with deterioration of important connective tissue constituents such as Collagen type I (Col I), Perlecan and Aggrecan. In summary our investigations show for the first time an association between soft flesh of Atlantic salmon and massive intracellular glycogen accumulation coinciding with degenerated mitochondria, myocyte detachment and altered extracellular matrix protein distribution. The results are important for further understanding the etiology of soft salmon.	[Torgersen, Jacob S.; Kohler, Achim; Pedersen, Mona E.; Morkore, Turid] Nofima AS, As, Norway; [Koppang, Erling Olaf] Norwegian Sch Vet Sci, Inst Basic Sci & Aquat Med, Oslo, Norway; [Stien, Lars H.] Inst Marine Res, N-5024 Bergen, Norway; [Kohler, Achim] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway	Nofima; Norwegian University of Life Sciences; Institute of Marine Research - Norway; Norwegian University of Life Sciences	Morkore, T (corresponding author), Nofima AS, As, Norway.	turid.morkore@nofima.no		Kohler, Achim/0000-0001-5759-1989	Norwegian Research Council (NFR) [190479/E40]; Norwegian Seafood Research Fund (FHF)	Norwegian Research Council (NFR)(Research Council of Norway); Norwegian Seafood Research Fund (FHF)	This project (Project number 190479/E40) was funded by the Norwegian Research Council (NFR) (http://www.forskningsradet.no/) and The Norwegian Seafood Research Fund (FHF) (http://www.fiskerifond.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2008, NEUROMUSCULAR DISORD, V18, P277, DOI 10.1016/j.nmd.2008.01.001; Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; ANG JF, 1985, J FOOD BIOCHEM, V9, P49, DOI 10.1111/j.1745-4514.1985.tb00338.x; Bahuaud D, 2010, AQUACULTURE, V310, P213, DOI 10.1016/j.aquaculture.2010.10.008; Bancroft JD, 2002, THEORY PRACTICE HIST, V5th; BREMNER HA, 1992, DEV FOOD SCI, V30, P39; Caballero MJ, 2009, AQUACULTURE, V291, P210, DOI 10.1016/j.aquaculture.2009.03.032; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; Di Mauro S, 2007, Acta Myol, V26, P35; Hanifi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064822; HATAE K, 1986, B JPN SOC SCI FISH, V52, P2001; Hurling R, 1996, J TEXTURE STUD, V27, P679, DOI 10.1111/j.1745-4603.1996.tb01001.x; Johnston IA, 2000, AQUACULTURE, V189, P335, DOI 10.1016/S0044-8486(00)00373-2; Johnston IA, 2006, AQUACULTURE, V256, P323, DOI 10.1016/j.aquaculture.2006.02.048; Jonsson A, 2001, AQUACULT NUTR, V7, P81, DOI 10.1046/j.1365-2095.2001.00152.x; Kiessling A, 2004, AQUACULTURE, V236, P645, DOI 10.1016/j.aquaculture.2004.02.030; Kim YJ, 2007, CYTOM PART A, V71A, P8, DOI 10.1002/cyto.a.20334; Koppang EO, 2005, J FISH DIS, V28, P13, DOI 10.1111/j.1365-2761.2004.00583.x; Larsson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039219; LAVETY J, 1988, INT J FOOD SCI TECH, V23, P23; Long DJ, 2008, J MOL HISTOL, V39, P1, DOI 10.1007/s10735-007-9093-6; Martinez I, 2011, FOOD CHEM, V126, P140, DOI 10.1016/j.foodchem.2010.10.090; Mitchie I., 2001, FARMED FISH QUALITY, V4, P129; Moreno HM, 2012, FOOD CHEM, V134, P678, DOI 10.1016/j.foodchem.2012.02.160; Morkore T, 2003, J FOOD SCI, V68, P1492, DOI 10.1111/j.1365-2621.2003.tb09672.x; Morkore T, 2009, J TEXTURE STUD, V40, P1, DOI 10.1111/j.1745-4603.2008.00166.x; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; Periago Ma.J., 2005, Aquaculture, V249, P175, DOI 10.1016/j.aquaculture.2005.02.047; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; SATO K, 1986, B JPN SOC SCI FISH, V52, P1595; Sertel O, 2011, COMPUT MED IMAG GRAP, V35, P616, DOI 10.1016/j.compmedimag.2011.01.009; Taylor RG, 2002, J FOOD SCI, V67, P2067, DOI 10.1111/j.1365-2621.2002.tb09502.x; Xu Z, 2010, MATRIX BIOL, V29, P461, DOI 10.1016/j.matbio.2010.06.001; Ytteborg E, 2010, CELL TISSUE RES, V342, P363, DOI 10.1007/s00441-010-1069-2; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	37	36	37	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85551	10.1371/journal.pone.0085551	http://dx.doi.org/10.1371/journal.pone.0085551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416425	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300087
J	Anderson, AE; Hure, AJ; Forder, PM; Powers, J; Kay-Lambkin, FJ; Loxton, DJ				Anderson, Amy E.; Hure, Alexis J.; Forder, Peta M.; Powers, Jennifer; Kay-Lambkin, Frances J.; Loxton, Deborah J.			Risky Drinking Patterns Are Being Continued into Pregnancy: A Prospective Cohort Study	PLOS ONE			English	Article							PRENATAL ALCOHOL EXPOSURE; BINGE DRINKING; WOMEN CHANGE; CONSUMPTION; INTELLIGENCE; BEHAVIORS; AUSTRALIA	Background: Risky patterns of alcohol use prior to pregnancy increase the risk of alcohol-exposed pregnancies and subsequent adverse outcomes. It is important to understand how consumption changes once women become pregnant. Objective: The aim of this study was to describe the characteristics of women that partake in risky drinking patterns before pregnancy and to examine how these patterns change once they become pregnant. Methods: A sample of 1577 women from the 1973-78 cohort of the Australian Longitudinal Study on Women's Health were included if they first reported being pregnant in 2000, 2003, 2006, 2009 and reported risky drinking patterns prior to that pregnancy. Multinomial logistic regression was used to determine which risky drinking patterns were most likely to continue into pregnancy. Results: When reporting risky drinking patterns prior to pregnancy only 6% of women reported weekly drinking only, whereas 46% reported binge drinking only and 48% reported both. Women in both binge categories were more likely to have experienced financial stress, not been partnered, smoked, used drugs, been nulliparous, experienced a violent relationship, and were less educated. Most women (46%) continued these risky drinking patterns into pregnancy, with 40% reducing these behaviors, and 14% completely ceasing alcohol consumption. Once pregnant, women who binged only prior to pregnancy were more likely to continue (55%) rather than reduce drinking (29%). Of the combined drinking group 61% continued to binge and 47% continued weekly drinking. Compared with the combined drinking group, binge only drinkers prior to pregnancy were less likely to reduce rather than continue their drinking once pregnant (OR = 0.37, 95% CI = 0.29, 0.47). Conclusions: Over a third of women continued risky drinking into pregnancy, especially binge drinking, suggesting a need to address alcohol consumption prior to pregnancy.	[Anderson, Amy E.; Hure, Alexis J.; Forder, Peta M.; Powers, Jennifer; Loxton, Deborah J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia; [Kay-Lambkin, Frances J.] Univ Newcastle, Prior Res Ctr Translat Neurosci & Mental Hlth, Callaghan, NSW 2308, Australia; [Kay-Lambkin, Frances J.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Randwick, NSW, Australia	University of Newcastle; University of Newcastle; University of New South Wales Sydney	Anderson, AE (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia.	Amy.Anderson@newcastle.edu.au		Kay-Lambkin, Frances/0000-0002-4252-5572; Hure, Alexis/0000-0003-2225-0986	Department of Health and Ageing [G0189875]	Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Australian Longitudinal Study on Women's Health was funded by the Department of Health and Ageing (G0189875), http://www.health.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvik A, 2006, ACTA OBSTET GYN SCAN, V85, P1292, DOI 10.1080/00016340600589958; Anderson AE, 2013, BJOG-INT J OBSTET GY, V120, P1366, DOI 10.1111/1471-0528.12356; Anderson AE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-777; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Brown WJBL, 1996, J WOMENS HEALTH, V5, P467, DOI DOI 10.1089/JWH.1996.5.467; Burns E, 2010, ADDICTION, V105, P601, DOI 10.1111/j.1360-0443.2009.02842.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carson G, 2010, J OBSTET GYNAECOL CA, V32, pS1, DOI 10.1016/S1701-2163(16)34633-3; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P529; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Crozier SR, 2009, PAEDIATR PERINAT EP, V23, P446, DOI 10.1111/j.1365-3016.2009.01036.x; de Chazeron I, 2008, ALCOHOL CLIN EXP RES, V32, P868, DOI 10.1111/j.1530-0277.2008.00646.x; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Feldman HS, 2011, AM J MED GENET A, V155A, P2949, DOI 10.1002/ajmg.a.34276; Floyd RL, 2007, AM J PREV MED, V32, P1, DOI 10.1016/j.amepre.2006.08.028; France K, 2010, SUBST USE MISUSE, V45, P1474, DOI 10.3109/10826081003682172; Gray R, 2006, REV FETAL EFFECTS PR; Harris M., 2009, GUIDELINES PREVENTIV; Henderson J, 2007, BJOG-INT J OBSTET GY, V114, P243, DOI 10.1111/j.1471-0528.2006.01163.x; Ingersoll KS, 2013, J SUBST ABUSE TREAT, V44, P407, DOI 10.1016/j.jsat.2012.10.001; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1222, DOI 10.1111/j.1471-0528.2012.03395.x; Kuehn D, 2012, ALCOHOL CLIN EXP RES, V36, P1811, DOI 10.1111/j.1530-0277.2012.01794.x; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Lewis SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049407; Livingston M., 2012, PERCEPTIONS LOW RISK; Marie Stopes International, 2008, REAL CHOIC WOM CONTR; McDonald SD, 2005, ADDICT BEHAV, V30, P853, DOI 10.1016/j.addbeh.2004.08.016; McNamara TK, 2005, AM J OBSTET GYNECOL, V193, P1981, DOI 10.1016/j.ajog.2005.04.053; *NAT HLTH MED RES, 1992, IS THER SAF LEV DAIL; National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH; National Health and Medical Research Council Commonwealth of Australia, 2001, AUSTR ALC GUID HLTH; O'Leary CM, 2012, DRUG ALCOHOL REV, V31, P170, DOI 10.1111/j.1465-3362.2011.00331.x; O'Leary CM, 2010, ADDICTION, V105, P74, DOI 10.1111/j.1360-0443.2009.02756.x; Peadon E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-510; Powers JR, 2013, MATERN CHILD HLTH J, V17, P76, DOI 10.1007/s10995-012-0949-3; Riley EP, 2004, AM J MED GENET C, V127C, P35, DOI 10.1002/ajmg.c.30014; Sayal K, 2009, PEDIATRICS, V123, pE289, DOI 10.1542/peds.2008-1861; Sheehan M, 2001, SUBST USE MISUSE, V36, P347, DOI 10.1081/JA-100102630; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; Strandberg-Larsen K, 2008, OBSTET GYNECOL, V111, P602, DOI 10.1097/AOG.0b013e3181661431; Strandberg-Larsen K, 2009, EPIDEMIOLOGY, V20, P884, DOI 10.1097/EDE.0b013e3181bbd46c; Thanh NX, 2010, J POPUL THER CLIN PH, V17, pE302; The Danish National Board of Health, 2010, HLTH HAB DUR PREGN; The Information Centre Lifestyles Statistics, 2007, STAT ALC ENGL 2007, P2007; Tough S, 2006, CLIN MED RES, V4, P97, DOI 10.3121/cmr.4.2.97; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2	49	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86171	10.1371/journal.pone.0086171	http://dx.doi.org/10.1371/journal.pone.0086171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454959	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100147
J	Araoka, T; Mae, S; Kurose, Y; Uesugi, M; Ohta, A; Yamanaka, S; Osafune, K				Araoka, Toshikazu; Mae, Shin-ichi; Kurose, Yuko; Uesugi, Motonari; Ohta, Akira; Yamanaka, Shinya; Osafune, Kenji			Efficient and Rapid Induction of Human iPSCs/ESCs into Nephrogenic Intermediate Mesoderm Using Small Molecule-Based Differentiation Methods	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RETINOIC ACID; MOUSE; KIDNEY; POPULATION; ODD-SKIPPED-RELATED-1; IDENTIFICATION; SPECIFICATION; ESTABLISHMENT; MAINTENANCE	The first step in developing regenerative medicine approaches to treat renal diseases using pluripotent stem cells must be the generation of intermediate mesoderm (IM), an embryonic germ layer that gives rise to kidneys. In order to achieve this goal, establishing an efficient, stable and low-cost method for differentiating IM cells using small molecules is required. In this study, we identified two retinoids, AM580 and TTNPB, as potent IM inducers by high-throughput chemical screening, and established rapid (five days) and efficient (80% induction rate) IM differentiation from human iPSCs using only two small molecules: a Wnt pathway activator, CHIR99021, combined with either AM580 or TTNPB. The resulting human IM cells showed the ability to differentiate into multiple cell types that constitute adult kidneys, and to form renal tubule-like structures. These small molecule differentiation methods can bypass the mesendoderm step, directly inducing IM cells by activating Wnt, retinoic acid (RA), and bone morphogenetic protein (BMP) pathways. Such methods are powerful tools for studying kidney development and may potentially provide cell sources to generate renal lineage cells for regenerative therapy.	[Araoka, Toshikazu; Mae, Shin-ichi; Kurose, Yuko; Ohta, Akira; Yamanaka, Shinya; Osafune, Kenji] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Uesugi, Motonari] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; Kyoto University; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Osafune, K (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	osafu@cira.kyoto-u.ac.jp	Uesugi, Motonari/AAM-9777-2020		Leading Project of MEXT; Uehara Memorial Foundation; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Japan Science and Technology Agency (JST) through PRESTO; JST Yamanaka iPS Cell Special Project; research grant "Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine"; JSPS	Leading Project of MEXT; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST) through PRESTO; JST Yamanaka iPS Cell Special Project(Japan Science & Technology Agency (JST)); research grant "Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine"; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by research grants from the Leading Project of MEXT, the Uehara Memorial Foundation and the Takeda Science Foundation, by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" and Grant-in-Aid for Young Scientists (B) to KO, and by Japan Science and Technology Agency (JST) through PRESTO to KO, JST Yamanaka iPS Cell Special Project to AO, SY and KO, and its research grant "Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine". SM was supported by a fellowship from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Brennan HC, 1999, DEVELOPMENT, V126, P5847; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Germain P, 2004, EMBO REP, V5, P877, DOI 10.1038/sj.embor.7400235; HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0; James RG, 2005, DEV BIOL, V288, P113, DOI 10.1016/j.ydbio.2005.09.025; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kim MJ, 2000, J INVEST DERMATOL, V114, P349, DOI 10.1046/j.1523-1747.2000.00868.x; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Lyu J, 2011, CELL RES, V21, P911, DOI 10.1038/cr.2011.47; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mascrez B, 1998, DEVELOPMENT, V125, P4691; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishikawa M, 2012, BIOCHEM BIOPH RES CO, V417, P897, DOI 10.1016/j.bbrc.2011.12.071; Obara-Ishihara T, 1999, DEVELOPMENT, V126, P1103; Oeda S, 2013, INT J DEV BIOL, V57, P383, DOI 10.1387/ijdb.130058ma; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Osafune K, 2002, DEV GROWTH DIFFER, V44, P161; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Ren XH, 2010, ACTA BIOCH BIOPH SIN, V42, P464, DOI 10.1093/abbs/gmq046; Saxen L., 1987, ORGANOGENESIS KIDNEY; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Wang QR, 2005, DEV BIOL, V288, P582, DOI 10.1016/j.ydbio.2005.09.024; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	75	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84881	10.1371/journal.pone.0084881	http://dx.doi.org/10.1371/journal.pone.0084881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454758	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100038
J	Duriez, O; Kato, A; Tromp, C; Dell'Omo, G; Vyssotski, AL; Sarrazin, F; Ropert-Coudert, Y				Duriez, Olivier; Kato, Akiko; Tromp, Clara; Dell'Omo, Giacomo; Vyssotski, Alexei L.; Sarrazin, Francois; Ropert-Coudert, Yan			How Cheap Is Soaring Flight in Raptors? A Preliminary Investigation in Freely-Flying Vultures	PLOS ONE			English	Article							DOUBLY LABELED WATER; DAILY ENERGY-EXPENDITURE; WHITE-BACKED VULTURE; HEART-RATE; GYPS-FULVUS; OXYGEN-CONSUMPTION; BODY ACCELERATION; HARNESS DESIGN; METABOLIC-RATE; BEHAVIOR	Measuring the costs of soaring, gliding and flapping flight in raptors is challenging, but essential for understanding their ecology. Among raptors, vultures are scavengers that have evolved highly efficient soaring-gliding flight techniques to minimize energy costs to find unpredictable food resources. Using electrocardiogram, GPS and accelerometer bio-loggers, we report the heart rate (HR) of captive griffon vultures (Gyps fulvus and G. himalayensis) trained for freely-flying. HR increased three-fold at take-off (characterized by prolonged flapping flight) and landing (>300 beats-per-minute, (bpm)) compared to baseline levels (80-100 bpm). However, within 10 minutes after the initial flapping phase, HR in soaring/gliding flight dropped to values similar to baseline levels, i.e. slightly lower than theoretically expected. However, the extremely rapid decrease in HR was unexpected, when compared with other marine gliders, such as albatrosses. Weather conditions influenced flight performance and HR was noticeably higher during cloudy compared to sunny conditions when prolonged soaring flight is made easier by thermal ascending air currents. Soaring as a cheap locomotory mode is a crucial adaptation for vultures who spend so long on the wing for wide-ranging movements to find food.	[Duriez, Olivier; Tromp, Clara] Univ Montpellier 2, Ctr Ecol Fonct & Evolut, UMR5175, Montpellier, France; [Duriez, Olivier; Sarrazin, Francois] Univ Paris 06, UMR7204, CERSP, Museum Natl Hist Nat, Paris, France; [Kato, Akiko; Tromp, Clara; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, Strasbourg, France; [Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, Strasbourg, France; [Dell'Omo, Giacomo] Ornis Ital, Rome, Italy; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, ETH Zurich, Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Duriez, O (corresponding author), Univ Montpellier 2, Ctr Ecol Fonct & Evolut, UMR5175, Montpellier, France.	olivier.duriez@cefe.cnrs.fr	Sarrazin, François/AAB-4227-2019; Sarrazin, Francois/B-7593-2013; Kato, Akiko/W-2447-2019; Duriez, Olivier/R-4772-2016	Sarrazin, François/0000-0001-5901-4819; Sarrazin, Francois/0000-0001-5901-4819; Duriez, Olivier/0000-0003-1868-9750; Vyssotski, Alexei/0000-0002-9021-1471; Dell'Omo, Giacomo/0000-0002-9601-9675; Kato, Akiko/0000-0002-8947-3634	French Agency ANR [ANR-07-BLAN-0201]	French Agency ANR(French National Research Agency (ANR))	Project funded by the French Agency ANR grant noANR-07-BLAN-0201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahat O, 1995, THESIS TEL AVIV U TE; Bevan RM, 1995, PHILOS T R SOC B, V350, P119, DOI 10.1098/rstb.1995.0146; BEVAN RM, 1994, J EXP BIOL, V193, P119; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bose M, 2007, IBIS, V149, P490, DOI 10.1111/j.1474-919X.2007.00674.x; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Duriez O, 2012, BIRD STUDY, V59, P193, DOI 10.1080/00063657.2012.658640; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; Ely CR, 1999, CONDOR, V101, P390, DOI 10.2307/1370002; Gillies JA, 2011, J AVIAN BIOL, V42, P377, DOI 10.1111/j.1600-048X.2011.05105.x; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Johnson JA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-65; KANWISHER JW, 1978, AUK, V95, P288; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; Mallory Mark L., 2008, Marine Ornithology, V36, P183; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; MASMAN D, 1988, ARDEA, V76, P64; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Mundy P., 1992, VULTURES AFRICA; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Norberg Ulla M., 1996, P199; Pelletier D, 2008, P ROY SOC B-BIOL SCI, V275, P2117, DOI 10.1098/rspb.2008.0422; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PENNYCUICK CJ, 1971, J EXP BIOL, V55, P39; Pennycuik Colin J., 2002, Avian Science, V2, P1; Prinzinger R, 2002, J ORNITHOL, V143, P456, DOI 10.1046/j.1439-0361.2002.02039.x; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Ropert-Coudert Y, 2004, IBIS, V146, P281, DOI 10.1111/j.1474-919x.2003.00250.x; Ropert-Coudert Y, 2006, MAR ECOL PROG SER, V328, P275, DOI 10.3354/meps328275; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sachs G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041449; Sakamoto KQ, 2013, J EXP BIOL, V216, P3175, DOI 10.1242/jeb.079905; Sapir N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013956; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Speakman J.R., 1997, DOUBLY LABELLED WATE; Spiegel O, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-5; TUCKER VA, 1988, J EXP BIOL, V140, P325; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wilbur SR., 1983, VULTURE BIOL MANAGEM; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Xirouchakis SM, 2009, WILDLIFE BIOL, V15, P37, DOI 10.2981/07-090	55	88	91	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84887	10.1371/journal.pone.0084887	http://dx.doi.org/10.1371/journal.pone.0084887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454760	Green Published, Green Accepted, gold			2022-12-27	WOS:000330235100039
J	Wong, KS; Snider, JD; Graham, C; Greenblatt, JF; Emili, A; Babu, M; Houry, WA				Wong, Keith S.; Snider, Jamie D.; Graham, Chris; Greenblatt, Jack F.; Emili, Andrew; Babu, Mohan; Houry, Walid A.			The MoxR ATPase RavA and Its Cofactor ViaA Interact with the NADH:Ubiquinone Oxidoreductase I in Escherichia coli	PLOS ONE			English	Article							INDUCIBLE LYSINE DECARBOXYLASE; PERIPLASMIC NITRATE REDUCTASE; NITRIC-OXIDE REDUCTASE; RESPIRATORY COMPLEX I; AAA PLUS ATPASE; BACTERICIDAL ANTIBIOTICS; PARACOCCUS-DENITRIFICANS; DIHYDRORHODAMINE 123; MUTATIONAL ANALYSIS; HYDROGEN-PEROXIDE	MoxR ATPases are widespread throughout bacteria and archaea. The experimental evidence to date suggests that these proteins have chaperone-like roles in facilitating the maturation of dedicated protein complexes that are functionally diverse. In Escherichia coli, the MoxR ATPase RavA and its putative cofactor ViaA are found to exist in early stationary-phase cells at 37 degrees C at low levels of about 350 and 90 molecules per cell, respectively. Both proteins are predominantly localized to the cytoplasm, but ViaA was also unexpectedly found to localize to the cell membrane. Whole genome microarrays and synthetic lethality studies both indicated that RavA-ViaA are genetically linked to Fe-S cluster assembly and specific respiratory pathways. Systematic analysis of mutant strains of ravA and viaA indicated that RavA-ViaA sensitizes cells to sublethal concentrations of aminoglycosides. Furthermore, this effect was dependent on RavA's ATPase activity, and on the presence of specific subunits of NADH: ubiquinone oxidoreductase I (Nuo Complex, or Complex I). Importantly, both RavA and ViaA were found to physically interact with specific Nuo subunits. We propose that RavA-ViaA facilitate the maturation of the Nuo complex.	[Wong, Keith S.; Snider, Jamie D.; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Graham, Chris; Babu, Mohan] Univ Regina, Dept Biochem, Res & Innovat Ctr, Regina, SK S4S 0A2, Canada; [Greenblatt, Jack F.; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto; University of Regina; University of Toronto	Houry, WA (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	walid.houry@utoronto.ca	Mohan, Babu P./I-7362-2019		Canadian Institutes of Health Research (CIHR) [TGF-53910]; University of Toronto; Natural Sciences and Engineering Research Council of Canada [DG-20234]; CIHR [MOP-82852, MOP-130374]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR(Canadian Institutes of Health Research (CIHR))	KSW is the recipient of a fellowship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Protein Folding and Interaction Dynamics: Principles and Diseases (TGF-53910) and a Doctoral Completion Award from the University of Toronto. This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada to MB (DG-20234) and from CIHR to JFG and AE (MOP-82852) and to WAH (MOP-130374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arai H, 1999, FEMS MICROBIOL LETT, V170, P19, DOI 10.1111/j.1574-6968.1999.tb13350.x; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Babu Mohan, 2009, Methods Mol Biol, V564, P373, DOI 10.1007/978-1-60761-157-8_22; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bartnikas TB, 1997, J BACTERIOL, V179, P3534, DOI 10.1128/jb.179.11.3534-3540.1997; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; DeBoer APN, 1996, EUR J BIOCHEM, V242, P592, DOI 10.1111/j.1432-1033.1996.0592r.x; Dieppedale J, 2013, MOL CELL PROTEOMICS, V12, P2278, DOI 10.1074/mcp.M112.024794; Dieppedale J, 2011, INFECT IMMUN, V79, P1428, DOI 10.1128/IAI.01012-10; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; El Bakkouri M, 2010, P NATL ACAD SCI USA, V107, P22499, DOI 10.1073/pnas.1009092107; Erhardt H, 2012, BBA-BIOENERGETICS, V1817, P863, DOI 10.1016/j.bbabio.2011.10.008; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fritsche E, 1999, J MOL BIOL, V288, P989, DOI 10.1006/jmbi.1999.2719; Gautier V, 2012, J MOL BIOL, V421, P662, DOI 10.1016/j.jmb.2012.01.047; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Goltermann L, 2013, J BIOL CHEM, V288, P10483, DOI 10.1074/jbc.M112.420380; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Goswami M, 2007, ANTIMICROB AGENTS CH, V51, P1119, DOI 10.1128/AAC.00779-06; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jain V, 2006, J MICROBIOL, V44, P1; JUNGST A, 1992, FEBS LETT, V314, P308, DOI 10.1016/0014-5793(92)81495-8; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Katerov V, 2000, CURR MICROBIOL, V40, P149, DOI 10.1007/s002849910031; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lee JE, 2000, RES MICROBIOL, V151, P605; LEMIRE BD, 1986, METHOD ENZYMOL, V126, P377; Ling JQ, 2012, MOL CELL, V48, P713, DOI 10.1016/j.molcel.2012.10.001; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Magrane M, 2011, DATABASE J BIOL DATA, V2011; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Park YK, 1996, MOL MICROBIOL, V20, P605, DOI 10.1046/j.1365-2958.1996.5441070.x; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pelzmann A, 2009, J BIOL CHEM, V284, P9578, DOI 10.1074/jbc.M805354200; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheele U, 2011, J VIROL, V85, P4812, DOI 10.1128/JVI.00072-11; Schneider D, 2008, BBA-BIOENERGETICS, V1777, P735, DOI 10.1016/j.bbabio.2008.03.003; Snider J, 2006, J BIOL CHEM, V281, P1532, DOI 10.1074/jbc.M511172200; Snider J, 2006, J STRUCT BIOL, V156, P200, DOI 10.1016/j.jsb.2006.02.009; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Tanapongpipat S, 1998, BIOCHEM J, V334, P355, DOI 10.1042/bj3340355; Todorovic S, 2008, J BIOL INORG CHEM, V13, P765, DOI 10.1007/s00775-008-0362-y; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Toyama H, 1998, FEMS MICROBIOL LETT, V166, P1; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; Tseng CP, 2001, J BACTERIOL, V183, P461, DOI 10.1128/JB.183.2.461-467.2001; Vanderlinde EM, 2011, J BACTERIOL; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6948, DOI 10.1128/jb.173.21.6948-6961.1991; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Wong KS, 2012, J STRUCT BIOL, V179, P211, DOI 10.1016/j.jsb.2012.03.010; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	81	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85529	10.1371/journal.pone.0085529	http://dx.doi.org/10.1371/journal.pone.0085529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454883	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100096
J	Gerber, S; Chadoeuf, J; Gugerli, F; Lascoux, M; Buiteveld, J; Cottrell, J; Dounavi, A; Fineschi, S; Forrest, LL; Fogelqvist, J; Goicoechea, PG; Jensen, JS; Salvini, D; Vendramin, GG; Kremer, A				Gerber, Sophie; Chadoeuf, Joel; Gugerli, Felix; Lascoux, Martin; Buiteveld, Joukje; Cottrell, Joan; Dounavi, Aikaterini; Fineschi, Silvia; Forrest, Laura L.; Fogelqvist, Johan; Goicoechea, Pablo G.; Jensen, Jan Svejgaard; Salvini, Daniela; Vendramin, Giovanni G.; Kremer, Antoine			High Rates of Gene Flow by Pollen and Seed in Oak Populations across Europe	PLOS ONE			English	Article							TORMINALIS L. CRANTZ; QUERCUS-PETRAEA; PATERNITY ANALYSIS; BUR OAK; REPRODUCTIVE SUCCESS; PARENTAGE ANALYSIS; DISPERSAL KERNEL; WILDSERVICE TREE; FOREST TREES; PATTERNS	Gene flow is a key factor in the evolution of species, influencing effective population size, hybridisation and local adaptation. We analysed local gene flow in eight stands of white oak (mostly Quercus petraea and Q. robur, but also Q. pubescens and Q. faginea) distributed across Europe. Adult trees within a given area in each stand were exhaustively sampled (range [239, 754], mean 423), mapped, and acorns were collected ([17,147], 51) from several mother trees ([3,47], 23). Seedlings ([65,387], 178) were harvested and geo-referenced in six of the eight stands. Genetic information was obtained from screening distinct molecular markers spread across the genome, genotyping each tree, acorn or seedling. All samples were thus genotyped at 5-8 nuclear microsatellite loci. Fathers/parents were assigned to acorns and seedlings using likelihood methods. Mating success of male and female parents, pollen and seed dispersal curves, and also hybridisation rates were estimated in each stand and compared on a continental scale. On average, the percentage of the wind-borne pollen from outside the stand was 60%, with large variation among stands (21-88%). Mean seed immigration into the stand was 40%, a high value for oaks that are generally considered to have limited seed dispersal. However, this estimate varied greatly among stands (20-66%). Gene flow was mostly intraspecific, with large variation, as some trees and stands showed particularly high rates of hybridisation. Our results show that mating success was unevenly distributed among trees. The high levels of gene flow suggest that geographically remote oak stands are unlikely to be genetically isolated, questioning the static definition of gene reserves and seed stands.	[Gerber, Sophie; Kremer, Antoine] INRA, UMR1202, BIOGECO, Cestas, France; [Gerber, Sophie; Kremer, Antoine] Univ Bordeaux, BIOGECO, UMR1202, Talence, France; [Chadoeuf, Joel] INRA, UR 1052, F-84143 Montfavet, France; [Gugerli, Felix; Dounavi, Aikaterini] WSL Swiss Fed Res Inst, Birmensdorf, Switzerland; [Lascoux, Martin; Fogelqvist, Johan] Uppsala Univ, Dept Ecol & Genet, Sci Life Lab, EBC, Uppsala, Sweden; [Buiteveld, Joukje] Wageningen UR, Alterra, Wageningen, Netherlands; [Cottrell, Joan; Forrest, Laura L.] Forest Res, No Res Stn, Roslin, Midlothian, Scotland; [Fineschi, Silvia; Salvini, Daniela] CNR, Inst Plant Protect, Florence, Italy; [Goicoechea, Pablo G.] NEIKER Tecnalia, Vitoria, Spain; [Jensen, Jan Svejgaard; Salvini, Daniela] Univ Copenhagen, Copenhagen, Denmark; [Vendramin, Giovanni G.] CNR, Inst Biosci & Bioresources, Florence, Italy	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Uppsala University; Wageningen University & Research; Consiglio Nazionale delle Ricerche (CNR); University of Copenhagen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Gerber, S (corresponding author), INRA, UMR1202, BIOGECO, Cestas, France.	sophie.gerber@pierroton.inra.fr	Gugerli, Felix/C-9369-2009; Gugerli, Felix/U-7195-2019; Vendramin, Giovanni G/K-9731-2014; Goicoechea, Pablo González/O-8276-2015; Fineschi, Silvia/ABF-9775-2020; Kremer, Antoine/G-2272-2018	Gugerli, Felix/0000-0003-3878-1845; Gugerli, Felix/0000-0003-3878-1845; Vendramin, Giovanni G/0000-0001-9921-7872; Goicoechea, Pablo González/0000-0002-5558-1098; buiteveld, joukje/0000-0003-1892-6760; Forrest, Laura/0000-0002-0235-9506; FINESCHI, SILVIA/0000-0002-3583-6073; Kremer, Antoine/0000-0002-3372-3235; Lascoux, Martin/0000-0003-1699-9042; Dounavi, Aikaterini/0000-0002-4738-6698	European Project "Fairoak" ("Synthetic maps of gene diversity and provenance performance for utilisation and conservation of oak genetic resources in Europe", European Commission Directorate General VI Agriculture) [FAIR PL95-0297]; European Union Project "Oakflow" ("Intra- & interspecific gene flow in oaks as mechanisms promoting genetic diversity and adaptive potential") [QLK5-2000-00960]; Swiss State Secretariat for Education and Research (SER) [99.0838]; Copenhagen University	European Project "Fairoak" ("Synthetic maps of gene diversity and provenance performance for utilisation and conservation of oak genetic resources in Europe", European Commission Directorate General VI Agriculture); European Union Project "Oakflow" ("Intra- & interspecific gene flow in oaks as mechanisms promoting genetic diversity and adaptive potential"); Swiss State Secretariat for Education and Research (SER); Copenhagen University	The work was funded by the European Project "Fairoak" ("Synthetic maps of gene diversity and provenance performance for utilisation and conservation of oak genetic resources in Europe", European Commission Directorate General VI Agriculture, contract FAIR PL95-0297), and the European Union Project "Oakflow" ("Intra- & interspecific gene flow in oaks as mechanisms promoting genetic diversity and adaptive potential", QLK5-2000-00960). The Swiss State Secretariat for Education and Research (SER, 99.0838) financially supported FG and AD. DS received a PhD grant from Copenhagen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Austerlitz F, 2007, HEREDITY, V99, P193, DOI 10.1038/sj.hdy.6800983; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Bacilieri R, 1996, ANN SCI FOREST, V53, P79, DOI 10.1051/forest:19960106; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; BOSSEMA I, 1979, BEHAVIOUR, V70, P1, DOI 10.1163/156853979X00016; Burczyk J, 2006, GENETICS, V173, P363, DOI 10.1534/genetics.105.046805; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; Buschbom J, 2011, J HERED, V102, P464, DOI 10.1093/jhered/esr023; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; CONNELL J H, 1971, P298; Craft KJ, 2010, AM J BOT, V97, P1999, DOI 10.3732/ajb.0900390; Curtu AL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-284; Curtu AL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-218; Diggle PJ, 1983, STAT ANAL SPATIAL PO; DOW BD, 1995, THEOR APPL GENET, V91, P137, DOI 10.1007/BF00220870; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Dupouey JL., 1993, ANN SCI FOREST, V50, p35S, DOI [10.1051/forest:19930702, DOI 10.1051/FOREST:19930702]; Efron B., 1994, INTRO BOOTSTRAP; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Gerber S, 2003, MOL ECOL NOTES, V3, P479, DOI 10.1046/j.1471-8286.2003.00439.x; Gerber S, 2000, MOL ECOL, V9, P1037, DOI 10.1046/j.1365-294x.2000.00961.x; Gonzalez-Rodriguez A, 2004, MOL ECOL, V13, P3467, DOI 10.1111/j.1365-294X.2004.02344.x; Goto S, 2006, MOL ECOL, V15, P2985, DOI 10.1111/j.1365-294X.2006.02976.x; Grivet D, 2005, MOL ECOL, V14, P3585, DOI 10.1111/j.1365-294X.2005.02680.x; Gugerli F, 2007, ANN BOT-LONDON, V99, P713, DOI 10.1093/aob/mcm006; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kamm U, 2009, HEREDITY, V103, P476, DOI 10.1038/hdy.2009.70; Kampfer S, 1998, HEREDITAS, V129, P183, DOI 10.1111/j.1601-5223.1998.00183.x; Karl SA, 2008, MOL ECOL, V17, P3973, DOI 10.1111/j.1365-294X.2008.03902.x; Klein EK, 2008, MOL ECOL, V17, P3323, DOI 10.1111/j.1365-294X.2008.03809.x; Kollmann J, 1996, VEGETATIO, V125, P193, DOI 10.1007/BF00044651; Koskela J, 2013, BIOL CONSERV, V157, P39, DOI 10.1016/j.biocon.2012.07.023; Kremer A, 2002, ANN FOR SCI, V59, P777, DOI 10.1051/forest:2002065; Leonarduzzi C, 2012, IFOREST, V5, P18, DOI 10.3832/ifor0606-009; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Lepais O, 2008, THESIS U BORDEAUX 1; Lepais O, 2011, EVOLUTION, V65, P156, DOI 10.1111/j.1558-5646.2010.01101.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MEAGHER TR, 1991, AM NAT, V137, P738, DOI 10.1086/285191; Moran EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036492; Moran EV, 2012, ECOLOGY, V93, P1082, DOI 10.1890/11-1428.1; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; Nakanishi A, 2005, MOL ECOL, V14, P4469, DOI 10.1111/j.1365-294X.2005.02736.x; Nakanishi A, 2004, SILVAE GENET, V53, P258, DOI 10.1515/sg-2004-0048; Neophytou C, 2011, EUR J FOREST RES, V130, P623, DOI 10.1007/s10342-010-0454-4; Niggemann M, 2012, J ECOL, V100, P264, DOI 10.1111/j.1365-2745.2011.01854.x; Oddou-Muratorio S, 2005, MOL ECOL, V14, P4441, DOI 10.1111/j.1365-294X.2005.02720.x; Pakkad G, 2008, FOREST ECOL MANAG, V255, P3819, DOI 10.1016/j.foreco.2008.03.017; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; Robledo-Arnuncio JJ, 2007, MOL ECOL, V16, P5098, DOI 10.1111/j.1365-294X.2007.03427.x; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Saintagne C, 2004, HEREDITY, V92, P20, DOI 10.1038/sj.hdy.6800358; Salvini D, 2009, PLANT BIOLOGY, V11, P758, DOI 10.1111/j.1438-8677.2008.00158.x; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Shea K, 2007, SCIENCE, V315, P1231, DOI 10.1126/science.1136096; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Steinkellner H, 1997, PLANT MOL BIOL, V33, P1093, DOI 10.1023/A:1005736722794; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Streiff R, 1998, GENET SEL EVOL, V30, pS137, DOI 10.1051/gse:19980708; Tufto J, 1997, THEOR POPUL BIOL, V52, P16, DOI 10.1006/tpbi.1997.1306; Valbuena-Carabana M, 2007, MOL ECOL, V16, P1207, DOI 10.1111/j.1365-294X.2007.03231.x; YAZDANI R, 1985, FOREST SCI, V31, P430	69	67	67	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85130	10.1371/journal.pone.0085130	http://dx.doi.org/10.1371/journal.pone.0085130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454802	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500043
J	Zuber, Z; Rozdzynska-Swiatkowska, A; Jurecka, A; Tylki-Szymanska, A				Zuber, Zbigniew; Rozdzynska-Swiatkowska, Agnieszka; Jurecka, Agnieszka; Tylki-Szymanska, Anna			The Effect of Recombinant Human Iduronate-2-Sulfatase (Idursulfase) on Growth in Young Patients with Mucopolysaccharidosis Type II	PLOS ONE			English	Article							REFERENCES; CHILDREN; DISEASE; HEIGHT	Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked, recessive, lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase. Early bone involvement leads to decreased growth velocity and short stature in nearly all patients. Our analysis aimed to investigate the effects of enzyme replacement therapy (ERT) with idursulfase (Elaprase) on growth in young patients with mucopolysaccharidosis type II. Analysis of longitudinal anthropometric data of MPS II patients (group 1, n = 13) who started ERT before 6 years of age (range from 3 months to 6 years, mean 3.6 years, median 4 years) was performed and then compared with retrospective analysis of data for MPS II patients naive to ERT (group 2, n = 50). Patients in group 1 received intravenous idursulfase at a standard dose of 0.58 mg/kg weekly for 52-288 weeks. The course of average growth curve for group 1 was very similar to growth pattern in group 2. The average value of body height in subsequent years in group 1 was a little greater than in group 2, however, the difference was not statistically significant. In studied patients with MPS II, idursulfase did not appear to alter the growth patterns.	[Zuber, Zbigniew] S Louis Reg Childrens Hosp, Dept Pediat, Krakow, Poland; [Rozdzynska-Swiatkowska, Agnieszka] Childrens Mem Hlth Inst, Anthropol Lab, Warsaw, Poland; [Jurecka, Agnieszka] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland; [Jurecka, Agnieszka] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Tylki-Szymanska, Anna] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland	Children's Memorial Health Institute; Fahrenheit Universities; University of Gdansk; Children's Memorial Health Institute; Children's Memorial Health Institute	Jurecka, A (corresponding author), Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland.	ajurecka@gmail.com		Rozdzynska-Swiatkowska, Agnieszka/0000-0001-6936-5989; Zuber, Zbigniew/0000-0001-9581-0601; Tylki-Szymanska, Anna/0000-0002-8935-1768				Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; Bonthuis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042506; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; Cieslik J, 1994, DZIECKO POZNANSKIE 9; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; Jones SA, 2013, MOL GENET METAB, V109, P41, DOI 10.1016/j.ymgme.2013.03.001; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Kulaga Z, 2013, EUR J PEDIATR, V172, P753, DOI 10.1007/s00431-013-1954-2; Muenzer J, 2011, GENET MED, V13, P102, DOI 10.1097/GIM.0b013e318206786f; Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; Rozdzynska A, 2011, ACTA PAEDIATR, V100, P456, DOI 10.1111/j.1651-2227.2010.02060.x; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; Scarpa M, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-72; Schulze-Frenking G, 2011, J INHERIT METAB DIS, V34, P203, DOI 10.1007/s10545-010-9215-2; Schwartz IVD, 2007, ACTA PAEDIATR, V96, P63, DOI 10.1111/j.1651-2227.2007.00212.x; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564	19	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85074	10.1371/journal.pone.0085074	http://dx.doi.org/10.1371/journal.pone.0085074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454794	gold, Green Submitted, Green Published			2022-12-27	WOS:000329922500039
J	Schoebel, CN; Stewart, J; Gruenwald, NJ; Rigling, D; Prospero, S				Schoebel, Corine N.; Stewart, Jane; Gruenwald, Niklaus J.; Rigling, Daniel; Prospero, Simone			Population History and Pathways of Spread of the Plant Pathogen Phytophthora plurivora	PLOS ONE			English	Article							STATISTICAL PROPERTIES; SELF-FERTILIZATION; GENETIC DIVERSITY; POWER ANALYSIS; NORTH-AMERICA; 2 TESTS; MIGRATION; INFERENCE; EVOLUTION; EXPANSION	Human activity has been shown to considerably affect the spread of dangerous pests and pathogens worldwide. Therefore, strict regulations of international trade exist for particularly harmful pathogenic organisms. Phytophthora plurivora, which is not subject to regulations, is a plant pathogen frequently found on a broad range of host species, both in natural and artificial environments. It is supposed to be native to Europe while resident populations are also present in the US. We characterized a hierarchical sample of isolates from Europe and the US and conducted coalescent-, migration, and population genetic analysis of sequence and microsatellite data, to determine the pathways of spread and the demographic history of this pathogen. We found P. plurivora populations to be moderately diverse but not geographically structured. High levels of gene flow were observed within Europe and unidirectional from Europe to the US. Coalescent analyses revealed a signal of a recent expansion of the global P. plurivora population. Our study shows that P. plurivora has most likely been spread around the world by nursery trade of diseased plant material. In particular, P. plurivora was introduced into the US from Europe. International trade has allowed the pathogen to colonize new environments and/or hosts, resulting in population growth.	[Schoebel, Corine N.; Rigling, Daniel; Prospero, Simone] Swiss Fed Inst Forest Snow & Landscape Res WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Switzerland; [Stewart, Jane; Gruenwald, Niklaus J.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR USA; [Stewart, Jane; Gruenwald, Niklaus J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; United States Department of Agriculture (USDA); Oregon State University	Schoebel, CN (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Switzerland.	corine.schoebel@wsl.ch	Grunwald, Niklaus` J/K-6041-2013; Schoebel, Corine/D-2801-2013; Prospero, Simone/B-7942-2018	Grunwald, Niklaus` J/0000-0003-1656-7602; Schoebel, Corine/0000-0001-9254-140X; Prospero, Simone/0000-0002-9129-8556; Rigling, Daniel/0000-0002-4338-5364	COST Switzerland [SER C10.0129]; Swiss National Science Foundation	COST Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by COST Switzerland (project SER C10.0129) and supported by an international short visit grant of the Swiss National Science Foundation to CNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aguayo J, 2013, PHYTOPATHOLOGY, V103, P190, DOI 10.1094/PHYTO-05-12-0116-R; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; [Anonymous], POPPR R PACKAGE GENE; [Anonymous], 1997, TFPGA TOOLS POPULATI; [Anonymous], 2004, GENETIX 4 05 LOGICIE; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Balci Y, 2007, PLANT DIS, V91, P705, DOI 10.1094/PDIS-91-6-0705; Banke S, 2005, MOL ECOL, V14, P1881, DOI 10.1111/j.1365-294X.2005.02536.x; Bhat RG, 2007, PLANT DIS, V91, P1556, DOI 10.1094/PDIS-91-12-1556; Bilgin R, 2007, MOL ECOL NOTES, V7, P416, DOI 10.1111/j.1471-8286.2006.01671.x; Billiard S, 2011, BIOL REV, V86, P421, DOI 10.1111/j.1469-185X.2010.00153.x; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Brelsfoard CL, 2012, PARASITE VECTOR, P5; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coetzee MPA, 2001, MOL ECOL, V10, P387, DOI 10.1046/j.1365-294x.2001.01187.x; Cornuet JM, 1996, GENETICS, V144, P2001; Dean MD, 2004, MOL PHYLOGENET EVOL, V32, P998, DOI 10.1016/j.ympev.2004.03.013; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Dorrance A., 2009, OOMYCETES GENETICS G; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubey S, 2011, ECOL EVOL, V1, P218, DOI 10.1002/ece3.25; Dutech C, 2012, MOL ECOL, V21, P3931, DOI 10.1111/j.1365-294X.2012.05575.x; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; FORSTER H, 1994, MOL PLANT MICROBE IN, V7, P780, DOI 10.1094/MPMI-7-0780; FRANCIS DM, 1993, CURR GENET, V24, P100, DOI 10.1007/BF00324672; Gijzen M., 2008, OOMYCETE GENETICS GE, P303, DOI [10.1002/9780470475898.ch15, DOI 10.1002/9780470475898.CH15]; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Gomez-Alpizar L, 2007, PNAS, V104, P462; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Goss EM, 2011, PHYTOPATHOLOGY, V101, P166, DOI 10.1094/PHYTO-05-10-0133; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Hey J, 1997, GENETICS, V145, P833; Hoerner GR, 1940, J AGRIC RES, V61, P0331; HUDSON RR, 1985, GENETICS, V111, P147; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Igic B, 2013, NEW PHYTOL, V198, P386, DOI 10.1111/nph.12182; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Jung T, 2009, PERSOONIA, V22, P95, DOI 10.3767/003158509X442612; Jung T, 2009, FOREST PATHOL, V39, P73, DOI 10.1111/j.1439-0329.2008.00566.x; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; King JP, 2000, MOL BIOL EVOL, V17, P1859, DOI 10.1093/oxfordjournals.molbev.a026287; Lawson R. H., 1996, Acta Horticulturae, P226; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Lilja A, 2011, AGR FOOD SCI, V20, P74, DOI 10.2137/145960611795163051; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; McKinney LV, 2012, FOREST PATHOL, V42, P69, DOI 10.1111/j.1439-0329.2011.00725.x; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Moralejo E, 2009, PLANT PATHOL, V58, P100, DOI 10.1111/j.1365-3059.2008.01930.x; Muscarella RA, 2011, PLOS ONE, V6; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; OU SH, 1980, ANNU REV PHYTOPATHOL, V18, P167, DOI 10.1146/annurev.py.18.090180.001123; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Pritchard JK, 2000, GENETICS, V155, P945; Prospero S, 2013, PLANT PATHOL, V62, P1063, DOI 10.1111/ppa.12027; Prospero S, 2013, INFECTIOUS FOREST DISEASES, P318, DOI 10.1079/9781780640402.0318; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Reich DE, 1999, MOL BIOL EVOL, V16, P453, DOI 10.1093/oxfordjournals.molbev.a026127; Salinari F, 2006, GLOBAL CHANGE BIOL, V12, P1299, DOI 10.1111/j.1365-2486.2006.01175.x; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schoebel CN, 2013, J EVOLUTION BIOL, V26, P600, DOI 10.1111/jeb.12077; Schoebel CN, 2013, PHYTOPATHOLOGY, V103, P1020, DOI 10.1094/PHYTO-01-13-0026-R; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Warfield CY, 2008, PLANT DIS, V92, P474, DOI 10.1094/PDIS-92-3-0474; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilson GA, 2003, GENETICS, V163, P1177	87	44	45	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85368	10.1371/journal.pone.0085368	http://dx.doi.org/10.1371/journal.pone.0085368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427303	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000329868200044
J	Wang, Z; Ko, JH; Challis, JH; Newell, KM				Wang, Zheng; Ko, Ji Hyun; Challis, John H.; Newell, Karl M.			The Degrees of Freedom Problem in Human Standing Posture: Collective and Component Dynamics	PLOS ONE			English	Article							QUIET; SYNERGIES; STANCE	The experiment was setup to investigate the coordination and control of the degrees of freedom (DFs) of human standing posture with particular reference to the identification of the collective and component variables. Subjects stood in 3 postural tasks: feet side by side, single left foot quiet stance and single left foot stance with body rocking at the ankle joint in the sagittal plane. All three postural tasks showed very high coherence (similar to 1) of center of pressure (COP) - center of mass (COM) in the low frequency range. The ankle and hip coherence was mid range (similar to.5) with the tasks having different ankle/hip compensatory cophase patterns. The findings support the view that the in-phase relation of the low frequency components of the COP-COM dynamic is the collective variable in the postural tasks investigated. The motions of the individual joints (ankle, knee, hip, neck) and couplings of pair wise joint synergies (e. g., ankle-hip) provide a supporting cooperative role to the preservation of the collective variable in maintaining the COM within the stability region of the base of support (BOS) and minimizing the amount of body motion consistent with the task constraint.	[Wang, Zheng; Ko, Ji Hyun; Challis, John H.; Newell, Karl M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Wang, Zheng] Univ Texas SW Med Ctr Dallas, Dept Psychiat & Pediat, Dallas, TX 75390 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, Z (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	Zheng.Wang@utsouthwestern.edu	Wang, Zheng/F-9345-2015; Wang, Zheng/F-8001-2017	Wang, Zheng/0000-0003-2265-0891; Wang, Zheng/0000-0003-2265-0891	 [NSF 0848339]		The study was supported by Grant NSF 0848339 (KMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 1998, EXP BRAIN RES, V118, P210, DOI 10.1007/s002210050274; Aramaki Y, 2001, EXP BRAIN RES, V136, P463, DOI 10.1007/s002210000603; Babinski F, 1899, REV NEUROLOGIQUE, V7, P806; Bardy BG, 1999, J EXP PSYCHOL HUMAN, V25, P1284, DOI 10.1037/0096-1523.25.5.1284; Batschelet E, 1981, CIRCULAR STAT BIOL; BEEK PJ, 1992, J MOTOR BEHAV, V24, P85, DOI 10.1080/00222895.1992.9941604; Benaim C, 1999, STROKE, V30, P1862, DOI 10.1161/01.STR.30.9.1862; Bernstein N, 1967, COORDINATION REGULAT; Bernstein N.A., 1996, RES ECOL PS; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Corriveau H, 2004, ARCH GERONTOL GERIAT, V39, P163, DOI 10.1016/j.archger.2004.03.001; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Dempster W.T., 1955, 55159 WADC, P55; Dubousset J, 1992, [No title captured], Patent No. [US Patent No 5147360 A, 5147360]; GREGORIC M, 1981, ACTA ORTHOP SCAND, V52, P59, DOI 10.3109/17453678108991759; GURFINKEL VS, 1995, NEUROSCIENCE, V68, P229, DOI 10.1016/0306-4522(95)00136-7; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Ihlen EAF, 2013, J BIOMECH, V46, P484, DOI 10.1016/j.jbiomech.2012.10.016; James EG, 2014, GAIT POSTURE, V39, P194, DOI 10.1016/j.gaitpost.2013.07.005; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Kelso S., 1995, DYNAMIC PATTERNS SEL; King DL, 1997, GAIT POSTURE, V6, P27, DOI 10.1016/S0966-6362(96)01101-0; Kuznetsov NA, 2012, J MOTOR BEHAV, V44, P241, DOI 10.1080/00222895.2012.688894; Minshew NJ, 2004, NEUROLOGY, V63, P2056, DOI 10.1212/01.WNL.0000145771.98657.62; Mitra S, 1998, HUM MOVEMENT SCI, V17, P17, DOI 10.1016/S0167-9457(97)00023-7; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; Otten E, 1999, PHILOS T ROY SOC B, V354, P869, DOI 10.1098/rstb.1999.0439; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; THELEN E, 1991, MONOGR SOC RES CHILD, V56, pR1, DOI 10.2307/1166099; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28	37	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85414	10.1371/journal.pone.0085414	http://dx.doi.org/10.1371/journal.pone.0085414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427307	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200048
J	Chen, X; Yang, Y; Zhou, Q; Weiss, JM; Howard, OZ; McPherson, JM; Wakefield, LM; Oppenheim, JJ				Chen, Xin; Yang, Yuan; Zhou, Qiong; Weiss, Jonathan M.; Howard, OlaMae Zack; McPherson, John M.; Wakefield, Lalage M.; Oppenheim, Joost J.			Effective Chemoimmunotherapy with Anti-TGF beta Antibody and Cyclophosphamide in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; SUPPRESSOR-CELLS; IMMUNITY; IMMUNOSUPPRESSION; METASTASIS; EXPRESSION; INDUCTION; CARCINOMA	TGF beta is reportedly responsible for accumulation of CD4(+)Foxp3(+) regulatory T cells (Tregs) in tumor. Thus, we treated mouse 4T1 mammary carcinoma with 1D11, a neutralizing anti-TGF beta (1,2,3) antibody. The treatment delayed tumor growth, but unexpectedly increased the proportion of Tregs in tumor. In vitro, 1D11 enhanced while TGF beta potently inhibited the proliferation of Tregs. To enhance the anti-tumor effects, 1D11 was administered with cyclophosphamide which was reported to eliminate intratumoral Tregs. This combination resulted in long term tumor-free survival of up to 80% of mice, and the tumor-free mice were more resistant to re-challenge with tumor. To examine the phenotype of tumor infiltrating immune cells, 4T1-tumor bearing mice were treated with 1D11 and a lower dose of cyclophosphamide. This treatment markedly inhibited tumor growth, and was accompanied by massive infiltration of IFN gamma-producing T cells. Furthermore, this combination markedly decreased the number of splenic CD11b(+)Gr1(+) cells, and increased their expression levels of MHC II and CD80. In a spontaneous 4T1 lung metastasis model with resection of primary tumor, this combination therapy markedly increased the survival of mice, indicating it was effective in reducing lethal metastasis burden. Taken together, our data show that anti-TGF beta antibody and cyclophosphamide represents an effective chemoimmunotherapeutic combination.	[Chen, Xin] Leidos Biomed Res Inc, Frederick Natl Lab, Basic Sci Program, Frederick, MD 21702 USA; [Yang, Yuan; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Frederick, MD 21701 USA; [Chen, Xin; Zhou, Qiong; Howard, OlaMae Zack; Oppenheim, Joost J.] NCI, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Weiss, Jonathan M.] NCI, Expt Immunol Lab, Ctr Canc Res, Frederick, MD 21701 USA; [McPherson, John M.] Genzyme Corp, Framingham, MA 01701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanofi-Aventis; Genzyme Corporation	Chen, X (corresponding author), Leidos Biomed Res Inc, Frederick Natl Lab, Basic Sci Program, Frederick, MD 21702 USA.	chenxin@mail.nih.gov; oppenhej@mail.nih.gov	Chen, Xin n/a/I-6601-2015; Wakefield, Lalage M/M-1963-2017	Chen, Xin n/a/0000-0002-2628-4027; Wakefield, Lalage M/0000-0003-4124-5250	National Cancer Institute, National Institutes of Health [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010881] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This Research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo I, 2000, BLOOD, V95, P212; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chopra M, 2013, CARCINOGENESIS, V34, P1296, DOI 10.1093/carcin/bgt038; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; Fulton Amy, 2006, Breast Dis, V26, P115; Ge YZ, 2012, CANCER IMMUNOL IMMUN, V61, P353, DOI 10.1007/s00262-011-1106-3; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Horwitz DA, 2013, CLIN IMMUNOL, V149, P450, DOI 10.1016/j.clim.2013.08.007; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; Li Zhaoyang, 2012, Int J Cancer, V131, P2584, DOI 10.1002/ijc.27572; Liu JQ, 2012, P NATL ACAD SCI USA, V109, P16618, DOI 10.1073/pnas.1117610109; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Mikyskova R, 2012, J IMMUNOTHER, V35, P374, DOI 10.1097/CJI.0b013e318255585a; Moschella F, 2011, CANCER RES, V71, P3528, DOI 10.1158/0008-5472.CAN-10-4523; Nagorsen D, 2003, CLIN CANCER RES, V9, P4296; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Ostrand-Rosenberg S, 2012, CANCER IMMUNOL IMMUN, V61, P1319, DOI 10.1007/s00262-012-1269-6; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Radojcic V, 2010, CANCER IMMUNOL IMMUN, V59, P137, DOI 10.1007/s00262-009-0734-3; Rentzsch C, 2003, CLIN CANCER RES, V9, P4376; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Salem ML, 2007, J IMMUNOTHER, V30, P40, DOI 10.1097/01.cji.0000211311.28739.e3; Sistigu A, 2011, SEMIN IMMUNOPATHOL, V33, P369, DOI 10.1007/s00281-011-0245-0; van der Most RG, 2009, CANCER IMMUNOL IMMUN, V58, P1219, DOI 10.1007/s00262-008-0628-9; Wada S, 2009, CANCER RES, V69, P4309, DOI 10.1158/0008-5472.CAN-08-4102; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yang L, 2008, CANCER RES, V68, P9107, DOI 10.1158/0008-5472.CAN-08-2556; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	41	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85398	10.1371/journal.pone.0085398	http://dx.doi.org/10.1371/journal.pone.0085398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416401	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300075
J	Rouhigharabaei, L; Ferreiro, JF; Tousseyn, T; van der Krogt, JA; Put, N; Haralambieva, E; Graux, C; Maes, B; Vicente, C; Vandenberghe, P; Cools, J; Wlodarska, I				Rouhigharabaei, Leila; Ferreiro, Julio Finalet; Tousseyn, Thomas; van der Krogt, Jo-Anne; Put, Natalie; Haralambieva, Eugenia; Graux, Carlos; Maes, Brigitte; Vicente, Carmen; Vandenberghe, Peter; Cools, Jan; Wlodarska, Iwona			Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1	PLOS ONE			English	Article							LYMPHOID-TISSUE LYMPHOMAS; ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR FOXP1; CARDIOMYOCYTE PROLIFERATION; CHROMOSOMAL-ABERRATION; PROSTATE-CANCER; DOWN-REGULATION; POOR-PROGNOSIS; MALT LYMPHOMA; GENE	The transcription factor FOXP1 is implicated in the pathogenesis of B-cell lymphomas through chromosomal translocations involving either immunoglobulin heavy chain (IGH) locus or non-IG sequences. The former translocation, t(3; 14)(p13; q32), results in dysregulated expression of FOXP1 juxtaposed with strong regulatory elements of IGH. Thus far, molecular consequences of rare non-IG aberrations of FOXP1 remain undetermined. Here, using molecular cytogenetics and molecular biology studies, we comprehensively analyzed four lymphoma cases with non-IG rearrangements of FOXP1 and compared these with cases harboring t(3; 14)(p13; q32)/IGH-FOXP1 and FOXP1-expressing lymphomas with no apparent structural aberrations of the gene. Our study revealed that non-IG rearrangements of FOXP1 are usually acquired during clinical course of various lymphoma subtypes, including diffuse large B cell lymphoma, marginal zone lymphoma and chronic lymphocytic leukemia, and correlate with a poor prognosis. Importantly, these aberrations constantly target the coding region of FOXP1, promiscuously fusing with coding and non-coding gene sequences at various reciprocal breakpoints (2q36, 10q24 and 3q11). The non-IG rearrangements of FOXP1, however, do not generate functional chimeric genes but commonly disrupt the full-length FOXP1 transcript leading to an aberrant expression of N-truncated FOXP1 isoforms (FOXP1NT), as shown by QRT-PCR and Western blot analysis. In contrast, t(3; 14)(p13; q32)/IGH-FOXP1 affects the 59 untranslated region of FOXP1 and results in overexpress the full-length FOXP1 protein (FOXP1FL). RNA-sequencing of a few lymphoma cases expressing FOXP1NT and FOXP1FL detected neither FOXP1-related fusions nor FOXP1 mutations. Further bioinformatic analysis of RNA-sequencing data retrieved a set of genes, which may comprise direct or non-direct targets of FOXP1NT, potentially implicated in disease progression. In summary, our findings point to a dual mechanism through which FOXP1 is implicated in B-cell lymphomagenesis. We hypothesize that the primary t(3; 14)(p13; q32)/IGH-FOXP1 activates expression of the FOXP1FL protein with potent oncogenic activity, whereas the secondary non-IG rearrangements of FOXP1 promote expression of the FOXP1NT proteins, likely driving progression of disease.	[Rouhigharabaei, Leila; Ferreiro, Julio Finalet; van der Krogt, Jo-Anne; Put, Natalie; Vicente, Carmen; Vandenberghe, Peter; Cools, Jan; Wlodarska, Iwona] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Tousseyn, Thomas] UZ Leuven, Translat Cell & Tissue Res KU Leuven, Dept Pathol, Louvain, Belgium; [Haralambieva, Eugenia] Univ Wurzburg, Dept Pathol, Wurzburg, Germany; [Graux, Carlos] Mont Godinne Univ Hosp, Yvoir, Belgium; [Maes, Brigitte] Virga Jesse Hosp, Hasselt, Belgium; [Vicente, Carmen; Cools, Jan] VIB, Ctr Biol Dis, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; University of Wurzburg; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Flanders Institute for Biotechnology (VIB)	Wlodarska, I (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	iwona.wlodarska@uzleuven.be	Maes, Brigitte/AFP-8088-2022; Vicente, Carmen/AAA-7098-2021	Vicente, Carmen/0000-0002-3363-3459; Cools, Jan/0000-0001-6626-5843; Vandenberghe, Peter/0000-0003-4719-1935; Rouhi, M.D., Ph.D., Leila/0000-0001-7997-5254; Tousseyn, Thomas/0000-0002-0397-1086	K.U.Leuven [3M040406]	K.U.Leuven(KU Leuven)	This study was supported by the concerted action grant from the K.U.Leuven no. 3M040406 (www.Kuleuven.be). PV is a senior clinical investigator of the FWO-Vlaanderen (www.FWO.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Banham AH, 2005, CLIN CANCER RES, V11, P1065; Banham AH, 2001, CANCER RES, V61, P8820; Barrans SL, 2004, BLOOD, V104, P2933, DOI 10.1182/blood-2004-03-1209; Brown PJ, 2008, BLOOD, V111, P2816, DOI 10.1182/blood-2007-09-115113; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Courts C, 2009, J NEUROPATH EXP NEUR, V68, P972, DOI 10.1097/NEN.0b013e3181b31cd6; Coyaud E, 2010, BLOOD, V115, P3089, DOI 10.1182/blood-2009-07-234229; Craig VJ, 2011, BLOOD, V117, P6227, DOI 10.1182/blood-2010-10-312231; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Fenton JAL, 2006, GENE CHROMOSOME CANC, V45, P164, DOI 10.1002/gcc.20278; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Goatly A, 2008, MODERN PATHOL, V21, P902, DOI 10.1038/modpathol.2008.74; Green MR, 2009, LEUKEMIA RES, V33, P1699, DOI 10.1016/j.leukres.2009.05.004; Hall DC, 2008, UROL ONCOL-SEMIN ORI, V26, P652, DOI 10.1016/j.urolonc.2007.07.017; Han SL, 2009, DIGEST SURG, V26, P156, DOI 10.1159/000212058; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Haralambieva E, 2006, LEUKEMIA, V20, P1300, DOI 10.1038/sj.leu.2404244; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Hoeller S, 2010, HISTOPATHOLOGY, V57, P73, DOI 10.1111/j.1365-2559.2010.03600.x; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Ishikawa ET, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2645; Jais JP, 2008, LEUKEMIA, V22, P1917, DOI 10.1038/leu.2008.188; Jiang W, 2012, MED ONCOL, V29, P3352, DOI 10.1007/s12032-012-0288-7; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Mao X, 2013, TUMOUR BIOL IN PRESS; Motegi M, 2000, AM J PATHOL, V156, P807, DOI 10.1016/S0002-9440(10)64948-6; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; NUNEZ G, 1989, P NATL ACAD SCI USA, V86, P4589, DOI 10.1073/pnas.86.12.4589; Pajer P, 2006, CANCER RES, V66, P78, DOI 10.1158/0008-5472.CAN-05-1728; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Sagaert X, 2006, J CLIN ONCOL, V24, P2490, DOI 10.1200/JCO.2006.05.6150; Sagardoy A, 2013, BLOOD, V121, P4311, DOI 10.1182/blood-2012-10-462846; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Streubel B, 2005, LEUKEMIA, V19, P652, DOI 10.1038/sj.leu.2403644; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang YZ, 2010, CELL CYCLE, V9, P4251, DOI 10.4161/cc.9.21.13924; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Wong KK, 2013, LEUKEMIA IN PRESS; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Zhai LZ, 2011, TUMOR BIOL, V32, P913, DOI 10.1007/s13277-011-0192-3; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210	59	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85851	10.1371/journal.pone.0085851	http://dx.doi.org/10.1371/journal.pone.0085851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416450	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300102
J	Stormer, C; Lummaa, V				Stoermer, Charlotte; Lummaa, Virpi			Increased Mortality Exposure within the Family Rather than Individual Mortality Experiences Triggers Faster Life-History Strategies in Historic Human Populations	PLOS ONE			English	Article							FATHER ABSENCE; REPRODUCTIVE STRATEGY; NATURAL-SELECTION; SEX-DIFFERENCES; PREDICTS AGE; EARLY STRESS; DYING YOUNG; LIVING FAST; RISK; LONGEVITY	Life History Theory predicts that extrinsic mortality risk is one of the most important factors shaping (human) life histories. Evidence from contemporary populations suggests that individuals confronted with high mortality environments show characteristic traits of fast life-history strategies: they marry and reproduce earlier, have shorter birth intervals and invest less in their offspring. However, little is known of the impact of mortality experiences on the speed of life histories in historical human populations with generally higher mortality risk, and on male life histories in particular. Furthermore, it remains unknown whether individual-level mortality experiences within the family have a greater effect on life-history decisions or family membership explains life-history variation. In a comparative approach using event history analyses, we study the impact of family versus individual-level effects of mortality exposure on two central life-history parameters, ages at first marriage and first birth, in three historical human populations (Germany, Finland, Canada). Mortality experience is measured as the confrontation with sibling deaths within the natal family up to an individual's age of 15. Results show that the speed of life histories is not adjusted according to individual-level mortality experiences but is due to family-level effects. The general finding of lower ages at marriage/reproduction after exposure to higher mortality in the family holds for both females and males. This study provides evidence for the importance of the family environment for reproductive timing while individual-level mortality experiences seem to play only a minor role in reproductive life history decisions in humans.	[Stoermer, Charlotte] Univ Giessen, Inst Philosophie, D-35390 Giessen, Germany; [Lummaa, Virpi] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Lummaa, Virpi] Wissensch Kolleg Berlin, Berlin, Germany	Justus Liebig University Giessen; University of Sheffield	Stormer, C (corresponding author), Univ Giessen, Inst Philosophie, D-35390 Giessen, Germany.	Charlotte.Stoermer@phil.uni-giessen.de	Lummaa, Virpi/AHB-0181-2022		VolkswagenStiftung; Royal Society of London; European Research Council	VolkswagenStiftung(Volkswagen); Royal Society of London(Royal Society of London); European Research Council(European Research Council (ERC)European Commission)	Funding from VolkswagenStiftung (http://www.volkswagenstiftung.de/); The Royal Society of London (http://royalsociety.org/grants/); European Research Council (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KG, 2010, HUM NATURE-INT BIOS, V21, P103, DOI 10.1007/s12110-010-9087-z; Beise J, 2001, VERHALTENSOKOLOGIE M; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Belsky J, 2010, DEV PSYCHOL, V46, P120, DOI 10.1037/a0015549; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Blossfeld H.-P., 2002, TECHNIQUES EVENT HIS; Bogaert AF, 2005, J ADOLESCENCE, V28, P541, DOI 10.1016/j.adolescence.2004.10.008; Bolund E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2002; BROCKERHOFF M, 1990, DEMOGRAPHY, V27, P601, DOI 10.2307/2061573; Charbonneau H., 2000, POPULATION HIST N AM, P99; Chisholm JS, 1999, HUM NATURE-INT BIOS, V10, P51, DOI 10.1007/s12110-999-1001-1; Chisholm JS, 2005, HUM NATURE-INT BIOS, V16, P233, DOI 10.1007/s12110-005-1009-0; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Coall DA, 2010, AM J HUM BIOL, V22, P143, DOI 10.1002/ajhb.20965; COX DR, 1972, J R STAT SOC B, V34, P187; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; Ellis BJ, 2009, HUM NATURE-INT BIOS, V20, P204, DOI 10.1007/s12110-009-9063-7; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Flinn MV, 2006, DEV REV, V26, P138, DOI 10.1016/j.dr.2006.02.003; Gagnon A, 2012, AM J HUM BIOL, V24, P654, DOI 10.1002/ajhb.22287; Gillespie DOS, 2008, P ROY SOC B-BIOL SCI, V275, P713, DOI 10.1098/rspb.2007.1000; Gillespie DOS, 2010, AM NAT, V176, P159, DOI 10.1086/653668; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Hayward Adam D., 2013, Evolution Medicine and Public Health, P106, DOI 10.1093/emph/eot007; Hayward AD, 2013, P NATL ACAD SCI USA, V110, P13886, DOI 10.1073/pnas.1301817110; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Lahdenpera M, 2011, J EVOLUTION BIOL, V24, P1053, DOI 10.1111/j.1420-9101.2011.02237.x; Mace R., 2005, GRANDMOTHERHOOD EVOL, P143; Mills M., 2011, INTRO SURVIVAL EVENT; Milot E, 2011, P NATL ACAD SCI USA, V108, P17040, DOI 10.1073/pnas.1104210108; Nettle D, 2011, P ROY SOC B-BIOL SCI, V278, P1721, DOI 10.1098/rspb.2010.1726; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; O'Quigley J, 2002, STAT MED, V21, P3219, DOI 10.1002/sim.1259; Olderbak SG, 2010, PERS INDIV DIFFER, V49, P234, DOI 10.1016/j.paid.2010.03.041; Omariba DWR, 2010, POPUL RES POLICY REV, V29, P275, DOI 10.1007/s11113-009-9140-y; Oyen N, 2009, EPIDEMIOLOGY, V20, P757, DOI 10.1097/EDE.0b013e3181ad5444; Pettay JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000606; Placek CD, 2012, P ROY SOC B-BIOL SCI, V279, P4003, DOI 10.1098/rspb.2012.1022; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Quinlan RJ, 2007, AM ANTHROPOL, V109, P164, DOI 10.1525/AA.2007.109.1.164; Quinlan RJ, 2006, AM ANTHROPOL, V108, P464, DOI 10.1525/aa.2006.108.3.464; Quinlan RJ, 2010, HUM NATURE-INT BIOS, V21, P124, DOI 10.1007/s12110-010-9085-1; Rickard IJ, 2010, ECOLOGY, V91, P3515, DOI 10.1890/10-0019.1; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sheppard P, 2012, BIOL LETTERS, V8, P237, DOI 10.1098/rsbl.2011.0747; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Stormer C, 2011, AM J HUM BIOL, V23, P201, DOI 10.1002/ajhb.21103; Vandezande M, 2010, EXPLAINING DEATH CLU, P1846; Voland E, 2000, EVOL ANTHROPOL, V9, P134; VOLAND E, 1995, HUMAN REPRODUCTIVE DECISIONS, P137; VOLAND E, 1995, HUM NATURE-INT BIOS, V6, P33, DOI 10.1007/BF02734134; Walker R, 2006, AM J HUM BIOL, V18, P295, DOI 10.1002/ajhb.20510; Wang XT, 2009, EVOL HUM BEHAV, V30, P77, DOI 10.1016/j.evolhumbehav.2008.09.006; Willfuhr KP, 2012, BIODEMOGR SOC BIOL, V58, P149, DOI 10.1080/19485565.2012.734745; Willfuhr KP, 2009, AM J HUM BIOL, V21, P488, DOI 10.1002/ajhb.20909; Willfuhr KP, 1670, BIODEMOGRAPHY SOCIAL; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Wilson M, 1996, POPUL ENVIRON, V18, P143, DOI 10.1007/BF02208408; Woods R, 2003, POPUL DEV REV, V29, P29, DOI 10.1111/j.1728-4457.2003.00029.x	62	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83633	10.1371/journal.pone.0083633	http://dx.doi.org/10.1371/journal.pone.0083633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421897	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000329862500061
J	Pozzi, L; Dorocic, IP; Wang, XM; Carlen, M; Meletis, K				Pozzi, Laura; Dorocic, Iskra Pollak; Wang, Xinming; Carlen, Marie; Meletis, Konstantinos			Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; FAST-SPIKING INTERNEURONS; MILD STRESS MODEL; PREFRONTAL CORTEX; GLUTAMATERGIC SYSTEM; ANIMAL-MODEL; KETAMINE; BLOCKADE; THERAPEUTICS; OSCILLATIONS	The underlying circuit imbalance in major depression remains unknown and current therapies remain inadequate for a large group of patients. Discovery of the rapid antidepressant effects of ketamine - an NMDA receptor (NMDAR) antagonist - has linked the glutamatergic system to depression. Interestingly, dysfunction in the inhibitory GABAergic system has also been proposed to underlie depression and deficits linked to GABAergic neurons have been found with human imaging and in post-mortem material from depressed patients. Parvalbumin-expressing (PV) GABAergic interneurons regulate local circuit function through perisomatic inhibition and their activity is NMDAR-dependent, providing a possible link between NMDAR and the inhibitory system in the antidepressant effect of ketamine. We have therefore investigated the role of the NMDAR-dependent activity of PV interneurons for the development of depression-like behavior as well as for the response to rapid antidepressant effects of NMDAR antagonists. We used mutant mice lacking NMDA neurotransmission specifically in PV neurons (PV-Cre+/NR1f/f) and analyzed depression-like behavior and anhedonia. To study the acute and sustained effects of a single NMDAR antagonist administration, we established a behavioral paradigm of repeated exposure to forced swimming test (FST). We did not observe altered behavioral responses in the repeated FST or in a sucrose preference test in mutant mice. In addition, the behavioral response to administration of NMDAR antagonists was not significantly altered in mutant PV-Cre+/NR1f/f mice. Our results show that NMDA-dependent neurotransmission in PV neurons is not necessary to regulate depression-like behaviors, and in addition that NMDARs on PV neurons are not a direct target for the NMDAR-induced antidepressant effects of ketamine and MK801.	[Pozzi, Laura; Dorocic, Iskra Pollak; Wang, Xinming; Carlen, Marie; Meletis, Konstantinos] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	Meletis, K (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	dinos.meletis@ki.se	Carlen, Marie Carlen/C-9112-2014; Pozzi, Laura/F-8687-2011; Meletis, Konstantinos/ABE-6777-2020	Carlen, Marie Carlen/0000-0003-1658-1631; Pozzi, Laura/0000-0001-7662-2904; Meletis, Konstantinos/0000-0001-5665-4781	Swedish Research Council (VR Medicin); Swedish Brain Foundation (Hjarnfonden); Marie Curie Reintegration grant; Strategic Neuroscience programme at Karolinska Institutet; NARSAD Young Investigator Awards; Ake Wiberg Stiftelse; O.E. och Edla Johanssons Stiftelse	Swedish Research Council (VR Medicin)(Swedish Research Council); Swedish Brain Foundation (Hjarnfonden); Marie Curie Reintegration grant(European Commission); Strategic Neuroscience programme at Karolinska Institutet; NARSAD Young Investigator Awards(NARSAD); Ake Wiberg Stiftelse; O.E. och Edla Johanssons Stiftelse	This study was supported by grants from the Swedish Research Council (VR Medicin), the Swedish Brain Foundation (Hjarnfonden), a Marie Curie Reintegration grant (KM), the Strategic Neuroscience programme at Karolinska Institutet, NARSAD Young Investigator Awards (to MC and KM), Ake Wiberg Stiftelse, and O.E. och Edla Johanssons Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Gabbay V, 2012, ARCH GEN PSYCHIAT, V69, P139, DOI 10.1001/archgenpsychiatry.2011.131; Goforth HW, 2007, J ECT, V23, P23, DOI 10.1097/01.yct.0000263257.44539.23; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Kugaya A, 2005, CNS SPECTRUMS, V10, P808, DOI 10.1017/S1092852900010403; LAYER RT, 1995, PHARMACOL BIOCHEM BE, V52, P621, DOI 10.1016/0091-3057(95)00155-P; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Ma XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056053; Machado-Vieira R, 2009, CURR PHARM DESIGN, V15, P1595, DOI 10.2174/138161209788168010; Marona-Lewicka, 1997, Stress, V2, P91; Mathews DC, 2012, DRUGS, V72, P1313, DOI 10.2165/11633130-000000000-00000; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Mohler H, 2011, NEUROPHARMACOLOGY, V60, P1042, DOI 10.1016/j.neuropharm.2010.10.020; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Murrough JW, 2013, BIOL PSYCHIAT, V74, P250, DOI 10.1016/j.biopsych.2012.06.022; MUSCAT R, 1992, BIOL PSYCHIAT, V31, P937, DOI 10.1016/0006-3223(92)90119-K; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nowak K, 2012, ACTA NEUROBIOL EXP, V72, P207; PAPP M, 1994, EUR J PHARMACOL, V263, P1, DOI 10.1016/0014-2999(94)90516-9; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Quirk MC, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.013.2009; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sanacora G, 2002, AM J PSYCHIAT, V159, P663, DOI 10.1176/appi.ajp.159.4.663; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sibille E, 2011, INT J NEUROPSYCHOPH, V14, P721, DOI 10.1017/S1461145710001616; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vardigan JD, 2010, PHARMACOL BIOCHEM BE, V95, P223, DOI 10.1016/j.pbb.2010.01.010; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhou ZQ, 2012, MED HYPOTHESES, V79, P85, DOI 10.1016/j.mehy.2012.04.007	49	46	48	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e83879	10.1371/journal.pone.0083879	http://dx.doi.org/10.1371/journal.pone.0083879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454710	Green Submitted, Green Published, gold			2022-12-27	WOS:000330236000004
J	Ge, SW; Hertel, B; Susnik, N; Rong, S; Dittrich, AM; Schmitt, R; Haller, H; von Vietinghoff, S				Ge, Shuwang; Hertel, Barbara; Susnik, Nathan; Rong, Song; Dittrich, Anna M.; Schmitt, Roland; Haller, Hermann; von Vietinghoff, Sibylle			Interleukin 17 Receptor A Modulates Monocyte Subsets and Macrophage Generation In Vivo	PLOS ONE			English	Article							DENDRITIC CELLS; BONE-MARROW; T-CELLS; CHRONIC INFLAMMATION; INFECTION; FIBROSIS; ACCUMULATION; SUPPRESSES; PATHOGENS; ANTIBODY	Interleukin (IL)-17A signaling via Interleukin 17 receptor A (Il17ra) contributes to the inflammatory host response by inducing recruitment of innate immune cells, but also plays a role in homeostatic neutrophilic granulocyte regulation. Monocytes, the other main innate immune cell, have a longer life span and can pursue multiple differentiation pathways towards tissue macrophages. Monocytes are divided into two subpopulations by expression of the Ly6C/Gr1 surface marker in mice. We here investigated the role of Il17ra in monocyte homeostasis and macrophage generation. In Il17ra(-/-) and in mixed bone marrow chimeric wt/Il17ra(-/-) mice, the concentrations of circulating Il17ra(-/-) Gr1(low) monocytes were significantly decreased compared to wt cells. Pulmonary, splenic and resident peritoneal Il17ra(-/-) macrophages were significantly fewer than of wt origin. Bone marrow progenitor and monocyte numbers were equal, but the proportion of Il17ra(-/-) Gr1(low) monocytes was already decreased at bone marrow level. After monocyte depletion, initial Gr1(high) and Gr1(low) monocyte regeneration of Il17ra(-/-) and wt cells was very similar. However, Il17ra(-/-) Gr1(low) counts were not sustained. After labeling with either fluorescent beads or BrdU, Il17ra(-/-) Gr1(high) monocyte transition to Gr1(low) cells was not detectable unlike wt cells. Monocyte recruitment in acute peritonitis, which is known to be largely due to Gr1(high) cell migration, was unaffected in an identical environment. Unilateral ureteral obstruction induces a less acute inflammatory and fibrotic kidney injury. Compared to wt cells in the same environment, Il17ra(-/-) macrophage accumulation in the kidney was decreased. In the absence of Il17ra on all myeloid cells, renal fibrosis was significantly attenuated. Our data show that Il17ra modulates Gr1(low) monocyte counts and suggest defective Gr1(high) to Gr1(low) monocyte transition as an underlying mechanism. Lack of Il17ra altered homeostatic tissue macrophage formation and diminished renal inflammation and fibrosis. Il17ra appears to be a novel modulator of monocyte phenotype and possible therapeutic target in renal fibrosis.	[Ge, Shuwang; Hertel, Barbara; Susnik, Nathan; Rong, Song; Schmitt, Roland; Haller, Hermann; von Vietinghoff, Sibylle] Hannover Med Sch, Dept Med, Hannover, Germany; [Dittrich, Anna M.] Hannover Med Sch, Dept Pediat, Hannover, Germany; [Ge, Shuwang] Huazhong Univ, Tongji Hosp, Dept Nephrol, Wuhan, Peoples R China	Hannover Medical School; Hannover Medical School; Huazhong University of Science & Technology	von Vietinghoff, S (corresponding author), Hannover Med Sch, Dept Med, Hannover, Germany.	vonVietinghoff.Sibylle@mh-hannover.de	Dittrich, Anna Maria/M-5640-2013; Dittrich, Anna/GRY-6738-2022; Schmitt, Roland/AAP-4609-2021	/0000-0001-9985-1515; Schmitt, Roland/0000-0003-4415-8355	National Science Foundation of China [81200531]; Deutsche Forschungsgemeinschaft [VI 508/4-1]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Shuwang Ge was supported by National Science Foundation of China (No. 81200531) and Sibylle von Vietinghoff by Deutsche Forschungsgemeinschaft (www.dfg.de) Grant VI 508/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barin JG, 2011, EUR J IMMUNOL; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Le Meur Y, 2002, J LEUKOCYTE BIOL, V72, P530; Lim AKH, 2009, DIABETOLOGIA, V52, P1669, DOI 10.1007/s00125-009-1399-3; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Menke J, 2009, J AM SOC NEPHROL, V20, P2581, DOI 10.1681/ASN.2009050499; Miah SMS, 2011, J IMMUNOL, V186, P2959, DOI 10.4049/jimmunol.1000112; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Peng YF, 2009, J IMMUNOL, V182, P2777, DOI 10.4049/jimmunol.0803172; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sorensen I, 2011, KIDNEY INT, V80, P1035, DOI 10.1038/ki.2011.214; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; von Vietinghoff S, 2011, J AM COLL CARDIOL, V57, P2194, DOI 10.1016/j.jacc.2010.12.030; von Vietinghoff S, 2010, KIDNEY INT, V78, P79, DOI 10.1038/ki.2010.84; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	39	71	71	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85461	10.1371/journal.pone.0085461	http://dx.doi.org/10.1371/journal.pone.0085461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454873	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100090
J	Gunnerbeck, A; Bonamy, AKE; Wikstrom, AK; Granath, F; Wickstrom, R; Cnattingius, S				Gunnerbeck, Anna; Bonamy, Anna-Karin Edstedt; Wikstrom, Anna-Karin; Granath, Fredrik; Wickstrom, Ronny; Cnattingius, Sven			Maternal Snuff Use and Smoking and the Risk of Oral Cleft Malformations - A Population-Based Cohort Study	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; ALPHA-GENE VARIANTS; CIGARETTE-SMOKING; OROFACIAL CLEFTS; BIRTH-DEFECTS; N-NITROSAMINES; MOIST SNUFF; PREGNANCY; NICOTINE; EXPOSURE	Objective: To determine if maternal use of snuff (containing high levels of nicotine, low levels of nitrosamines and no combustion products) is associated with an increased risk of oral cleft malformations in the infant and whether cessation of snuff use or smoking before the antenatal booking influences the risk. Method: A population-based cohort study was conducted on all live born infants, recorded in the Swedish Medical Birth Register from 1999 through 2009 (n = 1 086 213). Risks of oral clefts were evaluated by multivariate logistic regression analyses (using adjusted odds ratios, with 95% confidence intervals [CI]). Results: Among 975 866 infants that had information on maternal tobacco use, 1761 cases of oral clefts were diagnosed. More than 50% of the mothers who used snuff or smoked three months prior pregnancy stopped using before the antenatal booking. Almost 8% of the mothers were smoking at the antenatal booking and 1,1% of the mothers used snuff. Compared with infants of non-tobacco users, the adjusted odds ratios (95% CI) of any oral cleft for infants of mothers who continued to use snuff or to smoke were 1.48 [1.00-2.21] and 1.19 [1.01-1.41], respectively. In contrast, in infants of mothers who stopped using snuff or stopped smoking before the antenatal booking, the corresponding risks were not increased (adjusted odds ratios [95% CI] were 0.71 [0.44-1.14] and 0.88 [0.73-1.05], respectively). Conclusion: Maternal snuff use or smoking in early pregnancy is associated with an increased risk of oral clefts. Infants of mothers who stopped using snuff or stopped smoking before the antenatal booking had no increased risk of oral cleft malformations. Oral snuff or other sources of nicotine should not be recommended as an alternative for smoke-cessation during pregnancy.	[Gunnerbeck, Anna; Bonamy, Anna-Karin Edstedt; Wickstrom, Ronny] Karolinska Univ, Hosp Solna, Dept Womens & Childrens Hlth, Karolinska Inst,Neonatal Res Unit, Stockholm, Sweden; [Bonamy, Anna-Karin Edstedt; Wikstrom, Anna-Karin; Granath, Fredrik; Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University	Gunnerbeck, A (corresponding author), Karolinska Univ, Hosp Solna, Dept Womens & Childrens Hlth, Karolinska Inst,Neonatal Res Unit, Stockholm, Sweden.	anna.gunnerbeck@ki.se	Gunnerbeck, Anna/AGR-8400-2022; Bonamy, Anna-Karin E/B-7106-2012	Gunnerbeck, Anna/0000-0003-1808-1091; Bonamy, Anna-Karin E/0000-0003-4552-9912	Swedish Council for Working Life and Social Research [2009-1619, 2010-0643]; Karolinska Institutet; Stockholm County Council	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	The study was supported by grants from the Swedish Council for Working Life and Social Research (2009-1619 and 2010-0643) and by grants from Karolinska Institutet and Stockholm County Council. The sponsor of the study had no role in the study design, data collection, data analyses, decision to publish or preparation of the manuscript. The authors have no financial relationships relevant to this article to disclose.	Baroni T, 2010, J CELL PHYSIOL, V222, P748, DOI 10.1002/jcp.22006; Benowitz N L, 1997, Adv Dent Res, V11, P336; Brender JD, 2004, EPIDEMIOLOGY, V15, P330, DOI 10.1097/01.ede.0000121381.79831.7b; Brender JD, 2011, AM J EPIDEMIOL, V174, P1286, DOI 10.1093/aje/kwr254; Christensen K, 1999, AM J EPIDEMIOL, V149, P248; Chung KC, 2000, PLAST RECONSTR SURG, V105, P485, DOI 10.1097/00006534-200002000-00001; CNATTINGIUS S, 1988, BMJ-BRIT MED J, V297, P258, DOI 10.1136/bmj.297.6643.258; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Coleman T, 2012, NEW ENGL J MED, V366, P808, DOI 10.1056/NEJMoa1109582; Croen LA, 2001, AM J EPIDEMIOL, V153, P325, DOI 10.1093/aje/153.4.325; Dempsey DA, 2001, DRUG SAFETY, V24, P277, DOI 10.2165/00002018-200124040-00005; ERICSON A, 1979, AM J OBSTET GYNECOL, V135, P348, DOI 10.1016/0002-9378(79)90703-8; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gartner CE, 2007, LANCET, V369, P2010, DOI 10.1016/S0140-6736(07)60677-1; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Gunnerbeck A, 2011, PEDIATRICS, V128, P503, DOI 10.1542/peds.2010-3811; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hafstrom A, 2005, RESP PHYSIOL NEUROBI, V149, P325, DOI 10.1016/j.resp.2005.05.004; HOLM H, 1992, PSYCHOPHARMACOLOGY, V108, P507, DOI 10.1007/BF02247429; Huber JC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-34; Kallen K, 1997, CLEFT PALATE-CRAN J, V34, P11, DOI 10.1597/1545-1569_1997_034_0011_msaoc_2.3.co_2; Kang P, 2003, Orthod Craniofac Res, V6, P129, DOI 10.1034/j.1600-0544.2003.02236.x; KHOURY MJ, 1987, AM J PUBLIC HEALTH, V77, P623, DOI 10.2105/AJPH.77.5.623; KHOURY MJ, 1989, AM J DIS CHILD, V143, P333, DOI 10.1001/archpedi.1989.02150150091023; Lambe M, 2007, LANCET, V370, P1206, DOI 10.1016/S0140-6736(07)61531-1; Lammer EJ, 2005, EPIDEMIOLOGY, V16, P698, DOI 10.1097/01.ede.0000172136.26733.4b; Lindmark G, 1991, Acta Obstet Gynecol Scand, V70, P105, DOI 10.3109/00016349109006190; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Meyer KA, 2004, EPIDEMIOLOGY, V15, P671, DOI 10.1097/01.ede.0000142148.51230.60; Morales-Suarez-Varela MM, 2006, OBSTET GYNECOL, V107, P51, DOI 10.1097/01.AOG.0000194079.66834.d5; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Munger RG, 1996, TERATOLOGY, V54, P27, DOI 10.1002/(SICI)1096-9926(199607)54:1<27::AID-TERA4>3.0.CO;2-0; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Osterdahl BG, 2004, J AGR FOOD CHEM, V52, P5085, DOI 10.1021/jf049931a; Richter P, 2008, NICOTINE TOB RES, V10, P1645, DOI 10.1080/14622200802412937; Robert E, 1996, J CRAN GENET DEV BIO, V16, P234; Saad A Y, 1990, Biol Struct Morphog, V3, P31; Shaw GM, 1996, AM J HUM GENET, V58, P551; Shaw GM, 1999, J PEDIATR-US, V134, P298, DOI 10.1016/S0022-3476(99)70453-1; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Stepanov I, 2012, TOB CONTROL, V21, P44, DOI 10.1136/tc.2010.042192; Wehby GL, 2010, ORAL DIS, V16, P11, DOI 10.1111/j.1601-0825.2009.01587.x; WERLER MM, 1990, AM J EPIDEMIOL, V132, P926, DOI 10.1093/oxfordjournals.aje.a115735; Wikstrom AK, 2010, BJOG-INT J OBSTET GY, V117, P1005, DOI 10.1111/j.1471-0528.2010.02575.x; Wikstrom AK, 2010, EPIDEMIOLOGY, V21, P772, DOI 10.1097/EDE.0b013e3181f20d7e; Wyszynski DF, 1997, CLEFT PALATE-CRAN J, V34, P206, DOI 10.1597/1545-1569(1997)034<0206:MCSAOC>2.3.CO;2; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zeiger JS, 2005, CLEFT PALATE-CRAN J, V42, P58, DOI 10.1597/02-128.1; Zhao ZY, 2005, BIRTH DEFECTS RES B, V74, P383, DOI 10.1002/bdrb.20052	50	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84715	10.1371/journal.pone.0084715	http://dx.doi.org/10.1371/journal.pone.0084715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454740	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100030
J	Lehmann, A; Schonwiesner, M				Lehmann, Alexandre; Schoenwiesner, Marc			Selective Attention Modulates Human Auditory Brainstem Responses: Relative Contributions of Frequency and Spatial Cues	PLOS ONE			English	Article							COCHLEAR NUCLEUS; SPEECH; CORTEX; OSCILLATIONS; PROJECTIONS; MECHANISMS; THALAMUS	Selective attention is the mechanism that allows focusing one's attention on a particular stimulus while filtering out a range of other stimuli, for instance, on a single conversation in a noisy room. Attending to one sound source rather than another changes activity in the human auditory cortex, but it is unclear whether attention to different acoustic features, such as voice pitch and speaker location, modulates subcortical activity. Studies using a dichotic listening paradigm indicated that auditory brainstem processing may be modulated by the direction of attention. We investigated whether endogenous selective attention to one of two speech signals affects amplitude and phase locking in auditory brainstem responses when the signals were either discriminable by frequency content alone, or by frequency content and spatial location. Frequency-following responses to the speech sounds were significantly modulated in both conditions. The modulation was specific to the task-relevant frequency band. The effect was stronger when both frequency and spatial information were available. Patterns of response were variable between participants, and were correlated with psychophysical discriminability of the stimuli, suggesting that the modulation was biologically relevant. Our results demonstrate that auditory brainstem responses are susceptible to efferent modulation related to behavioral goals. Furthermore they suggest that mechanisms of selective attention actively shape activity at early subcortical processing stages according to task relevance and based on frequency and spatial cues.	[Lehmann, Alexandre; Schoenwiesner, Marc] Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Lehmann, Alexandre; Schoenwiesner, Marc] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lehmann, Alexandre; Schoenwiesner, Marc] CRBLM, Montreal, PQ, Canada; [Schoenwiesner, Marc] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Schonwiesner, M (corresponding author), Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada.	marc.schoenwiesner@umontreal.ca		Schonwiesner, Marc/0000-0002-2023-1207	Natural Sciences and Engineering Research Council of Canada (NSERC) [365345]; Department of Foreign Affairs and International Trade Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Foreign Affairs and International Trade Canada	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca) grant, #365345, to MS and a post-doctoral research grant from the Department of Foreign Affairs and International Trade Canada to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Brandao ML, 2001, PHYSIOL BEHAV, V72, P365, DOI 10.1016/S0031-9384(00)00418-2; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; CONNOLLY JF, 1989, PSYCHOPHYSIOLOGY, V26, P292, DOI 10.1111/j.1469-8986.1989.tb01920.x; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DIAMOND IT, 1969, BRAIN RES, V15, P305, DOI 10.1016/0006-8993(69)90160-7; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; GALBRAITH GC, 1995, INT J PSYCHOPHYSIOL, V19, P203, DOI 10.1016/0167-8760(95)00008-G; Galbraith GC, 1998, NEUROREPORT, V9, P1889, DOI 10.1097/00001756-199806010-00041; Galbraith GC, 2003, NEUROREPORT, V14, P735, DOI 10.1097/00001756-200304150-00015; GALBRAITH GC, 1993, BIOL PSYCHOL, V37, P3, DOI 10.1016/0301-0511(93)90024-3; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Hairston WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055215; HERNANDEZPEON R, 1956, SCIENCE, V123, P331, DOI 10.1126/science.123.3191.331; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Hood LJ, 1998, CLIN APPL AUDITORY B, V1st; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; Kawahara H., 2001, P MAVEBA, P13; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Muller N, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.001.2009; Mulders WHAM, 2000, HEARING RES, V144, P65, DOI 10.1016/S0378-5955(00)00046-0; OATMAN LC, 1980, ELECTROEN CLIN NEURO, V49, P314, DOI 10.1016/0013-4694(80)90225-4; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; PICTON TW, 1971, SCIENCE, V173, P351, DOI 10.1126/science.173.3994.351; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Skoe E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013645; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Varela Francisco J., 1993, INSCRIPTION CORPOREL, V1st; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; Weedman DL, 1996, J COMP NEUROL, V371, P311; Winer JA, 1998, J COMP NEUROL, V400, P147; Woldorff M, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P146; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Woods DL, 2001, J EXP PSYCHOL HUMAN, V27, P65, DOI 10.1037/0096-1523.27.1.65; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904	45	58	60	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85442	10.1371/journal.pone.0085442	http://dx.doi.org/10.1371/journal.pone.0085442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454869	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100087
J	Lopez-De-Andres, A; Jimenez-Garcia, R; Hernandez-Barrera, V; Jimenez-Trujillo, I; Gallardo-Pino, C; de Miguel, AG; Carrasco-Garrido, P				Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Gallardo-Pino, Carmen; Gil de Miguel, Angel; Carrasco-Garrido, Pilar			National Trends over One Decade in Hospitalization for Acute Myocardial Infarction among Spanish Adults with Type 2 Diabetes: Cumulative Incidence, Outcomes and Use of Percutaneous Coronary Intervention	PLOS ONE			English	Article							SEX DISPARITIES; RISK-FACTORS; FOLLOW-UP; MORTALITY; MELLITUS; DISEASE; PEOPLE; WOMEN; HEART; SURVIVAL	Background: This study aims to describe trends in the rate of acute myocardial infarction (AMI) and use of percutaneous coronary interventions (PCI) in patients with and without type 2 diabetes in Spain, 2001-2010. Methods: We selected all patients with a discharge of AMI using national hospital discharge data. Discharges were grouped by diabetes status: type 2 diabetes and no diabetes. In both groups PCIs were identified. The cumulative incidence of discharges attributed to AMI were calculated overall and stratified by diabetes status and year. We calculated length of stay and in-hospital mortality (IHM). Use of PCI was calculated stratified by diabetes status. Multivariate analysis was adjusted by age, sex, year and comorbidity. Results: From 2001 to 2010, 513,517 discharges with AMI were identified (30.3% with type 2 diabetes). The cumulative incidence of discharges due to AMI in diabetics patients increased (56.3 in 2001 to 71 cases per 100,000 in 2004), then decreased to 61.9 in 2010. Diabetic patients had significantly higher IHM (OR, 1.14; 95% CI, 1.05-1.17). The proportion of diabetic patients that underwent PCI increased from 11.9% in 2001 to 41.6% in 2010. Adjusted incidence of discharge in patients with diabetes who underwent PCI increased significantly (IRR, 3.49; 95% CI, 3.30-3.69). The IHM among diabetics patients who underwent a PCI did not change significantly over time. Conclusions: AMI hospitalization rates increased initially but declining slowly. From 2001 to 2010 the proportion of diabetic patients who undergo a PCI increased almost four-fold. Older age and more comorbidity may explain why IHM did not improve after a PCI.	[Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Gallardo-Pino, Carmen; Gil de Miguel, Angel; Carrasco-Garrido, Pilar] Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Madrid, Spain	Universidad Rey Juan Carlos	Lopez-De-Andres, A (corresponding author), Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Madrid, Spain.	ana.lopez@urjc.es	Jimenez-Garcia, Rodrigo/D-4953-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021; Lopez-de-Andres, Ana/D-4498-2019; Lopez-de-Andres, Ana/AAD-8703-2019	Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Lopez-de-Andres, Ana/0000-0001-5551-5181; Lopez-de-Andres, Ana/0000-0001-5551-5181; Hernandez-Barrera, Valentin/0000-0001-5790-1959; GIL DE MIGUEL, ANGEL/0000-0003-1295-7101	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) [PI10/00360]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III)	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI10/00360, Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2010, REV ENDOCR METAB DIS, V11, P75, DOI 10.1007/s11154-010-9135-3; Blondal M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-96; Booth GL, 2006, DIABETES CARE, V29, P32, DOI 10.2337/diacare.29.1.32; Bottle A, 2009, DIABETOLOGIA, V52, P74, DOI 10.1007/s00125-008-1170-1; Champney KP, 2007, AM HEART J, V153, P970, DOI 10.1016/j.ahj.2007.03.036; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Degano IR, 2013, REV ESP CARDIOL, V66, P472, DOI [10.1016/j.recesp.2013.01.019, 10.1016/j.rec.2013.01.018]; Ferrara A, 2008, DIABETES CARE, V31, P69, DOI 10.2337/dc07-1244; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gore MO, 2012, CIRC-CARDIOVASC QUAL, V5, P791, DOI 10.1161/CIRCOUTCOMES.112.965491; Gouni-Berthold I, 2008, DIABETES CARE, V31, P1389, DOI 10.2337/dc08-0194; Hirakawa Y, 2007, DIABETES RES CLIN PR, V75, P59, DOI 10.1016/j.diabres.2006.04.011; Instituto Nacional de Estadistica (INE), 2010, POP EST; Instituto Nacional de Gestion Sanitaria Ministerio de Sanidad y Consumo, 2001, CONJ MIN BAS DAT; Trujillo IJ, 2010, DIABETES METAB, V36, P29, DOI 10.1016/j.diabet.2009.06.007; Jimenez-Garcia R, 2009, J DIABETES COMPLICAT, V23, P394, DOI 10.1016/j.jdiacomp.2008.06.002; Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256; Lopez-de-Andres A, 2013, DIABETES RES CLIN PR, V99, P300, DOI 10.1016/j.diabres.2012.12.011; Lopez-de-Andres A, 2011, DIABETES CARE, V34, P1570, DOI 10.2337/dc11-0077; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Maier B, 2006, J INVEST MED, V54, P143, DOI 10.2310/6650.2006.05056; Ministry of Health Social Services and Equality, CONJ MIN BAS DAT; Norhammar A, 2008, HEART, V94, P1565, DOI 10.1136/hrt.2007.135038; Ouhoummane N, 2010, CAN J CARDIOL, V26, P523, DOI 10.1016/S0828-282X(10)70465-7; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rana JS, 2010, DIABETES CARE, V33, P1976, DOI 10.2337/dc10-0247; Ribera A, 2008, REV ESP CARDIOL, V61, P843, DOI 10.1016/S1885-5857(08)60232-7; Roche Madonna M, 2013, Diabetes Care, V36, P2582, DOI 10.2337/dc12-1272; Ruiz-Ramos Miguel, 2006, Gac Sanit, V20 Suppl 1, P15, DOI 10.1157/13086022; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Singh M, 2013, MAYO CLIN PROC, V88, P22, DOI 10.1016/j.mayocp.2012.09.014; Svensson AM, 2007, INT J CARDIOL, V119, P319, DOI 10.1016/j.ijcard.2006.07.156; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Vaccaro O, 2004, ARCH INTERN MED, V164, P1438, DOI 10.1001/archinte.164.13.1438; Vamos EP, 2012, DIABETES CARE, V35, P265, DOI 10.2337/dc11-1682; Whiteley L, 2005, DIABETES CARE, V28, P1588, DOI 10.2337/diacare.28.7.1588	37	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85697	10.1371/journal.pone.0085697	http://dx.doi.org/10.1371/journal.pone.0085697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454920	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100122
J	Richards, ZT; Hobbs, JPA				Richards, Zoe T.; Hobbs, Jean-Paul A.			Predicting Coral Species Richness: The Effect of Input Variables, Diversity and Scale	PLOS ONE			English	Article							HIGHER-TAXON RICHNESS; FUNCTIONAL REDUNDANCY; CLIMATE-CHANGE; BIODIVERSITY; SURROGATE; REEF; DECLINE; IMPACT; RESILIENCE; PATTERNS	Coral reefs are facing a biodiversity crisis due to increasing human impacts, consequently, one third of reef-building corals have an elevated risk of extinction. Logistic challenges prevent broad-scale species-level monitoring of hard corals; hence it has become critical that effective proxy indicators of species richness are established. This study tests how accurately three potential proxy indicators (generic richness on belt transects, generic richness on point-intercept transects and percent live hard coral cover on point-intercept transects) predict coral species richness at three different locations and two analytical scales. Generic richness (measured on a belt transect) was found to be the most effective predictor variable, with significant positive linear relationships across locations and scales. Percent live hard coral cover consistently performed poorly as an indicator of coral species richness. This study advances the practical framework for optimizing coral reef monitoring programs and empirically demonstrates that generic richness offers an effective way to predict coral species richness with a moderate level of precision. While the accuracy of species richness estimates will decrease in communities dominated by species-rich genera (e.g. Acropora), generic richness provides a useful measure of phylogenetic diversity and incorporating this metric into monitoring programs will increase the likelihood that changes in coral species diversity can be detected.	[Richards, Zoe T.] Western Australian Museum, Dept Aquat Zool, Welshpool, WA, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Western Australian Museum; University of Western Australia; University of Western Australia	Richards, ZT (corresponding author), Western Australian Museum, Dept Aquat Zool, Welshpool, WA, Australia.	zoe.richards@museum.wa.gov.au	Hobbs, Jean-Paul/I-8743-2012	Hobbs, Jean-Paul/0000-0003-0331-354X	Australian Museum Foundation; NOAA; Australian Department of Environment, Arts and Heritage	Australian Museum Foundation; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Australian Department of Environment, Arts and Heritage(Australian Government)	Funding was provided by the Australian Museum Foundation (http://australianmuseum.net.au/The-Australian-Museum-Foundation); The NOAA coral reef conservation programme (http://coastalmanagement.noaa.gov/programs/coral.html); and by the Australian Department of Environment, Arts and Heritage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1571, DOI 10.1098/rspb.1996.0230; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1267, DOI 10.1098/rspb.1996.0186; Balmford A, 2000, BIOL CONSERV, V93, P209, DOI 10.1016/S0006-3207(99)00140-8; Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bracken MES, 2012, ECOL LETT, V15, P461, DOI 10.1111/j.1461-0248.2012.01758.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Eakin CM, 2010, OCEANOGRAPHY, V23, P118, DOI 10.5670/oceanog.2010.10; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hendriks IE, 2006, SCIENCE, V312, P1715, DOI 10.1126/science.1128548; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUMPHRIES CJ, 1995, ANNU REV ECOL SYST, V26, P93, DOI 10.1146/annurev.es.26.110195.000521; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Magierowski RH, 2006, ECOL APPL, V16, P2264, DOI 10.1890/1051-0761(2006)016[2264:ROSOBI]2.0.CO;2; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Niemela J, 2000, ANN ZOOL FENN, V37, P307; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R Core Team, 2021, R LANGUAGE ENV STAT; Richards ZT, 2013, DIVERS DISTRIB, V19, P884, DOI 10.1111/ddi.12032; Richards ZT, 2013, CORAL REEFS, V32, P287, DOI 10.1007/s00338-012-0963-3; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Roy K, 1996, PHILOS T R SOC B, V351, P1605, DOI 10.1098/rstb.1996.0144; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Vanderklift MA, 1998, BIOL CONSERV, V86, P307, DOI 10.1016/S0006-3207(98)00036-6; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Veron JEN, 1995, CORALS SPACE TIME BI, p[48, 156]; Villasenor JL, 2005, CONSERV BIOL, V19, P232, DOI 10.1111/j.1523-1739.2005.00264.x; Wilkinson C., 2004, STATUS CORAL REEFS W; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2	60	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83965	10.1371/journal.pone.0083965	http://dx.doi.org/10.1371/journal.pone.0083965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454712	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100014
J	Wang, JZ; Garcia-Bailo, B; Nielsen, DE; El-Sohemy, A				Wang, Jingzhou; Garcia-Bailo, Bibiana; Nielsen, Daiva E.; El-Sohemy, Ahmed			ABO Genotype, 'Blood-Type' Diet and Cardiometabolic Risk Factors	PLOS ONE			English	Article							LOW-CARBOHYDRATE DIETS; LOW-FAT DIETS; FOOD-CONSUMPTION; CLINICAL-TRIALS; WEIGHT-LOSS; METAANALYSIS; PATTERNS; DISEASE; CANCER; ADULTS	Background: The 'Blood-Type' diet advises individuals to eat according to their ABO blood group to improve their health and decrease risk of chronic diseases such as cardiovascular disease. However, the association between blood type-based dietary patterns and health outcomes has not been examined. The objective of this study was to determine the association between 'blood-type' diets and biomarkers of cardiometabolic health and whether an individual's ABO genotype modifies any associations. Methods: Subjects (n = 1,455) were participants of the Toronto Nutrigenomics and Health study. Dietary intake was assessed using a one-month, 196-item food frequency questionnaire and a diet score was calculated to determine relative adherence to each of the four 'Blood-Type' diets. ABO blood group was determined by genotyping rs8176719 and rs8176746 in the ABO gene. ANCOVA, with age, sex, ethnicity, and energy intake as covariates, was used to compare cardiometabolic biomarkers across tertiles of each 'Blood-Type' diet score. Results: Adherence to the Type-A diet was associated with lower BMI, waist circumference, blood pressure, serum cholesterol, triglycerides, insulin, HOMA-IR and HOMA-Beta (P<0.05). Adherence to the Type-AB diet was also associated with lower levels of these biomarkers (P<0.05), except for BMI and waist circumference. Adherence to the Type-O diet was associated with lower triglycerides (P<0.0001). Matching the 'Blood-Type' diets with the corresponding blood group did not change the effect size of any of these associations. No significant association was found for the Type-B diet. Conclusions: Adherence to certain 'Blood-Type' diets is associated with favorable effects on some cardiometabolic risk factors, but these associations were independent of an individual's ABO genotype, so the findings do not support the 'Blood-Type' diet hypothesis.	[Wang, Jingzhou; Garcia-Bailo, Bibiana; Nielsen, Daiva E.; El-Sohemy, Ahmed] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada	University of Toronto	El-Sohemy, A (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.	a.el.sohemy@utoronto.ca	Nielsen, Daiva/AAT-5028-2020; Nielsen, Daiva/ACI-1414-2022	Nielsen, Daiva/0000-0002-4265-5748; Wang, Jingzhou/0000-0001-8142-2202; El-Sohemy, Ahmed/0000-0002-8877-6414	Advanced Foods and Materials Network [305352]; Ontario Graduate Scholarship	Advanced Foods and Materials Network; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by grant 305352 from the Advanced Foods and Materials Network (to AE-S). JW is a recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Cahill L, 2009, AM J EPIDEMIOL, V170, P464, DOI 10.1093/aje/kwp156; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N; Cusack L, 2013, AM J CLIN NUTR, V98, P99, DOI 10.3945/ajcn.113.058693; D'Adamo P, 2012, EAT RIGHT YOUR TYPE; d'Adamo PJ, 1996, EAT RIGHT 4 YOUR TYP; Fung TT, 2004, STROKE, V35, P2014, DOI 10.1161/01.STR.0000135762.89154.92; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Garcia-Bailo B, 2012, AM J CLIN NUTR, V95, P352, DOI 10.3945/ajcn.111.022657; Gates MA, 2011, INT J CANCER, V128, P482, DOI 10.1002/ijc.25339; Ghazarian H, 2011, ACTA HISTOCHEM, V113, P236, DOI 10.1016/j.acthis.2010.02.004; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Liese AD, 2011, CIRCULATION, V123, P1410, DOI 10.1161/CIRCULATIONAHA.110.955922; Mourant AE., 1976, DISTRIBUTION HUMAN B; NACHBAR MS, 1980, AM J CLIN NUTR, V33, P2338, DOI 10.1093/ajcn/33.11.2338; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Patterson E, 2013, J NUTR, V143, P74, DOI 10.3945/jn.112.166330; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Saitou N, 1997, MOL BIOL EVOL, V14, P399, DOI 10.1093/oxfordjournals.molbev.a025776; Santos FL, 2012, OBES REV, V13, P1048, DOI 10.1111/j.1467-789X.2012.01021.x; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; van Dam RM, 2003, AM J CLIN NUTR, V77, P1156, DOI 10.1093/ajcn/77.5.1156; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; Wu O, 2008, J THROMB HAEMOST, V6, P62; Xie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011972; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002	34	14	14	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84749	10.1371/journal.pone.0084749	http://dx.doi.org/10.1371/journal.pone.0084749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454746	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100033
J	Zhu, X; Yuan, M; Shakeel, M; Zhang, YJ; Wang, SL; Wang, X; Zhan, S; Kang, TH; Li, JH				Zhu, Xun; Yuan, Miao; Shakeel, Muhammad; Zhang, Youjun; Wang, Shaoli; Wang, Xin; Zhan, Sha; Kang, Tinghao; Li, Jianhong			Selection and Evaluation of Reference Genes for Expression Analysis Using qRT-PCR in the Beet Armyworm Spodoptera exigua (Hubner) (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							TIME RT-PCR; MESSENGER-RNA LEVELS; REAL-TIME; QUANTITATIVE PCR; DROSOPHILA-MELANOGASTER; HOUSEKEEPING GENES; BETA-ACTIN; INTERNAL CONTROL; VALIDATION; PROTEIN	Quantitative real-time PCR (qRT-PCR) is a reliable and reproducible technique for measuring and evaluating changes in gene expression. The most common method for analyzing qRT-PCR data is to normalize mRNA levels of target genes to internal reference genes. Evaluating and selecting stable reference genes on a case-by-case basis is critical. The present study aimed to facilitate gene expression studies by identifying the most suitable reference genes for normalization of mRNA expression in qRT-PCR analysis of the beet armyworm Spodoptera exigua (Lepidoptera: Noctuidae). For this purpose, three software tools (geNorm, NormFinder and BestKeeper) were used to investigate 10 candidate reference genes in nine developmental stages and five different tissues (epidermis, head, midgut, fat body and hemolymph) in three larval physiological stages (molting, feeding and wandering stages) of, S. exigua. With the exception of 18S ribosomal RNA (18S), all other candidate genes evaluated, beta-actin1(ACT1), beta-actin2 (ACT2), elongation factor1(EF1), elongation factor 2 (EF2), Glyceralde hyde-3-phosphate dehydrogenase (GAPDH), ribosomal protein L10 (L10), ribosomal protein L17A (L17A), superoxide dismutase (SOD), alpha-tubulin (TUB), proved to be acceptable reference genes. However, their suitability partly differed between physiological stages and different tissues. L10, EF2 and L17A ranked highest in all tissue sample sets. SOD, ACT2, GAPDH, EF1 and ACT1 were stably expressed in all developmental stage sample sets; ACT2, ACT1 and L10 for larvae sample sets; GAPDH, ACT1 and ACT2 for pupae and adults; SOD and L17A for males; and EF2 and SOD for females. The expression stability of genes varied in different conditions. The findings provided here demonstrated, with a few exceptions, the suitability of most of the 10 reference genes tested in tissues and life developmental stages. Overall, this study emphasizes the importance of validating reference genes for qRT-PCR analysis in S. exigua.	[Zhu, Xun; Yuan, Miao; Shakeel, Muhammad; Wang, Xin; Zhan, Sha; Kang, Tinghao; Li, Jianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China; [Zhu, Xun; Zhang, Youjun; Wang, Shaoli] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China.	jianhl@mail.hzau.edu.cn	Zhang, Youjun/AAY-7948-2020; Shakeel, Muhammad/B-5096-2019	Zhang, Youjun/0000-0003-3508-6695; Shakeel, Muhammad/0000-0002-8515-0053	National Natural Science Foundation of China [31201544]; Hubei Province Science & Technology Department of China [2011BFA018]; Beijing Natural Science Foundation of China [6102021]; Independent Innovation Foundation of Huazhong Agricultural University [2011PY123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Science & Technology Department of China; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); Independent Innovation Foundation of Huazhong Agricultural University	This research was supported by the National Natural Science Foundation of China (No. 31201544), Hubei Province Science & Technology Department of China (No. 2011BFA018), Beijing Natural Science Foundation of China (6102021), and Independent Innovation Foundation of Huazhong Agricultural University (No. 2011PY123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Carmo ACV, 2012, ANTIVIR RES, V94, P126, DOI 10.1016/j.antiviral.2011.12.010; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Choi JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042462; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fernandez AP, 2004, DEV BIOL, V276, P352, DOI 10.1016/j.ydbio.2004.08.040; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jiang Xinfu, 1999, Acta Entomologica Sinica, V42, P270; Lee S, 2011, J INSECT PHYSIOL, V57, P356, DOI 10.1016/j.jinsphys.2010.12.003; Li AQ, 2009, BBA-PROTEINS PROTEOM, V1794, P663, DOI 10.1016/j.bbapap.2008.11.025; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; Mosallanejad H, 2008, ARCH INSECT BIOCHEM, V67, P36, DOI 10.1002/arch.20220; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rocha CS, 2008, VIROLOGY, V380, P165, DOI 10.1016/j.virol.2008.08.005; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Smagghe G, 2003, PEST MANAG SCI, V59, P1203, DOI 10.1002/ps.756; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; Swevers L, 2008, INSECT BIOCHEM MOLEC, V38, P825, DOI 10.1016/j.ibmb.2008.06.001; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Zhang C, 2010, J INSECT PHYSIOL, V56, P788, DOI 10.1016/j.jinsphys.2010.02.001; Zhang DW, 2012, ARCH INSECT BIOCHEM, V79, P220, DOI 10.1002/arch.21018	58	108	113	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84730	10.1371/journal.pone.0084730	http://dx.doi.org/10.1371/journal.pone.0084730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454743	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100031
J	Castro-Sanchez, E; Charani, E; Drumright, LN; Sevdalis, N; Shah, N; Holmes, AH				Castro-Sanchez, Enrique; Charani, Esmita; Drumright, Lydia N.; Sevdalis, Nick; Shah, Nisha; Holmes, Alison H.			Fragmentation of Care Threatens Patient Safety in Peripheral Vascular Catheter Management in Acute Care- A Qualitative Study	PLOS ONE			English	Article							INTRAVASCULAR CATHETER; HEALTH-CARE; PREVENTION; IMPLEMENTATION; INFECTION; EDUCATION; RISK	Background: The use of peripheral vascular catheters (PVCs) is an extremely common and necessary clinical intervention, but inappropriate PVC care poses a major patient safety risk in terms of infection. Quality improvement initiatives have been proposed to reduce the likelihood of adverse events, but a lack of understanding about factors that influence behaviours of healthcare professionals limits the efficacy of such interventions. We undertook qualitative interviews with clinical staff from a large group of hospitals in order to understand influences on PVC care behaviors and subsequent patient safety. Methods: Ten doctors, ten clinical pharmacists, 18 nurses and one midwife at a National Health Service hospital group in London (United Kingdom) were interviewed between December 2010 and July 2011 using qualitative methods. Responses were analysed using a thematic framework. Results: Four key themes emerged: 1) Fragmentation of management and care, demonstrated with a lack of general overview and insufficient knowledge about expected standards of care or responsibility of different professionals; 2) feelings of resentment and frustration as a result of tensions in the workplace, due to the ambiguity about professional responsibilities; 3) disregard for existing hospital policy due to perceptions of flaws in the evidence used to support it; and 4) low-risk perception for the impact of PVC use on patient safety. Conclusion: Fragmentation of practice resulted in ill-defined responsibilities and interdisciplinary resentment, which coupled with a generally low perception of risk of catheter use, appeared to result in lack of maintaining policy PVC standards which could reduced patient safety. Resolution of these issues through clearly defining handover practice, teaching interdisciplinary duties and increasing awareness of PVC risks could result in preventing thousands of BSIs and other PVC-related infections annually.	[Castro-Sanchez, Enrique; Charani, Esmita; Drumright, Lydia N.; Shah, Nisha; Holmes, Alison H.] Univ London Imperial Coll Sci Technol & Med, Ctr Infect Prevent & Management, London, England; [Sevdalis, Nick] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Sevdalis, Nick] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Patient Safety & Serv Qual, London, England	Imperial College London; Imperial College London; Imperial College London	Castro-Sanchez, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Infect Prevent & Management, London, England.	e.castro-sanchez@imperial.ac.uk	Castro-Sanchez, Enrique/H-7893-2019; Shah, Nisha/ABC-5058-2021; Sevdalis, Nick/AAJ-6280-2020; Sevdalis, Nick/O-1419-2017	Castro-Sanchez, Enrique/0000-0002-3351-9496; Shah, Nisha/0000-0002-1872-4598; Sevdalis, Nick/0000-0001-7560-8924; Sevdalis, Nick/0000-0001-7560-8924; Holmes, Alison/0000-0001-5554-5743; Charani, Esmita/0000-0002-5938-1202; Drumright, Lydia/0000-0002-3361-8080	National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College; National Centre for Infection Prevention and Management; United Kingdom Clinical Research Council [UKCRC G0800777]; UK NIHR; NIHR Career Development Award [NIHR CDF-2011-04-017]; MRC [G0800777] Funding Source: UKRI; Medical Research Council [G0800777] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College; National Centre for Infection Prevention and Management; United Kingdom Clinical Research Council; UK NIHR(National Institute for Health Research (NIHR)); NIHR Career Development Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme at Imperial College (funding number not applicable) and the National Centre for Infection Prevention and Management funded by the United Kingdom Clinical Research Council (UKCRC G0800777). AH and NS are affiliated with the Imperial Centre for Patient Safety and Service Quality funded by the UK NIHR. LD is supported by an NIHR Career Development Award (NIHR CDF-2011-04-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd S, 2011, J HOSP INFECT, V77, P37, DOI 10.1016/j.jhin.2010.09.011; Carthey J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5283; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Charanil E, 2013, J ANTIMICROB CHEMOTH, V68, P960, DOI 10.1093/jac/dks492; Cook D, 2009, J HOSP MED, V4, P269, DOI 10.1002/jhm.461; Coopersmith CM, 2002, CRIT CARE MED, V30, P59, DOI 10.1097/00003246-200201000-00009; Curran E, 2008, J HOSP INFECT, V69, P307, DOI 10.1016/j.jhin.2008.04.007; Dixon-Woods M, 2010, QUAL SAF HEALTH CARE, V19, P74, DOI 10.1136/qshc.2008.029504; Edwards R, 2012, LANCET INFECT DIS, V12, P318, DOI 10.1016/S1473-3099(11)70283-3; Ferlie E, 2005, ACAD MANAGE J, V48, P117, DOI [10.5465/amj.2005.15993150, 10.2307/20159644]; Flodgren G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006559.pub2; Freixas N, 2013, CLIN MICROBIOL INFEC, V19, P838, DOI 10.1111/1469-0691.12049; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Health and Social Care Information Centre, 2012, HOSP EP STAT; Hewett DG, 2009, SOC SCI MED, V69, P1732, DOI 10.1016/j.socscimed.2009.09.048; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Johansson ME, 2009, J CLIN NURS, V18, P3366, DOI 10.1111/j.1365-2702.2009.02973.x; Kyratsis Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000872; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Mestre G, 2013, AM J INFECT CONTROL, V41, P520, DOI 10.1016/j.ajic.2012.07.014; Nugus P, 2010, SOC SCI MED, V71, P898, DOI 10.1016/j.socscimed.2010.05.029; Palese A, 2011, J INFUS MURS, V34, P319, DOI 10.1097/NAN.0b013e3182290a20; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Powell AE, 2012, SOC SCI MED, V75, P807, DOI 10.1016/j.socscimed.2012.03.049; PRONOVOST P, 2008, AM J INFECT CONTROL, V36; Royal College of Physicians, 2012, RES RCP HLTH SOC CAR; Sherertz RJ, 2000, ANN INTERN MED, V132, P641, DOI 10.7326/0003-4819-132-8-200004180-00007; Trinh TT, 2011, INFECT CONT HOSP EP, V32, P579, DOI 10.1086/660099; World Health Organization, 2008, TASK SHIFT RAT RED T; Zingg Walter, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS38, DOI 10.1016/S0924-8579(09)70565-5	32	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e86167	10.1371/journal.pone.0086167	http://dx.doi.org/10.1371/journal.pone.0086167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292TQ	24454958	Green Published, Green Accepted, gold			2022-12-27	WOS:000329925800056
J	Njomo, DW; Mukoko, DA; Nyamongo, NK; Karanja, J				Njomo, Doris W.; Mukoko, Dunstan A.; Nyamongo, Nipher K.; Karanja, Joan			Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya	PLOS ONE			English	Article							DIETHYLCARBAMAZINE; PROGRAM; ALBENDAZOLE; IVERMECTIN; INFECTION; INDIA	Introduction: Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filariasis (LF) elimination. No urban-specific guidelines on MDA in urban areas exist. Malindi district urban area had received 4 MDA rounds by the time the current study was implemented. Programme data showed average treatment coverage of 28.4% (2011 MDA), far below recommended minimum of 65-80%. Methods: To identify, design and test strategies for increased treatment coverage in urban areas, a quasi-experimental study was conducted in Malindi urban area. Three sub-locations with lowest treatment coverage in 2011 MDA were purposively selected. In the pre-test phase, 947 household heads sampled using systematic random method were interviewed for quantitative data. For qualitative data, 12 Focus Group Discussions (FGDs) with single sex adult and youth male and female groups and 3 with community drug distributors (CDDs) were conducted. Forty in-depth interviews with opinion leaders and self-administered questionnaires with District Public Health officers purposively selected were carried out. The quantitative data were analyzed using SPSS version 16 and statistical significance assessed by x(2) test. The qualitative data were analyzed manually according to study's themes. Results and Discussion: The identified strategies were implemented prior to and during 2012 MDA in two sub-locations (experimental) while in the third (control), usual MDA strategies were applied. In the post-test phase, 2012 MDA coverage in experimental and control sub-locations was comparatively assessed for effect of the newly designed strategies on urban MDA. Results indicated improved treatment coverage in experimental sub-locations, 77.1% in Shella and 66.0% in Barani. Central (control) sub-location also attained high coverage, 70.4% indicating average treatment coverage of 71%. Conclusion: The identified strategies contributed to increased treatment coverage in experimental sites and should be applied in urban areas. Due to closeness of sites, spillover effects may have contributed to increased coverage in the control site.	[Njomo, Doris W.; Nyamongo, Nipher K.] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Mukoko, Dunstan A.] Minist Hlth, Div Vector Borne & Neglected Trop Dis, Nairobi, Kenya; [Karanja, Joan] Minist Hlth, Malindi Dist Hosp, Malindi, Kenya	Kenya Medical Research Institute	Njomo, DW (corresponding author), Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya.	dnjomo@kemri.org		Karanja, Mary Joan/0000-0001-9521-5773	Neglected Tropical Diseases (NTDs) Support Centre at the Task Force for Global Health (Atlanta, GA, USA); Bill & Melinda Gates Foundation [OPP43922]	Neglected Tropical Diseases (NTDs) Support Centre at the Task Force for Global Health (Atlanta, GA, USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study received support from the Neglected Tropical Diseases (NTDs) Support Centre at the Task Force for Global Health (Atlanta, GA, USA) with funding from the Bill & Melinda Gates Foundation grant #: OPP43922. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P417; [Anonymous], 2009, KEN POP HOUS CENS HI, P1; Aswathy S, 2009, ANN TROP MED PARASIT, V103, P617, DOI 10.1179/000349809X12459740922255; Babu B, 2004, TROP MED INT HEALTH, V9, P702, DOI 10.1111/j.1365-3156.2004.01247.x; Bockarie MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1686; Carter A., 2010, FACTORS CONTRIBUTE L; Ichimori K, 2011, BOL MED HOSP INFANT, V68, P146; Ismail MM, 1998, T ROY SOC TROP MED H, V92, P94, DOI 10.1016/S0035-9203(98)90972-5; KHAN M E, 1991, World Health Statistics Quarterly, V44, P145; Kyelem D, 2008, AM J TROP MED HYG, V79, P480; Lammie P, 2007, B WORLD HEALTH ORGAN, V85, P545, DOI 10.2471/BLT.06.034108; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; MOULIAPELAT JP, 1995, TROP MED PARASITOL, V46, P9; Muralidhar MK, 2013, J PUB HLTH MED RES, V1, P1; Nandha B, 2007, Filaria J, V6, P7, DOI 10.1186/1475-2883-6-7; Njenga SM, 2008, T ROY SOC TROP MED H, V102, P1017, DOI 10.1016/j.trstmh.2008.04.039; Njomo D. W., 2012, Southern African Journal of Epidemiology & Infection, V27, P66; Njomo DW, 2012, ANN TROP MED PUBLIC, V5, P103, DOI 10.4103/1755-6783.95962; Njomo DW, 2012, AFRICAN J HLTH SCI, V20, P42; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6; Plaisier AP, 1998, METHOD INFORM MED, V37, P97; Ranganath Ts, 2012, Indian J Community Med, V37, P219, DOI 10.4103/0970-0218.103468; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; WEERASOORIYA MV, 2007, FILARIA J, V6, P6; WHO, 2000, OP GUID RAP MAPP BAN; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; World Health Organization, 2004, TRAIN MOD DRUG DISTR; Yirga D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-48	31	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83413	10.1371/journal.pone.0083413	http://dx.doi.org/10.1371/journal.pone.0083413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454703	gold, Green Published, Green Submitted			2022-12-27	WOS:000329925800008
J	Pan, H; Shen, KZ; Wang, XP; Meng, HZ; Wang, CJ; Jin, BY				Pan, Hao; Shen, Kezhen; Wang, Xueping; Meng, Hongzhou; Wang, Chaojun; Jin, Baiye			Protective Effect of Metalloporphyrins against Cisplatin-Induced Kidney Injury in Mice	PLOS ONE			English	Article							PEROXYNITRITE DECOMPOSITION CATALYST; MANGANESE-SUPEROXIDE-DISMUTASE; NRF2/HO-1 SIGNALING PATHWAY; INDUCED RENAL INJURY; NITRIC-OXIDE; INDUCED NEPHROTOXICITY; IN-VIVO; HEME OXYGENASE-1; OXIDATIVE/NITROSATIVE STRESS; NITROSATIVE STRESS	Oxidative and nitrative stress is a well-known phenomenon in cisplatin-induced nephrotoxicity. The purpose of this work is to study the role of two metalloporphyrins (FeTMPyP and MnTBAP), water soluble complexes, in cisplatin-induced renal damage and their ability to scavenge peroxynitrite. In cisplatin-induced nephropathy study in mice, renal nitrative stress was evident by the increase in protein nitration. Cisplatin-induced nephrotoxicity was also evident by the histological damage from the loss of the proximal tubular brush border, blebbing of apical membranes, tubular epithelial cell detachment from the basement membrane, or intra-luminal aggregation of cells and proteins and by the increase in blood urea nitrogen and serum creatinine. Cisplatin-induced apoptosis and cell death as shown by Caspase 3 assessments, TUNEL staining and DNA fragmentation Cisplatin-induced nitrative stress, apoptosis and nephrotoxicity were attenuated by both metalloporphyrins. Heme oxygenase (HO-1) also plays a critical role in metalloporphyrin-mediated protection of cisplatin-induced nephrotoxicity. It is evident that nitrative stress plays a critical role in cisplatin-induced nephrotoxicity in mice. Our data suggest that peroxynitrite is involved, at least in part, in cisplatin-induced nephrotoxicity and protein nitration and cisplatin-induced nephrotoxicity can be prevented with the use of metalloporphyrins.	[Pan, Hao; Wang, Xueping; Meng, Hongzhou; Wang, Chaojun; Jin, Baiye] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Kezhen] Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Jin, BY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China.	jinbaiye1964@aliyun.com		Pan, Hao/0000-0001-9925-0752	National Natural Science Foundation of China [81000302]; Science and Technology Department of Zhejiang Province [2013C37053, 2009C14015]; Zhejiang medical and health science and technology plan project [2012RCA022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province; Zhejiang medical and health science and technology plan project	This work was supported by grants from the National Natural Science Foundation of China (no. 81000302), the Science and Technology Department of Zhejiang Province (no. 2013C37053, 2009C14015), and the Zhejiang medical and health science and technology plan project(2012RCA022. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2010, J PHARMACOL EXP THER, V335, P2, DOI 10.1124/jpet.110.170084; APPLEGATE LA, 1991, CANCER RES, V51, P974; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Baliga R, 1998, KIDNEY INT, V53, P394, DOI 10.1046/j.1523-1755.1998.00767.x; Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BOOGAARD PJ, 1990, CONTRIB NEPHROL, V83, P208; Broeders N, 2002, KIDNEY INT, V61, P354, DOI 10.1046/j.1523-1755.2002.00129.x; Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Chirino YI, 2008, TOXICOLOGY, V245, P18, DOI 10.1016/j.tox.2007.12.007; Chirino Yolanda I., 2004, BMC Pharmacology, V4, P20, DOI 10.1186/1471-2210-4-20; Choi BM, 2008, J MED FOOD, V11, P230, DOI 10.1089/jmf.2007.591; Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; Dhar A, 2006, PHARMACOL RES, V54, P311, DOI 10.1016/j.phrs.2006.06.009; Dillioglugil MO, 2005, UROL INT, V75, P340, DOI 10.1159/000089171; Domitrovic R, 2013, TOXICOLOGY; Domitrovic R, 2013, FOOD CHEM TOXICOL, V62, P397, DOI 10.1016/j.fct.2013.09.003; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Estevez AG, 1998, J NEUROSCI, V18, P923; Fram Robert J., 1992, Current Opinion in Oncology, V4, P1073, DOI 10.1097/00001622-199212000-00012; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Kadikoylu G, 2004, HUM EXP TOXICOL, V23, P29, DOI 10.1191/0960327104ht413oa; Kang JHL, 2001, J TOXICOL ENV HEAL A, V64, P291, DOI 10.1080/152873901316981295; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim MG, 2010, J KOREAN MED SCI, V25, P557, DOI 10.3346/jkms.2010.25.4.557; Kumar P, 2013, ENVIRON TOXICOL PHAR, V36, P883, DOI 10.1016/j.etap.2013.08.004; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2096, DOI 10.1093/ndt/gfl194; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Li PKT, 2013, NAT REV NEPHROL, V9, P133, DOI 10.1038/nrneph.2013.20; Liaudet L, 2013, CURR VASC PHARMACOL, V11, P196; Liu DX, 2005, J NEUROTRAUM, V22, P1123, DOI 10.1089/neu.2005.22.1123; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nangle MR, 2004, EUR J PHARMACOL, V502, P143, DOI 10.1016/j.ejphar.2004.08.033; Ozkaya O, 2010, RENAL FAILURE, V32, P368, DOI 10.3109/08860221003611729; Pacher P, 2006, CURR OPIN PHARMACOL, V6, P136, DOI 10.1016/j.coph.2006.01.001; Pacher P, 2005, TRENDS PHARMACOL SCI, V26, P302, DOI 10.1016/j.tips.2005.04.003; Pacher P, 2005, CURR MED CHEM, V12, P267, DOI 10.2174/0929867053363207; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Saba H, 2007, FREE RADICAL BIO MED, V42, P1571, DOI 10.1016/j.freeradbiomed.2007.02.016; Sahin K, 2010, FOOD CHEM TOXICOL, V48, P2670, DOI 10.1016/j.fct.2010.06.038; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Salvemini D, 1999, BRIT J PHARMACOL, V127, P685, DOI 10.1038/sj.bjp.0702604; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Srivastava RC, 1996, BIOMETALS, V9, P139; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; Trujillo M, 2002, ARCH BIOCHEM BIOPHYS, V397, P91, DOI 10.1006/abbi.2001.2619; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	65	36	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e86057	10.1371/journal.pone.0086057	http://dx.doi.org/10.1371/journal.pone.0086057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454954	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800055
J	Eckerle, I; Ehlen, L; Kallies, R; Wollny, R; Corman, VM; Cottontail, VM; Tschapka, M; Oppong, S; Drosten, C; Muller, MA				Eckerle, Isabella; Ehlen, Lukas; Kallies, Rene; Wollny, Robert; Corman, Victor M.; Cottontail, Veronika M.; Tschapka, Marco; Oppong, Samuel; Drosten, Christian; Mueller, Marcel A.			Bat Airway Epithelial Cells: A Novel Tool for the Study of Zoonotic Viruses	PLOS ONE			English	Article							SEROLOGICAL EVIDENCE; INFECTION; CORONAVIRUSES; RABIES; HANTAVIRUS; STRAINS; FAMILY; AGENT; HOSTS	Bats have been increasingly recognized as reservoir of important zoonotic viruses. However, until now many attempts to isolate bat-borne viruses in cell culture have been unsuccessful. Further, experimental studies on reservoir host species have been limited by the difficulty of rearing these species. The epithelium of the respiratory tract plays a central role during airborne transmission, as it is the first tissue encountered by viral particles. Although several cell lines from bats were established recently, no well-characterized, selectively cultured airway epithelial cells were available so far. Here, primary cells and immortalized cell lines from bats of the two important suborders Yangochiroptera and Yinpterochiroptera, Carollia perspicillata (Seba's short-tailed bat) and Eidolon helvum (Straw-colored fruit bat), were successfully cultured under standardized conditions from both fresh and frozen organ specimens by cell outgrowth of organ explants and by the use of serum-free primary cell culture medium. Cells were immortalized to generate permanent cell lines. Cells were characterized for their epithelial properties such as expression of cytokeratin and tight junctions proteins and permissiveness for viral infection with Rift-Valley fever virus and vesicular stomatitis virus Indiana. These cells can serve as suitable models for the study of bat-borne viruses and complement cell culture models for virus infection in human airway epithelial cells.	[Eckerle, Isabella; Ehlen, Lukas; Kallies, Rene; Wollny, Robert; Corman, Victor M.; Drosten, Christian; Mueller, Marcel A.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Cottontail, Veronika M.; Tschapka, Marco] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Tschapka, Marco] Smithsonian Trop Res Inst, Balboa, Panama; [Oppong, Samuel] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	University of Bonn; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Kwame Nkrumah University Science & Technology	Eckerle, I (corresponding author), Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.	eckerle@virology-bonn.de	Müller, Marcel A./O-2425-2019; Corman, Victor M/K-1319-2019; Kallies, René/ACK-2998-2022	Müller, Marcel A./0000-0003-2242-5117; Corman, Victor M/0000-0002-3605-0136; Kallies, Rene/0000-0002-9195-0276; Eckerle, Isabella/0000-0002-4850-7172	German Research Foundation (DFG) [DR 772/3- 1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG grant DR 772/3- 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-26; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Baillie GJ, 2004, J VIROL, V78, P5784, DOI 10.1128/JVI.78.11.5784-5798.2004; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Baker KS, 2013, J VIROL, V87, P1348, DOI 10.1128/JVI.01202-12; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Carrington CVF, 2008, EMERG INFECT DIS, V14, P1890, DOI 10.3201/eid1412.080642; Corman VM, 2013, J GEN VIROL, V94, P1984, DOI 10.1099/vir.0.054841-0; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; de Almeida MF, 2011, REV SOC BRAS MED TRO, V44, P140, DOI 10.1590/S0037-86822011005000011; de Mattos CA, 2000, J WILDLIFE DIS, V36, P231, DOI 10.7589/0090-3558-36.2.231; de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Escutenaire S, 2001, VIRUS RES, V74, P1, DOI 10.1016/S0168-1702(00)00224-0; Fagrouch Z, 2012, J GEN VIROL, V93, P2652, DOI 10.1099/vir.0.044149-0; Fernandez Z, 2003, J MED ENTOMOL, V40, P522, DOI 10.1603/0022-2585-40.4.522; Gonzalez J. P., 2008, HUMAN HLTH FORESTS G, P161; Goris K, 2009, J VIROL, V83, P1962, DOI 10.1128/JVI.01271-08; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; KEMP GE, 1988, B SOC PATHOL EXOT, V81, P40; KEMP GE, 1972, AM J TROP MED HYG, V21, P356, DOI 10.4269/ajtmh.1972.21.356; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Peel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030346; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; PRICE JL, 1978, AM J TROP MED HYG, V27, P162, DOI 10.4269/ajtmh.1978.27.162; PRICE JL, 1978, AM J TROP MED HYG, V27, P153, DOI 10.4269/ajtmh.1978.27.153; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Punyadarsaniya D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028429; Razafindratsimandresy R, 2009, J GEN VIROL, V90, P44, DOI 10.1099/vir.0.006825-0; Reusken CBEM, 2010, VECTOR-BORNE ZOONOT, V10, P785, DOI 10.1089/vbz.2009.0173; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Sulkin S E, 1974, Monogr Virol, V8, P1; TESH RB, 1970, AM J EPIDEMIOL, V91, P216, DOI 10.1093/oxfordjournals.aje.a121130; Weiss S, 2012, EMERG INFECT DIS, V18, P159, DOI 10.3201/eid1801.111026; Wise J, 2002, CULTURE EPITHELIAL C, P391; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; You Yingjian, 2013, Methods Mol Biol, V945, P123, DOI 10.1007/978-1-62703-125-7_9; Zhang HJ, 2012, J VIROL, V86, P8014, DOI 10.1128/JVI.00723-12	58	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84679	10.1371/journal.pone.0084679	http://dx.doi.org/10.1371/journal.pone.0084679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454736	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500014
J	Wilke, SA; Raam, T; Antonios, JK; Bushong, EA; Koo, EH; Ellisman, MH; Ghosh, A				Wilke, Scott A.; Raam, Tara; Antonios, Joseph K.; Bushong, Eric A.; Koo, Edward H.; Ellisman, Mark H.; Ghosh, Anirvan			Specific Disruption of Hippocampal Mossy Fiber Synapses in a Mouse Model of Familial Alzheimer's Disease	PLOS ONE			English	Article							PATTERN SEPARATION; DENDRITIC SPINES; AMYLOID PLAQUES; TRANSGENIC MICE; NMDA RECEPTORS; A-BETA; CA3; AMPA; INHIBITION; EXPRESSION	The earliest stages of Alzheimer's disease (AD) are characterized by deficits in memory and cognition indicating hippocampal pathology. While it is now recognized that synapse dysfunction precedes the hallmark pathological findings of AD, it is unclear if specific hippocampal synapses are particularly vulnerable. Since the mossy fiber (MF) synapse between dentate gyrus (DG) and CA3 regions underlies critical functions disrupted in AD, we utilized serial block-face electron microscopy (SBEM) to analyze MF microcircuitry in a mouse model of familial Alzheimer's disease (FAD). FAD mutant MF terminal complexes were severely disrupted compared to control - they were smaller, contacted fewer postsynaptic spines and had greater numbers of presynaptic filopodial processes. Multi-headed CA3 dendritic spines in the FAD mutant condition were reduced in complexity and had significantly smaller sites of synaptic contact. Significantly, there was no change in the volume of classical dendritic spines at neighboring inputs to CA3 neurons suggesting input-specific defects in the early course of AD related pathology. These data indicate a specific vulnerability of the DG-CA3 network in AD pathogenesis and demonstrate the utility of SBEM to assess circuit specific alterations in mouse models of human disease.	[Wilke, Scott A.; Raam, Tara; Antonios, Joseph K.; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ghosh, Anirvan] F Hoffmann La Roche & Co Ltd, pRED, Neurosci Discovery & Translat Area, Basel, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Roche Holding	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	anirvan.ghosh@roche.com		Raam, Tara/0000-0003-2963-8588; Antonios, Joseph/0000-0003-2704-4743	NCRR [5P41RR004050]; NIH [NS064124]; Gatsby Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064124] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NCRR grant 5P41RR004050 to M. H. E., NIH Grant NS064124 to A. G. and a research grant from the Gatsby Charitable Trust to A. G. NCRR URL: http://www.nih.gov/about/almanac/organization/NCRR.htm; NIH URL: http://www.nih.gov/; Gatsby Charitable Trust URL: http://www.gatsby.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1998, J NEUROSCI, V18, P3386; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Bischofberger J, 2006, PFLUG ARCH EUR J PHY, V453, P361, DOI 10.1007/s00424-006-0093-2; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; HENDERSON VW, 1989, ARCH NEUROL-CHICAGO, V46, P391, DOI 10.1001/archneur.1989.00520400045018; Henze DA, 2002, J NEUROPHYSIOL, V87, P15, DOI 10.1152/jn.00394.2001; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jheng SS, 2009, BEHAV BRAIN RES, V200, P42, DOI 10.1016/j.bbr.2008.12.029; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller SG, 2011, NEUROIMAGE, V56, P851, DOI 10.1016/j.neuroimage.2011.03.028; Mueller SG, 2010, HUM BRAIN MAPP, V31, P1339, DOI 10.1002/hbm.20934; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palmer A, 2011, BIOCHEM SOC T, V39, P902, DOI 10.1042/BST0390902; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Rolls ET, 2010, BEHAV BRAIN RES, V215, P180, DOI 10.1016/j.bbr.2010.03.027; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040	49	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84349	10.1371/journal.pone.0084349	http://dx.doi.org/10.1371/journal.pone.0084349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454724	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500010
J	Dorval, V; Mandemakers, W; Jolivette, F; Coudert, L; Mazroui, R; De Strooper, B; Hebert, SS				Dorval, Veronique; Mandemakers, Wim; Jolivette, Francis; Coudert, Laetitia; Mazroui, Rachid; De Strooper, Bart; Hebert, Sebastien S.			Gene and MicroRNA Transcriptome Analysis of Parkinson's Related LRRK2 Mouse Models	PLOS ONE			English	Article							KINASE 2 LRRK2; TRANSLATIONAL REPRESSION; EXPRESSION; PROTEIN; ASSOCIATION; BRAIN; MUTATIONS; RESPONSES; DISEASE	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of genetic Parkinson's disease (PD). The biological function of LRRK2 and how mutations lead to disease remain poorly defined. It has been proposed that LRRK2 could function in gene transcription regulation; however, this issue remains controversial. Here, we investigated in parallel gene and microRNA (miRNA) transcriptome profiles of three different LRRK2 mouse models. Striatal tissue was isolated from adult LRRK2 knockout (KO) mice, as well as mice expressing human LRRK2 wildtype (hLRRK2-WT) or the PD-associated R1441G mutation (hLRRK2-R1441G). We identified a total of 761 genes and 24 miRNAs that were misregulated in the absence of LRRK2 when a false discovery rate of 0.2 was applied. Notably, most changes in gene expression were modest (i.e., <2 fold). By real-time quantitative RT-PCR, we confirmed the variations of selected genes (e. g., adra2, syt2, opalin) and miRNAs (e. g., miR-16, miR-25). Surprisingly, little or no changes in gene expression were observed in mice expressing hLRRK2-WT or hLRRK2-R1441G when compared to non-transgenic controls. Nevertheless, a number of miRNAs were misexpressed in these models. Bioinformatics analysis identified several miRNA-dependent and independent networks dysregulated in LRRK2-deficient mice, including PD-related pathways. These results suggest that brain LRRK2 plays an overall modest role in gene transcription regulation in mammals; however, these effects seem context and RNA type-dependent. Our data thus set the stage for future investigations regarding LRRK2 function in PD development.	[Dorval, Veronique; Jolivette, Francis; Coudert, Laetitia; Mazroui, Rachid; Hebert, Sebastien S.] CHUL, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [Dorval, Veronique; Jolivette, Francis; Hebert, Sebastien S.] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Coudert, Laetitia; Mazroui, Rachid] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada; [Mandemakers, Wim; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Mandemakers, Wim; De Strooper, Bart] VIB, Dept Mol & Dev Genet, Louvain, Belgium	Laval University; Laval University; Laval University; KU Leuven; Flanders Institute for Biotechnology (VIB)	Dorval, V (corresponding author), CHUL, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada.	veronique.dorval@crchul.ulaval.ca; Sebastien.hebert@neurosciences.ulaval.ca	de+Strooper, Bart/Z-1638-2019; Hébert, Sébastien S./Q-2729-2017	Mandemakers, Wim/0000-0003-2673-5972; Hebert, Sebastien/0000-0002-0391-9325	Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec - Sante; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Fonds de recherche du Quebec - Sante, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bailey RM, 2013, ACTA NEUROPATHOL; Bandmann O, 2012, NEUROLOGY, V78, P772, DOI 10.1212/WNL.0b013e318249f744; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Davies P, 2013, BIOCHEM J, V453, P101, DOI 10.1042/BJ20121742; Devine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022489; Dickson D. W., 2012, COLD SPRING HARB PER, V2; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dorval V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044060; Dorval Veronique, 2012, Front Neurol, V3, P12, DOI 10.3389/fneur.2012.00012; Ferree A, 2012, NEURODEGENER DIS, V10, P238, DOI 10.1159/000332599; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Gareau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055342; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Granic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060718; Habig K, 2008, NEUROGENETICS, V9, P83, DOI 10.1007/s10048-007-0114-0; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Kawakami F, 2013, FEBS J; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li TX, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/942412; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mandemakers W, 2012, NEUROBIOL DIS, V48, P582, DOI 10.1016/j.nbd.2012.07.017; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Meister G, 2013, NAT REV GENET; Molotski N, 2012, RNA, V18, P1612, DOI 10.1261/rna.033142.112; Nadler JJ, 2006, GENETICS, V174, P1229, DOI 10.1534/genetics.106.061481; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Nikonova EV, 2012, HUM MOL GENET, V21, P163, DOI 10.1093/hmg/ddr451; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Schulz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020820; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smith PY, 2011, HUM MOL GENET, V20, P4016, DOI 10.1093/hmg/ddr330; Trancikova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047784; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062	47	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85510	10.1371/journal.pone.0085510	http://dx.doi.org/10.1371/journal.pone.0085510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427314	gold, Green Published, Green Submitted			2022-12-27	WOS:000329868200055
J	Renk, H; Regamey, N; Hartl, D				Renk, Hanna; Regamey, Nicolas; Hartl, Dominik			Influenza A(H1N1)pdm09 and Cystic Fibrosis Lung Disease: A Systematic Meta-Analysis	PLOS ONE			English	Article							RESPIRATORY VIRAL-INFECTIONS; H1N1 VIRUS-INFECTION; PANDEMIC INFLUENZA; A H1N1; UNITED-STATES; CHILDREN; IMPACT; VACCINATION; PATHOGENS; ILLNESS	Background: To systematically assess the literature published on the clinical impact of Influenza A(H1N1)pdm09 on cystic fibrosis (CF) patients. Methods: An online search in PUBMED database was conducted. Original articles on CF patients with Influenza A(H1N1)pdm09 infection were included. We analyzed incidence, symptoms, clinical course and treatment. Results: Four surveys with a total of 202 CF patients infected by Influenza A(H1N1)pdm09 were included. The meta-analysis showed that hospitalisation rates were higher in CF patients compared to the general population. While general disease symptoms were comparable, the clinical course was more severe and case fatality rate (CFR) was higher in CF patients compared to asthmatics and the general population. Conclusions: Evidence so far suggests that CF patients infected with Influenza A(H1N1)pdm09 show increased morbidity and a higher CFR compared to patients with other chronic respiratory diseases and healthy controls. Particularly, CF patients with advanced stage disease seem to be more susceptible to severe lung disease. Accordingly, early antiviral and antibiotic treatment strategies are essential in CF patients. Preventive measures, including vaccination as well as hygiene measures during the influenza season, should be reinforced and improved in CF patients.	[Renk, Hanna; Hartl, Dominik] Univ Tubingen, Univ Childrens Hosp, Tubingen, Germany; [Regamey, Nicolas] Univ Bern, Inselspital, Dept Paediat, CH-3010 Bern, Switzerland; [Regamey, Nicolas] Univ Bern, Bern, Switzerland	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bern; University Hospital of Bern; University of Bern	Renk, H (corresponding author), Univ Tubingen, Univ Childrens Hosp, Tubingen, Germany.	Hanna.Renk@med.uni-tuebingen.de		Regamey, Nicolas/0000-0001-6849-6469; Renk, Hanna/0000-0001-7793-0968				Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bohmer MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-938; Burns JL, 2012, INFLUENZA OTHER RESP, V6, P218, DOI 10.1111/j.1750-2659.2011.00292.x; Canada PHAo Public Health Agency of Canada, 2011, FLU WATCH       0130; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chan M., 2009, WORLD NOW START 2009; Chattoraj SS, 2011, THORAX, V66, P333, DOI 10.1136/thx.2010.151431; Colombo C, 2011, THORAX, V66, P260, DOI 10.1136/thx.2010.157032; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; France MW, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-8; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hadler JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011677; Hoek RAS, 2013, SCAND J INFECT DIS, V45, P65, DOI 10.3109/00365548.2012.708942; Hollmeyer H, 2012, INFLUENZA OTHER RESP; Inamasu T, 2012, EMERG INFECT DIS, V18, P1882, DOI 10.3201/eid1811.111681; Institute RK, 2009, EPIDEMIOLOGISCHES B, P409; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kieninger E, 2012, EUR RESPIR J, V39, P297, DOI 10.1183/09031936.00054511; Kieninger E, 2012, CHEST; Lera E, 2011, EUR J PEDIATR, V170, P371, DOI 10.1007/s00431-011-1399-4; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Lopez L, 2011, INFLUENZA SURVEILLAN; McKenna JJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-57; Mehta G, 2010, J CYST FIBROS, V9, pS5, DOI 10.1016/j.jcf.2010.08.002; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Muscedere J, 2013, CHEST; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Mytton OT, 2012, EURO SURVEILL, V17, P20139; Nash EF, 2011, THORAX, V66, P259, DOI 10.1136/thx.2010.140822; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nishiura Hiroshi, 2010, Expert Rev Respir Med, V4, P329, DOI 10.1586/ers.10.24; Patria MF, 2013, EXPERT REV VACCINES, V12, P415, DOI [10.1586/erv.13.12, 10.1586/ERV.13.12]; Pecavar B, 2011, WIEN KLIN WOCHENSCHR, V123, P662, DOI 10.1007/s00508-011-0054-4; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; RAMSEY BW, 1989, AM J DIS CHILD, V143, P662, DOI 10.1001/archpedi.1989.02150180040017; Randolph AG, 2011, PEDIATRICS, V128, pE1450, DOI 10.1542/peds.2011-0774; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sachedina N, 2010, LANCET, V376, P1846, DOI 10.1016/S0140-6736(10)61195-6; Stelzer-Braid S, 2012, J VIROL METHODS, V186, P109, DOI 10.1016/j.jviromet.2012.08.008; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Van Ewijk BE, 2007, PEDIATR RES, V61, P398, DOI 10.1203/pdr.0b013e3180332d1c; van Ewijk Bart E, 2005, J Cyst Fibros, V4 Suppl 2, P31, DOI 10.1016/j.jcf.2005.05.011; van Ewijk BE, 2008, PEDIATRICS, V122, P1171, DOI 10.1542/peds.2007-3139; Viviani L, 2011, J CYST FIBROS, V10, P370, DOI 10.1016/j.jcf.2011.06.004; WANG EEL, 1984, NEW ENGL J MED, V311, P1653, DOI 10.1056/NEJM198412273112602; Wat D, 2003, POSTGRAD MED J, V79, P201, DOI 10.1136/pmj.79.930.201; Wat Dennis, 2003, Paediatr Respir Rev, V4, P172, DOI 10.1016/S1526-0542(03)00059-9; WHO, 2013, GEN HUM DIS MON DIS; WHO, 2013, EP VIR SIT UPD 2012; WHO, 2013, INFL UPD 182 182 3 4, V182, P3; Xu WL, 2006, J INTERF CYTOK RES, V26, P609, DOI 10.1089/jir.2006.26.609; Yang L, 2012, EURO SURVEILL, V17; Zheng S, 2003, IMMUNITY, V18, P619, DOI 10.1016/S1074-7613(03)00114-6	59	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e78583	10.1371/journal.pone.0078583	http://dx.doi.org/10.1371/journal.pone.0078583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427261	gold, Green Published, Green Submitted			2022-12-27	WOS:000329868200001
J	Xu, YJ; Gong, W; Peng, J; Wang, HR; Huang, J; Ding, H; Wang, DW				Xu, Yujun; Gong, Wei; Peng, Jia; Wang, Haoran; Huang, Jin; Ding, Hu; Wang, Dao Wen			Functional Analysis LRP6 Novel Mutations in Patients with Coronary Artery Disease	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; MUSCLE-CELL PROLIFERATION; LOW-DENSITY-LIPOPROTEIN; BETA-CATENIN; ATHEROSCLEROSIS; ANGIOGENESIS; MECHANISMS; VARIANTS; PATHWAYS; FAMILY	Background: Genetic architecture of coronary artery disease (CAD) is still to be defined. Since low density lipoprotein receptor-related protein 6 (LRP6) gene play critical roles in Wnt signal transduction which are important for vascular development and endodermis specification, we therefore resequenced it to search for mutations in CAD patients. Methods: We systemically sequenced all the exons and promoter region of LRP6 gene in a sample of 380 early onset CAD patients and 380 control subjects in Chinese. Results: In total, we identified 5 patient-specific mutations including K82N (two patients), S488Y (one patient), P1066T (two patients), P1206H (two patients) and I1264V (one patient) All these mutations located at the extracellular domain of LRP6 gene. In vitro functional analysis of patient-specific mutations demonstrated that these mutations resulted in a significant reduction in both protein level transporting to cell membrane and downstream Wnt signal activity. Furthermore, we found that LRP6 novel mutations attenuated proliferation and migration of human umbilical vein endothelial cells (HUVECs) when compared with wild type (WT) LRP6. Conclusion: Our results demonstrated that these loss-of-function variants might contribute to disease liability in a subset of CAD and defects in Wnt signal activation might be important contributing factors for the onset of CAD.	[Xu, Yujun; Gong, Wei; Peng, Jia; Wang, Haoran; Huang, Jin; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430074, Peoples R China; [Xu, Yujun; Gong, Wei; Peng, Jia; Wang, Haoran; Huang, Jin; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China; [Xu, Yujun] Sichuan Univ, West China Hosp, Intens Care Unit, Chengdu 610064, Peoples R China; [Peng, Jia] Sichuan Prov Hosp, Echocardiog Lab, Chengdu, Peoples R China; [Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Genet Diag Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Sichuan University; Huazhong University of Science & Technology	Ding, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430074, Peoples R China.	dingo8369@163.com; dwwang@tjh.tjmu.edu.cn	Wang, Haoran/ABC-6993-2021; huang, jin/GRY-1978-2022	Wang, Haoran/0000-0002-5534-6610; Wang, Dao Wen/0000-0002-9774-3980; ding, hu/0000-0002-1814-1552	973 program [2012CB518004]; 863 program [2012AA02A510]; National Nature Science Foundation of China [81100066]; Key Project of Health Ministration	973 program(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Health Ministration	This work was supported by 973 program (No. 2012CB518004), 863 program (No. 2012AA02A510), National Nature Science Foundation of China (No. 81100066) and Key Project of Health Ministration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedel A, 2008, CIRC RES, V103, P694, DOI 10.1161/CIRCRESAHA.107.166405; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Ding H, 2010, CIRC RES, V106, P1145, DOI 10.1161/CIRCRESAHA.109.215616; Francis AA, 2011, EXP CLIN CARDIOL, V16, P77; Gelfand BD, 2011, ARTERIOSCL THROM VAS, V31, P1625, DOI 10.1161/ATVBAHA.111.227827; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Keramati AR, 2011, P NATL ACAD SCI USA, V108, P1914, DOI 10.1073/pnas.1019443108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Sarzani R, 2011, NUTR METAB CARDIOVAS, V21, P150, DOI 10.1016/j.numecd.2009.08.004; Schunkert H, 2010, EUR HEART J, V31, P918, DOI 10.1093/eurheartj/ehq038; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tsaousi A, 2011, CURR OPIN LIPIDOL, V22, P350, DOI 10.1097/MOL.0b013e32834aa701; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449	29	18	21	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84345	10.1371/journal.pone.0084345	http://dx.doi.org/10.1371/journal.pone.0084345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427284	gold, Green Submitted, Green Published			2022-12-27	WOS:000329868200024
J	Blechert, J; Naumann, E; Schmitz, J; Herbert, BM; Tuschen-Caffier, B				Blechert, Jens; Naumann, Eva; Schmitz, Julian; Herbert, Beate M.; Tuschen-Caffier, Brunna			Startling Sweet Temptations: Hedonic Chocolate Deprivation Modulates Experience, Eating Behavior, and Eyeblink Startle	PLOS ONE			English	Article							BARRATT IMPULSIVENESS SCALE; DISORDER EXAMINATION-QUESTIONNAIRE; TEST MEAL INTAKE; GERMAN VERSION; FOOD CUES; PSYCHOMETRIC PROPERTIES; MOTIVATIONAL RESPONSES; ORBITOFRONTAL CORTEX; BULIMIA-NERVOSA; CALORIE CONTENT	Many individuals restrict their food intake to prevent weight gain. This restriction has both homeostatic and hedonic effects but their relative contribution is currently unclear. To isolate hedonic effects of food restriction, we exposed regular chocolate eaters to one week of chocolate deprivation but otherwise regular eating. Before and after this hedonic deprivation, participants viewed images of chocolate and images of high-calorie but non-chocolate containing foods, while experiential, behavioral and eyeblink startle responses were measured. Compared to satiety, hedonic deprivation triggered increased chocolate wanting, liking, and chocolate consumption but also feelings of frustration and startle potentiation during the intertrial intervals. Deprivation was further characterized by startle inhibition during both chocolate and food images relative to the intertrial intervals. Individuals who responded with frustration to the manipulation and those who scored high on a questionnaire of impulsivity showed more relative startle inhibition. The results reveal the profound effects of hedonic deprivation on experiential, behavioral and attentional/appetitive response systems and underscore the role of individual differences and state variables for startle modulation. Implications for dieting research and practice as well as for eating and weight disorders are discussed.	[Blechert, Jens] Salzburg Univ, Dept Clin Psychol Psychotherapy & Heath Psychol, A-5020 Salzburg, Austria; [Naumann, Eva; Schmitz, Julian; Tuschen-Caffier, Brunna] Univ Freiburg, Dept Clin Psychol & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany; [Herbert, Beate M.] Univ Ulm, Inst Psychol & Educ, Dept Hlth Psychol, D-89069 Ulm, Germany	Salzburg University; University of Freiburg; Ulm University	Tuschen-Caffier, B (corresponding author), Univ Freiburg, Dept Clin Psychol & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany.	tuschen@psychologie.uni-freiburg.de	Blechert, Jens/X-4040-2019; Naumann, Eva/ABE-1671-2021; Herbert, Beate/L-5036-2015	Blechert, Jens/0000-0002-3820-109X; Herbert, Beate/0000-0002-3284-4529	Albert Ludwigs University Freiburg	Albert Ludwigs University Freiburg	The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg.	Amsel A., 1992, FRUSTRATION THEORY; Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; Arana FS, 2003, J NEUROSCI, V23, P9632; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Berthoud HR, 2012, OBESITY, V14, p197S; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; Carter JC, 2001, BEHAV RES THER, V39, P625, DOI 10.1016/S0005-7967(00)00033-4; Cartwright Fiona, 2008, Eat Behav, V9, P1, DOI 10.1016/j.eatbeh.2007.01.006; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Cooper PJ, 1997, BRIT J PSYCHIAT, V171, P542, DOI 10.1192/bjp.171.6.542; Dagher A, 2012, TRENDS ENDOCRIN MET, V23, P250, DOI 10.1016/j.tem.2012.02.009; Davis M., 1999, STARTLE MODIFICATION, P95; Dinkel A, 2005, DIAGNOSTICA, V51, P67, DOI 10.1026/0012-1924.51.2.67; Dougherty DM, 2005, BEHAV RES METHODS, V37, P82, DOI 10.3758/BF03206401; Drobes DJ, 2001, BIOL PSYCHOL, V57, P153, DOI 10.1016/S0301-0511(01)00093-X; Erskine J. A. K., 2013, CHOCOLATE HLTH NUTR, V7, P479, DOI [10.1007/978-1-61779-803-0_36, DOI 10.1007/978-1-61779-803-0_36]; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Friederich HC, 2006, PSYCHOL MED, V36, P1327, DOI 10.1017/S0033291706008129; Galanti K, 2007, INT J EAT DISORDER, V40, P727, DOI 10.1002/eat.20441; Goldstone AP, 2009, EUR J NEUROSCI, V30, P1625, DOI 10.1111/j.1460-9568.2009.06949.x; Hartmann AS, 2011, PERCEPT MOTOR SKILL, V112, P353, DOI 10.2466/08.09.10.PMS.112.2.353-368; HARVEY J, 1993, APPETITE, V21, P105, DOI 10.1016/0195-6663(93)90003-3; Hawk LW, 2004, APPETITE, V43, P285, DOI 10.1016/j.appet.2004.06.008; Herbert BM, 2012, BIOL PSYCHOL, V89, P71, DOI 10.1016/j.biopsycho.2011.09.004; Herman C. P., 1980, OBESITY, P208; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; HITCHCOCK J, 1986, BEHAV NEUROSCI, V100, P11, DOI 10.1037/0735-7044.100.1.11; Hoefling A, 2008, APPETITE, V51, P681, DOI 10.1016/j.appet.2008.06.004; Hou RH, 2011, APPETITE, V56, P424, DOI 10.1016/j.appet.2011.01.019; Jasinska AJ, 2012, APPETITE; Jones JM, 2001, CAN MED ASSOC J, V165, P547; Kemps E, 2009, EXP CLIN PSYCHOPHARM, V17, P425, DOI 10.1037/a0017796; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; KISSILEFF HR, 1982, ANNU REV NUTR, V2, P371, DOI 10.1146/annurev.nu.02.070182.002103; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LAPPALAINEN R, 1990, INT J OBESITY, V14, P679; Laux L., 1981, STATE TRAIT ANGSTINV; Lipp OV, 2001, J PSYCHOPHYSIOL, V15, P173, DOI 10.1027//0269-8803.15.3.173; Long CG, 2011, BR J MED PSYCHOL, V55, P139; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; Macht M, 2011, EMOTION REGULATION AND WELL-BEING, P281, DOI 10.1007/978-1-4419-6953-8_17; Mann T, 2001, INT J EAT DISORDER, V29, P319, DOI 10.1002/eat.1025; Mauler BI, 2006, J ABNORM PSYCHOL, V115, P567, DOI 10.1037/0021-843X.115.3.567; Meule A, 2012, OBESITY FACTS S2; Meule A, 2014, APPETITE, V79, P174, DOI 10.1016/j.appet.2014.04.014; Meule A, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00669, 10.3389/fpsyg.2013.00177]; Meule Adrian, 2012, Front Psychiatry, V3, P64, DOI 10.3389/fpsyt.2012.00064; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Moreno-Dominguez S, 2012, APPETITE, V58, P111, DOI 10.1016/j.appet.2011.09.013; Nasser JA, 2004, APPETITE, V43, P303, DOI 10.1016/j.appet.2004.04.006; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Papachristou H, 2013, PSYCHOPHARMACOLOGY, V228, P641, DOI 10.1007/s00213-013-3063-3; Papachristou H, 2012, PSYCHOPHARMACOLOGY, V224, P145, DOI 10.1007/s00213-012-2747-4; Papachristou H, 2012, PSYCHOPHARMACOLOGY, V219, P511, DOI 10.1007/s00213-011-2240-5; Parylak SL, 2011, PHYSIOL BEHAV, V104, P149, DOI 10.1016/j.physbeh.2011.04.063; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Pelchat ML, 2000, PHYSIOL BEHAV, V68, P353, DOI 10.1016/S0031-9384(99)00190-0; Penas-Lledo E, 2002, INT J EAT DISORDER, V32, P98, DOI 10.1002/eat.10039; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Preuss UW, 2008, NERVENARZT, V79, P305, DOI 10.1007/s00115-007-2360-7; Rejeski WJ, 2010, APPETITE, V54, P77, DOI 10.1016/j.appet.2009.09.009; Rodriguez S, 2005, BIOL PSYCHOL, V70, P9, DOI 10.1016/j.biopsycho.2004.10.001; Schag K, 2013, OBESITY REV; Seibt B, 2007, EUR J SOC PSYCHOL, V37, P359, DOI 10.1002/ejsp.365; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Smeets E, 2009, APPETITE, V53, P370, DOI 10.1016/j.appet.2009.07.020; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stockburger J, 2009, NEUROIMAGE, V47, P1819, DOI 10.1016/j.neuroimage.2009.04.071; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tapper K, 2010, EMOTION, V10, P949, DOI 10.1037/a0020305; Thamotharan S, 2012, CLIN PSYCHOL REV; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; van Koningsbruggen GM, 2013, BR J HLTH PSYCHOL; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; WEINGARTEN HP, 1991, APPETITE, V17, P167, DOI 10.1016/0195-6663(91)90019-O; Wilhelm F. H., 2005, AUTONOMIC NERVOUS SY; Wittchen H.-U., 1997, SKID STRUKTURIERTES; WOOLEY OW, 1981, APPETITE, V2, P331, DOI 10.1016/S0195-6663(81)80019-0; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	85	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85679	10.1371/journal.pone.0085679	http://dx.doi.org/10.1371/journal.pone.0085679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291XP	24416437	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300095
J	Gherasim, C; Yadav, PK; Kabil, O; Niu, WN; Banerjee, R				Gherasim, Carmen; Yadav, Pramod K.; Kabil, Omer; Niu, Wei-Ning; Banerjee, Ruma			Nitrite Reductase Activity and Inhibition of H2S Biogenesis by Human Cystathionine beta-Synthase	PLOS ONE			English	Article							HYDROGEN-SULFIDE; TRANSSULFURATION PATHWAY; HEME; OXIDE; NO; SYSTEMS; METHEMOGLOBIN; HEMOGLOBIN; CYTOGLOBIN; MAGNITUDE	Nitrite was recognized as a potent vasodilator >130 years and has more recently emerged as an endogenous signaling molecule and modulator of gene expression. Understanding the molecular mechanisms that regulate nitrite metabolism is essential for its use as a potential diagnostic marker as well as therapeutic agent for cardiovascular diseases. In this study, we have identified human cystathionine beta-synthase (CBS) as a new player in nitrite reduction with implications for the nitrite-dependent control of H2S production. This novel activity of CBS exploits the catalytic property of its unusual heme cofactor to reduce nitrite and generate NO. Evidence for the possible physiological relevance of this reaction is provided by the formation of ferrous-nitrosyl (Fe-II-NO) CBS in the presence of NADPH, the human diflavin methionine synthase reductase (MSR) and nitrite. Formation of Fe-II-NO CBS via its nitrite reductase activity inhibits CBS, providing an avenue for regulating biogenesis of H2S and cysteine, the limiting reagent for synthesis of glutathione, a major antioxidant. Our results also suggest a possible role for CBS in intracellular NO biogenesis particularly under hypoxic conditions. The participation of a regulatory heme cofactor in CBS in nitrite reduction is unexpected and expands the repertoire of proteins that can liberate NO from the intracellular nitrite pool. Our results reveal a potential molecular mechanism for cross-talk between nitrite, NO and H2S biology.	[Gherasim, Carmen; Yadav, Pramod K.; Kabil, Omer; Niu, Wei-Ning; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Niu, Wei-Ning] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Peoples R China	University of Michigan System; University of Michigan; Northwestern Polytechnical University	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020; Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant from the National Institutes of Health (HL58984). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Benarroch EE, 2011, NEUROLOGY, V77, P1568, DOI 10.1212/WNL.0b013e318233b3e4; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Fago A, 2012, COMP BIOCHEM PHYS A, V162, P1, DOI 10.1016/j.cbpa.2012.01.011; Filipovic MR, 2012, J AM CHEM SOC, V134, P12016, DOI 10.1021/ja3009693; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gherasim CG, 2008, BIOCHEMISTRY-US, V47, P12515, DOI 10.1021/bi8008328; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Hon YY, 2010, DRUG METAB DISPOS, V38, P1707, DOI 10.1124/dmd.110.034355; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Kabil O, 2013, ANTIOXID REDOX SIGNA; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; KERY V, 1994, J BIOL CHEM, V269, P25283; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1999, BIOCHEMISTRY-US, V38, P7406, DOI 10.1021/bi995077i; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P253, DOI 10.1016/S0162-0134(01)00336-1; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Vega-Villa K, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.35; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Yadav PK, 2013, J BIOL CHEM; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yi J, 2011, ACTA CRYSTALLOGR F, V67, P647, DOI 10.1107/S1744309111012528; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	60	36	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85544	10.1371/journal.pone.0085544	http://dx.doi.org/10.1371/journal.pone.0085544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416422	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500255
J	Su, XN; Shang, L; Xu, QL; Li, NN; Chen, JH; Zhang, LP; Zhang, L; Hua, QZ				Su, Xiangni; Shang, Lei; Xu, Qiaoling; Li, Nannan; Chen, Jianhua; Zhang, Liping; Zhang, Lei; Hua, Qianzhen			Prevalence and Predictors of Mild Cognitive Impairment in Xi'an: A Community-Based Study among the Elders	PLOS ONE			English	Article							DEMENTIA RATING-SCALE; ALZHEIMERS-DISEASE; CLINICAL VALIDITY; EDUCATION; ATROPHY; BRAIN; CHINA	Mild cognitive impairment (MCI) is an intermediate stage between normal cognitive function and dementia among aging individuals. This study was designed to estimate the prevalence of MCI and explore the possible risk factors including gender disparities among community-dwelling older individuals. The study was conducted in Xi'an, China. This is a cross-sectional study. A total of 815 individuals, 60 years and older were selected by stratified random cluster sampling. Cognitive function was measured using the mini-mental status examination (MMSE), the Chinese version of the Dementia Rating Scales (CDRS) was used to apply the diagnostic of non-dementia, and activities of daily living (ADL) and instrumental activities of daily living (IADL) systems were used to functional status. The association between sociodemographic characteristics, lifestyle, history of chronic diseases and MCI were evaluated separately for men and women using the Pearson chi(2)-test and binary logistic regression. Of the 815 community-dwelling individuals, 145 were found to have MCI. Overall, the prevalence of MCI was 18.5%, with a prevalence of 19.6% in women (105/535), and 15.3% (40/261) in men. The results of the binary logistical regression analysis indicated that age and history of stroke were associated with MCI in men. For women, the risk factors were lower level of educational and lack of religious attendance. Results suggested that the factors capable of influencing MCI differed profoundly between older men and older women. For this reason, different preventative measures should be adopted to delay or reverse cognitive impairment among community-dwelling older men and women.	[Su, Xiangni; Xu, Qiaoling; Li, Nannan; Chen, Jianhua; Hua, Qianzhen] Fourth Mil Med Univ, Dept Nursing, Xian 710032, Peoples R China; [Shang, Lei] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China; [Zhang, Liping] Hlth Coll, Dept Nursing, Xian, Peoples R China; [Zhang, Lei] Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhang, L (corresponding author), Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Peoples R China.	shaochen@fmmu.edu.cn; qianzhen@fmmu.edu.cn	Zhang, Li/GWM-7501-2022		Key Science and Technology Projects of Shaanxi Province [2011K15-04-02]	Key Science and Technology Projects of Shaanxi Province	Financial support was provided by the Key Science and Technology Projects of Shaanxi Province (No: 2011K15-04-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, THERE WILL BE 35 MIL; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Chan AS, 2003, J INT NEUROPSYCH SOC, V9, P45, DOI 10.1017/S1355617703910058; Christensen H, 2007, GERONTOLOGY, V53, P82, DOI 10.1159/000096482; Cui GH, 2011, ACTA NEUROL SCAND, V124, P361, DOI 10.1111/j.1600-0404.2010.01484.x; Martinez MF, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-39; FERRARO KF, 1994, J SCI STUD RELIG, V33, P362, DOI 10.2307/1386495; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guan SC., 2008, CHIN J CEREBROVASC D, V9, P395, DOI DOI 10.1016/j.jns.2011.08.026; Guo QH, 2004, CHIN J CLIN PSYCHOL, V3, P237; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hill TD, 2006, J GERONTOL B-PSYCHOL, V61, pP3, DOI 10.1093/geronb/61.1.P3; [黄若燕 HUANG Ruoyan], 2008, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V34, P533; Jarvis G Eric, 2005, Transcult Psychiatry, V42, P657, DOI 10.1177/1363461505058921; KATZ S, 1989, J AM GERIATR SOC, V37, P267, DOI 10.1111/j.1532-5415.1989.tb06820.x; Katzman R, 1988, J CLIN EPIDEMIOL; Koepsell TD, 2008, NEUROLOGY, V70, P1732, DOI 10.1212/01.wnl.0000284603.85621.aa; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lei MY, 2008, CHIN MENT HLTH J, V22; Liu B, 2005, J GUANGZHOU U TRADIT, V22, P366; [刘吉林 Liu JL], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P5869; Mattis S, 1988, DEMENTIA RATING SCAL; MONSCH AU, 1995, ARCH NEUROL-CHICAGO, V52, P899, DOI 10.1001/archneur.1995.00540330081018; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Nie HW, 2011, INT J GERIATR PSYCH, V26, P558, DOI 10.1002/gps.2579; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Perneczky R, 2009, J ALZHEIMERS DIS, V17, P855, DOI 10.3233/JAD-2009-1117; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Rosario PW, 2012, ARQ BRAS ENDOCRINOL, V56, P338, DOI 10.1590/S0004-27302012000500011; Sasaki M, 2009, INT J GERIATR PSYCH, V24, P1119, DOI 10.1002/gps.2234; Shulman KI, 2006, INT PSYCHOGERIATR, V18, P281, DOI 10.1017/S1041610205002693; Stemmler M, 1994, NEW TRENDS DIAGNOSIS; Wu YG, 2005, J GUANGXI MED U, V22, P366; Xu MG, 2001, SHANGHAI ARCH PSYC S, V13, P15; Yanling H., 1990, CHIN J GERONTOL, V10, P266; Yu HuanQing, 2011, Progress in Modern Biomedicine, V11, P1885; Zhang MY, 1995, CHINA SHANGHAI PSYCH, V7, P3; Zhang W, 2010, J AGING RES, V2010; Zhang ZX, 2006, NEUROEPIDEMIOLOGY, V27, P177, DOI 10.1159/000096131; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P431; Zhou SN, 2006, CHIN STROKE, V10, P741; Zhu Z. Q., 2001, SHANGHAI ARCH PSYCHI, V13, P12	44	38	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83217	10.1371/journal.pone.0083217	http://dx.doi.org/10.1371/journal.pone.0083217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421876	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500036
C	Wang, LC; Chen, R; Kong, DH		Datta, A		Wang Lichun; Chen Ran; Kong Dehui			An Improved Patch based Multi-View Stereo (PMVS) Algorithm	PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND SERVICE SYSTEM (CSSS)	Advances in Intelligent Systems Research		English	Proceedings Paper	3rd International Conference on Computer Science and Service System (CSSS)	JUN 13-15, 2014	Bangkok, THAILAND			Multi-view reconstruction; PMVS; quasi-dense matching		Multi-view based reconstruction is always focused in computer graphics and many excellent algorithms have been reported these years. According to Middlebury benchmark, PMVS(Patch based Multi-View Stereo) outperforms all the other submitted algorithms [1]. In this paper, we propose an improved PMVS algorithm based on quasi-dense matching to save time cost of the original algorithm. Improved algorithm reduces running time for patch expansion through building a quasi-dense set of initial patches and depresses time complexity of the algorithm. The experiments demonstrate effectiveness of improved algorithm.	[Wang Lichun; Chen Ran; Kong Dehui] Beijing Univ Technol, Coll Metropolitan Transportat, Beijing Key Lab Multimedia & Intelligent Software, Beijing, Peoples R China	Beijing University of Technology	Wang, LC (corresponding author), Beijing Univ Technol, Coll Metropolitan Transportat, Beijing Key Lab Multimedia & Intelligent Software, Beijing, Peoples R China.			Wang, Lin/0000-0001-6911-0660				BAUMGART BG, 1974, THESIS STANFORD U; BRADLEY D, 2008, P IEEE C COMP VIS PA; Esteban CH, 2004, COMPUT VIS IMAGE UND, V96, P367, DOI 10.1016/j.cviu.2004.03.016; Faugeras O, 1998, IEEE T IMAGE PROCESS, V7, P336, DOI 10.1109/83.661183; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Furukawa Y, 2009, INT J COMPUT VISION, V81, P53, DOI 10.1007/s11263-008-0134-8; Goesele M., 2006, PROC IEEE COMPUT SOC, V2, P2402, DOI [10.1109/CVPR.2006.199, DOI 10.1109/CVPR.2006.199]; Habbecke M., 2006, INT FALL WORKSH VIS, P73; Hartley R., 2000, MULTIPLE VIEW GEOMET, V2; HEYDEN A, 1995, THESIS LUND I TECHNO; Hiep VH, 2009, PROC CVPR IEEE, P1430, DOI 10.1109/CVPRW.2009.5206617; KOLMOGOROV V, 2002, P 7 EUR C COMP VIS; Lhuillier M, 2005, IEEE T PATTERN ANAL, V27, P418, DOI 10.1109/TPAMI.2005.44; Lhuillier M, 2002, IEEE T PATTERN ANAL, V24, P1140, DOI 10.1109/TPAMI.2002.1023810; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Paris S., 2004, P AS C COMP VIS; Seitz S. M., 2010, MULTIVIEW STEREO EVA; Seitz S.M., 2006, CVPR; SINHA SN, 2007, P INT C COMP VIS; Strecha C., 2006, COMP VIS PATT REC 20, P2394, DOI [DOI 10.1109/CVPR.2006.78, 10.1109/CVPR.2006.78]; Torr PHS, 1997, INT J COMPUT VISION, V24, P271, DOI 10.1023/A:1007927408552; Tran S., 2006, P EUR C COMP VIS; Vogiatzis G., 2005, P IEEE C COMP VIS PA; Zaharescu A, 2007, LECT NOTES COMPUT SC, V4844, P166	24	14	16	0	15	ATLANTIS PRESS	PARIS	29 AVENUE LAVMIERE, PARIS, 75019, FRANCE	1951-6851		978-94-6252-012-7	ADV INTEL SYS RES			2014	109						9	12						4	Automation & Control Systems; Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Conference Proceedings Citation Index - Science (CPCI-S)	Automation & Control Systems; Computer Science	BC3ZP	24416438	Green Published, gold, Green Submitted			2022-12-27	WOS:000352132500007
J	Chatelard, S; Bodenmann, P; Vaucher, P; Herzig, L; Bischoff, T; Burnand, B				Chatelard, Sophia; Bodenmann, Patrick; Vaucher, Paul; Herzig, Lilli; Bischoff, Thomas; Burnand, Bernard			General Practitioners Can Evaluate the Material, Social and Health Dimensions of Patient Social Status	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; INEQUALITIES; DETERMINANTS	Objective: To identify which physician and patient characteristics are associated with physicians' estimation of their patient social status. Design: Cross-sectional multicentric survey. Setting: Fourty-seven primary care private offices in Western Switzerland. Participants: Random sample of 2030 patients >= 16, who encountered a general practitioner (GP) between September 2010 and February 2011. Main measures: Primary outcome: patient social status perceived by GPs, using the MacArthur Scale of Subjective Social Status, ranging from the bottom (0) to the top (10) of the social scale. Secondary outcome: Difference between GP's evaluation and patient's own evaluation of their social status. Potential patient correlates: material and social deprivation using the DiPCare-Q, health status using the EQ-5D, sources of income, and level of education. GP characteristics: opinion regarding patients' deprivation and its influence on health and care. Results: To evaluate patient social status, GPs considered the material, social, and health aspects of deprivation, along with education level, and amount and type of income. GPs declaring a frequent reflexive consideration of their own prejudice towards deprived patients, gave a higher estimation of patients' social status (+1.0, p = 0.002). Choosing a less costly treatment for deprived patients was associated with a lower estimation (-0.7, p = 0.002). GP's evaluation of patient social status was 0.5 point higher than the patient's own estimate (p<0.0001). Conclusions: GPs can perceive the various dimensions of patient social status, although heterogeneously, according partly to their own characteristics. Compared to patients' own evaluation, GPs overestimate patient social status.	[Chatelard, Sophia] Univ Grenoble 1, Dept Gen Practice, Grenoble, France; [Bodenmann, Patrick; Vaucher, Paul] Univ Lausanne, Vulnerable Populat Unit, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Vaucher, Paul] Univ Hosp Geneva, Dept Community Med & Primary Care, Geneva, Switzerland; [Herzig, Lilli; Bischoff, Thomas] Univ Lausanne, Inst Gen Practice, Lausanne, Switzerland; [Burnand, Bernard] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Lausanne; University of Geneva; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Chatelard, S (corresponding author), Univ Grenoble 1, Dept Gen Practice, Grenoble, France.	sophiachatelard@gmail.com	Vaucher, Paul/A-6259-2009	Vaucher, Paul/0000-0002-0652-0985; Bodenmann, Patrick/0000-0002-1058-1035	Swiss Academy of Medical Science; Department of Social Action and Health of the Canton of Vaud; Faculty of Biology and Medicine from the University of Lausanne	Swiss Academy of Medical Science; Department of Social Action and Health of the Canton of Vaud; Faculty of Biology and Medicine from the University of Lausanne	There were no fundings for the present study. The Swiss Academy of Medical Science, the Department of Social Action and Health of the Canton of Vaud and the Faculty of Biology and Medicine from the University of Lausanne gave fundings for the original study on which the present article is based. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Bloch G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-62; Chaix B, 2002, REV EPIDEMIOL SANTE, V50, P489; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Flores P, 2004, REV PRATICIEN, V54, P2263; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Merletti F, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S7; Norbury M, 2011, FAM PRACT, V28, P1, DOI 10.1093/fampra/cmq118; Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Ribet C, 2007, REV EPIDEMIOL SANTE, V55, P285, DOI 10.1016/j.respe.2007.04.001; Sass C, 2006, Sante Publique, V18, P513; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Thornton RLJ, 2011, PATIENT EDUC COUNS, V85, pE201, DOI 10.1016/j.pec.2011.07.015; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Vaucher P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000692; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Willems SJ, 2005, FAM PRACT, V22, P177, DOI 10.1093/fampra/cmh724	21	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84828	10.1371/journal.pone.0084828	http://dx.doi.org/10.1371/journal.pone.0084828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454752	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100034
J	Grafton, KT; Moir, LM; Black, JL; Hansbro, NG; Hansbro, PM; Burgess, JK; Oliver, BG				Grafton, Karryn T.; Moir, Lyn M.; Black, Judith L.; Hansbro, Nicole G.; Hansbro, Philip M.; Burgess, Janette K.; Oliver, Brian G.			LF-15 & T7, Synthetic Peptides Derived from Tumstatin, Attenuate Aspects of Airway Remodelling in a Murine Model of Chronic OVA-Induced Allergic Airway Disease	PLOS ONE			English	Article							ASTHMA; ANGIOGENESIS; INFLAMMATION; HYPERRESPONSIVENESS; IDENTIFICATION; SITE; MICE	Background: Tumstatin is a segment of the collagen-IV protein that is markedly reduced in the airways of asthmatics. Tumstatin can play an important role in the development of airway remodelling associated with asthma due to its anti-angiogenic properties. This study assessed the anti-angiogenic properties of smaller peptides derived from tumstatin, which contain the interface tumstatin uses to interact with the alpha V beta 3 integrin. Methods: Primary human lung endothelial cells were exposed to the LF-15, T3 and T7 tumstatin-derived peptides and assessed for cell viability and tube formation in vitro. The impact of the anti-angiogenic properties on airways hyperresponsiveness (AHR) was then examined using a murine model of chronic OVA-induced allergic airways disease. Results: The LF-15 and T7 peptides significantly reduced endothelial cell viability and attenuated tube formation in vitro. Mice exposed to OVA+ LF-15 or OVA+ T7 also had reduced total lung vascularity and AHR was attenuated compared to mice exposed to OVA alone. T3 peptides reduced cell viability but had no effect on any other parameters. Conclusion: The LF-15 and T7 peptides may be appropriate candidates for use as novel pharmacotherapies due to their small size and anti-angiogenic properties observed in vitro and in vivo.	[Grafton, Karryn T.; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Grafton, Karryn T.; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Hansbro, Nicole G.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Hansbro, Nicole G.; Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Oliver, BG (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	brianol@usyd.edu.au	Oliver, Brian/E-7939-2010; Burgess, Janette K/A-3597-2010; Burgess, Janette/M-7117-2019; Hansbro, Phil/G-7486-2013	Oliver, Brian/0000-0002-7122-9262; Hansbro, Phil/0000-0002-4741-3035; Burgess, Janette/0000-0001-9868-9966	Cooperative Research Centre for Asthma and Airways	Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding provided by Cooperative Research Centre for Asthma and Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asosingh K, 2007, J IMMUNOL, V178, P6482, DOI 10.4049/jimmunol.178.10.6482; Burgess JK, 2010, AM J RESP CRIT CARE, V181, P106, DOI 10.1164/rccm.200904-0631OC; Eikesdal HP, 2008, P NATL ACAD SCI USA, V105, P15040, DOI 10.1073/pnas.0807055105; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Herbert C, 2008, CLIN EXP ALLERGY, V38, P847, DOI 10.1111/j.1365-2222.2008.02950.x; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Laube BL, 2001, CHEST, V120, p99S, DOI 10.1378/chest.120.3_suppl.99S; Lee SY, 2006, J ALLERGY CLIN IMMUN, V117, P597, DOI 10.1016/j.jaci.2005.11.008; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Shifren A, 2012, J ALLERGY, V2012, P1, DOI DOI 10.1155/2012/316049; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Zan JH, 2012, MOL SIMULAT, V38, P498, DOI 10.1080/08927022.2011.649428	15	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85655	10.1371/journal.pone.0085655	http://dx.doi.org/10.1371/journal.pone.0085655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454912	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100115
J	Ni, J; Zhu, ZX; Wang, GH; Shen, YX; Zhang, YY; Wu, P				Ni, Jun; Zhu, Zhenxing; Wang, Gaohang; Shen, Yanxia; Zhang, Yanyan; Wu, Ping			Intragenic Suppressor of Osiaa23 Revealed a Conserved Tryptophan Residue Crucial for Protein-Protein Interactions	PLOS ONE			English	Article							AUXIN-RESPONSE-FACTOR; RICE ORYZA-SATIVA; LATERAL ROOT-FORMATION; AUX/IAA PROTEINS; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENE FAMILY; GROWTH; EXPRESSION; RECEPTOR	The Auxin/Indole-3-Acetic Acid (Aux/IAA) and Auxin Response Factor (ARF) are two important families that play key roles in auxin signal transduction. Both of the families contain a similar carboxyl-terminal domain (Domain III/IV) that facilitates interactions between these two families. In spite of the importance of protein-protein interactions among these transcription factors, the mechanisms involved in these interactions are largely unknown. In this study, we isolated six intragenic suppressors of an auxin insensitive mutant, Osiaa23. Among these suppressors, Osiaa23-R5 successfully rescued all the defects of the mutant. Sequence analysis revealed that an amino acid substitution occurred in the Tryptophan (W) residue in Domain IV of Osiaa23. Yeast two-hybrid experiments showed that the mutation in Domain IV prevents the protein-protein interactions between Osiaa23 and OsARFs. Phylogenetic analysis revealed that the W residue is conserved in both OsIAAs and OsARFs. Next, we performed site-specific amino acid substitutions within Domain IV of OsARFs, and the conserved W in Domain IV was exchanged by Serine (S). The mutated OsARF(WS)s can be released from the inhibition of Osiaa23 and maintain the transcriptional activities. Expression of OsARF(WS) s in Osiaa23 mutant rescued different defects of the mutant. Our results suggest a previously unknown importance of Domain IV in both families and provide an indirect way to investigate functions of OsARFs.	[Ni, Jun; Shen, Yanxia; Zhang, Yanyan] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Ni, Jun; Zhu, Zhenxing; Wu, Ping] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Zhenxing; Wang, Gaohang] Liaoning Acad Agr Sci, Agr Crops Mol Improving Lab, Shenyang, Peoples R China	Hangzhou Normal University; Zhejiang University	Ni, J (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	nijun@hznu.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LQ13C020005]; Qianjiang talents project of Science Technology Department of Zhejiang Province [2012R10059]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Qianjiang talents project of Science Technology Department of Zhejiang Province	This work was funded by Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ13C020005, and Qianjiang talents project of Science Technology Department of Zhejiang Province (2012R10059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia KA, 2009, CURR ISSUES MOL BIOL, V11, pI29, DOI 10.21775/cimb.011.i29; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Chen SY, 2003, PLANT J, V36, P105, DOI 10.1046/j.1365-313X.2003.01860.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle TJ, 2012, PLANT SCI, V190, P82, DOI 10.1016/j.plantsci.2012.04.003; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kitomi Y, 2012, PLANT SCI, V190, P116, DOI 10.1016/j.plantsci.2012.04.005; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu H, 2012, FUNCT PLANT BIOL, V39, P736, DOI 10.1071/FP12106; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Ni J, 2011, PLANT J, V68, P433, DOI 10.1111/j.1365-313X.2011.04698.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Sato Y, 2001, GENES GENET SYST, V76, P373, DOI 10.1266/ggs.76.373; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tromas A, 2010, CR BIOL, V333, P297, DOI 10.1016/j.crvi.2010.01.005; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Waller F, 2002, PLANT MOL BIOL, V50, P415, DOI 10.1023/A:1019818110761; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Zhu ZX, 2012, MOL PLANT, V5, P154, DOI 10.1093/mp/ssr074	49	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85358	10.1371/journal.pone.0085358	http://dx.doi.org/10.1371/journal.pone.0085358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454849	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100073
J	Xiao, FX; Zimpelmann, J; Agaybi, S; Gurley, SB; Puente, L; Burns, KD				Xiao, Fengxia; Zimpelmann, Joseph; Agaybi, Samih; Gurley, Susan B.; Puente, Lawrence; Burns, Kevin D.			Characterization of Angiotensin-Converting Enzyme 2 Ectodomain Shedding from Mouse Proximal Tubular Cells	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME-2 ACE2; KIDNEY-DISEASE; DIABETIC MICE; URINARY ACE2; EXPRESSION; CARBOXYPEPTIDASE	Angiotensin-converting enzyme 2 (ACE2) is highly expressed in the kidney proximal tubule, where it cleaves angiotensin (Ang) II to Ang-(1-7). Urinary ACE2 levels increase in diabetes, suggesting that ACE2 may be shed from tubular cells. The aim of this study was to determine if ACE2 is shed from proximal tubular cells, to characterize ACE2 fragments, and to study pathways for shedding. Studies involved primary cultures of mouse proximal tubular cells, with ACE2 activity measured using a synthetic substrate, and analysis of ACE2 fragments by immunoblots and mass spectrometry. The culture media from mouse proximal tubular cells demonstrated a time-dependent increase in ACE2 activity, suggesting constitutive ACE2 shedding. ACE2 was detected in media as two bands at similar to 90 kDa and similar to 70 kDa on immunoblots. By contrast, full-length ACE2 appeared at similar to 100 kDa in cell lysates or mouse kidney cortex. Mass spectrometry of the two deglycosylated fragments identified peptides matching mouse ACE2 at positions 18-706 and 18-577, respectively. The C-terminus of the 18-706 peptide fragment contained a non-tryptic site, suggesting that Met(706) is a candidate ACE2 cleavage site. Incubation of cells in high D-glucose (25 mM) (and to a lesser extent Ang II) for 48-72 h increased ACE2 activity in the media (p<0.001), an effect blocked by inhibition of a disintegrin and metalloproteinase (ADAM) 17. High D-glucose increased ADAM17 activity in cell lysates (p<0.05). These data indicate that two glycosylated ACE2 fragments are constitutively shed from mouse proximal tubular cells. ACE2 shedding is stimulated by high D-glucose, at least partly via an ADAM17-mediated pathway. The results suggest that proximal tubular shedding of ACE2 may increase in diabetes, which could enhance degradation of Ang II in the tubular lumen, and increase levels of Ang-(1-7).	[Xiao, Fengxia; Zimpelmann, Joseph; Agaybi, Samih; Burns, Kevin D.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Div Nephrol,Dept Med, Ottawa, ON, Canada; [Gurley, Susan B.] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Puente, Lawrence] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; Duke University; University of Ottawa; Ottawa Hospital Research Institute	Burns, KD (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Div Nephrol,Dept Med, Ottawa, ON, Canada.	kburns@ottawahospital.on.ca			Canadian Institutes of Health Research [MOP110929]; The Kidney Foundation of Canada [KFOC100005]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The Kidney Foundation of Canada	The sources of funding that have supported the work include: Canadian Institutes of Health Research: grant number: MOP110929; http://www.cihr-irsc.gc.ca/; and The Kidney Foundation of Canada: grant number: KFOC100005; http://www.kidney.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chodavarapu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062833; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Freour T, 2009, INT J MOL MED, V23, P41, DOI 10.3892/ijmm_00000099; Iwata M, 2009, AM J PHYSIOL-CELL PH, V297, pC1318, DOI 10.1152/ajpcell.00036.2009; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Lai ZW, 2011, BIOCHEMISTRY-US, V50, P5182, DOI 10.1021/bi200525y; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; Maluf-Meiken LC, 2012, INT J HYPERTENS, V2012, P58170; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Park SE, 2013, EUR J ENDOCRINOL, V168, P203, DOI 10.1530/EJE-12-0782; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Warner FJ, 2005, J BIOL CHEM, V280, P39353, DOI 10.1074/jbc.M508914200; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2013, AM J PHYSIOL-RENAL, V305, pF600, DOI 10.1152/ajprenal.00600.2012; Xiao FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037649; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Ye MH, 2012, HYPERTENSION, V60, P730, DOI 10.1161/HYPERTENSIONAHA.112.198622	30	47	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85958	10.1371/journal.pone.0085958	http://dx.doi.org/10.1371/journal.pone.0085958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454948	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100141
J	Zhang, LL; Li, D; Xu, R; Zheng, SC; He, HW; Wan, J; Feng, QL				Zhang, Lili; Li, Ding; Xu, Rui; Zheng, Sichun; He, Hongwu; Wan, Jian; Feng, Qili			Structural and Functional Analyses of a Sterol Carrier Protein in Spodoptera litura	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; FATTY-ACID; 2/3-OXOACYL-COA THIOLASE; LIPID-BINDING; GENE; INHIBITORS; RESOLUTION; EXPRESSION; IDENTIFICATION	Backgrounds: In insects, cholesterol is one of the membrane components in cells and a precursor of ecdysteroid biosynthesis. Because insects lack two key enzymes, squalene synthase and lanosterol synthase, in the cholesterol biosynthesis pathway, they cannot autonomously synthesize cholesterol de novo from simple compounds and therefore have to obtain sterols from their diet. Sterol carrier protein (SCP) is a cholesterol-binding protein responsible for cholesterol absorption and transport. Results: In this study, a model of the three-dimensional structure of SlSCPx-2 in Spodoptera litura, a destructive polyphagous agricultural pest insect in tropical and subtropical areas, was constructed. Docking of sterol and fatty acid ligands to SlSCPx2 and ANS fluorescent replacement assay showed that SlSCPx-2 was able to bind with relatively high affinities to cholesterol, stearic acid, linoleic acid, stigmasterol, oleic acid, palmitic acid and arachidonate, implying that SlSCPx may play an important role in absorption and transport of these cholesterol and fatty acids from host plants. Site-directed mutation assay of SlSCPx-2 suggests that amino acid residues F53, W66, F89, F110, I115, T128 and Q131 are critical for the ligandbinding activity of the SlSCPx-2 protein. Virtual ligand screening resulted in identification of several lead compounds which are potential inhibitors of SlSCPx-2. Bioassay for inhibitory effect of five selected compounds showed that AH-487/ 41731687, AG-664/14117324, AG-205/36813059 and AG-205/07775053 inhibited the growth of S. litura larvae. Conclusions: Compounds AH-487/41731687, AG-664/14117324, AG-205/36813059 and AG-205/07775053 selected based on structural modeling showed binding affinity to SlSCPx-2 protein and inhibitory effect on the growth of S. litura larvae.	[Zhang, Lili; Xu, Rui; Zheng, Sichun] S China Normal Univ, Sch Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Li, Ding; He, Hongwu; Wan, Jian; Feng, Qili] Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol CCNU, Wuhan, Peoples R China	South China Normal University; Central China Normal University	Wan, J (corresponding author), Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol CCNU, Wuhan, Peoples R China.	jianwan@mail.ccnu.edu.cn; qlfeng@scnu.edu.cn		Li, Ding/0000-0003-3130-6099	Chinese National Natural Science Foundation [31071688]; National Basic Research Program of China [2010CB126100]; Scientific Research Foundation of Graduate School of South China Normal University [2012kyjj124]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Scientific Research Foundation of Graduate School of South China Normal University	This research was supported by the Chinese National Natural Science Foundation (31071688), the National Basic Research Program of China (2010CB126100) and the Scientific Research Foundation of Graduate School of South China Normal University (2012kyjj124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYDON P, 1987, ARCH INSECT BIOCHEM, V5, P139, DOI 10.1002/arch.940050208; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Du X, 2012, J INSECT PHYSIOL, V58, P1413, DOI 10.1016/j.jinsphys.2012.08.005; Dyer DH, 2008, J LIPID RES, V49, P644, DOI 10.1194/jlr.M700460-JLR200; Dyer DH, 2009, MOL CELL BIOCHEM, V326, P67, DOI 10.1007/s11010-008-0007-z; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Edqvist J, 2004, J BIOL CHEM, V279, P53544, DOI 10.1074/jbc.M405099200; Elam C, 2011, EUR J MED CHEM, V46, P1512, DOI 10.1016/j.ejmech.2011.01.069; Frolov A, 1997, LIPIDS, V32, P1201, DOI 10.1007/s11745-997-0154-5; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Goroncy Alexander K., 2010, Journal of Structural and Functional Genomics, V11, P247, DOI 10.1007/s10969-010-9096-5; GRIENEISEN ML, 1994, INSECT BIOCHEM MOLEC, V24, P115, DOI 10.1016/0965-1748(94)90078-7; Guo XR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-102; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Kim Min-Sik, 2010, BMC Physiology, V10, P9, DOI 10.1186/1472-6793-10-9; Kim MS, 2005, J LIPID RES, V46, P650, DOI 10.1194/jlr.M400389-JLR200; Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Li D, 2012, J CHEM INF MODEL, V52, P1833, DOI 10.1021/ci300163v; Radek JT, 2010, BIOCHEMISTRY-US, V49, P7532, DOI 10.1021/bi902026v; Schroeder F, 2000, J BIOL CHEM, V275, P25547, DOI 10.1074/jbc.M000431200; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Takeuchi H, 2004, BIOCHEM J, V382, P93, DOI 10.1042/BJ20040717; Viitanen L, 2006, FEBS J, V273, P5641, DOI 10.1111/j.1742-4658.2006.05553.x; Vyazunova I, 2007, INSECT MOL BIOL, V16, P305, DOI 10.1111/j.1365-2583.2007.00729.x; Vyazunova Irina, 2008, P173; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Zhou H, 2006, PROTEINS, V65, P692, DOI 10.1002/prot.21129	33	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e81542	10.1371/journal.pone.0081542	http://dx.doi.org/10.1371/journal.pone.0081542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454688	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100003
J	Zhong, YP; Wang, B; Yan, JH; Cheng, LJ; Yao, LM; Xiao, L; Wu, TL				Zhong, Yunpeng; Wang, Biao; Yan, Junhui; Cheng, Linjing; Yao, Luming; Xiao, Liang; Wu, Tianlong			DL-beta-Aminobutyric Acid-Induced Resistance in Soybean against Aphis glycines Matsumura (Hemiptera: Aphididae)	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; AMINO-BUTYRIC ACID; MOLECULAR-CLONING; PHYTOPHTHORA-INFESTANS; 3-AMINOBUTYRIC ACID; DISEASE RESISTANCE; GENE-EXPRESSION; DOWNY MILDEW; L-GLUTAMINE; DEFENSE	Priming can improve plant innate capability to deal with the stresses caused by both biotic and abiotic factors. In this study, the effect of DL-beta-amino-n-butyric acid (BABA) against Aphis glycines Matsumura, the soybean aphid (SA) was evaluated. We found that 25 mM BABA as a root drench had minimal adverse impact on plant growth and also efficiently protected soybean from SA infestation. In both choice and non-choice tests, SA number was significantly decreased to a low level in soybean seedlings drenched with 25 mM BABA compared to the control counterparts. BABA treatment resulted in a significant increase in the activities of several defense enzymes, such as phenylalanine ammonia-lyase (PAL), peroxidase (POX), polyphenol oxidase (PPO), chitinase (CHI), and beta-1, 3-glucanase (GLU) in soybean seedlings attacked by aphid. Meanwhile, the induction of 15 defense-related genes by aphid, such as AOS, CHS, MMP2, NPR1-1, NPR1-2, and PR genes, were significantly augmented in BABA-treated soybean seedlings. Our study suggest that BABA application is a promising way to enhance soybean resistance against SA.	[Zhong, Yunpeng; Wang, Biao; Yan, Junhui; Cheng, Linjing; Yao, Luming; Xiao, Liang; Wu, Tianlong] Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban Agr South, Shanghai 200030, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Wang, B (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban Agr South, Shanghai 200030, Peoples R China.	wangbiao@sjtu.edu.cn; tianlongwu@263.net	Zhong, Yun/HCH-6868-2022		Major Projects of the Ministry of Agriculture [2013ZX08004-004]; National Natural Science Fund of China [31071435]; "948'' projects of the Ministry of Agriculture [2011-G1(2)-16]; Shanghai Horticulture Key Discipline Construction Fund [B209]	Major Projects of the Ministry of Agriculture; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); "948'' projects of the Ministry of Agriculture; Shanghai Horticulture Key Discipline Construction Fund	This work was supported by grants from the Major Projects of the Ministry of Agriculture (2013ZX08004-004), the National Natural Science Fund of China (31071435), "948'' projects of the Ministry of Agriculture (2011-G1(2)-16), and the Shanghai Horticulture Key Discipline Construction Fund (B209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKADA S, 1990, NUCLEIC ACIDS RES, V18, P5899, DOI 10.1093/nar/18.19.5899; Altamiranda EAG, 2008, AUSTRALAS PLANT PATH, V37, P421, DOI 10.1071/AP08033; Andreu AB, 2006, PEST MANAG SCI, V62, P162, DOI 10.1002/ps.1142; Barilli E, 2010, EUR J PLANT PATHOL, V128, P483, DOI 10.1007/s10658-010-9678-x; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Bonner CA, 1996, PLANT SCI, V113, P43, DOI 10.1016/0168-9452(95)04284-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Chamsai J, 2004, Z PFLANZENK PFLANZEN, V111, P273; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; COHEN Y, 1994, PHYSIOL MOL PLANT P, V44, P273, DOI 10.1016/S0885-5765(05)80030-X; Cohen Y, 2011, EUR J PLANT PATHOL, V130, P13, DOI 10.1007/s10658-010-9724-8; Cohen Y, 2010, EUR J PLANT PATHOL, V126, P553, DOI 10.1007/s10658-009-9564-6; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; deSa MM, 1996, MOL BIOL EVOL, V13, P1198, DOI 10.1093/oxfordjournals.molbev.a025685; DIAS MA, 1983, J EXP BOT, V34, P537, DOI 10.1093/jxb/34.5.537; Diaz-Montano J, 2006, COMPONENTS SOYBEAN R; Frank R L, 1991, DNA Seq, V1, P335, DOI 10.3109/10425179109020788; Fu DQ, 2009, MOL PLANT MICROBE IN, V22, P86, DOI 10.1094/MPMI-22-1-0086; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Harmel N, 2007, INSECT SCI, V14, P57, DOI 10.1111/j.1744-7917.2007.00126.x; Hartman G.L., 2001, PLANT HLTH PROGR, DOI [10.1094/PHP-2001-0205-1001-HN, DOI 10.1094/PHP-2001-0205-1001-HN]; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Hill CB, 2012, EUPHYTICA, V186, P635, DOI 10.1007/s10681-012-0695-z; Hill CB, 2004, CROP SCI, V44, P98, DOI 10.2135/cropsci2004.0098; Hodge S, 2006, ANN APPL BIOL, V148, P223, DOI 10.1111/j.1744-7348.2006.00061.x; Hodge S, 2005, B ENTOMOL RES, V95, P449, DOI 10.1079/BER2005375; Hodge S, 2011, BIOCONTROL, V56, P699, DOI 10.1007/s10526-011-9344-z; Hwang BK, 1997, PHYSIOL MOL PLANT P, V51, P305, DOI 10.1006/pmpp.1997.0119; Hwang BK, 2000, PLANT PATHOLOGY J, V16, P9; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Justyna P-G, 2013, ACTA PHYSIOL PLANT, P1; Kim C. S., 2008, Agricultural and Resource Economics Review, V37, P227; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Kongrit D, 2007, BIOSCI BIOTECH BIOCH, V71, P491, DOI 10.1271/bbb.60537; KOUKOL J, 1961, J BIOL CHEM, V236, P2692; Li Y, 2008, NEW PHYTOL, V179, P185, DOI 10.1111/j.1469-8137.2008.02443.x; Liu J, 2007, POSTHARVEST BIOL TEC, V44, P300, DOI 10.1016/j.postharvbio.2006.12.019; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Marcucci E, 2010, J PHYTOPATHOL, V158, P659, DOI 10.1111/j.1439-0434.2010.01677.x; Meng FL, 2011, THEOR APPL GENET, V123, P1459, DOI 10.1007/s00122-011-1680-y; Olivieri FP, 2009, EUR J PLANT PATHOL, V123, P47, DOI 10.1007/s10658-008-9340-z; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pociecha E, 2008, PHYSIOL MOL PLANT P, V73, P126, DOI 10.1016/j.pmpp.2009.03.005; Porat R, 2003, EUR J PLANT PATHOL, V109, P901, DOI 10.1023/B:EJPP.0000003624.28975.45; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Ramiro DA, 2006, J CHEM ECOL, V32, P1977, DOI 10.1007/s10886-006-9122-z; Sahebani N, 2011, ACTA PHYSIOL PLANT, V33, P443, DOI 10.1007/s11738-010-0564-0; Sandhu D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-105; Sasek V, 2012, EUR J PLANT PATHOL, V133, P279, DOI 10.1007/s10658-011-9897-9; SIEFERT F, 1994, PLANTA, V192, P431, DOI 10.1007/BF00198580; Siegrist J, 2000, PHYSIOL MOL PLANT P, V56, P95, DOI 10.1006/pmpp.1999.0255; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Slaughter AR, 2008, EUR J PLANT PATHOL, V122, P185, DOI 10.1007/s10658-008-9285-2; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; TAKEUCHI Y, 1990, PLANT PHYSIOL, V93, P673, DOI 10.1104/pp.93.2.673; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Upchurch RG, 2011, BIOTECHNOL LETT, V33, P2397, DOI 10.1007/s10529-011-0722-5; Upchurch RG, 2010, PHYSIOL MOL PLANT P, V75, P64, DOI 10.1016/j.pmpp.2010.08.007; Van der Ent S, 2009, NEW PHYTOL, V183, P419, DOI 10.1111/j.1469-8137.2009.02851.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Worrall D, 2012, NEW PHYTOL, V193, P770, DOI 10.1111/j.1469-8137.2011.03987.x; Wu CC, 2010, J EXP BOT, V61, P995, DOI 10.1093/jxb/erp363; Xiao L, 2012, J ECON ENTOMOL, V105, P2167, DOI 10.1603/EC12054; Yi SY, 1998, MOL CELLS, V8, P556; Zhang CF, 2011, POSTHARVEST BIOL TEC, V61, P145, DOI 10.1016/j.postharvbio.2011.02.008; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897	80	19	21	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85142	10.1371/journal.pone.0085142	http://dx.doi.org/10.1371/journal.pone.0085142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454805	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100056
J	Leigh, ND; Bian, GL; Ding, XL; Liu, H; Aygun-Sunar, S; Burdelya, LG; Gudkov, AV; Cao, XF				Leigh, Nicholas D.; Bian, Guanglin; Ding, Xilai; Liu, Hong; Aygun-Sunar, Semra; Burdelya, Lyudmila G.; Gudkov, Andrei V.; Cao, Xuefang			A Flagellin-Derived Toll-Like Receptor 5 Agonist Stimulates Cytotoxic Lymphocyte-Mediated Tumor Immunity	PLOS ONE			English	Article							T-CELL RESPONSES; NF-KAPPA-B; IN-VIVO; BACTERIAL FLAGELLIN; ANTITUMOR IMMUNITY; EFFECTIVE ADJUVANT; DENDRITIC CELLS; MESSENGER-RNAS; STRANDED-RNA; GRANZYME-B	Toll-like receptor (TLR) mediated recognition of pathogen associated molecular patterns allows the immune system to rapidly respond to a pathogenic insult. The "danger context'' elicited by TLR agonists allows an initially non-immunogenic antigen to become immunogenic. This ability to alter environment is highly relevant in tumor immunity, since it is inherently difficult for the immune system to recognize host-derived tumors as immunogenic. However, immune cells may have encountered certain TLR ligands associated with tumor development, yet the endogenous stimulation is typically not sufficient to induce spontaneous tumor rejection. Of special interest are TLR5 agonists, because there are no endogenous ligands that bind TLR5. CBLB502 is a pharmacologically optimized TLR5 agonist derived from Salmonella enterica flagellin. We examined the effect of CBLB502 on tumor immunity using two syngeneic lymphoma models, both of which do not express TLR5, and thus do not directly respond to CBLB502. Upon challenge with the T-cell lymphoma RMAS, CBLB502 treatment after tumor inoculation protects C57BL/6 mice from death caused by tumor growth. This protective effect is both natural killer (NK) cell-and perforin-dependent. In addition, CBLB502 stimulates clearance of the B-cell lymphoma A20 in BALB/c mice in a CD8(+) T cell-dependent fashion. Analysis on the cellular level via ImageStream flow cytometry reveals that CD11b(+) and CD11c(+) cells, but neither NK nor T cells, directly respond to CBLB502 as determined by NF kappa B nuclear translocation. Our findings demonstrate that CBLB502 stimulates a robust antitumor response by directly activating TLR5-expressing accessory immune cells, which in turn activate cytotoxic lymphocytes.	[Leigh, Nicholas D.; Bian, Guanglin; Ding, Xilai; Cao, Xuefang] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Liu, Hong] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Aygun-Sunar, Semra; Burdelya, Lyudmila G.; Gudkov, Andrei V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Cao, XF (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	Xuefang.Cao@RoswellPark.org	Leigh, Nicholas/AAV-6537-2021	Leigh, Nicholas/0000-0002-6978-6254; Gudkov, Andrei/0000-0003-2548-0154	Alliance Foundation Award from Roswell Park Alliance Foundation; American Cancer Society [IRG-02-197-9]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Alliance Foundation Award from Roswell Park Alliance Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Alliance Foundation Award (X. C.) from Roswell Park Alliance Foundation and Institutional Research Grant #IRG-02-197-9 (X. C.) from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bates JT, 2011, J IMMUNOL, V186, P6255, DOI 10.4049/jimmunol.1001855; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Ding XL, 2012, J IMMUNOL, V189, P4719, DOI 10.4049/jimmunol.1201206; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; El Andaloussi A, 2006, GLIA, V54, P526, DOI 10.1002/glia.20401; Faham A, 2010, J IMMUNOL, V185, P1744, DOI 10.4049/jimmunol.1000027; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Garaude J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002868; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; GLIMCHER LH, 1982, J EXP MED, V155, P445, DOI 10.1084/jem.155.2.445; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; KAUFMAN DS, 1993, J IMMUNOL, V150, P1429; KIM KJ, 1979, J IMMUNOL, V122, P549; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lonsdorf AS, 2003, J IMMUNOL, V171, P3941, DOI 10.4049/jimmunol.171.8.3941; Lyakh LA, 2000, J IMMUNOL, V165, P3647, DOI 10.4049/jimmunol.165.7.3647; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nishikado H, 2011, J IMMUNOL, V186, P5766, DOI 10.4049/jimmunol.1100370; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Salazar-Gonzalez RM, 2007, J IMMUNOL, V179, P6169, DOI 10.4049/jimmunol.179.9.6169; Scheel B, 2006, EUR J IMMUNOL, V36, P2807, DOI 10.1002/eji.200635910; Schwarz K, 2003, EUR J IMMUNOL, V33, P1465, DOI 10.1002/eji.200323919; Sfondrini L, 2006, J IMMUNOL, V176, P6624, DOI 10.4049/jimmunol.176.11.6624; Smyth MJ, 1998, J EXP MED, V188, P1611, DOI 10.1084/jem.188.9.1611; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	46	38	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85587	10.1371/journal.pone.0085587	http://dx.doi.org/10.1371/journal.pone.0085587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454895	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800051
J	Hasselbalch, HC; Skov, V; Larsen, TS; Thomassen, M; Riley, CH; Jensen, MK; Bjerrum, OW; Kruse, TA				Hasselbalch, Hans Carl; Skov, Vibe; Larsen, Thomas Stauffer; Thomassen, Mads; Riley, Caroline Hasselbalch; Jensen, Morten K.; Bjerrum, Ole Weis; Kruse, Torben A.			Transcriptional Profiling of Whole Blood Identifies a Unique 5-Gene Signature for Myelofibrosis and Imminent Myelofibrosis Transformation	PLOS ONE			English	Article							GENE-EXPRESSION; POLYCYTHEMIA-VERA; OLFACTOMEDIN 4; ESSENTIAL THROMBOCYTHEMIA; CD34(+) CELLS; CHRONIC INFLAMMATION; MYELOID METAPLASIA; PERIPHERAL-BLOOD; MUTATION STATUS; V617F MUTATION	Identifying a distinct gene signature for myelofibrosis may yield novel information of the genes, which are responsible for progression of essential thrombocythemia and polycythemia vera towards myelofibrosis. We aimed at identifying a simple gene signature - composed of a few genes - which were selectively and highly deregulated in myelofibrosis patients. Gene expression microarray studies have been performed on whole blood from 69 patients with myeloproliferative neoplasms. Amongst the top-20 of the most upregulated genes in PMF compared to controls, we identified 5 genes (DEFA4, ELA2, OLFM4, CTSG, and AZU1), which were highly significantly deregulated in PMF only. None of these genes were significantly regulated in ET and PV patients. However, hierarchical cluster analysis showed that these genes were also highly expressed in a subset of patients with ET (n = 1) and PV (n = 4) transforming towards myelofibrosis and/or being featured by an aggressive phenotype. We have identified a simple 5-gene signature, which is uniquely and highly significantly deregulated in patients in transitional stages of ET and PV towards myelofibrosis and in patients with PMF only. Some of these genes are considered to be responsible for the derangement of bone marrow stroma in myelofibrosis. Accordingly, this gene-signature may reflect key processes in the pathogenesis and pathophysiology of myelofibrosis development.	[Hasselbalch, Hans Carl] Univ Copenhagen, Dept Hematol, Roskilde Hosp, Roskilde, Denmark; [Skov, Vibe; Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Larsen, Thomas Stauffer] Odense Univ Hosp, Dept Hematol X, DK-5000 Odense, Denmark; [Riley, Caroline Hasselbalch; Jensen, Morten K.] Univ Copenhagen, Herlev Hosp, Dept Hematol L, DK-2730 Herlev, Denmark; [Bjerrum, Ole Weis] Univ Copenhagen, Rigshosp, Dept Hematol L, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Hasselbalch, HC (corresponding author), Univ Copenhagen, Dept Hematol, Roskilde Hosp, Roskilde, Denmark.	hans.hasselbalch@dadlnet.dk	Bjerrum, Ole Weis/AAF-9999-2019; Hasselbalch, Hans/H-2217-2017	Larsen, Thomas Stauffer/0000-0002-8418-6708; Hasselbalch, Hans/0000-0003-3936-8032	Danish Council for Independent Research \ Medical Sciences	Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF))	The study has received grants from the The Danish Council for Independent Research vertical bar Medical Sciences (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-sundhed-og-sygdom) The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkofsky-Fessler W, 2010, CLIN CANCER RES, V16, P4339, DOI 10.1158/1078-0432.CCR-10-1092; Borregaard N, 2001, CURR OPIN HEMATOL, V8, P23, DOI 10.1097/00062752-200101000-00005; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Catani L, 2009, LEUKEMIA, V23, P997, DOI 10.1038/leu.2008.357; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477; Grover PK, 2010, CANCER METAST REV, V29, P761, DOI 10.1007/s10555-010-9262-z; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Hasselbalch HC, 2013, LEUKEMIA RES, V37, P214, DOI 10.1016/j.leukres.2012.10.020; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hasselbalch HC, 2011, LEUKEMIA RES, V35, P1330, DOI 10.1016/j.leukres.2011.03.013; Hasselbalch HC, 2009, LEUKEMIA RES, V33, P11, DOI 10.1016/j.leukres.2008.06.002; Hasselbalch HC, 2013, LEUK RES; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones LC, 2005, STEM CELLS, V23, P631, DOI 10.1634/stemcells.2004-0131; Kralovics R, 2005, BLOOD, V106, P3374, DOI 10.1182/blood-2005-05-1889; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; Liu WL, 2010, BLOOD, V116, P4938, DOI 10.1182/blood-2009-10-246439; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Pellagatti A, 2003, CANCER RES, V63, P3940; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Rosti V, 2007, BLOOD CELL MOL DIS, V38, P280, DOI 10.1016/j.bcmd.2007.01.003; Skov V, 2012, LEUKEMIA RES, V36, P1387, DOI 10.1016/j.leukres.2012.07.009; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Skov V, 2012, LEUKEMIA LYMPHOMA, V53, P123, DOI 10.3109/10428194.2011.597905; Skov V, 2011, EUR J HAEMATOL, V87, P54, DOI 10.1111/j.1600-0609.2011.01618.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Xu M, 2005, BLOOD, V105, P4805; Yu L, 2011, NEOPLASMA, V58, P9, DOI 10.4149/neo_2011_01_9	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85567	10.1371/journal.pone.0085567	http://dx.doi.org/10.1371/journal.pone.0085567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454890	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500055
J	Nkonki, LL; Daviaud, E; Jackson, D; Chola, L; Doherty, T; Chopra, M; Robberstad, B				Nkonki, Lungiswa Leonora; Daviaud, Emmanuelle; Jackson, Debra; Chola, Lumbwe; Doherty, Tanya; Chopra, Mickey; Robberstad, Bjarne		Promise-EBF Study Grp	Costs of Promoting Exclusive Breastfeeding at Community Level in Three Sites in South Africa	PLOS ONE			English	Article							HEALTH-WORKERS; PROGRAMS; HIV/AIDS	Background: Community-based peer support has been shown to be effective in improving exclusive breastfeeding rates in a variety of settings. Methods: We conducted a cost analysis of a community cluster randomised-controlled trial (Promise-EBF), aimed at promoting exclusive infant feeding in three sites in South Africa. The costs were considered from the perspective of health service providers. Peer supporters in this trial visited women to support exclusive infant feeding, once antenatally and four times postpartum. Results: The total economic cost of the Promise-EBF intervention was US$393 656, with average costs per woman and per visit of US$228 and US$52, respectively. The average costs per woman and visit in an operational 'non research' scenario were US$137 and US$32 per woman and visit, respectively. Investing in the promotion of exclusive infant feeding requires substantial financial commitment from policy makers. Extending the tasks of multi-skilled community health workers (CHWs) to include promoting exclusive infant feeding is a potential option for reducing these costs. In order to avoid efficiency losses, we recommend that the time requirements for delivering the promotion of exclusive infant feeding are considered when integrating it within the existing activities of CHWs. Discussion: This paper focuses on interventions for exclusive infant feeding, but its findings more generally illustrate the importance of documenting and quantifying factors that affect the feasibility and sustainability of community-based interventions, which are receiving increased focus in low income settings.	[Nkonki, Lungiswa Leonora; Daviaud, Emmanuelle; Doherty, Tanya] MRC, Hlth Syst Res Unit, Tygerberg, South Africa; [Nkonki, Lungiswa Leonora; Robberstad, Bjarne] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Nkonki, Lungiswa Leonora; Chola, Lumbwe] Univ Stellenbosch, Fac Hlth Sci, Div Community Hlth, ZA-7600 Stellenbosch, South Africa; [Jackson, Debra; Doherty, Tanya] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Chopra, Mickey] UNICEF, New York, NY USA	University of Bergen; Stellenbosch University; University of the Western Cape; UNICEF	Nkonki, LL (corresponding author), MRC, Hlth Syst Res Unit, Tygerberg, South Africa.	Lungiswa.nkonki@mrc.ac.za	Van de Perre, Philippe/B-9692-2008; Nkonki, Lungiswa/AAA-8613-2021; Robberstad, Bjarne/AAG-9322-2020; Tylleskär, Thorkild/S-5529-2017; Chola, Lumbwe/AFX-3377-2022; Fadnes, Lars T/E-9086-2016	Van de Perre, Philippe/0000-0002-3912-0427; Robberstad, Bjarne/0000-0002-0708-2016; Tylleskär, Thorkild/0000-0003-4801-4324; Olsen, Oystein Evjen/0000-0003-0963-4731; Nankabirwa, Victoria/0000-0002-9952-8942; Jackson, Debra/0000-0003-3307-632X; Fadnes, Lars T/0000-0001-8757-2092; Nkonki, Lungiswa/0000-0003-2011-5844; Chola, Lumbwe/0000-0001-6488-2813	EU [INCO-CT 2004-003660]; MRC; Department of Science and Technology; South African National Research Foundation	EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Science and Technology(Department of Science & Technology (India)); South African National Research Foundation(National Research Foundation - South Africa)	The study was part of the EU-funded project Promise-EBF(contract no INCO-CT 2004-003660, www.promiseresearch.org). The costing sub-study was also financially supported by the MRC through funding from the Department of Science and Technology. DJ and TD are also supported by the South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2004, CHILDHOOD ILLNESS IM; Antenatal Survey, 2009, NAT ANT SENT HIV SYP; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bland RM, 2008, AIDS, V22, P883, DOI 10.1097/QAD.0b013e3282f768de; Chola Lumbwe, 2011, Cost Eff Resour Alloc, V9, P11, DOI 10.1186/1478-7547-9-11; Chola Lumbwe, 2009, Cost Eff Resour Alloc, V7, P16, DOI 10.1186/1478-7547-7-16; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Corluka A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-81; Creese A, 1994, COSTING ANAL PRIMARY; Daniels K, 2010, SUPERVISION COMMUNIT; Daviaud E, 2007, REMUNERATION INTEGRA; Desmond C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002454; Doherty T, 2006, HIV INFANT FEEDING O; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Expanded Public Works Programme, 2005, EXP PUBL WORKS PROGR; Federal Reserve Statistical Release, 2007, FED RES STAT REL FOR; Fiedler JL, 2008, HEALTH POLICY PLANN, V23, P222, DOI 10.1093/heapol/czn015; Friedman I, 2007, MORNING BEST PRACTIC; Jan S, 2008, SOC SCI MED, V66, P922, DOI 10.1016/j.socscimed.2007.11.010; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lewin SA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub2; Makan B, 1997, EC ANAL COMMUNITY HE; Nkonki LL, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-17; Nor B, 2009, J HUM LACT, V25, P427, DOI 10.1177/0890334409341050; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Statistics South Africa, 2008, HIST CPIX KEY IND; Tenerio A, 2009, EXTENDING DURATION E; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; UNAIDS, 2000, COST GUILDL HIV PREV; Walker DG, 2005, J COMMUN HEALTH, V30, P221, DOI 10.1007/s10900-004-1960-4; WHO, 2003, WORLD HLTH ORG GUID; *WHO UNICEF UNAIDS, 2000, HIV INF FEED COUNS T; World Health Organization, 2006, MAKING CHOICES HLTH	35	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e79784	10.1371/journal.pone.0079784	http://dx.doi.org/10.1371/journal.pone.0079784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427264	Green Published, gold			2022-12-27	WOS:000329868200004
J	Science, M; Maguire, JL; Russell, ML; Smieja, M; Walter, SD; Loeb, M				Science, Michelle; Maguire, Jonathon L.; Russell, Margaret L.; Smieja, Marek; Walter, Stephen D.; Loeb, Mark			Serum 25-Hydroxyvitamin D Level and Influenza Vaccine Immunogenicity in Children and Adolescents	PLOS ONE			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; ADULTS; TRIAL; DIFFERENTIATION; PREVALENCE; EXPRESSION; IMMUNITY; ENHANCE; SYSTEM	Background: Vaccination is an important strategy in the prevention of influenza, but immunologic response to vaccination can vary widely. Recent studies have shown an association between serum 25-hydroxyvitamin D (25[OH]D) levels and immune function. The purpose of this study was to determine if serum 25(OH)D level correlates with influenza vaccine immunogenicity in children and adolescents. Methods: We conducted a prospective cohort study of children age 3 to 15 years of age vaccinated with trivalent influenza vaccine (A/Brisbane/59/2007[H1N1]-like virus, A/Brisbane/10/2007 [H3N2]-like virus and B/Florida/4/2006-like virus) in Hutterite communities in Alberta, Saskatchewan and Manitoba. Serum 25(OH)D levels were measured at baseline and immunogenicity was assessed using hemagluttination inhibition (HAI) titers done at baseline and 3-5 weeks post vaccination. Logistic regression was used to assess the relationship between serum 25(OH)D level as both a continuous and dichotomous variable and seroprotection, seroconversion, fold increase in geometric mean titer (GMT) and post vaccination titer. Results: A total of 391 children and adolescents were included in the study and 221 (57% had post-vaccination HAI titers. The median serum 25(OH)D level was 61.0 nmol/L (Interquartile range [IQR] 50.0, 71.0). No relationship was found between serum 25(OH)D level and seroprotection (post-vaccination titer >= 40 and >= 320) or seroconversion (post-vaccination titer >= 40 for participants with pre-vaccine titer,10 or four-fold rise in post-vaccination titer for those with a pre-vaccine titer >= 10). Conclusion: Serum 25(OH)D level was not associated with influenza vaccine immunogenicity in otherwise healthy children and adolescents. Other strategies to enhance influenza vaccine response should continue to be evaluated in this population. The role of serum 25(OH)D level in vaccine responsiveness in other populations, especially those hyporesponsive to influenza vaccination, requires further study.	[Science, Michelle] Hosp Sick Children, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Science, Michelle; Smieja, Marek; Walter, Stephen D.; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Dept Paediat, Toronto, ON M5B 1W8, Canada; [Maguire, Jonathon L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Maguire, Jonathon L.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Russell, Margaret L.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Calgary; McMaster University; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	loebm@mcmaster.ca	Walter, Stephen/AAB-5548-2022	Walter, Stephen/0000-0003-4157-8928	Canadian Institutes for Health Research [MCT-88113]; National Institute for Allergy and Infectious Diseases [1 U01 AI 76208-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI076208] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Canadian Institutes for Health Research [grant number MCT-88113] and the National Institute for Allergy and Infectious Diseases [grant number #1 U01 AI 76208-01A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AH, 1996, REV MED MICROBIOL, V7, P23; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; BLACK SC, 2011, AM POETRY REV, V40, P30; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Chadha MK, 2011, PROSTATE, V71, P368, DOI 10.1002/pros.21250; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN; Cooper C, 2011, HIV CLIN TRIALS, V12, P275, DOI 10.1310/hct1205-275; Daynes RA, 1996, INFECT IMMUN, V64, P1100, DOI 10.1128/IAI.64.4.1100-1109.1996; DAYNES RA, 1994, ANN NY ACAD SCI, V730, P144, DOI 10.1111/j.1749-6632.1994.tb44246.x; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Food and Drug Administration, 2007, CLIN DAT NEED SUPP L; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Jackson LA, 2012, J INFECT DIS, V206, P811, DOI 10.1093/infdis/jis427; Kriesel JD, 1999, VACCINE, V17, P1883, DOI 10.1016/S0264-410X(98)00476-9; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Langlois Kellie, 2010, Health Rep, V21, P47; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Maguire JL, 2013, JAMA PEDIATR, V167, P230, DOI 10.1001/2013.jamapediatrics.226; Maguire JL, 2011, PAED CHILD HEALT-CAN, V16, pE11, DOI 10.1093/pch/16.2.e11; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OBERG F, 1993, J IMMUNOL, V150, P3487; Principi N, 2013, HUM VACCIN IN PRESS, P9; Public Health Agency of Canada, 2009, FLU WATCH       0531; Sundaram ME, 2013, VACCINE, V31, P2057, DOI 10.1016/j.vaccine.2013.02.028; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909	29	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83553	10.1371/journal.pone.0083553	http://dx.doi.org/10.1371/journal.pone.0083553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427274	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200014
J	Zhou, LP; Salvado, O; Dore, V; Bourgeat, P; Raniga, P; Macaulay, SL; Ames, D; Masters, CL; Ellis, KA; Villemagne, VL; Rowe, CC; Fripp, J				Zhou, Luping; Salvado, Olivier; Dore, Vincent; Bourgeat, Pierrick; Raniga, Parnesh; Macaulay, S. Lance; Ames, David; Masters, Colin L.; Ellis, Kathryn A.; Villemagne, Victor L.; Rowe, Christopher C.; Fripp, Jurgen		AIBL Res Grp	MR-Less Surface-Based Amyloid Assessment Based on C-11 PiB PET	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HUMAN BRAIN; NONRIGID REGISTRATION; A-BETA; IMAGES; SEGMENTATION; DEPOSITION; ATLAS; INFORMATION	Background: beta-amyloid (A beta) plaques in brain's grey matter (GM) are one of the pathological hallmarks of Alzheimer's disease (AD), and can be imaged in vivo using Positron Emission Tomography (PET) with C-11 or F-18 radiotracers. Estimating A beta burden in cortical GM has been shown to improve diagnosis and monitoring of AD. However, lacking structural information in PET images requires such assessments to be performed with anatomical MRI scans, which may not be available at different clinical settings or being contraindicated for particular reasons. This study aimed to develop an MR-less A beta imaging quantification method that requires only PET images for reliable A beta burden estimations. Materials and Methods: The proposed method has been developed using a multi-atlas based approach on C-11-PiB scans from 143 subjects (75 PiB+ and 68 PiB- subjects) in AIBL study. A subset of 20 subjects (PET and MRI) were used as atlases: 1) MRI images were co-registered with tissue segmentation; 2) 3D surface at the GM-WM interfacing was extracted and registered to a canonical space; 3) Mean PiB retention within GM was estimated and mapped to the surface. For other participants, each atlas PET image (and surface) was registered to the subject's PET image for PiB estimation within GM. The results are combined by subject-specific atlas selection and Bayesian fusion to generate estimated surface values. Results: All PiB+ subjects (N = 75) were highly correlated between the MR-dependent and the PET-only methods with Intraclass Correlation (ICC) of 0.94, and an average relative difference error of 13% (or 0.23 SUVR) per surface vertex. All PiB-subjects (N = 68) revealed visually akin patterns with a relative difference error of 16% (or 0.19 SUVR) per surface vertex. Conclusion: The demonstrated accuracy suggests that the proposed method could be an effective clinical inspection tool for A beta imaging scans when MRI images are unavaila ble.	[Zhou, Luping; Salvado, Olivier; Dore, Vincent; Bourgeat, Pierrick; Raniga, Parnesh; Fripp, Jurgen] CSIRO Preventat Hlth Flagship, CSIRO Computat Informat, Australian E Hlth Res Ctr, Herston, Qld, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hosp, Dept Nucl Med, Heidelberg, Vic 3084, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hosp, Ctr PET, Heidelberg, Vic 3084, Australia; [Zhou, Luping] Univ Wollongong, Dept Comp Sci & Software Engn, Wollongong, NSW, Australia; [Macaulay, S. Lance] CSIRO Preventat Hlth Natl Res Flagship, Parkville, Vic, Australia; [Masters, Colin L.; Ellis, Kathryn A.] Univ Melbourne, Mental Hlth Res Inst, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Ames, David] Natl Ageing Res Inst, Parkville, Vic, Australia; [Ames, David; Ellis, Kathryn A.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Wollongong; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Florey Institute of Neuroscience & Mental Health; University of Melbourne; National Ageing Research Institute; University of Melbourne	Zhou, LP (corresponding author), CSIRO Preventat Hlth Flagship, CSIRO Computat Informat, Australian E Hlth Res Ctr, Herston, Qld, Australia.	lupingz@uow.edu.au	Raniga, Parnesh/A-8620-2011; Dore, Vincent/A-7750-2011; Duesing, Konsta/H-2802-2013; Maruff, Paul/AAD-2454-2021; Fripp, Jurgen/A-8763-2011; Macaulay, Stuart Lance/A-6086-2008; Salvado, Olivier/C-8910-2009; Bourgeat, Pierrick T/A-1419-2010; Zhou, Luping/AAD-6045-2020; Villemagne, Victor/AAC-5406-2019; Rowe, Christopher/AAX-8748-2021	Dore, Vincent/0000-0002-8051-0558; Duesing, Konsta/0000-0003-3103-0600; Maruff, Paul/0000-0002-6947-9537; Fripp, Jurgen/0000-0001-9705-0079; Macaulay, Stuart Lance/0000-0001-5069-9516; Salvado, Olivier/0000-0002-2720-8739; Bourgeat, Pierrick T/0000-0002-2605-4766; Villemagne, Victor/0000-0002-5832-9875; Ellis, Kathryn/0000-0001-9097-9037; Savage, Gregory/0000-0002-5895-1947; Raniga, Parnesh/0000-0002-0106-6322	CSIRO; Science and Industry Endowment Fund (SIEF); Edith Cowan University; Florey neuro-sciences and Mental Health Research institutes; Alzheimer's Australia; National Age-ing Research Institute; Austin Health; CogState Ltd.; Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council; Dementia Collaborative Research Centers program; McCusker Alzheimer's Research Foundation; Government of Victoria, Australia; Pfizer International	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Science and Industry Endowment Fund (SIEF); Edith Cowan University; Florey neuro-sciences and Mental Health Research institutes; Alzheimer's Australia; National Age-ing Research Institute; Austin Health; CogState Ltd.(CogState Limited); Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centers program; McCusker Alzheimer's Research Foundation; Government of Victoria, Australia; Pfizer International(Pfizer)	Core funding for the AIBL study was provided by the CSIRO (http://www.csiro.au/) Flagship Collaboration Fund and the Science and Industry Endowment Fund (SIEF http://www.sief.org.au/) in partnership with Edith Cowan University (https://www.ecu.edu.au/), Florey neuro-sciences and Mental Health Research institutes (http://www.florey.edu.au/), Alzheimer's Australia (http://www.fightdementia.org.au/), National Age-ing Research Institute (http://www.mednwh.unimelb.edu.au/), Austin Health (http://www.austin.org.au/), CogState Ltd. (http://cogstate.com/), Hollywood Private Hospital (http://www.hollywood.ramsayhealth.com.au/), Sir Charles Gardner Hospital (http://www.scgh.health.wa.gov.au/). The AIBL study also receives funding from the National Health and Medical Research Council (http://www.nhmrc.gov.au/), the Dementia Collaborative Research Centers program (http://www.fightdementia.org.au/victoria/dementia-collaborative-research-centres-1.aspx), The McCusker Alzheimer's Research Foundation (http://alzheimers.com.au/) and Operational Infrastructure Support from the Government of Victoria (http://www.vic.gov.au/), Australia. Pfizer International (http://www.pfizer.com.au/default.aspx) has contributed financial support to AIBL to assist with analysis of blood samples and to further the AIBL research program. The funders had no role in study design and data analysis, decision to publish, or preparation of this manuscript.	Aalto S, 2009, EUR J NUCL MED MOL I, V36, P1651, DOI 10.1007/s00259-009-1174-1; Acosta O, 2012, J NEUROSCI METH, V205, P96, DOI 10.1016/j.jneumeth.2011.12.011; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Bourgeat P, 2012, MICCAI 2012 WORKSH N; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Dore V., 2011, Proceedings of the 2011 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2011), P13, DOI 10.1109/DICTA.2011.11; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Fodero-Tavoletti MT, 2009, J NUCL MED, V50, P198, DOI 10.2967/jnumed.108.057984; Fripp J, 2008, NEUROIMAGE, V43, P430, DOI 10.1016/j.neuroimage.2008.07.053; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; JOACHIM CL, 1989, AM J PATHOL, V135, P309; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Kemppainen NM, 2006, NEUROLOGY, V67, P1575, DOI 10.1212/01.wnl.0000240117.55680.0a; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; Lilja A., 2010, TOOLS AIDING DIAGNOS; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Raniga P, 2009, SPIE MED IM 2009; Raniga P, 2007, I S BIOMED IMAGING, P348, DOI 10.1109/ISBI.2007.356860; Rousset OG, 1998, J NUCL MED, V39, P904; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rueda A, 2010, J NEUROSCI METH, V188, P305, DOI 10.1016/j.jneumeth.2010.02.020; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Thal DR, 2006, SCI AGING KNOWLEDGE, V2006; Tolboom N, 2009, EUR J NUCL MED MOL I, V36, P1629, DOI 10.1007/s00259-009-1129-6; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Yasuno F, 2002, NEUROIMAGE, V16, P577, DOI 10.1006/nimg.2002.1120; Yotter RA, 2013, NEUROBIOL AGING, V34, P2835, DOI 10.1016/j.neurobiolaging.2013.05.030; Ziolko SK, 2006, NEUROIMAGE, V33, P94, DOI 10.1016/j.neuroimage.2006.05.063	40	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84777	10.1371/journal.pone.0084777	http://dx.doi.org/10.1371/journal.pone.0084777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427295	Green Published, gold			2022-12-27	WOS:000329868200035
J	Dhakal, S; Joshi, DD; Ale, A; Sharma, M; Dahal, M; Shah, Y; Pant, DK; Stephen, C				Dhakal, Santosh; Joshi, Durga Datt; Ale, Anita; Sharma, Minu; Dahal, Meena; Shah, Yogendra; Pant, Dhan Kumar; Stephen, Craig			Regional Variation in Pig Farmer Awareness and Actions Regarding Japanese Encephalitis in Nepal: Implications for Public Health Education	PLOS ONE			English	Article							VECTOR CONTROL; KNOWLEDGE; PREVENTION; IMPACT; VIRUS; INSECTICIDE; MALARIA; DISEASE; DENGUE	Japanese encephalitis (JE) is a mosquito-borne zoonotic disease that has pigs as the major amplifying hosts. It is the most important cause of viral encephalitis in people in Nepal and is spreading in its geographic distribution in that country. Pig farming is increasing in Nepal due to reducing cultural biases against pigs and government programs to support pig farming for poverty alleviation. Major strategies for JE prevention and control include education, vector control, and immunization of people and pigs. This study used a survey of 400 pig farmers in 4 areas of Nepal with different JE and pig farming histories to explore regional variations in farmer awareness and actions towards JE, the association of awareness and actions with farm and farmer variables, and the implications of these associations for public health education. Exposure to JE risk factors was common across pig farms and pig farming districts but there were significant district level differences in knowledge and practices related to on-farm JE risk reduction. Social factors such as literacy, gender, and cultural practices were associated with farmer attitudes, knowledge and practices for JE control. JE vaccine uptake was almost non-existent and mosquito control steps were inconsistently applied across all 4 districts. Income was not a determining factor of the differences, but all farmers were very poor. The low uptake of vaccine and lack of infrastructure or financial capacity to house pigs indoors or away from people suggest that farmer personal protection should be a priority target for education in Nepal. This study re-enforces the need to attack root causes of people's personal disease prevention behaviours and take into account local variation in needs and capacities when designing health or agriculture education programs.	[Dhakal, Santosh; Joshi, Durga Datt; Ale, Anita; Sharma, Minu; Dahal, Meena; Shah, Yogendra; Pant, Dhan Kumar] Natl Zoonoses & Food Hyg Res Ctr, Kathmandu, Nepal; [Stephen, Craig] Ctr Coastal Hlth, Nanaimo, BC, Canada; [Stephen, Craig] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Stephen, Craig] Univ Calgary, Fac Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Stephen, C (corresponding author), Ctr Coastal Hlth, Nanaimo, BC, Canada.	cstephen@ucalgary.ca	Pant, Dhan/HHN-2817-2022; Shah, Yogendra/AAU-7395-2020; Dhakal, Santosh/J-2906-2019	Shah, Yogendra/0000-0002-0820-4556; Dhakal, Santosh/0000-0002-4494-8608	International Development Research Centre, Ottawa, Canada	International Development Research Centre, Ottawa, Canada	This work was funded by a grant from the International Development Research Centre, Ottawa, Canada (www.idrc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAND CHINA; [Anonymous], STAT INF NEP AGR 201; Bista M B, 2005, JNMA J Nepal Med Assoc, V44, P51; dataset] National Institute of Statistics (NIS), 2011, POPULATION HOUSING C; Dhakal S, 2012, ZOONOSES PUBLIC HLTH, V59, P568, DOI 10.1111/j.1863-2378.2012.01498.x; Dutta P, 2011, AM J TROP MED HYG, V84, P466, DOI 10.4269/ajtmh.2011.10-0270; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Henrich TJ, 2003, MICROBES INFECT, V5, P603, DOI 10.1016/S1286-4579(03)00100-X; Houston R, 2003, NEPAL ANAL BASELINE; Igarashi A, 2002, CURR TOP MICROBIOL, V267, P139; Joshi D., 1983, NEPAS J, V2, P18; KLEIN RE, 1995, AM J TROP MED HYG, V52, P383, DOI 10.4269/ajtmh.1995.52.383; LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1; LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247; LUO DP, 1994, T ROY SOC TROP MED H, V88, P629, DOI 10.1016/0035-9203(94)90200-3; Nandha B, 2012, HEALTH EDUC RES, V27, P585, DOI 10.1093/her/cyr045; Obara M, 2011, AM J TROP MED HYG, V84, P695, DOI 10.4269/ajtmh.2011.10-0188; Pant S. D., 2009, Journal of Nepal Paediatric Society, V29, P35, DOI 10.3126/jnps.v29i1.1600; Parajuli MB, 1992, J NEPAL MED ASSOC, V30, P7; Rayamajhi A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-294; SEARO/WHO, 2002, REG COMM PROV AG IT; Sohn YM, 2000, EMERG INFECT DIS; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Subedi G, 2012, NEPAL POPULATION J, V17, P91; UMENAI T, 1985, B WORLD HEALTH ORGAN, V63, P625; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; WHO-IPD, 2012, REC JE CAS UNPUB; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x; Yasuoka J, 2006, AM J TROP MED HYG, V74, P1034, DOI 10.4269/ajtmh.2006.74.1034	31	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85399	10.1371/journal.pone.0085399	http://dx.doi.org/10.1371/journal.pone.0085399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416402	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300076
J	Ku, HC; Su, MJ				Ku, Hui-Chun; Su, Ming-Jai			DPP4 Deficiency Preserved Cardiac Function in Abdominal Aortic Banding Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; ANGIOTENSIN-ALDOSTERONE SYSTEM; LEFT-VENTRICULAR PERFORMANCE; MYOCARDIAL GLUCOSE-UPTAKE; HEART-FAILURE; CONSCIOUS DOGS; FAILING HEART; GLP-1; DISEASE	Dipeptidyl peptidase-4 (DPP4) enzyme inhibition has been reported to increase plasma glucagon-like peptide-1 (GLP-1) level for controlling postprandial glucose concentration. A prominent GLP-1 level in DPP4-deficient rats contributed to the resistance of endotoxemia and myocardial infarction. DPP4 deficiency also increased the capability against H2O2-induced stress in cardiomyocyte. However, long term effect of loss DPP4 activity on cardiac performance remained unclear. We used abdominal aortic banding (AAB) to induce pressure overload in wild-type and DPP4-deficient rats, and investigated the progression of heart failure. Cardiac histology and function were determined. Blood sample was collected for the plasma biochemical marker measurement. Heart weight to body weight ratio increased 1.2-fold after 6 weeks of AAB surgery. Cardiac function was compensated against pressure overload after 6 weeks of AAB surgery, but progressed to deterioration after 10 weeks of AAB surgery. AAB induced cardiac dysfunction was alleviated in DPP4-deficient rats. DPP4 activity increased significantly in wild-type rats after 10 weeks of AAB surgery, but remained unchanged in DPP4-deficient rats. In contrast, GLP-1 concentration was elevated by AAB after 6 weeks of surgery in DPP4-deficient rats, and remained high after 10 weeks of surgery. Ang II level markedly increased after 6 weeks of AAB surgery, but were less in DPP4-deficient rats. Massive collagen deposits in wild-type rat hearts appeared after 10 weeks of AAB surgery, which were alleviated in DPP4-deficient rats. Long term deficiency of DPP4 activity improved cardiac performance against pressure overload in rat, which may be attributed to a great quantity of GLP-1 accumulation during AAB.	[Ku, Hui-Chun; Su, Ming-Jai] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan	National Taiwan University	Su, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	mingja@ntu.edu.tw		SU, MING-JAI/0000-0001-8887-6899	National Science Council, Taiwan [NSC 101-2325-B-002 -058, NSC 102-2325-B-002 -056, NSC 102-2325-B-002 -086]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan (NSC 101-2325-B-002 -058, NSC 102-2325-B-002 -056, and NSC 102-2325-B-002 -086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Biernacka A, 2011, AGING DIS, V2, P158; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Bouzegrhane F, 2002, CARDIOVASC RES, V53, P304, DOI 10.1016/S0008-6363(01)00448-5; Brilla CG, 2000, CARDIOVASC RES, V47, P1, DOI 10.1016/S0008-6363(00)00092-4; Capuano A, 2013, DRUG DES DEV THER, V7, P989, DOI 10.2147/DDDT.S37647; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; Chaykovska L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027861; Chen WP, 2010, N-S ARCH PHARMACOL, V382, P441, DOI 10.1007/s00210-010-0562-1; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Dos Santos L, 2013, CIRC HEART FAIL; Doupis J, 2008, ADV THER, V25, P627, DOI 10.1007/s12325-008-0076-1; East JM, 2000, MOL MEMBR BIOL, V17, P189, DOI 10.1080/09687680010009646; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; Fisman EZ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-38; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Guinto PJ, 2009, AM J PHYSIOL-HEART C, V297, pH614, DOI 10.1152/ajpheart.01143.2008; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Khan MA, 2013, HEART FAIL REV, V18, P141, DOI 10.1007/s10741-012-9318-y; Klemann C, 2009, CLIN EXP IMMUNOL, V155, P357, DOI 10.1111/j.1365-2249.2008.03839.x; Ku HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054518; Ku HC, 2011, N-S ARCH PHARMACOL, V384, P197, DOI 10.1007/s00210-011-0665-3; Ku HC, 2010, N-S ARCH PHARMACOL, V382, P463, DOI 10.1007/s00210-010-0559-9; Lee SA, 2011, J CLIN ENDOCR METAB, V98, P2553; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Liu JY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/630537; Liu Q, 2010, CARDIOVASC DIABETOL, V9, DOI [10.1186/1475-2840-9-76, 10.1186/1475-2840-9-32]; Michel MC, 2008, N-S ARCH PHARMACOL, V377, P205, DOI 10.1007/s00210-008-0280-0; Monami M, 2013, DIABETES OBES METAB, V15, P112, DOI 10.1111/dom.12000; Monji A, 2013, AM J PHYSIOL-HEART C, V305, pH295, DOI 10.1152/ajpheart.00990.2012; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ni L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027294; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; Rijzewijk LJ, 2009, J AM COLL CARDIOL, V54, P1524, DOI 10.1016/j.jacc.2009.04.074; Sabbah HN, 2000, CARDIOVASC RES, V45, P704, DOI 10.1016/S0008-6363(99)00348-X; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Scheen AJ, 2013, NAT REV CARDIOL, V10, P73, DOI 10.1038/nrcardio.2012.183; Scirica BM, 2013, N ENGL J MED; Skov J, 2013, J CLIN ENDOCR METAB, V98, pE664, DOI 10.1210/jc.2012-3855; Stefan N, 2005, JAMA-J AM MED ASSOC, V294, P2578, DOI 10.1001/jama.294.20.2578-a; Takahashi A, 2013, AM J PHYSIOL-HEART C, V304, pH1361, DOI 10.1152/ajpheart.00454.2012; Thompson MA, 2007, MINI-REV MED CHEM, V7, P253, DOI 10.2174/138955707780059853; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang XM, 2013, CARDIOVASC DRUG THER, V27, P297, DOI 10.1007/s10557-013-6459-8; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhao TC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-90	56	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85634	10.1371/journal.pone.0085634	http://dx.doi.org/10.1371/journal.pone.0085634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416433	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300092
J	Towfic, F; Funt, JM; Fowler, KD; Bakshi, S; Blaugrund, E; Artyomov, MN; Hayden, MR; Ladkani, D; Schwartz, R; Zeskind, B				Towfic, Fadi; Funt, Jason M.; Fowler, Kevin D.; Bakshi, Shlomo; Blaugrund, Eran; Artyomov, Maxim N.; Hayden, Michael R.; Ladkani, David; Schwartz, Rivka; Zeskind, Benjamin			Comparing the Biological Impact of Glatiramer Acetate with the Biological Impact of a Generic	PLOS ONE			English	Article							REGULATORY T-CELLS; IL-1 RECEPTOR ANTAGONIST; MULTIPLE-SCLEROSIS; MICROARRAY; EXPRESSION; MONOCYTES; SELECTION; PROFILES; PATHWAYS; MOUSE	For decades, policies regarding generic medicines have sought to provide patients with economical access to safe and effective drugs, while encouraging the development of new therapies. This balance is becoming more challenging for physicians and regulators as biologics and non-biological complex drugs (NBCDs) such as glatiramer acetate demonstrate remarkable efficacy, because generics for these medicines are more difficult to assess. We sought to develop computational methods that use transcriptional profiles to compare branded medicines to generics, robustly characterizing differences in biological impact. We combined multiple computational methods to determine whether differentially expressed genes result from random variation, or point to consistent differences in biological impact of the generic compared to the branded medicine. We applied these methods to analyze gene expression data from mouse splenocytes exposed to either branded glatiramer acetate or a generic. The computational methods identified extensive evidence that branded glatiramer acetate has a more consistent biological impact across batches than the generic, and has a distinct impact on regulatory T cells and myeloid lineage cells. In summary, we developed a computational pipeline that integrates multiple methods to compare two medicines in an innovative way. This pipeline, and the specific findings distinguishing branded glatiramer acetate from a generic, can help physicians and regulators take appropriate steps to ensure safety and efficacy.	[Towfic, Fadi; Funt, Jason M.; Fowler, Kevin D.; Artyomov, Maxim N.; Zeskind, Benjamin] Immuneering Corp, Cambridge, MA 02142 USA; [Bakshi, Shlomo; Blaugrund, Eran; Hayden, Michael R.; Ladkani, David; Schwartz, Rivka] Teva Pharmaceut Ind, Petah Tiqwa, Israel	Teva Pharmaceutical Industries	Zeskind, B (corresponding author), Immuneering Corp, Cambridge, MA 02142 USA.	bzeskind@immuneering.com	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419	Teva Pharmaceutical Industries	Teva Pharmaceutical Industries(Teva Pharmaceutical Industries)	This research was funded by Teva Pharmaceutical Industries, and employees of Teva participated in all aspects of the study.	Anis S, 2013, GENE EXPRESSION BIOM; Anis S, 2010, GOOD RESPONDERS GLAT; Arnon R, 2004, P NATL ACAD SCI USA, V101, P14593, DOI 10.1073/pnas.0404887101; Bakshi S, 2013, EXPERT OPIN THER TAR, V17, P351, DOI 10.1517/14728222.2013.778829; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad Benjamin Milo, 2013, PREPROCESSCORE COLLE; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Carpintero R, 2010, P NATL ACAD SCI USA, V107, P17692, DOI 10.1073/pnas.1009443107; Dhib-Jalbut S, 2012, CLIN RESPONSE GLATIR; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; Ebbers HC, 2012, NAT BIOTECHNOL, V30, P1186, DOI 10.1038/nbt.2438; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenwood JC, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000357; Ho JWK, 2008, BIOINFORMATICS, V24, pI390, DOI 10.1093/bioinformatics/btn142; Holloway C, 2012, ANN NY ACAD SCI, V1276, P26, DOI 10.1111/j.1749-6632.2012.06811.x; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kozlowski S, 2011, NEW ENGL J MED, V365, P385, DOI 10.1056/NEJMp1107285; Leek J. T., 2013, SVA SURROGATE VARIAB, VR; Lowther DE, 2012, IMMUNOL REV, V248, P156, DOI 10.1111/j.1600-065X.2012.01130.x; Nicholas JM, 2009, FDA2009P0555; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Pul R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051867; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Ruggieri M, 2007, CNS DRUG REV, V13, P178, DOI 10.1111/j.1527-3458.2007.00010.x; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schellekens H, 2011, REGUL TOXICOL PHARM, V59, P176, DOI 10.1016/j.yrtph.2010.09.021; Schneider CK, 2012, NAT BIOTECHNOL, V30, P1179, DOI 10.1038/nbt.2447; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Varkony H, 2009, EXPERT OPIN PHARMACO, V10, P657, DOI [10.1517/14656560902802877 , 10.1517/14656560902802877]; Wang Z, 2006, J CLIN INVESTIGATION; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	45	27	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83757	10.1371/journal.pone.0083757	http://dx.doi.org/10.1371/journal.pone.0083757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421904	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500071
J	Wolf, W; Meese, K; Seedorf, M				Wolf, Wendelin; Meese, Klaus; Seedorf, Matthias			Ist2 in the Yeast Cortical Endoplasmic Reticulum Promotes Trafficking of the Amino Acid Transporter Bap2 to the Plasma Membrane	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; H+-ATPASE; TRYPTOPHAN PERMEASE; CYTOSOLIC PH; FLUORESCENT PROTEINS; INTRACELLULAR PH; CONTACT SITES; PROTON PUMPS; ER; VACUOLAR	The equipment of the plasma membrane in Saccharomyces cerevisiae with specific nutrient transporters is highly regulated by transcription, translation and protein trafficking allowing growth in changing environments. The activity of these transporters depends on a H+ gradient across the plasma membrane generated by the H+-ATPase Pma1. We found that the polytopic membrane protein Ist2 in the cortical endoplasmic reticulum (ER) is required for efficient leucine uptake during the transition from fermentation to respiration. Experiments employing tandem fluorescence timer protein tag showed that Ist2 was necessary for efficient trafficking of newly synthesized leucine transporter Bap2 from the ER to the plasma membrane. This finding explains the growth defect of ist2 Delta mutants during nutritional challenges and illustrates the important role of physical coupling between cortical ER and plasma membrane.	[Wolf, Wendelin; Meese, Klaus; Seedorf, Matthias] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Seedorf, M (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany.	m.seedorf@zmbh.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SE811/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SE811/5-2; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Brachmann CB, 1998, YEAST, V14, P115; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cohen R, 2007, FEMS MICROBIOL LETT, V273, P239, DOI 10.1111/j.1574-6968.2007.00798.x; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; ENTIAN KD, 1986, MICROBIOL SCI, V3, P366; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; Fernandes AR, 2003, YEAST, V20, P207, DOI 10.1002/yea.957; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johansen Jesper, 2012, Cell Logist, V2, P151; Khmelinskii A, 2012, NAT BIOTECHNOL; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Kim Y, 2005, EUKARYOT CELL, V4, P281, DOI 10.1128/EC.4.2.281-288.2005; Kim Y, 2003, P NATL ACAD SCI USA, V100, P15458, DOI 10.1073/pnas.2136651100; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Samarao SS, 2009, BBA-BIOMEMBRANES, V1788, P303, DOI 10.1016/j.bbamem.2008.11.006; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stradalova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035132; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; VALLEJO CG, 1989, YEAST, V5, P307, DOI 10.1002/yea.320050411; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wolf W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039703; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	65	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85418	10.1371/journal.pone.0085418	http://dx.doi.org/10.1371/journal.pone.0085418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416406	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500247
J	Zhang, Q; Du, Y; Xue, ZW; Chi, CW; Jia, XH; Tian, J				Zhang, Qian; Du, Yang; Xue, Zhenwen; Chi, Chongwei; Jia, Xiaohua; Tian, Jie			Comprehensive Evaluation of the Anti-Angiogenic and Anti-Neoplastic Effects of Endostar on Liver Cancer through Optical Molecular Imaging	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR ANGIOGENESIS; ORTHOTOPIC MODELS; METASTASIS; THERAPY; GROWTH	Molecular imaging enables non-invasive monitoring of tumor growth, progression, and drug treatment response, and it has become an important tool to promote biological studies in recent years. In this study, we comprehensively evaluated the in vivo anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer based on the optical molecular imaging systems including micro-computer tomography (Micro-CT), bioluminescence molecular imaging (BLI) and fluorescence molecular tomography (FMT). Firefly luciferase (fLuc) and green fluorescent protein (GFP) dual labeled human hepatocellular carcinoma cells (HCC-LM3-fLuc-GFP cells) were used to establish the subcutaneous and orthotopic liver tumor model. After the tumor cells were implanted 14 similar to 18 days, Endostar (5 mg/kg/day) was administered through an intravenous tail vein injection for continuous 14 days. The computer tomography angiography (CTA) and BLI were carried out for the subcutaneous tumor model. FMT was executed for the orthotopic tumor model. The CTA data showed that tumor vessel formation and the peritumoral vasculature of subcutaneous tumor in the Endostar treatment group was significantly inhibited compared to the control group. The BLI data exhibited the obvious tumor inhibition day 8 post-treatment. The FMT detected the tumor suppression effects of Endostar as early as day 4 post-treatment and measured the tumor location. The above data confirmed the effects of Endostar on anti-angiogenesis and tumor suppression on liver cancer. Our system combined CTA, BLI, and FMT to offer more comprehensive information about the effects of Endostar on the suppression of vessel and tumor formation. Optical molecular imaging system enabled the non-invasive and reliable assessment of anti-tumor drug efficacy on liver cancer.	[Zhang, Qian; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Zhang, Qian; Du, Yang; Xue, Zhenwen; Chi, Chongwei; Jia, Xiaohua; Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chinese Academy of Sciences; Institute of Automation, CAS	Tian, J (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	tian@ieee.org	du, yang/V-1086-2019; Tian, Jie/H-1190-2011	Tian, Jie/0000-0003-0498-0432	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China (NSFC) [81227901]; Academy of Sciences Fellowship for Young International Scientists [2013Y1GB0005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Academy of Sciences Fellowship for Young International Scientists	This paper is supported by the National Basic Research Program of China (973 Program) under Grant No. 2011CB707700, the National Natural Science Foundation of China (NSFC) under Grant No. 81227901 and the Academy of Sciences Fellowship for Young International Scientists (2013Y1GB0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avella DM, 2012, HEPATOLOGY, V55, P141, DOI 10.1002/hep.24652; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Blow N, 2009, NAT METHODS, V6, P465, DOI 10.1038/nmeth0609-465; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cai WB, 2008, METHOD ENZYMOL, V445, P141, DOI 10.1016/S0076-6879(08)03007-3; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Cheong SJ, 2011, NUCL MED BIOL, V38, P93, DOI 10.1016/j.nucmedbio.2010.05.009; Dong X, 2011, THORAC CARDIOV SURG, V59, P133, DOI 10.1055/s-0030-1250152; Feng YX, 2011, HEPATOLOGY, V53, P483, DOI 10.1002/hep.24075; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Folkman Judah, 2006, Sci STKE, V2006, ppe35, DOI 10.1126/stke.3542006pe35; Han D, 2010, APPL OPTICS, V49, P6930, DOI 10.1364/AO.49.006930; Han D, 2010, OPT EXPRESS, V18, P8630, DOI 10.1364/OE.18.008630; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hu H, 1937, ONCOL REP, V27, P1937; Jaffer FA, 2009, ARTERIOSCL THROM VAS, V29, P1017, DOI 10.1161/ATVBAHA.108.165530; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Ling Y, 2009, ANTICANCER RES, V29, P411; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; [马喜波 Ma Xibo], 2011, [生物物理学报, Acta Biophysica Sinica], V27, P355; Ma XB, 2011, MOL IMAGING, V10, P278, DOI 10.2310/7290.2010.00041; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Tam K, 2013, ADMET DMPK, V1, P29, DOI 10.5599/admet.1.3.7; Tian J, 2013, OPTICAL MULTIMODALIT, P389; Tian J, 2008, IEEE T INF TECHNOL B, V12, P800, DOI 10.1109/TITB.2008.926395; Virostko J, 2007, APPL OPTICS, V46, P2540, DOI 10.1364/AO.46.002540; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Xu W, 2010, MOL BIOL+, V44, P585, DOI 10.1134/S0026893310040138; Xue ZW, 2013, APPL OPTICS, V52, P2374, DOI 10.1364/AO.52.002374; Zhu SP, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/960573	36	27	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85559	10.1371/journal.pone.0085559	http://dx.doi.org/10.1371/journal.pone.0085559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416426	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500257
J	Krist, AC; Kay, AD; Larkin, K; Neiman, M				Krist, Amy C.; Kay, Adam D.; Larkin, Katelyn; Neiman, Maurine			Response to Phosphorus Limitation Varies among Lake Populations of the Freshwater Snail Potamopyrgus antipodarum	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; LOCAL ADAPTATION; PLOIDY LEVEL; HOST SEX; TREMATODE; INFECTION; SUSCEPTIBILITY; MAINTENANCE; PLASTICITY; EVOLUTION	Local adaptation - typically recognized as higher values of fitness-related traits for native vs. non-native individuals when measured in the native environment - is common in natural populations because of pervasive spatial variation in the intensity and type of natural selection. Although local adaptation has been primarily studied in the context of biotic interactions, widespread variation in abiotic characteristics of environments suggests that local adaptation in response to abiotic factors should also be common. Potamopyrgus antipodarum, a freshwater New Zealand snail that is an important model system for invasion biology and the maintenance of sexual reproduction, exhibits local adaptation to parasites and rate of water flow. As an initial step to determining whether P. antipodarum are also locally adapted to phosphorus availability, we examined whether populations differ in their responses to phosphorus limitation. We found that field-collected juvenile P. antipodarum grew at a lower rate and reached an important size threshold more slowly when fed a relatively low vs. a relatively high- phosphorus diet. We also detected significant across-population variation in individual growth rate. A marginally significant population-by-dietary phosphorus interaction along with a two-fold difference across populations in the extent of suppression of growth by low phosphorus suggests that populations of P. antipodarum may differ in their response to phosphorus limitation. Local adaptation may explain this variation, with the implication that snails from lakes with relatively low phosphorus availability should be less severely affected by phosphorus limitation than snails from lakes with higher phosphorus availability.	[Krist, Amy C.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Krist, Amy C.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Kay, Adam D.] Univ St Thomas, Dept Biol, St Paul, MN USA; [Larkin, Katelyn; Neiman, Maurine] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Wyoming; University of Wyoming; University of St Thomas Minnesota; University of Iowa	Krist, AC (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	krist@uwyo.edu			University of Iowa; Research Council of Norway [196468/V40]	University of Iowa; Research Council of Norway(Research Council of Norway)	Funding for Neiman comes from the University of Iowa and the Research Council of Norway (Project No. 196468/V40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2008, HYDROBIOLOGIA, V614, P107, DOI 10.1007/s10750-008-9529-3; BRADFORD MJ, 1995, OECOLOGIA, V103, P319, DOI 10.1007/BF00328620; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Dybdahl MF, 2004, J EVOLUTION BIOL, V17, P967, DOI 10.1111/j.1420-9101.2004.00759.x; DYBDAHL MF, 1995, J EVOLUTION BIOL, V8, P385, DOI 10.1046/j.1420-9101.1995.8030385.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Fox JA, 1996, EVOLUTION, V50, P1541, DOI 10.1111/j.1558-5646.1996.tb03926.x; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Holomuzki JR, 2006, ECOLOGY, V87, P1038, DOI 10.1890/0012-9658(2006)87[1038:HVAPTI]2.0.CO;2; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Jokela J, 1995, EVOLUTION, V49, P1268, DOI 10.1111/j.1558-5646.1995.tb04453.x; Jokela J, 2003, BIOL J LINN SOC, V79, P165, DOI 10.1046/j.1095-8312.2003.00181.x; King KC, 2011, OIKOS, V120, P1335, DOI 10.1111/j.1600-0706.2011.19241.x; Kistner EJ, 2013, ECOL EVOL, V3, P424, DOI 10.1002/ece3.471; Krist AC, 2000, PARASITOLOGY, V121, P395, DOI 10.1017/S0031182099006538; Krist AC, 2004, J EVOLUTION BIOL, V17, P33, DOI 10.1046/j.1420-9101.2003.00661.x; Krist AC, 1998, OECOLOGIA, V116, P575, DOI 10.1007/s004420050611; Laugen AT, 2003, J EVOLUTION BIOL, V16, P996, DOI 10.1046/j.1420-9101.2003.00560.x; Laukkanen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038225; Lenth RV., 2006, JAVA APPLETS POWER S; Lively CM, 2004, AM NAT, V164, pS6, DOI 10.1086/424605; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Lively CM, 1996, P ROY SOC B-BIOL SCI, V263, P891, DOI 10.1098/rspb.1996.0132; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; McKenzie VJ, 2013, CAN J ZOOL, V91, P30, DOI 10.1139/cjz-2012-0183; Neiman M, 2006, INVERTEBR BIOL, V125, P45, DOI 10.1111/j.1744-7410.2006.00038.x; Neiman M, 2013, HEREDITY, V110, P152, DOI 10.1038/hdy.2012.78; Neiman M, 2012, HEREDITY, V109, P57, DOI 10.1038/hdy.2012.13; Neiman M, 2009, J EVOLUTION BIOL, V22, P1359, DOI 10.1111/j.1420-9101.2009.01748.x; Neiman M, 2013, EVOL ECOL, V27, P1117, DOI 10.1007/s10682-013-9632-4; Neiman M, 2013, EVOLUTION, V67, P1511, DOI 10.1111/evo.12026; Neiman M, 2011, EVOLUTION, V65, P3202, DOI 10.1111/j.1558-5646.2011.01360.x; New Zealand Ministry for the Environment, 2010, LAK WAT QUAL NZ 2010; Osnas EE, 2006, J EVOLUTION BIOL, V19, P42, DOI 10.1111/j.1420-9101.2005.00994.x; Paczesniak D, 2013, MOL ECOL, V22, P4695, DOI 10.1111/mec.12422; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tibbets TM, 2010, OECOLOGIA, V163, P549, DOI 10.1007/s00442-009-1522-7; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; WALLACE C, 1992, J MOLLUS STUD, V58, P93, DOI 10.1093/mollus/58.2.93; Williams G. C., 1966, P307; WINTERBOURN M J, 1970, Proceedings of the Malacological Society of London, V39, P139	43	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85845	10.1371/journal.pone.0085845	http://dx.doi.org/10.1371/journal.pone.0085845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454936	gold, Green Published			2022-12-27	WOS:000330236000016
J	Costa, B; Taylor, JC; Kracker, L; Battista, T; Pittman, S				Costa, Bryan; Taylor, J. Christopher; Kracker, Laura; Battista, Tim; Pittman, Simon			Mapping Reef Fish and the Seascape: Using Acoustics and Spatial Modeling to Guide Coastal Management	PLOS ONE			English	Article							SPECIES RICHNESS; SPAWNING AGGREGATIONS; HABITAT; CLASSIFICATION; CONSERVATION; BIOGEOGRAPHY; PREDICTION; GRUNTS	Reef fish distributions are patchy in time and space with some coral reef habitats supporting higher densities (i.e., aggregations) of fish than others. Identifying and quantifying fish aggregations (particularly during spawning events) are often top priorities for coastal managers. However, the rapid mapping of these aggregations using conventional survey methods (e. g., non-technical SCUBA diving and remotely operated cameras) are limited by depth, visibility and time. Acoustic sensors (i.e., splitbeam and multibeam echosounders) are not constrained by these same limitations, and were used to concurrently map and quantify the location, density and size of reef fish along with seafloor structure in two, separate locations in the U. S. Virgin Islands. Reef fish aggregations were documented along the shelf edge, an ecologically important ecotone in the region. Fish were grouped into three classes according to body size, and relationships with the benthic seascape were modeled in one area using Boosted Regression Trees. These models were validated in a second area to test their predictive performance in locations where fish have not been mapped. Models predicting the density of large fish (>= 29 cm) performed well (i.e., AUC = 0.77). Water depth and standard deviation of depth were the most influential predictors at two spatial scales (100 and 300 m). Models of small (<= 11 cm) and medium (12-28 cm) fish performed poorly (i.e., AUC = 0.49 to 0.68) due to the high prevalence (45-79%) of smaller fish in both locations, and the unequal prevalence of smaller fish in the training and validation areas. Integrating acoustic sensors with spatial modeling offers a new and reliable approach to rapidly identify fish aggregations and to predict the density large fish in un-surveyed locations. This integrative approach will help coastal managers to prioritize sites, and focus their limited resources on areas that may be of higher conservation value.	[Costa, Bryan; Kracker, Laura; Battista, Tim; Pittman, Simon] NOAA, Biogeog Branch, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA; [Costa, Bryan] Consolidated Safety Serv, Fairfax, VA USA; [Taylor, J. Christopher] NOAA, Ctr Coastal Fisheries & Habitat Res, Natl Ctr Coastal Ocean Sci, Beaufort, NC USA; [Pittman, Simon] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); University of Plymouth	Costa, B (corresponding author), NOAA, Biogeog Branch, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA.	bryan.costa@noaa.gov		Pittman, Simon/0000-0002-4113-6970	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Office of Coast Survey	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Office of Coast Survey	This research was funded by the National Oceanic and Atmospheric Administration's Coral Reef Conservation Program (http://coralreef.noaa.gov/) and Office of Coast Survey (http://www.nauticalcharts.noaa.gov/). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aubry P, 2000, ECOLOGY, V81, P543; Battista TA, 2011, MBES DATA ACQUISITIO; Battista TA, 2010, MBES DATA ACQUISITIO; Breiman L., 2017, CLASSIFICATION REGRE; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Chapire RE, 2012, BOOSTING FDN ALGORIT; Collins AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024302; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Echoview, 2013, FISH TRACK ALG ECH A; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FishBase, 2013, FISHBASE GLOB INF SY; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Geselbracht L, 2009, AQUAT CONSERV, V19, P408, DOI 10.1002/aqc.992; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Heyman WD, 2008, B MAR SCI, V83, P531; Heyman WD, 2011, PROF GEOGR, V63, P429, DOI 10.1080/00330124.2011.585074; Hijmans RJ, 2012, SPECIES DISTRIBUTION; Hijmans RJ, 2012, GEOGRAPHIC DATA ANAL; Hitt S, 2011, MAR ECOL PROG SER, V427, P275, DOI 10.3354/meps09093; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; IHO-International Hydrographic Organization, 2008, IHO SPEC PUBL, V44; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Johnston Samuel V., 2006, NOAA Professional Paper NMFS, V5, P10; Kendall MS, 2003, ENVIRON BIOL FISH, V66, P19, DOI 10.1023/A:1023255022513; Knudby A, 2010, REMOTE SENS ENVIRON, V114, P1230, DOI 10.1016/j.rse.2010.01.007; Kobara S, 2013, OCEANOGR MAR BIOL, V51, P281; Koenig CC, 2000, B MAR SCI, V66, P593; Kracker LM, 2011, 130 NOS NCCOS NAT OC; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu C, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P4241; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; LOVE RH, 1977, J ACOUST SOC AM, V62, P1397, DOI 10.1121/1.381672; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; MEYER JL, 1985, LIMNOL OCEANOGR, V30, P146, DOI 10.4319/lo.1985.30.1.0146; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nash KL, 2013, ECOSYSTEMS, V16, P478, DOI 10.1007/s10021-012-9625-0; Nemeth R, 2013, NOAANMFSSE2013200341; OGDEN JC, 1977, MAR BIOL, V42, P273, DOI 10.1007/BF00397751; Olavo G, 2011, AQUAT CONSERV, V21, P199, DOI 10.1002/aqc.1174; Parker RO, 1998, 138 NMFS NAT OC ATM; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Plach P., 2003, P 2003 UK WORKSH COM, P38; Pontius RG, 2001, AGR ECOSYST ENVIRON, V85, P239, DOI 10.1016/S0167-8809(01)00187-6; R Core Team, 2012, R STATS PACK STATS V; Ribeiro Jr PJ, 2012, ANAL GEOSTATISTICAL; Roberts CM, 2003, ECOL APPL, V13, pS215; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sale PF, 1998, AUST J ECOL, V23, P202, DOI 10.1111/j.1442-9993.1998.tb00721.x; SEDBERRY GR, 2004, CHARACTERIZATION DEE; Simmonds J., 2005, FISHERIES ACOUSTICS; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y	65	35	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85555	10.1371/journal.pone.0085555	http://dx.doi.org/10.1371/journal.pone.0085555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454886	gold, Green Published			2022-12-27	WOS:000330235100097
J	Lee, J; Groh, JM				Lee, Jungah; Groh, Jennifer M.			Different Stimuli, Different Spatial Codes: A Visual Map and an Auditory Rate Code for Oculomotor Space in the Primate Superior Colliculus	PLOS ONE			English	Article							INFERIOR COLLICULUS; EYE-MOVEMENTS; SENSORIMOTOR INTEGRATION; RESPONSE PROPERTIES; SOUND LOCALIZATION; RECEPTIVE-FIELDS; ECHOLOCATING BAT; NEURAL CODE; CAT; NEURONS	Maps are a mainstay of visual, somatosensory, and motor coding in many species. However, auditory maps of space have not been reported in the primate brain. Instead, recent studies have suggested that sound location may be encoded via broadly responsive neurons whose firing rates vary roughly proportionately with sound azimuth. Within frontal space, maps and such rate codes involve different response patterns at the level of individual neurons. Maps consist of neurons exhibiting circumscribed receptive fields, whereas rate codes involve open-ended response patterns that peak in the periphery. This coding format discrepancy therefore poses a potential problem for brain regions responsible for representing both visual and auditory information. Here, we investigated the coding of auditory space in the primate superior colliculus(SC), a structure known to contain visual and oculomotor maps for guiding saccades. We report that, for visual stimuli, neurons showed circumscribed receptive fields consistent with a map, but for auditory stimuli, they had open-ended response patterns consistent with a rate or level-of-activity code for location. The discrepant response patterns were not segregated into different neural populations but occurred in the same neurons. We show that a read-out algorithm in which the site and level of SC activity both contribute to the computation of stimulus location is successful at evaluating the discrepant visual and auditory codes, and can account for subtle but systematic differences in the accuracy of auditory compared to visual saccades. This suggests that a given population of neurons can use different codes to support appropriate multimodal behavior.	[Lee, Jungah; Groh, Jennifer M.] Duke Univ, Dept Neurobiol, Ctr Cognit Neurosci, Dept Psychol & Neurosci, Durham, NC 27710 USA	Duke University	Lee, J (corresponding author), Duke Univ, Dept Neurobiol, Ctr Cognit Neurosci, Dept Psychol & Neurosci, Durham, NC 27710 USA.	vision.jungah.lee@gmail.com		Groh, Jennifer/0000-0002-6435-3935	National Institutes of Health [NS50942]; Korea Research Foundation; Korean Government [KRF-2008-356-H00003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NS50942)(http://grants.nih.gov/grants/oer.htm). JL was also supported by the Korea Research Foundation Grant funded by the Korean Government (KRF-2008-356-H00003)(http://www.krf.or.kr/KHPapp/eng/maina.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKIN LM, 1987, J NEUROPHYSIOL, V57, P1185, DOI 10.1152/jn.1987.57.4.1185; Barone P, 1996, J NEUROPHYSIOL, V75, P1206, DOI 10.1152/jn.1996.75.3.1206; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Devore S, 2009, NEURON, V62, P123, DOI 10.1016/j.neuron.2009.02.018; EISENMAN LM, 1974, BRAIN RES, V75, P203, DOI 10.1016/0006-8993(74)90742-2; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; FRENS MA, 1995, EXP BRAIN RES, V107, P103, DOI 10.1007/BF00228022; Goossens HHLM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002508; Groh JM, 2003, J COGNITIVE NEUROSCI, V15, P1217, DOI 10.1162/089892903322598166; Groh JM, 2001, BIOL CYBERN, V85, P159, DOI 10.1007/s004220100249; GUITTON D, 1980, EXP BRAIN RES, V39, P63; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KING AJ, 1983, J PHYSIOL-LONDON, V342, P361, DOI 10.1113/jphysiol.1983.sp014856; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KUSTOV AA, 1995, J NEUROPHYSIOL, V73, P1724, DOI 10.1152/jn.1995.73.4.1724; Lee J, 2012, J NEUROPHYSIOL, V108, P227, DOI 10.1152/jn.00706.2011; LEIMAN AL, 1972, EXP NEUROL, V35, P431, DOI 10.1016/0014-4886(72)90114-8; Lesica NA, 2010, J NEUROSCI, V30, P11696, DOI 10.1523/JNEUROSCI.0846-10.2010; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Metzger RR, 2004, J NEUROPHYSIOL, V92, P2622, DOI 10.1152/jn.00326.2004; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Middlebrooks JC, 1998, J NEUROPHYSIOL, V80, P863, DOI 10.1152/jn.1998.80.2.863; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; Middlebrooks JC, 1981, J NEUROSCI, V1, P107; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; PALMER AR, 1982, NATURE, V299, P248, DOI 10.1038/299248a0; Porter KK, 2006, PROG BRAIN RES, V155, P313, DOI 10.1016/S0079-6123(06)55018-6; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Salminen NH, 2010, BRAIN RES, V1306, P93, DOI 10.1016/j.brainres.2009.09.095; Salminen NH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007600; Samson FK, 2000, J NEUROPHYSIOL, V84, P1330, DOI 10.1152/jn.2000.84.3.1330; SCHLAGREY M, 1989, EXP BRAIN RES, V76, P537, DOI 10.1007/BF00248910; SCUDDER CA, 1988, J NEUROPHYSIOL, V59, P1455, DOI 10.1152/jn.1988.59.5.1455; SHIMOZAWA T, 1984, BRAIN RES, V311, P289; Stebbins, 1990, COMP PERCEPTION, V1, P351; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; Stecker GC, 2003, BIOL CYBERN, V89, P341, DOI 10.1007/s00422-003-0439-1; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; Tollin DJ, 2002, J NEUROSCI, V22, P1468, DOI 10.1523/JNEUROSCI.22-04-01468.2002; Valentine DE, 1997, J NEUROSCI, V17, P1720; von Bekesy G, 1930, PHYS Z, V31, P824; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Werner-Reiss U, 2008, J NEUROSCI, V28, P3747, DOI 10.1523/JNEUROSCI.5044-07.2008; WISE LZ, 1985, J NEUROPHYSIOL, V54, P185, DOI 10.1152/jn.1985.54.2.185; WONG D, 1984, HEARING RES, V16, P261, DOI 10.1016/0378-5955(84)90115-1; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006	55	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85017	10.1371/journal.pone.0085017	http://dx.doi.org/10.1371/journal.pone.0085017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454779	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100048
J	Neely, CJ; Kartchner, LB; Mendoza, AE; Linz, BM; Frelinger, JA; Wolfgang, MC; Maile, R; Cairns, BA				Neely, Crystal J.; Kartchner, Laurel B.; Mendoza, April E.; Linz, Brandon M.; Frelinger, Jeffrey A.; Wolfgang, Matthew C.; Maile, Robert; Cairns, Bruce A.			Flagellin Treatment Prevents Increased Susceptibility to Systemic Bacterial Infection after Injury by Inhibiting Anti-Inflammatory IL-10+IL-12-Neutrophil Polarization	PLOS ONE			English	Article							T-CELLS; MACROPHAGE POLARIZATION; LYMPHOCYTE APOPTOSIS; SUPPRESSOR-CELLS; TRAUMA PATIENTS; BURN INJURY; IL-10; SEPSIS; EXPRESSION; SURVIVAL	Severe trauma renders patients susceptible to infection. In sepsis, defective bacterial clearance has been linked to specific deviations in the innate immune response. We hypothesized that innate immune modulations observed during sepsis also contribute to increased bacterial susceptibility after severe trauma. A well-established murine model of burn injury, used to replicate infection following trauma, showed that wound inoculation with P. aeruginosa quickly spreads systemically. The systemic IL-10/IL-12 axis was skewed after burn injury with infection as indicated by a significant elevation in serum IL-10 and polarization of neutrophils into an anti-inflammatory ("N2"; IL-10(+) IL-12(-)) phenotype. Infection with an attenuated P. aeruginosa strain (Delta CyaB) was cleared better than the wildtype strain and was associated with an increased proinflammatory neutrophil ("N1"; IL-10(-) IL-12(+)) response in burn mice. This suggests that neutrophil polarization influences bacterial clearance after burn injury. Administration of a TLR5 agonist, flagellin, after burn injury restored the neutrophil response towards a N1 phenotype resulting in an increased clearance of wildtype P. aeruginosa after wound inoculation. This study details specific alterations in innate cell populations after burn injury that contribute to increased susceptibility to bacterial infection. In addition, for the first time, it identifies neutrophil polarization as a therapeutic target for the reversal of bacterial susceptibility after injury.	[Neely, Crystal J.; Kartchner, Laurel B.; Linz, Brandon M.; Maile, Robert; Cairns, Bruce A.] Univ N Carolina, Dept Microbiol & Immunol, North Carolina Jaycee Burn Ctr, Chapel Hill, NC 27515 USA; [Mendoza, April E.; Maile, Robert; Cairns, Bruce A.] Univ N Carolina, Dept Surg, North Carolina Jaycee Burn Ctr, Chapel Hill, NC USA; [Frelinger, Jeffrey A.] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Wolfgang, Matthew C.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona; University of North Carolina; University of North Carolina Chapel Hill	Maile, R (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, North Carolina Jaycee Burn Ctr, Chapel Hill, NC 27515 USA.	robmaile@med.unc.edu	Frelinger, Jeffrey A/F-2448-2014	Frelinger, Jeffrey A/0000-0002-2503-6267; Maile, Robert/0000-0002-9126-4188	Cairns BA [R01 GM076250-02, 2T32GM008450-16-20]; National Institutes of General Medicine Science [04/06/2009-03/31/2014, 07/1/2009-6/30/2014]; NRSA Trauma Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008450, R01GM076250] Funding Source: NIH RePORTER	Cairns BA; National Institutes of General Medicine Science; NRSA Trauma Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R01 GM076250-02 Cairns BA (PI) 04/06/2009-03/31/2014 National Institutes of General Medicine Science 2T32GM008450-16-20 Cairns BA (PI) 07/1/2009-6/30/2014 National Institute of General Medicine Science NRSA Trauma Research Fellowship The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Borregaard N, 1997, ANN NY ACAD SCI, V832, P62, DOI 10.1111/j.1749-6632.1997.tb46237.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cairns BA, 2001, SURGERY, V130, P210, DOI 10.1067/msy.2001.115835; Cairns B, 2006, J TRAUMA, V61, P293, DOI 10.1097/01.ta.0000228969.46633.bb; Cairns BA, 2008, J TRAUMA, V64, P1069, DOI 10.1097/TA.0b013e318166b7d9; Centers for Disease Control and Prevention, 2012, WEB BAS INJ STAT QUE; Cohen MJ, 2007, J TRAUMA, V62, P858, DOI 10.1097/01.ta.0000222975.03874.58; Csontos C, 2010, BURNS, V36, P483, DOI 10.1016/j.burns.2009.10.009; Cuenca AG, 2012, INTENS CARE MED, V38, P928, DOI 10.1007/s00134-012-2575-3; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Fukuzuka K, 2000, J TRAUMA, V49, P710, DOI 10.1097/00005373-200010000-00020; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Guo ZJ, 2003, J IMMUNOL, V171, P3983, DOI 10.4049/jimmunol.171.8.3983; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hart KM, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00029; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Jeannin P, 2011, IMMUNOTHERAPY-UK, V3, P23, DOI [10.2217/IMT.11.30, 10.2217/imt.11.30]; Jones SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064250; Kahlke V, 2002, SHOCK, V18, P24, DOI 10.1097/00024382-200207000-00005; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Kovacs EJ, 2004, MECH AGEING DEV, V125, P121, DOI 10.1016/j.mad.2003.11.007; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Maile R, 2006, J IMMUNOL, V176, P6717, DOI 10.4049/jimmunol.176.11.6717; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801; Maung AA, 2005, J LEUKOCYTE BIOL, V78, P565, DOI 10.1189/jlb.1204698; Mendoza AE, 2012, SHOCK, V38, P532, DOI 10.1097/SHK.0b013e31826c5b19; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Ni Choileain N, 2006, J IMMUNOL, V176, P225; Niven DJ, 2010, J HOSP INFECT, V76, P296, DOI 10.1016/j.jhin.2010.06.004; Noel G, 2011, SHOCK, V36, P149, DOI 10.1097/SHK.0b013e3182205cbc; Noel JG, 2007, SHOCK, V28, P684, DOI 10.1097/shk.0b013e31805362ed; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; Patel JC, 2000, J PEDIATR SURG, V35, P1174, DOI 10.1053/jpsu.2000.8722; Pellegrini JD, 2000, J SURG RES, V88, P200, DOI 10.1006/jsre.1999.5797; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schwacha MG, 2003, SHOCK, V20, P529, DOI 10.1097/01.shk.0000095059.62263.56; Schwacha MG, 2003, BURNS, V29, P1, DOI 10.1016/S0305-4179(02)00187-0; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Shigematsu K, 2009, J LEUKOCYTE BIOL, V86, P999, DOI 10.1189/jlb.0409235; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Sun L, 2009, AM J RESP CELL MOL, V41, P76, DOI 10.1165/rcmb.2008-0202OC; van Putten JPM, 2010, IMMUNOL LETT, V128, P8, DOI 10.1016/j.imlet.2009.09.007; Vicente-Suarez I, 2007, EUR J IMMUNOL, V37, P3164, DOI 10.1002/eji.200737306; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Yamaguchi T, 2000, J MED MICROBIOL, V49, P701, DOI 10.1099/0022-1317-49-8-701; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zedler S, 1999, CRIT CARE MED, V27, P66, DOI 10.1097/00003246-199901000-00028; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	62	39	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85623	10.1371/journal.pone.0085623	http://dx.doi.org/10.1371/journal.pone.0085623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454904	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100107
J	Yu, ZQ; Zhang, C; Chai, R; Du, Y; Gao, XH; Xing, JJ; Yu, ED; Zhang, W; Zhang, XQ; Cao, GW; Fu, CG				Yu, Zhiqi; Zhang, Chang; Chai, Rui; Du, Yan; Gao, Xianhua; Xing, Junjie; Yu, Enda; Zhang, Wei; Zhang, Xiaoqing; Cao, Guangwen; Fu, Chuangang			Prognostic Significance and Molecular Mechanism of ATP-Binding Cassette Subfamily C Member 4 in Resistance to Neoadjuvant Radiotherapy of Locally Advanced Rectal Carcinoma	PLOS ONE			English	Article							CYCLIC-ADENOSINE-MONOPHOSPHATE; PREOPERATIVE RADIOTHERAPY; COLORECTAL-CARCINOMA; DOWN-REGULATION; CELL-CYCLE; CANCER; PROTEIN; P53; RADIOSENSITIVITY; SENSITIVITY	Background: Mechanism of radioresistance in rectal carcinoma remains largely unknown. We aimed to evaluate the predictive role of ATP-binding cassette subfamily C member 4 (ABCC4) in locally advanced rectal carcinoma and explore possible molecular mechanisms by which ABCC4 confers the resistance to neoadjuvant radiotherapy. Methods: The expression of ABCC4 and P53 mutant in biopsy tissue specimens from 121 locally advanced rectal carcinoma patients was examined using immunohistochemistry. The factors contributing to 3-year overall survival and disease-free survival were evaluated using the Kaplan-Meier method and Cox proportional hazard model. Lentivirus-mediated small hairpin RNA was applied to inhibit ABCC4 expression in colorectal carcinoma cell line RKO, and investigate the radiosensitivity in xenograft model. Intracellular cyclic adenosine monophosphate concentration and cell cycle distribution following irradiation were detected. Results: High expression of ABCC4 and p53 mutant in pretreated tumors, poor pathological response, and high final tumor staging were significant factors independently predicted an unfavorable prognosis of locally advanced rectal carcinoma patients after neoadjuvant radiotherapy. Down-regulation of ABCC4 expression significantly enhanced irradiation-induced suppression of tumor growth in xenograft model. Furthermore, down-regulation of ABCC4 expression enhanced intracellular cyclic adenosine monophosphate production and noticeable deficiency of G1-S phase checkpoint in cell cycle following irradiation. Conclusions: Our study suggests that ABCC4 serves as a novel predictive biomarker that is responsible for the radioresistance and predicts a poor prognosis for locally advanced rectal carcinoma after neoadjuvant radiotherapy.	[Yu, Zhiqi; Zhang, Chang; Gao, Xianhua; Xing, Junjie; Yu, Enda; Zhang, Wei; Fu, Chuangang] Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai, Peoples R China; [Du, Yan; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Coll Basic Med Sci, Shanghai, Peoples R China; [Zhang, Xiaoqing] Second Mil Med Univ, Changhai Hosp, Dept Radiotherapy, Shanghai, Peoples R China; [Chai, Rui] Zhejiang Prov Peoples Hosp, Dept Colorectal Surg, Hangzhou, Zhejiang, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Zhejiang Provincial People's Hospital	Cao, GW (corresponding author), Second Mil Med Univ, Dept Epidemiol, Coll Basic Med Sci, Shanghai, Peoples R China.	gcao@smmu.edu.cn; fugang416@126.com	Du, Yan/AAD-5510-2020	Du, Yan/0000-0001-5413-7836; Cao, Guangwen/0000-0002-8094-1278; Zhang, Wei/0000-0003-3094-9711; Gao, Xian Hua/0000-0001-8020-6946	National Natural Science Foundation of China [30973460, 81272561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grants 30973460 and 81272561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AB, 2012, J NATL COMPR CANC NE, V10, P1528, DOI 10.6004/jnccn.2012.0158; Candas D, 2013, J MOL CELL BIOL, V5, P166, DOI 10.1093/jmcb/mjs062; Caricato M, 2006, EJSO-EUR J SURG ONC, V32, P126, DOI 10.1016/j.ejso.2005.11.001; Chang WJ, 2011, CLIN CANCER RES, V17, P5715, DOI 10.1158/1078-0432.CCR-11-0199; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P838, DOI 10.6004/jnccn.2009.0057; Fu CG, 1998, DIS COLON RECTUM, V41, P68, DOI 10.1007/BF02236898; Fukushima Y, 1999, EUR J CANCER, V35, P935, DOI 10.1016/S0959-8049(99)00035-0; Gradilone A, 2008, CURR CANCER DRUG TAR, V8, P414, DOI 10.2174/156800908785133178; Haste NM, 2012, MICROBES INFECT, V14, P838, DOI 10.1016/j.micinf.2012.05.004; Huynh T, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00178; Jakob C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027402; Ji-Fu E, 2012, MOL BIOL REP, V39, P3675, DOI 10.1007/s11033-011-1142-2; Jorgensen TJ, 2009, CANCER BIOL THER, V8, P665, DOI 10.4161/cbt.8.8.8304; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Li XP, 2011, CANCER-AM CANCER SOC, V117, P4201, DOI 10.1002/cncr.26028; Lin-Lee YC, 2001, BIOCHEM PHARMACOL, V61, P555, DOI 10.1016/S0006-2952(00)00592-X; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Marquez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028368; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sargent D, 2011, EUR J CANCER, V47, P990, DOI 10.1016/j.ejca.2010.12.015; Sassi Y, 2012, FASEB J, V26, P1009, DOI 10.1096/fj.11-194027; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Witkowski G, 2012, J PHYSIOL PHARMACOL, V63, P457; Wittgen HGM, 2012, BIOCHEM PHARMACOL, V84, P366, DOI 10.1016/j.bcp.2012.04.012; Yu ZQ, 2013, DIS COLON RECTUM, V56, P600, DOI 10.1097/DCR.0b013e31827c2b80; Zhao LQ, 2012, CARCINOGENESIS, V33, P2220, DOI 10.1093/carcin/bgs235	32	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85446	10.1371/journal.pone.0085446	http://dx.doi.org/10.1371/journal.pone.0085446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454870	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100088
J	Fang, Y; Jaiseng, W; Ma, Y; Hu, LL; Yamazaki, S; Zhang, XB; Hayafuji, T; Shi, L; Kuno, T				Fang, Yue; Jaiseng, Wurentuya; Ma, Yan; Hu, Lingling; Yamazaki, Shizuka; Zhang, Xibo; Hayafuji, Tsutomu; Shi, Lin; Kuno, Takayoshi			E3 Ubiquitin Ligase Pub1 Is implicated in Endocytosis of a GPI-Anchored Protein Ecm33 in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR TRAFFICKING; BINDING PROTEINS; DNA-REPAIR; CALCINEURIN; RSP5; PATHWAY; UBIQUITYLATION; CYTOKINESIS	We previously identified three glycosylphosphatidylinositol (GPI)-anchored proteins including Ecm33, as multicopy suppressors of the phenotypes of a mutant allele of cis4(+) that encodes a zinc transporter in fission yeast. Here, we further identified two multicopy suppressor genes, ubi1(+) and ubc4(+), encoding ubiquitin-ribosomal fusion protein and ubiquitin conjugating enzyme E2, respectively. In addition, Ubi1 or Ubc4 overexpression failed to suppress the phenotypes of the double deletion of cis4(+) and pub1(+) gene, which encodes a HECT-type ubiquitin ligase E3. During exponential phase GFP-Ecm33 localized at the growing cell tips of the cell surface and the medial region in wild-type cells. Notably, during the post-exponential and stationary phase, GFP-Ecm33 in wild-type cells was internalized and mostly localized to the Golgi/endosomes, but it was still stably localized at the cell surface in Delta pub1 cells. The Delta pub1 cells showed osomoremedial phenotypes to various drugs indicating their defects in cell wall integrity. Altogether, our findings reveal a novel role for Pub1 in endocytosis of Ecm33 and regulation of cell wall integrity in fission yeast.	[Fang, Yue; Zhang, Xibo; Shi, Lin; Kuno, Takayoshi] China Med Univ, Dept Biopharmaceut, Sch Pharm, Shenyang, Peoples R China; [Fang, Yue; Jaiseng, Wurentuya; Ma, Yan; Hu, Lingling; Yamazaki, Shizuka; Zhang, Xibo; Hayafuji, Tsutomu; Kuno, Takayoshi] Kobe Univ, Div Mol Pharmacol & Pharmacogen, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Jaiseng, Wurentuya] Inner Mongolia Univ Nationalities, Coll Mongolian Med, Tongliao, Peoples R China	China Medical University; Kobe University; Inner Mongolia University for Nationalities	Fang, Y (corresponding author), China Med Univ, Dept Biopharmaceut, Sch Pharm, Shenyang, Peoples R China.	fangyue@mail.cmu.edu.cn	hu, ling/GWC-1104-2022		National Natural Science Foundation of China [31071094]; Program for Liaoning Excellent Talents in University [LJQ2012067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Excellent Talents in University	This work was supported by the National Natural Science Foundation of China (No. 31071094) and Program for Liaoning Excellent Talents in University (No. LJQ2012067) to Yue Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Esteban V, 2008, CELL CYCLE, V7, P1269, DOI 10.4161/cc.7.9.5947; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fujita M, 2012, BIOCH BIOPHYS ACTA; Hiraishi H, 2009, BIOSCI BIOTECH BIOCH, V73, P2268, DOI 10.1271/bbb.90363; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Jaiseng W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041946; Kaliszewski P, 2008, ACTA BIOCHIM POL, V55, P649; Kaminska J, 2005, ACTA BIOCHIM POL, V52, P207; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Kwapisz M, 2005, RNA, V11, P1710, DOI 10.1261/rna.2131605; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Matsuo Y, 2011, J BIOL CHEM, V286, P13775, DOI 10.1074/jbc.M110.169953; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Saleki R, 1997, MOL GEN GENET, V254, P520, DOI 10.1007/s004380050447; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; Shcherbik N, 2011, RNA, V17, P1422, DOI 10.1261/rna.2615311; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Stoll KE, 2011, J BIOL CHEM, V286, P15165, DOI 10.1074/jbc.M110.203968; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Toda T, 1996, MOL CELL BIOL, V16, P6752; Tsutsumi S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706869200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yada T, 2001, J BIOL CHEM, V276, P13579, DOI 10.1074/jbc.M009260200; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	43	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85238	10.1371/journal.pone.0085238	http://dx.doi.org/10.1371/journal.pone.0085238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454826	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800028
J	D'Hertefeldt, T; Enestrom, JM; Pettersson, LB				D'Hertefeldt, Tina; Enestrom, Johanna M.; Pettersson, Lars B.			Geographic and Habitat Origin Influence Biomass Production and Storage Translocation in the Clonal Plant Aegopodium podagraria	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; EXTENSIVE PHYSIOLOGICAL INTEGRATION; LIFE-HISTORY VARIATION; FRAGARIA-CHILOENSIS; EVOLUTIONARY SIGNIFICANCE; LATITUDINAL GRADIENT; RANUNCULUS-REPTANS; GLECHOMA-HEDERACEA; CAREX-BIGELOWII; PERENNIAL HERB	Through physiological integration, clonal plants can support ramets in unfavourable patches, exploit heterogeneously distributed resources and distribute resources that are taken up over large areas. Physiological integration generally increases in adverse conditions, but it is not well known which factors determine the evolution of physiological integration. The aim of this study was to investigate if clonal plants from Southern and Northern populations of the clonal herb Aegopodium podagraria differed in physiological integration in terms of translocation of carbon to the rhizomes, and in biomass production using a reciprocal transplant experiment. Aegopodium podagraria from shaded conditions have been suggested to share more resources than clones from open conditions and therefore, plants from forest and open populations within the Southern and Northern regions were included. The regional growing conditions greatly affected biomass production. Plants grown in North Sweden produced more biomass and allocated more biomass to shoots, while plants grown in South Sweden allocated more biomass to rhizomes. There was a regional origin effect as plants originating from North Sweden produced more biomass in both regions. Within the Northern region, plants from shaded habitats translocated more C-14 to the rhizomes, suggesting more storage there than in plants from open habitats. In addition to genetic differentiation in biomass production between Northern and Southern populations, probably as a response to a shorter growing season in the North, there appeared to be genetic differentiation in physiological integration within the Northern region. This shows that both regional and local conditions need to be taken into account in future studies of genetic differentiation of physiological integration in clonal plants.	[D'Hertefeldt, Tina; Enestrom, Johanna M.; Pettersson, Lars B.] Lund Univ, Dept Biol, Biodivers Unit, Lund, Sweden	Lund University	D'Hertefeldt, T (corresponding author), Lund Univ, Dept Biol, Biodivers Unit, Lund, Sweden.	tina.dhertefeldt@biol.lu.se	Pettersson, Lars/AAX-3948-2020	Pettersson, Lars/0000-0001-5745-508X	C. Tryggers Foundation; Swedish Research council FORMAS; Gyllenstiernska Krapperupsiftelsen; Royal Physiographic Society Lund	C. Tryggers Foundation; Swedish Research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Gyllenstiernska Krapperupsiftelsen; Royal Physiographic Society Lund	This study was financed by the C. Tryggers Foundation and the Swedish Research council FORMAS (TD'H), Gyllenstiernska Krapperupsiftelsen (JE and TD'H) and the Royal Physiographic Society Lund (JE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; ASHMUN JW, 1982, ANN BOT-LONDON, V49, P403, DOI 10.1093/oxfordjournals.aob.a086264; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; CHAPIN FS, 1981, ARCTIC ALPINE RES, V13, P83; Chen JS, 2004, FLORA, V199, P342, DOI 10.1078/0367-2530-00162; Clausen JC, 1940, CARNEGIE I WASHINGTO, V520; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; D'Hertefeldt T, 2002, NEW PHYTOL, V156, P469, DOI 10.1046/j.1469-8137.2002.00529.x; Dawson W, 2012, NEW PHYTOL, V194, P859, DOI 10.1111/j.1469-8137.2012.04104.x; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; Dong BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013631; DOUST LL, 1987, J ECOL, V75, P555, DOI 10.2307/2260434; Enestrom J, 2008, THESIS LUND U LUNDSW; Enestrom J, 2009, NORD J BOT, V27, P437, DOI 10.1111/j.1756-1051.2009.00495.x; Ericsson S, 1991, NATUR NORR, V10, P77; Garske S, 2005, WEEDS GONE WILD ALIE; Ida TY, 2009, J PLANT RES, V122, P171, DOI 10.1007/s10265-008-0212-6; Jia X, 2010, PLANT SPEC BIOL, V25, P85, DOI 10.1111/j.1442-1984.2010.00271.x; Jonsdottir IS, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P109; JONSDOTTIR IS, 1988, OIKOS, V52, P120, DOI 10.2307/3565991; JONSDOTTIR IS, 1990, NEW PHYTOL, V114, P419, DOI 10.1111/j.1469-8137.1990.tb00409.x; Keble Martin W, 1965, CONCISE BRIT FLORA C; KIK C, 1990, J ECOL, V78, P962, DOI 10.2307/2260946; Klimesova J, 2006, CLO PLA3 DATABASE CO; Korsmo E, 1986, KORSMOS UGRASPLANSJE; LANDA K, 1992, OIKOS, V63, P348, DOI 10.2307/3544960; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Lotscher M, 1997, J ECOL, V85, P341, DOI 10.2307/2960506; Loveys BR, 2002, PLANT CELL ENVIRON, V25, P975, DOI 10.1046/j.1365-3040.2002.00879.x; MATTHEIS PJ, 1976, ANN BOT-LONDON, V40, P179, DOI 10.1093/oxfordjournals.aob.a085121; Meyer K, 1997, FLORA, V192, P335; Mossberg B, 2010, NYA NORDISKA FLORAN; NEWELL SJ, 1982, B TORREY BOT CLUB, V109, P306; Nilsson J, 2008, EVOL ECOL, V22, P437, DOI 10.1007/s10682-007-9199-z; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Prati D, 2000, OIKOS, V90, P442, DOI 10.1034/j.1600-0706.2000.900303.x; Price EAC, 2001, EVOL ECOL, V15, P347, DOI 10.1023/A:1016036916017; Raven P. H., 1999, BIOL PLANTS, V6th; REINARTZ JA, 1984, J ECOL, V72, P913, DOI 10.2307/2259540; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Roiloa SR, 2013, PLANT ECOL, V214, P521, DOI 10.1007/s11258-013-0186-x; Salisbury E. J ., 1942, REPROD CAPACITY PLAN; SAWADA S, 1994, FUNCT ECOL, V8, P400, DOI 10.2307/2389834; Schultz ET, 1997, OECOLOGIA, V109, P516, DOI 10.1007/s004420050112; Sjors H, 2007, SWEDISH PLANT GEOGRA, P5; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; STUEFER JF, 1994, OECOLOGIA, V100, P302, DOI 10.1007/BF00316958; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; Swedish Metrological and Hydrological Institute (SMHI), 2013, STRANG MES MOD SOL R; Swedish Metrological and Hydrological Institute (SMHI), 2011, PTHBV VERS 3 NAT MAP; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Zar JH, 1999, BIOSTATISTICAL ANAL; ZEEVAART JA, 1971, PLANT PHYSIOL, V47, P821, DOI 10.1104/pp.47.6.821	59	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85407	10.1371/journal.pone.0085407	http://dx.doi.org/10.1371/journal.pone.0085407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427305	Green Submitted, Green Published, gold			2022-12-27	WOS:000329868200046
J	Liang, W; Dai, CM; Zhou, XF; Zhang, YL				Liang, Wen; Dai, Chaomeng; Zhou, Xuefei; Zhang, Yalei			Application of Zero-Valent Iron Nanoparticles for the Removal of Aqueous Zinc Ions under Various Experimental Conditions	PLOS ONE			English	Article							GRANULAR FERRIC HYDROXIDE; ZEROVALENT IRON; HEAVY-METALS; WATER; ADSORPTION; DEGRADATION; REDUCTION; TOXICITY; SHELL; XPS	Application of zero-valent iron nanoparticles (nZVI) for Zn2+ removal and its mechanism were discussed. It demonstrated that the uptake of Zn2+ by nZVI was efficient. With the solids concentration of 1 g/L nZVI, more than 85% of Zn2+ could be removed within 2 h. The pH value and dissolved oxygen (DO) were the important factors of Zn2+ removal by nZVI. The DO enhanced the removal efficiency of Zn2+. Under the oxygen-contained condition, oxygen corrosion gave the nZVI surface a shell of iron (oxy) hydroxide, which could show high adsorption affinity. The removal efficiency of Zn2+ increased with the increasing of the pH. Acidic condition reduced the removal efficiency of Zn2+ by nZVI because the existing H+ inhibited the formation of iron (oxy) hydroxide. Adsorption and co-precipitation were the most likely mechanism of Zn2+ removal by nZVI. The FeOOH-shell could enhance the adsorption efficiency of nZVI. The removal efficiency and selectivity of nZVI particles for Zn2+ were higher than Cd2+. Furthermore, a continuous flow reactor for engineering application of nZVI was designed and exhibited high removal efficiency for Zn2+.	[Liang, Wen; Dai, Chaomeng; Zhou, Xuefei; Zhang, Yalei] Tongji Univ, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Dai, Chaomeng] Tongji Univ, Coll Civil Engn, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Dai, CM (corresponding author), Tongji Univ, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China.	daichaomeng@tongji.edu.cn; zhangyalei@tongji.edu.cn	ZHOU, XUE/F-6129-2013	Zhang, Yalei/0000-0002-3254-8965	National Key Technologies R&D Program of China [2012BAJ25B04]; New Century Excellent Talents in University [NCET-11-0391]; Shanghai Science and Technology Commission [11QH1402600]; National Natural Science Foundation of China [21246001, 51138009, 41101480]	National Key Technologies R&D Program of China(National Key Technology R&D Program); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technologies R&D Program of China (No. 2012BAJ25B04), New Century Excellent Talents in University (NCET-11-0391), the Project of Shanghai Science and Technology Commission (No. 11QH1402600), and the National Natural Science Foundation of China (key program No. 21246001, 51138009, 41101480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambashta RD, 2011, IND ENG CHEM RES, V50, P11771, DOI 10.1021/ie102121e; Badruzzaman M, 2004, WATER RES, V38, P4002, DOI 10.1016/j.watres.2004.07.007; Boparai HK, 2011, J HAZARD MATER, V186, P458, DOI 10.1016/j.jhazmat.2010.11.029; Celebi O, 2007, J HAZARD MATER, V148, P761, DOI 10.1016/j.jhazmat.2007.06.122; Chastain J, 1992, PERKIN ELMER CORP, V40, P221; Choe S, 2001, CHEMOSPHERE, V42, P367, DOI 10.1016/S0045-6535(00)00147-8; Committee SDW, 1977, DRINK WAT HLTH; Elliott DW, 2009, J ENVIRON ENG, V135, P317, DOI 10.1061/(ASCE)0733-9372(2009)135:5(317); Emsley J, 1989, ELEMENTS; EPA US, 2005, TOX REV ZINC COMP, P6; Fan J, 2009, J HAZARD MATER, V166, P904, DOI 10.1016/j.jhazmat.2008.11.091; Fang ZQ, 2011, DESALINATION, V268, P60, DOI 10.1016/j.desal.2010.09.051; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Gordon RB, 2006, P NATL ACAD SCI USA, V103, P1209, DOI 10.1073/pnas.0509498103; Guan XH, 2008, J HAZARD MATER, V156, P178, DOI 10.1016/j.jhazmat.2007.12.012; Hafez H., 2012, INT J ENG SCI TECHNO, V4, P3018; Hoerle S, 2004, CORROS SCI, V46, P1431, DOI 10.1016/j.corsci.2003.09.028; Iwasaki Y, 2009, ENVIRON TOXICOL CHEM, V28, P354, DOI 10.1897/08-200.1; Katsou E, 2011, CHEMOSPHERE, V82, P557, DOI 10.1016/j.chemosphere.2010.10.022; Kishimoto N, 2011, WATER AIR SOIL POLL, V221, P183, DOI 10.1007/s11270-011-0781-1; Klimkova S, 2011, CHEMOSPHERE, V82, P1178, DOI 10.1016/j.chemosphere.2010.11.075; Kwon JS, 2005, CHEMOSPHERE, V60, P1416, DOI 10.1016/j.chemosphere.2005.01.078; Li XQ, 2007, J PHYS CHEM C, V111, P6939, DOI 10.1021/jp0702189; Liu F., 2009, ANAL TEST TECHNOL IN, V15, P1; Lu SG, 2007, J HAZARD MATER, V149, P208, DOI 10.1016/j.jhazmat.2007.03.070; Miehr R, 2004, ENVIRON SCI TECHNOL, V38, P139, DOI 10.1021/es034237h; Naja G, 2008, ENVIRON SCI TECHNOL, V42, P4364, DOI 10.1021/es7028153; Otte K, 2012, SURF SCI, V606, P1623, DOI 10.1016/j.susc.2012.07.009; Rangsivek R, 2005, WATER RES, V39, P4153, DOI 10.1016/j.watres.2005.07.040; Sadowski Z, 2001, MINER ENG, V14, P547, DOI 10.1016/S0892-6875(01)00043-7; Salim R, 2003, PROCESS SAF ENVIRON, V81, P236, DOI 10.1205/095758203322299752; Signorini L, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.195423; Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001; WAGEMANN R, 1979, WATER RES, V13, P515, DOI 10.1016/0043-1354(79)90047-2; Wang CM, 2009, J AM CHEM SOC, V131, P8824, DOI 10.1021/ja900353f; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065282; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Yan WL, 2010, J CONTAM HYDROL, V118, P96, DOI 10.1016/j.jconhyd.2010.09.003	38	39	44	9	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85686	10.1371/journal.pone.0085686	http://dx.doi.org/10.1371/journal.pone.0085686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416439	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300097
J	Piscianz, E; Valencic, E; Cuzzoni, E; De Iudicibus, S; De Lorenzo, E; Decorti, G; Tommasini, A				Piscianz, Elisa; Valencic, Erica; Cuzzoni, Eva; De Iudicibus, Sara; De Lorenzo, Elisa; Decorti, Giuliana; Tommasini, Alberto			Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; JAK INHIBITOR; LYMPHOID DEVELOPMENT; JANUS KINASE; CP-690,550; ACTIVATION; RECIPIENTS; PLACEBO; DRUGS; CELLS	Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to its selective action on proliferating cells, Tofa can offer a way to block T cell activation, without toxic effects on resting cells. However, few studies have investigated the effects of Tofa on lymphocyte activation in vitro. Our aim was to study the action of Tofa on different lymphocyte subsets after in vitro stimulation and to track the behaviour of treated cells after interruption of the treatment. Peripheral blood lymphocytes were stimulated in vitro with mitogen and treated with two concentrations of Tofa. After a first period in culture, cells were washed and further incubated for an additional time. Lymphocyte subsets, activation phenotype and proliferation were assessed at the different time frames. As expected, Tofa was able to reduce the activation and proliferation of lymphocytes in the first four days of treatment. In addition the drug led to a relative decrease of Natural Killer, B cells and CD8 T cells compared to CD4 T cells. However, treated cells were still viable after the first period in culture and begun to proliferate, strikingly, in a dose dependent manner when the drug was removed from the environment by replacing the culture medium. This novel data does not necessarily predict a similar behaviour in vivo, but can warn about the clinical use of this drug when a discontinuation of treatment with Tofa is considered for any reason.	[Piscianz, Elisa; Valencic, Erica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Diagnost Med, Trieste, Italy; [Cuzzoni, Eva] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [De Iudicibus, Sara; Tommasini, Alberto] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Paediat, Trieste, Italy; [De Lorenzo, Elisa] IRCCS, Natl Canc Inst CRO, Dept Translat Res, Aviano, Italy; [Decorti, Giuliana] Univ Trieste, Dept Life Sci, Trieste, Italy	IRCCS Burlo Garofolo; University of Trieste; IRCCS Burlo Garofolo; IRCCS Aviano (CRO); University of Trieste	Piscianz, E (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Diagnost Med, Trieste, Italy.	elisa.piscianz@gmail.com	Tommasini, Alberto/AAE-3882-2020; Valencic, Erica/G-3067-2014	Tommasini, Alberto/0000-0002-6943-7927; Valencic, Erica/0000-0002-7380-8014; Piscianz, Elisa/0000-0001-7374-1684; Decorti, Giuliana/0000-0002-9714-6246				Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; Egli A, 2013, TRANSPLANTATION, V95, P448, DOI 10.1097/TP.0b013e318276a19f; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Kalluri Hari Varun, 2012, World J Transplant, V2, P51, DOI 10.5500/wjt.v2.i4.51; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; Kyttaris VC, 2012, DRUG DES DEV THER, V6, P245, DOI 10.2147/DDDT.S25426; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; O'Shea JJ, 2004, ANN RHEUM DIS, V63, P67, DOI 10.1136/ard.2004.028290; Paniagua R, 2005, TRANSPLANTATION, V80, P1283, DOI 10.1097/01.tp.0000177643.05739.cd; Pinchuk LM, 1996, J IMMUNOL, V157, P4363; Piscianz E, 2011, INT IMMUNOPHARMACOL, V11, P2242, DOI 10.1016/j.intimp.2011.09.009; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Soto H, 2008, SCAND J IMMUNOL, V68, P43, DOI 10.1111/j.1365-3083.2008.02117.x; Vafadari R, 2012, TRANSPLANTATION, V94, P465, DOI 10.1097/TP.0b013e3182626b5a; van Gurp EAFJ, 2009, TRANSPLANTATION, V87, P79, DOI 10.1097/TP.0b013e31818bbea7; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Vincenti F, 2012, AM J TRANSPLANT, V12, P2446, DOI 10.1111/j.1600-6143.2012.04127.x; Yoshida H, 2012, BIOCHEM BIOPH RES CO, V418, P234, DOI 10.1016/j.bbrc.2011.12.156	21	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85463	10.1371/journal.pone.0085463	http://dx.doi.org/10.1371/journal.pone.0085463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416411	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300080
J	McCracken, SF; Forstner, MRJ				McCracken, Shawn F.; Forstner, Michael R. J.			Oil Road Effects on the Anuran Community of a High Canopy Tank Bromeliad (Aechmea zebrina) in the Upper Amazon Basin, Ecuador	PLOS ONE			English	Article							RAIN-FOREST; SPECIES-DIVERSITY; FROG ASSEMBLAGES; WESTERN AMAZON; HERPETOFAUNA; BIRDS; DEFORESTATION; FRAGMENTATION; MICROCLIMATE; MIGRATION	Tropical forest canopies are among the most species-rich terrestrial habitats on earth and one of the remaining relatively unexplored biotic frontiers. Epiphytic bromeliads provide microhabitat for a high diversity of organisms in tropical forest canopies and are considered a keystone resource. A number of amphibians inhabit these phytotelmata, yet their ecological role and status in forest canopies remains unknown. For this study, anurans were collected from an upper canopy tank bromeliad (Aechmea zebrina) at similar to 20-45 m ((x) over bar = 33 m) above the forest floor. Bromeliads were sampled from trees located near trails in undisturbed primary rainforest and oil access roads in the Yasuni Biosphere Reserve of Amazonian Ecuador. We collected 95 anurans representing 10 species from 160 bromeliads in 32 trees. We used generalized linear mixed models to assess the effects of disturbance and habitat factors on the occupancy and abundance of anurans collected. Bromeliads in forest along oil roads had a lower occupancy and abundance of anurans than those in undisturbed forest, a somewhat unexpected result due to the intactness and quality of forest adjacent to the roads. Recorded habitat variables had no relationship with occupancy or abundance of anurans, and did not differ significantly between treatments. Our findings reveal that even the minimal footprint of natural resource extraction operations, primarily roads, in rainforest environments can have significant negative impacts on the unique upper canopy anuran community. Based on these results, we recommend that natural resource development treat rainforest habitat as an offshore system where roads are not used, employ industry best practice guidelines, and current access roads be protected from colonization and further deforestation.	[McCracken, Shawn F.; Forstner, Michael R. J.] SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [McCracken, Shawn F.] TADPOLE Org, San Marcos, TX USA	Texas State University System; Texas State University San Marcos	McCracken, SF (corresponding author), SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	smccracken@txstate.edu		McCracken, Shawn/0000-0001-6455-537X	National Science Foundation [0742306]; Texas State University - Department of Biology; TADPOLE Organization; Sigma Xi - The Scientific Research Society; Explorer's Club	National Science Foundation(National Science Foundation (NSF)); Texas State University - Department of Biology; TADPOLE Organization; Sigma Xi - The Scientific Research Society; Explorer's Club	This research was supported by the National Science Foundation (Graduate Research Fellowship Program and a GK-12 grant No. 0742306), Texas State University - Department of Biology, the TADPOLE Organization, Sigma Xi - The Scientific Research Society, and The Explorer's Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews Kimberly M., 2008, P121; Armbruster P, 2002, OIKOS, V96, P225, DOI 10.1034/j.1600-0706.2002.960204.x; Balslev H., 1987, OPERA BOT, V92, P37; Barbieri AF, 2009, POPUL RES POLICY REV, V28, P291, DOI 10.1007/s11113-008-9100-y; Barthlott W, 2001, PLANT ECOL, V152, P145, DOI 10.1023/A:1011483901452; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P7; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P394; Basset Y, 2004, BIODIVERS CONSERV, V13, P709, DOI 10.1023/B:BIOC.0000011722.44714.a4; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P4; Bell KE, 2006, CONSERV BIOL, V20, P1750, DOI 10.1111/j.1523-1739.2006.00522.x; Benzing DH, 1998, CLIMATIC CHANGE, V39, P519, DOI 10.1023/A:1005312307709; BENZING DH, 2000, BROMELIACEAE PROFILE; Blandin LC, 1976, CLIMA SUS CARACTERIS; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brighigna L, 2002, REV BIOL TROP, V50, P577; Buchanan Bryant W., 2006, P192; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canaday C, 2001, BIODIVERS CONSERV, V10, P567, DOI 10.1023/A:1016651827287; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; CIA, 2007, WORLD FACT BOOK 2007; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Dew JL, 2003, AM J PHYS ANTHROPOL, P89; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Ernst R, 2005, ECOLOGY, V86, P3111, DOI 10.1890/04-0800; Ernst R, 2008, J TROP ECOL, V24, P111, DOI 10.1017/S0266467407004737; Ernst Raffael, 2006, Ecotropica-Bonn, V12, P113; FAO, 2010, GLOBAL FOREST RESOUR; Finer M, 2009, ENVIRON RES LETT, V4, P1; Finer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063022; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Foley JA, 2003, FRONT ECOL ENVIRON, V1, P38, DOI 10.1890/1540-9295(2003)001[0038:GSHTEC]2.0.CO;2; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Freiberg M, 2001, PLANT ECOL, V153, P241, DOI 10.1023/A:1017540629725; Gao Z., 1998, ENV REGULATION OIL G; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Goosem M, 2002, WILDLIFE RES, V29, P277, DOI 10.1071/WR01058; Goosem Miriam, 1997, P241; Guayasamin JM, 2006, HERPETOLOGICA, V62, P191, DOI 10.1655/05-40.1; HEINEN JT, 1992, BIOTROPICA, V24, P431, DOI 10.2307/2388614; Hietz P, 1998, PURE APPL CHEM, V70, P1; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Keller A, 2009, J ANIM ECOL, V78, P305, DOI 10.1111/j.1365-2656.2008.01457.x; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kitching RL, 2001, ANNU REV ENTOMOL, V46, P729, DOI 10.1146/annurev.ento.46.1.729; Krebs C., 2008, ECOLOGICAL WORLD VIE; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2008, LIVING DYNAMIC TROPI, P295, DOI DOI 10.1002/9781444300321.CH23; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; Lowman MD, 2012, NEW PHYTOL, V194, P12, DOI 10.1111/j.1469-8137.2012.04076.x; McCracken Shawn, 2009, Herpetological Review, V40, P190; McCracken Shawn F., 2008, Herpetological Review, V39, P170; McCracken Shawn F., 2006, Phyllomedusa, V5, P135; Menin M, 2007, J TROP ECOL, V23, P539, DOI 10.1017/S0266467407004269; Moffett M. W., 1994, HIGH FRONTIER EXPLOR; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; NADKARNI NM, 1994, AM ZOOL, V34, P70; O'Rourke D, 2003, ANNU REV ENV RESOUR, V28, P587, DOI 10.1146/annurev.energy.28.050302.105617; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Parris KM, 2004, ECOGRAPHY, V27, P392, DOI 10.1111/j.0906-7590.2004.03711.x; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; PERRY DR, 1978, BIOTROPICA, V10, P155, DOI 10.2307/2388019; Pinheiro J. C., 2002, MIXED EFFECTS MODELS; Pitman NCA, 2002, ECOLOGY, V83, P3210, DOI 10.1890/0012-9658(2002)083[3210:ACOTSD]2.0.CO;2; Pohlman CL, 2009, AGR FOREST METEOROL, V149, P84, DOI 10.1016/j.agrformet.2008.07.003; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richardson BA, 1999, BIOTROPICA, V31, P321, DOI 10.1111/j.1744-7429.1999.tb00144.x; Schiesari L, 2003, COPEIA, P263, DOI 10.1643/0045-8511(2003)003[0263:TACBAD]2.0.CO;2; Schlaepfer MA, 2001, CONSERV BIOL, V15, P1079, DOI 10.1046/j.1523-1739.2001.0150041079.x; Semlitsch RD, 2007, CONSERV BIOL, V21, P159, DOI 10.1111/j.1523-1739.2006.00571.x; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; Skaug H., 2011, GLMMADMB GEN LINEAR; Southwood T.R.E., 1987, P3; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stuntz S, 2002, INT J BIOMETEOROL, V46, P53, DOI 10.1007/s00484-001-0117-8; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Terborgh JW, 1986, CONSERVATION BIOL SC; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; von Arx G, 2012, AGR FOREST METEOROL, V166, P144, DOI 10.1016/j.agrformet.2012.07.018; Wardhaugh CW, 2013, BIOL J LINN SOC, V109, P215, DOI 10.1111/bij.12029; WUNDER S, 2003, OIL WEALTH FATE FORE; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	88	16	17	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85470	10.1371/journal.pone.0085470	http://dx.doi.org/10.1371/journal.pone.0085470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416414	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500251
J	Osth, M; Ost, A; Kjolhede, P; Stralfors, P				Osth, Martin; Ost, Anita; Kjolhede, Preben; Stralfors, Peter			The Concentration of beta-Carotene in Human Adipocytes, but Not the Whole-Body Adipocyte Stores, Is Reduced in Obesity	PLOS ONE			English	Article							VITAMIN-A METABOLISM; ADIPOSE-TISSUE; INSULIN-RESISTANCE; SERUM CAROTENOIDS; DIETARY; PLASMA; RETINOL-BINDING-PROTEIN-4; PHOSPHORYLATION; QUEENSLAND; TRANSPORT	We have examined the concentration of beta-carotene in the fat of isolated abdominal subcutaneous adipocytes obtained from lean (BMI<23 kg/m(2)), non-obese with higher BMI (23 <= BMI<28 kg/m(2)), obese (BMI >= 28 kg/m(2)), and from a group of obese subjects with type 2 diabetes. The concentration of b-carotene was 50% lower in the adipocytes from the obese and obese/diabetic groups compared with the lean and non-obese groups. Interestingly, the total amount of beta-carotene in the adipocyte stores of each subject was constant among all groups. Triacylglycerol constituted 92 +/- 1% (by weight) of the adipocyte lipids in the lean group and this was increased to 99 +/- 2% in the obese group with diabetes (p<0.05). The concentration of cholesteryl esters was in all cases <0.1 g per 100 g of total lipids, demonstrating that mature human adipocytes have negligible stores of cholesteryl ester. Our findings demonstrate that adipocyte concentrations of beta-carotene are reduced in obese subjects. The lower concentrations in adipocytes from subjects with type 2 diabetes apparently reflect subjects obesity. Our finding that whole-body stores of beta-carotene in adipocytes are constant raises new questions regarding what function it serves, as well as the mechanisms for maintaining constant levels in the face of varied adipose tissue mass among individuals over a period of time.	[Osth, Martin; Ost, Anita; Kjolhede, Preben; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	peter.stralfors@liu.se		Stralfors, Peter/0000-0002-1196-1806	Swedish Diabetes Fund; Novo Nordic Foundation; University of Linkoping; Swedish Research Council	Swedish Diabetes Fund; Novo Nordic Foundation(Novo Nordisk Foundation); University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Diabetes Fund, Novo Nordic Foundation, University of Linkoping, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, BRIT J NUTR, V101, P86, DOI 10.1017/S0007114508998445; Amengual J, 2013, PLOS ONE, V6; Beydoun MA, 2012, J NUTR, V142, P1693, DOI 10.3945/jn.112.160416; BJORNSON LK, 1976, J LIPID RES, V17, P343; Brady WE, 1996, J NUTR, V126, P129, DOI 10.1093/jn/126.1.129; Chung HY, 2009, AM J CLIN NUTR, V90, P533, DOI 10.3945/ajcn.2009.27712; Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685; Coyne T, 2009, BRIT J NUTR, V102, P1668, DOI 10.1017/S000711450999081X; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; El-Sohemy A, 2002, AM J CLIN NUTR, V76, P172, DOI 10.1093/ajcn/76.1.172; Ford ES, 2003, EUR J CLIN NUTR, V57, P1157, DOI 10.1038/sj.ejcn.1601667; Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027; Gouranton E, 2008, FOOD CHEM TOXICOL, V46, P3832, DOI 10.1016/j.fct.2008.10.006; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; JOHNSON EJ, 1995, AM J CLIN NUTR, V62, P598, DOI 10.1093/ajcn/62.3.598; Kabagambe EK, 2005, J NUTR, V135, P1763, DOI 10.1093/jn/135.7.1763; KAPLAN LA, 1990, CLIN PHYSIOL BIOCH, V8, P1; Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065; Lee MJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1230, DOI 10.1152/ajpendo.90927.2008; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moussa M, 2011, MOL NUTR FOOD RES, V55, P578, DOI 10.1002/mnfr.201000399; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Parker RS, 1999, P NUTR SOC, V58, P155, DOI 10.1079/PNS19990021; PARKER RS, 1989, J NUTR, V119, P101, DOI 10.1093/jn/119.1.101; Ryden M, 2012, J INTERN MED, V272, P371, DOI [10.1111/j.1365-2796.2012.2534.x, 10.1111/j.1365-2796.2012.2534x.x]; SCHREIBMAN PH, 1975, J CLIN INVEST, V55, P986, DOI 10.1172/JCI108028; Sluijs I, 2009, J NUTR, V139, P987, DOI 10.3945/jn.108.101451; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; TOKUNAGA M, 1981, TOHOKU J EXP MED, V133, P451, DOI 10.1620/tjem.133.451; Virtanen SM, 1996, AM J EPIDEMIOL, V144, P968, DOI 10.1093/oxfordjournals.aje.a008867; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; Voutilainen S, 2006, AM J CLIN NUTR, V83, P1265; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	38	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85610	10.1371/journal.pone.0085610	http://dx.doi.org/10.1371/journal.pone.0085610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416432	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500259
J	Pfattheicher, S; Keller, J				Pfattheicher, Stefan; Keller, Johannes			Towards a Biopsychological Understanding of Costly Punishment: The Role of Basal Cortisol	PLOS ONE			English	Article							PRECONSCIOUS SELECTIVE ATTENTION; ECONOMIC DECISION-MAKING; SALIVARY CORTISOL; AGGRESSIVE-BEHAVIOR; SEX-DIFFERENCES; ALTRUISTIC PUNISHMENT; PROACTIVE AGGRESSION; 3RD-PARTY PUNISHMENT; SELF-REGULATION; HPA AXIS	Recent findings have documented a negative relation of basal endogenous cortisol and aggression after a provocation (i.e., reactive aggression) in humans. We build on these findings and investigated the relation of endogenous cortisol and reactive aggression in a social dilemma situation, that is, costly punishment of individuals who did not appropriately contribute to a common group project. Specifically, we predicted that basal cortisol is negatively related to costly punishment of uncooperative individuals. In the present study, basal cortisol was assessed prior to a public goods game with the option to punish other group members. In line with previous research on reactive aggression and basal cortisol, we found that basal cortisol was indeed negatively related to costly punishment. The findings are important for understanding costly punishment because this tendency has been documented as a possible basis for the evolution of cooperation.	[Pfattheicher, Stefan; Keller, Johannes] Univ Ulm, Dept Social Psychol, D-89069 Ulm, Germany	Ulm University	Pfattheicher, S (corresponding author), Univ Ulm, Dept Social Psychol, D-89069 Ulm, Germany.	stefan.pfattheicher@uni-ulm.de		Pfattheicher, Stefan/0000-0002-0161-1570	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The reported research has been partially supported by a grant from the German Research Foundation to Johannes Keller. The authors received no additional external funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Balliet D, 2013, PERSPECT PSYCHOL SCI, V8, P363, DOI 10.1177/1745691613488533; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P105, DOI 10.1037/0022-3514.72.1.105; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; Baumeister RF, 2000, SOC COGNITION, V18, P130, DOI 10.1521/soco.2000.18.2.130; Bertsch K, 2011, HORM BEHAV, V59, P428, DOI 10.1016/j.yhbeh.2010.12.010; Blair C, 2004, DEV PSYCHOBIOL, V45, P113, DOI 10.1002/dev.20022; Bohnke R, 2010, PSYCHONEUROENDOCRINO, V35, P1034, DOI 10.1016/j.psyneuen.2010.01.004; Bohnke R, 2010, J NEURAL TRANSM, V117, P629, DOI 10.1007/s00702-010-0391-x; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Brown LL, 1996, J PERS SOC PSYCHOL, V70, P362, DOI 10.1037/0022-3514.70.2.362; Brune M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073519; Bullock JG, 2010, J PERS SOC PSYCHOL, V98, P550, DOI 10.1037/a0018933; Chan ME, 2011, PERS INDIV DIFFER, V50, P700, DOI 10.1016/j.paid.2010.12.021; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Connor DF, 2003, CHILD PSYCHIAT HUM D, V33, P279, DOI 10.1023/A:1023084112561; Cook RD, 1982, RESIDUALS INFLUENCE; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.2307/1131875; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; Cubitt RP, 2011, J PUBLIC ECON, V95, P253, DOI 10.1016/j.jpubeco.2010.10.011; Cunningham WA, 2005, COGN AFFECT BEHAV NE, V5, P202, DOI 10.3758/CABN.5.2.202; Denson TF, 2006, J PERS SOC PSYCHOL, V90, P1032, DOI 10.1037/0022-3514.90.6.1032; Denson TF, 2013, PSYCHONEUROENDOCRINO, V38, P416, DOI 10.1016/j.psyneuen.2012.07.003; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Emanuele E, 2008, NEUROSCI LETT, V437, P158, DOI 10.1016/j.neulet.2008.04.006; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Eysenck HJ, 1970, BIOL BASIS PERSONALI; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Feilhauer J, 2013, PSYCHONEUROENDOCRINO, V38, P1586, DOI 10.1016/j.psyneuen.2013.01.005; Fiedler K, 2011, J EXP SOC PSYCHOL, V47, P1231, DOI 10.1016/j.jesp.2011.05.007; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Goetz J., 2010, PSYCHOL BULL, V136, P274; Halali E, 2013, J EXP PSYCH IN PRESS; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hinkelmann K, 2009, BIOL PSYCHIAT, V66, P879, DOI 10.1016/j.biopsych.2009.06.023; KING RJ, 1990, PERS INDIV DIFFER, V11, P287, DOI 10.1016/0191-8869(90)90242-J; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Leliveld MC, 2012, EUR J SOC PSYCHOL, V42, P135, DOI 10.1002/ejsp.872; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; Lopez-Duran NL, 2009, J ABNORM CHILD PSYCH, V37, P169, DOI 10.1007/s10802-008-9263-3; McBurnett K, 2000, ARCH GEN PSYCHIAT, V57, P38, DOI 10.1001/archpsyc.57.1.38; McCullough M., 2008, REVENGE EVOLUTION FO; MCDONALD JF, 1980, REV ECON STAT, V62, P318, DOI 10.2307/1924766; Montoya ER, 2012, MOTIV EMOTION, V36, P65, DOI 10.1007/s11031-011-9264-3; Nava F, 2006, J ADDICT DIS, V25, P9, DOI 10.1300/J069v25n02_02; Nelissen RMA, 2009, JUDGM DECIS MAK, V4, P543; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Osumi T, 2012, J AFFECT DISORDERS, V142, P331, DOI 10.1016/j.jad.2012.05.012; Pfattheicher S, 2013, J BEHAV DEC IN PRESS; Pfattheicher S, 2013, EUR J PERSONALITY, V27, P346, DOI 10.1002/per.1909; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Platje E, 2013, BIOL PSYCHOL, V93, P132, DOI 10.1016/j.biopsycho.2013.01.002; Poustka L, 2010, J NEURAL TRANSM, V117, P621, DOI 10.1007/s00702-010-0386-7; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schmidt B, 2013, PSYCHOPHYSIOLOGY, V50, P498, DOI 10.1111/psyp.12032; Shoal GD, 2003, J AM ACAD CHILD PSY, V42, P1101, DOI 10.1097/01.CHI.0000070246.24125.6D; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Stroud LR, 2002, BIOL PSYCHIAT, V52, P318, DOI 10.1016/S0006-3223(02)01333-1; Sylwester K, 2013, J NEUROSCI PSYCHOL E, V6, P167, DOI 10.1037/npe0000009; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tops M, 2011, PSYCHOPHYSIOLOGY, V48, P723, DOI 10.1111/j.1469-8986.2010.01131.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; van Goozen SHM, 2008, CURR DIR PSYCHOL SCI, V17, P224, DOI 10.1111/j.1467-8721.2008.00579.x; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; van Honk J, 1998, PSYCHONEUROENDOCRINO, V23, P741, DOI 10.1016/S0306-4530(98)00047-X; van Honk J, 2000, PSYCHONEUROENDOCRINO, V25, P577, DOI 10.1016/S0306-4530(00)00011-1; van Honk J, 2010, J PERS, V78, P67, DOI 10.1111/j.1467-6494.2009.00609.x; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wang CS, 2011, ORGAN BEHAV HUM DEC, V116, P46, DOI 10.1016/j.obhdp.2011.05.007; WINDLE M, 1994, PERS INDIV DIFFER, V17, P61, DOI 10.1016/0191-8869(94)90262-3; Zimmer C, 2003, CLIN J PAIN, V19, P233, DOI 10.1097/00002508-200307000-00006	87	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85691	10.1371/journal.pone.0085691	http://dx.doi.org/10.1371/journal.pone.0085691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416441	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500262
J	Werry, JM; Planes, S; Berumen, ML; Lee, KA; Braun, CD; Clua, E				Werry, Jonathan M.; Planes, Serge; Berumen, Michael L.; Lee, Kate A.; Braun, Camrin D.; Clua, Eric			Reef-Fidelity and Migration of Tiger Sharks, Galeocerdo cuvier, across the Coral Sea	PLOS ONE			English	Article							MARINE PROTECTED AREAS; FRENCH FRIGATE SHOALS; MOVEMENT PATTERNS; TELEMETRY; TRACKING; TRENDS; SCALE; CONSERVATION; SEGREGATION; PREDATORS	Knowledge of the habitat use and migration patterns of large sharks is important for assessing the effectiveness of large predator Marine Protected Areas (MPAs), vulnerability to fisheries and environmental influences, and management of shark-human interactions. Here we compare movement, reef-fidelity, and ocean migration for tiger sharks, Galeocerdo cuvier, across the Coral Sea, with an emphasis on New Caledonia. Thirty-three tiger sharks (1.54 to 3.9 m total length) were tagged with passive acoustic transmitters and their localised movements monitored on receiver arrays in New Caledonia, the Chesterfield and Lord Howe Islands in the Coral Sea, and the east coast of Queensland, Australia. Satellite tags were also used to determine habitat use and movements among habitats across the Coral Sea. Sub-adults and one male adult tiger shark displayed year-round residency in the Chesterfields with two females tagged in the Chesterfields and detected on the Great Barrier Reef, Australia, after 591 and 842 days respectively. In coastal barrier reefs, tiger sharks were transient at acoustic arrays and each individual demonstrated a unique pattern of occurrence. From 2009 to 2013, fourteen sharks with satellite and acoustic tags undertook wide-ranging movements up to 1114 km across the Coral Sea with eight detected back on acoustic arrays up to 405 days after being tagged. Tiger sharks dove 1136 m and utilised three-dimensional activity spaces averaged at 2360 km(3). The Chesterfield Islands appear to be important habitat for sub-adults and adult male tiger sharks. Management strategies need to consider the wide-ranging movements of large (sub-adult and adult) male and female tiger sharks at the individual level, whereas fidelity to specific coastal reefs may be consistent across groups of individuals. Coastal barrier reef MPAs, however, only afford brief protection for large tiger sharks, therefore determining the importance of other oceanic Coral Sea reefs should be a priority for future research.	[Werry, Jonathan M.] Griffith Univ, Australian Rivers Inst, Gold Coast, Qld, Australia; [Werry, Jonathan M.] Griffith Univ, Sch Environm, Gold Coast, Qld, Australia; [Werry, Jonathan M.] Ocean & Coast Res, Gold Coast, Qld, Australia; [Planes, Serge] Ctr Rech Insulaires & Observ Environm CRIOBE, Moorea, France; [Berumen, Michael L.; Braun, Camrin D.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Berumen, Michael L.] Woods Hole Oceanog Dept, Dept Biol, Woods Hole, MA USA; [Lee, Kate A.] Macquarie Univ, Grad Sch Environm, Marine Mammal Res Grp, N Ryde, NSW 2109, Australia; [Clua, Eric] CRISP Programme, Secretariat Pacific Community, Noumea, New Caledonia; [Clua, Eric] French Minist Agr & Fisheries, Paris, France	Griffith University; Griffith University; King Abdullah University of Science & Technology; Macquarie University	Werry, JM (corresponding author), Griffith Univ, Australian Rivers Inst, Gold Coast, Qld, Australia.	jwerry@oc-research.com	Berumen, Michael L/F-7745-2011; Clua, Eric EG/D-7820-2013; PLANES, Serge/ABF-1360-2021	Berumen, Michael L/0000-0003-2463-2742; Clua, Eric EG/0000-0001-7629-2685; Braun, Camrin/0000-0002-9317-9489	Agence Francaise de Developpement; French Pacific Fund; CRISP program; QLD Fisheries	Agence Francaise de Developpement; French Pacific Fund; CRISP program; QLD Fisheries	Funding was provided by the the Agence Francaise de Developpement (http://www.afd.fr), French Pacific Fund, the CRISP program (www.crisponline.info) and QLD Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JC, 1989, DEEP-SEA RES, V36, P957, DOI 10.1016/0198-0149(89)90037-X; [Anonymous], 2013, JOINT STATEMENT STRA; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Borsa P, 2010, PAC SCI, V64, P297, DOI 10.2984/64.2.297; Clarke S, 2007, MAR RESOUR ECON, V22, P305, DOI 10.1086/mre.22.3.42629561; Clua E, 2011, MAR FRESHWATER RES, V62, P764, DOI 10.1071/MF10163; Clua E, 2011, CONTRIBUTION BIOL IN; Clua E, 2013, MAR FRESHW BEHAV PHY, V46, P1, DOI 10.1080/10236244.2013.773127; Clua Eric, 2010, Am J Forensic Med Pathol, V31, P281, DOI 10.1097/PAF.0b013e3181ec7cb8; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; del Monte-Luna P, 2007, FISH FISH, V8, P107; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Driggers WB, 2008, AQUAT BIOL, V2, P161, DOI 10.3354/ab00045; Duffy Clinton A.J., 2012, P301; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Duong T, 2012, KS KERNEL SMOOTHING; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fitzpatrick R, 2013, PLOS ONE, V7; Francis Malcolm P., 2012, P319; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Galuardi B, 2010, ANALYZEPSAT; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Heap AD, 2008, AUST J EARTH SCI, V55, P555, DOI 10.1080/08120090801888669; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2006, J ANIM ECOL, V75, P666, DOI 10.1111/j.1365-2656.2006.01087.x; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Hill RD, 2001, P S TAGG TRACK MAR F, P315; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Knip DM, 2012, BIOL CONSERV, V148, P200, DOI 10.1016/j.biocon.2012.01.008; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Kohler NE, 1998, MAR FISH REV, V60, P87; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Mourier J, 2013, MOL ECOL, V22, P201, DOI 10.1111/mec.12103; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Natanson LJ, 1999, FISH B-NOAA, V97, P944; Nielsen A, 2011, CANADIAN J FISH AQUA, V64, P1055; Noriega R, 2011, FISH RES, V110, P472, DOI 10.1016/j.fishres.2011.06.005; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Otway NM, 2011, MAR FRESHWATER RES, V62, P607, DOI 10.1071/MF10139; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; PATERSON R A, 1991, Memoirs of the Queensland Museum, V30, P333; Polidoro BA, 2011, J MAR BIOL; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sandin Stuart A., 2010, P71; Simpfendorfer CA, 2009, IUCN RED LIST THREAT; Simpfendorfer CA, 2012, CAN J FISH AQUAT SCI, V69, P565, DOI 10.1139/F2011-179; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0	77	76	77	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83249	10.1371/journal.pone.0083249	http://dx.doi.org/10.1371/journal.pone.0083249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421879	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500039
J	Cameron, JD; Goldfield, GS; Finlayson, G; Blundell, JE; Doucet, E				Cameron, Jameason D.; Goldfield, Gary S.; Finlayson, Graham; Blundell, John E.; Doucet, Eric			Fasting for 24 Hours Heightens Reward from Food and Food-Related Cues	PLOS ONE			English	Article							WEIGHT-LOSS; EATING BEHAVIOR; ENERGY-INTAKE; REINFORCING VALUE; APPETITE SENSATIONS; OBESE SUBJECTS; BRAIN-REGIONS; HUNGER; DEPRIVATION; HUMANS	Introduction: We examined the impact of a 24 hour complete fast (vs. fed state) on two measures of food reward: 1) 'wanting', as measured by response to food images and by the relative-reinforcing value of food (RRV), and 2) 'liking', as measured by response to food images and the hedonic evaluation of foods consumed. Methods: Utilizing a randomized crossover design, 15 subjects (9 male; 6 female) aged 28.6 +/- 4.5 yrs with body mass index 25.3 +/- 1.4 kg/m(2) were randomized and counterbalanced to normal feeding (FED) and 24-hour fast (FASTED) conditions. Trait characteristics were measured with the Three Factor Eating Questionnaire. Two computer tasks measured food reward: 1) RRV progressive ratio task, 2) explicit 'liking' and 'wanting' (Leeds Food Preference Questionnaire, LFPQ). Also measured were ad libitum energy intake (EI; buffet) and food 'liking' (visual analogue scale) of personalized stimuli. Results: There were no significant anthropometric changes between conditions. Appetite scores, hedonic ratings of ` liking', and ad libitum EI all significantly increased under the FASTED condition (p<0.05). Under the FASTED condition there were significant increases in the RRV of snack foods; similarly, explicit 'wanting' and ` liking' significantly increased for all food categories. 'Liking' of sweet foods remained high across-meals under FASTED, but savory foods decreased in hedonic saliency. Conclusion: Relative to a fed state, we observed an increase in hedonic ratings of food, the rewarding value of food, and food intake after a 24 hr fast. Alliesthesia to food and food cues is suggested by heightened hedonic ratings under the FASTED condition relative to FED.	[Goldfield, Gary S.; Doucet, Eric] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Cameron, Jameason D.; Goldfield, Gary S.] Childrens Hosp Eastern Res Inst Ottawa, Ottawa, ON, Canada; [Finlayson, Graham; Blundell, John E.] Univ Leeds, Leeds, W Yorkshire, England	University of Ottawa; University of Leeds	Cameron, JD (corresponding author), Childrens Hosp Eastern Res Inst Ottawa, Ottawa, ON, Canada.	jcameron@cheo.on.ca		Blundell, John/0000-0002-7085-9596; Goldfield, Gary/0000-0001-6216-7824	Children's Hospital of 429 Eastern Ontario Volunteer Association	Children's Hospital of 429 Eastern Ontario Volunteer Association	GSG is supported by an Endowed Scholar Award from the Children's Hospital of 429 Eastern Ontario Volunteer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BERRIDGE KC, 1991, APPETITE, V16, P103, DOI 10.1016/0195-6663(91)90036-R; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Blundell J E, 1992, Journ Annu Diabetol Hotel Dieu, P239; BLUNDELL JE, 1988, CLIN NEUROPHARMACOL, V11, pS121; BOOTH DA, 1982, APPETITE, V3, P163, DOI 10.1016/S0195-6663(82)80009-3; Bryant EJ, 2012, APPETITE, V58, P234, DOI 10.1016/j.appet.2011.09.006; BULIK CM, 1994, PHYSIOL BEHAV, V55, P665, DOI 10.1016/0031-9384(94)90042-6; CABANAC M, 1990, PHYSIOL BEHAV, V47, P539, DOI 10.1016/0031-9384(90)90123-L; CABANAC M, 1972, J PHYSIOL-PARIS, V65, pA370; CABANAC M, 1973, J PHYSIOL-PARIS, V66, P113; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Cameron JD, 2008, PHYSIOL BEHAV, V94, P474, DOI 10.1016/j.physbeh.2008.02.014; DeCastro JM, 1996, NEUROSCI BIOBEHAV R, V20, P119, DOI 10.1016/0149-7634(95)00047-I; Drapeau V, 2007, APPETITE, V48, P159, DOI 10.1016/j.appet.2006.08.002; Drobes DJ, 2001, BIOL PSYCHOL, V57, P153, DOI 10.1016/S0301-0511(01)00093-X; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Epstein LH, 2012, APPETITE, V58, P157, DOI 10.1016/j.appet.2011.09.025; Epstein LH, 2011, AM J CLIN NUTR, V94, P12, DOI 10.3945/ajcn.110.010314; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; Finlayson G, 2008, APPETITE, V50, P120, DOI 10.1016/j.appet.2007.06.007; Finlayson G, 2007, NEUROSCI BIOBEHAV R, V31, P987, DOI 10.1016/j.neubiorev.2007.03.004; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Foster GD, 1998, INT J OBESITY, V22, P778, DOI 10.1038/sj.ijo.0800659; Frankham P, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-112; Franklin JC, 1948, J CLIN PSYCHOL, V4, P28, DOI 10.1002/1097-4679(194801)4:1<28::AID-JCLP2270040103>3.0.CO;2-F; FRENCH SA, 1994, INT J OBESITY, V18, P145; French SA, 2012, APPETITE, V59, P541, DOI 10.1016/j.appet.2012.07.001; Goldstone AP, 2009, EUR J NEUROSCI, V30, P1625, DOI 10.1111/j.1460-9568.2009.06949.x; Haase L, 2009, NEUROIMAGE, V44, P1008, DOI 10.1016/j.neuroimage.2008.09.044; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; Hetherington MM, 2000, INT J EAT DISORDER, V28, P272, DOI 10.1002/1098-108X(200011)28:3&lt;272::AID-EAT4&gt;3.0.CO;2-Q; HILL AJ, 1984, APPETITE, V5, P361, DOI 10.1016/S0195-6663(84)80008-2; Jiang T, 2008, PHYSIOL BEHAV, V95, P464, DOI 10.1016/j.physbeh.2008.07.014; JOHNSON J, 1993, APPETITE, V21, P25, DOI 10.1006/appe.1993.1034; Johnstone AM, 2002, INT J OBESITY, V26, P1623, DOI 10.1038/sj.ijo.0802151; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; LAENG B, 1993, APPETITE, V21, P247, DOI 10.1006/appe.1993.1043; LAPPALAINEN R, 1990, INT J OBESITY, V14, P679; LAPPALAINEN R, 1990, APPETITE, V14, P81, DOI 10.1016/0195-6663(90)90002-P; Lemmens SGT, 2009, PHYSIOL BEHAV, V98, P318, DOI 10.1016/j.physbeh.2009.06.008; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Macdiarmid JI, 1998, INT J OBESITY, V22, P1053, DOI 10.1038/sj.ijo.0800724; McNeil J, 2013, PHYSIOL BEHAV, V112, P84, DOI 10.1016/j.physbeh.2013.02.008; Nicklas JM, 2012, AM J PREV MED, V42, P481, DOI 10.1016/j.amepre.2012.01.005; Oh SY, 2002, EUR J CLIN NUTR, V56, P86, DOI 10.1038/sj.ejcn.1601285; Pekkarinen T, 1996, INT J OBESITY, V20, P332; Piech RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006581; Raynor HA, 2003, APPETITE, V40, P15, DOI 10.1016/S0195-6663(02)00161-7; Reiss S, 1996, BEHAV RES THER, V34, P621, DOI 10.1016/0005-7967(96)00041-1; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROLLS ET, 1983, PHYSIOL BEHAV, V30, P185, DOI 10.1016/0031-9384(83)90003-3; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; SPIEGEL TA, 1989, APPETITE, V13, P45, DOI 10.1016/0195-6663(89)90026-3; Stice E, 2013, NEUROIMAGE, V67, P322, DOI 10.1016/j.neuroimage.2012.11.028; Stoeckel LE, 2007, APPETITE, V48, P139, DOI 10.1016/j.appet.2006.07.079; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tang DW, 2012, PHYSIOL BEHAV, V106, P317, DOI 10.1016/j.physbeh.2012.03.009; Telch CF, 1996, APPETITE, V26, P221, DOI 10.1006/appe.1996.0017; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; WADDEN TA, 1987, INT J OBESITY, V11, P239; Yeomans MR, 1996, APPETITE, V27, P119, DOI 10.1006/appe.1996.0040; Yeomans MR, 1998, PHYSIOL BEHAV, V64, P501, DOI 10.1016/S0031-9384(98)00086-9; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x	67	49	50	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85970	10.1371/journal.pone.0085970	http://dx.doi.org/10.1371/journal.pone.0085970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454949	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000022
J	Ma, HY; Cheng, L; Hao, KJ; Li, YP; Song, XB; Zhou, HM; Jia, L				Ma, Hongye; Cheng, Lei; Hao, Keji; Li, Yanping; Song, Xiaobo; Zhou, Huimin; Jia, Li			Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1	PLOS ONE			English	Article							NF-KAPPA-B; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASES; ACUTE LYMPHOBLASTIC-LEUKEMIA; COLON-CARCINOMA CELLS; COLORECTAL-CANCER; GASTRIC-CANCER; IN-VITRO; ACTIVATION; GLYCOPROTEIN; INHIBITOR	beta-galactoside alpha 2, 6-sialyltransferse gene (ST6GAL) family has two members, which encode corresponding enzymes ST6Gal I and ST6Gal II. The present atudy was to investigate whether and how ST6GAL family involved in multidrug resistance (MDR) in human leukemia cell lines and bone marrow mononuclear cells (BMMC) of leukemia patients. Real-time PCR showed a high expression level of ST6GAL1 gene in both MDR cells and BMMCs (*P<0.05). Alternation of ST6GAL1 levels had a significant impact on drug-resistant phenotype changing of K562 and K562/ADR cells both in vitro and in vivo. However, no significant changes were observed of ST6GAL2 gene. Further data revealed that manipulation of ST6GAL1 modulated the activity of phosphoinositide 3 kinase (PI3K)/Akt signaling and consequently regulated the expression of P-glycoprotein (P-gp, *P<0.05) and multidrug resistance related protein 1 (MRP1, *P<0.05), which are both known to be associated with MDR. Therefore we postulate that ST6GAL1 is responsible for the development of MDR in human leukemia cells probably through medicating the activity of PI3K/Akt signaling and the expression of P-gp and MRP1.	[Ma, Hongye; Li, Yanping; Jia, Li] Med Univ, Coll Lab Med, Dalian, Liaoning Provin, Peoples R China; [Cheng, Lei] Dalian Med Univ, Affiliated Hosp 1, Dept Laparoscop Surg, Dalian, Liaoning Provin, Peoples R China; [Hao, Keji] Peking Univ, Peoples Hosp, Dept Nucl Med, Beijing 100871, Peoples R China; [Song, Xiaobo] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Tromso, Norway; [Zhou, Huimin] Dalian Med Univ, Dept Microbiol, Dalian, Liaoning Provin, Peoples R China	Dalian Medical University; Dalian Medical University; Peking University; UiT The Arctic University of Tromso; Dalian Medical University	Jia, L (corresponding author), Med Univ, Coll Lab Med, Dalian, Liaoning Provin, Peoples R China.	jiali@dlmedu.edu.cn	li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022		National Key Basic Research and Development Program (973 program) of China [2012CB822100]; National Natural Science Foundation of China [81071415, 81271910]	National Key Basic Research and Development Program (973 program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research and Development Program (973 program) of China (no. 2012CB822100), and supported by National Natural Science Foundation of China (81071415, 81271910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2006, ONCOGENE, V25, P1743, DOI 10.1038/sj.onc.1209201; Baran Y, 2011, J CANCER RES CLIN, V137, P1535, DOI 10.1007/s00432-011-1016-y; Barancik M, 2006, EUR J PHARM SCI, V29, P426, DOI 10.1016/j.ejps.2006.08.006; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bosch Tessa M., 2008, V448, P63, DOI 10.1007/978-1-59745-205-2_5; Conde I, 2010, EUR J HAEMATOL, V84, P430, DOI 10.1111/j.1600-0609.2010.01416.x; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; Dalziel M, 2001, GLYCOBIOLOGY, V11, P407, DOI 10.1093/glycob/11.5.407; Dobbin ZC, 2013, INT J MOL SCI, V14, P8213, DOI 10.3390/ijms14048213; Garcia MG, 2009, LEUKEMIA RES, V33, P288, DOI 10.1016/j.leukres.2008.06.010; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Gretschel S, 2003, ONCOLOGY-BASEL, V65, P139, DOI 10.1159/000072339; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Inagaki Y, 2007, HEPATO-GASTROENTEROL, V54, P53; Karajannis MA, 2006, LEUKEMIA, V20, P979, DOI 10.1038/sj.leu.2404203; Kars MD, 2007, ANTICANCER RES, V27, P4031; Kourti M, 2007, INT J HEMATOL, V86, P166, DOI 10.1532/IJH97.E0624; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li J, 2012, MED ONCOL, V29, P84, DOI 10.1007/s12032-010-9771-1; Maraldi T, 2011, INT J ONCOL, V38, P427, DOI 10.3892/ijo.2010.850; Marques DS, 2010, LEUKEMIA RES, V34, P757, DOI 10.1016/j.leukres.2009.11.004; Matkovic K, 2006, LEUKEMIA, V20, P941, DOI 10.1038/sj.leu.2404204; Milflores-Flores L, 2012, J BIOSCIENCES, V37, P259, DOI 10.1007/s12038-012-9194-6; Morishita N, 2012, PEDIATR BLOOD CANCER, V59, P83, DOI 10.1002/pbc.24034; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Pandurangan AK, 2013, ASIAN PAC J CANCER P, V14, P2201, DOI 10.7314/APJCP.2013.14.4.2201; Perez-Garay M, 2013, INT J BIOCH CELL BIO; Petit D, 2010, J BIOL CHEM, V285, P38399, DOI 10.1074/jbc.M110.163931; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takashima S, 2003, J BIOCHEM, V134, P287, DOI 10.1093/jb/mvg142; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357; Wang HH, 2012, PHARMAZIE, V67, P187, DOI 10.1691/ph.2012.1585; Wu Q, 2009, J HUAZHONG U SCI-MED, V29, P451, DOI 10.1007/s11596-009-0412-x; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065218; Zhang ZH, 2012, INT J BIOCHEM CELL B, V44, P1244, DOI 10.1016/j.biocel.2012.04.026; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	47	40	50	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85113	10.1371/journal.pone.0085113	http://dx.doi.org/10.1371/journal.pone.0085113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454800	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000008
J	Andreou, M; Yan, CYI; Skourides, PA				Andreou, Maria; Irene Yan, Chao Yun; Skourides, Paris A.			40LoVe and Samba Are Involved in Xenopus Neural Development and Functionally Distinct from hnRNP AB	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; CELL-MIGRATION; NUCLEAR IMPORT; RICH DOMAIN; A1; LOCALIZATION; ELEMENT; INTERACTS; ADHESION	Heterogeneous nuclear ribonucleoproteins (hnRNPs) comprise a large group of modular RNA-binding proteins classified according to their conserved domains. This modular nature, coupled with a large choice of alternative splice variants generates functional diversity. Here, we investigate the biological differences between 40LoVe, its splice variant Samba and its pseudoallele hnRNP AB in neural development. Loss of function experiments lead to defects in neural development with reduction of eye size, which stem primarily from increased apoptosis and reduced proliferation in neural tissues. Despite very high homology between 40LoVe/Samba and hnRNP AB, these proteins display major differences in localization, which appear to be in part responsible for functional differences. Specifically, we show that the 40Love/Samba carboxy-terminal domain (GRD) enables nucleocytoplasmic shuttling behavior. This domain is slightly different in hnRNP AB, leading to nuclear-restricted localization. Finally, we show that shuttling is required for 40LoVe/Samba function in neural development.	[Andreou, Maria; Skourides, Paris A.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Irene Yan, Chao Yun] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil	University of Cyprus; Universidade de Sao Paulo	Skourides, PA (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	skourip@ucy.ac.cy	Yan, Chao Yun Irene/B-4700-2011	Yan, Chao Yun Irene/0000-0003-0527-5719; Skourides, Paris/0000-0003-3502-5729	Cyprus Research Promotion Foundation [ANABAThetaMISigmaH/0609/28]; European Union	Cyprus Research Promotion Foundation; European Union(European Commission)	This work was funded by Cyprus Research Promotion Foundation (ANABA Theta MI Sigma H/0609/28) and co-funded by the Structural Funds of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemark M, 1998, J BIOL CHEM, V273, P18881, DOI 10.1074/jbc.273.30.18881; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Czaplinski K, 2006, RNA, V12, P213, DOI 10.1261/rna.2820106; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Yan CYI, 2009, DEV DYNAM, V238, P204, DOI 10.1002/dvdy.21826; Katz ZB, 2012, GENE DEV, V26, P1885, DOI 10.1101/gad.190413.112; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kobel HR, 1986, GENETICS POLYPLOID X; Kroll TT, 2009, MECH DEVELOP, V126, P523, DOI 10.1016/j.mod.2009.03.007; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; MILLER L, 1977, IN VITRO CELL DEV B, V13, P557; NcNally LM, 2006, J BIOL CHEM, V281, P2478, DOI 10.1074/jbc.M511215200; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sinnamon JR, 2012, RNA, V18, P704, DOI 10.1261/rna.030742.111; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Suzuki M, 2005, FEBS J, V272, P3975, DOI 10.1111/j.1742-4658.2005.04820.x; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Van Dusen CM, 2010, MOL CELL BIOL, V30, P2552, DOI 10.1128/MCB.00230-09; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85026	10.1371/journal.pone.0085026	http://dx.doi.org/10.1371/journal.pone.0085026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454782	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100049
J	Fenutria, R; Martinez, VG; Simoes, I; Postigo, J; Gil, V; Martinez-Florensa, M; Sintes, J; Naves, R; Cashman, KS; Alberola-Ila, J; Ramos-Casals, M; Soldevila, G; Raman, C; Merino, J; Merino, R; Engel, P; Lozano, F				Fenutria, Rafael; Martinez, Vanesa G.; Simoes, Ines; Postigo, Jorge; Gil, Victor; Martinez-Florensa, Mario; Sintes, Jordi; Naves, Rodrigo; Cashman, Kevin S.; Alberola-Ila, Jose; Ramos-Casals, Manel; Soldevila, Gloria; Raman, Chander; Merino, Jesus; Merino, Ramon; Engel, Pablo; Lozano, Francisco			Transgenic Expression of Soluble Human CD5 Enhances Experimentally-Induced Autoimmune and Anti-Tumoral Immune Responses	PLOS ONE			English	Article							T-CELL-ACTIVATION; B-CELLS; SIGNAL-TRANSDUCTION; MICE; RECEPTOR; DOMAIN; INHIBITION; DISEASE; SUBSET; ENCEPHALOMYELITIS	CD5 is a lymphoid-specific transmembrane glycoprotein constitutively expressed on thymocytes and mature T and B1a lymphocytes. Current data support the view that CD5 is a negative regulator of antigen-specific receptor-mediated signaling in these cells, and that this would likely be achieved through interaction with CD5 ligand/s (CD5L) of still undefined nature expressed on immune or accessory cells. To determine the functional consequence of loss of CD5/CD5L interaction in vivo, a new transgenic mouse line was generated (shCD5E mu Tg), expressing a circulating soluble form of human CD5 (shCD5) as a decoy to impair membrane-bound CD5 function. These shCD5E mu Tg mice showed an enhanced response to autologous antigens, as deduced from the presentation of more severe forms of experimentally inducible autoimmune disease (collagen-induced arthritis, CIA; and experimental autoimmune encephalitis, EAE), as well as an increased anti-tumoral response in non-orthotopic cancer models (B16 melanoma). This enhancement of the immune response was in agreement with the finding of significantly reduced proportions of spleen and lymph node Treg cells (CD4+CD25+FoxP3+), and of peritoneal IL-10-producing and CD5+ B cells, as well as an increased proportion of spleen NKT cells in shCD5E mu Tg mice. Similar changes in lymphocyte subpopulations were observed in wild-type mice following repeated administration of exogenous recombinant shCD5 protein. These data reveal the relevant role played by CD5/CD5L interactions on the homeostasis of some functionally relevant lymphocyte subpopulations and the modulation of immune responses to autologous antigens.	[Fenutria, Rafael; Martinez, Vanesa G.; Simoes, Ines; Martinez-Florensa, Mario; Lozano, Francisco] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Postigo, Jorge; Merino, Jesus; Merino, Ramon] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Gil, Victor; Ramos-Casals, Manel] Hosp Clin Barcelona, Serv Malalties Autoimmunes Sistemiques, Barcelona, Spain; [Sintes, Jordi; Engel, Pablo; Lozano, Francisco] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Barcelona, Spain; [Naves, Rodrigo; Raman, Chander] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cashman, Kevin S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Alberola-Ila, Jose] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Soldevila, Gloria] Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Merino, Ramon] Univ Cantabria, SODERCAN, CSIC, Inst Biomed & Biotecnol Cantabria, E-39005 Santander, Spain; [Lozano, Francisco] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Cantabria; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Oklahoma Medical Research Foundation; Universidad Nacional Autonoma de Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Barcelona; Hospital Clinic de Barcelona	Lozano, F (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	flozano@clinic.ub.es	LOZANO, FRANCISCO/AAB-7888-2019; Merino, Ramón/L-1310-2014; Lozano-Soto, Francisco/AAB-7930-2019; Naves, Rodrigo/H-4829-2014; Engel, Pablo/R-5907-2019; Sintes, Jordi/K-6551-2014; Simoes, Ines Tadeu/A-6693-2018	LOZANO, FRANCISCO/0000-0003-1119-4368; Merino, Ramón/0000-0002-5306-0635; Lozano-Soto, Francisco/0000-0003-3714-2304; Naves, Rodrigo/0000-0002-1203-3593; Engel, Pablo/0000-0001-8410-252X; Sintes, Jordi/0000-0002-1836-7076; Simoes, Ines Tadeu/0000-0003-1730-7263; Soldevila, Gloria/0000-0003-1539-2548; Ramos-Casals, Manuel/0000-0001-5709-6734; alberola-ila, Jose/0000-0003-2439-553X	Spanish Ministerio de Economia y Competitividad [Plan Nacional de I+D+i] [SAF2010-19717]; Generalitat de Catalunya [2009SGR1101]; Instituto de Salud Carlos III [Spanish Network for Research in Infectious Diseases] [REIPI RD12/0015/0018]; Spanish Ministerio de Economia y Competitividad [SAF2011-22463, IPT2011-1527-010000, JCI-2010-06378]; European Regional Development Fund; Ministerio de Economia y Competitividad [SAF2012-34059]; NIH [AI1076562]; National Multiple Sclerosis Society [RG3891]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya [2010TEM37]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Spanish Ministerio de Economia y Competitividad [Plan Nacional de I+D+i](Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III [Spanish Network for Research in Infectious Diseases](Instituto de Salud Carlos III); Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); Ministerio de Economia y Competitividad(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the Spanish Ministerio de Economia y Competitividad [Plan Nacional de I+D+i, SAF2010-19717], Generalitat de Catalunya [2009SGR1101], and Instituto de Salud Carlos III [Spanish Network for Research in Infectious Diseases, REIPI RD12/0015/0018] to FL, from Spanish Ministerio de Economia y Competitividad [SAF2011-22463], co-funded by the European Regional Development Fund, to RM, from Ministerio de Economia y Competitividad [SAF2012-34059], co-funded by the European Regional Development Fund, and the Spanish Ministerio de Economia y Competitividad (IPT2011-1527-010000) associated to Fibrostatin SL, to JM, and from NIH AI1076562 and National Multiple Sclerosis Society RG3891 to CR. MM-F and VGM are recipients of fellowships from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya [2010TEM37] and from Spanish Ministerio de Economia y Competitividad [JCI-2010-06378], respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBEROLAILA J, 1992, J IMMUNOL, V148, P1287; Axtell RC, 2004, J IMMUNOL, V173, P2928, DOI 10.4049/jimmunol.173.5.2928; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO;2-G; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Bowen MA, 1997, EUR J IMMUNOL, V27, P1469, DOI 10.1002/eji.1830270625; BURGESS KE, 1992, P NATL ACAD SCI USA, V89, P9311, DOI 10.1073/pnas.89.19.9311; Calvo J, 1999, TISSUE ANTIGENS, V54, P128, DOI 10.1034/j.1399-0039.1999.540203.x; Cariappa A, 2007, J IMMUNOL, V179, P2270, DOI 10.4049/jimmunol.179.4.2270; CEUPPENS JL, 1986, J IMMUNOL, V137, P1816; Dasu T, 2008, IMMUNOL LETT, V119, P103, DOI 10.1016/j.imlet.2008.05.008; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Gary-Gouy H, 2002, BLOOD, V100, P4537, DOI 10.1182/blood-2002-05-1525; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Gimferrer I, 2003, J BIOL CHEM, V278, P8564, DOI 10.1074/jbc.M209591200; HUANG HJS, 1987, P NATL ACAD SCI USA, V84, P204, DOI 10.1073/pnas.84.1.204; Itoh M, 1999, J IMMUNOL, V162, P5317; JAMIN C, 1992, IMMUNOL LETT, V31, P79, DOI 10.1016/0165-2478(92)90014-F; JONES NH, 1986, NATURE, V323, P346, DOI 10.1038/323346a0; LEDBETTER JA, 1985, J IMMUNOL, V135, P2331; Lenz LL, 2009, P NATL ACAD SCI USA, V106, P1303, DOI 10.1073/pnas.0812579106; Lopez-Hoyos M, 2003, ARTHRITIS RHEUM, V48, P2353, DOI 10.1002/art.11107; Lozano F, 2000, CRIT REV IMMUNOL, V20, P347; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Noh G, 2001, CLIN EXP ALLERGY, V31, P1932, DOI 10.1046/j.1365-2222.2001.01124.x; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Ordonez-Rueda D, 2009, EUR J IMMUNOL, V39, P2233, DOI 10.1002/eji.200839053; Ramos-Casals M, 2001, RHEUMATOLOGY, V40, P1056, DOI 10.1093/rheumatology/40.9.1056; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Rodamilans B, 2007, J STRUCT BIOL, V159, P144, DOI 10.1016/j.jsb.2007.01.003; RONCHESE F, 1994, J EXP MED, V179, P809, DOI 10.1084/jem.179.3.809; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Sarrias MR, 2004, TISSUE ANTIGENS, V63, P335, DOI 10.1111/j.0001-2815.2004.00193.x; Sestero CM, 2012, J IMMUNOL, V189, P2918, DOI 10.4049/jimmunol.1200065; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; Tabbekh M, 2011, J IMMUNOL, V187, P102, DOI 10.4049/jimmunol.1004145; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Vera J, 2009, P NATL ACAD SCI USA, V106, P1506, DOI 10.1073/pnas.0805846106; WEE SF, 1994, CELL IMMUNOL, V158, P353, DOI 10.1006/cimm.1994.1282; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	45	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84895	10.1371/journal.pone.0084895	http://dx.doi.org/10.1371/journal.pone.0084895			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454761	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100040
J	Luo, YM; Huang, XT; Yang, Z; Li, BL; Liu, J; Wei, DT				Luo, Yangmei; Huang, Xiting; Yang, Zhen; Li, Baolin; Liu, Jie; Wei, Dongtao			Regional Homogeneity of Intrinsic Brain Activity in Happy and Unhappy Individuals	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; WORKING-MEMORY; HAPPINESS; METAANALYSIS; PERSONALITY; DEPRESSION; ATTENTION; NETWORKS; DISORDER	Background: Why are some people happier than others? This question has intrigued many researchers. However, limited work has addressed this question within a neuroscientific framework. Methods: The present study investigated the neural correlates of trait happiness using the resting-state functional magnetic resonance imaging (rs-fMRI) approach. Specifically, regional homogeneity (ReHo) was examined on two groups of young adults: happy and unhappy individuals (N = 25 per group). Results: Decreased ReHo in unhappy relative to happy individuals was observed within prefrontal cortex, medial temporal lobe, superior temporal lobe, and retrosplenial cortex. In contrast, increased ReHo in unhappy relative to happy individuals was observed within the dorsolateral prefrontal cortex, middle cingulate gyrus, putamen, and thalamus. In addition, the ReHo within the left thalamus was negatively correlated with Chinese Happiness Inventory (CHI) score within the happy group. Limitations: As an exploratory study, we examined how general trait happiness is reflected in the regional homogeneity of intrinsic brain activity in a relatively small sample. Examining other types of happiness in a larger sample using a multitude of intrinsic brain activity indices are warranted for future work. Conclusions: The local synchronization of BOLD signal is altered in unhappy individuals. The regions implicated in this alteration partly overlapped with previously identified default mode network, emotional circuitry, and rewarding system, suggesting that these systems may be involved in happiness.	[Luo, Yangmei; Huang, Xiting; Li, Baolin; Liu, Jie; Wei, Dongtao] SWU, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Luo, Yangmei; Huang, Xiting; Li, Baolin; Liu, Jie; Wei, Dongtao] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Yang, Zhen] Ctr Developing Brain, Child Mind Inst, New York, NY USA	Southwest University - China	Huang, XT (corresponding author), SWU, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xthuang@swu.edu.cn; zhyangpsych@gmail.com		Luo, Yangmei/0000-0002-4440-6980	Fundamental Research Funds for the Central Universities [SWU1209469]; Key Discipline Fund of the National 211 Project, China [NSKD11001]; Faculty of Psychology in Southwest University [TR201201-1]; key project of humanities and social sciences of Chongqing from Southwest University [12SKB005]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of the National 211 Project, China; Faculty of Psychology in Southwest University; key project of humanities and social sciences of Chongqing from Southwest University	This study was supported by "the Fundamental Research Funds for the Central Universities'' (SWU1209469) to the first author; the Key Discipline Fund of the National 211 Project, China (NSKD11001); the Research Team's Construction Project from the Faculty of Psychology in Southwest University (2012) (TR201201-1); and the key project of humanities and social sciences of Chongqing from Southwest University (2012) (12SKB005) to the corresponding author and research fellow. Study design, data collection and analysis were supported by the Research Team's Construction Project from the Faculty of Psychology in Southwest University (2012) (TR201201-1) and the Key Discipline Fund of the National 211 Project, China (NSKD11001). The Fundamental Research Funds for the Central Universities (SWU1209469) and the key project of humanities and social sciences of Chongqing from Southwest University (2012) (12SKB005) have roles in preparation of the manuscript and decision to publish.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Cunningham W, 2013, SOC COGN AF IN PRESS; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davidson RJ, 1999, CURR OPIN NEUROBIOL, V9, P228, DOI 10.1016/S0959-4388(99)80032-4; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; FELDT LS, 1961, PSYCHOMETRIKA, V26, P307, DOI 10.1007/BF02289799; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Lai CH, 2012, J AFFECT DISORDERS, V136, P453, DOI 10.1016/j.jad.2011.11.004; Lewis G, 2013, SOC COGN AF IN PRESS; Liu CH, 2013, PROG NEURO-PSYCHOPH, V41, P52, DOI 10.1016/j.pnpbp.2012.11.010; Liu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048181; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Lu L, 1997, PERS INDIV DIFFER, V23, P453; Lyubomirsky S, 2001, AM PSYCHOL, V56, P239, DOI 10.1037/0003-066X.56.3.239; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lyubomirsky S, 2011, EMOTION, V11, P1152, DOI 10.1037/a0025479; Ma ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053148; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pe ML, 2013, COGNITION, V126, P335, DOI 10.1016/j.cognition.2012.10.002; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stawarczyk D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00363; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Urry HL, 2004, PSYCHOL SCI, V15, P367, DOI 10.1111/j.0956-7976.2004.00686.x; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wei LQ, 2011, BRAIN RES, V1419, P68, DOI 10.1016/j.brainres.2011.08.060; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xu J, 1991, PSYCHOL SCI, V4, P32; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuan R, 2013, MAGN RESON IMAGING, V31, P1492, DOI 10.1016/j.mri.2013.07.005; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	72	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85181	10.1371/journal.pone.0085181	http://dx.doi.org/10.1371/journal.pone.0085181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454814	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100061
J	Muhsen, K; Lagos, R; Reymann, MK; Graham, DY; Pasetti, MF; Levine, MM				Muhsen, Khitam; Lagos, Rosanna; Reymann, Mardi K.; Graham, David Y.; Pasetti, Marcela F.; Levine, Myron M.			Age-Dependent Association among Helicobacter pylori Infection, Serum Pepsinogen Levels and Immune Response of Children to Live Oral Cholera Vaccine CVD 103-HgR	PLOS ONE			English	Article							DOUBLE-BLIND; ENVIRONMENTAL-ENTEROPATHY; DEVELOPING-COUNTRIES; STRAIN CVD-103-HGR; ROTAVIRUS VACCINES; GASTRIC-ACIDITY; VIBRIO-CHOLERAE; IMMUNOGENICITY; TRIAL; SAFETY	Background: Through its effects on gastric secretion, we hypothesized that Helicobacter pylori infection may influence oral immunization. Accordingly, we examined the association between H. pylori infection, serum pepsinogen (PG) (measures for H. pylori gastritis) and vibriocidal antibody (a correlate of protection) seroconversion following oral immunization with CVD 103-HgR live cholera vaccine among children of different ages. Methods: Sera from 422 Chilean children who were vaccinated with a single dose of CVD 103-HgR were tested by ELISA for serum IgG antibodies to H. pylori, PG I and PG II levels and antibodies to Shigella flexneri 2a lipopolysaccharide and hepatitis A virus (as markers of low socioeconomic status and exposure to enteric pathogens). Results: The likelihood of vibriocidal antibody seroconversion following vaccination with CVD 103-HgR was significantly decreased in H. pylori-seropositive children age 6 months to 4 years with PG II. 8 mg/L (adjusted OR 0.14 (95% CI 0.03-0.61; P = 0.009), and also in H. pylori seropositives with lower PG II level (adjusted OR 0.34, 95% CI 0.14-0.83; P = 0.017), compared to H. pylori-seronegatives. H. pylori-seropositive children aged 5-9 years with serum PG I. 30 mg/L (indicating more severe gastritis) had higher odds of vibriocidal seroconversion than those with lower PG I levels (adjusted OR 4.41, 95% CI 1.2615.38; P = 0.02). There was no significant association between exposures to S. flexneri 2a or hepatitis A virus and vibriocidal seroconversion. Conclusions: As H. pylori gastritis progresses with increasing pediatric age in developing country venues, changes in gastric secretion ensue that we believe explain the observed differences in age-related immune responses to immunization with live oral cholera vaccine. The effect of H. pylori and changes of gastric acid secretion on the immunogenicity of various oral vaccines should be studied in different developing, transitional and industrialized country settings.	[Muhsen, Khitam; Reymann, Mardi K.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Pasetti, Marcela F.] Univ Maryland, Sch Med, Dept Pediat, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Lagos, Rosanna] Hosp Ninos Roberto del Rio, Ctr Vacunas Desarrollo, Santiago, Chile; [Graham, David Y.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Baylor College of Medicine	Muhsen, K (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.	khitam15@yahoo.com; mlevine@medicine.umaryland.edu	Graham, David/AAL-2165-2021	Muhsen, Khitam/0000-0003-1086-7559; Pasetti, Marcela/0000-0003-0894-4009	World Health Organization; NIH [AI-35948, UO1AI35948]; National Institute of Allergy and Infectious Diseases [AI-45251, NO1 AI 15096]; Center for Vaccine Development, University of Maryland School of Medicine [AI-45251, NO1 AI 15096]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045251, U01AI035948, N01AI015096] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Vaccine Development, University of Maryland School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the World Health Organization; NIH cooperative research agreements (AI-35948 and UO1AI35948) and research contracts (AI-45251 and NO1 AI 15096) between the National Institute of Allergy and Infectious Diseases and Center for Vaccine Development, University of Maryland School of Medicine. The funding sources did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have financial conflicts of interest with respect to the subject of this research. Prof. M. Levine is the co-holder of patents but at present CVD 103-HgR is not available commercially. However, PaxVax, a vaccine manufacturer in San Diego, CA, has initiated a clinical development program to re-commercialize CVD 103-HgR (as VibrioVaxH) and return it to market as a licensed vaccine within the next few years.	Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Calam J, 1997, GASTROENTEROLOGY, V113, pS43, DOI 10.1016/S0016-5085(97)80010-8; CLEMENS J, 1995, J INFECT DIS, V171, P1653, DOI 10.1093/infdis/171.6.1653; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; CRYZ SJ, 1990, VACCINE, V8, P577, DOI 10.1016/0264-410X(90)90012-B; de Angelis GL, 2007, DIGEST DIS, V25, P206, DOI 10.1159/000103886; dos Reis JC, 2007, DIGEST DIS SCI, V52, P1253, DOI 10.1007/s10620-006-9288-9; FAGUNDESNETO U, 1984, J TROP PEDIATRICS, V30, P204, DOI 10.1093/tropej/30.4.204; Fix AD, 2002, AM J TROP MED HYG, V66, P628, DOI 10.4269/ajtmh.2002.66.628; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Ganga-Zandzou PS, 1999, PEDIATRICS, V104, P216, DOI 10.1542/peds.104.2.216; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; GITELSON S, 1971, ISRAEL J MED SCI, V7, P663; GOTUZZO E, 1993, INFECT IMMUN, V61, P3994, DOI 10.1128/IAI.61.9.3994-3997.1993; Guariso G, 2009, CLIN CHIM ACTA, V402, P54, DOI 10.1016/j.cca.2008.12.014; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; HOPKINS RJ, 1993, J INFECT DIS, V168, P222, DOI 10.1093/infdis/168.1.222; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kalach T, 2004, J PEDIATR GASTR NUTR, V39, P568, DOI 10.1097/00005176-200411000-00025; Kato S, 2005, ARCH PEDIAT ADOL MED, V159, P415, DOI 10.1001/archpedi.159.5.415; Kindermann A, 2001, J CLIN MICROBIOL, V39, P3591, DOI 10.1128/JCM.39.10.3591-3596.2001; Kolvusalo AI, 2007, DIAGN MICR INFEC DIS, V57, P35, DOI 10.1016/j.diagmicrobio.2006.06.022; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; KOTLOFF KL, 1992, INFECT IMMUN, V60, P4430, DOI 10.1128/IAI.60.10.4430-4432.1992; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Lagos R, 1999, PEDIATR INFECT DIS J, V18, P624, DOI 10.1097/00006454-199907000-00011; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; LAGOS R, 1995, INFECT IMMUN, V63, P707, DOI 10.1128/IAI.63.2.707-709.1995; Lagos R., 1996, B HOSP INFANT MEX, P214; Leon-Barua R, 2006, T ROY SOC TROP MED H, V100, P567, DOI 10.1016/j.trstmh.2005.09.013; LEVINE MM, 1987, LANCET, V1, P1049; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Lopes AI, 2006, SCAND J GASTROENTERO, V41, P524, DOI 10.1080/00365520500337098; Muhsen K, 2014, J INFECT DIS, V209, P1452, DOI 10.1093/infdis/jit625; Nugalieva ZZ, 2006, HELICOBACTER, V11, P69, DOI 10.1111/j.1523-5378.2006.00380.x; ODERDA G, 1990, J CLIN PATHOL, V43, P762, DOI 10.1136/jcp.43.9.762; Prado V, 1999, PEDIATR INFECT DIS J, V18, P500, DOI 10.1097/00006454-199906000-00005; Rennels MB, 1996, PEDIATRICS, V97, P7; SACK GH, 1972, B WORLD HEALTH ORGAN, V47, P31; SCHIRALDI O, 1974, B WORLD HEALTH ORGAN, V51, P349; Shahinian ML, 2000, LANCET, V355, P377, DOI 10.1016/S0140-6736(99)05143-0; SUAREHAWARATANA P, 1992, J INFECT DIS, V165, P1042, DOI 10.1093/infdis/165.6.1042; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; SUHARYONO, 1992, LANCET, V340, P689, DOI 10.1016/0140-6736(92)92231-4; Tacket CO, 1999, INFECT IMMUN, V67, P6341; Torres J, 2000, ARCH MED RES, V31, P431, DOI 10.1016/S0188-4409(00)00099-0	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83999	10.1371/journal.pone.0083999	http://dx.doi.org/10.1371/journal.pone.0083999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454714	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100016
J	van Bergen, CAM; Verdegaal, EME; Honders, MW; Hoogstraten, C; Steijn-van Tol, AQMJ; de Quartel, L; de Jong, J; Meyering, M; Falkenburg, JHF; Griffioen, M; Osanto, S				van Bergen, Cornelis A. M.; Verdegaal, Elisabeth M. E.; Honders, M. Wilhelmina; Hoogstraten, Conny; Steijn-van Tol, A. Q. M. Jeanne; de Quartel, Linda; de Jong, Joan; Meyering, Maaike; Falkenburg, J. H. Frederik; Griffioen, Marieke; Osanto, Susanne			Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; ALPHA-L-FUCOSIDASE; WHOLE-GENOME ASSOCIATION; T-CELLS; CANCER; IDENTIFICATION; CONTRIBUTE; REGRESSION; VIRUS	Allogeneic stem cell transplantation (alloSCT) followed by donor lymphocyte infusion (DLI) can be applied as immunotherapeutic intervention to treat malignant diseases. Here, we describe a patient with progressive metastatic clear cell renal cell carcinoma (RCC) who was treated with T cell depleted non-myeloablative alloSCT and DLI resulting in disease regression accompanied by extensive graft versus host disease (GVHD). We characterized the specificity of this immune response, and detected a dominant T cell population recognizing a novel minor histocompatibility antigen (MiHA) designated LB-FUCA2-1V. T cells specific for LB-FUCA2-1V were shown to recognize RCC cell lines, supporting a dominant role in the graft versus tumor (GVT) reaction. However, coinciding with the gradual disappearance of chronic GVHD, the anti-tumor effect declined and 3 years after alloSCT the metastases became progressive again. To re-initiate the GVT reaction, escalating doses of DLI were given, but no immune response could be induced and the patient died of progressive disease 8.5 years after alloSCT. Gene expression studies illustrated that only a minimal number of genes shared expression between RCC and professional antigen presenting cells but were not expressed by non-malignant healthy tissues, indicating that in patients suffering from RCC, GVT reactivity after alloSCT may be unavoidably linked to GVHD.	[van Bergen, Cornelis A. M.; Honders, M. Wilhelmina; Hoogstraten, Conny; Falkenburg, J. H. Frederik; Griffioen, Marieke] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands; [Verdegaal, Elisabeth M. E.; Steijn-van Tol, A. Q. M. Jeanne; de Quartel, Linda; de Jong, Joan; Meyering, Maaike; Osanto, Susanne] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Bergen, CAM (corresponding author), Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands.	c.a.m.van_bergen@lumc.nl; e.m.e.verdegaal@lumc.nl	Griffioen, Marieke/ABA-1561-2021; Van Bergen, Cornelis/N-4773-2019; Verdegaal, Elizabeth/Y-2597-2018; Van Bergen, Cornelis A.M./P-5782-2016	Griffioen, Marieke/0000-0002-3001-4441; Van Bergen, Cornelis/0000-0001-6386-4517; Verdegaal, Elizabeth/0000-0002-4449-8707; Van Bergen, Cornelis A.M./0000-0001-6386-4517	Dutch Cancer Society [UL-2004-3013]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society grant no. UL-2004-3013 (www.kwfkankerbestrijding.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum FR, 2003, ANNU REV MED, V54, P491, DOI 10.1146/annurev.med.54.101601.152456; Barge RMY, 2003, EXP HEMATOL, V31, P865, DOI 10.1016/S0301-472X(03)00200-5; Bishop MR, 2004, HAEMATOLOGICA, V89, P599; Bregni M, 2011, EXPERT REV ANTICANC, V11, P901, DOI [10.1586/era.11.12, 10.1586/ERA.11.12]; Broen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021699; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Cordero OJ, 2001, EUR J BIOCHEM, V268, P3321, DOI 10.1046/j.1432-1327.2001.02237.x; Falkenburg JHF, 2011, BIOL BLOOD MARROW TR, V17, pS33, DOI 10.1016/j.bbmt.2010.11.009; Feng X, 2008, TRENDS IMMUNOL, V29, P624, DOI 10.1016/j.it.2008.09.004; Giardina MG, 1998, CANCER-AM CANCER SOC, V83, P2468, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2468::AID-CNCR9>3.3.CO;2-P; Griffioen M, 2012, HAEMATOL-HEMATOL J, V97, P1196, DOI 10.3324/haematol.2011.049478; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383; Norde WJ, 2011, CANCER RES, V71, P5111, DOI 10.1158/0008-5472.CAN-11-0108; Overes IM, 2009, CANCER IMMUNOL IMMUN, V58, P429, DOI 10.1007/s00262-008-0569-3; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Shah M, 2008, CANCER-AM CANCER SOC, V113, P336, DOI 10.1002/cncr.23556; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Tykodi SS, 2008, CLIN CANCER RES, V14, P5260, DOI 10.1158/1078-0432.CCR-08-0028; Tykodi SS, 2011, EXPERT OPIN BIOL TH, V11, P763, DOI 10.1517/14712598.2011.566855; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; van der Zouwen B, 2012, BIOL BLOOD MARROW TR, V18, P1353, DOI 10.1016/j.bbmt.2012.06.017; von Dem Borne PA, 2006, HAEMATOLOGICA, V91, P1559; WANG JW, 1995, CANCER RES, V55, P3654	30	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85198	10.1371/journal.pone.0085198	http://dx.doi.org/10.1371/journal.pone.0085198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454818	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100065
J	Zhao, XT; Yue, WT; Zhang, LN; Ma, L; Jia, WY; Qian, Z; Zhang, CY; Wang, Y				Zhao, Xiaoting; Yue, Wentao; Zhang, Lina; Ma, Li; Jia, Wenyun; Qian, Zhe; Zhang, Chunyan; Wang, Yue			Downregulation of PAX6 by shRNA Inhibits Proliferation and Cell Cycle Progression of Human Non-Small Cell Lung Cancer Cell Lines	PLOS ONE			English	Article							EXPRESSION; GROWTH; PATHWAY; METHYLATION; SUPPRESSES; RECEPTOR; PROTEIN; GENES	Background: The transcription factor PAX6 is primarily expressed in embryos. PAX6 is also expressed in several tumors and plays an oncogenic role. However, little is known about the role of PAX6 in lung cancer. Methods: The function of PAX6 in lung cancer cells was evaluated by small interfering RNA-mediated depletion of the protein followed by analyses of cell proliferation, anchorage-independent growth, and cell cycle arrest. The changes of cyclin D1, pRB, ERK1/2, p38 expression caused by PAX6 inhibition were detected using western-blotting. The PAX6 mRNA level in 52 pairs of tumors and corresponding matched adjacent normal tissues from non-small cell lung cancer patients and lung cancer cell lines was detected by real-time PCR. Results: Suppression of PAX6 expression inhibited cell growth and colony formation in A549 and H1299 cells. The percentage of cells in G1-phase increased when PAX6 expression was inhibited. The cyclin D1 protein level, as well as the pRB phosphorylation level, decreased as a result of PAX6 down-regulation. The activity of ERK1/2 and p38 was also suppressed in PAX6 knock-down cells. The PAX6 mRNA was highly expressed in lung cancer tissue and lung cancer cell lines. In most patients (about 65%), the relative ratio of PAX6 mRNA in primary NSCLC versus adjacent tissues exceeded 100. Conclusions: Our data implicated that PAX6 accelerates cell cycle progression by activating MAPK signal pathway. PAX6 mRNA levels were significantly elevated in primary lung cancer tissues compared to their matched adjacent tissues.	[Zhao, Xiaoting; Yue, Wentao; Zhang, Lina; Ma, Li; Jia, Wenyun; Qian, Zhe; Zhang, Chunyan; Wang, Yue] Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Capital Medical University	Yue, WT (corresponding author), Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China.	yue.wentao@gmail.com	; Yue, Wentao/N-7699-2013	ZHANG, LINA/0000-0003-3671-8690; Yue, Wentao/0000-0002-5917-1125	Beijing Novel Program [2006B34]; Beijing Research Foundation for Excellent Talents [20061D03]; Beijing Cultivation Project for Key Technical and Medicine Product [Z101100055610030]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201210025024]	Beijing Novel Program(Beijing Municipal Science & Technology Commission); Beijing Research Foundation for Excellent Talents; Beijing Cultivation Project for Key Technical and Medicine Product; Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This work was supported by Beijing Novel Program grant (No. 2006B34); Beijing Research Foundation for Excellent Talents (No. 20061D03); Beijing Cultivation Project for Key Technical and Medicine Product (No. Z101100055610030); the Scientific Research Common Program of Beijing Municipal Commission of Education (No. KM201210025024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SW, 2011, INVEST OPHTH VIS SCI, V52, P4560, DOI 10.1167/iovs.10-5487; Berkhout M, 2007, MODERN PATHOL, V20, P1253, DOI 10.1038/modpathol.3800952; Bonnefont J, 2011, CELL DEATH DIFFER, V18, P293, DOI 10.1038/cdd.2010.102; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Gladden AB, 2003, CANCER CELL, V4, P160, DOI 10.1016/S1535-6108(03)00217-4; Hellwinkel OJC, 2008, BJU INT, V101, P753, DOI 10.1111/j.1464-410X.2007.07322.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanteti R, 2007, J THORACIC ONCOLOGY, V2, pS541, DOI [10.1097/1001.JTO.0000283590.0000209867.0000283563, DOI 10.1097/1001.JT0.0000283590.0000209867.0000283563]; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Ma B, 2011, ONCOL REP, V26, P135, DOI 10.3892/or.2011.1291; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Mascarenhas JB, 2009, J BIOL CHEM, V284, P27524, DOI 10.1074/jbc.M109.047209; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Salgia R, 2011, SEMIN ONCOL, V38, P274, DOI 10.1053/j.seminoncol.2011.01.012; Sellheyer K, 2011, BRIT J DERMATOL, V164, P696, DOI 10.1111/j.1365-2133.2010.10158.x; Shahi MH, 2011, TUMOR BIOL, V32, P113, DOI 10.1007/s13277-010-0105-x; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yoshizaki Kaichi, 2010, Brain and Nerve (Tokyo), V62, P1315; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880; Zhou YH, 2005, J NEURO-ONCOL, V71, P223, DOI 10.1007/s11060-004-1720-4; Zhou YH, 2003, CLIN CANCER RES, V9, P3369; Zhou YH, 2010, J NEURO-ONCOL, V96, P191, DOI 10.1007/s11060-009-9963-8	32	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85738	10.1371/journal.pone.0085738	http://dx.doi.org/10.1371/journal.pone.0085738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454925	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100127
J	Abbas, M; Majid, AA; Ismail, AIM; Rashid, A				Abbas, Muhammad; Majid, Ahmad Abd; Ismail, Ahmad Izani Md; Rashid, Abdur			Numerical Method Using Cubic B-Spline for a Strongly Coupled Reaction-Diffusion System	PLOS ONE			English	Article							BOUNDARY-VALUE-PROBLEMS; EQUATION	In this paper, a numerical method for the solution of a strongly coupled reaction-diffusion system, with suitable initial and Neumann boundary conditions, by using cubic B-spline collocation scheme on a uniform grid is presented. The scheme is based on the usual finite difference scheme to discretize the time derivative while cubic B-spline is used as an interpolation function in the space dimension. The scheme is shown to be unconditionally stable using the von Neumann method. The accuracy of the proposed scheme is demonstrated by applying it on a test problem. The performance of this scheme is shown by computing L-infinity and L-2 error norms for different time levels. The numerical results are found to be in good agreement with known exact solutions.	[Abbas, Muhammad] Univ Sargodha, Dept Math, Sargodha, Pakistan; [Abbas, Muhammad; Majid, Ahmad Abd; Ismail, Ahmad Izani Md] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Rashid, Abdur] Gomal Univ, Dept Math, Dera Ismail Khan, Pakistan	University of Sargodha; Universiti Sains Malaysia; Gomal University	Abbas, M (corresponding author), Univ Sargodha, Dept Math, Sargodha, Pakistan.	m.abbas@uos.edu.pk	Abbas, Muhammad/K-8190-2019	Abbas, Muhammad/0000-0002-0491-1528; Ahmad Izani, Ismail/0000-0003-1092-5579	FRGS Grant from the School of Mathematical Sciences, Universiti Sains Malaysia, Penang, Malaysia [203/PMATHS/6711324]; School of Mathematical Sciences, Universiti Sains Malaysia, Penang, Malaysia	FRGS Grant from the School of Mathematical Sciences, Universiti Sains Malaysia, Penang, Malaysia; School of Mathematical Sciences, Universiti Sains Malaysia, Penang, Malaysia	This work was fully supported by FRGS Grant of No. 203/PMATHS/6711324 from the School of Mathematical Sciences, Universiti Sains Malaysia, Penang, Malaysia. The first author was supported by Post Doctorate Fellowship from School of Mathematical Sciences, Universiti Sains Malaysia, Penang, Malaysia, during a part of the time in which the research was carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badraoui S, 2002, J ELECT DIFF EQ, V74, P1; BICKLEY WG, 1968, COMPUT J, V11, P206, DOI 10.1093/comjnl/11.2.206; Burdern R.L., 2004, NUMERICAL ANAL; Caglar H, 2008, CHAOS SOLITON FRACT, V38, P1197, DOI 10.1016/j.chaos.2007.01.056; Caglar H, 2010, J COMPUT ANAL APPL, V12, P544; Caglar N, 2009, COMPUT MATH APPL, V57, P757, DOI 10.1016/j.camwa.2008.09.033; Cao HY, 2008, NUMER METH PART D E, V24, P9, DOI 10.1002/num.20232; Daddiouaissa EH, 2008, ELECT J D EQS, V14, P1; Dag I, 2005, APPL MATH COMPUT, V163, P199, DOI 10.1016/j.amc.2004.01.028; De Boor C., 1978, APPL MATH SCI, V27, DOI DOI 10.1007/978-1-4612-6333-3; Farin G.E., 1996, CURVES SURFACES COMP; FYFE DJ, 1969, COMPUT J, V12, P188, DOI 10.1093/comjnl/12.2.188; Ghoreishi M, 2011, B BELG MATH SOC-SIM, V18, P471, DOI 10.36045/bbms/1313604451; Goh J, 2012, J APPL MATH, DOI 10.1155/2012/458701; Goh J, 2011, COMPUT MATH APPL, V62, P4492, DOI 10.1016/j.camwa.2011.10.028; Jiang CX, 2000, NONLINEAR STUD, V7, P227; Kirane M, 1989, J MATH ANAL APPL, V138, P1172; Liao SJ, 1997, INT J NONLINEAR MECH, V32, P815, DOI 10.1016/S0020-7462(96)00101-1; Liao SJ., 1992, THESIS SJ TONG U SHA; Mittal RC, 2011, COMMUN NONLINEAR SCI, V16, P1304, DOI 10.1016/j.cnsns.2010.06.028; Prenter P.M., 1989, SPLINES VARIATIONAL; Rosenberg DUV, 1969, METHODS SOLUTON PART, V113; Sahin A., 2009, THESIS ESKISEHIR OSM; Somathilake LW, 2005, J APPL MATH, V1, P23	24	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83265	10.1371/journal.pone.0083265	http://dx.doi.org/10.1371/journal.pone.0083265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427270	gold, Green Published, Green Submitted			2022-12-27	WOS:000329868200010
J	Fujiwara, M; Mohr, MS; Greenberg, A				Fujiwara, Masami; Mohr, Michael S.; Greenberg, Aaron			The Effects of Disease-Induced Juvenile Mortality on the Transient and Asymptotic Population Dynamics of Chinook Salmon (Oncorhynchus tshawytscha)	PLOS ONE			English	Article							PARASITE CERATOMYXA-SHASTA; BACTERIAL KIDNEY-DISEASE; KLAMATH RIVER-BASIN; PACIFIC SALMON; OREGON-CALIFORNIA; STRUCTURED POPULATIONS; FISH; RESISTANCE; RESPONSES; HISTORY	The effects of an increased disease mortality rate on the transient and asymptotic dynamics of Chinook salmon (Oncorhynchus tshawytscha) were investigated. Disease-induced mortality of juvenile salmon has become a serious concern in recent years. However, the overall effects of disease mortality on the asymptotic and transient dynamics of adult spawning abundance are still largely unknown. We explored various scenarios with regard to the density-dependent process, the distribution of survivorship over the juvenile phase, the disease mortality rate, and the infusion of stray hatchery fish. Our results suggest that the sensitivity to the disease mortality rate of the equilibrium adult spawning abundance and resilience (asymptotic return rate toward this equilibrium following a small perturbation) varied widely and differently depending on the scenario. The resilience and coefficient of variation of adult spawning abundance following a large perturbation were consistent with each other under the scenarios investigated. We conclude that the increase in disease mortality likely has an effect on fishery yield under a fluctuating environment, not only because the mean equilibrium adult spawning abundance has likely been reduced, but also because the resilience has likely decreased and the variance in adult spawning abundance has likely increased. We also infer the importance of incorporating finer-scale spatiotemporal information into population models and demonstrate a means for doing so within a matrix population modeling framework.	[Fujiwara, Masami] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Mohr, Michael S.] NOAA, Fisheries Ecol Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA USA; [Greenberg, Aaron] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	Texas A&M University System; Texas A&M University College Station; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz	Fujiwara, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	fujiwara@tamu.edu	Fujiwara, Masami/C-3115-2012	Fujiwara, Masami/0000-0002-9255-6043	U. S. National Oceanic and Atmospheric Administration, National 468 Marine Fisheries Service (NOAA/NMFS) [NA07NMF4540337]	U. S. National Oceanic and Atmospheric Administration, National 468 Marine Fisheries Service (NOAA/NMFS)	This research was supported by the U. S. National Oceanic and Atmospheric Administration, National 468 Marine Fisheries Service (NOAA/NMFS), grant NA07NMF4540337. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkoosh MR, 1998, T AM FISH SOC, V127, P360, DOI 10.1577/1548-8659(1998)127&lt;0360:ISOJCS&gt;2.0.CO;2; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI 10.1139/F02-066; Bartholomew JL, 2007, DIS AQUAT ORGAN, V78, P137, DOI 10.3354/dao01877; Bartholomew JL, 1997, J PARASITOL, V83, P859, DOI 10.2307/3284281; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; BEVERTON RJH, 1957, UK MINISTRY AGR FISH, V2; Bjork SJ, 2009, DIS AQUAT ORGAN, V86, P29, DOI 10.3354/dao02092; California Hatchery Scientific Review Group, 2012, CAL HATCH REV STAT R; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2008, DEMOGR RES, V18, P59, DOI 10.4054/DemRes.2008.18.3; Caswell H, 2009, J DIFFER EQU APPL, V15, P349, DOI 10.1080/10236190802282669; Foott JS, 1992, DIS SURVEY TRINITY R; Foott JS, 2003, FY 2002 INVESTIGATIO; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; FRYER JL, 1981, ANNU REV MICROBIOL, V35, P273, DOI 10.1146/annurev.mi.35.100181.001421; FRYER JL, 1993, FISH RES, V17, P15, DOI 10.1016/0165-7836(93)90004-Q; Fujiwara M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00107; Fujiwara M, 2011, T AM FISH SOC, V140, P1380, DOI 10.1080/00028487.2011.621811; Goldwasser L, 2001, SUPPORTING DATABASE; Hallett SL, 2006, DIS AQUAT ORGAN, V71, P109, DOI 10.3354/dao071109; HEALEY MC, 1984, CAN J FISH AQUAT SCI, V41, P476, DOI 10.1139/f84-057; Jacobson KC, 2003, J AQUAT ANIM HEALTH, V15, P1, DOI 10.1577/1548-8667(2003)015&lt;0001:CEONAA&gt;2.0.CO;2; Jacobson KC, 2008, MAR ECOL PROG SER, V354, P235, DOI 10.3354/meps07232; Klamath River Technical Advisory Team, 2002, KLAM RIV FALL CHIN A; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2009, P ROY SOC B-BIOL SCI, V276, P2819, DOI 10.1098/rspb.2009.0317; LICHATOWICH J, 1995, FISHERIES, V20, P10, DOI 10.1577/1548-8446(1995)020<0010:AATTDA>2.0.CO;2; Neubert MG, 1997, ECOLOGY, V78, P653, DOI 10.1890/0012-9658(1997)078[0653:ATRFMT]2.0.CO;2; Nicholas JW, 1988, FISH DIVISION INFORM; Nichols K, 2005, FY 2004 INVESTIGATIO; Nichols K, 2009, FY 2008 INVESTIGATIO; Nichols K., 2007, FY 2006 INVESTIGATIO; Nichols K, 2003, FY 2002 INVESTIGATIO; NICHOLS K, 2007, FY 2005 INVESTIGATIO; Nichols K., 2008, FY 2007 INVESTIGATIO; *PAC FISH MAN COUN, 2008, 1 PAC FISH MAN COUNC; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Pimm SL, 1991, BALANCE NATURE ECOLO; Ralston S, 2008, CAN J FISH AQUAT SCI, V65, P588, DOI 10.1139/F07-174; Ray RA, 2010, DIS AQUAT ORGAN, V93, P63, DOI 10.3354/dao02281; Scheuerell MD, 2006, CAN J FISH AQUAT SCI, V63, P1596, DOI 10.1139/F06-056; Stocking RW, 2007, J PARASITOL, V93, P78, DOI 10.1645/GE-939R.1; Stocking RW, 2006, J AQUAT ANIM HEALTH, V18, P194, DOI 10.1577/H05-036.1; Stone R, 2008, FY 2006 INVESTIGATIO; Walker RL, 1993, DIS SURVEY KLAMATH R; Worden L, 2010, THEOR POPUL BIOL, V78, P239, DOI 10.1016/j.tpb.2010.07.004	46	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85464	10.1371/journal.pone.0085464	http://dx.doi.org/10.1371/journal.pone.0085464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427310	Green Submitted, Green Published, gold			2022-12-27	WOS:000329868200051
J	Hipp, JR; Corcoran, J; Wickes, R; Li, TB				Hipp, John R.; Corcoran, Jonathan; Wickes, Rebecca; Li, Tiebei			Examining the Social Porosity of Environmental Features on Neighborhood Sociability and Attachment	PLOS ONE			English	Article							COMMUNITY ATTACHMENT; BUILT ENVIRONMENT; PHYSICAL-ACTIVITY; OLDER-ADULTS; URBAN; NETWORKS; TIES; DIVERSITY; TRUST	The local neighborhood forms an integral part of our lives. It provides the context through which social networks are nurtured and the foundation from which a sense of attachment and cohesion with fellow residents can be established. Whereas much of the previous research has examined the role of social and demographic characteristic in relation to the level of neighboring and cohesion, this paper explores whether particular environmental features in the neighborhood affect social porosity. We define social porosity as the degree to which social ties flow over the surface of a neighborhood. The focus of our paper is to examine the extent to which a neighborhood's environmental features impede the level of social porosity present among residents. To do this, we integrate data from the census, topographic databases and a 2010 survey of 4,351 residents from 146 neighborhoods in Australia. The study introduces the concepts of wedges and social holes. The presence of two sources of wedges is measured: rivers and highways. The presence of two sources of social holes is measured: parks and industrial areas. Borrowing from the geography literature, several measures are constructed to capture how these features collectively carve up the physical environment of neighborhoods. We then consider how this influences residents' neighboring behavior, their level of attachment to the neighborhood and their sense of neighborhood cohesion. We find that the distance of a neighborhood to one form of social hole-industrial areas-has a particularly strong negative effect on all three dependent variables. The presence of the other form of social hole-parks-has a weaker negative effect. Neighborhood wedges also impact social interaction. Both the length of a river and the number of highway fragments in a neighborhood has a consistent negative effect on neighboring, attachment and cohesion.	[Hipp, John R.] Univ Calif Irvine, Irvine, CA 92697 USA; [Corcoran, Jonathan; Wickes, Rebecca] Univ Queensland, Brisbane, Qld, Australia; [Li, Tiebei] Griffith Univ, Brisbane, Qld 4111, Australia	University of California System; University of California Irvine; University of Queensland; Griffith University	Hipp, JR (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.	hippj@UCI.edu	Wickes, Rebecca/F-5062-2015; Corcoran, Jonathan/A-4631-2010	Wickes, Rebecca/0000-0002-6136-4815; Corcoran, Jonathan/0000-0003-3565-6061	Australian Research Council [RO700002, DP1093960, DP1094589]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (RO700002, DP1093960, and DP1094589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RE, 1992, J COMMUNITY PSYCHOL, V20, P353, DOI 10.1002/1520-6629(199210)20:4<353::AID-JCOP2290200409>3.0.CO;2-Z; AHLBRANDT R., 1984, NEIGHBORHOODS PEOPLE; Bolan M, 1997, DEMOGRAPHY, V34, P225, DOI 10.2307/2061701; Butts CT, 2012, SOC NETWORKS, V34, P82, DOI 10.1016/j.socnet.2011.08.003; CAMPBELL KE, 1992, SOC FORCES, V70, P1077, DOI 10.2307/2580202; Caplow T, 1950, AM SOCIOL REV, V15, P357, DOI 10.2307/2087177; Durkheim E., 1893, DIVISION LABOUR SOC; Festinger L., 1950, SOCIAL PRESSURES INF; Fischer C. S., 1982, DWELL FRIENDS PERSON; FISCHER CS, 1975, AM J SOCIOL, V80, P1319, DOI 10.1086/225993; GREENBAUM SD, 1985, SOC NETWORKS, V7, P47, DOI 10.1016/0378-8733(85)90008-5; Groff Elizabeth R., 2011, SECUR J, V25, P1, DOI DOI 10.1057/SJ.2011.1; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Hanibuchi T, 2012, HEALTH PLACE, V18, P229, DOI 10.1016/j.healthplace.2011.09.015; Hipp JR, 2006, URBAN STUD, V43, P2503, DOI 10.1080/00420980600970706; Hipp JR, 2009, CITY COMMUNITY, V8, P5, DOI 10.1111/j.1540-6040.2009.01267.x; Homel R., 1997, POLICING PREVENTION, P133; Janowitz Morris, 1952, COMMUNITY PRESS URBA; KASARDA JD, 1974, AM SOCIOL REV, V39, P328, DOI 10.2307/2094293; Lancee B, 2011, J ETHN MIGR STUD, V37, P597, DOI 10.1080/1369183X.2011.545277; Laurence J, 2013, J ELECT PUBLIC OPIN, V23, P255, DOI 10.1080/17457289.2013.808641; LEE BA, 1991, SOCIOL FORUM, V6, P525, DOI 10.1007/BF01114475; Leigh A, 2006, ECON REC, V82, P268, DOI 10.1111/j.1475-4932.2006.00339.x; LOGAN JR, 1994, AM J SOCIOL, V100, P453, DOI 10.1086/230543; Lowenkamp CT, 2003, J RES CRIME DELINQ, V40, P351, DOI 10.1177/0022427803256077; Lund H, 2003, J AM PLANN ASSOC, V69, P414, DOI 10.1080/01944360308976328; Mazerolle L., 2007, 1 AUSTR RES COUNC; Mazerolle L., 2012, 1 AUSTR RES COUNC; Mesch GS, 1998, ENVIRON BEHAV, V30, P504, DOI 10.1177/001391659803000405; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Richard L, 2009, HEALTH PROMOT INT, V24, P46, DOI 10.1093/heapro/dan039; Rodriguez DA, 2006, J AM PLANN ASSOC, V72, P43, DOI 10.1080/01944360608976723; Rogers SH, 2011, APPL RES QUAL LIFE, V6, P201, DOI 10.1007/s11482-010-9132-4; Sampson RJ, 1999, AM SOCIOL REV, V64, P633, DOI 10.2307/2657367; SAMPSON RJ, 1991, SOC FORCES, V70, P43, DOI 10.2307/2580061; SAMPSON RJ, 1988, AM SOCIOL REV, V53, P766, DOI 10.2307/2095822; Sampson RJ, 2013, CRIMINOLOGY, V51, P1, DOI 10.1111/1745-9125.12002; Simmel G., 1903, GEORG SIMMEL INDIVID, P324; Stolle D, 2008, POLIT STUD-LONDON, V56, P57, DOI 10.1111/j.1467-9248.2007.00717.x; Talen E, 1999, URBAN STUD, V36, P1361, DOI 10.1080/0042098993033; Volker B, 2007, EUR SOCIOL REV, V23, P99, DOI 10.1093/esr/jc1022; Warner BD, 1997, SOC PROBL, V44, P520, DOI 10.1525/sp.1997.44.4.03x0235a; WHEELER JO, 1971, ANN ASSOC AM GEOGR, V61, P371, DOI 10.1111/j.1467-8306.1971.tb00789.x; Wickes R, 2011, 1 AUSTR RES COUNC; Wickes R, 2014, J URBAN AFF, V36, P51, DOI 10.1111/juaf.12015; Wirth L, 1938, AM J SOCIOL, V44, P1, DOI 10.1086/217913; Woldoff RA, 2002, SOC FORCES, V81, P87, DOI 10.1353/sof.2002.0065; Wood L, 2008, HEALTH PLACE, V14, P15, DOI 10.1016/j.healthplace.2007.04.004	48	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84544	10.1371/journal.pone.0084544	http://dx.doi.org/10.1371/journal.pone.0084544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427288	Green Published, gold			2022-12-27	WOS:000329868200028
J	Kong, LT; Wu, F; Tang, YQ; Ren, L; Kong, DY; Liu, Y; Xu, K; Wang, F				Kong, Lingtao; Wu, Feng; Tang, Yanqing; Ren, Ling; Kong, Dongyan; Liu, Ying; Xu, Ke; Wang, Fei			Frontal-Subcortical Volumetric Deficits in Single Episode, Medication-Naive Depressed Patients and the Effects of 8 Weeks Fluoxetine Treatment: A VBM-DARTEL Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; LATE-LIFE DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; GRAY-MATTER REDUCTION; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; UNIPOLAR DEPRESSION; MOOD DISORDERS; FUNCTIONAL CONNECTIVITY; COGNITIVE DEFICITS	Background: Convergent studies suggest that morphological abnormalities of frontal-subcortical circuits which involved with emotional and cognitive processing may contribute to the pathophysiology of major depressive disorder (MDD). Antidepressant treatment which has been reported to reverse the functional abnormalities of frontal-subcortical circuits in MDD may have treating effects to related brain morphological abnormalities. In this study, we used voxel-based morphometry method to investigate whole brain structural abnormalities in single episode, medication-naive MDD patients. Furthermore, we investigated the effects of an 8 weeks pharmacotherapy with fluoxetine. Methods: 28 single episode, medication-naive MDD participants and 28 healthy controls (HC) acquired the baseline high-resolution structural magnetic resonance imaging (sMRI) scan. 24 MDD participants acquired a follow-up sMRI scan after 8 weeks antidepressant treatment. Gray matter volumetric (GMV) difference between groups was examined. Results: Medication-naive MDD had significantly decreased GMV in the right dorsolateral prefrontal cortex and left middle frontal gyrus as well as increased GMV in the left thalamus and right insula compared to HC (P<0.05, corrected). Moreover, treated MDD had significantly increased GMV in the left middle frontal gyrus and right orbitofrontal cortex compared to HC (P<0.05, corrected). No difference on GMV was detected between medication-naive MDD group and treated MDD group. Conclusions: This study of single episode, medication-naive MDD subjects demonstrated structural abnormalities of frontal-subcortical circuitsin the early stage of MDD and the effects of 8 weeks successful antidepressant treatment, suggesting these abnormalities may play an important role in the neuropathophysiology of MDD at its onset.	[Kong, Lingtao; Wu, Feng; Tang, Yanqing; Liu, Ying] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Ren, Ling; Xu, Ke; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Liaoning, Peoples R China; [Kong, Dongyan] Quanzhou First Hosp, Dept Psychol, Quanzhou, Fujian, Peoples R China; [Wang, Fei] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	China Medical University; China Medical University; Yale University	Liu, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China.	liuyingpsy@yahoo.com.cn; kexu@vip.sina.com			National Natural Science Foundation of China [81101012, 81071099]; Liaoning Doctor Scientific Foundation [20111099]; Liaoning Science and Technology Foundation [2008225010-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Doctor Scientific Foundation; Liaoning Science and Technology Foundation	This study was supported by the National Natural Science Foundation of China (Grant No 81101012, 81071099), the Liaoning Doctor Scientific Foundation (Grant No 20111099), the Liaoning Science and Technology Foundation (Grant No 2008225010-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2005, BIOL PSYCHIAT, V58, P151, DOI 10.1016/j.biopsych.2005.03.022; Ahdidan J, 2011, ACTA PSYCHIAT SCAND, V123, P211, DOI 10.1111/j.1600-0447.2010.01644.x; Amico F, 2011, J PSYCHIATR NEUROSCI, V36, P15, DOI 10.1503/jpn.090186; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Chang CC, 2011, PSYCHIAT RES-NEUROIM, V193, P1, DOI 10.1016/j.pscychresns.2011.01.003; Chen SN, 2009, HUM BRAIN MAPP, V30, P2304, DOI 10.1002/hbm.20669; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Fales CL, 2009, J AFFECT DISORDERS, V112, P206, DOI 10.1016/j.jad.2008.04.027; First M.B., 2016, STRUCTURED CLIN INTE; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Frodl T, 2008, J PSYCHIATR NEUROSCI, V33, P423; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hoflich A, 2012, REV NEUROSCIENCE, V23, P227, DOI 10.1515/revneuro-2012-0038; Janssen J, 2007, INT J GERIATR PSYCH, V22, P468, DOI 10.1002/gps.1790; Kerestes R, 2012, PSYCHOL MED, V42, P29, DOI 10.1017/S0033291711001097; Kim AJ, 2008, PSYCHIAT RES-NEUROIM, V164, P114, DOI 10.1016/j.pscychresns.2007.12.020; Kong LT, 2013, J PSYCHIATR RES, V47, P733, DOI 10.1016/j.jpsychires.2013.02.003; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Marchand WR, 2012, NEUROSCI LETT, V514, P86, DOI 10.1016/j.neulet.2012.02.063; Marchand WR, 2010, BRAIN STRUCT FUNCT, V215, P73, DOI 10.1007/s00429-010-0280-y; Ohira K, 2013, NEUROPSYCHOPHARMACOL, V38, P909, DOI 10.1038/npp.2013.2; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Remijnse PL, 2009, PSYCHOL MED, V39, P1503, DOI 10.1017/S0033291708005072; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Turner AD, 2012, NEUROPSYCHOLOGIA, V50, P2348, DOI 10.1016/j.neuropsychologia.2012.06.003; Vasic N, 2008, J AFFECT DISORDERS, V109, P107, DOI 10.1016/j.jad.2007.11.011; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Zhang XC, 2012, J AFFECT DISORDERS, V136, P443, DOI 10.1016/j.jad.2011.11.005; Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014	53	58	63	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e79055	10.1371/journal.pone.0079055	http://dx.doi.org/10.1371/journal.pone.0079055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427263	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200003
J	Kurt, L; Kugler, KG; Coleman, PT; Liebovitch, LS				Kurt, Levent; Kugler, Katharina G.; Coleman, Peter T.; Liebovitch, Larry S.			Behavioral and Emotional Dynamics of Two People Struggling to Reach Consensus about a Topic on Which They Disagree	PLOS ONE			English	Article							CONFLICT; CHANNEL; MODEL	We studied the behavioral and emotional dynamics displayed by two people trying to resolve a conflict. 59 groups of two people were asked to talk for 20 minutes to try to reach a consensus about a topic on which they disagreed. The topics were abortion, affirmative action, death penalty, and euthanasia. Behavior data were determined from audio recordings where each second of the conversation was assessed as proself, neutral, or prosocial. We determined the probability density function of the durations of time spent in each behavioral state. These durations were well fit by a stretched exponential distribution, exp(kt(-a)) with an exponent, a, of approximately 0.3. This indicates that the switching between behavioral states is not a random Markov process, but one where the probability to switch behavioral states decreases with the time already spent in that behavioral state. The degree of this "memory" was stronger in those groups who did not reach a consensus and where the conflict grew more destructive than in those that did. Emotion data were measured by having each person listen to the audio recording and moving a computer mouse to recall their negative or positive emotional valence at each moment in the conversation. We used the Hurst rescaled range analysis and power spectrum to determine the correlations in the fluctuations of the emotional valence. The emotional valence was well described by a random walk whose increments were uncorrelated. Thus, the behavior data demonstrated a "memory" of the duration already spent in a behavioral state while the emotion data fluctuated as a random walk whose steps did not have a "memory" of previous steps. This work demonstrates that statistical analysis, more commonly used to analyze physical phenomena, can also shed interesting light on the dynamics of processes in social psychology and conflict management.	[Kurt, Levent] CUNY Queens Coll, Div Math & Nat Sci, Queens, NY USA; [Kugler, Katharina G.] Univ Munich, Dept Psychol, Munich, Germany; [Coleman, Peter T.] Columbia Univ Teachers Coll, Int Ctr Cooperat & Conflict Resolut, Dept Org & Leadership, New York, NY 10027 USA; [Liebovitch, Larry S.] CUNY Queens Coll, Dean Div Math & Nat Sci, Dept Phys, Queens, NY USA; [Liebovitch, Larry S.] CUNY Queens Coll, Dean Div Math & Nat Sci, Dept Psychol, Queens, NY USA	City University of New York (CUNY) System; University of Munich; Columbia University Teachers College; City University of New York (CUNY) System; City University of New York (CUNY) System	Kurt, L (corresponding author), CUNY Queens Coll, Div Math & Nat Sci, Queens, NY USA.	LKurt@gc.cuny.edu			Queens College, City University of New York	Queens College, City University of New York	This study was funded by Queens College, City University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Tal D, 2007, AM BEHAV SCI, V50, P1430, DOI 10.1177/0002764207302462; Brown C., 2010, FRACTAL ANAL; Churilla A, 1995, ANN BIOMED ENG, V24, P99; Coleman P.T., 2003, J PEACE PSYCHOL, V9, P1, DOI [10.1207/S15327949PAC0901_01, DOI 10.1207/S15327949PAC0901_01, https://doi.org/10.1207/S15327949PAC0901_01]; Coleman PT, 2012, NEGOTIATION J, V28, P7, DOI 10.1111/j.1571-9979.2011.00324.x; Coleman PT, 2006, PEACE CONFL, V12, P325, DOI 10.1207/s15327949pac1204_3; Coleman PT, 2000, INT J CONFL MANAGE, V11, P300, DOI 10.1108/eb022843; Cox D. R., 1970, RENEWAL THEORY; De Dreu C. K. W, 2007, SOCIAL PSYCHOL HDB B; De Dreu CKW, 2008, J ORGAN BEHAV, V29, P5, DOI 10.1002/job.474; Deutsch M., 1973, RESOLUTION CONFLICT; Feder J, 1988, FRACTALS; Follett MP, 1973, POWER DYNAMIC ADM CO; Gottman J, 2002, PERS SOC PSYCHOL REV, V6, P326, DOI 10.1207/S15327957PSPR0604_07; Hollander M., 1973, NONPARAMETRIC STAT M; knight Andrew, 1999, BASICS MATLAB; Kriesberg L, 1989, INTERACTABLE CONFLIC; Kriesberg L, 2005, ANAL CASES INTERACAT, P65; Kriesberg L, 1999, POWER DYNAMIC ADM CO, P332; Kugler K. G., 2011, 20113 WOP; Liebovitch L. S., 1998, FRACTALS CHAOS SIMPL; LIEBOVITCH LS, 1992, BIOPHYS J, V63, P1579, DOI 10.1016/S0006-3495(92)81732-0; Liebovitch LS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.017101; LIEBOVITCH LS, 1987, BIOPHYS J, V52, P979, DOI 10.1016/S0006-3495(87)83290-3; Losada M, 1999, MATH COMPUT MODEL, V30, P179, DOI 10.1016/S0895-7177(99)00189-2; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Nowak A., 1998, DYNAMICAL SOCIAL PSY; Shlesinger MF, 2001, NATURE, V411, P641, DOI 10.1038/35079702; Tjosvold D, 1998, APPL PSYCHOL-INT REV, V47, P285, DOI 10.1080/026999498377818; Tjosvold D, 2008, J ORGAN BEHAV, V29, P19, DOI 10.1002/job.473; Vallacher RR, 2013, ATTRACTED CONFLICT D; van Beek J, 1992, ENG MED BIOL MAGAZIN, V11, P57	32	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84608	10.1371/journal.pone.0084608	http://dx.doi.org/10.1371/journal.pone.0084608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427290	Green Published, gold			2022-12-27	WOS:000329868200030
J	Brinkmann, M; Blenkle, H; Salowsky, H; Bluhm, K; Schiwy, S; Tiehm, A; Hollert, H				Brinkmann, Markus; Blenkle, Henning; Salowsky, Helena; Bluhm, Kerstin; Schiwy, Sabrina; Tiehm, Andreas; Hollert, Henner			Genotoxicity of Heterocyclic PAHs in the Micronucleus Assay with the Fish Liver Cell Line RTL-W1	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; POLYCYCLIC AROMATIC-HYDROCARBONS; SISTER-CHROMATID EXCHANGES; EFFECT-DIRECTED ANALYSIS; LIFE-CYCLE TEST; COMET ASSAY; IN-VITRO; NATURAL ATTENUATION; DNA-DAMAGE; SALMONELLA-TYPHIMURIUM	Heterocyclic aromatic hydrocarbons are, together with their un-substituted analogues, widely distributed throughout all environmental compartments. While fate and effects of homocyclic PAHs are well-understood, there are still data gaps concerning the ecotoxicology of heterocyclic PAHs: Only few publications are available investigating these substances using in vitro bioassays. Here, we present a study focusing on the identification and quantification of clastogenic and aneugenic effects in the micronucleus assay with the fish liver cell line RTL-W1 that was originally derived from rainbow trout (Oncorhynchus mykiss). Real concentrations of the test items after incubation without cells were determined to assess chemical losses due to, e. g., sorption or volatilization, by means of gas chromatography-mass spectrometry. We were able to show genotoxic effects for six compounds that have not been reported in vertebrate systems before. Out of the tested substances, 2,3-dimethylbenzofuran, benzothiophene, quinoline and 6-methylquinoline did not cause substantial induction of micronuclei in the cell line. Acridine caused the highest absolute induction. Carbazole, acridine and dibenzothiophene were the most potent substances compared with 4-nitroquinoline oxide, a well characterized genotoxicant with high potency used as standard. Dibenzofuran was positive in our investigation and tested negative before in a mammalian system. Chemical losses during incubation ranged from 29.3% (acridine) to 91.7% (benzofuran) and may be a confounding factor in studies without chemical analyses, leading to an underestimation of the real potency. The relative potency of the investigated substances was high compared with their un-substituted PAH analogues, only the latter being typically monitored as priority or indicator pollutants. Hetero-PAHs are widely distributed in the environment and even more mobile, e. g. in ground water, than homocyclic PAHs due to the higher water solubility. We conclude that this substance class poses a high risk to water quality and should be included in international monitoring programs.	[Brinkmann, Markus; Blenkle, Henning; Bluhm, Kerstin; Schiwy, Sabrina; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res, Dept Ecosyst Anal, Aachen, Germany; [Salowsky, Helena; Tiehm, Andreas] Water Technol Ctr, Dept Environm Biotechnol, Karlsruhe, Germany	RWTH Aachen University	Brinkmann, M (corresponding author), Rhein Westfal TH Aachen, Inst Environm Res, Dept Ecosyst Anal, Aachen, Germany.	markus.brinkmann@bio5.rwth-aachen.de	Schiwy, Sabrina/AAM-6459-2020; Brinkmann, Markus/L-3879-2013; Hollert, Henner/A-1027-2009	Brinkmann, Markus/0000-0002-4985-263X; Hollert, Henner/0000-0001-5776-5619	Seed funds project of RWTH Aachen University; German Excellence Initiative; German National Academic Foundation ("Studienstiftung des deutschen Volkes")	Seed funds project of RWTH Aachen University; German Excellence Initiative; German National Academic Foundation ("Studienstiftung des deutschen Volkes")	The authors acknowledge financial support by a Seed funds project of RWTH Aachen University supported by the German Excellence Initiative. M. B. received a personal stipend from the German National Academic Foundation ("Studienstiftung des deutschen Volkes"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 2142722006 ISO; Asakura S, 1997, ENVIRON MOL MUTAGEN, V30, P459, DOI 10.1002/(SICI)1098-2280(1997)30:4<459::AID-EM11>3.0.CO;2-C; Bartos T, 2006, ENVIRON TOXICOL, V21, P343, DOI 10.1002/tox.20190; Benisek M, 2011, TOXICOL LETT, V200, P169, DOI 10.1016/j.toxlet.2010.11.011; Blotevogel J, 2008, GRUNDWASSER, V13, P147, DOI 10.1007/s00767-008-0077-6; Blum P, 2011, J CONTAM HYDROL, V126, P181, DOI 10.1016/j.jconhyd.2011.08.004; Boettcher M, 2011, MUTAT RES-GEN TOX EN, V723, P152, DOI 10.1016/j.mrgentox.2011.04.012; Boettcher M, 2010, MUTAT RES-GEN TOX EN, V700, P11, DOI 10.1016/j.mrgentox.2010.04.016; Brack W, 2000, ENVIRON TOXICOL CHEM, V19, P2493, DOI 10.1002/etc.5620191015; Brack Werner, 2012, Environmental Sciences Europe, V24, P29, DOI 10.1186/2190-4715-24-29; BROWN BR, 1980, MUTAT RES, V72, P373, DOI 10.1016/0027-5107(80)90112-8; DEBNATH AK, 1992, MUTAT RES, V280, P55, DOI 10.1016/0165-1218(92)90018-U; Diekmann M, 2004, AQUAT TOXICOL, V68, P27, DOI 10.1016/j.aquatox.2004.01.019; Diekmann M, 2004, AQUAT TOXICOL, V68, P13, DOI 10.1016/j.aquatox.2004.01.020; Douben P.E.T., 2003, PAHS ECOTOXICOLOGICA; Dutson Sheryl M., 1997, Environmental Toxicology and Chemistry, V16, P2113, DOI 10.1897/1551-5028(1997)016<2113:CDDTAM>2.3.CO;2; Dyreborg S, 1997, J CONTAM HYDROL, V25, P177, DOI 10.1016/S0169-7722(96)00042-3; Eisentraeger A, 2008, ENVIRON TOXICOL CHEM, V27, P1590, DOI [10.1897/07-201.1, 10.1897/07-201]; Frank D, 2010, ABLEITUNG GERINGFUGI; GALLOWAY SM, 1987, ENVIRON MOL MUTAGEN, V10, P1, DOI 10.1002/em.2850100502; Grummt Tamara, 2013, Environmental Sciences Europe, V25, P27, DOI 10.1186/2190-4715-25-27; Hakura A, 2007, J HEALTH SCI, V53, P470, DOI 10.1248/jhs.53.470; Hallare AV, 2011, J SOIL SEDIMENT, V11, P141, DOI 10.1007/s11368-010-0302-7; Hawliczek A, 2012, REPROD TOXICOL, V33, P213, DOI 10.1016/j.reprotox.2011.11.001; Higley E, 2012, ENVIRON TOXICOL CHEM, V31, P1053, DOI 10.1002/etc.1777; Hinger G, 2011, ENVIRON SCI POLLUT R, V18, P1297, DOI 10.1007/s11356-011-0483-7; HIRAO K, 1976, CANCER RES, V36, P329; Jernbro S, 2007, ENVIRON SCI POLLUT R, V14, P85, DOI 10.1065/espr2007.01.384; Jha AA, 2002, MUTAT RES-GEN TOX EN, V521, P11, DOI 10.1016/S1383-5718(02)00210-3; Johnston WT, 2008, BIOTECH HISTOCHEM, V83, P83, DOI 10.1080/10520290802136793; Kirpnick Z, 2005, MUTAT RES-GEN TOX EN, V582, P116, DOI 10.1016/j.mrgentox.2005.01.005; Klee N, 2004, ENVIRON SCI POLLUT R, V11, P313, DOI 10.1007/BF02979645; Kosmehl T, 2008, MUTAT RES-GEN TOX EN, V650, P1, DOI 10.1016/j.mrgentox.2007.09.009; Kosmehl Thomas, 2004, Journal of Soils and Sediments, V4, P84, DOI 10.1007/BF02991050; Larsson M, 2012, ENVIRON TOXICOL CHEM, V31, P1149, DOI 10.1002/etc.1776; LAVOIE EJ, 1988, FOOD CHEM TOXICOL, V26, P625, DOI 10.1016/0278-6915(88)90233-5; LAVOIE EJ, 1982, MUTAT RES, V101, P141, DOI 10.1016/0165-1218(82)90004-0; LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606; Mackay D, 2000, ENVIRON POLLUT, V110, P375, DOI 10.1016/S0269-7491(00)00162-7; Meyer S, 2000, CHEMOSPHERE, V40, P359, DOI 10.1016/S0045-6535(99)00237-4; Moir D, 1997, J ENVIRON SCI HEAL B, V32, P545, DOI 10.1080/03601239709373102; OCHIAI M, 1986, MUTAT RES, V172, P189, DOI 10.1016/0165-1218(86)90056-X; Peddinghaus S, 2012, REPROD TOXICOL, V33, P224, DOI 10.1016/j.reprotox.2011.12.005; Phelps JB, 2002, MUTAT RES-GEN TOX EN, V521, P103, DOI 10.1016/S1383-5718(02)00221-8; Reifferscheid G, 2008, MUTAT RES-GEN TOX EN, V649, P15, DOI 10.1016/j.mrgentox.2007.07.015; Reineke AK, 2007, ENVIRON SCI TECHNOL, V41, P5314, DOI 10.1021/es070405k; Robbiano L, 2004, TOXICOLOGY, V204, P187, DOI 10.1016/j.tox.2004.06.057; Rocha PS, 2009, ECOTOX ENVIRON SAFE, V72, P1842, DOI 10.1016/j.ecoenv.2009.04.013; Schnurstein A, 2001, ECOTOX ENVIRON SAFE, V49, P187, DOI 10.1006/eesa.2001.2050; Schuettrumpf Holger, 2011, Environmental Sciences Europe, V23, P39, DOI 10.1186/2190-4715-23-39; Schulze S, 2004, WATER SCI TECHNOL, V50, P347, DOI 10.2166/wst.2004.0348; Seitz N, 2008, MUTAT RES-GEN TOX EN, V652, P38, DOI 10.1016/j.mrgentox.2007.12.004; Sovadinova I, 2006, ENVIRON TOXICOL CHEM, V25, P1291, DOI 10.1897/05-388R.1; Suzuki H, 2009, MUTAGENESIS, V24, P9, DOI 10.1093/mutage/gen047; Suzuki T, 2007, J HEALTH SCI, V53, P325, DOI 10.1248/jhs.53.325; Tiehm A, 2008, WATER SCI TECHNOL, V58, P1349, DOI 10.2166/wst.2008.730; Tiehm A, 2003, OIL GAS SCI TECHNOL, V58, P449, DOI 10.2516/ogst:2003028; WEILLTHEVENET N, 1981, MUTAT RES, V88, P355, DOI 10.1016/0165-1218(81)90027-6; WEYAND EH, 1993, FOOD CHEM TOXICOL, V31, P707, DOI 10.1016/0278-6915(93)90141-K; WILD D, 1983, FOOD CHEM TOXICOL, V21, P707, DOI 10.1016/0278-6915(83)90202-8; Wolz J, 2011, J SOIL SEDIMENT, V11, P82, DOI 10.1007/s11368-010-0267-6; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	62	36	36	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85692	10.1371/journal.pone.0085692	http://dx.doi.org/10.1371/journal.pone.0085692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416442	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300098
J	Buri, P; Humbert, JY; Arlettaz, R				Buri, Pierrick; Humbert, Jean-Yves; Arlettaz, Raphael			Promoting Pollinating Insects in Intensive Agricultural Matrices: Field-Scale Experimental Manipulation of Hay-Meadow Mowing Regimes and Its Effects on Bees	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; DIVERSITY; BIODIVERSITY; CONSERVATION; HYMENOPTERA; ABUNDANCE; COMMUNITIES; COMPONENTS; RESOURCES; APIFORMES	Bees are a key component of biodiversity as they ensure a crucial ecosystem service: pollination. This ecosystem service is nowadays threatened, because bees suffer from agricultural intensification. Yet, bees rarely benefit from the measures established to promote biodiversity in farmland, such as agri-environment schemes (AES). We experimentally tested if the spatio-temporal modification of mowing regimes within extensively managed hay meadows, a widespread AES, can promote bees. We applied a randomized block design, replicated 12 times across the Swiss lowlands, that consisted of three different mowing treatments: 1) first cut not before 15 June (conventional regime for meadows within Swiss AES); 2) first cut not before 15 June, as treatment 1 but with 15% of area left uncut serving as a refuge; 3) first cut not before 15 July. Bees were collected with pan traps, twice during the vegetation season (before and after mowing). Wild bee abundance and species richness significantly increased in meadows where uncut refuges were left, in comparison to meadows without refuges: there was both an immediate (within year) and cumulative (from one year to the following) positive effect of the uncut refuge treatment. An immediate positive effect of delayed mowing was also evidenced in both wild bees and honey bees. Conventional AES could easily accommodate such a simple management prescription that promotes farmland biodiversity and is likely to enhance pollination services.	[Buri, Pierrick; Humbert, Jean-Yves; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Sion, Switzerland	University of Bern; Swiss Ornithological Institute	Buri, P (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	pierrick.buri@iee.unibe.ch	Arlettaz, Raphaël/O-2182-2016; Buri, Pierrick/I-3749-2019	Arlettaz, Raphaël/0000-0001-6360-5339; Buri, Pierrick/0000-0003-1038-9550; Humbert, Jean-Yves/0000-0002-5756-6748	Swiss National Science Foundation [31003A_125398/1]; Federal Office of Environment; cantonal office of environment, Bern; cantonal office of environment, Vaud; cantonal office of environment, Basel-Landschaft; cantonal office of environment, Aargau; cantonal office of environment, Neuchatel; cantonal office of environment, Fribourg; cantonal office of environment, Valais; cantonal office of environment, Graubunden; cantonal office of agriculture, Bern; cantonal office of agriculture, Vaud; cantonal office of agriculture, Basel-Landschaft; cantonal office of agriculture, Aargau; cantonal office of agriculture, Neuchatel; cantonal office of agriculture, Fribourg; cantonal office of agriculture, Valais; cantonal office of agriculture, Graubunden	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office of Environment; cantonal office of environment, Bern; cantonal office of environment, Vaud; cantonal office of environment, Basel-Landschaft; cantonal office of environment, Aargau; cantonal office of environment, Neuchatel; cantonal office of environment, Fribourg; cantonal office of environment, Valais; cantonal office of environment, Graubunden; cantonal office of agriculture, Bern; cantonal office of agriculture, Vaud; cantonal office of agriculture, Basel-Landschaft; cantonal office of agriculture, Aargau; cantonal office of agriculture, Neuchatel; cantonal office of agriculture, Fribourg; cantonal office of agriculture, Valais; cantonal office of agriculture, Graubunden	This project was supported by a grant of the Swiss National Science Foundation to R. A. (No. 31003A_125398/1), the Federal Office of Environment, and the following cantonal offices of environment and/or agriculture: Bern,Vaud, Basel-Landschaft, Aargau, Neuchatel, Fribourg, Valais and Graubunden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Albrecht M, 2007, J APPL ECOL, V44, P813, DOI 10.1111/j.1365-2664.2007.01306.x; Amiet F, 1999, APIDAE 2 COLLETES DU; Amiet F., 2004, APIDAE 4 ANTHIDIUM C; Amiet F., 2007, APIDAE 5 AMMOBATES A; Amiet F., 1996, APIDAE; [Anonymous], 1998, VERORDNUNG DIREKTZAH, P229; [Anonymous], 2009, BEWIRTSCHAFTUNGSVERT, P1; Bates D, 2012, PACKAGE LME4; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Burel F, 1998, ACTA OECOL, V19, P47, DOI 10.1016/S1146-609X(98)80007-6; C. suisse de cartographie de la Faune, 2001, APIDAE 3 HALICTUS LA; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Droege S, 2010, INSECT CONSERV DIVER, V3, P15, DOI 10.1111/j.1752-4598.2009.00074.x; FOAG, 2012, RAPP AGR 2011; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Furieri A., 2008, SPATIALITE COMPLETE; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gotelli NJ, 2013, ECOSIMR 1 00; Haaland C, 2011, INSECT CONSERV DIVER, V4, P60, DOI 10.1111/j.1752-4598.2010.00098.x; Hart K., 2011, GREENING CAP DELIVER; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Heneberg P, 2013, J INSECT CONSERV, V17, P473, DOI 10.1007/s10841-012-9529-5; Humbert JY, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-9; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kindt R., 2005, WORLD; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Kwaiser KS, 2008, AGR ECOSYST ENVIRON, V124, P200, DOI 10.1016/j.agee.2007.09.012; Le Feon V, 2013, AGR ECOSYST ENVIRON, V166, P94, DOI 10.1016/j.agee.2011.06.020; Littlewood NA, 2012, INSECT CONSERV DIVER, V5, P1, DOI 10.1111/j.1752-4598.2011.00174.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Potts SG, 2009, J APPL ECOL, V46, P369, DOI 10.1111/j.1365-2664.2009.01609.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pywell RF, 2011, J INSECT CONSERV, V15, P853, DOI 10.1007/s10841-011-9383-x; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; Quantum GIS Development Team, 2012, QGIS QUANT GIS GEOGR; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasmont P, 2010, CATALOGUE SOUS GENRE, P1; Roulston TH, 2007, J KANSAS ENTOMOL SOC, V80, P179, DOI 10.2317/0022-8567(2007)80[179:ACOPTA]2.0.CO;2; Russell KN, 2005, BIOL CONSERV, V124, P133, DOI 10.1016/j.biocon.2005.01.022; SchmidEgger C., 1997, ILLUSTRIERTE BESTIMM, VIII; Schmidt MH, 2008, BIODIVERS CONSERV, V17, P3003, DOI 10.1007/s10531-008-9412-6; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Swisstopo, 2012, VECT 25; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Valtonen A., 2006, Animal Biodiversity and Conservation, V29, P133; Veddeler D, 2006, OIKOS, V112, P594, DOI 10.1111/j.0030-1299.2006.14111.x; Warren J, 2008, AGRI-ENVIRONMENT, P1; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	66	46	50	3	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85635	10.1371/journal.pone.0085635	http://dx.doi.org/10.1371/journal.pone.0085635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416434	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300093
J	Parandhaman, DK; Hanna, LE; Narayanan, S				Parandhaman, Dinesh Kumar; Hanna, Luke Elizabeth; Narayanan, Sujatha			PknE, a Serine/Threonine Protein Kinase of Mycobacterium tuberculosis Initiates Survival Crosstalk That Also Impacts HIV Coinfection	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; NECROSIS-FACTOR-ALPHA; CCR5 EXPRESSION; UP-REGULATION; INFECTION; REPLICATION; PATHWAYS; CXCR4; MODULATION; APOPTOSIS	Serine threonine protein kinases (STPK) play a major role in the pathogenesis of Mycobacterium tuberculosis. Here, we examined the role of STPK pknE, using a deletion mutant DpknE in the modulation of intracellular signaling events that favor M. tuberculosis survival. Phosphorylation kinetics of MAPK (p38MAPK, ErkK and SAPK/JNK) was defective in DpknE compared to wild-type infected macrophages. This defective signaling dramatically delayed and reduced the phosphorylation kinetics of transcription factors ATF-2 and c-JUN in DpknE infected macrophages. MAPK inhibitors instead of reducing the phosphorylation in DpknE infected macrophages, revealed crosstalks with ErkK signaling influenced by SAPK/JNK and p38 pathways independently. Modulations in intra cellular signaling altered the expression of coreceptors CCR5 and CXCR4 in DpknE infected macrophages. In conclusion, pknE plays a role in MAPK crosstalks that enables intracellular survival of M. tuberculosis. This survival strategy also impacts HIV/TB coinfection.	[Parandhaman, Dinesh Kumar; Narayanan, Sujatha] Natl Inst Res TB, Dept Immunol, Madras, Tamil Nadu, India; [Hanna, Luke Elizabeth] Natl Inst Res TB, HIV Div, Dept Clin Res, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Narayanan, S (corresponding author), Natl Inst Res TB, Dept Immunol, Madras, Tamil Nadu, India.	sujatha.sujatha36@gmail.com			ICMR	ICMR(Indian Council of Medical Research (ICMR))	DKP was supported by ICMR Senior Research fellowship and the study was carried with intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Blond D, 2000, J VIROL, V74, P8904, DOI 10.1128/JVI.74.19.8904-8912.2000; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Dasgupta B, 2003, SCAND J IMMUNOL, V57, P366, DOI 10.1046/j.1365-3083.2003.01227.x; Fraziano M, 1999, AIDS RES HUM RETROV, V15, P869, DOI 10.1089/088922299310575; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Giri RK, 2005, AM J PHYSIOL-CELL PH, V289, pC264, DOI 10.1152/ajpcell.00461.2004; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Hoshino Y, 2004, J IMMUNOL, V172, P6251, DOI 10.4049/jimmunol.172.10.6251; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kumar D, 2012, INFECT GENET EVOL, V12, P737, DOI 10.1016/j.meegid.2011.09.008; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Lande R, 2003, J IMMUNOL, V170, P1174, DOI 10.4049/jimmunol.170.3.1174; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lei JQ, 2005, BIOCHEM BIOPH RES CO, V329, P610, DOI 10.1016/j.bbrc.2005.02.022; Malhotra V, 2010, MICROBIOL-SGM, V156, P2829, DOI 10.1099/mic.0.040675-0; Meszaros B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002118; Mukai T, 2001, J LEUKOCYTE BIOL, V70, P422; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Rojas M, 2002, CELL IMMUNOL, V217, P58, DOI 10.1016/S0008-8749(02)00515-4; Rosas-Taraco AG, 2006, AIDS RES HUM RETROV, V22, P45, DOI 10.1089/aid.2006.22.45; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Yang CS, 2006, CLIN EXP IMMUNOL, V143, P150, DOI 10.1111/j.1365-2249.2005.02966.x; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107; Zhou HR, 2005, TOXICOL SCI, V87, P113, DOI 10.1093/toxsci/kfi234	34	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83541	10.1371/journal.pone.0083541	http://dx.doi.org/10.1371/journal.pone.0083541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421891	Green Published, gold, Green Accepted			2022-12-27	WOS:000329862500054
J	Rodrigues Hoffmann, A; Patterson, AP; Diesel, A; Lawhon, SD; Ly, HJ; Stephenson, CE; Mansell, J; Steiner, JM; Dowd, SE; Olivry, T; Suchodolski, JS				Rodrigues Hoffmann, Aline; Patterson, Adam P.; Diesel, Alison; Lawhon, Sara D.; Ly, Hoai Jaclyn; Stephenson, Christine Elkins; Mansell, Joanne; Steiner, Joerg M.; Dowd, Scot E.; Olivry, Thierry; Suchodolski, Jan S.			The Skin Microbiome in Healthy and Allergic Dogs	PLOS ONE			English	Article							CANINE ATOPIC-DERMATITIS; STAPHYLOCOCCUS-INTERMEDIUS; TASK-FORCE; BACTERIAL; DIVERSITY; IDENTIFICATION; COLONIZATION; EXPRESSION; SEARCH; NASAL	Background: Changes in the microbial populations on the skin of animals have traditionally been evaluated using conventional microbiology techniques. The sequencing of bacterial 16S rRNA genes has revealed that the human skin is inhabited by a highly diverse and variable microbiome that had previously not been demonstrated by culture-based methods. The goals of this study were to describe the microbiome inhabiting different areas of the canine skin, and to compare the skin microbiome of healthy and allergic dogs. Methodology/Principal Findings: DNA extracted from superficial skin swabs from healthy (n = 12) and allergic dogs (n = 6) from different regions of haired skin and mucosal surfaces were used for 454-pyrosequencing of the 16S rRNA gene. Principal coordinates analysis revealed clustering for the different skin sites across all dogs, with some mucosal sites and the perianal regions clustering separately from the haired skin sites. The rarefaction analysis revealed high individual variability between samples collected from healthy dogs and between the different skin sites. Higher species richness and microbial diversity were observed in the samples from haired skin when compared to mucosal surfaces or mucocutaneous junctions. In all examined regions, the most abundant phylum and family identified in the different regions of skin and mucosal surfaces were Proteobacteria and Oxalobacteriaceae. The skin of allergic dogs had lower species richness when compared to the healthy dogs. The allergic dogs had lower proportions of the Betaproteobacteria Ralstonia spp. when compared to the healthy dogs. Conclusions/Significance: The study demonstrates that the skin of dogs is inhabited by much more rich and diverse microbial communities than previously thought using culture-based methods. Our sequence data reveal high individual variability between samples collected from different patients. Differences in species richness was also seen between healthy and allergic dogs, with allergic dogs having lower species richness when compared to healthy dogs.	[Rodrigues Hoffmann, Aline; Ly, Hoai Jaclyn; Mansell, Joanne] Texas A&M Univ, Dept Vet Pathol, Coll Vet Med & Biomed Sci, Dermatopathol Specialty Serv, College Stn, TX 77843 USA; [Patterson, Adam P.; Diesel, Alison] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Clin Dermatol Serv, College Stn, TX USA; [Stephenson, Christine Elkins; Steiner, Joerg M.; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX USA; [Lawhon, Sara D.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Clin Microbiol Lab, College Stn, TX USA; [Dowd, Scot E.] MR DNA Lab, Shallowater, TX USA; [Olivry, Thierry] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Olivry, Thierry] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rodrigues Hoffmann, A (corresponding author), Texas A&M Univ, Dept Vet Pathol, Coll Vet Med & Biomed Sci, Dermatopathol Specialty Serv, College Stn, TX 77843 USA.	arodrigues@cvm.tamu.edu	Olivry, Thierry/AAV-7869-2021; rodrigues hoffmann, aline/L-6859-2017; Lawhon, Sara D./G-5147-2011; Diesel, Alison/H-7256-2019; Dowd, Scot E/M-5386-2017	Olivry, Thierry/0000-0003-1399-0034; rodrigues hoffmann, aline/0000-0001-6148-2531; Lawhon, Sara D./0000-0001-9154-8909; Diesel, Alison/0000-0002-8688-7495; Dowd, Scot E/0000-0002-6296-1427				ALLAKER RP, 1992, VET REC, V130, P303, DOI 10.1136/vr.130.14.303; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Favrot C, 2010, VET DERMATOL, V21, P23, DOI 10.1111/j.1365-3164.2009.00758.x; Fazakerley J, 2009, VET DERMATOL, V20, P179, DOI 10.1111/j.1365-3164.2009.00745.x; Furiani N, 2011, VET DERMATOL, V22, P490, DOI 10.1111/j.1365-3164.2011.00979.x; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Grahn N, 2003, FEMS MICROBIOL LETT, V219, P87, DOI 10.1016/S0378-1097(02)01190-4; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Harvey RG, 1998, VET DERMATOL, V9, P99, DOI 10.1046/j.1365-3164.1998.00093.x; HARVEY RG, 1995, VET DERMATOL, V6, P79, DOI [10.1111/j.1365-3164.1995.tb00047.x, 10.1111/j.1365-3164.1994.tb00015.x]; Hata TR, 2008, SEMIN CUTAN MED SURG, V27, P144, DOI 10.1016/j.sder.2008.04.002; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Herz U, 1998, INT ARCH ALLERGY IMM, V115, P179, DOI 10.1159/000023899; Hillier A, 2001, VET IMMUNOL IMMUNOP, V81, P147, DOI 10.1016/S0165-2427(01)00296-3; Johnson LR, 2001, J AM VET MED ASSOC, V219, P1247, DOI 10.2460/javma.2001.219.1247; Kasempimolporn Songsri, 2003, Journal of the Medical Association of Thailand, V86, P1162; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Lynch K, 2011, MOL DETECTION HUMAN; Marsella R, 2006, VET DERMATOL, V17, P306, DOI 10.1111/j.1365-3164.2006.00541.x; Miller WH, 2012, MULLER KIRKS SMALL A, P184; Olivry T, 1996, ARCH DERMATOL RES, V288, P579, DOI 10.1007/BF02505260; Olivry T, 1997, AM J DERMATOPATH, V19, P477, DOI 10.1097/00000372-199710000-00008; Olivry T, 2013, VET DERMATOL, V24, P97, DOI 10.1111/j.1365-3164.2012.01088.x; Olivry T, 2012, CHEM IMMUNOL ALLERGY, V96, P61, DOI 10.1159/000331884; Olivry T, 2010, VET DERMATOL, V21, P233, DOI 10.1111/j.1365-3164.2010.00889.x; PUGH GW, 1986, AM J VET RES, V47, P2343; SaijonmaaKoulumies LE, 1996, VET DERMATOL, V7, P153, DOI 10.1111/j.1365-3164.1996.tb00240.x; Sasaki T, 2007, J CLIN MICROBIOL, V45, P2770, DOI 10.1128/JCM.00360-07; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sturgeon A, 2012, VET DERMATOL, V23, P68; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Wanke I, 2011, J INVEST DERMATOL, V131, P382, DOI 10.1038/jid.2010.328; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101	45	74	76	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83197	10.1371/journal.pone.0083197	http://dx.doi.org/10.1371/journal.pone.0083197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421875	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500035
J	Feng, SM; Cai, M; Liu, PC; Wei, L; Wang, JS; Qi, J; Deng, LF				Feng, Shengmei; Cai, Ming; Liu, Pengcheng; Wei, Li; Wang, Jinshen; Qi, Jin; Deng, Lianfu			Atp6v1c1 May Regulate Filament Actin Arrangement in Breast Cancer Cells	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; V-ATPASE; SUBUNIT-C; F-ACTIN; INVASION; PH; INVADOPODIA; OSTEOCLASTS; EXPRESSION; CARCINOMA	Previous studies have shown that the rate of breast cancer metastasis correlates with the expression of vacuolar H+-ATPases (V-ATPases). However, how V-ATPase is involved in breast cancer metastasis remains unknown. Our previous study showed that Atp6v1c1-depleted osteoclasts did not form organized actin rings and that Atp6v1c1 co-localizes with F-actin. In this study, we found that the normal arrangement of filamentous actin is disrupted in Atp6v1c1-depleted 4T1 mouse breast cancer cells and in the ATP6V1C1-depleted human breast cancer cell lines MDA-MB-231 and MDA-MB-435s. We further found that Atp6v1c1 co-localizes with F-actin in 4T1 cells. The results of our study suggest that high expression of Atp6v1c1 affects the actin structure of cancer cells such that it facilitates breast cancer metastasis. The findings also indicate that Atp6v1c1 could be a novel target for breast cancer metastasis therapy.	[Feng, Shengmei; Wei, Li; Wang, Jinshen; Qi, Jin; Deng, Lianfu] Jiao Tong Univ, Sch Med, Shanghai Key Lab Prevent & Treatment Bone & Joint, Shanghai Inst Traumatol & Orthopaed,Ruijin Hosp, Shanghai 200030, Peoples R China; [Cai, Ming; Liu, Pengcheng] Tongji Univ, Sch Med, Shanghai Peoples 10, Dept Orthopaed, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Feng, SM (corresponding author), Jiao Tong Univ, Sch Med, Shanghai Key Lab Prevent & Treatment Bone & Joint, Shanghai Inst Traumatol & Orthopaed,Ruijin Hosp, Shanghai 200030, Peoples R China.	fengshengmei@yahoo.com.cn; lfdeng@msn.com			National Natural Science Foundation of China [30901525]; Shanghai Natural Science Foundation [09ZR1428900]; Shanghai Education Commission Foundation [10YZ39]; Talents Cultivation Plan of Shanghai Health System [XYQ2011050]; Science and Technology Grant from the Medical School of Shanghai, Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Education Commission Foundation; Talents Cultivation Plan of Shanghai Health System; Science and Technology Grant from the Medical School of Shanghai, Jiaotong University	This work was supported by the National Natural Science Foundation of China (Grant 30901525), Shanghai Natural Science Foundation (Grant 09ZR1428900), Shanghai Education Commission Foundation (Grant 10YZ39), Talents Cultivation Plan of Shanghai Health System (XYQ2011050), and a Science and Technology Grant from the Medical School of Shanghai, Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Desai B, 2008, J BIOL CHEM, V283, P13856, DOI 10.1074/jbc.M709401200; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; KANE PM, 1995, J BIOL CHEM, V270, P17025; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Otero-Rey EM, 2008, ORAL ONCOL, V44, P193, DOI 10.1016/j.oraloncology.2007.02.011; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yang SY, 2007, J CELL SCI, V120, P3362, DOI 10.1242/jcs.008300	20	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84833	10.1371/journal.pone.0084833	http://dx.doi.org/10.1371/journal.pone.0084833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454753	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100036
J	Genty, E; Clay, Z; Hobaiter, C; Zuberbuhler, K				Genty, Emilie; Clay, Zanna; Hobaiter, Catherine; Zuberbuehler, Klaus			Multi-Modal Use of a Socially Directed Call in Bonobos	PLOS ONE			English	Article							PAN-PANISCUS; GESTURAL COMMUNICATION; WILD CHIMPANZEES; REPERTOIRE; COMBINATIONS; SEQUENCES; LANGUAGE; BEHAVIOR; MODIFY; SIGNAL	'Contest hoots' are acoustically complex vocalisations produced by adult and subadult male bonobos (Pan paniscus). These calls are often directed at specific individuals and regularly combined with gestures and other body signals. The aim of our study was to describe the multi-modal use of this call type and to clarify its communicative and social function. To this end, we observed two large groups of bonobos, which generated a sample of 585 communicative interactions initiated by 10 different males. We found that contest hooting, with or without other associated signals, was produced to challenge and provoke a social reaction in the targeted individual, usually agonistic chase. Interestingly, 'contest hoots' were sometimes also used during friendly play. In both contexts, males were highly selective in whom they targeted by preferentially choosing individuals of equal or higher social rank, suggesting that the calls functioned to assert social status. Multi-modal sequences were not more successful in eliciting reactions than contest hoots given alone, but we found a significant difference in the choice of associated gestures between playful and agonistic contexts. During friendly play, contest hoots were significantly more often combined with soft than rough gestures compared to agonistic challenges, while the calls' acoustic structure remained the same. We conclude that contest hoots indicate the signaller's intention to interact socially with important group members, while the gestures provide additional cues concerning the nature of the desired interaction.	[Genty, Emilie; Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland; [Genty, Emilie; Hobaiter, Catherine; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9AJ, Fife, Scotland; [Clay, Zanna] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	University of Neuchatel; University of St Andrews; Emory University	Genty, E (corresponding author), Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland.	emilie.genty@unine.ch	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Hobaiter, Cat/0000-0002-3893-0524	Leverhulme Trust Research Leadership Award [F/00 268/AP]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC grant [283871]	Leverhulme Trust Research Leadership Award(Leverhulme Trust); European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC grant(European Research Council (ERC))	The research leading to these results has received funding from the Leverhulme Trust Research Leadership Award F/00 268/AP (http://www.leverhulme.ac.uk/) and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007 2013)/ERC grant agreement no 283871 (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; Arnold K, 2012, BRAIN LANG, V120, P303, DOI 10.1016/j.bandl.2011.10.001; Badrian A., 1984, P325; Bavelas JB, 2000, J LANG SOC PSYCHOL, V19, P163, DOI 10.1177/0261927X00019002001; Bermejo M, 1999, FOLIA PRIMATOL, V70, P328, DOI 10.1159/000021717; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Casar C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0535; Call J., 2007, GESTURAL COMMUNICATI; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; de Luna AG, 2010, ANIM BEHAV, V79, P739, DOI 10.1016/j.anbehav.2009.12.031; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; De Waal FBM, 2003, ANN NY ACAD SCI, V1000, P7, DOI 10.1196/annals.1280.003; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; Fusani L, 1997, BEHAVIOUR, V134, P321, DOI 10.1163/156853997X00566; GARDNER RA, 1969, SCIENCE, V165, P664, DOI 10.1126/science.165.3894.664; Genty E, 2010, ANIM COGN, V13, P287, DOI 10.1007/s10071-009-0266-4; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hammerschmidt K., 2008, EVOLUTION COMMUNICAT; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hayes K. J., 1951, Proceedings of the American Philosophical Society, V95, P105; HENNESSY DF, 1981, BEHAVIOUR, V78, P188, DOI 10.1163/156853981X00329; Herrmann E, 2013, J COMP PSYCHOL, V127, P63, DOI 10.1037/a0028929; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Ingmanson Ellen J., 1996, P190; Iverson JM, 1998, NATURE, V396, P228, DOI 10.1038/24300; KANO T, 1980, J HUM EVOL, V9, P243, DOI 10.1016/0047-2484(80)90053-6; Kano T., 1992, LAST APE PYGMY CHIMP; KURODA S, 1980, Primates, V21, P181, DOI 10.1007/BF02374032; Lameira AR, 2014, TRENDS COGN SCI, V18, P60, DOI 10.1016/j.tics.2013.10.013; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal Katja, 2006, GESTURE, V6, P1, DOI [10.1075/gest.6.1.02lie, DOI 10.1075/GEST.6.1.02LIE]; Micheletta J, 2013, AM J PRIMATOL, V75, P763, DOI 10.1002/ajp.22105; Miles H.L.W., 1990, P511, DOI 10.1017/CBO9780511665486.021; MORRIS D, 1977, MANWATCHING; Morris D, 1994, HUMAN ANIMAL LANGUAG; Ouattara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007808; Paoli T, 2008, DEV PRIMATOL-PROG PR, P39, DOI 10.1007/978-0-387-74787-3_3; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Partan SR, 2002, BEHAVIOUR, V139, P993, DOI 10.1163/15685390260337877; Patterson F., 1981, ED KOKO; Patterson F, 1979, LANGUAGE INTERVENTIO, P325; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Pika S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1567; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Preuschoft H., 1993, HANDS PRIMATES; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Rowe C, 1996, NATURE, V383, P520, DOI 10.1038/383520a0; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Savage S., 1978, P613; Savage-Rumbaugh E.S., 1977, P97; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2011, ANIM BEHAV, V81, P919, DOI 10.1016/j.anbehav.2011.02.002; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; Stevens JMG, 2006, PRIMATES, V47, P210, DOI 10.1007/s10329-005-0177-1; Tanner JE, 1996, CURR ANTHROPOL, V37, P162, DOI 10.1086/204484; TANNER JE, 1993, PRIMATES, V34, P451, DOI 10.1007/BF02382654; Tanner Joanne E., 1999, P211, DOI 10.1017/CBO9780511542305.012; TOMASELLO M, 1989, PRIMATES, V30, P35, DOI 10.1007/BF02381209; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; Tomasello M., 1997, EVOLUTION COMMUNICAT, V1, P223, DOI [DOI 10.1075/EOC.1.2.04TOM, 10.1075/eoc.1.2.04tom]; Tomasello Michael, 2007, P1; Uetz GW, 2009, ANIM BEHAV, V78, P299, DOI 10.1016/j.anbehav.2009.04.023; Wiesendanger M, 1999, EXP BRAIN RES, V128, P1, DOI 10.1007/s002210050810	77	53	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84738	10.1371/journal.pone.0084738	http://dx.doi.org/10.1371/journal.pone.0084738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454745	Green Published, Green Accepted, gold			2022-12-27	WOS:000330235100032
J	Guilligay, D; Kadlec, J; Crepin, T; Lunardi, T; Bouvier, D; Kochs, G; Ruigrok, RWH; Cusack, S				Guilligay, Delphine; Kadlec, Jan; Crepin, Thibaut; Lunardi, Thomas; Bouvier, Denis; Kochs, Georg; Ruigrok, Rob W. H.; Cusack, Stephen			Comparative Structural and Functional Analysis of Orthomyxovirus Polymerase Cap-Snatching Domains	PLOS ONE			English	Article							INFLUENZA-VIRUS POLYMERASE; MESSENGER-RNA; THOGOTO VIRUS; VIRION RNA; VIRAL-RNA; DHORI VIRUS; ENDONUCLEASE; BINDING; PA; IDENTIFICATION	Orthomyxovirus Influenza A virus (IAV) heterotrimeric polymerase performs transcription of viral mRNAs by cap-snatching, which involves generation of capped primers by host pre-mRNA binding via the PB2 subunit cap-binding site and cleavage 10-13 nucleotides from the 5' cap by the PA subunit endonuclease. Thogotoviruses, tick-borne orthomyxoviruses that includes Thogoto (THOV), Dhori (DHOV) and Jos (JOSV) viruses, are thought to perform cap-snatching by cleaving directly after the cap and thus have no heterogeneous, host-derived sequences at the 5' extremity of their mRNAs. Based on recent work identifying the cap-binding and endonuclease domains in IAV polymerase, we determined the crystal structures of two THOV PB2 domains, the putative cap-binding and the so-called '627-domain', and the structures of the putative endonuclease domains (PA-Nter) of THOV and DHOV. Despite low sequence similarity, corresponding domains have the same fold confirming the overall architectural similarity of orthomyxovirus polymerases. However the putative Thogotovirus cap-snatching domains in PA and PB2 have non-conservative substitutions of key active site residues. Biochemical analysis confirms that, unlike the IAV domains, the THOV and DHOV PA-Nter domains do not bind divalent cations and have no endonuclease activity and the THOV central PB2 domain does not bind cap analogues. On the other hand, sequence analysis suggests that other, non-influenza, orthomyxoviruses, such as salmon anemia virus (isavirus) and Quaranfil virus likely conserve active cap-snatching domains correlating with the reported occurrence of heterogeneous, host-derived sequences at the 5' end of the mRNAs of these viruses. These results highlight the unusual nature of transcription initiation by Thogotoviruses.	[Guilligay, Delphine; Crepin, Thibaut; Bouvier, Denis; Ruigrok, Rob W. H.] Univ Grenoble Alpes, Unit Virus Host Cell Interact, Grenoble, France; [Guilligay, Delphine; Crepin, Thibaut; Bouvier, Denis; Ruigrok, Rob W. H.] CNRS, Unit Virus Host Cell Interact, Grenoble, France; [Guilligay, Delphine; Kadlec, Jan; Lunardi, Thomas; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn & Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Kochs, Georg] Univ Med Ctr Freiburg, Inst Virol, Freiburg, Germany	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); University of Freiburg	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn & Unit Virus Host Cell Interact, F-38042 Grenoble, France.	cusack@embl.fr	Kadlec, Jan/G-3235-2014	CREPIN, Thibaut/0000-0003-2663-1794; Cusack, Stephen/0000-0002-9324-0796; Kadlec, Jan/0000-0002-4853-6918	FRISBI [ANR-10-INSB-05-02]; Grenoble Partnership for Structural Biology (PSB); European Union Seventh Framework Programme (FP7) project FLUPHARM [259751]	FRISBI; Grenoble Partnership for Structural Biology (PSB); European Union Seventh Framework Programme (FP7) project FLUPHARM	This work used the platforms of the Grenoble Instruct Centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and the Grenoble Partnership for Structural Biology (PSB). The work was partly funded with European Union Seventh Framework Programme (FP7) project FLUPHARM (No. 259751 to R. R and S. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albo C, 1996, J VIROL, V70, P9013, DOI 10.1128/JVI.70.12.9013-9017.1996; ANDERSON CR, 1973, INDIAN J MED RES, V61, P1416; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Bussetti AV, 2012, J GEN VIROL, V93, P293, DOI 10.1099/vir.0.035121-0; BUTENKO AM, 1987, VOP VIRUSOL+, P724; CIANCI C, 1995, J VIROL, V69, P3995, DOI 10.1128/JVI.69.7.3995-3999.1995; Crepin T, 2010, J VIROL, V84, P9096, DOI 10.1128/JVI.00995-10; Da Silva EVP, 2005, AM J TROP MED HYG, V73, P1050, DOI 10.4269/ajtmh.2005.73.1050; Datta K, 2013, NUCL ACIDS RES; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fauquet CM, 2005, VIRUS TAXONOMY, P681; FODOR E, 1995, J VIROL, V69, P4012, DOI 10.1128/JVI.69.7.4012-4019.1995; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P17, DOI 10.1016/j.virol.2010.09.003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAIG DA, 1965, J GEN MICROBIOL, V38, P389, DOI 10.1099/00221287-38-3-389; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Leahy MB, 1997, VIRUS RES, V50, P215, DOI 10.1016/S0168-1702(97)00072-5; Leahy MB, 1998, J VIROL, V72, P2305, DOI 10.1128/JVI.72.3.2305-2309.1998; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Morin B, 2010, PLOS PATHOG, V6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noble E, 2012, VIROLOGY, V433, P27, DOI 10.1016/j.virol.2012.07.008; Perez D., 2011, VIRUS TAXONOMY, P749; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Presti RM, 2009, J VIROL, V83, P11599, DOI 10.1128/JVI.00677-09; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Sandvik T, 2000, ARCH VIROL, V145, P1659, DOI 10.1007/s007050070082; Siebler J, 1996, ARCH VIROL, V141, P1587, DOI 10.1007/BF01718257; Snow M, 2003, VIRUS RES, V92, P99, DOI 10.1016/S0168-1702(02)00322-2; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Taylor MJ, 2008, NUCLEIC ACIDS RES, V36, P6021, DOI 10.1093/nar/gkn605; Weber F, 1996, J VIROL, V70, P8361, DOI 10.1128/JVI.70.12.8361-8367.1996; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	52	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84973	10.1371/journal.pone.0084973	http://dx.doi.org/10.1371/journal.pone.0084973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454773	Green Published, gold			2022-12-27	WOS:000330235100046
J	Kakoschke, T; Kakoschke, S; Magistro, G; Schubert, S; Borath, M; Heesemann, J; Rossier, O				Kakoschke, Tamara; Kakoschke, Sara; Magistro, Giuseppe; Schubert, Soeren; Borath, Marc; Heesemann, Juergen; Rossier, Ombeline			The RNA Chaperone Hfq Impacts Growth, Metabolism and Production of Virulence Factors in Yersinia enterocolitica	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; ENVELOPE STRESS-RESPONSE; ESCHERICHIA-COLI K-12; OMPA MESSENGER-RNA; GCVB GENE ENCODES; SALMONELLA-TYPHIMURIUM; TRANSCRIPTIONAL REGULATION; SIDEROPHORE PRODUCTION; CHROMOSOMAL GENES; EXPRESSION	To adapt to changes in environmental conditions, bacteria regulate their gene expression at the transcriptional but also at the post-transcriptional level, e.g. by small RNAs (sRNAs) which modulate mRNA stability and translation. The conserved RNA chaperone Hfq mediates the interaction of many sRNAs with their target mRNAs, thereby playing a global role in fine-tuning protein production. In this study, we investigated the significance of Hfq for the enteropathogen Yersina enterocolitica serotype O:8. Hfq facilitated optimal growth in complex and minimal media. Our comparative protein analysis of parental and hfq-negative strains suggested that Hfq promotes lipid metabolism and transport, cell redox homeostasis, mRNA translation and ATP synthesis, and negatively affects carbon and nitrogen metabolism, transport of siderophore and peptides and tRNA synthesis. Accordingly, biochemical tests indicated that Hfq represses ornithine decarboxylase activity, indole production and utilization of glucose, mannitol, inositol and 1,2-propanediol. Moreover, Hfq repressed production of the siderophore yersiniabactin and its outer membrane receptor FyuA. In contrast, hfq mutants exhibited reduced urease production. Finally, strains lacking hfq were more susceptible to acidic pH and oxidative stress. Unlike previous reports in other Gram-negative bacteria, Hfq was dispensable for type III secretion encoded by the virulence plasmid. Using a chromosomally encoded FLAG-tagged Hfq, we observed increased production of Hfq-FLAG in late exponential and stationary phases. Overall, Hfq has a profound effect on metabolism, resistance to stress and modulates the production of two virulence factors in Y. enterocolitica, namely urease and yersiniabactin.	[Kakoschke, Tamara; Kakoschke, Sara; Magistro, Giuseppe; Schubert, Soeren; Heesemann, Juergen; Rossier, Ombeline] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Borath, Marc] Univ Munich, Prot Anal Unit, Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich	Rossier, O (corresponding author), Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany.	rossier@mvp.uni-muenchen.de		Rossier, Ombeline/0000-0003-4987-1811	Wissenschaftlichen Herausgeberkollegium der Munnchener Medizinischen Wochenschrift; Bayerischen Gleichstellungsforderung; Forderprogramm fur Forschung und Lehre of the Ludwig-Maximilians University Medical School	Wissenschaftlichen Herausgeberkollegium der Munnchener Medizinischen Wochenschrift; Bayerischen Gleichstellungsforderung; Forderprogramm fur Forschung und Lehre of the Ludwig-Maximilians University Medical School	This work was supported in part by grants from the Wissenschaftlichen Herausgeberkollegium der Munnchener Medizinischen Wochenschrift and from the Bayerischen Gleichstellungsforderung to O.R. T.K. received a fellowship from the Forderprogramm fur Forschung und Lehre of the Ludwig-Maximilians University Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov R, 2005, INT J MED MICROBIOL, V295, P19, DOI 10.1016/j.ijmm.2004.11.007; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Antonenko V, 2003, FEMS MICROBIOL LETT, V219, P249, DOI 10.1016/S0378-1097(03)00047-8; Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BADGER JL, 1995, J BACTERIOL, V177, P5370, DOI 10.1128/jb.177.18.5370-5373.1995; Bai G, 2010, J BACTERIOL, V192, P4239, DOI 10.1128/JB.00504-10; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Beauregard A, 2013, RNA BIOL, V10, P397, DOI 10.4161/rna.23590; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; deKoningWard TF, 1997, FEMS MICROBIOL LETT, V147, P221, DOI 10.1016/S0378-1097(96)00528-9; DEKONINGWARD TF, 1995, INFECT IMMUN, V63, P3790, DOI 10.1128/IAI.63.10.3790-3795.1995; Diestra E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008301; Dorrell N, 1998, FEMS MICROBIOL LETT, V165, P145, DOI 10.1016/S0378-1097(98)00267-5; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Garzetti D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-467; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gerhardt P., 1994, METHODS GEN MOL BACT; Gripenberg-Lerche C, 2000, INFECT IMMUN, V68, P942, DOI 10.1128/IAI.68.2.942-947.2000; GUILVOUT I, 1993, J BACTERIOL, V175, P5488, DOI 10.1128/JB.175.17.5488-5504.1993; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; HEESEMANN J, 1993, MOL MICROBIOL, V8, P397, DOI 10.1111/j.1365-2958.1993.tb01583.x; HEESEMANN J, 1986, INFECT IMMUN, V54, P561, DOI 10.1128/IAI.54.2.561-567.1986; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2010, RES MOL MICROBIOLOGY, P1; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; KINDER SA, 1993, GENE, V136, P271, DOI 10.1016/0378-1119(93)90478-L; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Lin HH, 2011, J BACTERIOL, V193, P5833, DOI 10.1128/JB.05359-11; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; McArthur SD, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-52; Mildiner-Earley S, 2006, INFECT IMMUN, V74, P4361, DOI 10.1128/IAI.00154-06; Nakao H, 1995, MOL MICROBIOL, V18, P859, DOI 10.1111/j.1365-2958.1995.18050859.x; Oellerich MF, 2007, INFECT IMMUN, V75, P3802, DOI 10.1128/IAI.00419-07; Pelludat C, 1998, J BACTERIOL, V180, P538, DOI 10.1128/JB.180.3.538-546.1998; Pelludat C, 2003, J BACTERIOL, V185, P5648, DOI 10.1128/JB.185.18.5648-5653.2003; Pelludat C, 2002, INFECT IMMUN, V70, P1832, DOI 10.1128/IAI.70.4.1832-1841.2002; Pelludat C, 2000, MOL CHARAKTERISIERUN; PEPE JC, 1993, P NATL ACAD SCI USA, V90, P6473, DOI 10.1073/pnas.90.14.6473; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Reines M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002978; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; ROGGENKAMP A, 1995, FEMS MICROBIOL LETT, V134, P69, DOI 10.1016/0378-1097(95)00383-G; ROSE RE, 1988, NUCLEIC ACIDS RES, V16, P356, DOI 10.1093/nar/16.1.356; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; SAKEN E, 1994, J MED MICROBIOL, V41, P329, DOI 10.1099/00222615-41-5-329; Salvail H, 2012, WIRES RNA, V3, P26, DOI 10.1002/wrna.102; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sasse J, 2009, CURR PROTOC MOL BIOL; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Sebbane F, 2001, INFECT IMMUN, V69, P170, DOI 10.1128/IAI.69.1.170-176.2001; Shakhnovich EA, 2009, MOL MICROBIOL, V74, P347, DOI 10.1111/j.1365-2958.2009.06856.x; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Trcek J, 2002, MICROBIOL-SGM, V148, P1457, DOI 10.1099/00221287-148-5-1457; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997; Tsui HCT, 1996, J BACTERIOL, V178, P5719, DOI 10.1128/jb.178.19.5719-5731.1996; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vytvytska O, 1998, P NATL ACAD SCI USA, V95, P14118, DOI 10.1073/pnas.95.24.14118; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilharm G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-27; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Zhang YH, 2009, ACTA BIOCH BIOPH SIN, V41, P709, DOI 10.1093/abbs/gmp059	99	31	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86113	10.1371/journal.pone.0086113	http://dx.doi.org/10.1371/journal.pone.0086113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454955	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100145
J	Kretschy, N; Somoza, MM				Kretschy, Nicole; Somoza, Mark M.			Comparison of the Sequence-Dependent Fluorescence of the Cyanine Dyes Cy3, Cy5, DyLight DY547 and DyLight DY647 on Single-Stranded DNA	PLOS ONE			English	Article							LIGHT-DIRECTED SYNTHESIS; MICROARRAYS; STACKING; CONTEXT	Cyanine dyes are commonly used for fluorescent labeling of DNA and RNA oligonucleotides in applications including qPCR, sequencing, fluorescence in situ hybridization, Forster resonance energy transfer, and labeling for microarray hybridization. Previous research has shown that the fluorescence efficiency of Cy3 and Cy5, covalently attached to the 59 end of single-stranded DNA, is strongly sequence dependent. Here, we show that DY547 and DY647, two alternative cyanine dyes that are becoming widely used for nucleic acid labeling, have a similar pattern of sequence-dependence, with adjacent purines resulting in higher intensity and adjacent cytosines resulting in lower intensity. Investigated over the range of all 1024 possible DNA 5mers, the intensities of Cy3 and Cy5 drop by similar to 50% and similar to 65% with respect to their maxima, respectively, whereas the intensities of DY547 and DY647 fall by similar to 45% and similar to 40%, respectively. The reduced magnitude of change of the fluorescence intensity of the DyLight dyes, particularly of DY647 in comparison with Cy5, suggests that these dyes are less likely to introduce sequence-dependent bias into experiments based on fluorescent labeling of nucleic acids.	[Kretschy, Nicole; Somoza, Mark M.] Univ Vienna, Inst Inorgan Chem, Vienna, Austria	University of Vienna	Somoza, MM (corresponding author), Univ Vienna, Inst Inorgan Chem, Vienna, Austria.	mark.somoza@univie.ac.at		Somoza, Mark/0000-0002-8039-1341	University of Vienna; Faculty of Chemistry of the University of Vienna; Austrian Science Fund [FWF P23797]; Austrian Science Fund (FWF) [P 23797] Funding Source: researchfish	University of Vienna; Faculty of Chemistry of the University of Vienna; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding by the University of Vienna, the Faculty of Chemistry of the University of Vienna, and the Austrian Science Fund (FWF P23797) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbavwe C, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-57; Agbavwe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022177; De Backer MD, 2001, ANTIMICROB AGENTS CH, V45, P1660, DOI 10.1128/AAC.45.6.1660-1670.2001; DOKTYCZ MJ, 1990, BIOPOLYMERS, V30, P829, DOI 10.1002/bip.360300718; Franssen-van Hal NLW, 2013, ANAL CHEM, V85, P5950, DOI 10.1021/ac400746j; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; Glen Research, 2009, GLEN REP NEW FLUORES; Guckian KM, 2000, J AM CHEM SOC, V122, P2213, DOI 10.1021/ja9934854; Harvey BJ, 2009, J FLUORESC, V19, P443, DOI 10.1007/s10895-008-0431-1; Harvey BJ, 2009, PHOTOCH PHOTOBIO SCI, V8, P1105, DOI 10.1039/b905078g; Iqbal A, 2008, BIOCHEMISTRY-US, V47, P7857, DOI 10.1021/bi800773f; Jeon Hosang, 2007, Genomics & Informatics, V5, P113; Lackey JG, 2009, CHIM OGGI, V27, P30; Lackey JG, 2009, J AM CHEM SOC, V131, P8496, DOI 10.1021/ja9002074; LUBYPHELPS K, 1993, BIOPHYS J, V65, P236, DOI 10.1016/S0006-3495(93)81075-0; Mikelsons L, 2005, PHOTOCH PHOTOBIO SCI, V4, P798, DOI 10.1039/b508720a; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Ruan Q, 2007, BIOCHEMISTRY-US, V46, P7006, DOI 10.1021/bi700294K; Sack M, 2013, ANAL CHEM, V85, P8513, DOI 10.1021/ac4024318; Sain A, 2006, PHYSICA A, V369, P679, DOI 10.1016/j.physa.2006.01.084; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; SOLIE TN, 1968, J MOL BIOL, V33, P61, DOI 10.1016/0022-2836(68)90281-7; Spiriti J, 2011, BIOPHYS J, V100, P1049, DOI 10.1016/j.bpj.2011.01.014; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167	27	20	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85605	10.1371/journal.pone.0085605	http://dx.doi.org/10.1371/journal.pone.0085605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454899	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100104
J	Lau, J; Zhou, Q; Sutton, SE; Herman, AE; Schmedt, C; Glynne, R				Lau, Janet; Zhou, Qiang; Sutton, Susan E.; Herman, Ann E.; Schmedt, Christian; Glynne, Richard			Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; CHRONIC MYELOID-LEUKEMIA	(1) Aim/Hypothesis: Recent studies indicate that tyrosine kinase inhibitors, including imatinib, can reverse hyperglycemia in non-obese diabetic (NOD) mice, a model of type 1 diabetes (T1D). Imatinib inhibits c-Abl, c-Kit, and PDGFRs. Next-generation tyrosine kinase inhibitors for T1D treatment should maintain activities required for efficacy while sparing inhibition of targets that might otherwise lead to adverse events. In this study, we investigated the contribution of c-Kit inhibition by imatinib in reversal of hyperglycemia in NOD mice. (2) Methods: The T670I mutation in c-Kit, which confers imatinib resistance, was engineered into the mouse genome and bred onto the NOD background. Hematopoietic stem cells (HSCs) from NOD.c-Kit(T670I) mice and NOD.c-Kit(wt) littermates were expanded in the presence or absence of imatinib to verify imatinib resistance of the c-Kit(T670I) allele. Diabetic mice were treated with imatinib at the onset of hyperglycemia for three weeks, and blood glucose was monitored. (3) Results: In vitro expansion of HSCs from NOD.c-Kit(wt) mice was sensitive to imatinib, while expansion of HSCs from NOD.c-Kit(T670I) mice was insensitive to imatinib. However, in vivo treatment with imatinib lowered blood glucose levels in both strains of mice. (4) Conclusions/Interpretation: The HSC experiment confirmed that, in NOD.c-Kit(T670I) mice, c-Kit is resistant to imatinib. As both NOD.c-Kit(T670I) and NOD.c-Kit(wt) mice responded comparably to imatinib, c-Kit inhibition does not substantially contribute to the efficacy of imatinib in T1D. Thus, we conclude that inhibition of c-Kit is not required in next-generation tyrosine kinase inhibitors for T1D treatment, and may be selected against to improve the safety profile.	[Lau, Janet; Herman, Ann E.] Novartis Res Fdn, Genom Inst, JDRF Pharmacol, San Diego, CA USA; [Zhou, Qiang; Sutton, Susan E.; Schmedt, Christian; Glynne, Richard] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Novartis; Novartis	Glynne, R (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	rglynne@gnf.org			Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)	Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation)	Funding for this work was provided by the Novartis Research Foundation and the Novartis Institute of Biomedical Research (NIBR). J. Lau was supported as a postdoctoral fellow by an agreement between the Genomics Institute of the Novartis Research Foundation (GNF) and the Juvenile Diabetes Research Foundation (JDRF). The funders had no role in the study design, data collection and analysis, or preparation of the manuscript. Legal approval for publication before submission was obtained from GNF and NIBR.	Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Gitelman SE BJ, 2013, IMATINIB TREATMENT R; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Pricl S, 2005, MOL CANCER THER, V4, P1167, DOI 10.1158/1535-7163.MCT-05-0101; Suttorp M, 2010, HEMATOL-AM SOC HEMAT, P368, DOI 10.1182/asheducation-2010.1.368; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; Tutone M, 2011, BIOINFORMATION, V7, P296; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Welsh N, 2012, EXPERT OPIN INV DRUG, V21, P1743, DOI 10.1517/13543784.2012.724398	15	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84900	10.1371/journal.pone.0084900	http://dx.doi.org/10.1371/journal.pone.0084900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454763	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100041
J	Li, LJ; Zeng, H; Ou, B; Luo, BM; Xiao, XY; Zhong, WJ; Zhao, XB; Zhao, ZZ; Yang, HY; Zhi, H				Li, Lu-Jing; Zeng, Hong; Ou, Bing; Luo, Bao-Ming; Xiao, Xiao-Yun; Zhong, Wen-Jing; Zhao, Xin-Bao; Zhao, Zi-Zhuo; Yang, Hai-Yun; Zhi, Hui			Ultrasonic Elastography Features of Phyllodes Tumors of the Breast: A Clinical Research	PLOS ONE			English	Article							MAMMOGRAPHY; LESIONS; FIBROADENOMAS; ASPIRATION; PHYLLOIDES; DIAGNOSIS; MASSES	The purpose of this study was to analyze the ultrasonic elastography features of phyllodes tumors of the breast comparing with fibroadenomas. A retrospective database was queried for the patients diagnosed as phyllodes tumors and fibroadenomas at Sun Yat-sen Memorial Hospital from January 2008 to August 2012. Three hundred and fifty lesions from 323 consecutive patients were included in the study. All the cases were examined by conventional ultrasonography and ultrasound elastography. Ultrasound elastography was used to calculate strain ratio of the lesions with bilateral breast tissue at the same depth as reference. There were 36 phyllodes tumors (27 benign, 8 borderline, 1 malignant) and 314 fibroadenomas (158 the pericanalicular type, 103 the intracanalicular type, 53 other special types). The strain ratio for phyllodes tumors (3.19 +/- 2.33) was significantly higher than for fibroadenomas (1.69 +/- 0.88) (p < 0.05). The Spearmans correlation coefficient between strain ratio of ultrasound elastography and pathological groups was significant, with a value of 0.17 (p < 0.05). Ultrasound elastography could provide additional information to differentiate phyllodes tumors from fibroadenoma in breast.	[Li, Lu-Jing; Ou, Bing; Luo, Bao-Ming; Xiao, Xiao-Yun; Zhong, Wen-Jing; Zhao, Xin-Bao; Zhao, Zi-Zhuo; Yang, Hai-Yun; Zhi, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Hong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ou, B (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China.	oubing77@163.com.cn; kendy181hui@yahoo.com.cn	Li, Lujing/AAW-3653-2020					Adamietz BR, 2011, ULTRASCHALL MED, V32, P67, DOI 10.1055/s-0031-1282024; ALAGARATNAM TT, 1985, CLIN RADIOL, V36, P175, DOI 10.1016/S0009-9260(85)80104-5; Blanco AJ, 1999, EUR RADIOL, V9, P356, DOI 10.1007/s003300050680; BUCHBERGER W, 1991, AM J ROENTGENOL, V157, P715, DOI 10.2214/ajr.157.4.1654022; Chao TC, 2003, EUR RADIOL, V13, P88, DOI 10.1007/s00330-002-1370-x; COLEBEUGLET C, 1983, RADIOLOGY, V146, P481, DOI 10.1148/radiology.146.2.6294737; COSMACINI P, 1992, EUR J RADIOL, V15, P11, DOI 10.1016/0720-048X(92)90194-E; FAJARDO LL, 1988, INVEST RADIOL, V23, P505, DOI 10.1097/00004424-198807000-00004; Farria DM, 1996, AM J ROENTGENOL, V167, P187, DOI 10.2214/ajr.167.1.8659370; Feder JM, 1999, RADIOGRAPHICS, V19, pS11, DOI 10.1148/radiographics.19.suppl_1.g99oc07s11; Goel NB, 2005, RADIOGRAPHICS, V25, P1547, DOI 10.1148/rg.256045183; Hoyt K, 2006, PHYS MED BIOL, V51, P197, DOI 10.1088/0031-9155/51/2/001; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; JACKSON VP, 1993, RADIOLOGY, V188, P297, DOI 10.1148/radiology.188.2.8327668; Jacobs TW, 2005, AM J CLIN PATHOL, V124, P342, DOI 10.1309/5N2C4N5XCV8XW8JL; Jung YS, 2005, J PAEDIATR CHILD H, V41, P78, DOI 10.1111/j.1440-1754.2005.00545.x; Kaufman CS, 2002, AM J SURG, V184, P394, DOI 10.1016/S0002-9610(02)01010-3; Kinoshita Takayuki, 2004, Breast J, V10, P232, DOI 10.1111/j.1075-122X.2004.21316.x; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Pacinda SJ, 1998, J ADOLESCENT HEALTH, V23, P3, DOI 10.1016/S1054-139X(97)00271-1; PAGE JE, 1991, CLIN RADIOL, V44, P8, DOI 10.1016/S0009-9260(05)80217-X; ROWELL MD, 1993, AM J SURG, V165, P376, DOI 10.1016/S0002-9610(05)80849-9; Tan HN, 2012, EUR J RADIOL, V81, pE62, DOI 10.1016/j.ejrad.2011.01.085; Wurdinger S, 2005, AM J ROENTGENOL, V185, P1317, DOI 10.2214/AJR.04.1620; Yang WT, 1996, J ULTRAS MED, V15, P637; Zhi H, 2008, ACAD RADIOL, V15, P1347, DOI 10.1016/j.acra.2008.08.003; Zhi H, 2010, ACAD RADIOL, V17, P1227, DOI 10.1016/j.acra.2010.05.004; Zissis C, 1998, BREAST CANCER RES TR, V48, P205, DOI 10.1023/A:1005980831359	29	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85257	10.1371/journal.pone.0085257	http://dx.doi.org/10.1371/journal.pone.0085257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454830	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100067
J	Seif, M; Impelido, ML; Apps, MG; Wheate, NJ				Seif, Marian; Impelido, Michael L.; Apps, Michael G.; Wheate, Nial J.			Topical Cream-Based Dosage Forms of the Macrocyclic Drug Delivery Vehicle Cucurbit[6]uril	PLOS ONE			English	Article							PERCUTANEOUS-ABSORPTION; DRIVING-FORCE; COMPLEXES; ENCAPSULATION; CYTOTOXICITY; RECOGNITION; PERMEATION; PEPTIDES; ENHANCE; WATER	The macrocycle family of molecules called cucurbit[n] urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of cucurbit[6] uril (CB[6]) in topical cream-based formulations for either localised treatment or for transdermal delivery. Cucurbit[6] uril was formulated into both buffered cream aqueous-and oily cream-based dosage forms. The solid state interaction of CB[6] with other excipients was studied by differential scanning calorimetry and the macrocycle's transdermal permeability was determined using rat skin. Significant solid state interactions were observed between CB[6] and the other dosage form excipients. At concentrations up to 32% w/w the buffered aqueous cream maintained its normal consistency and could be effectively applied to skin, but the oily cream was too stiff and is not suitable as a dosage form. Cucurbit[6] uril does not permeate through skin; as such, the results imply that cucurbituril-based topical creams may potentially only have applications for localised skin treatment and not for transdermal drug delivery.	[Seif, Marian; Impelido, Michael L.; Apps, Michael G.; Wheate, Nial J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney	Wheate, NJ (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	nial.wheate@sydney.edu.au	Wheate, Nial/A-9990-2008	Wheate, Nial/0000-0002-0505-1363				[Anonymous], [No title captured]; Appel EA, 2012, CHEM COMMUN, V48, P9843, DOI 10.1039/c2cc35131e; Bhasikuttan AC, 2011, CHEM COMMUN, V47, P9959, DOI 10.1039/c1cc12091c; Biedermann F, 2012, J AM CHEM SOC, V134, P15318, DOI 10.1021/ja303309e; Biedermann F, 2010, CHEM-EUR J, V16, P13716, DOI 10.1002/chem.201002274; Cheng XJ, 2013, ANGEW CHEM INT EDIT, V52, P7252, DOI 10.1002/anie.201210267; Fan ZF, 2011, J INCL PHENOM MACRO, V71, P577, DOI 10.1007/s10847-011-9981-y; Ghosh I, 2012, ADV DRUG DELIVER REV, V64, P764, DOI 10.1016/j.addr.2012.01.015; Gupta VK, 1999, PHARMACEUT RES, V16, P1602, DOI 10.1023/A:1018916907263; Hettiarachchi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010514; Isaacs L, 2009, CHEM COMMUN, P619, DOI 10.1039/b814897j; Koner AL, 2011, CAN J CHEM, V89, P139, DOI 10.1139/V10-079; Krause-Heuer AM, 2009, J MED CHEM, V52, P5474, DOI 10.1021/jm9007104; Lagona J, 2005, ANGEW CHEM INT EDIT, V44, P4844, DOI 10.1002/anie.200460675; Li N, 2010, INT J PHARMACEUT, V387, P167, DOI 10.1016/j.ijpharm.2009.12.025; Liu H, 2011, J INCL PHENOM MACRO, V71, P583, DOI 10.1007/s10847-011-9982-x; Macartney DH, 2011, ISR J CHEM, V51, P600, DOI 10.1002/ijch.201100040; Masson E, 2012, RSC ADV, V2, P1213, DOI 10.1039/c1ra00768h; McInnes FJ, 2010, ORG BIOMOL CHEM, V8, P765, DOI 10.1039/b918372h; Montes-Navajas P, 2009, PHOTOCH PHOTOBIO SCI, V8, P1743, DOI 10.1039/b9pp00041k; Nau WM, 2011, ISR J CHEM, V51, P559, DOI 10.1002/ijch.201100044; Carvalho CP, 2011, CHEM COMMUN, V47, P8793, DOI 10.1039/c1cc12954f; Patel MR, 2011, PHARM DEV TECHNOL, V16, P250, DOI 10.3109/10837451003610845; Plumb JA, 2012, METALLOMICS, V4, P561, DOI 10.1039/c2mt20054f; Rastogi SC, 2000, CONTACT DERMATITIS, V43, P339, DOI 10.1034/j.1600-0536.2000.043006339.x; Reczek JJ, 2009, J AM CHEM SOC, V131, P2408, DOI 10.1021/ja808936y; Saleh N, 2013, J INCL PHENOM MACRO, DOI [10.1007/s10847-10013-10352-10848, DOI 10.1007/S10847-10013-10352-10848]; Saleh N, 2011, SUPRAMOL CHEM, V23, P654, DOI 10.1080/10610278.2011.593631; Sansom LN, 2012, AUSTR PHARM FORMULAR; Silva SMC, 2012, EUR J PHARM BIOPHARM, V80, P663, DOI 10.1016/j.ejpb.2011.11.010; Talukder R, 2011, AAPS PHARMSCITECH, V12, P1227, DOI 10.1208/s12249-011-9697-8; Urbach AR, 2011, ISR J CHEM, V51, P664, DOI 10.1002/ijch.201100035; Uzunova VD, 2010, ORG BIOMOL CHEM, V8, P2037, DOI 10.1039/b925555a; Walker S, 2011, ISR J CHEM, V51, P616, DOI 10.1002/ijch.201100033; Walker S, 2010, MOL PHARMACEUT, V7, P2166, DOI 10.1021/mp100191b; Wang RB, 2008, ORG BIOMOL CHEM, V6, P1955, DOI 10.1039/b801591k; Wang RB, 2009, DALTON T, P3584, DOI 10.1039/b904028e; Wheate NJ, 2008, J INORG BIOCHEM, V102, P2060, DOI 10.1016/j.jinorgbio.2008.06.005; Williams AC, 2003, TRANSDERMAL TOPICAL; Wyman IW, 2010, ORG BIOMOL CHEM, V8, P247, DOI 10.1039/b915694a; Yamada K, 2011, J OLEO SCI, V60, P31, DOI 10.5650/jos.60.31; Zhao YJ, 2010, ORG BIOMOL CHEM, V8, P3328, DOI 10.1039/c003732j; Zhao YJ, 2008, ORG BIOMOL CHEM, V6, P4509, DOI 10.1039/b813759e; Zhou YY, 2009, MICROCHIM ACTA, V164, P63, DOI 10.1007/s00604-008-0032-3	44	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85361	10.1371/journal.pone.0085361	http://dx.doi.org/10.1371/journal.pone.0085361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454850	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100074
J	Varghese, B; Roy, R; Saha, S; Roalkvam, S				Varghese, Beena; Roy, Reetabrata; Saha, Somen; Roalkvam, Sidsel			Fostering Maternal and Newborn Care in India the Yashoda Way: Does This Improve Maternal and Newborn Care Practices during Institutional Delivery?	PLOS ONE			English	Article							LABOR	Background: The Yashoda program, named after a legendary foster-mother in Indian mythology, under the Norway-India Partnership Initiative was launched as a pilot program in 2008 to improve the quality of maternal and neonatal care at facilities in select districts of India. Yashodas were placed mainly at district hospitals, which are high delivery load facilities, to provide support and care to mothers and newborns during their stay at these facilities. This study presents the results from the evaluation of this intervention in two states in India. Methods: Data collection methods included in-depth interviews with healthcare providers and mothers and a survey of mothers who had recently delivered within a quasi-experimental design. Fifty IDIs were done and 1,652 mothers who had delivered in the past three months were surveyed during 2010 and 2011. Results: A significantly higher proportion of mothers at facilities with Yashodas (55 percent to 97 percent) received counseling on immunization, breastfeeding, family planning, danger signs, and nutrition compared to those in control districts (34 percent to 66 percent). Mothers in intervention facilities were four to five times more likely to receive postnatal checks than mothers in control facilities. Among mothers who underwent cesarean sections, initiation of breastfeeding within five hours was 50 percent higher in intervention facilities. Mothers and families also reported increased support, care and respect at intervention facilities. Conclusion: Yashoda as mothers' aide thus seems to be an effective intervention to improve quality of maternal and newborn care in India. Scaling up of this intervention is recommended in district hospitals and other facilities with high volume of deliveries.	[Varghese, Beena; Saha, Somen] Publ Hlth Fdn India, New Delhi, India; [Roy, Reetabrata] London Sch Hyg & Trop Med, London WC1, England; [Saha, Somen] Indian Inst Publ Hlth, Gandhinagar, Gujarat, India; [Roalkvam, Sidsel] Univ Oslo, Ctr Dev & Environm, Oslo, Norway	Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; University of Oslo	Varghese, B (corresponding author), Publ Hlth Fdn India, New Delhi, India.	beena.varghese@phfi.org	Saha, Somen/C-6286-2012	Saha, Somen/0000-0002-8043-3388	Norwegian Ministry of Foreign Affairs	Norwegian Ministry of Foreign Affairs	This study was funded by the Norwegian Ministry of Foreign Affairs and is linked to the Norway India Partnership Initiative on health. The funding agency did not have a role in the study design, the conduct of the research, or in preparing the manuscript.	Campero L, 1998, SOC SCI MED, V47, P395, DOI 10.1016/S0277-9536(98)00077-X; Chandramauli C., 2011, CENSUS INDIA 2011 PR, V1; Dongre AA, 2010, EFFECT MONETARY INCE; Government of Tamil Nadu, 2006, NOT BIRTH COMP PROGR; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Hodnett ED, 2007, COCHRANE DATABASE SY, V3; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Koumouitzes-Douvia J, 2006, J PERINAT EDUC, V15, P34, DOI 10.1624/105812406X151402; Leslie MS, 2007, J PERINAT EDUC, V16, p10S, DOI 10.1624/105812407X173137; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Saha S, 2013, B WHO UNPUB; SOSA R, 1980, NEW ENGL J MED, V303, P597, DOI 10.1056/NEJM198009113031101; Subha Sri B, 2009, TRANSLATING MED EVID	13	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84145	10.1371/journal.pone.0084145	http://dx.doi.org/10.1371/journal.pone.0084145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454718	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100017
J	Wang, L; Qian, L				Wang, Li; Qian, Li			miR-24 Regulates Intrinsic Apoptosis Pathway in Mouse Cardiomyocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CARDIAC MYOCYTE APOPTOSIS; BAX TRANSLOCATION; CELL-DEATH; HEART-FAILURE; MICRORNA; BCL-2; RECOGNITION; DISEASES; TARGET	Numerous cardiac diseases, including myocardial infarction (MI) and chronic heart failure, have been associated with cardiomyocyte apoptosis. Promoting cell survival by inhibiting apoptosis is one of the effective strategies to attenuate cardiac dysfunction caused by cardiomyocyte loss. miR-24 has been shown as an anti-apoptotic microRNA in various animal models. In vivo delivery of miR-24 into a mouse MI model suppressed cardiac cell death, attenuated infarct size, and rescued cardiac dysfunction. However, the molecular pathway by which miR-24 inhibits cardiomyocyte apoptosis is not known. Here we found that miR-24 negatively regulates mouse primary cadiomyocyte cell death through functioning in the intrinsic apoptotic pathways. In ER-mediated intrinsic pathway, miR-24 genetically interacts with the CEBP homologous gene CHOP as knocking down of CHOP partially attenuated the induced apoptosis by miR-24 inhibition. In mitochondria-involved intrinsic pathway, miR-24 inhibits the initiation of apoptosis through suppression of Cytochrome C release and Bax translocation from cytosol to mitochondria. These results provide mechanistic insights into the miR-24 mediated antiapoptotic effects in murine cardiomyocytes.	[Wang, Li; Qian, Li] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA; [Wang, Li; Qian, Li] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Qian, L (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	li_qian@med.unc.edu	wang, li/O-1425-2015	wang, li/0000-0001-8927-6772	UNC-Chapel Hill	UNC-Chapel Hill	This work was supported by the start-up funds to the Qian Lab from UNC-Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bedner E, 2000, CYTOMETRY, V41, P83, DOI 10.1002/1097-0320(20001001)41:2<83::AID-CYTO1>3.0.CO;2-R; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Gao CF, 2001, EXP CELL RES, V265, P145; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Jia L, 2001, ONCOGENE, V20, P4817, DOI 10.1038/sj.onc.1204628; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; Kang PM, 2003, TRENDS MOL MED, V9, P177, DOI 10.1016/S1471-4914(03)00025-X; Kang PM, 2002, CIRC J, V66, P1, DOI 10.1253/circj.66.1; Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3; Kitsis RN, 2007, NAT MED, V13, P539, DOI 10.1038/nm0507-539; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mathur A, 2004, LANCET, V364, P183, DOI 10.1016/S0140-6736(04)16632-4; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Shore GC, 2008, CELL, V135, P1004, DOI 10.1016/j.cell.2008.11.029; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	41	26	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85389	10.1371/journal.pone.0085389	http://dx.doi.org/10.1371/journal.pone.0085389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454859	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100080
J	Zhang, XM; Zajac, AL; Huang, LY; Behlke, MA; Tsourkas, A				Zhang, Xuemei; Zajac, Allison L.; Huang, Lingyan; Behlke, Mark A.; Tsourkas, Andrew			Imaging the Directed Transport of Single Engineered RNA Transcripts in Real-Time Using Ratiometric Bimolecular Beacons	PLOS ONE			English	Article							BICOID MESSENGER-RNA; MOLECULAR BEACONS; LIVING CELLS; LOCALIZATION; DYNAMICS; MECHANISM; REVEALS; VISUALIZATION; EXPRESSION; PARTICLES	The relationship between RNA expression and cell function can often be difficult to decipher due to the presence of both temporal and sub-cellular processing of RNA. These intricacies of RNA regulation can often be overlooked when only acquiring global measurements of RNA expression. This has led to development of several tools that allow for the real-time imaging of individual engineered RNA transcripts in living cells. Here, we describe a new technique that utilizes an oligonucleotide-based probe, ratiometric bimolecular beacon (RBMB), to image RNA transcripts that were engineered to contain 96-tandem repeats of the RBMB target sequence in the 3'-untranslated region. Binding of RBMBs to the target RNA resulted in discrete bright fluorescent spots, representing individual transcripts, that could be imaged in real-time. Since RBMBs are a synthetic probe, the use of photostable, bright, and red-shifted fluorophores led to a high signal-to-background. RNA motion was readily characterized by both mean squared displacement and moment scaling spectrum analyses. These analyses revealed clear examples of directed, Brownian, and subdiffusive movements.	[Zhang, Xuemei; Tsourkas, Andrew] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Zajac, Allison L.] Univ Penn, Philadelphia, PA 19104 USA; [Huang, Lingyan; Behlke, Mark A.] Integrated DNA Technol Inc, Coralville, IA USA	University of Pennsylvania; University of Pennsylvania	Tsourkas, A (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	atsourk@seas.upenn.edu	Tsourkas, Andrew/AAM-8252-2020	Tsourkas, Andrew/0000-0001-7758-1753; Behlke, Mark/0000-0002-4218-857X	National Science Foundation CAREER Award [0953583]; National Institute of Health [NCI/R21-CA116102, NCI/R21-CA125088, NIBIB/R01-EB012065, NCI/R01-CA157766]; NATIONAL CANCER INSTITUTE [R01CA157766, R21CA116102, R21CA125088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012065] Funding Source: NIH RePORTER; Directorate For Engineering [0953583] Funding Source: National Science Foundation	National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation CAREER Award (0953583) and the National Institute of Health NCI/R21-CA116102, NCI/R21-CA125088, NIBIB/R01-EB012065, NCI/R01-CA157766. The funding agencies that supported this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chen AK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm593; Chen AK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq436; Chen AK, 2009, J INNOV OPT HEAL SCI, V2, P315, DOI 10.1142/S179354580900070X; Chen AK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp837; Chen AK, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn331; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Daigle N, 2007, NAT METHODS, V4, P633, DOI 10.1038/NMETH1065; Dictenberg J, 2012, TRENDS BIOTECHNOL, V30, P621, DOI 10.1016/j.tibtech.2012.09.004; Drake TJ, 2005, CHEMBIOCHEM, V6, P2041, DOI 10.1002/cbic.200500046; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Ishihama Y, 2009, BIOCHEM BIOPH RES CO, V381, P33, DOI 10.1016/j.bbrc.2009.02.001; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kang WM, 2013, NANO LETT, V13, P2448, DOI 10.1021/nl400423c; Mhlanga MM, 2005, NUCLEIC ACIDS RES, V33, P1902, DOI 10.1093/nar/gki302; Molenaar C, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e89; Nitin N, 2008, BIOCONJUGATE CHEM, V19, P2205, DOI 10.1021/bc800322a; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Rhee WJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-30; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh062; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shan JG, 2003, J NEUROSCI, V23, P8859; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Tadakuma H, 2006, BIOCHEM BIOPH RES CO, V344, P772, DOI 10.1016/j.bbrc.2006.03.202; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; van den Bogaard Patrick T. C., 2008, V464, P91; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; Zhang XM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt561; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	43	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85813	10.1371/journal.pone.0085813	http://dx.doi.org/10.1371/journal.pone.0085813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454933	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100134
J	Mendo, T; Lyle, JM; Moltschaniwskyj, NA; Tracey, SR; Semmens, JM				Mendo, Tania; Lyle, Jeremy M.; Moltschaniwskyj, Natalie A.; Tracey, Sean R.; Semmens, Jayson M.			Habitat Characteristics Predicting Distribution and Abundance Patterns of Scallops in D'Entrecasteaux Channel, Tasmania	PLOS ONE			English	Article							DENSITY-DEPENDENT PREDATION; PLACOPECTEN-MAGELLANICUS; SETTLEMENT; SURVIVAL; CRABS; SEA; BAY; RECRUITMENT; SUBSTRATE; GROUNDS	Habitat characteristics greatly influence the patterns of distribution and abundance in scallops, providing structure for the settlement of spat and influencing predation risk and rates of survival. Establishing scallop-habitat relationships is relevant to understanding the ecological processes that regulate scallop populations and to managing critical habitats. This information is particularly relevant for the D'Entrecasteaux Channel, south-eastern Tasmania (147.335 W, 43.220 S), a region that has supported significant but highly variable scallop production over many years, including protracted periods of stock collapse. Three species of scallops are present in the region; the commercial scallop Pecten fumatus, the queen scallop Equichlamys bifrons, and the doughboy scallop Mimachlamys asperrima. We used dive surveys and Generalized Additive Modelling to examine the relationship between the distribution and abundance patterns of each species and associated habitat characteristics. The aggregated distribution of each species could be predicted as a function of sediment type and species-specific habitat structural components. While P. fumatus was strongly associated with finer sediments and E. bifrons with coarse grain sediments, M. asperrima had a less selective association, possibly related to its ability to attach on a wide range of substrates. Other habitat characteristics explaining P. fumatus abundance were depth, Asterias amurensis abundance, shell and macroalgae cover. Equichlamys bifrons was strongly associated with macroalgae and seagrass cover, whereas M. asperrima abundance was greatly explained by sponge cover. The models define a set of relationships from which plausible hypotheses can be developed. We propose that these relationships are mediated by predation pressure as well as the specific behavioural characteristics of each species. The findings also highlight the specific habitat characteristics that are relevant for spatial management and habitat restoration plans.	[Mendo, Tania; Lyle, Jeremy M.; Tracey, Sean R.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia	University of Tasmania; University of Newcastle	Mendo, T (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	taniamendow@yahoo.com	Lyle, Jeremy M/J-7170-2014; Moltschaniwskyj, Natalie/AAB-7236-2019; Mendo, Tania/AAH-7734-2020	Lyle, Jeremy M/0000-0001-9670-5854; Mendo, Tania/0000-0003-4397-2064; Semmens, Jayson/0000-0003-1742-6692; Moltschaniwskyj, Natalie/0000-0001-9709-9876	Fishwise Community Grants Scheme; Endeavour International Postgraduate Research Scholarship (EIPRS)	Fishwise Community Grants Scheme; Endeavour International Postgraduate Research Scholarship (EIPRS)(Australian Government)	This project was funded by the Fishwise Community Grants Scheme administered by the Department of Primary Industries, Parks, Water and Environment, Australia. The first author was supported by an Endeavour International Postgraduate Research Scholarship (EIPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2000, J SHELLFISH RES, V19, P749; Andruskiw M, 2008, ECOLOGY, V89, P2273, DOI 10.1890/07-1428.1; [Anonymous], 2006, MATLAB VERS 7 2 0 23; Brand AR., 2006, DEV AQUAC FISH SCI, V35, P651, DOI [DOI 10.1016/S0167-9309(06)80039-6, 10.1016/S0167-9309(06)80039-6]; Bremec C, 2008, J SHELLFISH RES, V27, P273, DOI 10.2983/0730-8000(2008)27[273:PSSOSZ]2.0.CO;2; Byrne M, 1997, MAR BIOL, V127, P673, DOI 10.1007/s002270050058; Cantillanez M., 2000, REPROD VIE LARVAIRE; CHERNOFF H, 1987, J EXP MAR BIOL ECOL, V109, P155, DOI 10.1016/0022-0981(87)90013-X; Crawley M.J., 2007, R BOOK; Dalla Rosa L, 2012, CONT SHELF RES, V36, P89, DOI 10.1016/j.csr.2012.01.017; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V132, P123, DOI 10.1016/0022-0981(89)90219-0; EGGLESTON DB, 1995, ECOL MONOGR, V65, P193, DOI 10.2307/2937137; EGGLESTON DB, 1992, MAR ECOL PROG SER, V85, P55, DOI 10.3354/meps085055; Eleftheriou A., 2008, METHODS STUDY MARINE; Elliot JM, 1971, FRESHWATER BIOL ASS, V25; Fairbridge W. S., 1954, Australian Journal of Marine and Freshwater Research, V4, P1; Folk R.L., 1980, PETROLOGY SEDIMENTAR; Gatehouse JSI, 1971, PROCEDURES SEDIMENTO; HARVEY M, 1993, MAR ECOL PROG SER, V99, P283, DOI 10.3354/meps099283; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hatanaka M, 1958, TOHOKU J AGR RES, V9, P159; HECK KL, 1981, J EXP MAR BIOL ECOL, V53, P125, DOI 10.1016/0022-0981(81)90014-9; Hedger R, 2004, FISH RES, V70, P17, DOI 10.1016/j.fishres.2004.07.002; Herzfeld M, 2010, MAR FRESHWATER RES, V61, P568, DOI 10.1071/MF09134; HORTLE ME, 1987, AQUACULTURE, V66, P79, DOI 10.1016/0044-8486(87)90285-7; Howarth LM, 2011, MAR BIOL, V158, P1767, DOI 10.1007/s00227-011-1690-y; Hutson KS, 2005, MAR ECOL PROG SER, V298, P305, DOI 10.3354/meps298305; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; LANGTON RW, 1990, J EXP MAR BIOL ECOL, V144, P157, DOI 10.1016/0022-0981(90)90026-9; Ling SD, 2012, J APPL ECOL, V49, P733, DOI 10.1111/j.1365-2664.2012.02133.x; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; MERRILL A S, 1976, Nautilus, V90, P54; Minchin D, 2003, AQUAT LIVING RESOUR, V16, P521, DOI 10.1016/j.aquliv.2003.07.004; MINCHIN D, 1992, J MAR BIOL ASSOC UK, V72, P807, DOI 10.1017/S0025315400060057; Minchinton TE, 1997, OECOLOGIA, V111, P45, DOI 10.1007/s004420050206; Moksnes PO, 2002, J EXP MAR BIOL ECOL, V271, P41, DOI 10.1016/S0022-0981(02)00041-2; MYERS JH, 1978, ENVIRON ENTOMOL, V7, P619, DOI 10.1093/ee/7.5.619; MYERS JP, 1980, CAN J ZOOL, V58, P1564, DOI 10.1139/z80-216; NOAA, 2013, GLOB SELF CONS HIER; OLSEN A. M., 1955, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V6, P392; Pacheco A, 2006, J EXP MAR BIOL ECOL, V333, P27, DOI 10.1016/j.jembe.2005.11.017; PERRIN R A, 1988, Papers and Proceedings of the Royal Society of Tasmania, V122, P179; PITCHER CR, 1987, J EXP MAR BIOL ECOL, V112, P233, DOI 10.1016/0022-0981(87)90071-2; POHLE DG, 1991, MAR ECOL PROG SER, V74, P47, DOI 10.3354/meps074047; R Development Core Team, 2010, R FDN R LANG ENV STA; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; STOKESBURY KDE, 1993, MAR ECOL PROG SER, V96, P159, DOI 10.3354/meps096159; SWARTZMAN G, 1995, CAN J FISH AQUAT SCI, V52, P369, DOI 10.1139/f95-039; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Talman SG, 2004, MAR ECOL PROG SER, V269, P197, DOI 10.3354/meps269197; Tracey SR, 2011, FISHERIES MANAG ECOL, V18, P221, DOI 10.1111/j.1365-2400.2010.00775.x; TUPPER M, 1995, CAN J FISH AQUAT SCI, V52, P1834, DOI 10.1139/f95-176; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wolf BM, 1997, J SHELLFISH RES, V16, P533; Wong MC, 2003, J EXP MAR BIOL ECOL, V287, P155, DOI 10.1016/S0022-0981(02)00551-8; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zacharin W, 1991, 42 MAR LAB DIV SEA F; Zacharin W. F, 1995, GROWTH REPROD RECRUI; Zacharin Will, 1994, Memoirs of the Queensland Museum, V36, P299; Zuur Alain F., 2009, P1	64	14	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85895	10.1371/journal.pone.0085895	http://dx.doi.org/10.1371/journal.pone.0085895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454945	Green Published, gold			2022-12-27	WOS:000329922500059
J	Tian, YW; Liu, YF; He, PC; Liu, F; Zhou, NC; Cheng, XY; Shi, LL; Zhu, HC; Zhao, J; Wang, Y; Zhang, M				Tian, Yuwang; Liu, Yanfeng; He, Pengcheng; Liu, Feng; Zhou, Naicen; Cheng, Xiaoyan; Shi, Lili; Zhu, Huachao; Zhao, Jing; Wang, Yuan; Zhang, Mei			Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein	PLOS ONE			English	Article							PHOSPHATASE 2A; REALGAR NANOPARTICLES; TRIOXIDE; INHIBITOR; EXPRESSION; MANAGEMENT; FUSION; GROWTH; PP2A; ATRA	Tetra-arsenic tetra-sulfide (As4S4) is an arsenic compound with anti-tumor activity, especially in acute promyelocytic leukemia (APL) that are resistant to retinoic acid (RA). Although recent studies revealed that the therapeutic action of As4S4 is closely associated with the induction of cellular apoptosis, the exact molecular mechanism of action of As4S4 in RA-resistant APL remains to be clarified. In this study, we found that As4S4-induced apoptosis was accompanied by reduced mRNA and protein expression of SET gene in RA-resistant NB4-R1 cells. Moreover, RNAi knockdown of SET gene further promoted As4S4-induced apoptosis, while SET over-expression inhibited it, suggesting that As4S4 induces apoptosis through the reduction of SET protein in NB4-R1 cells. We also demonstrated that the knockdown of SET gene resulted in the upregulation of protein phosphatase 2 (PP2A) expression and the downregulation of promyelocytic leukemia and retinoic acid receptor alpha fusion gene (PML-RAR alpha) expression, which were enhanced by As4S4 treatments. By contrast, over-expression of SET gene resulted in PP2A downregulation and PML-RAR alpha upregulation, which were abolished by As4S4 pretreatment. Since PP2A is a pro-apoptotic factor and PMLRAR alpha is an anti-apoptotic factor, our results suggest that As4S4-induced apoptosis in NB4-R1 cells is through the downregulation of SET protein expression, which in turn increases PP2A and reduces PML-RAR alpha expressions to lead to cell apoptosis.	[Tian, Yuwang] Beijing Mil Area PLA, Gen Hosp, Dept Pathol, Beijing, Peoples R China; [Liu, Yanfeng; He, Pengcheng; Liu, Feng; Zhou, Naicen; Cheng, Xiaoyan; Shi, Lili; Zhu, Huachao; Zhao, Jing; Wang, Yuan; Zhang, Mei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	He, PC (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China.	hepc@163.com; meizhang102@gmail.com			Natural Science Foundation of China [81000218]; Fundamental Research Funds for the Central Universities; Shaanxi Province Science, and Technology Development Fund, China [2010K01-135, 2012KTCL03-12]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shaanxi Province Science, and Technology Development Fund, China	This study was supported by the Natural Science Foundation of China (81000218), the Fundamental Research Funds for the Central Universities, the Shaanxi Province Science, and Technology Development Fund, China (nos. 2010K01-135 and 2012KTCL03-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Balaz P, 2010, TOXINS, V2, P1568, DOI 10.3390/toxins2061568; Breccia M, 2012, EXPERT OPIN PHARMACO, V13, P1031, DOI 10.1517/14656566.2012.677436; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chen GQ, 1996, BLOOD, V88, P1052; Cristobal I, 2012, HAEMATOL-HEMATOL J, V97, P543, DOI 10.3324/haematol.2011.050542; CUNNINGHAM I, 1989, BLOOD, V73, P1116; Degos L, 2001, ONCOGENE, V20, P7140, DOI 10.1038/sj.onc.1204763; Falanga A, 2003, BEST PRACT RES CL HA, V16, P463, DOI 10.1016/S1521-6926(03)00059-8; FORNEROD M, 1995, ONCOGENE, V10, P1739; Hoffman E, 2010, POSTEP HIG MED DOSW, V64, P284; Holmes D, 2012, CASE REP ONCOL MED, V2012, DOI 10.1155/2012/313057; Irie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051242; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2012, CURR MOL MED, V12, P268, DOI 10.2174/156652412799218930; Kamimura T, 2011, CANCER SCI, V102, P1929, DOI 10.1111/j.1349-7006.2011.02045.x; Kogan SC, 2009, CANCER CELL, V15, P7, DOI 10.1016/j.ccr.2008.12.012; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lin Quan-de, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P19; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lu DP, 2002, BLOOD, V99, P3136, DOI 10.1182/blood.V99.9.3136; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Mathews V, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.056; Mattson JC, 2000, CLIN LAB MED, V20, P83; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ouellet V, 2006, INT J CANCER, V119, P2119, DOI 10.1002/ijc.22054; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Qi J, 2010, LEUKEMIA RES, V34, P1506, DOI 10.1016/j.leukres.2010.03.038; Ravandi F, 2009, J CLIN ONCOL, V27, P504, DOI 10.1200/JCO.2008.18.6130; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; Tallman MS, 2008, BEST PRACT RES CL HA, V21, P659, DOI 10.1016/j.beha.2008.09.002; Teng Zhi-ping, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P236; Tong Y, 2004, BLOOD, V104, P4219, DOI 10.1182/blood-2004-04-1433; Tse WP, 2009, INT J MOL MED, V24, P189, DOI 10.3892/ijmm_00000222; Wang Feng-rong, 2005, Zhonghua Nei Ke Za Zhi, V44, P730; Wang Jing-Zhi, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P464; Wang XB, 2007, ARCH PHARM RES, V30, P653, DOI 10.1007/BF02977662; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Ye HQ, 2005, BIOL TRACE ELEM RES, V103, P117, DOI 10.1385/BTER:103:2:117; Zayed A, 2007, LEUKEMIA LYMPHOMA, V48, P489, DOI 10.1080/10428190601136163	42	4	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83184	10.1371/journal.pone.0083184	http://dx.doi.org/10.1371/journal.pone.0083184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454695	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500003
J	Jones, AM; Berkelmans, R				Jones, Alison M.; Berkelmans, Ray			Flood Impacts in Keppel Bay, Southern Great Barrier Reef in the Aftermath of Cyclonic Rainfall	PLOS ONE			English	Article							PHOTOSYSTEM-II HERBICIDES; SUSPENDED SEDIMENTS; CORAL RECRUITMENT; CLIMATE-CHANGE; WATER-QUALITY; SALINITY; EXPOSURE; LAGOON; FERTILIZATION; COMMUNITIES	In December 2010, the highest recorded Queensland rainfall associated with Tropical Cyclone 'Tasha' caused flooding of the Fitzroy River in Queensland, Australia. A massive flood plume inundated coral reefs lying 12 km offshore of the Central Queensland coast near Yeppoon and caused 40-100% mortality to coral fringing many of the islands of Keppel Bay down to a depth of similar to 8 m. The severity of coral mortality was influenced by the level of exposure to low salinity seawater as a result of the reef's distance from the flood plume and to a lesser extent, water depth and whether or not the reef faced the plume source. There was no evidence in this study of mortality resulting from pollutants derived from the nearby Fitzroy Catchment, at least in the short term, suggesting that during a major flood, the impact of low salinity on corals outweighs that of pollutants. Recovery of the reefs in Keppel Bay from the 2010/2011 Fitzroy River flood is likely to take 10-15 years based on historical recovery periods from a similar event in 1991; potentially impacting visitor numbers for tourism and recreational usage. In the meantime, activities like snorkeling, diving and coral viewing will be focused on the few shallow reefs that survived the flood, placing even further pressure on their recovery. Reef regeneration, restoration and rehabilitation are measures that may be needed to support tourism in the short term. However, predictions of a warming climate, lower rainfall and higher intensity summer rain events in the Central and Coastal regions of Australia over the next decade, combined with the current anthropogenic influences on water quality, are likely to slow regeneration with consequent impact on long-term reef resilience.	[Jones, Alison M.] Cent Queensland Univ, Rockhampton, Qld 4702, Australia; [Berkelmans, Ray] Townsville Mail Ctr, Australian Inst Marine Sci, Townsville, Qld, Australia	Central Queensland University; Australian Institute of Marine Science	Jones, AM (corresponding author), Cent Queensland Univ, Rockhampton, Qld 4702, Australia.	a.jones@cqu.edu.au	Jones, Alison/AAF-5530-2020		Centre for Environmental Management at Central Queensland University	Centre for Environmental Management at Central Queensland University	This study was made possible by funding provided by the Centre for Environmental Management at Central Queensland University and permitted by the Great Barrier Reef Marine Park Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2006, AUSTR BUR STAT QUEEN; ABS, 2011, AUSTR BUR STAT QUEEN; AIMS, 2011, AUSTR I MAR SCI SQUR; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2011, EXTREME WEATHER GREA; Ayling AL, 1998, EFFECTS DAINTREE RIV; Berkelmans R, 2012, CORAL REEFS, V31, P1103, DOI 10.1007/s00338-012-0930-z; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bostock H, 2006, 50 COOP RES CTR COAS; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; Butler IR, 2013, CORAL REEFS, V32, P1149, DOI 10.1007/s00338-013-1064-7; Byron GT, 1992, WORKSH IMP FLOOD; Cantin NE, 2007, MAR ECOL PROG SER, V344, P81, DOI 10.3354/meps07059; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Furnas M., 2003, CATCHMENT CORALS TER; Gallant AJE, 2007, AUST METEOROL MAG, V56, P223; GBRMPA, 2013, VESS REG LEV GREAT B; GBRMPA, 2013, ENV MAN CHARG EMC DA; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harrington L, 2005, MAR POLLUT BULL, V51, P415, DOI 10.1016/j.marpolbul.2004.10.042; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Herzfeld M, 2006, 38 CRC COAST ZON EST; Heyward AJ, 2002, MAR ECOL PROG SER, V230, P113, DOI 10.3354/meps230113; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; IBISWorld, 2011, QUEENSL FLOODS EC IM; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones Alison M., 2011, Diversity, V3, P329, DOI 10.3390/d3030329; Jones R, 2005, MAR POLLUT BULL, V51, P495, DOI 10.1016/j.marpolbul.2005.06.027; Kennedy K, 2010, REEF RESC MAR MON PR; Kennedy K, 2012, MAR POLLUT BULL, V64, P1495, DOI 10.1016/j.marpolbul.2012.05.014; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; LEWIS EL, 1980, IEEE J OCEANIC ENG, V5, P3, DOI 10.1109/JOE.1980.1145448; Magnusson M, 2010, MAR POLLUT BULL, V60, P1978, DOI 10.1016/j.marpolbul.2010.07.031; O'Neill JP, 1992, WORKSHOP SERIES, V17, P36; Packett B, 2007, P 5 AUSTR STREAM MAN, P294; Packett R, 2009, MAR POLLUT BULL, V58, P976, DOI 10.1016/j.marpolbul.2009.02.017; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Roelfsema C, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3430107; Saltzer R, 2002, UNDERSTANDING GREAT; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Scott A, 2013, MAR ENVIRON RES, V92, P10, DOI 10.1016/j.marenvres.2013.08.001; Tamelander J, 2002, AMBIO, V31, P551, DOI 10.1639/0044-7447(2002)031[0551:CRFAMM]2.0.CO;2; Thompson A., 2011, REEF RESCUE MARINE P, P127; TISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V460, P113, DOI 10.1016/0005-2728(77)90157-8; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Walsh KJE, 2004, CLIM DYNAM, V22, P47, DOI 10.1007/s00382-003-0362-0; Wolanski E, 1996, CONT SHELF RES, V16, P1437, DOI 10.1016/0278-4343(95)00087-9; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009	58	42	42	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84739	10.1371/journal.pone.0084739	http://dx.doi.org/10.1371/journal.pone.0084739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427294	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200034
J	Rao, C; Lin, SL; Ruan, WJ; Wen, H; Wu, DJ; Deng, H				Rao, Cui; Lin, Shan-Li; Ruan, Wen-Jing; Wen, Huan; Wu, Dan-Ju; Deng, Hong			High Expression of IGFBP7 in Fibroblasts Induced by Colorectal Cancer Cells Is Co-Regulated by TGF-beta and Wnt Signaling in a Smad2/3-Dvl2/3-Dependent Manner	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-7; EPITHELIAL-CELLS; PROSTATE-CANCER; CARCINOMA-CELLS; BREAST-CANCER; TUMOR STROMA; IN-SITU; INSULIN; CATENIN; IDENTIFICATION	Fibroblasts in the tumor microenvironment are a key determinant in cancer progression and may be a promising target for cancer therapy. Insulin-like growth factor binding protein 7 (IGFBP7) is known as a tumor suppressor in colorectal cancer (CRC). The present study investigated the inductive mechanism of IGFBP7 expression in fibroblasts by supernatant from the CRC cell line, SW620. The results showed that the expression of IGFBP7 was up-regulated in the fibroblasts when treated with SW620 supernatant and exogenous TGF-beta 1. The IGFBP7 induced by SW620 supernatant or TGF-beta 1 was partially inhibited by the TGF-beta 1 specific antibody AF and TGF-beta 1 receptor antagonist SB431542. The Wnt signaling-targeted genes, c-Myc, CCND1 and the proteins Dvl2/3, were all up-regulated in fibroblasts expressing high levels of IGFBP7, and the upregulation could be inhibited both by the Wnt signaling antagonist Dickkopf-1 (DKK1) and by the TGF-beta 1 receptor antagonist SB431542. In conclusion, CRC cells promote the high expression of IGFBP7 in fibroblasts, most likely through the co-regulation of TGF-beta and Wnt signaling in a Smad2/3-Dvl2/3 dependent manner. Taken together, these data suggest that the fibroblasts could be a novel therapeutic target in tumor therapy.	[Rao, Cui; Lin, Shan-Li; Ruan, Wen-Jing; Wen, Huan; Deng, Hong] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Dan-Ju] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Deng, H (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	hongdeng@zju.edu.cn			Natural Science Foundation of Zhejiang Province [LY12H16027]; National Natural Science Foundation of China [30870971]; Major Program of the National Natural Science Foundation of China [81090420, 81090421]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of Zhejiang Province (LY12H16027), the National Natural Science Foundation of China (30870971) and the Major Program of the National Natural Science Foundation of China (81090420, 81090421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 1996, CELL GROWTH DIFFER, V7, P1671; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; An W, 2012, ANN SURG ONCOL, V19, P3971, DOI 10.1245/s10434-012-2407-2; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Benatar T, 2012, BREAST CANCER RES TR, V133, P563, DOI 10.1007/s10549-011-1816-4; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Degeorges A, 1999, CANCER RES, V59, P2787; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Georges RB, 2011, CANCER BIOL THER, V12, P69, DOI 10.4161/cbt.12.1.15719; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kishibe J, 2000, J BIOL CHEM, V275, P15321, DOI 10.1074/jbc.275.20.15321; Komatsu S, 2000, BIOCHEM BIOPH RES CO, V267, P109, DOI 10.1006/bbrc.1999.1937; Liu M, 2011, INT J CANCER, V129, P1795, DOI 10.1002/ijc.26116; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Mamidi A, 2012, CELL DEATH DIFFER, V19, P1689, DOI 10.1038/cdd.2012.50; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Okamura J, 2012, CANCER BIOL THER, V13, P148, DOI 10.4161/cbt.13.3.18695; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Pen A, 2011, CANCER BIOL THER, V12, P634, DOI 10.4161/cbt.12.7.17171; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Sato J, 1999, J CELL BIOCHEM, V75, P187, DOI 10.1002/(SICI)1097-4644(19991101)75:2<187::AID-JCB1>3.0.CO;2-R; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Seth A, 2003, ANTICANCER RES, V23, P2043; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sprenger CC, 1999, CANCER RES, V59, P2370; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomimaru Y, 2012, INT J CANCER, V130, P319, DOI 10.1002/ijc.25994; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2009, MOL CANCER THER, V8, P3009, DOI 10.1158/1535-7163.MCT-09-0470; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908	51	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85340	10.1371/journal.pone.0085340	http://dx.doi.org/10.1371/journal.pone.0085340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427302	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200043
J	Dong, SY; Zhang, L; Li, WY; Du, J; Liu, XL; Chen, XT				Dong, Siyuan; Zhang, Lin; Li, Wenya; Du, Jiang; Liu, Xiangli; Chen, Xitao			Evaluation of Video-Assisted Thoracoscopic Surgery for Pulmonary Metastases: A Meta-Analysis	PLOS ONE			English	Article							PORT SITE RECURRENCES; SOFT-TISSUE SARCOMA; LUNG-CANCER; THORACIC-SURGERY; RESECTION; THORACOTOMY; LOBECTOMY; LESIONS; CHEMOTHERAPY; MANAGEMENT	Background: To evaluate the evidence comparing video-assisted thoracic surgery (VATS) and open thoracotomy in the treatment of metastatic lung cancer using meta-analytical techniques. Methods: A literature search was undertaken until July 2013 to identify the comparative studies evaluating disease-free survival rates and survival rates. The pooled odds ratios (OR) and the 95% confidence intervals (95% CI) were calculated with the fixed or random effect models. Results: Six retrospective studies were included in our meta-analysis. These studies included a total of 546 patients: 235 patients were treated with VATS, and 311 patients were treated with open thoracotomy. The VATS and the thoracotomy did not demonstrate a significant difference in the 1-, 3-, 5-year survival rates and the 1-year disease-free survival rate. There were significant statistical differences between the 3-year disease free survival rate (p = 0.04), which favored open thoracotomy. Conclusions: The VATS approach is a safe and feasible treatment in terms of the survival rate for metastatic lung cancer compared with the thoracotomy. The 3-year disease-free survival rate in the VATS group is inferior to that of open thoracotomy. The VATS approach could not completely replace open thoracotomy.	[Dong, Siyuan; Zhang, Lin; Li, Wenya; Du, Jiang; Liu, Xiangli; Chen, Xitao] China Med Univ, Hosp 1, Dept Thorac Surg, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Zhang, L (corresponding author), China Med Univ, Hosp 1, Dept Thorac Surg, Shenyang, Liaoning Provin, Peoples R China.	zhanglincmu@163.com						Ambrogi V, 2000, ANN THORAC SURG, V70, P1847, DOI 10.1016/S0003-4975(00)01806-3; [Anonymous], 1997, J THORAC CARDIOVASC, V113, P37; Carballo M, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-13; CASSON AG, 1992, CANCER, V69, P662, DOI 10.1002/1097-0142(19920201)69:3<662::AID-CNCR2820690311>3.0.CO;2-I; Cerfolio RJ, 2011, ANN THORAC SURG, V91, P1696, DOI 10.1016/j.athoracsur.2011.02.075; Chao YK, 2012, THORAC CARDIOV SURG, V60, P398, DOI 10.1055/s-0031-1295574; Chen YR, 2007, J FORMOS MED ASSOC, V106, P911, DOI 10.1016/S0929-6646(08)60061-3; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Eckardt J, 2012, CHEST, V142, P1598, DOI 10.1378/chest.12-0249; Flores RM, 2011, J THORAC CARDIOV SUR, V141, P59, DOI 10.1016/j.jtcvs.2010.08.062; Gossot D, 2009, ANN THORAC SURG, V87, P238, DOI 10.1016/j.athoracsur.2008.09.036; Johnstone PAS, 1996, J CLIN ONCOL, V14, P1950, DOI 10.1200/JCO.1996.14.6.1950; Kandioler D, 1998, ANN THORAC SURG, V65, P909, DOI 10.1016/S0003-4975(98)00019-8; Kayton ML, 2006, J PEDIATR SURG, V41, P200, DOI 10.1016/j.jpedsurg.2005.10.024; Kondo Haruhiko, 2005, Int J Clin Oncol, V10, P81; Margaritora S, 2002, EUR J CARDIO-THORAC, V21, P1111, DOI 10.1016/S1010-7940(02)00119-7; McCormack PM, 1996, ANN THORAC SURG, V62, P213, DOI 10.1016/0003-4975(96)00253-6; Molnar TF, 2010, J THORAC ONCOL, V5, pS140, DOI 10.1097/JTO.0b013e3181dcf62c; Mutsaerts ELAR, 2002, EUR J SURG ONCOL, V28, P864, DOI 10.1053/ejso.2002.1284; Mutsaerts ELAR, 2001, EUR J SURG ONCOL, V27, P327, DOI 10.1053/ejso.2000.1037; Nakajima J, 2001, SURG ENDOSC-ULTRAS, V15, P849, DOI 10.1007/s004640090005; Nakas A, 2009, EUR J CARDIO-THORAC, V36, P469, DOI 10.1016/j.ejcts.2009.03.050; Parsons AM, 2004, ANN THORAC SURG, V78, P1910, DOI 10.1016/j.athoracsur.2004.05.065; Paul S, 2010, J THORAC CARDIOV SUR, V139, P366, DOI 10.1016/j.jtcvs.2009.08.026; Petersen RP, 2007, ANN THORAC SURG, V83, P1245, DOI 10.1016/j.athoracsur.2006.12.029; Porter GA, 2004, J THORAC CARDIOV SUR, V127, P1366, DOI 10.1016/j.jtcvs.2003.11.016; ROTH JA, 1986, ANN THORAC SURG, V42, P134, DOI 10.1016/S0003-4975(10)60504-8; Rusch VW, 2010, J THORAC ONCOL, V5, pS130, DOI 10.1097/JTO.0b013e3181dca268; Schaeff B, 1998, DIGEST SURG, V15, P124, DOI 10.1159/000018605; Treasure T, 2007, ANN ROY COLL SURG, V89, P744, DOI 10.1308/003588407X232198; VANHALTEREN HK, 1995, CHEST, V107, P1526, DOI 10.1378/chest.107.6.1526; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009	32	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85329	10.1371/journal.pone.0085329	http://dx.doi.org/10.1371/journal.pone.0085329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416392	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300070
J	Hedd, A; Montevecchi, WA; Phillips, RA; Fifield, DA				Hedd, April; Montevecchi, William A.; Phillips, Richard A.; Fifield, David A.			Seasonal Sexual Segregation by Monomorphic Sooty Shearwaters Puffinus griseus Reflects Different Reproductive Roles during the Pre-Laying Period	PLOS ONE			English	Article							TRANS-EQUATORIAL MIGRATION; PELAGIC SEABIRD; CORYS SHEARWATERS; FORAGING STRATEGIES; ROUND DISTRIBUTION; ACTIVITY PATTERNS; HABITAT USE; BEHAVIOR; ALBATROSSES; OCEAN	Tracking technology has revolutionized knowledge of seabird movements; yet, few studies have examined sex differences in distribution and behavior of small to medium-sized, sexually-monomorphic seabirds. Application of bird-borne geolocation-immersion loggers revealed seasonal segregation in the sexually-monomorphic Sooty Shearwater Puffinus griseus, mainly in the pre-laying period, when there were clear differences in reproductive roles. Shearwaters first returned to the Falkland Islands on 27 Sept +/- 8 d; males, on average, 8 d earlier than females. Prior to egg-laying, distribution at sea, colony attendance and behaviour depended on sex. Males foraged locally over the southern Patagonian Shelf and Burdwood Bank, spending mainly single days at sea and intervening nights in the burrow. Females, who flew for more of the day during this time, foraged in more distant areas of the northern Patagonian Shelf and Argentine Basin that were deeper, warmer and relatively more productive. Attendance of females at the colony was also more variable than that of males and, overall, males were present for significantly more of the pre-laying period (38 vs. 19% of time). Sex differences were reduced following egg-laying, with males and females using similar foraging areas and making trips of similar mean duration in incubation (7.6 +/- 2.7 d) and chick-rearing (1.4 +/- 1.3 d). Congruence continued into the non-breeding period, with both sexes showing similar patterns of activity and areas of occupancy in the NW Atlantic. Thus, seasonal changes in reproductive roles influenced patterns of sexual segregation; this occurred only early in the season, when male Sooty Shearwaters foraged locally, returning regularly to the colony to defend (or maintain) the burrow or the mate, while females concentrated on building resources for egg development in distant and relatively more productive waters.	[Hedd, April; Montevecchi, William A.; Fifield, David A.] Mem Univ Newfoundland, Dept Psychol, Cognit & Behav Ecol Program, St John, NF, Canada; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Memorial University Newfoundland; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hedd, A (corresponding author), Mem Univ Newfoundland, Dept Psychol, Cognit & Behav Ecol Program, St John, NF, Canada.	ahedd@mun.ca		Hedd, April/0000-0003-2222-2627	NSERC Discovery Grant; Government of Canada's Program for International Polar Year; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada's Program for International Polar Year; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was supported by an NSERC Discovery Grant and the Government of Canada's Program for International Polar Year to WAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bugoni L, 2011, J ORNITHOL, V152, P261, DOI 10.1007/s10336-010-0577-x; Campagna C, 2007, DEEP-SEA RES PT I, V54, P1792, DOI 10.1016/j.dsr.2007.06.006; Catry Paulo, 2005, P351; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Copello S, 2011, MAR BIOL, V158, P1247, DOI 10.1007/s00227-011-1645-3; Croxall JP, 2002, AQUAT CONSERV, V12, P101, DOI 10.1002/aqc.480; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; FAO (Food and Agriculture Organization), 2010, FISH AQ STAT 2008; Fifield DA, 2013, ORNITHOL MO IN PRESS; Fraser GS, 2002, CONDOR, V104, P413, DOI 10.1650/0010-5422(2002)104[0413:MFDIPC]2.0.CO;2; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gaston AJ, 2011, MAR BIOL, V158, P1929, DOI 10.1007/s00227-011-1704-9; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis Jacob, 2005, P92; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Harris MP, 2010, MAR BIOL, V157, P827, DOI 10.1007/s00227-009-1365-0; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; Hill RD, 1994, ELEPHANT SEALS POPUL; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; Navarro J, 2009, MAR ECOL PROG SER, V378, P259, DOI 10.3354/meps07880; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Paiva VH, 2010, MAR ECOL PROG SER, V398, P259, DOI 10.3354/meps08319; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Phillips RA, 2009, MAR ECOL PROG SER, V391, P279, DOI 10.3354/meps08028; Pinet P, 2012, ANIM BEHAV, V83, P979, DOI 10.1016/j.anbehav.2012.01.019; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Rayner MJ, 2012, EMU, V112, P107, DOI 10.1071/MU11066; Rivas AL, 2006, CONT SHELF RES, V26, P703, DOI 10.1016/j.csr.2006.01.013; Rodhouse P. G., 1995, ICES Marine Science Symposia, V199, P425; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weimerskirch H, 2000, ECOLOGY, V81, P309, DOI 10.1890/0012-9658(2000)081[0309:SDIPIA]2.0.CO;2; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Welcker J, 2009, IBIS, V151, P502, DOI 10.1111/j.1474-919X.2009.00931.x; Woods R, 2006, IMPORTANT BIRD AREAS, P99; Yamamoto T, 2011, MAR ECOL PROG SER, V424, P191, DOI 10.3354/meps08973	55	50	52	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85572	10.1371/journal.pone.0085572	http://dx.doi.org/10.1371/journal.pone.0085572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416429	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329866300090
J	Iqbal, MS; Rahman, M; Islam, R; Banik, A; Amin, MB; Akter, F; Talukder, KA				Iqbal, Mohd S.; Rahman, Mostafizur; Islam, Rafiad; Banik, Atanu; Amin, M. Badrul; Akter, Fatema; Talukder, Kaisar Ali			Plasmid-Mediated Sulfamethoxazole Resistance Encoded by the sul2 Gene in the Multidrug-Resistant Shigella flexneri 2a Isolated from Patients with Acute Diarrhea in Dhaka, Bangladesh	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; GENOTYPIC CHARACTERIZATION; STRAINS; SUSCEPTIBILITY; SONNEI; AZITHROMYCIN; SALMONELLA; PREVALENCE	In this study, mechanisms of plasmid-mediated sulfamethoxazole resistances in the clinical strains of multi-drug resistant (MDR) Shigella flexneri 2a were elucidated for the first time in Bangladesh. From 2006 to 2011, a total of 200 S. flexneri 2a strains were randomly selected from the stock of the Enteric and Food Microbiology Laboratory of icddr, b. Antimicrobial susceptibility of the strains showed 73%, 98%, 93%, 58%, 98%, 64% and 4% resistance to trimethoprim-sulfamethoxazole, nalidixic acid, ampicillin, erythromycin, tetracycline, ciprofloxacin and ceftriaxone respectively. Plasmid profiling revealed heterogeneous patterns and interestingly, all the trimethoprim-sulfamethoxazole resistant (SXTR) strains yielded a distinct 4.3 MDa plasmid compared to that of the trimethoprim-sulfamethoxazole susceptible (SXTS) strains. Curing of this 4.3 MDa plasmid resulted in the susceptibility to sulfamethoxazole alone suggesting the involvement of this plasmid in the resistance of sulfamethoxazole. Moreover, PCR analysis showed the presence of sul2 gene in SXTR strains which is absent in SXTS strains as well as in the 4.3 MDa plasmid-cured derivatives, confirming the involvement of sul2 in the resistance of sulfamethoxazole. Furthermore, pulsed-field gel electrophoresis (PFGE) analysis revealed that both the SXTR and SXTS strains were clonal. This study will significantly contributes to the knowledge on acquired drug resistance of the mostly prevalent S. flexneri 2a and further warrants continuous monitoring of the prevalence and correlation of this resistance determinants amongst the clinical isolates of Shigella and other enteric pathogens around the world to provide effective clinical management of the disease.	[Iqbal, Mohd S.; Rahman, Mostafizur; Islam, Rafiad; Banik, Atanu; Amin, M. Badrul; Akter, Fatema; Talukder, Kaisar Ali] Icddr B, Ctr Food & Waterborne Dis CFWD, Dhaka, Bangladesh; [Iqbal, Mohd S.] Icddr B, Ctr Control Chron Dis CCCD, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Iqbal, MS (corresponding author), Icddr B, Ctr Food & Waterborne Dis CFWD, Dhaka, Bangladesh.	msiqbal@icddrb.org	Islam, Rafiad/ABD-8068-2021	Islam, Rafiad/0000-0001-5039-6240; amin, mansour/0000-0003-4207-9522; Amin, Mohammed Badrul/0000-0002-7181-6432; Rahman, Md Mostafizur/0000-0002-7890-6342	icddr,b; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This study was funded by icddr,b (www.icddrb.org) and its donors which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to icddr, b research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Barman S, 2010, INT J ANTIMICROB AG, V36, P348, DOI 10.1016/j.ijantimicag.2010.06.037; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Faiz M. A., 2011, Regional Health Forum, V15, P1; Ghosh S, 2011, J MED MICROBIOL, V60, P1460, DOI 10.1099/jmm.0.032920-0; HAIDER K, 1989, EPIDEMIOL INFECT, V102, P421, DOI 10.1017/S0950268800030132; Howie RL, 2010, MICROB DRUG RESIST, V16, P245, DOI 10.1089/mdr.2010.0028; Hu LF, 2011, INT J ANTIMICROB AG, V37, P230, DOI 10.1016/j.ijantimicag.2010.10.025; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Nigro SJ, 2011, J ANTIMICROB CHEMOTH, V66, P2175, DOI 10.1093/jac/dkr230; Rahman M, 2007, J HEALTH POPUL NUTR, V25, P158; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; Schultsz C, 2012, DRUGS, V72, P1, DOI 10.2165/11597960-000000000-00000; Talukder KA, 2003, J CLIN MICROBIOL, V41, P110, DOI 10.1128/JCM.41.1.110-117.2003; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Talukder KA, 2006, J MED MICROBIOL, V55, P1257, DOI 10.1099/jmm.0.46641-0; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Vrints M, 2009, J CLIN MICROBIOL, V47, P1379, DOI 10.1128/JCM.02460-08	21	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85338	10.1371/journal.pone.0085338	http://dx.doi.org/10.1371/journal.pone.0085338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416393	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300071
J	Khattar, M; Miyahara, Y; Schroder, PM; Xie, AN; Chen, WH; Stepkowski, SM				Khattar, Mithun; Miyahara, Yoshihiro; Schroder, Paul M.; Xie, Aini; Chen, Wenhao; Stepkowski, Stanislaw M.			Interleukin-21 Is a Critical Regulator of CD4 and CD8 T Cell Survival during Priming under Interleukin-2 Deprivation Conditions	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; IL-2 RECEPTOR; MICE; ACTIVATION; INDUCTION; TOLERANCE; RESPONSES; LOCUS; DIFFERENTIATION; AUTOIMMUNITY	Optimal T cell activation and expansion require binding of the common gamma-chain (gamma c) cytokine Interleukin-2 (IL-2) to its cognate receptor that in turn engages a gamma c/Janus tyrosine kinase (Jak) 3 signaling pathway. Because of its restricted expression by antigen-activated T cells and its obligatory role in promoting their survival and proliferation, IL-2 has been considered as a selective therapeutic target for preventing T cell mediated diseases. However, in order to further explore IL2 targeted therapy, it is critical to precisely understand its role during early events of T cell activation. In this study, we delineate the role of IL-2 and other gamma c cytokines in promoting the survival of CD4 and CD8 T cells during early phases of priming. Under IL-2 inhibitory conditions (by neutralizing anti-IL-2 mAbs), the survival of activated CD8(+) T cells was reduced, whereas CD4(+) T cells remained much more resistant. These results correlated with reduced Bcl-2 expression, and mitochondrial membrane potential in CD8(+) T cells in comparison to CD4(+) T cells. However, using transwell co-culture assays we have found that CD4(+) T cells could rescue the survival of CD8(+) T cells even under IL-2 deprived conditions via secretion of soluble factors. A cytokine screen performed on CD8+ T cells cultured alone revealed that IL-21, another cc cytokine, was capable of rescuing their survival under IL-2 deprivation. Indeed, blocking the IL-21 signaling pathway along with IL-2 neutralization resulted in significantly reduced survival of both CD4(+) and CD8+ T cells. Taken together, we have shown that under IL-2 deprivation conditions, IL-21 may act as the major survival factor promoting T cell immune responses. Thus, investigation of IL-2 targeted therapies may need to be revisited to consider blockade of the IL-21 signaling pathways as an adjunct to provide more effective control of T cell immune responses.	[Khattar, Mithun; Miyahara, Yoshihiro; Schroder, Paul M.; Stepkowski, Stanislaw M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH 43606 USA; [Xie, Aini; Chen, Wenhao] Houston Methodist Res Inst, Transplant Immunol Ctr, Houston, TX USA	University System of Ohio; University of Toledo; The Methodist Hospital System; The Methodist Hospital - Houston	Stepkowski, SM (corresponding author), Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	Stanislaw.Stepkowski@utoledo.edu	Khattar, Mithun/AAD-4760-2020; Chen, Wenhao/J-6553-2019; Khattar, Mithun/O-4415-2014	Chen, Wenhao/0000-0002-0626-3739; Khattar, Mithun/0000-0002-4355-4623	National Institutes of Health [5RO1AI090244]; American Heart Association [11SDG7690000]; UT-Biomedical Science Innovation Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); UT-Biomedical Science Innovation Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institutes of Health (grant number 5RO1AI090244), the American Heart Association (grant number 11SDG7690000) and the UT-Biomedical Science Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Borie DC, 2005, TRANSPLANTATION, V79, P791, DOI 10.1097/01.TP.0000157117.30290.6F; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Campara M, 2010, EXPERT OPIN BIOL TH, V10, P959, DOI 10.1517/14712598.2010.485187; Castro I, 2012, J IMMUNOL, V189, P4321, DOI 10.4049/jimmunol.1202067; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Guo ZY, 2013, J IMMUNOL, V190, P3153, DOI 10.4049/jimmunol.1200751; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Johnson LDS, 2009, SCIENCE, V324, P1525, DOI 10.1126/science.1176487; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Matarrese P, 2003, CELL DEATH DIFFER, V10, P609, DOI 10.1038/sj.cdd.4401212; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; McGuire HM, 2011, DIABETES, V60, P867, DOI 10.2337/db10-1157; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrelli A, 2011, DIABETES, V60, P3223, DOI 10.2337/db11-0880; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Quaedackers ME, 2009, TRANSPLANTATION, V88, P1002, DOI 10.1097/TP.0b013e3181b9ced7; Rojas Monica A, 2009, Ther Adv Neurol Disord, V2, P291, DOI 10.1177/1756285609337992; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stepkowski SM, 2005, J IMMUNOL, V175, P4236, DOI 10.4049/jimmunol.175.7.4236; Stepkowski SM, 2006, TRANSPLANTATION, V82, P295, DOI 10.1097/01.tp.0000228903.03118.be; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang GH, 2010, IMMUNOL LETT, V132, P61, DOI 10.1016/j.imlet.2010.06.001; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236; ZIER KS, 1984, DIABETES, V33, P552, DOI 10.2337/diabetes.33.6.552; ZURAWSKI SM, 1986, J IMMUNOL, V137, P3354; Zurgil N, 2002, BIOCHEM BIOPH RES CO, V290, P1573, DOI 10.1006/bbrc.2002.6382	56	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85882	10.1371/journal.pone.0085882	http://dx.doi.org/10.1371/journal.pone.0085882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416451	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300103
J	Liu, ZQ; Li, T; Jiang, KS; Huang, QL; Chen, YC; Qian, F				Liu, Zhiqiang; Li, Tao; Jiang, Kesheng; Huang, Qiaoli; Chen, Yicheng; Qian, Feng			Induction of Chemoresistance by All-Trans Retinoic Acid via a Noncanonical Signaling in Multiple Myeloma Cells	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; AP-ENDONUCLEASE APE1/REF-1; DRUG-RESISTANCE GENE; UP-REGULATION; GROWTH-INHIBITION; BINDING PROTEIN; DOWN-REGULATION; DNA-DAMAGE; EXPRESSION; CREB	Despite the successful application of all-trans retinoic acid (ATRA) in multiple myeloma treatment, ATRA-induced chemoresistance in the myeloma patients is very common in clinic. In this study, we evaluated the effect of ATRA on the expression of apurinic endonuclease/redox factor-1 (Ape/Ref-1) in the U266 and RPMI-8226 myeloma cells to explore the chemoresistance mechanism involved. ATRA treatment induced upregulation of Ape/Ref-1 via a noncanonical signaling pathway, leading to enhanced pro-survival activity counteracting melphalan (an alkylating agent). ATRA rapidly activated p38-MSK (mitogen- and stress activated protein kinase) cascade to phosphorylate cAMP response element-binding protein (CREB). Phosphorylated CREB was recruited to the Ape/Ref-1 promoter to evoke the gene expression. The stimulation of ATRA on Ape/Ref-1 expression was attenuated by either p38-MSK inhibitors or overexpression of dominant-negative MSK1 mutants. Moreover, ATRA-mediated Ape/Ref-1 upregulation was correlated with histone modification and activation of CBP/p300, an important cofactors for CREB transcriptional activity. C646, a competitive CBP/p300 inhibitor, abolished the upregulation of Ape/Ref-1 induced by ATRA. Intriguingly, CBP rather than p300 played a dominant role in the expression of Ape/Ref-1. Hence, our study suggests the existence of a noncanonical mechanism involving p38-MSK-CREB cascade and CBP induction to mediate ATRA-induced Ape/Ref-1 expression and acquired chemoresistance in myeloma cells.	[Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Div Canc Med, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Li, Tao; Jiang, Kesheng; Huang, Qiaoli] Zhejiang Normal Univ, Coll Chem & Life Sci, Dept Biol, Jinhua, Zhejiang, Peoples R China; [Chen, Yicheng] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Qian, Feng] Yangtze Univ, Sch Med, Dept Med Funct, Jinzhou, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Zhejiang Normal University; Zhejiang University; Yangtze University	Li, T (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Dept Biol, Jinhua, Zhejiang, Peoples R China.	litao@zjnu.cn	Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097	National Natural Sciences Foundation of China [31101057, 81101929]; Sciences Foundation of Jinhua City [2010-3-071]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Sciences Foundation of Jinhua City	This work was supported by the National Natural Sciences Foundation of China (31101057, 81101929), and the Sciences Foundation of Jinhua City (2010-3-071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Apostolatos H, 2010, J BIOL CHEM, V285, P25987, DOI 10.1074/jbc.M110.100735; BATES SE, 1989, MOL CELL BIOL, V9, P4337, DOI 10.1128/MCB.9.10.4337; Bjorklund CC, 2013, LEUKEMIA; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; Chen YH, 1999, BLOOD, V94, P251, DOI 10.1182/blood.V94.1.251.413k42_251_259; De Genaro P, 2013, INVEST OPHTH VIS SCI, V54, P3143, DOI 10.1167/iovs.12-11049; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Falco P, 2007, EXPERT REV ANTICANC, V7, P945, DOI 10.1586/14737140.7.7.945; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Friedmann Y, 2006, MOL PHARMACOL, V70, P1395, DOI 10.1124/mol.106.022962; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Giltaire S, 2009, BRIT J DERMATOL, V160, P505, DOI 10.1111/j.1365-2133.2008.08960.x; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grosch S, 1999, BIOCHEM BIOPH RES CO, V261, P859, DOI 10.1006/bbrc.1999.1125; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Huang HW, 2009, LEUKEMIA LYMPHOMA, V50, P966, DOI 10.1080/10428190902866724; Huang HW, 2009, EUR J HAEMATOL, V83, P191, DOI 10.1111/j.1600-0609.2009.01277.x; Kast RE, 2008, CANCER BIOL THER, V7, P1515, DOI 10.4161/cbt.7.10.6573; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Koskela K, 2004, LEUKEMIA LYMPHOMA, V45, P749, DOI 10.1080/10428190310001628158; Levy Y, 1996, CLIN EXP IMMUNOL, V104, P167, DOI 10.1046/j.1365-2249.1996.d01-637.x; Liu Z, 2013, ONCOGENE; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Matsushita H, 1998, BLOOD, V91, P2452, DOI 10.1182/blood.V91.7.2452.2452_2452_2458; Musto P, 1997, HAEMATOLOGICA, V82, P354; Okamura T, 1998, EXP HEMATOL, V26, P501; Oliveira AMM, 2006, BEHAV NEUROSCI, V120, P724, DOI 10.1037/0735-7044.120.3.724; Otsuki T, 2003, LEUKEMIA LYMPHOMA, V44, P1651, DOI 10.1080/1042819031000099652; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Saeki K, 2003, J LEUKOCYTE BIOL, V73, P673, DOI 10.1189/jlb.1002512; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Stromskaya TP, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-15; Tabe Y, 2006, BLOOD, V107, P1546, DOI 10.1182/blood-2004-10-4126; Tokura Y, 2002, LEUKEMIA RES, V26, P29, DOI 10.1016/S0145-2126(01)00094-7; Trocoli A, 2011, AUTOPHAGY, V7, P1108, DOI 10.4161/auto.7.10.16623; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Wong JC, 2012, J CELL BIOCHEM, V113, P3587, DOI 10.1002/jcb.24237; Xiong JJ, 2008, BIOSCI BIOTECH BIOCH, V72, P3206, DOI 10.1271/bbb.80415; Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883; Youn H, 2013, CANCER LETT, V331, P192, DOI 10.1016/j.canlet.2012.12.019; Zhang Ya-Ping, 2010, Zoological Research, V31, P1	45	8	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85571	10.1371/journal.pone.0085571	http://dx.doi.org/10.1371/journal.pone.0085571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416428	Green Submitted, gold, Green Published			2022-12-27	WOS:000329866300089
J	Gumulec, J; Raudenska, M; Adam, V; Kizek, R; Masarik, M				Gumulec, Jaromir; Raudenska, Martina; Adam, Vojtech; Kizek, Rene; Masarik, Michal			Metallothionein - Immunohistochemical Cancer Biomarker: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; KI-67 ANTIGEN-EXPRESSION; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; CLINICOPATHOLOGICAL SIGNIFICANCE; CONFERS RESISTANCE; MOLECULAR MARKERS; TUMOR PROGRESSION; BREAST CARCINOMAS; DRUG-RESISTANCE	Metallothionein (MT) has been extensively investigated as a molecular marker of various types of cancer. In spite of the fact that numerous reviews have been published in this field, no meta-analytical approach has been performed. Therefore, results of to-date immunohistochemistry-based studies were summarized using meta-analysis in this review. Web of science, PubMed, Embase and CENTRAL databases were searched (up to April 30, 2013) and the eligibility of individual studies and heterogeneity among the studies was assessed. Random and fixed effects model meta-analysis was employed depending on the heterogeneity, and publication bias was evaluated using funnel plots and Egger's tests. A total of 77 studies were included with 8,015 tissue samples (4,631 cases and 3,384 controls). A significantly positive association between MT staining and tumors (vs. healthy tissues) was observed in head and neck (odds ratio, OR 9.95; 95% CI 5.82-17.03) and ovarian tumors (OR 7.83; 1.09-56.29), and a negative association was ascertained in liver tumors (OR 0.10; 0.03-0.30). No significant associations were identified in breast, colorectal, prostate, thyroid, stomach, bladder, kidney, gallbladder, and uterine cancers and in melanoma. While no associations were identified between MT and tumor staging, a positive association was identified with the tumor grade (OR 1.58; 1.08-2.30). In particular, strong associations were observed in breast, ovarian, uterine and prostate cancers. Borderline significant association of metastatic status and MT staining were determined (OR 1.59; 1.03-2.46), particularly in esophageal cancer. Additionally, a significant association between the patient prognosis and MT staining was also demonstrated (hazard ratio 2.04; 1.47-2.81). However, a high degree of inconsistence was observed in several tumor types, including colorectal, kidney and prostate cancer. Despite the ambiguity in some tumor types, conclusive results are provided in the tumors of head and neck, ovary and liver and in relation to the tumor grade and patient survival.	[Gumulec, Jaromir; Raudenska, Martina; Masarik, Michal] Masaryk Univ, Dept Pathol Physiol, Brno, Czech Republic; [Gumulec, Jaromir; Raudenska, Martina; Adam, Vojtech; Kizek, Rene; Masarik, Michal] Brno Univ Technol, Cent European Inst Technol, CS-61090 Brno, Czech Republic; [Adam, Vojtech; Kizek, Rene] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic	Masaryk University Brno; Brno University of Technology; Mendel University in Brno	Masarik, M (corresponding author), Masaryk Univ, Dept Pathol Physiol, Brno, Czech Republic.	masarik@med.muni.cz	Raudenska, Martina/F-9187-2012; Masarik, Michal/D-9920-2012; Adam, Vojtech/D-7686-2012; Kizek, Rene/D-7748-2012; Gumulec, Jaromir/D-7638-2012	Raudenska, Martina/0000-0001-8258-6671; Masarik, Michal/0000-0003-1172-7195; Adam, Vojtech/0000-0002-8527-286X; Gumulec, Jaromir/0000-0002-9658-3444; Kizek, Rene/0000-0002-0467-6169	Central European Institute of Technology [CEITEC CZ.1.05/1.1.00/02.0068]; Internal Grant Agency of Ministry of Health of the Czech Republic [IGA MH NT14337-3/2013]	Central European Institute of Technology; Internal Grant Agency of Ministry of Health of the Czech Republic	Financial support from Central European Institute of Technology (CEITEC CZ.1.05/1.1.00/02.0068) and Internal Grant Agency of Ministry of Health of the Czech Republic (IGA MH NT14337-3/2013) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia TA, 2001, ANN THORAC SURG, V72, P859, DOI 10.1016/S0003-4975(01)02838-7; Aschner M, 1998, BRAIN RES, V813, P254, DOI 10.1016/S0006-8993(98)00947-0; Athanassiadou P, 2007, TUMORI J, V93, P189; Babula P, 2012, METALLOMICS, V4, P739, DOI 10.1039/c2mt20081c; Bay BH, 2001, ACTA HISTOCHEM CYTOC, V34, P171, DOI 10.1267/ahc.34.171; Bay BH, 2006, EXP BIOL MED, V231, P1516, DOI 10.1177/153537020623100910; BIER B, 1994, BREAST CANCER RES TR, V30, P213, DOI 10.1007/BF00665963; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Bouzourene H, 2002, CANCER-AM CANCER SOC, V95, P1003, DOI 10.1002/cncr.10780; Brown JJ, 2003, LARYNGOSCOPE, V113, P393, DOI 10.1097/00005537-200303000-00001; Bruewer M, 2002, WORLD J SURG, V26, P726, DOI 10.1007/s00268-002-6266-z; CAI L, 1995, CHEM-BIOL INTERACT, V96, P143, DOI 10.1016/0009-2797(94)03585-V; Cardoso SV, 2002, VIRCHOWS ARCH, V441, P174, DOI 10.1007/s00428-001-0588-3; Chan KYY, 2006, MODERN PATHOL, V19, P1546, DOI 10.1038/modpathol.3800674; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; CHIN JL, 1993, CANCER, V72, P3029, DOI 10.1002/1097-0142(19931115)72:10<3029::AID-CNCR2820721027>3.0.CO;2-6; Cortesi M, 2008, PROSTATE, V68, P994, DOI 10.1002/pros.20766; Costello LC, 2012, EXPERT REV ANTICANC, V12, P121, DOI [10.1586/ERA.11.190, 10.1586/era.11.190]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DouglasJones AG, 1997, VIRCHOWS ARCH, V430, P373, DOI 10.1007/s004280050046; Dumanska Malgorzata, 2004, Folia Morphol (Warsz), V63, P107; Dutsch-Wicherek M, 2013, CELL TISSUE RES, V352, P341, DOI 10.1007/s00441-013-1566-1; Dziegiel P, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P43; Dziegiel P, 2003, HISTOL HISTOPATHOL, V18, P401, DOI 10.14670/HH-18.401; Ebadi M, 1996, NEUROCHEM INT, V29, P159, DOI 10.1016/0197-0186(95)00116-6; Ebara M, 2000, J HEPATOL, V33, P415, DOI 10.1016/S0168-8278(00)80277-9; Ebert MPA, 2000, CANCER RES, V60, P1995; Eckschlager T, 2009, CURR PROTEIN PEPT SC, V10, P360, DOI 10.2174/138920309788922243; Eid H, 1998, J CANCER RES CLIN, V124, P31, DOI 10.1007/s004320050130; El Sharkarvy SL, 2008, APPL IMMUNOHISTO M M, V16, P108, DOI 10.1097/PAI.0b013e31806d9b88; El Sharkawy SL, 2006, J CLIN PATHOL, V59, P1171, DOI 10.1136/jcp.2005.033746; Endo T, 2004, J GASTROENTEROL, V39, P1196, DOI 10.1007/s00535-004-1471-1; Ferrario C, 2008, LAB INVEST, V88, P474, DOI 10.1038/labinvest.2008.17; Franklin RB, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-32; FRESNO M, 1993, VIRCHOWS ARCH A, V423, P215, DOI 10.1007/BF01614773; Fuertes MA, 2003, CHEM REV, V103, P645, DOI 10.1021/cr020010d; Galizia G, 2006, J SURG ONCOL, V93, P241, DOI 10.1002/jso.20402; Gallicchio L, 2004, TOXICOL LETT, V152, P245, DOI 10.1016/j.toxlet.2004.05.007; Germain I, 1996, INT J GYNECOL PATHOL, V15, P54, DOI 10.1097/00004347-199601000-00009; Gomulkiewicz A, 2010, FOLIA HISTOCHEM CYTO, V48, P242, DOI 10.2478/v10042-010-0011-5; GOULDING H, 1995, BRIT J CANCER, V72, P968, DOI 10.1038/bjc.1995.443; Gumulec J, 2012, NEOPLASMA, V59, P191, DOI 10.4149/neo_2012_025; Gumulec J, 2011, CURR MED CHEM, V18, P5041, DOI 10.2174/092986711797636126; HAERSLEV T, 1994, PATHOL RES PRACT, V190, P675, DOI 10.1016/S0344-0338(11)80746-6; HAERSLEV T, 1995, APMIS, V103, P279, DOI 10.1111/j.1699-0463.1995.tb01107.x; Hanada K, 1998, J INVEST DERMATOL, V111, P582, DOI 10.1046/j.1523-1747.1998.00342.x; Hellemans G, 1999, NEPHRON, V83, P331, DOI 10.1159/000045425; Hengstler JG, 2001, INT J CANCER, V95, P121, DOI 10.1002/1097-0215(20010320)95:2<121::AID-IJC1021>3.0.CO;2-N; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hishikawa Y, 1999, BRIT J CANCER, V81, P712, DOI 10.1038/sj.bjc.6690753; Hishikawa Y, 2001, ONCOLOGY-BASEL, V61, P162, DOI 10.1159/000055368; Hoey JG, 1997, TOXICOL LETT, V92, P149, DOI 10.1016/S0378-4274(97)00049-0; Huang GW, 2002, WORLD J GASTROENTERO, V8, P650, DOI 10.3748/wjg.v8.i4.650; Huang Y, 2003, INT J CANCER, V104, P735, DOI 10.1002/ijc.11006; Ioachim E, 2003, BREAST, V12, P111, DOI 10.1016/S0960-9776(02)00290-4; Ioachim E, 1999, PATHOL RES PRACT, V195, P809, DOI 10.1016/S0344-0338(99)80102-2; Ioachim EE, 1999, J CLIN PATHOL, V52, P876, DOI 10.1136/jcp.52.12.876; Ioachim EE, 2000, J PATHOL, V191, P269, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH616>3.0.CO;2-Q; Ishii K, 2001, J BIOCHEM, V129, P253, DOI 10.1093/oxfordjournals.jbchem.a002852; Iszard MB, 1995, TOXICOLOGY, V104, P25, DOI 10.1016/0300-483X(95)03118-Y; Izawa JI, 1998, UROLOGY, V52, P767, DOI 10.1016/S0090-4295(98)00323-9; Janssen AML, 2000, J PATHOL, V192, P293, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH712>3.0.CO;2-Z; Jin RX, 2004, PATHOL ONCOL RES, V10, P74, DOI 10.1007/BF02893459; Jin RX, 2002, CARCINOGENESIS, V23, P81, DOI 10.1093/carcin/23.1.81; Jin RX, 2001, BREAST CANCER RES TR, V66, P265, DOI 10.1023/A:1010658907462; Johnson LA, 2010, METHODS, V52, P316, DOI 10.1016/j.ymeth.2010.08.004; Joseph MG, 2001, CANCER, V92, P836, DOI 10.1002/1097-0142(20010815)92:4<836::AID-CNCR1390>3.0.CO;2-K; Kanda M, 2009, INT J ONCOL, V35, P477, DOI 10.3892/ijo_00000359; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; KELLEY SL, 1988, SCIENCE, V241, P1813, DOI 10.1126/science.3175622; Kondo Y, 1997, MOL PHARMACOL, V52, P195, DOI 10.1124/mol.52.2.195; Krizkova S, 2012, DRUG METAB REV, V44, P287, DOI 10.3109/03602532.2012.725414; Krolicka A, 2010, ANTICANCER RES, V30, P4945; Kubo S, 2005, BIOL PHARM BULL, V28, P1137, DOI 10.1248/bpb.28.1137; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Lee SS, 2008, ORAL ONCOL, V44, P180, DOI 10.1016/j.oraloncology.2007.01.019; Lu Dong-Dong, 2003, Yale Journal of Biology and Medicine, V76, P55; Ma HQ, 2009, LAT AM J PHARM, V28, P827; Arriaga JM, 2012, HUM PATHOL, V43, P197, DOI 10.1016/j.humpath.2011.04.015; McCluggage WG, 1999, HISTOPATHOLOGY, V34, P51; McCluggage WG, 2002, INT J GYNECOL CANCER, V12, P62, DOI 10.1046/j.1525-1438.2002.01081.x; McCluggage WG, 1998, INT J GYNECOL PATHOL, V17, P29, DOI 10.1097/00004347-199801000-00006; Meijer C, 2000, INT J CANCER, V85, P777, DOI 10.1002/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; Mitropoulos Dionisios, 2005, World J Surg Oncol, V3, P5, DOI 10.1186/1477-7819-3-5; Moussa M, 1997, CLIN INVEST MED, V20, P371; Muramatsu Y, 2000, ANTICANCER RES, V20, P257; MURPHY D, 1991, BRIT J CANCER, V63, P711, DOI 10.1038/bjc.1991.160; Nakayama A, 2002, BIOL PHARM BULL, V25, P426, DOI 10.1248/bpb.25.426; Namdarghanbari M, 2011, J BIOL INORG CHEM, V16, P1087, DOI 10.1007/s00775-011-0823-6; NARTEY N, 1987, AM J PATHOL, V129, P177; Nguyen A, 2000, CANCER LETT, V160, P133, DOI 10.1016/S0304-3835(00)00534-6; Nordberg M, 2000, CELL MOL BIOL, V46, P451; Oyama T, 1996, ONCOLOGY, V53, P112; Ozer H, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-124; Pastuszewski W, 2007, ANTICANCER RES, V27, P335; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P29, DOI 10.1016/j.proghi.2008.10.001; Perez-Gutierrez S, 2007, PATHOL ONCOL RES, V13, P203, DOI 10.1007/BF02893500; Reeve VE, 2000, IMMUNOLOGY, V100, P399, DOI 10.1046/j.1365-2567.2000.00026.x; Ryvolova M, 2012, J CHROMATOGR A, V1226, P31, DOI 10.1016/j.chroma.2011.10.015; Saika T, 1992, Nihon Hinyokika Gakkai Zasshi, V83, P636; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; SCHMID KW, 1993, VIRCHOWS ARCH A, V422, P153, DOI 10.1007/BF01607167; SCHMID KW, 1994, ENDOCR PATHOL, V5, P114, DOI 10.1007/BF02921379; SCHWARZ MA, 1995, P NATL ACAD SCI USA, V92, P4452, DOI 10.1073/pnas.92.10.4452; Sens MA, 2000, ENVIRON HEALTH PERSP, V108, P413; Shibuya K, 2008, J TOXICOL SCI, V33, P651, DOI 10.2131/jts.33.651; Shukla VK, 1998, HISTOPATHOLOGY, V33, P154, DOI 10.1046/j.1365-2559.1998.00474.x; Sochor J, 2012, INT J ELECTROCHEM SC, V7, P2136; Sugita K, 2001, AM J DERMATOPATH, V23, P29, DOI 10.1097/00000372-200102000-00005; Sunada F, 2005, WORLD J GASTROENTERO, V11, P5696, DOI 10.3748/wjg.v11.i36.5696; Sundelin K, 1997, EUR J CANCER, V33, P1860, DOI 10.1016/S0959-8049(97)00216-5; Surowiak P, 2006, BRIT J CANCER, V95, P339, DOI 10.1038/sj.bjc.6603254; Surowiak P, 2005, VIRCHOWS ARCH, V447, P626, DOI 10.1007/s00428-005-1228-0; SUZUKI T, 1992, TOHOKU J EXP MED, V166, P251, DOI 10.1620/tjem.166.251; Takahashi S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-41; Tan Y, 1999, J PATHOL, V189, P60, DOI 10.1002/(SICI)1096-9896(199909)189:1<60::AID-PATH387>3.0.CO;2-J; Tao X, 2007, HEPATOL RES, V37, P820, DOI 10.1111/j.1872-034X.2007.00113.x; Tews DS, 2000, J NEURO-ONCOL, V50, P227, DOI 10.1023/A:1006491405010; Theocharis S, 2002, HISTOPATHOLOGY, V40, P143, DOI 10.1046/j.1365-2559.2002.01325.x; Theocharis SE, 2004, HISTOPATHOLOGY, V45, P103, DOI 10.1111/j.1365-2559.2004.01922.x; Theocharis S, 2011, HISTOPATHOLOGY, V59, P514, DOI 10.1111/j.1365-2559.2011.03947.x; Thirumoorthy N, 2007, WORLD J GASTROENTERO, V13, P993, DOI 10.3748/wjg.v13.i7.993; Tsangaris GT, 1998, ANTICANCER RES, V18, P2423; Tuccari G, 2000, HISTOL HISTOPATHOL, V15, P1035, DOI 10.14670/HH-15.1035; Wei H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-7; Weinlich G, 2007, J EUR ACAD DERMATOL, V21, P669, DOI 10.1111/j.1468-3083.2006.02051.x; Weinlich G, 2006, BRIT J CANCER, V94, P835, DOI 10.1038/sj.bjc.6603028; Werynska B, 2013, EXP MOL PATHOL, V94, P301, DOI 10.1016/j.yexmp.2012.10.006; Wulfing C, 2007, WORLD J UROL, V25, P199, DOI 10.1007/s00345-006-0141-8; Yamasaki M, 2007, ONCOL REP, V18, P1145; Yamasaki Y, 2006, UROLOGY, V67, P530, DOI 10.1016/j.urology.2005.09.033; Zagorianakou N, 2006, HISTOL HISTOPATHOL, V21, P341, DOI 10.14670/HH-21.341; ZELGER B, 1993, HISTOPATHOLOGY, V23, P257, DOI 10.1111/j.1365-2559.1993.tb01198.x; Zhang Ruifen, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P95; Zhang XH, 1998, BRIT J UROL, V81, P9; Zhou XD, 2006, TOXICOL SCI, V91, P467, DOI 10.1093/toxsci/kfj174	137	65	66	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85346	10.1371/journal.pone.0085346	http://dx.doi.org/10.1371/journal.pone.0085346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416395	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500241
J	Simon, TD; Pope, CE; Browd, SR; Ojemann, JG; Riva-Cambrin, J; Mayer-Hamblett, N; Rosenfeld, M; Zerr, DM; Hoffman, L				Simon, Tamara D.; Pope, Christopher E.; Browd, Samuel R.; Ojemann, Jeffrey G.; Riva-Cambrin, Jay; Mayer-Hamblett, Nicole; Rosenfeld, Margaret; Zerr, Danielle M.; Hoffman, Lucas			Evaluation of Microbial Bacterial and Fungal Diversity in Cerebrospinal Fluid Shunt Infection	PLOS ONE			English	Article							VENTRICULOPERITONEAL SHUNTS; CLINICAL MICROBIOLOGY; CHRONIC WOUNDS; MANAGEMENT; IDENTIFICATION; HYDROCEPHALUS; BIOFILMS; PATHOGENICITY; EXPERIENCE; CHILDREN	Background: Cerebrospinal fluid shunt infection can be recalcitrant. Recurrence is common despite appropriate therapy for the pathogens identified by culture. Improved diagnostic and therapeutic approaches are required, and culture-independent molecular approaches to cerebrospinal fluid shunt infections have not been described. Objectives: To identify the bacteria and fungi present in cerebrospinal fluid from children with cerebrospinal fluid shunt infection using a high-throughput sequencing approach, and to compare those results to those from negative controls and conventional culture. Methods: This descriptive study included eight children <= 18 years old undergoing treatment for culture-identified cerebrospinal fluid shunt infection. After routine aerobic culture of each cerebrospinal fluid sample, deoxyribonucleic acid (DNA) extraction was followed by amplification of the bacterial 16S rRNA gene and the fungal ITS DNA region tag-encoded FLX-Titanium amplicon pyrosequencing and microbial phylogenetic analysis. Results: The microbiota analyses for the initial cerebrospinal fluid samples from all eight infections identified a variety of bacteria and fungi, many of which did not grow in conventional culture. Detection by conventional culture did not predict the relative abundance of an organism by pyrosequencing, but in all cases, at least one bacterial taxon was detected by both conventional culture and pyrosequencing. Individual bacterial species fluctuated in relative abundance but remained above the limits of detection during infection treatment. Conclusions: Numerous bacterial and fungal organisms were detected in these cerebrospinal fluid shunt infections, even during and after treatment, indicating diverse and recalcitrant shunt microbiota. In evaluating cerebrospinal fluid shunt infection, fungal and anaerobic bacterial cultures should be considered in addition to aerobic bacterial cultures, and culture-independent approaches offer a promising alternative diagnostic approach. More effective treatment of cerebrospinal fluid shunt infections is needed to reduce unacceptably high rates of reinfection, and this work suggests that one effective strategy may be reduction of the diverse microbiota present in infection.	[Simon, Tamara D.; Pope, Christopher E.; Mayer-Hamblett, Nicole; Rosenfeld, Margaret; Zerr, Danielle M.; Hoffman, Lucas] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Simon, Tamara D.; Mayer-Hamblett, Nicole; Rosenfeld, Margaret; Zerr, Danielle M.; Hoffman, Lucas] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA; [Browd, Samuel R.; Ojemann, Jeffrey G.] Univ Washington, Dept Neurol Surg, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Riva-Cambrin, Jay] Univ Utah, Primary Childrens Med Ctr, Div Pediat Neurosurg, Dept Neurosurg, Salt Lake City, UT USA; [Hoffman, Lucas] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Hoffman, Lucas] Seattle Childrens Res Inst, Ctr Infect & Prematur Res, Seattle, WA USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Simon, TD (corresponding author), Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA.	Tamara.Simon@seattlechildrens.org	Hoffman, Lucas/AAX-1853-2021	Rosenfeld, Margaret/0000-0002-8105-614X; Ojemann, Jeffrey/0000-0001-7580-8934	Seattle Children's Center for Clinical and Translational Research; CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [ULI RR025014]; STARS-kids; Clinical and Translational Science Award (CTSA) pilot funds at the University of Utah; CTSA from the NCRR [ULI RR025014]; National Institute of Neurological Disorders And Stroke [K23NS062900]; Children's Hospital Association via the Pediatric Research in Inpatient Setting Network Executive Council; NIH [1R01HL098084, 1K02HL105543]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL105543, R01HL098084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS062900] Funding Source: NIH RePORTER	Seattle Children's Center for Clinical and Translational Research; CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); STARS-kids; Clinical and Translational Science Award (CTSA) pilot funds at the University of Utah; CTSA from the NCRR; National Institute of Neurological Disorders And Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Children's Hospital Association via the Pediatric Research in Inpatient Setting Network Executive Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This publication was supported by Seattle Children's Center for Clinical and Translational Research, and CTSA Grant Number ULI RR025014 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). Collection of CSF specimens from patients was supported by STARS-kids, Clinical and Translational Science Award (CTSA) pilot funds at the University of Utah, Seattle Children's Center for Clinical and Translational Research, and CTSA Grant Number ULI RR025014 from the NCRR. TDS is supported by Award K23NS062900 from the National Institute of Neurological Disorders And Stroke, the Children's Hospital Association via the Pediatric Research in Inpatient Setting Network Executive Council, and Seattle Children's Center for Clinical and Translational Research. LH is supported by NIH grants 1R01HL098084 and 1K02HL105543. None of the sponsors participated in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or NIH.	Bayston R, 2012, ANTIMICROB AGENTS CH, V56, P2842, DOI 10.1128/AAC.06326-11; CHIOU CC, 1994, CLIN INFECT DIS, V19, P1049, DOI 10.1093/clinids/19.6.1049; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; FANHAVARD P, 1987, CLIN PHARMACY, V6, P866; Fux CA, 2006, CLIN MICROBIOL INFEC, V12, P331, DOI 10.1111/j.1469-0691.2006.01361.x; Gardner P, 1988, Curr Clin Top Infect Dis, V9, P185; GARDNER P, 1985, MED CLIN N AM, V69, P297; GUEVARA JA, 1987, J NEUROSURG, V67, P438, DOI 10.3171/jns.1987.67.3.0438; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; He ZG, 2007, APPL ENVIRON MICROB, V73, P168, DOI 10.1128/AEM.02023-06; Kanev PM, 2003, PEDIATR NEUROSURG, V39, P285, DOI 10.1159/000075255; Kestle JRW, 2006, J NEUROSURG, V105, P177, DOI 10.3171/ped.2006.105.3.177; Kestle JRW, 2003, NEUROL CLIN, V21, P883, DOI 10.1016/S0733-8619(03)00016-1; Kulkarni AV, 2001, PEDIATR NEUROSURG, V35, P66, DOI 10.1159/000050393; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; MORISSETTE I, 1993, CAN J NEUROL SCI, V20, P118, DOI 10.1017/S0317167100047661; NELSON JD, 1984, PEDIATR INFECT DIS J, V3, pS30, DOI 10.1097/00006454-198405001-00011; ODIO C, 1984, AM J DIS CHILD, V138, P1103, DOI 10.1001/archpedi.1984.02140500009004; Rhoads DD, 2012, INT J MOL SCI, V13, P2535, DOI 10.3390/ijms13032535; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; SELLS CJ, 1977, PEDIATRICS, V59, P614; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Tuan TJ, 2011, PEDIATR INFECT DIS J, V30, P731, DOI 10.1097/INF.0b013e318218ac0e; Venes J L, 1989, Infect Dis Clin North Am, V3, P289; Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8; WALTERS BC, 1984, J NEUROSURG, V60, P1014, DOI 10.3171/jns.1984.60.5.1014; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548	32	8	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83229	10.1371/journal.pone.0083229	http://dx.doi.org/10.1371/journal.pone.0083229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421877	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500037
J	Willemoes, M; Strandberg, R; Klaassen, RHG; Tottrup, AP; Vardanis, Y; Howey, PW; Thorup, K; Wikelski, M; Alerstam, T				Willemoes, Mikkel; Strandberg, Roine; Klaassen, Raymond H. G.; Tottrup, Anders P.; Vardanis, Yannis; Howey, Paul W.; Thorup, Kasper; Wikelski, Martin; Alerstam, Thomas			Narrow-Front Loop Migration in a Population of the Common Cuckoo Cuculus canorus, as Revealed by Satellite Telemetry	PLOS ONE			English	Article							ORIENTATION SYSTEM; RING RECOVERIES; BIRDS; NAVIGATION; TRACKING; MODEL; SONGBIRDS; PATTERNS; MIGRANTS; OSPREYS	Narrow migration corridors known in diurnal, social migrants such as raptors, storks and geese are thought to be caused by topographical leading line effects in combination with learning detailed routes across generations. Here, we document narrow-front migration in a nocturnal, solitary migrant, the common cuckoo Cuculus canorus, using satellite telemetry. We tracked the migration of adult cuckoos from the breeding grounds in southern Scandinavia (n = 8), to wintering sites in south-western Central Africa (n = 6) and back to the breeding grounds (n = 3). Migration patterns were very complex; in addition to the breeding and wintering sites, six different stopover sites were identified during the 16,000 km annual route that formed a large-scale clockwise loop. Despite this complexity, individuals showed surprisingly similar migration patterns, with very little variation between routes. We compared observed tracks with simulated routes based on vector orientation (with and without effects of barriers on orientation and survival). Observed distances between routes were often significantly smaller than expected if the routes were established on the basis of an innate vector orientation programme. Average distance between individuals in eastern Sahel after having migrated more than 5,000 km for example, was merely 164 km. This implies that more sophisticated inherent guiding mechanisms, possibly involving elements of intermediate goal area navigation or more elaborate external cues, are necessary to explain the complex narrow-front migration pattern observed for the cuckoos in this study.	[Willemoes, Mikkel; Tottrup, Anders P.; Thorup, Kasper] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Strandberg, Roine; Klaassen, Raymond H. G.; Vardanis, Yannis; Alerstam, Thomas] Lund Univ, Dept Biol, Lund, Sweden; [Klaassen, Raymond H. G.] Univ Groningen, Dutch Montagus Harrier Fdn, Groningen, Netherlands; [Klaassen, Raymond H. G.] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Howey, Paul W.] Microwave Telemetry Inc, Columbia, MD USA; [Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany	University of Copenhagen; Lund University; University of Groningen; University of Groningen; Max Planck Society; University of Konstanz	Willemoes, M (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	mwkristensen@snm.ku.dk	Willemoes, Mikkel/J-9391-2012; Klaassen, Raymond/K-3027-2013; Tøttrup, Anders P/N-3836-2013; Thorup, Kasper/A-4835-2013	Willemoes, Mikkel/0000-0001-9363-6304; Tøttrup, Anders P/0000-0001-8776-9629; Thorup, Kasper/0000-0002-0320-0601	Danish National Research Foundation; Swedish Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by the Danish National Research Foundation http://dg.dk/en/and Swedish Research Council http://www.vr.se/inenglish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2009, CIRCSTATS CIRCULAR S; Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 2000, EXPTL BIOL REV, P105; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; [Anonymous], 2008, SVENSK RINGMARKNINGS; Argos, 2011, ARG US MAN; Berthold P., 2001, BIRD MIGRATION; Berthold P, 1996, CONTROL BIRD MIGRATI; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; BTO, 2012, TRACK CUCK AFR BACK; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Cramp S., 1985, HDB BIRDS EUROPE MID; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; ESRI, 2011, ARCGIS; Essen Lv, 1982, AQUILA, V89, P103; Fisher N., 1995, STAT ANAL CIRCULAR D; Fransson T, 2005, J AVIAN BIOL, V36, P6, DOI 10.1111/j.0908-8857.2005.03471.x; Fransson T, 2008, SVENSK RINGMARKNINGS, V2; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Hijmans RJ, 2012, GEOSPHERE SPHERICAL; Julliard R, 2006, IBIS, V148, P735, DOI 10.1111/j.1474-919X.2006.00573.x; Lewin-Koh N.J., 2012, MAPTOOLS TOOLS READI; Telleria JL, 2009, BIRD CONSERV INT, V19, P131, DOI 10.1017/S0959270908008137; Mellone U, 2011, J AVIAN BIOL, V42, P468, DOI 10.1111/j.1600-048X.2011.05454.x; Microwave Telemetry Inc, 2005, MICR TEL INC NEWSL; Moreau R. E., 1961, Ibis, V103a, P373, DOI 10.1111/j.1474-919X.1961.tb02454.x; Moreau R. E., 1972, PALEARCTIC AFRICAN B; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 1998, ANIM BEHAV, V56, P899, DOI 10.1006/anbe.1998.0826; Pebesma E.I., 2005, CLASSES METHODS SPAT, V5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RABOL J, 1978, OIKOS, V30, P216, DOI 10.2307/3543481; Rahbek, 2006, DANSK TRAEKFUGLEATLA; Rappe A, 1965, AVES, V2, P27; Royal Society for the Protection of Birds, 2009, HUNT DANG ON WORLDS; Schuz E., 1951, HORSTADIUS SEDITOR, P249; SEEL DC, 1977, IBIS, V119, P309, DOI 10.1111/j.1474-919X.1977.tb08250.x; STERBETZ I, 1968, Vogelwarte, V24, P266; Strandberg R, 2009, P ROY SOC B-BIOL SCI, V276, P727, DOI 10.1098/rspb.2008.1202; Thorup K, 2003, OIKOS, V103, P350, DOI 10.1034/j.1600-0706.2003.12163.x; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x; Thorup Kasper, 2000, Animal Behaviour Forum, V60, pF3; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; WALLRAFF HG, 1978, OIKOS, V30, P401, DOI 10.2307/3543490; Wiltschko R, 2001, ANIM BEHAV, V62, P245, DOI 10.1006/anbe.2001.1751	48	65	67	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83515	10.1371/journal.pone.0083515	http://dx.doi.org/10.1371/journal.pone.0083515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421890	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500053
J	Boddaert, J; Cohen-Bittan, J; Khiami, F; Le Manach, Y; Raux, M; Beinis, JY; Verny, M; Riou, B				Boddaert, Jacques; Cohen-Bittan, Judith; Khiami, Frederic; Le Manach, Yannick; Raux, Mathieu; Beinis, Jean-Yves; Verny, Marc; Riou, Bruno			Postoperative Admission to a Dedicated Geriatric Unit Decreases Mortality in Elderly Patients with Hip Fracture	PLOS ONE			English	Article							WORLDWIDE PREVALENCE; EXCESS MORTALITY; CONTROLLED-TRIAL; CLINICAL-TRIAL; OLDER PATIENTS; RISK; OUTCOMES; IMPACT; HOSPITALIZATION; INTERVENTION	Background: Elderly patients with hip fracture have a 5 to 8 fold increased risk of death during the months following surgery. We tested the hypothesis that early geriatric management of these patients focused on co-morbidities and rehabilitation improved long term mortality. Methods and Findings: In a cohort study over a 6 year period, we compared patients aged >70 years with hip fracture admitted to orthopedic versus geriatric departments in a time series analysis corresponding to the creation of a dedicated geriatric unit. Co-morbidities were assessed using the Cumulative Illness Rating Scale (CIRS). Each cohort was compared to matched cohorts extracted from a national registry (n = 51,275) to validate the observed results. Main outcome measure was 6-month mortality. We included 131 patients in the orthopedic cohort and 203 in the geriatric cohort. Co-morbidities were more frequent in the geriatric cohort (median CIRS: 8 vs 5, P<0.001). In the geriatric cohort, the proportion of patients who never walked again decreased (6% versus 22%, P<0.001). At 6 months, re-admission (14% versus 29%, P = 0.007) and mortality (15% versus 24%, P = 0.04) were decreased. When co-morbidities were taken into account, the risk ratio of death at 6 months was reduced (0.43, 95% CI 0.25 to 0.73, P = 0.002). Using matched cohorts, the average treatment effects on the treated associated to early geriatric management indicated a reduction in hospital mortality (263%; 95% CI: 292% to 26%, P = 0.006). Conclusions: Early admission to a dedicated geriatric unit improved 6-month mortality and morbidity in elderly patients with hip fracture.	[Boddaert, Jacques; Cohen-Bittan, Judith; Raux, Mathieu; Verny, Marc; Riou, Bruno] Univ Paris 06, UMRS 956, UMRS 1158, Paris, France; [Boddaert, Jacques; Verny, Marc] Grp Hosp GH Pitie Salpetriere, AP HP, Dept Geriatr, Paris, France; [Khiami, Frederic] GH Pitie Salpetriere, AP HP, Dept Orthoped Surg & Trauma, Paris, France; [Le Manach, Yannick] McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Anesthesia, Hamilton, ON, Canada; [Le Manach, Yannick] McMaster Univ, Dept Clin Epidemiol & Biostat, Michael DeGroote Sch Med, Fac Hlth Sci, Hamilton, ON, Canada; [Raux, Mathieu] GH Pitie Salpetriere, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Beinis, Jean-Yves] Grp Hosp Charles Foix, AP HP, Dept Rehabil, Ivry, France; [Riou, Bruno] GH Pitie Salpetriere, AP HP, Dept Emergency Med & Surg, Paris, France; [Raux, Mathieu; Riou, Bruno] INSERM, UMRS 956, UMRS 1158, UMR 689, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; McMaster University; McMaster University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Boddaert, J (corresponding author), Univ Paris 06, UMRS 956, UMRS 1158, Paris, France.	jacques.boddaert@psl.aphp.fr	Le Manach, Yannick/AAE-5700-2019	Le Manach, Yannick/0000-0003-0474-8545; Verny, Marc/0000-0001-7960-9705; RAUX, Mathieu/0000-0003-2493-9146				Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Adunsky A, 2003, J GERONTOL A-BIOL, V58, P542; Agence Nationale de Securite du Medicament (ANSM), 2002, REC TRANSF GLOB ROUG; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bass E, 2007, ANN EPIDEMIOL, V17, P514, DOI 10.1016/j.annepidem.2006.12.004; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; BERGSTROM N, 1987, NURS CLIN N AM, V22, P417; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cram P, 2011, JAMA-J AM MED ASSOC, V305, P1560, DOI 10.1001/jama.2011.478; Endo Y, 2005, J ORTHOP TRAUMA, V19, P29, DOI 10.1097/00005131-200501000-00006; Fisher AA, 2006, J ORTHOP TRAUMA, V20, P172, DOI 10.1097/01.bot.0000202220.88855.16; Friedman SM, 2009, ARCH INTERN MED, V169, P1712, DOI 10.1001/archinternmed.2009.321; GILCHRIST WJ, 1988, BRIT MED J, V297, P1116, DOI 10.1136/bmj.297.6656.1116; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Johnell O, 2004, OSTEOPOROSIS INT, V15, P897, DOI 10.1007/s00198-004-1627-0; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kammerlander C, 2010, OSTEOPOROSIS INT, V21, pS637, DOI 10.1007/s00198-010-1396-x; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; KENNIE DC, 1988, BRIT MED J, V297, P1083, DOI 10.1136/bmj.297.6656.1083; Koval KJ, 2004, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000132266.59787.d2; Leung AHC, 2011, J TRAUMA, V71, P1390, DOI 10.1097/TA.0b013e31821f7e60; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; MYERS AH, 1991, AM J EPIDEMIOL, V134, P1128, DOI 10.1093/oxfordjournals.aje.a116016; Naglie G, 2002, CAN MED ASSOC J, V167, P25; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Penrod JD, 2008, J GERONTOL A-BIOL, V63, P867, DOI 10.1093/gerona/63.8.867; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rapp K, 2008, J BONE MINER RES, V23, P1825, DOI 10.1359/JBMR.080702; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Vidan MT, 2011, ANN INTERN MED, V155, P226, DOI 10.7326/0003-4819-155-4-201108160-00006	37	107	110	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83795	10.1371/journal.pone.0083795	http://dx.doi.org/10.1371/journal.pone.0083795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454708	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100012
J	Espinosa, O; Mitsopoulos, K; Hakas, J; Pearl, F; Zvelebil, M				Espinosa, Octavio; Mitsopoulos, Konstantinos; Hakas, Jarle; Pearl, Frances; Zvelebil, Marketa			Deriving a Mutation Index of Carcinogenicity Using Protein Structure and Protein Interfaces	PLOS ONE			English	Article							SOMATIC MUTATIONS; FUNCTIONAL CONSEQUENCES; MISSENSE VARIANTS; HOT-SPOTS; CANCER; PREDICTION; POLYMORPHISMS; BRCA1; RESIDUES; PATHWAY	With the advent of Next Generation Sequencing the identification of mutations in the genomes of healthy and diseased tissues has become commonplace. While much progress has been made to elucidate the aetiology of disease processes in cancer, the contributions to disease that many individual mutations make remain to be characterised and their downstream consequences on cancer phenotypes remain to be understood. Missense mutations commonly occur in cancers and their consequences remain challenging to predict. However, this knowledge is becoming more vital, for both assessing disease progression and for stratifying drug treatment regimes. Coupled with structural data, comprehensive genomic databases of mutations such as the 1000 Genomes project and COSMIC give an opportunity to investigate general principles of how cancer mutations disrupt proteins and their interactions at the molecular and network level. We describe a comprehensive comparison of cancer and neutral missense mutations; by combining features derived from structural and interface properties we have developed a carcinogenicity predictor, InCa (Index of Carcinogenicity). Upon comparison with other methods, we observe that InCa can predict mutations that might not be detected by other methods. We also discuss general limitations shared by all predictors that attempt to predict driver mutations and discuss how this could impact high-throughput predictions. A web interface to a server implementation is publicly available at http://inca.icr.ac.uk/.	[Espinosa, Octavio; Mitsopoulos, Konstantinos; Hakas, Jarle; Zvelebil, Marketa] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Pearl, Frances] Inst Canc Res, UK Canc Therapeut Unit, London SW3 6JB, England; [Pearl, Frances] Univ Sussex, Sch Life Sci, Translat Drug Discovery Grp, Brighton, E Sussex, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Sussex	Zvelebil, M (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Marketa.Zvelebil@icr.ac.uk		Zvelebil, Marketa/0000-0001-8018-5591; Mitsopoulos, Costas/0000-0002-9116-5921; Pearl, Frances/0000-0002-8210-4393	Breakthrough Breast Cancer, UK; Daphne Jackson Fellowship; UK Medical Research Council	Breakthrough Breast Cancer, UK; Daphne Jackson Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Breakthrough Breast Cancer, UK (http://www.breakthrough.org.uk/). FP was supported by a Daphne Jackson Fellowship and the UK Medical Research Council. The funders provided the funding for the authors and the materials required for the investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anne TM, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/179351; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Boutselakis H, 2003, NUCLEIC ACIDS RES, V31, P458, DOI 10.1093/nar/gkg065; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Carlsson J, 2009, FEBS J, V276, P4142, DOI 10.1111/j.1742-4658.2009.07124.x; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492; Chao EC, 2008, HUM MUTAT, V29, P852, DOI 10.1002/humu.20735; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; Custodio A, 2012, J CANCER RES CLIN, V138, P867, DOI 10.1007/s00432-012-1161-y; Damm F, 2012, LEUKEMIA, V26, P2027, DOI 10.1038/leu.2012.86; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frederic MY, 2009, HUM MUTAT, V30, P952, DOI 10.1002/humu.20970; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurst JM, 2009, HUM MUTAT, V30, P616, DOI 10.1002/humu.20898; Izarzugaza JMG, 2009, PROTEINS, V77, P892, DOI 10.1002/prot.22512; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morris JR, 2002, J BIOL CHEM, V277, P9382, DOI 10.1074/jbc.M109249200; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pal A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-103; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Sims D, 2010, BREAST CANCER RES TR, V124, P567, DOI 10.1007/s10549-010-0945-5; Srivastava P, 2012, ARCH MED RES, V43, P117, DOI 10.1016/j.arcmed.2012.02.006; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Talavera D, 2010, PROTEINS, V78, P518, DOI 10.1002/prot.22574; Velankar S, 2011, ACTA CRYSTALLOGR D, V67, P324, DOI 10.1107/S090744491004117X; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang X, 2012, NAT BIOTECHNOL; Wang XP, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-25; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999	67	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84598	10.1371/journal.pone.0084598	http://dx.doi.org/10.1371/journal.pone.0084598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454733	Green Published, Green Accepted, gold			2022-12-27	WOS:000330235100027
J	Klein, D; Rotarska-Jagiela, A; Genc, E; Sritharan, S; Mohr, H; Roux, F; Han, CE; Kaiser, M; Singer, W; Uhlhaas, PJ				Klein, Daniel; Rotarska-Jagiela, Anna; Genc, Erhan; Sritharan, Sharmili; Mohr, Harald; Roux, Frederic; Han, Cheol E.; Kaiser, Marcus; Singer, Wolf; Uhlhaas, Peter J.			Adolescent Brain Maturation and Cortical Folding: Evidence for Reductions in Gyrification	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; NEURAL SYNCHRONY; SCHIZOPHRENIA; THICKNESS; CHILDHOOD; NETWORKS; VOLUME; AREA; ASSOCIATION	Evidence from anatomical and functional imaging studies have highlighted major modifications of cortical circuits during adolescence. These include reductions of gray matter (GM), increases in the myelination of cortico-cortical connections and changes in the architecture of large-scale cortical networks. It is currently unclear, however, how the ongoing developmental processes impact upon the folding of the cerebral cortex and how changes in gyrification relate to maturation of GM/WM-volume, thickness and surface area. In the current study, we acquired high-resolution (3 Tesla) magnetic resonance imaging (MRI) data from 79 healthy subjects (34 males and 45 females) between the ages of 12 and 23 years and performed whole brain analysis of cortical folding patterns with the gyrification index (GI). In addition to GI-values, we obtained estimates of cortical thickness, surface area, GM and white matter (WM) volume which permitted correlations with changes in gyrification. Our data show pronounced and widespread reductions in GI-values during adolescence in several cortical regions which include precentral, temporal and frontal areas. Decreases in gyrification overlap only partially with changes in the thickness, volume and surface of GM and were characterized overall by a linear developmental trajectory. Our data suggest that the observed reductions in GI-values represent an additional, important modification of the cerebral cortex during late brain maturation which may be related to cognitive development.	[Klein, Daniel; Rotarska-Jagiela, Anna; Genc, Erhan; Sritharan, Sharmili; Roux, Frederic; Singer, Wolf; Uhlhaas, Peter J.] Max Planck Inst Brain Res, Dept Neurophysiol, Frankfurt, Germany; [Klein, Daniel; Genc, Erhan; Sritharan, Sharmili; Roux, Frederic; Singer, Wolf; Uhlhaas, Peter J.] Max Planck Gesell, Ernst Strungmann Inst ESI Neurosci Cooperat, Frankfurt, Germany; [Mohr, Harald] Goethe Univ Frankfurt, Inst Psychol, Dept Neurocognit Psychol, D-60054 Frankfurt, Germany; [Mohr, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60054 Frankfurt, Germany; [Han, Cheol E.; Kaiser, Marcus] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Kaiser, Marcus] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kaiser, Marcus] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Singer, Wolf] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany; [Uhlhaas, Peter J.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Max Planck Society; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt; Seoul National University (SNU); Newcastle University - UK; Newcastle University - UK; Goethe University Frankfurt; University of Glasgow	Uhlhaas, PJ (corresponding author), Max Planck Inst Brain Res, Dept Neurophysiol, Frankfurt, Germany.	peter.uhlhaas@glasgow.ac.uk	Genc, Erhan/T-9376-2018; Singer, Wolf/D-6874-2012; /AAG-3051-2020; Kaiser, Marcus/A-7166-2008; ROUX, FREDERIC/B-7436-2019	Genc, Erhan/0000-0001-6514-5479; Kaiser, Marcus/0000-0002-4654-3110; Han, Cheol/0000-0002-9994-6861; ROUX, FREDERIC/0000-0001-8854-8879	Max Planck Society; National Research Foundation of Korea; Ministry of Education, Science and Technology [R32-10142]; EPSRC [EP/K026992/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K026992/1] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Max Planck Society (P. J. Uhlhaas) and by National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R32-10142, C. E. Han). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; Blakemore SJ, 2008, Q J EXP PSYCHOL, V61, P40, DOI 10.1080/17470210701508715; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Farmer SF, 2007, J PHYSIOL-LONDON, V579, P389, DOI 10.1113/jphysiol.2006.123174; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Galvan A, 2012, DEV COGN NEUROS-NETH, V2, P293, DOI 10.1016/j.dcn.2012.02.002; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Garvey MA, 2003, CLIN NEUROPHYSIOL, V114, P1662, DOI 10.1016/S1388-2457(03)00130-5; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Giedd JN, 1999, BIOL PSYCHIAT, V46, P892, DOI 10.1016/S0006-3223(99)00072-4; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Harris JM, 2004, BIOL PSYCHIAT, V56, P182, DOI 10.1016/j.biopsych.2004.04.007; Hogstrom LJ, 2012, CEREB CORTEX; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; Jou RJ, 2010, J CHILD NEUROL, V25, P1462, DOI 10.1177/0883073810368311; Joyner AH, 2009, P NATL ACAD SCI USA, V106, P15483, DOI 10.1073/pnas.0901866106; Kippenhan JS, 2005, J NEUROSCI, V25, P7840, DOI 10.1523/JNEUROSCI.1722-05.2005; Kulynych JJ, 1997, BIOL PSYCHIAT, V41, P995, DOI 10.1016/S0006-3223(96)00292-2; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Luders E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00034; Mutlu AK, 2013, NEUROIMAGE, V82, P200, DOI 10.1016/j.neuroimage.2013.05.076; Palaniyappan L, 2013, JAMA PSYCHIAT, V70, P1031, DOI 10.1001/jamapsychiatry.2013.203; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Palaniyappan L, 2011, BIOL PSYCHIAT, V69, P974, DOI 10.1016/j.biopsych.2010.12.012; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus Tomas, 2008, Nat Rev Neurosci, V9, P947, DOI 10.1038/nrn2513; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Petermann F, 2010, HAWIK 4; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Ramsden S, 2011, NATURE, V479, P113, DOI 10.1038/nature10514; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; Rogers J, 2010, NEUROIMAGE, V53, P1103, DOI 10.1016/j.neuroimage.2010.02.020; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Schaer M, 2009, DEV MED CHILD NEUROL, V51, P746, DOI 10.1111/j.1469-8749.2009.03281.x; Su S, 2013, HUM BRAIN MAPP, V34, P1230, DOI 10.1002/hbm.21510; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tewes U., 1994, HAWIE R HAMBURG WECH; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vogeley K, 2000, AM J PSYCHIAT, V157, P34, DOI 10.1176/ajp.157.1.34; Werkle-Bergner M, 2009, CLIN NEUROPHYSIOL, V120, P1291, DOI 10.1016/j.clinph.2009.04.012; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	65	73	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84914	10.1371/journal.pone.0084914	http://dx.doi.org/10.1371/journal.pone.0084914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454765	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000330235100042
J	McKinnon, LR; Hughes, SM; De Rosa, SC; Martinson, JA; Plants, J; Brady, KE; Gumbi, PP; Adams, DJ; Vojtech, L; Galloway, CG; Fialkow, M; Lentz, G; Gao, DY; Shu, ZQ; Nyanga, B; Izulla, P; Kimani, J; Kimwaki, S; Bere, A; Moodie, Z; Landay, AL; Passmore, JAS; Kaul, R; Novak, RM; McElrath, MJ; Hladik, F				McKinnon, Lyle R.; Hughes, Sean M.; De Rosa, Stephen C.; Martinson, Jeffrey A.; Plants, Jill; Brady, Kirsten E.; Gumbi, Pamela P.; Adams, Devin J.; Vojtech, Lucia; Galloway, Christine G.; Fialkow, Michael; Lentz, Gretchen; Gao, Dayong; Shu, Zhiquan; Nyanga, Billy; Izulla, Preston; Kimani, Joshua; Kimwaki, Steve; Bere, Alfred; Moodie, Zoe; Landay, Alan L.; Passmore, Jo-Ann S.; Kaul, Rupert; Novak, Richard M.; McElrath, M. Juliana; Hladik, Florian			Optimizing Viable Leukocyte Sampling from the Female Genital Tract for Clinical Trials: An International Multi-Site Study	PLOS ONE			English	Article							T-CELL SUBSET; HIV-1 VACCINE; INTEGRIN ALPHA(4)BETA(7); ORAL TENOFOVIR; INFECTION; IMMUNITY; MICROBICIDES; ENVELOPE; DEFINES; MARKERS	Background: Functional analysis of mononuclear leukocytes in the female genital mucosa is essential for understanding the immunologic effects of HIV vaccines and microbicides at the site of HIV exposure. However, the best female genital tract sampling technique is unclear. Methods and Findings: We enrolled women from four sites in Africa and the US to compare three genital leukocyte sampling methods: cervicovaginal lavages (CVL), endocervical cytobrushes, and ectocervical biopsies. Absolute yields of mononuclear leukocyte subpopulations were determined by flow cytometric bead-based cell counting. Of the non-invasive sampling types, two combined sequential cytobrushes yielded significantly more viable mononuclear leukocytes than a CVL (p<0.0001). In a subsequent comparison, two cytobrushes yielded as many leukocytes (similar to 10,000) as one biopsy, with macrophages/monocytes being more prominent in cytobrushes and T lymphocytes in biopsies. Sample yields were consistent between sites. In a subgroup analysis, we observed significant reproducibility between replicate same-day biopsies (r = 0.89, p = 0.0123). Visible red blood cells in cytobrushes increased leukocyte yields more than three-fold (p = 0.0078), but did not change their subpopulation profile, indicating that these leukocytes were still largely derived from the mucosa and not peripheral blood. We also confirmed that many CD4(+) T cells in the female genital tract express the alpha 4 beta 7 integrin, an HIV envelope-binding mucosal homing receptor. Conclusions: CVL sampling recovered the lowest number of viable mononuclear leukocytes. Two cervical cytobrushes yielded comparable total numbers of viable leukocytes to one biopsy, but cytobrushes and biopsies were biased toward macrophages and T lymphocytes, respectively. Our study also established the feasibility of obtaining consistent flow cytometric analyses of isolated genital cells from four study sites in the US and Africa. These data represent an important step towards implementing mucosal cell sampling in international clinical trials of HIV prevention.	[McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [McKinnon, Lyle R.; Nyanga, Billy; Izulla, Preston; Kimani, Joshua; Kimwaki, Steve; Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Hughes, Sean M.; Vojtech, Lucia; Fialkow, Michael; Lentz, Gretchen; Hladik, Florian] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Martinson, Jeffrey A.; Plants, Jill; Brady, Kirsten E.; Landay, Alan L.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Gumbi, Pamela P.; Bere, Alfred; Passmore, Jo-Ann S.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [De Rosa, Stephen C.; Adams, Devin J.; Galloway, Christine G.; Moodie, Zoe; McElrath, M. Juliana; Hladik, Florian] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Gao, Dayong; Shu, Zhiquan] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [Passmore, Jo-Ann S.] Natl Hlth Lab Serv, Cape Town, South Africa; [Kaul, Rupert] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Novak, Richard M.] Univ Illinois, Coll Med, Chicago, IL USA; [McElrath, M. Juliana; Hladik, Florian] Univ Washington, Dept Med, Seattle, WA USA; [De Rosa, Stephen C.; McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Toronto; University of Nairobi; University of Washington; University of Washington Seattle; Rush University; University of Cape Town; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hladik, F (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.	fhladik@fhcrc.org	Hladik, Florian/AAR-8852-2021; Hladik, Florian/G-1041-2012	Hladik, Florian/0000-0002-0375-2764; Hladik, Florian/0000-0002-0375-2764; Kaul, Rupert/0000-0002-1586-4093; Hughes, Sean/0000-0002-9409-9405; Vojtech, Lucia/0000-0003-2343-0719; Lindley, Jill/0000-0001-8218-359X; Shu, Zhiquan/0000-0002-9261-5832; McKinnon, Lyle/0000-0002-7157-0700	Mucosal Immunology Group; supplement to the HIV Vaccine Trials Network (HVTN) grant, an HIV/AIDS clinical trials network; National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health [UM1AI068618]; NIAID [UM1AI068636]; Canadian Institutes of Health Research [MOP-89983]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068636, U01AI068635, UM1AI068636, UM1AI068635, UM1AI068618, U01AI068618] Funding Source: NIH RePORTER	Mucosal Immunology Group; supplement to the HIV Vaccine Trials Network (HVTN) grant, an HIV/AIDS clinical trials network; National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funds received through the Mucosal Immunology Group (http://public.hivmucosalgroup.org), a group funded by a supplement to the HIV Vaccine Trials Network (HVTN) grant, an HIV/AIDS clinical trials network funded by the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (UM1AI068618); by UM1AI068636 (AIDS Clinical Trials Group Network) funded by NIAID; and by MOP-89983 funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burgener A, 2013, J VIROL, V87, P5141, DOI 10.1128/JVI.03347-12; Burgers WA, 2012, AIDS RES HUM RETROV, V28, P641, DOI [10.1089/aid.2011.0239, 10.1089/AID.2011.0239]; Chandra N, 2013, AIDS RES HUM RETROV, V29, P592, DOI 10.1089/aid.2012.0271; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cohen J, 2013, SCIENCE, V340, P667, DOI 10.1126/science.340.6133.667; Gisselquist D, 2012, LANCET INFECT DIS, V12, P510, DOI [10.1016/S1473-3099(12)70115-9, 10.1016/S1473-3099(12)70153-6]; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Hasselrot K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047570; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Hladik F, 1999, J IMMUNOL, V163, P2306; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Jespers V, 2013, SEX TRANSM DIS, V40, P729, DOI 10.1097/01.olq.0000431070.38601.03; Kyongo JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043951; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Louissaint NA, 2012, J INFECT DIS, V205, P725, DOI 10.1093/infdis/jir841; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Quayle AJ, 2004, AIDS RES HUM RETROV, V20, P543, DOI 10.1089/088922204323087796; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, AIDS RES HUM RETROV, V28, P400, DOI [10.1089/aid.2011.0240, 10.1089/AID.2011.0240]; Saba E, 2013, MUCOSAL IMMUNOL, V6, P1081, DOI 10.1038/mi.2013.2; Sabbaj S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028894; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Trimble CL, 2010, J IMMUNOL, V185, P7107, DOI 10.4049/jimmunol.1002756; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; Venkatesh KK, 2013, AM J REPROD IMMUNOL, V69, P68, DOI 10.1111/aji.12029; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4	37	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85675	10.1371/journal.pone.0085675	http://dx.doi.org/10.1371/journal.pone.0085675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454917	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100119
J	Ricketts, CJ; Hill, VK; Linehan, WM				Ricketts, Christopher J.; Hill, Victoria K.; Linehan, W. Marston			Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) Project	PLOS ONE			English	Article							WNT ANTAGONIST GENE; SUPPRESSOR GENE; DNA METHYLATION; PROMOTER METHYLATION; CANCER; FBN2; IDENTIFICATION; INACTIVATION; EXPRESSION; MUTATIONS	The recent publication of the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project has provided an immense wealth and breadth of data providing an invaluable tool for confirmation and expansion upon previous observations in a large data set containing multiple data types including DNA methylation, somatic mutation, and clinical information. In clear cell renal cell carcinoma (CCRCC) many genes have been demonstrated to be epigenetically inactivated by promoter hypermethylated and in a small number of cases to be associated with clinical outcome. This study created two cohorts based on the Illumina BeadChip array used to confirm the frequency of tumor-specific hypermethylation of these published hypermethylated genes, assess the impact of somatic mutation or chromosomal loss and provide the most comprehensive assessment to date of the association of this hypermethylation with patient survival. Hypermethylation of the Fibrillin 2 (FBN2) gene was the most consistent epigenetic biomarker for CCRCC across both cohorts in 40.2% or 52.5% of tumors respectively. Hypermethylation of the secreted frizzled-related protein 1 (SFRP1) gene and the basonuclin 1 (BNC1) gene were both statistically associated with poorer survival in both cohorts (SFRP1 - p=<0.0001 or 0.0010 and BNC1 - p=<0.0001 or 0.0380) and represented better independent markers of survival than tumor stage, grade or dimension in one cohort and tumor stage or dimension in the other cohort. Loss of the SFRP1 protein can potentially activate the WNT pathway and this analysis highlighted hypermethylation of several other WNT pathway regulating genes and demonstrated a poorer survival outcome for patients with somatic mutation of these genes. The success of demethylating drugs in hematological malignances and the current trials in solid tumors suggest that the identification of clinically relevant hypermethylated genes combined with therapeutic advances may improve the effectiveness and usefulness of such drugs in clear cell renal cell carcinoma.	[Ricketts, Christopher J.; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hill, Victoria K.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Linehan, WM (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	WML@nih.gov	Ricketts, Christopher/AAV-9580-2020		Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011028, ZIABC011043, ZIABC011038, ZIDBC011089] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awakura Y, 2008, ONCOL REP, V20, P1257, DOI 10.3892/or_00000138; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Boldrup L, 2012, EUR J CANCER, V48, P1401, DOI 10.1016/j.ejca.2011.06.032; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen H, 2005, LUNG CANCER, V50, P43, DOI 10.1016/j.lungcan.2005.04.013; Cooper SJ, 2012, MOL CANCER THER, V11, P2105, DOI 10.1158/1535-7163.MCT-11-0873; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Haruki S, 2010, CARCINOGENESIS, V31, P1027, DOI 10.1093/carcin/bgq053; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hibi K, 2012, ANTICANCER RES, V32, P4371; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Howlader N, 2013, SEER CANC STAT REV 1; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kawakami K, 2011, INT J CANCER, V128, P541, DOI 10.1002/ijc.25357; Kawamoto K, 2008, INT J CANCER, V123, P535, DOI 10.1002/ijc.23514; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Leshchenko VV, 2010, BLOOD, V116, P1025, DOI 10.1182/blood-2009-12-257485; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Morris MR, 2010, GENOME MED, V2, DOI 10.1186/gm180; Morrissey C, 2001, CANCER RES, V61, P7277; Pawlowski R, 2013, INT J CANCER, V132, pE11, DOI 10.1002/ijc.27822; Peters I, 2012, BJU INT, V110, pE144, DOI 10.1111/j.1464-410X.2011.10862.x; Ricketts CJ, 2012, EPIGENETICS-US, V7, P278, DOI 10.4161/epi.7.3.19103; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Tsunoda S, 2009, ONCOL REP, V21, P1067, DOI 10.3892/or_00000325; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zhang DJ, 2012, ONCOL REP, V28, P1785, DOI 10.3892/or.2012.1997	48	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85621	10.1371/journal.pone.0085621	http://dx.doi.org/10.1371/journal.pone.0085621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454902	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100106
J	Tamura, A; Yamada, N; Yaguchi, Y; Machida, Y; Mori, I; Osanai, M				Tamura, Atsushi; Yamada, Naohiro; Yaguchi, Yuichi; Machida, Yoshio; Mori, Issei; Osanai, Makoto			Both Neurons and Astrocytes Exhibited Tetrodotoxin-Resistant Metabotropic Glutamate Receptor-Dependent Spontaneous Slow Ca2+ Oscillations in Striatum	PLOS ONE			English	Article							SPONTANEOUS CALCIUM TRANSIENTS; GREEN FLUORESCENT PROTEIN; BASAL GANGLIA; INTRACELLULAR CALCIUM; ENDOPLASMIC-RETICULUM; EXPRESSION; MODULATION; IMMUNOREACTIVITY; TRANSMISSION; POPULATIONS	The striatum plays an important role in linking cortical activity to basal ganglia outputs. Group I metabotropic glutamate receptors (mGluRs) are densely expressed in the medium spiny projection neurons and may be a therapeutic target for Parkinson's disease. The group I mGluRs are known to modulate the intracellular Ca2+ signaling. To characterize Ca2+ signaling in striatal cells, spontaneous cytoplasmic Ca2+ transients were examined in acute slice preparations from transgenic mice expressing green fluorescent protein (GFP) in the astrocytes. In both the GFP-negative cells (putativeneurons) and astrocytes of the striatum, spontaneous slow and long-lasting intracellular Ca2+ transients (referred to as slow Ca2+ oscillations), which lasted up to approximately 200 s, were found. Neither the inhibition of action potentials nor ionotropic glutamate receptors blocked the slow Ca2+ oscillation. Depletion of the intracellular Ca2+ store and the blockade of inositol 1,4,5-trisphosphate receptors greatly reduced the transient rate of the slow Ca2+ oscillation, and the application of an antagonist against mGluR5 also blocked the slow Ca2+ oscillation in both putative-neurons and astrocytes. Thus, the mGluR5-inositol 1,4,5-trisphosphate signal cascade is the primary contributor to the slow Ca2+ oscillation in both putativeneurons and astrocytes. The slow Ca2+ oscillation features multicellular synchrony, and both putative-neurons and astrocytes participate in the synchronous activity. Therefore, the mGluR5-dependent slow Ca2+ oscillation may involve in the neuron-glia interaction in the striatum.	[Tamura, Atsushi; Mori, Issei; Osanai, Makoto] Tohoku Univ, Grad Sch Med, Dept Radiol Imaging & Informat, Sendai, Miyagi 980, Japan; [Tamura, Atsushi; Osanai, Makoto] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Yamada, Naohiro; Yaguchi, Yuichi] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan; [Machida, Yoshio] Tohoku Univ, Grad Sch Med, Dept Med Imaging & Appl Radiol, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); Osaka University; Tohoku University	Osanai, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Radiol Imaging & Informat, Sendai, Miyagi 980, Japan.	osanai@med.tohoku.ac.jp	Osanai, Makoto/B-7048-2009	Osanai, Makoto/0000-0002-3572-8195	Japan Society for the Promotion of Science KAKENHI [19300105, 23590255]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 19300105, 23590255 (http://www.jsps.go.jp/english/index.html) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Aguado F, 2002, J NEUROSCI, V22, P9430; Ambrosi G, 2010, BRAIN RES BULL, V82, P29, DOI 10.1016/j.brainresbull.2010.01.011; Ango F, 2000, J NEUROSCI, V20, P8710; Arizono M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002498; Bargas J, 1999, NEUROSCIENCE, V88, P479, DOI 10.1016/S0306-4522(98)00211-5; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Bonsi P, 2007, AMINO ACIDS, V32, P189, DOI 10.1007/s00726-006-0320-3; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Clements MA, 2013, J NEUROSCI, V33, P2697, DOI 10.1523/JNEUROSCI.4759-12.2013; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Deister CA, 2009, J NEUROSCI, V29, P8452, DOI 10.1523/JNEUROSCI.0576-09.2009; Dietz B, 2012, J NEUROSCI, V32, P10699, DOI 10.1523/JNEUROSCI.0372-12.2012; Galarraga E, 2007, NEUROSCIENCE, V146, P537, DOI 10.1016/j.neuroscience.2007.01.032; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mao LM, 2003, EUR J NEUROSCI, V17, P741, DOI 10.1046/j.1460-9568.2003.02495.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Muramatsu Y, 2003, GLIA, V42, P307, DOI 10.1002/glia.10225; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; Osanai M, 2013, JAPANESE UNEXAMINED, Patent No. 2013-215114; Osanai M, 2010, 2010 NEUR M PLANN SA; Osanai M, 2006, NEUROSCI LETT, V402, P81, DOI 10.1016/j.neulet.2006.04.012; Osanai M, 2013, NEUROSCI RES, V75, P46, DOI 10.1016/j.neures.2012.10.008; Osanai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013738; Oueslati A, 2005, EUR J NEUROSCI, V22, P2765, DOI 10.1111/j.1460-9568.2005.04498.x; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pasti L, 1997, J NEUROSCI, V17, P7817; RICHTERLANDSBERG C, 1995, J NEUROSCI RES, V42, P657, DOI 10.1002/jnr.490420508; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Tallaksen-Greene SJ, 1998, BRAIN RES, V780, P210, DOI 10.1016/S0006-8993(97)01141-4; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tamura A, 2012, BOTH NEURONS ASTROCY; Tang TS, 2004, J BIOL CHEM, V279, P42082, DOI 10.1074/jbc.M407389200; TESTA CM, 1994, J NEUROSCI, V14, P3005; Vacas J, 2003, BRAIN RES, V992, P272, DOI 10.1016/j.brainres.2003.08.055; Vorndran C, 1995, BIOPHYS J, V69, P2112, DOI 10.1016/S0006-3495(95)80082-2; Wang JQ, 2002, GLUTAMATE ADDICTION, P157; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P51, DOI 10.1023/B:CEMN.0000012724.79184.b6; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	53	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85351	10.1371/journal.pone.0085351	http://dx.doi.org/10.1371/journal.pone.0085351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454845	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100072
J	Wu, XC; Pertovaara, H; Korkola, P; Dastidar, P; Jarvenpaa, R; Eskola, H; Kellokumpu-Lehtinen, PL				Wu, Xingchen; Pertovaara, Hannu; Korkola, Pasi; Dastidar, Prasun; Jarvenpaa, Ritva; Eskola, Hannu; Kellokumpu-Lehtinen, Pirkko-Liisa			Correlations between Functional Imaging Markers Derived from PET/CT and Diffusion-Weighted MRI in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; C-REACTIVE PROTEIN; GLUCOSE-METABOLISM; FDG PET/CT; ADC MEASUREMENTS; PRIMARY TUMOR; COEFFICIENT; BETA-2-MICROGLOBULIN; PREDICTOR; PROGNOSIS	Objectives: To investigate the correlations between functional imaging markers derived from positron emission tomography/computed tomography (PET/CT) and diffusion-weighted magnetic resonance imaging (DWI) in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Further to compare the usefulness of these tumor markers in differentiating diagnosis of the two common types of Non-Hodgkin's lymphoma (NHL). Materials and Methods: Thirty-four consecutive pre-therapy adult patients with proven NHL (23 DLBCL and 11 FL) underwent PET/CT and MRI examinations and laboratory tests. The maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and metabolic tumor burden (MTB) were determined from the PET/CT images. DWI was performed in addition to conventional MRI sequences using two b values (0 and 800 s/mm(2)). The minimum and mean apparent diffusion coefficient (ADC(min) and ADC(mean)) were measured on the parametric ADC maps. Results: The SUVmax correlated inversely with the ADC(min) (r = -0.35, p<0.05). The ADC(min), ADC(mean), serum thymidine kinase (TK), Beta 2-microglobulin (B2m), lactate dehydrogenase (LD), and C-reactive protein (CRP) correlated with both whole-body MTV and whole-body MTB (p<0.05 or 0.01). The SUVmax, TK, LD, and CRP were significantly higher in the DLBCL group than in the FL group. Receiver operating characteristic curve analysis showed that they were reasonable predictors in differentiating DLBCL from FL. Conclusions: The functional imaging markers determined from PET/CT and DWI are associated, and the SUVmax is superior to the ADC(min) in differentiating DLBCL from FL. All the measured serum markers are associated with functional imaging markers. Serum LD, TK, and CRP are useful in differentiating DLBCL from FL.	[Wu, Xingchen; Pertovaara, Hannu; Kellokumpu-Lehtinen, Pirkko-Liisa] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Wu, Xingchen; Dastidar, Prasun; Jarvenpaa, Ritva; Eskola, Hannu] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland; [Wu, Xingchen; Dastidar, Prasun; Kellokumpu-Lehtinen, Pirkko-Liisa] Univ Tampere, Sch Med, Tampere, Finland; [Korkola, Pasi] Tampere Univ Hosp, Dept Nucl Med, Med Imaging Ctr, Tampere, Finland; [Eskola, Hannu] Tampere Univ Technol, Dept Elect & Telecommun, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Tampere University	Wu, XC (corresponding author), Tampere Univ Hosp, Dept Oncol, Tampere, Finland.	Xingchen.Wu@uta.fi	Eskola, Hannu/G-4279-2014	Eskola, Hannu/0000-0003-1673-2305	Biomedical Image Quantification/University Alliance of Finland; Elna Savolainen Fund of Pirkanmaa Hospital District Research Center	Biomedical Image Quantification/University Alliance of Finland; Elna Savolainen Fund of Pirkanmaa Hospital District Research Center	This study was supported by the Biomedical Image Quantification/University Alliance of Finland and the Elna Savolainen Fund of Pirkanmaa Hospital District Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Y, 2012, TUMOR BIOL, V33, P1039, DOI 10.1007/s13277-012-0337-z; Crumley ABC, 2006, BRIT J CANCER, V94, P1568, DOI 10.1038/sj.bjc.6603150; Flowers CR, 2010, CL LYMPH MYELOM LEUK, V10, P414, DOI 10.3816/CLML.2010.n.086; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu J, 2011, MOL IMAGING BIOL, V13, P1020, DOI 10.1007/s11307-010-0433-7; HAGBERG H, 1983, CANCER, V51, P2220, DOI 10.1002/1097-0142(19830615)51:12<2220::AID-CNCR2820511212>3.0.CO;2-A; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Hirano M, 2012, AM J ROENTGENOL, V198, P717, DOI 10.2214/AJR.11.7093; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Holzapfel K, 2009, EUR J RADIOL, V72, P381, DOI 10.1016/j.ejrad.2008.09.034; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; JAGANNATH S, 1986, J CLIN ONCOL, V4, P859, DOI 10.1200/JCO.1986.4.6.859; JOHNSON PWM, 1993, BRIT J CANCER, V67, P792, DOI 10.1038/bjc.1993.144; Kwee TC, 2011, MAGN RESON MATER PHY, V24, P1, DOI 10.1007/s10334-010-0226-7; LAPELA M, 1995, BLOOD, V86, P3522, DOI 10.1182/blood.V86.9.3522.bloodjournal8693522; Matsubayashi RN, 2010, J ONCOL, V2010, DOI 10.1155/2010/821048; Nakamura K, 2013, EUR J NUCL MED MOL I, V40, P52, DOI 10.1007/s00259-012-2240-7; Nakamura K, 2012, EUR J NUCL MED MOL I, V39, P283, DOI 10.1007/s00259-011-1978-7; Okada M, 2010, RADIOGRAPHICS, V30, P939, DOI 10.1148/rg.304095150; Papajik T, 2011, EUR J HAEMATOL, V86, P32, DOI 10.1111/j.1600-0609.2010.01532.x; Park S, 2012, AM J HEMATOL, V87, P937, DOI 10.1002/ajh.23267; Patterson DM, 2008, NAT CLIN PRACT ONCOL, V5, P220, DOI 10.1038/ncponc1073; Punwani S, 2010, CANCER BIOMARK, V7, P249, DOI 10.3233/CBM-2010-0197; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Schoder H, 2005, J CLIN ONCOL, V23, P4643, DOI 10.1200/JCO.2005.12.072; Shou Y, 2012, J CANCER RES THER, V8, P96, DOI 10.4103/0973-1482.95182; Tang BF, 2009, MOL IMAGING BIOL, V11, P296, DOI 10.1007/s11307-009-0226-z; Topolcan Ondrej, 2008, Expert Opin Med Diagn, V2, P129, DOI 10.1517/17530059.2.2.129; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Wong CS, 2012, EUR J RADIOL, V81, P2122, DOI 10.1016/j.ejrad.2011.09.003; Wu XC, 2013, EUR J RADIOL, V82, pE158, DOI 10.1016/j.ejrad.2012.11.021; Wu XC, 2012, LEUKEMIA LYMPHOMA, V53, P400, DOI 10.3109/10428194.2011.622420; Wu XC, 2011, EUR J RADIOL, V79, pE117, DOI 10.1016/j.ejrad.2011.04.062; Wu XC, 2011, MOL IMAGING BIOL, V13, P785, DOI 10.1007/s11307-010-0404-z; Wu XC, 2011, NMR BIOMED, V24, P1181, DOI 10.1002/nbm.1689; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	36	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84999	10.1371/journal.pone.0084999	http://dx.doi.org/10.1371/journal.pone.0084999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454777	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100047
J	Harihar, S; Pounds, KM; Iwakuma, T; Seidah, NG; Welch, DR				Harihar, Sitaram; Pounds, Keke M.; Iwakuma, Tomoo; Seidah, Nabil G.; Welch, Danny R.			Furin Is the Major Proprotein Convertase Required for KISS1-to-Kisspeptin Processing	PLOS ONE			English	Article							KISS1 METASTASIS SUPPRESSOR; PROTEIN-COUPLED RECEPTOR; CELL-LINES; MUTATION; PUBERTY; CANCER; GENE; KISSPEPTIN-10; REPRODUCTION; ACTIVATION	KISS1 is a broadly functional secreted proprotein that is then processed into small peptides, termed kisspeptins (KP). Since sequence analysis showed cleavage at KR or RR dibasic sites of the nascent protein, it was hypothesized that enzyme(s) belonging to the proprotein convertase family of proteases process KISS1 to generate KP. To this end, cell lines over-expressing KISS1 were treated with the proprotein convertase inhibitors, Dec-RVKR-CMK and alpha 1-PDX, and KISS1 processing was completely inhibited. To identify the specific enzyme(s) responsible for KISS1 processing, mRNA expression was systematically analyzed for six proprotein convertases found in secretory pathways. Consistent expression of the three proteases - furin, PCSK5 and PCSK7 - were potentially implicated in KISS1 processing. However, shRNA-mediated knockdown of furin - but not PCSK5 or PCSK7 - blocked KISS1 processing. Thus, furin appears to be the essential enzyme for the generation of kisspeptins.	[Harihar, Sitaram; Pounds, Keke M.; Iwakuma, Tomoo; Welch, Danny R.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA; [Iwakuma, Tomoo; Welch, Danny R.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA; [Pounds, Keke M.; Iwakuma, Tomoo; Welch, Danny R.] Univ Kansas, Med Ctr, Dept Mol Physiol, Kansas City, KS 66103 USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Montreal, PQ, Canada	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Welch, DR (corresponding author), Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA.	Dwelch@KUMC.edu	Harihar, Sitaram/Q-4088-2016; Seidah, Nabil/I-3596-2013; Welch, Danny R/B-7310-2009; harihar, sitaram/AAO-1476-2020	Harihar, Sitaram/0000-0003-4953-7282; Seidah, Nabil/0000-0001-6503-9342; Welch, Danny R/0000-0002-1951-4947; harihar, sitaram/0000-0003-4953-7282	U.S. National Cancer Institute [RO1-CA134981]; Susan G. Komen for the Cure [SAC11037]; National Foundation for Cancer Research-Center for Metastasis Research; Kansas Bioscience Authority [P30-CA168524]; American Cancer Society [RSG-09-169-01-CS]; Canada Chair Grant [216684]; NATIONAL CANCER INSTITUTE [P30CA168524, R01CA134981] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Foundation for Cancer Research-Center for Metastasis Research; Kansas Bioscience Authority; American Cancer Society(American Cancer Society); Canada Chair Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are extremely grateful for the direct financial support for this project from U.S. National Cancer Institute RO1-CA134981 (to DRW). Partial support for this project was received from Susan G. Komen for the Cure SAC11037 (to DRW), National Foundation for Cancer Research-Center for Metastasis Research (to DRW), Kansas Bioscience Authority (DRW is a Kansas Bioscience Authority Eminent Scholar), P30-CA168524 (to DRW), American Cancer Society RSG-09-169-01-CS (to TI) and Canada Chair Grant #216684 (to NGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2012, COMP BIOCHEM PHYS A, V162, P265, DOI 10.1016/j.cbpa.2012.03.019; Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Beier DR, 2003, NEW ENGL J MED, V349, P1589, DOI 10.1056/NEJMp038155; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Matsui H, 2012, ENDOCRINOLOGY, V153, P5297, DOI 10.1210/en.2012-1388; Milton Nathaniel G N, 2012, J Amino Acids, V2012, P691463, DOI 10.1155/2012/691463; Milton NGN, 2012, ACS CHEM NEUROSCI, V3, P706, DOI 10.1021/cn300045d; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Navarro VM, 2012, NAT REV ENDOCRINOL, V8, P40, DOI 10.1038/nrendo.2011.147; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2006, J NEUROENDOCRINOL, V18, P298, DOI 10.1111/j.1365-2826.2006.01417.x; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Thompson EL, 2004, J NEUROENDOCRINOL, V16, P850, DOI 10.1111/j.1365-2826.2004.01240.x; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Vogel G, 2005, SCIENCE, V309, P551, DOI 10.1126/science.309.5734.551; Wang HH, 2012, AM J PATHOL, V180, P1170, DOI 10.1016/j.ajpath.2011.11.020; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	35	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84958	10.1371/journal.pone.0084958	http://dx.doi.org/10.1371/journal.pone.0084958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454770	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500028
J	Lofters, A; Slater, M; Kirst, M; Shankardass, K; Quinonez, C				Lofters, Aisha; Slater, Morgan; Kirst, Maritt; Shankardass, Ketan; Quinonez, Carlos			How Do People Attribute Income-Related Inequalities in Health? A Cross-Sectional Study in Ontario, Canada	PLOS ONE			English	Article							SOCIAL DETERMINANTS; PUBLIC AWARENESS; POVERTY; DISCRIMINATION; OUTCOMES; EQUITY; ACCESS; CARE; NEED	Context: Substantive equity-focused policy changes in Ontario, Canada have yet to be realized and may be limited by a lack of widespread public support. An understanding of how the public attributes inequalities can be informative for developing widespread support. Therefore, the objectives of this study were to examine how Ontarians attribute income-related health inequalities. Methods: We conducted a telephone survey of 2,006 Ontarians using random digit dialing. The survey included thirteen questions relevant to the theme of attributions of income-related health inequalities, with each statement linked to a known social determinant of health. The statements were further categorized depending on whether the statement was framed around blaming the poor for health inequalities, the plight of the poor as a cause of health inequalities, or the privilege of the rich as a cause of health inequalities. Results: There was high agreement for statements that attributed inequalities to differences between the rich and the poor in terms of employment, social status, income and food security, and conversely, the least agreement for statements that attributed inequalities to differences in terms of early childhood development, social exclusion, the social gradient and personal health practices and coping skills. Mean agreement was lower for the two statements that suggested blame for income-related health inequalities lies with the poor (43.1%) than for the three statements that attributed inequalities to the plight of the poor (58.3%) or the eight statements that attributed inequalities to the privilege of the rich (58.7%). Discussion: A majority of this sample of Ontarians were willing to attribute inequalities to the social determinants of health, and were willing to accept messages that framed inequalities around the privilege of the rich or the plight of the poor. These findings will inform education campaigns, campaigns aimed at increasing public support for equity-focused public policy, and knowledge translation strategies.	[Lofters, Aisha; Kirst, Maritt; Shankardass, Ketan; Quinonez, Carlos] St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Lofters, Aisha; Slater, Morgan] Univ Toronto, St Michaels Dept Family & Community Med, Toronto, ON, Canada; [Kirst, Maritt; Quinonez, Carlos] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Shankardass, Ketan] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada; [Quinonez, Carlos] Univ Toronto, Fac Dent, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Wilfrid Laurier University; University of Toronto	Lofters, A (corresponding author), St Michaels Hosp, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	aisha.lofters@utoronto.ca		Slater, Morgan/0000-0003-3967-2501; Kirst, Maritt/0000-0002-2662-8475	Population Health Improvement Research Network (PHIRN) of the Applied Health Research Network Initiative, Government of Ontario	Population Health Improvement Research Network (PHIRN) of the Applied Health Research Network Initiative, Government of Ontario	Data collection and analysis for this work was supported by the Population Health Improvement Research Network (PHIRN) of the Applied Health Research Network Initiative, Government of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CAN PROV PUBL US MIC; [Anonymous], 2005, SEL HIGHL PUBL VIEWS; [Anonymous], 2011, SOC ENV HLTH HLTH PU; Appelbaum LD, 2001, POLIT PSYCHOL, V22, P419; Aubrun A., 2007, EXTERNAL FACTORS VS; Bullock H. E., 2003, J POVERTY, V7, P35, DOI [10.1300/J134v07n03_03, DOI 10.1300/J134V07N03_03]; Canadian Institutes of Health Research, 2012, HLTH EQ MATT IPPH ST; Chirumbolo A, 2004, INT J PSYCHOL, V39, P245, DOI 10.1080/00207590444000005; Dion KL, 1996, CAN J BEHAV SCI, V28, P203, DOI 10.1037/0008-400X.28.3.203; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Gollust SE, 2009, AM J PUBLIC HEALTH, V99, P2160, DOI 10.2105/AJPH.2009.161414; Gomez D, 2012, SURGERY, V152, P179, DOI 10.1016/j.surg.2012.04.006; Guimond S, 2003, J PERS SOC PSYCHOL, V84, P697, DOI 10.1037/0022-3514.84.4.697; GUIMOND S, 1989, SOC PSYCHOL QUART, V52, P126, DOI 10.2307/2786912; Heider F, 1958, PSYCHOL INTERPERSONA, P336; Hofstede G, 2010, CULTURES ORG SOFTWAR, V3rd; HOWLAND J, 1993, APPL ECON, V25, P1413, DOI 10.1080/00036849300000146; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Krzyzanowska MK, 2009, PROJECT ONTARIO WOME, V1; Lopez GE, 1998, POLIT PSYCHOL, V19, P305, DOI 10.1111/0162-895X.00106; Marmot M, 2008, J EPIDEMIOL COMMUN H, V62, P1095, DOI 10.1136/jech.2008.081695; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mikkonen J., 2010, SOCIAL DETERMINANTS; Mio JS, 2003, HDB RACIAL ETHNIC MI; Mitchell A., 2002, WORKING PAPER SERIES; Ng E, 2004, CAN MED ASSOC J, V170, P1545, DOI 10.1503/cmaj.1031528; Niederdeppe J, 2008, MILBANK Q, V86, P481, DOI 10.1111/j.1468-0009.2008.00530.x; Pease Bob., 2009, THEORISING SOCIAL EX, P37; Percy-Smith J., 2000, POLICY RESPONSES SOC, P1; Putland C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-67; Raphael D, 2002, POVERTY INCOME INEQU; Reutter L, 1999, CAN J PUBLIC HEALTH, V90, P13, DOI 10.1007/BF03404091; Reutter LI, 2006, CAN REV SOC ANTHROP, V43, P1, DOI 10.1111/j.1755-618X.2006.tb00852.x; Reutter LI, 2002, CAN J PUBLIC HEALTH, V93, P297, DOI 10.1007/BF03405021; Robinson JW, 2009, SOCIOL SPECTRUM, V29, P489, DOI 10.1080/02732170902904681; Shankardass K, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-26; Shields Margot, 2004, Health Rep, V15 Suppl, P45; Shirazi R, 2005, J CROSS CULT PSYCHOL, V36, P96, DOI 10.1177/0022022104271428; Stephens C, 2010, J HEALTH PSYCHOL, V15, P993, DOI 10.1177/1359105310371554; Teelucksingh C., 2005, WORKING PRECARIOUSLY; Tjepkema Michael, 2004, Health Rep, V15 Suppl, P9; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ	43	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85286	10.1371/journal.pone.0085286	http://dx.doi.org/10.1371/journal.pone.0085286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292SL	24454835	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500051
J	Papavlassopoulos, H; Mishra, YK; Kaps, S; Paulowicz, I; Abdelaziz, R; Elbahri, M; Maser, E; Adelung, R; Rohl, C				Papavlassopoulos, Heike; Mishra, Yogendra K.; Kaps, Soeren; Paulowicz, Ingo; Abdelaziz, Ramzy; Elbahri, Mady; Maser, Edmund; Adelung, Rainer; Roehl, Claudia			Toxicity of Functional Nano-Micro Zinc Oxide Tetrapods: Impact of Cell Culture Conditions, Cellular Age and Material Properties	PLOS ONE			English	Article							HUMAN DERMAL FIBROBLASTS; INDUCE OXIDATIVE STRESS; ZNO NANOPARTICLES; CONTACT INHIBITION; CANCER-CELLS; APOPTOSIS; NANOMATERIALS; GROWTH; NANOSTRUCTURES; CYTOTOXICITY	With increasing production and applications of nanostructured zinc oxide, e. g., for biomedical and consumer products, the question of safety is getting more and more important. Different morphologies of zinc oxide structures have been synthesized and accordingly investigated. In this study, we have particularly focused on nano-micro ZnO tetrapods (ZnO-T), because their large scale fabrication has been made possible by a newly introduced flame transport synthesis approach which will probably lead to several new applications. Moreover, ZnO-T provide a completely different morphology then classical spherical ZnO nanoparticles. To get a better understanding of parameters that affect the interactions between ZnO-T and mammalian cells, and thus their biocompatibility, we have examined the impact of cell culture conditions as well as of material properties on cytotoxicity. Our results demonstrate that the cell density of fibroblasts in culture along with their age, i.e., the number of preceding cell divisions, strongly affect the cytotoxic potency of ZnO-T. Concerning the material properties, the toxic potency of ZnO-T is found to be significantly lower than that of spherical ZnO nanoparticles. Furthermore, the morphology of the ZnO-T influenced cellular toxicity in contrast to surface charges modified by UV illumination or O-2 treatment and to the material age. Finally, we have observed that direct contact between tetrapods and cells increases their toxicity compared to transwell culture models which allow only an indirect effect via released zinc ions. The results reveal several parameters that can be of importance for the assessment of ZnO-T toxicity in cell cultures and for particle development.	[Papavlassopoulos, Heike; Maser, Edmund; Roehl, Claudia] Univ Kiel, Inst Toxicol & Pharmacol Nat Scientists, Kiel, Germany; [Mishra, Yogendra K.; Kaps, Soeren; Paulowicz, Ingo; Abdelaziz, Ramzy; Elbahri, Mady; Adelung, Rainer] Univ Kiel, Inst Mat Sci, Kiel, Germany; [Elbahri, Mady] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Geesthacht, Germany; [Roehl, Claudia] Fed Inst Risk Assessment, ZEBET Alternat Methods Anim Expt, Berlin, Germany	University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Federal Institute for Risk Assessment	Mishra, YK (corresponding author), Univ Kiel, Inst Mat Sci, Kiel, Germany.	ykm@tf.uni-kiel.de; claudia.roehl@gmx.net	Mishra, Yogendra Kumar/G-6241-2010; Adelung, Rainer/AAU-1027-2021; Maser, Edmund/B-1728-2010; Elbahri, Prof. Dr. Mady/B-4273-2015	Mishra, Yogendra Kumar/0000-0002-8786-9379; Adelung, Rainer/0000-0002-2617-678X; Elbahri, Prof. Dr. Mady/0000-0002-6720-1945; Abdelaziz, Ramzy/0000-0002-8349-1751	German Research Foundation (DFG) [SFB 855-A5, Ad/183/10-1]; Humboldt Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation)	Authors HP, EM and CR would like to acknowledge a grant from Medical Faculty (Christiana Albertina University Kiel). Authors also thank the German Research Foundation (DFG) for financial support under schemes SFB 855-A5 and Ad/183/10-1. YKM acknowledges the Humboldt Foundation for postdoctoral grant. ME thanks to DFG for SFB 677 and EL554/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3400; Adelung R., 2011, Germany Patent, Patent No. [DE 2011/000282, 2011000282, DE2011/000282]; Adelung R, 2011, Elastic material with a pore space bridged at the particle level by nanobridges between particles., Patent No. [WO2011116751-A3, 2011116751A3]; Ahamed M, 2011, NANOMED-NANOTECHNOL, V7, P904, DOI 10.1016/j.nano.2011.04.011; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Andres-Pons A, 2012, CELL SIGNAL, V24, P577, DOI 10.1016/j.cellsig.2011.10.012; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Burnett ME, 2011, PHOTODERMATOL PHOTO, V27, P58, DOI 10.1111/j.1600-0781.2011.00557.x; Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789; Deng XY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115101; Elbahri M, 2007, ADV MATER, V19, P1262, DOI 10.1002/adma.200601694; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Fiore M, 1999, EXP CELL RES, V251, P102, DOI 10.1006/excr.1999.4542; Han ZJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174019; Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8; Heng BC, 2011, ARCH TOXICOL, V85, P695, DOI 10.1007/s00204-010-0608-7; Hsiao IL, 2011, SCI TOTAL ENVIRON, V409, P1219, DOI 10.1016/j.scitotenv.2010.12.033; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949; Hussain SM, 2009, ADV MATER, V21, P1549, DOI 10.1002/adma.200801395; IWANAGA H, 1993, J CRYST GROWTH, V134, P275, DOI 10.1016/0022-0248(93)90136-K; Jelaska A, 1998, J CELL PHYSIOL, V175, P19, DOI 10.1002/(SICI)1097-4652(199804)175:1<19::AID-JCP3>3.0.CO;2-F; Jin X, 2013, ADV MATER; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Kao YY, 2012, TOXICOL SCI, V125, P462, DOI 10.1093/toxsci/kfr319; Kathawala MH, 2013, SMALL, V9, P1504, DOI 10.1002/smll.201201452; Kocbek P, 2010, SMALL, V6, P1908, DOI 10.1002/smll.201000032; Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025; Landsiedel R, 2010, ADV MATER, V22, P2601, DOI 10.1002/adma.200902658; Levenberg S, 1999, ONCOGENE, V18, P869, DOI 10.1038/sj.onc.1202396; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Liu Jia-hui, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P790; Liu XX, 2012, P NATL ACAD SCI USA, V109, P8280, DOI 10.1073/pnas.1205880109; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mammone T, 2006, CELL BIOL INT, V30, P903, DOI 10.1016/j.cellbi.2006.06.010; Meyer K, 2011, TOXICOL IN VITRO, V25, P1721, DOI 10.1016/j.tiv.2011.08.011; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Moos PJ, 2010, CHEM RES TOXICOL, V23, P733, DOI 10.1021/tx900203v; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; Nie L, 2006, SMALL, V2, P621, DOI 10.1002/smll.200500193; Nohynek GJ, 2008, SKIN PHARMACOL PHYS, V21, P136, DOI 10.1159/000131078; Oberringer M, 2007, BIOL CELL, V99, P197, DOI 10.1042/BC20060116; Park SC, 1999, J GERONTOL A-BIOL, V54, pB78, DOI 10.1093/gerona/54.2.B78; Piacentini M, 2002, J NEUROCHEM, V81, P1061; Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001; Rasmussen JW, 2010, EXPERT OPIN DRUG DEL, V7, P1063, DOI 10.1517/17425247.2010.502560; Richter L, 2011, LAB CHIP, V11, P2551, DOI 10.1039/c1lc20256a; Rohl C, 2005, TOXICOL APPL PHARM, V204, P36, DOI 10.1016/j.taap.2004.08.007; Ronning C, 2005, J APPL PHYS, V98, DOI 10.1063/1.1997290; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Song WH, 2010, TOXICOL LETT, V199, P389, DOI 10.1016/j.toxlet.2010.10.003; Sun RD, 2001, J PHYS CHEM B, V105, P1984, DOI 10.1021/jp002525j; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Taccola L, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S16581; Tong XH, 2013, TOXICOLOGY, V310, P53, DOI 10.1016/j.tox.2013.05.010; Umar A, 2013, J BIOMED NANOTECHNOL, V9, P1794, DOI 10.1166/jbn.2013.1751; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P441, DOI 10.1166/jbn.2013.1593; Wahab R, 2011, J BIOL INORG CHEM, V16, P431, DOI 10.1007/s00775-010-0740-0; Wang BB, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/10/102005; Wang HJ, 2010, TOXICOL IN VITRO, V24, P1953, DOI 10.1016/j.tiv.2010.08.005; Wille S, 2011, SPIE NEWSROOM, DOI [10.1117/2.1201111.003944, DOI 10.1117/2.1201111.003944)]; Xue ZG, 2010, INT J CELL BIOL, V2010; Zhang JH, 2012, ADV MATER, V24, P1232, DOI 10.1002/adma.201104535	66	85	85	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84983	10.1371/journal.pone.0084983	http://dx.doi.org/10.1371/journal.pone.0084983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454775	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500029
J	Zhang, ZZ; Guo, X; Herrera, C; Tao, YL; Wu, Q; Wu, AM; Wang, H; Bartnikas, TB; Wang, FD				Zhang, Zhuzhen; Guo, Xin; Herrera, Carolina; Tao, Yunlong; Wu, Qian; Wu, Aimin; Wang, Hao; Bartnikas, Thomas B.; Wang, Fudi			Bmp6 Expression Can Be Regulated Independently of Liver Iron in Mice	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN 6; HEPCIDIN EXPRESSION; TRANSFERRIN RECEPTOR; HYPOTRANSFERRINEMIC MICE; PEPTIDE HEPCIDIN; GENE-EXPRESSION; MOUSE-LIVER; IN-VIVO; HEMOJUVELIN; OVERLOAD	The liver is the primary organ for storing iron and plays a central role in the regulation of body iron levels by secretion of the hormone Hamp1. Although many factors modulate Hamp1 expression, their regulatory mechanisms are poorly understood. Here, we used conditional knockout mice for the iron exporter ferroportin1 (Fpn1) to modulate tissue iron in specific tissues in combination with iron-deficient or iron-rich diets and transferrin (Tf) supplementation to investigate the mechanisms underlying Hamp1 expression. Despite liver iron overload, expression of bone morphogenetic protein 6 (Bmp6), a potent-stimulator of Hamp1 expression that is expressed under iron-loaded conditions, was decreased. We hypothesized that factors other than liver iron must play a role in controlling Bmp6 expression. Our results show that erythropoietin and Tf-bound iron do not underlie the down-regulation of Bmp6 in our mice models. Moreover, Bmp6 was down-regulated under conditions of high iron demand, irrespective of the presence of anemia. We therefore inferred that the signals were driven by high iron demand. Furthermore, we also confirmed previous suggestions that Tf-bound iron regulates Hamp1 expression via Smad1/5/8 phosphorylation without affecting Bmp6 expression, and the effect of Tf-bound iron on Hamp1 regulation appeared before a significant change in Bmp6 expression. Together, these results are consistent with novel mechanisms for regulating Bmp6 and Hamp1 expression.	[Zhang, Zhuzhen; Guo, Xin; Tao, Yunlong; Wu, Qian; Wu, Aimin; Wang, Hao; Wang, Fudi] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Inst Nutr & Food Safety,Sch Publ Hlth, Lab Nutr & Metab,Ctr Nutr & Hlth,Dept Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhuzhen; Guo, Xin; Tao, Yunlong; Wu, Qian; Wu, Aimin; Wang, Hao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai, Peoples R China; [Herrera, Carolina; Bartnikas, Thomas B.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Brown University	Wang, FD (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Inst Nutr & Food Safety,Sch Publ Hlth, Lab Nutr & Metab,Ctr Nutr & Hlth,Dept Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	fwang@zju.edu.cn	Wang, Fudi/L-7888-2018; Wu, Aimin/AAD-8903-2020; Tao, Yunlong/I-8328-2019; Wang, Hao/Z-1709-2018	Wang, Fudi/0000-0001-8730-0003; Tao, Yunlong/0000-0003-0377-7133; Zhang, Zhuzhen/0000-0001-6787-3920; Wu, Qian/0000-0003-3934-0128; Wang, Hao/0000-0001-7661-3688	Ministry of Science and Technology of China (973 Program) [2011CB966200, 2012BAD33B05]; National Natural Science Foundation of China [31200892, 31225013, 31330036, 31030039]; National Institutes of Health (NIH) [R00DK084122]; Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP512]; SA-SIBS Scholarship Program; Zhejiang University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK084122] Funding Source: NIH RePORTER	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; SA-SIBS Scholarship Program; Zhejiang University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the Ministry of Science and Technology of China (973 Program) (grant numbers 2011CB966200, 2012BAD33B05); the National Natural Science Foundation of China (grant numbers 31200892 to ZZ, 31225013, 31330036, and 31030039 to FW); National Institutes of Health (NIH) grant to TBB (grant number R00DK084122); The Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (grant number 2012KIP512) and SA-SIBS Scholarship Program. This work was also supported by the Distinguished Professorship Program from Zhejiang University (to FW). FW is Principal Investigator at the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2007, AM J HEMATOL, V82, P1128, DOI 10.1002/ajh.21075; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bartnikas TB, 2012, HAEMATOL-HEMATOL J, V97, P189, DOI 10.3324/haematol.2011.054031; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Frazer DM, 2012, BRIT J HAEMATOL, V157, P615, DOI 10.1111/j.1365-2141.2012.09104.x; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; HAYASHI A, 1993, AM J HUM GENET, V53, P201; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Parrow NL, 2012, BLOOD, V119, P3187, DOI 10.1182/blood-2012-01-405563; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Ramey G, 2009, HAEMATOL-HEMATOL J, V94, P765, DOI 10.3324/haematol.2008.003541; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wilkins SJ, 2006, BLOOD, V107, P1659, DOI 10.1182/blood-2005-07-2614; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang ZZ, 2012, HEPATOLOGY, V56, P961, DOI 10.1002/hep.25746; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	42	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84906	10.1371/journal.pone.0084906	http://dx.doi.org/10.1371/journal.pone.0084906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454764	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500024
J	Faggi, F; Mitola, S; Sorci, G; Riuzzi, F; Donato, R; Codenotti, S; Poliani, PL; Cominelli, M; Vescovi, R; Rossi, S; Calza, S; Colombi, M; Penna, F; Costelli, P; Perini, I; Sampaolesi, M; Monti, E; Fanzani, A				Faggi, Fiorella; Mitola, Stefania; Sorci, Guglielmo; Riuzzi, Francesca; Donato, Rosario; Codenotti, Silvia; Poliani, Pietro Luigi; Cominelli, Manuela; Vescovi, Raffaella; Rossi, Stefania; Calza, Stefano; Colombi, Marina; Penna, Fabio; Costelli, Paola; Perini, Ilaria; Sampaolesi, Maurilio; Monti, Eugenio; Fanzani, Alessandro			Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma	PLOS ONE			English	Article							CARCINOMA CELL-LINES; EMBRYONAL RHABDOMYOSARCOMA; ALVEOLAR RHABDOMYOSARCOMA; DOWN-REGULATION; IN-VIVO; CHILDHOOD RHABDOMYOSARCOMA; TYROSINE PHOSPHORYLATION; THERAPEUTIC TARGET; GENE-EXPRESSION; BREAST-CANCER	Caveolin-1 (Cav-1) can ambiguously behave as either tumor suppressor or oncogene depending on its phosphorylation state and the type of cancer. In this study we show that Cav-1 was phosphorylated on tyrosine 14 (pCav-1) by Src-kinase family members in various human cell lines and primary mouse cultures of rhabdomyosarcoma (RMS), the most frequent soft-tissue sarcoma affecting childhood. Cav-1 overexpression in the human embryonal RD or alveolar RH30 cells yielded increased pCav-1 levels and reinforced the phosphorylation state of either ERK or AKT kinase, respectively, in turn enhancing in vitro cell proliferation, migration, invasiveness and chemoresistance. In contrast, reducing the pCav-1 levels by administration of a Src-kinase inhibitor or through targeted Cav-1 silencing counteracted the malignant in vitro phenotype of RMS cells. Consistent with these results, xenotransplantation of Cav-1 overexpressing RD cells into nude mice resulted in substantial tumor growth in comparison to control cells. Taken together, these data point to pCav-1 as an important and therapeutically valuable target for overcoming the progression and multidrug resistance of RMS.	[Faggi, Fiorella; Mitola, Stefania; Codenotti, Silvia; Poliani, Pietro Luigi; Cominelli, Manuela; Vescovi, Raffaella; Rossi, Stefania; Calza, Stefano; Colombi, Marina; Monti, Eugenio; Fanzani, Alessandro] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Sorci, Guglielmo; Riuzzi, Francesca; Donato, Rosario] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Penna, Fabio; Costelli, Paola] Univ Turin, Dept Expt Med & Oncol, Turin, Italy; [Perini, Ilaria; Sampaolesi, Maurilio] Univ Hosp Gasthuisberg, Stem Cell Res Inst, B-3000 Louvain, Belgium; [Sampaolesi, Maurilio] Univ Pavia, Human Anat Sect, I-27100 Pavia, Italy	University of Brescia; University of Perugia; University of Turin; KU Leuven; University Hospital Leuven; University of Pavia	Fanzani, A (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	fanzani@med.unibs.it	Penna, Fabio/K-5090-2016; Sampaolesi, Maurilio/H-6509-2013; Calza, Stefano/AAM-9790-2021; Cominelli, Manuela/J-9988-2016; Donato, Rosario/I-3943-2019; POLIANI, Pietro Luigi/E-8145-2010	Penna, Fabio/0000-0002-2774-6027; Sampaolesi, Maurilio/0000-0002-2422-3757; Calza, Stefano/0000-0003-4996-7995; Cominelli, Manuela/0000-0002-4520-6104; FANZANI, Alessandro/0000-0001-7475-2668; MONTI, Eugenio/0000-0002-4742-7445; MITOLA, Stefania/0000-0002-5557-738X; Colombi, Marina/0000-0002-3105-5990; POLIANI, Pietro Luigi/0000-0002-5662-8978; Riuzzi, Francesca/0000-0001-7908-3379	Fondazione Cariplo grant; Grant NEDD - Network Enabled Drug Design, Regione Lombardia; "Associazione Italiana per la Ricerca sul Cancro" (MFAG) [9161, 6021]; University of Brescia research fund	Fondazione Cariplo grant(Fondazione Cariplo); Grant NEDD - Network Enabled Drug Design, Regione Lombardia; "Associazione Italiana per la Ricerca sul Cancro" (MFAG)(Fondazione AIRC per la ricerca sul cancro); University of Brescia research fund	This work was supported by the Fondazione Cariplo grant to EM, Grant NEDD - Network Enabled Drug Design, Regione Lombardia to EM, "Associazione Italiana per la Ricerca sul Cancro" (MFAG Project n. 9161 to SM and Project 6021 to RD) and University of Brescia research fund (ex 60%) to AF and EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2012, BIOCHEM BIOPH RES CO, V426, P363, DOI 10.1016/j.bbrc.2012.08.092; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Astolfi A, 2001, GENE, V274, P139, DOI 10.1016/S0378-1119(01)00619-9; Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bai L, 2012, J CELL BIOCHEM, V113, P322, DOI 10.1002/jcb.23358; Bai Y, 2012, CANCER RES, V72, P2501, DOI 10.1158/0008-5472.CAN-11-3015; Bender FC, 2000, CANCER RES, V60, P5870; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Burgermeister E, 2008, CANCER LETT, V268, P187, DOI 10.1016/j.canlet.2008.03.055; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; CHARDIN P, 1985, INT J CANCER, V35, P647, DOI 10.1002/ijc.2910350513; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Crose Lisa E. S., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/756982; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Fanzani A, 2013, TRENDS MOL MED, V19, P546, DOI 10.1016/j.molmed.2013.07.001; FELIX CA, 1992, CANCER RES, V52, P2243; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gamez-Pozo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033752; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Guenther MK, 2013, CANCER LETT, V337, P200, DOI 10.1016/j.canlet.2013.05.010; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hanson CA, 2013, TRAFFIC, V14, P663, DOI 10.1111/tra.12066; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hehlgans S, 2011, AM J CANCER RES, V1, P521; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043041; Hinson ARP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00183; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Jankowski K, 2003, CANCER RES, V63, P7926; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Jothi M, 2012, CELL CYCLE, V11, P895, DOI 10.4161/cc.11.5.19346; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2013, FEBS J, V280, P4323, DOI 10.1111/febs.12421; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li SW, 1996, J BIOL CHEM, V271, P3863; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Linardic CM, 2005, CANCER RES, V65, P4490, DOI 10.1158/0008-5472.CAN-04-3194; Liu L, 2013, ONCOGENE; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; LOLLINI PL, 1991, INVAS METAST, V11, P116; Madaro L, 2013, J CELL BIOCHEM, V114, P1843, DOI 10.1002/jcb.24526; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Marshall AD, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-25; Matveev SV, 2002, AM J PHYSIOL-CELL PH, V282, pC935, DOI 10.1152/ajpcell.00349.2001; Olanich ME, 2013, EXPERT OPIN THER TAR, V17, P607, DOI 10.1517/14728222.2013.772136; Onisto M, 2005, INT J ONCOL, V27, P791; Parham DM, 2013, ADV ANAT PATHOL, V20, P387, DOI 10.1097/PAP.0b013e3182a92d0d; Parham DM, 2012, PEDIATR DEVEL PATHOL, V15, P211, DOI 10.2350/10-12-0953-PB.1; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Perez EA, 2011, J SURG RES, V170, pE243, DOI 10.1016/j.jss.2011.03.001; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Quest AFG, 2013, CURR MOL MED, V13, P266; Quest AFG, 2008, J CELL MOL MED, V12, P1130, DOI 10.1111/j.1582-4934.2008.00331.x; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Rossi S, 2011, J CELL MOL MED, V15, P2553, DOI 10.1111/j.1582-4934.2011.01364.x; Rossi S, 2011, EUR J CANCER, V47, P761, DOI 10.1016/j.ejca.2010.10.018; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Sainz-Jaspeado M, 2011, ONCOTARGET, V2, P305; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Schaaf G, 2010, CANCER RES, V70, P762, DOI 10.1158/0008-5472.CAN-09-2532; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Storer NY, 2013, DEVELOPMENT, V140, P3040, DOI 10.1242/dev.087858; STRATTON MR, 1989, CANCER RES, V49, P6324; Taniguchi E, 2008, ONCOGENE, V27, P6550, DOI 10.1038/onc.2008.255; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; Yi JS, 2013, J PROTEOME RES; Zanola A, 2012, J CELL MOL MED	91	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84618	10.1371/journal.pone.0084618	http://dx.doi.org/10.1371/journal.pone.0084618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427291	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200031
J	Monchamp, ME; Pick, FR; Beisner, BE; Maranger, R				Monchamp, Marie-Eve; Pick, Frances R.; Beisner, Beatrix E.; Maranger, Roxane			Nitrogen Forms Influence Microcystin Concentration and Composition via Changes in Cyanobacterial Community Structure	PLOS ONE			English	Article							BLUE-GREEN-ALGAE; DISSOLVED ORGANIC NITROGEN; FRESH-WATER; PHOSPHORUS; EUTROPHICATION; DOMINANCE; LAKES; GROWTH; PHYTOPLANKTON; AERUGINOSA	The eutrophication of freshwaters is a global health concern as lakes with excess nutrients are often subject to toxic cyanobacterial blooms. Although phosphorus is considered the main element regulating cyanobacterial biomass, nitrogen (N) concentration and more specifically the availability of different N forms may influence the overall toxicity of blooms. In this study of three eutrophic lakes prone to cyanobacterial blooms, we examined the effects of nitrogen species and concentrations and other environmental factors in influencing cyanobacterial community structure, microcystin (MC) concentrations and MC congener composition. The identification of specific MC congeners was of particular interest as they vary widely in toxicity. Different nitrogen forms appeared to influence cyanobacterial community structure leading to corresponding effects on MC concentrations and composition. Total MC concentrations across the lakes were largely explained by a combination of abiotic factors: dissolved organic nitrogen, water temperature and ammonium, but Microcystis spp. biomass was overall the best predictor of MC concentrations. Environmental factors did not appear to affect MC congener composition directly but there were significant associations between specific MC congeners and particular species. Based on redundancy analyses (RDA), the relative biomass of Microcystis aeruginosa was associated with MC-RR, M. wesenbergii with MC-LA and Aphanizomenon flos-aquae with MC-YR. The latter two species are not generally considered capable of MC production. Total nitrogen, water temperature, ammonium and dissolved organic nitrogen influenced the cyanobacterial community structure, which in turn resulted in differences in the dominant MC congener and the overall toxicity.	[Monchamp, Marie-Eve; Maranger, Roxane] Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol & Environm Aquat GRIL, Montreal, PQ H3C 3J7, Canada; [Pick, Frances R.] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Beisner, Beatrix E.] Univ Quebec, Dept Biol Sci, Grp Rech Interuniv Limnol & Environm Aquat GRIL, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; University of Ottawa; University of Quebec; University of Quebec Montreal	Maranger, R (corresponding author), Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol & Environm Aquat GRIL, CP 6128, Montreal, PQ H3C 3J7, Canada.	r.maranger@umontreal.ca	Beisner, Beatrix/ABG-7855-2020; Pick, Frances R/AAD-6379-2021; Pick, Frances/P-2473-2017	Beisner, Beatrix/0000-0001-6972-6887; Pick, Frances/0000-0002-5486-4061; Maranger, Roxane/0000-0002-2509-4678; Monchamp, Marie-Eve/0000-0001-5361-5162	Fonds de Recherche Quebecois sur la Nature et les Technologies FQRNT; Groupe de Recherche Interuniversitaire en Limnologie et Ecologie Aquatique (GRIL)	Fonds de Recherche Quebecois sur la Nature et les Technologies FQRNT; Groupe de Recherche Interuniversitaire en Limnologie et Ecologie Aquatique (GRIL)	Funding was provided by a Fonds de Recherche Quebecois sur la Nature et les Technologies FQRNT-Team grant to RM, BB and FP and the Groupe de Recherche Interuniversitaire en Limnologie et Ecologie Aquatique (GRIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STANDARD METHODS EXA; Aranda-Rodriguez R, 2005, ENVIRON TOXICOL, V20, P390, DOI 10.1002/tox.20116; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; BLOMQVIST P, 1994, ARCH HYDROBIOL, V132, P141; Bronk D, 2007, BIOGEOSCIENCES, V3, P1247; Bronk DA, 2000, MAR CHEM, V69, P163, DOI 10.1016/S0304-4203(99)00103-6; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; Cerasino L, 2012, OCEANOL HYDROBIOL ST, V41, P54, DOI 10.2478/s13545-012-0028-9; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cronberg G., 2006, MANUAL AQUATIC CYANO; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dolman AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038757; Donald DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053277; Donald DB, 2011, LIMNOL OCEANOGR, V56, P2161, DOI 10.4319/lo.2011.56.6.2161; Downing JA, 2001, CAN J FISH AQUAT SCI, V58, P1905, DOI 10.1139/cjfas-58-10-1905; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; Downing TG, 2005, ENVIRON TOXICOL, V20, P257, DOI 10.1002/tox.20106; Falconer IR, 1999, ENVIRON TOXICOL, V14, P5, DOI 10.1002/(SICI)1522-7278(199902)14:1<5::AID-TOX3>3.3.CO;2-S; Fastner J, 1999, ENVIRON TOXICOL, V14, P13, DOI 10.1002/(SICI)1522-7278(199902)14:1<13::AID-TOX4>3.0.CO;2-D; Ferber LR, 2004, FRESHWATER BIOL, V49, P690, DOI 10.1111/j.1365-2427.2004.01218.x; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1213, DOI 10.4319/lo.2010.55.3.1213; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; Giani A, 2005, CAN J FISH AQUAT SCI, V62, P2100, DOI 10.1139/F05-124; Glibert PM, 2004, MAR ECOL PROG SER, V280, P73, DOI 10.3354/meps280073; Gosselain V, 2000, HYDROBIOLOGIA, V438, P139, DOI 10.1023/A:1004122331683; Graham JL, 2004, WATER RES, V38, P4395, DOI 10.1016/j.watres.2004.08.004; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Lee SJ, 2000, J APPL MICROBIOL, V89, P323, DOI 10.1046/j.1365-2672.2000.01112.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; McCarthy MJ, 2007, HYDROBIOLOGIA, V581, P195, DOI 10.1007/s10750-006-0496-2; McCarthy MJ, 2009, LIMNOLOGY, V10, P215, DOI 10.1007/s10201-009-0277-5; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; OECD, 1982, EUTR WAT MON ASS CON, DOI DOI 10.1002/IROH.19840690206; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PICK FR, 1987, NEW ZEAL J MAR FRESH, V21, P425, DOI 10.1080/00288330.1987.9516238; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Reynolds CS, 2000, HYDROBIOLOGIA, V424, P91, DOI 10.1023/A:1003901012233; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Rolland A, 2005, J PLANKTON RES, V27, P683, DOI 10.1093/plankt/fbi042; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; SHAPIRO J, 1973, SCIENCE, V179, P382, DOI 10.1126/science.179.4071.382; SIVONEN K, 1999, TOXIC CYANOBACTERIA, P44; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Tillmanns AR, 2011, LAKE RESERV MANAGE, V27, P183, DOI 10.1080/07438141.2011.587095; Tonk L, 2008, FEMS MICROBIOL ECOL, V65, P383, DOI 10.1111/j.1574-6941.2008.00541.x; Van de Waal DB, 2009, ECOL LETT, V12, P1326, DOI 10.1111/j.1461-0248.2009.01383.x; Via-Ordorika L, 2004, SYST APPL MICROBIOL, V27, P592, DOI 10.1078/0723202041748163; WATANABE MM, 1992, J PHYCOL, V28, P761, DOI 10.1111/j.0022-3646.1992.00761.x; Watson SB, 1997, LIMNOL OCEANOGR, V42, P487, DOI 10.4319/lo.1997.42.3.0487; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Wetzel R. G., 1983, LIMNOLOGY, V2nd; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Xu Y, 2008, ENVIRON POLLUT, V156, P162, DOI 10.1016/j.envpol.2007.12.027	70	99	102	5	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85573	10.1371/journal.pone.0085573	http://dx.doi.org/10.1371/journal.pone.0085573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427318	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200059
J	Sivagangabalan, G; Nazzari, H; Bignolais, O; Maguy, A; Naud, P; Farid, T; Masse, S; Gaborit, N; Varro, A; Nair, K; Backx, P; Vigmond, E; Nattel, S; Demolombe, S; Nanthakumar, K				Sivagangabalan, Gopal; Nazzari, Hamed; Bignolais, Olivier; Maguy, Ange; Naud, Patrice; Farid, Talha; Masse, Stephane; Gaborit, Nathalie; Varro, Andras; Nair, Krishnakumar; Backx, Peter; Vigmond, Edward; Nattel, Stanley; Demolombe, Sophie; Nanthakumar, Kumaraswamy			Regional Ion Channel Gene Expression Heterogeneity and Ventricular Fibrillation Dynamics in Human Hearts	PLOS ONE			English	Article							POTASSIUM CURRENT; IN-VIVO; TRANSMURAL HETEROGENEITY; MYOCYTES; CHANNELOPATHIES; CALSEQUESTRIN; MECHANISMS; CURRENTS; FAILURE	Rationale: Structural differences between ventricular regions may not be the sole determinant of local ventricular fibrillation (VF) dynamics and molecular remodeling may play a role. Objectives: To define regional ion channel expression in myopathic hearts compared to normal hearts, and correlate expression to regional VF dynamics. Methods and Results: High throughput real-time RT-PCR was used to quantify the expression patterns of 84 ion-channel, calcium cycling, connexin and related gene transcripts from sites in the LV, septum, and RV in 8 patients undergoing transplantation. An additional eight non-diseased donor human hearts served as controls. To relate local ion channel expression change to VF dynamics localized VF mapping was performed on the explanted myopathic hearts right adjacent to sampled regions. Compared to non-diseased ventricles, significant differences (p<0.05) were identified in the expression of 23 genes in the myopathic LV and 32 genes in the myopathic RV. Within the myopathic hearts significant regional (LV vs septum vs RV) expression differences were observed for 13 subunits: Nav1.1, Cx43, Ca3.1, Cav alpha 2 delta 2, Cav beta 2, HCN2, Na/K ATPase-1, CASQ1, CASQ2, RYR2, Kir2.3, Kir3.4, SUR2 (p<0.05). In a subset of genes we demonstrated differences in protein expression between control and myopathic hearts, which were concordant with the mRNA expression profiles for these genes. Variability in the expression of Cx43, hERG, Na+/K+ ATPase beta 1 and Kir2.1 correlated to variability in local VF dynamics (p<0.001). To better understand the contribution of multiple ion channel changes on VF frequency, simulations of a human myocyte model were conducted. These simulations demonstrated the complex nature by which VF dynamics are regulated when multi-channel changes are occurring simultaneously, compared to known linear relationships. Conclusions: Ion channel expression profile in myopathic human hearts is significantly altered compared to normal hearts. Multi-channel ion changes influence VF dynamic in a complex manner not predicted by known single channel linear relationships.	[Sivagangabalan, Gopal; Nazzari, Hamed; Farid, Talha; Masse, Stephane; Nair, Krishnakumar; Backx, Peter; Nanthakumar, Kumaraswamy] Toronto Gen Hosp, Toronto, ON, Canada; [Bignolais, Olivier; Gaborit, Nathalie; Demolombe, Sophie] INSERM, UMR915, Inst Thorax, Nantes, France; [Bignolais, Olivier; Gaborit, Nathalie; Demolombe, Sophie] CNRS, ERL3147, Nantes, France; [Bignolais, Olivier; Gaborit, Nathalie; Demolombe, Sophie] Univ Nantes, Nantes, France; [Varro, Andras] Univ Szeged, Szeged, Hungary; [Varro, Andras] Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary; [Maguy, Ange; Naud, Patrice; Vigmond, Edward] IHU LIRYC, Electrophysiol & Heart Modeling Inst, Pessac, France; [Maguy, Ange; Naud, Patrice; Vigmond, Edward] Univ Bordeaux 1, Lab IMB, F-33405 Talence, France; [Nattel, Stanley] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Szeged University; Hungarian Academy of Sciences; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal; Universite de Montreal	Nanthakumar, K (corresponding author), Toronto Gen Hosp, Toronto, ON, Canada.	k.nanthakumar@uhn.on.ca	, Nanthakumar/AAA-9943-2020; Varro, Andras/M-2647-2016; Maguy, Ange/ABG-9298-2021; Gaborit, Nathalie/D-4977-2015; Nair, Krishnakumar/AAU-7806-2020	Gaborit, Nathalie/0000-0002-5231-6555; Maguy, Ange/0000-0003-0170-7430; Nattel, Stanley/0000-0002-5565-3311	CIHR [MOP777687]; Heart and Stroke Foundation of Canada Research Fellowship; government of France through the ANR Investissements d'Avenir grant [ANR-10-IAHU-04]	CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada Research Fellowship(Heart & Stroke Foundation of Canada); government of France through the ANR Investissements d'Avenir grant(French National Research Agency (ANR))	This research was funded by grants from CIHR MOP777687 to Dr. Nanthakumar. Dr. Sivagangabalan is a recipient of a Heart and Stroke Foundation of Canada Research Fellowship. Part of this work was supported by the government of France through the ANR Investissements d'Avenir grant ANR-10-IAHU-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2013, GENE, V517, P1, DOI 10.1016/j.gene.2012.12.061; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Evans FG, 1999, IEEE T BIO-MED ENG, V46, P1090, DOI 10.1109/10.784140; Farid TA, 2011, CIRC RES, V109, P1309, DOI 10.1161/CIRCRESAHA.110.232918; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Glukhov AV, 2012, CIRCULATION, V125, P1835, DOI 10.1161/CIRCULATIONAHA.111.047274; Hashimoto N, 2008, J CARDIOVASC PHARM, V51, P162, DOI 10.1097/FJC.0b013e31815e854c; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; KOUMI S, 1995, CIRCULATION, V92, P164, DOI 10.1161/01.CIR.92.2.164; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Lebeche D, 2004, CIRCULATION, V110, P3435, DOI 10.1161/01.CIR.0000148176.33730.3F; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Lou Q, 2011, CIRCULATION, V123, P1881, DOI 10.1161/CIRCULATIONAHA.110.989707; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; NAIR K, 2009, CIRCULATION S2, V120, pS630; Nanthakumar K, 2005, J CARDIOVASC ELECTR, V16, P425, DOI 10.1046/j.1540-8167.2005.40517.x; Nanthakumar K, 2002, CIRC RES, V91, P733, DOI 10.1161/01.RES.0000038945.66661.21; Nanthakumar K, 2007, AM J PHYSIOL-HEART C, V293, pH875, DOI 10.1152/ajpheart.01415.2006; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Sekar RB, 2009, CIRC RES, V104, P355, DOI 10.1161/CIRCRESAHA.108.178335; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Sridhar A, 2006, AM J PHYSIOL-HEART C, V291, pH2192, DOI 10.1152/ajpheart.01146.2005; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; Thomas SP, 2005, CIRCULATION, V112, P157, DOI 10.1161/CIRCULATIONAHA.104.503631; Tung L, 2007, J ELECTROCARDIOL, V40, pS62, DOI 10.1016/j.jelectrocard.2007.06.018; Umapathy K, 2009, MED ENG PHYS, V31, P964, DOI 10.1016/j.medengphy.2009.05.009; Umapathy K, 2009, IEEE T BIO-MED ENG, V56, P328, DOI 10.1109/TBME.2008.2006031; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; Wu TJ, 1998, J AM COLL CARDIOL, V32, P187, DOI 10.1016/S0735-1097(98)00184-3; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002	40	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e82179	10.1371/journal.pone.0082179	http://dx.doi.org/10.1371/journal.pone.0082179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427266	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329868200006
J	Zhou, ZM; Zhou, B; Ren, LP; Meng, QX				Zhou, Zhenming; Zhou, Bo; Ren, Liping; Meng, Qingxiang			Effect of Ensiled Mulberry Leaves and Sun-Dried Mulberry Fruit Pomace on Finishing Steer Growth Performance, Blood Biochemical Parameters, and Carcass Characteristics	PLOS ONE			English	Article							MORUS-ALBA; RUMINAL FERMENTATION; ANTIOXIDANT ACTIVITY; LOTUS-CORNICULATUS; CONDENSED TANNINS; FORAGE DIGESTION; UREA KINETICS; RUMEN; INSULIN; GLUCOSE	Fifty-one Simmental crossbred steers (357.0+/-16.5 kg) were used to compare a standard total mix ration (TMR) with variants on animal performance, ruminal fermentation, blood biochemical parameters, and carcass characteristics. Corn grain and cotton seed meal were partially replaced by ensiled mulberry leaves (EML) or sun-dried mulberry fruit pomace (SMFP). Experimental diets had similar amounts of crude protein (CP), acid detergent fiber (ADF), and metabolizable energy (ME). Animals were divided into three groups: control group (CONT), 8% EML group, and 6.3% SMFP group. Performance, including average daily weight gain (ADG), and dry matter intake (DMI), was measured. Blood and rumen samples were collected at the end of the experiment (16 weeks). There were no differences in final body weight (P = 0.743), ADG (P = 0.425), DMI (P = 0.642), or ADG/DMI (P = 0.236) between the groups. There were no differences (P = 0.2024) in rumen pH values; ammonia N was lower (P = 0.0076) in SMFP than in the EML and CONT groups. There were differences in the concentrations of total and individual volatile fatty acids, while no differences were determined in blood biochemical parameters (i.e., plasma glucose, urea concentrations, triglycerides, total protein, insulin, IgG, alanine transaminase, and aspartate aminotransferase, P >= 0.098). No differences were observed in carcass characteristics (P >= 0.513), tenderness (P = 0.844), adipose and lean color values (P >= 0.149), and chemical composition (P >= 0.400); however, intramuscular fat was lower in the EML and SMFP groups compared to the CONT animals (P = 0.034). In conclusion, diets supplemented with these two mulberry products in an isocaloric and isonitrogenous manner have similar effects to corn grain and cotton seed meals on steer performance, blood biochemical parameters and carcass characteristics, with the exception of ruminal VFA concentrations and lower intramuscular fat content.	[Zhou, Zhenming; Zhou, Bo; Ren, Liping; Meng, Qingxiang] China Agr Univ, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Zhou, Zhenming; Zhou, Bo; Ren, Liping; Meng, Qingxiang] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Meng, QX (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Beijing 100094, Peoples R China.	qxmeng@cau.edu.cn	Meng, Q./GSI-6185-2022		National Nature Science Foundation of China [31101738]; China Agricultural Research System [CARS-38]; Chinese Universities Scientific Fund [2013QJ071, 2012 QJ108]; National Scientific Programme [2011CB302705]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research System; Chinese Universities Scientific Fund; National Scientific Programme	This study was funded by the National Nature Science Foundation of China (31101738), China Agricultural Research System (CARS-38), Chinese Universities Scientific Fund (2013QJ071, 2012 QJ108) and National Scientific Programme (2011CB302705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett EJ, 2012, J ANIM SCI, V90, P960, DOI 10.2527/jas.2011-4027; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Bailey EA, 2012, J ANIM SCI, V90, P3492, DOI 10.2527/jas.2011-4458; Bailey EA, 2012, J ANIM SCI, V90, P3505, DOI 10.2527/jas.2011-4459; Butkhup L, 2013, INT J FOOD SCI TECH, V48, P934, DOI 10.1111/ijfs.12044; Chen JJ, 2007, ASIA PAC J CLIN NUTR, V16, P290; Cheong SH, 2012, ANIM PROD SCI, V52, P240, DOI 10.1071/AN11087; Choi J, 2013, ARCH PHARM RES; Deshmukh S. V., 1993, World Rabbit Science, V1, P67; Doran MP, 2007, ANIM FEED SCI TECH, V138, P239, DOI 10.1016/j.anifeedsci.2006.11.016; Hogan S, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-71; Isabelile M, 2008, J AGR FOOD CHEM, V56, P9410, DOI 10.1021/jf801527a; JOHNSON DD, 1982, J ANIM SCI, V55, P1224, DOI 10.2527/jas1982.5551224x; LAARVELD B, 1981, ENDOCRINOLOGY, V108, P2217, DOI 10.1210/endo-108-6-2217; Li YL, 2006, ARCH ANIM NUTR, V60, P402, DOI 10.1080/17450390600884401; Liu JX, 2001, SMALL RUMINANT RES, V39, P131, DOI 10.1016/S0921-4488(00)00180-2; Lopez-Campos O, 2011, J ANIM SCI, V89, P1153, DOI 10.2527/jas.2010-2977; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; Min BR, 2012, J ANIM SCI, V90, P3556, DOI 10.2527/jas.2011-4931; Min BR, 2000, J AGR SCI, V134, P305, DOI 10.1017/S0021859699007698; Min BR, 2002, CAN J MICROBIOL, V48, P911, DOI 10.1139/W02-087; *MIN CO LTD, 1994, PREC COL COMM COL CO; Price BD, 2011, J ANIM SCI, V89, P809, DOI 10.2527/jas.2010-3187; Romero-Huelva M, 2012, J DAIRY SCI, V95, P6015, DOI 10.3168/jds.2012-5573; Sagdic O, 2011, J FOOD SCI, V76, pM515, DOI 10.1111/j.1750-3841.2011.02323.x; Salinas-Chavira J, 2011, TROP ANIM HEALTH PRO, V43, P995, DOI 10.1007/s11250-011-9797-1; Sami AS, 2004, J ANIM PHYSIOL AN N, V88, P179, DOI 10.1111/j.1439-0396.2004.00455.x; Taasoli G, 2008, Pak J Biol Sci, V11, P294, DOI 10.3923/pjbs.2008.294.297; Tesseraud S, 2007, DOMEST ANIM ENDOCRIN, V33, P123, DOI 10.1016/j.domaniend.2006.06.002; Todaro M, 2007, J ANIM VET ADV, V6, P509; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vu CC, 2011, ASIAN AUSTRAL J ANIM, V24, P1233, DOI 10.5713/ajas.2011.90328; Wang W, 2012, AM J CHINESE MED, V40, P349, DOI 10.1142/S0192415X12500279; Weiss WP, 1997, J DAIRY SCI, V80, P2896, DOI 10.3168/jds.S0022-0302(97)76254-4; Winkelman LA, 2012, J DAIRY SCI, V95, P6974, DOI 10.3168/jds.2011-5045; Xue F, 2011, ANIM FEED SCI TECH, V169, P61, DOI 10.1016/j.anifeedsci.2011.05.011; Yang WZ, 2012, J ANIM SCI, V90, P1301, DOI 10.2527/jas.2011-4372; Zhou B, 2012, J ANIM FEED SCI, V21, P188, DOI 10.22358/jafs/66063/2012; Zou YX, 2012, INT J MOL SCI, V13, P16544, DOI 10.3390/ijms131216544	39	18	25	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85406	10.1371/journal.pone.0085406	http://dx.doi.org/10.1371/journal.pone.0085406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427304	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200045
J	Parker, HJ; Sauka-Spengler, T; Bronner, M; Elgar, G				Parker, Hugo J.; Sauka-Spengler, Tatjana; Bronner, Marianne; Elgar, Greg			A Reporter Assay in Lamprey Embryos Reveals Both Functional Conservation and Elaboration of Vertebrate Enhancers	PLOS ONE			English	Article							HOX GENE-REGULATION; EVOLUTIONARY ORIGIN; EXPRESSION; TRANSGENESIS; INSIGHTS; CLONING; IDENTIFICATION; GENOME	The sea lamprey is an important model organism for investigating the evolutionary origins of vertebrates. As more vertebrate genome sequences are obtained, evolutionary developmental biologists are becoming increasingly able to identify putative gene regulatory elements across the breadth of the vertebrate taxa. The identification of these regions makes it possible to address how changes at the genomic level have led to changes in developmental gene regulatory networks and ultimately to the evolution of morphological diversity. Comparative genomics approaches using sea lamprey have already predicted a number of such regulatory elements in the lamprey genome. Functional characterisation of these sequences and other similar elements requires efficient reporter assays in lamprey. In this report, we describe the development of a transient transgenesis method for lamprey embryos. Focusing on conserved non-coding elements (CNEs), we use this method to investigate their functional conservation across the vertebrate subphylum. We find instances of both functional conservation and lineage-specific functional evolution of CNEs across vertebrates, emphasising the utility of functionally testing homologous CNEs in their host species.	[Parker, Hugo J.; Elgar, Greg] Natl Inst Med Res, MRC, Div Syst Biol, London NW7 1AA, England; [Sauka-Spengler, Tatjana; Bronner, Marianne] CALTECH, Div Biol, Pasadena, CA 91125 USA	MRC National Institute for Medical Research; California Institute of Technology	Elgar, G (corresponding author), Natl Inst Med Res, MRC, Div Syst Biol, London NW7 1AA, England.	gelgar@nimr.mrc.ac.uk		Elgar, Greg/0000-0001-7323-1596; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Parker, Hugo/0000-0001-7646-2007; Bronner, Marianne/0000-0003-4274-1862	MRC [U117597141, GM090049, DE017911]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090049] Funding Source: NIH RePORTER; Medical Research Council [MC_U117597141, G0902418] Funding Source: researchfish; MRC [G0902418, MC_U117597141] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC core funding (U117597141) to GE and grants GM090049 and DE017911 to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biemar F, 2001, MECH DEVELOP, V109, P427, DOI 10.1016/S0925-4773(01)00554-8; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Carr JL, 1998, J EXP ZOOL, V280, P73, DOI 10.1002/(SICI)1097-010X(19980101)280:1<73::AID-JEZ9>3.0.CO;2-E; Cerny R, 2010, P NATL ACAD SCI USA, V107, P17262, DOI 10.1073/pnas.1009304107; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Goode DK, 2011, DEVELOPMENT, V138, P879, DOI 10.1242/dev.055996; Guerin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005374; Haming D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026543; Irvine SQ, 2002, J EXP ZOOL, V294, P47, DOI 10.1002/jez.10090; Kano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013332; Kusakabe R, 2003, J EXP ZOOL PART B, V296B, P87, DOI 10.1002/jez.b.00011; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Murakami Y, 2004, DEVELOPMENT, V131, P983, DOI 10.1242/dev.00986; Murakami Y, 2001, DEVELOPMENT, V128, P3521; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Nikitina N, 2009, COLD SPRING HARB, V15; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Parker HJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-637; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108; Zerucha T, 2001, MECH DEVELOP, V102, P247, DOI 10.1016/S0925-4773(01)00299-4	37	14	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85492	10.1371/journal.pone.0085492	http://dx.doi.org/10.1371/journal.pone.0085492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416417	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000329866300083
J	Yang, F; Zhou, YL; Yin, LH; Zhu, GC; Liang, GY; Pu, YP				Yang, Fei; Zhou, Yuanlong; Yin, Lihong; Zhu, Guangcan; Liang, Geyu; Pu, Yuepu			Microcystin-Degrading Activity of an Indigenous Bacterial Strain Stenotrophomonas acidaminiphila MC-LTH2 Isolated from Lake Taihu	PLOS ONE			English	Article							ENZYMATIC PATHWAY; FRESH-WATER; DEGRADATION; LR; RR; BIODEGRADATION; GENE	Microcystin-LR (MC-LR) and microcystin-RR (MC-RR) produced by harmful cyanobacterial blooms (HCBs) pose substantial threats to the ecosystem and public health due to their potential hepatotoxicity. Degradation of microcystins (MCs) by indigenous bacteria represents a promising method for removing MCs from fresh water without harming the aquatic environment, but only a few microcystin (MC)-degrading bacteria have been isolated and had their mechanisms reported. This study aimed to isolate indigenous bacteria from Lake Taihu, and investigate the capability and mechanism of MC degradation by these bacteria. During a Microcystis bloom, an indigenous MC-degrading bacterium designated MC-LTH2 was successfully isolated from Lake Taihu, and identified as Stenotrophomonas acidaminiphila based on phylogenetic analysis. In the presence of MC-LR together with MC-RR, the strain MC-LTH2 was capable of totally degrading both simultaneously in 8 days, at rates of 3.0 mg/(L-d) and 5.6 mg/(L-d), respectively. The degradation rates of MCs were dependent on temperature, pH, and initial MC concentration. Adda (3-amino-9-methoxy-2, 6, 8-trimethyl-10-phenyldeca-4, 6-dienoic acid) was detected as an intermediate degradation product of MCs using high performance liquid chromatography coupled with time-of-flight mass spectrometry (HPLC-TOF-MS). To the best of our knowledge, this is the first report of Stenotrophomonas acidaminiphila capable of degrading two MC analogues and other compounds containing Adda residue completely under various conditions, although the mlrA gene in the strain was not detected. These results indicate the Stenotrophomonas acidaminiphila strain MC-LTH2 possesses a significant potential to be used in bioremediation of water bodies contaminated by MC-LR and MC-RR, and is potentially involved in the degradation of MCs during the disappearance of the HCBs in Lake Taihu.	[Yang, Fei; Zhou, Yuanlong; Yin, Lihong; Zhu, Guangcan; Liang, Geyu; Pu, Yuepu] SE Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210018, Peoples R China	Southeast University - China	Pu, YP (corresponding author), SE Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210018, Peoples R China.	yppu@seu.edu.cn		Yang, Fei/0000-0001-5687-0556	National Natural Science Foundation of China [30972440]; National Science and Technology Major Project [2012ZX07101-005, 2012ZX07403-001]; Jiangsu Province postgraduate Innovation Project [CX10B-087Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Jiangsu Province postgraduate Innovation Project	This research was supported by National Natural Science Foundation of China (30972440), the National Science and Technology Major Project (2012ZX07101-005, 2012ZX07403-001), and the Jiangsu Province postgraduate Innovation Project (CX10B-087Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamri SA, 2012, SAUDI J BIOL SCI, V19, P435, DOI 10.1016/j.sjbs.2012.06.006; Bourne DG, 1996, APPL ENVIRON MICROB, V62, P4086, DOI 10.1128/AEM.62.11.4086-4094.1996; Bourne DG, 2001, ENVIRON TOXICOL, V16, P523, DOI 10.1002/tox.10013.abs; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Chen J, 2010, INT J MOL SCI, V11, P896, DOI 10.3390/ijms11030896; Chen P, 2012, ENVIRON SCI TECHNOL, V46, P2345, DOI 10.1021/es2036338; Chen XG, 2010, WATER RES, V44, P1884, DOI 10.1016/j.watres.2009.11.025; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; Gagala I, 2012, POL J ENVIRON STUD, V21, P1125; Harada K, 2004, TOXICON, V44, P107, DOI 10.1016/j.toxicon.2004.04.003; Ho L, 2007, WATER RES, V41, P4685, DOI 10.1016/j.watres.2007.06.057; Hu LB, 2009, NEW BIOTECHNOL, V26, P205, DOI 10.1016/j.nbt.2009.09.001; Imanishi S, 2005, CHEM RES TOXICOL, V18, P591, DOI 10.1021/tx049677g; Ito E, 2002, TOXICON, V40, P1017, DOI 10.1016/S0041-0101(02)00099-5; Jones Gary J., 1994, Natural Toxins, V2, P228, DOI 10.1002/nt.2620020412; Li Xiaoqin, 2010, Journal of Southeast University (English Edition), V26, P96; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Manage PM, 2009, APPL ENVIRON MICROB, V75, P6924, DOI 10.1128/AEM.01928-09; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; Okano K, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/954291; Park HD, 2001, ENVIRON TOXICOL, V16, P337, DOI 10.1002/tox.1041; Saito T, 2003, FEMS MICROBIOL LETT, V229, P271, DOI 10.1016/S0378-1097(03)00847-4; Saitou T, 2003, J WATER SUPPLY RES T, V52, P13, DOI 10.2166/aqua.2003.0002; Shimizu K, 2012, J BIOSCI BIOENG, V114, P630, DOI 10.1016/j.jbiosc.2012.07.004; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Stone R, 2011, SCIENCE, V333, P1210, DOI 10.1126/science.333.6047.1210; Takenaka S, 1997, CHEMOSPHERE, V34, P749, DOI 10.1016/S0045-6535(97)00002-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang JF, 2010, CHINESE J CHEM ENG, V18, P108, DOI 10.1016/S1004-9541(08)60330-4; Wang SC, 2012, ENVIRON SCI TECHNOL, V46, P3442, DOI 10.1021/es203675y; WHO, 1998, GUID DRINK WAT QUAL, V2nd, P95; Yan H, 2012, J ENVIRON SCI-CHINA, V24, P1816, DOI 10.1016/S1001-0742(11)61016-4; Yang F, 2013, BIOMED ENVIRON SCI, V26, P148, DOI 10.3967/0895-3988.2013.02.009; Yang H, 2006, B ENVIRON CONTAM TOX, V77, P367, DOI 10.1007/s00128-006-1075-y	36	44	47	4	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e86216	10.1371/journal.pone.0086216	http://dx.doi.org/10.1371/journal.pone.0086216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416455	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300104
J	Hong, H; Xiao, WB; Maitta, RW				Hong, Hong; Xiao, Wenbin; Maitta, Robert W.			Steady Increment of Immature Platelet Fraction Is Suppressed by Irradiation in Single-Donor Platelet Components during Storage	PLOS ONE			English	Article							THROMBOCYTOPENIA; RADIATION; IPF	Circulating immature platelet fraction (IPF) reflects real-time thrombopoiesis and correlates with platelet recovery from thrombocytopenic presentations. To understand the dynamics of IPF in platelet transfusions, we quantified the %-IPF in single-donor platelet components (SDP) during prolonged storage. %-IPF significantly increased from baseline by day 5 post-donation. Absolute IPF counts (A-IPC) had similar significant increments. However, gamma-irradiation suppressed the increments of %-IPF and A-IPC by >50%. Ultrastructural analysis of SDP units at day 10 showed well preserved morphology of immature platelets. Our findings suggest that IPF might actively expand ex-vivo and may have a longer shelf life than their mature counterparts. Closer study of IPF may be of critical clinical importance for transfusion practices.	[Hong, Hong; Xiao, Wenbin; Maitta, Robert W.] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH USA; [Hong, Hong; Xiao, Wenbin; Maitta, Robert W.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Maitta, RW (corresponding author), Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH USA.	robert.maitta@uhhospitals.org	Maitta, Robert/J-9318-2019	Maitta, Robert/0000-0002-5424-5519; Hong, Hong/0000-0002-1009-3621; Xiao, Wenbin/0000-0001-8586-8500	Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio	Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio	This study was fully supported by a grant from the Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio, awarded to RWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, THROMB RES, V118, P463, DOI 10.1016/j.thromres.2005.09.007; Barsam SJ, 2011, BLOOD, V117, P5723, DOI 10.1182/blood-2010-11-321398; Bat T, 2013, TRANSFUSION, V53, P1201, DOI 10.1111/j.1537-2995.2012.03918.x; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Harrison P, 1997, PLATELETS, V8, P379; Jung H, 2010, KOREAN J LAB MED, V30, P451, DOI 10.3343/kjlm.2010.30.5.451; KALOVIDOURIS AE, 1981, ACTA RADIOL ONCOL, V20, P333, DOI 10.3109/02841868109130218; Kickler TS, 2006, AM J CLIN PATHOL, V125, P282, DOI 10.1309/50H8JYHN9JWCKAM7; KUCAN Z, 1971, BIOPHYS J, V11, P237; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Maurer-Spurej E, 2010, INT J LAB HEMATOL, V32, pE1, DOI 10.1111/j.1751-553X.2008.01097.x; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; Parco S, 2012, ONCOTARGETS THER, V5, DOI 10.2147/OTT.S27883; Sandgren P, 2013, TRANSFUSION; Shanwell A, 2006, TRANSFUSION, V46, P973, DOI 10.1111/j.1537-2995.2006.00830.x; SWEENEY JD, 1994, TRANSFUSION, V34, P779, DOI 10.1046/j.1537-2995.1994.34994378279.x; Zucker Marjorie L, 2006, Lab Hematol, V12, P125, DOI 10.1532/LH96.06012	19	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85465	10.1371/journal.pone.0085465	http://dx.doi.org/10.1371/journal.pone.0085465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416412	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500250
J	Li, JM; Lu, CL; Cheng, MC; Luu, SU; Hsu, SH; Hu, TM; Tsai, HY; Chen, CH				Li, Jun-Ming; Lu, Chao-Lin; Cheng, Min-Chih; Luu, Sy-Ueng; Hsu, Shih-Hsin; Hu, Tsung-Ming; Tsai, Hsin-Yao; Chen, Chia-Hsiang			Role of the DLGAP2 Gene Encoding the SAP90/PSD-95-Associated Protein 2 in Schizophrenia	PLOS ONE			English	Article							CANDIDATE GENE; PSYCHOSIS; FAMILY; MODEL	Aberrant synaptic dysfunction is implicated in the pathogenesis of schizophrenia. The DLGAP2 gene encoding the SAP90/PSD-95-associated protein 2 (SAPAP2) located at the post-synaptic density of neuronal cells is involved in the neuronal synaptic function. This study aimed to investigate whether the DLGAP2 gene is associated with schizophrenia. We resequenced the putative promoter region and all the exons of the DLGAP2 gene in 523 patients with schizophrenia and 596 non-psychotic controls from Taiwan and conducted a case-control association analysis. We identified 19 known SNPs in this sample. Association analysis of 9 SNPs with minor allele frequency greater than 5% showed no association with schizophrenia. However, we found a haplotype (CCACCAACT) significantly associated with schizophrenia (odds ratio: 2.5, p<0.001). We also detected 16 missense mutations and 1 amino acid-insertion mutation in this sample. Bioinformatic analysis showed some of these mutations were damaging or pathological to the protein function, but we did not find increased burden of these mutations in the patient group. Notably, we identified 5 private rare variants in 5 unrelated patients, respectively, including c.269+9C>T, c.269+13C>T, c.269+47C>T, c.269+55C>T at intron 1 and c.-232A>G at untranslated exon 2 of the DLGAP2 gene. These rare variants were not detected in 559 control subjects. Further reporter gene assay of these rare variants except c.-269+13C>T showed significantly elevated promoter activity than the wild type, suggesting increased DLGAP2 gene expression may contribute to the pathogenesis of schizophrenia. Our results indicate that DLGAP2 is a susceptible gene of schizophrenia.	[Li, Jun-Ming; Luu, Sy-Ueng] Taoyuan Armed Forces Gen Hosp, Dept Psychiat, Tao Yuan, Taiwan; [Lu, Chao-Lin] Hualien Armed Forces Gen Hosp, Dept Psychiat, Hualien, Taiwan; [Cheng, Min-Chih; Hsu, Shih-Hsin; Hu, Tsung-Ming; Tsai, Hsin-Yao] Taipei Vet Gen Hosp, Yuli Branch, Yuli Mental Hlth Res Ctr, Dept Psychiat, Hualien, Taiwan; [Chen, Chia-Hsiang] Chang Gung Mem Hosp Linkou, Dept Psychiat, Tao Yuan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan	Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Cheng, MC (corresponding author), Taipei Vet Gen Hosp, Yuli Branch, Yuli Mental Hlth Res Ctr, Dept Psychiat, Hualien, Taiwan.	cmc@vhyl.gov.tw; cchen3801@gmail.com	Cheng, Min-Chih/B-1363-2013	Cheng, Min-Chih/0000-0002-2962-0911; Chen, Chia-Hsiang/0000-0002-8232-2403	Taoyuan Armed Forces General Hospital; Hualien Armed Forces General Hospital in Taiwan	Taoyuan Armed Forces General Hospital; Hualien Armed Forces General Hospital in Taiwan	Funding for this study was provided by the Taoyuan Armed Forces General Hospital, and the Hualien Armed Forces General Hospital in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman L, 2011, COMPR PSYCHIAT, V52, P181, DOI 10.1016/j.comppsych.2010.05.007; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Chien WH, 2010, CLIN GENET, V78, P449, DOI 10.1111/j.1399-0004.2010.01395.x; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-26; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Crane J, 2011, AM J MED GENET B, V156B, P108, DOI 10.1002/ajmg.b.31134; den Dunnen Johan T, 2003, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0713s37; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kumar RA, 2010, CLIN GENET, V78, P517, DOI 10.1111/j.1399-0004.2010.01530_1.x; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li JM, 2013, PSYCHIAT RES, V208, P84, DOI 10.1016/j.psychres.2012.12.015; Li JM, 2013, PSYCHIAT RES, V205, P13, DOI 10.1016/j.psychres.2012.08.014; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Ozgen HM, 2009, CLIN GENET, V76, P348, DOI 10.1111/j.1399-0004.2009.01254.x; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ranta S, 2000, EUR J HUM GENET, V8, P381, DOI 10.1038/sj.ejhg.5200440; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Verpelli C, 2012, ADV EXP MED BIOL, V970, P29, DOI 10.1007/978-3-7091-0932-8_2; Waltereit R, 2013, WORLD J BIO IN PRESS; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Zuchner S, 2009, MOL PSYCHIATR, V14, P6, DOI 10.1038/mp.2008.83	30	14	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85373	10.1371/journal.pone.0085373	http://dx.doi.org/10.1371/journal.pone.0085373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416398	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500243
J	Lu, JW; Liao, CY; Yang, WY; Lin, YM; Jin, SLC; Wang, HD; Yuh, CH				Lu, Jeng-Wei; Liao, Chung-Yi; Yang, Wan-Yu; Lin, Yueh-Min; Jin, Shiow-Lian Catherine; Wang, Horng-Dar; Yuh, Chiou-Hwa			Overexpression of Endothelin 1 Triggers Hepatocarcinogenesis in Zebrafish and Promotes Cell Proliferation and Migration through the AKT Pathway	PLOS ONE			English	Article							B-VIRUS X; HUMAN HEPATOCELLULAR-CARCINOMA; LIVER-SPECIFIC EXPRESSION; HEPATITIS-B; TRANSGENIC ZEBRAFISH; COLORECTAL-CANCER; GENE-EXPRESSION; MYC EXPRESSION; GROWTH-FACTOR; IN-VITRO	Hepatocarcinogenesis commonly involves the gradual progression from hepatitis to fibrosis and cirrhosis, and ultimately to hepatocellular carcinoma (HCC). Endothelin 1 (Edn1) has been identified as a gene that is significantly up-regulated in HBx-induced HCC in mice. In this study, we further investigated the role of edn1 in hepatocarcinogenesis using a transgenic zebrafish model and a cell culture system. Liver-specific edn1 expression caused steatosis, fibrosis, glycogen accumulation, bile duct dilation, hyperplasia, and HCC in zebrafish. Overexpression of EDN1 in 293T cells enhanced cell proliferation and cell migration in in vitro and xenotransplantation assays and was accompanied with up-regulation of several cell cycle/proliferation- and migration-specific genes. Furthermore, expression of the unfolded protein response (UPR) pathway-related mediators, such as spliced XBP1, ATF6, IRE1, and PERK, was also up-regulated at both the RNA and protein levels. In the presence of an EDN1 inhibitor or an AKT inhibitor, these increases were diminished and the EDN1-induced migration ability also was disappeared, suggesting that the EDN1 effects act through activation of the AKT pathway to enhance the UPR and subsequently activate the expression of downstream genes. Additionally, p-AKT is enhanced in the edn1 transgenic fish compared to the GFP-mCherry control. The micro RNA miR-1 was found to inhibit the expression of EDN1. We also observed an inverse correlation between EDN1 and miR-1 expression in HCC patients. In conclusion, our data suggest that EDN1 plays an important role in HCC progression by activating the PI3K/AKT pathway and is regulated by miR-1.	[Lu, Jeng-Wei; Liao, Chung-Yi; Yang, Wan-Yu; Yuh, Chiou-Hwa] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Lu, Jeng-Wei; Jin, Shiow-Lian Catherine] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Changhua County, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; National Central University; Changhua Christian Hospital; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University	Yuh, CH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan.	chyuh@nhri.org.tw	Yuh, Chiou-Hwa/E-3972-2010; Yuh, Chiou-Hwa/AAL-2938-2020; Yuh, Chiou-Hwa/AAL-3531-2020	Wang, Horng-Dar/0000-0001-9570-3611; Lu, Jeng-Wei/0000-0003-2128-2046	National Research Program for Genomic Medicine (NRPGM) [99-3112-B-400-010]; National Science Council (NSC) [101-2321-B-400-017]; National Health Research Institute; Liver Disease Prevention & Treatment Research Foundation (Taiwan); NSC [101-2321-B-400-014]	National Research Program for Genomic Medicine (NRPGM)(Ministry of Science and Technology, Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Liver Disease Prevention & Treatment Research Foundation (Taiwan); NSC(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Research Program for Genomic Medicine (NRPGM) (99-3112-B-400-010) and the National Science Council (NSC) (101-2321-B-400-017) to CHY. Additional funding from the National Health Research Institute provided to CHY is gratefully acknowledged. The fellowship and funding to Jeng-Wei Lu and Dr. Chiou-Hwa Yuh, respectively, from the Liver Disease Prevention & Treatment Research Foundation (Taiwan) is also highly acknowledged. The authors would like to thank the Taiwan Zebrafish Core Facility at NTHU-NHRI for providing the fish lines and resources; TZeTH is supported by a grant from the NSC (101-2321-B-400-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2000, GUT, V47, P685, DOI 10.1136/gut.47.5.685; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Arai M, 2006, FEBS LETT, V580, P184, DOI 10.1016/j.febslet.2005.11.072; Asham E, 2001, BRIT J CANCER, V85, P1759, DOI 10.1054/bjoc.2001.2193; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; Grant K, 2007, BRIT J SURG, V94, P106, DOI 10.1002/bjs.5536; Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002; Her GM, 2011, BBA-MOL CELL BIOL L, V1811, P536, DOI 10.1016/j.bbalip.2011.06.011; Hobbie KR, 2012, VET PATHOL, V49, P372, DOI 10.1177/0300985811409443; ISHIBASHI M, 1993, J CLIN ENDOCR METAB, V76, P378, DOI 10.1210/jc.76.2.378; Jain S, 2010, AM J TRANSL RES, V2, P105; KAR S, 1995, BIOCHEM BIOPH RES CO, V216, P514, DOI 10.1006/bbrc.1995.2652; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kojima K, 1995, SURG ONCOL, V4, P309, DOI 10.1016/S0960-7404(10)80043-X; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Li Z, 2013, DIS MODEL MECH, V6, P414, DOI 10.1242/dmm.010462; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LIN TY, 1987, BRIT J SURG, V74, P839, DOI 10.1002/bjs.1800740931; Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914; Lu JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076951; Lu JW, 2013, ACTA HISTOCHEM, V115, P728, DOI 10.1016/j.acthis.2013.02.012; Lu JW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0379-5; Lu JW, 2012, CARCINOGENESIS, V33, P209, DOI 10.1093/carcin/bgr224; Marrero CR, 2007, ARCH MED RES, V38, P612, DOI 10.1016/j.arcmed.2006.09.004; Matsuura A, 1998, HYPERTENSION, V32, P89, DOI 10.1161/01.HYP.32.1.89; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; NAKAMUTA M, 1993, AM J GASTROENTEROL, V88, P248; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; OIKAWA T, 1994, BRIT J CANCER, V69, P1059, DOI 10.1038/bjc.1994.208; Pedram A, 1997, J BIOL CHEM, V272, P17097, DOI 10.1074/jbc.272.27.17097; Pfab T, 2004, BRIT J PHARMACOL, V141, P215, DOI 10.1038/sj.bjp.0705601; Rosano L, 2001, CANCER RES, V61, P8340; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Tseng WF, 2011, DEV BIOL, V357, P541, DOI 10.1016/j.ydbio.2011.06.040; van Malensteina H, 2012, CANCER LETT, V315, P178, DOI 10.1016/j.canlet.2011.09.039; Wu MH, 2012, J CELL PHYSIOL, V227, P3016, DOI 10.1002/jcp.23043; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhao YT, 2011, CLIN ORTHOP RELAT R, V469, P3190, DOI 10.1007/s11999-011-1939-2; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	51	57	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85318	10.1371/journal.pone.0085318	http://dx.doi.org/10.1371/journal.pone.0085318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416389	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500238
J	Oh, SW; Ahn, SY; Jianwei, X; Kim, KW; Kim, S; Na, KY; Chae, DW; Kim, S; Chin, HJ				Oh, Se Won; Ahn, Shin Young; Jianwei, Xu; Kim, Ki Woong; Kim, Sejoong; Na, Ki Young; Chae, Dong Wan; Kim, Suhnggwon; Chin, Ho Jun			Relationship between Changes in Body Fat and a Decline of Renal Function in the Elderly	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; MASS INDEX; WEIGHT CHANGE; OBESITY; ASSOCIATION; RISK; AGE; ADULTS; LIFE	Obesity is a risk factor for chronic kidney disease, and its prevalence among the elderly is increasing. We investigated the effects of changes in body fat percentage (BFP) on the longitudinal changes in the estimated glomerular filtration rate (eGFR) in the elderly. This prospective cohort study included 390 participants aged >65 years who underwent bioelectrical impedance analysis at baseline and follow-up as a part of the Korean Longitudinal Study on Health and Aging. After a median follow-up period of 5.3 years, BFP was significantly higher than that at the start point (P<0.05). Participants who had the largest increase in BFP had the highest BMI and waist circumference (WC) (P<0.001). The highest tertile had the highest white blood cell count and erythrocyte sedimentation rate, incidence of rapid progression, and decline in eGFR >25% (P <= 0.017, P = 0.025, P = 0.005, respectively). The lowest tertile had the lowest triglyceride and highest high-density lipoprotein levels (P<0.05). The adjusted decline rate in eGFR was correlated with a change in BFP (P = 0.039), but not with that in BMI or WC. The highest tertile had a 4.875-fold increase in the risk for rapid progression to a decline in eGFR (95% CI: 1.366-17.397) and a 4.931-fold decrease in the risk to a decline in eGFR>25% (95% CI: 1.617-15.037), when compared with the lowest tertile. In subgroup analysis, the incidence of renal outcomes was significantly increased according to the increase in BFP in patients with lower eGFR (P <= 0.010). A change in BFP may be associated with inflammation and dyslipidemia development, and longitudinal changes in body fat are related to a decrease in eGFR in the elderly.	[Oh, Se Won] Eulji Univ, Coll Med, Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Ahn, Shin Young; Jianwei, Xu; Kim, Sejoong; Na, Ki Young; Chae, Dong Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Kyeong Kido, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Ahn, Shin Young; Kim, Sejoong; Na, Ki Young; Chae, Dong Wan; Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ, Med Res Ctr, Renal Inst, Seoul, South Korea	Eulji University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Kyeong Kido, South Korea.	mednep@snubh.org	Kim, Ki Woong/D-5801-2012; Kim, Sejoong/J-5356-2015; Oh, Se Won/G-2632-2017	Kim, Ki Woong/0000-0002-1103-3858; Kim, Sejoong/0000-0002-7238-9962; Oh, Se Won/0000-0003-3795-9322; Xu, Jinawei/0000-0001-8049-0422	Pfizer Global Pharmaceuticals [06-05-039]; Seongnam City Government in Korea [800-20050211]	Pfizer Global Pharmaceuticals(Pfizer); Seongnam City Government in Korea	This work was supported by an independent Research Grant (IRG) from Pfizer Global Pharmaceuticals (grant no. 06-05-039) and a Grant for developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Korea (grant no. 800-20050211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Carvalho LK, 2012, NEPHROL DIAL TRANSPL, V27, P1423, DOI 10.1093/ndt/gfr450; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dey DK, 2001, EUR J CLIN NUTR, V55, P482, DOI 10.1038/sj.ejcn.1601208; Diehr P, 2008, J AM GERIATR SOC, V56, P76, DOI 10.1111/j.1532-5415.2007.01500.x; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elia M, 2000, EUR J CLIN NUTR, V54, pS92, DOI 10.1038/sj.ejcn.1601030; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Gaba A, 2013, EUR J NUTR IN PRESS; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Han SS, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-39; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kramer H, 2011, AM J KIDNEY DIS, V58, P177, DOI 10.1053/j.ajkd.2011.02.390; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; Ramkumar N, 2004, J RENAL NUTR, V14, P201, DOI 10.1053/j.jm.2004.07.009; Reuser M, 2008, EUR J EPIDEMIOL, V23, P601, DOI 10.1007/s10654-008-9269-8; Ricks J, 2011, AM J KIDNEY DIS, V58, P574, DOI 10.1053/j.ajkd.2011.03.023; Tamba S, 2010, ATHEROSCLEROSIS, V211, P601, DOI 10.1016/j.atherosclerosis.2010.02.037; TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WILLIAMSON DF, 1993, INT J OBESITY, V17, P279; Yamashita K, 2012, CIRC J, V76, P2435, DOI 10.1253/circj.CJ-12-0337; Zoccali C, 2012, CURR OPIN NEPHROL HY, V21, P641, DOI 10.1097/MNH.0b013e328358a02b	39	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e84052	10.1371/journal.pone.0084052	http://dx.doi.org/10.1371/journal.pone.0084052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454716	Green Published, gold, Green Submitted			2022-12-27	WOS:000330236000006
J	Funabara, D; Ohmori, F; Kinoshita, S; Koyama, H; Mizutani, S; Ota, A; Osakabe, Y; Nagai, K; Maeyama, K; Okamoto, K; Kanoh, S; Asakawa, S; Watabe, S				Funabara, Daisuke; Ohmori, Fumito; Kinoshita, Shigeharu; Koyama, Hiroki; Mizutani, Saeri; Ota, Ayaka; Osakabe, Yuki; Nagai, Kiyohito; Maeyama, Kaoru; Okamoto, Kikuhiko; Kanoh, Satoshi; Asakawa, Shuichi; Watabe, Shugo			Novel Genes Participating in the Formation of Prismatic and Nacreous Layers in the Pearl Oyster as Revealed by Their Tissue Distribution and RNA Interference Knockdown	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; MATRIX PROTEIN; PINCTADA-FUCATA; SHELL MATRIX; CALCIFICATION; GLYCOSYLATION; PREDICTION; MANTLE; FAMILY	In our previous publication, we identified novel gene candidates involved in shell formation by EST analyses of the nacreous and prismatic layer-forming tissues in the pearl oyster Pinctada fucata. In the present study, 14 of those genes, including two known genes, were selected and further examined for their involvement in shell formation using the RNA interference. Molecular characterization based on the deduced amino acid sequences showed that seven of the novel genes encode secretory proteins. The tissue distribution of the transcripts of the genes, as analyzed by RT-PCR and in situ hybridization, was mostly consistent with those obtained by the EST analysis reported previously. Shells in the pearl oysters injected with dsRNAs targeting genes 000027, 000058, 000081, 000096, 000113 (nacrein), 000118, 000133 and 000411 (MSI60), which showed expression specific to the nacreous layer forming tissues, showed abnormal surface appearance in this layer. Individuals injected with dsRNAs targeting genes 000027, 000113 and 000133 also exhibited abnormal prismatic layers. Individuals injected with dsRNAs targeting genes 000031, 000066, 000098, 000145, 000194 and 000200, which showed expression specific to prismatic layer forming tissues, displayed an abnormal surface appearance in both the nacreous and prismatic layers. Taken together, the results suggest that the genes involved in prismatic layer formation might also be involved in the formation of the nacreous layers.	[Funabara, Daisuke; Mizutani, Saeri; Ota, Ayaka; Osakabe, Yuki; Kanoh, Satoshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan; [Ohmori, Fumito; Kinoshita, Shigeharu; Koyama, Hiroki; Asakawa, Shuichi; Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Nagai, Kiyohito] K Mikimoto & Co Ltd, Pearl Res Lab, Shima, Mie, Japan; [Maeyama, Kaoru; Okamoto, Kikuhiko] Mikimoto Pharmaceut Co Ltd, Ise, Mie, Japan; [Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 228, Japan	Mie University; University of Tokyo; Kitasato University	Funabara, D (corresponding author), Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan.	funabara@bio.mie-u.ac.jp	Kinoshita, Shigeharu/AGY-8644-2022					Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GORDON J, 1980, MAR BIOL, V57, P251, DOI 10.1007/BF00387568; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Miyashita T, 2002, VELIGER, V45, P250; Norizuki Michiko, 2008, Frontiers of Materials Science in China, V2, P167, DOI 10.1007/S11706-008-0028-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; Southgate P, 2008, PEARL OYSTER, pVII; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takakura D, 2008, MAR BIOTECHNOL, V10, P290, DOI 10.1007/s10126-007-9063-8; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Wang N, 2012, MAR BIOTECHNOL, V14, P177, DOI 10.1007/s10126-011-9400-9; Wang N, 2009, COMP BIOCHEM PHYS B, V154, P346, DOI 10.1016/j.cbpb.2009.07.012; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6	35	26	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84706	10.1371/journal.pone.0084706	http://dx.doi.org/10.1371/journal.pone.0084706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454739	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100029
J	Hayat, T; Shafiq, A; Alsaedi, A				Hayat, Tasawar; Shafiq, Anum; Alsaedi, Ahmed			Effect of Joule Heating and Thermal Radiation in Flow of Third Grade Fluid over Radiative Surface	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; STAGNATION-POINT FLOW; HOMOTOPY ANALYSIS METHOD; STRETCHING SHEET; MHD FLOW; ENTROPY GENERATION; MICROPOLAR FLUID; DISK	This article addresses the boundary layer flow and heat transfer in third grade fluid over an unsteady permeable stretching sheet. The transverse magnetic and electric fields in the momentum equations are considered. Thermal boundary layer equation includes both viscous and Ohmic dissipations. The related nonlinear partial differential system is reduced first into ordinary differential system and then solved for the series solutions. The dependence of velocity and temperature profiles on the various parameters are shown and discussed by sketching graphs. Expressions of skin friction coefficient and local Nusselt number are calculated and analyzed. Numerical values of skin friction coefficient and Nusselt number are tabulated and examined. It is observed that both velocity and temperature increases in presence of electric field. Further the temperature is increased due to the radiation parameter. Thermal boundary layer thickness increases by increasing Eckert number.	[Hayat, Tasawar; Shafiq, Anum] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Shafiq, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	anumshafiq@ymail.com	Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Shafiq, Anum/F-9967-2018; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Shafiq, Anum/0000-0001-7186-7216; Alsaedi, Ahmed/0000-0003-3452-8922; 	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [10-130/1433 HiCi]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah under grant no. (10-130/1433 HiCi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P3140, DOI 10.1016/j.cnsns.2010.11.018; Abel MS, 2008, COMMUN NONLINEAR SCI, V13, P1808, DOI 10.1016/j.cnsns.2007.04.007; Ahmad K., 2010, JQMA, V6, P117; Bataineh AS, 2009, COMMUN NONLINEAR SCI, V14, P409, DOI 10.1016/j.cnsns.2007.10.007; Bhattacharyya K, 2013, AIN SHAMS ENG J, V4, P259, DOI 10.1016/j.asej.2012.07.002; Ellahi R, 2012, INT J HEAT MASS TRAN, V55, P6384, DOI 10.1016/j.ijheatmasstransfer.2012.06.026; Emam T., 2012, J EGYPT MATH SOC, V20, P215, DOI [10.1016/j.joems.2012.08.016, DOI 10.1016/J.JOEMS.2012.08.016]; Hassan HN, 2012, APPL MATH COMPUT, V219, P708, DOI 10.1016/j.amc.2012.06.065; Hayat T, 2013, J THERMOPHYS HEAT TR, V27, P761, DOI 10.2514/1.T4059; Hayat T, 2012, APPL MATH MECH-ENGL, V33, P749, DOI 10.1007/s10483-012-1584-9; Hayat T, 2012, INT J NUMER METH FL, V69, P1350, DOI 10.1002/fld.2642; Hayat T, 2012, J MECH, V28, P209, DOI 10.1017/jmech.2012.21; Hayat T, 2011, INT J NUMER METH FL, V66, P820, DOI 10.1002/fld.2285; Hayat T, 2011, INT J NUMER METH FL, V67, P1073, DOI 10.1002/fld.2405; Hussain M, 2013, J FRANKLIN I, V350, P194, DOI 10.1016/j.jfranklin.2012.07.005; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Keimanesh M, 2011, COMPUT MATH APPL, V62, P2871, DOI 10.1016/j.camwa.2011.07.054; Liao S., 2012, HOMOTOPY ANAL METHOD; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Loureiro JBR, 2013, J NON-NEWTON FLUID, V199, P20, DOI 10.1016/j.jnnfm.2013.05.003; Mahmoud MAA, 2011, MATH COMPUT MODEL, V54, P1228, DOI 10.1016/j.mcm.2011.03.034; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mandal IC, 2013, AIN SHAMS ENG J, V4, P103, DOI 10.1016/j.asej.2012.06.004; Motsa SS, 2010, COMPUT FLUIDS, V39, P1219, DOI 10.1016/j.compfluid.2010.03.004; Mukhopadhyay S, 2013, ALEX ENG J, V52, P259, DOI 10.1016/j.aej.2013.02.003; Mustafa M, 2012, Z NATURFORSCH A, V67, P70, DOI 10.5560/ZNA.2011-0057; Olanrewaju PO., 2012, WORLD APPL SCI J, V16, P37; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P1197, DOI 10.1016/j.cnsns.2009.05.051; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Raptis A, 1998, INT COMMUN HEAT MASS, V25, P289, DOI 10.1016/S0735-1933(98)00016-5; Rashidi MM, 2013, ENERGY, V55, P497, DOI 10.1016/j.energy.2013.01.036; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rashidi MM, 2011, COMMUN NONLINEAR SCI, V16, P1874, DOI 10.1016/j.cnsns.2010.08.016; Renardy M, 2012, J NON-NEWTON FLUID, V189, P14, DOI 10.1016/j.jnnfm.2012.09.010; Sahoo B, 2012, COMPUT MATH APPL, V63, P1244, DOI 10.1016/j.camwa.2011.12.041; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; Shafiq A, 2013, BRAZILIAN J CHEM ENG, V30; Sparrow EM., 1978, RAD HEAT TRANSFER; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Turkyilmazoglu M, 2011, INT J NONLIN MECH, V46, P306, DOI 10.1016/j.ijnonlinmec.2010.09.012	41	115	115	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83153	10.1371/journal.pone.0083153	http://dx.doi.org/10.1371/journal.pone.0083153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454694	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100006
J	Gao, Y; Song, CY; Hui, LP; Li, CY; Wang, JY; Tian, Y; Han, X; Chen, Y; Tian, DL; Qiu, XS; Wang, EH				Gao, Ying; Song, Chengyang; Hui, Linping; Li, Chun-yu; Wang, Junying; Tian, Ye; Han, Xu; Chen, Yong; Tian, Da-Li; Qiu, Xueshan; Wang, Enhua			Overexpression of RNF146 in Non-Small Cell Lung Cancer Enhances Proliferation and Invasion of Tumors through the Wnt/beta-catenin Signaling Pathway	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; BREAST-CANCER; BETA-CATENIN; AXIN; PROGRESSION; LIGASE	Studies have suggested a possible correlation between the newly identified E3 ubiquitin ligase ring finger protein 146 (RNF146) and tumor development. However, until now, studies on RNF146 have been restricted to poly(ADP-ribosyl)ation and ubiquitin ligation, whereas the role of RNF146 in tumor biology has rarely been reported. In the present study, the role of RNF146 in non-small cell lung cancer (NSCLC) was investigated. The results showed that the expression of RNF146 was increased in clinical lung cancer samples and cell lines. RNF146 expression correlated with tumor size, differentiation level, lymphatic metastasis, pTNM staging, and prognosis of patients in stage I. RNF146 expression was negatively correlated with Axin expression but positively correlated with the nuclear expression of beta-catenin in NSCLC tissues. RNF146 downregulated the expression of Axin in lung cancer cell lines and induced the expression and nuclear distribution of b-catenin. Overexpression of RNF146 in NSCLC cell lines increased the levels of cyclinD1, cyclinE, and CDK4, promoted cell cycle G(0)/G(1)-S transitions, and regulated cell proliferation. Overexpression of RNF146 led to upregulated levels of matrix metalloproteinases 2 and 7 and enhanced lung cancer cell invasiveness, events that were mediated by the classical Wnt/beta-catenin signaling pathway. In summary, the data in the present study indicate that RNF146 regulated the development and progression of NSCLC by enhancing cell growth, invasion, and survival, suggesting that RNF146 may be a potential treatment target in NSCLC.	[Gao, Ying; Wang, Junying; Qiu, Xueshan; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Gao, Ying; Wang, Junying; Qiu, Xueshan; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China; [Gao, Ying] China Med Univ, Dept Pathol, Affiliated Hosp 4, Shenyang, Liaoning, Peoples R China; [Song, Chengyang; Li, Chun-yu; Tian, Ye; Han, Xu; Chen, Yong; Tian, Da-Li] China Med Univ, Dept Thorac Surg, Affiliated Hosp 4, Shenyang, Liaoning, Peoples R China; [Hui, Linping] China Med Univ, Lab Ctr, Affiliated Hosp 4, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Qiu, XS (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.	xueshanqiu@gmail.com.cn			National Science Foundation of China [30972967, 30973502]; Specialized Research Fund for the Doctoral Program of Higher Education [20092104110018]; Program for Liaoning Excellent Talents in University and Liaoning Provincial Science and technology [2012225072]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Liaoning Excellent Talents in University and Liaoning Provincial Science and technology	This work was supported by grants from the National Science Foundation of China (No. 30972967 and 30973502), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20092104110018), Program for Liaoning Excellent Talents in University and Liaoning Provincial Science and technology plan program (No. 2012225072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken EV, 1998, VIRCHOWS ARCH, V439, P725; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Degot S, 2002, ONCOGENE, V21, P4422, DOI 10.1038/sj.onc.1205611; Duprez E, 1997, ONCOGENE, V14, P1563, DOI 10.1038/sj.onc.1200995; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Impola U, 2004, J PATHOL, V202, P14, DOI 10.1002/path.1479; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Menachem TD, 2009, FAM CANCER, V8, P399, DOI 10.1007/s10689-009-9255-7; Nakajima M, 2003, BRIT J CANCER, V88, P1734, DOI 10.1038/sj.bjc.6600941; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Sobin L, 2009, TNM CLASSIFICATION M; Thomas P, 2000, J PATHOL, V190, P150; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; Xu HT, 2007, ANN SURG ONCOL, V14, P3251, DOI 10.1245/s10434-007-9555-9; Xu HT, 2006, AM J CLIN PATHOL, V125, P534, DOI 10.1309/0MDY02KHEW1F6RT6; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	23	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85377	10.1371/journal.pone.0085377	http://dx.doi.org/10.1371/journal.pone.0085377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454854	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800042
J	Jackson, D; Atkinson, J; Guevara, CI; Zhang, CY; Kery, V; Moon, SJ; Virata, C; Yang, P; Lowe, C; Pinkstaff, J; Cho, H; Knudsen, N; Manibusan, A; Tian, F; Sun, Y; Lu, YC; Sellers, A; Jia, XC; Joseph, I; Anand, B; Morrison, K; Pereira, DS; Stover, D				Jackson, Dowdy; Atkinson, John; Guevara, Claudia I.; Zhang, Chunying; Kery, Vladimir; Moon, Sung-Ju; Virata, Cyrus; Yang, Peng; Lowe, Christine; Pinkstaff, Jason; Cho, Ho; Knudsen, Nick; Manibusan, Anthony; Tian, Feng; Sun, Ying; Lu, Yingchun; Sellers, Aaron; Jia, Xiao-Chi; Joseph, Ingrid; Anand, Banmeet; Morrison, Kendall; Pereira, Daniel S.; Stover, David			In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates	PLOS ONE			English	Article							BREAST-CANCER; TRASTUZUMAB-DM1; ONCOGENE	Antibody drug conjugates (ADCs) are monoclonal antibodies designed to deliver a cytotoxic drug selectively to antigen expressing cells. Several components of an ADC including the selection of the antibody, the linker, the cytotoxic drug payload and the site of attachment used to attach the drug to the antibody are critical to the activity and development of the ADC. The cytotoxic drugs or payloads used to make ADCs are typically conjugated to the antibody through cysteine or lysine residues. This results in ADCs that have a heterogeneous number of drugs per antibody. The number of drugs per antibody commonly referred to as the drug to antibody ratio (DAR), can vary between 0 and 8 drugs for a IgG(1) antibody. Antibodies with 0 drugs are ineffective and compete with the ADC for binding to the antigen expressing cells. Antibodies with 8 drugs per antibody have reduced in vivo stability, which may contribute to non target related toxicities. In these studies we incorporated a non-natural amino acid, para acetyl phenylalanine, at two unique sites within an antibody against Her2/neu. We covalently attached a cytotoxic drug to these sites to form an ADC which contains two drugs per antibody. We report the results from the first direct preclinical comparison of a site specific non-natural amino acid antiHer2 ADC and a cysteine conjugated anti-Her2 ADC. We report that the site specific non-natural amino acid anti-Her2 ADCs have superior in vitro serum stability and preclinical toxicology profile in rats as compared to the cysteine conjugated antiHer2 ADCs. We also demonstrate that the site specific non-natural amino acid anti-Her2 ADCs maintain their in vitro potency and in vivo efficacy against Her2 expressing human tumor cell lines. Our data suggests that site specific non-natural amino acid ADCs may have a superior therapeutic window than cysteine conjugated ADCs.	[Jackson, Dowdy; Atkinson, John; Guevara, Claudia I.; Zhang, Chunying; Kery, Vladimir; Moon, Sung-Ju; Virata, Cyrus; Yang, Peng; Lowe, Christine; Jia, Xiao-Chi; Joseph, Ingrid; Anand, Banmeet; Morrison, Kendall; Pereira, Daniel S.; Stover, David] Agensys Inc, Santa Monica, CA 90404 USA; [Pinkstaff, Jason; Cho, Ho; Knudsen, Nick; Manibusan, Anthony; Tian, Feng; Sun, Ying; Lu, Yingchun; Sellers, Aaron] Ambrx Inc, La Jolla, CA USA		Jackson, D (corresponding author), Agensys Inc, Santa Monica, CA 90404 USA.	djackson@agensys.com			Agensys, Inc; Ambrx, Inc	Agensys, Inc; Ambrx, Inc	All studies were funded by Agensys, Inc and/or Ambrx, Inc. There were no private or government funding agencies used to fund these studies. All studies were conceived and performed by Agensys or Ambrx employees, with the exception of the rat toxicology studies, which were designed by Agensys and Ambrx employees and paid for by Agensys, Inc. The data analysis, preparation of the manuscript and the decision to publish were made by Agensys, Inc and Ambrx, Inc.	Axup JY, 2012, P NATL ACAD SCI US; Barok M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2868; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Crisalli P, 2013, J ORG CHEM, V78, P1184, DOI 10.1021/jo302746p; Goldmacher VS, 2011, THER DELIV, V2, P397, DOI 10.4155/TDE.10.98; Guha M., 2012, NAT BIOTECHNOL, V30, P728; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hubalek M, 2010, WIEN MED WOCHENSCHR, V160, P506, DOI 10.1007/s10354-010-0838-6; Hurvitz SA, 2012, THER ADV MED ONCOL, V4, P235, DOI 10.1177/1758834012451205; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Meden H, 1997, EUR J OBSTET GYN R B, V71, P173, DOI 10.1016/S0301-2115(96)02630-9; Papazisis KT, 2004, INT J CLIN PRACT, V58, P581, DOI 10.1111/j.1368-5031.2004.00203.x; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; TRAIL PA, 1993, SCIENCE, V261, P212, DOI 10.1126/science.8327892; Valliere-Douglass JF, 2012, ANAL CHEM, V84, P2843, DOI 10.1021/ac203346c; Xu K, 2011, ANAL BIOCHEM, V412, P56, DOI 10.1016/j.ab.2011.01.004	19	85	96	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83865	10.1371/journal.pone.0083865	http://dx.doi.org/10.1371/journal.pone.0083865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454709	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800011
J	Tsai, MH; Chu, SM; Hsu, JF; Lien, RY; Huang, HR; Chiang, MC; Fu, RH; Lee, CW; Huang, YC				Tsai, Ming-Horng; Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Lee, Chiang-Wen; Huang, Yhu-Chering			Polymicrobial Bloodstream Infection in Neonates: Microbiology, Clinical Characteristics, and Risk Factors	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; BIRTH-WEIGHT INFANTS; INTENSIVE-CARE-UNIT; LATE-ONSET SEPSIS; ENTEROCOCCAL BACTEREMIA; PEDIATRIC-PATIENTS; MORTALITY; CHILDREN; EPIDEMIOLOGY	Background: Polymicrobial bloodstream infections (PBSIs) have been associated with complex underlying medical conditions and a high incidence of specific microorganisms in several settings, but the relevant data are scarce in neonates. Methods: Positive blood cultures from January 2004 to December 2011 in the neonatal intensive care unit (NICU) of Chang Gung Memorial Hospital (CGMH) were reviewed. Each neonate with PBSI (case episode) was matched to two episodes of monomicrobial BSI (control episode) by birth weight, gestational age and gender. Records were reviewed to compare their underlying medical conditions, organisms isolated, adequacy of therapy, clinical characteristics and outcomes. Results: Forty-five episodes of PBSI (4.4% of all neonatal BSIs) were identified in 43 neonates. Gram-negative organisms constituted 59.8% of all PBSI pathogens, and 33 (73.3%) of PBSIs were caused by at least one Gram-negative organism. PBSIs were significantly more likely to be the recurrent episode and have endotracheal tube in place. No significant difference was found between PBSIs and controls in terms of demographics and most chronic conditions. PBSIs were significantly associated with a higher severity of illness, a longer duration of septic symptoms, and a higher rate of modification of antimicrobial regimens than monomicrobial BSIs. However, the sepsis-attributable mortality rates were comparable between these two groups. Conclusions: In the NICU, PBSIs were more often caused by Gram-negative bacilli, and often occurred in neonates without any chronic conditions. The clinical significance of PBSIs included a more severe illness, longer duration of septic symptoms and a higher rate of modification of antimicrobial regimens.	[Tsai, Ming-Horng] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Neonatol, Tao Yuan, Taiwan; [Tsai, Ming-Horng; Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Tsai, Ming-Horng; Lee, Chiang-Wen] Chang Gung Univ Sci & Technol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Huang, YC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw						Armenian SH, 2005, PEDIATR INFECT DIS J, V24, P309, DOI 10.1097/01.inf.0000157086.97503.bd; Beekmann SE, 2003, J CLIN MICROBIOL, V41, P3119, DOI 10.1128/JCM.41.7.3119-3125.2003; Bizzarro MJ, 2008, INFECT CONT HOSP EP, V29, P914, DOI 10.1086/591323; BONADIO WA, 1988, AM J DIS CHILD, V142, P1158, DOI 10.1001/archpedi.1988.02150110036014; CHRISTIE C, 1994, J PEDIATR-US, V125, P392, DOI 10.1016/S0022-3476(05)83282-2; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Das I, 1998, PEDIATR INFECT DIS J, V17, P1154, DOI 10.1097/00006454-199812000-00011; Downes KJ, 2008, CLIN INFECT DIS, V46, P387, DOI 10.1086/525265; EI-Mahallawy H, 2005, INT J INFECT DIS, V9, P43; Gordon A, 2006, PEDIATR INFECT DIS J, V25, P25, DOI 10.1097/01.inf.0000195628.35980.2e; GRAY JE, 1992, PEDIATRICS, V90, P561; Gupta P, 2005, J PAEDIATR CHILD H, V41, P365, DOI 10.1111/j.1440-1754.2005.00633.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Makhoul IR, 2005, CLIN INFECT DIS, V40, P218, DOI 10.1086/426444; McKenzie FE, 2006, J CLIN EPIDEMIOL, V59, P760, DOI 10.1016/j.jclinepi.2005.12.009; McNeeley DF, 1996, PEDIATR INFECT DIS J, V15, P800, DOI 10.1097/00006454-199609000-00013; RELLO J, 1993, INTENS CARE MED, V19, P22, DOI 10.1007/BF01709273; Sutter D, 2008, PEDIATR INFECT DIS J, V27, P400, DOI 10.1097/INF.0b013e31816591be; Tsai MH, 2011, INFECT CONT HOSP EP, V32, P258, DOI 10.1086/658335; Tsai MH, 2009, PEDIATR INFECT DIS J, V28, P966, DOI 10.1097/INF.0b013e3181aa3a29; WEINSTEIN MP, 1986, DIAGN MICR INFEC DIS, V5, P185, DOI 10.1016/0732-8893(86)90001-5; William Taeusch H, 2006, AVERYS DIS NEWBORN; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40	26	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83082	10.1371/journal.pone.0083082	http://dx.doi.org/10.1371/journal.pone.0083082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454692	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800006
J	Wu, SY; Gao, YL; Zhang, YP; Wang, ED; Xu, XN; Lei, ZR				Wu, Shengyong; Gao, Yulin; Zhang, Yaping; Wang, Endong; Xu, Xuenong; Lei, Zhongren			An Entomopathogenic Strain of Beauveria bassiana against Frankliniella occidentalis with no Detrimental Effect on the Predatory Mite Neoseiulus barkeri : Evidence from Laboratory Bioassay and Scanning Electron Microscopic Observation	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; 2 NATURAL ENEMIES; METARHIZIUM-ANISOPLIAE; PERGANDE THYSANOPTERA; BIOLOGICAL-CONTROL; RESISTANCE; MECHANISMS; CUCUMBER; FUNGUS	Among 28 isolates of Beauveria bassiana tested for virulence against F. occidentalis in laboratory bioassays, we found strain SZ-26 as the most potent, causing 96% mortality in adults at 1 x10(7) mL(-1) conidia after 4 days. The effect of the strain SZ-26 on survival, longevity and fecundity of the predatory mite Neoseiulus (Amblyseius) barkeri Hughes were studied under laboratory conditions. The bioassay results showed that the corrected mortalities were less than 4 and 8% at 10 days following inoculation of the adult and the larvae of the predator, respectively, with 1x10(7) conidia mL(-1) of SZ-26. Furthermore, no fungal hyphae were found in dead predators. The oviposition and postoviposition durations, longevity, and fecundity displayed no significant differences after inoculation with SZ-26 using first-instar larvae of F. occidentalis as prey in comparison with untreated predator. In contrast, the preoviposition durations were significantly longer. Observations with a scanning electron microscope, revealed that many conidia were attached to the cuticles of F. occidentalis at 2 h after treatment with germ tubes oriented toward cuticle at 24 h, penetration of the insect cuticle at 36 h, and finally, fungal colonization of the whole insect body at 60 h. In contrast, we never observed penetration of the predator's cuticle and conidia were shed gradually from the body, further demonstrating that B. bassiana strain SZ-26 show high toxicity against F. occidentalis but no pathogenicity to predatory mite.	[Wu, Shengyong; Gao, Yulin; Zhang, Yaping; Wang, Endong; Xu, Xuenong; Lei, Zhongren] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lei, ZR (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zrlei@ippcaas.cn	Gao, Yu/HGE-1937-2022		National Special Fund for the Commonwealth Agricultural Research [200903032]; National Modern Agricultural Science and Technology City Industry of Beijing [Z121100001212006]; National Key Basic Research Program [2009CB119004]	National Special Fund for the Commonwealth Agricultural Research; National Modern Agricultural Science and Technology City Industry of Beijing; National Key Basic Research Program(National Basic Research Program of China)	This research was supported by the National Special Fund for the Commonwealth Agricultural Research (200903032), National Modern Agricultural Science and Technology City Industry of Beijing (Z121100001212006) and the National Key Basic Research Program (973 Projects Grant 2009CB119004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bielza P, 2008, PEST MANAG SCI, V64, P1131, DOI 10.1002/ps.1620; Boaria A., 2011, IOBC/WPRS Bulletin, V66, P245; Broadbent AB, 1997, CAN ENTOMOL, V129, P907, DOI 10.4039/Ent129907-5; BRODSGAARD H F, 1989, Tidsskrift for Planteavl, V93, P83; Charnley A.K., 1991, P267; FARISH DJ, 1972, ANIM BEHAV, V20, P662, DOI 10.1016/S0003-3472(72)80139-8; Furtado I.P., 1997, Ecossistema, V21, P85; Gao YL, 2012, BIOCONTROL SCI TECHN, V22, P803, DOI 10.1080/09583157.2012.691158; GILLESPIE DR, 1989, ENTOMOPHAGA, V34, P185, DOI 10.1007/BF02372667; Gonzalez-Zamora J. E., 1992, Boletin de Sanidad Vegetal, Plagas, V18, P265; Jacobson RJ, 2001, BIOCONTROL SCI TECHN, V11, P391, DOI 10.1080/09583150120055808; Jarosik Vojtech, 1995, Acta Societatis Zoologicae Bohemicae, V59, P177; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Lacey L. A., 2002, Documentos - Embrapa Soja, P31; Leckie BM, 2008, BIOCONTROL SCI TECHN, V18, P697, DOI 10.1080/09583150802262906; Liang XH, 2010, INSECT SCI, V17, P535, DOI 10.1111/j.1744-7917.2010.01337.x; [吕丁丁 LV DingDing], 2008, [微生物学通报, Microbiology], V35, P443; Maniania NK, 2002, MYCOPATHOLOGIA, V155, P229, DOI 10.1023/A:1021177626246; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Poprawski TJ, 1998, ENVIRON ENTOMOL, V27, P785, DOI 10.1093/ee/27.3.785; Pozzebon A, 2010, TRENDS IN ACAROLOGY, P465, DOI 10.1007/978-90-481-9837-5_77; Rodriguez-Reina J.M., 1992, Boletin de Sanidad Vegetal Plagas, V18, P253; Roy HE, 1998, J INVERTEBR PATHOL, V71, P236, DOI 10.1006/jipa.1997.4736; Seiedy M, 2012, BIOCONTROL SCI TECHN, V22, P873, DOI 10.1080/09583157.2012.695010; Seyed-Talebi FS, 2012, BIOCONTROL SCI TECHN, V22, P293, DOI 10.1080/09583157.2012.655709; SHAW JG, 1967, J ECON ENTOMOL, V60, P1751, DOI 10.1093/jee/60.6.1751; Shipp JL, 1998, J ECON ENTOMOL, V91, P671, DOI 10.1093/jee/91.3.671; Shipp L., 2002, Bulletin OILB/SROP, V25, P237; Simelane DO, 2008, BIOL CONTROL, V44, P128, DOI 10.1016/j.biocontrol.2007.10.004; SPSS, 2005, SPSS US GUID VERS 14; STLEGER RJ, 1995, CAN J BOT, V73, pS1119, DOI 10.1139/b95-367; Van de Veire M, 2002, BIOCONTROL, V47, P101, DOI 10.1023/A:1014473023912; van der Hoeven W.A.D., 1990, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V1, P25; VESTERGAARD S, 1995, BIOCONTROL SCI TECHN, V5, P185, DOI 10.1080/09583159550039909; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wang JH, 2011, MICROB BIOTECHNOL, V4, P479, DOI 10.1111/j.1751-7915.2010.00197.x; Wang YaHui, 2011, Chinese Journal of Biological Control, V27, P324; Wekesa VW, 2007, BIOL CONTROL, V41, P408, DOI 10.1016/j.biocontrol.2007.03.003; Wen JinZeng, 2003, Plant Protection, V29, P50; Yuan SY, 2011, J HUAZHONG AGR U, V2, P177; YUDIN LS, 1986, ENVIRON ENTOMOL, V15, P1292, DOI 10.1093/ee/15.6.1292; Zhang SY, 2008, INSECT SCI, V15, P125, DOI 10.1111/j.1744-7917.2008.00192.x	43	39	46	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84732	10.1371/journal.pone.0084732	http://dx.doi.org/10.1371/journal.pone.0084732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454744	Green Submitted, gold, Green Published			2022-12-27	WOS:000329925800014
J	Barros, AMG; Pereira, JMC				Barros, Ana M. G.; Pereira, Jose M. C.			Wildfire Selectivity for Land Cover Type: Does Size Matter?	PLOS ONE			English	Article							SOUTHERN-CALIFORNIA; MEDITERRANEAN BASIN; LANDSCAPE DYNAMICS; BURN PROBABILITY; FIRE REGIMES; FOREST-FIRES; FUEL AGE; MANAGEMENT; PORTUGAL; PATTERNS	Previous research has shown that fires burn certain land cover types disproportionally to their abundance. We used quantile regression to study land cover proneness to fire as a function of fire size, under the hypothesis that they are inversely related, for all land cover types. Using five years of fire perimeters, we estimated conditional quantile functions for lower (avoidance) and upper (preference) quantiles of fire selectivity for five land cover types - annual crops, evergreen oak woodlands, eucalypt forests, pine forests and shrublands. The slope of significant regression quantiles describes the rate of change in fire selectivity (avoidance or preference) as a function of fire size. We used Monte-Carlo methods to randomly permutate fires in order to obtain a distribution of fire selectivity due to chance. This distribution was used to test the null hypotheses that 1) mean fire selectivity does not differ from that obtained by randomly relocating observed fire perimeters; 2) that land cover proneness to fire does not vary with fire size. Our results show that land cover proneness to fire is higher for shrublands and pine forests than for annual crops and evergreen oak woodlands. As fire size increases, selectivity decreases for all land cover types tested. Moreover, the rate of change in selectivity with fire size is higher for preference than for avoidance. Comparison between observed and randomized data led us to reject both null hypotheses tested (alpha = 0.05) and to conclude it is very unlikely the observed values of fire selectivity and change in selectivity with fire size are due to chance.	[Barros, Ana M. G.; Pereira, Jose M. C.] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal	Universidade de Lisboa	Barros, AMG (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal.	barros.anamg@gmail.com	Pereira, José/N-2829-2019; Pereira, Jose MC/I-1283-2014	Pereira, José/0000-0003-2583-3669; Pereira, Jose MC/0000-0003-2583-3669	Fundacao para a Ciencia e Tecnologia Ph.D. Grant [SFRH/BD/40398/2007]; EC [243888]	Fundacao para a Ciencia e Tecnologia Ph.D. Grant; EC(European CommissionEuropean Commission Joint Research Centre)	This paper was supported by the Fundacao para a Ciencia e Tecnologia Ph.D. Grant SFRH/BD/40398/2007. JMCP participated in this research under the framework of research projects "Forest fire under climate, social and economic changes in Europe, the Mediterranean and other fire-affected areas of the world (FUME)", EC FP7 Grant Agreement No. 243888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 1997, NORTHWEST SCI, V71, P153; Bajocco S, 2008, LANDSCAPE ECOL, V23, P241, DOI 10.1007/s10980-007-9176-5; Boer MM, 2008, LANDSCAPE ECOL, V23, P899, DOI 10.1007/s10980-008-9260-5; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Breiman L, 1993, CLASSIFICATION REGRE; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Buskirk SW, 2006, J WILDLIFE MANAGE, V70, P358, DOI 10.2193/0022-541X(2006)70[358:MFSORS]2.0.CO;2; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Carmo M, 2011, LANDSCAPE URBAN PLAN, V100, P169, DOI 10.1016/j.landurbplan.2010.11.017; CNIG, 1990, COS90 CART OC SOL PO; Falk DA, 2007, ECOSYSTEMS, V10, P809, DOI 10.1007/s10021-007-9070-7; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Fernandes PM, 2013, LANDSCAPE URBAN PLAN, V110, P175, DOI 10.1016/j.landurbplan.2012.10.014; Fernandes PM, 2012, INT J WILDLAND FIRE, V21, P380, DOI 10.1071/WF10063; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Hoinka K, 2012, INT J WILDLAND FIRE, V18, P36; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Keeley JE, 2001, CONSERV BIOL, V15, P1561, DOI 10.1046/j.1523-1739.2001.t01-1-00186.x; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Keeley JE, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P350; Keeley JE, 2009, J FOREST, V107, P287; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 2011, QUANTILE REGRESSION, P1; Koenker R, 2005, QUANTILE REGRESSION, P255; Koutsias N, 2003, INT J WILDLAND FIRE, P1; Koutsias N, 2012, AGR FOREST METEOROL, V156, P41, DOI 10.1016/j.agrformet.2011.12.006; Li YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024299; Lloret F, 2002, LANDSCAPE ECOL, V17, P745, DOI 10.1023/A:1022966930861; Loepfe L, 2010, FOREST ECOL MANAG, V259, P2366, DOI 10.1016/j.foreco.2010.03.009; Manly B, 2010, RESOURCE SELECTION A, P240; MINNICH RA, 1983, SCIENCE, V219, P1287, DOI 10.1126/science.219.4590.1287; Minnich RA, 2001, CONSERV BIOL, V15, P1549, DOI 10.1046/j.1523-1739.2001.01067.x; Miranda P., 2002, CLIMATE CHANGE PORTU, P23; Moreira F, 2001, LANDSCAPE ECOL, V16, P557, DOI 10.1023/A:1013130528470; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moreira F, 2010, LANDSCAPE ECOL, V25, P1405, DOI 10.1007/s10980-010-9491-0; Moreira F, 2009, INT J WILDLAND FIRE, V18, P563, DOI 10.1071/WF07098; Moreno JM, 2011, INT J WILDLAND FIRE, V20, P678, DOI 10.1071/WF10005; Moritz MA, 2003, ECOLOGY, V84, P351, DOI 10.1890/0012-9658(2003)084[0351:SAOCOS]2.0.CO;2; Moritz MA, 1997, ECOL APPL, V7, P1252, DOI 10.1890/1051-0761(1997)007[1252:AEDEFI]2.0.CO;2; Nunes MCS, 2005, LANDSCAPE ECOL, V20, P661, DOI 10.1007/s10980-005-0070-8; Oliveira S, 2014, INT J WILDLAND FIRE, V23, P620, DOI 10.1071/WF12053; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Pereira J, 2003, FIRE RISK BURNED ARE, P23; Pereira MG, 2005, AGR FOREST METEOROL, V129, P11, DOI 10.1016/j.agrformet.2004.12.007; Pezzatti GB, 2009, PLANT BIOSYST, V143, P609, DOI 10.1080/11263500903233292; Rundel, 2012, FIRE MEDITERRANEAN E, P83; Schoenberg FP, 2003, INT J WILDLAND FIRE, V12, P1, DOI 10.1071/WF02053; Silva JS, 2009, PLANT BIOSYST, V143, P597, DOI 10.1080/11263500903233250; Silva JS, 2011, LANDSCAPE URBAN PLAN, V101, P349, DOI 10.1016/j.landurbplan.2011.03.001; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Terrell JW, 1996, T AM FISH SOC, V125, P104, DOI 10.1577/1548-8659(1996)125<0104:MSFHLF>2.3.CO;2; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1	58	55	57	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84760	10.1371/journal.pone.0084760	http://dx.doi.org/10.1371/journal.pone.0084760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454747	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500018
J	Ceccarelli, V; Nocentini, G; Billi, M; Racanicchi, S; Riccardi, C; Roberti, R; Grignani, F; Binaglia, L; Vecchini, A				Ceccarelli, Veronica; Nocentini, Giuseppe; Billi, Monia; Racanicchi, Serena; Riccardi, Carlo; Roberti, Rita; Grignani, Francesco; Binaglia, Luciano; Vecchini, Alba			Eicosapentaenoic Acid Activates RAS/ERK/C/EBP beta Pathway through H-Ras Intron 1 CpG Island Demethylation in U937 Leukemia Cells	PLOS ONE			English	Article							DNA METHYLATION; MONOCYTIC DIFFERENTIATION; GENE-EXPRESSION; CANCER-CELLS; LIPID RAFTS; C/EBP-BETA; TRANSCRIPTION; EPIGENETICS; PCR; HYPERMETHYLATION	Epigenetic alterations, including aberrant DNA methylation, contribute to tumor development and progression. Silencing of tumor suppressor genes may be ascribed to promoter DNA hypermethylation, a reversible phenomenon intensely investigated as potential therapeutic target. Previously, we demonstrated that eicosapentaenoic acid (EPA) exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein delta (C/EBP delta). The C/EBPb/C/EBP delta heterodimer formed appears essential for the monocyte differentiation commitment. The present study aims to evaluate the effect of EPA on RAS/extracellular signal regulated kinases (ERK1/2)/C/EBP beta pathway, known to be induced during the monocyte differentiation program. We found that EPA conditioning of U937 leukemia cells activated RAS/ERK/C/EBP beta pathway, increasing the C/EBP beta and ERK1/2 active phosphorylated forms. Transcriptional induction of the upstream activator H-Ras gene resulted in increased expression of H-Ras protein in the active pool of non raft membrane fraction. H-Ras gene analysis identified an hypermethylated CpG island in intron 1 that can affect the DNA-protein interaction modifying RNA polymerase II (RNAPII) activity. EPA treatment demethylated almost completely this CpG island, which was associated with an enrichment of active RNAPII. The increased binding of the H-Ras transcriptional regulator p53 to its consensus sequence within the intronic CpG island further confirmed the effect of EPA as demethylating agent. Our results provide the first evidence that an endogenous polyunsaturated fatty acid (PUFA) promotes a DNA demethylation process responsible for the activation of RAS/ERK/C/EBP beta pathway during the monocyte differentiation commitment. The new role of EPA as demethylating agent paves the way for studying PUFA action when aberrant DNA methylation is involved.	[Ceccarelli, Veronica; Billi, Monia; Racanicchi, Serena; Roberti, Rita; Grignani, Francesco; Binaglia, Luciano; Vecchini, Alba] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Nocentini, Giuseppe; Riccardi, Carlo] Univ Perugia, Dept Med, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Vecchini, A (corresponding author), Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy.	alba.vecchini@unipg.it	Nocentini, Giuseppe/B-9412-2013; Riccardi, Carlo/N-4610-2014; Nocentini, Giuseppe/GZB-0146-2022; Grignani, Francesco/AAC-2565-2022	Nocentini, Giuseppe/0000-0002-5209-0488; Riccardi, Carlo/0000-0001-9257-3997; ROBERTI, Rita/0000-0003-4131-5933; Ceccarelli, Veronica/0000-0003-0424-6940; Vecchini, Alba/0000-0003-1253-7625	Ministero delle Politiche Agricole, Alimentari e Forestali; Italian Association for Cancer Research (AIRC) [IG-9390]; Fondazione Cassa di Risparmio di Perugia [2012.0137.021]	Ministero delle Politiche Agricole, Alimentari e Forestali; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This research was supported by grants from Ministero delle Politiche Agricole, Alimentari e Forestali to LB, Italian Association for Cancer Research (AIRC) to FG (project IG-9390), and Fondazione Cassa di Risparmio di Perugia to CR (project 2012.0137.021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Ceccarelli V, 2011, J BIOL CHEM, V286, P27092, DOI 10.1074/jbc.M111.253609; Dai ZY, 2004, ONCOGENE, V23, P3521, DOI 10.1038/sj.onc.1207441; Diakiw SM, 2012, LEUKEMIA RES, V36, P110, DOI 10.1016/j.leukres.2011.09.013; Dorrell C, 2004, MOL CELL BIOL, V24, P6993, DOI 10.1128/MCB.24.16.6993-7002.2004; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; HASHIMOTOGOTOH T, 1988, ANTICANCER RES, V8, P851; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HIBI S, 1993, BLOOD, V81, P1841; HONKAWA H, 1987, MOL CELL BIOL, V7, P2933, DOI 10.1128/MCB.7.8.2933; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; ITOH YH, 1986, ANAL BIOCHEM, V154, P200, DOI 10.1016/0003-2697(86)90515-4; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; Klug M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r46; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Ko YG, 1999, J IMMUNOL, V162, P7217; Kotsinas A, 2001, CANCER GENET CYTOGEN, V126, P147, DOI 10.1016/S0165-4608(00)00407-6; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Luo J, 2010, INT J BIOL SCI, V6, P784; MACALA LJ, 1983, J LIPID RES, V24, P1243; Mack GS, 2006, J NATL CANCER I, V98, P1443, DOI 10.1093/jnci/djj447; Maher J, 1996, LEUKEMIA, V10, P83; Marcinkowska E, 2006, EXP CELL RES, V312, P2054, DOI 10.1016/j.yexcr.2006.03.003; Medvedeva YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-48; Membrino A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024421; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Pethe V, 1999, J BIOL CHEM, V274, P30969, DOI 10.1074/jbc.274.43.30969; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Siddiqui RA, 2007, NUTR CLIN PRACT, V22, P74, DOI 10.1177/011542650702200174; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; van Roon EHJ, 2011, EUR J HUM GENET, V19, P307, DOI 10.1038/ejhg.2010.187; Williams JA, 2012, BIOPHYS J, V103, P228, DOI 10.1016/j.bpj.2012.06.016; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Zachos G, 1997, CRIT REV ONCOL HEMAT, V26, P65, DOI 10.1016/S1040-8428(97)00013-9	55	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85025	10.1371/journal.pone.0085025	http://dx.doi.org/10.1371/journal.pone.0085025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454781	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500032
J	Hu, WT; Li, JX; Su, H; Wang, JW; Xu, JS; Liu, YN; Huang, M; Cheng, XS				Hu, Weitong; Li, Juxiang; Su, Hai; Wang, Jiwei; Xu, Jinsong; Liu, Yanna; Huang, Ming; Cheng, Xiaoshu			The Inter-Arm Diastolic Blood Pressure Difference Induced by One Arm Ischemia: A New Approach to Assess Vascular Endothelia Function	PLOS ONE			English	Article							FLOW-MEDIATED VASODILATION; BRACHIAL-ARTERY; EXERCISE; DYSFUNCTION; REACTIVITY; HUMANS; AGE	Objectives: To evaluate whether inter-arm diastolic blood pressure difference (DBPl-r) induced by one arm ischemia correlates with flow-mediated dilatation (FMD). Methods: Bilateral arm BPs were simultaneously measured with two automatic devices and right brachial artery diameter (D) was measured by ultrasound technique in 108 subjects (56 hypertensives and 52 normotensives). Following baseline diameter (D0) and BP measurement, right brachial artery was occluded for 5 minutes. The diameter was measured at 1, 1.5 and 2 min, and bilateral BPs measured at 3, 4 and 5 min after occlusion release. Their averages were recorded as post-D and post-BP, respectively. The difference between post-D and D0 (Delta D) was calculated as the percentage increase of artery diameter (Delta D/D0). The BP difference between left and right arms was calculated as BPl-r, and the difference of post-BPl-r and baseline BPl-r was recorded as the net change of BPl-r (Delta BPl-r). Results: At baseline, bilateral SBPs and DBPs were similar. Right arm ischemia induced significant DBP decline only in the right arm (68.8+/-12.7 vs 72.6+/-12.0 mmHg, P<0.05), which led to an increase of Delta DBPl-r (4.00+/-3.75 vs 0.78+/-4.47 mmHg, P<0.05). A positive correlation was seen between Delta D/D0 and Delta DBPl-r (r = 0.744, p<0.001). Furthermore, the correlation between age and Delta DBPl-r (r = -0.358, P<0.01) was similar to that between age and D/D0 (r = -0.398, P<0.01). Meanwhile, both Delta DBPl-r and Delta D/D0 were significantly lower in hypertensive patients than in normotensive patients. Conclusion: The inter-arm DBP difference induced by one arm ischemia may be a potential index for clinical evaluation of vascular endothelial function.	[Hu, Weitong; Li, Juxiang; Su, Hai; Cheng, Xiaoshu] Nanchang Univ, Res Inst Cardiovasc Dis, Nanchang, Jiangxi, Peoples R China; [Hu, Weitong; Li, Juxiang; Su, Hai; Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China; [Wang, Jiwei; Xu, Jinsong; Liu, Yanna; Huang, Ming] Nanchang Univ, Affiliated Hosp 2, Clin Echocardiog Lab, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Su, H (corresponding author), Nanchang Univ, Res Inst Cardiovasc Dis, Nanchang, Jiangxi, Peoples R China.	suyihappy@sohu.com			National High Technology Research and Development Program of China (863 Program) [2012AA02A516]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tahami BA, 2011, CLIN HEMORHEOL MICRO, V47, P87, DOI 10.3233/CH-2010-1370; Black MA, 2009, AM J PHYSIOL-HEART C, V297, pH1109, DOI 10.1152/ajpheart.00226.2009; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; DeVan AE, 2011, AM J PHYSIOL-HEART C, V300, pH813, DOI 10.1152/ajpheart.00845.2010; Faizi AK, 2009, CLIN PHYSIOL FUNCT I, V29, P372, DOI 10.1111/j.1475-097X.2009.00882.x; Faria TD, 2010, EUR J APPL PHYSIOL, V110, P359, DOI 10.1007/s00421-010-1508-5; Gaenzer H, 2001, J AM COLL CARDIOL, V38, P1313, DOI 10.1016/S0735-1097(01)01575-3; Hong DZ, 2011, BLOOD PRESS MONIT, V16, P134, DOI 10.1097/MBP.0b013e328346a81e; Hu WT, 2013, BLOOD PRESS MONIT, V18, P107, DOI 10.1097/MBP.0b013e32835d101b; MacDonald JR, 2002, J HUM HYPERTENS, V16, P225, DOI 10.1038/sj.jhh.1001377; Sala C, 2006, AM J HYPERTENS, V19, P713, DOI 10.1016/j.amjhyper.2005.08.021; Varady KA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-8; Zhang XQ, 2011, CIRCULATION, V124, P77, DOI 10.1161/CIRCULATIONAHA.110.990333	15	9	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84765	10.1371/journal.pone.0084765	http://dx.doi.org/10.1371/journal.pone.0084765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454748	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500019
J	Moll, G; Hult, A; von Bahr, L; Alm, JJ; Heldring, N; Hamad, OA; Stenbeck-Funke, L; Larsson, S; Teramura, Y; Roelofs, H; Nilsson, B; Fibbe, WE; Olsson, ML; Le Blanc, K				Moll, Guido; Hult, Annika; von Bahr, Lena; Alm, Jessica J.; Heldring, Nina; Hamad, Osama A.; Stenbeck-Funke, Lillemor; Larsson, Stella; Teramura, Yuji; Roelofs, Helene; Nilsson, Bo; Fibbe, Willem E.; Olsson, Martin L.; Le Blanc, Katarina			Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; STEM-CELLS; STEROID-RESISTANT; WHOLE-BLOOD; CALF SERUM; TRANSPLANTATION; EXPANSION; IDENTIFICATION; ALTERNATIVES; EXPRESSION	Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens - genetically governed antigenic determinants - at all given steps of MSC-therapy, from cell isolation and preparation for clinical use, to final recipient outcome. We found that clinical MSCs do not inherently express or upregulate ABO blood group antigens after inflammatory challenge or in vitro differentiation. Although antigen adsorption from standard culture supplements was minimal, MSCs adsorbed small quantities of ABO antigen from fresh human AB plasma (ABP), dependent on antigen concentration and adsorption time. Compared to cells washed in non-immunogenic human serum albumin (HSA), MSCs washed with ABP elicited stronger blood responses after exposure to blood from healthy O donors in vitro, containing high titers of ABO antibodies. Clinical evaluation of hematopoietic stem cell transplant (HSCT) recipients found only very low titers of anti-A/B agglutination in these strongly immunocompromised patients at the time of MSC treatment. Patient analysis revealed a trend for lower clinical response in blood group O recipients treated with ABP-exposed MSC products, but not with HSA-exposed products. We conclude, that clinical grade MSCs are ABO-neutral, but the ABP used for washing and infusion of MSCs can contaminate the cells with immunogenic ABO substance and should therefore be substituted by non-immunogenic HSA, particularly when cells are given to immunocompentent individuals.	[Moll, Guido; Alm, Jessica J.; Heldring, Nina; Larsson, Stella; Le Blanc, Katarina] Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, Stockholm, Sweden; [Hult, Annika; Olsson, Martin L.] Lund Univ, Div Hematol & Transfus Med, Dept Lab Med, Lund, Sweden; [von Bahr, Lena; Le Blanc, Katarina] Karolinska Univ, Huddinge Hosp, Hematol Ctr, Stockholm, Sweden; [Hamad, Osama A.; Stenbeck-Funke, Lillemor; Teramura, Yuji; Nilsson, Bo] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Roelofs, Helene; Fibbe, Willem E.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Karolinska Institutet; Lund University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Moll, G (corresponding author), Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, Stockholm, Sweden.	guido.moll@ki.se	Le Blanc, Katarina/L-4631-2019; Moll, Guido/Q-1044-2018; Moll, Guido/L-6321-2019; Nilsson, Bo/B-3102-2012	Moll, Guido/0000-0001-6173-5957; Nilsson, Bo/0000-0003-0057-2730; Olsson, Martin L/0000-0003-1647-9610	Swedish Cancer Society [11 0315]; Children's Cancer Foundation [PROJ11/034]; Swedish Medical Research Council [K2011-??X-20742-04-6, K2011-65X-12219-15-6, K2011-14251]; VINNOVA [2010-00501]; Stockholm County Council (ALF) [20110152]; Cancer Society in Stockholm; Swedish Society of Medicine; Tobias Foundation; Karolinska Institutet; Swedish Research Council/VINNOVA/Swedish Foundation Strategic Research [6076170]; Juvenile Diabetes Foundation International; NIH [2U01AI065192-06]; governmental research grants to the university and regional laboratories in Lund (ALF); Region Skane Fund for Research and Development; Medical Faculty at Lund University, Sweden; Netherlands Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065192] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26106709] Funding Source: KAKEN	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); VINNOVA(Vinnova); Stockholm County Council (ALF)(Stockholm County Council); Cancer Society in Stockholm; Swedish Society of Medicine; Tobias Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council/VINNOVA/Swedish Foundation Strategic Research(VinnovaSwedish Research Council); Juvenile Diabetes Foundation International; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); governmental research grants to the university and regional laboratories in Lund (ALF); Region Skane Fund for Research and Development; Medical Faculty at Lund University, Sweden; Netherlands Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Swedish Cancer Society (11 0315), the Children's Cancer Foundation (PROJ11/034), the Swedish Medical Research Council (K2011-??X-20742-04-6), VINNOVA (2010-00501), the Stockholm County Council (ALF) (20110152), the Cancer Society in Stockholm, the Swedish Society of Medicine, the Tobias Foundation, and Karolinska Institutet (to K. L. B); the Swedish Medical Research Council (K2011-65X-12219-15-6), the Swedish Research Council/VINNOVA/Swedish Foundation Strategic Research (6076170), the Juvenile Diabetes Foundation International, and the NIH (2U01AI065192-06) (to B.N.); the Swedish Medical Research Council (K2011-14251), governmental research grants to the university and regional laboratories in Lund (ALF), Region Skane Fund for Research and Development, the Medical Faculty at Lund University, Sweden (to M.L.O.); and the Netherlands Institute for Regenerative Medicine (to W. E. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Bianco-Miotto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004788; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Connolly-Andersen AM, 2011, J VIROL, V85, P7766, DOI 10.1128/JVI.02469-10; Deak E, 2010, CYTOTHERAPY, V12, P260, DOI 10.3109/14653240903401840; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Galili U, 2006, TRANSFUS APHER SCI, V35, P45, DOI 10.1016/j.transci.2006.05.007; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Heiskanen A, 2009, GLYCOCONJUGATE J, V26, P367, DOI 10.1007/s10719-008-9217-6; Hirvonen T, 2012, STEM CELLS DEV, V21, P455, DOI 10.1089/scd.2011.0405; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hosseini-Maaf B, 2007, TRANSFUSION, V47, P2110, DOI 10.1111/j.1537-2995.2007.01436.x; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111; Nilsson B, 1998, BLOOD, V92, P1661, DOI 10.1182/blood.V92.5.1661; Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005; OLSSON ML, 1995, VOX SANG, V69, P242; Olsson ML, 2001, BLOOD, V98, P1585, DOI 10.1182/blood.V98.5.1585; Orntoft TF, 1996, CANCER RES, V56, P1031; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Ringden O, 2011, BONE MARROW TRANSPL, V46, P1158, DOI 10.1038/bmt.2010.262; Schafer R, 2011, BRIT J HAEMATOL, V153, P520, DOI 10.1111/j.1365-2141.2011.08652.x; Schallmoser Katharina, 2013, Methods Mol Biol, V946, P349, DOI 10.1007/978-1-62703-128-8_22; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Storry J R, 2009, Immunohematology, V25, P48; Stussi G, 2007, SWISS MED WKLY, V137, P15; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Toki D, 2009, TRANSPLANTATION, V88, P1186, DOI 10.1097/TP.0b013e3181ba07ec; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023	37	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85040	10.1371/journal.pone.0085040	http://dx.doi.org/10.1371/journal.pone.0085040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454787	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500034
J	Servillo, L; Giovane, A; Cautela, D; Castaldo, D; Balestrieri, ML				Servillo, Luigi; Giovane, Alfonso; Cautela, Domenico; Castaldo, Domenico; Balestrieri, Maria Luisa			Where Does N-epsilon-Trimethyllysine for the Carnitine Biosynthesis in Mammals Come from?	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; GAMMA-BUTYROBETAINE; AMINO-ACIDS; LYSINE; METABOLISM; PURIFICATION; DERIVATIVES; DEFICIENCY; SKELETAL; LIVER	N-epsilon-trimethyllysine (TML) is a non-protein amino acid which takes part in the biosynthesis of carnitine. In mammals, the breakdown of endogenous proteins containing TML residues is recognized as starting point for the carnitine biosynthesis. Here, we document that one of the main sources of TML could be the vegetables which represent an important part of daily alimentation for most mammals. A HPLC-ESI-MS/ MS method, which we previously developed for the analysis of N-G-methylarginines, was utilized to quantitate TML in numerous vegetables. We report that TML, believed to be rather rare in plants as free amino acid, is, instead, ubiquitous in them and at not negligible levels. The occurrence of TML has been also confirmed in some vegetables by a HPLC method with fluorescence detection. Our results establish that TML can be introduced as free amino acid in conspicuous amounts from vegetables. The current opinion is that mammals utilize the breakdown of their endogenous proteins containing TML residues as starting point for carnitine biosynthesis. However, our finding raises the question of whether a tortuous and energy expensive route as the one of TML formation from the breakdown of endogenous proteins is really preferred when the substance is so easily available in vegetable foods. On the basis of this result, it must be taken into account that in mammals TML might be mainly introduced by diet. However, when the alimentary intake becomes insufficient, as during starvation, it might be supplied by endogenous protein breakdown.	[Servillo, Luigi; Giovane, Alfonso; Balestrieri, Maria Luisa] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Cautela, Domenico] Stn Sperimentale Ind Essenze & Derivati Dagli Agr, Reggio Di Calabria, Italy; [Castaldo, Domenico] Univ Salerno, Dipartimento Ingn Ind & ProdAl Scarl, Fisciano, SA, Italy	Universita della Campania Vanvitelli; University of Salerno	Servillo, L (corresponding author), Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	luigi.servillo@unina2.it	Cautela, Domenico/J-5235-2013	Cautela, Domenico/0000-0003-4894-0299; Giovane, Alfonso/0000-0002-2508-2597; Balestrieri, Maria Luisa/0000-0001-6001-1789	grant PON Nutrafast [01_01226]; Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR)	grant PON Nutrafast; Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the grant PON Nutrafast no. 01_01226 sponsored by the Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIJN: Association of the Industry of Juice and Nectars, 1994, COD PRACT EV FRUIT V; BLUNDEN G, 1982, J NAT PROD, V45, P449, DOI 10.1021/np50022a015; BORUM PR, 1977, J BIOL CHEM, V252, P5651; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; CASTALDO D, 1992, J AGR FOOD CHEM, V40, P594, DOI 10.1021/jf00016a013; Cautela D, 2008, J AGR FOOD CHEM, V56, P5407, DOI 10.1021/jf8006823; Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109; Curtis TY, 2009, J AGR FOOD CHEM, V57, P1013, DOI 10.1021/jf8031292; D'Argenio G, 2006, FASEB J, V20, P2544, DOI 10.1096/fj.06-5950fje; DIMARIA P, 1982, BIOCHEMISTRY-US, V21, P1036, DOI 10.1021/bi00534a033; DUNN WA, 1981, J BIOL CHEM, V256, P2437; DUNN WA, 1984, J BIOL CHEM, V259, P764; HOUTZ RL, 1989, P NATL ACAD SCI USA, V86, P1855, DOI 10.1073/pnas.86.6.1855; Houtz RL, 2008, J EXP BOT, V59, P1635, DOI 10.1093/jxb/erm360; HUSZAR G, 1975, J MOL BIOL, V94, P311, DOI 10.1016/0022-2836(75)90205-3; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; LABADIE J, 1976, BIOCHEM J, V160, P85, DOI 10.1042/bj1600085; LOIUDICE R, 1995, FOOD CHEM, V53, P81, DOI 10.1016/0308-8146(95)95791-4; LOMBARD KA, 1989, AM J CLIN NUTR, V50, P301, DOI 10.1093/ajcn/50.2.301; MacKinnon SL, 2010, J APPL PHYCOL, V22, P489, DOI 10.1007/s10811-009-9483-0; MORSE RK, 1975, BIOCHEMISTRY-US, V14, P4316, DOI 10.1021/bi00690a028; Piergiovanni A. R., 2011, Food and Nutrition Sciences, V2, P207, DOI 10.4236/fns.2011.23028; REBOUCHE CJ, 1995, METABOLISM, V44, P624, DOI 10.1016/0026-0495(95)90120-5; REBOUCHE CJ, 1986, J NUTR, V116, P751; Rippa S, 2012, PLANT PHYSIOL BIOCH, V60, P109, DOI 10.1016/j.plaphy.2012.08.001; Rozan P, 2001, PHYTOCHEMISTRY, V58, P281, DOI 10.1016/S0031-9422(01)00200-X; Servillo L, 2013, NITRIC OXIDE-BIOL CH, V30, P43, DOI 10.1016/j.niox.2013.02.080; Shek PYI, 2006, J PHYS CHEM A, V110, P8282, DOI 10.1021/jp055426k; Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004; Stephens FB, 2011, AM J CLIN NUTR, V94, P938, DOI 10.3945/ajcn.111.012047; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; THOMPSON MP, 1989, PLANT PHYSIOL, V89, P501, DOI 10.1104/pp.89.2.501; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; WATTERSON DM, 1980, BIOCHEMISTRY-US, V19, P5762, DOI 10.1021/bi00566a015	35	44	45	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84589	10.1371/journal.pone.0084589	http://dx.doi.org/10.1371/journal.pone.0084589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454731	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500013
J	Zhu, Y; Ye, XS; Zhu, B; Pei, XH; Wei, L; Wu, JQ; Zhao, WH				Zhu, Ying; Ye, Xiaoshuang; Zhu, Bei; Pei, Xiaohua; Wei, Lu; Wu, Jianqing; Zhao, Weihong			Comparisons between the 2012 New CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) Equations and Other Four Approved Equations	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; POSITION STATEMENT; CHINESE PATIENTS; GFR ESTIMATION; RENAL-DISEASE; CREATININE; DIET	Objective: The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) reported two equations in 2012: one based on cystatin C concentration (CKD-EPI2012cys) and the other using both serum creatinine and cystatin C concentrations (CKD-EPI2012Scr-cys). We compared the adaptability of new formulae with other four equations. Methods: Participants (n = 788; median age, 54 [range, 19-94] years) were recruited from the First Affiliated Hospital of Nanjing Medical University. The reference glomerular filtration rate (rGFR) was measured by a (99)mTc-DTPA renal dynamic imaging method, and the estimated glomerular filtration rate (eGFR) was calculated separately by the Chinese adapted Modification of Diet in Renal Disease equation (C-MDRD), MacIsaac, Ma, serum creatinine-based CKD-EPI equation (CKD-EPI2009Scr), CKD-EPI2012cys and CKD-EPI2012Scr-cys equations. We compared the performance of six equations with rGFR. Results: Median rGFR was 76.35 (interquartile range, 59.03-92.50) mL/min/1.73 m(2). Compared with CKD-EPI2009Scr, CKDEPI2012Scr-cys formula had better diagnostic value with larger area under the receiver operating characteristic curve (ROCAUC, 0.879, p = 0.006), especially in young participants (ROCAUC, 0.883, p = 0.005). CKD-EPI2012cys equation did not perform better than other available equations. Accuracy (the proportion of eGFR within 30% of rGFR [P-30]) of the CKD-EPI2012Scr-cys equation (77.03%) was inferior only to MacIsaac equation (80.2%) in the entire participants, but performed best in young participants with normal or mildly-injured GFR. Neither of the two new CKD-EPI equations achieved any ideal P30 in the elderly participants with moderately-severely injured GFR. Linear regression analysis demonstrated a consistent result. In this study, CKD-EPI2012Scr-cys had a relatively better diagnosis consistency of GFR stage between the eGFR and rGFR in the whole cohort. Conclusion: CKD-EPI2012Scr-cys appeared less biased and more accurate in overall participants. Neither of the new CKD-EPI equations achieved ideal accuracy in senior participants with moderately-severely injured GFR. A large-scale study with more subjects and cooperating centers to develop new formulae for the elderly is assumed to be necessary.	[Zhu, Ying; Ye, Xiaoshuang; Zhu, Bei; Pei, Xiaohua; Wei, Lu; Zhao, Weihong] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Div Nephrol, Nanjing, Jiangsu, Peoples R China; [Zhu, Ying] Huaian First Peoples Hosp, Dept Nephrol, Huaian, Jiangsu, Peoples R China; [Wu, Jianqing] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Div Respirat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhao, WH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Div Nephrol, Nanjing, Jiangsu, Peoples R China.	zhaoweihong_1@medmail.com.cn			Innovation of Science and Technology Achievement Transformation Fund of Jiangsu Province [BL2012066]; National Natural Science Foundation of China [H0511-810705]; Major State Basic Research Development Program of China [2013CB530803]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	Innovation of Science and Technology Achievement Transformation Fund of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Innovation of Science and Technology Achievement Transformation Fund of Jiangsu Province BL2012066, the National Natural Science Foundation of China H0511-810705, the grants from the Major State Basic Research Development Program of China 2013CB530803, and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions JX10231801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvet Y, 2006, PEDIATR NEPHROL, V21, P1299, DOI 10.1007/s00467-006-0145-z; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; Hojs R, 2008, CLIN NEPHROL, V70, P10; Hojs R, 2010, NEPHRON CLIN PRACT, V114, pC118, DOI 10.1159/000254384; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kilbride HS, 2013, AM J KIDNEY DIS, V61, P57, DOI 10.1053/j.ajkd.2012.06.016; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Ma YC, 2007, KIDNEY INT, V72, P1535, DOI 10.1038/sj.ki.5002566; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Macdonald J, 2006, AM J KIDNEY DIS, V48, P712, DOI 10.1053/j.ajkd.2006.07.001; Mindikoglu AL, 2013, HEPATOLOGY IN PRESS; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Obiols J, 2013, CLIN BIOCH IN PRES; Pei XH, 2012, SCAND J UROL NEPHROL, V46, P223, DOI 10.3109/00365599.2012.660985; Pei XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057852; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Rule AD, 2013, KIDNEY INT, V83, P1169, DOI 10.1038/ki.2013.7; Sjostrom P, 2005, SCAND J CLIN LAB INV, V65, P111, DOI 10.1080/00365510510013523; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431; Vinge E, 1999, SCAND J CLIN LAB INV, V59, P587, DOI 10.1080/00365519950185076; Wasen E, 2003, AM J KIDNEY DIS, V42, P36, DOI 10.1016/S0272-6386(03)00406-2; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	29	35	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84688	10.1371/journal.pone.0084688	http://dx.doi.org/10.1371/journal.pone.0084688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454737	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500015
J	Vandersickel, N; Kazbanov, IV; Nuitermans, A; Weise, LD; Pandit, R; Panfilov, AV				Vandersickel, Nele; Kazbanov, Ivan V.; Nuitermans, Anita; Weise, Louis D.; Pandit, Rahul; Panfilov, Alexander V.			A Study of Early Afterdepolarizations in a Model for Human Ventricular Tissue	PLOS ONE			English	Article							TORSADES-DE-POINTES; SPIRAL BREAKUP; LONG; MECHANISMS; PROLONGATION; TURBULENCE; SYNCHRONIZATION; PROPAGATION; CALCIUM; VOLTAGE	Sudden cardiac death is often caused by cardiac arrhythmias. Recently, special attention has been given to a certain arrhythmogenic condition, the long-QT syndrome, which occurs as a result of genetic mutations or drug toxicity. The underlying mechanisms of arrhythmias, caused by the long-QT syndrome, are not fully understood. However, arrhythmias are often connected to special excitations of cardiac cells, called early afterdepolarizations (EADs), which are depolarizations during the repolarizing phase of the action potential. So far, EADs have been studied mainly in isolated cardiac cells. However, the question on how EADs at the single-cell level can result in fibrillation at the tissue level, especially in human cell models, has not been widely studied yet. In this paper, we study wave patterns that result from single-cell EAD dynamics in a mathematical model for human ventricular cardiac tissue. We induce EADs by modeling experimental conditions which have been shown to evoke EADs at a single-cell level: by an increase of L-type Ca currents and a decrease of the delayed rectifier potassium currents. We show that, at the tissue level and depending on these parameters, three types of abnormal wave patterns emerge. We classify them into two types of spiral fibrillation and one type of oscillatory dynamics. Moreover, we find that the emergent wave patterns can be driven by calcium or sodium currents and we find phase waves in the oscillatory excitation regime. From our simulations we predict that arrhythmias caused by EADs can occur during normal wave propagation and do not require tissue heterogeneities. Experimental verification of our results is possible for experiments at the cell-culture level, where EADs can be induced by an increase of the L-type calcium conductance and by the application of I-Kr blockers, and the properties of the emergent patterns can be studied by optical mapping of the voltage and calcium.	[Vandersickel, Nele; Kazbanov, Ivan V.; Weise, Louis D.; Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [Nuitermans, Anita; Weise, Louis D.] Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands; [Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India	Ghent University; Utrecht University; Indian Institute of Science (IISC) - Bangalore	Vandersickel, N (corresponding author), Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium.	nele.vandersickel@ugent.be	Panfilov, Alexander/G-8459-2016; Vandersickel, Nele/B-2984-2016	Panfilov, Alexander/0000-0003-2643-642X; 	Research-Foundation Flanders (FWO Vlaanderen); Department of Science and Technology (DST), India; University Grants Commission (UGC), India; Robert Bosch Centre for Cyber Physical Systems (IISc); Research-Foundation Flanders (FWO)	Research-Foundation Flanders (FWO Vlaanderen)(FWO); Department of Science and Technology (DST), India(Department of Science & Technology (India)); University Grants Commission (UGC), India(University Grants Commission, India); Robert Bosch Centre for Cyber Physical Systems (IISc); Research-Foundation Flanders (FWO)(FWO)	N.similar to Vandersickel and I. Kazbanov are supported by the Research-Foundation Flanders (FWO Vlaanderen). The computational resources (STEVIN Supercomputer Infrastructure) and services used in this work were kindly provided by Ghent University, the Flemish Supercomputer Center (VSC), the Hercules Foundation and the Flemish Government - department EWI. R. Pandit acknowledges support from the research grants from the Department of Science and Technology (DST), India, the University Grants Commission (UGC), India, and the Robert Bosch Centre for Cyber Physical Systems (IISc). AV Panfilov also acknowledges the support of the Research-Foundation Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2007, EUROPACE, V9, P4, DOI 10.1093/europace/eum166; Asano Y, 1997, J AM COLL CARDIOL, V29, P831, DOI 10.1016/S0735-1097(96)00588-8; Askar SFA, 2013, CARDIOVASC RES, V97, P171, DOI 10.1093/cvr/cvs290; Brosch SF, 1998, CLIN EXP PHARMACOL P, V25, P225, DOI 10.1111/j.1440-1681.1998.t01-11-.x; Chang MG, 2012, HEART RHYTHM, V9, P115, DOI 10.1016/j.hrthm.2011.08.014; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; CRANEFIELD PF, 1977, CIRC RES, V41, P415, DOI 10.1161/01.RES.41.4.415; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Fink M, 2010, BASIC CLIN PHARMACOL, V106, P243, DOI 10.1111/j.1742-7843.2009.00534.x; Gallacher DJ, 2007, CARDIOVASC RES, V76, P247, DOI 10.1016/j.cardiores.2007.06.019; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; JANUARY CT, 1988, CIRC RES, V62, P563, DOI 10.1161/01.RES.62.3.563; Kadota S, 2013, EUR HEART J, V34, P1147, DOI 10.1093/eurheartj/ehs418; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Liu GX, 2012, J PHYSIOL-LONDON, V590, P1171, DOI 10.1113/jphysiol.2011.218164; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Majumder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018052; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Maree AFM, 1997, PHYS REV LETT, V78, P1819, DOI 10.1103/PhysRevLett.78.1819; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Noda T, 2004, EUR HEART J, V25, P2149, DOI 10.1016/j.ehj.2004.08.020; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; Panfilov AV, 1999, PHYS REV E, V59, pR6251, DOI 10.1103/PhysRevE.59.R6251; PANFILOV AV, 1990, PHYS LETT A, V151, P23, DOI 10.1016/0375-9601(90)90840-K; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; Qi X, 2009, CIRC-ARRHYTHMIA ELEC, V2, P295, DOI 10.1161/CIRCEP.108.815654; Qu Z, 2013, CARDIOVASC RES; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Ten Tusscher KHWJ, 2003, AM J PHYSIOL-HEART C, V284, pH542, DOI 10.1152/ajpheart.00608.2002; Ten Tusscher KHWJ, 2007, CIRC RES, V100, pE87, DOI 10.1161/CIRCRESAHA.107.150730; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Trayanova NA, 2011, CIRC RES, V108, P113, DOI 10.1161/CIRCRESAHA.110.223610; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Viswanathan PC, 1999, CARDIOVASC RES, V42, P530, DOI 10.1016/S0008-6363(99)00035-8; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Volders PGA, 1997, CARDIOVASC RES, V34, P348, DOI 10.1016/S0008-6363(96)00270-2; Vos MA, 2008, BRIT J PHARMACOL, V154, P1523, DOI 10.1038/bjp.2008.277; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; Yang PC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000658; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	57	52	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84595	10.1371/journal.pone.0084595	http://dx.doi.org/10.1371/journal.pone.0084595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427289	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329868200029
J	Liu, JP; Chen, L; Zhou, Y; Liu, XZ; Tang, KL				Liu, Junpeng; Chen, Lei; Zhou, You; Liu, Xiangzhou; Tang, Kanglai			Insulin-Like Growth Factor-1 and Bone Morphogenetic Protein-2 Jointly Mediate Prostaglandin E2-Induced Adipogenic Differentiation of Rat Tendon Stem Cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; REPETITIVE MOTION; GENE-EXPRESSION; FIBROBLASTS; INCREASES; RESPONSES; MATRIX; ROLES; E-2	Tendinopathy is characterized histopathologically by lipid accumulation and tissue calcification. Adipogenic and osteogenic differentiation of tendon stem cells (TSCs) are believed to play key roles in these processes. The major inflammatory mediator prostaglandin E2 (PGE2) has been shown to induce osteogenic differentiation of TSCs via bone morphogenetic protein-2 (BMP-2), and BMP-2 has also been implicated in adipogenic differentiation of stem cells. We therefore examined the mechanisms responsible for PGE2-induced adipogenesis in rat TSCs in vitro. Insulin-like growth factor-1 (IGF-1) mRNA and protein were significantly up-regulated in PGE2-stimulated TSCs, measured by quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Incubation with specific inhibitors of cAMP, cAMP-dependent protein kinase A (PKA), and CCAAT/enhancer binding protein-delta (CEBP delta) demonstrated that IGF-1 up-regulation occurred via a cAMP/PKA/CEBP delta pathway. Furthermore, neither IGF-1 nor BMP-2 alone was able to mediate adipogenic differentiation of TSCs, but IGF-1 together with BMP-2 significantly increased adipogenesis, indicated by Oil Red O staining. Moreover, knock-down of endogenous IGF-1 and BMP2 abolished PGE2-induced adipogenic differentiation. Phosphorylation of CREB and Smad by IGF-1 and BMP-2, respectively, were required for induction of the adipogenesis-related peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) gene and for adipogenic differentiation. In conclusion, IGF-1 and BMP-2 together mediate PGE2-induced adipogenic differentiation of TSCs in vitro via a CREB-and Smad-dependent mechanism. This improved understanding of the mechanisms responsible for tendinopathies may help the development of more effective therapies.	[Liu, Junpeng; Zhou, You; Liu, Xiangzhou; Tang, Kanglai] Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Chongqing, Peoples R China; [Chen, Lei] Wuhan Gen Hosp Guangzhou Mil Reg, Dept Orthopaed, Wuhan, Peoples R China	Army Medical University	Tang, KL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Chongqing, Peoples R China.	tangkanglai@126.com			National Nature Science Foundation of China [81230040]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (grant nos. 81230040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEKINDERS LC, 1993, MED SCI SPORT EXER, V25, P603; ALMEKINDERS LC, 1995, AM J SPORT MED, V23, P119, DOI 10.1177/036354659502300120; ARCHAMBAULT JM, 1995, SPORTS MED, V20, P77, DOI 10.2165/00007256-199520020-00003; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; CHARD MD, 1994, ANN RHEUM DIS, V53, P30, DOI 10.1136/ard.53.1.30; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen TL, 2001, J CELL BIOCHEM, V82, P187, DOI 10.1002/jcb.1145; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; de Mos M, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-16; Devkota AC, 2007, J ORTHOP RES, V25, P1078, DOI 10.1002/jor.20389; Devkota AC, 2010, CONNECT TISSUE RES, V51, P306, DOI 10.3109/03008200903318261; Fenwick S, 2002, RHEUMATOLOGY, V41, pA474, DOI 10.1093/rheumatology/41.4.474; GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Ji CH, 2003, MOL ENDOCRINOL, V17, P1834, DOI 10.1210/me.2002-0235; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Liu JP, 2013, BIOCHEM BIOPH RES CO, V435, P514, DOI 10.1016/j.bbrc.2012.11.083; Lui Pauline Po Yee, 2009, J Orthop Surg Res, V4, P27, DOI 10.1186/1749-799X-4-27; Maffulli N, 1998, ARTHROSCOPY, V14, P840, DOI 10.1016/S0749-8063(98)70021-0; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Riley GP, 1996, ANN RHEUM DIS, V55, P109, DOI 10.1136/ard.55.2.109; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rui YF, 2013, J ORTHOP RES, V31, P746, DOI 10.1002/jor.22290; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Zhang JY, 2012, J ORTHOP RES, V30, P47, DOI 10.1002/jor.21485; Zhang JY, 2010, J ORTHOP RES, V28, P1178, DOI 10.1002/jor.21123; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	36	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85469	10.1371/journal.pone.0085469	http://dx.doi.org/10.1371/journal.pone.0085469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416413	gold, Green Submitted, Green Published			2022-12-27	WOS:000329866300081
J	Pleger, B; Draganski, B; Schwenkreis, P; Lenz, M; Nicolas, V; Maier, C; Tegenthoff, M				Pleger, Burkhard; Draganski, Bogdan; Schwenkreis, Peter; Lenz, Melanie; Nicolas, Volkmar; Maier, Christoph; Tegenthoff, Martin			Complex Regional Pain Syndrome Type I Affects Brain Structure in Prefrontal and Motor Cortex	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; MIDBRAIN PERIAQUEDUCTAL GRAY; PRIMARY SOMATOSENSORY CORTEX; CHRONIC BACK-PAIN; CRPS-I; CORTICAL REORGANIZATION; VASCULAR ABNORMALITIES; MACAQUE MONKEYS; MATTER; PROJECTIONS	The complex regional pain syndrome (CRPS) is a rare but debilitating pain disorder that mostly occurs after injuries to the upper limb. A number of studies indicated altered brain function in CRPS, whereas possible influences on brain structure remain poorly investigated. We acquired structural magnetic resonance imaging data from CRPS type I patients and applied voxel-by-voxel statistics to compare white and gray matter brain segments of CRPS patients with matched controls. Patients and controls were statistically compared in two different ways: First, we applied a 2-sample ttest to compare whole brain white and gray matter structure between patients and controls. Second, we aimed to assess structural alterations specifically of the primary somatosensory (S1) and motor cortex (M1) contralateral to the CRPS affected side. To this end, MRI scans of patients with left-sided CRPS (and matched controls) were horizontally flipped before preprocessing and region-of-interest-based group comparison. The unpaired ttest of the "non-flipped" data revealed that CRPS patients presented increased gray matter density in the dorsomedial prefrontal cortex. The same test applied to the "flipped" data showed further increases in gray matter density, not in the S1, but in the M1 contralateral to the CRPS-affected limb which were inversely related to decreased white matter density of the internal capsule within the ipsilateral brain hemisphere. The gray-white matter interaction between motor cortex and internal capsule suggests compensatory mechanisms within the central motor system possibly due to motor dysfunction. Altered gray matter structure in dorsomedial prefrontal cortex may occur in response to emotional processes such as pain-related suffering or elevated analgesic top-down control.	[Pleger, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Pleger, Burkhard] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Draganski, Bogdan] CHU Vaudois, Dept Neurosci Clin, Lab Rech Neuroimagerie LREN, Lausanne, Switzerland; [Schwenkreis, Peter; Lenz, Melanie; Tegenthoff, Martin] Univ Hosp Bergmannsheil, Dept Neurol, Bochum, Germany; [Nicolas, Volkmar] Univ Hosp Bergmannsheil, Dept Radiol, Bochum, Germany; [Maier, Christoph] Univ Hosp Bergmannsheil, Dept Pain Treatment, Bochum, Germany	Max Planck Society; Leipzig University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Pleger, B (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	bpleger@cbs.mpg.de	Draganski, Bogdan/C-3096-2016	Draganski, Bogdan/0000-0002-5159-5919	BMBF [Bernstein Focus, State Dependencies of Learning] [01GQ0975, 18GL4DW4, 01GQ0963 (TP 4)]	BMBF [Bernstein Focus, State Dependencies of Learning]	This work was supported by the BMBF [Bernstein Focus, State Dependencies of Learning 01GQ0975; Project 18GL4DW4 to B. P. and 01GQ0963 (TP 4) to M. T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1999, PAIN, V80, P539, DOI 10.1016/S0304-3959(98)00246-2; An X, 1998, J COMP NEUROL, V401, P455; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruehl S, 2010, ANESTHESIOLOGY, V113, P713, DOI 10.1097/ALN.0b013e3181e3db38; Chang LJ, 2011, NEURON, V70, P560, DOI 10.1016/j.neuron.2011.02.056; Di Pietro F, 2013, J PAIN, V14, P1001, DOI 10.1016/j.jpain.2013.04.001; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Lenz M, 2011, NEUROLOGY, V77, P1096, DOI 10.1212/WNL.0b013e31822e1436; Lenz M, 2013, PAIN; Macoveanu J, 2013, EUR NEUROPSYCHOPHARM, V23, P919, DOI 10.1016/j.euroneuro.2012.09.006; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MANTYH PW, 1983, J NEUROPHYSIOL, V49, P567, DOI 10.1152/jn.1983.49.3.567; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; Mechias ML, 2010, NEUROIMAGE, V49, P1760, DOI 10.1016/j.neuroimage.2009.09.040; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ongur D, 1998, J COMP NEUROL, V401, P480; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pleger B, 2004, EXP BRAIN RES, V155, P115, DOI 10.1007/s00221-003-1738-4; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Porro CA, 2003, NEUROIMAGE, V19, P1738, DOI 10.1016/S1053-8119(03)00184-8; Reinersmann A, 2013, PAIN, V154, P1519, DOI 10.1016/j.pain.2013.03.039; Reinersmann A, 2012, PAIN, V153, P2174, DOI 10.1016/j.pain.2012.05.025; Reinersmann A, 2010, NEUROSCI LETT, V486, P240, DOI 10.1016/j.neulet.2010.09.062; Remy F, 2003, NEUROIMAGE, V19, P655, DOI 10.1016/S1053-8119(03)00146-0; Rommel O, 2001, PAIN, V93, P279, DOI 10.1016/S0304-3959(01)00332-3; Rommel O, 1999, PAIN, V80, P95, DOI 10.1016/S0304-3959(98)00202-4; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schwenkreis P, 2003, NEUROLOGY, V61, P515, DOI 10.1212/WNL.61.4.515; Stankewitz A, 2013, PAIN, V154, P1732, DOI 10.1016/j.pain.2013.05.019; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Tecchio F, 2002, HUM BRAIN MAPP, V17, P28, DOI 10.1002/hbm.10049; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaneker M, 2005, PAIN, V115, P204, DOI 10.1016/j.pain.2005.02.031; Wasner G, 1998, NEUROL CLIN, V16, P851, DOI 10.1016/S0733-8619(05)70101-8; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Wasner G, 1999, ARCH NEUROL-CHICAGO, V56, P613, DOI 10.1001/archneur.56.5.613	53	38	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85372	10.1371/journal.pone.0085372	http://dx.doi.org/10.1371/journal.pone.0085372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416397	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300073
J	Islam, MM; Valderas, JM; Yen, L; Dawda, P; Jowsey, T; McRae, IS				Islam, M. Mofizul; Valderas, Jose M.; Yen, Laurann; Dawda, Paresh; Jowsey, Tanisha; McRae, Ian S.			Multimorbidity and Comorbidity of Chronic Diseases among the Senior Australians: Prevalence and Patterns	PLOS ONE			English	Article							BURDEN; HEALTH; CARE	Understanding patterns and identifying common clusters of chronic diseases may help policymakers, researchers, and clinicians to understand the needs of the care process better and potentially save both provider and patient time and cost. However, only limited research has been conducted in this area, and ambiguity remains as those limited previous studies used different approaches to identify common clusters and findings may vary with approaches. This study estimates the prevalence of common chronic diseases and examines co-occurrence of diseases using four approaches: (i) identification of the most occurring pairs and triplets of comorbid diseases; performing (ii) cluster analysis of diseases, (iii) principal component analysis, and (iv) latent class analysis. Data were collected using a questionnaire mailed to a cross-sectional sample of senior Australians, with 4574 responses. Eighty-two percent of respondents reported having at least one chronic disease and over 52% reported having at least two chronic diseases. Respondents suffering from any chronic diseases had an average of 2.4 comorbid diseases. Three defined groups of chronic diseases were identified: (i) asthma, bronchitis, arthritis, osteoporosis and depression; (ii) high blood pressure and diabetes; and (iii) cancer, with heart disease and stroke either making a separate group or "attaching" themselves to different groups in different analyses. The groups were largely consistent across the approaches. Stability and sensitivity analyses also supported the consistency of the groups. The consistency of the findings suggests there is co-occurrence of diseases beyond chance, and patterns of co-occurrence are important for clinicians, patients, policymakers and researchers. Further studies are needed to provide a strong evidence base to identify comorbid groups which would benefit from appropriate guidelines for the care and management of patients with particular disease clusters.	[Islam, M. Mofizul; Yen, Laurann; Dawda, Paresh; Jowsey, Tanisha; McRae, Ian S.] Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia; [Valderas, Jose M.] Univ Exeter, Sch Med, Exeter, Devon, England	Australian National University; University of Exeter	Islam, MM (corresponding author), Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia.	mofizul.islam@anu.edu.au	Valderas, Jose M/Y-9814-2019; Valderas, Jose M/G-7967-2014; Dawda, Paresh/I-6947-2015; Islam, M Mofizul/E-8160-2012	Valderas, Jose M/0000-0002-9299-1555; Dawda, Paresh/0000-0003-2727-8320; ibitoye, oluwabunmi/0000-0002-9723-2347; Islam, M Mofizul/0000-0003-1330-863X; Jowsey, Tanisha/0000-0003-1499-9225	National Health and Medical Research Council [402793]; Australian Government Department of Health and Ageing as part of its Primary Health Care Research Evaluation and Development (PHCRED) Strategy; National Institute for Health Research [NIHR/CS/010/024] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing as part of its Primary Health Care Research Evaluation and Development (PHCRED) Strategy(Australian GovernmentDepartment of Health & Ageing); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the National Health and Medical Research Council ID (402793, 2006). The Australian Primary Health Care Research Institute is funded by the Australian Government Department of Health and Ageing as part of its Primary Health Care Research Evaluation and Development (PHCRED) Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspin C, 2010, AUST NZ J PUBL HEAL, V34, P386, DOI 10.1111/j.1753-6405.2010.00571.x; Australian Bureau of Statistics, 2007, NAT HLTH SURV SUMM R; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; Dickens C, 2001, RHEUMATOLOGY, V40, P1327, DOI 10.1093/rheumatology/40.12.1327; Everitt B. S., 2001, CLUSTER ANAL; Eyre H, 2004, DIABETES CARE, V27, P1812, DOI 10.2337/diacare.27.7.1812; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Jowsey T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059379; Kaufman L. R., 2005, FINDING GROUPS DATA; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Knox SA, 2008, MED J AUSTRALIA, V189, P66, DOI 10.5694/j.1326-5377.2008.tb01918.x; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; McCarron M, 2013, RES DEV DISABIL, V34, P521, DOI 10.1016/j.ridd.2012.07.029; McCormick WC, 2005, J AM GERIATR SOC, V53, P2227, DOI 10.1111/j.1532-5415.2005.00504.x; McRae I, 2012, AUSTR J PRIMARY HLTH; Parchman ML., 2007, APPL MULTIVAR RES, V12, P163, DOI [DOI 10.22329/AMR.V12I3.658, 10.22329/amr.v12i3.658]; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Vu T, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-45; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	35	169	176	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83783	10.1371/journal.pone.0083783	http://dx.doi.org/10.1371/journal.pone.0083783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421905	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500073
J	Lodder, SS; van Putten, MJAM				Lodder, Shaun S.; van Putten, Michel J. A. M.			A Self-Adapting System for the Automated Detection of Inter-Ictal Epileptiform Discharges	PLOS ONE			English	Article							LONG-TERM EEG; SPIKE DETECTION; EPILEPSY; CLASSIFICATION; EVENTS	Purpose: Scalp EEG remains the standard clinical procedure for the diagnosis of epilepsy. Manual detection of inter-ictal epileptiform discharges (IEDs) is slow and cumbersome, and few automated methods are used to assist in practice. This is mostly due to low sensitivities, high false positive rates, or a lack of trust in the automated method. In this study we aim to find a solution that will make computer assisted detection more efficient than conventional methods, while preserving the detection certainty of a manual search. Methods: Our solution consists of two phases. First, a detection phase finds all events similar to epileptiform activity by using a large database of template waveforms. Individual template detections are combined to form "IED nominations'', each with a corresponding certainty value based on the reliability of their contributing templates. The second phase uses the ten nominations with highest certainty and presents them to the reviewer one by one for confirmation. Confirmations are used to update certainty values of the remaining nominations, and another iteration is performed where ten nominations with the highest certainty are presented. This continues until the reviewer is satisfied with what has been seen. Reviewer feedback is also used to update template accuracies globally and improve future detections. Key Findings: Using the described method and fifteen evaluation EEGs (241 IEDs), one third of all inter-ictal events were shown after one iteration, half after two iterations, and 74%, 90%, and 95% after 5, 10 and 15 iterations respectively. Reviewing fifteen iterations for the 20-30 min recordings 1took approximately 5 min. Significance: The proposed method shows a practical approach for combining automated detection with visual searching for inter-ictal epileptiform activity. Further evaluation is needed to verify its clinical feasibility and measure the added value it presents.	[Lodder, Shaun S.; van Putten, Michel J. A. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Neurol & Clin Neurophysiol, Enschede, Netherlands	University of Twente; Medical Spectrum Twente	Lodder, SS (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	s.s.lodder@utwente.nl	van Putten, Michel J.A.M./D-6519-2018	van Putten, Michel J.A.M./0000-0001-8319-3626				Agbenu J, 2012, SEIZURE-EUR J EPILEP, V21, P422, DOI 10.1016/j.seizure.2012.04.006; Argoud FIM, 2006, MED BIOL ENG COMPUT, V44, P459, DOI 10.1007/s11517-006-0056-y; De Lucia M, 2008, MED BIOL ENG COMPUT, V46, P263, DOI 10.1007/s11517-007-0289-4; Faulkner HJ, 2012, CLIN NEUROPHYSIOL, V123, P1732, DOI 10.1016/j.clinph.2012.01.023; Friedman DE, 2009, J CLIN NEUROPHYSIOL, V26, P213, DOI 10.1097/WNP.0b013e3181b2f2da; Halford JJ, 2013, J NEUROSCI METH, V212, P308, DOI 10.1016/j.jneumeth.2012.11.005; Halford JJ, 2009, CLIN NEUROPHYSIOL, V120, P1909, DOI 10.1016/j.clinph.2009.08.007; Inan ZH, 2007, COMPUT BIOL MED, V37, P1160, DOI 10.1016/j.compbiomed.2006.10.010; Indiradevi KP, 2008, COMPUT BIOL MED, V38, P805, DOI 10.1016/j.compbiomed.2008.04.010; Ji ZF, 2011, IEEE T BIO-MED ENG, V58, P2478, DOI 10.1109/TBME.2011.2157917; Kumar Y, 2012, RES J APPL SCI ENG T, V4, P3588; Leach JP, 2006, J NEUROL NEUROSUR PS, V77, P1040, DOI 10.1136/jnnp.2005.084871; Lodder SS, 2013, CLIN NEUROPHYSIOL; Nonclercq A, 2009, NEUROPHYSIOL CLIN, V39, P123, DOI 10.1016/j.neucli.2008.12.001; Nonclercq A, 2012, J NEUROSCI METH, V210, P259, DOI 10.1016/j.jneumeth.2012.07.015; Scherg M, 2012, EPILEPSIA, V53, P1196, DOI 10.1111/j.1528-1167.2012.03503.x; Shen CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065862; Subasi A, 2006, EXPERT SYST APPL, V31, P320, DOI 10.1016/j.eswa.2005.09.027; Van Hese P, 2008, CLIN NEUROPHYSIOL, V119, P1756, DOI 10.1016/j.clinph.2008.04.009; Wang CM, 2010, COGN NEURODYNAMICS, V4, P233, DOI 10.1007/s11571-010-9120-2; Wilson SB, 2002, CLIN NEUROPHYSIOL, V113, P1873, DOI 10.1016/S1388-2457(02)00297-3; Zhou J, 2012, IEEE ENG MED BIO, P3959, DOI 10.1109/EMBC.2012.6346833	22	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85180	10.1371/journal.pone.0085180	http://dx.doi.org/10.1371/journal.pone.0085180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454813	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100060
J	Walters, KA; Huang, YG; Azaro, M; Tobin, K; Lehner, T; Brzustowicz, LM; Vieland, VJ				Walters, Kimberly A.; Huang, Yungui; Azaro, Marco; Tobin, Kathleen; Lehner, Thomas; Brzustowicz, Linda M.; Vieland, Veronica J.			Meta-Analysis of Repository Data: Impact of Data Regularization on NIMH Schizophrenia Linkage Results	PLOS ONE			English	Article							GENOME SCAN; GENETIC MAPS; FAMILIES; ANCESTRY; MEXICAN; LOCI	Human geneticists are increasingly turning to study designs based on very large sample sizes to overcome difficulties in studying complex disorders. This in turn almost always requires multi-site data collection and processing of data through centralized repositories. While such repositories offer many advantages, including the ability to return to previously collected data to apply new analytic techniques, they also have some limitations. To illustrate, we reviewed data from seven older schizophrenia studies available from the NIMH-funded Center for Collaborative Genomic Studies on Mental Disorders, also known as the Human Genetics Initiative (HGI), and assessed the impact of data cleaning and regularization on linkage analyses. Extensive data regularization protocols were developed and applied to both genotypic and phenotypic data. Genome-wide nonparametric linkage (NPL) statistics were computed for each study, over various stages of data processing. To assess the impact of data processing on aggregate results, Genome-Scan Meta-Analysis (GSMA) was performed. Examples of increased, reduced and shifted linkage peaks were found when comparing linkage results based on original HGI data to results using post-processed data within the same set of pedigrees. Interestingly, reducing the number of affected individuals tended to increase rather than decrease linkage peaks. But most importantly, while the effects of data regularization within individual data sets were small, GSMA applied to the data in aggregate yielded a substantially different picture after data regularization. These results have implications for analyses based on other types of data (e.g., case-control GWAS or sequencing data) as well as data obtained from other repositories.	[Walters, Kimberly A.; Huang, Yungui; Vieland, Veronica J.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Azaro, Marco; Tobin, Kathleen; Brzustowicz, Linda M.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Lehner, Thomas] NIMH, Genom Res Branch, Bethesda, MD 20892 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Walters, KA (corresponding author), Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA.	kimberly.walters02@nationwidechildrens.org			National Institutes of Health [R01 MH086117, U24 MH068457]; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457, R01MH086117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants R01 MH086117 and U24 MH068457. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 2008, AM J PSYCHIAT, V165, P1185, DOI 10.1176/appi.ajp.2008.07121869; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Escamilla MA, 2007, AM J MED GENET B, V144B, P193, DOI 10.1002/ajmg.b.30411; Escamilla M, 2009, AM J PSYCHIAT, V166, P442, DOI 10.1176/appi.ajp.2008.08040612; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Lange K, 2001, AM J HUM GENET, V69, P504; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Vieland VJ, 2011, HUM HERED, V72, P276, DOI 10.1159/000330634; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wiener HW, 2009, SCHIZOPHR RES, V109, P70, DOI 10.1016/j.schres.2009.02.007; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84696	10.1371/journal.pone.0084696	http://dx.doi.org/10.1371/journal.pone.0084696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454738	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800013
J	Pan, L; Wang, MY; Xie, XM; Du, CJ; Guo, YZ				Pan, Lei; Wang, Manyuan; Xie, Xiaomei; Du, Changjun; Guo, Yongzhong			Effects of Anabolic Steroids on Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Article							RESPIRATORY SOCIETY STATEMENT; BODY-COMPOSITION; NUTRITIONAL-STATUS; GROWTH-HORMONE; WEIGHT-LOSS; COPD; MORTALITY; MASS; REHABILITATION; TESTOSTERONE	Background: Anabolic steroids are known to improve body composition and muscle strength in healthy people. However, whether anabolic steroids improve the physical condition and function in patients with chronic obstructive pulmonary disease (COPD) remains undetermined. A meta-analysis was conducted to review the current evidence regarding the effects of anabolic steroids on COPD patients. Methods: A comprehensive literature search of PubMed and EMBASE was performed to identify randomised controlled trials that examine the effects of anabolic steroids on COPD patients. Weighted mean differences (WMDs) with 95% confidence intervals were calculated to determine differences between anabolic steroid administration and control conditions. Results: Eight eligible studies involving 273 COPD patients were identified in this meta-analysis. Significant improvements were found in body weight (0.956 kg), fat-free mass (1.606 kg), St. George's Respiratory Questionnaire total score (-6.336) and symptom score (-12.148). The apparent improvements in maximal inspiratory pressure (2.740 cmH(2)O) and maximal expiratory pressure (12.679 cmH(2)O) were not significant. The effects on handgrip strength, forced expiratory volume in one second (FEV1), predicted FEV1 percent, PaO2, PaCO2 and six-min walk distance were negative, with WMDs of -0.245 kg, -0.096 L/sec, -1.996% of predicted, -1.648 cmHg, -0.039 cmHg and -16.102 meters, respectively. Conclusions: Limited evidence available from the published literature suggests that the benefit of anabolic steroids on COPD patients cannot be denied. However, further studies are needed to identify the specific benefits and adverse effects of anabolic steroids on COPD patients and to determine the optimal populations and regimes of anabolic steroids in COPD patients.	[Pan, Lei] Binzhou Med Univ, Affiliated Hosp, Dept Resp & Crit Care Med, Binzhou, Peoples R China; [Wang, Manyuan] Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China; [Xie, Xiaomei] Southeast Univ, Coll Med, Affiliated Xuzhou Hosp, Dept Radiotherapy,Xuzhou Cent Hosp, Xuzhou, Peoples R China; [Du, Changjun; Guo, Yongzhong] Southeast Univ, Coll Med, Affiliated Xuzhou Hosp, Dept Resp Med,Xuzhou Cent Hosp, Xuzhou, Peoples R China	Binzhou Medical University; Capital Medical University; Southeast University - China; Southeast University - China	Guo, YZ (corresponding author), Southeast Univ, Coll Med, Affiliated Xuzhou Hosp, Dept Resp Med,Xuzhou Cent Hosp, Xuzhou, Peoples R China.	yongzhguo@sina.cn	yongzh, guo/AAJ-5207-2020	Xie, Xiaomei/0000-0001-8258-1539	Xuzhou Central Hospital [XZB201227]	Xuzhou Central Hospital	This work is supported by the Research Grant from Xuzhou Central Hospital (XZB201227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian V, 2012, CURR OPIN PULM MED, V18, P112, DOI 10.1097/MCP.0b013e32834feb37; Burdet L, 1997, AM J RESP CRIT CARE, V156, P1800, DOI 10.1164/ajrccm.156.6.9704142; Casaburi R, 2004, AM J RESP CRIT CARE, V170, P870, DOI 10.1164/rccm.200305-617OC; Creutzberg EC, 2003, CHEST, V124, P1733, DOI 10.1378/chest.124.5.1733; Debigare R, 2003, CHEST, V124, P83, DOI 10.1378/chest.124.1.83; Eisner MD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-7; Ferreira IM, 1998, CHEST, V114, P19, DOI 10.1378/chest.114.1.19; Ferreira IM, 2012, COCHRANE DB SYST REV, V12, pD998; Franssen FME, 2004, CHEST, V125, P2021, DOI 10.1378/chest.125.6.2021; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; GrayDonald K, 1996, AM J RESP CRIT CARE, V153, P961, DOI 10.1164/ajrccm.153.3.8630580; Hallin R, 2007, RESP MED, V101, P1954, DOI 10.1016/j.rmed.2007.04.009; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; PAPE GS, 1991, CHEST, V99, P1495, DOI 10.1378/chest.99.6.1495; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; SCHOLS AMWJ, 1995, AM J RESP CRIT CARE, V152, P1268, DOI 10.1164/ajrccm.152.4.7551381; Sharma S, 2008, Chron Respir Dis, V5, P169, DOI 10.1177/1479972308092350; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Svartberg J, 2004, RESP MED, V98, P906, DOI 10.1016/j.rmed.2004.02.015; Velema MS, 2012, CURR OPIN PULM MED, V18, P118, DOI 10.1097/MCP.0b013e32834e9001; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; World Health Organization, 2008, World health statistics 2008; Yan Jun-Hong, 2013, PLoS One, V8, pe61806, DOI 10.1371/journal.pone.0061806; Yeh SS, 2002, CHEST, V122, P421, DOI 10.1378/chest.122.2.421	31	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84855	10.1371/journal.pone.0084855	http://dx.doi.org/10.1371/journal.pone.0084855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427297	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200037
J	Bertella, MA; Pires, FR; Feng, L; Stanley, HE				Bertella, Mario A.; Pires, Felipe R.; Feng, Ling; Stanley, Harry Eugene			Confidence and the Stock Market: An Agent-Based Approach	PLOS ONE			English	Article							TECHNICAL ANALYSIS; FINANCIAL-MARKETS; FLUCTUATIONS; PRICE; DYNAMICS; BEHAVIOR; MODEL	Using a behavioral finance approach we study the impact of behavioral bias. We construct an artificial market consisting of fundamentalists and chartists to model the decision-making process of various agents. The agents differ in their strategies for evaluating stock prices, and exhibit differing memory lengths and confidence levels. When we increase the heterogeneity of the strategies used by the agents, in particular the memory lengths, we observe excess volatility and kurtosis, in agreement with real market fluctuations-indicating that agents in real-world financial markets exhibit widely differing memory lengths. We incorporate the behavioral traits of adaptive confidence and observe a positive correlation between average confidence and return rate, indicating that market sentiment is an important driver in price fluctuations. The introduction of market confidence increases price volatility, reflecting the negative effect of irrationality in market behavior.	[Bertella, Mario A.] Sao Paulo State Univ UNESP, Dept Econ, Sao Paulo, Brazil; [Bertella, Mario A.; Feng, Ling; Stanley, Harry Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Bertella, Mario A.; Feng, Ling; Stanley, Harry Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Pires, Felipe R.] Companhia Metropolitano Sao Paulo, Sao Paulo, Brazil; [Feng, Ling] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Feng, Ling] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore	Universidade Estadual Paulista; Boston University; Boston University; National University of Singapore; National University of Singapore	Feng, L (corresponding author), Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.	felney@gmail.com	Bertella, Mario A./AAW-7716-2020; Feng, Ling/ABD-1751-2020; Rodrigues, Pedro Henrique/D-3109-2014	Bertella, Mario A./0000-0003-3237-0455; Feng, Ling/0000-0001-6578-2558; Stanley, H./0000-0003-2800-4495	Sao Paulo State University (UNESP); Sao Paulo Research Foundation (FAPESP) [2012/17670-6]; ONR [N00014-12-1-0548]; DTRA [HDTRA-1-10-1-0014, HDTRA-1-09-1-0035]; NSF [CMMI 1125290]	Sao Paulo State University (UNESP); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ONR(Office of Naval Research); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NSF(National Science Foundation (NSF))	Professor Bertella acknowledges the support from Sao Paulo State University (UNESP) and Sao Paulo Research Foundation (FAPESP) (2012/17670-6). Professor H. Eugene Stanley acknowledges the support from ONR (GrantN00014-12-1-0548), DTRA (Grant HDTRA-1-10-1-0014, Grant HDTRA-1-09-1-0035), and NSF (Grant CMMI 1125290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrighi DM, 2005, REV ECON CONTEMP, V9, P41; Alfarano S, 2007, MACROECON DYN, V11, P80, DOI 10.1017/S1365100506060299; Arthur WB, 1996, SANTA FE I WORKING P; Barberis N, 2003, HANDB ECON, V21, P1053; Boswijk HP, 2007, J ECON DYN CONTROL, V31, P1938, DOI 10.1016/j.jedc.2007.01.001; Chen SH, 2001, J ECON DYN CONTROL, V25, P363, DOI 10.1016/S0165-1889(00)00030-0; Cont R, 2000, MACROECON DYN, V4, P170; Duffy J, 1999, INT J GAME THEORY, V28, P131, DOI 10.1007/s001820050102; Farmer JD, 2002, J ECON BEHAV ORGAN, V49, P149, DOI 10.1016/S0167-2681(02)00065-3; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Kahneman D, 1998, J PORTFOLIO MANAGE, V24, P52, DOI 10.3905/jpm.1998.409643; LeBaron B, 1999, J ECON DYN CONTROL, V23, P1487, DOI 10.1016/S0165-1889(98)00081-5; Lebaron B, 2006, HANDB ECON, V13, P1187; Lo AW, 2004, J PORTFOLIO MANAGE, P15, DOI 10.3905/jpm.2004.442611; Lovric M, 2011, BEHAV FINANCE AGENT; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Malkiel BG, 1970, J FINANC, V25, P383; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Menkhoff L, 2010, J BANK FINANC, V34, P2573, DOI 10.1016/j.jbankfin.2010.04.014; Odean T., 1998, DO INVESTORS TRADE T; Plerou V, 1999, PHYS REV E, V60, P6519, DOI 10.1103/PhysRevE.60.6519; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Sato AH, 2002, EMPIRICAL SCI FINANC; Solomon S, 2000, MICROSCOPIC SIMULATI; Takahashi H., 2003, JASSS-J ARTIF SOC S, V6, P3; TAKAYASU H, 1992, PHYSICA A, V184, P127, DOI 10.1016/0378-4371(92)90161-I; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Varian H.R., 1992, MICROECONOMIC ANAL, V3rd ed.; Yamada K, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051120	31	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83488	10.1371/journal.pone.0083488	http://dx.doi.org/10.1371/journal.pone.0083488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421888	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500051
J	Havird, JC; Santos, SR				Havird, Justin C.; Santos, Scott R.			Performance of Single and Concatenated Sets of Mitochondrial Genes at Inferring Metazoan Relationships Relative to Full Mitogenome Data	PLOS ONE			English	Article							AMINO-ACID REPLACEMENT; PHYLOGENETIC-RELATIONSHIPS; EUTHYNEURAN GASTROPODS; GENOMES; EVOLUTION; INFORMATION; SYSTEMATICS; CHARACTERS; SEQUENCES; RATES	Mitochondrial (mt) genes are some of the most popular and widely-utilized genetic loci in phylogenetic studies of metazoan taxa. However, their linked nature has raised questions on whether using the entire mitogenome for phylogenetics is overkill (at best) or pseudoreplication (at worst). Moreover, no studies have addressed the comparative phylogenetic utility of mitochondrial genes across individual lineages within the entire Metazoa. To comment on the phylogenetic utility of individual mt genes as well as concatenated subsets of genes, we analyzed mitogenomic data from 1865 metazoan taxa in 372 separate lineages spanning genera to subphyla. Specifically, phylogenies inferred from these datasets were statistically compared to ones generated from all 13 mt protein-coding (PC) genes (i.e., the "supergene" set) to determine which single genes performed "best" at, and the minimum number of genes required to, recover the "supergene" topology. Surprisingly, the popular marker COX1 performed poorest, while ND5, ND4, and ND2 were most likely to reproduce the "supergene" topology. Averaged across all lineages, the longest similar to 2 mt PC genes were sufficient to recreate the "supergene" topology, although this average increased to,5 genes for datasets with 40 or more taxa. Furthermore, concatenation of the three "best" performing mt PC genes outperformed that of the three longest mt PC genes (i.e, ND5, COX1, and ND4). Taken together, while not all mt PC genes are equally interchangeable in phylogenetic studies of the metazoans, some subset can serve as a proxy for the 13 mt PC genes. However, the exact number and identity of these genes is specific to the lineage in question and cannot be applied indiscriminately across the Metazoa.	[Havird, Justin C.; Santos, Scott R.] Auburn Univ, Dept Biol Sci, Molette Biol Lab Environm & Climate Change Studie, Auburn, AL 36849 USA; [Havird, Justin C.; Santos, Scott R.] Auburn Univ, Cellular & Mol Biosci Program, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Havird, JC (corresponding author), Auburn Univ, Dept Biol Sci, Molette Biol Lab Environm & Climate Change Studie, Auburn, AL 36849 USA.	jhavird@auburn.edu	Santos, Scott R/A-7472-2009	Havird, Justin/0000-0002-8692-6503				Abascal F, 2007, MOL BIOL EVOL, V24, P1; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 1983, EVOLUTION GENES PROT, P223; Avise John C., 1994, pi; Belinky F, 2012, MOL PHYLOGENET EVOL, V63, P702, DOI 10.1016/j.ympev.2012.02.008; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Dayrat B, 2002, ZOOL J LINN SOC-LOND, V135, P403, DOI 10.1046/j.1096-3642.2002.00018.x; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Dinapoli A, 2010, MOL PHYLOGENET EVOL, V55, P60, DOI 10.1016/j.ympev.2009.09.019; Douglas DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-14; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GODDARD W, 1994, MATH BIOSCI, V123, P215, DOI 10.1016/0025-5564(94)90012-4; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Havird JC, 2010, ZOOTAXA, P1; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Howe CJ, 2008, CURR BIOL, V18, pR429, DOI 10.1016/j.cub.2008.04.007; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Jenner RA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-21; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Mansion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050076; Medina M, 2011, MAR GENOM, V4, P51, DOI 10.1016/j.margen.2010.12.006; Mereschkovsky K.S, 1905, BIOL ZBL, V85, P593, DOI DOI 10.1017/S0967026299002231; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; San Mauro D, 2009, SYST BIOL, V58, P425, DOI 10.1093/sysbio/syp043; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simmons MP, 2004, MOL PHYLOGENET EVOL, V32, P913, DOI 10.1016/j.ympev.2004.04.011; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoger I, 2013, MOL PHYLOGENET EVOL, V69, P376, DOI 10.1016/j.ympev.2012.11.017; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vrijenhoek RC, 2012, MOL ECOL, V21, P4155, DOI 10.1111/j.1365-294X.2012.05658.x; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661	63	31	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84080	10.1371/journal.pone.0084080	http://dx.doi.org/10.1371/journal.pone.0084080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24454717	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500092
J	Johansen, JL				Johansen, Jacob L.			Quantifying Water Flow within Aquatic Ecosystems Using Load Cell Sensors: A Profile of Currents Experienced by Coral Reef Organisms around Lizard Island, Great Barrier Reef, Australia	PLOS ONE			English	Article							WAVE EXPOSURE; FIELD; VELOCITY; MODEL; HYDRODYNAMICS; BREAKAGE; FORCES	Current velocity in aquatic environments has major implications for the diversity, abundance and ecology of aquatic organisms, but quantifying these currents has proven difficult. This study utilises a simple and inexpensive instrument (<$150) to provide a detailed current velocity profile of the coral-reef system around Lizard Island (Great Barrier Reef, Australia) at a spatial and temporal scale relevant to the ecology of individual benthos and fish. The instrument uses load-cell sensors to provide a correlation between sensor output and ambient current velocity of 99%. Each instrument is able to continuously record current velocities to >500 cms(-1) and wave frequency to >100 Hz over several weeks. Sensor data are registered and processed at 16 MHz and 10 bit resolution, with a measuring precision of 0.06+/-0.04%, and accuracy of 0.51+/-0.65% (mean +/-S.D.). Each instrument is also pressure rated to 120 m and shear stresses <= 20 kNm(-2) allowing deployment in harsh environments. The instrument was deployed across 27 coral reef sites covering the crest (3 m), mid-slope (6 m) and deep-slope (9 m depth) of habitats directly exposed, oblique or sheltered from prevailing winds. Measurements demonstrate that currents over the reef slope and crest varies immensely depending on depth and exposure: Currents differ up to 9-fold within habitats only separated by 3 m depth and 15-fold between exposed, oblique and sheltered habitats. Comparisons to ambient weather conditions reveal that currents around Lizard Island are largely wind driven. Zero to 22.5 knot winds correspond directly to currents of 0 to >82 cms(-1), while tidal currents rarely exceed 5.5 cms(-1). Rather, current velocity increases exponentially as a function of wave height (0 to 1.6 m) and frequency (0.54 to 0.20 Hz), emphasizing the enormous effect of wind and waves on organisms in these shallow coral reef habitats.	[Johansen, Jacob L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Johansen, Jacob L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Johansen, JL (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	jacob.johansen@my.jcu.edu.au			Lizard Island Research Station Doctoral Fellowship	Lizard Island Research Station Doctoral Fellowship	This study was funded by the Lizard Island Research Station Doctoral Fellowship. http://australianmuseum.net.au/Lizard-Island-Research-Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL EC, 1994, J EXP MAR BIOL ECOL, V181, P9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Collar P, 2001, ENCY OCEAN SCI, P2796; DONELAN MA, 1978, REV SCI INSTRUM, V49, P298, DOI 10.1063/1.1135395; Figurski JD, 2011, LIMNOL OCEANOGR-METH, V9, P204, DOI 10.4319/lom.2011.9.204; Finelli CM, 2009, CORAL REEFS, V28, P461, DOI 10.1007/s00338-009-0481-0; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; Gaylord B, 1999, J EXP MAR BIOL ECOL, V239, P85, DOI 10.1016/S0022-0981(99)00031-3; Gaylord B, 2008, BIOL BULL-US, V215, P295, DOI 10.2307/25470713; Grigg RW, 1998, CORAL REEFS, V17, P263, DOI 10.1007/s003380050127; Hearn CJ, 2011, CORAL REEFS, V30, P1, DOI 10.1007/s00338-011-0752-4; Herbers THC, 2010, J ATMOS OCEAN TECH, V27, P210, DOI 10.1175/2009JTECHO681.1; Johansen JL, 2007, CORAL REEFS, V26, P577, DOI 10.1007/s00338-007-0217-y; Kennen JG, 2010, ECOHYDROLOGY, V3, P88, DOI 10.1002/eco.99; Kinsman B, 2002, WIND WAVES THEIR GEN; Lancaster J, 2010, RIVER RES APPL, V26, P385, DOI 10.1002/rra.1274; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002789; Mach KJ, 2011, J EXP BIOL, V214, P1571, DOI 10.1242/jeb.051623; MacVicar BJ, 2007, EARTH SURF PROC LAND, V32, P1412, DOI 10.1002/esp.1497; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Marchant R, IEEE J OCEANIC ENG, DOI [10.1109/JOE.2012.2236151, DOI 10.1109/J0E.2012.2236151]; McIntyre N, 2008, P I CIVIL ENG-WAT M, V161, P199, DOI 10.1680/wama.2008.161.4.199; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Nikora V, 2010, RIVER RES APPL, V26, P367, DOI 10.1002/rra.1291; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; PONTIUS PE, 1982, EXP MECH, V22, P81, DOI 10.1007/BF02325907; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; Randall JE, 1997, FISHES GREAT BARRIER; Schutter M, 2010, CORAL REEFS, V29, P737, DOI 10.1007/s00338-010-0617-2; Stone MC, 2007, J HYDRAUL RES, V45, P752, DOI 10.1080/00221686.2007.9521813; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; SWAIN J, 1992, P INDIAN AS-EARTH, V101, P215, DOI 10.1007/BF02878133; Utter BD, 1996, J EXP BIOL, V199, P2645; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vogel S, 2020, LIFE MOVING FLUIDS P	37	28	28	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83240	10.1371/journal.pone.0083240	http://dx.doi.org/10.1371/journal.pone.0083240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421878	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329862500038
J	Pampeno, C; Derkatch, IL; Meruelo, D				Pampeno, Christine; Derkatch, Irina L.; Meruelo, Daniel			Interaction of Human Laminin Receptor with Sup35, the [PSI+] Prion-Forming Protein from S. cerevisiae: A Yeast Model for Studies of LamR Interactions with Amyloidogenic Proteins	PLOS ONE			English	Article							DE-NOVO APPEARANCE; CELL-SURFACE RECEPTOR; BINDING-PROTEIN; RIBOSOMAL-PROTEIN; PROPAGATION; MODULATION; VIRUS; OVEREXPRESSION; CYTOSKELETON; AGGREGATION	The laminin receptor (LamR) is a cell surface receptor for extracellular matrix laminin, whereas the same protein within the cell interacts with ribosomes, nuclear proteins and cytoskeletal fibers. LamR has been shown to be a receptor for several bacteria and viruses. Furthermore, LamR interacts with both cellular and infectious forms of the prion protein, PrPC and PrPSc. Indeed, LamR is a receptor for PrPC. Whether LamR interacts with PrPSc exclusively in a capacity of the PrP receptor, or LamR specifically recognizes prion determinants of PrPSc, is unclear. In order to explore whether LamR has a propensity to interact with prions and amyloids, we examined LamR interaction with the yeast prion-forming protein, Sup35. Sup35 is a translation termination factor with no homology or functional relationship to PrP. Plasmids expressing LamR or LamR fused with the green fluorescent protein (GFP) were transformed into yeast strain variants differing by the presence or absence of the prion conformation of Sup35, respectively [PSI+] and [psi(-)]. Analyses by immunoprecipitation, centrifugal fractionation and fluorescent microscopy reveal interaction between LamR and Sup35 in [PSI+] strains. The presence of [PSI+] promotes LamR co-precipitation with Sup35 as well as LamR aggregation. In [PSI+] cells, LamR tagged with GFP or mCherry forms bright fluorescent aggregates that co-localize with visible [PSI+] foci. The yeast prion model will facilitate studying the interaction of LamR with amyloidogenic prions in a safe and easily manipulated system that may lead to a better understanding and treatment of amyloid diseases.	[Pampeno, Christine; Meruelo, Daniel] NYU, Sch Med, Gene Therapy Ctr, Inst Canc, New York, NY USA; [Pampeno, Christine; Meruelo, Daniel] NYU, Sch Med, Dept Pathol, New York, NY USA; [Derkatch, Irina L.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10027 USA	New York University; New York University; Columbia University	Derkatch, IL (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10027 USA.	ild2103@columbia.edu; DM01@mac.com			U.S. Public Health Grant from the National Cancer Institute [CA100687]; National Institutes of Health [7 R01 GM070934-06]; NATIONAL CANCER INSTITUTE [R01CA100687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070934] Funding Source: NIH RePORTER	U.S. Public Health Grant from the National Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by U.S. Public Health Grant CA100687 from the National Cancer Institute to D. M., a generous donation from the Litwin foundation and a Research and License agreement between NYU and Cynvec. This work was also supported by National Institutes of Health (grant 7 R01 GM070934-06) to I. L. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005; Bagriantsev S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-32; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; Chen MS, 1996, BBA-PROTEIN STRUCT M, V1297, P124, DOI 10.1016/S0167-4838(96)00140-9; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; CODY RL, 1986, EXP CELL RES, V165, P107, DOI 10.1016/0014-4827(86)90536-7; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Derkatch IL, 2007, PRION, V1, P161, DOI 10.4161/pri.1.3.4837; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; HUNTER I, 1992, J BIOL CHEM, V267, P6006; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P1159; Jamieson KV, 2008, J BIOL CHEM, V283, P3002, DOI 10.1074/jbc.C700206200; Jamieson KV, 2011, J MOL BIOL, V405, P24, DOI 10.1016/j.jmb.2010.10.028; Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t; KEPPEL E, 1991, J CELL SCI, V100, P789; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Kolodziejczak D, 2010, J MOL BIOL, V402, P293, DOI 10.1016/j.jmb.2010.06.055; Kushnirov VV, 2007, PRION, V1, P179, DOI 10.4161/pri.1.3.4840; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Liebman SW, 2006, METHODS, V39, P23, DOI 10.1016/j.ymeth.2006.04.010; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Ould-Abeih MB, 2012, BIOCHEMISTRY-US, V51, P4807, DOI 10.1021/bi300335r; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Piro JR, 2011, BIOCHEMISTRY-US, V50, P7111, DOI 10.1021/bi200786p; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Serio TR, 2002, ADV PROTEIN CHEM, V59, P391; Sherman F., 1986, METHODS YEAST GENETI; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tuite MF, 2007, PRION, V1, P101, DOI 10.4161/pri.1.2.4665; Venticinque L, 2012, J PROTEOME RES, V11, P4863, DOI 10.1021/pr300307h; Venticinque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015895; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; WEWER UM, 1987, CANCER RES, V47, P5691; Wickner RB, 2011, SEMIN CELL DEV BIOL, V22, P469, DOI 10.1016/j.semcdb.2011.02.021; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; YANNARIELLOBROWN J, 1988, J CELL BIOL, V106, P1773, DOI 10.1083/jcb.106.5.1773; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	80	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e86013	10.1371/journal.pone.0086013	http://dx.doi.org/10.1371/journal.pone.0086013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416454	gold, Green Published, Green Submitted			2022-12-27	WOS:000329862500269
J	Evangelista, D; Cardona, G; Guenther-Gleason, E; Huynh, T; Kwong, A; Marks, D; Ray, N; Tisbe, A; Tse, K; Koehl, M				Evangelista, Dennis; Cardona, Griselda; Guenther-Gleason, Eric; Huynh, Tony; Kwong, Austin; Marks, Dylan; Ray, Neil; Tisbe, Adrian; Tse, Kyle; Koehl, Mimi			Aerodynamic Characteristics of a Feathered Dinosaur Measured Using Physical Models. Effects of Form on Static Stability and Control Effectiveness	PLOS ONE			English	Article							4-WINGED DINOSAURS; JIUFOTANG FORMATION; LONG FEATHERS; EVOLUTION; CHINA; ARCHAEOPTERYX; MICRORAPTOR; PERFORMANCE; FLIGHT; THEROPOD	We report the effects of posture and morphology on the static aerodynamic stability and control effectiveness of physical models based on the feathered dinosaur, Microraptor gui, from the Cretaceous of China. Postures had similar lift and drag coefficients and were broadly similar when simplified metrics of gliding were considered, but they exhibited different stability characteristics depending on the position of the legs and the presence of feathers on the legs and the tail. Both stability and the function of appendages in generating maneuvering forces and torques changed as the glide angle or angle of attack were changed. These are significant because they represent an aerial environment that may have shifted during the evolution of directed aerial descent and other aerial behaviors. Certain movements were particularly effective ( symmetric movements of the wings and tail in pitch, asymmetric wing movements, some tail movements). Other appendages altered their function from creating yaws at high angle of attack to rolls at low angle of attack, or reversed their function entirely. While M. gui lived after Archaeopteryx and likely represents a side experiment with feathered morphology, the general patterns of stability and control effectiveness suggested from the manipulations of forelimb, hindlimb and tail morphology here may help understand the evolution of flight control aerodynamics in vertebrates. Though these results rest on a single specimen, as further fossils with different morphologies are tested, the findings here could be applied in a phylogenetic context to reveal biomechanical constraints on extinct flyers arising from the need to maneuver.	[Evangelista, Dennis; Guenther-Gleason, Eric; Huynh, Tony; Marks, Dylan; Tisbe, Adrian; Koehl, Mimi] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Cardona, Griselda; Tse, Kyle] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Kwong, Austin; Ray, Neil] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Evangelista, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	devangel77b@gmail.com	Evangelista, Dennis/N-4434-2013	Evangelista, Dennis/0000-0002-6565-8300; Huynh, Tony/0000-0003-2964-1795	National Science Foundation (NSF) Minority Graduate Research Fellowship; NSF Integrative Graduate Education and Research Traineeship (IGERT) [DGE-0903711]; Virginia G. and Robert E. Gill Chair	National Science Foundation (NSF) Minority Graduate Research Fellowship(National Science Foundation (NSF)); NSF Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF)); Virginia G. and Robert E. Gill Chair	The work was funded in part by a National Science Foundation (NSF) Minority Graduate Research Fellowship (to DE), NSF Integrative Graduate Education and Research Traineeship (IGERT) # DGE-0903711 (to R Full, MK, R Dudley, and R Fearing), and the Virginia G. and Robert E. Gill Chair (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Anderson JD., 2017, FUNDAMENTALS AERODYN; Angst D, 2011, NATURWISSENSCHAFTEN, P1; Beebe CW, 1915, ZOOLOGICA, V2, P39; Benton MJ, 1997, VERTEBRATE PALEONTOL; Byrnes G, 2011, INTEGR COMP BIOL, V51, P991, DOI 10.1093/icb/icr069; Cardona G, 2011, AM SOC BIOMECH; Chatterjee S, 2003, NATURWISSENSCHAFTEN, V90, P27, DOI 10.1007/s00114-002-0385-0; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; CHEER AYL, 1987, J THEOR BIOL, V129, P17, DOI 10.1016/S0022-5193(87)80201-1; COLBERT EDWIN H., 1962, AMER MUS NOVITATES, V2076, P1; Davis M, 2008, 4 WINGED DIANOSAUR N; Duan S.-Y., 1995, WOOD ANATOMY RES P I, P166; Dudley R, 2011, INTEGR COMP BIOL, V51, P926, DOI 10.1093/icb/icr002; Dyke G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3489; EMERSON SB, 1990, EVOLUTION, V44, P2153, DOI 10.1111/j.1558-5646.1990.tb04320.x; EMERSON SB, 1990, EVOLUTION, V44, P1931, DOI 10.1111/j.1558-5646.1990.tb04300.x; Etkin B., 1996, DYNAMICS FLIGHT STAB, V3rd; Evangelista D. J., 2013, THESIS U CALIFORNIA; Evangelista DJ, 2012, SO INT COMP BIOL ANN; Fish FE, 2006, ANNU REV FLUID MECH, V38, P193, DOI 10.1146/annurev.fluid.38.050304.092201; GANS C, 1987, PALEOBIOLOGY, V13, P415; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Habib M, 2012, SOC VERT PAL ANN M 2; Hall J, 2012, SOC VERTEBRATE PALEO; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019790; Hedenstrom A, 2001, J EXP BIOL, V204, P1167; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; HEPTONSTALL WB, 1970, NATURE, V228, P185, DOI 10.1038/228185a0; Hoerner SF, 1993, FLUID DYNAMIC DRAG; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huynh T, 2013, SOC INT COMP BIOL AN; Huynh T, 2011, SOC VERTEBRATE PALEO; JENKINS FA, 1984, J MORPHOL, V182, P197, DOI 10.1002/jmor.1051820207; Jones AR, 2008, J AIRCRAFT, V45, P342, DOI 10.2514/1.33001; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Koehl MAR, 2011, INTEGR COMP BIOL, V51, P1002, DOI 10.1093/icb/icr112; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; KUNDU P.K., 2004, FLUID MECH-SOV RES; Kwong A, 2013, SOC INT COMP BIOL AN; Lauder GV, 2002, INTEGR COMP BIOL, V42, P1009, DOI 10.1093/icb/42.5.1009; Lehmann FO, 2007, J EXP BIOL, V210, P1362, DOI 10.1242/jeb.02746; Liem K.F., 2000, FUNCTIONAL ANATOMY V; Lighthill J., 1975, P423; Lippincott WA, 1920, AM NAT, V54, P535, DOI 10.1086/279784; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; McCay MG, 2003, BIOTROPICA, V35, P94, DOI 10.1646/0006-3606(2003)035[0094:WUTRFC]2.0.CO;2; McCay MG, 2001, J EXP BIOL, V204, P2817; McCay MG, 2001, THESIS U CALIFORNIA; McCormick B.W., 1995, AERODYNAMICS AERONAU; McMasters J. H., 1979, NASA LANGLEY RES C 1, V1; Munk JD, 2011, THESIS U CALIFORNIA; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Padian K, 2003, BIOSCIENCE, V53, P450; Park H, 2010, J EXP BIOL, V213, P3269, DOI 10.1242/jeb.046052; Peterson K, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046008; Peterson K, 2011, SO INT COMP BIOL ANN; Peterson K, 2013, SOC INT COMP BIOL AN; Peterson K, 2011, IEEE INT C INT ROBOT; Phillips WF, 2004, MECH FLIGHT; R Core Team, 2016, R FDN STAT COMP; Reynolds O, 1875, COLLECTED PAPERS MEC, V1903, P1; Saunders G, 1977, DYNAMICS HELICOPTER; Shapiro AH, 1961, SHAPE FLOW FLUID DYN; Smith J. M., 1953, New Biol, VNo. 14, P64; Standen EM, 2007, J EXP BIOL, V210, P325, DOI 10.1242/jeb.02661; Standen EM, 2005, J EXP BIOL, V208, P2753, DOI 10.1242/jeb.01706; Stengel R.F., 2004, FLIGHT DYNAMICS; Tedrake R., 2009, 14 INT S ROB RES LUC; Tisbe A, 2011, SOC INT COMP BIOL AN; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Waldrop LD, 2012, THESIS U CALIFORNIA; Wang JK, 2005, J EXP BIOL, V208, P3785, DOI 10.1242/jeb.01852; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2005, NATURE, V438, pE3, DOI 10.1038/nature04355; Xu X, 2004, J VERTEBR PALEONTOL, V24, p251A, DOI DOI 10.1671/21; Xu X, 2006, INTEGR ZOOL, V1, P4, DOI 10.1111/j.1749-4877.2006.00004.x; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Zeng Y, THESI U CALIFORNIA B; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753; Zhou ZH, 2003, NATURWISSENSCHAFTEN, V90, P220, DOI 10.1007/s00114-003-0416-5; Zhou ZH, 2004, CHINESE SCI BULL, V49, P754, DOI 10.1360/04wd0120; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou Zhong-He, 2006, Vertebrata Palasiatica, V44, P74	94	16	16	0	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85203	10.1371/journal.pone.0085203	http://dx.doi.org/10.1371/journal.pone.0085203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454820	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100066
J	Hong, Y; Wang, YJ; Deng, Z; Wu, Q; Zhang, JM				Hong, Yuan; Wang, Yong-Jie; Deng, Zheng; Wu, Qun; Zhang, Jian-Min			Stent-Assisted Coiling versus Coiling in Treatment of Intracranial Aneurysm: A Systematic Review and MetaAnalysis	PLOS ONE			English	Review							GUGLIELMI DETACHABLE COILS; MIDTERM FOLLOW-UP; OF-THE-LITERATURE; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; NEUROFORM-STENT; OCCLUSION; EMBOLIZATION; CLOPIDOGREL; COMPACTION	Background and Purpose: Stent-assisted coiling was initially invented for wide-neck aneurysms, but is now used for smaller berry aneurysms. The aim of this study was to compare the safety and efficiency of stent-assisted coiling with conventional coiling in treatment of intracranial aneurysms. Methods: A meta-analysis of studies that compared stent-assisted coiling with coiling only was conducted by searching English literatures via Pubmed, Medline and Cochrane Library databases without restricting the publication year. The primary outcomes in this study were immediate occlusion, progressive thrombosis rate, all-complication rate and angiographic recurrence. The secondary outcomes examined were packing density, mortality, permanent complication and thromboembolic complication rate. Results: Ten retrospective cohort studies were included. There is currently only one unfinished randomized study. Although the stent-assisted coiling group tended to show a lower initial occlusion rate than that of the coiling-only group (57.6% versus 68.7%; OR, 0.66; 95% CI, 0.30-1.44; P = 0.30), it achieved a significantly higher progressive thrombosis rate during follow up compared to that of the coiling only group (37.5% versus 19.4%; OR, 2.75; 95% CI, 1.95-3.86; P, 0.00001) and a significantly lower recurrence rate (16.2% versus 34.4%; OR, 0.35; 95% CI, 0.25-0.49; P, 0.00001). With respect to safety concerns, the all-complication rate (17.6% versus 15.9%; OR, 1.12; 95% CI, 0.77-1.62; P = 0.56), mortality rate (9.1% versus 2.6%; OR, 2.31; 95% CI, 0.68-7.82; P = 0.18), permanent complication rate (5.6% versus 3.9%; OR, 1.52; 95% CI, 0.96-2.41; P = 0.08) and thromboembolic complication rate (4.2% versus 4.9%; OR, 0.99; 95% CI, 0.41-2.38; P = 0.97) did not show significant difference between the two groups. Conclusions: Stent-assisted coiling has a lower recurrence rate than conventional coiling. Analysis of complication events did not show any significant difference between the two methods. Despite the findings reported herein, further validation by well-designed prospective studies is needed.	[Hong, Yuan; Wang, Yong-Jie; Deng, Zheng; Wu, Qun; Zhang, Jian-Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wu, Q (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China.	wuqun30639@sina.cn; zjm135vip@sina.com			National Natural Science Foundation of China [81171096]; Natural Science Foundation of Zhejiang province [Z2090200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province)	The work was partially supported by grants from the National Natural Science Foundation of China (81171096, http://www.nsfc.gov.cn) and the Natural Science Foundation of Zhejiang province (Z2090200, http://www.zjnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari SH, 2012, J NEUROINTERV SURG; Albuquerque FC, 2011, NEUROSURGERY, V68, P820, DOI 10.1227/NEU.0b013e3182077f17; Benitez RP, 2004, NEUROSURGERY, V54, P1359, DOI 10.1227/01.NEU.0000124484.87635.CD; Biondi A, 2007, NEUROSURGERY, V61, P460, DOI 10.1227/01.NEU.0000290890.62201.A9; Bodily KD, 2011, AM J NEURORADIOL, V32, P1232, DOI 10.3174/ajnr.A2478; Chalouhi N, 2012, NEUROSURGERY, V71, P785, DOI 10.1227/NEU.0b013e318265a416; Colby GP, 2012, J NEUROINTERV SURG, V4, P116, DOI 10.1136/jnis.2011.004911; Darsaut TE, 2012, J NEUROINTERV SURG, V4, P178, DOI 10.1136/neurintsurg-2011-010065; Fiorella D, 2005, NEUROSURGERY, V56, P1191, DOI 10.1227/01.NEU.0000159645.86823.AF; Gordhan A, 2011, NEUROL RES, V33, P942, DOI 10.1179/1743132811Y.0000000014; Higashida RT, 1997, J NEUROSURG, V87, P944, DOI 10.3171/jns.1997.87.6.0944; Izar B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024875; Kan P, 2013, NEUROSURGERY, V72, P216, DOI [10.1227/NEU.0b013e31827b9183, 10.1227/NEU.0b013e31827b93ea]; Kawanabe Y, 2001, ACTA NEUROCHIR, V143, P451, DOI 10.1007/s007010170073; Kim DJ, 2010, ACTA NEUROCHIR, V152, P423, DOI 10.1007/s00701-009-0522-z; Koebbe Christopher J, 2006, Neurosurgery, V59, pS93; Kole MK, 2005, J NEUROSURG, V102, P607, DOI 10.3171/jns.2005.102.4.0607; Kung DK, 2011, J NEUROSURG, V114, P1021, DOI 10.3171/2010.9.JNS10445; Lanzino G, 2005, NEUROSURGERY, V57, P449, DOI 10.1227/01.NEU.0000170538.74899.7F; Lawson MF, 2011, NEUROSURGERY, V69, P598, DOI 10.1227/NEU.0b013e3182181c2b; Lee DH, 2008, AM J NEURORADIOL, V29, P1389, DOI 10.3174/ajnr.A1070; Li H, 2013, STROKE, V44, P29, DOI 10.1161/STROKEAHA.112.663559; Li MH, 2006, AM J NEURORADIOL, V27, P1107; Mocco J, 2011, NEUROSURGERY, V69, P908, DOI 10.1227/NEU.0b013e318228490c; Ogilvy CS, 2011, J NEUROINTERV SURG, V3, P14, DOI 10.1136/jnis.2010.002303; Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114; Prabhakaran S, 2008, AM J NEURORADIOL, V29, P281, DOI 10.3174/ajnr.A0818; Raymond J, 2013, AM J NEURORADIOL, V34, P570, DOI 10.3174/ajnr.A3231; Raymond J, 2003, STROKE, V34, P2801, DOI 10.1161/01.STR.0000098651.14384.AB; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Reavey-Cantwell JF, 2009, NEUROSURGERY, V64, P890, DOI 10.1227/01.NEU.0000341904.39691.2F; Shapiro M, 2012, AM J NEURORADIOL, V33, P159, DOI 10.3174/ajnr.A2719; Sluzewski M, 2004, RADIOLOGY, V231, P653, DOI 10.1148/radiol.2313030460; Tahtinen OI, 2009, RADIOLOGY, V253, P199, DOI 10.1148/radiol.2531081923; Tateshima S, 2009, J NEUROSURG, V111, P22, DOI 10.3171/2009.2.JNS081324; Yahia AM, 2008, NEUROCRIT CARE, V8, P19, DOI 10.1007/s12028-007-9001-7; Yahia AM, 2010, J NEUROIMAGING, V20, P113, DOI 10.1111/j.1552-6569.2009.00390.x; Zhu YQ, 2010, J ENDOVASC THER, V17, P55, DOI 10.1583/09-2688.1	38	153	168	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e82311	10.1371/journal.pone.0082311	http://dx.doi.org/10.1371/journal.pone.0082311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454690	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100004
J	Kota, S; Charaka, VK; Ringgaard, S; Waldor, MK; Misra, HS				Kota, Swathi; Charaka, Vijaya K.; Ringgaard, Simon; Waldor, Matthew K.; Misra, Hari S.			PprA Contributes to Deinococcus radiodurans Resistance to Nalidixic Acid, Genome Maintenance after DNA Damage and Interacts with Deinococcal Topoisomerases	PLOS ONE			English	Article							RADIATION-RESISTANCE; SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; CELL-DIVISION; PROTEIN; BACTERIUM; FAMILY; REPAIR; RADIORESISTANCE; MECHANISMS	PprA is known to contribute to Deinococcus radiodurans' remarkable capacity to survive a variety of genotoxic assaults. The molecular bases for PprA's role(s) in the maintenance of the damaged D. radiodurans genome are incompletely understood, but PprA is thought to promote D. radiodurans's capacity for DSB repair. PprA is found in a multiprotein DNA processing complex along with an ATP type DNA ligase, and the D. radiodurans toposiomerase IB (DraTopoIB) as well as other proteins. Here, we show that PprA is a key contributor to D. radiodurans resistance to nalidixic acid (Nal), an inhibitor of topoisomerase II. Growth of wild type D. radiodurans and a pprA mutant were similar in the absence of exogenous genotoxic insults; however, the pprA mutant exhibited marked growth delay and a higher frequency of anucleate cells following treatment with DNA-damaging agents. We show that PprA interacts with both DraTopoIB and the Gyrase A subunit (DraGyrA) in vivo and that purified PprA enhances DraTopoIB catalysed relaxation of supercoiled DNA. Thus, besides promoting DNA repair, our findings suggest that PprA also contributes to preserving the integrity of the D. radiodurans genome following DNA damage by interacting with DNA topoisomerases and by facilitating the actions of DraTopoIB.	[Kota, Swathi; Charaka, Vijaya K.; Misra, Hari S.] Bhabha Atom Res Ctr, Div Mol Biol, Mumbai 400085, Maharashtra, India; [Charaka, Vijaya K.; Ringgaard, Simon; Waldor, Matthew K.; Misra, Hari S.] Harvard Univ, Brigham & Womens Hosp, Dept Microbiol & Immunobiol, Sch Med,Div Infect Dis, Boston, MA 02115 USA; [Charaka, Vijaya K.; Ringgaard, Simon; Waldor, Matthew K.; Misra, Hari S.] HHMI, Boston, MA USA	Bhabha Atomic Research Center (BARC); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Misra, HS (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Mumbai 400085, Maharashtra, India.	hsmisra@barc.gov.in	Charaka, Vijaya/Q-5198-2019	Misra, Hari/0000-0002-9349-1229; Ringgaard, Simon/0000-0002-4980-5964; Waldor, Matthew/0000-0003-1843-7000	Bhabha Atomic Research Centre; Harvard Medical School; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	Bhabha Atomic Research Centre; Harvard Medical School; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Bhabha Atomic Research Centre, Harvard Medical School and HHMI. HSM is grateful to Fulbright Commission, United States- India Education Foundation (USIEF) for Fulbright-Nehru Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NM, 2009, NUCLEIC ACIDS RES, V37, P693, DOI 10.1093/nar/gkn1009; Battista JR, 2000, CURR BIOL, V10, pR204, DOI 10.1016/S0960-9822(00)00353-5; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Das AD, 2012, BBA-GEN SUBJECTS, V1820, P1052, DOI 10.1016/j.bbagen.2012.03.014; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Garinther WI, 1997, MOL CELL BIOL, V17, P3520, DOI 10.1128/MCB.17.7.3520; Hiraku Y, 2000, ARCH BIOCHEM BIOPHYS, V382, P211, DOI 10.1006/abbi.2000.2025; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; Kota S, 2010, BIOCHEM CELL BIOL, V88, P783, DOI [10.1139/O10-075, 10.1139/o10-075]; Kota S, 2008, BIOCHEM CELL BIOL, V86, P448, DOI [10.1139/O08-122, 10.1139/o08-122]; Krogh BO, 2002, P NATL ACAD SCI USA, V99, P1853, DOI 10.1073/pnas.032613199; Lecointe F, 2004, GENE, V336, P25, DOI 10.1016/j.gene.2004.04.006; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Misra HS, 2006, MOL MICROBIOL, V59, P1308, DOI 10.1111/j.1365-2958.2005.05005.x; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Narumi I, 2003, TRENDS MICROBIOL, V11, P422, DOI 10.1016/S0966-842X(03)00204-X; Rajpurohit YS, 2008, J BACTERIOL, V190, P3948, DOI 10.1128/JB.00026-08; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Ringgaard S, 2011, GENE DEV, V25, P1544, DOI 10.1101/gad.2061811; Sambrook J., 2001, MOL CLONING LAB MANU; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; Taneja B, 2006, EMBO J, V25, P398, DOI 10.1038/sj.emboj.7600922; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	40	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85288	10.1371/journal.pone.0085288	http://dx.doi.org/10.1371/journal.pone.0085288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454836	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100069
J	Moon, J; Lee, ST; Choi, J; Jung, KH; Yang, H; Khalid, A; Kim, JM; Park, KI; Shin, JW; Ban, JJ; Yi, GS; Lee, SK; Jeon, D; Chu, K				Moon, Jangsup; Lee, Soon-Tae; Choi, Jiye; Jung, Keun-Hwa; Yang, Hyunwoo; Khalid, Arshi; Kim, Jeong-Min; Park, Kyung-Il; Shin, Jung-Won; Ban, Jae-Jun; Yi, Gwan-Su; Lee, Sang Kun; Jeon, Daejong; Chu, Kon			Unique Behavioral Characteristics and microRNA Signatures in a Drug Resistant Epilepsy Model	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; RAT PILOCARPINE MODEL; ELEVATED PLUS-MAZE; SPONTANEOUS SEIZURES; PSYCHIATRIC COMORBIDITY; MULTIDRUG-RESISTANCE; STATUS EPILEPTICUS; P-GLYCOPROTEIN; MOUSE MODEL; LEVETIRACETAM	Background: Pharmacoresistance is a major issue in the treatment of epilepsy. However, the mechanism underlying pharmacoresistance to antiepileptic drugs (AEDs) is still unclear, and few animal models have been established for studying drug resistant epilepsy (DRE). In our study, spontaneous recurrent seizures (SRSs) were investigated by video-EEG monitoring during the entire procedure. Methods/Principal Findings: In the mouse pilocarpine-induced epilepsy model, we administered levetiracetam (LEV) and valproate (VPA) in sequence. AED-responsive and AED-resistant mice were naturally selected after 7-day treatment of LEV and VPA. Behavioral tests (open field, object exploration, elevated plus maze, and light-dark transition test) and a microRNA microarray test were performed. Among the 37 epileptic mice with SRS, 23 showed significantly fewer SRSs during administration of LEV (n = 16, LEV sensitive (LS) group) or VPA (n = 7, LEV resistant/VPA sensitive (LRVS) group), while 7 epileptic mice did not show any amelioration with either of the AEDs (n = 7, multidrug resistant (MDR) group). On the behavioral assessment, MDR mice displayed distinctive behaviors in the object exploration and elevated plus maze tests, which were not observed in the LS group. Expression of miRNA was altered in LS and MDR groups, and we identified 4 miRNAs (miR-206, miR-374, miR-468, and miR-142-5p), which were differently modulated in the MDR group versus both control and LS groups. Conclusion: This is the first study to identify a pharmacoresistant subgroup, resistant to 2 AEDs, in the pilocarpine-induced epilepsy model. We hypothesize that modulation of the identified miRNAs may play a key role in developing pharmacoresistance and behavioral alterations in the MDR group.	[Choi, Jiye; Yang, Hyunwoo; Khalid, Arshi; Yi, Gwan-Su; Jeon, Daejong] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp,Biomed Res Inst, Lab Neurotherapeut,Comprehens Epilepsy Ctr,Dept N, Seoul, South Korea; [Choi, Jiye; Yang, Hyunwoo; Khalid, Arshi; Yi, Gwan-Su; Jeon, Daejong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Jeong-Min] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Neurol, Seoul 156756, South Korea; [Park, Kyung-Il] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Chung Ang University; Chung Ang University Hospital; Inje University	Jeon, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	clark@kaist.ac.kr; stemcell.snu@gmail.com	Yi, Gwan-Su/A-7896-2011; Jeon, Daejong/C-1814-2011	Yi, Gwan-Su/0000-0003-0012-6546; Choi, Jiye/0000-0001-8719-5151; Kim, Jeong-Min/0000-0001-7213-5527; Lee, Soon-Tae/0000-0003-4767-7564; Park, Kyung-Il/0000-0001-8064-6749; Moon, Jangsup/0000-0003-1282-4528; Jeon, Daejong/0000-0002-6998-7603; Jung, Keun-Hwa/0000-0003-1433-8005; Chu, Kon/0000-0001-5863-0302	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111393]; Korea Health 21 R&D grant, Ministry of Health and Welfare, Republic of Korea [A120051]; Seoul National University Hospital Research Funds [0420120630]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Korea Health 21 R&D grant, Ministry of Health and Welfare, Republic of Korea; Seoul National University Hospital Research Funds	This study was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A111393; K. C.) and the Korea Health 21 R&D grant, Ministry of Health and Welfare, Republic of Korea (A120051; D.J.). K. C. was supported by Seoul National University Hospital Research Funds (0420120630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes S, 2007, J PHARMACOL EXP THER, V320, P331, DOI 10.1124/jpet.106.102491; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Bethmann K, 2008, NEUROBIOL DIS, V31, P169, DOI 10.1016/j.nbd.2008.01.005; Bethmann K, 2007, EPILEPSIA, V48, P816, DOI 10.1111/j.1528-1167.2007.00980.x; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Brandt C, 2004, EPILEPSIA, V45, P1488, DOI 10.1111/j.0013-9580.2004.16904.x; CHAPMAN A, 1982, PROG NEUROBIOL, V19, P315, DOI 10.1016/0301-0082(82)90010-7; Chu K, 2008, EPILEPSIA, V49, P1723, DOI 10.1111/j.1528-1167.2008.01644.x; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Eccleston A, 2007, NATURE, V447, P395, DOI 10.1038/447395a; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Gastens AM, 2008, EPILEPSIA, V49, P1759, DOI 10.1111/j.1528-1167.2008.01659.x; Glien M, 2002, EPILEPSIA, V43, P350, DOI 10.1046/j.1528-1157.2002.18101.x; Groticke I, 2008, EXP NEUROL, V213, P71, DOI 10.1016/j.expneurol.2008.04.036; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hellwig S, 2012, EPILEPSY BEHAV, V23, P272, DOI 10.1016/j.yebeh.2011.12.001; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jeon D, 2011, EPILEPSIA; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kanner AM, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2010.02907.x; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Klitgaard H, 2003, SEIZURE-EUR J EPILEP, V12, P92, DOI 10.1016/S1059131102001930; Kobow K, 2013, EPILEPSIA, V54, P41, DOI 10.1111/epi.12183; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; LOSCHER W, 1991, J PHARMACOL EXP THER, V258, P483; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; NOYER M, 1995, EUR J PHARMACOL, V286, P137, DOI 10.1016/0014-2999(95)00436-O; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Postma T, 2000, EPILEPSIA, V41, P1514; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Rogawski Michael A, 2008, Epilepsy Curr, V8, P127, DOI 10.1111/j.1535-7511.2008.00272.x; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Schmidt D, 2009, EPILEPSY CURR, V9, P47, DOI 10.1111/j.1535-7511.2008.01289.x; Seo J, 2013, EXP NEUROL, V241, P38, DOI 10.1016/j.expneurol.2012.11.024; Smyth MD, 2002, EPILEPSY RES, V50, P251, DOI 10.1016/S0920-1211(02)00051-7; Swinkels WAM, 2005, EPILEPSY BEHAV, V7, P37, DOI 10.1016/j.yebeh.2005.04.012; van Vliet EA, 2008, EPILEPSIA, V49, P1151, DOI 10.1111/j.1528-1167.2007.01516.x; Volk HA, 2005, BRAIN, V128, P1358, DOI 10.1093/brain/awh437	48	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85617	10.1371/journal.pone.0085617	http://dx.doi.org/10.1371/journal.pone.0085617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454901	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100105
J	Seiger, N; van Veen, M; Almeida, H; Steyerberg, EW; van Meurs, AHJ; Carneiro, R; Alves, CF; Maconochie, I; van der Lei, J; Moll, HA				Seiger, Nienke; van Veen, Mirjam; Almeida, Helena; Steyerberg, Ewout W.; van Meurs, Alfred H. J.; Carneiro, Rita; Alves, Claudio F.; Maconochie, Ian; van der Lei, Johan; Moll, Henriette A.			Improving the Manchester Triage System for Pediatric Emergency Care: An International Multicenter Study	PLOS ONE			English	Article							VITAL SIGNS; ACUITY SCALE; SEVERITY; IMPUTATION	Objectives: This multicenter study examines the performance of the Manchester Triage System (MTS) after changing discriminators, and with the addition use of abnormal vital sign in patients presenting to pediatric emergency departments (EDs). Design: International multicenter study Settings: EDs of two hospitals in The Netherlands (2006-2009), one in Portugal (November-December 2010), and one in UK (June-November 2010). Patients: Children (< 16years) triaged with the MTS who presented at the ED. Methods: Changes to discriminators (MTS 1) and the value of including abnormal vital signs (MTS 2) were studied to test if this would decrease the number of incorrect assignment. Admission to hospital using the new MTS was compared with those in the original MTS. Likelihood ratios, diagnostic odds ratios (DORs), and c-statistics were calculated as measures for performance and compared with the original MTS. To calculate likelihood ratios and DORs, the MTS had to be dichotomized in low urgent and high urgent. Results: 60,375 patients were included, of whom 13% were admitted. When MTS 1 was used, admission to hospital increased from 25% to 29% for MTS ` very urgent' patients and remained similar in lower MTS urgency levels. The diagnostic odds ratio improved from 4.8 (95% CI 4.5-5.1) to 6.2 (95% CI 5.9-6.6) and the c-statistic remained 0.74. MTS 2 did not improve the performance of the MTS. Conclusions: MTS 1 performed slightly better than the original MTS. The use of vital signs (MTS 2) did not improve the MTS performance.	[Seiger, Nienke; van Veen, Mirjam; Moll, Henriette A.] Erasmus MC Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands; [Almeida, Helena; Carneiro, Rita; Alves, Claudio F.] Hosp Fernando Fonseca, Dept Pediat, Amadora, Portugal; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van Meurs, Alfred H. J.] Juliana Childrens Hosp, Haga Hosp, Dept Pediat, The Hague, Netherlands; [Maconochie, Ian] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Pediat Accid & Emergency, London, England; [van der Lei, Johan] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Hospital Professor Doutor Fernando Fonseca, EPE; Erasmus University Rotterdam; Erasmus MC; Haga Hospital; Imperial College London; Erasmus University Rotterdam; Erasmus MC	Moll, HA (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands.	h.a.moll@erasmusmc.nl		Maconochie, Ian/0000-0001-6319-8550	Europe Container Terminals B.V.	Europe Container Terminals B.V.	The study was funded by an unrestricted grant from Europe Container Terminals B.V. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ANN EMERG MED, V42, P530, DOI 10.1067/mem.2003.377; Armstrong B, 2008, EMERG MED J, V25, P799, DOI 10.1136/emj.2007.052951; Baumann MR, 2005, ACAD EMERG MED, V12, P219, DOI 10.1197/j.aem.2004.09.023; Cooper RJ, 2002, ANN EMERG MED, V39, P223, DOI 10.1067/mem.2002.121524; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; FitzGerald G, 2010, EMERG MED J, V27, P86, DOI 10.1136/emj.2009.077081; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Gilboy N, 2005, J EMERG NURS, V31, P357, DOI 10.1016/j.jen.2005.05.011; Gilboy N, 2005, EMERGENCY SEVERITY I; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gravel J, 2012, ANN EMERG MED; Gravel Jocelyn, 2006, Paediatr Child Health, V11, P211; Ma W, 2008, AM J EMERG MED, V26, P893, DOI 10.1016/j.ajem.2008.02.024; Mackway-Jones K, 2006, EMERGENCY TRIAGE, Vxiii; Mackway-Jones K, 1997, EMERGENCY TRIAGE, Vix; Maldonado T, 2004, PEDIATRICS, V114, P356, DOI 10.1542/peds.114.2.356; McGillivray David, 2006, Paediatr Child Health, V11, P209; Moll HA, 2010, J CLIN EPIDEMIOL, V63, P384, DOI 10.1016/j.jclinepi.2009.07.009; Roukema J, 2006, EMERG MED J, V23, P906, DOI 10.1136/emj.2006.038877; Salk ED, 1998, ANN EMERG MED, V32, P655, DOI 10.1016/S0196-0644(98)70063-0; Seiger N, 2011, ARCH DIS CHILD, V96, P653, DOI 10.1136/adc.2010.206797; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; van Veen M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1501; Veen van M, 2012, EMERG MED J; Warren DW, 2008, CAN J EMERG MED, V10, P224	26	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83267	10.1371/journal.pone.0083267	http://dx.doi.org/10.1371/journal.pone.0083267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454699	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100007
J	Zhao, L; Zhang, LH; Zhang, XL; Li, ZZ; Tian, LW; Wang, YXJ				Zhao, Lin; Zhang, Lihong; Zhang, Xiaolin; Li, Zhenzhong; Tian, Linwei; Wang, Yi-Xiang J.			An Analysis of 1256 Cases of Sporadic Ruptured Cerebral Aneurysm in a Single Chinese Institution	PLOS ONE			English	Article							INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; RISK-FACTORS; SIZE; LOCATION; POPULATION	Background: To review the epidemiology of sporadic ruptured cerebral aneurysm. Methods: This is a retrospective study of consecutive 1256 Chinese patients between January 2006 and January 2013, who were admitted to the Second Hospital of Hebei Medical University, China, for spontaneous subarachnoid hemorrhage due to a rupture of cerebral artery aneurysm. In 288 males and 478 females, the size of aneurysms was measured by a neuroradiologist on DSA. In 123 males and 184 females, the size of the ruptured aneurysms was not measured. The remaining patients, with 61 males and 122 females, had multiple aneurysms, and the medical record could not reliably determine the specific aneurysm responsible for the rupture. Results: In total there were 784 females and 472 males with a female/male ratio of 1.66. The female/male ratio was down to 0.50 for patients younger than 35 yrs. For both males and females, aneurysm rupture was most common during the age of 50-59 yrs. Ruptured aneurysms were mostly of 2 mm-5 mm in size (47.1%), followed by 5 mm-10 mm (39.7%). Ruptured single cerebral aneurysm occurred in anterior circulation in 95.0% of the cases, with 5.0% occurred in posterior circulation. Ruptured aneurysm most commonly occurred at posterior communicating artery (34.9%) and anterior communicating artery (29.5%). 183 cases (14.6%) had multiple aneurysms. Conclusions: With younger patients, there is a male predominance in our series. Ninety percent of patients have ruptured aneurysms less than 10 mm in size.	[Zhao, Lin] Hebei Med Univ, Hosp 2, Dept Neurosurg, Shijiazhuang, Hebei Province, Peoples R China; [Zhang, Lihong; Li, Zhenzhong] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei Province, Peoples R China; [Zhang, Xiaolin] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Hebei Province, Peoples R China; [Tian, Linwei] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Yi-Xiang J.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Zhang, LH (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei Province, Peoples R China.	lihongzhang.med@gmail.com; yixiang_wang@cuhk.edu.hk	Tian, Linwei/A-9736-2009; Wang, Yi Xiang/I-5952-2016	Tian, Linwei/0000-0002-4739-1534; Wang, Yi Xiang/0000-0001-5697-0717; Tian, Linwei/0000-0003-2240-8886				Aarhus M, 2009, ACTA NEUROCHIR, V151, P1569, DOI 10.1007/s00701-009-0316-3; Baccin CE, 2006, ACTA NEUROCHIR, V148, P1091, DOI 10.1007/s00701-006-0860-z; Baumann F, 2008, ACT NEUR S, V103, P19; Clarke G, 2005, ACTA NEUROCHIR, V147, P259, DOI 10.1007/s00701-004-0473-3; Clarke M, 2008, NEURORADIOLOGY, V50, P653, DOI 10.1007/s00234-008-0411-9; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dickey P, 1994, Conn Med, V58, P583; Ellamushi HE, 2001, J NEUROSURG, V94, P728, DOI 10.3171/jns.2001.94.5.0728; Forget TR, 2001, NEUROSURGERY, V49, P1322, DOI 10.1097/00006123-200112000-00006; Howng Shen-Long, 1995, Journal of the Formosan Medical Association, V94, pS73; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Kaminogo M, 2003, STROKE, V34, P16, DOI 10.1161/01.STR.0000046763.48330.AD; KASSELL NF, 1983, NEUROSURGERY, V12, P291, DOI 10.1227/00006123-198303000-00007; Lai H. P., 2009, Hong Kong Medical Journal, V15, P262; Meissner I, 2012, J NEUROSURG, V116, P1238, DOI 10.3171/2012.1.JNS11779; NAKAGAWA T, 1994, J NEUROSURG, V80, P217, DOI 10.3171/jns.1994.80.2.0217; Ohashi Y, 2004, SURG NEUROL, V61, P239, DOI 10.1016/S0090-3019(03)00427-0; Osawa M, 2001, ACTA NEUROCHIR, V143, P655, DOI 10.1007/s007010170043; PAKARINEN S, 1967, ACTA NEUROL SCAND, VS 43, P9; PHILLIPS LH, 1980, NEUROLOGY, V30, P1034, DOI 10.1212/WNL.30.10.1034; Qureshi AI, 1998, NEUROSURGERY, V43, P22, DOI 10.1097/00006123-199807000-00013; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Roessler K, 2011, WIEN KLIN WOCHENSCHR, V123, P444, DOI 10.1007/s00508-011-1598-z; Salunke P, 2010, BRIT J NEUROSURG, V24, P686, DOI 10.3109/02688697.2010.515320; Shiue I, 2011, CEREBROVASC DIS, V31, P573, DOI 10.1159/000324938; SO SC, 1979, SURG NEUROL, V12, P319; UJIIE H, 1993, STROKE, V24, P1850, DOI 10.1161/01.STR.24.12.1850; Weir B, 2002, J NEUROSURG, V96, P64, DOI 10.3171/jns.2002.96.1.0064; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401	30	30	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85668	10.1371/journal.pone.0085668	http://dx.doi.org/10.1371/journal.pone.0085668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454914	gold, Green Published			2022-12-27	WOS:000330235100117
J	Fraiman, D; Saunier, G; Martins, EF; Vargas, CD				Fraiman, Daniel; Saunier, Ghislain; Martins, Eduardo F.; Vargas, Claudia D.			Biological Motion Coding in the Brain: Analysis of Visually Driven EEG Functional Networks	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SYNCHRONIZATION LIKELIHOOD; RECOGNIZING GENDER; PERCEPTION; PREMOTOR; AREAS; CONNECTIVITY; INFORMATION; MODULATION; EFFICIENCY	Herein, we address the time evolution of brain functional networks computed from electroencephalographic activity driven by visual stimuli. We describe how these functional network signatures change in fast scale when confronted with point-light display stimuli depicting biological motion (BM) as opposed to scrambled motion (SM). Whereas global network measures (average path length, average clustering coefficient, and average betweenness) computed as a function of time did not discriminate between BM and SM, local node properties did. Comparing the network local measures of the BM condition with those of the SM condition, we found higher degree and betweenness values in the left frontal (F7) electrode, as well as a higher clustering coefficient in the right occipital (O2) electrode, for the SM condition. Conversely, for the BM condition, we found higher degree values in central parietal (Pz) electrode and a higher clustering coefficient in the left parietal (P3) electrode. These results are discussed in the context of the brain networks involved in encoding BM versus SM.	[Fraiman, Daniel] Univ San Andres, Lab Invest Neurociencia, Dept Matemat & Ciencias, Buenos Aires, DF, Argentina; [Fraiman, Daniel] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Saunier, Ghislain; Martins, Eduardo F.; Vargas, Claudia D.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neurobiol 2, BR-21941 Rio De Janeiro, Brazil; [Saunier, Ghislain] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio de Janeiro; Universidade Federal do Para	Vargas, CD (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neurobiol 2, BR-21941 Rio De Janeiro, Brazil.	cdvargas@biof.ufrj.br	Saunier, Ghislain/D-8488-2016; Vargas, Claudia D./A-1523-2016; Fraiman, Daniel/E-1581-2018	Saunier, Ghislain/0000-0002-0882-7788; Vargas, Claudia D./0000-0001-6202-3580; Fraiman, Daniel/0000-0002-0482-9137	Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP) [2011/51350-6]; Conselho Nacional de Pesquisa (CNPq) [480108/2012-9, 478537/2012-3]; Fundacao de amparo a pesquisa do Rio de JAneiro FAPERJ [E-26/111.655/2012, E-26/110.526/2012]; Programa de apoyo a la investigacion de la Universidad San Andres (PAI UdeSA); University of Sao Paulo (USP)	Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de amparo a pesquisa do Rio de JAneiro FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de apoyo a la investigacion de la Universidad San Andres (PAI UdeSA); University of Sao Paulo (USP)	This work is part of University of Sao Paulo (USP) project Mathematics, computation, language and the brain, Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP) project NeuroMat (grant 2011/51350-6), Conselho Nacional de Pesquisa (CNPq) (grants 480108/2012-9 and 478537/2012-3), Fundacao de amparo a pesquisa do Rio de JAneiro FAPERJ (grants E-26/111.655/2012 and E-26/110.526/2012) and Programa de apoyo a la investigacion de la Universidad San Andres (PAI UdeSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Battelli L, 2003, NEUROPSYCHOLOGIA, V41, P1808, DOI 10.1016/S0028-3932(03)00182-9; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Boersma M, 2011, HUM BRAIN MAPP, V32, P413, DOI 10.1002/hbm.21030; Bonda E, 1996, J NEUROSCI, V16, P3737; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calmels C, 2012, NEUROSCIENCE, V212, P49, DOI 10.1016/j.neuroscience.2012.03.045; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fontana AP, 2012, NEUROIMAGE, V59, P556, DOI 10.1016/j.neuroimage.2011.07.046; Fraiman D, 2012, FRONT PHYSIOL, V307, P1; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton AF, 2007, ATTENTION PERFORM, P381, DOI DOI 10.1093/ACPR0F:0S0/9780199231447.003.0018; Hars M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025903; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jokisch D, 2005, BEHAV BRAIN RES, V157, P195, DOI 10.1016/j.bbr.2004.06.025; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KOZLOWSKI LT, 1978, PERCEPT PSYCHOPHYS, V23, P459, DOI 10.3758/BF03204150; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Krakowski AI, 2011, NEUROIMAGE, V56, P373, DOI 10.1016/j.neuroimage.2011.01.058; McKay LS, 2012, NEUROIMAGE, V59, P1524, DOI 10.1016/j.neuroimage.2011.08.033; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pavlova M, 2006, CEREB CORTEX, V16, P321, DOI 10.1093/cercorbhi108; Pavlova M, 2004, CEREB CORTEX, V14, P181, DOI 10.1093/cercor/bhg117; Peraza LR, 2012, J NEUROSCI METH, V207, P189, DOI 10.1016/j.jneumeth.2012.04.007; Pollick FE, 2002, VISION RES, V42, P2345, DOI 10.1016/S0042-6989(02)00196-7; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Ptito M, 2003, NEUROIMAGE, V19, P246, DOI 10.1016/S1053-8119(03)00082-X; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Saunier G, 2013, BEHAV BRAIN RES, V236, P166, DOI 10.1016/j.bbr.2012.08.038; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schenk T, 1997, NEUROPSYCHOLOGIA, V35, P1299, DOI 10.1016/S0028-3932(97)00005-5; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Sporns O., 2011, NETWORKS BRAIN; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; van Kemenade BM, 2012, J COGNITIVE NEUROSCI, V24, P896, DOI 10.1162/jocn_a_00194; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239	58	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84612	10.1371/journal.pone.0084612	http://dx.doi.org/10.1371/journal.pone.0084612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454734	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800012
J	Meier, K; Hansen, MM; Normandeau, E; Mensberg, KLD; Frydenberg, J; Larsen, PF; Bekkevold, D; Bernatchez, L				Meier, Kristian; Hansen, Michael Moller; Normandeau, Eric; Mensberg, Karen-Lise D.; Frydenberg, Jane; Larsen, Peter Foged; Bekkevold, Dorte; Bernatchez, Louis			Local Adaptation at the Transcriptome Level in Brown Trout: Evidence from Early Life History Temperature Genomic Reaction Norms	PLOS ONE			English	Article							CHARR SALVELINUS-FONTINALIS; SALMON SALMO-SALAR; ATLANTIC SALMON; GENE-EXPRESSION; CLIMATE-CHANGE; LAKE WHITEFISH; ECOLOGICAL SPECIATION; POPULATION-STRUCTURE; SPAWNING MIGRATION; SELECTION	Local adaptation and its underlying molecular basis has long been a key focus in evolutionary biology. There has recently been increased interest in the evolutionary role of plasticity and the molecular mechanisms underlying local adaptation. Using transcriptome analysis, we assessed differences in gene expression profiles for three brown trout (Salmo trutta) populations, one resident and two anadromous, experiencing different temperature regimes in the wild. The study was based on an F2 generation raised in a common garden setting. A previous study of the F1 generation revealed different reaction norms and significantly higher Q(ST) than F-ST among populations for two early life-history traits. In the present study we investigated if genomic reaction norm patterns were also present at the transcriptome level. Eggs from the three populations were incubated at two temperatures (5 and 8 degrees C) representing conditions encountered in the local environments. Global gene expression for fry at the stage of first feeding was analysed using a 32k cDNA microarray. The results revealed differences in gene expression between populations and temperatures and population x temperature interactions, the latter indicating locally adapted reaction norms. Moreover, the reaction norms paralleled those observed previously at early life-history traits. We identified 90 cDNA clones among the genes with an interaction effect that were differently expressed between the ecologically divergent populations. These included genes involved in immune-and stress response. We observed less plasticity in the resident as compared to the anadromous populations, possibly reflecting that the degree of environmental heterogeneity encountered by individuals throughout their life cycle will select for variable level of phenotypic plasticity at the transcriptome level. Our study demonstrates the usefulness of transcriptome approaches to identify genes with different temperature reaction norms. The responses observed suggest that populations may vary in their susceptibility to climate change.	[Meier, Kristian; Mensberg, Karen-Lise D.; Bekkevold, Dorte] Tech Univ Denmark, Natl Inst Aquat Resources, Silkeborg, Denmark; [Hansen, Michael Moller; Frydenberg, Jane; Larsen, Peter Foged] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Normandeau, Eric; Bernatchez, Louis] Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1K 7P4, Canada	Technical University of Denmark; Aarhus University; Laval University	Hansen, MM (corresponding author), Aarhus Univ, Dept Biosci, Aarhus C, Denmark.	mmh@biology.au.dk	Hansen, Michael/I-5979-2013; Bekkevold, Dorte/AAT-1098-2021; Hansen, Michael M./Z-5047-2019	Hansen, Michael/0000-0001-5372-4828; Hansen, Michael M./0000-0001-5372-4828; Bernatchez, Louis/0000-0002-8085-9709; Bekkevold, Dorte/0000-0002-5297-032X				Aguilar A, 2006, MOL ECOL, V15, P923, DOI 10.1111/j.1365-294X.2006.02843.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; ALLENDORF FW, 1984, EVOL GENET, P55; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amstutz U, 2006, AQUACULTURE, V260, P326, DOI 10.1016/j.aquaculture.2006.06.007; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Bougas B, 2013, HEREDITY, V110, P484, DOI 10.1038/hdy.2012.113; Boulet M, 2012, CURR ZOOL, V58, P158, DOI 10.1093/czoolo/58.1.158; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croisetiere S, 2010, MOL IMMUNOL, V47, P1817, DOI 10.1016/j.molimm.2009.12.012; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Derome N, 2006, MOL BIOL EVOL, V23, P2370, DOI 10.1093/molbev/msl110; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Evans ML, 2012, MOL ECOL, V21, P4038, DOI 10.1111/j.1365-294X.2012.05682.x; Evans TG, 2011, MOL ECOL, V20, P4472, DOI 10.1111/j.1365-294X.2011.05276.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Franks SJ, 2012, ANNU REV GENET, V46, P185, DOI 10.1146/annurev-genet-110711-155511; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Galliano M, 2003, BIOCHEM J, V376, P433, DOI 10.1042/BJ20030413; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gibson G, 2002, MOL ECOL, V11, P17, DOI 10.1046/j.0962-1083.2001.01425.x; Giger T, 2006, CURR BIOL, V16, pR281, DOI 10.1016/j.cub.2006.03.053; Giger T, 2008, MOL ECOL, V17, P3095, DOI 10.1111/j.1365-294X.2008.03820.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hansen MM, 2002, MOL ECOL, V11, P2523, DOI 10.1046/j.1365-294X.2002.01634.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Kao CM, 2008, COMP BIOCHEM PHYS B, V149, P541, DOI 10.1016/j.cbpb.2006.05.017; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Larsen PF, 2011, J FISH BIOL, V78, P1, DOI 10.1111/j.1095-8649.2010.02834.x; Larsen PF, 2007, MOL ECOL, V16, P4674, DOI 10.1111/j.1365-294X.2007.03530.x; Meier K, 2011, HEREDITY, V106, P488, DOI 10.1038/hdy.2010.164; Merila J, 2014, EVOLUTIONAR IN PRESS, V7; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; Narum SR, 2010, MOL ECOL, V19, P4622, DOI 10.1111/j.1365-294X.2010.04839.x; Nath S, 2006, IMMUNOGENETICS, V58, P443, DOI 10.1007/s00251-006-0094-5; Neves JV, 2009, DEV COMP IMMUNOL, V33, P848, DOI 10.1016/j.dci.2009.02.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci M, 1998, J EVOLUTION BIOL, V11, P285, DOI 10.1007/s000360050089; Quinn NL, 2011, PHYSIOL GENOMICS, V43, P685, DOI 10.1152/physiolgenomics.00008.2011; Quinn NL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-539; Renaut S, 2011, MOL ECOL, V20, P545, DOI 10.1111/j.1365-294X.2010.04952.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Rogers SM, 2005, MOL ECOL, V14, P351, DOI 10.1111/j.1365-294X.2004.02396.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; SPITZE K, 1993, GENETICS, V135, P367; St-Cyr J, 2008, MOL ECOL, V17, P1850, DOI 10.1111/j.1365-294X.2008.03696.x; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Tang SJ, 1999, FEBS LETT, V459, P95, DOI 10.1016/S0014-5793(99)01229-6; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Tonteri A, 2010, MOL ECOL, V19, P1273, DOI 10.1111/j.1365-294X.2010.04573.x; Tymchuk WV, 2010, MOL ECOL, V19, P1842, DOI 10.1111/j.1365-294X.2010.04596.x; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weber RE, 2011, ACTA PHYSIOL, V202, P549, DOI 10.1111/j.1748-1716.2010.02204.x	76	39	39	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85171	10.1371/journal.pone.0085171	http://dx.doi.org/10.1371/journal.pone.0085171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454810	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800025
J	Nemati, F; de Montrion, C; Lang, G; Kraus-Berthier, L; Carita, G; Sastre-Garau, X; Berniard, A; Vallerand, D; Geneste, O; de Plater, L; Pierre, A; Lockhart, B; Desjardins, L; Piperno-Neumann, S; Depil, S; Decaudin, D				Nemati, Fariba; de Montrion, Catherine; Lang, Guillaume; Kraus-Berthier, Laurence; Carita, Guillaume; Sastre-Garau, Xavier; Berniard, Aurelie; Vallerand, David; Geneste, Olivier; de Plater, Ludmilla; Pierre, Alain; Lockhart, Brian; Desjardins, Laurence; Piperno-Neumann, Sophie; Depil, Stephane; Decaudin, Didier			Targeting Bcl-2/Bcl-X-L Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts	PLOS ONE			English	Article							INTRAARTERIAL HEPATIC FOTEMUSTINE; BCL-2 ANTISENSE OLIGONUCLEOTIDE; CHRONIC LYMPHOCYTIC-LEUKEMIA; RANDOMIZED PHASE-II; CELL-LUNG-CANCER; OBLIMERSEN SODIUM; LIVER METASTASES; CARCINOMA-CELLS; LYMPHOMA-CELLS; EXPRESSION	Purpose: Uveal melanoma (UM) is associated with a high risk of metastases and lack of efficient therapies. Reduced capacity for apoptosis induction by chemotherapies is one obstacle to efficient treatments. Human UM is characterized by high expression of the anti-apoptotic protein Bcl-2. Consequently, regulators of apoptosis such as Bcl-2 family inhibitors may constitute an attractive approach to UM therapeutics. In this aim, we have investigated the efficacy of the Bcl-2/Bcl-X-L inhibitor S44563 on 4 UM Patient-Derived Xenografts (PDXs) and derived-cell lines. Experimental Design: Four well characterized UM PDXs were used for in vivo experiments. S44563 was administered alone or combined with fotemustine either concomitantly or after the alkylating agent. Bcl-2, Bcl-X-L, and Mcl-1 expressions after S44563 administration were evaluated by immunohistochemistry (IHC). Results: S44563 administered alone by at 50 and 100 mg/kg i.p. induced a significant tumour growth inhibition in only one xenograft model with a clear dose effect. However, when S44563 was concomitantly administered with fotemustine, we observed a synergistic activity in 3 out of the 4 tested models. In addition, S44563 administered after fotemustine induced a tumour growth delay in 2 out of 3 tested xenografts. Finally, IHC analyses showed that Bcl-2, Bcl-X-L, and Mcl-1 expression were not modified after S44563 administration. Conclusion: The novel anti-apoptotic experimental compound S44563, despite a relative low efficacy when administered alone, increased the efficacy of fotemustine in either concomitant or sequential combinations or indeed subsequent to fotemustine. These data support further exploration of potential therapeutic effect of Bcl-2/Bcl-X-L inhibition in human UM.	[Nemati, Fariba; Lang, Guillaume; Carita, Guillaume; Berniard, Aurelie; Vallerand, David; de Plater, Ludmilla; Decaudin, Didier] Inst Curie, Dept Translat Res, Lab Preclin Invest, Paris, France; [de Montrion, Catherine; Pierre, Alain; Lockhart, Brian; Depil, Stephane] Inst Rech Servier, IDRS, Croissy Sur Seine, France; [Kraus-Berthier, Laurence; Geneste, Olivier; Depil, Stephane] Inst Rech Int Servier, IRIS, Suresnes, France; [Sastre-Garau, Xavier] Inst Curie, Dept Tumor Biol, Paris, France; [Desjardins, Laurence] Inst Curie, Dept Ophthalmol Oncol, Paris, France; [Piperno-Neumann, Sophie; Decaudin, Didier] Inst Curie, Dept Med Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Servier; Institut de Recherches Internationales Servier; Servier; Institut de Recherches Internationales Servier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decaudin, D (corresponding author), Inst Curie, Dept Translat Res, Lab Preclin Invest, Paris, France.	Didier.decaudin@curie.net		Sastre-Garau, Xavier/0000-0001-5992-2083	Servier Laboratories	Servier Laboratories	The study was supported by Servier Laboratories. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Chana JS, 1999, BRIT J OPHTHALMOL, V83, P110, DOI 10.1136/bjo.83.1.110; Chanan-Khan AA, 2009, LEUKEMIA LYMPHOMA, V50, P559, DOI 10.1080/10428190902748971; Coupland SE, 1998, BRIT J OPHTHALMOL, V82, P961, DOI 10.1136/bjo.82.8.961; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Guo Lin-jie, 2003, Zhonghua Yan Ke Za Zhi, V39, P73; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hussein MR, 2005, J CLIN PATHOL, V58, P486, DOI 10.1136/jcp.2004.023291; Jain HV, 2011, CANCER RES, V71, P705, DOI 10.1158/0008-5472.CAN-10-3174; Jay V, 1996, ARCH PATHOL LAB MED, V120, P497; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Kujala E, 2003, OPHTHALMOLOGY, V110, P962; Laurent C, 2013, MOL ONCOL, V7, P625, DOI 10.1016/j.molonc.2013.02.004; Lawry J, 1999, EYE, V13, P301, DOI 10.1038/eye.1999.79; Loriot Y, 2012, AM ASS CANC RES ANN; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; MOOY CM, 1995, AM J PATHOL, V147, P1097; Nemati F, 2010, CLIN CANCER RES, V16, P2352, DOI 10.1158/1078-0432.CCR-09-3066; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; O'Brien S, 2009, J CLIN ONCOL, V27, P5208, DOI 10.1200/JCO.2009.22.5748; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pepper C, 2001, LEUKEMIA LYMPHOMA, V42, P491, DOI 10.3109/10428190109064606; Peters S, 2006, ANN ONCOL, V17, P578, DOI 10.1093/annonc/mdl009; PRESCHER G, 1992, LANCET, V339, P691, DOI 10.1016/0140-6736(92)90861-V; Reuland SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024294; Rudin CM, 2008, J CLIN ONCOL, V26, P870, DOI 10.1200/JCO.2007.14.3461; Salmon RJ, 1998, EUR J SURG ONCOL, V24, P127, DOI 10.1016/S0748-7983(98)91485-8; Simoes-Wust AP, 2002, BREAST CANCER RES TR, V76, P157, DOI 10.1023/A:1020543004400; Sternberg CN, 2009, ANN ONCOL, V20, P1264, DOI 10.1093/annonc/mdn784; Sulkowska M, 2001, TUMORI, V87, P54, DOI 10.1177/030089160108700112; Tan N, 2011, CLIN CANCER RES, V17, P1394, DOI 10.1158/1078-0432.CCR-10-2353; Touzeau C, 2011, CLIN CANCER RES, V17, P5973, DOI 10.1158/1078-0432.CCR-11-0955; Trolet J, 2009, INVEST OPHTH VIS SCI, V50, P2572, DOI 10.1167/iovs.08-2296; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Voelter V, 2008, MELANOMA RES, V18, P220, DOI 10.1097/CMR.0b013e32830317de; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Xu HS, 2010, CLIN CANCER RES, V16, P4392, DOI 10.1158/1078-0432.CCR-10-0640; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zall H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-164; Zhang C, 2011, MOL CANCER THER, V10, P1264, DOI 10.1158/1535-7163.MCT-10-1091	49	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e80836	10.1371/journal.pone.0080836	http://dx.doi.org/10.1371/journal.pone.0080836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454684	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500001
J	Rich, C; Geraci, M; Griffiths, L; Sera, F; Dezateux, C; Cortina-Borja, M				Rich, Carly; Geraci, Marco; Griffiths, Lucy; Sera, Francesco; Dezateux, Carol; Cortina-Borja, Mario			Quality Control Methods in Accelerometer Data Processing: Identifying Extreme Counts	PLOS ONE			English	Article							MEASURED PHYSICAL-ACTIVITY; DANISH CHILDREN; UNITED-STATES; POPULATION; PATTERNS; FITNESS; DESIGN; SAMPLE	Background: Accelerometers are designed to measure plausible human activity, however extremely high count values (EHCV) have been recorded in large-scale studies. Using population data, we develop methodological principles for establishing an EHCV threshold, propose a threshold to define EHCV in the ActiGraph GT1M, determine occurrences of EHCV in a large-scale study, identify device-specific error values, and investigate the influence of varying EHCV thresholds on daily vigorous PA (VPA). Methods: We estimated quantiles to analyse the distribution of all accelerometer positive count values obtained from 9005 seven-year old children participating in the UK Millennium Cohort Study. A threshold to identify EHCV was derived by differentiating the quantile function. Data were screened for device-specific error count values and EHCV, and a sensitivity analysis conducted to compare daily VPA estimates using three approaches to accounting for EHCV. Results: Using our proposed threshold of >= 11,715 counts/minute to identify EHCV, we found that only 0.7% of all non-zero counts measured in MCS children were EHCV; in 99.7% of these children, EHCV comprised < 1% of total non-zero counts. Only 11 MCS children (0.12% of sample) returned accelerometers that contained negative counts; out of 237 such values, 211 counts were equal to -32,768 in one child. The medians of daily minutes spent in VPA obtained without excluding EHCV, and when using a higher threshold (>= 19,442 counts/minute) were, respectively, 6.2% and 4.6% higher than when using our threshold (6.5 minutes; p<0.0001). Conclusions: Quality control processes should be undertaken during accelerometer fieldwork and prior to analysing data to identify monitors recording error values and EHCV. The proposed threshold will improve the validity of VPA estimates in children's studies using the ActiGraph GT1M by ensuring only plausible data are analysed. These methods can be applied to define appropriate EHCV thresholds for different accelerometer models.	[Rich, Carly; Geraci, Marco; Griffiths, Lucy; Sera, Francesco; Dezateux, Carol; Cortina-Borja, Mario] UCL, Med Res Ctr Epidemiol Child Hlth, London, England	University of London; University College London	Rich, C (corresponding author), UCL, Med Res Ctr Epidemiol Child Hlth, London, England.	c.rich@ucl.ac.uk	Geraci, Marco/B-9588-2009; Borja, Mario Cortina/A-3847-2009; Sera, Francesco/C-8176-2011	Geraci, Marco/0000-0002-6311-8685; Borja, Mario Cortina/0000-0003-0627-2624; Sera, Francesco/0000-0002-8890-6848; Dezateux, Carol/0000-0001-9787-6276; Griffiths, Lucy/0000-0001-9230-624X; Rich, Carly/0000-0003-4717-5855	Wellcome Trust [084686/Z/08/A]; UK Medical Research Council [G0400546]; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Economic and Social Research Council; consortium of government departments; Medical Research Council [G0400546] Funding Source: researchfish; MRC [G0400546] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); consortium of government departments; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MCS accelerometer project was funded by the Wellcome Trust (grant 084686/Z/08/A). The MRC Centre of Epidemiology for Child Health is supported by funds from the UK Medical Research Council (grant G0400546). Research at the UCL Institute of Child Health & Great Ormond Street Hospital for Children receives a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The Millennium Cohort Study is funded by grants to Centre for Longitudinal Studies at the Institute of Education from the Economic and Social Research Council and a consortium of government departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brage S, 2004, INT J OBESITY, V28, P1503, DOI 10.1038/sj.ijo.0802772; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Colley Rachel, 2010, Health Rep, V21, P63; Department of Health, 2011, START ACT STAY ACT R; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Geraci M, 2012, TECHNICAL REPORT ACC; Geraci M, 2013, PAWACC PHYS ACTIVITY; HALL P, 1988, J ROY STAT SOC B MET, V50, P381; John D, 2010, MED SCI SPORT EXER, V42, P368, DOI 10.1249/MSS.0b013e3181b3af49; Koenker R., 2012, QUANTREG QUANTILE RE; Kozey SL, 2010, MED SCI SPORT EXER, V42, P971, DOI 10.1249/MSS.0b013e3181c29e90; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Matthews CE, 2012, MED SCI SPORTS EXERC, V44, pS68; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; McClain JJ, 2010, AM COLL SPORTS MED A; ODEH RE, 1971, TECHNOMETRICS, V13, P912; Owen CG, 2009, INT J EPIDEMIOL, V38, P1082, DOI 10.1093/ije/dyp176; Page AS, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-2; Pate RR, 2002, ANN EPIDEMIOL, V12, P303, DOI 10.1016/S1047-2797(01)00263-0; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Plewis I., 2007, MILLENNIUM COHORT SU, P1; Powell J.L., 1991, NONPARAMETR SEMIPARA, P357; Pulsford RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021822; R Core Development Team, R LANG ENV STAT COMP; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485; Smith Kate, 2002, Popul Trends, P30; Tremblay MS, 2005, MED SCI SPORT EXER, V37, P1187, DOI 10.1249/01.mss.0000170079.71522.a6; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2006, MED SCI SPORT EXER, V38, P380, DOI 10.1249/01.mss.0000183848.25845.e0; Tucker J, 2010, AM COLL SPORTS MED 2; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388	36	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85134	10.1371/journal.pone.0085134	http://dx.doi.org/10.1371/journal.pone.0085134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454804	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500044
J	Boughattas, S; Ayari, K; Sa, TM; Aoun, K; Bouratbine, A				Boughattas, Sonia; Ayari, Khaled; Sa, Tongmin; Aoun, Karim; Bouratbine, Aida			Survey of the Parasite Toxoplasma gondii in Human Consumed Ovine Meat in Tunis City	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; HUMAN CONSUMPTION; SHEEP; PREVALENCE; INFECTION; SEROPREVALENCE; STRAINS; ANTIBODIES; ANIMALS; TISSUES	Toxoplasmosis has been recognized as parasitic zoonosis with the highest human incidence. The human infection by the parasite can lead to severe clinical manifestations in congenital toxoplasmosis and immunocompromised patients. Contamination occurs mainly by foodborne ways especially consumption of raw or undercooked meat. In contrast to other foodborne infections, toxoplasmosis is a chronic infection which would make its economic and social impact much higher than even previously anticipated. Ovine meat was advanced as a major risk factor, so we investigated its parasite survey, under natural conditions. Serological MAT technique and touchdown PCR approaches were used for prevalence determination of the parasite in slaughtered sheep intended to human consumption in Tunis City. The genotyping was carried by SNPs analysis of SAG3 marker. Anti-Toxoplasma antibodies were present in 38.2% of young sheep and in 73.6% of adult sheep. Molecular detection revealed the contamination of 50% of ewes' tissue. Sequencing and SNPs analysis enabled unambiguous typing of meat isolates and revealed the presence of mixed strains as those previously identified from clinical samples in the same area. Our findings conclude that slaughtered sheep are highly infected, suggesting them as a major risk factor of Toxoplasma gondii transmission by meat consumption. Special aware should target consequently this factor when recommendations have to be established by the health care commanders.	[Boughattas, Sonia; Sa, Tongmin] Chungbuk Natl Univ, Coll Agr Life & Environm Sci, Dept Environm & Biol Chem, Cheongju, Chungbuk, South Korea; [Boughattas, Sonia; Ayari, Khaled; Aoun, Karim; Bouratbine, Aida] Inst Pasteur Tunis, Parasitol Lab, Tunis, Tunisia	Chungbuk National University; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis	Bouratbine, A (corresponding author), Inst Pasteur Tunis, Parasitol Lab, Tunis, Tunisia.	aida.bouratbine@pasteur.rns.tn		Boughattas, Sonia/0000-0001-7216-7852	Ministry of Higher Education Research and Technology in Tunisia	Ministry of Higher Education Research and Technology in Tunisia	This study was supported by the Ministry of Higher Education Research and Technology in Tunisia and carried out within the framework of the Research Lab "Parasitoses emergentes" LR 05SP03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Samra N, 2007, J S AFR VET ASSOC, V78, P116; Alvarado-Esquivel C, 2012, J PARASITOL, V98, P271, DOI 10.1645/GE-2958.1; Andreoletti O., 2007, EFSA J, V583, P1; Bastiaensen P., 1999, Tropicultura, V16/17, P18; BEKELE T, 1989, VET RES COMMUN, V13, P371, DOI 10.1007/BF00346069; Ben Rachid M S, 1970, Tunis Med, V48, P101; Berger F., 2007, TOXOPLASMOSE FRANCE; Berger-Schoch AE, 2011, ZOONOSES PUBLIC HLTH, V58, P472, DOI 10.1111/j.1863-2378.2011.01395.x; Boughattas S, 2011, TROP BIOMED, V28, P615; Boughattas S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-218; Boughattas S, 2010, AM J TROP MED HYG, V82, P1041, DOI 10.4269/ajtmh.2010.09-0691; Cenci-Goga BT, 2011, FOODBORNE PATHOG DIS, V8, P751, DOI 10.1089/fpd.2010.0795; Chabbert E, 2004, J CLIN MICROBIOL, V42, P1719, DOI 10.1128/JCM.42.4.1719-1722.2004; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dumetre A, 2006, VET PARASITOL, V142, P376, DOI 10.1016/j.vetpar.2006.07.005; Fakhfakh Najla, 2013, Tunis Med, V91, P188; Gajadhar AA, 2006, REV SCI TECH OIE, V25, P595, DOI 10.20506/rst.25.2.1679; Gharbi M, 2013, Bull Soc Pathol Exot, V106, P184, DOI 10.1007/s13149-013-0290-4; Glor SB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-85; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Halos L, 2010, INT J PARASITOL, V40, P193, DOI 10.1016/j.ijpara.2009.06.009; Hecker YP, 2013, TROP ANIM HLTH PROD; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kamani J, 2010, TROP ANIM HEALTH PRO, V42, P793, DOI 10.1007/s11250-009-9488-3; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; Oncel Taraneh, 2005, Turkiye Parazitoloji Dergisi, V29, P10; Opsteegh M, 2010, INT J FOOD MICROBIOL, V139, P193, DOI 10.1016/j.ijfoodmicro.2010.02.027; Preacher K.J., 2001, CALCULATION CHI SQUA; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sawadogo P, 2005, VET PARASITOL, V130, P89, DOI 10.1016/j.vetpar.2005.03.025; Shaapan RM, 2008, VET PARASITOL, V153, P359, DOI 10.1016/j.vetpar.2008.02.016; Tenter AM, 2009, MEM I OSWALDO CRUZ, V104, P364, DOI 10.1590/S0074-02762009000200033; van der Puije WNA, 2000, ACTA TROP, V76, P21, DOI 10.1016/S0001-706X(00)00084-X; Villena I, 2012, VET PARASITOL, V183, P203, DOI 10.1016/j.vetpar.2011.08.001; WALDELAND H, 1976, ACTA VET SCAND, V17, P432	36	40	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85044	10.1371/journal.pone.0085044	http://dx.doi.org/10.1371/journal.pone.0085044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427300	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200040
J	Li, WJ; Wang, L; Yang, YF				Li, Weijun; Wang, Lin; Yang, Yufang			Chinese Tone and Vowel Processing Exhibits Distinctive Temporal Characteristics: An Electrophysiological Perspective from Classical Chinese Poem Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ERP; COMPREHENSION; VIOLATIONS; MEMORY; WORDS; MODEL; P600	Classical Chinese poems have strict regulations on the acoustic pattern of each syllable and are semantically meaningless. Using such poems, this study characterized the temporal order of tone and vowel processing using event-related potentials (ERPs). The target syllable of the poem was either correct or deviated from the correct syllable at tone, vowel or both levels. Vowel violation elicited a negative effect between 300 and 500 ms regardless of the tone correctness, while tone violation elicited a positive effect between 600 and 1000 ms. The results suggest that the vowel information was available earlier than the tone information. Moreover, there was an interaction between the effect of vowel and tone violations between 600 and 1000 ms, showing that the vowel violation produced a positive effect only when the tone was correct. This indicates that vowel and tone processing interacts in the later processing stage, which involves both error detection and reanalysis of the spoken input. Implications of the present results for models of speech perception are discussed.	[Li, Weijun; Wang, Lin; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	wangl@psych.ac.cn; yangyf@psych.ac.cn		Wang, Lin/0000-0001-6911-0660	National Natural Science Foundation of China [31000505, 31070904, 31200849]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Numbers: 31000505, 31070904 and 31200849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brown-Schmidt S, 2004, J PSYCHOLINGUIST RES, V33, P103, DOI 10.1023/B:JOPR.0000017223.98667.10; Coch D, 2008, DEVELOPMENTAL SCI, V5, P467; Coch D, 2008, PSYCHOPHYSIOLOGY, V45, P949, DOI 10.1111/j.1469-8986.2008.00701.x; Coch D, 2008, BRAIN LANG, V104, P230, DOI 10.1016/j.bandl.2007.06.003; Cutler A, 1997, PERCEPT PSYCHOPHYS, V59, P165, DOI 10.3758/BF03211886; Duanmu S, 2003, PHONOLOGY STANDARD C, P219; Dumay N, 2001, J COGNITIVE NEUROSCI, V13, P121, DOI 10.1162/089892901564117; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Gandour J, 2003, HUM BRAIN MAPP, V20, P185, DOI 10.1002/hbm.10137; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Gandour J. T, 2006, ENCY LANGUAGE LINGUI, V12, P751, DOI DOI 10.1016/B0-08-044854-2/04796-9; Grossi G, 2001, J COGNITIVE NEUROSCI, V13, P610, DOI 10.1162/089892901750363190; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Hu JH, 2012, PSYCHOPHYSIOLOGY, V49, P1179, DOI 10.1111/j.1469-8986.2012.01406.x; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Liu SY, 2007, LANG COGNITIVE PROC, V22, P566, DOI 10.1080/01690960600989600; Luck S., 2005, INTRO EVENT RELATED, P104; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Perrin F, 2003, COGNITIVE BRAIN RES, V17, P36, DOI 10.1016/S0926-6410(03)00078-8; PRAAMSTRA P, 1993, COGNITIVE BRAIN RES, V1, P73, DOI 10.1016/0926-6410(93)90013-U; Radeau M, 1998, BIOL PSYCHOL, V48, P183, DOI 10.1016/S0301-0511(98)00012-X; Repp B.H., 1990, J ACOUST SOC AM, V87, pS46, DOI [10.1121/1.2028239, DOI 10.1121/1.2028239]; RUGG MD, 1984, BRAIN LANG, V23, P225, DOI 10.1016/0093-934X(84)90065-8; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P435, DOI 10.1016/0028-3932(84)90038-1; Schirmer A, 2005, J COGNITIVE NEUROSCI, V17, P1, DOI 10.1162/0898929052880057; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Taft M., 1992, LANGUAGE PROCESSING, P151, DOI DOI 10.1016/S0166-4115(08)61891-9; Tong YX, 2008, LANG COGNITIVE PROC, V23, P689, DOI 10.1080/01690960701728261; van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; Wagensveld B, 2012, BRAIN RES, V1483, P63, DOI 10.1016/j.brainres.2012.09.018; WANG L, 2005, CHINESE PROSODY; Xu Y, 1998, PHONETICA, V55, P179, DOI 10.1159/000028432; Yao DZ, 2007, COMPUT BIOL MED, V37, P1529, DOI 10.1016/j.compbiomed.2007.02.002; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Ye Y, 1999, LANG COGNITIVE PROC, V14, P609, DOI 10.1080/016909699386202	46	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85683	10.1371/journal.pone.0085683	http://dx.doi.org/10.1371/journal.pone.0085683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291XP	24416438	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300096
J	Chen, HL; VanBuren, V				Chen, Hailin; VanBuren, Vincent			A Provisional Gene Regulatory Atlas for Mouse Heart Development	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; UNITED-STATES; NETWORKS; DISCOVERY; DISEASE; COMMUNITIES; COMPLEXITY; DATABASE; DEFECTS; MODULES	Congenital Heart Disease (CHD) is one of the most common birth defects. Elucidating the molecular mechanisms underlying normal cardiac development is an important step towards early identification of abnormalities during the developmental program and towards the creation of early intervention strategies. We developed a novel computational strategy for leveraging high-content data sets, including a large selection of microarray data associated with mouse cardiac development, mouse genome sequence, ChIP-seq data of selected mouse transcription factors and Y2H data of mouse protein-protein interactions, to infer the active transcriptional regulatory network of mouse cardiac development. We identified phase-specific expression activity for 765 overlapping gene co-expression modules that were defined for obtained cardiac lineage microarray data. For each co-expression module, we identified the phase of cardiac development where gene expression for that module was higher than other phases. Co-expression modules were found to be consistent with biological pathway knowledge in Wikipathways, and met expectations for enrichment of pathways involved in heart lineage development. Over 359,000 transcription factor-target relationships were inferred by analyzing the promoter sequences within each gene module for overrepresentation against the JASPAR database of Transcription Factor Binding Site (TFBS) motifs. The provisional regulatory network will provide a framework of studying the genetic basis of CHD.	[Chen, Hailin; VanBuren, Vincent] Texas A&M HSC Coll Med, Dept Med Physiol, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	VanBuren, V (corresponding author), Texas A&M HSC Coll Med, Dept Med Physiol, Temple, TX USA.	vanburen@tamu.edu						Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Boneva RS, 2001, CIRCULATION, V103, P2376; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Donofrio MT, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/359390; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Gupta R, 2011, NUCLEIC ACIDS RES, V39, pD92, DOI 10.1093/nar/gkq1171; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Qi Yuan, 2006, PLoS Comput Biol, V2, pe174, DOI 10.1371/journal.pcbi.0020174; Qiu YY, 2009, INT J BIOCHEM CELL B, V41, P531, DOI 10.1016/j.biocel.2008.06.020; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; van Esch JHM, 2010, CARDIOVASC RES, V86, P401, DOI 10.1093/cvr/cvq004; VanBuren V, 2012, SCI REP-UK, V2, DOI 10.1038/srep01011; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weismann CG, 2007, CURR OPIN CARDIOL, V22, P200, DOI 10.1097/HCO.0b013e3280f629c7; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	43	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83364	10.1371/journal.pone.0083364	http://dx.doi.org/10.1371/journal.pone.0083364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421884	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500044
J	Henschel, P; Coad, L; Burton, C; Chataigner, B; Dunn, A; MacDonald, D; Saidu, Y; Hunter, LTB				Henschel, Philipp; Coad, Lauren; Burton, Cole; Chataigner, Beatrice; Dunn, Andrew; MacDonald, David; Saidu, Yohanna; Hunter, Luke T. B.			The Lion in West Africa Is Critically Endangered	PLOS ONE			English	Article							PANTHERA-LEO; NATIONAL-PARK; CONSERVATION; DECLINES; EXTINCTION; DIVERSITY; PLAYBACKS; MAMMALS; SIZE	The African lion has declined to,35,000 individuals occupying 25% of its historic range. The situation is most critical for the geographically isolated populations in West Africa, where the species is considered regionally endangered. Elevating their conservation significance, recent molecular studies establish the genetic distinctiveness of West and Central African lions from other extant African populations. Interventions to save West African lions are urgently required. However formulating effective conservation strategies has been hampered by a lack of data on the species' current distribution, status, and potential management deficiencies of protected areas (PAs) harboring lions. Our study synthesized available expert opinion and field data to close this knowledge gap, and formulate recommendations for the conservation of West African lions. We undertook lion surveys in 13 large (>500 km(2)) PAs and compiled evidence of lion presence/absence for a further eight PAs. All PAs were situated within Lion Conservation Units, geographical units designated as priority lion areas by wildlife experts at a regional lion conservation workshop in 2005. Lions were confirmed in only 4 PAs, and our results suggest that only 406 (273-605) lions remain in West Africa, representing <250 mature individuals. Confirmed lion range is estimated at 49,000 km(2), or 1.1% of historical range in West Africa. PAs retaining lions were larger than PAs without lions and had significantly higher management budgets. We encourage revision of lion taxonomy, to recognize the genetic distinctiveness of West African lions and highlight their potentially unique conservation value. Further, we call for listing of the lion as critically endangered in West Africa, under criterion C2a(ii) for populations with <250 mature individuals. Finally, considering the relative poverty of lion range states in West Africa, we call for urgent mobilization of investment from the international community to assist range states to increase management effectiveness of PAs retaining lions.	[Henschel, Philipp; Hunter, Luke T. B.] Panthera, New York, NY 10018 USA; [Coad, Lauren] Univ Oxford, Environm Change Inst, Oxford, England; [Coad, Lauren] Univ Queensland, Sch Geog & Environm Planning, Brisbane, Qld, Australia; [Burton, Cole] Univ Alberta, Alberta Biodivers Monitoring Inst, Edmonton, AB, Canada; [Burton, Cole] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Chataigner, Beatrice] IUCN, Protected Area Program, Ouagadougou, Burkina Faso; [Dunn, Andrew] Wildlife Conservat Soc, Nigeria Program, Calabar, Nigeria; [MacDonald, David] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford OX1 3PS, England; [Saidu, Yohanna] Nigeria Natl Pk Serv, Garki Abuja, Nigeria	University of Oxford; University of Queensland; University of Alberta; University of Victoria; University of Oxford	Henschel, P (corresponding author), Panthera, New York, NY 10018 USA.	phenschel@panthera.org	Hunter, Luke T.B./H-3324-2019; Burton, Cole/AAF-9234-2019; Burton, Cole/J-3184-2012	Hunter, Luke T.B./0000-0001-9653-6544; Burton, Cole/0000-0002-8799-3847; Burton, Cole/0000-0002-8799-3847	Panthera; National Geographic's Big Cat Initiative [B1_12]; Oxford Martin School; DWM the Recanati-Kaplan Foundation; Robertson Foundation	Panthera; National Geographic's Big Cat Initiative; Oxford Martin School; DWM the Recanati-Kaplan Foundation; Robertson Foundation	Field survey efforts were funded by Panthera (www.panthera.org), with additional funds from National Geographic's Big Cat Initiative (grant B1_12; http://animals.nationalgeographic.com/animals/big-cats/). LC furthermore acknowledges the support of the Oxford Martin School, and DWM the Recanati-Kaplan Foundation and Robertson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2004, Cat News, V41, P35; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bauer H, 2003, CR BIOL, V326, pS112, DOI 10.1016/S1631-0691(03)00047-7; Bauer H, 2010, MAMMALIA, V74, P363, DOI 10.1515/MAMM.2010.048; Belbachir F, 2008, IUCN 2011 IUCN RED L; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Blom B, 2010, ENVIRON SCI POLICY, V13, P164, DOI 10.1016/j.envsci.2010.01.002; Bouche P., 2004, RECENSEMENT AERIEN T; Bouche P, 2006, MOLE WILDLIFE SURVEY; Bouche P, 2012, OUAGADOUGOU; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; BREITENMOSER U, 2012, CAT NEWS, V57, P3; Brockington D, 2010, CONSERV LETT, V3, P106, DOI 10.1111/j.1755-263X.2010.00094.x; Brugiere D, 2012, ORYX, V46, P253, DOI 10.1017/S0030605311000391; Burton AC, 2012, BIODIVERS CONSERV, V21, P3079, DOI 10.1007/s10531-012-0355-6; Burton AC, 2011, BIOL CONSERV, V144, P2344, DOI 10.1016/j.biocon.2011.06.014; CENAGREF, 2013, PLAN ACT CONS LION B; Coad L., 2013, PARKS, V19; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Delvingt W, 2007, NAZINGA; Dubach JM, 2013, CONSERV GENET, P1; Dufour S, 2008, PROGRAMME GESTION CO; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; Galat G, 1992, DENOMBREMENT GRANDE; Granier N, 2004, ETUDE CHIMPANZES AIR; Gros PM, 1998, BIOL CONSERV, V85, P137, DOI 10.1016/S0006-3207(97)00135-3; Henschel Philipp, 2010, Cat News, V52, P34; Inah EI, 2005, J SUSTAIN AGR, V27, P125, DOI 10.1300/J064v27n01_08; IUCN, 2006, CONS STRAT LION W CE; IUCN, 2012, IUCN RED LIST THREAT; IUCN/SSC, 2001, IUCN RED LIST CAT CR; IUCN SSC ANTELOPE SPECIALIST GROUP, 2008, IUCN RED LIST THREAT; Jackson P., 1996, BIOL CONSERVATION; Leverington F, 2010, MANAGEMENT EFFECTIVE; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Macdonald DW, 2012, BIOL CONSERV, V147, P107, DOI 10.1016/j.biocon.2011.12.018; Mazak JH, 2010, J ZOOL, V281, P194, DOI 10.1111/j.1469-7998.2010.00694.x; Mole National Park, 2011, MOLE NATL PARK MANAG; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Nyanganji G, 2011, SURVEY LIONS PANTHER; Ogutu JO, 1998, AFR J ECOL, V36, P83, DOI 10.1046/j.1365-2028.1998.113-89113.x; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; PFNH, 2009, RAPP ACT MAI JUILL 2; R Core Team, 2013, R LANG ENV STAT COMP; Renaud P, 2006, INVENTAIRE AERIEN TE; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Schaller G. B., 1972, SERENGETI LION; Sinsin B, 2002, MAMMALIA, V66, P369, DOI 10.1515/mamm.2002.66.3.369; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; STANDER P E, 1991, Madoqua, V18, P1; Stuart C., 2003, FIELD GUIDE TRACKS S; Thorn M, 2010, S AFR J WILDL RES, V40, P77, DOI 10.3957/056.040.0113; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R., 2012, IUCN RED LIST THREAT	63	80	82	8	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83500	10.1371/journal.pone.0083500	http://dx.doi.org/10.1371/journal.pone.0083500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421889	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500052
J	Pinto, C; Pinho, D; Sousa, S; Pinheiro, M; Egas, C; Gomes, AC				Pinto, Catia; Pinho, Diogo; Sousa, Susana; Pinheiro, Miguel; Egas, Conceicao; Gomes, Ana C.			Unravelling the Diversity of Grapevine Microbiome	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; VITIS-VINIFERA; ACID BACTERIA; WINE GRAPES; BIOCONTROL; RESISTANCE; BOTRYTIS; ECOLOGY; FUNGAL; YEASTS	Vitis vinifera is one of the most widely cultivated fruit crops with a great economic impact on the global industry. As a plant, it is naturally colonised by a wide variety of both prokaryotic and eukaryotic microorganisms that interact with grapevine, having either beneficial or phytopathogenic effects, who play a major role in fruit yield, grape quality and, ultimately, in the evolution of grape fermentation and wine production. Therefore, the objective of this study was to extensively characterize the natural microbiome of grapevine. Considering that the majority of microorganisms are uncultivable, we have deeply studied the microflora of grapevine leaves using massive parallel rDNA sequencing, along its vegetative cycle. Among eukaryotic population the most abundant microorganisms belonged to the early diverging fungi lineages and Ascomycota phylum, whereas the Basidiomycota were the least abundant. Regarding prokaryotes, a high diversity of Proteobacteria, Firmicutes and Actinobacteria was unveiled. Indeed, the microbial communities present in the vineyard during its vegetative cycle were shown to be highly structured and dynamic. In all cases, the major abundant microorganisms were the yeast-like fungus Aureobasidium and the prokaryotic Enterobacteriaceae. Herein, we report the first complete microbiome landscape of the vineyard, through a metagenomic approach, and highlight the analysis of the microbial interactions within the vineyard and its importance for the equilibrium of the microecosystem of grapevines.	[Pinto, Catia; Pinho, Diogo; Sousa, Susana; Gomes, Ana C.] Biocant Biotechnol Innovat Ctr, Genom Unit, Cantanhede, Portugal; [Pinheiro, Miguel; Egas, Conceicao] Biocant Biotechnol Innovat Ctr, Adv Serv Unit, Cantanhede, Portugal		Gomes, AC (corresponding author), Biocant Biotechnol Innovat Ctr, Genom Unit, Cantanhede, Portugal.	acgomes@biocant.pt	rolshausen, philippe/F-7999-2011; Pinheiro, Miguel/K-6572-2017; Gomes, Ana Catarina/A-2628-2015; Egas, Conceição/K-4866-2014; Pinho, Diogo/ABG-5993-2021	Pinheiro, Miguel/0000-0002-6601-7513; Gomes, Ana Catarina/0000-0002-4989-6026; Egas, Conceição/0000-0002-2307-5414; Pinho, Diogo/0000-0002-0377-2802	FEDER - COMPETE through "Quadro de Referencia Estrategico Nacional" - QREN [FCOMP-01-0202-FEDER-011498, FCOMP-01-0124-FEDER-008749]; FEDER through "Programa Operacional Factores de Competitividade" - COMPETE; FEDER through FCT - "Fundacao para a Ciencia e a Tecnologia"	FEDER - COMPETE through "Quadro de Referencia Estrategico Nacional" - QREN; FEDER through "Programa Operacional Factores de Competitividade" - COMPETE; FEDER through FCT - "Fundacao para a Ciencia e a Tecnologia"	This work was carried out within the InovWine project, which funded by FEDER - COMPETE, through "Quadro de Referencia Estrategico Nacional" - QREN, with the reference FCOMP-01-0202-FEDER-011498, and within the project FCOMP-01-0124-FEDER-008749, which is financed with funds from FEDER through the "Programa Operacional Factores de Competitividade" - COMPETE, and FCT - "Fundacao para a Ciencia e a Tecnologia". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2006, J APPL MICROBIOL, V100, P712, DOI 10.1111/j.1365-2672.2006.02890.x; Barata A, 2008, J APPL MICROBIOL, V104, P1182, DOI 10.1111/j.1365-2672.2007.03631.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Batta Y. A., 2006, Journal of Applied Horticulture (Lucknow), V8, P29; Bisson Linda F., 2009, P47, DOI 10.1007/978-3-540-85463-0_3; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Cabras P, 1999, J AGR FOOD CHEM, V47, P3854, DOI 10.1021/jf990005j; Cabras P, 1997, J AGR FOOD CHEM, V45, P476, DOI 10.1021/jf960353a; Calonnec A, 2004, PLANT PATHOL, V53, P434, DOI 10.1111/j.0032-0862.2004.01016.x; Chervin C., 2012, Crop post-harvest: science and technology. Volume 3: perishables, P187; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Comitini F, 2008, ANN MICROBIOL, V58, P489, DOI 10.1007/BF03175547; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferreira RB, 2004, TRENDS BIOTECHNOL, V22, P168, DOI 10.1016/j.tibtech.2004.02.001; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Fusi M, 2010, FOOD CONTROL, V21, P830, DOI 10.1016/j.foodcont.2009.11.009; Garijo P, 2011, EUR FOOD RES TECHNOL, V233, P359, DOI 10.1007/s00217-011-1528-3; Gomes E., 2009, GRAPEVINE MOL PHYSL, P407, DOI DOI 10.1007/978-90-481-2305-6_15; Grube M, 2011, FUNGAL BIOL-UK, V115, P978, DOI 10.1016/j.funbio.2011.04.004; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Jackson R.S., 2000, WINE SCI PRINCIPLES, P375, DOI [10.1016/B978-0-12-373646-8.50004-4, DOI 10.1016/B978-0-12-373646-8.50004-4]; JOYEUX A, 1984, APPL ENVIRON MICROB, V48, P153, DOI 10.1128/AEM.48.1.153-156.1984; Koenig Helmut, 2009, P3, DOI 10.1007/978-3-540-85463-0_1; Laimer M, 2009, J PLANT PATHOL, V91, P7; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Manuel Guillamon Jose, 2009, P31, DOI 10.1007/978-3-540-85463-0_2; Martins I, 2010, RELATORIO ACTIVIDADE, P1; Mocali S, 2010, RES MICROBIOL, V161, P497, DOI 10.1016/j.resmic.2010.04.010; Mostert L, 2001, MYCOLOGIA, V93, P146, DOI 10.2307/3761612; Nisiotou AA, 2011, INT J FOOD MICROBIOL, V145, P432, DOI 10.1016/j.ijfoodmicro.2011.01.017; Pereira A, 2003, PROTECCAO INTEGRADA; Phalip V, 2006, FEMS MICROBIOL ECOL, V56, P321, DOI 10.1111/j.1574-6941.2006.00102.x; Prakitchaiwattana CJ, 2004, FEMS YEAST RES, V4, P865, DOI 10.1016/j.femsyr.2004.05.004; Raspor P, 2010, FOOD TECHNOL BIOTECH, V48, P336; Rego C, 2007, ACT 7 S VIT AL EV PO, P107; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; Renouf V, 2007, APPL MICROBIOL BIOT, V75, P149, DOI 10.1007/s00253-006-0798-3; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Serra R, 2005, RES MICROBIOL, V156, P515, DOI 10.1016/j.resmic.2004.12.005; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sipiczki M, 2006, APPL ENVIRON MICROB, V72, P6716, DOI 10.1128/AEM.01275-06; Siqueira Jose F Jr, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10743; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Toit W, 2002, ANAL MICROBIOL, V52, P155; Trotel-Aziz P, 2008, ENVIRON EXP BOT, V64, P21, DOI 10.1016/j.envexpbot.2007.12.009; Urbez-Torres JR, 2006, PLANT DIS, V90, P1490, DOI 10.1094/PD-90-1490; van der Waals JE, 2004, PLANT DIS, V88, P959, DOI 10.1094/PDIS.2004.88.9.959; Visconti A, 2008, FOOD ADDIT CONTAM A, V25, P193, DOI 10.1080/02652030701744546; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xu J, 2009, MICROBIOL-SGM, V155, P174, DOI 10.1099/mic.0.022103-0; Zahavi T, 2000, POSTHARVEST BIOL TEC, V20, P115, DOI 10.1016/S0925-5214(00)00118-6	60	179	184	1	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85622	10.1371/journal.pone.0085622	http://dx.doi.org/10.1371/journal.pone.0085622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454903	Green Published, gold, Green Submitted			2022-12-27	WOS:000330236000014
J	Uhernik, AL; Li, L; LaVoy, N; Velasquez, MJ; Smith, JP				Uhernik, Amy L.; Li, Lun; LaVoy, Nathan; Velasquez, Micah J.; Smith, Jeffrey P.			Regulation of Monocarboxylic Acid Transporter-1 by cAMP Dependent Vesicular Trafficking in Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							INTRACELLULAR PH INDICATOR; TISSUE-SPECIFIC POLARITY; EXPRESSION; EPITHELIA; GREEN; NEOVASCULARIZATION; ACIDIFICATION; MECHANISMS; PROTEINS; PATHWAY	In this study, a detailed characterization of Monocarboxylic Acid Transporter-1 (Mct1) in cytoplasmic vesicles of cultured rat brain microvascular endothelial cells shows them to be a diverse population of endosomes intrinsic to the regulation of the transporter by a brief 25 to 30 minute exposure to the membrane permeant cAMP analog, 8Br-cAMP. The vesicles are heterogeneous in size, mobility, internal pH, and co-localize with discreet markers of particular types of endosomes including early endosomes, clathrin coated vesicles, caveolar vesicles, trans-golgi, and lysosomes. The vesicular localization of Mct1 was not dependent on its N or C termini, however, the size and pH of Mct1 vesicles was increased by deletion of either terminus demonstrating a role for the termini in vesicular trafficking of Mct1. Using a novel BCECF-AM based assay developed in this study, 8Br-cAMP was shown to decrease the pH of Mct1 vesicles after 25 minutes. This result and method were confirmed in experiments with a ratiometric pH-sensitive EGFP-mCherry dual tagged Mct1 construct. Overall, the results indicate that cAMP signaling reduces the functionality of Mct1 in cerebrovascular endothelial cells by facilitating its entry into a highly dynamic vesicular trafficking pathway that appears to lead to the transporter's trafficking to autophagosomes and lysosomes.	[Uhernik, Amy L.; Li, Lun; LaVoy, Nathan; Velasquez, Micah J.; Smith, Jeffrey P.] Colorado State Univ Pueblo, Dept Biol, Pueblo, CO 81001 USA	Colorado State University	Smith, JP (corresponding author), Colorado State Univ Pueblo, Dept Biol, Pueblo, CO 81001 USA.	jeff.smith@colostate-pueblo.edu			National Institutes of Health, National Institute of Neurological Disorders and Stroke [1R15NS062404-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS062404] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, Grant 1R15NS062404-01A2. The authors have no conflicts of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Candela P, 2008, ENDOTHELIUM-J ENDOTH, V15, P254, DOI 10.1080/10623320802487759; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Froberg MK, 2001, NEUROREPORT, V12, P761, DOI 10.1097/00001756-200103260-00030; Gallagher SM, 2009, AM J PHYSIOL-CELL PH, V296, pC414, DOI 10.1152/ajpcell.00430.2008; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Koryakina Y, 2012, CELL BIOL INT, V36, P1171, DOI 10.1042/CBI20120134; Kraft C, 2012, CURR OPIN CELL BIOL, V24, P496, DOI 10.1016/j.ceb.2012.05.001; Liman TG, 2012, CEREBROVASC DIS, V33, P492, DOI 10.1159/000337155; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; MELLMAN I, 1992, J EXP BIOL, V172, P39; Miranda-Goncalves V, 2013, NEURO-ONCOLOGY, V15, P172, DOI 10.1093/neuonc/nos298; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; SHI LB, 1991, BIOPHYS J, V59, P1208, DOI 10.1016/S0006-3495(91)82336-0; Smith JK, 2012, PSYCHOL AESTHET CREA, V6, P1, DOI 10.1037/a0027241; Smith JP, 2006, J BIOL CHEM, V281, P2053, DOI 10.1074/jbc.M511577200; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; STRAUBINGER RM, 1990, BIOCHEMISTRY-US, V29, P4929, DOI 10.1021/bi00472a025; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Uhernik AL, 2011, BRAIN RES, V1376, P10, DOI 10.1016/j.brainres.2010.12.060; Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8; Vijay N, 2013, CURR PHARM DES; Virgintino D, 2002, NEUROSCIENCE, V115, P145, DOI 10.1016/S0306-4522(02)00374-3; Yang LL, 2008, J BIOL CHEM, V283, P21703, DOI 10.1074/jbc.M800809200	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85957	10.1371/journal.pone.0085957	http://dx.doi.org/10.1371/journal.pone.0085957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454947	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000021
J	van Ooyen, A; Carnell, A; de Ridder, S; Tarigan, B; Mansvelder, HD; Bijma, F; de Gunst, M; van Pelt, J				van Ooyen, Arjen; Carnell, Andrew; de Ridder, Sander; Tarigan, Bernadetta; Mansvelder, Huibert D.; Bijma, Fetsje; de Gunst, Mathisca; van Pelt, Jaap			Independently Outgrowing Neurons and Geometry-Based Synapse Formation Produce Networks with Realistic Synaptic Connectivity	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; GRAPH-THEORETICAL ANALYSIS; MEDIAL PREFRONTAL CORTEX; COMPLEX BRAIN NETWORKS; RAT BARREL CORTEX; PYRAMIDAL NEURONS; VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; DENDRITIC MORPHOLOGY; SCHIZOPHRENIA	Neuronal signal integration and information processing in cortical networks critically depend on the organization of synaptic connectivity. During development, neurons can form synaptic connections when their axonal and dendritic arborizations come within close proximity of each other. Although many signaling cues are thought to be involved in guiding neuronal extensions, the extent to which accidental appositions between axons and dendrites can already account for synaptic connectivity remains unclear. To investigate this, we generated a local network of cortical L2/3 neurons that grew out independently of each other and that were not guided by any extracellular cues. Synapses were formed when axonal and dendritic branches came by chance within a threshold distance of each other. Despite the absence of guidance cues, we found that the emerging synaptic connectivity showed a good agreement with available experimental data on spatial locations of synapses on dendrites and axons, number of synapses by which neurons are connected, connection probability between neurons, distance between connected neurons, and pattern of synaptic connectivity. The connectivity pattern had a small-world topology but was not scale free. Together, our results suggest that baseline synaptic connectivity in local cortical circuits may largely result from accidentally overlapping axonal and dendritic branches of independently outgrowing neurons.	[van Ooyen, Arjen; Carnell, Andrew; de Ridder, Sander; Mansvelder, Huibert D.; van Pelt, Jaap] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands; [Tarigan, Bernadetta; Bijma, Fetsje; de Gunst, Mathisca] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Ooyen, A (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands.	arjen.van.ooyen@falw.vu.nl	Tarigan, Bernadetta/AAD-1843-2019; Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; de Ridder, Sander/0000-0001-7250-7239	European Union [216593]; Netherlands Organization for Scientific Research [635.100.017]	European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the BIO-ICT project SECO (grant number 216593) of the 7th Framework Programme of the European Union, and the NETFORM project (grant number 635.100.017) of the Computational Life Sciences program of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirikian B, 2005, PLOS COMPUT BIOL, V1, P74, DOI 10.1371/journal.pcbi.0010011; Arendt T, 1997, J NEUROSCI, V17, P516; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen W, 2011, FRONT COMPUT NEUROSC, V5, DOI DOI 10.3389/FNC0M.2011.00014; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Cho MW, 2010, INT J IMAG SYST TECH, V20, P108, DOI 10.1002/ima.20229; CHU PH, 1994, INT J BIFURCAT CHAOS, V4, P237, DOI 10.1142/S0218127494000198; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Costa LD, 2002, NETWORK-COMP NEURAL, V13, P283, DOI 10.1088/0954-898X/13/3/303; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Cullen TJ, 2006, BRIT J PSYCHIAT, V188, P26, DOI 10.1192/bjp.bp.104.008169; da Silva S, 2011, CURR OPIN NEUROBIOL, V21, P61, DOI 10.1016/j.conb.2010.07.007; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Gaiteri C, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00010; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Isbister CM, 1999, J NEUROSCI, V19, P2589; Kaiser M, 2009, CEREB CORTEX, V19, P3001, DOI 10.1093/cercor/bhp071; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; Kotter R, 2002, NEUROSCIENCE DATABAS, P171; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; LOHMANN H, 1994, J COMP NEUROL, V344, P543, DOI 10.1002/cne.903440405; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Morelli LG, 2004, EUR PHYS J B, V38, P495, DOI 10.1140/epjb/e2004-00144-7; Neymotin SA, 2011, J COMPUT NEUROSCI, V30, P69, DOI 10.1007/s10827-010-0253-4; Nisbach F, 2007, EUR PHYS J B, V58, P185, DOI 10.1140/epjb/e2007-00214-4; Nunez JL, 1998, DEV BRAIN RES, V111, P89, DOI 10.1016/S0165-3806(98)00125-4; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; PETERS A, 1979, TRENDS NEUROSCI, V2, P183, DOI 10.1016/0166-2236(79)90074-2; Polinsky M, 2000, J NEUROSCI, V20, P1044, DOI 10.1523/JNEUROSCI.20-03-01044.2000; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Roxin A, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00008; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; Tigerholm J, 2013, HIPPOCAMPUS, V23, P87, DOI 10.1002/hipo.22061; UYLINGS HBM, 1994, PROG BRAIN RES, V102, P109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van Pelt J, 2001, METH NE FRO NEUROSCI, P179; van Pelt J, 2001, ANAT EMBRYOL, V204, P255, DOI 10.1007/s004290100197; Van Pelt J., 2005, MODELING NEUROSCIENC, P89, DOI DOI 10.1201/9780203390979.CH5; van Pelt J, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00148; VANPELT J, 2003, BRAIN MIND, V4, P51, DOI DOI 10.1023/A:1024160131897; Voges N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00041; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; YAMADA M, 1988, J NEUROL NEUROSUR PS, V51, P1088, DOI 10.1136/jnnp.51.8.1088; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	76	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85858	10.1371/journal.pone.0085858	http://dx.doi.org/10.1371/journal.pone.0085858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454938	Green Published, gold			2022-12-27	WOS:000330236000017
J	Gach, JS; Achenbach, CJ; Chromikova, V; Berzins, B; Lambert, N; Landucci, G; Forthal, DN; Katlama, C; Jung, BH; Murphy, RL				Gach, Johannes S.; Achenbach, Chad J.; Chromikova, Veronika; Berzins, Baiba; Lambert, Nina; Landucci, Gary; Forthal, Donald N.; Katlama, Christine; Jung, Barbara H.; Murphy, Robert L.			HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; B-CELL RESPONSES; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; DISEASE PROGRESSION; ELITE SUPPRESSORS; IMMUNE-RESPONSES; VACCINE TARGET; C INFECTION	The majority of potent and broadly neutralizing antibodies against HIV-1 have been isolated from untreated patients with acute or chronic infection. To assess the extent of HIV-1 specific antibody response and neutralization after many years of virologic suppression from potent combination ART, we examined antibody binding titers and neutralization of 51 patients with chronic HIV-1 infection on suppressive ART for at least three years. In this cross-sectional analysis, we found high antibody titers against gp120, gp41, and the membrane proximal external region (MPER) in 59%, 43%, and 27% of patients, respectively. We observed significantly higher endpoint binding titers for gp120 and gp41 for patients with.10 compared to <= 10 years of detectable HIV RNA. Additionally, we observed higher median gp120 and gp41 antibody titers in patients with HIV RNA < 50 copies/mL for <= 5 years. 22% of patients neutralized a HIV-1 primary isolate (HIV-1(JR-FL)) and 8% neutralized a HIV-2/HIV-1 MPER chimera. Significantly greater HIV-1(JR-FL) neutralization was found among patients with.10 years of detectable HIV RNA (8/20 [40.0%] versus 3/31 [9.7%] for <= 10 years, p = 0.02) and a trend toward greater neutralization in patients with <= 5 years of HIV RNA,50 copies/mL (7/20 [35.0%] versus 4/31 [12.9%] for > 5 years, p = 0.08). All patients with neutralizing activity mediated successful phagocytosis of VLPs by THP-1 cells after antibody opsonization. Our findings of highly specific antibodies to several structural epitopes of HIV-1 with antibody effector functions and neutralizing activity after long-term suppressive ART, suggest continuous antigenic stimulation and evolution of HIV-specific antibody response occurs before and after suppression with ART. These patients, particularly those with slower HIV progression and more time with detectable viremia prior to initiation of suppressive ART, are a promising population to identify and further study functional antibodies against HIV-1.	[Gach, Johannes S.; Jung, Barbara H.] Northwestern Univ, Div Gastroenterol, Chicago, IL 60611 USA; [Achenbach, Chad J.; Berzins, Baiba; Lambert, Nina; Murphy, Robert L.] Northwestern Univ, Div Infect Dis, Chicago, IL 60611 USA; [Achenbach, Chad J.; Berzins, Baiba; Lambert, Nina; Murphy, Robert L.] Northwestern Univ, Ctr Global Hlth, Chicago, IL 60611 USA; [Gach, Johannes S.; Chromikova, Veronika; Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Div Infect Dis, Irvine, CA USA; [Chromikova, Veronika] Univ Bodenkultur Wien, Inst Appl Microbiol, Vienna, Austria; [Katlama, Christine] Univ Paris 06, Hop Pitie Salpetriere, Paris, France	Northwestern University; Northwestern University; Northwestern University; University of California System; University of California Irvine; University of Natural Resources & Life Sciences, Vienna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gach, JS (corresponding author), Northwestern Univ, Div Gastroenterol, Chicago, IL 60611 USA.	jgach@uci.edu	Achenbach, Chad/AAQ-4035-2020	Murphy, Robert/0000-0003-3936-2052; Gach, Johannes/0000-0002-5043-5710; Achenbach, Chad/0000-0003-4847-7249	Objectif Recherche Vaccin SIDA (ORVACS); National Institutes of Health [R01 CA141057-01, P30 CA060553, R01AI084136]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA141057] Funding Source: NIH RePORTER	Objectif Recherche Vaccin SIDA (ORVACS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Objectif Recherche Vaccin SIDA (ORVACS) and the National Institutes of Health (grant numbers R01 CA141057-01 and P30 CA060553 to BHJ; R01AI084136 to DNF) provided support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Binley JM, 2000, J INFECT DIS, V182, P945, DOI 10.1086/315774; Blankson JN, 2010, DISCOV MED, V9, P261; Braibant M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-103; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Falkensammer B, 2007, FRONT BIOSCI, V12, P2148, DOI 10.2741/2218; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gach JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072054; Gach JS, 2011, CURR TOP MED CHEM, V11, P2997; Gach JS, 2010, J BIOL CHEM, V285, P1122, DOI 10.1074/jbc.M109.058792; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Holl V, 2009, VIRUSES-BASEL, V1, P1265, DOI 10.3390/v1031265; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Humbert M, 2006, AIDS REV, V8, P51; Ingale S, 2010, J PEPT SCI, V16, P716, DOI 10.1002/psc.1325; Killian MS, 2006, AIDS RES HUM RETROV, V22, P640, DOI 10.1089/aid.2006.22.640; Kim JH, 2001, AIDS RES HUM RETROV, V17, P1021, DOI 10.1089/088922201300343708; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Langedijk JPM, 2012, NAT MED, V18, P1616, DOI 10.1038/nm.2993; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Massanella M, 2013, CURR HIV-AIDS REP, V10, P33, DOI 10.1007/s11904-012-0150-8; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Saksena NK, 2010, HIV AIDS-RES PALLIAT, V2, P103; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	73	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85371	10.1371/journal.pone.0085371	http://dx.doi.org/10.1371/journal.pone.0085371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454852	Green Published, gold			2022-12-27	WOS:000330235100076
J	Kis, A; Bence, M; Lakatos, G; Pergel, E; Turcsan, B; Pluijmakers, J; Vas, J; Elek, Z; Bruder, I; Foldi, L; Sasvari-Szekely, M; Miklosi, A; Ronai, Z; Kubinyi, E				Kis, Anna; Bence, Melinda; Lakatos, Gabriella; Pergel, Eniko; Turcsan, Borbala; Pluijmakers, Jolanda; Vas, Judit; Elek, Zsuzsanna; Bruder, Ildiko; Foeldi, Levente; Sasvari-Szekely, Maria; Miklosi, Adam; Ronai, Zsolt; Kubinyi, Eniko			Oxytocin Receptor Gene Polymorphisms Are Associated with Human Directed Social Behavior in Dogs (Canis familiaris)	PLOS ONE			English	Article							PURE-BRED DOGS; ATTACHMENT; GAZE; OXTR; INTELLIGENCE; METHYLATION; COGNITION; MICRORNA; GENOME	The oxytocin system has a crucial role in human sociality; several results prove that polymorphisms of the oxytocin receptor gene are related to complex social behaviors in humans. Dogs' parallel evolution with humans and their adaptation to the human environment has made them a useful species to model human social interactions. Previous research indicates that dogs are eligible models for behavioral genetic research, as well. Based on these previous findings, our research investigated associations between human directed social behaviors and two newly described (-212AG, 19131AG) and one known (rs8679684) single nucleotide polymorphisms (SNPs) in the regulatory regions (59 and 39 UTR) of the oxytocin receptor gene in German Shepherd (N = 104) and Border Collie (N = 103) dogs. Dogs' behavior traits have been estimated in a newly developed test series consisting of five episodes: Greeting by a stranger, Separation from the owner, Problem solving, Threatening approach, Hiding of the owner. Buccal samples were collected and DNA was isolated using standard protocols. SNPs in the 39 and 59 UTR regions were analyzed by polymerase chain reaction based techniques followed by subsequent electrophoresis analysis. The gene-behavior association analysis suggests that oxytocin receptor gene polymorphisms have an impact in both breeds on (i) proximity seeking towards an unfamiliar person, as well as their owner, and on (ii) how friendly dogs behave towards strangers, although the mediating molecular regulatory mechanisms are yet unknown. Based on these results, we conclude that similarly to humans, the social behavior of dogs towards humans is influenced by the oxytocin system.	[Kis, Anna; Turcsan, Borbala; Bruder, Ildiko; Foeldi, Levente; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Kis, Anna; Turcsan, Borbala] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Bence, Melinda; Lakatos, Gabriella; Miklosi, Adam; Kubinyi, Eniko] MTA ELTE, Comparat Ethol Res Grp, Budapest, Hungary; [Pergel, Eniko; Elek, Zsuzsanna; Sasvari-Szekely, Maria; Ronai, Zsolt] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Pluijmakers, Jolanda] Catholic Univ Coll Ghent, Dept Ethol & Anim Welf, Brugge, Belgium; [Vas, Judit] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; MTA-ELTE Comparative Ethology Research Group; Semmelweis University; Norwegian University of Life Sciences	Kis, A (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	vargane.kis.anna@ttk.mta.hu; bencemelinda@gmail.com	Kubinyi, Eniko/B-5824-2013; Turcsán, Borbála/I-7983-2018; Vas, Judit/GRJ-7640-2022; Ronai, Zsolt/A-2473-2008; Miklosi, Adam/N-5147-2017	Kubinyi, Eniko/0000-0002-4468-9845; Turcsán, Borbála/0000-0002-0197-5243; Ronai, Zsolt/0000-0002-0909-7932; Miklosi, Adam/0000-0003-4831-8985; Kis, Anna/0000-0001-8728-4795	Hungarian Academy of Sciences [MTA 01 031]; Hungarian Scientific Research Fund [OTKA K100695, K84036, 107726]; Bolyai Foundation of the Hungarian Academy of Sciences; ESF [06-RNP-020]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ESF(European Commission)	Financial support was provided by the Hungarian Academy of Sciences (MTA 01 031), the Hungarian Scientific Research Fund (OTKA K100695; K84036; 107726), the Bolyai Foundation of the Hungarian Academy of Sciences, and an ESF Research Networking Programme "CompCog'': The Evolution of Social Cognition (06-RNP-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; [Anonymous], 2012, CURRENT OPINION NEUR; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bertino JR, 2007, PHARMACOGENOMICS, V8, P1625, DOI 10.2217/14622416.8.12.1625; Bradshaw JWS, 1999, RES VET SCI, V66, P73, DOI 10.1053/rvsc.1998.0246; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Chase K, 2009, J HERED, V100, pS37, DOI 10.1093/jhered/esp011; Chen FS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00200; Dayeh TA, 2013, DIABETOLOGIA, V56, P1036, DOI 10.1007/s00125-012-2815-7; Diederich C, 2006, APPL ANIM BEHAV SCI, V97, P51, DOI 10.1016/j.applanim.2005.11.018; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Falkenberg VR, 2011, NEUROMOL MED, V13, P66, DOI 10.1007/s12017-010-8138-2; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Gillath O, 2008, PERS SOC PSYCHOL B, V34, P1396, DOI 10.1177/0146167208321484; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hejjas K, 2007, ANIM GENET, V38, P629, DOI 10.1111/j.1365-2052.2007.01657.x; Hernadi A, 2013, ANIMAL COGNITI UNPUB; Hernadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043267; Herzmann G, 2013, PSYCHONEURO IN PRESS; Hollander E, 2007, BIOL PSYCHIAT, V61, P498, DOI 10.1016/j.biopsych.2006.05.030; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Kovacs-Nagy R, 2013, AM J MED GENET B, V162B, P404, DOI 10.1002/ajmg.b.32157; Kubinyi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030271; Lakatos G, 2011, ANIM COGN, V15, P18; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lischke A, 2012, PSYCHONEUROENDOCRINO, V37, P475, DOI 10.1016/j.psyneuen.2011.07.015; Liu JCJ, 2012, HORM BEHAV, V62, P585, DOI 10.1016/j.yhbeh.2012.09.002; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; Marx Peter, 2011, Neuropsychopharmacol Hung, V13, P139; McGraw LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029345; Munafo MR, 2009, ADDICTION, V104, P1439, DOI 10.1111/j.1360-0443.2009.02662.x; Notari L, 2007, APPL ANIM BEHAV SCI, V103, P118, DOI 10.1016/j.applanim.2006.03.018; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Stallen M, 2012, PSYCHOL SCI, V23, P1288, DOI 10.1177/0956797612446026; Takeuchi Y, 2006, J VET MED SCI, V68, P789, DOI 10.1292/jvms.68.789; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wan M, 2013, ANIMAL GENE IN PRESS; Wood E, 2006, TXB BIOCH CLIN CORRE; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012	55	73	74	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83993	10.1371/journal.pone.0083993	http://dx.doi.org/10.1371/journal.pone.0083993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454713	gold, Green Published, Green Accepted			2022-12-27	WOS:000330235100015
J	Mugisha, V; Teasdale, CA; Wang, CH; Lahuerta, M; Nuwagaba-Biribonwoha, H; Tayebwa, E; Ingabire, E; Ingabire, P; Sahabo, R; Twyman, P; Abrams, EJ				Mugisha, Veronicah; Teasdale, Chloe A.; Wang, Chunhui; Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Tayebwa, Edwin; Ingabire, Eugenie; Ingabire, Pacifique; Sahabo, Ruben; Twyman, Peter; Abrams, Elaine J.		Identifying Optimal Models HIV	Determinants of Mortality and Loss to Follow-Up among Adults Enrolled in HIV Care Services in Rwanda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAM; SUB-SAHARAN AFRICA; SOUTH-AFRICA; SCALE-UP; OUTCOMES; COHORT; RETENTION; SURVIVAL; UGANDA; RISK	Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rates of loss to follow-up (LTF) and mortality have been documented in HIV care and treatment programs. Methods: We analyzed routinely-collected data on HIV-infected patients >= 15 years enrolled at 41 healthcare facilities in Rwanda from 2005 to 2010. LTF was defined as not attending clinic in the last 12 months for pre-ART patients and 6 months for ART patients. For the pre-ART period, sub-distribution hazards models were constructed to estimate LTF and death to account for competing risks. Kaplan-Meier (KM) and Cox proportional hazards models were used for patients on ART. Results: 31,033 ART-naive adults were included, 64% were female and 75% were WHO stage I or II at enrollment. 17,569 (56%) patients initiated ART. Pre-ART competing risk estimates of LTF at 2 years was 11.2% (95% CI, 10.9-11.6%) and 2.9% for death (95% CI 2.7-3.1%). Among pre-ART patients, male gender was associated with higher LTF (adjusted sub-hazard ratio (aSHR) 1.3, 95% CI 1.1-1.5) and death (aSHR 1.7, 95% CI 1.4-2.1). Low CD4 count (CD4,<100 vs. $ 350 aSHR 0.2, 95% CI 0.1-0.3) and higher WHO stage (WHO stage IV vs. stage I aSHR 0.4, 95% CI 0.2-0.6) were protective against pre-ART LTF. KM estimates for LTF and death in ART patients at 2 years were 4.4% (95% CI 4.4-4.5%) and 6.3% (95% CI 6.2-6.4%). In patients on ART, male gender was associated with LTF (adjusted hazard ratio (AHR) 1.4, 95% CI 1.2-1.7) and death (AHR1.3, 95% CI 1.2-1.5). Mortality was higher for ART patients >= 40 years and in those with lower CD4 count at ART initiation. Conclusions: Low rates of LTF and death were founds among pre-ART and ART patients in Rwanda but greater efforts are needed to retain patients in care prior to ART initiation, particularly among those who are healthy at enrollment.	[Mugisha, Veronicah; Teasdale, Chloe A.; Wang, Chunhui; Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Tayebwa, Edwin; Ingabire, Eugenie; Sahabo, Ruben; Twyman, Peter; Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA; [Mugisha, Veronicah; Teasdale, Chloe A.; Wang, Chunhui; Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Abrams, Elaine J.] Columbia Univ, Identifying Optimal Models HIV Care Africa Study, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Teasdale, Chloe A.; Lahuerta, Maria; Ingabire, Pacifique; Abrams, Elaine J.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Twyman, Peter] Minist Hlth Rwanda, Kigali, Rwanda; Keep Child Alive Fdn, New York, NY USA	Columbia University; Columbia University; Columbia University	Teasdale, CA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA.	ct116@columbia.edu			The President's Emergency Plan for AIDS Relief through the United States Centers for Disease Control and Prevention [5U62PS223540, 5U2GPS001537]; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS223540] Funding Source: NIH RePORTER	The President's Emergency Plan for AIDS Relief through the United States Centers for Disease Control and Prevention; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by The President's Emergency Plan for AIDS Relief through the United States Centers for Disease Control and Prevention (Grant numbers: 5U62PS223540 and 5U2GPS001537). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-39; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Druyts E, 2012, AIDS; El-Sadr WM, 2012, JAIDS-J ACQ IMM DEF, V60, pS96, DOI 10.1097/QAI.0b013e31825eb27b; Elul B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053586; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Hassan AS, 2012, TROP MED INT HEALTH, V17, P82, DOI 10.1111/j.1365-3156.2011.02889.x; Health M. o., 2009, GUID PROV COMPR CAR; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Lahuerta M, 2011, JAIDS-J ACQ IMM DEF, V58, pE75, DOI 10.1097/QAI.0b013e31822ac0a9; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mugglin C, 2012, C RETR OPP INF SEATT; Mugglin C, 2012, TROPICAL MED INT HLT; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; R. Ministry of Health, 2006, HUM RES HLTH STRAT P; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rogers WH., 1993, STATA TECHNICAL B RE, V13, P19; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rwanda MoH, 2011, ANN REP JUL 2010 JUN; Rwanda Rd, 2003, GUIDE UTILISATION ME; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; UNAIDS, 2012, WORLD AIDS DAY REP G; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; WHO, 2011, HIV AIDS; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	36	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85774	10.1371/journal.pone.0085774	http://dx.doi.org/10.1371/journal.pone.0085774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454931	Green Published, gold			2022-12-27	WOS:000330235100132
J	Tang, RD; Dai, JP				Tang, Rendong; Dai, Jiapei			Spatiotemporal Imaging of Glutamate-Induced Biophotonic Activities and Transmission in Neural Circuits	PLOS ONE			English	Article							PHOTON-EMISSION; BRAIN; LIGHT; PHOSPHORYLATION; BIOLUMINESCENCE; NEURONS; FORM	The processing of neural information in neural circuits plays key roles in neural functions. Biophotons, also called ultra-weak photon emissions (UPE), may play potential roles in neural signal transmission, contributing to the understanding of the high functions of nervous system such as vision, learning and memory, cognition and consciousness. However, the experimental analysis of biophotonic activities (emissions) in neural circuits has been hampered due to technical limitations. Here by developing and optimizing an in vitro biophoton imaging method, we characterize the spatiotemporal biophotonic activities and transmission in mouse brain slices. We show that the long-lasting application of glutamate to coronal brain slices produces a gradual and significant increase of biophotonic activities and achieves the maximal effect within approximately 90 min, which then lasts for a relatively long time (>200 min). The initiation and/or maintenance of biophotonic activities by glutamate can be significantly blocked by oxygen and glucose deprivation, together with the application of a cytochrome c oxidase inhibitor (sodium azide), but only partly by an action potential inhibitor (TTX), an anesthetic (procaine), or the removal of intracellular and extracellular Ca2+. We also show that the detected biophotonic activities in the corpus callosum and thalamus in sagittal brain slices mostly originate from axons or axonal terminals of cortical projection neurons, and that the hyperphosphorylation of microtubule-associated protein tau leads to a significant decrease of biophotonic activities in these two areas. Furthermore, the application of glutamate in the hippocampal dentate gyrus results in increased biophotonic activities in its intrahippocampal projection areas. These results suggest that the glutamate-induced biophotonic activities reflect biophotonic transmission along the axons and in neural circuits, which may be a new mechanism for the processing of neural information.	[Tang, Rendong; Dai, Jiapei] South Cent Univ Nationalities, Wuhan Inst Neurosci & Neuroengn, Wuhan, Peoples R China; [Tang, Rendong; Dai, Jiapei] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Dai, Jiapei] South Cent Univ Nationalities, Coll Pharm, Dept Pharmacol, Wuhan, Peoples R China	South Central Minzu University; South Central Minzu University; South Central Minzu University	Dai, JP (corresponding author), South Cent Univ Nationalities, Wuhan Inst Neurosci & Neuroengn, Wuhan, Peoples R China.	jdai@mail.scuec.edu.cn		Tang, Rendong/0000-0002-3622-3383; Dai, Jiapei/0000-0002-1474-5754	National Natural Science Foundation of China [31070961]; Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from the South-Central University for Nationalities [XJS09001, CJS12001, CJS12002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from the South-Central University for Nationalities	This work was supported by the National Natural Science Foundation of China (31070961) and the Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from the South-Central University for Nationalities (XJS09001, CJS12001 and CJS12002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; ALBRECHTBUEHLER G, 1992, P NATL ACAD SCI USA, V89, P8288, DOI 10.1073/pnas.89.17.8288; ARIAS C, 1993, J NEUROCHEM, V61, P673; Barth AL, 2012, TRENDS NEUROSCI, V35, P345, DOI 10.1016/j.tins.2012.03.008; BERNROIDER G, 2004, FORMA, V19, P55; Bokkon I, 2011, J PHOTOCH PHOTOBIO B, V103, P192, DOI 10.1016/j.jphotobiol.2011.03.011; Bruno V, 1993, Funct Neurol, V8, P279; Buzsaki G, 2007, NATURE, V446, P267, DOI 10.1038/446267a; Chalifoux JR, 2011, J NEUROSCI, V31, P16435, DOI 10.1523/JNEUROSCI.2777-11.2011; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cohen S., 2003, Indian Journal of Experimental Biology, V41, P440; COLLI L, 1955, EXPERIENTIA, V11, P479, DOI 10.1007/BF02166829; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; Devaraj B, 1997, CURR OPIN SOLID ST M, V2, P188, DOI 10.1016/S1359-0286(97)80064-2; Dotta BT, 2012, NEUROSCI LETT, V513, P151, DOI 10.1016/j.neulet.2012.02.021; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Grass F, 2004, MED HYPOTHESES, V62, P169, DOI 10.1016/S0306-9877(03)00308-6; Gurvitch A.G., 1926, PROBLEM ZELLTEILUNG; Hameroff SR, 2007, COGNITIVE SCI, V31, P1035, DOI 10.1080/03640210701704004; Hameroff SR, 2013, BEHAV BRAIN SCI, V36, P287, DOI 10.1017/S0140525X1200297X; Kataoka Y, 2001, BIOCHEM BIOPH RES CO, V285, P1007, DOI 10.1006/bbrc.2001.5285; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lee WCA, 2011, CURR OPIN NEUROBIOL, V21, P801, DOI 10.1016/j.conb.2011.07.004; Nakano M., 2005, J BIOLUMIN CHEMILUM, V4, P231, DOI DOI 10.1002/BI0.1170040133; Obrenovitch TP, 1999, ANN NY ACAD SCI, V890, P273, DOI 10.1111/j.1749-6632.1999.tb08004.x; OBRENOVITCH TP, 1994, BRIT J PHARMACOL, V113, P1295, DOI 10.1111/j.1476-5381.1994.tb17139.x; Popp F.A., 1994, BIOELECTRODYNAMICS B, P293; Popp FA, 2003, INTEGRATIVE BIOPHYSICS: BIOPHOTONICS, P387; Prasad A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01211; Purves D, 2012, NEUROSCIENCE; Rahnama M, 2011, J INTEGR NEUROSCI, V10, P65, DOI 10.1142/S0219635211002622; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Sun Y, 2010, PHOTOCH PHOTOBIO SCI, V9, P315, DOI 10.1039/b9pp00125e; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Vladimirov Iu A, 1971, Biofizika, V16, P952; Wang C, 2011, BRAIN RES, V1369, P1, DOI 10.1016/j.brainres.2010.10.077; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; ZHURAVLE.AI, 1973, BIOFIZIKA+, V18, P1037	42	39	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85643	10.1371/journal.pone.0085643	http://dx.doi.org/10.1371/journal.pone.0085643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454909	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100112
J	Calingacion, M; Laborte, A; Nelson, A; Resurreccion, A; Concepcion, JC; Daygon, VD; Mumm, R; Reinke, R; Dipti, S; Bassinello, PZ; Manful, J; Sophany, S; Lara, KC; Bao, JS; Xie, LH; Loaiza, K; El-hissewy, A; Gayin, J; Sharma, N; Rajeswari, S; Manonmani, S; Rani, NS; Kota, S; Indrasari, SD; Habibi, F; Hosseini, M; Tavasoli, F; Suzuki, K; Umemoto, T; Boualaphanh, C; Lee, HH; Hung, YP; Ramli, A; Aung, PP; Ahmad, R; Wattoo, JI; Bandonill, E; Romero, M; Brites, CM; Hafeel, R; Lur, HS; Cheaupun, K; Jongdee, S; Blanco, P; Bryant, R; Lang, NT; Hall, RD; Fitzgerald, M				Calingacion, Mariafe; Laborte, Alice; Nelson, Andrew; Resurreccion, Adoracion; Concepcion, Jeanaflor Crystal; Daygon, Venea Dara; Mumm, Roland; Reinke, Russell; Dipti, Sharifa; Bassinello, Priscila Zaczuk; Manful, John; Sophany, Sakhan; Lara, Karla Cordero; Bao, Jinsong; Xie, Lihong; Loaiza, Katerine; El-hissewy, Ahmad; Gayin, Joseph; Sharma, Neerja; Rajeswari, Sivakami; Manonmani, Swaminathan; Rani, N. Shobha; Kota, Suneetha; Indrasari, Siti Dewi; Habibi, Fatemeh; Hosseini, Maryam; Tavasoli, Fatemeh; Suzuki, Keitaro; Umemoto, Takayuki; Boualaphanh, Chanthkone; Lee, Huei Hong; Hung, Yiu Pang; Ramli, Asfaliza; Aung, Pa Pa; Ahmad, Rauf; Wattoo, Javed Iqbal; Bandonill, Evelyn; Romero, Marissa; Brites, Carla Moita; Hafeel, Roshni; Lur, Huu-Sheng; Cheaupun, Kunya; Jongdee, Supanee; Blanco, Pedro; Bryant, Rolfe; Nguyen Thi Lang; Hall, Robert D.; Fitzgerald, Melissa			Diversity of Global Rice Markets and the Science Required for Consumer-Targeted Rice Breeding	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; STARCH-SYNTHASE-IIA; GRAIN LENGTH; GELATINIZATION TEMPERATURE; EATING QUALITY; GENE; GS3; ASSOCIATION; ALLELE; YIELD	With the ever-increasing global demand for high quality rice in both local production regions and with Western consumers, we have a strong desire to understand better the importance of the different traits that make up the quality of the rice grain and obtain a full picture of rice quality demographics. Rice is by no means a 'one size fits all' crop. Regional preferences are not only striking, they drive the market and hence are of major economic importance in any rice breeding/improvement strategy. In this analysis, we have engaged local experts across the world to perform a full assessment of all the major rice quality trait characteristics and importantly, to determine how these are combined in the most preferred varieties for each of their regions. Physical as well as biochemical characteristics have been monitored and this has resulted in the identification of no less than 18 quality trait combinations. This complexity immediately reveals the extent of the specificity of consumer preference. Nevertheless, further assessment of these combinations at the variety level reveals that several groups still comprise varieties which consumers can readily identify as being different. This emphasises the shortcomings in the current tools we have available to assess rice quality and raises the issue of how we	[Calingacion, Mariafe; Laborte, Alice; Nelson, Andrew; Resurreccion, Adoracion; Concepcion, Jeanaflor Crystal; Daygon, Venea Dara; Fitzgerald, Melissa] Int Rice Res Inst, Los Banos, Laguna, Philippines; [Calingacion, Mariafe] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Calingacion, Mariafe; Resurreccion, Adoracion; Concepcion, Jeanaflor Crystal; Daygon, Venea Dara; Reinke, Russell; Dipti, Sharifa; Bassinello, Priscila Zaczuk; Manful, John; Sophany, Sakhan; Lara, Karla Cordero; Bao, Jinsong; Xie, Lihong; Loaiza, Katerine; El-hissewy, Ahmad; Gayin, Joseph; Sharma, Neerja; Rajeswari, Sivakami; Manonmani, Swaminathan; Rani, N. Shobha; Kota, Suneetha; Indrasari, Siti Dewi; Habibi, Fatemeh; Hosseini, Maryam; Tavasoli, Fatemeh; Suzuki, Keitaro; Umemoto, Takayuki; Boualaphanh, Chanthkone; Lee, Huei Hong; Ramli, Asfaliza; Aung, Pa Pa; Ahmad, Rauf; Wattoo, Javed Iqbal; Bandonill, Evelyn; Romero, Marissa; Brites, Carla Moita; Hafeel, Roshni; Lur, Huu-Sheng; Cheaupun, Kunya; Jongdee, Supanee; Blanco, Pedro; Bryant, Rolfe; Nguyen Thi Lang; Hall, Robert D.; Fitzgerald, Melissa] Int Network Qual Rice, Wageningen, Netherlands; [Mumm, Roland; Hall, Robert D.] Plant Res Int, Wageningen, Netherlands; [Mumm, Roland; Hall, Robert D.] Ctr BioSyst Genom, Wageningen, Netherlands; [Reinke, Russell] NSW Dept Ind & Investment, Yanco Agr Inst, Yanco, NSW, Australia; [Dipti, Sharifa] Bangladesh Rice Res Inst, Grain Qual & Nutr Div, Gazipur, Bangladesh; [Bassinello, Priscila Zaczuk] EMBRAPA Rice & Beans, Santo Antonio De Goias, Go, Brazil; [Manful, John] Africa Rice Ctr AfricaRice, Cotonou, Benin; [Sophany, Sakhan] Cambodian Agr Res & Dev Inst, Phnom Penh, Cambodia; [Lara, Karla Cordero] Mejoramiento Genet Arroz INIA CRI Quilamapu, Vicente Mendez, Chile; [Bao, Jinsong] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China; [Xie, Lihong] China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Loaiza, Katerine] CIAT, Lab Calidad FLAR CIAT, Cali, Colombia; [El-hissewy, Ahmad] Rice Res & Training Ctr, ARC, Rice Res Sect, Field Crops Res Inst, Sakha, Kafr El Shiekh, Egypt; [Gayin, Joseph] CSIR Food Res Inst, Accra, Ghana; [Sharma, Neerja] Punjab Agr Univ, Dept Plant Breeding & Genet, Rice Sect, Ludhiana 141004, Punjab, India; [Rajeswari, Sivakami; Manonmani, Swaminathan] Tamil Nadu Agr Univ, Ctr Plant Breeding & Genet, Dept Rice, Coimbatore 641003, Tamil Nadu, India; [Rani, N. Shobha; Kota, Suneetha] Directorate Rice Res, Crop Improvement Sect, Hyderabad, Andhra Pradesh, India; [Indrasari, Siti Dewi] Indonesian Ctr Rice Res ICRR BB Padi, Sukamandi, Subang Jawa Bar, Indonesia; [Habibi, Fatemeh; Hosseini, Maryam; Tavasoli, Fatemeh] Rice Res Inst Iran, Rasht, Iran; [Suzuki, Keitaro] NARO Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Umemoto, Takayuki] NARO Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan; [Boualaphanh, Chanthkone] NAFRI, Rice & Cash Crop Res Inst, Viangchan, Lao PDR, Laos; [Lee, Huei Hong; Hung, Yiu Pang] Univ Putra Malaysia, Fac Agr & Food Sci, Bintulu Sarawak, Malaysia; [Ramli, Asfaliza] MARDI Seberang Perai Beg Berkunci, Pusat Penyelidikan Padi Dan Tanaman Ind, Seberang Perai Pulau Pen, Malaysia; [Aung, Pa Pa] Minist Agr & Irrigat, Myanmar Agr Serv, Ctr Plant Biotechnol, Yangon, Myanmar; [Ahmad, Rauf] Natl Agr Res Ctr, Rice Programme, Islamabad, Pakistan; [Wattoo, Javed Iqbal] Natl Inst Biotechnol & Genet Engn, Faislabad, Pakistan; [Bandonill, Evelyn; Romero, Marissa] Philippine Rice Res Inst, Rice Chem & Food Sci Div, Sci City Munoz, Nueva Ecija, Philippines; [Brites, Carla Moita] Inst Nacl Invest Agr & Vet, Oeiras, Portugal; [Hafeel, Roshni] Dept Agr, Rice Res Stn, Ambalantota, Sri Lanka; [Lur, Huu-Sheng] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Jongdee, Supanee] Khon Kaen Rice Res Ctr, Khon Kaen, Thailand; [Blanco, Pedro] INIA Treinta Tres, Natl Agr Res Inst, Rice Res Program, Treinta Tres, CP, Uruguay; [Bryant, Rolfe] USDA ARS, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Nguyen Thi Lang] Cuulong Delta Rice Res Inst, Genet & Plant Breeding Div, Can Tho, Vietnam	CGIAR; International Rice Research Institute (IRRI); Wageningen University & Research; Centre for BioSystems Genomics; NSW Department of Primary Industries; Bangladesh Rice Research Institute (BRRI); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CGIAR; Africa Rice Center; Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Alliance; International Center for Tropical Agriculture - CIAT; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Punjab Agricultural University; Tamil Nadu Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Universiti Putra Malaysia; National Agricultural Research Council - Pakistan; Pakistan Institute of Engineering & Applied Science; Philippine Rice Research Institute; National Taiwan University; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA); United States Department of Agriculture (USDA)	Fitzgerald, M (corresponding author), Int Rice Res Inst, Los Banos, Laguna, Philippines.	m.fitzgerald2@uq.edu.au	Nelson, Andy/G-3649-2012; Concepcion, Crystal/ABO-1212-2022; Bao, Jinsong/A-7413-2008; Fitzgerald, Melissa/AAP-6672-2020; Brites, Carla/C-4792-2009; HALL, ROBERT D/B-8707-2015; Brites, Carla/AAT-5977-2020; Hosseni chakeshtori, Maryam/N-8325-2017; Daygon, Venea Dara/Y-2263-2018; Calingacion, Mariafe/O-6252-2016	Nelson, Andy/0000-0002-7249-3778; Concepcion, Crystal/0000-0003-4524-2794; Bao, Jinsong/0000-0002-9606-6615; Fitzgerald, Melissa/0000-0002-0761-764X; Brites, Carla/0000-0003-1949-172X; HALL, ROBERT D/0000-0002-5786-768X; Brites, Carla/0000-0003-1949-172X; Hosseni chakeshtori, Maryam/0000-0003-0911-8251; Daygon, Venea Dara/0000-0003-0805-5148; YIU, Panghung/0000-0001-6223-9859; Calingacion, Mariafe/0000-0002-7560-2036; Mumm, Roland/0000-0002-0603-1508; Lee, Huei Hong/0000-0002-0257-3203	International Network for Quality Rice (INQR); International Rice Research Institute (IRRI); Wageningen University Research (WUR); Monsanto Beachell Borlaug Scholarship Foundation	International Network for Quality Rice (INQR); International Rice Research Institute (IRRI)(CGIAR); Wageningen University Research (WUR); Monsanto Beachell Borlaug Scholarship Foundation	This work was supported by International Network for Quality Rice (INQR), International Rice Research Institute (IRRI), Wageningen University Research (WUR), and the Monsanto Beachell Borlaug Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazari A, 2012, AM J SCI RES, P70; Anang B. T., 2011, International Journal of AgriScience, V1, P67; ANZ, 2012, GREEN PAST GLOB SOFT; Asian Development Bank (ADB), 2012, FOOD SEC POV AS PAC; Ayres NM, 1997, THEOR APPL GENET, V94, P773, DOI 10.1007/s001220050477; Azabagaoglu M. O., 2009, Agricultura Tropica et Subtropica, V42, P118; Bao JS, 2006, THEOR APPL GENET, V113, P1171, DOI 10.1007/s00122-006-0355-6; Boualaphanh C, 2011, CROP SCI, V51, P2067, DOI 10.2135/cropsci2011.02.0103; Bryant RJ, 2011, FOOD CHEM, V124, P501, DOI 10.1016/j.foodchem.2010.06.061; BUTTERY RG, 1983, J AGR FOOD CHEM, V31, P823, DOI 10.1021/jf00118a036; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Calingacion MN, 2012, METABOLOMICS, V8, P771, DOI 10.1007/s11306-011-0374-4; Champagne ET, 2010, RICE, V3, P270, DOI 10.1007/s12284-010-9057-4; Chen MH, 2008, J CEREAL SCI, V47, P536, DOI 10.1016/j.jcs.2007.06.013; Commission E, 2003, OFFICIAL J EUROPEAN, P1; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Cuevas R P, 2012, GENETIC DIVERSITY; Cuevas RP, 2010, FUNCT PLANT BIOL, V37, P439, DOI 10.1071/FP09258; Diako C, 2010, CONSUMER PERCEPTIONS; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fan CC, 2009, THEOR APPL GENET, V118, P465, DOI 10.1007/s00122-008-0913-1; FAO WaI, 2012, STAT FOOD INS WORLD; Fitzgerald MA, 2010, WOODHEAD PUBL FOOD S, P212, DOI 10.1533/9781845699529.2.212; Fitzgerald MA, 2008, PLANT BIOTECHNOL J, V6, P416, DOI 10.1111/j.1467-7652.2008.00327.x; Fitzgerald MA, 2009, CEREAL CHEM, V86, P492, DOI 10.1094/CCHEM-86-5-0492; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Foundation TG, 2012, FEED AS WORLD AUSTR; Government A, 2012, AUSTR AS CENT; HALL T, 1999, BIOEDIT USER FRIENDL, V98, P41; Huang R, 2012, TRENDS PLANT SCI; International Organization for Standardization, 2011, 618503 IEC, P10; Juliano B. O., 1985, RICE CHEM TECHNOLOGY, V2nd, P43; Khush GS, 1979, RICE GRAIN QUALITY E, P22; Larkin PD, 2003, MOL BREEDING, V12, P335, DOI 10.1023/B:MOLB.0000006797.51786.92; Lee JW, 2012, JPN WORLD ECON, V24, P101, DOI 10.1016/j.japwor.2012.01.005; Limpawattana M, 2010, J FOOD SCI, V75, pS199, DOI 10.1111/j.1750-3841.2010.01577.x; Little R, 1958, CEREAL CHEM J, V35; Lommen A, 2012, METABOLOMICS, V8, P719, DOI 10.1007/s11306-011-0369-1; Mikami I, 2008, THEOR APPL GENET, V116, P979, DOI 10.1007/s00122-008-0729-z; Minten B, 2013, WORLD DEV, V42, P100, DOI 10.1016/j.worlddev.2012.06.015; Mohanty S, 2013, RICE TODAY, V13, P44; Musa M., 2011, AM INT J CONT RES, V1, P159; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Rachmat R., 2006, Indonesian Journal of Agricultural Science, V7, P27; Rozen S, 2000, Methods Mol Biol, V132, P365; SANO Y, 1984, THEOR APPL GENET, V68, P467, DOI 10.1007/BF00254822; Slade L., 1989, FRONTIERS CARBOHYDRA, P215; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; Stern N, 2006, EC CLIMATE CHANGE ST, P700; Supakornchuwong C, 2012, J SENS STUD, V27, P71, DOI 10.1111/j.1745-459X.2011.00369.x; Suwannaporn P, 2008, BRIT FOOD J, V110, P595, DOI 10.1108/00070700810877906; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Tomlins KI, 2005, FOOD QUAL PREFER, V16, P79, DOI 10.1016/j.foodqual.2004.02.002; Tran NA, 2011, THEOR APPL GENET, V123, P519, DOI 10.1007/s00122-011-1604-x; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Umemoto T, 2005, FUNCT PLANT BIOL, V32, P763, DOI 10.1071/FP04214; Umemoto T, 2008, PLANT PROD SCI, V11, P472, DOI 10.1626/pps.11.472; VIRK PS, 1995, HEREDITY, V74, P170, DOI 10.1038/hdy.1995.25; Wanchana S, 2003, PLANT SCI, V165, P1193, DOI 10.1016/S0168-9452(03)00326-1; Ward RM, 2006, BIOMACROMOLECULES, V7, P866, DOI 10.1021/bm050617e; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Waters DLE, 2006, PLANT BIOTECHNOL J, V4, P115, DOI 10.1111/j.1467-7652.2005.00162.x; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhao XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066218	65	168	177	8	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85106	10.1371/journal.pone.0085106	http://dx.doi.org/10.1371/journal.pone.0085106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292TQ	24454799	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800022
J	Ehashi, T; Takemura, T; Hanagata, N; Minowa, T; Kobayashi, H; Ishihara, K; Yamaoka, T				Ehashi, Tomo; Takemura, Taro; Hanagata, Nobutaka; Minowa, Takashi; Kobayashi, Hisatoshi; Ishihara, Kazuhiko; Yamaoka, Tetsuji			Comprehensive Genetic Analysis of Early Host Body Reactions to the Bioactive and Bio-Inert Porous Scaffolds	PLOS ONE			English	Article							IN-VIVO; MACROPHAGE ACTIVATION; PHOSPHOLIPID POLYMERS; ADHERENT CELLS; TISSUE; ANGIOGENESIS; EXPRESSION; IMPLANT; BIOMATERIALS; ADHESION	To design scaffolds for tissue regeneration, details of the host body reaction to the scaffolds must be studied. Host body reactions have been investigated mainly by immunohistological observations for a long time. Despite of recent dramatic development in genetic analysis technologies, genetically comprehensive changes in host body reactions are hardly studied. There is no information about host body reactions that can predict successful tissue regeneration in the future. In the present study, porous polyethylene scaffolds were coated with bioactive collagen or bio-inert poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) (PMB) and were implanted subcutaneously and compared the host body reaction to those substrates by normalizing the result using control non-coat polyethylene scaffold. The comprehensive analyses of early host body reactions to the scaffolds were carried out using a DNA microarray assay. Within numerous genes which were expressed differently among these scaffolds, particular genes related to inflammation, wound healing, and angiogenesis were focused upon. Interleukin (IL)-1 beta and IL-10 are important cytokines in tissue responses to biomaterials because IL-1 beta promotes both inflammation and wound healing and IL-10 suppresses both of them. IL-1 beta was up-regulated in the collagen-coated scaffold. Collagen-specifically up-regulated genes contained both M1-and M2-macrophage- related genes. Marked vessel formation in the collagen-coated scaffold was occurred in accordance with the up-regulation of many angiogenesis-inducible factors. The DNA microarray assay provided global information regarding the host body reaction. Interestingly, several up-regulated genes were detected even on the very bio-inert PMB-coated surfaces and those genes include inflammation-suppressive and wound healing-suppressive IL-10, suggesting that not only active tissue response but also the inert response may relates to these genetic regulations.	[Ehashi, Tomo; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Osaka, Japan; [Ehashi, Tomo; Yamaoka, Tetsuji] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Takemura, Taro; Hanagata, Nobutaka; Minowa, Takashi] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Ibaraki, Japan; [Kobayashi, Hisatoshi] Natl Inst Mat Sci, Biomat Ctr, Ibaraki, Japan; [Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Sch Engn, Tokyo, Japan; [Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan	National Cerebral & Cardiovascular Center - Japan; Japan Science & Technology Agency (JST); National Institute for Materials Science; National Institute for Materials Science; University of Tokyo; University of Tokyo	Yamaoka, T (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Osaka, Japan.	yamtet@ri.ncvc.go.jp	kobayashi, hisatoshi/H-2720-2011; EHASHI, Tomo/H-4817-2016	kobayashi, hisatoshi/0000-0001-9487-0725; Hanagata, Nobutaka/0000-0001-6079-3426; Minowa, Takashi/0000-0003-0046-5230	Core Research Evolutional Science and Technology (CREST) [20106014]; Grants-in-Aid for Scientific Research [26670623] Funding Source: KAKEN	Core Research Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Core Research Evolutional Science and Technology (CREST; http://www.jst.go.jp/crest/nanoif/english/index.html) and Grant-in-Aid for Scientific Research on Innovation Areas (20106014; http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425; Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025; Crawford DC, 2012, J BONE JOINT SURG AM, V94A, P979, DOI 10.2106/JBJS.K.00533; DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403; Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a.20016; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.3.CO;2-0; ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105; Jiang F, 2008, J CELL MOL MED, V12, P2062, DOI 10.1111/j.1582-4934.2008.00199.x; Jing CB, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/6/065001; Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649; Kihara S, 2003, ARTIF ORGANS, V27, P188, DOI 10.1046/j.1525-1594.2003.t01-2-06993.x; Kyomoto M, 2011, CLIN ORTHOP RELAT R, V469, P2327, DOI 10.1007/s11999-010-1718-5; LAWLER J, 1989, BLOOD, V74, P2022; LAWLER JW, 1977, THROMB HAEMOSTASIS, V37, P355; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lips PAM, 2006, J BIOMED MATER RES A, V76A, P699, DOI 10.1002/jbm.a.30530; Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Matheson LA, 2006, J BIOMED MATER RES A, V76A, P52, DOI 10.1002/jbm.a.30448; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mitragotri S, 2011, NAT MATER, V8, P15; Myers T, 2009, INVEST NEW DRUG, V27, P304, DOI 10.1007/s10637-008-9175-7; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Patel JD, 2005, J BIOMED MATER RES A, V73A, P359, DOI 10.1002/jbm.a.30302; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939; Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317; Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433; Sawada SI, 2006, J BIOMED MATER RES A, V79A, P476, DOI 10.1002/jbm.a.30820; Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.3.CO;2-V; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Underwood RA, 2011, J BIOMED MATER RES A, V98A, P499, DOI 10.1002/jbm.a.33125; Wijeyekoon R, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00078; Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145; Ye SH, 2010, COLLOID SURFACE B, V79, P357, DOI 10.1016/j.colsurfb.2010.04.018; Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033; Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/01.sla.0000143302.48223.7e	54	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85132	10.1371/journal.pone.0085132	http://dx.doi.org/10.1371/journal.pone.0085132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454803	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800023
J	Lin, XXB; Farhangfar, A; Valcheva, R; Sawyer, MB; Dieleman, L; Schieber, A; Ganzle, MG; Baracos, V				Lin, Xiaoxi B.; Farhangfar, Arazm; Valcheva, Rosica; Sawyer, Michael B.; Dieleman, Levinus; Schieber, Andreas; Gaenzle, Michael G.; Baracos, Vickie			The Role of Intestinal Microbiota in Development of Irinotecan Toxicity and in Toxicity Reduction through Dietary Fibres in Rats	PLOS ONE			English	Article							BETA-GLUCURONIDASE ACTIVITY; MONOCARBOXYLATE TRANSPORTER; BACTERIAL TRANSLOCATION; BUTYRATE; MICROFLORA; EXPRESSION; CANCER; INULIN; BIFIDOBACTERIA; CHEMOTHERAPY	CPT-11 is a drug used as chemotherapy for colorectal cancer. CPT-11 causes toxic side-effects in patients. CPT-11 toxicity has been attributed to the activity of intestinal microbiota, however, intestinal microbiota may also have protective effects in CP!-11 chemotherapy. This study aimed to elucidate mechanisms through which microbiota and dietary fibres could modify host health. Rats bearing a Ward colon carcinoma were treated with a two-cycle CPT-11/5-fluorouracil therapy recapitulating clinical therapy of colorectal cancer. Animals were fed with a semi-purified diet or a semi-purified diet was supplemented with non-digestible carbohydrates (isomalto-oligosaccharides, resistant starch, fructo-oligosaccharides, or inulin) in 3 independent experiments. Changes in intestinal microbiota, bacteria translocating to mesenteric lymphnodes, cecal GUD activity, and cecal SCFA production, and the intestinal concentration of CPT-11 and its metabolites were analysed. Non-digestible carbohydrates significantly influenced feed intake, body weight and other indicators of animal health. The identification of translocating bacteria and their quantification in cecal microbiota indicated that overgrowth of the intestine by opportunistic pathogens was not a major contributor to CPT-11 toxicity. Remarkably, fecal GUD activity positively correlated to body weight and feed intake but negatively correlated to cecal SN-38 concentrations and IL1-beta. The reduction in CPT-11 toxicity by non-digestible carbohydrates did not correlate to stimulation of specific bacterial taxa. However, cecal butyrate concentrations and feed intake were highly correlated. The protective role of intestinal butyrate production was substantiated by a positive correlation of the host expression of MCT1 (monocarboxylate transporter 1) with body weight as well as a positive correlation of the abundance of bacterial butyryl-CoA gene with cecal butyrate concentrations. These correlations support the interpretation that the influence of dietary fibre on CPT-11 toxicity is partially mediated by an increased cecal production of butyrate.	[Lin, Xiaoxi B.; Farhangfar, Arazm; Schieber, Andreas; Gaenzle, Michael G.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Farhangfar, Arazm; Sawyer, Michael B.; Baracos, Vickie] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Valcheva, Rosica; Dieleman, Levinus] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Schieber, Andreas] Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany	University of Alberta; University of Alberta; University of Alberta; University of Bonn	Ganzle, MG (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	mgaenzle@ualberta.ca	Dieleman, Levinus/AAT-8198-2021; Gänzle, Michael/F-1432-2017	Gänzle, Michael/0000-0003-0972-928X; Baracos, Vickie/0000-0002-9609-1001; Dieleman, Levinus/0000-0001-7852-2122	Canadian Institute of Health Research; National Science and Engineering Research Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Canadian Institute of Health Research and the National Science and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dasooqi N, 2011, CHEMOTHERAPY, V57, P43, DOI 10.1159/000321477; Anthony Lowell, 2007, Curr Opin Support Palliat Care, V1, P35, DOI 10.1097/SPC.0b013e328133f2ad; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Brandi G, 2006, CLIN CANCER RES, V12, P1299, DOI 10.1158/1078-0432.CCR-05-0750; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cenci G, 2000, J BASIC MICROB, V40, P311, DOI 10.1002/1521-4028(200012)40:5/6<311::AID-JOBM311>3.0.CO;2-5; CHAPMAN MAS, 1994, GUT, V35, P73, DOI 10.1136/gut.35.1.73; Corona G, 2010, THER DRUG MONIT, V32, P638, DOI 10.1097/FTD.0b013e3181ec3bf5; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; Farhangfar A, 2012, THESIS U ALBERTA; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gill CIR, 2002, BRIT J NUTR, V88, pS73, DOI 10.1079/BJN2002632; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; HORECKER BL, 1966, ANNU REV MICROBIOL, V20, P253, DOI 10.1146/annurev.mi.20.100166.001345; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Juskiewicz J, 2006, J ANIM PHYSIOL AN N, V90, P200, DOI 10.1111/j.1439-0396.2005.00591.x; Lin XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039764; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Ranganna K, 2007, FEBS J, V274, P5962, DOI 10.1111/j.1742-4658.2007.06119.x; Raninen K, 2011, NUTR REV, V69, P9, DOI 10.1111/j.1753-4887.2010.00358.x; Regmi PR, 2011, J NUTR, V141, P1273, DOI 10.3945/jn.111.140509; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; ROWLAND IR, 1985, CRC CR REV TOXICOL, V16, P31, DOI 10.3109/10408448509041324; SHIAU SY, 1983, J NUTR, V113, P138, DOI 10.1093/jn/113.1.138; Sparreboom A, 1998, CLIN CANCER RES, V4, P2747; Stringer AM, 2009, CURR DRUG METAB, V10, P79, DOI 10.2174/138920009787048419; Takasuna K, 1996, CANCER RES, V56, P3752; Takesue Y, 2005, WORLD J SURG, V29, P198, DOI 10.1007/s00268-004-7576-0; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Van den Abbeele P, 2011, ENVIRON MICROBIOL, V13, P2667, DOI 10.1111/j.1462-2920.2011.02533.x; van der Logt EMJ, 2003, CARCINOGENESIS, V24, P1651, DOI 10.1093/carcin/bgg117; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wu WT, 2011, BRIT J NUTR, V105, P593, DOI 10.1017/S0007114510004009; Xue HY, 2008, J NUTR, V138, P740, DOI 10.1093/jn/138.4.740; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Zwielehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028654	48	118	121	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83644	10.1371/journal.pone.0083644	http://dx.doi.org/10.1371/journal.pone.0083644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454707	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800010
J	Smith, K; Zeng, XM; Lin, J				Smith, Katie; Zeng, Ximin; Lin, Jun			Discovery of Bile Salt Hydrolase Inhibitors Using an Efficient High-Throughput Screening System	PLOS ONE			English	Article							ANTIBIOTIC GROWTH PROMOTERS; ACID PHENETHYL ESTER; BROILER-CHICKENS; CAFFEIC ACID; LACTOBACILLUS-SALIVARIUS; INTESTINAL MICROBIOTA; CAMPYLOBACTER-JEJUNI; COPPER-SULFATE; CARNOSIC ACID; SUBTHERAPEUTIC LEVELS	The global trend of restricting the use of antibiotic growth promoters (AGP) in animal production necessitates the need to develop valid alternatives to maintain productivity and sustainability of food animals. Previous studies suggest inhibition of bile salt hydrolase (BSH), an intestinal bacteria-produced enzyme that exerts negative impact on host fat digestion and utilization, is a promising approach to promote animal growth performance. To achieve the long term goal of developing novel alternatives to AGPs, in this study, a rapid and convenient high-throughput screening (HTS) system was developed and successfully used for identification of BSH inhibitors. With the aid of a high-purity BSH from a chicken Lactobacillus salivarius strain, we optimized various screening conditions (e.g. BSH concentration, reaction buffer pH, incubation temperature and length, substrate type and concentration) and establish a precipitation-based screening approach to identify BSH inhibitors using 96-well or 384-well microplates. A pilot HTS was performed using a small compound library comprised of 2,240 biologically active and structurally diverse compounds. Among the 107 hits, several promising and potent BSH inhibitors (e. g. riboflavin and phenethyl caffeate) were selected and validated by standard BSH activity assay. Interestingly, the HTS also identified a panel of antibiotics as BSH inhibitor; in particular, various tetracycline antibiotics and roxarsone, the widely used AGP, have been demonstrated to display potent inhibitory effect on BSH. Together, this study developed an efficient HTS system and identified several BSH inhibitors with potential as alternatives to AGP. In addition, the findings from this study also suggest a new mode of action of AGP for promoting animal growth.	[Smith, Katie; Zeng, Ximin; Lin, Jun] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Lin, J (corresponding author), Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA.	jlin6@utk.edu			University of Tennessee AgResearch Innovation Grant	University of Tennessee AgResearch Innovation Grant	No current external funding sources for this study. The work was supported by internal grant award (University of Tennessee AgResearch Innovation Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol S, 2012, CELL BIOCHEM FUNCT, V30, P438, DOI 10.1002/cbf.2817; Altug ME, 2008, BRAIN RES, V1201, P135, DOI 10.1016/j.brainres.2008.01.053; [Anonymous], 2012, VET REC, V170, P404; [Anonymous], 1987, VITAMIN TOLERANCE AN; Arias VJ, 2006, POULTRY SCI, V85, P999, DOI 10.1093/ps/85.6.999; Armstrong TA, 2004, J ANIM SCI, V82, P1234; Azad N, 2011, CELL J, V13, P39; Basu P, 2008, ENVIRON HEALTH PERSP, V116, P520, DOI 10.1289/ehp.10885; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Chan GCF, 2013, CLIN REV ALLERG IMMU, V44, P262, DOI 10.1007/s12016-012-8322-2; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Collier CT, 2003, J ANIM SCI, V81, P3035; Combs GF, 2012, VITAMINS: FUNDAMENTAL ASPECTS IN NUTRITION AND HEALTH, 4TH EDITION, P277, DOI 10.1016/B978-0-12-381980-2.00011-6; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dos Santos JS, 2013, J BURN CARE RES; Du GJ, 2012, NUTRIENTS, V4, P1679, DOI 10.3390/nu4111679; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Engberg RM, 2000, POULTRY SCI, V79, P1311, DOI 10.1093/ps/79.9.1311; Ewing HP, 1998, POULTRY SCI, V77, P445, DOI 10.1093/ps/77.3.445; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; Guban J, 2006, POULTRY SCI, V85, P2186, DOI 10.1093/ps/85.12.2186; Hamilton-Miller JMT, 2000, J ANTIMICROB CHEMOTH, V46, P852, DOI 10.1093/jac/46.5.852; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jacela JY, 2010, J SWINE HEALTH PROD, V18, P87, DOI 10.4148/2378-5977.7068; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Knarreborg A, 2004, J NUTR, V134, P1487, DOI 10.1093/jn/134.6.1487; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; Kuo CF, 2011, J AGR FOOD CHEM, V59, P3674, DOI 10.1021/jf104837w; La-Ongkhum O, 2011, POULTRY SCI, V90, P1532, DOI 10.3382/ps.2010-01288; Lee KJ, 2008, FOOD CHEM TOXICOL, V46, P2445, DOI 10.1016/j.fct.2008.03.032; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2013, FOODBORNE PATHOG DIS, V10, P331, DOI 10.1089/fpd.2012.1348; Liu ZH, 2011, POULTRY SCI, V90, P1782, DOI 10.3382/ps.2010-01215; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Miles RD, 1998, POULTRY SCI, V77, P416, DOI 10.1093/ps/77.3.416; Moran L, 2012, MEAT SCI, V91, P430, DOI 10.1016/j.meatsci.2012.02.027; Mounnissamy VM, 2002, INDIAN J HETEROCY CH, V12, P85; Mountzouris KC, 2010, POULTRY SCI, V89, P58, DOI 10.3382/ps.2009-00308; Nachman KE, 2013, ENVIRON HEALTH PERSP, V121, P818, DOI 10.1289/ehp.1206245; Oldenburg K, 2005, COMB CHEM HIGH T SCR, V8, P499, DOI 10.2174/1386207054867364; Patel AK, 2010, APPL BIOCHEM BIOTECH, V162, P166, DOI 10.1007/s12010-009-8738-1; Rettedal E, 2009, APPL ENVIRON MICROB, V75, P5489, DOI 10.1128/AEM.02220-08; Sharifi SD, 2012, POULTRY SCI, V91, P918, DOI 10.3382/ps.2011-01844; Shelton NW, 2011, J ANIM SCI, V89, P2440, DOI 10.2527/jas.2010-3432; Smith JW, 1997, J ANIM SCI, V75, P1861; Stern NJ, 2006, ANTIMICROB AGENTS CH, V50, P3111, DOI 10.1128/AAC.00259-06; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; TERAO J, 1994, ARCH BIOCHEM BIOPHYS, V308, P278, DOI 10.1006/abbi.1994.1039; Trendafilova A, 2011, NAT PROD COMMUN, V6, P1851; van den Bogaard AE, 1999, DRUGS, V58, P589, DOI 10.2165/00003495-199958040-00002; Wang Z, 2012, APPL ENVIRON MICROB, V78, P8795, DOI 10.1128/AEM.02519-12; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Xiang QS, 2013, FOOD CHEM TOXICOL, V53, P1, DOI 10.1016/j.fct.2012.11.001; Yilmaz A, 2005, CURR EYE RES, V30, P755, DOI 10.1080/02713680590967962; Zhou H, 2007, POULTRY SCI, V86, P2541, DOI 10.3382/ps.2007-00267	62	34	37	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85344	10.1371/journal.pone.0085344	http://dx.doi.org/10.1371/journal.pone.0085344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454844	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800039
J	Zhao, BH; Li, L; Liu, JT; Li, HZ; Zhang, CL; Han, PF; Zhang, YF; Yuan, XH; Ge, RS; Chu, YH				Zhao, Binghai; Li, Li; Liu, Jieting; Li, Hongzhi; Zhang, Chunlei; Han, Pengfei; Zhang, Yufei; Yuan, Xiaohuan; Ge, Ren Shan; Chu, Yanhui			Exposure to Perfluorooctane Sulfonate In Utero Reduces Testosterone Production in Rat Fetal Leydig Cells	PLOS ONE			English	Article							TESTICULAR DYSGENESIS SYNDROME; SERUM CONCENTRATIONS; PERFLUORINATED COMPOUNDS; PERFLUOROALKYL ACIDS; GENE-EXPRESSION; BLOOD-SERUM; TESTIS; DIFFERENTIATION; POPULATION; SUBSTANCES	Background: Perfluorooctane sulfonate (PFOS) is a synthetic material that has been widely used in industrial applications for decades. Exposure to PFOS has been associated with decreased adult testosterone level, and Leydig cell impairment during the time of adulthood. However, little is known about PFOS effects in utero on fetal Leydig cells (FLC). Methods and Results: The present study investigated effects of PFOS on FLC function. Pregnant Sprague Dawley female rats received vehicle (0.05% Tween20) or PFOS (5, 20 mg/kg) by oral gavage from gestational day (GD) 11-19. At GD20, testosterone (T) production, FLC numbers and ultrastructure, testicular gene and protein expression levels were examined. The results indicate that exposures to PFOS have affected FLC function as evidenced by decreased T production, impaired FLC, reduced FLC number, and decreased steroidogenic capacity and cholesterol level in utero. Conclusion: The present study shows that PFOS is an endocrine disruptor of male reproductive system as it causes reduction of T production and impairment of rat fetal Leydig cells.	[Zhao, Binghai; Li, Li; Liu, Jieting; Li, Hongzhi; Zhang, Chunlei; Zhang, Yufei; Yuan, Xiaohuan; Chu, Yanhui] Heilongjiang Key Lab Antifibrosis Biotherapy, Heilongjiang, Peoples R China; [Han, Pengfei] Mudanjiang Med Univ, Hong Qi Hosp, Heilongjiang, Peoples R China; [Ge, Ren Shan] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China	Mudanjiang Medical University; Wenzhou Medical University	Chu, YH (corresponding author), Heilongjiang Key Lab Antifibrosis Biotherapy, Heilongjiang, Peoples R China.	yanhui_chu@163.com	Zhang, yufei/HHC-7375-2022		Natural Science Foundation of China [81102149, 81372951, 81070329]; Heilongjiang Province Education Fund [1252G065]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Education Fund	This work was supported in part by Natural Science Foundation of China (No. 81102149 and No. 81372951 to Binghai Zhao, No. 81070329 to Yanhui Chu) and the Heilongjiang Province Education Fund (1252G065) to Binghai Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarossa A, 2013, ENVIRON INT, V51, P27, DOI 10.1016/j.envint.2012.10.001; Beumer TL, 2000, MOL REPROD DEV, V56, P353, DOI 10.1002/1098-2795(200007)56:3&lt;353::AID-MRD4&gt;3.0.CO;2-3; BIEGEL LB, 1995, TOXICOL APPL PHARM, V134, P18, DOI 10.1006/taap.1995.1164; Chang SC, 2009, REPROD TOXICOL, V27, P387, DOI 10.1016/j.reprotox.2009.01.005; Chen MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042474; CODESAL J, 1990, J ANAT, V172, P103; Crawford BA, 1997, J PEDIATR ENDOCR MET, V10, P401; Du GZ, 2013, ENVIRON TOXICOL CHEM, V32, P353, DOI 10.1002/etc.2034; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Fowler PA, 2009, J CLIN ENDOCR METAB, V94, P4688, DOI 10.1210/jc.2009-0994; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787; Ge RS, 2005, ENDOCRINOLOGY, V146, P2657, DOI 10.1210/en.2005-0046; Giesy JP, 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI 10.1021/es022253t; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Goldman JM, 2000, CRIT REV TOXICOL, V30, P135, DOI 10.1080/10408440091159185; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Hasegawa T, 2000, MOL ENDOCRINOL, V14, P1462, DOI 10.1210/me.14.9.1462; Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001; Jensen AA, 2008, INT J ANDROL, V31, P161, DOI 10.1111/j.1365-2605.2008.00870.x; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Ji K, 2012, ENVIRON INT, V45, P78, DOI 10.1016/j.envint.2012.03.007; Lau C, 2004, TOXICOL APPL PHARM, V198, P231, DOI 10.1016/j.taap.2003.11.031; Lee YJ, 2013, CHEMOSPHERE, V90, P1603, DOI 10.1016/j.chemosphere.2012.08.035; Lindh CH, 2012, CHEMOSPHERE, V88, P1269, DOI 10.1016/j.chemosphere.2012.03.049; LORDING DW, 1972, J REPROD FERTIL, V29, P261; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Maisonet M, 2012, ENVIRON HEALTH PERSP, V120, P1432, DOI 10.1289/ehp.1003096; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Miyake H, 2000, CANCER RES, V60, P2547; MONTPETIT ML, 1986, PROSTATE, V8, P25, DOI 10.1002/pros.2990080105; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2003, ENVIRON SCI TECHNOL, V37, P888, DOI 10.1021/es020955c; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; Payne AH, 2007, LEYDIG CELL HLTH DIS, P135; Shi ZM, 2007, TOXICOL SCI, V98, P206, DOI 10.1093/toxsci/kfm070; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Vestergren R, 2012, ENVIRON INT, V49, P120, DOI 10.1016/j.envint.2012.08.016; Wei Liu, 2007, Huanjing Kexue, V28, P2068; Zhang W, 2011, ECOTOX ENVIRON SAFE, V74, P1787, DOI 10.1016/j.ecoenv.2011.04.027; Zhao BH, 2010, CHEM-BIOL INTERACT, V188, P38, DOI 10.1016/j.cbi.2010.07.001; Zhao BH, 2010, J STEROID BIOCHEM, V118, P13, DOI 10.1016/j.jsbmb.2009.09.010	43	46	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e78888	10.1371/journal.pone.0078888	http://dx.doi.org/10.1371/journal.pone.0078888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454680	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800002
J	Buard, J; Rivals, E; de Segonzac, DD; Garres, C; Caminade, P; de Massy, B; Boursot, P				Buard, Jerome; Rivals, Eric; de Segonzac, Denis Dunoyer; Garres, Charlotte; Caminade, Pierre; de Massy, Bernard; Boursot, Pierre			Diversity of Prdm9 Zinc Finger Array in Wild Mice Unravels New Facets of the Evolutionary Turnover of this Coding Minisatellite	PLOS ONE			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; HYBRID MALE-STERILITY; MOUSE MUS-MUSCULUS; HOUSE MOUSE; GENUS MUS; DNA RECOGNITION; MITOCHONDRIAL; HISTORY; INSTABILITY; LANDSCAPE	In humans and mice, meiotic recombination events cluster into narrow hotspots whose genomic positions are defined by the PRDM9 protein via its DNA binding domain constituted of an array of zinc fingers (ZnFs). High polymorphism and rapid divergence of the Prdm9 gene ZnF domain appear to involve positive selection at DNA-recognition amino-acid positions, but the nature of the underlying evolutionary pressures remains a puzzle. Here we explore the variability of the Prdm9 ZnF array in wild mice, and uncovered a high allelic diversity of both ZnF copy number and identity with the caracterization of 113 alleles. We analyze features of the diversity of ZnF identity which is mostly due to non-synonymous changes at codons -1, 3 and 6 of each ZnF, corresponding to amino-acids involved in DNA binding. Using methods adapted to the minisatellite structure of the ZnF array, we infer a phylogenetic tree of these alleles. We find the sister species Mus spicilegus and M. macedonicus as well as the three house mouse (Mus musculus) subspecies to be polyphyletic. However some sublineages have expanded independently in Mus musculus musculus and M. m. domesticus, the latter further showing phylogeographic substructure. Compared to random genomic regions and non-coding minisatellites, none of these patterns appears exceptional. In silico prediction of DNA binding sites for each allele, overlap of their alignments to the genome and relative coverage of the different families of interspersed repeated elements suggest a large diversity between PRDM9 variants with a potential for highly divergent distributions of recombination events in the genome with little correlation to evolutionary distance. By compiling PRDM9 ZnF protein sequences in Primates, Muridae and Equids, we find different diversity patterns among the three amino-acids most critical for the DNA-recognition function, suggesting different diversification timescales.	[Buard, Jerome; de Segonzac, Denis Dunoyer; Garres, Charlotte; de Massy, Bernard] CNRS, Inst Human Genet, UPR 1142, Montpellier, France; [Rivals, Eric] Univ Montpellier 2, Lab Informat Robot & Microelect Montpellier, UMR 5506, CNRS, Montpellier, France; [de Segonzac, Denis Dunoyer; Garres, Charlotte; Caminade, Pierre; Boursot, Pierre] Univ Montpellier 2, Inst Sci Evolut Montpellier, CNRS, Inst Rech Dev, Montpellier, France; [Rivals, Eric] Inst Biol Computat, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	de Massy, B (corresponding author), CNRS, Inst Human Genet, UPR 1142, Montpellier, France.	bernard.de-massy@igh.cnrs.fr	Boursot, Pierre/D-5860-2011	Boursot, Pierre/0000-0001-6366-2341; Rivals, Eric/0000-0003-3791-3973	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [09-BLAN-0269-01]; Fondation pour la Recherche Medicale; Labex "EpigenMed" program of MENRT; Conseil Scientifique of Universite Montpellier 2 [AAP2011]; Region Languedoc Roussillon (grant Chercheur d'Avenir); NUMEV Labex; MASTODONS Defi from CNRS; Investissements d'Avenir (grant Institut Computational Biology)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Labex "EpigenMed" program of MENRT; Conseil Scientifique of Universite Montpellier 2; Region Languedoc Roussillon (grant Chercheur d'Avenir)(Region Occitanie); NUMEV Labex; MASTODONS Defi from CNRS; Investissements d'Avenir (grant Institut Computational Biology)(French National Research Agency (ANR))	JB and BdM are supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche (09-BLAN-0269-01), and the Fondation pour la Recherche Medicale. DD is recipient of a fellowship by from the Labex "EpigenMed" program of MENRT. The project was partly funded by the Conseil Scientifique of Universite Montpellier 2 (AAP2011 to PB). ER is supported by the Region Languedoc Roussillon (grant Chercheur d'Avenir), the NUMEV Labex, the MASTODONS Defi from CNRS, and by Investissements d'Avenir (grant Institut Computational Biology). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baines JF, 2007, GENETICS, V175, P1911, DOI 10.1534/genetics.106.069419; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berard S, 2003, J COMPUT BIOL, V10, P357, DOI 10.1089/10665270360688066; Berard S, 2006, EVOL BIOINFORM, V2, P303; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Billings T, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r35; Bonhomme F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r80; Bonhomme F, 2011, P ROY SOC B-BIOL SCI, V278, P1034, DOI 10.1098/rspb.2010.1228; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Britton-Davidian J, 2005, BIOL J LINN SOC, V84, P379, DOI 10.1111/j.1095-8312.2005.00441.x; Carvalho AM, 2006, IEEE ACM T COMPUT BI, V3, P126, DOI 10.1109/TCBB.2006.16; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Clement Y, 2013, MOL BIOL EV IN PRESS; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Darvish J, 2006, FOLIA ZOOL, V55, P349; de Massy B, 2013, ANN REV GEN IN PRESS; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Duvaux L, 2011, MOL ECOL, V20, P5248, DOI 10.1111/j.1365-294X.2011.05343.x; Geraldes A, 2011, MOL ECOL, V20, P4722, DOI 10.1111/j.1365-294X.2011.05285.x; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Groeneveld LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039064; Guenoche A., 2001, Computational Biology. First International Conference on Biology, Informatics, and Mathematics, JOBIM 2000. Selected Papers (Lecture Notes in Computer Science Vol.2066), P45; Halligan DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000825; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Jeffreys AJ, 2013, P NATL ACAD SCI USA, V110, P600, DOI 10.1073/pnas.1220813110; Karn RC, 2002, MOL BIOL EVOL, V19, P462, DOI 10.1093/oxfordjournals.molbev.a004102; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Mckee B. D., 2009, V5, P56, DOI 10.1159/000166619; McVean G, 2010, PHILOS T R SOC B, V365, P1213, DOI 10.1098/rstb.2009.0299; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oka A, 2010, GENETICS, V186, P339, DOI 10.1534/genetics.110.118976; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Persikov AV, 2013, NUCL ACIDS IN PRESS; Phifer-Rixey M, 2012, MOL BIOL EVOL, V29, P2949, DOI 10.1093/molbev/mss105; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; R Core Team, 2012, R LANG ENV STAT COMP; Rajabi-Maham H, 2012, BIOL J LINN SOC, V107, P295, DOI 10.1111/j.1095-8312.2012.01957.x; SHE JX, 1990, BIOL J LINN SOC, V41, P83, DOI 10.1111/j.1095-8312.1990.tb00823.x; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Staubach F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002891; Steiner CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061746; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Tucker PK, 2005, BIOL J LINN SOC, V84, P653, DOI 10.1111/j.1095-8312.2005.00462.x; Turner LM, 2012, EVOLUTION, V66, P443, DOI 10.1111/j.1558-5646.2011.01445.x; Vyskocilova M, 2009, MAMM GENOME, V20, P83, DOI 10.1007/s00335-008-9164-3; Webster MT, 2012, TRENDS GENET, V28, P101, DOI 10.1016/j.tig.2011.11.002; White MA, 2012, GENETICS, V191, P917, DOI 10.1534/genetics.112.140251; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	80	45	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85021	10.1371/journal.pone.0085021	http://dx.doi.org/10.1371/journal.pone.0085021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454780	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500031
J	Sandor, ME; Chazdon, RL				Sandor, Manette E.; Chazdon, Robin L.			Remnant Trees Affect Species Composition but Not Structure of Tropical Second-Growth Forest	PLOS ONE			English	Article							BURN AGRICULTURAL SYSTEM; SEED RAIN; ABANDONED PASTURE; RECRUITMENT; VEGETATION; CONSERVATION; REGENERATION; SUCCESSION; DISPERSAL; DIVERSITY	Remnant trees, spared from cutting when tropical forests are cleared for agriculture or grazing, act as nuclei of forest regeneration following field abandonment. Previous studies on remnant trees were primarily conducted in active pasture or old fields abandoned in the previous 2-3 years, and focused on structure and species richness of regenerating forest, but not species composition. Our study is among the first to investigate the effects of remnant trees on neighborhood forest structure, biodiversity, and species composition 20 years post-abandonment. We compared the woody vegetation around individual remnant trees to nearby plots without remnant trees in the same second-growth forests ("control plots"). Forest structure beneath remnant trees did not differ significantly from control plots. Species richness and species diversity were significantly higher around remnant trees. The species composition around remnant trees differed significantly from control plots and more closely resembled the species composition of nearby old-growth forest. The proportion of old-growth specialists and generalists around remnant trees was significantly greater than in control plots. Although previous studies show that remnant trees may initially accelerate secondary forest growth, we found no evidence that they locally affect stem density, basal area, and seedling density at later stages of regrowth. Remnant trees do, however, have a clear effect on the species diversity, composition, and ecological groups of the surrounding woody vegetation, even after 20 years of forest regeneration. To accelerate the return of diversity and old-growth forest species into regrowing forest on abandoned land, landowners should be encouraged to retain remnant trees in agricultural or pastoral fields.	[Sandor, Manette E.; Chazdon, Robin L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Sandor, ME (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	manette.sandor@uconn.edu	; Chazdon, Robin/O-9766-2018	Sandor, Manette/0000-0002-3665-4837; Chazdon, Robin/0000-0002-7349-5687	Blue Moon Fund; Ronald Bamford Endowment Fund Award	Blue Moon Fund; Ronald Bamford Endowment Fund Award	Our study was funded by Blue Moon Fund (http://www.bluemoonfund.org/) and a Ronald Bamford Endowment Fund Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R., 2018, ADELANTE VASCULAR PL; [Anonymous], 2011, PROGRAM CLAM CLASSIF; Barrantes G., 1999, EVALUACION PLANES MA; Carriere SM, 2002, J TROP ECOL, V18, P353, DOI 10.1017/S0266467402002250; Carriere SM, 2002, J TROP ECOL, V18, P375, DOI 10.1017/S0266467402002262; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 2014, SOCIAL LIVE IN PRESS; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Colwell R, 2012, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cubina A, 2001, BIOTROPICA, V33, P260, DOI 10.1111/j.1744-7429.2001.tb00177.x; de la Pena-Domene M, 2013, ECOL APPL, V23, P1124, DOI 10.1890/12-1728.1; Elmqvist T, 2002, CONSERV ECOL, V5; Fischer J, 2002, BIODIVERS CONSERV, V11, P833, DOI 10.1023/A:1015318328007; Galindo-Gonzalez J, 2003, SOUTHWEST NAT, V48, P579, DOI 10.1894/0038-4909(2003)048&lt;0579:FBIITA&gt;2.0.CO;2; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Guevara S, 2004, BIOTROPICA, V36, P99, DOI 10.1646/02111; GUEVARA S, 1992, J VEG SCI, V3, P655, DOI 10.2307/3235833; GUEVARA S, 1986, VEGETATIO, V66, P77; GUEVARA S, 1993, VEGETATIO, V108, P319; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Harvey CA, 2011, FOREST ECOL MANAG, V261, P1664, DOI 10.1016/j.foreco.2010.11.004; Herrera W, 1986, CLIMA COSTA RICA, P118; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holdridge L.R., 1971, FOREST ENV TROPICAL; Holl KD, 2011, RESTOR ECOL, V19, P470, DOI 10.1111/j.1526-100X.2010.00674.x; Holl KD, 1999, BIOTROPICA, V31, P229, DOI 10.1111/j.1744-7429.1999.tb00135.x; Janzen D.H., 1983, P619; KERNAN C, 1995, J ECOL, V83, P65, DOI 10.2307/2261151; Laborde J, 2008, ECOSCIENCE, V15, P6, DOI 10.2980/1195-6860(2008)15[6:TASSDI]2.0.CO;2; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; MCDONNELL MJ, 1983, OECOLOGIA, V56, P109, DOI 10.1007/BF00378225; Morales-Salazar MS, 2013, REV FOR MESOAM KURU-, V10, P1; Murray K. Greg, 2008, P192, DOI 10.1007/978-0-387-33642-8_8; Nadkarni NM, 2009, CONSERV BIOL, V23, P1117, DOI 10.1111/j.1523-1739.2009.01235.x; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Oksanen J., 2016, R PACKAG; Oliver C.D., 1990, FOREST STAND DYNAMIC; Quesada F.J., 1997, ARBOLES PENINSULA OS; R Development Core Team, 2011, R LANG ENV STAT COMP; Schlawin J, 2008, J VEG SCI, V19, P485, DOI 10.3170/2008-8-18387; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; Slocum MG, 2001, ECOLOGY, V82, P2547, DOI 10.1890/0012-9658(2001)082[2547:HTSDAR]2.0.CO;2; Slocum MG, 2000, PLANT ECOL, V149, P51, DOI 10.1023/A:1009892821864; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; White GM, 2002, P NATL ACAD SCI USA, V99, P2038, DOI 10.1073/pnas.042649999; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; YARRANTON GA, 1974, J ECOL, V62, P417, DOI 10.2307/2258988; Zambrano A. M. A., 2010, Journal of Ecotourism, V9, P62, DOI 10.1080/14724040902953076	54	48	49	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83284	10.1371/journal.pone.0083284	http://dx.doi.org/10.1371/journal.pone.0083284			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454700	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500007
J	Tende, T; Hansson, B; Ottosson, U; Akesson, M; Bensch, S				Tende, Talatu; Hansson, Bengt; Ottosson, Ulf; Akesson, Mikael; Bensch, Staffan			Individual Identification and Genetic Variation of Lions (Panthera leo) from Two Protected Areas in Nigeria	PLOS ONE			English	Article							INBREEDING DEPRESSION; POPULATION-SIZE; CONSERVATION GENETICS; GAME-RESERVE; AFRICAN LION; FECAL DNA; EXTINCTION; SERENGETI; DIVERSITY; TRACKING	This survey was conducted in two protected areas in Nigeria to genetically identify individual lions and to determine the genetic variation within and between the populations. We used faecal sample DNA, a non-invasive alternative to the risky and laborious task of taking samples directly from the animals, often preceded by catching and immobilization. Data collection in Yankari Game Reserve (YGR) spanned through a period of five years (2008 -2012), whereas data in Kainji Lake National Park (KLNP) was gathered for a period of three years (2009, 2010 and 2012). We identified a minimum of eight individuals (2 males, 3 females, 3 unknown) from YGR and a minimum of ten individuals (7 males, 3 females) from KLNP. The two populations were found to be genetically distinct as shown by the relatively high fixation index (F-ST = 0.17) with each population exhibiting signs of inbreeding (YGR F-IS = 0.49, KLNP F-IS = 0.38). The genetic differentiation between the Yankari and Kainji lions is assumed to result from large spatial geographic distance and physical barriers reducing gene flow between these two remaining wild lion populations in Nigeria. To mitigate the probable inbreeding depression in the lion populations within Nigeria it might be important to transfer lions between parks or reserves or to reintroduce lions from the zoos back to the wild.	[Tende, Talatu; Ottosson, Ulf] Univ Jos, Dept Zool, AP Leventis Ornithol Res Inst, Jos, Plateau State, Nigeria; [Tende, Talatu; Hansson, Bengt; Bensch, Staffan] Lund Univ, Dept Biol, Lund, Sweden; [Akesson, Mikael] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	University of Jos; Lund University; Swedish University of Agricultural Sciences	Tende, T (corresponding author), Univ Jos, Dept Zool, AP Leventis Ornithol Res Inst, Jos, Plateau State, Nigeria.	talatu.tende@biol.lu.se	Åkesson, Mikael/K-5370-2014; Hansson, Bengt/L-8874-2013	Hansson, Bengt/0000-0001-6694-8169	Kolmarden zoo conservation fund Sweden; Leventis foundation; Swedish Research Council [621-2009-4945, 621-2010-5277]	Kolmarden zoo conservation fund Sweden; Leventis foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Kolmarden zoo conservation fund Sweden and the Leventis foundation provided the funds for the field and laboratory work. The study was supported by grants from the Swedish Research Council (621-2009-4945 to BH; 621-2010-5277 to SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFOLAYAN TA, 1978, OIKOS, V31, P376, DOI 10.2307/3543665; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Ball SJ, 2000, HEREDITY, V84, P677, DOI 10.1046/j.1365-2540.2000.00721.x; Balme G.A., 2007, J WILDLIFE MANAGE, V73, P433; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bellemain E, 2004, MOL ECOL NOTES, V4, P519, DOI 10.1111/j.1471-8286.2004.00711.x; Bensch S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000072; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dunham Jason, 1999, Conservation Ecology, V3, pUnpaginated; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Ernest HB, 2000, MOL ECOL, V9, P433, DOI 10.1046/j.1365-294x.2000.00890.x; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Frankel O. H., 1970, Proceedings of the Linnean Society, New South Wales, V95, P158; FRANKEL OH, 1974, GENETICS, V78, P53; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham Richard, 2004, P85, DOI 10.1017/CBO9780511542022.008; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; GILBERT DA, 1991, J HERED, V82, P378, DOI 10.1093/oxfordjournals.jhered.a111107; Goudet J., 2002, FSTAT COMPUTER PROGR; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Jackson P., 1996, BIOL CONSERVATION; Kays RW, 2002, CAN J ZOOL, V80, P471, DOI 10.1139/Z02-024; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KENDALL KC, 1992, ECOL APPL, V2, P422, DOI 10.2307/1941877; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Laikre L, 1996, BIOL CONSERV, V76, P69, DOI 10.1016/0006-3207(95)00084-4; Laikre L, 1999, HEREDITAS, V130, P203, DOI 10.1111/j.1601-5223.1999.00203.x; LAIKRE L, 1991, CONSERV BIOL, V5, P33, DOI 10.1111/j.1523-1739.1991.tb00385.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LANDE R, 1995, CONSERV BIOL, V9, P782, DOI 10.1046/j.1523-1739.1995.09040782.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lehmann MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003998; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Lyke MM, 2013, MOL ECOL, V22, P2787, DOI 10.1111/mec.12279; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Morris DW, 2009, ANN NY ACAD SCI, V1162, P334, DOI 10.1111/j.1749-6632.2009.04494.x; Munson L, 1996, J REPROD FERTIL, V108, P11, DOI 10.1530/jrf.0.1080011; Murphy MA, 2002, CONSERV GENET, V3, P435, DOI 10.1023/A:1020503330767; Nyanganji G, 2012, 2011 SURVEY LION PAN; OBRIEN SJ, 1987, NATL GEOGR RES, V3, P114; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piggott MP, 2004, CONSERV GENET, V5, P417, DOI 10.1023/B:COGE.0000031138.67958.44; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saccheri IJ, 2002, P ROY SOC B-BIOL SCI, V269, P1073, DOI 10.1098/rspb.2002.1963; Sargeant G.A., 2011, WILD1 R TOOLS WILDLI; Schwartz MK, 1998, ANIM CONSERV, V1, P293, DOI 10.1111/j.1469-1795.1998.tb00040.x; Seddon JM, 2005, CONSERV GENET, V6, P147, DOI 10.1007/s10592-004-7734-9; Shankaranarayanan P, 1997, ELECTROPHORESIS, V18, P1693, DOI 10.1002/elps.1150180938; SLATKIN M, 1995, GENETICS, V139, P457; SPIELMAN D, 1992, ZOO BIOL, V11, P343, DOI 10.1002/zoo.1430110506; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Spong G, 2001, P ROY SOC B-BIOL SCI, V268, P2571, DOI 10.1098/rspb.2001.1835; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tende T, 2010, J AFR ECOL, V59, P7; Uphyrkina O, 2003, CR BIOL, V326, P93, DOI DOI 10.1016/S1631-0691(03)00044-1; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; Wilson DE, 2009, HDB MAMMALS WORLD, V1; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Zhang HM, 2009, CONSERV GENET, V10, P589, DOI 10.1007/s10592-008-9576-3	91	10	10	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84288	10.1371/journal.pone.0084288	http://dx.doi.org/10.1371/journal.pone.0084288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427283	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200023
J	Caldwell, LK; Pierce, AL; Riley, LG; Duncan, CA; Nagler, JJ				Caldwell, Lucius K.; Pierce, Andrew L.; Riley, Larry G.; Duncan, Christine A.; Nagler, James J.			Plasma Nesfatin-1 Is Not Affected by Long-Term Food Restriction and Does Not Predict Rematuration among Iteroparous Female Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; EARLY SEXUAL-MATURATION; SALMON SALMO-SALAR; GROWTH-FACTOR-I; GENE-EXPRESSION; COHO SALMON; FISH GONADOTROPINS; ENDOCRINE FACTORS; METABOLIC-RATE; PUBERTY ONSET	The metabolic peptide hormone nesfatin-1 has been linked to the reproductive axis in fishes. The purpose of this study was to determine how energy availability after spawning affects plasma levels of nesfatin-1, the metabolic peptide hormone ghrelin, and sex steroid hormones in rematuring female rainbow trout (Oncorhynchus mykiss). To limit reproductive maturation, a group of female trout was food-restricted after spawning and compared with a control group that was fed a standard broodstock ration. The experiment was conducted twice, once using two-year-old trout (second-time spawners) and once using three-year-old trout (third-time spawners). During monthly sampling, blood was collected from all fish, and a subset of fish from each treatment was sacrificed for pituitaries. Pituitary follicle-stimulating hormone-beta (fsh-beta) mRNA expression was analyzed with q-RT-PCR; plasma hormone levels were quantified by radioimmunoassay (17 beta-estradiol and ghrelin) and enzyme-linked immunosorbent assay (11-keto-testosterone and nesfatin-1). Although plasma nesfatin-1 levels increased significantly in the months immediately after spawning within both feeding treatments, plasma nesfatin-1 did not differ significantly between the two treatments at any point. Similarly, plasma ghrelin levels did not differ significantly between the two treatments at any point. Food restriction arrested ovarian development by 15-20 weeks after spawning, shown by significantly lower plasma E2 levels among restricted-ration fish. Pituitary fsh-beta mRNA levels were higher among control-ration fish than restricted-ration fish starting at 20 weeks, but did not differ significantly between treatment groups until 30 weeks after spawning. Within both treatment groups, plasma 11-KT was elevated immediately after spawning and rapidly decreased to and persisted at low levels; starting between 20 and 25 weeks after spawning, plasma 11-KT was higher among control-ration fish than restricted-ration fish. The results from these experiments do not provide support for plasma nesfatin-1 as a signal for the initiation of reproductive development in rematuring female rainbow trout.	[Caldwell, Lucius K.; Pierce, Andrew L.; Nagler, James J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Caldwell, Lucius K.; Pierce, Andrew L.; Nagler, James J.] Univ Idaho, Ctr Reprod Biol, Moscow, ID 83843 USA; [Pierce, Andrew L.] Columbia River Intertribal Fish Commiss, Portland, OR USA; [Riley, Larry G.; Duncan, Christine A.] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA	Idaho; University of Idaho; Idaho; University of Idaho; California State University System; California State University Fresno	Caldwell, LK (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	cald0653@vandals.uidaho.edu	Pierce, Andrew/X-2332-2019	Pierce, Andrew/0000-0002-2096-6043	Bonneville Power Administration (CRITFC) [2007-401-00]	Bonneville Power Administration (CRITFC)	This research was funded by the Bonneville Power Administration (www.bpa.gov) (CRITFC (www.critfc.org) Project 2007-401-00, Steelhead Kelt Reconditioning and Reproductive Success Evaluation Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, ZOOL SCI, V14, P1, DOI 10.2108/zsj.14.1; Ando H, 2004, GEN COMP ENDOCR, V137, P109, DOI 10.1016/j.ygcen.2004.02.012; Augustine S, 2011, COMP BIOCHEM PHYS A, V159, P275, DOI 10.1016/j.cbpa.2011.03.016; Baker DM, 2000, BIOL REPROD, V63, P865, DOI 10.1095/biolreprod63.3.865; Banerjee A, 2008, GEN COMP ENDOCR, V155, P827, DOI 10.1016/j.ygcen.2007.09.016; BAROILLER JF, 1987, GEN COMP ENDOCR, V66, P85, DOI 10.1016/0016-6480(87)90353-4; Barreiro ML, 2004, MOL CELL ENDOCRINOL, V226, P1, DOI 10.1016/j.mce.2004.07.015; Bobe J, 2010, MOL CELL ENDOCRINOL, V316, P66, DOI 10.1016/j.mce.2009.09.017; Broggi J, 2007, FUNCT ECOL, V21, P528, DOI 10.1111/j.1365-2435.2007.01255.x; Caldwell LK, 2013, GEN COMP ENDOCR, V194, P124, DOI 10.1016/j.ygcen.2013.09.005; Campbell B, 2003, FISH PHYSIOL BIOCHEM, V28, P287, DOI 10.1023/B:FISH.0000030557.60141.33; Carrillo M, 2009, ANN NY ACAD SCI, V1163, P49, DOI 10.1111/j.1749-6632.2008.03645.x; Castellano JM, 2011, ENDOCRINOLOGY, V152, P3396, DOI 10.1210/en.2010-1415; CHADWICK EMP, 1987, CAN J FISH AQUAT SCI, V44, P1320, DOI 10.1139/f87-156; Davies B, 1999, GEN COMP ENDOCR, V115, P155, DOI 10.1006/gcen.1999.7301; Ebling FJP, 2000, NEUROREPORT, V11, pR23, DOI 10.1097/00001756-200011090-00002; Feng KE, 2013, J EXPT ZOOLOGY A; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; Forsgren KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098772; Frantzen M, 2004, J FISH BIOL, V65, P1526, DOI 10.1111/j.0022-1112.2004.00564.x; FUKAGAWA NK, 1990, AM J PHYSIOL, V259, pE233, DOI 10.1152/ajpendo.1990.259.2.E233; Goebel M, 2009, GASTROENTEROLOGY, V136, pA584; Gonzalez R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099630; Gonzalez R, 2012, GEN COMP ENDOCR, V176, P341, DOI 10.1016/j.ygcen.2011.11.021; Gonzalez R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015201; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Hevroy EM, 2012, GEN COMP ENDOCR, V175, P118, DOI 10.1016/j.ygcen.2011.10.007; Hook SE, 2011, ENVIRON TOXICOL CHEM, V30, P309, DOI 10.1002/etc.407; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; James MO, 2011, J STEROID BIOCHEM, V127, P167, DOI 10.1016/j.jsbmb.2010.10.003; Jonsson E, 2013, GEN COMP EN IN PRESS; Jonsson E, 2007, COMP BIOCHEM PHYS A, V147, P1116, DOI 10.1016/j.cbpa.2007.03.024; Jonsson E, 2010, GEN COMP ENDOCR, V166, P39, DOI 10.1016/j.ygcen.2009.11.001; Kah O, 2009, FISH PHYSIOL, V28, P75, DOI 10.1016/S1546-5098(09)28002-2; Kennedy J, 2008, J FISH BIOL, V72, P78, DOI 10.1111/j.1095-8649.2007.01651.x; Kerbel B, 2012, J NEUROENDOCRINOL, V24, P366, DOI 10.1111/j.1365-2826.2011.02246.x; King HR, 2003, AQUACULTURE, V219, P797, DOI 10.1016/S0044-8486(02)00647-6; Kitazawa T, 2012, GEN COMP ENDOCR, V178, P539, DOI 10.1016/j.ygcen.2012.06.025; Kortner TM, 2009, COMP BIOCHEM PHYS A, V152, P304, DOI 10.1016/j.cbpa.2008.11.001; Lents CA, 2013, DOMEST ANIM ENDOCRIN, V45, P89, DOI 10.1016/j.domaniend.2013.06.002; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Lokman PM, 2002, GEN COMP ENDOCR, V129, P1, DOI 10.1016/S0016-6480(02)00562-2; Mateos J, 2002, COMP BIOCHEM PHYS B, V132, P75, DOI 10.1016/S1096-4959(01)00535-8; Matsubara T, 2003, FISH PHYSIOL BIOCHEM, V28, P295, DOI 10.1023/B:FISH.0000030559.71954.37; McMaster ME, 1992, PROTOCOL MEASURING C; Miandare HK, 2013, GEN COMP ENDOCR, V182, P41, DOI 10.1016/j.ygcen.2012.11.013; Mueller CA, 2012, COMP BIOCHEM PHYS A, V163, P95, DOI 10.1016/j.cbpa.2012.05.190; Munakata A, 2012, AQUACULTURE, V362, P158, DOI 10.1016/j.aquaculture.2010.11.027; Nocillado JN, 2008, MOL REPROD DEV, V75, P355, DOI 10.1002/mrd.20744; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Peterson BC, 2012, GEN COMP ENDOCR, V176, P231, DOI 10.1016/j.ygcen.2012.01.022; Picha ME, 2009, GEN COMP ENDOCR, V161, P365, DOI 10.1016/j.ygcen.2009.01.026; Repaci A, 2011, MOL CELL ENDOCRINOL, V340, P70, DOI 10.1016/j.mce.2011.02.022; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; Riley L, 2013, FRONTIERS ENDOCRINOL, V4; Riley LG, 2008, ZOOL SCI, V25, P821, DOI 10.2108/zsj.25.821; Roa J, 2010, MOL CELL ENDOCRINOL, V324, P87, DOI 10.1016/j.mce.2009.12.018; Setiawan AN, 2012, GEN COMP ENDOCR, V176, P132, DOI 10.1016/j.ygcen.2011.12.041; Shearer K, 2006, AQUACULTURE, V252, P545, DOI 10.1016/j.aquaculture.2005.06.027; Shearer KD, 2000, AQUACULTURE, V190, P343, DOI 10.1016/S0044-8486(00)00406-3; Shepperd E, 2012, GEN COMP ENDOCR, V176, P426, DOI 10.1016/j.ygcen.2012.01.014; Shimokata H, 1993, Nihon Ronen Igakkai Zasshi, V30, P572; Skillman AD, 2006, ENVIRON TOXICOL CHEM, V25, P2997, DOI 10.1897/05-565R.1; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Tena-Sempere M, 2005, GROWTH HORM IGF RES, V15, P83, DOI 10.1016/j.ghir.2005.02.001; Tena-Sempere M, 2012, EUR J ENDOCRINOL, V167, P733, DOI 10.1530/EJE-12-0669; Unniappan S, 2010, GEN COMP ENDOCR, V167, P340, DOI 10.1016/j.ygcen.2009.12.003; Vacher C, 2002, GEN COMP ENDOCR, V127, P198, DOI 10.1016/S0016-6480(02)00046-1; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Yamamoto Y, 2011, GEN COMP ENDOCR, V172, P331, DOI 10.1016/j.ygcen.2011.03.017; Yaron Z, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1500; Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0; You L, 2004, CHEM-BIOL INTERACT, V147, P233, DOI 10.1016/j.cbi.2004.01.006; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	74	24	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85700	10.1371/journal.pone.0085700	http://dx.doi.org/10.1371/journal.pone.0085700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416444	gold, Green Published, Green Submitted			2022-12-27	WOS:000329866300099
J	Lind, A; Brekke, K; Pettersen, FO; Mollnes, TE; Troseid, M; Kvale, D				Lind, Andreas; Brekke, Kristin; Pettersen, Frank Olav; Mollnes, Tom Eirik; Troseid, Marius; Kvale, Dag			A Parameter for IL-10 and TGF-beta Mediated Regulation of HIV-1 Specific T Cell Activation Provides Novel Information and Relates to Progression Markers	PLOS ONE			English	Article							IMMUNE ACTIVATION; LYMPHOCYTE-ACTIVATION; DISEASE PROGRESSION; INFECTION; IMMUNODEFICIENCY; RESPONSES; CD4(+); DIVISION; PD-1; INFLAMMATION	HIV replication is only partially controlled by HIV-specific activated effector T cells in chronic HIV infection and strategies are warranted to improve their efficacy. Chronic T cell activation is generally accompanied by regulation of antigen-specific T cell responses which may impair an effective control of chronic infections. The impact of HIV-induced T cell regulation on individual patients' disease progression is largely unknown, since classical T cell activation assays reflect net activation with regulation as unknown contributing factor. We here explore a quantitative parameter for antigen-induced cytokine-mediated regulation (R-AC) of HIV-specific effector T cell activation by functional antibody-blockade of IL-10 and transforming growth factor-beta. HIV Env- and Gag-specific T cell activation and R-AC were estimated in peripheral blood mononuclear cells from 30 treatment-naive asymptomatic HIV-infected progressors (CD4 count 472/mu l, HIV RNA 37500 copies/ml) stimulated with overlapping peptide panels for 6 days. R-AC was estimated from differences in T cell activation between normal and blocked cultures, and related to annual CD4 loss, immune activation (CD38) and microbial translocation (plasma lipopolysaccharides). R-AC was heterogeneously distributed between individual patients and the two HIV antigens. Notably, RAC did not correlate to corresponding classical activation. Env R-AC correlated with CD38 and CD4 loss rates (r>=0.37, p=<0.046) whereas classical Gag activation tended to correlate with HIV RNA (r = -0.35, p = 0.06). 14 patients (47%) with low R-AC's to both Env and Gag had higher CD8 counts (p = 0.014) and trends towards lower annual CD4 loss (p = 0.056) and later start with antiretroviral treatment (p = 0.07) than the others. In contrast, patients with high R-AC to both Env and Gag (n = 8) had higher annual CD4 loss (p = 0.034) and lower CD8 counts (p = 0.014). R-AC to Env and Gag was not predicted by classical activation parameters and may thus provide additional information on HIV-specific immunity. R-AC and other assessments of regulation deserve further in-depth exploration.	[Lind, Andreas; Brekke, Kristin; Pettersen, Frank Olav; Troseid, Marius; Kvale, Dag] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Lind, Andreas; Mollnes, Tom Eirik; Kvale, Dag] Univ Oslo, Inst Clin Med, Oslo, Norway; [Mollnes, Tom Eirik] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Mollnes, Tom Eirik] Nordland Hosp, Res Lab, Bodo, Norway; [Mollnes, Tom Eirik] Univ Tromso, Tromso, Norway; [Mollnes, Tom Eirik; Kvale, Dag] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo	Kvale, D (corresponding author), Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway.	dag.kvale@medisin.uio.no	Lind, Andreas/AAN-3730-2021; Mollnes, Tom/ABI-5183-2020	Lind, Andreas/0000-0002-8289-8410; Kvale, Dag/0000-0001-6410-2530	Research Council of Norway (RCN) in the GLOBVAC program, RCN [179389]	Research Council of Norway (RCN) in the GLOBVAC program, RCN(Research Council of Norway)	The study was supported by the Research Council of Norway (RCN) in the GLOBVAC program (http://www.forskningsradet.no/prognett-globvac/Home_page/1224697869238), RCN grant no. 179389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Holm M, 2008, CURR HIV RES, V6, P49, DOI 10.2174/157016208783571955; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Jin HT, 2011, BMB REP, V44, P217, DOI 10.5483/BMBRep.2011.44.4.217; Kalland ME, 2011, J IMMUNOL, V187, P5233, DOI 10.4049/jimmunol.1101804; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kran AMB, 2004, AIDS, V18, P1875, DOI 10.1097/00002030-200409240-00003; Kvale D, 1999, AIDS, V13, P195, DOI 10.1097/00002030-199902040-00007; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Lind A, 2013, VACCINE IN PRESS, DOI [10.1016/j.vaccine.2013.07.037., DOI 10.1016/J.VACCINE.2013.07.037.PMID:23906886]; Lind A, 2012, SCAND J INFECT DIS, V44, P566, DOI 10.3109/00365548.2011.653581; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McKarns SC, 2005, J IMMUNOL, V174, P2071, DOI 10.4049/jimmunol.174.4.2071; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Pantaleo G, 2013, CURR OPIN HIV AIDS, V8, P236, DOI 10.1097/COH.0b013e32835fd5cd; Pettersen FO, 2010, CLIN EXP IMMUNOL, V161, P315, DOI 10.1111/j.1365-2249.2010.04179.x; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85604	10.1371/journal.pone.0085604	http://dx.doi.org/10.1371/journal.pone.0085604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416431	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300091
J	Neilans, EG; Holfoth, DP; Radziwon, KE; Portfors, CV; Dent, ML				Neilans, Erikson G.; Holfoth, David P.; Radziwon, Kelly E.; Portfors, Christine V.; Dent, Micheal L.			Discrimination of Ultrasonic Vocalizations by CBA/CaJ Mice (Mus musculus) Is Related to Spectrotemporal Dissimilarity of Vocalizations	PLOS ONE			English	Article							COMMUNICATION; ORGANIZATION	The function of ultrasonic vocalizations (USVs) produced by mice (Mus musculus) is a topic of broad interest to many researchers. These USVs differ widely in spectrotemporal characteristics, suggesting different categories of vocalizations, although this has never been behaviorally demonstrated. Although electrophysiological studies indicate that neurons can discriminate among vocalizations at the level of the auditory midbrain, perceptual acuity for vocalizations has yet to be determined. Here, we trained CBA/CaJ mice using operant conditioning to discriminate between different vocalizations and between a spectrotemporally modified vocalization and its original version. Mice were able to discriminate between vocalization types and between manipulated vocalizations, with performance negatively correlating with spectrotemporal similarity. That is, discrimination performance was higher for dissimilar vocalizations and much lower for similar vocalizations. The behavioral data match previous neurophysiological results in the inferior colliculus (IC), using the same stimuli. These findings suggest that the different vocalizations could carry different meanings for the mice. Furthermore, the finding that behavioral discrimination matched neural discrimination in the IC suggests that the IC plays an important role in the perceptual discrimination of vocalizations.	[Neilans, Erikson G.; Holfoth, David P.; Radziwon, Kelly E.; Dent, Micheal L.] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Portfors, Christine V.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Washington State University	Dent, ML (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.	mdent@buffalo.edu			NIH [DC009483, DC012302]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012302, R03DC009483] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH DC009483 and DC012302 to MLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bregman A.S., 1990, AUDITORY SCENE ANAL; DOOLING RJ, 1987, J COMP PSYCHOL, V101, P367, DOI 10.1037/0735-7036.101.4.367; EHRET G, 1976, J ACOUST SOC AM, V59, P1421, DOI 10.1121/1.381030; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1982, J COMP PHYSIOL, V148, P245, DOI 10.1007/BF00619131; Grimsley Jasmine M S, 2012, Front Behav Neurosci, V6, P89, DOI 10.3389/fnbeh.2012.00089; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Holmstrom L, 2009, HEARING RES, V247, P1, DOI 10.1016/j.heares.2008.09.012; Holmstrom LA, 2010, J NEUROSCI, V30, P802, DOI 10.1523/JNEUROSCI.1964-09.2010; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2011, NEUROSCIENCE, V193, P429, DOI 10.1016/j.neuroscience.2011.07.025; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Radziwon KE, 2009, J COMP PHYSIOL A, V195, P961, DOI 10.1007/s00359-009-0472-1; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Shepard KN, 2011, GENES BRAIN BEHAV, V10, P28, DOI 10.1111/j.1601-183X.2010.00580.x	24	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85405	10.1371/journal.pone.0085405	http://dx.doi.org/10.1371/journal.pone.0085405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416405	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300077
J	Breeze, TD; Vaissiere, BE; Bommarco, R; Petanidou, T; Seraphides, N; Kozak, L; Scheper, J; Biesmeijer, JC; Kleijn, D; Gyldenkaerne, S; Moretti, M; Holzschuh, A; Steffan-Dewenter, I; Stout, JC; Partel, M; Zobel, M; Potts, SG				Breeze, Tom D.; Vaissiere, Bernard E.; Bommarco, Riccardo; Petanidou, Theodora; Seraphides, Nicos; Kozak, Lajos; Scheper, Jeroen; Biesmeijer, Jacobus C.; Kleijn, David; Gyldenkaerne, Steen; Moretti, Marco; Holzschuh, Andrea; Steffan-Dewenter, Ingolf; Stout, Jane C.; Paertel, Meelis; Zobel, Martin; Potts, Simon G.			Agricultural Policies Exacerbate Honeybee Pollination Service Supply-Demand Mismatches Across Europe	PLOS ONE			English	Article							FRUIT-SET; SEQUENTIAL INTRODUCTION; ECOSYSTEM SERVICES; BEES; COLONIES; DECLINES; DENSITY; ENHANCE; BIODIVERSITY; HYMENOPTERA	Declines in insect pollinators across Europe have raised concerns about the supply of pollination services to agriculture. Simultaneously, EU agricultural and biofuel policies have encouraged substantial growth in the cultivated area of insect pollinated crops across the continent. Using data from 41 European countries, this study demonstrates that the recommended number of honeybees required to provide crop pollination across Europe has risen 4.9 times as fast as honeybee stocks between 2005 and 2010. Consequently, honeybee stocks were insufficient to supply >90% of demands in 22 countries studied. These findings raise concerns about the capacity of many countries to cope with major losses of wild pollinators and highlight numerous critical gaps in current understanding of pollination service supplies and demands, pointing to a pressing need for further research into this issue.	[Breeze, Tom D.; Potts, Simon G.] Univ Reading, Ctr Agri Environm Res, Reading, Berks, England; [Vaissiere, Bernard E.] INRA, Avignon, France; [Bommarco, Riccardo] Swedish Univ Agr Sci, Uppsala, Sweden; [Petanidou, Theodora] Univ Aegean, Dept Geog, Mitilini, Greece; [Seraphides, Nicos] Cyprus Agr Res Inst, Nicosia, Cyprus; [Kozak, Lajos] Univ Debrecen, Dept Nat Conservat Zool & Game Management, H-4012 Debrecen, Hungary; [Scheper, Jeroen; Kleijn, David] Alterra, Anim Ecol Team, Wageningen, Netherlands; [Biesmeijer, Jacobus C.] Nat Biodivers Ctr, Darwinweg, Netherlands; [Kleijn, David] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Gyldenkaerne, Steen] Aarhus Univ, Inst Environm Sci, Danish Ctr Environm & Energy, Aarhus, Denmark; [Moretti, Marco] Swiss Fed Inst Forest Snow & Landscape Res, Community Ecol Res Unit, Bellinzona, Switzerland; [Holzschuh, Andrea; Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Stout, Jane C.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia	University of Reading; INRAE; Swedish University of Agricultural Sciences; University of Aegean; University of Debrecen; Wageningen University & Research; Naturalis Biodiversity Center; Wageningen University & Research; Aarhus University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Wurzburg; Trinity College Dublin; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Breeze, TD (corresponding author), Univ Reading, Ctr Agri Environm Res, Reading, Berks, England.	t.d.breeze@reading.ac.uk	Breeze, Tom/AAU-7068-2021; Kleijn, David/HCH-3477-2022; Zobel, Martin/H-1336-2015; Stout, Jane/AAS-8867-2020; Bommarco, Riccardo/E-7109-2016; Petanidou, Theodora/AAU-3212-2020; Holzschuh, Andrea/X-8989-2018; Stout, Jane C/B-1631-2010; Potts, Simon G/C-7250-2008; Scheper, Jeroen/G-1385-2015; Pärtel, Meelis/D-5493-2012; Potts, Simon/ABF-9221-2020; Breeze, Tom/ABC-6373-2021	Breeze, Tom/0000-0002-8929-8354; Zobel, Martin/0000-0001-7957-6704; Stout, Jane/0000-0002-2027-0863; Bommarco, Riccardo/0000-0001-8888-0476; Petanidou, Theodora/0000-0003-1883-0945; Holzschuh, Andrea/0000-0002-5235-4746; Stout, Jane C/0000-0002-2027-0863; Potts, Simon G/0000-0002-2045-980X; Scheper, Jeroen/0000-0002-4314-996X; Pärtel, Meelis/0000-0002-5874-0138; Potts, Simon/0000-0002-2045-980X; Kleijn, David/0000-0003-2500-7164; Steffan-Dewenter, Ingolf/0000-0003-1359-3944; Biesmeijer, Koos/0000-0003-0328-0573; Moretti, Marco/0000-0002-5845-3198	European Community [244090]; BBSRC [BB/I000348/1, BB/I000275/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000275/1, BB/I000348/1] Funding Source: researchfish	European Community(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research received funding from the European Community's Seventh Framework Programme(FP7/2007-2013) under grant agreement no 244090, STEP Project (Status and Trends of European Pollinators: www.step-project.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, 2011, TRENDS ECOL EVOL, V27, P142; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Banse M, 2011, BIOMASS BIOENERG, V35, P2385, DOI 10.1016/j.biombioe.2010.09.001; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043; Britz W, 2011, AGR ECOSYST ENVIRON, V142, P102, DOI 10.1016/j.agee.2009.11.003; Burton RJF, 2008, SOCIOL RURALIS, V48, P16, DOI 10.1111/j.1467-9523.2008.00452.x; Carreck NL, 1997, BEE WORLD, V78, P67, DOI 10.1080/0005772X.1997.11099337; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; European Commission, 2011, PROP REG EUR PARL CO; European Parliament, 2013, DIR PAYM FARM SUPP S; Eurostat, 2013, SELL PRIC CROP PROD; Eurostat, 2012, SAL PEST TONN ACT IN; Food and Environment Research Agency, 2012, PEST US STAT; Free J., 1993, CROP POLLINATION INS; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Harper GL, 2008, J INSECT CONSERV, V12, P147, DOI 10.1007/s10841-007-9072-y; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Herzon I, 2007, J NAT CONSERV, V15, P10, DOI 10.1016/j.jnc.2006.08.001; Hodge I, 2010, LAND USE POLICY, V27, P270, DOI 10.1016/j.landusepol.2009.03.005; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Holzschuh A, 2011, P ROY SOC B-BIOL SCI, V278, P3444, DOI 10.1098/rspb.2011.0268; Hudewenz A, 2013, J AGR SCI FIRSTVIEW, V152, P770, DOI [10.1017/S0021859613000440, DOI 10.1017/80021859613000440]; Ings TC, 2006, J APPL ECOL, V43, P940, DOI 10.1111/j.1365-2664.2006.01199.x; Isbell F, 2013, ECOL LETT, V16, P454, DOI 10.1111/ele.12066; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jauker F, 2012, BASIC APPL ECOL, V13, P268, DOI 10.1016/j.baae.2012.03.010; Kim IS, 2013, FOOD POLICY, V38, P59, DOI 10.1016/j.foodpol.2012.10.006; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Lebuhn G, 2013, CONSERV BIOL, V27, P113, DOI 10.1111/j.1523-1739.2012.01962.x; Manning R, 2005, AUST J EXP AGR, V45, P1307, DOI 10.1071/EA02170; Marris G, 2011, PEST RISK ASSESSMENT; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pocol CB, 2012, J FOOD AGRIC ENVIRON, V10, P132; Popa AA, 2011, ANALELE U DIN ORADEA, V2011, P297; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rader R, 2011, J APPL ECOL, V46, P1080; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Rucker RR, 2012, AM J AGR ECON, V94, P956, DOI 10.1093/ajae/aas031; Sabbahi R, 2005, J ECON ENTOMOL, V98, P367, DOI 10.1603/0022-0493-98.2.367; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Sheffield CS, 2008, CAN ENTOMOL, V140, P589, DOI 10.4039/N08-011; Stern RA, 2004, J HORTIC SCI BIOTECH, V79, P652, DOI 10.1080/14620316.2004.11511821; Stern RA, 2001, J HORTIC SCI BIOTECH, V76, P17, DOI 10.1080/14620316.2001.11511320; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; SUMNER D. A., 2006, AGR RESOURCE EC UPDA, V9, P9; UN, 2011, COMP MACR CONT REG G; Vaissiere B.E, 2011, PROTOCOL DETECT ASSE; Veterinary Medical Directorate, 2011, BEE PROD SIT EUR; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Woodcock BA, 2013, AGR ECOSYST ENVIRON, V171, P1, DOI 10.1016/j.agee.2013.03.005; World Bank, 2013, AGR VAL ADD GDP; World Bank, 2013, GDP PER CAP; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	72	137	143	6	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82996	10.1371/journal.pone.0082996	http://dx.doi.org/10.1371/journal.pone.0082996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421873	Green Published, Green Accepted, gold			2022-12-27	WOS:000329862500024
J	Choo, MS; Jeong, CW; Jung, JH; Lee, SB; Jeong, H; Son, H; Kim, HH; Oh, SJ; Cho, SY				Choo, Min Soo; Jeong, Chang Wook; Jung, Jae Hyun; Lee, Seung Bae; Jeong, Hyeon; Son, Hwancheol; Kim, Hyeon Hoe; Oh, Seung-june; Cho, Sung Yong			External Validation and Evaluation of Reliability and Validity of the S-ReSC Scoring System to Predict Stone-Free Status after Percutaneous Nephrolithotomy	PLOS ONE			English	Article							ACCESS	Objectives: The Seoul National University Renal Stone Complexity (S-ReSC) scoring system was developed to predict the stone-free rate (SFR) after single-tract percutaneous nephrolithotomy (PCNL). This study is an external validation of this scoring system. Materials and methods: A retrospective review included 327 patients who underwent PCNL at 2 tertiary referral centers. The S-ReSC score was assigned from 1 to 9 based on the number of sites involved. The stone free status was defined as either complete clearance or clinically insignificant residual fragments,4 mm in size at 1 month follow-up imaging. Interobserver and test-retest reliabilities were evaluated. The statistical performance of the prediction model was assessed by its predictive accuracy, predictive probability, and clinical usefulness. Results: The overall SFR was 65.4%. SFRs were 83.9%, 47.6%, and 21.4% in low (1-2), intermediate (3-4), and high (5-9) score groups, respectively, with significant differences (P < 0.001). Inter-observer and test-retest reliabilities revealed almost perfect agreements. External validation of the S-ReSC scoring system revealed an AUC of 0.731 (95% CI 0.675-0.788). The AUC of 3-titered S-ReSC score groups was 0.691 (95% CI, 0.629-0.753). The calibration plot showed that the predicted probability of SFR had a concordance comparable to that of the observed frequency. The Hosmer-Lemeshow goodness-offit statistic revealed an adequate performance of the predictive model (P = 0.10). Inter-observer and test-retest reliability showed a good level of agreement. Conclusions: The S-ReSC scoring system is useful in predicting the post-PCNL SFR and in describing the complexity of renal stones.	[Choo, Min Soo; Jeong, Chang Wook; Jung, Jae Hyun; Kim, Hyeon Hoe; Oh, Seung-june] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Lee, Seung Bae; Jeong, Hyeon; Son, Hwancheol; Cho, Sung Yong] Seoul Natl Univ, Boramae Med Ctr, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Cho, SY (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Urol, Seoul, South Korea.	kmoretry@daum.net	Oh, Seung-June/D-6015-2012	Oh, Seung-June/0000-0002-0322-3539				El-Nahas AR, 2007, J UROLOGY, V177, P576, DOI 10.1016/j.juro.2006.09.048; El-Nahas AR, 2012, UROLOGY, V79, P1236, DOI 10.1016/j.urology.2012.01.026; Ganpule AP, 2009, J ENDOUROL, V23, P1675, DOI 10.1089/end.2009.1535; Jeong CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065888; Kacker R, 2008, J UROLOGY, V180, P958, DOI 10.1016/j.juro.2008.05.031; Mishra S, 2012, CURR OPIN UROL, V22, P148, DOI 10.1097/MOU.0b013e32834fc306; Morris DS, 2006, J UROLOGY, V175, P1731, DOI 10.1016/S0022-5347(05)00994-8; Munver R, 2001, J UROLOGY, V166, P1242, DOI 10.1016/S0022-5347(05)65745-X; Olbert PJ, 2007, UROL RES, V35, P225, DOI 10.1007/s00240-007-0112-6; Osman MM, 2005, EUR UROL, V47, P860, DOI 10.1016/j.eururo.2005.01.005; Romero Victoriano, 2010, Rev Urol, V12, pe86; Rosa M, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-10; Sampaio F J, 2001, Curr Opin Urol, V11, P359, DOI 10.1097/00042307-200107000-00004; Shahrour K, 2012, UROLOGY, V80, P19, DOI 10.1016/j.urology.2011.12.065; Singla M, 2008, UROLOGY, V71, P1039, DOI 10.1016/j.urology.2007.11.072; Thomas K, 2011, UROLOGY, V78, P277, DOI 10.1016/j.urology.2010.12.026; Williams SK, 2008, J ENDOUROL, V22, P1835, DOI 10.1089/end.2008.9795; Yanke BV, 2005, J UROLOGY, V173, P421, DOI 10.1097/01.ju.0000150522.82760.00	18	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83628	10.1371/journal.pone.0083628	http://dx.doi.org/10.1371/journal.pone.0083628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421896	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500060
J	Reichwald, K; Jorgensen, TZ; Tougaard, P; Skov, S				Reichwald, Kirsten; Jorgensen, Tina Z.; Tougaard, Peter; Skov, Soren			TL1A Induces TCR Independent IL-6 and TNF-alpha Production and Growth of PLZF(+) Leukocytes	PLOS ONE			English	Article							REGULATORY T-CELLS; IFN-GAMMA PRODUCTION; CYTOKINE 1A TL1A; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; NATURAL-KILLER; RECEPTOR; PROLIFERATION; ACTIVATION; EXPRESSION	An elevated level of the cytokine TL1A is known to be associated with several autoimmune diseases, e. g. rheumatoid arthritis and inflammatory bowel disease. However, the mode of action of TL1A remains elusive. In this study, we investigated the role of TL1A in a pro-inflammatory setting, using human leukocytes purified from healthy donors. We show that TL1A, together with IL-12, IL-15 and IL-18, directly induces the production of IL-6 and TNF-alpha from leukocytes. Interestingly, TL1A-induced IL-6 was not produced by CD14(+) monocytes. We further show that the produced IL-6 is fully functional, as measured by its ability to signal through the IL-6 receptor, and that the induction of IL-6 is independent of TCR stimulation. Furthermore, the transcription factor PLZF was induced in stimulated cells. These results offer a substantial explanation for the role of TL1A, since TNF-alpha and IL-6 are directly responsible for much of the inflammatory state in many autoimmune diseases. Our study suggests that TL1A is a possible target for the treatment of autoimmune diseases.	[Reichwald, Kirsten; Jorgensen, Tina Z.; Tougaard, Peter; Skov, Soren] Univ Copenhagen, Immunol Lab, Fac Med & Hlth Sci, Frederiksberg C, Denmark	University of Copenhagen	Reichwald, K (corresponding author), Univ Copenhagen, Immunol Lab, Fac Med & Hlth Sci, Frederiksberg C, Denmark.	kire@sund.ku.dk; sosk@sund.ku.dk	Tougaard, Peter/Q-8695-2016	Tougaard, Peter/0000-0003-1304-4152; Jorgensen, Tina Zenia/0000-0003-3586-2332; Skov, Soren/0000-0003-0732-0026	University of Copenhagen	University of Copenhagen	The research was funded by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MB, 2009, J IMMUNOL, V182, P6763, DOI 10.4049/jimmunol.0801792; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Assier E, 2010, JOINT BONE SPINE, V77, P532, DOI 10.1016/j.jbspin.2010.07.007; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2012, DIGEST LIVER DIS, V44, P30, DOI 10.1016/j.dld.2011.09.002; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; Buchan SL, 2012, EUR J IMMUNOL, V42, P580, DOI 10.1002/eji.201041950; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fleming JO, 2013, INT J PARASITOL, V43, P259, DOI 10.1016/j.ijpara.2012.10.025; Gagnon J, 2008, J IMMUNOL, V180, P7958, DOI 10.4049/jimmunol.180.12.7958; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Harris KM, 2011, J LEUKOCYTE BIOL, V90, P727, DOI 10.1189/jlb.0311132; Itsumi M, 2009, EUR J IMMUNOL, V39, P1784, DOI 10.1002/eji.200839106; Jones GW, 2011, FASEB J, V25, P409, DOI 10.1096/fj.10-166843; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Konsta M, 2012, RHEUMATOLOGY, DOI [10.1093/rheumatology/kes316, DOI 10.1093/RHEUMAT0L0GY/KES316]; Kotaja N, 2004, NAT GENET, V36, P551, DOI 10.1038/ng0604-551; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lee YJ, 2010, J EXP MED, V207, P237, DOI 10.1084/jem.20091519; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Niedbala W, 2002, EUR J IMMUNOL, V32, P341, DOI 10.1002/1521-4141(200202)32:2<341::AID-IMMU341>3.0.CO;2-X; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rodrigues L, 2009, MOL IMMUNOL, V46, P1494, DOI 10.1016/j.molimm.2008.12.033; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Skov S, 2000, J IMMUNOL, V164, P3500, DOI 10.4049/jimmunol.164.7.3500; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Twohig JP, 2012, FASEB J, V26, P3575, DOI 10.1096/fj.11-200618; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; Vujanovic L, 2010, BLOOD, V116, P575, DOI 10.1182/blood-2009-08-240325; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85793	10.1371/journal.pone.0085793	http://dx.doi.org/10.1371/journal.pone.0085793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416448	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500266
J	Peters, RM; Goldreich, D				Peters, Ryan M.; Goldreich, Daniel			Tactile Spatial Acuity in Childhood: Effects of Age and Fingertip Size	PLOS ONE			English	Article							ORIENTATION DISCRIMINATION; MEISSNERS CORPUSCLES; GRATING ORIENTATION; MERKEL CELLS; HUMAN BRAIN; RESOLUTION; SKIN; MECHANORECEPTORS; THRESHOLDS; MATURATION	Tactile acuity is known to decline with age in adults, possibly as the result of receptor loss, but less is understood about how tactile acuity changes during childhood. Previous research from our laboratory has shown that fingertip size influences tactile spatial acuity in young adults: those with larger fingers tend to have poorer acuity, possibly because mechanoreceptors are more sparsely distributed in larger fingers. We hypothesized that a similar relationship would hold among children. If so, children's tactile spatial acuity might be expected to worsen as their fingertips grow. However, concomitant CNS maturation might result in more efficient perceptual processing, counteracting the effect of fingertip growth on tactile acuity. To investigate, we conducted a cross-sectional study, testing 116 participants ranging in age from 6 to 16 years on a precision-controlled tactile grating orientation task. We measured each participant's grating orientation threshold on the dominant index finger, along with physical properties of the fingertip: surface area, volume, sweat pore spacing, and temperature. We found that, as in adults, children with larger fingertips (at a given age) had significantly poorer acuity, yet paradoxically acuity did not worsen significantly with age. We propose that finger growth during development results in a gradual decline in innervation density as receptive fields reposition to cover an expanding skin surface. At the same time, central maturation presumably enhances perceptual processing.	[Peters, Ryan M.; Goldreich, Daniel] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University	Goldreich, D (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	goldrd@mcmaster.ca		Goldreich, Daniel/0000-0002-5104-2185	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada: http://www.nserccrsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN LE, 1986, J ACOUST SOC AM, V80, P118, DOI 10.1121/1.394172; Bleyenheuft Y, 2006, SOMATOSENS MOT RES, V23, P83, DOI 10.1080/08990220600816440; Bleyenheuft Y, 2010, SOMATOSENS MOT RES, V27, P9, DOI 10.3109/08990220903471831; BOLTON CF, 1966, NEUROLOGY, V16, P1; BRUCE MF, 1980, J NEUROL NEUROSUR PS, V43, P730, DOI 10.1136/jnnp.43.8.730; CAUNA N, 1964, ADV BIOL SKIN, P63; Craig JC, 1999, SOMATOSENS MOT RES, V16, P197, DOI 10.1080/08990229970456; Dillon YK, 2001, J ANAT, V199, P577, DOI 10.1046/j.1469-7580.2001.19950577.x; Ellemberg D, 1999, VISION RES, V39, P2325, DOI 10.1016/S0042-6989(98)00280-6; Gescheider GA, 2005, SOMATOSENS MOT RES, V22, P255, DOI 10.1080/08990220500420236; GESCHEIDER GA, 1994, SOMATOSENS MOT RES, V11, P345, DOI 10.3109/08990229409028878; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Goldreich D, 2003, J NEUROSCI, V23, P3439; GOLDREICH D, 2009, JOVE-J VIS EXP; Goldreich D, 2006, PERCEPT PSYCHOPHYS, V68, P1363, DOI 10.3758/BF03193735; Guclu B, 2008, SOMATOSENS MOT RES, V25, P123, DOI 10.1080/08990220802131234; Guclu B, 2007, J EXP CHILD PSYCHOL, V98, P113, DOI 10.1016/j.jecp.2007.05.003; Guinard JX, 2000, TRENDS FOOD SCI TECH, V11, P273, DOI 10.1016/S0924-2244(01)00015-2; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; Hildebrand GD, 2011, PEDIATRIC RETINA, P39, DOI 10.1007/978-3-642-12041-1_2; IGGO A, 1982, ANNU REV NEUROSCI, V5, P1, DOI 10.1146/annurev.ne.05.030182.000245; JENSEN JK, 1993, PSYCHOL SCI, V4, P104, DOI 10.1111/j.1467-9280.1993.tb00469.x; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Kuhrt H, 2012, PROG RETIN EYE RES, V31, P605, DOI 10.1016/j.preteyeres.2012.08.001; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Leveque JL, 2000, J INVEST DERMATOL, V115, P454, DOI 10.1046/j.1523-1747.2000.00055.x; Lewis TL, 2007, J VISION, V7, DOI 10.1167/7.4.9; Manning H, 2006, SOMATOSENS MOT RES, V23, P147, DOI 10.1080/08990220601093460; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; MONTGOMERY DC, 2010, APPL STAT PROBABILIT, P449; Moore JK, 2001, JARO-J ASSOC RES OTO, V2, P297, DOI 10.1007/s101620010052; MORRONGIELLO BA, 1987, J EXP CHILD PSYCHOL, V44, P413, DOI 10.1016/0022-0965(87)90043-9; Nolano M, 2003, ANN NEUROL, V54, P197, DOI 10.1002/ana.10615; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pare M, 2002, J COMP NEUROL, V445, P347, DOI 10.1002/cne.10196; Peters RM, 2009, J NEUROSCI, V29, P15756, DOI 10.1523/JNEUROSCI.3684-09.2009; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1204, DOI 10.1152/jn.1981.46.6.1204; SATO H, 1991, ACTA OTO-LARYNGOL, V111, P1037, DOI 10.3109/00016489109138447; Sripati AP, 2006, J NEUROPHYSIOL, V95, P3852, DOI 10.1152/jn.01240.2005; Stevens JC, 1996, SOMATOSENS MOT RES, V13, P153, DOI 10.3109/08990229609051403; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Verrillo RT, 1998, SOMATOSENS MOT RES, V15, P93, DOI 10.1080/08990229870826; WERNER L, 2011, HUMAN AUDITORY DEV, P1; Wong M, 2013, J NEUROSCI, V33, P9345, DOI 10.1523/JNEUROSCI.0514-13.2013; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Yamada N, 1996, ACTA ANAT, V155, P242; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4	51	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84650	10.1371/journal.pone.0084650	http://dx.doi.org/10.1371/journal.pone.0084650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24454612	Green Published, gold, Green Submitted			2022-12-27	WOS:000328741900061
J	Johst, S; Orzada, S; Fischer, A; Schafer, LC; Nassenstein, K; Umutlu, L; Lauenstein, TC; Ladd, ME; Maderwald, S				Johst, Soeren; Orzada, Stephan; Fischer, Anja; Schaefer, Lena C.; Nassenstein, Kai; Umutlu, Lale; Lauenstein, Thomas C.; Ladd, Mark E.; Maderwald, Stefan			Sequence Comparison for Non-Enhanced MRA of the Lower Extremity Arteries at 7 Tesla	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; TIME-INTERLEAVED ACQUISITION; DISEASE; PULSES; MODES	In this study three sequences for non-contrast-enhanced MRA of the lower extremity arteries at 7T were compared. Cardiac triggering was used with the aim to reduce signal variations in the arteries. Two fast single-shot 2D sequences, a modified Ultrafast Spoiled Gradient Echo (UGRE) sequence and a variant of the Quiescent-Interval Single-Shot (QISS) sequence were triggered via phonocardiogram and compared in volunteer examinations to a non-triggered 2D gradient echo (GRE) sequence. For image acquisition, a 16-channel transmit/receive coil and a manually positionable AngioSURF table were used. To tackle B-1 inhomogeneities at 7T, Time-Interleaved Acquisition of Modes (TIAMO) was integrated in GRE and UGRE. To compare the three sequences quantitatively, a vessel-to-background ratio (VBR) was measured in all volunteers and stations. In conclusion, cardiac triggering was able to suppress flow artifacts satisfactorily. The modified UGRE showed only moderate image artifacts. Averaged over all volunteers and stations, GRE reached a VBR of 4.18 +/- 0.05, UGRE 5.20 +/- 0.06, and QISS 2.72 +/- 0.03. Using cardiac triggering and TIAMO imaging technique was essential to perform non-enhanced MRA of the lower extremities vessels at 7T. The modified UGRE performed best, as observed artifacts were only moderate and the highest average VBR was reached.	[Johst, Soeren; Orzada, Stephan; Fischer, Anja; Schaefer, Lena C.; Ladd, Mark E.; Maderwald, Stefan] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Johst, Soeren; Orzada, Stephan; Fischer, Anja; Schaefer, Lena C.; Nassenstein, Kai; Umutlu, Lale; Lauenstein, Thomas C.; Ladd, Mark E.] Univ Duisburg Essen, Univ Hosp, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Johst, S (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	soeren.johst@uni-duisburg-essen.de	Ladd, Mark E./B-3285-2011; Maderwald, Stefan/B-4241-2011; Orzada, Stephan/H-6745-2019	Orzada, Stephan/0000-0001-9784-4354; Ladd, Mark/0000-0002-4128-9440	European Research Council under European Union [291903]; German Research Foundation (DFG); University Duisburg-Essen	European Research Council under European Union(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); University Duisburg-Essen	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 291903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the German Research Foundation (DFG) and the University Duisburg-Essen in the funding programme Open Access Publishing.	Ackerman M J, 1995, Medinfo, V8 Pt 2, P1195; Bitz AK, 2009, P INT SOC MAG RESON, V17, P4767; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Cukur T, 2009, MAGN RESON MED, V61, P1533, DOI 10.1002/mrm.21921; Edelman RR, 2010, MAGN RESON MED, V63, P951, DOI 10.1002/mrm.22287; Fan ZY, 2009, MAGN RESON MED, V62, P1523, DOI 10.1002/mrm.22142; Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Gutzeit A, 2011, EUR RADIOL, V21, P1979, DOI 10.1007/s00330-011-2132-4; Herborn CU, 2004, AM J ROENTGENOL, V182, P1427, DOI 10.2214/ajr.182.6.1821427; Hodnett PA, 2011, RADIOLOGY, V260, P282, DOI 10.1148/radiol.11101336; Hoult DI, 2000, J MAGN RESON IMAGING, V12, P46, DOI 10.1002/1522-2586(200007)12:1<46::AID-JMRI6>3.0.CO;2-D; Johst S, 2012, INVEST RADIOL, V47, P445, DOI 10.1097/RLI.0b013e31824ef21f; Lanzman RS, 2010, ROFO-FORTSCHR RONTG, V182, P861, DOI 10.1055/s-0029-1245328; Maderwald S, 2011, ISMRM 19 ANN M 2011, P1322; Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9; Nakamura K, 2011, MAGN RESON MED, V65, P595, DOI 10.1002/mrm.22614; Nassenstein K, 2012, EUR RADIOL, V22, P2679, DOI 10.1007/s00330-012-2547-6; Nassenstein K, 2012, EUR RADIOL, V22, P559, DOI 10.1007/s00330-011-2279-z; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Orzada S, 2012, MAGN RESON MED, V67, P1033, DOI 10.1002/mrm.23081; Orzada S., 2010, 18 P INT SOC MRM, V18, P50; Orzada S, 2010, MAGN RESON MED, V64, P327, DOI 10.1002/mrm.22527; Prince MR, 2009, J MAGN RESON IMAGING, V30, P1298, DOI 10.1002/jmri.21973; Quick HH, 2004, ROFO-FORTSCHR RONTG, V176, P163, DOI 10.1055/s-2004-817623; Rasch D., 2004, PSYCHOL SCI, V46, P175; Snyder CJ, 2009, MAGN RESON MED, V61, P517, DOI 10.1002/mrm.21895; Teeuwisse WM, 2012, MAGN RESON MED, V67, P1285, DOI 10.1002/mrm.23108; Thomsen HS, 2006, EUR RADIOL, V16, P2619, DOI 10.1007/s00330-006-0495-8; Umutlu L, 2013, EUR RADIOL, V23, P1059, DOI 10.1007/s00330-012-2666-0; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Yazdanbakhsh P, 2009, VARIABLE POWER COMBI, P397	33	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e86274	10.1371/journal.pone.0086274	http://dx.doi.org/10.1371/journal.pone.0086274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454963	gold, Green Submitted, Green Published			2022-12-27	WOS:000330236000024
J	Wong, MM; Yin, XK; Potter, C; Yu, BQ; Cai, H; Di Bernardini, E; Xu, QB				Wong, Mei Mei; Yin, Xiaoke; Potter, Claire; Yu, Baoqi; Cai, Hao; Di Bernardini, Elisabetta; Xu, Qingbo			Over-Expression of HSP47 Augments Mouse Embryonic Stem Cell Smooth Muscle Differentiation and Chemotaxis	PLOS ONE			English	Article							NEOINTIMAL FORMATION; CHEMOKINE RECEPTOR; HEMATOPOIETIC STEM; PROTEIN HSP47; COLLAGEN; MIGRATION; GRAFTS; GROWTH; HEAT-SHOCK-PROTEIN-47; FIBROBLASTS	In the recent decade, embryonic stem cells (ESC) have emerged as an attractive cell source of smooth muscle cells (SMC) for vascular tissue engineering owing to their unlimited self-renewal and differentiation capacities. Despite their promise in therapy, their efficacy is still hampered by the lack of definitive SMC differentiation mechanisms and difficulties in successful trafficking of the ESC towards a site of injury or target tissue. Heat shock protein 47 (HSP47) is a 47-kDa molecular chaperone that is required for the maturation of various types of collagen and has been shown to be a critical modulator of different pathological and physiological processes. To date, the role of HSP47 on ESC to SMC differentiation or ESC chemotaxis is not known and may represent a potential molecular approach by which ESC can be manipulated to increase their efficacy in clinic. We provide evidence that HSP47 is highly expressed during ESC differentiation into the SMC lineage and that HSP47 reduction results in an attenuation of the differentiation. Our experiments using a HSP47 plasmid transfection system show that gene over-expression is sufficient to induce ESC-SMC differentiation, even in the absence of exogenous stimuli. Furthermore, HSP47 over-expression in ESC also increases their chemotaxis and migratory responses towards a panel of chemokines, likely via the upregulation of chemokine receptors. Our findings provide direct evidence of induced ESC migration and differentiation into SMC via the over-expression of HSP47, thus identifying a novel approach of molecular manipulation that can potentially be exploited to improve stem cell therapy for vascular repair and regeneration.	[Wong, Mei Mei; Yin, Xiaoke; Potter, Claire; Yu, Baoqi; Cai, Hao; Di Bernardini, Elisabetta; Xu, Qingbo] Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, London WC2R 2LS, England	University of London; King's College London	Xu, QB (corresponding author), Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, London WC2R 2LS, England.	qingbo.xu@kcl.ac.uk	Yin, Xiaoke/AAZ-2658-2020	Yin, Xiaoke/0000-0002-5172-0935	British Heart Foundation/United Kingdom [BHFPG/04/29]; British Heart Foundation [RG/09/004/27647] Funding Source: researchfish	British Heart Foundation/United Kingdom(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Grant Number: BHFPG/04/29/British Heart Foundation/United Kingdom. FunderWebsite: http://www.bhf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Cho C, 2002, J NEUROVIROL, V8, P573, DOI 10.1080/13550280290101003; DeVries ME, 1999, SEMIN IMMUNOL, V11, P95, DOI 10.1006/smim.1999.0165; Du ZY, 2013, LIVER TRANSPLANT, V19, P215, DOI 10.1002/lt.23577; Grudzinska MK, 2013, ARTERIOSCL THROM VAS, V33, P1271, DOI 10.1161/ATVBAHA.112.300773; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hebert C, 1999, J CELL BIOCHEM, V73, P248, DOI 10.1002/(SICI)1097-4644(19990501)73:2<248::AID-JCB11>3.0.CO;2-A; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Iwashita T, 2000, HUM PATHOL, V31, P1498, DOI 10.1053/hupa.2000.20378; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; MINOWADA G, 1995, J CLIN INVEST, V95, P3, DOI 10.1172/JCI117655; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Moriyama T, 1998, KIDNEY INT, V54, P110, DOI 10.1046/j.1523-1755.1998.00964.x; Murakami S, 2001, ATHEROSCLEROSIS, V157, P361, DOI 10.1016/S0021-9150(00)00743-7; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Razzaque MS, 2000, NEPHRON, V86, P339, DOI 10.1159/000045790; Rocnik EF, 2002, J BIOL CHEM, V277, P38571, DOI 10.1074/jbc.M206689200; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Umehara H, 2001, TRENDS IMMUNOL, V22, P602, DOI 10.1016/S1471-4906(01)02051-8; vanderLoop FTL, 1997, ARTERIOSCL THROM VAS, V17, P665, DOI 10.1161/01.ATV.17.4.665; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wong MM, 2013, ARTERIOSCL THROM VAS, V33, P2397, DOI 10.1161/ATVBAHA.113.301595; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2012, ARTERIOSCL THROM VAS, V32, P730, DOI 10.1161/ATVBAHA.111.243188; Xiao QZ, 2010, THROMB HAEMOSTASIS, V104, P440, DOI 10.1160/TH09-11-0794; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Xie CQ, 2011, BIOMATERIALS, V32, P4369, DOI 10.1016/j.biomaterials.2011.02.049; Yokota SI, 2003, BIOCHEM BIOPH RES CO, V303, P413, DOI 10.1016/S0006-291X(03)00352-8; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999	37	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e86118	10.1371/journal.pone.0086118	http://dx.doi.org/10.1371/journal.pone.0086118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454956	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000023
J	Ahn, YY; Lee, DS; Burd, H; Blank, W; Kapatral, V				Ahn, Yong-Yeol; Lee, Deok-Sun; Burd, Henry; Blank, William; Kapatral, Vinayak			Metabolic Network Analysis-Based Identification of Antimicrobial Drug Targets in Category A Bioterrorism Agents	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; ESCHERICHIA-COLI; BACILLUS-ANTHRACIS; YERSINIA-PESTIS; STAPHYLOCOCCUS-AUREUS; GENE; RECONSTRUCTION; NOVICIDA; BACTERIA; STRAINS	The 2001 anthrax mail attacks in the United States demonstrated the potential threat of bioterrorism, hence driving the need to develop sophisticated treatment and diagnostic protocols to counter biological warfare. Here, by performing flux balance analyses on the fully-annotated metabolic networks of multiple, whole genome-sequenced bacterial strains, we have identified a large number of metabolic enzymes as potential drug targets for each of the three Category A-designated bioterrorism agents including Bacillus anthracis, Francisella tularensis and Yersinia pestis. Nine metabolic enzymes-belonging to the coenzyme A, folate, phosphatidyl-ethanolamine and nucleic acid pathways common to all strains across the three distinct genera were identified as targets. Antimicrobial agents against some of these enzymes are available. Thus, a combination of cross species-specific antibiotics and common antimicrobials against shared targets may represent a useful combinatorial therapeutic approach against all Category A bioterrorism agents.	[Ahn, Yong-Yeol] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Lee, Deok-Sun] Inha Univ, Dept Nat Med Sci, Inchon, South Korea; [Lee, Deok-Sun] Inha Univ, Dept Phys, Inchon, South Korea; [Burd, Henry; Blank, William; Kapatral, Vinayak] Igenbio Inc, Chicago, IL 60607 USA	Indiana University System; Indiana University Bloomington; Inha University; Inha University	Kapatral, V (corresponding author), Igenbio Inc, Chicago, IL 60607 USA.	vinayak@integratedgenomics.com	Ahn, Yong-Yeol/C-6334-2011; Lee, Deok-Sun/D-1335-2011	Ahn, Yong-Yeol/0000-0002-4352-4301; KAPATRAL, VINAYAK/0000-0002-0501-3738; Lee, Deok-Sun/0000-0002-5093-6582	National Institutes of Health [5U01AI070499-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 5U01AI070499-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Barrow EW, 2007, ANTIMICROB AGENTS CH, V51, P4447, DOI 10.1128/AAC.00628-07; Bourne CR, 2010, ANTIMICROB AGENTS CH, V54, P3825, DOI 10.1128/AAC.00361-10; Boyle DS, 1998, J BACTERIOL, V180, P6429; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chaperon DN, 2006, APPL ENVIRON MICROB, V72, P1288, DOI 10.1128/AEM.72.2.1288-1294.2006; Charusanti P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-163; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gilligan PH, 2002, CURR OPIN MICROBIOL, V5, P489, DOI 10.1016/S1369-5274(02)00359-4; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Hare RS, 2001, J BACTERIOL, V183, P1694, DOI 10.1128/JB.183.5.1694-1706.2001; Johansson A, 2001, J CLIN MICROBIOL, V39, P3140, DOI 10.1128/JCM.39.9.3140-3146.2001; Joyce Andrew R., 2008, V416, P433, DOI 10.1007/978-1-59745-321-9_30; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08; Mathieu M, 2005, J BIOL CHEM, V280, P18916, DOI 10.1074/jbc.M413799200; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Pilo P, 2011, INFECT GENET EVOL, V11, P1218, DOI 10.1016/j.meegid.2011.05.013; Pohanka M, 2009, FOLIA MICROBIOL, V54, P263, DOI 10.1007/s12223-009-0046-1; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Wei Y, 2000, MOL MICROBIOL, V43, P1651; Wong JD, 2000, ANTIMICROB AGENTS CH, V44, P1995, DOI 10.1128/AAC.44.7.1995-1996.2000; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	33	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85195	10.1371/journal.pone.0085195	http://dx.doi.org/10.1371/journal.pone.0085195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454817	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100064
J	Jin, YX; Jeon, Y; Lee, SH; Kwon, MS; Kim, T; Cui, XS; Hyun, SH; Kim, NH				Jin, Yong-Xun; Jeon, Yubyeol; Lee, Sung-Hyun; Kwon, Mo-Sun; Kim, Teoan; Cui, Xiang-Shun; Hyun, Sang-Hwan; Kim, Nam-Hyung			Production of Pigs Expressing a Transgene under the Control of a Tetracycline-Inducible System	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NUCLEAR TRANSFER EMBRYOS; GENE-EXPRESSION; MICE; DOXYCYCLINE; TRANSCRIPTION; ACTIVATION; GENERATION; CHICKENS; PROMOTER	Pigs are anatomically and physiologically closer to humans than other laboratory animals. Transgenic (TG) pigs are widely used as models of human diseases. The aim of this study was to produce pigs expressing a tetracycline (Tet)-inducible transgene. The Tet-on system was first tested in infected donor cells. Porcine fetal fibroblasts were infected with a universal doxycycline-inducible vector containing the target gene enhanced green fluorescent protein (eGFP). At 1 day after treatment with 1 mu g/ml doxycycline, the fluorescence intensity of these cells was increased. Somatic cell nuclear transfer (SCNT) was then performed using these donor cells. The Tet-on system was then tested in the generated porcine SCNT-TG embryos. Of 4,951 porcine SCNT-TG embryos generated, 850 were cultured in the presence of 1 mu g/ml doxycycline in vitro. All of these embryos expressed eGFP and 15 embryos developed to blastocyst stage. The remaining 4,101 embryos were transferred to thirty three surrogate pigs from which thirty eight cloned TG piglets were obtained. PCR analysis showed that the transgene was inserted into the genome of each of these piglets. Two TG fibroblast cell lines were established from these TG piglets, and these cells were used as donor cells for re-cloning. The re-cloned SCNT embryos expressed the eGFP transgene under the control of doxycycline. These data show that the expression of transgenes in cloned TG pigs can be regulated by the Tet-on/off systems.	[Jin, Yong-Xun; Lee, Sung-Hyun; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Jeon, Yubyeol; Hyun, Sang-Hwan] Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea; [Kwon, Mo-Sun; Kim, Teoan] Catholic Univ Daegu, Sch Med, Taegu, South Korea	Chungbuk National University; Chungbuk National University; Catholic University of Daegu	Hyun, SH (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea.	shhyun@cbu.ac.kr; nhkim@chungbuk.ac.kr			Next-Generation Bio Green 21 Program, Rural Development Administration, Republic of Korea [PJ00956901, PJ00956302, PJ009080]	Next-Generation Bio Green 21 Program, Rural Development Administration, Republic of Korea	This work was supported by grants (# PJ00956901, PJ00956302 and PJ009080) from the Next-Generation Bio Green 21 Program, Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas D, 2011, THERIOGENOLOGY, V75, P256, DOI 10.1016/j.theriogenology.2010.08.012; Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; Cho YS, 2011, TRANSGENIC RES, V20, P1333, DOI 10.1007/s11248-011-9501-2; Choi BR, 2006, MOL REPROD DEV, V73, P1221, DOI 10.1002/mrd.20543; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gil GC, 2008, GLYCOBIOLOGY, V18, P526, DOI 10.1093/glycob/cwn035; Giraldo Angelica M, 2012, Methods Mol Biol, V885, P105, DOI 10.1007/978-1-61779-845-0_8; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hemann M, 2012, VET RES COMMUN, V36, P187, DOI 10.1007/s11259-012-9524-z; Hong SG, 2009, GENESIS, V47, P314, DOI 10.1002/dvg.20504; Jiang BC, 2012, GENET MOL RES, V11, P2946, DOI 10.4238/2012.July.10.5; Jin YX, 2009, ANIM REPROD SCI, V115, P137, DOI 10.1016/j.anireprosci.2008.10.021; Jin YX, 2013, REPROD FERTIL DEV; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; Kim MJ, 2011, GENESIS, V49, P472, DOI 10.1002/dvg.20737; Klymiuk N, 2012, FASEB J, V26, P1086, DOI 10.1096/fj.11-185041; Koo BC, 2010, TRANSGENIC RES, V19, P437, DOI 10.1007/s11248-009-9327-3; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Kwak SS, 2012, THERIOGENOLOGY, V77, P1186, DOI 10.1016/j.theriogenology.2011.10.025; Kwak SS, 2012, J VET MED SCI, V74, P1095, DOI 10.1292/jvms.12-0050; Lamartina S, 2003, MOL THER, V7, P271, DOI 10.1016/S1525-0016(02)00051-5; Lee SH, 2007, POULTRY SCI, V86, P2221, DOI 10.1093/ps/86.10.2221; ORIAN JM, 1989, ENDOCRINOLOGY, V124, P455, DOI 10.1210/endo-124-1-455; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Popa I, 2002, MOL CELL BIOL, V22, P2057, DOI 10.1128/MCB.22.7.2057-2067.2002; Roth S, 2009, GENESIS, V47, P7, DOI 10.1002/dvg.20446; Song K, 2009, MOL REPROD DEV, V76, P611, DOI 10.1002/mrd.20989; Takiguchi M, 2010, J THROMB HAEMOST, V8, P2751, DOI 10.1111/j.1538-7836.2010.04077.x; Tong J, 2011, TRANSGENIC RES, V20, P933, DOI 10.1007/s11248-010-9454-x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Watanabe M, 2012, TRANSGENIC RES, V21, P605, DOI 10.1007/s11248-011-9561-3; Weidenfeld-Baranboim K, 2009, NUCLEIC ACIDS RES, V37, P2194, DOI 10.1093/nar/gkp083; Yeom HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046646; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	34	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86146	10.1371/journal.pone.0086146	http://dx.doi.org/10.1371/journal.pone.0086146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454957	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100146
J	Wu, CL; Qu, XH; Mao, YQ; Li, HW; Liu, FX; Zhu, ZN				Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Liu, Fengxiang; Zhu, Zhenan			Developmental Dysplasia of the Hip, Age, BMI, Place of Residence and Tobacco Abuse Increase the Odds of Aseptic Loosening in Chinese Patients	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; KNEE ARTHROPLASTY; RISK-FACTORS; SMOKING; TRIAL; INTERVENTION; COMPONENT	Purpose: The purpose of this hospital-based case-control study was to evaluate the patient-related risk factors for aseptic loosening after total hip arthroplasty (THA) and total knee arthroplasty (TKA) in Chinese patients. Methods: From January 2000 to December 2012, 67 patients undergoing THA and TKA who developed aseptic loosening were detected as case subjects and 336 patients without aseptic loosening, matched by the year of index surgery and type of surgery, were selected as controls. Conditional logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs). Results: The demographic factors and comorbid conditions associated with a risk-adjusted increase in aseptic loosening (in decreasing order of significance) were a rural place of residence (OR = 2.28; 95% CI: 1.21-4.30; p = 0.011), body mass index (BMI) >= 28 kg/m(2) (vs. 18.5-28 kg/m(2)) (OR = 2.29; 95% CI: 1.19-4.41; p = 0.013), developmental dysplasia of the hip (DDH) (OR = 2.91; 95% CI: 1.11-7.66; p = 0.030), tobacco abuse (OR = 2.88; 95% CI: 1.05-7.89; p = 0.039), and age <45 years (vs. 45-65 years) (OR = 2.63; 95% CI: 1.01-6.80; p = 0.047). Conclusions: Patients aged <45 years and those with a BMI of >= 28 kg/m(2), a preoperative diagnosis of DDH, history of tobacco abuse, or living in rural areas are at increased risk for aseptic loosening after THA and TKA in Chinese population. Additional systematic large-scale studies are needed to verify these results.	[Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Liu, Fengxiang; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, FX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China.	liu_fengxiang@126.com; zhenan_zhu@126.com	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890	National Natural Science Foundation of China [81171729]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (number 81171729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordini B, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-69; Bozic KJ, 2013, J ARTHROPLASTY; Bozic KJ, 2013, CLIN ORTHOP RELAT RE; BRAND RA, 1986, CLIN ORTHOP RELAT R, P185; CARLSSON AS, 1980, CLIN ORTHOP RELAT R, P262; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corten K, 2011, CLIN ORTHOP RELAT R, V469, P209, DOI 10.1007/s11999-010-1459-5; DIHLMANN W, 1991, RADIOLOGE, V31, P496; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Flugsrud GB, 2007, ACTA ORTHOP, V78, P99, DOI 10.1080/17453670610013493; Greiner B, 1997, Z ORTHOP GRENZGEB, V135, P292, DOI 10.1055/s-2008-1039391; GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17; Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400; Haverkamp D, 2008, CLIN ORTHOP RELAT R, V466, P1162, DOI 10.1007/s11999-008-0129-3; Kapadia BH, 2012, J ARTHROPLASTY, V27, P1690, DOI 10.1016/j.arth.2012.03.057; Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d; Malik MHA, 2004, INT ORTHOP, V28, P211, DOI 10.1007/s00264-004-0556-z; Manley M, 2009, J ARTHROPLASTY, V24, P1061, DOI 10.1016/j.arth.2008.06.011; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Munger P, 2006, ACTA ORTHOP, V77, P567, DOI 10.1080/17453670610012629; Namba RS, 2013, J ARTHROPLASTY, V28, P122, DOI 10.1016/j.arth.2013.04.050; Poultsides LA, 2013, J ARTHROPLASTY, V28, P385, DOI 10.1016/j.arth.2012.06.027; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; Santaguida PL, 2008, CAN J SURG, V51, P428; Streit MR, 2013, CLIN ORTHOP RELAT R, V471, P3262, DOI 10.1007/s11999-013-3033-4	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85562	10.1371/journal.pone.0085562	http://dx.doi.org/10.1371/journal.pone.0085562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454888	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100099
J	Zhong, YF; Zhang, XW; Cai, XF; Wang, K; Chen, YP; Deng, YY				Zhong, Yifei; Zhang, Xianwen; Cai, Xianfan; Wang, Ke; Chen, Yiping; Deng, Yueyi			Puerarin Attenuated Early Diabetic Kidney Injury through Down-Regulation of Matrix Metalloproteinase 9 in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; RENAL-DISEASE; NEPHROPATHY; ALBUMINURIA; PODOCYTES; MMP-9; MICROALBUMINURIA; PROGRESSION; GENE	Radix puerariae, a traditional Chinese herbal medication, has been used successfully to treat patients with early stage of diabetic nephropathy. However, the underlined mechanism of this renal protective effect has not been determined. In the current study, we investigated the effects and the mechanism of puerarin in Streptozotocin (STZ)-induced diabetic rats. We treated STZ-rats with either puerarin or losartan, an angiotensin II receptor blocker, as compared to those treated with vehicle. We found that both puerarin and losartan attenuated kidney hypertrophy, mesangial expansion, proteinuria, and podocyte foot process effacement in STZ rats. In addition, both puerarin and losartan increased expression of podocyte slit diaphragm proteins such as nephrin and podocin. Interestingly, we found that puerarin treatment induced a more pronounced suppression of oxidative stress production and S-nitrosylation of proteins in the diabetic kidneys as compared to losartan treatment. Furthermore, we found that matrix metalloproteinase-9 (MMP-9), which is known to be activated by oxidative stress and S-nitrosylation of proteins, was also suppressed more extensively by puerarin than losartan. In conclusion, these data provide for the first time the potential mechanism to support the use of puerarin in the treatment of early diabetic nephropathy.	[Zhong, Yifei; Zhang, Xianwen; Cai, Xianfan; Chen, Yiping; Deng, Yueyi] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Div Nephrol, Shanghai, Peoples R China; [Wang, Ke] Natl Engn Res Ctr Biochip Shanghai, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Zhong, YF (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Div Nephrol, Shanghai, Peoples R China.	yifeilily@126.com; dengyueyi@medmail.com.cn	Chen, Yi/HIR-2608-2022; zhang, xian/GYA-0290-2022		National Natural Science Foundation of China for Young Investigators [1999-30901944]; Shanghai Bureau of Health for Young Investigators [2011-XYQ2011059]; National Natural Science Foundation of China [30973725]; Shanghai Natural Science Foundation for Young Investigators [2012-ZR1450500]; Graduate student creative project of the Shanghai University of Traditional Chinese Medicine [22]	National Natural Science Foundation of China for Young Investigators; Shanghai Bureau of Health for Young Investigators; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation for Young Investigators; Graduate student creative project of the Shanghai University of Traditional Chinese Medicine	YF Zhong is supported by National Natural Science Foundation of China for Young Investigators (1999-30901944) and Shanghai Bureau of Health for Young Investigators (2011-XYQ2011059); YY Deng is supported by National Natural Science Foundation of China (30973725); XW Zhang is supported by Shanghai Natural Science Foundation for Young Investigators (2012-ZR1450500); XF Cai is supported by Graduate student creative project of the Shanghai University of Traditional Chinese Medicine (22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KL, 2000, AM J PATHOL, V157, P303, DOI 10.1016/S0002-9440(10)64541-5; Araki SI, 2003, J AM SOC NEPHROL, V14, P2015, DOI 10.1097/01.ASN.0000077347.27669.5C; Asanuma K, 2002, KIDNEY INT, V62, P822, DOI 10.1046/j.1523-1755.2002.00539.x; Bai YL, 2006, CELL PHYSIOL BIOCHEM, V17, P57, DOI 10.1159/000091464; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Choi YE, 2010, EVID-BASED COMPL ALT, V7, P433, DOI 10.1093/ecam/nen021; Dong D C, 1987, Zhong Xi Yi Jie He Za Zhi, V7, P403; Duan Hui-jun, 2004, Yaoxue Xuebao, V39, P481; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Fernandez D, 2011, BBA-MOL CELL RES, V1813, P1504, DOI 10.1016/j.bbamcr.2011.05.009; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; Forbes JM, 2003, J AM SOC NEPHROL, V14, pS254, DOI 10.1097/01.ASN.0000077413.41276.17; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hammond J B, 1988, Methods Mol Biol, V3, P25, DOI 10.1385/0-89603-126-8:25; Hirakawa S, 2003, AM J KIDNEY DIS, V42, P133, DOI 10.1016/S0272-6386(03)00416-5; IJpelaar DHT, 2008, AM J PHYSIOL-RENAL, V294, pF758, DOI 10.1152/ajprenal.00457.2007; Jia WP, 2009, NEPHROL DIAL TRANSPL, V24, P3724, DOI 10.1093/ndt/gfp349; Kataya HAH, 2008, EVID-BASED COMPL ALT, V5, P281, DOI 10.1093/ecam/nem029; Kluger MA, 2013, KIDNEY INT, V83, P865, DOI 10.1038/ki.2012.483; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; Lelongt B, 1997, J CELL BIOL, V136, P1363, DOI 10.1083/jcb.136.6.1363; Lelongt B, 2001, CURR OPIN NEPHROL HY, V10, P7, DOI 10.1097/00041552-200101000-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; lian S., 2010, SHANGHAI J TRAD CHIN, V44, P3; Liu RN, 2006, AM J CHINESE MED, V34, P1037, DOI 10.1142/S0192415X06004508; Liu SY, 2005, CELL PHYSIOL BIOCHEM, V16, P207, DOI 10.1159/000089846; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; MOGENSEN CE, 1993, AM J KIDNEY DIS, V22, P174, DOI 10.1016/S0272-6386(12)70184-1; Noriega-Cisneros R, 2013, MITOCHONDRION; Okada R, 2012, AM J NEPHROL, V36, P444, DOI 10.1159/000343742; Osicka TM, 2000, DIABETES, V49, P87, DOI 10.2337/diabetes.49.1.87; Packham DK, 2012, J AM SOC NEPHROL, V23, P123, DOI 10.1681/ASN.2011040378; Parving HH, 2002, DIABETES CARE, V25, P406, DOI 10.2337/diacare.25.2.406; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; ROSSING P, 1993, DIABETES, V42, P715, DOI 10.2337/diabetes.42.5.715; Rossing P, 2013, NAT REV NEPHROL, V9, P128, DOI 10.1038/nrneph.2013.13; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; von Luttichau I, 2002, BIOL CHEM, V383, P1271; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wan YG, 2005, NEPHRON EXP NEPHROL, V99, pE121, DOI 10.1159/000083980; Wang G.G., 2011, EVID-BASED COMPL ALT, V2011; Wu L, 2007, PHYTOMEDICINE, V14, P652, DOI 10.1016/j.phymed.2007.07.060; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang HY, 2011, EXP GERONTOL, V46, P30, DOI 10.1016/j.exger.2010.09.013; Zhang XW, 2009, THEORY PRACTICE DIAG, V8, P4	52	39	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85690	10.1371/journal.pone.0085690	http://dx.doi.org/10.1371/journal.pone.0085690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454919	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100121
J	Hibert, P; Prunier-Mirebeau, D; Beseme, O; Chwastyniak, M; Tamareille, S; Pinet, F; Prunier, F				Hibert, Pierre; Prunier-Mirebeau, Delphine; Beseme, Olivia; Chwastyniak, Maggy; Tamareille, Sophie; Pinet, Florence; Prunier, Fabrice			Modifications in Rat Plasma Proteome after Remote Ischemic Preconditioning (RIPC) Stimulus: Identification by a SELDI-TOF-MS Approach	PLOS ONE			English	Article							APOLIPOPROTEIN-C-III; PEPTIDE B-BETA(15-42); MYOCARDIAL-INFARCTION; CARDIAC-SURGERY; HUMORAL-FACTORS; TROPONIN-T; INJURY; TRANSTHYRETIN; HAPTOGLOBIN; PROTECTS	Remote ischemic preconditioning's (RIPC) ability to render the myocardium resistant to subsequent prolonged ischemia is now clearly established in different species, including humans. Strong evidence suggests that circulating humoral mediators play a key role in signal transduction, but their identities still need to be established. Our study sought to identify potential circulating RIPC mediators using a proteomic approach. Rats were exposed to 10-min limb ischemia followed by 5-(RIPC 5') or 10-min (RIPC 109) reperfusion prior to blood sampling. The control group only underwent blood sampling. Plasma samples were isolated for proteomic analysis using surface-enhanced laser desorption and ionization - time of flight - mass spectrometry (SELDI-TOF-MS). A total of seven proteins, including haptoglobin and transthyretin, were detected as up-or down-regulated in response to RIPC. These proteins had previously been identified as associated with organ protection, anti-inflammation, and various cellular and molecular responses to ischemia. In conclusion, this study indicates that RIPC results in significant modulations of plasma proteome.	[Hibert, Pierre; Prunier-Mirebeau, Delphine; Tamareille, Sophie; Prunier, Fabrice] UNAM Univ, Angers, France; [Hibert, Pierre; Tamareille, Sophie; Prunier, Fabrice] Univ Angers, Lab Cardioprotect Remodelage & Thrombose, Angers, France; [Prunier-Mirebeau, Delphine] Univ Angers, INSERM, U771, CNRS,UMR 6214,CHU Angers,Dept Biochim & Genet, Angers, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] INSERM, U744, F-59045 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Univ Lille Nord France, IFR142, Lille, France; [Pinet, Florence] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France; [Prunier, Fabrice] CHU Angers, Serv Cardiol, Angers, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Prunier, F (corresponding author), UNAM Univ, Angers, France.	faprunier@chu-angers.fr	Tamareille, Sophie/K-1770-2015; Prunier, Fabrice/A-5210-2011; Pinet, Florence/F-2892-2013; Prunier, Delphine/K-3301-2015	Tamareille, Sophie/0000-0001-8563-6558; Pinet, Florence/0000-0002-5471-1487; 	Servier and Conseil General du Maine et Loire; ANR [ANR-11-EMMA-029-01]; Fondation Coeur Recherche	Servier and Conseil General du Maine et Loire(Region Pays de la Loire); ANR(French National Research Agency (ANR)); Fondation Coeur Recherche	Pierre Hibert was supported by fellowships from Servier and Conseil General du Maine et Loire. This work was supported in part by grants from ANR (ANR-11-EMMA-029-01) and the Fondation Coeur & Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028698; Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Beseme O, 2010, ELECTROPHORESIS, V31, P2697, DOI 10.1002/elps.201000188; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; BORISH L, 1992, INFLAMMATION, V16, P471, DOI 10.1007/BF00918973; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Breivik L, 2011, BASIC RES CARDIOL, V106, P135, DOI 10.1007/s00395-010-0133-0; Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Cubedo J, 2012, ATHEROSCLEROSIS, V222, P263, DOI 10.1016/j.atherosclerosis.2012.02.024; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; Dickson EW, 2001, J MOL CELL CARDIOL, V33, P1751, DOI 10.1006/jmcc.2001.1436; Dickson EW, 1999, J THROMB THROMBOLYS, V8, P123, DOI 10.1023/A:1008911101951; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Dubois E, 2011, EUR HEART J, V32, P115, DOI 10.1093/eurheartj/ehq108; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Fertin M, 2011, J PROTEOMICS, V74, P420, DOI 10.1016/j.jprot.2010.12.005; Fertin M, 2010, PROTEOM CLIN APPL, V4, P654, DOI 10.1002/prca.200900178; Gerber Y, 2003, PREV MED, V37, P18, DOI 10.1016/S0091-7435(03)00051-3; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Hibert P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077211; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Jenkins DP, 1997, HEART, V77, P314, DOI 10.1136/hrt.77.4.314; Kawakami A, 2009, J ATHEROSCLER THROMB, V16, P6, DOI 10.5551/jat.E607; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Krishnamoorthy A, 2011, BLOOD, V118, P1934, DOI 10.1182/blood-2011-02-338061; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Pell TJ, 1998, AM J PHYSIOL-HEART C, V275, pH1542, DOI 10.1152/ajpheart.1998.275.5.H1542; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Pinet F, 2008, PROTEOMICS, V8, P1798, DOI 10.1002/pmic.200700781; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Salvatore A, 2007, BIOCHEMISTRY-US, V46, P11158, DOI 10.1021/bi7006349; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571, DOI 10.1152/ajpheart.2000.278.5.H1571; Serejo FC, 2007, J CARDIOVASC PHARM, V49, P214, DOI 10.1097/FJC.0b013e3180325ad9; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Sousa MM, 2000, J LIPID RES, V41, P58; Suzuyama K, 2004, MOL BRAIN RES, V129, P44, DOI 10.1016/j.molbrainres.2004.06.021; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70; Zacharowski K, 2007, SHOCK, V27, P631, DOI 10.1097/SHK.0b013e31802fa038	51	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85669	10.1371/journal.pone.0085669	http://dx.doi.org/10.1371/journal.pone.0085669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454915	Green Published, gold			2022-12-27	WOS:000329922500058
J	Li, ZJ; Yang, H; Li, YP; Long, J; Liang, YC				Li, Zhaojun; Yang, Hua; Li, Yupeng; Long, Jian; Liang, Yongchao			Cross-Species Extrapolation of Prediction Model for Lead Transfer from Soil to Corn Grain under Stress of Exogenous Lead	PLOS ONE			English	Article							HEAVY-METALS; TRACE-ELEMENTS; CADMIUM; CD; PH; SORPTION; PB; AVAILABILITY; NICKEL; ZN	There has been increasing concern in recent years regarding lead (Pb) transfer in the soil-plant system. In this study the transfer of Pb (exogenous salts) was investigated from a wide range of Chinese soils to corn grain (Zhengdan 958). Prediction models were developed with combination of the Pb bioconcentration factor (BCF) of Zhengdan 958, and soil pH, organic matter (OM) content, and cation exchange capacity (CEC) through multiple stepwise regressions. Moreover, these prediction models from Zhengdan 958 were applied to other non-model corn species through cross-species extrapolation approach. The results showed that the soil pH and OM were the major factors that controlled Pb transfer from soil to corn grain. The lower pH and OM could improve the bioaccumulation of Pb in corn grain. No significant differences were found between two prediction models derived from the different exogenous Pb contents. When the prediction models were applied to other non-model corn species, the ratio ranges between the predicted BCF values and the measured BCF values were within an interval of 2-fold and close to the solid line of 1: 1 relationship. Moreover, the prediction model i.e. Log[ BCF] = -0.098 pH-0.150 log[OM] -1.894 at the treatment of high Pb can effectively reduce the measured BCF intra-species variability for all non-model corn species. These suggested that this prediction model derived from the high Pb content was more adaptable to be applied to other non-model corn species to predict the Pb bioconcentration in corn grain and assess the ecological risk of Pb in different agricultural soils.	[Li, Zhaojun; Yang, Hua; Li, Yupeng; Liang, Yongchao] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China; [Yang, Hua; Long, Jian] Guizhou Normal Univ, Guizhou Key Lab Mt Environm, Guiyang, Peoples R China; [Li, Yupeng] Shanxi Normal Univ, Coll City & Environm Sci, Linfen, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Guizhou Normal University; Shanxi Normal University	Li, ZJ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China.	lizhaojun@caas.cn	Liang, Yongchao/D-5809-2012; Li, zhaojun/E-5735-2012; Liang, Yongchao/S-9281-2019	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	Special Fund of Public Industry in China [200903015]; Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences [2013-9]	Special Fund of Public Industry in China; Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences	This work was jointly supported by the Special Fund of Public Industry in China (Agriculture, project no. 200903015, http://www.moa.gov.cn/) and the Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences (2013-9, http://www.iarrp.cn/SoisWeb/home/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ML, 2004, J ENVIRON QUAL, V33, P532, DOI 10.2134/jeq2004.0532; Allard Patrick, 2010, Integrated Environmental Assessment and Management, V6, P28, DOI 10.1897/IEAM_2009-010.1; Antoniadis V, 2008, CHEMOSPHERE, V71, P759, DOI 10.1016/j.chemosphere.2007.10.015; BAKER AJM, 1994, NEW PHYTOL, V127, P61, DOI 10.1111/j.1469-8137.1994.tb04259.x; BALL DF, 1964, J SOIL SCI, V15, P84, DOI 10.1111/j.1365-2389.1964.tb00247.x; Bang JS, 2004, J ENVIRON QUAL, V33, P891, DOI 10.2134/jeq2004.0891; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cao Ying, 2009, Journal of Maize Sciences, V17, P80; Cecchi M, 2008, GEODERMA, V144, P287, DOI 10.1016/j.geoderma.2007.11.023; Chapman EEV, 2013, ENVIRON POLLUT, V179, P326, DOI 10.1016/j.envpol.2013.04.027; Chen WP, 2009, AGR ECOSYST ENVIRON, V129, P212, DOI 10.1016/j.agee.2008.09.001; Chien CC, 2008, J ENVIRON SCI, V20, P359, DOI 10.1016/S1001-0742(08)60056-X; Chopin EIB, 2007, WATER AIR SOIL POLL, V182, P245, DOI 10.1007/s11270-007-9336-x; CHRISTENSEN TH, 1984, WATER AIR SOIL POLL, V21, P105, DOI 10.1007/BF00163616; Deleebeeck NME, 2007, AQUAT TOXICOL, V84, P223, DOI 10.1016/j.aquatox.2007.03.025; Deleebeeck NME, 2007, ECOTOX ENVIRON SAFE, V67, P1, DOI 10.1016/j.ecoenv.2006.10.001; Dohrmann R, 2006, APPL CLAY SCI, V34, P38, DOI 10.1016/j.clay.2006.02.009; Gandois L, 2010, EUR J SOIL SCI, V61, P271, DOI 10.1111/j.1365-2389.2009.01215.x; Ge Y, 2005, SOIL SEDIMENT CONTAM, V14, P53, DOI 10.1080/15320380590891817; Ge Y, 2000, ENVIRON POLLUT, V107, P137, DOI 10.1016/S0269-7491(99)00119-0; Grover P, 2010, INT J HYG ENVIR HEAL, V213, P99, DOI 10.1016/j.ijheh.2010.01.005; Hettiarachchi GM, 2003, J ENVIRON QUAL, V32, P1684, DOI 10.2134/jeq2003.1684; Hough RL, 2004, ENVIRON HEALTH PERSP, V112, P215, DOI 10.1289/ehp.5589; Hrudey SE, 1995, BIOAVAILABILITY ENV; Jung MC, 2008, SENSORS-BASEL, V8, P2413, DOI 10.3390/s8042413; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Kuo S, 2004, SOIL SCI, V169, P363, DOI 10.1097/01.ss.0000128014.15268.d9; Larras F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044458; Li YueFang, 2010, Journal of Agro-Environment Science, V29, P2260; Li ZJ, 2006, CHEMOSPHERE, V62, P1374, DOI 10.1016/j.chemosphere.2005.07.050; Martinez-Villegas N, 2004, CHEMOSPHERE, V57, P1537, DOI 10.1016/j.chemosphere.2004.08.099; Moreno JL, 1996, BIORESOURCE TECHNOL, V55, P251, DOI 10.1016/0960-8524(96)00009-0; Nahmani J, 2007, ENVIRON POLLUT, V145, P402, DOI 10.1016/j.envpol.2006.04.009; NAIDU R, 1994, EUR J SOIL SCI, V45, P419, DOI 10.1111/j.1365-2389.1994.tb00527.x; Puschenreiter M, 2005, PLANT SOIL ENVIRON, V51, P1, DOI 10.17221/3549-PSE; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Raskin Ilya, 1994, Current Opinion in Biotechnology, V5, P285, DOI 10.1016/0958-1669(94)90030-2; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Rezvani M., 2011, AUSTR J AGR ENG AJAE, V2, P114; Rodriguez JA, 2008, CHEMOSPHERE, V70, P1085, DOI 10.1016/j.chemosphere.2007.07.056; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Sauve S, 2003, ENVIRON SCI TECHNOL, V37, P5191, DOI 10.1021/es030059g; Schlekat CE, 2010, SCI TOTAL ENVIRON, V408, P6148, DOI 10.1016/j.scitotenv.2010.09.012; Shahid M, 2011, ECOTOX ENVIRON SAFE, V74, P78, DOI 10.1016/j.ecoenv.2010.08.037; Simmons RW, 2008, PLANT SOIL, V302, P125, DOI 10.1007/s11104-007-9460-9; Smical AI, 2008, ENVIRON ENG MANAG J, V7, P609, DOI 10.30638/eemj.2008.085; USEPA, 1992, EPA540R94044; Van Sprang PA, 2009, SCI TOTAL ENVIRON, V407, P5373, DOI 10.1016/j.scitotenv.2009.06.029; Wang AS, 2006, PLANT SOIL, V281, P325, DOI 10.1007/s11104-005-4642-9; Wang J, 2009, GEODERMA, V148, P299, DOI 10.1016/j.geoderma.2008.10.015; Wang Xi, 2012, P1; Wang XP, 2004, CHEMOSPHERE, V55, P811, DOI 10.1016/j.chemosphere.2003.12.003; Yang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080855; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P359, DOI 10.1007/s10653-005-4670-7; Zarcinas BA, 1996, COMMUN SOIL SCI PLAN, V27, P1331, DOI 10.1080/00103629609369636; Zeng F, 2001, ENVIRON POLLUT, V159, P84; Zeng FR, 2011, ENVIRON POLLUT, V159, P84, DOI 10.1016/j.envpol.2010.09.019; Zhang HZ, 2011, J ENVIRON SCI-CHINA, V23, P70, DOI 10.1016/S1001-0742(10)60375-0; Zhao XJ, 2013, RES J CHEM ENVIRON, V17, P74	61	7	7	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85688	10.1371/journal.pone.0085688	http://dx.doi.org/10.1371/journal.pone.0085688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416440	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500261
J	Thompson, AM; Martin, KA; Rzucidlo, EM				Thompson, Anne Marie; Martin, Kathleen A.; Rzucidlo, Eva M.			Resveratrol Induces Vascular Smooth Muscle Cell Differentiation through Stimulation of SirT1 and AMPK	PLOS ONE			English	Article							SIRTUINS; DISEASE; NAD(+)	Phenotypic plasticity in vascular smooth muscle cells (VSMC) is necessary for vessel maintenance, repair and adaptation to vascular changes associated with aging. De-differentiated VSMC contribute to pathologies including atherosclerosis and intimal hyperplasia. As resveratrol has been reported to have cardio-protective effects, we investigated its role in VSMC phenotypic modulation. We demonstrated the novel finding that resveratrol promoted VSMC differentiation as measured by contractile protein expression, contractile morphology and contraction in collagen gels. Resveratrol induced VSMC differentiation through stimulation of SirT1 and AMPK. We made the novel finding that low or high dose resveratrol had an initially different mechanism on induction of differentiation. We found that low dose resveratrol stimulated differentiation through SirT1-mediated activation of AKT, whereas high dose resveratrol stimulated differentiation through AMPK-mediated inhibition of the mTORC1 pathway, allowing activation of AKT. The health effects of resveratrol in cardiovascular diseases, cancer and longevity are an area of active research. We have demonstrated a supplemental avenue where-by resveratrol may promote health by maintaining and enhancing plasticity of the vasculature.	[Thompson, Anne Marie; Rzucidlo, Eva M.] Dartmouth Med Sch, Vasc Surg Sect, Lebanon, NH USA; [Martin, Kathleen A.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06504 USA	Dartmouth College; Yale University	Rzucidlo, EM (corresponding author), Dartmouth Med Sch, Vasc Surg Sect, Lebanon, NH USA.	eva.m.rzucidlo@hitchcock.org		Martin, Kathleen/0000-0002-1748-0034	Hitchcock Foundation, Dartmouth Department of Surgery Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091013, R01HL118430, R01HL119529] Funding Source: NIH RePORTER	Hitchcock Foundation, Dartmouth Department of Surgery Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Hitchcock Foundation, Dartmouth Department of Surgery Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur J, 2006, NATURE REV, V5; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chang Z, 2010, FRONTIERS BIOSCIENCE; Ding M, 2011, ARTERIOSCLEROSIS THR, V31; Fullerton MD, 2010, DIABETES, V59, P551, DOI 10.2337/db09-1732; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; KLAR AJS, 1979, GENETICS, V93, P37; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LI XM, 1994, J BIOL CHEM, V269, P19653; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; MURRAY TR, 1990, J CELL PHYSIOL, V143, P26, DOI 10.1002/jcp.1041430105; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ruderman N, 2010, AM J PHYSL ENDOCRINO, V298; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Westphal C, 2007, TRENDS BIOCH SCI, V32; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	23	68	71	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85495	10.1371/journal.pone.0085495	http://dx.doi.org/10.1371/journal.pone.0085495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416418	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500253
J	Andresen, LC; Dungait, JAJ; Bol, R; Selsted, MB; Ambus, P; Michelsen, A				Andresen, Louise C.; Dungait, Jennifer A. J.; Bol, Roland; Selsted, Merete B.; Ambus, Per; Michelsen, Anders			Bacteria and Fungi Respond Differently to Multifactorial Climate Change in a Temperate Heathland, Traced with C-13-Glycine and FACE CO2	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; ELEVATED ATMOSPHERIC CO2; PHOSPHOLIPID FATTY-ACID; SOIL ORGANIC-MATTER; UTILIZATION PATTERNS; CARBON-DIOXIDE; NITROGEN; PLANT; MICROORGANISMS; TURNOVER	It is vital to understand responses of soil microorganisms to predicted climate changes, as these directly control soil carbon (C) dynamics. The rate of turnover of soil organic carbon is mediated by soil microorganisms whose activity may be affected by climate change. After one year of multifactorial climate change treatments, at an undisturbed temperate heathland, soil microbial community dynamics were investigated by injection of a very small concentration (5.12 mu g Cg(-1) soil) of C-13-labeled glycine (C-13(2), 99 atom %) to soils in situ. Plots were treated with elevated temperature (+1 degrees C, T), summer drought (D) and elevated atmospheric carbon dioxide (510 ppm [CO2]), as well as combined treatments (TD, TCO2, DCO2 and TDCO2). The C-13 enrichment of respired CO2 and of phospholipid fatty acids (PLFAs) was determined after 24 h. C-13-glycine incorporation into the biomarker PLFAs for specific microbial groups (Gram positive bacteria, Gram negative bacteria, actinobacteria and fungi) was quantified using gas chromatography-combustion-stable isotope ratio mass spectrometry (GC-C-IRMS). Gram positive bacteria opportunistically utilized the freshly added glycine substrate, i.e. incorporated C-13 in all treatments, whereas fungi had minor or no glycine derived C-13-enrichment, hence slowly reacting to a new substrate. The effects of elevated CO2 did suggest increased direct incorporation of glycine in microbial biomass, in particular in G(+) bacteria, in an ecosystem subjected to elevated CO2. Warming decreased the concentration of PLFAs in general. The FACE CO2 was C-13-depleted (delta C-13 = 12.2 parts per thousand) compared to ambient (delta C-13=similar to-8 parts per thousand), and this enabled observation of the integrated longer term responses of soil microorganisms to the FACE over one year. All together, the bacterial (and not fungal) utilization of glycine indicates substrate preference and resource partitioning in the microbial community, and therefore suggests a diversified response pattern to future changes in substrate availability and climatic factors.	[Andresen, Louise C.; Michelsen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Dungait, Jennifer A. J.; Bol, Roland] Rothamsted Res North Wyke, Sustainable Soils & Grassland Syst Dept, Okehampton, England; [Bol, Roland] Forschungszentrum Julich, Inst Bio & Geosci, D-52425 Julich, Germany; [Selsted, Merete B.; Ambus, Per] Tech Univ Denmark, DK-2800 Lyngby, Denmark	University of Copenhagen; Helmholtz Association; Research Center Julich; Technical University of Denmark	Andresen, LC (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	louise.andresen@gu.se	Ambus, Per L/B-2514-2015; Dungait, Jennifer/AAV-7301-2021; Dungait, Jenni/F-1110-2013; Michelsen, Anders/L-5279-2014	Ambus, Per L/0000-0001-7580-524X; Dungait, Jenni/0000-0001-9074-4174; Michelsen, Anders/0000-0002-9541-8658; Andresen, Louise C./0000-0002-4890-889X; bol, roland/0000-0003-3015-7706	Villum Kann Rasmussen Foundation; Air Liquide; DONG Energy; SMC Pneutmatic A/S; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005214] Funding Source: researchfish; BBSRC [BBS/E/C/00005214] Funding Source: UKRI	Villum Kann Rasmussen Foundation(Villum Fonden); Air Liquide; DONG Energy; SMC Pneutmatic A/S; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The CLIMAITE experiment is sponsored by the Villum Kann Rasmussen Foundation with co-funding from Air Liquide, DONG Energy and SMC Pneutmatic A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Albert KR, 2011, J EXP BOT, V62, P4253, DOI 10.1093/jxb/err133; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; Andresen LC, 2005, OECOLOGIA, V144, P585, DOI 10.1007/s00442-005-0044-1; Andresen LC, 2009, ACTA OECOL, V313, P283; Andresen LC, 2011, APPL SOIL ECOL, V51, P94, DOI 10.1016/j.apsoil.2011.09.005; Andresen LC, 2011, RAPID COMMUN MASS SP, V25, P1485, DOI 10.1002/rcm.4907; Bardgett RD, 1997, SOIL BIOL BIOCHEM, V29, P1285, DOI 10.1016/S0038-0717(97)00019-9; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Begon M., 1996, ECOLOGY; Blagodatskaya E, 2010, GLOBAL CHANGE BIOL, V16, P836, DOI 10.1111/j.1365-2486.2009.02006.x; Bol R, 2005, RAPID COMMUN MASS SP, V19, P3216, DOI 10.1002/rcm.2156; Bull ID, 2000, NATURE, V405, P175, DOI 10.1038/35012061; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Denef K, 2007, BIOGEOSCIENCES, V4, P769, DOI 10.5194/bg-4-769-2007; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Drissner D, 2007, EUR J SOIL SCI, V58, P260, DOI 10.1111/j.1365-2389.2006.00838.x; Dungait JAJ, 2011, EUR J SOIL SCI, V62, P117, DOI 10.1111/j.1365-2389.2010.01321.x; Dungait JAJ, 2013, SOIL BIOL BIOCHEM, V64, P57, DOI 10.1016/j.soilbio.2013.03.036; Dungait JAJ, 2009, ORG GEOCHEM, V40, P1210, DOI 10.1016/j.orggeochem.2009.08.001; Evershed RP, 2006, CURR OPIN BIOTECH, V17, P72, DOI 10.1016/j.copbio.2006.01.003; Feng XJ, 2010, GLOBAL CHANGE BIOL, V16, P2104, DOI 10.1111/j.1365-2486.2009.02080.x; Feng XJ, 2010, ORG GEOCHEM, V41, P573, DOI 10.1016/j.orggeochem.2010.02.013; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Glaser B, 2006, GLOBAL CHANGE BIOL, V12, P1521, DOI 10.1111/j.1365-2486.2006.01186.x; Gray SB, 2011, SOIL SCI SOC AM J, V75, P2217, DOI 10.2136/sssaj2011.0135; Guenet B, 2012, GEODERMA, V170, P331, DOI 10.1016/j.geoderma.2011.12.002; Haei M, 2011, SOIL BIOL BIOCHEM, V43, P2069, DOI 10.1016/j.soilbio.2011.06.005; Hobbie EA, 2004, PLANT SOIL, V259, P331, DOI 10.1023/B:PLSO.0000020975.75850.ca; Illeris L, 1999, ARCT ANTARCT ALP RES, V31, P264, DOI 10.2307/1552256; Ineson P, 1998, PLANT SOIL, V198, P89, DOI 10.1023/A:1004298309606; Jin VL, 2010, GLOBAL CHANGE BIOL, V16, P2334, DOI 10.1111/j.1365-2486.2010.02207.x; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lesuffleur F, 2010, PLANT SOIL, V333, P191, DOI 10.1007/s11104-010-0334-1; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; MCGILL WB, 1975, SOIL BIOL BIOCHEM, V7, P57, DOI 10.1016/0038-0717(75)90032-2; Mehring M, 2011, AGRON SUSTAIN DEV, V31, P719, DOI 10.1007/s13593-011-0013-5; Meidute S, 2008, SOIL BIOL BIOCHEM, V40, P2334, DOI 10.1016/j.soilbio.2008.05.011; Meli SM, 2003, BIOL FERT SOILS, V37, P96, DOI 10.1007/s00374-002-0570-5; Michelsen A, 2012, AMBIO, V41, P218, DOI 10.1007/s13280-012-0303-4; Mikkelsen TN, 2008, FUNCT ECOL, V22, P185, DOI 10.1111/j.1365-2435.2007.01362.x; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Paterson E, 2008, SOIL BIOL BIOCHEM, V40, P2434, DOI 10.1016/j.soilbio.2008.06.005; Paterson E, 2009, NEW PHYTOL, V184, P19, DOI 10.1111/j.1469-8137.2009.03001.x; PERETTO R, 1993, FEMS MICROBIOL LETT, V114, P85, DOI [10.1111/j.1574-6968.1993.tb06555.x, 10.1016/0378-1097(93)90146-S]; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Rinnan R, 2007, SOIL BIOL BIOCHEM, V39, P3014, DOI 10.1016/j.soilbio.2007.05.035; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rinnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056532; Rinnan R, 2009, APPL ENVIRON MICROB, V75, P3611, DOI 10.1128/AEM.02865-08; SAS Institute, 2004, SAS SYST WIND; Schmidt IK, 2000, SOIL BIOL BIOCHEM, V32, P707, DOI 10.1016/S0038-0717(99)00207-2; Selsted MB, 2012, GLOBAL CHANGE BIOL, V18, P1216, DOI 10.1111/j.1365-2486.2011.02634.x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Thornton B, 2011, RAPID COMMUN MASS SP, V25, P2433, DOI 10.1002/rcm.5148; Waldrop MP, 2004, BIOGEOCHEMISTRY, V67, P235, DOI 10.1023/B:BIOG.0000015321.51462.41; Wiesenberg GLB, 2008, ORG GEOCHEM, V39, P103, DOI 10.1016/j.orggeochem.2007.09.006; Wiesenberg GLB, 2008, ORG GEOCHEM, V39, P91, DOI 10.1016/j.orggeochem.2007.09.005; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	72	34	42	5	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85070	10.1371/journal.pone.0085070	http://dx.doi.org/10.1371/journal.pone.0085070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454793	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100053
J	Lagah, S; Tan, IL; Radhakrishnan, P; Hirst, RA; Ward, JH; O'Callaghan, C; Smith, SJ; Stevens, MFG; Grundy, RG; Rahman, R				Lagah, Sunil; Tan, I-Li; Radhakrishnan, Priya; Hirst, Robert A.; Ward, Jennifer H.; O'Callaghan, Chris; Smith, Stuart J.; Stevens, Malcolm F. G.; Grundy, Richard G.; Rahman, Ruman			RHPS4 G-Quadruplex Ligand Induces Anti-Proliferative Effects in Brain Tumor Cells	PLOS ONE			English	Article							C-MYC; TELOMERASE INHIBITION; IN-VITRO; INITIATING CELLS; CANCER; GROWTH; PROLIFERATION; METHOSULFATE; THERAPEUTICS; MAINTENANCE	Background: Telomeric 39 overhangs can fold into a four-stranded DNA structure termed G-quadruplex (G4), a formation which inhibits telomerase. As telomerase activation is crucial for telomere maintenance in most cancer cells, several classes of G4 ligands have been designed to directly disrupt telomeric structure. Methods: We exposed brain tumor cells to the G4 ligand 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl] acridinium methosulfate (RHPS4) and investigated proliferation, cell cycle dynamics, telomere length, telomerase activity and activated c-Myc levels. Results: Although all cell lines tested were sensitive to RHPS4, PFSK-1 central nervous system primitive neuroectodermal cells, DAOY medulloblastoma cells and U87 glioblastoma cells exhibited up to 30-fold increased sensitivity compared to KNS42 glioblastoma, C6 glioma and Res 196 ependymoma cells. An increased proportion of S-phase cells were observed in medulloblastoma and high grade glioma cells whilst CNS PNET cells showed an increased proportion of G1-phase cells. RHPS4-induced phenotypes were concomitant with telomerase inhibition, manifested in a telomere length-independent manner and not associated with activated c-Myc levels. However, anti-proliferative effects were also observed in normal neural/endothelial cells in vitro and ex vivo. Conclusion: This study warrants in vivo validation of RHPS4 and alternative G4 ligands as potential anti-cancer agents for brain tumors but highlights the consideration of dose-limiting tissue toxicities.	[Lagah, Sunil; Tan, I-Li; Ward, Jennifer H.; Smith, Stuart J.; Grundy, Richard G.; Rahman, Ruman] Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England; [Radhakrishnan, Priya; Hirst, Robert A.] Univ Leicester, Leicester Royal Infirm, Dept Infect Immun & Inflammat, Leicester, Leics, England; [O'Callaghan, Chris] UCL, Dept Resp Med, Portex Unit, Inst Child Hlth, London, England; [O'Callaghan, Chris] Great Ormond St Hosp Sick Children, London, England; [Stevens, Malcolm F. G.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Leicester; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Nottingham	Rahman, R (corresponding author), Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England.	ruman.rahman@nottingham.ac.uk	Hirst, Robert/AAD-1649-2022; Rahman, Ruman/FFR-5799-2022	Rahman, Ruman/0000-0002-6541-9983; Ward, Jennifer/0000-0002-3906-0858; Smith, Stuart/0000-0002-4556-2707	Joseph Foote Trust; University of Nottingham	Joseph Foote Trust; University of Nottingham	This work was funded by the Joseph Foote Trust and a Nottingham Advanced Research Fellowship from the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066242; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Castelo-Branco P, 2011, CLIN CANCER RES, V17, P111, DOI 10.1158/1078-0432.CCR-10-2075; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; De Cian A, 2007, P NATL ACAD SCI USA, V104, P17347, DOI 10.1073/pnas.0707365104; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; DOROVINIZIS K, 1991, LAB INVEST, V64, P425; Gomez D, 2002, CANCER RES, V62, P3365; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Gowan SM, 2001, MOL PHARMACOL, V60, P981, DOI 10.1124/mol.60.5.981; Grand CL, 2002, EUR J CANCER, V38, pS106; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Heald RA, 2002, J MED CHEM, V45, P590, DOI 10.1021/jm011015q; Hirst RA, 2000, PEDIATR RES, V47, P381, DOI 10.1203/00006450-200003000-00016; Horikawa I, 1999, CANCER RES, V59, P826; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Husby J, 2013, BIOPOLYMERS, V99, P989, DOI 10.1002/bip.22340; Incles CM, 2004, MOL CANCER THER, V3, P1201; Kim Julie, 2013, Frontiers in Genetics, V4, P162, DOI 10.3389/fgene.2013.00162; Lemarteleur T, 2004, BIOCHEM BIOPH RES CO, V323, P802, DOI 10.1016/j.bbrc.2004.08.150; Leonetti C, 2004, MOL PHARMACOL, V66, P1138, DOI 10.1124/mol.104.001537; Leonetti C, 2008, CLIN CANCER RES, V14, P7284, DOI 10.1158/1078-0432.CCR-08-0941; Liu JP, 2010, BBA-REV CANCER, V1805, P35, DOI 10.1016/j.bbcan.2009.09.001; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Miller S, 2011, NEURO-ONCOLOGY, V13, P866, DOI 10.1093/neuonc/nor070; Miyazaki T, 2012, CLIN CANCER RES, V18, P1268, DOI 10.1158/1078-0432.CCR-11-1795; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Ou TM, 2011, J MED CHEM, V54, P5671, DOI 10.1021/jm200062u; Patel KP, 2004, CYTOTECHNOLOGY, V45, P91, DOI 10.1007/s10616-004-5132-2; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pennarun G, 2005, ONCOGENE, V24, P2917, DOI 10.1038/sj.onc.1208468; Phatak P, 2007, BRIT J CANCER, V96, P1223, DOI 10.1038/sj.bjc.6603691; Rahman R, 2010, MOL CANCER THER, V9, P2568, DOI 10.1158/1535-7163.MCT-10-0272; Reed J, 2008, ANAL BIOCHEM, V380, P99, DOI 10.1016/j.ab.2008.05.013; Ruden M, 2013, CANCER TREAT REV, V39, P444, DOI 10.1016/j.ctrv.2012.06.007; Sagi J, 2013, J BIOMOL STRUCT 0325; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Shalaby T, 2010, MOL CANCER THER, V9, P167, DOI 10.1158/1535-7163.MCT-09-0586; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Tahara H, 2006, EJC SUPPL, V4, P189, DOI 10.1016/S1359-6349(06)70632-2; Williams HE, 2003, CLIN CANCER RES, V9, p6083S; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wu XP, 2012, BBA-MOL CELL RES, V1823, P2130, DOI 10.1016/j.bbamcr.2012.08.003; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	56	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86187	10.1371/journal.pone.0086187	http://dx.doi.org/10.1371/journal.pone.0086187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454961	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100149
J	Terao, C; Hashimoto, M; Furu, M; Nakabo, S; Ohmura, K; Nakashima, R; Imura, Y; Yukawa, N; Yoshifuji, H; Matsuda, F; Ito, H; Fujii, T; Mimori, T				Terao, Chikashi; Hashimoto, Motomu; Furu, Moritoshi; Nakabo, Shuichiro; Ohmura, Koichiro; Nakashima, Ran; Imura, Yoshitaka; Yukawa, Naoichiro; Yoshifuji, Hajime; Matsuda, Fumihiko; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo			Inverse Association between Air Pressure and Rheumatoid Arthritis Synovitis	PLOS ONE			English	Article							DISEASE-ACTIVITY INDEX; RAT MODEL; PAIN; WEATHER; SEASON; PREDICTORS; CONSENSUS; DAMAGE	Rheumatoid arthritis (RA) is a bone destructive autoimmune disease. Many patients with RA recognize fluctuations of their joint synovitis according to changes of air pressure, but the correlations between them have never been addressed in large-scale association studies. To address this point we recruited large-scale assessments of RA activity in a Japanese population, and performed an association analysis. Here, a total of 23,064 assessments of RA activity from 2,131 patients were obtained from the KURAMA (Kyoto University Rheumatoid Arthritis Management Alliance) database. Detailed correlations between air pressure and joint swelling or tenderness were analyzed separately for each of the 326 patients with more than 20 assessments to regulate intra-patient correlations. Association studies were also performed for seven consecutive days to identify the strongest correlations. Standardized multiple linear regression analysis was performed to evaluate independent influences from other meteorological factors. As a result, components of composite measures for RA disease activity revealed suggestive negative associations with air pressure. The 326 patients displayed significant negative mean correlations between air pressure and swellings or the sum of swellings and tenderness (p = 0.00068 and 0.00011, respectively). Among the seven consecutive days, the most significant mean negative correlations were observed for air pressure three days before evaluations of RA synovitis (p = 1.7 x 10(-7), 0.00027, and 8.3 x 10(-8), for swellings, tenderness and the sum of them, respectively). Standardized multiple linear regression analysis revealed these associations were independent from humidity and temperature. Our findings suggest that air pressure is inversely associated with synovitis in patients with RA.	[Terao, Chikashi; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Nakabo, Shuichiro; Ohmura, Koichiro; Nakashima, Ran; Imura, Yoshitaka; Yukawa, Naoichiro; Yoshifuji, Hajime; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	a0001101@kuhp.kyoto-u.ac.jp	Yoshifuji, Hajime/AAZ-1657-2020		Grants-in-Aid for Scientific Research [24659274] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; de Rooy DPC, 2012, ANN RHEUM DIS, V71, P2055, DOI 10.1136/annrheumdis-2012-201565; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; EDSTROM G, 1948, ANN RHEUM DIS, V7, P76, DOI 10.1136/ard.7.2.76; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Gorin AA, 1999, PAIN, V81, P173, DOI 10.1016/S0304-3959(99)00010-X; HAWLEY DJ, 1994, PAIN, V59, P227, DOI 10.1016/0304-3959(94)90075-2; HOLLANDER JL, 1963, ARCH ENVIRON HEALTH, V6, P527, DOI 10.1080/00039896.1963.10663436; Iikuni N, 2007, RHEUMATOLOGY, V46, P846, DOI 10.1093/rheumatology/kel414; Jin Y, 2008, PAIN, V135, P221, DOI 10.1016/j.pain.2007.05.020; Mouterde G, 2011, ANN RHEUM DIS, V70, P1251, DOI 10.1136/ard.2010.144402; Patberg WR, 2004, J RHEUMATOL, V31, P1327; PATBERG WR, 1985, J RHEUMATOL, V12, P711; Redelmeier DA, 1996, P NATL ACAD SCI USA, V93, P2895, DOI 10.1073/pnas.93.7.2895; Sato J, 2004, NEUROSCI LETT, V354, P46, DOI 10.1016/j.neulet.2003.09.057; Sato J, 1999, NEUROSCI LETT, V266, P21, DOI 10.1016/S0304-3940(99)00260-8; Sato J, 2000, EXP BRAIN RES, V133, P442, DOI 10.1007/s002210000451; SIBLEY JT, 1985, J RHEUMATOL, V12, P707; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; Strusberg I, 2002, J RHEUMATOL, V29, P335; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Terao C, 2012, MOD RHEUMATOL, V22, P426, DOI 10.1007/s10165-011-0535-3; van Riel PLCM, 2000, ANN RHEUM DIS, V59, P28; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177	26	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85376	10.1371/journal.pone.0085376	http://dx.doi.org/10.1371/journal.pone.0085376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454853	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100077
J	Edwards, DN; Machwe, A; Wang, ZG; Orren, DK				Edwards, Deanna N.; Machwe, Amrita; Wang, Zhigang; Orren, David K.			Intramolecular Telomeric G-Quadruplexes Dramatically Inhibit DNA Synthesis by Replicative and Translesion Polymerases, Revealing their Potential to Lead to Genetic Change	PLOS ONE			English	Article							K+ SOLUTION; SYNDROME HELICASE; REPEAT SEQUENCE; HUMAN GENOME; HUMAN-CELLS; IN-VITRO; STABILITY; TETRAPLEX; D(CGG)(N); ETA	Recent research indicates that hundreds of thousands of G-rich sequences within the human genome have the potential to form secondary structures known as G-quadruplexes. Telomeric regions, consisting of long arrays of TTAGGG/AATCCC repeats, are among the most likely areas in which these structures might form. Since G-quadruplexes assemble from certain G-rich single-stranded sequences, they might arise when duplex DNA is unwound such as during replication. Coincidentally, these bulky structures when present in the DNA template might also hinder the action of DNA polymerases. In this study, single-stranded telomeric templates with the potential to form G-quadruplexes were examined for their effects on a variety of replicative and translesion DNA polymerases from humans and lower organisms. Our results demonstrate that single-stranded templates containing four telomeric GGG runs fold into intramolecular G-quadruplex structures. These intramolecular G quadruplexes are somewhat dynamic in nature and stabilized by increasing KCl concentrations and decreasing temperatures. Furthermore, the presence of these intramolecular G-quadruplexes in the template dramatically inhibits DNA synthesis by various DNA polymerases, including the human polymerase d employed during lagging strand replication of G-rich telomeric strands and several human translesion DNA polymerases potentially recruited to sites of replication blockage. Notably, misincorporation of nucleotides is observed when certain translesion polymerases are employed on substrates containing intramolecular G-quadruplexes, as is extension of the resulting mismatched base pairs upon dynamic unfolding of this secondary structure. These findings reveal the potential for blockage of DNA replication and genetic changes related to sequences capable of forming intramolecular G-quadruplexes.	[Edwards, Deanna N.; Machwe, Amrita; Wang, Zhigang; Orren, David K.] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA; [Machwe, Amrita; Wang, Zhigang; Orren, David K.] Univ Kentucky, Markey Canc Ctr, Coll Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Orren, DK (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA.	dkorre2@uky.edu		Edwards, Deanna/0000-0001-5481-5879	National Institute on Aging [R01 AG027258]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027258] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R01 AG027258 from the National Institute on Aging to David K. Orren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; CLARK JM, 1987, J MOL BIOL, V198, P123, DOI 10.1016/0022-2836(87)90462-1; Damerla RR, 2012, CELL CYCLE, V11, P3036, DOI 10.4161/cc.21399; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Lee JY, 2005, P NATL ACAD SCI USA, V102, P18938, DOI 10.1073/pnas.0506144102; Lee MYWT, 2012, ENVIRON MOL MUTAGEN, V53, P683, DOI 10.1002/em.21743; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Maxam A M, 1980, Methods Enzymol, V65, P499; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Prakash A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/896947; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Searle MS, 2004, ORG BIOMOL CHEM, V2, P810, DOI 10.1039/b314559j; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Tang J, 2008, NUCLEIC ACIDS RES, V36, P1200, DOI 10.1093/nar/gkm1137; THIER SO, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90334-7; Vorlickova M, 2005, NUCLEIC ACIDS RES, V33, P5851, DOI 10.1093/nar/gki898; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Washington MT, 2001, J BIOL CHEM, V276, P2263, DOI 10.1074/jbc.M009049200; Weitzmann MN, 1996, J BIOL CHEM, V271, P20958, DOI 10.1074/jbc.271.34.20958; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; WOODFORD KJ, 1994, J BIOL CHEM, V269, P27029; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P7833, DOI 10.1002/anie.200903858; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhang ML, 2010, NAT STRUCT MOL BIOL, V17, P202, DOI 10.1038/nsmb.1760; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	55	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e80664	10.1371/journal.pone.0080664	http://dx.doi.org/10.1371/journal.pone.0080664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454683	gold, Green Submitted, Green Published			2022-12-27	WOS:000329925800004
J	Jimbo, R; Tovar, N; Janal, MN; Mousa, R; Marin, C; Yoo, D; Teixeira, HS; Anchieta, RB; Bonfante, EA; Konishi, A; Takeda, K; Kurihara, H; Coelho, PG				Jimbo, Ryo; Tovar, Nick; Janal, Malvin N.; Mousa, Ramy; Marin, Charles; Yoo, Daniel; Teixeira, Hellen S.; Anchieta, Rodolfo B.; Bonfante, Estevam A.; Konishi, Akihiro; Takeda, Katsuhiro; Kurihara, Hidemi; Coelho, Paulo G.			The Effect of Brain-Derived Neurotrophic Factor on Periodontal Furcation Defects	PLOS ONE			English	Article							GUIDED TISSUE REGENERATION; HYALURONIC-ACID; BEAGLE DOGS; BDNF; MAINTENANCE; EXPRESSION; NEURONS; DISEASE; GENE	This study aimed to observe the regenerative effect of brain-derived neurotrophic factor (BDNF) in a non-human primate furcation defect model. Class II furcation defects were created in the first and second molars of 8 non-human primates to simulate a clinical situation. The defect was filled with either, Group A: BDNF (500 mu g/ml) in high-molecular weight-hyaluronic acid (HMW-HA), Group B: BDNF (50 mu g/ml) in HMW-HA, Group C: HMW-HA acid only, Group D: empty defect, or Group E: BDNF (500 mu g/ml) in saline. The healing status for all groups was observed at different time-points with micro computed tomography. The animals were euthanized after 11 weeks, and the tooth-bone specimens were subjected to histologic processing. The results showed that all groups seemed to successfully regenerate the alveolar buccal bone, however, only Group A regenerated the entire periodontal tissue, i.e., alveolar bone, cementum and periodontal ligament. It is suggested that the use of BDNF in combination with a scaffold such as the hyaluronic acid in periodontal furcation defects may be an effective treatment option.	[Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Tovar, Nick; Mousa, Ramy; Yoo, Daniel; Teixeira, Hellen S.; Anchieta, Rodolfo B.; Coelho, Paulo G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Janal, Malvin N.] NYU, Dept Epidemiol & Hlth Promot, New York, NY USA; [Marin, Charles; Konishi, Akihiro] UNIGRANRIO, Dept Dent, Rio De Janeiro, Brazil; [Marin, Charles; Bonfante, Estevam A.; Konishi, Akihiro] Univ Sao Paulo, Bauru Sch Dent, Dept Prosthodont, Integrated Ctr Res, Sao Paulo, Brazil; [Takeda, Katsuhiro; Kurihara, Hidemi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Periodontal Med, Div Appl Life Sci,Minami Ku, Hiroshima, Japan	Malmo University; New York University; New York University; Universidade do Grande Rio; Universidade de Sao Paulo; Hiroshima University	Jimbo, R (corresponding author), Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.	ryo.jimbo@mah.se	Anchieta, Rodolfo Bruniera/H-2000-2011; Janal, Malvin/AAA-2036-2020; Bonfante, Estevam/F-7238-2012; Coelho, Paulo G/B-2999-2014; Anchieta, Rodolfo/M-4142-2017	Bonfante, Estevam/0000-0001-6867-8350; Coelho, Paulo G/0000-0001-8347-6124; Yoo, Doo-Yeol/0000-0003-2814-5482; Anchieta, Rodolfo/0000-0002-7920-7885	Dentsply IH	Dentsply IH	This study was funded by Dentsply IH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki T, 2005, J PERIODONTAL RES, V40, P245, DOI 10.1111/j.1600-0765.2005.00799.x; Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Gilbert GH, 2002, J PERIODONTOL, V73, P1427, DOI 10.1902/jop.2002.73.12.1427; GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x; GOTTLOW J, 1992, J CLIN PERIODONTOL, V19, P315, DOI 10.1111/j.1600-051X.1992.tb00651.x; Jepsen S, 2002, J CLIN PERIODONTOL, V29, P103, DOI 10.1034/j.1600-051X.29.s3.6.x; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kajiya M, 2009, J CELL PHYSIOL, V221, P696, DOI 10.1002/jcp.21909; KUBO T, 1995, DEV BRAIN RES, V85, P249, DOI 10.1016/0165-3806(94)00220-T; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; LINDHE J, 1982, J CLIN PERIODONTOL, V9, P115, DOI 10.1111/j.1600-051X.1982.tb01227.x; LINDHE J, 1975, Journal of Clinical Periodontology, V2, P67, DOI 10.1111/j.1600-051X.1975.tb01727.x; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MITSIADIS TA, 1995, INT J DEV BIOL, V39, P195; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Needleman I, 2002, J PERIODONTAL RES, V37, P380, DOI 10.1034/j.1600-0765.2002.01369.x; Oortgiesen DA, 2012, J TISSUE ENG REGEN M; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; PARK JB, 1995, J PERIODONTOL, V66, P462, DOI 10.1902/jop.1995.66.6.462; Pirnazar P, 1999, J PERIODONTOL, V70, P370, DOI 10.1902/jop.1999.70.4.370; PONTORIERO R, 1992, J CLIN PERIODONTOL, V19, P159, DOI 10.1111/j.1600-051X.1992.tb00632.x; Prato GPP, 2003, J PERIODONTOL, V74, P262, DOI 10.1902/jop.2003.74.2.262; Saruta J, 2010, STRESS, V13, P238, DOI 10.3109/10253890903296728; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; Takeda K, 2011, TISSUE ENG PT A, V17, P955, DOI [10.1089/ten.tea.2010.0070, 10.1089/ten.TEA.2010.0070]; Tsuboi Y, 2001, J DENT RES, V80, P881, DOI 10.1177/00220345010800030701; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7	29	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84845	10.1371/journal.pone.0084845	http://dx.doi.org/10.1371/journal.pone.0084845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454754	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800015
J	Yang, B; Xu, J; Xu, FY; Zou, Z; Ye, CY; Mei, CL; Mao, ZG				Yang, Bo; Xu, Jing; Xu, Fengying; Zou, Zui; Ye, Chaoyang; Mei, Changlin; Mao, Zhiguo			Intravascular Administration of Mannitol for Acute Kidney Injury Prevention: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACUTE-RENAL-FAILURE; CARDIOPULMONARY BYPASS; RANDOMIZED-TRIALS; HYDRATION; FUROSEMIDE; QUALITY; NEPHROTOXICITY; SALINE	Background: The effects of mannitol administration on acute kidney injury (AKI) prevention remain uncertain, as the results from clinical studies were conflicting. Due to the lack of strong evidence, the KDIGO Guideline for AKI did not propose completely evidence-based recommendations on this issue. Methods: We searched PubMed, EMBASE, clinicaltrials.gov and Cochrane Controlled Trials Register. Randomized controlled trials on adult patients at increased risk of AKI were considered on the condition that they compared the effects of intravascular administration of mannitol plus expansion of intravascular volume with expansion of intravascular volume alone. We calculated pooled risk ratios, numbers needed to treat and mean differences with 95% confidence intervals for dichotomous data and continuous data, respectively. Results: Nine trials involving 626 patients were identified. Compared with expansion of intravascular volume alone, mannitol infusion for AKI prevention in high-risk patients can not reduce the serum creatinine level (MD 1.63, 95% CI 26.02 to 9.28). Subgroup analyses demonstrated that serum creatinine level is negatively affected by the use of mannitol in patients undergoing an injection of radiocontrast agents (MD 17.90, 95% CI 8.56 to 27.24). Mannitol administration may reduce the incidence of acute renal failure or the need of dialysis in recipients of renal transplantation (RR 0.34, 95% CI 0.21 to 0.57, NNT 3.03, 95% CI 2.17 to 5.00). But similar effects were not found in patients at high AKI risk, without receiving renal transplantation (RR 0.29, 95% CI 0.01 to 6.60). Conclusions: Intravascular administration of mannitol does not convey additional beneficial effects beyond adequate hydration in the patients at increased risk of AKI. For contrast-induced nephropathy, the use of mannitol is even detrimental. Further research evaluating the efficiency of mannitol infusions in the recipients of renal allograft should be undertaken.	[Yang, Bo; Xu, Jing; Ye, Chaoyang; Mei, Changlin; Mao, Zhiguo] Second Mil Med Univ, Changzheng Hosp, Kidney Inst Chinese Peoples Liberat Army, Div Nephrol, Shanghai, Peoples R China; [Xu, Fengying; Zou, Zui] Second Mil Med Univ, Changzheng Hosp, Div Anesthesiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Mei, CL (corresponding author), Second Mil Med Univ, Changzheng Hosp, Kidney Inst Chinese Peoples Liberat Army, Div Nephrol, Shanghai, Peoples R China.	chlmei1954@126.com; maozhiguo93@gmail.com		Zou, Zui/0000-0002-8433-8388; Yang, Bo/0000-0003-0680-1469	National Nature Science Fund of China [81000281]; Chinese Society of Nephrology [13030340419]; Major Fundamental Research Program of Shanghai Committee of Science and Technology [12DJ1400300]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period [2011BAI10B00]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Society of Nephrology; Major Fundamental Research Program of Shanghai Committee of Science and Technology; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period	Zhiguo Mao is an Outstanding Young Scholar of Second Miliatory Medical University. This work was supported by the National Nature Science Fund of China (No. 81000281), the Chinese Society of Nephrology (No. 13030340419), Major Fundamental Research Program of Shanghai Committee of Science and Technology (No. 12DJ1400300), and Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period (No. 2011BAI10B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSARRAF M, 1982, CANCER TREAT REP, V66, P31; Carcoana OV, 2003, ANESTH ANALG, V97, P1222, DOI 10.1213/01.ANE.0000086727.42573.A8; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; CONGER JD, 1995, AM J KIDNEY DIS, V26, P565, DOI 10.1016/0272-6386(95)90590-1; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; GADALLAH MF, 1995, AM J MED SCI, V309, P219, DOI 10.1097/00000441-199504000-00006; Garcia GG, 2012, NEPHROL DIAL TRANSPL; Goksin I, 2011, ANN VASC SURG, V25, P1118, DOI 10.1016/j.avsg.2011.07.007; GUBERN JM, 1988, SURGERY, V103, P39; Hankiewicz J, 1967, Pol Med J, V6, P563; Harel Z, 2008, CURR OPIN NEPHROL HY, V17, P624, DOI 10.1097/MNH.0b013e32830f4590; HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J; Higgins J.P.T, 2011, BMJ, V343; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ho KM, 2010, ANAESTHESIA, V65, P283, DOI 10.1111/j.1365-2044.2009.06228.x; Ho KM, 2006, BMJ-BRIT MED J, V333, P420, DOI 10.1136/bmj.38902.605347.7C; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Karajala V, 2009, MINERVA ANESTESIOL, V75, P251; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Khoury W, 2010, J SURG RES, V160, P163, DOI 10.1016/j.jss.2008.10.016; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lee RA, 2012, AM J HEALTH-SYST PH, V69, P1961, DOI 10.2146/ajhp110624; Majumdar SR, 2009, AM J KIDNEY DIS, V54, P602, DOI 10.1053/j.ajkd.2009.03.024; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Nicholson ML, 1996, BRIT J SURG, V83, P1230, DOI 10.1002/bjs.1800830916; NISSENSON AR, 1979, WESTERN J MED, V131, P277; Santoso JT, 2003, CANCER CHEMOTH PHARM, V52, P13, DOI 10.1007/s00280-003-0620-1; Schetz Miet, 2004, Best Pract Res Clin Anaesthesiol, V18, P75, DOI 10.1016/j.bpa.2003.09.003; Schnuelle P, 2006, TRANSPL INT, V19, P947, DOI 10.1111/j.1432-2277.2006.00356.x; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Seeliger E, 2012, INVEST RADIOL, V47, P240, DOI 10.1097/RLI.0b013e31823acbaa; Smith MNA, 2008, ANAESTHESIA, V63, P701, DOI 10.1111/j.1365-2044.2007.05408.x; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Sreeram GM, 2004, J CARDIOTHOR VASC AN, V18, P548, DOI 10.1053/j.jvca.2004.07.010; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; VANVALENBERG PLJ, 1987, TRANSPLANTATION, V44, P784, DOI 10.1097/00007890-198712000-00012; Venkataraman R, 2008, CRIT CARE MED, V36, pS166, DOI 10.1097/CCM.0b013e318168c74a; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; WEIMAR W, 1983, TRANSPLANTATION, V35, P99; WEISBERG LS, 1994, KIDNEY INT, V45, P259, DOI 10.1038/ki.1994.32; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Yallop KG, 2008, ANAESTHESIA, V63, P576, DOI 10.1111/j.1365-2044.2008.05540.x	43	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85029	10.1371/journal.pone.0085029	http://dx.doi.org/10.1371/journal.pone.0085029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454783	Green Submitted, gold, Green Published			2022-12-27	WOS:000329925800020
J	Lin, CN; Sun, WSW; Lu, HY; Ng, SC; Liao, YS; Syu, WJ				Lin, Ching-Nan; Sun, Wei-Sheng W.; Lu, Hui-Yin; Ng, Swee-Chuan; Liao, Ying-Shu; Syu, Wan-Jr			Protein Interactions and Regulation of EscA in Enterohemorrhagic E. coli	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; III SECRETION SYSTEMS; PATHOGENICITY ISLAND; 2ND CHAPERONE; O157-H7; LOCUS; PATHOGENESIS; APPARATUS; SEQUENCE; ESPB	Infections caused by enterohemorrhagic Escherichia coli (EHEC) can lead to diarrhea with abdominal cramps and sometimes are complicated by severe hemolytic uremic syndrome. EHEC secretes effector proteins into host cells through a type III secretion system that is composed of proteins encoded by a chromosomal island, locus for the enterocyte effacement (LEE). EspA is the major component of the filamentous structure connecting the bacteria and the host's cells. Synthesis and secretion of EspA must be carefully controlled since the protein is prone to polymerize. CesAB, CesA2, and EscL have been identified as being able to interact with EspA. Furthermore, the intracellular level of EspA declines when cesAB, cesA2, and escL are individually deleted. Here, we report a LEE gene named l0033, which also affects the intracellular level of EspA. We renamed l0033 as escA since its counterpart in enteropathogenic E. coli has been recently described. Similar to CesAB, EscL, and CesA2, EscA interacts with EspA and enhances the protein stability of EspA. However, EscA is also able to interact with inner membrane-associated EscL, CesA2, and EscN, but not with cytoplasmic CesAB. In terms of gene organizations, escA locates in LEE3. Expression of EscA is faithfully regulated via Mpc, the first gene product of LEE3. Since Mpc is tightly regulated to low level, we suggest that EscA is highly synchronized and critical to the process of escorting EspA to its final destination.	[Lin, Ching-Nan; Lu, Hui-Yin; Ng, Swee-Chuan; Liao, Ying-Shu; Syu, Wan-Jr] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Sun, Wei-Sheng W.] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Sun, Wei-Sheng W.; Syu, Wan-Jr] Acad Sinica, Taiwan Int Grad Program Mol Med, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Syu, WJ (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	wjsyu@ym.edu.tw			Ministry of Education, Aim for the Top University Plan and Grant from the National Science Council, Republic of China ( Taiwan) [NSC101-2320-B-010-048-MY2]	Ministry of Education, Aim for the Top University Plan and Grant from the National Science Council, Republic of China ( Taiwan)	This work was supported in part by a Grant from Ministry of Education, Aim for the Top University Plan and Grant NSC101-2320-B-010-048-MY2 from the National Science Council, Republic of China ( Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Biemans-Oldehinkel E, 2011, J BACTERIOL, V193, P5514, DOI 10.1128/JB.05235-11; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Chen L, 2011, MOL CELL, V44, P734, DOI 10.1016/j.molcel.2011.09.022; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Creasey EA, 2003, MICROBIOL-SGM, V149, P3639, DOI 10.1099/mic.0.26735-0; Creasey EA, 2003, MICROBIOL-SGM, V149, P2093, DOI 10.1099/mic.0.26355-0; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Ku CP, 2009, J BIOL CHEM, V284, P1686, DOI 10.1074/jbc.M807478200; Lin CN, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-84; Neves BC, 2003, INFECT IMMUN, V71, P2130, DOI 10.1128/IAI.71.4.2130-2141.2003; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Sal-Man N, 2012, J BACTERIOL, V194, P2819, DOI 10.1128/JB.00103-12; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Su MSW, 2008, MICROBIOL-SGM, V154, P1094, DOI 10.1099/mic.0.2007/013946-0; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Yu YC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-52	31	112	114	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85354	10.1371/journal.pone.0085354	http://dx.doi.org/10.1371/journal.pone.0085354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454847	gold, Green Submitted, Green Published			2022-12-27	WOS:000329922500053
J	Nagao, M; Asai, A; Inaba, W; Kawahara, M; Shuto, Y; Kobayashi, S; Sanoyama, D; Sugihara, H; Yagihashi, S; Oikawa, S				Nagao, Mototsugu; Asai, Akira; Inaba, Wataru; Kawahara, Momoyo; Shuto, Yuki; Kobayashi, Shunsuke; Sanoyama, Daisuke; Sugihara, Hitoshi; Yagihashi, Soroku; Oikawa, Shinichi			Characterization of Pancreatic Islets in Two Selectively Bred Mouse Lines with Different Susceptibilities to High-Fat Diet-Induced Glucose Intolerance	PLOS ONE			English	Article							BETA-CELL MASS; IMPAIRED INSULIN-SECRETION; GOTO-KAKIZAKI RATS; GENE-EXPRESSION; ANIMAL-MODELS; MICE; NIDDM; BIOSYNTHESIS; PATHOGENESIS; CONTRIBUTES	Hereditary predisposition to diet-induced type 2 diabetes has not yet been fully elucidated. We recently established 2 mouse lines with different susceptibilities (resistant and prone) to high-fat diet (HFD)-induced glucose intolerance by selective breeding (designated selectively bred diet-induced glucose intolerance-resistant [SDG-R] and -prone [SDG-P], respectively). To investigate the predisposition to HFD-induced glucose intolerance in pancreatic islets, we examined the islet morphological features and functions in these novel mouse lines. Male SDG-P and SDG-R mice were fed a HFD for 5 weeks. Before and after HFD feeding, glucose tolerance was evaluated by oral glucose tolerance test (OGTT). Morphometry and functional analyses of the pancreatic islets were also performed before and after the feeding period. Before HFD feeding, SDG-P mice showed modestly higher postchallenge blood glucose levels and lower insulin increments in OGTT than SDG-R mice. Although SDG-P mice showed greater beta cell proliferation than SDG-R mice under HFD feeding, SDG-P mice developed overt glucose intolerance, whereas SDG-R mice maintained normal glucose tolerance. Regardless of whether it was before or after HFD feeding, the isolated islets from SDG-P mice showed impaired glucose-and KCl-stimulated insulin secretion relative to those from SDG-R mice; accordingly, the expression levels of the insulin secretion-related genes in SDG-P islets were significantly lower than those in SDG-R islets. These findings suggest that the innate predispositions in pancreatic islets may determine the susceptibility to diet-induced diabetes. SDG-R and SDG-P mice may therefore be useful polygenic animal models to study the gene-environment interactions in the development of type 2 diabetes.	[Nagao, Mototsugu; Asai, Akira; Kawahara, Momoyo; Shuto, Yuki; Kobayashi, Shunsuke; Sanoyama, Daisuke; Sugihara, Hitoshi; Oikawa, Shinichi] Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, Tokyo 113, Japan; [Inaba, Wataru; Yagihashi, Soroku] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori, Japan	Nippon Medical School; Hirosaki University	Oikawa, S (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, 1-1-5 Sendagi, Tokyo 113, Japan.	shinichi@nms.ac.jp	Nagao, Mototsugu/D-3473-2018	Nagao, Mototsugu/0000-0001-6880-5161; Asai, Akira/0000-0003-2557-9111	Japan Society for the Promotion of Science; Nippon Medical School; Lilly Grant Office; Japan Metabolic Syndrome Study Group	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nippon Medical School; Lilly Grant Office; Japan Metabolic Syndrome Study Group	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, a Grant-in-Aid for Medical Research from Nippon Medical School, a grant from the Lilly Grant Office, and a grant from the Japan Metabolic Syndrome Study Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Asai A, 2013, ATHEROSCLEROSIS, V231, P421, DOI 10.1016/j.atherosclerosis.2013.10.009; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Babaya N, 2010, DIABETOLOGIA, V53, P1362, DOI 10.1007/s00125-010-1737-5; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; CHEN KW, 1995, DIABETES CARE, V18, P747, DOI 10.2337/diacare.18.6.747; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Ernst SJ, 2009, ENDOCRINOLOGY, V150, P1132, DOI 10.1210/en.2008-0991; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Inaba W, 2012, EUR J PHARMACOL, V691, P297, DOI 10.1016/j.ejphar.2012.07.030; Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021; Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; KIMURA K, 1982, TOHOKU J EXP MED, V137, P453, DOI 10.1620/tjem.137.453; Koyama M, 1998, AM J PATHOL, V153, P537, DOI 10.1016/S0002-9440(10)65596-4; Koyama M, 2000, METABOLISM, V49, P347, DOI 10.1016/S0026-0495(00)90242-7; Ktorza A, 1997, DIABETES METAB, V23, P38; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Marshall JA, 2002, DIABETES CARE, V25, P620, DOI 10.2337/diacare.25.3.620; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Mizukami H, 2008, VIRCHOWS ARCH, V452, P383, DOI 10.1007/s00428-007-0508-2; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Nagao M, 2012, J DIABETES INVEST, V3, P245, DOI 10.1111/j.2040-1124.2011.00175.x; Nesher R, 1999, DIABETES, V48, P731, DOI 10.2337/diabetes.48.4.731; Noushmehr H, 2005, DIABETES, V54, P472, DOI 10.2337/diabetes.54.2.472; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; PERMUTT MA, 1984, J CLIN INVEST, V73, P1344, DOI 10.1172/JCI111337; Portha B, 2001, DIABETES, V50, pS89, DOI 10.2337/diabetes.50.2007.S89; Ritz-Laser B, 1999, ENDOCRINOLOGY, V140, P4005, DOI 10.1210/en.140.9.4005; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; SHIBATA M, 1980, TOHOKU J EXP MED, V130, P139, DOI 10.1620/tjem.130.139; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; UEDA H, 1995, DIABETOLOGIA, V38, P503, DOI 10.1007/BF00400717; Wallin T, 2010, BBA-MOL CELL BIOL L, V1801, P191, DOI 10.1016/j.bbalip.2009.11.002; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84725	10.1371/journal.pone.0084725	http://dx.doi.org/10.1371/journal.pone.0084725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454742	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500017
J	Wand, H; Iversen, J; Law, M; Maher, L				Wand, Handan; Iversen, Jenny; Law, Matthew; Maher, Lisa			Quilt Plots: A Simple Tool for the Visualisation of Large Epidemiological Data	PLOS ONE			English	Article							NEEDLE	Background: Graphical representation of data is one of the most easily comprehended forms of explanation. The current study describes a simple visualization tool which may allow greater understanding of medical and epidemiological data. Method: We propose a simple tool for visualization of data, known as a "quilt plot'', that provides an alternative to presenting large volumes of data as frequency tables. Data from the Australian Needle and Syringe Program survey are used to illustrate "quilt plots''. Conclusion: Visualization of large volumes of data using "quilt plots'' enhances interpretation of medical and epidemiological data. Such intuitive presentations are particularly useful for the rapid assessment of problems in the data which cannot be readily identified by manual review. We recommend that, where possible, "quilt plots'' be used along with traditional quantitative assessments of the data as an explanatory data analysis tool.	[Wand, Handan; Iversen, Jenny; Law, Matthew; Maher, Lisa] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Wand, H (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	hwand@kirby.unsw.edu.au		Maher, Lisa/0000-0001-6020-6519; Iversen, Jenny/0000-0002-0062-7300; Law, Matthew/0000-0002-3540-8837	Australian Government Department of Health and Ageing; ANSPS National Advisory Group; Australian collaboration of Needle and Syringe Programs; National Health and Medical Research Council Senior Research Fellowship	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); ANSPS National Advisory Group; Australian collaboration of Needle and Syringe Programs; National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Needle and Syringe Program Survey (ANSPS) is funded by the Australian Government Department of Health and Ageing and this work was supported by the ANSPS National Advisory Group and the Australian collaboration of Needle and Syringe Programs. The views expressed in this publication do not necessarily represent the position of the Australian Government. Lisa Maher is supported by a National Health and Medical Research Council Senior Research Fellowship. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrapani TK, 1998, PROFESSIONAL MARKETI, V1, P232; Cox NJ, 2008, STATA J, V8, P105, DOI 10.1177/1536867X0800800107; DONG JP, 1995, ANN STAT, V23, P1143, DOI 10.1214/aos/1176324702; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Iversen J, 2011, PREVALENCE HIV HCV I; Jarvis James N, 2007, Pediatr Rheumatol Online J, V5, P13, DOI 10.1186/1546-0096-5-13; Kirby Institute, 2011, HIV VIR HEP SEX TRAN; MacDonald M, 1997, MED J AUSTRALIA, V166, P237, DOI 10.5694/j.1326-5377.1997.tb140102.x; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P201, DOI 10.1099/00221287-17-1-201; Topp L, 2008, JAIDS-J ACQ IMM DEF, V47, P632, DOI 10.1097/QAI.0b013e31816a1d68	10	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85047	10.1371/journal.pone.0085047	http://dx.doi.org/10.1371/journal.pone.0085047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454789	Green Submitted, gold, Green Published			2022-12-27	WOS:000329922500036
J	Guilleux, A; Blanchin, M; Hardouin, JB; Sebille, V				Guilleux, Alice; Blanchin, Myriam; Hardouin, Jean-Benoit; Sebille, Veronique			Power and Sample Size Determination in the Rasch Model: Evaluation of the Robustness of a Numerical Method to Non-Normality of the Latent Trait	PLOS ONE			English	Article							ITEM RESPONSE THEORY; PATIENT-REPORTED OUTCOMES; CLASSICAL TEST THEORY; TRIALS	Patient-reported outcomes (PRO) have gained importance in clinical and epidemiological research and aim at assessing quality of life, anxiety or fatigue for instance. Item Response Theory (IRT) models are increasingly used to validate and analyse PRO. Such models relate observed variables to a latent variable (unobservable variable) which is commonly assumed to be normally distributed. A priori sample size determination is important to obtain adequately powered studies to determine clinically important changes in PRO. In previous developments, the Raschpower method has been proposed for the determination of the power of the test of group effect for the comparison of PRO in cross-sectional studies with an IRT model, the Rasch model. The objective of this work was to evaluate the robustness of this method (which assumes a normal distribution for the latent variable) to violations of distributional assumption. The statistical power of the test of group effect was estimated by the empirical rejection rate in data sets simulated using a non-normally distributed latent variable. It was compared to the power obtained with the Raschpower method. In both cases, the data were analyzed using a latent regression Rasch model including a binary covariate for group effect. For all situations, both methods gave comparable results whatever the deviations from the model assumptions. Given the results, the Raschpower method seems to be robust to the non-normality of the latent trait for determining the power of the test of group effect.	[Guilleux, Alice; Blanchin, Myriam; Hardouin, Jean-Benoit; Sebille, Veronique] Univ Nantes, SPHERE Biostat Pharmacoepidemiol & Subject Measur, F-44035 Nantes, France	Nantes Universite	Guilleux, A (corresponding author), Univ Nantes, SPHERE Biostat Pharmacoepidemiol & Subject Measur, F-44035 Nantes, France.	alice.quilleux@univ-nantes.fr	Blanchin, Myriam/D-3169-2019; Blanchin, Myriam/L-8989-2015; Hardouin, Jean-benoit/J-8225-2015; Sebille, Veronique/I-3309-2015; Sébille, Véronique/L-8761-2015	Blanchin, Myriam/0000-0003-1318-7620; Sebille, Veronique/0000-0002-0780-7742; Hardouin, Jean-Benoit/0000-0001-8664-623X	French National Research Agency [N 2010 PRSP 008 01]	French National Research Agency(French National Research Agency (ANR))	This study was supported by the French National Research Agency, under reference N 2010 PRSP 008 01.(http://www.agence-nationale-recherche.fr/programmes-de-recherche/appel-detail/programme-de-recherche-en-sante-publique-prsp-2009/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057279; Bottomley A, 2009, EUR J CANCER, V45, P347, DOI 10.1016/j.ejca.2008.09.032; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; Embretson S, 2000, MULTIVARIATE APPL BO; Fischer G.H., 1995, RASCH MODELS FDN REC, P39; Fischer G. H., 1995, RASCH MODELS FDN REC, P3; Fitzmaurice G.M., 2004, WILEY SERIES PROBABI; Hardouin JB, 2012, STAT MED, V31, P1277, DOI 10.1002/sim.4387; Joly F, 2007, ANN ONCOL, V18, P1935, DOI 10.1093/annonc/mdm121; Litiere S, 2008, STAT MED, V27, P3125, DOI 10.1002/sim.3157; Litiere S, 2010, STAT MED, V29, P2166, DOI 10.1002/sim.3908; McCulloch CE, 2011, STAT SCI, V26, P388, DOI 10.1214/11-STS361; Rasch G., 1977, DANISH YB PHILOS, V14, P58; Reeve BB, 2007, QUAL LIFE RES, V16, P1, DOI 10.1007/s11136-007-9220-6; Sapin C, 2005, J ADOLESCENT HEALTH, V36, P327, DOI 10.1016/j.jadohealth.2004.01.016; Sebille V, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-24; THISSEN D, 1982, PSYCHOMETRIKA, V47, P175, DOI 10.1007/BF02296273; Waller J, 2013, PREV MED, V56, P35, DOI 10.1016/j.ypmed.2012.10.028	19	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83652	10.1371/journal.pone.0083652	http://dx.doi.org/10.1371/journal.pone.0083652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427276	gold, Green Published, Green Submitted			2022-12-27	WOS:000329868200016
J	Zhang, QH; Lei, XH; Lu, H				Zhang, Qinghao; Lei, Xiaohong; Lu, Hong			Alterations of Epigenetic Signatures in Hepatocyte Nuclear Factor 4 alpha Deficient Mouse Liver Determined by Improved ChIP-qPCR and (h)MeDIP-qPCR Assays	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; DNA METHYLATION; TRANSCRIPTION FACTORS; HISTONE METHYLATION; MESSENGER-RNAS; IMMUNOPRECIPITATION; EXPRESSION; FACTOR-4-ALPHA; HETEROCHROMATIN; IDENTIFICATION	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a liver-enriched transcription factor essential for liver development and function. In hepatocytes, HNF4 alpha regulates a large number of genes important for nutrient/xenobiotic metabolism and cell differentiation and proliferation. Currently, little is known about the epigenetic mechanism of gene regulation by HNF4 alpha. In this study, the global and specific alterations at the selected gene loci of representative histone modifications and DNA methylations were investigated in Hnf4 alpha-deficient female mouse livers using the improved MeDIP-, hMeDIP- and ChIP-qPCR assay. Hnf4 alpha deficiency significantly increased hepatic total IPed DNA fragments for histone H3 lysine-4 dimethylation (H3K4me2), H3K4me3, H3K9me2, H3K27me3 and H3K4 acetylation, but not for H3K9me3, 5-methylcytosine, or 5-hydroxymethylcytosine. At specific gene loci, the relative enrichments of histone and DNA modifications were changed to different degree in Hnf4 alpha-deficient mouse liver. Among the epigenetic signatures investigated, changes in H3K4me3 correlated the best with mRNA expression. Additionally, Hnf4 alpha-deficient livers had increased mRNA expression of histone H1.2 and H3.3 as well as epigenetic modifiers Dnmt1, Tet3, Setd7, Kmt2c, Ehmt2, and Ezh2. In conclusion, the present study provides convenient improved (h) MeDIP- and ChIP-qPCR assays for epigenetic study. Hnf4 alpha deficiency in young-adult mouse liver markedly alters histone methylation and acetylation, with fewer effects on DNA methylation and 5-hydroxymethylation. The underlying mechanism may be the induction of epigenetic enzymes responsible for the addition/removal of the epigenetic signatures, and/or the loss of HNF4 alpha per se as a key coordinator for epigenetic modifiers.	[Zhang, Qinghao; Lei, Xiaohong; Lu, Hong] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Lu, H (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	luh@upstate.edu			National Institutes of Health (NIH) [ES019487, CA143656, CA159350]; NATIONAL CANCER INSTITUTE [R03CA159350, R03CA143656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health (NIH) grants: ES019487, CA143656, and CA159350 (http://grants.nih.gov/grants/guide/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Brebi-Mieville P, 2012, EPIGENETICS-US, V7, P106, DOI 10.4161/epi.7.1.18647; Chellappa K, 2012, BIOMARK MED, V6, P297, DOI [10.2217/BMM.12.23, 10.2217/bmm.12.23]; Choudhuri S, 2003, DRUG METAB DISPOS, V31, P1337, DOI 10.1124/dmd.31.11.1337; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Elliott GO, 2013, NUCLEIC ACIDS RES, V41, P2228, DOI 10.1093/nar/gks1451; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Hughes JF, 2002, GENOMICS, V80, P453, DOI 10.1006/geno.2002.6856; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; Imai S, 2009, MOL PHARMACOL, V75, P568, DOI 10.1124/mol.108.052589; Ishihara S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq203; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Kassner I, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-1; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liang P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-231; Lim CY, 2013, DEVELOPMENT; Lisanti S, 2012, EPIGENETICS-US, V7, P615, DOI 10.4161/epi.20028; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Lu H, 2012, EPIGENETICS-US, V7, P914, DOI 10.4161/epi.21113; Lu H, 2010, TOXICOL SCI, V118, P380, DOI 10.1093/toxsci/kfq280; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Rollini P, 1999, P NATL ACAD SCI USA, V96, P10308, DOI 10.1073/pnas.96.18.10308; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sorensen AL, 2009, METHODS MOL BIOL, V567, P249, DOI 10.1007/978-1-60327-414-2_16; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Thomas AM, 2013, PHARM RES; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Walesky C, 2013, AM J PHYSIOL-GASTR L, V304, pG26, DOI 10.1152/ajpgi.00064.2012; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710	48	15	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84925	10.1371/journal.pone.0084925	http://dx.doi.org/10.1371/journal.pone.0084925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427299	Green Published, gold			2022-12-27	WOS:000329868200039
J	Gutierrez, MAC; Vivero, RJ; Velez, ID; Porter, CH; Uribe, S				Contreras Gutierrez, Maria Angelica; Vivero, Rafael J.; Velez, Ivan D.; Porter, Charles H.; Uribe, Sandra			DNA Barcoding for the Identification of Sand Fly Species (Diptera, Psychodidae, Phlebotominae) in Colombia	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; FLIES DIPTERA; LUTZOMYIA-LONGIPALPIS; MITOCHONDRIAL PSEUDOGENES; MOLECULAR-IDENTIFICATION; CYTOCHROME-B; VECTORS; LEISHMANIASIS; EVOLUTIONARY; TAXONOMY	Sand flies include a group of insects that are of medical importance and that vary in geographic distribution, ecology, and pathogen transmission. Approximately 163 species of sand flies have been reported in Colombia. Surveillance of the presence of sand fly species and the actualization of species distribution are important for predicting risks for and monitoring the expansion of diseases which sand flies can transmit. Currently, the identification of phlebotomine sand flies is based on morphological characters. However, morphological identification requires considerable skills and taxonomic expertise. In addition, significant morphological similarity between some species, especially among females, may cause difficulties during the identification process. DNA-based approaches have become increasingly useful and promising tools for estimating sand fly diversity and for ensuring the rapid and accurate identification of species. A partial sequence of the mitochondrial cytochrome oxidase gene subunit I (COI) is currently being used to differentiate species in different animal taxa, including insects, and it is referred as a barcoding sequence. The present study explored the utility of the DNA barcode approach for the identification of phlebotomine sand flies in Colombia. We sequenced 700 bp of the COI gene from 36 species collected from different geographic localities. The COI barcode sequence divergence within a single species was <2% in most cases, whereas this divergence ranged from 9% to 26.6% among different species. These results indicated that the barcoding gene correctly discriminated among the previously morphologically identified species with an efficacy of nearly 100%. Analyses of the generated sequences indicated that the observed species groupings were consistent with the morphological identifications. In conclusion, the barcoding gene was useful for species discrimination in sand flies from Colombia.	[Contreras Gutierrez, Maria Angelica; Vivero, Rafael J.; Velez, Ivan D.] Univ Antioquia, Program Study & Control Trop Dis, Medellin, Colombia; [Porter, Charles H.] Ctr Dis Control & Prevent CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Uribe, Sandra] Univ Nacl Colombia, Mol Systemat Grp, Medellin, Colombia	Universidad de Antioquia; Centers for Disease Control & Prevention - USA; Universidad Nacional de Colombia	Gutierrez, MAC (corresponding author), Univ Antioquia, Program Study & Control Trop Dis, Medellin, Colombia.	maria.contreras@pecet-colombia.org	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; VIVERO GOMEZ, RAFAEL JOSE/0000-0001-6768-4097; Uribe Soto, Sandra Ines/0000-0002-4762-0552	Program of Study and Control of Tropical Diseases (PECET); Molecular Systematics Group; Centers for Disease Control and Prevention (CDC)	Program of Study and Control of Tropical Diseases (PECET); Molecular Systematics Group; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work received financial support from Program of Study and Control of Tropical Diseases (PECET), Molecular Systematics Group and Centers for Disease Control and Prevention (CDC) project Influence of Global Warming on Vector-borne Disease Transmission in Colombia. The funding institutions, PECET, GSM and CDC, had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Acevedo M, 2008, B DIR MALARIOL SANEA, V48, P2; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amora SSA, 2009, NEOTROP ENTOMOL, V38, P303, DOI 10.1590/S1519-566X2009000300001; Contreras MA, 2012, BIOMEDICA, V32, P263, DOI 10.1590/S0120-41572012000300014; Aransay AM, 1999, INSECT MOL BIOL, V8, P179, DOI 10.1046/j.1365-2583.1999.820179.x; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Beati L, 2004, INT J PARASITOL, V34, P225, DOI 10.1016/j.ijpara.2003.10.012; Bejarano Eduar Elias, 2006, Folia Entomologica Mexicana, V45, P47; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Besansky NJ, 2003, TRENDS PARASITOL, V19, P545, DOI 10.1016/j.pt.2003.09.015; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Carrasquilla MC, 2012, MEM I OSWALDO CRUZ, V107, P993, DOI 10.1590/S0074-02762012000800005; Casiraghi M., 2010, TOOLS IDENTIFYING BI, P269; Clare EL, 2008, J MOL EVOL, V66, P362, DOI 10.1007/s00239-008-9088-2; Cohnstaedt LW, 2011, AM J TROP MED HYG, V84, P913, DOI 10.4269/ajtmh.2011.11-0040; COMER JA, 1991, PARASSITOLOGIA, VOL 33, SUPPLEMENTO, DECEMBER 1991, P143; CROZIER RH, 1993, GENETICS, V133, P97; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; De Oliveira MT, 2005, DNA SEQUENCE, V16, P156, DOI 10.1080/10425170500039901; Depaquit J, 2000, INSECT MOL BIOL, V9, P293, DOI 10.1046/j.1365-2583.2000.00179.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Bejarano EE, 2010, MEM I OSWALDO CRUZ, V105, P322, DOI 10.1590/S0074-02762010000300014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferro C, 2011, BIOMEDICA S3, V31, P50; Ferro C, 1988, I NACL SALUD 1917 19, P219; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galati EAB, 2010, PHLEBOTOMINAE DIPTER, VI; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Herbeck JT, 2003, J MOL EVOL, V56, P691, DOI 10.1007/s00239-002-2437-7; Hodgkinson VH, 2003, AM J TROP MED HYG, V69, P386, DOI 10.4269/ajtmh.2003.69.386; Hoy M, 2006, INSECT MOL GENETICS; Hoyos R, 2012, REV COLOMB ENTOMOL, V38, P134; Ibanez-Bernal Sergio, 1999, Folia Entomologica Mexicana, V107, P61; Ishikawa EAY, 1999, MEM I OSWALDO CRUZ, V94, P339, DOI 10.1590/S0074-02761999000300010; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Vivero RJ, 2009, REV COLOMB ENTOMOL, V35, P83; Kato H, 2008, AM J TROP MED HYG, V79, P719, DOI 10.4269/ajtmh.2008.79.719; Kato H, 2007, AM J TROP MED HYG, V77, P324, DOI 10.4269/ajtmh.2007.77.324; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Kumar NP, 2012, MOL ECOL RESOUR, V12, P414, DOI 10.1111/j.1755-0998.2012.03117.x; Kuwahara K, 2009, ACTA TROP, V112, P131, DOI 10.1016/j.actatropica.2009.07.010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Marin D, 2008, MEM 35 C, P135; Martins AVWP, 1978, AM SAND FLIES DIPTER; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MEMMOTT J, 1991, MED VET ENTOMOL, V5, P403, DOI 10.1111/j.1365-2915.1991.tb00568.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; MONTOYALERMA J, 1999, INSECTOS COLOMBIA, V13, P211; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Morlais I, 2002, DNA SEQUENCE, V13, P123, DOI 10.1080/10425170290030051; Munstermann L.E., 2004, BIOL DIS VECTORS, P141; OSORNO-MESA E, 1972, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V14, P45; Polly R, 2007, FIELDS VIROLOGY, P1975; Quintero L, 2009, B MAL SALUD AMB, V52; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Leite LAR, 2012, BIOTA NEOTROP, V12, P301, DOI 10.1590/S1676-06032012000300029; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scarpassa VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037341; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Soto SIU, 2001, MOL PHYLOGENET EVOL, V18, P84, DOI 10.1006/mpev.2000.0863; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Testa JM, 2002, ACTA TROP, V84, P205, DOI 10.1016/S0001-706X(02)00187-0; Torgerson DG, 2003, AM J TROP MED HYG, V69, P484, DOI 10.4269/ajtmh.2003.69.484; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; VIVERO RAFAEL J, 2011, Acta biol.Colomb., V16, P209; Vivero RJ, 2007, BIOMEDICA, V27, P429, DOI 10.7705/biomedica.v27i3.205; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Young D.G., 1979, REV BLOODSUCKING PSY; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1; Zapata S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-144; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	86	57	59	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85496	10.1371/journal.pone.0085496	http://dx.doi.org/10.1371/journal.pone.0085496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454877	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100093
J	Lipp, AM; Juhasz, K; Paar, C; Ogris, C; Eckerstorfer, P; Thuenauer, R; Hesse, J; Nimmervoll, B; Stockinger, H; Schutz, GJ; Bodenhofer, U; Balogi, Z; Sonnleitner, A				Lipp, Anna M.; Juhasz, Kata; Paar, Christian; Ogris, Christoph; Eckerstorfer, Paul; Thuenauer, Roland; Hesse, Jan; Nimmervoll, Benedikt; Stockinger, Hannes; Schuetz, Gerhard J.; Bodenhofer, Ulrich; Balogi, Zsolt; Sonnleitner, Alois			Lck Mediates Signal Transmission from CD59 to the TCR/CD3 Pathway in Jurkat T Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; PLASMA-MEMBRANE; ANCHORED PROTEINS; LYMPHOCYTE-ACTIVATION; QUANTITATIVE-ANALYSIS; CUTTING EDGE; ZETA-CHAIN; TRANSDUCTION; RAFTS; MOLECULES	The glycosylphosphatidylinositol (GPI)-anchored molecule CD59 has been implicated in the modulation of T cell responses, but the underlying molecular mechanism of CD59 influencing T cell signaling remained unclear. Here we analyzed Jurkat T cells stimulated via anti-CD3 epsilon- or anti-CD59-coated surfaces, using time-resolved single-cell Ca2+ imaging as a read-out for stimulation. This analysis revealed a heterogeneous Ca2+ response of the cell population in a stimulus-dependent manner. Further analysis of T cell receptor (TCR)/CD3 deficient or overexpressing cells showed that CD59-mediated signaling is strongly dependent on TCR/CD3 surface expression. In protein co-patterning and fluorescence recovery after photobleaching experiments no direct physical interaction was observed between CD59 and CD3 at the plasma membrane upon anti-CD59 stimulation. However, siRNA-mediated protein knock-downs of downstream signaling molecules revealed that the Src family kinase Lck and the adaptor molecule linker of activated T cells (LAT) are essential for both signaling pathways. Furthermore, flow cytometry measurements showed that knock-down of Lck accelerates CD3 re-expression at the cell surface after anti-CD59 stimulation similar to what has been observed upon direct TCR/CD3 stimulation. Finally, physically linking Lck to CD3 xi completely abolished CD59-triggered Ca2+ signaling, while signaling was still functional upon direct TCR/CD3 stimulation. Altogether, we demonstrate that Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells, and propose that CD59 may act via Lck to modulate T cell responses.	[Lipp, Anna M.; Juhasz, Kata; Paar, Christian; Thuenauer, Roland; Hesse, Jan; Nimmervoll, Benedikt; Balogi, Zsolt; Sonnleitner, Alois] Ctr Adv Bioanal GmbH, Linz, Austria; [Ogris, Christoph; Bodenhofer, Ulrich] Johannes Kepler Univ Linz, Inst Bioinformat, Linz, Austria; [Eckerstorfer, Paul; Stockinger, Hannes] Med Univ Vienna, Mol Immunol Unit, Inst Hyg & Appl Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Schuetz, Gerhard J.] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria	Johannes Kepler University Linz; Medical University of Vienna; Technische Universitat Wien	Balogi, Z (corresponding author), Ctr Adv Bioanal GmbH, Linz, Austria.	zsolt.balogi@cbl.at; alois.sonnleitner@cbl.at	Nimmervoll, Benedikt/N-7649-2016; Ogris, Christoph/R-9248-2018; Ogris, Christoph/AAG-3120-2020; Schuetz, Gerhard/B-1243-2008; Stockinger, Hannes/E-5173-2011; Juhasz, Kata/ABB-9246-2020; Bodenhofer, Ulrich/B-7030-2008	Nimmervoll, Benedikt/0000-0003-3908-4603; Ogris, Christoph/0000-0003-3969-1585; Ogris, Christoph/0000-0003-3969-1585; Schuetz, Gerhard/0000-0003-1542-1089; Stockinger, Hannes/0000-0001-6404-4430; Bodenhofer, Ulrich/0000-0001-6859-8828; Hesse, Jan/0000-0001-9648-7316	European Regional Development Fund (EFRE); state of Upper Austria; GEN-AU Project of the Austrian Federal Ministry for Science and Research	European Regional Development Fund (EFRE)(European Commission); state of Upper Austria; GEN-AU Project of the Austrian Federal Ministry for Science and Research(Austrian Science Fund (FWF))	This work was supported by the European Regional Development Fund (EFRE), the state of Upper Austria and the GEN-AU Project of the Austrian Federal Ministry for Science and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL NGB, 1995, BIOPHYS J, V69, P1178, DOI 10.1016/S0006-3495(95)79992-1; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; Anton O, 2008, J EXP MED, V205, P3201, DOI 10.1084/jem.20080552; Arrol HP, 2008, CLIN EXP IMMUNOL, V153, P86, DOI 10.1111/j.1365-2249.2008.03677.x; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Bijlmakers MJJE, 1999, J CELL BIOL, V145, P457, DOI 10.1083/jcb.145.3.457; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; DAVIES A, 1993, IMMUNOL RES, V12, P258, DOI 10.1007/BF02918257; de Wet B, 2011, J BIOL CHEM, V286, P4072, DOI 10.1074/jbc.M110.165415; DECKERT M, 1995, EUR J IMMUNOL, V25, P1815, DOI 10.1002/eji.1830250704; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Horejsi V, 1998, IMMUNOL LETT, V63, P63, DOI 10.1016/S0165-2478(98)00054-6; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; KORTY PE, 1991, J IMMUNOL, V146, P4092; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Legembre P, 2006, J IMMUNOL, V176, P716, DOI 10.4049/jimmunol.176.2.716; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Loertscher R, 2002, TRANSPL IMMUNOL, V9, P93, DOI 10.1016/S0966-3274(02)00013-8; Longhi MP, 2005, J IMMUNOL, V175, P7098, DOI 10.4049/jimmunol.175.11.7098; Methi T, 2005, J IMMUNOL, V175, P7398, DOI 10.4049/jimmunol.175.11.7398; Methi T, 2008, EUR J IMMUNOL, V38, P2557, DOI 10.1002/eji.200737837; Millan J, 1998, EUR J IMMUNOL, V28, P3675, DOI 10.1002/(SICI)1521-4141(199811)28:11<3675::AID-IMMU3675>3.3.CO;2-X; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Paar C, 2007, EUR J CELL BIOL, V86, P253, DOI 10.1016/j.ejcb.2007.03.001; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Sivasankar B, 2009, J IMMUNOL, V182, P5203, DOI 10.4049/jimmunol.0804243; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Wang TY, 2005, J BIOL CHEM, V280, P22839, DOI 10.1074/jbc.M502920200; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Xie XH, 2012, CELL IMMUNOL, V274, P1, DOI 10.1016/j.cellimm.2012.02.013; Zimmermann L, 2010, J BIOL CHEM, V285, P6063, DOI 10.1074/jbc.M109.025981	50	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85934	10.1371/journal.pone.0085934	http://dx.doi.org/10.1371/journal.pone.0085934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454946	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100140
J	Samson, H; Fiori-Duharcourt, N; Dore-Mazars, K; Lemoine, C; Vergilino-Perez, D				Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine			Perceptual and Gaze Biases during Face Processing: Related or Not?	PLOS ONE			English	Article							VISUAL HEMISPACE BIAS; CHIMERIC FACES; SACCADIC LATENCY; ASYMMETRIES; RECOGNITION; TASK; DIFFICULTY; JUDGMENTS; PATTERNS; BEHAVIOR	Previous studies have demonstrated a left perceptual bias while looking at faces, due to the fact that observers mainly use information from the left side of a face (from the observer's point of view) to perform a judgment task. Such a bias is consistent with the right hemisphere dominance for face processing and has sometimes been linked to a left gaze bias, i.e. more and/or longer fixations on the left side of the face. Here, we recorded eye-movements, in two different experiments during a gender judgment task, using normal and chimeric faces which were presented above, below, right or left to the central fixation point or on it (central position). Participants performed the judgment task by remaining fixated on the fixation point or after executing several saccades (up to three). A left perceptual bias was not systematically found as it depended on the number of allowed saccades and face position. Moreover, the gaze bias clearly depended on the face position as the initial fixation was guided by face position and landed on the closest half-face, toward the center of gravity of the face. The analysis of the subsequent fixations revealed that observers move their eyes from one side to the other. More importantly, no apparent link between gaze and perceptual biases was found here. This implies that we do not look necessarily toward the side of the face that we use to make a gender judgment task. Despite the fact that these results may be limited by the absence of perceptual and gaze biases in some conditions, we emphasized the inter-individual differences observed in terms of perceptual bias, hinting at the importance of performing individual analysis and drawing attention to the influence of the method used to study this bias.	[Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine] Univ Paris 05, Lab Vis Act Cognit, Inst Univ Paris Descartes Psychol, Inst Psychol, Boulogne Billancourt, France; [Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine] Univ Paris 05, INC, Boulogne Billancourt, France; [Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine] Sorbonne Paris Cite, Boulogne Billancourt, France; [Dore-Mazars, Karine; Vergilino-Perez, Dorine] Inst Univ France, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Vergilino-Perez, D (corresponding author), Univ Paris 05, Lab Vis Act Cognit, Inst Univ Paris Descartes Psychol, Inst Psychol, Boulogne Billancourt, France.	dorine.vergilino-perez@parisdescartes.fr						Arizpe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031106; Armann R, 2009, ATTEN PERCEPT PSYCHO, V71, P1107, DOI 10.3758/APP.71.5.1107; Bava S, 2005, BRAIN COGNITION, V59, P1, DOI 10.1016/j.bandc.2005.03.004; Becker W., 1989, NEUROBIOLOGY SACCADI; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Brady N, 2005, BRAIN COGNITION, V58, P334, DOI 10.1016/j.bandc.2005.01.001; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P2051, DOI 10.1016/j.neuropsychologia.2010.03.026; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Butler SH, 2008, CORTEX, V44, P665, DOI 10.1016/j.cortex.2007.02.001; Butler SH, 2006, BRAIN RES, V1124, P96, DOI 10.1016/j.brainres.2006.09.069; Carbary TJ, 2002, BRAIN COGNITION, V48, P304, DOI 10.1006/brcg.2001.1367; Carbary TJ, 2001, BRAIN COGNITION, V46, P57; Coolican J, 2008, BRAIN COGNITION, V66, P176, DOI 10.1016/j.bandc.2007.07.001; Cooper TJ, 2007, NEUROPSYCHOLOGIA, V45, P2910, DOI 10.1016/j.neuropsychologia.2007.06.005; Everdell IT, 2007, PERCEPTION, V36, P1535, DOI 10.1068/p5852; GALLOIS P, 1989, REV NEUROL, V145, P661; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; GREGA DM, 1988, CORTEX, V24, P91, DOI 10.1016/S0010-9452(88)80019-4; Guo K, 2011, PSYCHOL RES; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HEYWOOD S, 1980, Q J EXP PSYCHOL, V32, P335, DOI 10.1080/14640748008401169; Hsiao JH, 2012, J VISION, V12, DOI 10.1167/12.2.22; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Iwanaga Keisuke, 2011, Rinsho Shinkeigaku, V51, P354; KAPOULA Z, 1985, VISION RES, V25, P1155, DOI 10.1016/0042-6989(85)90105-1; KAPOULA Z, 1986, VISION RES, V26, P735, DOI 10.1016/0042-6989(86)90087-8; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Leonards U, 2005, VISION RES, V45, P2677, DOI 10.1016/j.visres.2005.03.009; LEVINE SC, 1986, BRAIN COGNITION, V5, P291, DOI 10.1016/0278-2626(86)90033-3; LUH KE, 1991, BRAIN COGNITION, V16, P83, DOI 10.1016/0278-2626(91)90087-O; MATTINGLEY JB, 1994, NEUROPSYCHOLOGIA, V32, P805, DOI 10.1016/0028-3932(94)90019-1; MERTENS I, 1993, NEUROPSYCHOLOGIA, V31, P989, DOI 10.1016/0028-3932(93)90154-R; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; MORENO CR, 1990, NEUROPSYCHOLOGIA, V28, P199, DOI 10.1016/0028-3932(90)90101-S; Perez DV, 2012, NEUROPSYCHOLOGIA, V50, P2796, DOI 10.1016/j.neuropsychologia.2012.07.039; Peterson MF, 2013, PSYCHOL SCI, V24, P1216, DOI 10.1177/0956797612471684; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Phillips ML, 1997, BRAIN COGNITION, V35, P225, DOI 10.1006/brcg.1997.0939; Quinn KA, 2011, BRIT J PSYCHOL, V102, P849, DOI 10.1111/j.2044-8295.2011.02030.x; RHODES G, 1985, BRAIN COGNITION, V4, P197, DOI 10.1016/0278-2626(85)90070-3; Saether L, 2009, VISION RES, V49, P2870, DOI 10.1016/j.visres.2009.09.001; Said CP, 2011, PHILOS T R SOC B, V366, P1660, DOI 10.1098/rstb.2010.0351; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Yovel G, 2008, NEUROPSYCHOLOGIA, V46, P3061, DOI 10.1016/j.neuropsychologia.2008.06.017	58	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85746	10.1371/journal.pone.0085746	http://dx.doi.org/10.1371/journal.pone.0085746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454927	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100129
J	Toth, A; Fodor, K; Praznovszky, T; Tubak, V; Udvardy, A; Hadlaczky, G; Katona, RL				Toth, Anna; Fodor, Katalin; Praznovszky, Tuende; Tubak, Vilmos; Udvardy, Andor; Hadlaczky, Gyula; Katona, Robert L.			Novel Method to Load Multiple Genes onto a Mammalian Artificial Chromosome	PLOS ONE			English	Article							ALPHA-SATELLITE; ENGINEERED CHROMOSOMES; HUMAN MINICHROMOSOMES; CELL THERAPY; GENERATION; VECTORS; DNA; CONSTRUCTION; PROSPECTS; DELIVERY	Mammalian artificial chromosomes are natural chromosome-based vectors that may carry a vast amount of genetic material in terms of both size and number. They are reasonably stable and segregate well in both mitosis and meiosis. A platform artificial chromosome expression system (ACEs) was earlier described with multiple loading sites for a modified lambda-integrase enzyme. It has been shown that this ACEs is suitable for high-level industrial protein production and the treatment of a mouse model for a devastating human disorder, Krabbe's disease. ACEs-treated mutant mice carrying a therapeutic gene lived more than four times longer than untreated counterparts. This novel gene therapy method is called combined mammalian artificial chromosome-stem cell therapy. At present, this method suffers from the limitation that a new selection marker gene should be present for each therapeutic gene loaded onto the ACEs. Complex diseases require the cooperative action of several genes for treatment, but only a limited number of selection marker genes are available and there is also a risk of serious side-effects caused by the unwanted expression of these marker genes in mammalian cells, organs and organisms. We describe here a novel method to load multiple genes onto the ACEs by using only two selectable marker genes. These markers may be removed from the ACEs before therapeutic application. This novel technology could revolutionize gene therapeutic applications targeting the treatment of complex disorders and cancers. It could also speed up cell therapy by allowing researchers to engineer a chromosome with a predetermined set of genetic factors to differentiate adult stem cells, embryonic stem cells and induced pluripotent stem (iPS) cells into cell types of therapeutic value. It is also a suitable tool for the investigation of complex biochemical pathways in basic science by producing an ACEs with several genes from a signal transduction pathway of interest.	[Toth, Anna; Fodor, Katalin; Praznovszky, Tuende; Tubak, Vilmos; Hadlaczky, Gyula; Katona, Robert L.] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Udvardy, Andor] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Katona, RL (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	katona.robert@brc.mta.hu	Udvardy, Andor/AAA-1473-2022		Hungarian National Technology Program [TECH_09_A1-DKMACTER]	Hungarian National Technology Program	This work was supported by Hungarian National Technology Program Grant: TECH_09_A1-DKMACTER (http://www.nih.gov.hu/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzioni F, 1997, CANCER LETT, V118, P135, DOI 10.1016/S0304-3835(97)00323-6; Au HC, 1999, CYTOGENET CELL GENET, V86, P194, DOI 10.1159/000015338; Auriche C, 2001, EMBO REP, V2, P102, DOI 10.1093/embo-reports/kve018; Basu J, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-21; Basu J, 2005, TRENDS MOL MED, V11, P251, DOI 10.1016/j.molmed.2005.03.006; Basu J, 2005, NUCLEIC ACIDS RES, V33, P587, DOI 10.1093/nar/gki207; Basu J, 2006, PEDIATR CLIN N AM, V53, P843, DOI 10.1016/j.pcl.2006.08.013; Bridger JM, 2004, CYTOGENET GENOME RES, V107, P5, DOI 10.1159/000079563; Brown WRA, 2000, TRENDS BIOTECHNOL, V18, P218, DOI 10.1016/S0167-7799(00)01438-4; CARINE K, 1986, SOMAT CELL MOLEC GEN, V12, P479, DOI 10.1007/BF01539919; Carl FP, 2004, BIOPROCESSING, P61; Cooke H, 2001, Cloning Stem Cells, V3, P243, DOI 10.1089/15362300152725963; Csonka E, 2000, J CELL SCI, V113, P3207; Duncan A, 2007, CURR OPIN BIOTECH, V18, P420, DOI 10.1016/j.copbio.2007.09.004; Ehrhardt A, 2008, CURR GENE THER, V8, P147, DOI 10.2174/156652308784746440; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; Grimes BR, 2005, CHROMOSOMA, V114, P230, DOI 10.1007/s00412-005-0017-5; Grimes BR, 2002, GENE THER, V9, P713, DOI 10.1038/sj.gt.3301763; Grimes BR, 2002, MOL THER, V5, P798, DOI 10.1006/mthe.2002.0612; HADLACZKY G, 1991, P NATL ACAD SCI USA, V88, P8106, DOI 10.1073/pnas.88.18.8106; Hadlaczky G, 2001, CURR OPIN MOL THER, V3, P125; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; Henning KA, 1999, P NATL ACAD SCI USA, V96, P592, DOI 10.1073/pnas.96.2.592; Hollo G, 1996, CHROMOSOME RES, V4, P240, DOI 10.1007/BF02254965; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Ikeno M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp058; Irvine DV, 2005, TRENDS BIOTECHNOL, V23, P575, DOI 10.1016/j.tibtech.2005.10.001; Kaname T, 2005, CHROMOSOME RES, V13, P411, DOI 10.1007/s10577-005-0979-4; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Katona RL, 2008, CELL MOL LIFE SCI, V65, P3830, DOI 10.1007/s00018-008-8442-2; Katona RL, 2011, METHODS MOL BIOL, V738, P199, DOI 10.1007/978-1-61779-099-7_14; Kazuki Y, 2011, MOL THER, V19, P1591, DOI 10.1038/mt.2011.136; Kennard ML, 2009, BIOTECHNOL BIOENG, V104, P526, DOI 10.1002/bit.22407; Kennard ML, 2009, BIOTECHNOL BIOENG, V104, P540, DOI 10.1002/bit.22406; Kereso J, 1996, CHROMOSOME RES, V4, P226, DOI 10.1007/BF02254964; Kouprina N, 2003, NUCLEIC ACIDS RES, V31, P922, DOI 10.1093/nar/gkg182; Kouprina N, 2013, CELL MOL LIFE SCI, V70, P1135, DOI 10.1007/s00018-012-1113-3; Larin Z, 2002, TRENDS GENET, V18, P313, DOI 10.1016/S0168-9525(02)02679-3; Lewis MES, 2001, CLIN GENET, V59, P12, DOI 10.1034/j.1399-0004.2001.59012.1.x; LIM HN, 2003, METH MOL B, V240, P167; Lindenbaum M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh169; Lipps HJ, 2003, GENE, V304, P23, DOI 10.1016/S0378-1119(02)01215-5; Macnab S, 2009, GENE THER, V16, P1180, DOI 10.1038/gt.2009.102; Mills W, 1999, HUM MOL GENET, V8, P751, DOI 10.1093/hmg/8.5.751; Nakashima H, 2005, J CELL SCI, V118, P5885, DOI 10.1242/jcs.02702; PRAZNOVSZKY T, 1991, P NATL ACAD SCI USA, V88, P11042, DOI 10.1073/pnas.88.24.11042; Raimondi E, 2011, METHODS MOL BIOL, V738, P41, DOI 10.1007/978-1-61779-099-7_3; Ren XY, 2006, STEM CELL REV, V2, P43, DOI 10.1385/SCR:2:1:43; Saffery R, 2001, P NATL ACAD SCI USA, V98, P5705, DOI 10.1073/pnas.091468498; Seymour LW, 2009, HUM GENE THER, V20, P291, DOI 10.1089/hum.2009.1309; Shen MH, 2000, CURR BIOL, V10, P31, DOI 10.1016/S0960-9822(99)00261-4; Suzuki N, 2006, J BIOL CHEM, V281, P26615, DOI 10.1074/jbc.M603053200; Voet T, 2001, GENOME RES, V11, P124, DOI 10.1101/gr.159901; Wong LH, 2002, GENE THER, V9, P724, DOI 10.1038/sj.gt.3301756; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	57	4	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85565	10.1371/journal.pone.0085565	http://dx.doi.org/10.1371/journal.pone.0085565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454889	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100100
J	Edvardsen, E; Hem, E; Anderssen, SA				Edvardsen, Elisabeth; Hem, Erlend; Anderssen, Sigmund A.			End Criteria for Reaching Maximal Oxygen Uptake Must Be Strict and Adjusted to Sex and Age: A Cross-Sectional Study	PLOS ONE			English	Article							BLOOD LACTATE; CARDIORESPIRATORY RESPONSE; EXERCISE TESTS; MEN; PLATEAU; FITNESS; WOMEN; CONSUMPTION; LIFE; POPULATION	Objective: To describe different end criteria for reaching maximal oxygen uptake (VO2max) during a continuous graded exercise test on the treadmill, and to explore the manner by which different end criteria have an impact on the magnitude of the VO2max result. Methods: A sample of 861 individuals (390 women) aged 20-85 years performed an exercise test on a treadmill until exhaustion. Gas exchange, heart rate, blood lactate concentration and Borg Scale(6-20) rating were measured, and the impact of different end criteria on VO2max was studied;VO2 leveling off, maximal heart rate (HRmax), different levels of respiratory exchange ratio (RER), and postexercise blood lactate concentration. Results: Eight hundred and four healthy participants (93%) fulfilled the exercise test until voluntary exhaustion. There were no sex-related differences in HRmax, RER, or Borg Scale rating, whereas blood lactate concentration was 18% lower in women (P<0.001). Forty-two percent of the participants achieved a plateau in VO2; these individuals had 5% higher ventilation (P= 0.033), 4% higher RER (P<0.001), and 5% higher blood lactate concentration (P= 0.047) compared with participants who did not reach a VO2 plateau. When using RER >= 1.15 or blood lactate concentration >= 8.0 mmol center dot L-1, VO2max was 4% (P= 0.012) and 10% greater (P<0.001), respectively. A blood lactate concentration >= 8.0 mmol center dot L-1 excluded 63% of the participants in the 50-85-year-old cohort. Conclusions: A range of typical end criteria are presented in a random sample of subjects aged 20-85 years. The choice of end criteria will have an impact on the number of the participants as well as the VO2max outcome. Suggestions for new recommendations are given.	[Edvardsen, Elisabeth; Hem, Erlend; Anderssen, Sigmund A.] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Edvardsen, Elisabeth] Oslo Univ Hosp, Dept Pulm Med, Oslo, Norway	Norwegian School of Sport Sciences; University of Oslo	Edvardsen, E (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway.	elisabeth.edvardsen@nih.no						AASTRAND P, 2003, TXB WORK PHYSL; Aastrand P O, 1952, EXPT STUDIES PHYS WO; American College of Sports Medicine, 2010, ACMS GUID EX TEST PR; Armstrong RB, 1988, EXERCISE NUTR ENERGY, P9; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Astorino TA, 2005, BRIT J SPORT MED, V39, P655, DOI 10.1136/bjsm.2004.016550; ASTRAND I, 1973, J APPL PHYSIOL, V35, P649, DOI 10.1152/jappl.1973.35.5.649; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BORG G, 1987, EUR J APPL PHYSIOL O, V56, P679, DOI 10.1007/BF00424810; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Brown JD, 2002, J SPORT MED PHYS FIT, V42, P135; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Church TS, 2008, J AGING PHYS ACTIV, V16, P408, DOI 10.1123/japa.16.4.408; Davis JA, 2002, CLIN PHYSIOL FUNCT I, V22, P332, DOI 10.1046/j.1475-097X.2002.00440.x; Doherty M, 2003, EUR J APPL PHYSIOL, V89, P619, DOI 10.1007/s00421-003-0845-z; DRINKWATER BL, 1975, J GERONTOL, V30, P385, DOI 10.1093/geronj/30.4.385; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; INBAR O, 1994, MED SCI SPORT EXER, V26, P538; ISSEKUTZ B, 1962, J APPL PHYSIOL, V17, P47, DOI 10.1152/jappl.1962.17.1.47; ISSEKUTZ B, 1961, J APPL PHYSIOL, V16, P606, DOI 10.1152/jappl.1961.16.4.606; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Lacour JR, 2007, EUR J APPL PHYSIOL, V101, P241, DOI 10.1007/s00421-007-0487-7; Medbo JI, 2000, SCAND J CLIN LAB INV, V60, P367, DOI 10.1080/003655100750019279; Misquita NA, 2001, J WOMEN HEALTH GEN-B, V10, P879, DOI 10.1089/152460901753285787; MYERS J, 1990, J APPL PHYSIOL, V68, P404, DOI 10.1152/jappl.1990.68.1.404; Naughton GA, 1997, EUR J APPL PHYSIOL O, V76, P525, DOI 10.1007/s004210050285; Nelson MD, 2010, MED SCI SPORT EXER, V42, P255, DOI 10.1249/MSS.0b013e3181b0e534; Noakes TD, 1998, MED SCI SPORT EXER, V30, P1381, DOI 10.1097/00005768-199809000-00007; Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Ramos-Barbon D, 1999, CHEST, V115, P410, DOI 10.1378/chest.115.2.410; Sandoval DA, 2002, J APPL PHYSIOL, V92, P504, DOI 10.1152/japplphysiol.00526.2001; SIDNEY KH, 1977, J APPL PHYSIOL, V43, P280, DOI 10.1152/jappl.1977.43.2.280; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Weber GL, 2000, EUR J APPL PHYSIOL, V82, P255, DOI 10.1007/s004210000214; Yoon BK, 2007, MED SCI SPORT EXER, V39, P1186, DOI 10.1249/mss.0b13e318054e304	41	180	181	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85276	10.1371/journal.pone.0085276	http://dx.doi.org/10.1371/journal.pone.0085276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454832	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000329925800032
J	Zhang, JS; Zhao, J; Zhang, SH; He, CY				Zhang, Ji-Si; Zhao, Jing; Zhang, Shaohua; He, Chaoying			Efficient Gene Silencing Mediated by Tobacco Rattle Virus in an Emerging Model Plant Physalis	PLOS ONE			English	Article							INFLATED CALYX SYNDROME; MORPHOLOGICAL NOVELTY; FUNCTIONAL-ANALYSIS; CHINESE LANTERN; EVOLUTION; TOOL; BIOSYNTHESIS; RESISTANCE; MPF2	The fruit of Physalis has a berry and a novelty called inflated calyx syndrome (ICS, also named the 'Chinese lantern'). Elucidation of the underlying developmental mechanisms of fruit diversity demands an efficient gene functional inference platform. Here, we tested the application of the tobacco rattle virus (TRV)-mediated gene-silencing system in Physalis floridana. First, we characterized the putative gene of a phytoene desaturase in P. floridana (PfPDS). Infecting the leaves of the Physalis seedlings with the PfPDS-TRV vector resulted in a bleached plant, including the developing leaves, floral organs, ICS, berry, and seed. These results indicated that a local VIGS treatment can efficiently induce a systemic mutated phenotype. qRT-PCR analyses revealed that the bleaching extent correlated to the mRNA reduction of the endogenous PfPDS. Detailed comparisons of multiple infiltration and growth protocols allowed us to determine the optimal methodologies for VIGS manipulation in Physalis. We subsequently utilized this optimized VIGS methodology to downregulate the expression of two MADS-box genes, MPF2 and MPF3, and compared the resulting effects with gene-downregulation mediated by RNA interference (RNAi) methods. The VIGS-mediated gene knockdown plants were found to resemble the mutated phenotypes of floral calyx, fruiting calyx and pollen maturation of the RNAi transgenic plants for both MPF2 and MPF3. Moreover, the two MADS-box genes were appeared to have a novel role in the pedicel development in P. floridana. The major advantage of VIGS-based gene knockdown lies in practical aspects of saving time and easy manipulation as compared to the RNAi. Despite the lack of heritability and mosaic mutation phenotypes observed in some organs, the TRV-mediated gene silencing system provides an alternative efficient way to infer gene function in various developmental processes in Physalis, thus facilitating understanding of the genetic basis of the evolution and development of the morphological diversities within the Solanaceae.	[Zhang, Ji-Si; Zhao, Jing; Zhang, Shaohua; He, Chaoying] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Zhang, Ji-Si; Zhao, Jing; Zhang, Shaohua] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, CY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	chaoying@ibcas.ac.cn	zhao, jing/B-3868-2019		National Natural Science Foundation of China [31070203, 30870175]; Hundred Talent Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants (31070203, 30870175) from the National Natural Science Foundation of China ( to C.H.) and by the Hundred Talent Program of the Chinese Academy of Sciences to C.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Chung E, 2004, MOL CELLS, V17, P377; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Gould B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-6; He CY, 2007, PLANT J, V49, P935, DOI 10.1111/j.1365-313X.2006.03008.x; He CY, 2010, PLANTA, V231, P767, DOI 10.1007/s00425-009-1087-z; He CY, 2005, P NATL ACAD SCI USA, V102, P5779, DOI 10.1073/pnas.0501877102; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; HINTON WF, 1975, AM J BOT, V62, P198, DOI 10.2307/2441596; Hu JY, 2007, MOL BIOL EVOL, V24, P2443, DOI 10.1093/molbev/msm177; Khan MR, 2009, MOL BIOL EVOL, V26, P2463, DOI 10.1093/molbev/msp159; Kjemtrup S, 1998, PLANT J, V14, P91, DOI 10.1046/j.1365-313X.1998.00101.x; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lonnig WE., 2010, FLORICULTURE ORNAM B, V4, P1; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Nagamatsu A, 2007, PLANT BIOTECHNOL J, V5, P778, DOI 10.1111/j.1467-7652.2007.00288.x; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Orzaez D, 2006, PLANT PHYSIOL, V140, P3, DOI 10.1104/pp.105.068221; Price AH, 2006, TRENDS PLANT SCI, V11, P213, DOI 10.1016/j.tplants.2006.03.006; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Senthil-Kumar M, 2011, PLANT BIOTECHNOL J, V9, P797, DOI 10.1111/j.1467-7652.2011.00589.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turnage MA, 2002, PLANT J, V30, P107, DOI 10.1046/j.1365-313X.2002.01261.x; Wang L, 2012, J EXP BOT, V63, P6457, DOI 10.1093/jxb/ers299; Waterhouse PM, 2006, SCIENCE, V313, P54, DOI 10.1126/science.1130818; Wuriyanghan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066050; Zhang J, 2012, PLANTA, V236, P1247, DOI 10.1007/s00425-012-1684-0; Zhao J, 2013, PLANT CELL, V25, P2002, DOI 10.1105/tpc.113.111757	41	17	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85534	10.1371/journal.pone.0085534	http://dx.doi.org/10.1371/journal.pone.0085534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454885	gold, Green Published, Green Submitted			2022-12-27	WOS:000329925800049
J	Richmond, TK; Elliott, MN; Franzini, L; Kawachi, I; Caughy, MO; Gilliland, MJ; Walls, CE; Franklin, FA; Lowry, R; Banspach, SW; Schuster, MA				Richmond, Tracy K.; Elliott, Marc N.; Franzini, Luisa; Kawachi, Ichiro; Caughy, Margaret O.; Gilliland, M. Janice; Walls, Courtney E.; Franklin, Frank A.; Lowry, Richard; Banspach, Stephen W.; Schuster, Mark A.			School Programs and Characteristics and Their Influence on Student BMI: Findings from Healthy Passages	PLOS ONE			English	Article							OBESITY	Background: Little is known about the contribution of school contextual factors to individual student body mass index (BMI). We set out to determine if school characteristics/resources: (1) are associated with student BMI; (2) explain racial/ethnic disparities in student BMI; and (3) explain school-level differences in student BMI. Methods: Using gender-stratified multi-level modeling strategies we examined the association of school characteristics/resources and individual BMI in 4,387 5th graders in the Healthy Passages Longitudinal Study of Adolescent Health. Additionally, we examined the association of race/ethnicity and individual BMI as well as the between-school variance in BMI before and after adding individual and school characteristics to test for attenuation. Results: The school-level median household income, but not physical activity or nutrition resources, was inversely associated with female BMI (beta = 20.12, CI: -0.21,-0.02). Neither school demographics nor physical activity/nutrition resources were predictive of individual BMI in males. In Black females, school characteristics attenuated the association of race/ethnicity and BMI. Individual student characteristics-not school characteristics/resources-reduced the between-school variation in BMI in males by nearly one-third and eliminated it in females. Conclusions: In this cohort of 5th graders, school SES was inversely associated with female BMI while school characteristics and resources largely explained Black/White disparities in female weight status. Between-school differences in average student weight status were largely explained by the composition of the student body not by school characteristics or programming.	[Richmond, Tracy K.] Boston Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA; [Elliott, Marc N.] RAND Corp, Stat, Santa Monica, CA USA; [Franzini, Luisa] Univ Texas Sch Publ Hlth, Div Management Policy & Community Hlth, Blue Cross & Blue Shield Texas Res Program Paymen, Houston, TX USA; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Caughy, Margaret O.] Univ Texas Sch Publ Hlth, Dallas, TX USA; [Walls, Courtney E.] Decis Resources, Epidemiol, Burlington, MA USA; [Franklin, Frank A.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Maternal & Child Hlth, Birmingham, AL 35294 USA; [Lowry, Richard; Banspach, Stephen W.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Schuster, Mark A.] Boston Childrens Hosp, Dept Med, Boston, MA USA	Harvard University; Boston Children's Hospital; RAND Corporation; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Harvard University; Boston Children's Hospital	Richmond, TK (corresponding author), Boston Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA.	tracy.richmond@childrens.harvard.edu			Centers for Disease Control and Prevention, Prevention Research Centers [U48DP000046, U48DP000057, U48DP000056]; National Institutes of Health (NIH) [NICHD K01 HD058042]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD058042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000046, U48DP000057, U48DP000056] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, Prevention Research Centers(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Healthy Passages Study is funded by the Centers for Disease Control and Prevention, Prevention Research Centers (cooperative agreements U48DP000046, U48DP000057, and U48DP000056). Tracy Richmond is funded by the National Institutes of Health (NIH) Career Development award (NICHD K01 HD058042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fox MK, 2009, J AM DIET ASSOC, V109, pS108, DOI 10.1016/j.jada.2008.10.065; Frankenberg E, 2002, RACE AM SCH RAPIDLY; GLEASON PM, 2001, CHILDRENS DIETS MID; Johnston LD, 2007, AM J PREV MED, V33, pS195, DOI 10.1016/j.amepre.2007.07.015; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; O'Malley PM, 2009, J ADOLESCENT HEALTH, V45, pS71, DOI 10.1016/j.jadohealth.2009.04.008; Richmond TK, 2008, OBESITY, V16, P1324, DOI 10.1038/oby.2008.48; Schuster MA, 2012, NEW ENGL J MED, V367, P735, DOI 10.1056/NEJMsa1114353; StataCorp, 2011, STAT STAT SOFTW REL, P173; Story M, 2006, FUTURE CHILD, V16, P109, DOI 10.1353/foc.2006.0007; Terry-McElrath YM, 2009, J ADOLESCENT HEALTH, V45, pS45, DOI 10.1016/j.jadohealth.2009.04.007; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 2010, ARCH PEDIAT ADOL MED, V164, P1167, DOI 10.1001/archpediatrics.2010.218; Windle M, 2004, AM J PREV MED, V27, P164, DOI 10.1016/j.amepre.2004.04.007	14	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83254	10.1371/journal.pone.0083254	http://dx.doi.org/10.1371/journal.pone.0083254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454697	Green Published, gold			2022-12-27	WOS:000329922500005
J	Turoczi, Z; Aranyi, P; Lukats, A; Garbaisz, D; Lotz, G; Harsanyi, L; Szijarto, A				Turoczi, Zsolt; Aranyi, Peter; Lukats, Akos; Garbaisz, David; Lotz, Gabor; Harsanyi, Laszlo; Szijarto, Attila			Muscle Fiber Viability, a Novel Method for the Fast Detection of Ischemic Muscle Injury in Rats	PLOS ONE			English	Article							ACUTE LIMB ISCHEMIA; SKELETAL-MUSCLE; REPERFUSION INJURY; FROZEN-SECTION; TISSUE; METABOLISM; PROTECTION; MANAGEMENT; DIAGNOSIS; OXIDASE	Acute lower extremity ischemia is a limb- and life-threatening clinical problem. Rapid detection of the degree of injury is crucial, however at present there are no exact diagnostic tests available to achieve this purpose. Our goal was to examine a novel technique -which has the potential to accurately assess the degree of ischemic muscle injury within a short period of time - in a clinically relevant rodent model. Male Wistar rats were exposed to 4, 6, 8 and 9 hours of bilateral lower limb ischemia induced by the occlusion of the infrarenal aorta. Additional animals underwent 8 and 9 hours of ischemia followed by 2 hours of reperfusion to examine the effects of revascularization. Muscle samples were collected from the left anterior tibial muscle for viability assessment. The degree of muscle damage (muscle fiber viability) was assessed by morphometric evaluation of NADH-tetrazolium reductase reaction on frozen sections. Right hind limbs were perfusion-fixed with paraformaldehyde and glutaraldehyde for light and electron microscopic examinations. Muscle fiber viability decreased progressively over the time of ischemia, with significant differences found between the consecutive times. High correlation was detected between the length of ischemia and the values of muscle fiber viability. After reperfusion, viability showed significant reduction in the 8-hour-ischemia and 2-hour-reperfusion group compared to the 8-hour-ischemia-only group, and decreased further after 9 hours of ischemia and 2 hours of reperfusion. Light- and electron microscopic findings correlated strongly with the values of muscle fiber viability: lesser viability values represented higher degree of ultrastructural injury while similar viability results corresponded to similar morphological injury. Muscle fiber viability was capable of accurately determining the degree of muscle injury in our rat model. Our method might therefore be useful in clinical settings in the diagnostics of acute ischemic muscle injury.	[Turoczi, Zsolt; Aranyi, Peter; Garbaisz, David; Harsanyi, Laszlo; Szijarto, Attila] Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary; [Lukats, Akos] Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary; [Lotz, Gabor] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University	Turoczi, Z (corresponding author), Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary.	zsturoczi@gmail.com	David, Garbaisz/C-8022-2014	David, Garbaisz/0000-0001-8047-3665; Lukats, Akos/0000-0003-3468-2866				BARIE PS, 1988, J SURG RES, V44, P284, DOI 10.1016/0022-4804(88)90059-5; BELKIN M, 1988, AM J SURG, V156, P83, DOI 10.1016/S0002-9610(88)80360-X; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; BLEBEA J, 1987, J SURG RES, V43, P311, DOI 10.1016/0022-4804(87)90087-4; Brandao ML, 2003, J SURG RES, V110, P235, DOI 10.1016/S0022-4804(02)00093-8; BRYANT RE, 1958, CIRC RES, V6, P699, DOI 10.1161/01.RES.6.6.699; Cahoon NJ, 2013, PLAST RECONSTR SURG, V131, P473, DOI 10.1097/PRS.0b013e31827c6e0b; Carmo-Araujo EM, 2007, INT J EXP PATHOL, V88, P147, DOI 10.1111/j.1365-2613.2007.00526.x; Chan RK, 2004, J SURG RES, V122, P54, DOI 10.1016/j.jss.2004.05.003; Ciena AP, 2011, MICRON, V42, P871, DOI 10.1016/j.micron.2011.06.003; COLBURN MD, 1992, J SURG RES, V52, P309, DOI 10.1016/0022-4804(92)90108-C; Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054; FARBER JL, 1981, AM J PATHOL, V102, P271; Gillani S, 2012, INJURY, V43, P670, DOI 10.1016/j.injury.2011.03.008; Gyurkovics E, 2011, J SURG RES, V169, P139, DOI 10.1016/j.jss.2009.10.014; HARRIS K, 1986, AM J PHYSIOL, V250, pH213, DOI 10.1152/ajpheart.1986.250.2.H213; Heatley MK, 2012, INT J GYNECOL PATHOL, V31, P111, DOI 10.1097/PGP.0b013e318226043b; Henke PK, 2009, SEMIN VASC SURG, V22, P34, DOI 10.1053/j.semvascsurg.2009.01.002; Herbert KJ, 2001, EUR J PHARMACOL, V424, P59, DOI 10.1016/S0014-2999(01)01133-5; HICKEY MJ, 1992, J SURG RES, V53, P369, DOI 10.1016/0022-4804(92)90063-6; Homer-Vanniasinkam S, 2001, EUR J VASC ENDOVASC, V22, P523, DOI 10.1053/ejvs.2001.1467; IDSTROM JP, 1990, AM J PHYSIOL, V258, pH1668, DOI 10.1152/ajpheart.1990.258.6.H1668; JANDA J, 1974, PHYSIOL BOHEMOSLOV, V23, P521; JENNINGS RB, 1975, AM J PATHOL, V81, P179; JENNINGS RB, 1969, AM J CARDIOL, V24, P753, DOI 10.1016/0002-9149(69)90464-0; JENNISCHE E, 1985, ACTA PHYSIOL SCAND, V125, P727, DOI 10.1111/j.1748-1716.1985.tb07776.x; KARPATI G, 1974, J NEUROL SCI, V23, P129, DOI 10.1016/0022-510X(74)90148-8; KLEIN HH, 1981, VIRCHOWS ARCH A, V393, P287, DOI 10.1007/BF00430828; Knight KR, 1997, EUR J PHARMACOL, V332, P273, DOI 10.1016/S0014-2999(97)01101-1; LINDSAY TF, 1990, J VASC SURG, V12, P8, DOI 10.1067/mva.1990.19946; MALAN E, 1963, J CARDIOVASC SURG, V4, P212; McAllister SE, 2008, AM J PHYSIOL-REG I, V295, pR681, DOI 10.1152/ajpregu.90303.2008; Merrick MA, 1999, MED SCI SPORT EXER, V31, P1516, DOI 10.1097/00005768-199911000-00004; Miedema JR, 2010, J GASTROINTEST LIVER, V19, P181; MOORE DH, 1956, J BIOPHYS BIOCHEM CY, V2, P755, DOI 10.1083/jcb.2.6.755; Nanobashvili J, 2003, SURGERY, V133, P91, DOI 10.1067/msy.2003.65; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; NOVIKOFF AB, 1961, J BIOPHYS BIOCHEM CY, V9, P47, DOI 10.1083/jcb.9.1.47; Pemberton M, 1999, EUR J VASC ENDOVASC, V17, P72, DOI 10.1053/ejvs.1998.0709; PETRASEK PF, 1994, J VASC SURG, V19, P623, DOI 10.1016/S0741-5214(94)70035-4; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Rutherford RB, 2009, SEMIN VASC SURG, V22, P5, DOI 10.1053/j.semvascsurg.2008.12.003; SCHAPER W, 1979, BASIC RES CARDIOL, V74, P46, DOI 10.1007/BF01907684; Schmidt RL, 2011, AM J CLIN PATHOL, V136, P729, DOI 10.1309/AJCP2SD8RFQEUZJW; SEIFERT FC, 1985, J CARDIOVASC SURG, V26, P502; Troitzsch D, 2013, SHOCK, V39, P220, DOI 10.1097/SHK.0b013e31828044f6; Troitzsch D, 2011, J SURG RES, V169, P156, DOI 10.1016/j.jss.2009.08.017; Tsubota H, 2010, EUR J VASC ENDOVASC, V40, P804, DOI 10.1016/j.ejvs.2010.08.014; WACHSTEIN M, 1955, AM J PATHOL, V31, P353; Walters TJ, 2011, J TRAUMA, V70, P1192, DOI 10.1097/TA.0b013e318217879a; Wang JX, 2005, ACTA PHARMACOL SIN, V26, P821, DOI 10.1111/j.1745-7254.2005.00128.x; Wang WZ, 2011, PLAST RECONSTR SURG, V128, p685E, DOI 10.1097/PRS.0b013e318230c57b; Woitaske MD, 1998, PLAST RECONSTR SURG, V102, P2052, DOI 10.1097/00006534-199811000-00037	53	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84783	10.1371/journal.pone.0084783	http://dx.doi.org/10.1371/journal.pone.0084783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454750	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500021
J	Wei, B; Zhang, RZ; Guo, JJ; Liu, DM; Li, AL; Fan, RC; Mao, L; Zhang, XQ				Wei, Bo; Zhang, Rong-Zhi; Guo, Juan-Juan; Liu, Dan-Mei; Li, Ai-Li; Fan, Ren-Chun; Mao, Long; Zhang, Xiang-Qi			Genome-Wide Analysis of the MADS-Box Gene Family in Brachypodium distachyon	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; ENDOSPERM DEVELOPMENT; DOMAIN PROTEIN; EVOLUTIONARY ANALYSIS; TRANSCRIPTION FACTORS; CENTRAL CELL; ARABIDOPSIS; RICE; DUPLICATION; DIVERGENCE	MADS-box genes are important transcription factors for plant development, especially floral organogenesis. Brachypodium distachyon is a model for biofuel plants and temperate grasses such as wheat and barley, but a comprehensive analysis of MADS-box family proteins in Brachypodium is still missing. We report here a genome-wide analysis of the MADS-box gene family in Brachypodium distachyon. We identified 57 MADS-box genes and classified them into 32 MIKCc-type, 7 MIKC*-type, 9 M alpha, 7 M beta and 2 M gamma MADS-box genes according to their phylogenetic relationships to the Arabidopsis and rice MADS-box genes. Detailed gene structure and motif distribution were then studied. Investigation of their chromosomal localizations revealed that Brachypodium MADS-box genes distributed evenly across five chromosomes. In addition, five pairs of type II MADS-box genes were found on synteny blocks derived from whole genome duplication blocks. We then performed a systematic expression analysis of Brachypodium MADS-box genes in various tissues, particular floral organs. Further detection under salt, drought, and low-temperature conditions showed that some MADS-box genes may also be involved in abiotic stress responses, including type I genes. Comparative studies of MADS-box genes among Brachypodium, rice and Arabidopsis showed that Brachypodium had fewer gene duplication events. Taken together, this work provides useful data for further functional studies of MADS-box genes in Brachypodium distachyon.	[Wei, Bo; Fan, Ren-Chun; Zhang, Xiang-Qi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Zhang, Rong-Zhi; Guo, Juan-Juan; Liu, Dan-Mei; Li, Ai-Li; Mao, Long] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhang, Rong-Zhi; Guo, Juan-Juan; Liu, Dan-Mei; Li, Ai-Li; Mao, Long] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Mao, L (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	maolong@caas.net.cn; xqzhang@genetics.ac.cn	GUO, JUAN/HIK-2220-2022		National Key Technology R D Program [2011BAD07B00]; National Natural Science Foundation of China [31101141]; National High Tech Program [2012AA100108]; National Science Foundation of China [31070260]	National Key Technology R D Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by National Key Technology R & D Program (2011BAD07B00), National Natural Science Foundation of China (31101141), National High Tech Program (2012AA100108) and National Science Foundation of China (31070260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2009, PLANT PHYSIOL, V149, P1713, DOI 10.1104/pp.109.135806; Airoldi CA, 2012, J GENET GENOMICS, V39, P157, DOI 10.1016/j.jgg.2012.02.008; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Angenent GC, 1996, TRENDS PLANT SCI, V1, P228; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bemer M, 2008, PLANT CELL, V20, P2088, DOI 10.1105/tpc.108.058958; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; Burland T. G., 1999, BIOINFORMATICS METHO; Causier B, 2002, SCIENCE, V296, P275, DOI 10.1126/science.1071401; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Eckardt N.A, 2008, PLANT CELL, V20, P3, DOI [10.1105/tpc.108.058586, DOI 10.1105/TPC.108.058586]; Fan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062288; FISCHER A, 1995, NUCLEIC ACIDS RES, V23, P1901, DOI 10.1093/nar/23.11.1901; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo X. Y., 2004, RICE SINENCE, V12, P173; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kang IH, 2008, PLANT CELL, V20, P635, DOI 10.1105/tpc.107.055137; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kramer EM, 1998, GENETICS, V149, P765; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee HL, 2011, MOL BIOL EVOL, V28, P3367, DOI 10.1093/molbev/msr169; Lee JH, 2012, PLANT SCI, V185, P97, DOI 10.1016/j.plantsci.2011.09.003; Lee S, 2008, PLANT J, V54, P93, DOI 10.1111/j.1365-313X.2008.03406.x; Leseberg CH, 2006, GENE, V378, P84, DOI 10.1016/j.gene.2006.05.022; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu C, 2013, DEV CELL, V24, P612, DOI 10.1016/j.devcel.2013.02.013; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nayar S, 2013, J EXP BOT, V64, P4239, DOI 10.1093/jxb/ert231; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang XC, 2012, PLANT PHYSIOL, V160, P788, DOI 10.1104/pp.112.200980; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiwari S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-72; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wei B, 2013, J PLANT PHYSIOL, V170, P424, DOI 10.1016/j.jplph.2012.11.013; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xiao H, 2003, PLANT MOL BIOL, V52, P957, DOI 10.1023/A:1025401611354; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yao SG, 2008, PLANT CELL PHYSIOL, V49, P853, DOI 10.1093/pcp/pcn050; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhao T, 2006, MOL GENET GENOMICS, V276, P334, DOI 10.1007/s00438-006-0147-3	79	63	76	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84781	10.1371/journal.pone.0084781	http://dx.doi.org/10.1371/journal.pone.0084781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454749	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500020
J	Amendah, DD; Buigut, S; Mohamed, S				Amendah, Djesika D.; Buigut, Steven; Mohamed, Shukri			Coping Strategies among Urban Poor: Evidence from Nairobi, Kenya	PLOS ONE			English	Article								Aims: In Kenya, it is estimated that 60 to 80% of urban residents live in slum or slum-like conditions. This study investigates expenditures patterns of slum dwellers in Nairobi, their coping strategies and the determinants of those coping strategies. Method: We use a dataset from the Indicator Development for Surveillance of Urban Emergencies (IDSUE) research study conducted in four Nairobi slums from April 2012 to September 2012. The dataset includes information related to household livelihoods, earned incomes of household members, expenditures, shocks, and coping strategies. Results: Food spending is the single most important component, accounting for 52% of total households' income and 42% of total expenditures. Households report a variety of coping strategies over the last four weeks preceding the interview. The most frequently used strategy is related to reduction in food consumption, followed by the use of credit, with 69% and 52% of households reporting using these strategies respectively. A substantial proportion of households also report removing children from school to manage spending shortfalls. Formal employment, owning a business, rent-free housing, belonging to the two top tiers of income brackets, and being a member of social safety net reduced the likelihood of using any coping strategy. Exposure to shocks and larger number of children under 15 years increased the probability of using a coping strategy. Policy Implications: Policies that contain food price inflation, improve decent-paying job opportunities for the urban poor are likely to reduce the use of negative coping strategies by providing urban slum dwellers with steady and reliable sources of income. In addition, enhancing access to free primary schooling in the slums would help limit the need to use detrimental strategies like "removing" children from school.	[Amendah, Djesika D.; Mohamed, Shukri] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Buigut, Steven] Amer Univ Dubai, Dept Accounting Finance & Econ, Dubai, U Arab Emirates	African Population & Health Research Centre; American University in Dubai (AUD)	Amendah, DD (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.	damendah@aphrc.org	Buigut, Steven/ABA-3423-2021; Mohamed, Shukri F/R-1769-2019	Mohamed, Shukri F/0000-0002-8693-1943; Buigut, Steven/0000-0003-0178-5076	Office of Foreign Disaster Assistance, US Agency for International Development	Office of Foreign Disaster Assistance, US Agency for International Development(United States Agency for International Development (USAID))	This work was made possible through the generous support of the American people through the Office of Foreign Disaster Assistance, US Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; Aguiar M, 2005, J POLIT ECON, V113, P919, DOI 10.1086/491590; Alem Y, 2010, CSAE WORKING PAPER S; APHRC (African Population and Health Research Centre), 2002, POP HLTH DYN NAIR IN; Browning M, 1996, J ECON LIT, V34, P1797; Cameron LA, 2001, B INDONES ECON STUD, V37, P43, DOI 10.1080/000749101300046492; Candiracci S, 2007, UN HABITAT KENYA SLU; Christiaensen L, 2004, UNDERSTANDING HOUSEH, P1; Dercon S., 2002, WIDER DISCUSSION PAP; Elung'ata P., 2013, SHARED TOILETS NAIRO; Emina J, 2011, J URBAN HEALTH, V88, P200, DOI 10.1007/s11524-011-9594-1; Faye O, 2011, J URBAN HLTH B NEW Y, V88; Fotso JC, 2008, J URBAN HEALTH, V85, P428, DOI 10.1007/s11524-008-9263-1; Gunther I, 2009, WORLD DEV, V37, P1222, DOI 10.1016/j.worlddev.2008.11.006; Kenya National Bureau of Statistics, 2007, BAS REP WELL KEN BAS; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; KNBS (Kenya National Bureau of Statistics), 2012, EC SURV 2012; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Mberu B, 2011, 6 AFR POP C OUAG BUR; Oketch M, 2010, DEV PRACT, V20, P603, DOI 10.1080/09614521003763095; Skoufias E., 2005, EUR J DEV RES, V17, P24, DOI [10.1080/09578810500066498, DOI 10.1080/09578810500066498]; United Nations, WORLD POP PROSP 2010; World Bank, 2006, KEN INS INF POV JOBS; World Bank Poverty Reduction and Economic Management Unit Africa Region, 2008, KEN POV IN ASS 44190; Zimmerman CC, 1932, Q J ECON, V47, P78, DOI 10.2307/1885186; Ziraba Abdhalah Kasiira, 2009, Reprod Health, V6, P6, DOI 10.1186/1742-4755-6-6	26	37	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83428	10.1371/journal.pone.0083428	http://dx.doi.org/10.1371/journal.pone.0083428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427272	Green Published, gold			2022-12-27	WOS:000329868200012
J	Patelis, A; Gunnbjornsdottir, M; Borres, MP; Burney, P; Gislason, T; Toren, K; Forsberg, B; Alving, K; Malinovschi, A; Janson, C				Patelis, Antonios; Gunnbjornsdottir, Maria; Borres, Magnus P.; Burney, Peter; Gislason, Thorarinn; Toren, Kjell; Forsberg, Bertil; Alving, Kjell; Malinovschi, Andrei; Janson, Christer			Natural History of Perceived Food Hypersensitivity and IgE Sensitisation to Food Allergens in a Cohort of Adults	PLOS ONE			English	Article							RESPIRATORY-HEALTH-SURVEY; SKIN-TEST REACTIVITY; HOUSE-DUST MITE; SERUM IGE; CHILDHOOD ASTHMA; IMMUNOGLOBULIN-E; NITRIC-OXIDE; PREVALENCE; POPULATION; CHILDREN	Background: No longitudinal studies exist on the natural history of food hypersensitivity and IgE sensitisation to food allergens in adults. Objective: To examine the natural history of food hypersensitivity, the natural history of IgE sensitisation to food allergens and to investigate the risk factors for new onset food hypersensitivity. Methods: Food hypersensitivity was questionnaire-assessed in 2307 individuals (aged 20-45 years) from Iceland and Sweden during the European Community Respiratory Health Survey both at baseline and follow-up 9 years later. IgE food and aeroallergen sensitisation were assessed in a subgroup of these individuals (n = 807). Values of 0.35 kU/L and above were regarded as positive sensitisation. Results: Food hypersensitivity was reported by 21% of the subjects and this proportion remained unchanged at follow-up (p = 0.58). Fruits, nuts and vegetables were the three most common causes of food hypersensitivity, with a similar prevalence at baseline and follow-up. The prevalence IgE sensitisation to food allergens decreased in general by 56% (p < 0.001) and IgE sensitisation to peanut decreased in particular by 67% (p = 0.003). The prevalence of timothy grass IgE sensitisation decreased by 15% (p = 0.003) while cat, mite and birch IgE sensitisation did not decrease significantly. Female sex, rhinitis, eczema and presence of IgE sensitisation to aeroallergens were independently associated with new onset food hypersensitivity. Conclusion: The prevalence of food hypersensitivity remained unchanged while the prevalence of IgE sensitisation to food allergens decreased in adults over a 9-year follow-up period. The decrease in prevalence of IgE sensitisation to food allergens was considerably larger than the change in prevalence of IgE sensitisation to aeroallergens.	[Patelis, Antonios; Gunnbjornsdottir, Maria; Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Borres, Magnus P.] Thermo Fischer Sci, Immunodiagnost, Uppsala, Sweden; [Gislason, Thorarinn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Gislason, Thorarinn] Landspitali Univ Hosp, Dept Resp Med & Sleep, Reykjavik, Iceland; [Toren, Kjell] Univ Gothenburg, Inst Med, Sect Occupat & Environm Med, Gothenburg, Sweden; [Forsberg, Bertil] Umea Univ, Div Occupat & Environm Med, Umea, Sweden; [Borres, Magnus P.; Alving, Kjell] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Burney, Peter] Univ London Imperial Coll Sci Technol & Med, London, England; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden	Uppsala University; University of Iceland; Landspitali National University Hospital; University of Gothenburg; Umea University; Uppsala University; Imperial College London; Uppsala University	Patelis, A (corresponding author), Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden.	antonios.patelis@medsci.uu.se	; Alving, Kjell/M-4579-2014	Burney, Peter/0000-0001-8635-5678; Patelis, Antonios/0000-0001-7837-1862; Alving, Kjell/0000-0003-0784-0443	Swedish Heart and Lung Foundation; Vardal Foundation for Health Care Science and Allergy Research; Swedish Association against Asthma and Allergy; Agnes and Mac Rudberg's Foundation; Bror Hjerpstedt Foundation	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vardal Foundation for Health Care Science and Allergy Research; Swedish Association against Asthma and Allergy; Agnes and Mac Rudberg's Foundation; Bror Hjerpstedt Foundation	This study was supported financially by the Swedish Heart and Lung Foundation, the Vardal Foundation for Health Care Science and Allergy Research, the Swedish Association against Asthma and Allergy, Agnes and Mac Rudberg's Foundation and the Bror Hjerpstedt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DR, 1996, J ALLERGY CLIN IMMUN, V97, P1247, DOI 10.1016/S0091-6749(96)70192-6; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P919, DOI 10.1016/0091-6749(87)90241-7; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P16, DOI 10.1016/S0091-6749(87)80010-6; Bjornsson E, 1996, ANN ALLERG ASTHMA IM, V77, P327; BOUSQUET J, 1990, J ALLERGY CLIN IMMUN, V85, P1039, DOI 10.1016/0091-6749(90)90048-9; Broadfield E, 2002, J ALLERGY CLIN IMMUN, V109, P969, DOI 10.1067/mai.2002.124772; Burney P, 2010, ALLERGY, V65, P1182, DOI 10.1111/j.1398-9995.2010.02346.x; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Carsin AE, 2013, INT ARCH ALLERGY IMM, V160, P387, DOI 10.1159/000342464; Eggesbo M, 1999, PEDIATR ALLERGY IMMU, V10, P122, DOI 10.1034/j.1399-3038.1999.00022.x; European Community Respiratory Health Survey IISC, 2002, EUR RESP J, V20, P1071; Gislason D, 1999, ALLERGY, V54, P1160, DOI 10.1034/j.1398-9995.1999.00093.x; Hughes JL, 2010, PEDIAT ALLERG IMM-UK, V21, P1107, DOI 10.1111/j.1399-3038.2010.01071.x; Jackola DR, 2004, HUM IMMUNOL, V65, P20, DOI 10.1016/j.humimm.2003.10.012; Jarvis D, 2005, J ALLERGY CLIN IMMUN, V116, P675, DOI 10.1016/j.jaci.2005.05.009; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Karakaya G, 2006, Allergol Immunopathol (Madr), V34, P257; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Linneberg A, 2002, CLIN EXP ALLERGY, V32, P1702, DOI 10.1046/j.1365-2222.2002.01537.x; Linneberg A, 2010, INT ARCH ALLERGY IMM, V151, P142, DOI 10.1159/000236004; Linneberg A, 2000, J ALLERGY CLIN IMMUN, V106, P247, DOI 10.1067/mai.2000.108312; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Malinovschi A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-92; Olafsdottir IS, 2005, THORAX, V60, P451, DOI 10.1136/thx.2004.035774; ORYSZCZYN MP, 1995, AM J RESP CRIT CARE, V151, P663; Paganelli R, 1998, ALLERGY, V53, P763; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; Ramesh S, 2008, CLIN REV ALLERG IMMU, V34, P217, DOI 10.1007/s12016-007-8034-1; RAWLE FC, 1983, CLIN ALLERGY, V13, P409, DOI 10.1111/j.1365-2222.1983.tb02616.x; Sampson HA, 1996, PEDIAT ALLERG IMM-UK, V7, P42, DOI 10.1111/j.1399-3038.1996.tb00394.x; Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; Sherrill DL, 1999, J ALLERGY CLIN IMMUN, V104, P28, DOI 10.1016/S0091-6749(99)70110-7; Sicherer SH, 2013, J ALLERGY CLIN IMMUN, V131, P55, DOI 10.1016/j.jaci.2012.11.007; Skypala I, 2011, J AM DIET ASSOC, V111, P1877, DOI 10.1016/j.jada.2011.09.001; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; TAYLOR SL, 1986, J AM DIET ASSOC, V86, P599; Warm K, 2012, J ALLERGY CLIN IMMUN, V129, P136, DOI 10.1016/j.jaci.2011.08.033; Woods RK, 2001, EUR J CLIN NUTR, V55, P298, DOI 10.1038/sj.ejcn.1601159; YOUNG E, 1994, LANCET, V343, P1127, DOI 10.1016/S0140-6736(94)90234-8	41	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85333	10.1371/journal.pone.0085333	http://dx.doi.org/10.1371/journal.pone.0085333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427301	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200042
J	Cavanagh, DR; Kocken, CHM; White, JH; Cowan, GJM; Samuel, K; Dubbeld, MA; Voorberg-van der Wel, A; Thomas, AW; McBride, JS; Arnot, DE				Cavanagh, David R.; Kocken, Clemens H. M.; White, John H.; Cowan, Graeme J. M.; Samuel, Kay; Dubbeld, Martin A.; Voorberg-van der Wel, Annemarie; Thomas, Alan W.; McBride, Jana S.; Arnot, David E.			Antibody Responses to a Novel Plasmodium falciparum Merozoite Surface Protein Vaccine Correlate with Protection against Experimental Malaria Infection in Aotus Monkeys	PLOS ONE			English	Article							ANTIGENIC POLYMORPHISM; SEQUENCE DIVERSITY; CRITICAL PATH; C-TERMINUS; PARASITE; ADJUVANT; EFFICACY; IMMUNIZATION; IMMUNITY; BLOCK-2	The Block 2 region of the merozoite surface protein-1 (MSP-1) of Plasmodium falciparum has been identified as a target of protective immunity by a combination of seroepidemiology and parasite population genetics. Immunogenicity studies in small animals and Aotus monkeys were used to determine the efficacy of recombinant antigens derived from this region of MSP-1 as a potential vaccine antigen. Aotus lemurinus griseimembra monkeys were immunized three times with a recombinant antigen derived from the Block 2 region of MSP-1 of the monkey-adapted challenge strain, FVO of Plasmodium falciparum, using an adjuvant suitable for use in humans. Immunofluorescent antibody assays (IFA) against erythrocytes infected with P. falciparum using sera from the immunized monkeys showed that the MSP-1 Block 2 antigen induced significant antibody responses to whole malaria parasites. MSP-1 Block 2 antigen-specific enzyme-linked immunosorbent assays (ELISA) showed no significant differences in antibody titers between immunized animals. Immunized animals were challenged with the virulent P. falciparum FVO isolate and monitored for 21 days. Two out of four immunized animals were able to control their parasitaemia during the follow-up period, whereas two out of two controls developed fulminating parasitemia. Parasite-specific serum antibody titers measured by IFA were four-fold higher in protected animals than in unprotected animals. In addition, peptide-based epitope mapping of serum antibodies from immunized Aotus showed distinct differences in epitope specificities between protected and unprotected animals.	[Cavanagh, David R.; White, John H.; Cowan, Graeme J. M.; McBride, Jana S.; Arnot, David E.] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Kocken, Clemens H. M.; Dubbeld, Martin A.; Voorberg-van der Wel, Annemarie; Thomas, Alan W.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Samuel, Kay] Univ Edinburgh, Scottish Natl Blood Transfus Serv, Cell Therapy Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Cavanagh, DR (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland.	david.cavanagh@ed.ac.uk	Cowan, Graeme/F-2842-2011; Arnot, David/S-1984-2019	Cowan, Graeme/0000-0002-1949-4253; Arnot, David/0000-0002-3027-1130; Kocken, Clemens/0000-0002-4784-1734; Voorberg - van der Wel, Annemarie/0000-0001-9403-0515; Cavanagh, David/0000-0003-4360-2637	Commission of the European Union [QLK2-CT-2002-01197]	Commission of the European Union(European Commission)	The work was supported by a grant from the Commission of the European Union (QLK2-CT-2002-01197) to the EUROMALVAC2 consortium, coordinated by David Arnot. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Baruch DI, 2002, P NATL ACAD SCI USA, V99, P3860, DOI 10.1073/pnas.022018399; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; BREWER JM, 1994, VACCINE, V12, P613, DOI 10.1016/0264-410X(94)90265-8; Burghaus PA, 1996, INFECT IMMUN, V64, P3614, DOI 10.1128/IAI.64.9.3614-3619.1996; Cavanagh DR, 1997, MOL BIOCHEM PARASIT, V85, P197, DOI 10.1016/S0166-6851(96)02826-5; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Cavanagh DR, 2001, INFECT IMMUN, V69, P1207, DOI 10.1128/IAI.69.2.1207-1211.2001; Cavanagh DR, 1998, J IMMUNOL, V161, P347; COLLINS WE, 1992, MEM I OSWALDO CRUZ, V87, P401, DOI 10.1590/S0074-02761992000700068; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Cowan GJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026616; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; FENTON B, 1991, MOL CELL BIOL, V11, P963, DOI 10.1128/MCB.11.2.963; Galamo CD, 2009, J INFECT DIS, V199, P1151, DOI 10.1086/597426; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Gozalo AS, 2007, COMPARATIVE MED, V57, P396; Heppner DG, 2001, TRENDS PARASITOL, V17, P419, DOI 10.1016/S1471-4922(01)02012-8; HERRERA MA, 1992, INFECT IMMUN, V60, P154, DOI 10.1128/IAI.60.1.154-158.1992; Herrera S, 2002, INT J PARASITOL, V32, P1625, DOI 10.1016/S0020-7519(02)00191-1; HERRERA S, 1992, AM J TROP MED HYG, V47, P682, DOI 10.4269/ajtmh.1992.47.682; Hisaeda H, 2002, J INFECT DIS, V185, P657, DOI 10.1086/339187; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; HUI GSN, 1992, INFECT IMMUN, V60, P1422, DOI 10.1128/IAI.60.4.1422-1433.1992; Jiang GF, 2000, ACTA TROP, V74, P51, DOI 10.1016/S0001-706X(99)00045-5; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Jouin H, 2001, EUR J IMMUNOL, V31, P539, DOI 10.1002/1521-4141(200102)31:2&lt;539::AID-IMMU539&gt;3.0.CO;2-1; KUMAR S, 1995, MOL MED, V1, P325, DOI 10.1007/BF03401557; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Locher CP, 1996, EXP PARASITOL, V84, P74, DOI 10.1006/expr.1996.0091; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Makobongo MO, 2006, J INFECT DIS, V193, P731, DOI 10.1086/500150; Malaga CA, 2004, J MED PRIMATOL, V33, P109, DOI 10.1111/j.1600-0684.2004.00060.x; Mawili-Mboumba DP, 2003, J INFECT DIS, V187, P1137, DOI 10.1086/368414; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCBRIDE JS, 1985, J EXP MED, V161, P160, DOI 10.1084/jem.161.1.160; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Otsyula N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-29; Pink J Richard, 2004, Vaccine, V22, P2097, DOI 10.1016/j.vaccine.2004.01.021; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; PYE D, 1991, INFECT IMMUN, V59, P2403, DOI 10.1128/IAI.59.7.2403-2411.1991; Rono J, 2013, CLIN INFECT DIS, V57, P1409, DOI 10.1093/cid/cit556; SCHMIDT LH, 1978, AM J TROP MED HYG, V27, P671, DOI 10.4269/ajtmh.1978.27.671; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; SIDDIQUI WA, 1986, INFECT IMMUN, V52, P314, DOI 10.1128/IAI.52.1.314-318.1986; SIDDIQUI WA, 1987, P NATL ACAD SCI USA, V84, P3014, DOI 10.1073/pnas.84.9.3014; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stoute JA, 2007, VACCINE, V25, P176, DOI 10.1016/j.vaccine.2005.11.037; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Stowers AW, 2001, TRENDS PARASITOL, V17, P415, DOI 10.1016/S1471-4922(01)02011-6; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Tetteh KKA, 2005, INFECT IMMUN, V73, P5928, DOI 10.1128/IAI.73.9.5928-5935.2005; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Tsuji M, 2001, BIOL CHEM, V382, P553, DOI 10.1515/BC.2001.069; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006	67	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83704	10.1371/journal.pone.0083704	http://dx.doi.org/10.1371/journal.pone.0083704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421900	Green Submitted, gold, Green Published			2022-12-27	WOS:000329862500066
J	Smith, R; Solberg, R; Jacobsen, LL; Voreland, AL; Rustan, AC; Thoresen, GH; Johansen, HT				Smith, Robert; Solberg, Rigmor; Jacobsen, Linn Lokken; Voreland, Anette Larsen; Rustan, Arild Christian; Thoresen, G. Hege; Johansen, Harald Thidemann			Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes	PLOS ONE			English	Article							CATHEPSIN-B; INDUCED MYOTOXICITY; INSULIN-RESISTANCE; ATORVASTATIN; PRAVASTATIN; DEPLETION; STATINS; DEGRADATION; ACTIVATION; TOXICITY	Simvastatin, a HMG-CoA reductase inhibitor, is prescribed worldwide to patients with hypercholesterolemia. Although simvastatin is well tolerated, side effects like myotoxicity are reported. The mechanism for statin-induced myotoxicity is still poorly understood. Reports have suggested impaired mitochondrial dysfunction as a contributor to the observed myotoxicity. In this regard, we wanted to study the effects of simvastatin on glucose metabolism and the activity of legumain, a cysteine protease. Legumain, being the only known asparaginyl endopeptidase, has caspase-like properties and is described to be involved in apoptosis. Recent evidences indicate a regulatory role of both glucose and statins on cysteine proteases in monocytes. Satellite cells were isolated from the Musculus obliquus internus abdominis of healthy human donors, proliferated and differentiated into polynuclear myotubes. Simvastatin with or without mevalonolactone, farnesyl pyrophosphate or geranylgeranyl pyrophosphate were introduced on day 5 of differentiation. After 48 h, cells were either harvested for immunoblotting, ELISA, cell viability assay, confocal imaging or enzyme activity analysis, or placed in a fuel handling system with [C-14] glucose or [H-3] deoxyglucose for uptake and oxidation studies. A dose-dependent decrease in both glucose uptake and oxidation were observed in mature myotubes after exposure to simvastatin in concentrations not influencing cell viability. In addition, simvastatin caused a decrease in maturation and activity of legumain. Dysregulation of glucose metabolism and decreased legumain activity by simvastatin points out new knowledge about the effects of statins on skeletal muscle, and may contribute to the understanding of the myotoxicity observed by statins.	[Smith, Robert; Solberg, Rigmor; Jacobsen, Linn Lokken; Voreland, Anette Larsen; Rustan, Arild Christian; Thoresen, G. Hege] Univ Oslo, Dept Pharmaceut Biosci, Sch Pharm, Fac Math & Nat Sci, Oslo, Norway; [Thoresen, G. Hege; Johansen, Harald Thidemann] Univ Oslo, Dept Pharmacol, Inst Clin Med, Fac Med, Oslo, Norway; [Thoresen, G. Hege; Johansen, Harald Thidemann] Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Smith, R (corresponding author), Univ Oslo, Dept Pharmaceut Biosci, Sch Pharm, Oslo, Norway.	robert.smith@farmasi.uio.no		Solberg, Rigmor/0000-0001-7205-4401; Johansen, Harald Thidemann/0000-0001-6617-1732	University of Oslo; Anders Jahres foundation for the Promotion of Science; S.G. Sonneland foundation; Norwegian Pharmaceutical Society	University of Oslo; Anders Jahres foundation for the Promotion of Science; S.G. Sonneland foundation; Norwegian Pharmaceutical Society	This study was supported by The University of Oslo, Anders Jahres foundation for the Promotion of Science, S.G. Sonneland foundation and The Norwegian Pharmaceutical Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2013, CELL TISSUE RES; Abisi S, 2008, BRIT J SURG, V95, P333, DOI 10.1002/bjs.5989; Arora R, 2006, J CARDIOVASC PHARM T, V11, P105, DOI 10.1177/1074248406288758; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; COLELLA R, 1986, BIOMED BIOCHIM ACTA, V45, P1413; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; Flint OP, 1997, TOXICOL APPL PHARM, V145, P99, DOI 10.1006/taap.1997.8174; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; GHIRLANDA G, 1993, J CLIN PHARMACOL, V33, P226, DOI 10.1002/j.1552-4604.1993.tb03948.x; Halfon S, 1998, FEBS LETT, V438, P114, DOI 10.1016/S0014-5793(98)01281-2; Haugen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052980; Itagaki M, 2009, J PHARMACOL SCI, V109, P94, DOI 10.1254/jphs.08238FP; Jadot M, 2001, EUR J BIOCHEM, V268, P1392, DOI 10.1046/j.1432-1327.2001.02006.x; Johansen HT, 1999, ANAL BIOCHEM, V273, P278, DOI 10.1006/abio.1999.4221; Koh KK, 2008, DIABETES CARE, V31, P776, DOI 10.2337/dc07-2199; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Liu C, 2003, CANCER RES, V63, P2957; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Malenda A, 2012, NEOPLASIA, V14, P311, DOI 10.1593/neo.12444; Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P70, DOI 10.1016/j.bbrc.2010.09.115; Minogue S, 2010, J LIPID RES, V51, P2314, DOI 10.1194/jlr.M005751; Moheimani F, 2012, ATHEROSCLEROSIS, V223, P144, DOI 10.1016/j.atherosclerosis.2012.04.026; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; PEDERSEN TR, 1994, LANCET, V344, P1383; Peres C, 2003, FEBS LETT, V534, P164, DOI 10.1016/S0014-5793(02)03832-2; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; QIAN F, 1991, BIOMED BIOCHIM ACTA, V50, P531; Sakamoto K, 2007, FASEB J, V21, P4087, DOI 10.1096/fj.07-8713com; Sakamoto K, 2011, J PHARMACOL EXP THER, V338, P62, DOI 10.1124/jpet.111.179762; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Sinzinger H, 2002, J CARDIOVASC PHARM, V40, P163, DOI 10.1097/00005344-200208000-00001; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; Skottheim IB, 2008, EUR J PHARM SCI, V33, P317, DOI 10.1016/j.ejps.2007.12.009; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Takaguri A, 2008, J PHARMACOL SCI, V107, P80, DOI 10.1254/jphs.FP0072403; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Wang ZH, 2010, J CLIN PHARMACOL, V50, P311, DOI 10.1177/0091270009340889; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; WERLE B, 1995, BIOL CHEM H-S, V376, P157, DOI 10.1515/bchm3.1995.376.3.157; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064	51	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85721	10.1371/journal.pone.0085721	http://dx.doi.org/10.1371/journal.pone.0085721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416446	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500264
J	Sparks, JS; Schelly, RC; Smith, WL; Davis, MP; Tchernov, D; Pieribone, VA; Gruber, DF				Sparks, John S.; Schelly, Robert C.; Smith, W. Leo; Davis, Matthew P.; Tchernov, Dan; Pieribone, Vincent A.; Gruber, David F.			The Covert World of Fish Biofluorescence: A Phylogenetically Widespread and Phenotypically Variable Phenomenon	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; FAMILY KNERIIDAE TELEOSTEI; HIGHER-LEVEL RELATIONSHIPS; REEF FISHES; MOLECULAR PHYLOGENY; COLOR-VISION; MITOGENOMIC PERSPECTIVE; MITOCHONDRIAL GENOMES; POLARIZATION VISION; BEHAVIORAL EVIDENCE	The discovery of fluorescent proteins has revolutionized experimental biology. Whereas the majority of fluorescent proteins have been identified from cnidarians, recently several fluorescent proteins have been isolated across the animal tree of life. Here we show that biofluorescence is not only phylogenetically widespread, but is also phenotypically variable across both cartilaginous and bony fishes, highlighting its evolutionary history and the possibility for discovery of numerous novel fluorescent proteins. Fish biofluorescence is especially common and morphologically variable in cryptically patterned coral-reef lineages. We identified 16 orders, 50 families, 105 genera, and more than 180 species of biofluorescent fishes. We have also reconstructed our current understanding of the phylogenetic distribution of biofluorescence for ray-finned fishes. The presence of yellow long-pass intraocular filters in many biofluorescent fish lineages and the substantive color vision capabilities of coral-reef fishes suggest that they are capable of detecting fluoresced light. We present species-specific emission patterns among closely related species, indicating that biofluorescence potentially functions in intraspecific communication and evidence that fluorescence can be used for camouflage. This research provides insight into the distribution, evolution, and phenotypic variability of biofluorescence in marine lineages and examines the role this variation may play.	[Sparks, John S.; Schelly, Robert C.; Pieribone, Vincent A.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA; [Sparks, John S.; Schelly, Robert C.; Gruber, David F.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Smith, W. Leo; Davis, Matthew P.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Tchernov, Dan] Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-31999 Haifa, Israel; [Pieribone, Vincent A.] Yale Univ, John B Pierce Lab Inc, Dept Cellular & Mol Physiol, New Haven, CT USA; [Gruber, David F.] CUNY Bernard M Baruch Coll, Dept Nat Sci, New York, NY 10010 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Kansas; University of Haifa; Yale University; The John B Pierce Laboratory, Inc; City University of New York (CUNY) System; Baruch College (CUNY)	Sparks, JS (corresponding author), Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA.	jsparks@amnh.org; davidfgruber@gmail.com	Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270; Pieribone, Vincent/0000-0002-5836-5454	American Museum of Natural History; City University of New York; National Science Foundation [DEB-0444842, IOS-0749943, DEB-1258141, MCB-0920572, DRL-1007747, DEB-0732642, DEB-1060869, DEB-1257555]; National Institutes of Health (NIH) [U24NS057631, R01NS083875]; National Geographic Waitt Grants [W101-10, W214-12]; Direct For Biological Sciences [1257555] Funding Source: National Science Foundation; Division Of Environmental Biology [1543654] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1227093] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065110, U24NS057631, R01NS083875] Funding Source: NIH RePORTER	American Museum of Natural History; City University of New York; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic Waitt Grants(National Geographic Society); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Museum of Natural History, City University of New York, National Science Foundation grants DEB-0444842, IOS-0749943, and DEB-1258141 to JSS, MCB-0920572 and DRL-1007747 to DFG, DEB-0732642 and DEB-1060869 to WLS, DEB-1257555 and DEB-1258141 to MPD, WLS, and JSS, National Institutes of Health (NIH) grants U24NS057631 and R01NS083875 to VAP and National Geographic Waitt Grants #W101-10 to DFG and #W214-12 to JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews K, 2007, BIOL LETTERS, V3, P265, DOI 10.1098/rsbl.2007.0016; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; Arnold RJ, 2012, MOL PHYLOGENET EVOL, V62, P117, DOI 10.1016/j.ympev.2011.09.012; Asgharian H, 2011, MOL ECOL RESOUR, V11, P461, DOI 10.1111/j.1755-0998.2011.02989.x; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Davis Matthew P., 2010, P431; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; Douglas RH, 1998, NATURE, V393, P423, DOI 10.1038/30871; Dunlap PV, 2007, CLADISTICS, V23, P507, DOI 10.1111/j.1096-0031.2007.00157.x; Espineira M, 2008, J AGR FOOD CHEM, V56, P10594, DOI 10.1021/jf801728q; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Fu CZ, 2012, MOL PHYLOGENET EVOL, V62, P848, DOI 10.1016/j.ympev.2011.11.031; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gruber DF, 2008, BIOL BULL-US, V215, P143, DOI 10.2307/25470695; Guo Li, 2011, Acta Hydrobiologica Sinica, V35, P449; Haddock SHD, 2005, SCIENCE, V309, P263, DOI 10.1126/science.1110441; Haddock SHD, 2010, P ROY SOC B-BIOL SCI, V277, P1155, DOI 10.1098/rspb.2009.1774; HAWRYSHYN CW, 1992, AM SCI, V80, P164; HEINERMANN PH, 1984, EXP BIOL, V43, P127; Holcroft NI, 2008, ICHTHYOL RES, V55, P274, DOI 10.1007/s10228-007-0026-x; Holcroft NI, 2004, MOL PHYLOGENET EVOL, V32, P749, DOI 10.1016/j.ympev.2004.04.002; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Ilves KL, 2007, COPEIA, P180, DOI 10.1643/0045-8511(2007)7[180:AHCAHN]2.0.CO;2; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Inoue JG, 2003, MOL BIOL EVOL, V20, P1917, DOI 10.1093/molbev/msg206; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Ishiguro N, 2001, FISHERIES SCI, V67, P474, DOI 10.1046/j.1444-2906.2001.00283.x; Ishiguro NB, 2003, MOL PHYLOGENET EVOL, V27, P476, DOI 10.1016/S1055-7903(02)00418-9; Jaafar TNAM, 2012, PLOS ONE, V7, DOI [DOI 10.1371/journal.pone.0049623, DOI 10.1371/JOURNAL.PONE.0049623]; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; Johnsen S. N., 2012, OPTICS LIFE BIOL GUI; Kaeding AJ, 2007, APPL ENVIRON MICROB, V73, P3173, DOI 10.1128/AEM.02212-06; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lavoue S, 2005, MOL PHYLOGENET EVOL, V37, P165, DOI 10.1016/j.ympev.2005.03.024; Lavoue S, 2008, MOL PHYLOGENET EVOL, V47, P1111, DOI 10.1016/j.ympev.2007.12.002; Lavoue S, 2012, ICHTHYOL RES, V59, P104, DOI 10.1007/s10228-011-0258-7; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Li CH, 2011, MOL PHYLOGENET EVOL, V60, P463, DOI 10.1016/j.ympev.2011.05.004; LOBEL PS, 1978, PAC SCI, V32, P193; Lopez J.A., 2004, COPEIA; Losey GS, 2003, COPEIA, P433, DOI 10.1643/01-053; Marie AD, 2007, CORAL REEFS, V26, P841, DOI 10.1007/s00338-007-0273-3; Marshall J, 1999, CURR BIOL, V9, P755, DOI 10.1016/S0960-9822(99)80336-4; Mathger LM, 2009, J EXP BIOL, V212, P2133, DOI 10.1242/jeb.020800; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Miya M, 2007, ICHTHYOL RES, V54, P323, DOI 10.1007/s10228-007-0408-0; MORIN JG, 1971, J CELL PHYSIOL, V77, P313, DOI 10.1002/jcp.1040770305; Moritz T, 2006, ICHTHYOL EXPLOR FRES, V17, P65; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2012, MOL PHYLOGENET EVOL, V63, P388, DOI 10.1016/j.ympev.2012.01.011; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; Ribeiro AD, 2012, MOL ECOL RESOUR, V12, P1012, DOI 10.1111/1755-0998.12007; Roa-Varon A, 2009, MOL PHYLOGENET EVOL, V52, P688, DOI 10.1016/j.ympev.2009.03.020; Roth MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01421; Roth MS, 2010, J EXP BIOL, V213, P3644, DOI 10.1242/jeb.040881; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Santini F, 2013, MOL PHYLOGENET EVOL, V66, P153, DOI 10.1016/j.ympev.2012.09.022; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shashar N, 1997, BIOL BULL-US, V193, P207, DOI 10.1086/BBLv193n2p207; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Siebeck UE, 2008, J EXP BIOL, V211, P354, DOI 10.1242/jeb.012880; Smith PJ, 2012, POLAR BIOL, V35, P1297, DOI 10.1007/s00300-012-1173-8; Sparks John S., 2003, Ichthyological Exploration of Freshwaters, V14, P317; Sparks JS, 2005, CLADISTICS, V21, P305, DOI 10.1111/j.1096-0031.2005.00067.x; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Theiss SM, 2007, J COMP PHYSIOL A, V193, P67, DOI 10.1007/s00359-006-0171-0; Van-Eyk SM, 2011, J EXP BIOL, V214, P4186, DOI 10.1242/jeb.061853; Varela AI, 2012, MAR BIOL, V159, P1049, DOI 10.1007/s00227-012-1885-x; Vogt A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003766; Vukusic P, 2005, SCIENCE, V310, P1151, DOI 10.1126/science.1116612; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Weigt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041059; Wucherer MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037913; Yamanoue Y, 2004, ICHTHYOL RES, V51, P269, DOI 10.1007/s10228-004-0218-6; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017; Zwickl DJ., 2006, THESIS	103	99	99	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83259	10.1371/journal.pone.0083259	http://dx.doi.org/10.1371/journal.pone.0083259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421880	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500040
J	Cui, J; Liu, SK; Zhang, B; Wang, HD; Sun, HJ; Song, SH; Qiu, XM; Liu, Y; Wang, XL; Jiang, ZQ; Liu, ZJ				Cui, Jun; Liu, Shikai; Zhang, Bing; Wang, Hongdi; Sun, Hongjuan; Song, Shuhui; Qiu, Xuemei; Liu, Yang; Wang, Xiuli; Jiang, Zhiqiang; Liu, Zhanjiang			Transciptome Analysis of the Gill and Swimbladder of Takifugu rubripes by RNA-Seq	PLOS ONE			English	Article							RECEPTOR GENE FAMILY; EXPRESSION ANALYSIS; JAPANESE PUFFERFISH; BRANCHING-MORPHOGENESIS; REDUNDANT ROLES; CCR9 EXPRESSION; READ ALIGNMENT; FUGU-RUBRIPES; CHEMOKINE; SOX17	The fish gill, as one of the mucosal barriers, plays an important role in mucosal immune response. The fish swimbladder functions for regulating buoyancy. The fish swimbladder has long been postulated as a homologous organ of the tetrapod lung, but the molecular evidence is scarce. In order to provide new information that is complementary to gill immune genes, initiate new research directions concerning the genetic basis of the gill immune response and understand the molecular function of swimbladder as well as its relationship with lungs, transcriptome analysis of the fugu Takifugu rubripes gill and swimbladder was carried out by RNA-Seq. Approximately 55,061,524 and 44,736,850 raw sequence reads from gill and swimbladder were generated, respectively. Gene ontology (GO) and KEGG pathway analysis revealed diverse biological functions and processes. Transcriptome comparison between gill and swimbladder resulted in 3,790 differentially expressed genes, of which 1,520 were up-regulated in the swimbladder while 2,270 were down-regulated. In addition, 406 up regulated isoforms and 296 down regulated isoforms were observed in swimbladder in comparison to gill. By the gene enrichment analysis, the three immune-related pathways and 32 immune-related genes in gill were identified. In swimbladder, five pathways including 43 swimbladder-enriched genes were identified. This work should set the foundation for studying immune-related genes for the mucosal immunity and provide genomic resources to study the relatedness of the fish swimbladder and mammalian lung.	[Cui, Jun; Wang, Hongdi; Sun, Hongjuan; Qiu, Xuemei; Liu, Yang; Wang, Xiuli; Jiang, Zhiqiang] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Zhang, Bing; Song, Shuhui] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Aquat Genom Unit, Program Cell & Mol Biosci, Auburn, AL 36849 USA	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Auburn University System; Auburn University; Auburn University System; Auburn University	Wang, XL (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	xiuliwang417@sina.com; zhqjiang@dlou.edu.cn; LIUZHAN@auburn.edu	Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019; Cui, Jun/P-9378-2015	Liu, Shikai/0000-0001-5777-489X; 	Program for Liaoning Excellent Talents in University [LR201010]; Dalian Ocean University [2012HYDX07]	Program for Liaoning Excellent Talents in University; Dalian Ocean University	This project was supported by the Program for Liaoning Excellent Talents in University (LR201010) and the grant of Dalian Ocean University (2012HYDX07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabyev BY, 2000, DEV COMP IMMUNOL, V24, P765, DOI 10.1016/S0145-305X(00)00035-5; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Arena A, 2000, MICROBIOLOGICA, V23, P105; Beck BH, 2012, FISH SHELLFISH IMMUN, V33, P1008, DOI 10.1016/j.fsi.2012.08.018; Bei JX, 2006, MOL IMMUNOL, V43, P860, DOI 10.1016/j.molimm.2005.06.040; Bird S, 2005, DEV COMP IMMUNOL, V29, P775, DOI 10.1016/j.dci.2005.01.002; Bird S, 2005, IMMUNOGENETICS, V56, P909, DOI 10.1007/s00251-004-0741-7; Boucherat O, 2012, BIOL OPEN, V1, P677, DOI 10.1242/bio.20121701; Brocker Chad, 2010, Human Genomics, V5, P30; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chan TM, 2009, DEV BIOL, V326, P456, DOI 10.1016/j.ydbio.2008.11.010; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Daniels GD, 1999, J LEUKOCYTE BIOL, V65, P684, DOI 10.1002/jlb.65.5.684; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dean CH, 2005, DEV BIOL, V286, P270, DOI 10.1016/j.ydbio.2005.07.034; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dickerson H, 1998, IMMUNOL REV, V22, P465; Dong Wei-ren, 2006, Journal of Zhejiang University Science Edition, V33, P688; Fang W, 2006, COMP BIOCHEM PHYS B, V143, P335, DOI 10.1016/j.cbpb.2005.12.009; Fu Jian-hua, 2008, Zhonghua Er Ke Za Zhi, V46, P540; Fujiki K, 1999, IMMUNOGENETICS, V49, P909, DOI 10.1007/s002510050573; Goostrey A, 2005, DEV COMP IMMUNOL, V29, P229, DOI 10.1016/j.dci.2004.06.012; Grier DG, 2009, NEONATOLOGY, V96, P50, DOI 10.1159/000201739; Gunimaladevi I, 2007, FISH SHELLFISH IMMUN, V22, P351, DOI 10.1016/j.fsi.2006.05.009; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kobayashi D, 2006, DEV GROWTH DIFFER, V48, P283, DOI 10.1111/j.1440-169x.2006.00870.x; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; Korenaga H, 2010, FISH SHELLFISH IMMUN, V28, P809, DOI 10.1016/j.fsi.2010.01.016; Lange AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005711; Lee HS, 2012, IMMUNOBIOLOGY, V217, P402, DOI 10.1016/j.imbio.2011.10.014; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2013, ARCH IMMUNOL THER EX, V61, P237, DOI 10.1007/s00005-013-0223-4; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu Y, 2009, MOL IMMUNOL, V46, P498, DOI 10.1016/j.molimm.2008.10.003; Long QM, 2000, MECH DEVELOP, V97, P183, DOI 10.1016/S0925-4773(00)00408-1; Lu C, 2013, FISH SHELLFISH IMMUN, V34, P372, DOI 10.1016/j.fsi.2012.11.004; Lu IN, 2012, DEV COMP IMMUNOL, V38, P203, DOI 10.1016/j.dci.2012.07.003; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Owen R, 1846, LECT COMP ANATOMY PH; Park J, 2010, DEV DYNAM, V239, P514, DOI 10.1002/dvdy.22192; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Park KS, 2006, DEV BIOL, V294, P192, DOI 10.1016/j.ydbio.2006.02.038; Perry SF, 2001, COMP BIOCHEM PHYS A, V129, P37, DOI 10.1016/S1095-6433(01)00304-X; Perry SF, 2004, RESP PHYSIOL NEUROBI, V144, P125, DOI 10.1016/j.resp.2004.06.018; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Schepers GE, 2000, NUCLEIC ACIDS RES, V28, P1473, DOI 10.1093/nar/28.6.1473; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Shu WG, 2002, DEVELOPMENT, V129, P4831; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Su Jian-Guo, 2008, Acta Hydrobiologica Sinica, V32, P728, DOI 10.3724/SP.J.0000.2008.50728; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang T, 2007, J IMMUNOL, V179, P1475, DOI 10.4049/jimmunol.179.3.1475; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winata CL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-3; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Xia XH, 2011, BIOCHEM GENET, V49, P161, DOI 10.1007/s10528-010-9396-2; Xia XH, 2010, J GENET, V89, P183, DOI 10.1007/s12041-010-0024-z; Yang ChunRong, 2011, Journal of Fisheries of China, V35, P641; Yang Ming, 2006, Journal of Oceanography in Taiwan Strait, V25, P330; Yin A, 2012, BBA-MOL CELL RES, V1823, P236, DOI 10.1016/j.bbamcr.2011.09.018; Yin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018431; Yin DT, 2012, DISCOV MED, V14, P33; Yoshiura Y, 2003, IMMUNOGENETICS, V55, P296, DOI 10.1007/s00251-003-0582-9; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019; Zou J, 2003, IMMUNOGENETICS, V55, P325, DOI 10.1007/s00251-003-0580-y	87	30	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85505	10.1371/journal.pone.0085505	http://dx.doi.org/10.1371/journal.pone.0085505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454879	Green Submitted, gold, Green Published			2022-12-27	WOS:000330236000010
J	Yamamoto, T; Kodama, T; Lee, J; Utsunomiya, N; Hayashi, S; Sakamoto, H; Kuramoto, H; Kadowaki, M				Yamamoto, Takeshi; Kodama, Toshihisa; Lee, Jaemin; Utsunomiya, Naho; Hayashi, Shusaku; Sakamoto, Hiroshi; Kuramoto, Hirofumi; Kadowaki, Makoto			Anti-Allergic Role of Cholinergic Neuronal Pathway via alpha 7 Nicotinic ACh Receptors on Mucosal Mast Cells in a Murine Food Allergy Model	PLOS ONE			English	Article							ANTIINFLAMMATORY PATHWAY; ACETYLCHOLINE-RECEPTOR; VAGUS NERVE; ULCERATIVE-COLITIS; IMMUNE-RESPONSES; MICE; INFLAMMATION; DIARRHEA; CHYMASE	The prevalence of food allergy (FA) has increased in developed countries over the past few decades. However, no effective drug therapies are currently available. Therefore, we investigated cholinergic anti-inflammatory pathway as a regulatory system to ameliorate disrupted mucosal immune homeostasis in the gut based on the pathophysiological elucidation of mucosal mast cells (MMCs) in a murine FA model. BALB/c mice sensitized with ovalbumin received repeated oral ovalbumin for the development of FA. FA mice developed severe allergic diarrhea and exhibited enhanced type 2 helper T (Th2) cell immune responses in both systemic immunity and mucosal immunity, along with MMCs hyperplasia in the colon. MMCs were localized primarily in the strategic position of the mucosal epithelium. Furthermore, the allergic symptoms did not develop in p85 alpha disrupted phosphoinositide-3 kinase-deficient mice that lacked mast cells in the gut. Vagal stimulation by 2-deoxy-D-glucose and drug treatment with nicotinic ACh receptor (nAChR) agonists (nicotine and alpha 7 nAChR agonist GTS-21) alleviated the allergic symptoms in the FA mice. Nicotine treatment suppressed MMCs hyperplasia, enhanced MPO and upregulated mRNA expression of Th1 and Th2 cytokines in the FA mice colon. MMCs, which are negatively regulated by alpha 7 nAChRs, were often located in close proximity to cholinergic CGRP-immunoreactive nerve fibers in the FA mice colon. The present results reveal that the cholinergic neuroimmune interaction via alpha 7 nAChRs on MMCs is largely involved in maintaining intestinal immune homeostasis and can be a target for a new therapy against mucosal immune diseases with homeostatic disturbances such as FA.	[Yamamoto, Takeshi; Kodama, Toshihisa; Lee, Jaemin; Utsunomiya, Naho; Hayashi, Shusaku; Kadowaki, Makoto] Toyama Univ, Inst Nat Med, Div Gastrointestinal Pathophysiol, Toyama 930, Japan; [Sakamoto, Hiroshi] Hlth Sci Univ, Dept Phys Therapy, Fujikawaguchiko, Yamanashi, Japan; [Kuramoto, Hirofumi] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan	University of Toyama; Kyoto Institute of Technology	Kadowaki, M (corresponding author), Toyama Univ, Inst Nat Med, Div Gastrointestinal Pathophysiol, Toyama 930, Japan.	makotok@inm.u-toyama.ac.jp	Hayashi, Shusaku/AAP-1185-2020	Hayashi, Shusaku/0000-0002-8304-7255; YAMAMOTO, Takeshi/0000-0002-4383-6954	Ministry of Education, Culture, Sports, Science and Technology of Japan [25460891, 24590879]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/j-grantsinaid/index.html) to T. Yamamoto (No. 25460891) and M. Kadowaki (No. 24590879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Bauer O, 2000, NEWS PHYSIOL SCI, V15, P213, DOI 10.1152/physiologyonline.2000.15.5.213; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; BIENENSTOCK J, 2003, AUTONOMIC NEUROIMMUN; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Dhawan S, 2012, LIFE SCI, V91, P1038, DOI 10.1016/j.lfs.2012.04.042; Eigenmann PA, 2003, CURR OPIN ALLERGY CL, V3, P199, DOI [10.1097/00130832-200306000-00008, 10.1097/01.all.0000072715.82112.5e]; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Kageyama-Yahara N, 2008, BIOCHEM BIOPH RES CO, V377, P321, DOI 10.1016/j.bbrc.2008.10.004; Kageyama-Yahara N, 2010, FEBS LETT, V584, P111, DOI 10.1016/j.febslet.2009.11.007; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Lakhan SE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-129; MacDonald TT, 2009, CURR OPIN GASTROEN, V25, P521, DOI 10.1097/MOG.0b013e3283306236; Mazzoni A, 2006, J IMMUNOL, V177, P3577, DOI 10.4049/jimmunol.177.6.3577; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MILLER HRP, 1972, AM J PATHOL, V69, P195; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Van der Zanden EP, 2009, NEUROGASTROENT MOTIL, V21, P6, DOI 10.1111/j.1365-2982.2008.01252.x; van Diest SA, 2012, BBA-MOL BASIS DIS, V1822, P74, DOI 10.1016/j.bbadis.2011.03.019; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wastling JM, 1998, AM J PATHOL, V153, P491, DOI 10.1016/S0002-9440(10)65592-7; Yamamoto T, 2009, INT ARCH ALLERGY IMM, V148, P175, DOI 10.1159/000161578; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	40	49	52	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85888	10.1371/journal.pone.0085888	http://dx.doi.org/10.1371/journal.pone.0085888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454942	gold, Green Submitted, Green Published			2022-12-27	WOS:000330236000019
J	Demetriou, C; Abu-Amero, S; Thomas, AC; Ishida, M; Aggarwal, R; Al-Olabi, L; Leon, LJ; Stafford, JL; Syngelaki, A; Peebles, D; Nicolaides, KH; Regan, L; Stanier, P; Moore, GE				Demetriou, Charalambos; Abu-Amero, Sayeda; Thomas, Anna C.; Ishida, Miho; Aggarwal, Reena; Al-Olabi, Lara; Leon, Lydia J.; Stafford, Jaime L.; Syngelaki, Argyro; Peebles, Donald; Nicolaides, Kypros H.; Regan, Lesley; Stanier, Philip; Moore, Gudrun E.			Paternally Expressed, Imprinted Insulin-Like Growth Factor-2 in Chorionic Villi Correlates Significantly with Birth Weight	PLOS ONE			English	Article							IGF-I RECEPTOR; GESTATIONAL-AGE; FETAL-GROWTH; CORD-BLOOD; PLACENTAL EXPRESSION; PHLDA2 GENE; INTRAUTERINE; RESTRICTION; METHYLATION; IGFBP-1	Context: Fetal growth involves highly complex molecular pathways. IGF2 is a key paternally expressed growth hormone that is critical for in utero growth in mice. Its role in human fetal growth has remained ambiguous, as it has only been studied in term tissues. Conversely the maternally expressed growth suppressor, PHLDA2, has a significant negative correlation between its term placental expression and birth weight. Objective: The aim of this study is to address the role in early gestation of expression of IGF1, IGF2, their receptors IGF1R and IGF2R, and PHLDA2 on term birth weight. Design: Real-time quantitative PCR was used to investigate mRNA expression of IGF1, IGF2, IGF1R, IGF2R and PHLDA2 in chorionic villus samples (CVS) (n = 260) collected at 11-13 weeks' gestation. Expression was correlated with term birth weight using statistical package R including correction for several confounding factors. Results: Transcript levels of IGF2 and IGF2R revealed a significant positive correlation with birth weight (0.009 and 0.04, respectively). No effect was observed for IGF1, IGF1R or PHLDA2 and birth weight. Critically, small for gestational age (SGA) neonates had significantly lower IGF2 levels than appropriate for gestational age neonates (p = 3.6 x 10(-7)). Interpretation: Our findings show that IGF2 mRNA levels at 12 weeks gestation could provide a useful predictor of future fetal growth to term, potentially predicting SGA babies. SGA babies are known to be at a higher risk for type 2 diabetes. This research reveals an imprinted, parentally driven rheostat for in utero growth.	[Demetriou, Charalambos; Abu-Amero, Sayeda; Thomas, Anna C.; Ishida, Miho; Al-Olabi, Lara; Leon, Lydia J.; Stafford, Jaime L.; Stanier, Philip; Moore, Gudrun E.] UCL, Fetal Dev & Growth Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London, England; [Demetriou, Charalambos; Regan, Lesley] Univ London Imperial Coll Sci Technol & Med, Dept Obstet & Gynaecol, London, England; [Aggarwal, Reena; Peebles, Donald] UCL, Inst Womens Hlth, London, England; [Syngelaki, Argyro; Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England	University of London; University College London; Imperial College London; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Moore, GE (corresponding author), UCL, Fetal Dev & Growth Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London, England.	gudrun.moore@ucl.ac.uk	Moore, Gudrun/A-2092-2009; Stanier, Philip/C-1593-2008	Stanier, Philip/0000-0001-9340-8117; Nicolaides, Kypros/0000-0003-1266-0711; Syngelaki, Argyro/0000-0001-5856-6072; Lopes, Jaime/0000-0002-9795-1093; Leon, Lydia/0000-0001-5228-9713	Save the Baby Unit; Great Ormond Street Hospital Children's Charity; MRC; Wellbeing of Women; Sparks; Wellcome Trust; MRC [G0801438, G1001689] Funding Source: UKRI; Medical Research Council [G0801438, G1001689] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1241] Funding Source: researchfish	Save the Baby Unit; Great Ormond Street Hospital Children's Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellbeing of Women(Wellbeing of Women (WoW)); Sparks; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity	CD is funded by Save the Baby Unit (http://www.savethebabyunit.org/). PS is funded by Great Ormond Street Hospital Children's Charity (http://www.gosh.org/gen/). GEM Fetal growth and development research team is funded by the MRC (http://www.mrc.ac.uk/index.htm), Wellbeing of Women (http://www.wellbeingofwomen.org.uk/), Sparks (http://www.sparks.org.uk/) and the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero SN, 1998, MOL REPROD DEV, V49, P229, DOI 10.1002/(SICI)1098-2795(199803)49:3<229::AID-MRD2>3.0.CO;2-Q; Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; ALBERTSSONWIKLAND K, 1993, ACTA PAEDIATR, V82, P438, DOI 10.1111/j.1651-2227.1993.tb12718.x; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Demendi C, 2012, EUR J OBSTET GYN R B, V160, P40, DOI 10.1016/j.ejogrb.2011.10.005; Eggermann T, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028936; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Iniguez G, 2010, HORM RES PAEDIAT, V73, P320, DOI 10.1159/000308163; Ishida M, 2012, AM J HUM GENET, V90, P715, DOI 10.1016/j.ajhg.2012.02.021; Klammt J, 2008, TRENDS ENDOCRIN MET, V19, P197, DOI 10.1016/j.tem.2008.03.003; Klauwer D, 1997, ACTA PAEDIATR, V86, P826; Koukoura O, 2011, INT J MOL MED, V28, P481, DOI 10.3892/ijmm.2011.754; Koutsaki M, 2011, GROWTH HORM IGF RES, V21, P31, DOI 10.1016/j.ghir.2010.12.002; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Laviola L, 2005, ENDOCRINOLOGY, V146, P1498, DOI 10.1210/en.2004-1332; Le Bouc Y, 2003, B ACAD NAT MED PARIS, V187, P1225, DOI 10.1016/S0001-4079(19)33906-8; Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Ong K, 2000, J CLIN ENDOCR METAB, V85, P4266, DOI 10.1210/jc.85.11.4266; Petry CJ, 2011, DIABETES, V60, P3090, DOI 10.2337/db11-0689; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; Street ME, 2006, EUR J ENDOCRINOL, V155, P567, DOI 10.1530/eje.1.02251; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; WILLISON K, 1991, TRENDS GENET, V7, P107, DOI 10.1016/0168-9525(91)90441-R	40	34	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85454	10.1371/journal.pone.0085454	http://dx.doi.org/10.1371/journal.pone.0085454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454871	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100089
J	Desamericq, G; Dolbeau, G; Verny, C; Charles, P; Durr, A; Youssov, K; Simonin, C; Azulay, JP; Tranchant, C; Goizet, C; Damier, P; Broussolle, E; Demonet, JF; Morgado, G; de Langavant, LC; Macquin-Mavier, I; Bachoud-Levi, AC; Maison, P				Desamericq, Gaelle; Dolbeau, Guillaume; Verny, Christophe; Charles, Perrine; Durr, Alexandra; Youssov, Katia; Simonin, Clemence; Azulay, Jean-Philippe; Tranchant, Christine; Goizet, Cyril; Damier, Philippe; Broussolle, Emmanuel; Demonet, Jean-Francois; Morgado, Graca; de Langavant, Laurent Cleret; Macquin-Mavier, Isabelle; Bachoud-Levi, Anne-Catherine; Maison, Patrick			Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort	PLOS ONE			English	Article							FOLLOW-UP; OPEN-LABEL; DISEASE; OLANZAPINE; TETRABENAZINE; INDIVIDUALS; THERAPY; CHOREA; GENE	Purpose: Huntington's disease is a rare condition. Patients are commonly treated with antipsychotics and tetrabenazine. The evidence of their effect on disease progression is limited and no comparative study between these drugs has been conducted. We therefore compared the effectiveness of antipsychotics on disease progression. Methods: 956 patients from the Huntington French Speaking Group were followed for up to 8 years between 2002 and 2010. The effectiveness of treatments was assessed using Unified Huntington's Disease Rating Scale (UHDRS) scores and then compared using a mixed model adjusted on a multiple propensity score. Results: 63% of patients were treated with antipsychotics during the survey period. The most commonly prescribed medications were dibenzodiazepines (38%), risperidone (13%), tetrabenazine (12%) and benzamides (12%). There was no difference between treatments on the motor and behavioural declines observed, after taking the patient profiles at the start of the drug prescription into account. In contrast, the functional decline was lower in the dibenzodiazepine group than the other antipsychotic groups (Total Functional Capacity: 0.41 +/- 0.17 units per year vs. risperidone and 0.54 +/- 0.19 vs. tetrabenazine, both p<0.05). Benzamides were less effective than other antipsychotics on cognitive evolution (Stroop interference, Stroop color and Literal fluency: p<0.05). Conclusions: Antipsychotics are widely used to treat patients with Huntington's disease. Although differences in motor or behavioural profiles between patients according to the antipsychotics used were small, there were differences in drug effectiveness on the evolution of functional and cognitive scores.	[Desamericq, Gaelle; Dolbeau, Guillaume; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Hop Henri Mondor, INSERM, Equipe 01, U955, F-94010 Creteil, France; [Desamericq, Gaelle; Dolbeau, Guillaume; Youssov, Katia; Morgado, Graca; de Langavant, Laurent Cleret; Macquin-Mavier, Isabelle; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Univ Paris Est, Fac Med, Creteil, France; [Desamericq, Gaelle; Macquin-Mavier, Isabelle] Hop H Mondor A Chenevier, Serv Pharmacol Clin, Creteil, France; [Desamericq, Gaelle; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Ecole Normale Super, Dept Etud Cognit, F-75231 Paris, France; [Dolbeau, Guillaume] Hop H Mondor A Chenevier, Unite Rech Clin, Creteil, France; [Verny, Christophe] CHU Angers, Serv Neurol, Ctr Reference Malad Neurogenet, Angers, France; [Verny, Christophe] CNRS, INSERM, UMR 6214, U1083, Angers, France; [Charles, Perrine; Durr, Alexandra; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Hop H Mondor A Chenevier, Ctr Reference Malad Huntington, Creteil, France; [Charles, Perrine] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Simonin, Clemence] CHRU Lille, Dept Neurol & Movement Disorders, F-59037 Lille, France; [Simonin, Clemence] INSERM, JPArc Team 6, UMR837, F-59045 Lille, France; [Simonin, Clemence] Univ Lille 2 Law & Hlth, Lille, France; [Azulay, Jean-Philippe] Hop Enfants La Timone, Serv Neurol & Pathol Mouvement, Marseille, France; [Tranchant, Christine] CHU Hautepierre, Serv Neurol, F-67098 Strasbourg, France; [Tranchant, Christine] Univ Strasbourg, Strasbourg, France; [Goizet, Cyril] CHU Bordeaux, Serv Genet Med, EA4576, Univ Bordeaux Segalen,Lab Malad Rares Genet & Met, Bordeaux, France; [Damier, Philippe] INSERM, Ctr Invest Clin 004, Nantes, France; [Broussolle, Emmanuel] Univ Lyon 1, Fac Med, F-69365 Lyon, France; [Broussolle, Emmanuel] Univ Lyon 1, Maieut Lyon Sud Charles Merieux, F-69365 Lyon, France; [Broussolle, Emmanuel] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Serv Neurol C, Lyon, France; [Broussolle, Emmanuel] CNRS, Ctr Neurosci Cognit, UMR5229, Bron, France; [Demonet, Jean-Francois] CHU Vaudois, Dept Clin Neurosci, Ctr Leenaards Memoire, Lausanne, Switzerland; [Morgado, Graca] Hop Henri Mondor, INSERM, Ctr Invest Clin 006, F-94010 Creteil, France; [Morgado, Graca] Hop H Mondor A Chenevier, AP HP, Pole Rech Clin Sante Publ, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Maison, P (corresponding author), Hop Henri Mondor, INSERM, Equipe 01, U955, F-94010 Creteil, France.	patrick.maison@hmn.aphp.fr	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; Broussolle, Emmanuel/H-1592-2017; Damier, Philippe/T-7829-2019; GOIZET, Cyril/M-4576-2014	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Broussolle, Emmanuel/0000-0002-0410-9519; GOIZET, Cyril/0000-0002-1913-889X; tranchant, christine/0000-0002-2895-1292; Cleret de Langavant, Laurent/0000-0001-6551-4641; Simonin, Clemence/0000-0002-2282-4372; Demonet, Jean-Francois/0000-0003-0100-6175	Institut National de la Sante et la recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS) - Institut des Maladies Rares et I'AP-HP (DRCD); EUSA Pharma	Institut National de la Sante et la recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS) - Institut des Maladies Rares et I'AP-HP (DRCD); EUSA Pharma	This work was supported by cooperative contracts between the Institut National de la Sante et la recherche Medicale (INSERM), the Association Francaise contre les Myopathies (AFM), the Association Huntington France (AHF), and the Groupement d'Interet Scientifique (GIS) - Institut des Maladies Rares et I'AP-HP (DRCD). The team received a grant (about 5000 euro) from EUSA Pharma but EUSA Pharma did not fund directly this study. They wish only data on the use of tetrabenazine, not any result about effectiveness and comparisons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NEUROLOGY, V66, P366, DOI [10.1212/01.wnl.0000198586.85250.13, DOI 10.1212/01.WNL.0000198586.85250.13]; Bonelli RM, 2006, CURR PHARM DESIGN, V12, P2701, DOI 10.2174/138161206777698693; Bonelli RM, 2004, INT CLIN PSYCHOPHARM, V19, P51, DOI 10.1097/00004850-200403000-00001; Bonelli RM, 2002, CLIN NEUROPHARMACOL, V25, P263, DOI 10.1097/00002826-200209000-00007; Erdemoglu AK, 2002, EUR J NEUROL, V9, P182, DOI 10.1046/j.1468-1331.2002.0354e.x; FEIGIN A, 1995, MOVEMENT DISORD, V10, P211, DOI 10.1002/mds.870100213; Frank S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-62; Guo XF, 2011, NEUROSCI LETT, V503, P141, DOI 10.1016/j.neulet.2011.08.027; Jankovic J, 1997, NEUROLOGY, V48, P358, DOI 10.1212/WNL.48.2.358; Laks J, 2004, ARQ NEURO-PSIQUIAT, V62, P1092, DOI 10.1590/S0004-282X2004000600030; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006456.pub2; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008; Nance MA, 1996, MOVEMENT DISORD, V11, P542, DOI 10.1002/mds.870110509; Orth M., 2010, PLOS CURR, V2; Paleacu D, 2002, ACTA NEUROL SCAND, V105, P441, DOI 10.1034/j.1600-0404.2002.01197.x; PENNEY JB, 1990, MOVEMENT DISORD, V5, P93, DOI 10.1002/mds.870050202; Priller J, 2008, MOVEMENT DISORD, V23, P1788, DOI 10.1002/mds.22188; Quinn N, 1985, J Neurol Neurosurg Psychiatry, V48, P292, DOI 10.1136/jnnp.48.3.292; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; SHOULSON I, 1981, NEUROLOGY, V31, P1333, DOI 10.1212/WNL.31.10.1333; Spreeuwenberg MD, 2010, MED CARE, V48, P166, DOI 10.1097/MLR.0b013e3181c1328f; Squitieri F, 2001, NEUROPSY NEUROPSY BE, V14, P69; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; van Vugt JPP, 2004, MOVEMENT DISORD, V19, P285, DOI 10.1002/mds.10718; Venuto CS, 2012, MOVEMENT DISORD, V27, P31, DOI 10.1002/mds.23953; 1996, MOVEMENT DISORD, V11, P136, DOI DOI 10.1002/MDS.870110204; 1993, CELL, V72, P971	29	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85430	10.1371/journal.pone.0085430	http://dx.doi.org/10.1371/journal.pone.0085430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454865	Green Published, gold			2022-12-27	WOS:000330235100083
J	Klaasen, M; Roest, HJ; van der Hoek, W; Goossens, B; Secka, A; Stegeman, A				Klaasen, Marieke; Roest, Hendrik-Jan; van der Hoek, Wim; Goossens, Bart; Secka, Arss; Stegeman, Arjan			Coxiella burnetii Seroprevalence in Small Ruminants in The Gambia	PLOS ONE			English	Article							HOSPITALIZED FEBRILE PATIENTS; Q-FEVER; DOMESTIC RUMINANTS; GOATS; PREVALENCE; ANTIBODIES; DIAGNOSIS; CHILDREN; MALARIA; SHEEP	Background: Q fever is a zoonosis caused by Coxiella burnetii, a Gram negative bacterium present worldwide. Small ruminants are considered the main reservoirs for infection of humans. This study aimed to estimate the extent of C. burnetii infection among sheep and goats in part of The Gambia. Methodology/Principal Findings: This survey was carried out from March to May 2012 at two areas in The Gambia. The first area comprised a cluster of seven rural villages situated 5-15 km west of Farafenni as well as the local abattoir. A second sampling was done at the central abattoir in Abuko (30 km from the capital, Banjul) in the Western Region. Serum samples were obtained from 490 goats and 398 sheep. In addition, 67 milk samples were obtained from lactating dams. Sera were tested with a Q fever ELISA kit. C. burnetii DNA was extracted from milk samples and then detected using a specific quantitative multiplex PCR assay, targeting the IS1111a element. A multivariable mixed logistic regression model was used to examine the relationship between seropositivity and explanatory variables. An overall seroprevalence of 21.6% was found. Goats had a significantly higher seroprevalence than sheep, respectively 24.2% and 18.5%. Seropositive animals were significantly older than seronegative animals. Animals from the villages had a significantly lower seroprevalence than animals from the central abattoir (15.1% versus 29.1%). C. burnetii DNA was detected in 2 out of 67 milk samples, whereas 8 samples gave a doubtful result. Conclusion/Significance: A substantial C. burnetii seroprevalence in sheep and goats in The Gambia was demonstrated. People living in close proximity to small ruminants are exposed to C. burnetii. Q fever should be considered as a possible cause of acute febrile illness in humans in The Gambia. Future studies should include a simultaneous assessment of veterinary and human serology, and include aetiology of febrile illness in local clinics.	[Klaasen, Marieke; Stegeman, Arjan] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Roest, Hendrik-Jan] Cent Vet Inst, Dept Bacteriol & TSEs, Lelystad, Netherlands; [van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands; [Goossens, Bart] SOS Childrens Villages Int, Bakau, Gambia; [Secka, Arss] Int Trypanotolerance Ctr, Banjul, Gambia	Utrecht University; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Stegeman, A (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	J.A.Stegeman@uu.nl			Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This project was funded by a grant of the Dutch Ministry of Economic Affairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN ID, 1987, INFECTION, V15, P323, DOI 10.1007/BF01647731; Bates D., 2011, PACKAGE LME4 LINEAR; Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Devendra C., 2005, Livestock and wealth creation: improving the husbandry of animals kept by resource-poor people in developing countries, P29; Dohoo I. R., 2009, VET EPIDEMIOLOGIC RE, V2, P584; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Geerts S, 2009, TRENDS PARASITOL, V25, P132, DOI 10.1016/j.pt.2008.12.004; Georgiev M, 2013, EURO SURVEILL, V18; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Goossens B, 1998, VET REC, V142, P277, DOI 10.1136/vr.142.11.277; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; Horigan MW, 2011, J VET DIAGN INVEST, V23, P924, DOI 10.1177/1040638711416971; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; KELLY PJ, 1993, S AFR MED J, V83, P21; Kobbe R, 2008, EMERG INFECT DIS, V14, P344, DOI 10.3201/eid1402.070971; Maichomo M W, 2000, Afr J Health Sci, V7, P114; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McQuiston JH, 2002, J AM VET MED ASSOC, V221, P796, DOI 10.2460/javma.2002.221.796; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Ndip LM, 2004, EMERG INFECT DIS, V10, P432, DOI 10.3201/eid1003.020713; Osaer S, 1999, VET PARASITOL, V82, P101, DOI 10.1016/S0304-4017(99)00011-4; Osaer S, 1999, THESIS UTRECHT U UTR, P300; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; R Development Core Team, 2011, R LANG ENV STAT COMP; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Ruiz-Fons F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-3; Ryan E, 2011, VET REC, V169, p280B, DOI 10.1136/vr.d5208; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; Vaidya VM, 2010, COMP IMMUNOL MICROB, V33, P307, DOI 10.1016/j.cimid.2008.10.006; van der Hoek W, 2013, TROP MED INT HEALTH, V18, P850, DOI 10.1111/tmi.12116; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270	37	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85424	10.1371/journal.pone.0085424	http://dx.doi.org/10.1371/journal.pone.0085424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454863	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100082
J	Basner, A; Antranikian, G				Basner, Alexander; Antranikian, Garabed			Isolation and Biochemical Characterization of a Glucose Dehydrogenase from a Hay Infusion Metagenome	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; THERMOPLASMA-ACIDOPHILUM; HALOFERAX-MEDITERRANEI; PURIFICATION; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; METABOLISM; ENZYME; EXPRESSION; MECHANISM; OXIDATION	Glucose hydrolyzing enzymes are essential to determine blood glucose level. A high-throughput screening approach was established to identify NAD(P)-dependent glucose dehydrogenases for the application in test stripes and the respective blood glucose meters. In the current report a glucose hydrolyzing enzyme, derived from a metagenomic library by expressing recombinant DNA fragments isolated from hay infusion, was characterized. The recombinant clone showing activity on glucose as substrate exhibited an open reading frame of 987 bp encoding for a peptide of 328 amino acids. The isolated enzyme showed typical sequence motifs of short-chain-dehydrogenases using NAD(P) as a co-factor and had a sequence similarity between 33 and 35% to characterized glucose dehydrogenases from different Bacillus species. The identified glucose dehydrogenase gene was expressed in E. coli, purified and subsequently characterized. The enzyme, belonging to the superfamily of short-chain dehydrogenases, shows a broad substrate range with a high affinity to glucose, xylose and glucose-6-phosphate. Due to its ability to be strongly associated with its cofactor NAD(P), the enzyme is able to directly transfer electrons from glucose oxidation to external electron acceptors by regenerating the cofactor while being still associated to the protein.	[Basner, Alexander; Antranikian, Garabed] Hamburg Univ Technol, Inst Tech Microbiol, Hamburg, Germany	Hamburg University of Technology	Antranikian, G (corresponding author), Hamburg Univ Technol, Inst Tech Microbiol, Hamburg, Germany.	antranikian@tuhh.de			Hamburg University of Technology	Hamburg University of Technology	The project was funded by the Hamburg University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anastassiadis Savas, 2007, Recent Pat Biotechnol, V1, P167, DOI 10.2174/187220807780809472; Avigad G, 1975, Methods Enzymol, V41, P142; BACH JA, 1962, J BACTERIOL, V83, P699, DOI 10.1128/JB.83.4.699-707.1962; Baik SH, 2003, APPL MICROBIOL BIOT, V61, P329, DOI 10.1007/s00253-002-1215-1; Bhatti HN, 2006, CAN J MICROBIOL, V52, P519, DOI 10.1139/W05-158; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Carius Y, 2010, J BIOL CHEM, V285, P20006, DOI 10.1074/jbc.M110.113738; DAHMS AS, 1972, J BIOL CHEM, V247, P2222; DEMURA M, 1989, BIOSENSORS, V4, P361, DOI 10.1016/0265-928X(89)80002-1; Filling C, 2001, BIOCHEM BIOPH RES CO, V289, P712, DOI 10.1006/bbrc.2001.6032; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; FUJITA Y, 1977, J BACTERIOL, V132, P282, DOI 10.1128/JB.132.1.282-293.1977; GIARDINA P, 1986, BIOCHEM J, V239, P517, DOI 10.1042/bj2390517; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen T, 2002, FEMS MICROBIOL LETT, V216, P249, DOI 10.1016/S0378-1097(02)01021-2; HILT W, 1991, BIOCHIM BIOPHYS ACTA, V1076, P298, DOI 10.1016/0167-4838(91)90281-4; Hones J, 2008, DIABETES TECHNOL THE, V10, pS10, DOI 10.1089/dia.2008.0005; Inose K, 2003, BBA-PROTEINS PROTEOM, V1645, P133, DOI 10.1016/S1570-9639(02)00534-4; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Kristan Katja, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-28; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; METZGER RP, 1972, ARCH BIOCHEM BIOPHYS, V149, P102, DOI 10.1016/0003-9861(72)90303-7; NAGAO T, 1992, J BACTERIOL, V174, P5013, DOI 10.1128/JB.174.15.5013-5020.1992; Nishiya Y, 2004, BIOSCI BIOTECH BIOCH, V68, P2451, DOI 10.1271/bbb.68.2451; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Pennacchio A, 2010, EXTREMOPHILES, V14, P193, DOI 10.1007/s00792-009-0298-3; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Pire C, 2000, J MOL CATAL B-ENZYM, V10, P409, DOI 10.1016/S1381-1177(99)00113-7; RAGUNATHAN S, 1994, ARCH BIOCHEM BIOPHYS, V310, P360, DOI 10.1006/abbi.1994.1179; Ramchandani N, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-28; Siebers B, 1997, ARCH MICROBIOL, V168, P120, DOI 10.1007/s002030050477; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TSAI CS, 1995, ARCH BIOCHEM BIOPHYS, V316, P163, DOI 10.1006/abbi.1995.1024; Tsujimura S, 2006, BIOSCI BIOTECH BIOCH, V70, P654, DOI 10.1271/bbb.70.654; Wohlfahrt G, 2004, MOL CELL BIOCHEM, V260, P69, DOI 10.1023/B:MCBI.0000026056.75937.98; Wohlsen TD, 2011, LETT APPL MICROBIOL, V53, P155, DOI 10.1111/j.1472-765X.2011.03086.x; Yamamoto K, 2001, J BIOCHEM, V129, P303, DOI 10.1093/oxfordjournals.jbchem.a002858; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024; Yasutaka M, 1989, J FERMENTATION BIOEN, P374; Yasutake Y, 2007, J MOL BIOL, V367, P1034, DOI 10.1016/j.jmb.2007.01.029	49	12	12	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85844	10.1371/journal.pone.0085844	http://dx.doi.org/10.1371/journal.pone.0085844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454935	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800053
J	Girotto, G; Vuckovic, D; Buniello, A; Lorente-Canovas, B; Lewis, M; Gasparini, P; Steel, KP				Girotto, Giorgia; Vuckovic, Dragana; Buniello, Annalisa; Lorente-Canovas, Beatriz; Lewis, Morag; Gasparini, Paolo; Steel, Karen P.			Expression and Replication Studies to Identify New Candidate Genes Involved in Normal Hearing Function	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROTEIN; GRM7; IMPAIRMENT; MULTIPLE; ISOFORMS; DEAFNESS; TUBULIN; CELLS; PTPRQ	Considerable progress has been made in identifying deafness genes, but still little is known about the genetic basis of normal variation in hearing function. We recently carried out a Genome Wide Association Study (GWAS) of quantitative hearing traits in southern European populations and found several SNPs with suggestive but none with significant association. In the current study, we followed up these SNPs to investigate which of them might show a genuine association with auditory function using alternative approaches. Firstly, we generated a shortlist of 19 genes from the published GWAS results. Secondly, we carried out immunocytochemistry to examine expression of these 19 genes in the mouse inner ear. Twelve of them showed distinctive cochlear expression patterns. Four showed expression restricted to sensory hair cells (Csmd1, Arsg, Slc16a6 and Gabrg3), one only in marginal cells of the stria vascularis (Dclk1) while the others (Ptprd, Grm8, GlyBP, Evi5, Rimbp2, Ank2, Cdh13) in multiple cochlear cell types. In the third step, we tested these 12 genes for replication of association in an independent set of samples from the Caucasus and Central Asia. Nine out of them showed nominally significant association (p<0.05). In particular, 4 were replicated at the same SNP and with the same effect direction while the remaining 5 showed a significant association in a gene-based test. Finally, to look for genotype-phenotype relationship, the audiometric profiles of the three genotypes of the most strongly associated gene variants were analyzed. Seven out of the 9 replicated genes (CDH13, GRM8, ANK2, SLC16A6, ARSG, RIMBP2 and DCLK1) showed an audiometric pattern with differences between different genotypes further supporting their role in hearing function. These data demonstrate the usefulness of this multistep approach in providing new insights into the molecular basis of hearing and may suggest new targets for treatment and prevention of hearing impairment.	[Girotto, Giorgia; Vuckovic, Dragana; Gasparini, Paolo] Univ Trieste, Dept Med Sci, Trieste, Italy; [Buniello, Annalisa; Lorente-Canovas, Beatriz; Lewis, Morag; Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge, England; [Buniello, Annalisa; Lorente-Canovas, Beatriz; Lewis, Morag; Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy	University of Trieste; Wellcome Trust Sanger Institute; University of London; King's College London; IRCCS Burlo Garofolo	Girotto, G (corresponding author), Univ Trieste, Dept Med Sci, Trieste, Italy.	giorgia.girotto@burlo.trieste.it	Gasparini, Paolo/B-6173-2014; Girotto, Giorgia/I-9452-2018	Vuckovic, Dragana/0000-0001-9343-6142; Buniello, Annalisa/0000-0002-4623-8642; Lewis, Morag/0000-0002-1846-8600; Girotto, Giorgia/0000-0003-4507-6589; Gasparini, Paolo/0000-0002-0859-0856	Italian Ministry of Health; Telethon Foundation [GGP09037]; Welcome Trust [098051, WT100669MA]; Medical Research Council (MRC); MRC [MC_qA137918, G0300212] Funding Source: UKRI; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish	Italian Ministry of Health(Ministry of Health, Italy); Telethon Foundation(Fondazione Telethon); Welcome Trust(Wellcome Trust); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Results have been obtained thanks to funds from a) Italian Ministry of Health (RF and RC to PG), b) Telethon Foundation (GGP09037) to PG, c) Welcome Trust (grant no. 098051) to KPS, d) Welcome Trust (grant no. WT100669MA) to KPS, e) Medical Research Council (MRC) to KPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Blanton SH, 2002, J MED GENET, V39, P567, DOI 10.1136/jmg.39.8.567; Bryant EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063469; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; El-Amraoui A, 2013, PROG MOL BIOL TRANSL, V116, P361, DOI 10.1016/B978-0-12-394311-8.00016-9; Faitar SL, 2005, GENOMICS, V86, P594, DOI 10.1016/j.ygeno.2005.06.002; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Girotto G, 2011, AUDIOL MED, V9, P135; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Lin PT, 2000, J NEUROSCI, V20, P9152; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Nayak G, 2011, DEV NEUROBIOL, V71, P129, DOI 10.1002/dneu.20831; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; Parsons MJ, 2013, AM J MED GENET B, V162B, P431, DOI 10.1002/ajmg.b.32106; Plenge RM, 2011, ARTHRITIS RHEUM-US, V63, P2839, DOI 10.1002/art.30509; Schulz HL, 2002, NEUROSCI LETT, V326, P37, DOI 10.1016/S0304-3940(02)00306-3; Shahin H, 2010, J MED GENET, V47, P643, DOI 10.1136/jmg.2009.075697; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Tannenbaum J, 1997, CELL MOTIL CYTOSKEL, V38, P146, DOI 10.1002/(SICI)1097-0169(1997)38:2<146::AID-CM4>3.0.CO;2-5; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266	32	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85352	10.1371/journal.pone.0085352	http://dx.doi.org/10.1371/journal.pone.0085352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454846	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800040
J	Zhou, B; Qin, SJ; Han, XP; He, Z; Xie, JR; Wang, BH				Zhou, Bin; Qin, Shujia; Han, Xiao-Pu; He, Zhe; Xie, Jia-Rong; Wang, Bing-Hong			A Model of Two-Way Selection System for Human Behavior	PLOS ONE			English	Article								Two-way selection is a common phenomenon in nature and society. It appears in the processes like choosing a mate between men and women, making contracts between job hunters and recruiters, and trading between buyers and sellers. In this paper, we propose a model of two-way selection system, and present its analytical solution for the expectation of successful matching total and the regular pattern that the matching rate trends toward an inverse proportion to either the ratio between the two sides or the ratio of the state total to the smaller group's people number. The proposed model is verified by empirical data of the matchmaking fairs. Results indicate that the model well predicts this typical real-world two-way selection behavior to the bounded error extent, thus it is helpful for understanding the dynamics mechanism of the real-world two-way selection system.	[Zhou, Bin; He, Zhe; Xie, Jia-Rong; Wang, Bing-Hong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Zhou, Bin; He, Zhe; Xie, Jia-Rong; Wang, Bing-Hong] Univ Sci & Technol China, Ctr Nonlinear Sci, Hefei 230026, Peoples R China; [Zhou, Bin] Jiangsu Univ Sci & Technol, Suzhou Inst Technol, Suzhou, Peoples R China; [Qin, Shujia] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Han, Xiao-Pu] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Han, Xiao-Pu] Hangzhou Normal Univ, Alibaba Business Coll, Hangzhou, Zhejiang, Peoples R China; [Wang, Bing-Hong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Jiangsu University of Science & Technology; Suzhou University of Science & Technology; Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Hangzhou Normal University; Hangzhou Normal University; Wenzhou University	Wang, BH (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China.	bhwang@ustc.edu.cn	he, zhe/GSJ-2307-2022; Han, Xiao-Pu/E-8401-2010		National Important Research Project [91024026]; National Natural Science Foundation of China [11205040, 11105024, 11275186]; Major Important Project Fund for Anhui University Nature Science Research [KJ2011ZD07]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20093402110032]	National Important Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Important Project Fund for Anhui University Nature Science Research; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the National Important Research Project (Grant No. 91024026), the National Natural Science Foundation of China (No. 11205040, 11105024, 11275186), the Major Important Project Fund for Anhui University Nature Science Research (Grant No. KJ2011ZD07) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20093402110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldarelli G, 2001, PHYSICA A, V300, P325, DOI 10.1016/S0378-4371(01)00327-2; Chakraborti A, 2013, ARXIV13052121; Guillaume JL, 2004, INFORM PROCESS LETT, V90, P215, DOI 10.1016/j.ipl.2004.03.007; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Laureti P, 2003, PHYSICA A, V324, P49, DOI 10.1016/S0378-4371(02)01953-2; Li Lin, 2008, P 23 NAT C ART INT, V8, P1189; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Omero MJ, 1997, J PHYS I, V7, P1723, DOI 10.1051/jp1:1997166; Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006; Zanette DH, 2001, PHYSICA A, V295, P1, DOI 10.1016/S0378-4371(01)00046-2; Zhang CJ, 2012, PHYSICA A, V391, P1822, DOI 10.1016/j.physa.2011.09.038; Zhang YC, 2001, PHYSICA A, V299, P104, DOI 10.1016/S0378-4371(01)00278-3; Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033	15	5	5	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e81424	10.1371/journal.pone.0081424	http://dx.doi.org/10.1371/journal.pone.0081424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454687	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500002
J	Lalioti, VS; Ilari, A; O'Connell, DJ; Poser, E; Sandoval, IV; Colotti, G				Lalioti, Vasiliki S.; Ilari, Andrea; O'Connell, David J.; Poser, Elena; Sandoval, Ignacio V.; Colotti, Gianni			Sorcin Links Calcium Signaling to Vesicle Trafficking, Regulates Polo-Like Kinase 1 and Is Necessary for Mitosis	PLOS ONE			English	Article							BINDING PROTEIN; ANNEXIN-VII; AURORA-A; MULTIDRUG-RESISTANCE; CRYSTAL-STRUCTURE; UP-REGULATION; CA2+ CURRENT; CELL; IDENTIFICATION; LOCALIZATION	Sorcin, a protein overexpressed in many multi-drug resistant cancers, dynamically localizes to distinct subcellular sites in 3T3-L1 fibroblasts during cell-cycle progression. During interphase sorcin is in the nucleus, in the plasma membrane, in endoplasmic reticulum (ER) cisternae, and in ER-derived vesicles localized along the microtubules. These vesicles are positive to RyR, SERCA, calreticulin and Rab10. At the beginning of mitosis, sorcin-containing vesicles associate with the mitotic spindle, and during telophase are concentrated in the cleavage furrow and, subsequently, in the midbody. Sorcin regulates dimensions and calcium load of the ER vesicles by inhibiting RYR and activating SERCA. Analysis of sorcin interactome reveals calcium-dependent interactions with many proteins, including Polo-like kinase 1 (PLK1), Aurora A and Aurora B kinases. Sorcin interacts physically with PLK1, is phosphorylated by PLK1 and induces PLK1 autophosphorylation, thereby regulating kinase activity. Knockdown of sorcin results in major defects in mitosis and cytokinesis, increase in the number of rounded polynucleated cells, blockage of cell progression in G2/M, apoptosis and cell death. Sorcin regulates calcium homeostasis and is necessary for the activation of mitosis and cytokinesis.	[Lalioti, Vasiliki S.; Sandoval, Ignacio V.] CSIC Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Celular & Inmunol, Cantoblanco Ctr Invest Biomed Red Enfermedades He, Madrid, Spain; [Ilari, Andrea; Colotti, Gianni] Univ Roma La Sapienza, CNR Natl Res Council Italy, Inst Mol Biol & Pathol, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [O'Connell, David J.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Poser, Elena] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University College Dublin; Sapienza University Rome	Lalioti, VS (corresponding author), CSIC Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Celular & Inmunol, Cantoblanco Ctr Invest Biomed Red Enfermedades He, Madrid, Spain.	vlalioti@cbm.uam.es; gianni.colotti@uniroma1.it	Colotti, Gianni/AAG-4918-2019; Ilari, Andrea/AAC-7670-2022; Colotti, Gianni/D-2015-2010; Ilari, Andrea/T-5501-2017	Ilari, Andrea/0000-0002-7754-399X; Colotti, Gianni/0000-0002-9913-0635; Ilari, Andrea/0000-0002-7754-399X; O'Connell, David/0000-0002-6461-7750; LALIOTI, VASILIKI/0000-0002-4273-6126	Fondo de Investigaciones Sanitarias de Espana [PI11/00922]; PRIN MIUR; Italian Ministry of Economy and Finance; Progetto Bandiera CNR Nanomax Nadine [P2010IT01]	Fondo de Investigaciones Sanitarias de Espana(Spanish Government); PRIN MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Economy and Finance; Progetto Bandiera CNR Nanomax Nadine	This work was supported by grants PI11/00922 Fondo de Investigaciones Sanitarias de Espana, PRIN 2007 MIUR, funds from Italian Ministry of Economy and Finance to the CNR for the Project FaReBio di Qualita (qPMO), Progetto Bandiera CNR Nanomax Nadine, P2010IT01 cooperation CSIC-CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DF, 2007, J MOL CELL CARDIOL, V43, P492, DOI 10.1016/j.yjmcc.2007.07.003; Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, P12; Barr FA, 2005, METHOD ENZYMOL, V403, P391, DOI 10.1016/S0076-6879(05)03034-X; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colotti G, 2006, BIOCHEMISTRY-US, V45, P12519, DOI 10.1021/bi060416a; Deng LM, 2010, MED ONCOL, V27, P1102, DOI 10.1007/s12032-009-9342-5; Dickson EJ, 2012, P NATL ACAD SCI USA, V109, pE3539, DOI 10.1073/pnas.1218247109; DWYER N, 1976, J CELL BIOL, V70, P581, DOI 10.1083/jcb.70.3.581; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Fowler MR, 2008, EXP PHYSIOL, V93, P1233, DOI 10.1113/expphysiol.2008.043497; Franceschini S, 2008, FASEB J, V22, P295, DOI 10.1096/fj.07-8988com; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; He QC, 2011, ONCOL REP, V25, P237, DOI 10.3892/or_00001066; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ilari A, 2002, J MOL BIOL, V317, P447, DOI 10.1006/jmbi.2002.5417; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KAO JPY, 1990, J CELL BIOL, V111, P183, DOI 10.1083/jcb.111.1.183; Kawakami M, 2007, BIOL PHARM BULL, V30, P1065, DOI 10.1248/bpb.30.1065; KEITH CH, 1985, NATURE, V316, P848, DOI 10.1038/316848a0; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Landriscina M, 2010, CANCER RES, V70, P6577, DOI 10.1158/0008-5472.CAN-10-1256; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Maddalena F, 2011, CANCER RES, V71, P7659, DOI 10.1158/0008-5472.CAN-11-2172; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matsumoto T, 2005, BASIC RES CARDIOL, V100, P250, DOI 10.1007/s00395-005-0518-7; Mella M, 2003, J BIOL CHEM, V278, P24921, DOI 10.1074/jbc.M213276200; MEYERS MB, 1987, BIOCHEM PHARMACOL, V36, P2373, DOI 10.1016/0006-2952(87)90606-X; MEYERS MB, 1995, FEBS LETT, V357, P230, DOI 10.1016/0014-5793(94)01338-2; Nagpal JK, 2007, EUR J CLIN INVEST, V37, P658, DOI 10.1111/j.1365-2362.2007.01841.x; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Connell DJ, 2010, MOL CELL PROTEOMICS, V9, P1118, DOI 10.1074/mcp.M900324-MCP200; OHTA Y, 1990, P NATL ACAD SCI USA, V87, P5341, DOI 10.1073/pnas.87.14.5341; Padar S, 2004, BRIT J PHARMACOL, V142, P305, DOI 10.1038/sj.bjp.0705755; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Pickel VM, 1997, J COMP NEUROL, V386, P625, DOI 10.1002/(SICI)1096-9861(19971006)386:4<625::AID-CNE8>3.0.CO;2-4; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Qi J, 2006, BIOCHEM BIOPH RES CO, V349, P303, DOI 10.1016/j.bbrc.2006.08.042; Qu YQ, 2010, MED ONCOL, V27, P1303, DOI 10.1007/s12032-009-9379-5; RATAN RR, 1986, P NATL ACAD SCI USA, V83, P5136, DOI 10.1073/pnas.83.14.5136; Salzer U, 2002, BLOOD, V99, P2569, DOI 10.1182/blood.V99.7.2569; Schmit TL, 2012, CANCER RES, V72, P3864, DOI 10.1158/0008-5472.CAN-12-0714; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Suarez J, 2013, AM J PHYSIOL-CELL PH, V304, pC248, DOI 10.1152/ajpcell.00039.2012; Szulc Jolanta, 2008, V434, P291, DOI 10.1007/978-1-60327-248-3_18; Tan YH, 2003, LEUKEMIA RES, V27, P125, DOI 10.1016/S0145-2126(02)00083-8; TOMBES RM, 1989, J CELL BIOL, V109, P627, DOI 10.1083/jcb.109.2.627; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; VANDERBLIEK AM, 1988, CANCER RES, V48, P5927; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yang YX, 2008, J CELL BIOCHEM, V104, P1010, DOI 10.1002/jcb.21687; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Zamparelli C, 1997, FEBS LETT, V409, P1, DOI 10.1016/S0014-5793(97)00464-X; Zhao P, 2010, CHEM-BIOL INTERACT, V186, P166, DOI 10.1016/j.cbi.2010.04.015; Zhou Y, 2006, LEUKEMIA RES, V30, P469, DOI 10.1016/j.leukres.2005.08.024	71	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85438	10.1371/journal.pone.0085438	http://dx.doi.org/10.1371/journal.pone.0085438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427308	Green Published, gold			2022-12-27	WOS:000329868200049
J	Mahajan, IM; Chen, MD; Muro, I; Robertson, JD; Wright, CW; Bratton, SB				Mahajan, Indra M.; Chen, Miao-Der; Muro, Israel; Robertson, John D.; Wright, Casey W.; Bratton, Shawn B.			BH3-Only Protein BIM Mediates Heat Shock-Induced Apoptosis	PLOS ONE			English	Article							STRESS-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; CELL-DEATH; MITOCHONDRIAL PERMEABILIZATION; MEMBRANE PERMEABILIZATION; BCL-2 PROTEINS; CASPASE-2; BAX; ACTIVATION; COMPLEX	Acute heat shock can induce apoptosis through a canonical pathway involving the upstream activation of caspase-2, followed by BID cleavage and stimulation of the intrinsic pathway. Herein, we report that the BH3-only protein BIM, rather than BID, is essential to heat shock-induced cell death. We observed that BIM-deficient cells were highly resistant to heat shock, exhibiting short and long-term survival equivalent to Bax(-/-)Bak(-/-) cells and better than either Bid(-/-) or dominantnegative caspase-9-expressing cells. Only Bim(-/-) and Bax(-/-)Bak(-/-) cells exhibited resistance to mitochondrial outer membrane permeabilization and loss of mitochondrial inner membrane potential. Moreover, while dimerized caspase-2 failed to induce apoptosis in Bid(-/-) cells, it readily did so in Bim(-/-) cells, implying that caspase-2 kills exclusively through BID, not BIM. Finally, BIM reportedly associates with MCL-1 following heat shock, and Mcl-1(-/-) cells were indeed sensitized to heat shock-induced apoptosis. However, pharmacological inhibition of BCL-2 and BCL-XL with ABT-737 also sensitized cells to heat shock, most likely through liberation of BIM. Thus, BIM mediates heat shock-induced apoptosis through a BAX/BAK-dependent pathway that is antagonized by antiapoptotic BCL-2 family members.	[Mahajan, Indra M.; Chen, Miao-Der; Bratton, Shawn B.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Mahajan, Indra M.; Chen, Miao-Der; Muro, Israel; Wright, Casey W.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Kansas; University of Kansas Medical Center	Bratton, SB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX USA.	sbbratton@mdanderson.org		Wright, Casey/0000-0002-9512-1264; Bratton, Shawn/0000-0003-2895-5020	National Institutes of Health [CA129521, GM096101]; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by R01 grants, CA129521 and GM096101, from the National Institutes of Health (all to SBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chigancas V, 2000, CANCER RES, V60, P2458; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Milleron RS, 2006, J BIOL CHEM, V281, P16991, DOI 10.1074/jbc.M512754200; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Parsons MJ, 2013, CELL DEATH IN PRESS; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Shelton SN, 2010, J BIOL CHEM, V285, P40525, DOI 10.1074/jbc.M110.167635; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	44	11	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84388	10.1371/journal.pone.0084388	http://dx.doi.org/10.1371/journal.pone.0084388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427286	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200026
J	Rupp, O; Becker, J; Brinkrolf, K; Timmermann, C; Borth, N; Puhler, A; Noll, T; Goesmann, A				Rupp, Oliver; Becker, Jennifer; Brinkrolf, Karina; Timmermann, Christina; Borth, Nicole; Puehler, Alfred; Noll, Thomas; Goesmann, Alexander			Construction of a Public CHO Cell Line Transcript Database Using Versatile Bioinformatics Analysis Pipelines	PLOS ONE			English	Article							RNA; SEQUENCE; GENERATION; ALIGNMENT; PROTEIN; PLATFORM; PROGRAM; BLAST	Chinese hamster ovary (CHO) cell lines represent the most commonly used mammalian expression system for the production of therapeutic proteins. In this context, detailed knowledge of the CHO cell transcriptome might help to improve biotechnological processes conducted by specific cell lines. Nevertheless, very few assembled cDNA sequences of CHO cells were publicly released until recently, which puts a severe limitation on biotechnological research. Two extended annotation systems and web-based tools, one for browsing eukaryotic genomes (GenDBE) and one for viewing eukaryotic transcriptomes (SAMS), were established as the first step towards a publicly usable CHO cell genome/transcriptome analysis platform. This is complemented by the development of a new strategy to assemble the ca. 100 million reads, sequenced from a broad range of diverse transcripts, to a high quality CHO cell transcript set. The cDNA libraries were constructed from different CHO cell lines grown under various culture conditions and sequenced using Roche/454 and Illumina sequencing technologies in addition to sequencing reads from a previous study. Two pipelines to extend and improve the CHO cell line transcripts were established. First, de novo assemblies were carried out with the Trinity and Oases assemblers, using varying k-mer sizes. The resulting contigs were screened for potential CDS using ESTScan. Redundant contigs were filtered out using cd-hit-est. The remaining CDS contigs were re-assembled with CAP3. Second, a reference-based assembly with the TopHat/Cufflinks pipeline was performed, using the recently published draft genome sequence of CHO-K1 as reference. Additionally, the de novo contigs were mapped to the reference genome using GMAP and merged with the Cufflinks assembly using the cuffmerge software. With this approach 28,874 transcripts located on 16,492 gene loci could be assembled. Combining the results of both approaches, 65,561 transcripts were identified for CHO cell lines, which could be clustered by sequence identity into 17,598 gene clusters.	[Rupp, Oliver; Becker, Jennifer; Brinkrolf, Karina; Puehler, Alfred; Noll, Thomas; Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Rupp, Oliver; Becker, Jennifer; Timmermann, Christina; Noll, Thomas] Univ Bielefeld, D-33615 Bielefeld, Germany; [Borth, Nicole] Univ Bodenkultur Wien, Dept Biotechnol, Vienna, Austria; [Borth, Nicole] ACIB, Graz, Austria; [Borth, Nicole] ACIB, Vienna, Austria; [Rupp, Oliver; Goesmann, Alexander] Univ Giessen, D-35390 Giessen, Germany	University of Bielefeld; University of Bielefeld; University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; Austrian Centre of Industrial Biotechnology; Justus Liebig University Giessen	Rupp, O (corresponding author), Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany.	oliver@cebitec.uni-bielefeld.de	Noll, Thomas/A-3539-2012	Noll, Thomas/0000-0003-0748-3423; Puhler, Alfred/0000-0003-4723-2960; Borth, Nicole/0000-0001-6324-9338; Rupp, Oliver/0000-0003-2755-6458; Goesmann, Alexander/0000-0002-7086-2568	European Union; German federal state North Rhine-Westphalia (NRW); CLIB Graduate Cluster Industrial Biotechnology; Ziel2.NRW; European Regional Development Fund; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (MIWF); ACIB; COMET K2 center of the Austrian FFG	European Union(European Commission); German federal state North Rhine-Westphalia (NRW); CLIB Graduate Cluster Industrial Biotechnology; Ziel2.NRW; European Regional Development Fund(European Commission); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (MIWF); ACIB; COMET K2 center of the Austrian FFG	The project is co-funded by the European Union (European Regional Development Fund - Investing in your future) and the German federal state North Rhine-Westphalia (NRW). JB acknowledges the receipt of a scholarship from the CLIB Graduate Cluster Industrial Biotechnology (http://www.graduatecluster.net/). CT is funded by Ziel2.NRW (http://www.ziel2.nrw.de/), the European Regional Development Fund and Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (MIWF). NB acknowledges funding by ACIB (http://lamp3.tugraz.at/similar to acib/index.php/wbindex/start), a COMET K2 center of the Austrian FFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Bekel T, 2009, J BIOTECHNOL, V140, P3, DOI 10.1016/j.jbiotec.2009.01.006; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Boutet E, 2007, PLANT BIOINFORMATICS, P89, DOI DOI 10.1007/978-1-59745-535-0_; Brinkrolf K, 2013, NAT BIOTECHNOL, V31, P694, DOI 10.1038/nbt.2645; Clarke K, 2013, SCI CHINA LIFE SCI, V56, P156, DOI 10.1007/s11427-013-4444-x; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Ernst Wolfgang, 2006, Biotechnology Journal, V1, P639, DOI 10.1002/biot.200600010; Gatti MD, 2007, J BIOSCI BIOENG, V103, P82, DOI 10.1263/jbb.103.82; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grasso C, 2004, BIOINFORMATICS, V20, P1546, DOI 10.1093/bioinformatics/bth126; Grasso C, 2003, BIOINFORMATICS, V19, P1446, DOI 10.1093/bioinformatics/btg175; Hammond S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-67; Hassan MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-696; Hazelhurst S, 2008, BIOINFORMATICS, V24, P1542, DOI 10.1093/bioinformatics/btn203; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; Hide W, 1994, J Comput Biol, V1, P199, DOI 10.1089/cmb.1994.1.199; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacob NM, 2010, BIOTECHNOL BIOENG, V105, P1002, DOI 10.1002/bit.22588; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Kantardjieff A, 2009, BIOTECHNOL ADV, V27, P1028, DOI 10.1016/j.biotechadv.2009.05.023; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lewis NE, 2013, NAT BIOTECH; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu BX, 2013, SCI CHINA LIFE SCI, V56, P143, DOI 10.1007/s11427-013-4442-z; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Schneider J, 2011, J BIOTECHNOL, V155, P118, DOI 10.1016/j.jbiotec.2010.10.076; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yee JC, 2008, BIOTECHNOL BIOENG, V101, P1359, DOI 10.1002/bit.21984; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	45	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85568	10.1371/journal.pone.0085568	http://dx.doi.org/10.1371/journal.pone.0085568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427317	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200058
J	Aneni, EC; Roberson, LL; Maziak, W; Agatston, AS; Feldman, T; Rouseff, M; Tran, TH; Blumenthal, RS; Blaha, MJ; Blankstein, R; Al-Mallah, MH; Budoff, MJ; Nasir, K				Aneni, Ehimen C.; Roberson, Lara L.; Maziak, Wasim; Agatston, Arthur S.; Feldman, Theodore; Rouseff, Maribeth; Tran, Thinh H.; Blumenthal, Roger S.; Blaha, Michael J.; Blankstein, Ron; Al-Mallah, Mouaz H.; Budoff, Matthew J.; Nasir, Khurram			A Systematic Review of Internet-Based Worksite Wellness Approaches for Cardiovascular Disease Risk Management: Outcomes, Challenges & Opportunities	PLOS ONE			English	Review							PHYSICAL-ACTIVITY INTERVENTIONS; OVERWEIGHT WORKING POPULATION; TAILORED WEIGHT MANAGEMENT; HEALTH-PROMOTION; FOLLOW-UP; PROGRAM; NUTRITION; WORKPLACE; EMPLOYEES; EFFICACY	Context: The internet is gaining popularity as a means of delivering employee-based cardiovascular (CV) wellness interventions though little is known about the cardiovascular health outcomes of these programs. In this review, we examined the effectiveness of internet-based employee cardiovascular wellness and prevention programs. Evidence Acquisition: We conducted a systematic review by searching PubMed, Web of Science and Cochrane library for all published studies on internet-based programs aimed at improving CV health among employees up to November 2012. We grouped the outcomes according to the American Heart Association (AHA) indicators of cardiovascular wellbeing - weight, BP, lipids, smoking, physical activity, diet, and blood glucose. Evidence Synthesis: A total of 18 randomized trials and 11 follow-up studies met our inclusion/exclusion criteria. Follow-up duration ranged from 6 - 24 months. There were significant differences in intervention types and number of components in each intervention. Modest improvements were observed in more than half of the studies with weight related outcomes while no improvement was seen in virtually all the studies with physical activity outcome. In general, internet-based programs were more successful if the interventions also included some physical contact and environmental modification, and if they were targeted at specific disease entities such as hypertension. Only a few of the studies were conducted in persons at-risk for CVD, none in blue-collar workers or low-income earners. Conclusion: Internet based programs hold promise for improving the cardiovascular wellness among employees however much work is required to fully understand its utility and long term impact especially in special/at-risk populations.	[Aneni, Ehimen C.; Roberson, Lara L.; Agatston, Arthur S.; Feldman, Theodore; Nasir, Khurram] Baptist Hlth Med Grp, Ctr Prevent & Wellness Res, Miami Beach, FL 33145 USA; [Rouseff, Maribeth; Tran, Thinh H.] Baptist Hlth South Florida, Miami, FL USA; [Maziak, Wasim; Nasir, Khurram] Florida Int Univ, Dept Epidemiol, Robert Stempel Coll Publ Hlth, Miami, FL 33199 USA; [Blumenthal, Roger S.; Blaha, Michael J.; Nasir, Khurram] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA; [Blankstein, Ron] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Al-Mallah, Mouaz H.] King Abdul Aziz Cardiac Ctr, Riyadh, Saudi Arabia; [Budoff, Matthew J.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Nasir, Khurram] Florida Int Univ, Dept Med, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; State University System of Florida; Florida International University	Nasir, K (corresponding author), Baptist Hlth Med Grp, Ctr Prevent & Wellness Res, Miami Beach, FL 33145 USA.	KhurramN@baptisthealth.net	Budoff, Matthew/ABD-5175-2021; Blumenthal, Roger S/H-3223-2018; Maziak, Wasim/V-7567-2017	Budoff, Matthew/0000-0002-9616-1946; Blumenthal, Roger S/0000-0003-1910-3168; Al-Mallah, Mouaz/0000-0003-2348-0484				Aittasalo M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-403; Arem H, 2011, OBES REV, V12, pe236, DOI 10.1111/j.1467-789X.2010.00787.x; Baicker K, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0626; Benedict MA, 2008, AM J HEALTH PROMOT, V22, P408, DOI 10.4278/ajhp.22.6.408; Bennett JB, 2011, J OCCUP ENVIRON MED, V53, P911, DOI 10.1097/JOM.0b013e3182258bd8; Bureau USC, 2010, REP INT US HOUS HOUS; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003440.pub3; Carnethon M, 2009, CIRCULATION, V120, P1725, DOI 10.1161/CIRCULATIONAHA.109.192653; Colkesen EB, 2011, VASC HEALTH RISK MAN, V7, P67, DOI 10.2147/VHRM.S16340; Dekkers JC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-49; Graham AL, 2007, J OCCUP ENVIRON MED, V49, P821, DOI 10.1097/JOM.0b013e3180d09e6f; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Hotta K, 2007, INT J CLIN PRACT, V61, P1997, DOI 10.1111/j.1742-1241.2007.01466.x; Hughes SL, 2011, AM J PUBLIC HEALTH, V101, P883, DOI 10.2105/AJPH.2010.300082; Hutchinson AD, 2012, HEALTH PROMOT INT, V27, P238, DOI 10.1093/heapro/dar035; Jung H, 2012, J TELEMED TELECARE, V18, P339, DOI 10.1258/jtt.2012.120318; Kang JY, 2010, DIABETES RES CLIN PR, V90, P26, DOI 10.1016/j.diabres.2010.06.006; Kodama S, 2012, INT J OBESITY, V36, P675, DOI 10.1038/ijo.2011.121; Leeks KD, 2010, AM J PREV MED, V38, pS263, DOI 10.1016/j.amepre.2009.10.034; Lewis A., 2013, IS IT TIME REEXAMINE; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; McHugh J, 2012, J HEALTH COMMUN, V17, P278, DOI 10.1080/10810730.2011.626496; Moore TJ, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1114; Morgan PJ, 2009, OBESITY, V17, P2025, DOI 10.1038/oby.2009.85; Ogilvie D, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-8; Papadaki A, 2005, BRIT J NUTR, V94, P290, DOI 10.1079/BJN20051476; Papadaki A, 2008, PATIENT EDUC COUNS, V73, P256, DOI 10.1016/j.pec.2008.05.030; Perez AP, 2009, PREV CHRONIC DIS, V6; Petersen R, 2008, J OCCUP ENVIRON MED, V50, P163, DOI 10.1097/JOM.0b013e31815c6cf6; Pratt David S, 2006, Dis Manag, V9, P284, DOI 10.1089/dis.2006.9.284; Prochaska JO, 2008, PREV MED, V46, P226, DOI 10.1016/j.ypmed.2007.11.007; Proper KI, 2003, CLIN J SPORT MED, V13, P106, DOI 10.1097/00042752-200303000-00008; Reijonsaari K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-344; Robroek SJW, 2012, HEALTH EDUC RES, V27, P399, DOI 10.1093/her/cys015; Roger VL, 2011, CIRCULATION; Sarno L, 2009, NURS OUTLOOK, V57, P246, DOI 10.1016/j.outlook.2009.03.002; Shephard RJ, 1996, AM J HEALTH PROMOT, V10, P436, DOI 10.4278/0890-1171-10.6.436; Slootmaker SM, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1139; Speck RM, 2010, HEALTH PROMOT PRACT, V11, P741, DOI 10.1177/1524839908330745; Spittaels H, 2007, HEALTH EDUC RES, V22, P385, DOI 10.1093/her/cyl096; Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172; Thorndike AN, 2012, AM J PREV MED, V43, P27, DOI 10.1016/j.amepre.2012.02.029; van den Berg MH, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e26; van Genugten L, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1901; van Wier MF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-6; Vandelanotte C, 2007, AM J PREV MED, V33, P54, DOI 10.1016/j.amepre.2007.02.041; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; Watson AJ, 2012, AM HEART J, V164, P625, DOI 10.1016/j.ahj.2012.06.013; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376	49	53	54	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83594	10.1371/journal.pone.0083594	http://dx.doi.org/10.1371/journal.pone.0083594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421894	Green Published, gold			2022-12-27	WOS:000329862500058
J	Figueira, M; Moschioni, M; De Angelis, G; Barocchi, M; Sabharwal, V; Masignani, V; Pelton, SI				Figueira, Marisol; Moschioni, Monica; De Angelis, Gabriella; Barocchi, Michele; Sabharwal, Vishakha; Masignani, Vega; Pelton, Stephen I.			Variation of Pneumococcal Pilus-1 Expression Results in Vaccine Escape during Experimental Otitis Media [EOM]	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; VIRULENCE; MICE	The pneumococcal Pilus-1 enhances attachment to epithelial cells in the respiratory tract and subsequent invasion. Pilus-1 expression is bi-stable and positively regulated by the RlrA transcriptional regulator. To delineate the role of pilus-1 in Experimental Otitis Media (EOM), we evaluated colonization and disease due to a Streptococcus pneumoniae (SP) wild type strain (Taiwan19F-14 wt) and its otherwise isogenic pilus-1 and pilus-2 deficient mutant (Taiwan19F-14 Delta PI-1/PI-2-) as well as potential for a chimeric protein (RrgB321) vaccine candidate for prevention of middle ear (ME) disease. Methods: Chinchillas were challenged intranasally with either Taiwan19F-14 wt or Taiwan19F-14PI-1/PI-2 deficient mutant. ME status was assessed and direct cultures performed. New cohorts of animals were immunized with RrgB321 or alum. Intranasal challenge with Taiwan19F-14 wt [erythromycin susceptible E(S)] was performed. Subsequently, a second cohort of animals was immunized and challenged with either Taiwan19F-14 wt or a Pilus-1 over-expressing mutant [Taiwan19F-14+pMU1328_Pc-rlrA mutant; E resistant (R)] strain. Pilus-1 expression was analyzed in SP isolated from nasopharynx (NP) and ME fluids by flow cytometry. Results: Culture positive EOM developed following challenge with either wild type SP (Taiwan19F-14) or its pilus-1 deficient mutant. Culture positive EOM developed following challenge with wild type in both RrgB321 immunized and control animals. Pilus-1 expression in ME fluids was significantly higher in controls compared to immunized chinchillas. In second cohort of immunized and control animals challenged with the over-expressing Pilus-1 mutant, delayed development of EOM in the immunized animals was observed. Pneumococci recovered from ME fluid of immunized animals were no longer E(R) signifying the loss of the pMU1328_Pc-rlrA plasmid. Conclusion: Pneumococcal pilus-1 was not essential for EOM. Regulation of Pilus-1 expression in ME fluids in the presence of anti RrgB321 antibody was essential for survival of S. pneumoniae. Pneumococci have evolved mechanisms of regulation of non-essential surface proteins to evade host defenses.	[Figueira, Marisol; Sabharwal, Vishakha; Pelton, Stephen I.] Boston Med Ctr, Maxwell Finland Lab Infect Dis, Sect Pediat Infect Dis, Boston, MA 02118 USA; [Moschioni, Monica; De Angelis, Gabriella; Barocchi, Michele; Masignani, Vega] Novartis Vaccines & Diagnost, Siena, Italy	Boston Medical Center; Novartis	Figueira, M (corresponding author), Boston Med Ctr, Maxwell Finland Lab Infect Dis, Sect Pediat Infect Dis, Boston, MA 02118 USA.	Marisol.Figuiera@bmc.org	Sabharwal, Vishakha/GXG-8148-2022	Sabharwal, Vishakha/0000-0002-5092-4442; Pelton, Stephen/0000-0003-4862-5344	Novartis Vaccines and Diagnostics, Siena, Italy	Novartis Vaccines and Diagnostics, Siena, Italy	Supported by a research grant from Novartis Vaccines and Diagnostics, Siena, Italy. This manuscript was a collaboration between Drs. Pelton and Figueira at Boston University and Drs. Barocchi, De Angelis, Moschioni and Masignani at Novartis Vaccines. As such all 6 investigators were involved in study design, analysis, and preparation of the manuscript.	ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Babl FE, 2002, ANTIMICROB AGENTS CH, V46, P2194, DOI 10.1128/AAC.46.7.2194-2199.2002; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Figueira MA, 2007, INFECT IMMUN, V75, P325, DOI 10.1128/IAI.01054-06; KARASIC RB, 1989, PEDIATR INFECT DIS J, V8, pS62; Moschioni M, 2010, CLIN MICROBIOL INFEC, V16, P1501, DOI [10.1111/j.1469-0691.2009.03105.x, 10.1111/j.1469-0691.2010.03105.x]; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Pancotto L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02040; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Sabharwal V, 2012, MICROBES INFECT, V14, P712, DOI 10.1016/j.micinf.2012.02.008; Sabharwal V, 2009, INFECT IMMUN, V77, P1121, DOI 10.1128/IAI.01148-08; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514, DOI 10.1128/JCM.36.12.3514-3519.1998	17	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83798	10.1371/journal.pone.0083798	http://dx.doi.org/10.1371/journal.pone.0083798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421906	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500074
J	Nishio, M; Satoh, M				Nishio, Motohide; Satoh, Masahiro			Including Dominance Effects in the Genomic BLUP Method for Genomic Evaluation	PLOS ONE			English	Article							INFORMATION; PREDICTION; SELECTION; VALUES	We evaluated the performance of GBLUP including dominance genetic effect (GBLUP-D) by estimating variances and predicting genetic merits in a computer simulation and 2 actual traits (T4 and T5) in pigs. In simulation data, GBLUP-D explained more than 50% of dominance genetic variance. Moreover, GBLUP-D yielded estimated total genetic effects over 1.2% more accurate than those yielded by GBLUP. In particular, when the dominance genetic variance was large, the accuracy could be substantially improved by increasing the number of markers. The dominance genetic variances in T4 and T5 accounted for 9.6% and 6.3% of the phenotypic variances, respectively. Estimates of such small dominance genetic variances contributed little to the improvement of the accuracies of estimated total genetic effects. In both simulation and pig data, there were nearly no differences in the estimates of additive genetic effects or their variance between GBLUP-D and GBLUP. Therefore, we conclude GBLUP-D is a feasible approach to improve genetic performance in crossbred populations with large dominance genetic variation and identify mating systems with good combining ability.	[Nishio, Motohide; Satoh, Masahiro] NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan	Nishio, M (corresponding author), NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan.	mtnishio@affrc.go.jp						Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; Da Y, 2013, J DAIRY SCI S1, V96, P620; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Falconer D. S., 1996, INTRO QUANTITATIVE G; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mc Hugh N, 2011, J DAIRY SCI, V94, P4109, DOI 10.3168/jds.2010-4016; Meuwissen THE, 2001, GENETICS, V157, P1819; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Sun C, 2013, J DAIRY SCI IN PRESS; Toro MA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-33; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vitezica ZG, 2013, GENETICS IN PRESS; Wang C, 2013, J DAIRY SCI S1, V96, P620; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wittenburg D, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-74; Xu S, 2013, GENETICS IN PRESS; Yao C, 2013, J DAIRY SCI, V96, P6716, DOI 10.3168/jds.2012-6237	27	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85792	10.1371/journal.pone.0085792	http://dx.doi.org/10.1371/journal.pone.0085792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416447	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500265
J	Berenji, B; Chou, T; D'Orsogna, MR				Berenji, Bijan; Chou, Tom; D'Orsogna, Maria R.			Recidivism and Rehabilitation of Criminal Offenders: A Carrot and Stick Evolutionary Game	PLOS ONE			English	Article							COOPERATION; PUNISHMENT; CRIME; ALLOWS	Motivated by recent efforts by the criminal justice system to treat and rehabilitate nonviolent offenders rather than focusing solely on their punishment, we introduce an evolutionary game theoretic model to study the effects of "carrot and stick" intervention programs on criminal recidivism. We use stochastic simulations to study the evolution of a population where individuals may commit crimes depending on their past history, surrounding environment and, in the case of recidivists, on any counseling, educational or training programs available to them after being punished for their previous crimes. These sociological factors are embodied by effective parameters that determine the decision making probabilities. Players may decide to permanently reform or continue engaging in criminal activity, eventually reaching a state where they are considered incorrigible. Depending on parameter choices, the outcome of the game is a society with a majority of virtuous, rehabilitated citizens or incorrigibles. Since total resources may be limited, we constrain the combined punishment and rehabilitation costs per crime to be fixed, so that increasing one effort will necessarily decrease the other. We find that the most successful strategy in reducing crime is to optimally allocate resources so that after being punished, criminals experience impactful intervention programs, especially during the first stages of their return to society. Excessively harsh or lenient punishments are less effective. We also develop a system of coupled ordinary differential equations with memory effects to give a qualitative description of our simulated societal dynamics. We discuss our findings and sociological implications.	[Berenji, Bijan; Chou, Tom; D'Orsogna, Maria R.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA; [D'Orsogna, Maria R.] Calif State Univ Northridge, Dept Math, Los Angeles, CA USA	University of California System; University of California Los Angeles; California State University System; California State University Northridge	D'Orsogna, MR (corresponding author), Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA.	dorsogna@csun.edu		Berenji, Bijan/0000-0002-4551-772X	National Science Foundation [DM-1021850, DM-1021818]; ARO through MURI [W911NF-11-1-0332, 58386MA]	National Science Foundation(National Science Foundation (NSF)); ARO through MURI(MURI)	This work was supported by the National Science Foundation through grants DM-1021850 (to MRD) and DM-1021818 (to TC), and by the ARO through the MURI grant W911NF-11-1-0332 (to MRD) and grant 58386MA (to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; [Anonymous], 1974, ESSAYS EC CRIME PUNI; Arenas A, 2011, J THEOR BIOL, V279, P113, DOI 10.1016/j.jtbi.2011.03.017; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Bushway SD, 2004, CRIME PUNISHMENT PAT; Colvin M, 2002, CRIMINOLOGY, V40, P19, DOI 10.1111/j.1745-9125.2002.tb00948.x; Crow Iain, 2001, TREATMENT REHABILITA; Cullen FT, 2002, CRIME PUBLIC POLICIE; Cullen FT, 2011, PRISON J, V91, p48S; D'Orsogna MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061458; Donohue JJ, 1998, J LEGAL STUD, V27, P1; Farrington D., 1985, PREDICTION CRIMINOLO; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gachter S, 2012, NATURE, V483, P39, DOI 10.1038/483039a; Gibbons R., 1992, GAME THEORY APPL EC; Gomez-Gardenes J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00620; Gordon MB, 2009, EUR PHYS J B, V68, P133, DOI 10.1140/epjb/e2009-00066-x; Hallevy G, 2013, RIGHT BE PUNISHED; Hawkins Gordon, 2001, PUNISHMENT DEMOCRACY; HECKATHORN DD, 1988, AM J SOCIOL, V94, P535, DOI 10.1086/229029; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helland E, 2007, J HUM RESOUR, V42, P309; Kalos M. H., 2009, MONTE CARLO METHODS; MacKenzie D. L., 2002, EVIDENCE BASED CRIME; Maruna S, 2011, CRIME PUNISHMENT; Nagin D. S., 1998, CRIME JUSTICE REV RE; Nagin DS, 2009, IMPRISONMENT REOFFEN, V38; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Perc M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076063; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Pratt TC, 2000, CRIMINOLOGY, V38, P931, DOI 10.1111/j.1745-9125.2000.tb00911.x; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P1165, DOI 10.1073/pnas.1115219109; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Surette R, 2002, CRIME DELINQUENCY, V48, P46, DOI 10.1177/0011128702048001002; Sutter M, 2010, REV ECON STUD, V77, P1540, DOI 10.1111/j.1467-937X.2010.00608.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; United States Bureau of Justice Statistics, 2011, DIR EXP CRIM JUST FU; United States Bureau of Justice Statistics, 2010, CORR POP US; United States Bureau of Justice Statistics, 2011, ARR US 1980 2009	46	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85531	10.1371/journal.pone.0085531	http://dx.doi.org/10.1371/journal.pone.0085531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	24454884	Green Published, Green Submitted, gold			2022-12-27	WOS:000330236000012
J	Zhao, SR; Fung-Leung, WP; Bittner, A; Ngo, K; Liu, XJ				Zhao, Shanrong; Fung-Leung, Wai-Ping; Bittner, Anton; Ngo, Karen; Liu, Xuejun			Comparison of RNA-Seq and Microarray in Transcriptome Profiling of Activated T Cells	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; PROBE SETS; NORMALIZATION; ANNOTATION; TOOL	To demonstrate the benefits of RNA-Seq over microarray in transcriptome profiling, both RNA-Seq and microarray analyses were performed on RNA samples from a human T cell activation experiment. In contrast to other reports, our analyses focused on the difference, rather than similarity, between RNA-Seq and microarray technologies in transcriptome profiling. A comparison of data sets derived from RNA-Seq and Affymetrix platforms using the same set of samples showed a high correlation between gene expression profiles generated by the two platforms. However, it also demonstrated that RNA-Seq was superior in detecting low abundance transcripts, differentiating biologically critical isoforms, and allowing the identification of genetic variants. RNA-Seq also demonstrated a broader dynamic range than microarray, which allowed for the detection of more differentially expressed genes with higher fold-change. Analysis of the two datasets also showed the benefit derived from avoidance of technical issues inherent to microarray probe performance such as cross-hybridization, non-specific hybridization and limited detection range of individual probes. Because RNA-Seq does not rely on a pre-designed complement sequence detection probe, it is devoid of issues associated with probe redundancy and annotation, which simplified interpretation of the data. Despite the superior benefits of RNA-Seq, microarrays are still the more common choice of researchers when conducting transcriptional profiling experiments. This is likely because RNA-Seq sequencing technology is new to most researchers, more expensive than microarray, data storage is more challenging and analysis is more complex. We expect that once these barriers are overcome, the RNA-Seq platform will become the predominant tool for transcriptome analysis.	[Zhao, Shanrong; Liu, Xuejun] Janssen Res & Dev LLC, Syst Pharmacol & Biomarkers, San Diego, CA USA; [Fung-Leung, Wai-Ping; Ngo, Karen] Janssen Res & Dev LLC, Immunol, San Diego, CA USA; [Bittner, Anton] Janssen Res & Dev LLC, CREATe Integrat Syst Biol, San Diego, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Zhao, SR (corresponding author), Janssen Res & Dev LLC, Syst Pharmacol & Biomarkers, San Diego, CA USA.	shanrong_zhao@yahoo.com; xliu3@its.jnj.com		Fung-Leung, Wai-Ping/0000-0001-7013-8855				Baker M, 2010, NAT METHODS, V7, P495, DOI 10.1038/nmeth0710-495; Baldi P, 2002, DNA MICROARRAY GENE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Cui XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004229; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Le HS, 2013, NUCL ACIDS IN PRESS; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Nurtdinov RN, 2010, NUCLEIC ACIDS RES, V38, pD726, DOI 10.1093/nar/gkp969; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; PONTIUS JU, 2003, NCBI HDB, pCH21; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roge R, 2007, SCAND J IMMUNOL, V65, P202, DOI 10.1111/j.1365-3083.2006.01879.x; Schatz MC, 2010, NAT BIOTECHNOL, V28, P691, DOI 10.1038/nbt0710-691; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; Speed T., 2003, STAT ANAL GENE EXPRE; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang W., 2012, PLOS ONE, V7; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	41	608	616	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e78644	10.1371/journal.pone.0078644	http://dx.doi.org/10.1371/journal.pone.0078644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454679	Green Published, gold, Green Submitted			2022-12-27	WOS:000330236000002
J	Hung, SF; Chung, SD; Kuo, HC				Hung, Shun-Fa; Chung, Shiu-Dong; Kuo, Hann-Chorng			Increased Serum C-Reactive Protein Level Is Associated with Increased Storage Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia	PLOS ONE			English	Article							OVERACTIVE BLADDER SYNDROME; GROWTH-FACTOR LEVELS; ERECTILE DYSFUNCTION; ANTIMUSCARINIC THERAPY; SUBSCORE RATIO; DISEASE; INFLAMMATION; SCORE; RISK; HEALTH	Objective: Chronic inflammation is considered as one of the contributing mechanisms of lower urinary tract symptoms (LUTS). Serum C-reactive protein (CRP) level is the widely used biomarker of inflammatory status. This study investigated the association between serum CRP level in men with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) before and after medical treatment. Methods: A total of 853 men with BPH and LUTS were enrolled. All patients completed the International Prostate Symptoms Score (IPSS) questionnaire and urological examinations. The parameters of uroflowmetry (maximum flow rate, Qmax; voided volume, VV), post-void residual (PVR), total prostate volume (TPV) and transition zone index (TZI), serum prostate specific antigen (PSA), and serum CRP levels were obtained. All patients were treated with alpha-blocker or antimuscarinic agent based on the IPSS voiding to storage subscore ratio (IPSS-V/S). Correlation analyses were performed between serum CRP levels with age, IPSS, TPV, TZI, Qmax, PVR, VV, PSA and between baseline and post treatment. Results: The mean age was 66.9+/-11.6 years old and the mean serum CRP levels were 0.31+/-0.43 mg/dL. Univariate analyses revealed serum CRP levels were significantly associated with age (p<0.001), PSA levels (p=0.005) and VV (p=0.017), but not significantly associated with TPV (p=0.854) or PVR (p=0.068). CRP levels were positively associated with urgency (p<0.001) and nocturia (p<0.001) subscore of IPSS, total IPSS (p=0.008) and storage IPSS (p<0.001) and negatively associated with IPSS-V/S ratio (p=0.014). Multivariate analyses revealed that serum CRP levels were significantly associated with age (p=0.004) and storage IPSS subscore p<0.001). Patients with IPSS-V/S<1 and treated with tolterodine for 3 months had significant decrease of CRP levels after treatment. Conclusion: Serum CRP levels are associated with storage LUTS and sensory bladder disorders, suggesting chronic inflammation might play a role in the patients with storage predominant LUTS.	[Hung, Shun-Fa; Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Chung, Shiu-Dong; Kuo, Hann-Chorng] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Far Eastern Memorial Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Bank AJ, 2003, INT J IMPOT RES, V15, P231, DOI 10.1038/sj.ijir.3901012; Chiu AF, 2012, INT J UROL, V19, P995, DOI 10.1111/j.1442-2042.2012.03095.x; Chiu AF, 2012, UROLOGY, V79, P260, DOI 10.1016/j.urology.2011.10.020; Chiurlia E, 2005, J AM COLL CARDIOL, V46, P1503, DOI 10.1016/j.jacc.2005.06.068; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Di Silverio F, 2003, EUR UROL, V43, P164, DOI 10.1016/S0302-2838(02)00548-1; Gervaix A, 2001, PEDIATR INFECT DIS J, V20, P507, DOI 10.1097/00006454-200105000-00007; Giugliano F, 2004, J ENDOCRINOL INVEST, V27, P665, DOI 10.1007/BF03347500; Glasser DB, 2007, INT J CLIN PRACT, V61, P1294, DOI 10.1111/j.1742-1241.2007.01454.x; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; Hsiao SM, 2012, INT UROGYNECOL J, V23, P935, DOI 10.1007/s00192-012-1715-1; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Jiang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059176; KOHNEN PW, 1979, J UROLOGY, V121, P755, DOI 10.1016/S0022-5347(17)56980-3; Kuo HC, 2007, UROLOGY, V70, P272, DOI 10.1016/j.urology.2007.03.063; Kupelian V, 2012, BJU INT, V110, P401, DOI 10.1111/j.1464-410X.2011.10769.x; Kupelian V, 2009, UROLOGY, V73, P950, DOI 10.1016/j.urology.2008.12.012; Lehrer S, 2005, BJU INT, V95, P961, DOI 10.1111/j.1464-410X.2005.05447.x; Liao CH, 2011, INT J CLIN PRACT, V65, P552, DOI 10.1111/j.1742-1241.2011.02638.x; Liao CH, 2012, INT J CLIN PRACT, V66, P139, DOI 10.1111/j.1742-1241.2011.02864.x; Liao CH, 2011, UROLOGY, V78, P1373, DOI 10.1016/j.urology.2011.04.076; Liu HT, 2011, NEUROUROL URODYNAM, V30, P1525, DOI 10.1002/nau.21118; Liu HT, 2009, BJU INT, V103, P1668, DOI 10.1111/j.1464-410X.2009.08380.x; Mora S, 2009, CLIN CHEM, V55, P219, DOI 10.1373/clinchem.2008.109728; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nickel JC, 2007, J UROLOGY, V178, P896, DOI 10.1016/j.juro.2007.05.041; Ohgaki K, 2012, UROLOGY, V79, P1372, DOI 10.1016/j.urology.2012.03.006; Sauver JLS, 2009, AM J EPIDEMIOL, V169, P1281, DOI 10.1093/aje/kwp085; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Vlachopoulos C, 2006, EUR HEART J, V27, P2640, DOI 10.1093/eurheartj/ehl341	31	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85588	10.1371/journal.pone.0085588	http://dx.doi.org/10.1371/journal.pone.0085588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454896	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100102
J	Nicolai, MPJ; Keller, JJ; de Vries, L; van der Meulen-de Jong, AE; Nicolai, JJ; Hardwick, JCH; Putter, H; Pelger, RCM; Elzevier, HW				Nicolai, Melianthe P. J.; Keller, Josbert J.; de Vries, Lieke; van der Meulen-de Jong, Andrea E.; Nicolai, Jan J.; Hardwick, James C. H.; Putter, Hein; Pelger, Rob C. M.; Elzevier, Henk W.			The Impact of Sexual Abuse in Patients Undergoing Colonoscopy	PLOS ONE			English	Article							CHRONIC PELVIC PAIN; PHYSICAL ABUSE; RETROSPECTIVE REPORTS; GI ILLNESS; HISTORY; PREVALENCE; WOMEN; SYMPTOMS; DISORDERS; EXPERIENCES	Background: Sexual abuse has been linked to strong effects on gastrointestinal health. Colonoscopy can provoke intense emotional reactions in patients with a sexual abuse history and may lead to avoidance of endoscopic procedures. Objective: To determine whether care around colonoscopy needs adjustment for patients with sexual abuse experience, thereby exploring targets for the improvement of care around colonoscopic procedures. Methods: Questionnaires were mailed to patients (n = 1419) from two centers within 11 months after colonoscopy. Differences in experience of the colonoscopy between patients with and without a sexual abuse history were assessed and patients' views regarding physicians' inquiry about sexual abuse and care around endoscopic procedures were obtained. Results: A total of 768 questionnaires were analyzed. The prevalence of sexual abuse was 3.9% in male and 9.5% in female patients. Patients born in a non-western country reported more sexual abuse (14.9%) than those born in a western country (6.3%; p = 0.008). Discomfort during colonoscopy was indicated on a scale from 0 to 10, mean distress score of patients with sexual abuse was 4.8(+/- 3.47) compared to 3.5(+/- 3.11) in patients without a sexual abuse history (p = 0.007). Abdominal pain was a predictor for higher distress during colonoscopy (beta= -0.019 (SE = 0.008); p = 0.02, as well as the number of complaints indicated as reason for colonoscopy (beta = 0.738 (SE = 0.276); p = 0.008). Of patients with sexual abuse experience, 53.8% believed gastroenterologists should ask about it, 43.4% said deeper sedation during colonoscopy would diminish the distress. Conclusions: Sexual abuse is prevalent in patients presenting for colonoscopy. Patients with a sexual abuse history experience more distress during the procedure and indicate that extra attention around and during colonoscopy may diminish this distress.	[Nicolai, Melianthe P. J.; Pelger, Rob C. M.; Elzevier, Henk W.] Leiden Univ, Med Ctr, Dept Urol, Leiden, Netherlands; [Keller, Josbert J.; Nicolai, Jan J.] HAGA Teaching Hosp, Dept Gastroenterol, The Hague, Netherlands; [de Vries, Lieke] Westeinde Ziekenhuis, Dept Urol, The Hague, Netherlands; [van der Meulen-de Jong, Andrea E.; Hardwick, James C. H.] Leiden Univ, Med Ctr, Dept Gastroenterol, Leiden, Netherlands; [Putter, Hein] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nicolai, MPJ (corresponding author), Leiden Univ, Med Ctr, Dept Urol, Leiden, Netherlands.	melianthenicolai@gmail.com	Pelger, Rob/ABF-9029-2021; Nicolai, Melianthe PJ/C-2991-2011; Putter, Hein/C-2244-2018; van der Meulen, Andrea/AAU-9430-2020; Elzevier, Hendrik Willem/CAF-3026-2022; Hardwick, James/J-4862-2013	Pelger, Rob/0000-0001-6328-6462; Putter, Hein/0000-0001-5395-1422; van der Meulen, Andrea/0000-0001-9353-5431; Elzevier, Hendrik Willem/0000-0001-9636-0200; Hardwick, James/0000-0002-9575-5099; Nicolai, Melianthe/0000-0002-2381-3376				Baccini F, 2003, DIGEST LIVER DIS, V35, P256, DOI 10.1016/S1590-8658(03)00075-6; Bal BS, 2012, DIGEST DIS SCI, V57, P2527, DOI 10.1007/s10620-012-2188-2; Basile Kathleen C, 2007, Violence Vict, V22, P437, DOI 10.1891/088667007781553955; Beck JJH, 2011, J SEX MED, V8, P2733, DOI 10.1111/j.1743-6109.2011.02389.x; Berzin TM, 2010, DIGEST DIS SCI, V55, P2869, DOI 10.1007/s10620-010-1197-2; Borum ML, 2009, GASTROENTEROL NURS, V32, P222, DOI 10.1097/SGA.0b013e3181abaa92; Both S, 2012, J SEX MED, V9, P2888, DOI 10.1111/j.1743-6109.2012.02910.x; Bouchoucha M, 2013, CLIN RES HEPATOL GAS, V37, P422, DOI 10.1016/j.clinre.2012.10.011; Davy E, 2006, GASTROENTEROL NURS, V29, P221, DOI 10.1097/00001610-200605000-00003; Delvaux M, 1997, EUR J GASTROEN HEPAT, V9, P345, DOI 10.1097/00042737-199704000-00006; Drossman DA, 1996, GASTROENTEROLOGY, V110, P999, DOI 10.1053/gast.1996.v110.pm8613034; DROSSMAN DA, 1995, ANN INTERN MED, V123, P782, DOI 10.7326/0003-4819-123-10-199511150-00007; Drossman DA, 2000, PSYCHOSOM MED, V62, P309, DOI 10.1097/00006842-200005000-00004; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Farley MS, 2002, J FAM PRACTICE, V51, P827; Faubion SS, 2012, MAYO CLIN PROC, V87, P187, DOI 10.1016/j.mayocp.2011.09.004; Fergusson DM, 2011, INT J METH PSYCH RES, V20, P93, DOI 10.1002/mpr.337; Fleming JM, 1997, MED J AUSTRALIA, V166, P65, DOI 10.5694/j.1326-5377.1997.tb138722.x; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Hilden M, 2003, ACTA OBSTET GYN SCAN, V82, P1030; Huber JD, 2009, J SEX MED, V6, P791, DOI 10.1111/j.1743-6109.2008.01139.x; Imhoff LR, 2012, ARCH SURG-CHICAGO, V147, P1123, DOI 10.1001/archsurg.2012.1144; Kellogg N, 2005, PEDIATRICS, V116, P506, DOI 10.1542/peds.2005-1336; Klingele CJ, 2010, NEUROGASTROENT MOTIL, V22, P1094, DOI 10.1111/j.1365-2982.2010.01539.x; Koriat A, 2000, ANNU REV PSYCHOL, V51, P481, DOI 10.1146/annurev.psych.51.1.481; Leeners B, 2007, PSYCHOSOMATICS, V48, P385, DOI 10.1176/appi.psy.48.5.385; LEROI AM, 1995, INT J COLORECTAL DIS, V10, P200, DOI 10.1007/BF00346219; Leserman J, 1996, PSYCHOSOM MED, V58, P4, DOI 10.1097/00006842-199601000-00002; Leserman J, 2007, TRAUMA VIOLENCE ABUS, V8, P331, DOI 10.1177/1524838007303240; LOFTUS EF, 1993, AM PSYCHOL, V48, P518, DOI 10.1037/0003-066X.48.5.518; LONGSTRETH GF, 1993, DIGEST DIS SCI, V38, P1581, DOI 10.1007/BF01303163; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Nicolai MPJ, 2012, J SEX MED, V9, P1277, DOI 10.1111/j.1743-6109.2012.02683.x; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Parris W C, 1985, J Tenn Med Assoc, V78, P493; Ringel Y, 2008, GASTROENTEROLOGY, V134, P396, DOI 10.1053/j.gastro.2007.11.011; Sitzia J, 1998, INT J QUAL HEALTH C, V10, P311, DOI 10.1093/intqhc/10.4.311; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Swahnberg K, 2011, EUR J OBSTET GYN R B, V157, P200, DOI 10.1016/j.ejogrb.2011.02.025; TALLEY NJ, 1994, GASTROENTEROLOGY, V107, P1040, DOI 10.1016/0016-5085(94)90228-3; Voorham-Van der Zalm PJ, 2008, NEUROUROL URODYNAM, V27, P301, DOI 10.1002/nau.20514; Voorham-van der Zalm PJ, 2011, NEUROUROL URODYNAM, V30, P536, DOI 10.1002/nau.21053; WALKER E, 1988, AM J PSYCHIAT, V145, P75; Walker EA, 1996, J PSYCHOSOM OBST GYN, V17, P39, DOI 10.3109/01674829609025662; Weitlauf JC, 2010, J WOMENS HEALTH, V19, P1271, DOI 10.1089/jwh.2009.1673	45	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85034	10.1371/journal.pone.0085034	http://dx.doi.org/10.1371/journal.pone.0085034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454784	Green Published, gold			2022-12-27	WOS:000330235100050
J	Vasilaki, E; Giugliano, M				Vasilaki, Eleni; Giugliano, Michele			Emergence of Connectivity Motifs in Networks of Model Neurons with Short- and Long-Term Plastic Synapses	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; WORKING-MEMORY; FIRE MODEL; LAYER 2/3; CELLS; HETEROGENEITY; INPUTS; RULE	Recent experimental data from the rodent cerebral cortex and olfactory bulb indicate that specific connectivity motifs are correlated with short-term dynamics of excitatory synaptic transmission. It was observed that neurons with short-term facilitating synapses form predominantly reciprocal pairwise connections, while neurons with short-term depressing synapses form predominantly unidirectional pairwise connections. The cause of these structural differences in excitatory synaptic microcircuits is unknown. We show that these connectivity motifs emerge in networks of model neurons, from the interactions between short-term synaptic dynamics (SD) and long-term spike-timing dependent plasticity (STDP). While the impact of STDP on SD was shown in simultaneous neuronal pair recordings in vitro, the mutual interactions between STDP and SD in large networks are still the subject of intense research. Our approach combines an SD phenomenological model with an STDP model that faithfully captures long-term plasticity dependence on both spike times and frequency. As a proof of concept, we first simulate and analyze recurrent networks of spiking neurons with random initial connection efficacies and where synapses are either all short-term facilitating or all depressing. For identical external inputs to the network, and as a direct consequence of internally generated activity, we find that networks with depressing synapses evolve unidirectional connectivity motifs, while networks with facilitating synapses evolve reciprocal connectivity motifs. We then show that the same results hold for heterogeneous networks, including both facilitating and depressing synapses. This does not contradict a recent theory that proposes that motifs are shaped by external inputs, but rather complements it by examining the role of both the external inputs and the internally generated network activity. Our study highlights the conditions under which SD-STDP might explain the correlation between facilitation and reciprocal connectivity motifs, as well as between depression and unidirectional motifs.	[Vasilaki, Eleni; Giugliano, Michele] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Vasilaki, Eleni; Giugliano, Michele] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Giugliano, Michele] Swiss Fed Inst Technol Lausanne, Brain Mind Inst, Lausanne, Switzerland	University of Sheffield; University of Antwerp; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Giugliano, M (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	michele.giugliano@uantwerpen.be	Giugliano, Michele/A-5666-2012	Giugliano, Michele/0000-0003-2626-594X; Vasilaki, Eleni/0000-0003-3705-7070	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN") [264872]; European Commission (Future Emerging Technology programme project "BRAINLEAP") [306502]; Royal Society [JP091330-2009/R4]; Flemish agency for Innovation by Science and Technology [90455/1955]; Interuniversity Attraction Poles Program (IUAP); Belgian Science Policy Office; Engineering and Physical Sciences Research Council [EP/J019534/1]; Engineering and Physical Sciences Research Council (e-futures award) [EFXD12003/EFXD12004]; EPSRC [EP/J019534/1] Funding Source: UKRI	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN")(European Commission); European Commission (Future Emerging Technology programme project "BRAINLEAP")(European Commission); Royal Society(Royal Society of London); Flemish agency for Innovation by Science and Technology; Interuniversity Attraction Poles Program (IUAP)(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council (e-futures award)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partly supported by the European Commission (FP7 Marie Curie Initial Training Network "NAMASEN," grant n. 264872, http://cordis.europa.eu/fp7; the Future Emerging Technology programme project "BRAINLEAP" grant n. 306502, http://cordis.europa.eu/fp7/ict/fet-open) and by the Royal Society (travel grant JP091330-2009/R4, http://royalsociety.org). MG also acknowledges additional support from the Flemish agency for Innovation by Science and Technology (grant n. 90455/1955, http://www.iwt.be) and from the Interuniversity Attraction Poles Program (IUAP), initiated by the Belgian Science Policy Office (http://www.belspo.be); EV acknowledges additional support from the Engineering and Physical Sciences Research Council (grant n. EP/J019534/1 and e-futures award EFXD12003/EFXD12004, http://efutures.ac.uk/xd). Access to the supercomputer facilities CalcUA (University of Antwerp) and Tier 1 (Flemish Supercomputer Center - VSC) is warmly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; [Anonymous], 2009, PLOS COMPUT BIOL, V5; Barabasi AL, 2005, NAT PHYS, V1, P68, DOI 10.1038/nphys162; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bourjaily MA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00037; BOWER JM, 1986, P NATL ACAD SCI USA, V83, P1115, DOI 10.1073/pnas.83.4.1115; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brunel N, 1997, CEREB CORTEX, V7, P237; Buonomano DV, 1999, J NEUROSCI, V19, P6748, DOI 10.1523/JNEUROSCI.19-16-06748.1999; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; Cowan W, 2003, SYNAPSES; Dayan P, 2001, COMPUTATIONAL NEUROS; Del Giudice P, 2003, J PHYSIOL-PARIS, V97, P659, DOI 10.1016/j.jphysparis.2004.01.021; Del Giudice P, 2001, NEUROCOMPUTING, V38, P1175, DOI 10.1016/S0925-2312(01)00557-4; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Geracitano R, 2007, J PHYSIOL-LONDON, V585, P117, DOI 10.1113/jphysiol.2007.142570; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00023; Gilson M, 2009, BIOL CYBERN, V101, P411, DOI 10.1007/s00422-009-0343-4; Giugliano M, 2008, BIOL CYBERN, V99, P303, DOI 10.1007/s00422-008-0270-9; Gjorgjieva J, 2011, P NATL ACAD SCI USA, V108, P19383, DOI 10.1073/pnas.1105933108; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; HUBERT LJ, 1979, QUAL QUANT, V13, P77; Kempter R, 1996, ADV NEUR IN, V8, P124; Kunkel S, 2011, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00160; La Camera G, 2008, BIOL CYBERN, V99, P279, DOI 10.1007/s00422-008-0272-7; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Linster C, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00157; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; Loebel A, 2013, J NEUROSCI, V33, P6257, DOI 10.1523/JNEUROSCI.3740-12.2013; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1998, NEUROPHARMACOLOGY, V37, P489, DOI 10.1016/S0028-3908(98)00049-5; Markram H, 1998, P NAT ACAD SCI US, V95; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Pfister JP, 2006, ADV NEURAL INF PROC, V17, P1409; Pignatelli M, 2009, THESIS ECOLE POLYTEC; Pimentel DO, 2008, J PHYSIOL-LONDON, V586, P2107, DOI 10.1113/jphysiol.2007.149575; Renart A, 2004, MATH COMP BIOL SER, P431; Reyes A, 1999, J NEUROSCI, V19, P3827; Richmond P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018539; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sterrat D, 2011, PRINCIPLES COMPUTATI; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks M, 2005, SYNAPTIC DYNAMICS, P245; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tuckwell H. C., 1989, STOCHASTIC PROCESSES; Varela JA, 1997, J NEUROSCI, V17, P7926; Vasilaki E, 2012, ICANN 2012; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	69	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84626	10.1371/journal.pone.0084626	http://dx.doi.org/10.1371/journal.pone.0084626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454735	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000330235100028
J	Cho, SY; Choo, MS; Jung, JH; Jeong, CW; Oh, S; Lee, SB; Son, H; Jeong, H				Cho, Sung Yong; Choo, Min Soo; Jung, Jae Hyun; Jeong, Chang Wook; Oh, Sohee; Lee, Seung Bae; Son, Hwancheol; Jeong, Hyeon			Cumulative Sum Analysis for Experiences of a Single-Session Retrograde Intrarenal Stone Surgery and Analysis of Predictors for Stone-Free Status	PLOS ONE			English	Article							DIGITAL FLEXIBLE URETEROSCOPES; MATCHED-PAIR ANALYSIS; PERCUTANEOUS NEPHROLITHOTOMY; RENAL STONES; SHOCKWAVE LITHOTRIPSY; KIDNEY-STONES; LOWER-POLE; MANAGEMENT; EFFICACY; DIAMETER	Introduction: This study investigated the learning curve of a single-session retrograde intrarenal surgery (RIRS) in patients with mid-sized stones. Competence and trainee proficiency for RIRS was assessed using cumulative sum analysis (CUSUM). Materials and Methods: The study design and the use of patients' information stored in the hospital database were approved by the Institutional Review Board of our institution. A retrospective review was performed for 100 patients who underwent a single-session RIRS. Patients were included if the main stone had a maximal diameter between 10 and 30 mm. The presence of a residual stone was checked on postoperative day 1 and at one-month follow-up visit. Fragmentation efficacy was calculated "removed stone volume (mm 3) divided by operative time (min)''. CUSUM analysis was used for monitoring change in fragmentation efficacy, and we tested whether or not acceptable surgical outcomes were achieved. Results: The mean age was 54.7 +/- 14.8 years. Serum creatinine level did not change significantly. Estimated GFR and hemoglobin were within normal limits postoperatively. The CUSUM curve tended to be flat until the 25th case and showed a rising pattern but declined again until the 56th case. After that point, the fragmentation efficacy reached a plateau. The acceptable level of fragmentation efficacy was 25 ml/min. Multivariate logistic regression analyses showed that stone-free rate was significantly lower for cases with multiple stones than those with a single stone (OR = 0.147, CI 0.032 - 0.674, P value = 0.005) and for cases with higher number of sites (OR = 0.676, CI 0.517 - 0.882, P value = 0.004). Conclusions: The statistical analysis of RIRS learning experience revealed that 56 cases were required for reaching a plateau in the learning curve. The number of stones and the number of sites were significant predictors for stone-free status.	[Cho, Sung Yong; Lee, Seung Bae; Son, Hwancheol; Jeong, Hyeon] Seoul Natl Univ, Dept Urol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Choo, Min Soo; Jung, Jae Hyun; Jeong, Chang Wook] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Oh, Sohee] Seoul Natl Univ, Dept Biostat, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeong, H (corresponding author), Seoul Natl Univ, Dept Urol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea.	drjh@brm.co.kr						Akman T, 2012, J ENDOUROL, V26, P625, DOI 10.1089/end.2011.0526; Akman T, 2012, BJU INT, V109, P1384, DOI 10.1111/j.1464-410X.2011.10691.x; Atkinson S, 1994, Manag Care Q, V2, P57; Bach C, 2012, UROL INT, V89, P408, DOI 10.1159/000341429; Bozkurt OF, 2011, J ENDOUROL, V25, P1131, DOI 10.1089/end.2010.0737; Bryniarski P, 2012, J ENDOUROL, V26, P52, DOI 10.1089/end.2011.0235; Goli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076404; Havel D, 1998, EUR UROL, V33, P396, DOI 10.1159/000019623; Hussain M, 2011, J ENDOUROL, V25, P45, DOI 10.1089/end.2010.0236; Jeong CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065888; Jeong CW, 2012, INT BRAZ J UROL, V38, P362, DOI 10.1590/S1677-55382012000300009; Karaolides T, 2013, UROLOGY, V81, P717, DOI 10.1016/j.urology.2013.01.016; Kim TB, 2013, CUAJ-CAN UROL ASSOC, V7, pE156, DOI 10.5489/cuaj.473; Lim TO, 2002, INT J QUAL HEALTH C, V14, P251, DOI 10.1093/oxfordjournals.intqhc.a002616; Lucio J, 2011, INT BRAZ J UROL, V37, P477, DOI 10.1590/S1677-55382011000400006; Miller NL, 2007, BMJ-BRIT MED J, V334, P468, DOI 10.1136/bmj.39113.480185.80; Resorlu B, 2013, WORLD J UROL, V31, P1581, DOI 10.1007/s00345-012-0991-1; Zeng GH, 2013, J UROLOGY, V190, P2133, DOI 10.1016/j.juro.2013.06.085	18	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84878	10.1371/journal.pone.0084878	http://dx.doi.org/10.1371/journal.pone.0084878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454757	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800016
J	Fazzari, M; Trostchansky, A; Schopfer, FJ; Salvatore, SR; Sanchez-Calvo, B; Vitturi, D; Valderrama, R; Barroso, JB; Radi, R; Freeman, BA; Rubbo, H				Fazzari, Marco; Trostchansky, Andres; Schopfer, Francisco J.; Salvatore, Sonia R.; Sanchez-Calvo, Beatriz; Vitturi, Dario; Valderrama, Raquel; Barroso, Juan B.; Radi, Rafael; Freeman, Bruce A.; Rubbo, Homero			Olives and Olive Oil Are Sources of Electrophilic Fatty Acid Nitroalkenes	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; NITRO-OLEIC ACID; NITROLINOLEIC ACID; ANTIINFLAMMATORY PROPERTIES; VASCULAR INFLAMMATION; MEDITERRANEAN DIET; ALPHA-TOCOPHEROL; HUMAN BLOOD; GENERATION; TRANSDUCTION	Extra virgin olive oil (EVOO) and olives, key sources of unsaturated fatty acids in the Mediterranean diet, provide health benefits to humans. Nitric oxide (center dot NO) and nitrite (NO2-)-dependent reactions of unsaturated fatty acids yield electrophilic nitroalkene derivatives (NO2-FA) that manifest salutary pleiotropic cell signaling responses in mammals. Herein, the endogenous presence of NO2-FA in both EVOO and fresh olives was demonstrated by mass spectrometry. The electrophilic nature of these species was affirmed by the detection of significant levels of protein cysteine adducts of nitro-oleic acid (NO2-OA-cysteine) in fresh olives, especially in the peel. Further nitration of EVOO by NO2- under acidic gastric digestive conditions revealed that human consumption of olive lipids will produce additional nitro-conjugated linoleic acid (NO2-cLA) and nitro-oleic acid (NO2-OA). The presence of free and protein-adducted NO2-FA in both mammalian and plant lipids further affirm a role for these species as signaling mediators. Since NO2-FA instigate adaptive anti-inflammatory gene expression and metabolic responses, these redox-derived metabolites may contribute to the cardiovascular benefits associated with the Mediterranean diet.	[Fazzari, Marco; Schopfer, Francisco J.; Salvatore, Sonia R.; Vitturi, Dario; Freeman, Bruce A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Fazzari, Marco] Fdn Ri MED, Palermo, Italy; [Sanchez-Calvo, Beatriz; Valderrama, Raquel; Barroso, Juan B.] Univ Jaen, Dept Biol Expt, Jaen, Andalucia, Spain; [Trostchansky, Andres; Radi, Rafael; Rubbo, Homero] Univ Republica, Fac Med, Dept Bioquim, Montevideo, Uruguay; [Trostchansky, Andres; Radi, Rafael; Rubbo, Homero] Univ Republica, Fac Med, Ctr Free Rad & Biomed Res, Montevideo, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidad de Jaen; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Freeman, BA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	freerad@pitt.edu; hrubbo@fmed.edu.uy	Barroso, Juan B./G-8041-2014; Trostchansky, Andres/I-5624-2019; Vitturi, Dario/Z-3469-2019; Marco, Fazzari/AAA-2229-2019; Albarracín, Juan Bautista Barroso/ABC-2908-2020; Valderrama, Raquel/H-5937-2015; Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020	Trostchansky, Andres/0000-0002-9721-7577; Marco, Fazzari/0000-0002-4051-4431; Albarracín, Juan Bautista Barroso/0000-0002-9477-9195; Schopfer, Francisco Jose/0000-0001-9526-695X; Valderrama Rodriguez, Raquel/0000-0003-2253-0101; Rubbo, Homero/0000-0002-7897-6551; Vitturi, Dario/0000-0003-0354-4567; Salvatore, Sonia/0000-0002-9942-3905	Fondo Clemente Estable-ANII [FCE_516]; Fondo Maria Vinas-ANII [FMV_2009_2913]; ICGEB-Italy; CSIC-Uruguay; Junta de Andalucia [AGR-6374, BIO286]; NIH [R01-HL058115, R01-HL64937, P30DK072506, P01-HL103455, R01 AT006822-01]; Society for Free Radical Biology and Medicine Mini-fellowship; National Center for Complementary & Integrative Health [R01AT006822] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103455, R37HL058115, R01HL058115, R01HL064937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	Fondo Clemente Estable-ANII; Fondo Maria Vinas-ANII; ICGEB-Italy; CSIC-Uruguay; Junta de Andalucia(Junta de Andalucia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Free Radical Biology and Medicine Mini-fellowship; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Fondo Clemente Estable-ANII (FCE_516) and Fondo Maria Vinas-ANII (FMV_2009_2913) to AT; ICGEB-Italy and CSIC-Uruguay (HR); ERDF-cofinanced grant from Junta de Andalucia (project AGR-6374 and group BIO286) to JBB; NIH grants R01-HL058115, R01-HL64937, P30DK072506, P01-HL103455 (BAF) and R01 AT006822-01 (FJS); and a Society for Free Radical Biology and Medicine Mini-fellowship to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Bonacci G, 2011, J AM SOC MASS SPECTR, V22, P1534, DOI 10.1007/s13361-011-0185-x; Carluccio MA, 2003, ARTERIOSCL THROM VAS, V23, P622, DOI 10.1161/01.ATV.0000062884.69432.A0; Catharino RR, 2005, ANAL CHEM, V77, P7429, DOI 10.1021/ac0512507; Cert A, 2000, J CHROMATOGR A, V881, P131, DOI 10.1016/S0021-9673(00)00389-7; Cheng WL, 2004, J AGR FOOD CHEM, V52, P71, DOI 10.1021/jf0348626; Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K; Cole MP, 2009, CIRC RES, V105, P965, DOI 10.1161/CIRCRESAHA.109.199075; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Corpas FJ, 2013, NEW PHYTOL, V199, P633, DOI 10.1111/nph.12380; Covas MI, 2007, PHARMACOL RES, V55, P175, DOI 10.1016/j.phrs.2007.01.010; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Evans ME, 2002, J NUTR BIOCHEM, V13, P508, DOI 10.1016/S0955-2863(02)00211-5; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Frankel EN, 2011, J AGR FOOD CHEM, V59, P785, DOI 10.1021/jf103813t; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; Lavelli V, 2006, J AGR FOOD CHEM, V54, P3002, DOI 10.1021/jf052918l; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2013, GUT, V62, P616, DOI 10.1136/gutjnl-2011-301649; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Lundberg JO, 2009, ARCH PHARM RES, V32, P1119, DOI 10.1007/s12272-009-1803-z; Nadtochiy SM, 2011, NUTRITION, V27, P733, DOI 10.1016/j.nut.2010.12.006; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Napolitano A, 2004, CHEM RES TOXICOL, V17, P1329, DOI 10.1021/tx049880b; Rastrelli L, 2002, J AGR FOOD CHEM, V50, P5566, DOI 10.1021/jf011063j; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Rocha BS, 2012, FREE RADICAL BIO MED, V52, P693, DOI 10.1016/j.freeradbiomed.2011.11.011; Romani A, 2007, J AGR FOOD CHEM, V55, P1315, DOI 10.1021/jf062335r; Rubbo H, 2009, ARCH BIOCHEM BIOPHYS, V484, P167, DOI 10.1016/j.abb.2008.11.007; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Teissier E, 1996, CLIN CHEM, V42, P430; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Trostchansky A, 2011, J BIOL CHEM, V286, P12891, DOI 10.1074/jbc.M110.154518; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404	56	73	74	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84884	10.1371/journal.pone.0084884	http://dx.doi.org/10.1371/journal.pone.0084884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454759	Green Published, Green Accepted, gold			2022-12-27	WOS:000329925800017
J	Yi, SL; Liu, XJ; Zhong, JQ; Zhang, Y				Yi, Shao-lei; Liu, Xiao-jun; Zhong, Jing-quan; Zhang, Yun			Role of Caveolin-1 in Atrial Fibrillation as an Anti-Fibrotic Signaling Molecule in Human Atrial Fibroblasts	PLOS ONE			English	Article							RAT CARDIAC FIBROBLASTS; P42/44 MAP KINASE; IN-VIVO; DOWN-REGULATION; HEART-FAILURE; KNOCKOUT MICE; EXPRESSION; FIBROSIS; CARDIOMYOPATHY; TGF-BETA-1	Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general population; yet, the precise mechanisms resulting in AF are not fully understood. Caveolin-1 (Cav-1), the principal structural component of caveolae organelles in cardiac fibroblasts, is involved in several cardiovascular conditions; however, the study on its function in atrium, in particular, in AF, is still lacking. This report examines the hypothesis that Cav-1 confers an anti-AF effect by mediating atrial structural remodeling through its anti-fibrotic action. We evaluated the expression of Cav-1, transforming growth factor-beta 1 (TGF-beta 1), and fibrosis in atrial specimens of 13 patients with AF and 10 subjects with sinus rhythm, and found that the expression of Cav-1 was significantly downregulated, whereas TGF-beta 1 level, collagens I/III contents and atrial fibrosis were markedly increased, in AF. Western blot analysis demonstrated that treatment of human atrial fibroblasts (HAFs) with TGF-beta 1 resulted in a concentration-and time-dependent repression of Cav-1. Downregulation of Cav-1 with siRNA increased the TGF-beta 1-induced activation of Smad signal pathway and collagens production in HAFs. Furthermore, incubation of HAFs with the peptides derived from Cav-1 to achieve Cav-1 gain-of-function abolished the TGF-beta 1-induced production of collagens I/III and decreases of MMP-2/-9 expression. Therefore it was concluded that Cav-1 is an important anti-AF signaling mediator by conferring its anti-fibrotic effects in atrium.	[Yi, Shao-lei; Liu, Xiao-jun; Zhong, Jing-quan; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Yi, Shao-lei; Liu, Xiao-jun; Zhong, Jing-quan; Zhang, Yun] Shandong Univ, Chinese Minist Publ Hlth, Dept Cardiol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Yi, Shao-lei] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhong, JQ (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan, Shandong, Peoples R China.	haifeng200314@live.whut.edu.cn			Natural Science Foundation of China [81270238]; Scientific Research Foundation for the Doctoral Degree, State Education Ministry of China [20100131110059]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Doctoral Degree, State Education Ministry of China	This study was sponsored by the Natural Science Foundation of China (81270238) and the Scientific Research Foundation for the Doctoral Degree, State Education Ministry of China (20100131110059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Barth K, 2010, HISTOCHEM CELL BIOL, V134, P31, DOI 10.1007/s00418-010-0716-8; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Chaudhary KR, 2013, J CARDIOVASC PHARM, V61, P258, DOI 10.1097/FJC.0b013e31827afcee; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Cruz JA, 2012, AM J PHYSIOL-HEART C, V302, pH2518, DOI 10.1152/ajpheart.01140.2011; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Fu CL, 2010, BBA-MOL CELL BIOL L, V1801, P702, DOI 10.1016/j.bbalip.2010.04.001; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hori Y, 2012, AM J PHYSIOL-CELL PH, V303, pC947, DOI 10.1152/ajpcell.00401.2011; Jasmin JF, 2011, AM J PHYSIOL-HEART C, V300, pH1274, DOI 10.1152/ajpheart.01173.2010; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Lei B, 2011, J PHARMACOL SCI, V117, P98, DOI 10.1254/jphs.11065FP; Levick SP, 2008, AM J PHYSIOL-HEART C, V295, pH1375, DOI 10.1152/ajpheart.907.2008; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lin CS, 2008, CELL MOL LIFE SCI, V65, P1489, DOI 10.1007/s00018-008-7408-8; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Mariscalco G, 2006, J THORAC CARDIOV SUR, V131, P1364, DOI 10.1016/j.jtcvs.2006.01.040; Miyasato SK, 2011, MATRIX BIOL, V30, P318, DOI 10.1016/j.matbio.2011.05.003; Moe GW, 2008, J CARD FAIL, V14, P768, DOI 10.1016/j.cardfail.2008.07.229; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Pan CH, 2007, FEBS LETT, V581, P526, DOI 10.1016/j.febslet.2007.01.014; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Piech A, 2002, AM J PHYSIOL-HEART C, V282, pH219, DOI 10.1152/ajpheart.2002.282.1.H219; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Redondo S, 2012, VASC HEALTH RISK MAN, V8, P533, DOI 10.2147/VHRM.S28041; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Seto SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058481; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Turner NA, 2003, CARDIOVASC RES, V57, P784, DOI 10.1016/S0008-6363(02)00729-0; Uray IP, 2003, CARDIOVASC RES, V59, P57, DOI 10.1016/S0008-6363(03)00352-3; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Xiao H, 2010, CLIN CARDIOL, V33, P149, DOI 10.1002/clc.20713; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	47	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85144	10.1371/journal.pone.0085144	http://dx.doi.org/10.1371/journal.pone.0085144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454806	gold, Green Submitted, Green Published			2022-12-27	WOS:000329925800024
J	Zhao, R; Meng, FY; Wang, NS; Ma, WL; Yan, QT				Zhao, Rui; Meng, Fanyi; Wang, Nisha; Ma, Wenli; Yan, Qitao			Silencing of CHD5 Gene by Promoter Methylation in Leukemia	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; INACTIVATING MUTATIONS; HUMAN BREAST; ALLELIC LOSS; DNA-BINDING; 1P; CHROMOSOME-1; DELETION; REGIONS; FAMILY	Chromodomain helicase DNA binding protein 5 (CHD5) was previously proposed to function as a potent tumor suppressor by acting as a master regulator of a tumor-suppressive network. CHD5 is down-regulated in several cancers, including leukemia and is responsible for tumor generation and progression. However, the mechanism of CHD5 down-regulation in leukemia is largely unknown. In this study, quantitative reverse-transcriptase polymerase chain reaction and western blotting analyses revealed that CHD5 was down-regulated in human leukemia cell lines and samples. Luciferase reporter assays showed that most of the baseline regulatory activity was localized from 500 to 200 bp upstream of the transcription start site. Bisulfite DNA sequencing of the identified regulatory element revealed that the CHD5 promoter was hypermethylated in human leukemia cells and samples. Thus, CHD5 expression was inversely correlated with promoter DNA methylation in these samples. Treatment with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (DAC) activates CHD5 expression in human leukemia cell lines. In vitro luciferase reporter assays demonstrated that methylation of the CHD5 promoter repressed its promoter activity. Furthermore, a chromatin immunoprecipitation assay combined with qualitative PCR identified activating protein 2 (AP2) as a potential transcription factor involved in CHD5 expression and indicated that treatment with DAC increases the recruitment of AP2 to the CHD5 promoter. In vitro transcription-factor activity studies showed that AP2 over-expression was able to activate CHD5 promoter activity. Our findings indicate that repression of CHD5 gene expression in human leukemia is mediated in part by DNA methylation of its promoter.	[Zhao, Rui; Wang, Nisha; Ma, Wenli; Yan, Qitao] Southern Med Univ, Inst Mol Biol, Guangzhou, Guangdong, Peoples R China; [Meng, Fanyi] Southern Med Univ, Dept Hematol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yan, QT (corresponding author), Southern Med Univ, Inst Mol Biol, Guangzhou, Guangdong, Peoples R China.	wenlima1964@163.com			National Natural Science Foundation of China [81100383/H0812, 81000226/H0812]; Natural Science Foundation of Guangdong Province [S2011040005521, A2011360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was funded by the National Natural Science Foundation of China (81100383/H0812, 81000226/H0812) and the Natural Science Foundation of Guangdong Province (S2011040005521, A2011360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Baylin SB, 1998, ADV CANCER RES, V72, P141; BELLO MJ, 1995, INT J CANCER, V64, P207; BELLO MJ, 1995, CANCER GENET CYTOGEN, V83, P160, DOI 10.1016/0165-4608(95)00064-V; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; BIECHE I, 1993, CANCER RES, V53, P1990; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Cheung TH, 2005, GYNECOL ONCOL, V96, P510, DOI 10.1016/j.ygyno.2004.10.035; Du XL, 2013, CLIN TRANSL ONCOL, V15, P198, DOI 10.1007/s12094-012-0903-2; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kleer CG, 2000, ENDOCR PATHOL, V11, P137, DOI 10.1385/EP:11:2:137; Koyama H, 2012, CLIN CANCER RES, V18, P1588, DOI 10.1158/1078-0432.CCR-11-2644; Lang J, 2011, BRIT J DERMATOL, V164, P1010, DOI 10.1111/j.1365-2133.2011.10223.x; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Melendez B, 2003, LEUKEMIA RES, V27, P627, DOI 10.1016/S0145-2126(02)00278-3; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; MOLEY JF, 1992, CANCER RES, V52, P770; Mori N, 2003, BRIT J HAEMATOL, V122, P226, DOI 10.1046/j.1365-2141.2003.04434.x; Mori N, 1998, BLOOD, V92, P3405, DOI 10.1182/blood.V92.9.3405.421k44_3405_3409; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; Paul S, 2013, CELL REP, V3, P92, DOI 10.1016/j.celrep.2012.12.009; Piaskowski S, 2005, CANCER GENET CYTOGEN, V162, P63, DOI 10.1016/j.cancergencyto.2005.02.009; Poetsch M, 2003, MELANOMA RES, V13, P29, DOI 10.1097/00008390-200302000-00006; PRAML C, 1995, ONCOGENE, V11, P1357; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; Wong RRY, 2011, GYNECOL OBSTET INVES, V72, P203, DOI 10.1159/000323883; Wu X, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3182; Zhao R, 2012, LUNG CANCER, V76, P324, DOI 10.1016/j.lungcan.2011.11.019	50	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85172	10.1371/journal.pone.0085172	http://dx.doi.org/10.1371/journal.pone.0085172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454811	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500046
J	Luz, M; Spannl-Muller, S; Ozhan, G; Kagermeier-Schenk, B; Rhinn, M; Weidinger, G; Brand, M				Luz, Marta; Spannl-Mueller, Stephanie; Oezhan, Guenes; Kagermeier-Schenk, Birgit; Rhinn, Muriel; Weidinger, Gilbert; Brand, Michael			Dynamic Association with Donor Cell Filopodia and Lipid-Modification Are Essential Features of Wnt8a during Patterning of the Zebrafish Neuroectoderm	PLOS ONE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; PLASMA-MEMBRANE; SIGNALING PATHWAY; SONIC HEDGEHOG; IN-VIVO; PROTEINS; WINGLESS; DROSOPHILA; SECRETION; POSTERIORIZATION	Background: Wnt proteins are conserved signaling molecules that regulate pattern formation during animal development. Many Wnt proteins are post-translationally modified by addition of lipid adducts. Wnt8a provides a crucial signal for patterning the anteroposterior axis of the developing neural plate in vertebrates. However, it is not clear how this protein propagates from its source, the blastoderm margin, to the target cells in the prospective neural plate, and how lipid-modifications might influence Wnt8a propagation and activity. Results: We have dynamically imaged biologically active, fluorescently tagged Wnt8a in living zebrafish embryos. We find that Wnt8a localizes to membrane-associated, punctate structures in live tissue. In Wnt8a expressing cells, these puncta are found on filopodial cellular processes, from where the protein can be released. In addition, Wnt8a is found colocalized with Frizzled receptor-containing clusters on signal receiving cells. Combining in vitro and in vivo assays, we compare the roles of conserved Wnt8a residues in cell and non-cell-autonomous signaling activity and secretion. Non-signaling Wnt8 variants show these residues can regulate Wnt8a distribution in producing cell membranes and filopodia as well as in the receiving tissue. Conclusions: Together, our results show that Wnt8a forms dynamic clusters found on filopodial donor cell and on signal receiving cell membranes. Moreover, they demonstrate a differential requirement of conserved residues in Wnt8a protein for distribution in producing cells and receiving tissue and signaling activity during neuroectoderm patterning.	[Luz, Marta; Spannl-Mueller, Stephanie; Rhinn, Muriel; Brand, Michael] Tech Univ Dresden, CRTD, D-01062 Dresden, Germany; [Luz, Marta; Spannl-Mueller, Stephanie; Oezhan, Guenes; Kagermeier-Schenk, Birgit; Rhinn, Muriel; Weidinger, Gilbert; Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Brand, M (corresponding author), Tech Univ Dresden, CRTD, D-01062 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Ozhan, Gunes/HGU-9280-2022; Brand, Michael/A-5509-2010; Weidinger, Gilbert/A-8342-2010; Ozhan, Gunes/Q-3816-2018	Ozhan, Gunes/0000-0002-4806-5917; Brand, Michael/0000-0001-5711-6512; Weidinger, Gilbert/0000-0003-3599-6760; Rhinn, Muriel/0000-0002-1918-0246; Spannl, Stephanie/0000-0001-5999-1564	Deutsche Forschungsgemeinschaft [SFB 655-A3]; EU (Zf-Models and Endotrack)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU (Zf-Models and Endotrack)	This work was supported by grants to M. B. by the Deutsche Forschungsgemeinschaft(SFB 655-A3) and the EU (Zf-Models and Endotrack). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Brand M., 2002, ZEBRAFISH PRACTICAL; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Erter CE, 2001, DEVELOPMENT, V128, P3571; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Iizuka-Kogo A, 2005, HISTOCHEM CELL BIOL, V123, P67, DOI 10.1007/s00418-004-0729-2; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kagermeier-Schenk B, 2011, DEV CELL; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kiecker C, 2001, DEVELOPMENT, V128, P4189; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Miura GI, 2006, CELL CYCLE, V5, P1184, DOI 10.4161/cc.5.11.2804; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Ozhan G, 2013, DEV CELL, V26, P331, DOI 10.1016/j.devcel.2013.07.020; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Raible F, 2004, TRENDS NEUROSCI, V27, P727, DOI 10.1016/j.tins.2004.10.003; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reifers F, 1998, DEVELOPMENT, V125, P2381; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Rhinn M, 2006, CURR OPIN NEUROBIOL, V16, P5, DOI 10.1016/j.conb.2006.01.005; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Rhinn M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-12; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	57	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84922	10.1371/journal.pone.0084922	http://dx.doi.org/10.1371/journal.pone.0084922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427298	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200038
J	Yamaguchi, H; Yoshida, N; Takanashi, M; Ito, Y; Fukami, K; Yanagihara, K; Yashiro, M; Sakai, R				Yamaguchi, Hideki; Yoshida, Nachi; Takanashi, Miho; Ito, Yuumi; Fukami, Kiyoko; Yanagihara, Kazuyoshi; Yashiro, Masakazu; Sakai, Ryuichi			Stromal Fibroblasts Mediate Extracellular Matrix Remodeling and Invasion of Scirrhous Gastric Carcinoma Cells	PLOS ONE			English	Article							CANCER-CELLS; MYOFIBROBLASTS; GROWTH; PROLIFERATION; METASTASIS; INHIBITOR; BETA; ROCK	Scirrhous gastric carcinoma (SGC) has the worst prognosis of all gastric cancers, owing to its rapid expansion by invasion and frequent peritoneal dissemination. Due to the increased proliferation of stromal fibroblasts (SFs) that occurs within SGC lesions and the peritoneal metastatic sites, SFs have been proposed to support the progression of this disease. However, the biological and molecular basis and the pathological role of the intercellular interaction between SGC cells and SFs remain largely unknown. In this study, we investigated the role of SFs in the invasion of the extracellular matrix (ECM) by SGC cells. When SGC cells were cocultured with SFs derived from SGC tissue on three-dimensional (3D) Matrigel, they were attracted together to form large cellular aggregates that invaded within the Matrigel. Time-lapse imaging revealed that this process was associated with extensive contraction and remodeling of the ECM. Immunofluorescence and biochemical analysis showed that SGC cells stimulate phosphorylation of myosin light chain and actomyosin-mediated mechanical remodeling of the ECM by SFs. By utilizing this assay system for inhibitor library screening, we have identified several inhibitors that potently suppress the cooperation between SGC cells and SFs to form the invasive structures. Among them, a Src inhibitor dasatinib impaired the interaction between SGC cells and SFs both in vitro and in vivo and effectively blocked peritoneal dissemination of SGC cells. These results indicate that SFs mediate mechanical remodeling of the ECM by SGC cells, thereby promoting invasion and peritoneal dissemination of SGC.	[Yamaguchi, Hideki; Yoshida, Nachi; Takanashi, Miho; Ito, Yuumi; Sakai, Ryuichi] Natl Canc Ctr, Res Inst, Div Metastasis & Invas Signaling, Chuo Ku, Tokyo 104, Japan; [Takanashi, Miho; Ito, Yuumi; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Hachioji, Tokyo 19203, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 558, Japan	National Cancer Center - Japan; Tokyo University of Pharmacy & Life Sciences; National Cancer Center - Japan; Osaka Metropolitan University	Sakai, R (corresponding author), Natl Canc Ctr, Res Inst, Div Metastasis & Invas Signaling, Chuo Ku, Tokyo 104, Japan.	rsakai@ncc.go.jp	Sakai, Ryuichi/R-7741-2017; Yamaguchi, Hideki/AAP-1767-2021	Yamaguchi, Hideki/0000-0003-2125-9655; Sakai, Ryuichi/0000-0001-6833-1103	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; National Cancer Center Research and Development Fund [23-A-9]; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Tokyo Biochemical Research Foundation	This work was supported by Grants-in-Aid for Scientific Research by the Japan Society for the Promotion of Science; by Grants-in-Aid for Scientific Research on Innovative Areas by the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan for the 3rd term Comprehensive 10-year Strategy for Cancer Control. This work was supported in part by the National Cancer Center Research and Development Fund (23-A-9), and also by Grant-in-Aid from the Tokyo Biochemical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Ikeguchi M, 2009, SURG TODAY, V39, P290, DOI 10.1007/s00595-008-3860-1; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Nakazawa K, 2003, CANCER RES, V63, P8848; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schenone S, 2010, EXPERT OPIN INV DRUG, V19, P931, DOI 10.1517/13543784.2010.499898; Semba S, 2009, BRIT J CANCER, V101, P1365, DOI 10.1038/sj.bjc.6605309; Tendo M, 2005, CANCER SCI, V96, P451, DOI 10.1111/j.1349-7006.2005.00066.x; URA H, 1991, CANCER RES, V51, P3550; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yashiro M, 1996, BRIT J CANCER, V74, P1096, DOI 10.1038/bjc.1996.496; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Yashiro M, 2007, INT J CANCER, V120, P686, DOI 10.1002/ijc.22329; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Zhi KK, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-66	31	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85485	10.1371/journal.pone.0085485	http://dx.doi.org/10.1371/journal.pone.0085485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427313	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200054
J	Huang, YJ; Qi, AM; King, GJ; Fitt, BDL				Huang, Yong-Ju; Qi, Aiming; King, Graham J.; Fitt, Bruce D. L.			Assessing Quantitative Resistance against Leptosphaeria maculans (Phoma Stem Canker) in Brassica napus (Oilseed Rape) in Young Plants	PLOS ONE			English	Article							POLYGENIC RESISTANCE; MAJOR GENE; IN-FIELD; A-GROUP; DISEASE; POPULATIONS; AVIRULENCE; BLACKLEG; FRANCE; WHEAT	Quantitative resistance against Leptosphaeria maculans in Brassica napus is difficult to assess in young plants due to the long period of symptomless growth of the pathogen from the appearance of leaf lesions to the appearance of canker symptoms on the stem. By using doubled haploid (DH) lines A30 (susceptible) and C119 (with quantitative resistance), quantitative resistance against L. maculans was assessed in young plants in controlled environments at two stages: stage 1, growth of the pathogen along leaf veins/petioles towards the stem by leaf lamina inoculation; stage 2, growth in stem tissues to produce stem canker symptoms by leaf petiole inoculation. Two types of inoculum (ascospores; conidia) and three assessment methods (extent of visible necrosis; symptomless pathogen growth visualised using the GFP reporter gene; amount of pathogen DNA quantified by PCR) were used. In stage 1 assessments, significant differences were observed between lines A30 and C119 in area of leaf lesions, distance grown along veins/petioles assessed by visible necrosis or by viewing GFP and amount of L. maculans DNA in leaf petioles. In stage 2 assessments, significant differences were observed between lines A30 and C119 in severity of stem canker and amount of L. maculans DNA in stem tissues. GFP-labelled L. maculans spread more quickly from the stem cortex to the stem pith in A30 than in C119. Stem canker symptoms were produced more rapidly by using ascospore inoculum than by using conidial inoculum. These results suggest that quantitative resistance against L. maculans in B. napus can be assessed in young plants in controlled conditions. Development of methods to phenotype quantitative resistance against plant pathogens in young plants in controlled environments will help identification of stable quantitative resistance for control of crop diseases.	[Huang, Yong-Ju; Qi, Aiming; Fitt, Bruce D. L.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England; [Huang, Yong-Ju; Qi, Aiming; King, Graham J.; Fitt, Bruce D. L.] Rothamsted Res, Dept Plant Pathol & Microbiol, Harpenden, Herts, England; [King, Graham J.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia	University of Hertfordshire; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Southern Cross University	Huang, YJ (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England.	y.huang8@herts.ac.uk	King, Graham J/AAW-3368-2020; Qi, Aiming/AAH-7872-2021	King, Graham J/0000-0002-5975-6051; Qi, Aiming/0000-0002-0784-9520; Bruce D. L., Fitt/0000-0003-3981-6456	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E001610/1, BB/I017585/1]; Department for Environment, Food and Rural Affairs (Defra); HGCA; British Council; DuPont; Perry Foundation; Felix Thornley Cobbold Agricultural Trust; Chadacre Agricultural Trust; Biotechnology and Biological Sciences Research Council [BB/I017585/1, BB/D015200/1, BBS/E/C/00004693, BB/E001610/1, BB/I017585/2] Funding Source: researchfish; BBSRC [BB/D015200/1, BB/I017585/1, BB/I017585/2, BB/E001610/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); HGCA; British Council(The British Council in India); DuPont; Perry Foundation; Felix Thornley Cobbold Agricultural Trust; Chadacre Agricultural Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC, BB/E001610/1, and BB/I017585/1), the Department for Environment, Food and Rural Affairs (Defra), HGCA, the British Council, DuPont, the Perry Foundation, the Felix Thornley Cobbold Agricultural Trust, and the Chadacre Agricultural Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balesdent MH, 2001, PHYTOPATHOLOGY, V91, P70, DOI 10.1094/PHYTO.2001.91.1.70; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Brun H, 2011, 13 INT RAP C CROP PR, P507; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; Chartrain L, 2004, PHYTOPATHOLOGY, V94, P497, DOI 10.1094/PHYTO.2004.94.5.497; Czembor PC, 2003, GENOME, V46, P546, DOI 10.1139/G03-036; da Silva MR, 2012, EUR J PLANT PATHOL, V134, P315, DOI 10.1007/s10658-012-9991-7; Delourme R, 2008, ANN APPL BIOL, V153, P259, DOI 10.1111/j.1744-7348.2008.00258.x; Delourme R, 2006, EUR J PLANT PATHOL, V114, P41, DOI 10.1007/s10658-005-2108-9; Delourme R, 2011, 13 INT RAP C CROP PR, P505; Fitt BDL, 2011, PLANT PATHOL, V60, P44, DOI 10.1111/j.1365-3059.2010.02413.x; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Hammond-Kosack KE, 2007, RESISTANCE GENES R G, DOI [10.1002/9780470015902.a0020119, DOI 10.1002/9780470015902.A0020119]; Hayward A, 2012, PLANT BIOLOGY, V14, P1, DOI 10.1111/j.1438-8677.2011.00481.x; Huang YJ, 2009, PLANT PATHOL, V58, P314, DOI 10.1111/j.1365-3059.2008.01957.x; Huang YJ, 2006, NEW PHYTOL, V170, P129, DOI 10.1111/j.1469-8137.2006.01651.x; Huang YJ, 2005, EUR J PLANT PATHOL, V111, P263, DOI 10.1007/s10658-004-4421-0; Huang YJ, 2003, PLANT PATHOL, V52, P245, DOI 10.1046/j.1365-3059.2003.00813.x; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Lindhout P, 2002, EUPHYTICA, V124, P217, DOI 10.1023/A:1015686601404; Liu SY, 2006, PLANT PATHOL, V55, P401, DOI 10.1111/j.1365-3059.2006.01354.x; Marcroft SJ, 2012, PLANT PATHOL, V61, P934, DOI 10.1111/j.1365-3059.2011.02580.x; Marcroft SJ, 2012, CROP PASTURE SCI, V63, P338, DOI 10.1071/CP11341; McDonald Bruce, 2010, New Phytol, V185, P3, DOI 10.1111/j.1469-8137.2009.03108.x; Oliver RP, 2008, PLANT PATHOL, V57, P527, DOI 10.1111/j.1365-3059.2007.01787.x; Payne RW, 2011, GUIDE GENSTAT RELE 2; Pilet ML, 1998, THEOR APPL GENET, V96, P23, DOI 10.1007/s001220050704; Powers SJ, 2010, ANN APPL BIOL, V157, P55, DOI 10.1111/j.1744-7348.2010.00409.x; Raman R, 2012, THEOR APPL GENET, V125, P405, DOI 10.1007/s00122-012-1842-6; Rimmer SR, 2006, CAN J PLANT PATHOL, V28, pS288, DOI 10.1080/07060660609507386; Rouxel T, 2003, EUR J PLANT PATHOL, V109, P871, DOI 10.1023/A:1026189225466; Rouxel T, 2013, NEW PHYTOL, V197, P356, DOI 10.1111/nph.12099; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Soanes DM, 2008, TRENDS MICROBIOL, V16, P507, DOI 10.1016/j.tim.2008.08.002; Sprague SJ, 2006, EUR J PLANT PATHOL, V114, P33, DOI 10.1007/s10658-005-3683-5; Sprague SJ, 2007, NEW PHYTOL, V176, P211, DOI 10.1111/j.1469-8137.2007.02156.x; Stachowiak A, 2006, EUR J PLANT PATHOL, V114, P67, DOI 10.1007/s10658-005-2931-z; Stonard JF, 2010, EUR J PLANT PATHOL, V126, P97, DOI 10.1007/s10658-009-9525-0; Talukder ZI, 2004, NEW PHYTOL, V162, P197, DOI 10.1111/j.1469-8137.2004.01010.x; Toscano-Underwood C, 2001, PLANT PATHOL, V50, P28, DOI 10.1046/j.1365-3059.2001.00526.x; Travadon R, 2007, PLANT PATHOL, V56, P595, DOI 10.1111/j.1365-3059.2007.01572.x; Travadon R, 2009, PLANT PATHOL, V58, P461, DOI 10.1111/j.1365-3059.2008.02014.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Zhou Y, 1999, EUR J PLANT PATHOL, V105, P715, DOI 10.1023/A:1008761219493	47	35	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84924	10.1371/journal.pone.0084924	http://dx.doi.org/10.1371/journal.pone.0084924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454767	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100043
J	Lin, CJ; Tu, PC; Chern, CM; Hsiao, FJ; Chang, FC; Cheng, HL; Tang, CW; Lee, YC; Chen, WT; Lee, IH				Lin, Chun-Jen; Tu, Pei-Chi; Chern, Chang-Ming; Hsiao, Fu-Jung; Chang, Feng-Chi; Cheng, Hsien-Lin; Tang, Chih-Wei; Lee, Yi-Chung; Chen, Wei-Ta; Lee, I-Hui			Connectivity Features for Identifying Cognitive Impairment in Presymptomatic Carotid Stenosis	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; HUMAN BRAIN; STROKE; SCALE; RISK; PERFORMANCE; PREDICTION; DIZZINESS; NETWORKS	Severe asymptomatic stenosis of the internal carotid artery (ICA) leads to increased incidence of mild cognitive impairment (MCI) likely through silent embolic infarcts and/or chronic hypoperfusion, but the brain dysfunction is poorly understood and difficult to diagnose. Thirty cognitively intact subjects with asymptomatic, severe (>= 70%), unilateral stenosis of the ICA were compared with 30 healthy controls, matched for age, sex, cardiovascular risk factors and education level, on a battery of neuropsychiatric tests, voxel-based morphometry of magnetic resonance imaging (MRI), diffusion tensor imaging and brain-wise, seed-based analysis of resting-state functional MRI. Multivariate regression models and multivariate pattern classification (support vector machines) were computed to assess the relationship between connectivity measures and neurocognitive performance. The patients had worse dizziness scores and poorer verbal memory, executive function and complex visuo-spatial performance than controls. Twelve out of the 30 patients (40%) were considered to have MCI. Nonetheless, the leukoaraiosis Sheltens scores, hippocampal and brain volumes were not different between groups. Their whole-brain mean fractional anisotropy (FA) was significantly reduced and regional functional connectivity (Fc) was significantly impaired in the dorsal attention network (DAN), frontoparietal network, sensorimotor network and default mode network. In particular, the Fc strength at the insula of the DAN and the mean FA were linearly related with attention performance and dizziness severity, respectively. The multivariate pattern classification gave over 90% predictive accuracy of individuals with MCI or severe dizziness. Cognitive decline in stroke-free individuals with severe carotid stenosis may arise from nonselective widespread disconnections of long-range, predominantly interhemispheric non-hippocampal pathways. Connectivity measures may serve as both predictors for cases at risk and therapeutic targets for mitigating vascular cognitive impairment.	[Lin, Chun-Jen] Taipei Vet Gen Hosp, Hsinchu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lin, Chun-Jen; Tu, Pei-Chi; Chern, Chang-Ming; Hsiao, Fu-Jung; Tang, Chih-Wei; Chen, Wei-Ta; Lee, I-Hui] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Chern, Chang-Ming; Lee, Yi-Chung; Chen, Wei-Ta; Lee, I-Hui] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsiao, Fu-Jung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Cheng, Hsien-Lin] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Tang, Chih-Wei] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Lee, Yi-Chung; Chen, Wei-Ta] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei City Hospital; Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University	Lee, IH (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	ihlee@vghtpe.gov.tw	Lee, Yi-Chung/GZK-7162-2022; Lee, Yi-Chung/H-8813-2019	Lee, Yi-Chung/0000-0003-0102-164X	National Science Council [NSC-100-2314-B-075-021, NSC-101-2314-B-075-035]; National Yang-Ming University [101AC-B16, 102AC-B17]; Taipei Veterans General Hospital in Taiwan [V101C-062, V101E1-008, V102C-080, V102E1-0036]	National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University; Taipei Veterans General Hospital in Taiwan	This work was supported by The National Science Council (NSC-100-2314-B-075-021, NSC-101-2314-B-075-035), the National Yang-Ming University (101AC-B16, 102AC-B17), and the Taipei Veterans General Hospital (V101C-062, V101E1-008, V102C-080, V102E1-0036) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chen YH, 2012, INT J CARDIOL, V157, P104, DOI 10.1016/j.ijcard.2011.10.086; Cheng HL, 2012, STROKE, V43, P2567, DOI 10.1161/STROKEAHA.111.645614; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Johnston SC, 2004, ANN INTERN MED, V140, P237, DOI 10.7326/0003-4819-140-4-200402170-00005; Joy S, 2003, ASSESSMENT, V10, P56, DOI 10.1177/0095399702250335; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEHERICY S, 1994, AM J NEURORADIOL, V15, P929; Liu CY, 1998, PSYCHOL REP, V82, P211, DOI 10.2466/PR0.82.1.211-214; Liu MG, 2013, J NEUROPHYSIOLOGY; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Marshall RS, 2011, STROKE, V42, P221, DOI 10.1161/STROKEAHA.110.595645; Mendiz OA, 2012, J NEUROSURG, V116, P179, DOI 10.3171/2011.9.JNS11532; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Popovic IM, 2011, COGN BEHAV NEUROL, V24, P145, DOI 10.1097/WNN.0b013e3182313020; Post RE, 2010, AM FAM PHYSICIAN, V82, P361; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Shin BM, 2011, J NEUROL SCI, V305, P121, DOI 10.1016/j.jns.2011.02.031; Silvestrini M, 2009, NEUROLOGY, V72, P1062, DOI 10.1212/01.wnl.0000345015.35520.52; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sun YW, 2011, BEHAV BRAIN RES, V223, P388, DOI 10.1016/j.bbr.2011.05.006; Sztriha LK, 2009, J NEUROL SCI, V283, P36, DOI 10.1016/j.jns.2009.02.307; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tu PC, 2012, NEUROIMAGE, V59, P238, DOI 10.1016/j.neuroimage.2011.07.086; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang PN, 2006, NEUROBIOL AGING, V27, P1797, DOI 10.1016/j.neurobiolaging.2005.10.002; Wang PN, 2011, J NEUROL NEUROSUR PS, V82, P165, DOI 10.1136/jnnp.2010.209122; Yoshizaki K, 2008, EXP NEUROL, V210, P585, DOI 10.1016/j.expneurol.2007.12.005	42	13	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85441	10.1371/journal.pone.0085441	http://dx.doi.org/10.1371/journal.pone.0085441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454868	gold, Green Published, Green Submitted			2022-12-27	WOS:000330235100086
J	Sipka, A; Klaessig, S; Duhamel, GE; Swinkels, J; Rainard, P; Schukken, Y				Sipka, Anja; Klaessig, Suzanne; Duhamel, Gerald E.; Swinkels, Jantijn; Rainard, Pascal; Schukken, Ynte			Impact of Intramammary Treatment on Gene Expression Profiles in Bovine Escherichia coli Mastitis	PLOS ONE			English	Article							ENDOTOXIN-INDUCED MASTITIS; MAMMARY-GLAND; EPITHELIAL-CELLS; BINDING-PROTEIN; INNATE IMMUNITY; LACTATING COWS; IN-VITRO; EFFICACY; NEUTROPHILS; INFECTION	Clinical mastitis caused by E. coli accounts for significant production losses and animal welfare concerns on dairy farms worldwide. The benefits of therapeutic intervention in mild to moderate cases are incompletely understood. We investigated the effect of intramammary treatment with cefapirin alone or in combination with prednisolone on gene expression profiles in experimentally-induced E. coli mastitis in six mid-lactating Holstein Friesian cows. Cows were challenged with E. coli in 3 quarters and received 4 doses of 300 mg cefapirin in one quarter and 4 doses of 300 mg cefapirin together with 20 mg prednisolone in another quarter. At 24 h (n = 3) or 48 h (n = 3) post-challenge, tissue samples from control and treated quarters were collected for microarray analysis. Gene expression analysis of challenged, un-treated quarters revealed an up-regulation of transcripts associated with immune response functions compared to un-challenged quarters. Both treatments resulted in down-regulation of these transcripts compared to challenged, un-treated quarters most prominently for genes representing Chemokine and TLR-signaling pathways. Gene expression of Lipopolysaccharide Binding Protein (LBP), CCL2 and CXCL2 were only significantly down-regulated in cefapirin-prednisolone-treated quarters compared to un-treated controls. Down-regulation of chemokines was further confirmed on the basis of protein levels in milk whey for CXCL1, CXCL2 and CXCL8 in both treatments with a greater decrease in cefapirin-prednisolone-treated quarters. The data reveal a significant effect of treatment on cell recruitment with a more pronounced effect in cefapirin-prednisolone- treated quarters. Provided a rapid bacteriological clearance, combination therapy may prevent neutrophil-induced tissue damage and promote recovery of the gland.	[Sipka, Anja; Klaessig, Suzanne; Schukken, Ynte] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Duhamel, Gerald E.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Swinkels, Jantijn] GD Anim Hlth Ctr, Deventer, Netherlands; [Rainard, Pascal] INRA, UMR1282, F-37380 Nouzilly, France; [Rainard, Pascal] Univ Tours, ISP UMR1282, Tours, France	Cornell University; Cornell University; INRAE; Universite de Tours	Sipka, A (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	ass233@cornell.edu	Schukken, Ynte H/C-3405-2008; Schukken, Ynte/ABD-3352-2021	Schukken, Ynte H/0000-0002-8250-4194; Schukken, Ynte/0000-0002-8250-4194; Rainard, Pascal/0000-0002-5477-2626; Swinkels, Jantijn/0000-0001-7267-8097	Merck Animal Health	Merck Animal Health(Merck & Company)	The study was partially funded by Merck Animal Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; Bradley AJ, 2001, J CLIN MICROBIOL, V39, P1845, DOI 10.1128/JCM.39.5.1845-1849.2001; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Cannizzo FT, 2013, RES VET SCI, V95, P540, DOI 10.1016/j.rvsc.2013.03.025; CAPUCO AV, 1986, AM J VET RES, V47, P663; Ci XX, 2008, INFLAMMATION, V31, P422, DOI 10.1007/s10753-008-9094-y; Constable P. D., 2009, Guide to antimicrobial use in animals, P143, DOI 10.1002/9781444302639.ch9; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Hewson J, 2011, AM J VET RES, V72, P1613, DOI 10.2460/ajvr.72.12.1613; Hirvonen J, 1999, ACTA VET SCAND, V40, P35; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; Ledbetter TK, 2001, AM J VET RES, V62, P286, DOI 10.2460/ajvr.2001.62.286; LOHUIS JACM, 1988, J DAIRY SCI, V71, P2782, DOI 10.3168/jds.S0022-0302(88)79872-0; LOHUIS JACM, 1989, J DAIRY SCI, V72, P241, DOI 10.3168/jds.S0022-0302(89)79102-5; Malazdrewich C, 2004, MICROB PATHOGENESIS, V36, P227, DOI 10.1016/j.micpath.2003.12.002; Mercer PF, 2013, AM J RESP CELL MOL B; Mitterhuemer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-138; Murphy PM, 2000, PHARMACOL REV, V52, P145; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Petzl W, 2008, VET RES, V39, DOI 10.1051/vetres:2007057; Poutrel B, 2008, J DAIRY RES, V75, P310, DOI 10.1017/S0022029908003348; PYORALA S, 1994, J DAIRY SCI, V77, P453, DOI 10.3168/jds.S0022-0302(94)76973-3; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rainard P, 2010, CLIN VACCINE IMMUNOL, V17, P848, DOI 10.1128/CVI.00447-09; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Schukken YH, 2011, J DAIRY SCI, V94, P6203, DOI 10.3168/jds.2011-4290; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; SHAPIRA L, 1995, INFLAMMATION, V19, P289, DOI 10.1007/BF01534388; Shpigel NY, 1997, J DAIRY SCI, V80, P318, DOI 10.3168/jds.S0022-0302(97)75941-1; Sipka A., 2013, J DAIRY SCI; Smith GW, 2005, VET CLIN N AM-FOOD A, V21, P595, DOI 10.1016/j.cvfa.2005.07.005; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Suojala L, 2013, J VET PHARMACOL THER, V36, P521, DOI 10.1111/jvp.12057; Suojala L, 2010, J DAIRY SCI, V93, P1960, DOI 10.3168/jds.2009-2462; Troelstra A, 1997, J LEUKOCYTE BIOL, V61, P173, DOI 10.1002/jlb.61.2.173; Wagner SA, 2004, AM J VET RES, V65, P64, DOI 10.2460/ajvr.2004.65.64; Wenz JR, 2006, J DAIRY SCI, V89, P3408, DOI 10.3168/jds.S0022-0302(06)72377-3; Ziegeler S, 2006, ACTA ANAESTH SCAND, V50, P1103, DOI 10.1111/j.1399-6576.2006.01112.x	45	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85579	10.1371/journal.pone.0085579	http://dx.doi.org/10.1371/journal.pone.0085579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454893	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800050
J	Gnjidic, D; Hilmer, SN; Hartikainen, S; Tolppanen, AM; Taipale, H; Koponen, M; Bell, JS				Gnjidic, Danijela; Hilmer, Sarah N.; Hartikainen, Sirpa; Tolppanen, Anna-Maija; Taipale, Heidi; Koponen, Marjaana; Bell, J. Simon			Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer's Disease: A National Population Cohort Study	PLOS ONE			English	Article							BURDEN INDEX; ANTICHOLINERGIC DRUGS; FUNCTIONAL DECLINE; PHYSICAL FUNCTION; MEDICATION USE; CO-MORBIDITY; REGISTER; POLYPHARMACY; RESIDENTS; DEMENTIA	Background: Evidence is lacking about outcomes associated with the cumulative use of anticholinergic and sedative drugs in people with Alzheimer's disease (AD). This retrospective cohort study investigated the relationship between cumulative exposure to anticholinergic and sedative drugs and hospitalization and mortality in people with and without AD in Finland. Methods: Community-dwelling people aged 65 years and over, with AD on December 31st 2005 (n = 16,603) and individually matched (n = 16,603) comparison persons (age, sex, region of residence) were identified by the Social Insurance Institution of Finland. Drug utilization data were extracted from the Finnish National Prescription Register. Exposure to anticholinergic and sedative drugs was defined using the Drug Burden Index (DBI). Hospitalization and mortality data were extracted from national registers. Cox and zero-inflated negative binomial analyses were used to investigate the relationship between DBI and hospitalization and mortality over a one-year follow-up. Results: In total, 5.8% of people with AD and 3.7% without AD died during 2006. For every unit increase in DBI, the adjusted hazard ratio for mortality was 1.21 (95% confidence intervals [CI]: 1.09-1.33) among people with AD, and 1.37 (95% CI: 1.20-1.56) among people without AD. Overall, 44.3% of people with AD and 33.4% without AD were hospitalized. When using no DBI exposure as the reference group, the adjusted incidence rate ratio for length of hospital stay among high DBI group (>= 1) in people with AD was 1.15 (95% CI: 1.05-1.26) and 1.63 (95% CI: 1.41-1.88) in people without AD. Conclusion: There is a dose-response relationship between cumulative anticholinergic and sedative drug use and hospitalization and mortality in people with and without AD.	[Gnjidic, Danijela] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Gnjidic, Danijela] Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Gnjidic, Danijela] Concord RG Hosp, Sydney, NSW, Australia; [Hartikainen, Sirpa; Taipale, Heidi; Koponen, Marjaana; Bell, J. Simon] Univ Eastern Finland, Sch Pharm, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Bell, J. Simon] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Adelaide, SA 5001, Australia; [Bell, J. Simon] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Melbourne, Vic 3004, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Concord Repatriation General Hospital; University of Eastern Finland; University of Eastern Finland; University of South Australia; Monash University	Gnjidic, D (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	danijela.gnjidic@sydney.edu.au	Hilmer, Sarah N/AAW-8554-2020	Hilmer, Sarah/0000-0002-5970-1501	Alzheimer's Australia Dementia Research Foundation; Australian National Health and Medical Research Council (NHMRC); University of Eastern Finland, Faculty of Health Sciences	Alzheimer's Australia Dementia Research Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Eastern Finland, Faculty of Health Sciences	This study was supported by the Alzheimer's Australia Dementia Research Foundation. The sponsor had no role in the study design, data collection, data analysis, data interpretation, writing of this report or the decision to submit for publication. Danijela Gnjidic is supported by the Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship. Anna-Maija Tolppanen, Heidi Taipale, Marjaana Koponen and Sirpa Hartikainen acknowledge strategic funding received from the University of Eastern Finland, Faculty of Health Sciences.	Andersen F, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-58; Boudreau RM, 2009, PHARMACOEPIDEM DR S, V18, P916, DOI 10.1002/pds.1797; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; Gnjidic D, 2012, FUNDAM CLIN PHARM; Gnjidic D, 2012, ANN MED, V44, P458, DOI 10.3109/07853890.2011.573499; Gnjidic D, 2012, NEW ENGL J MED, V366, P859, DOI 10.1056/NEJMc1114768; Gnjidic D, 2012, J CLIN PHARMACOL, V52, P258, DOI 10.1177/0091270010395591; Gray SL, 2006, J AM GERIATR SOC, V54, P224, DOI 10.1111/j.1532-5415.2005.00571.x; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Hilmer SN, 2007, ARCH INTERN MED, V167, P781, DOI 10.1001/archinte.167.8.781; Hilmer SN, 2013, MED J AUSTRALIA, V198, P77, DOI 10.5694/mja12.11593; Hilmer SN, 2012, J GERONTOL A-BIOL, V67, P181, DOI 10.1093/gerona/glr066; Hilmer SN, 2009, AM J MED, V122, P1142, DOI 10.1016/j.amjmed.2009.02.021; Johnell K, 2008, DRUG AGING, V25, P871, DOI 10.2165/00002512-200825100-00006; JOST BC, 1995, J AM GERIATR SOC, V43, P1248, DOI 10.1111/j.1532-5415.1995.tb07401.x; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kumpula EK, 2011, J CLIN PHARMACOL, V51, P256, DOI 10.1177/0091270010368410; Laitinen ML, 2011, INT PSYCHOGERIATR, V23, P1623, DOI 10.1017/S1041610211001621; Landi F, 2007, CLIN PHARMACOL THER, V81, P235, DOI 10.1038/sj.clpt.6100035; Lau DT, 2011, AM J ALZHEIMERS DIS, V26, P606, DOI 10.1177/1533317511432734; Lau DT, 2010, ALZ DIS ASSOC DIS, V24, P56, DOI 10.1097/WAD.0b013e31819d6ec9; Lieberman Joseph A 3rd, 2004, Prim Care Companion J Clin Psychiatry, V6, P20; Lonnroos E, 2013, J ALZHEIMERS DIS, V33, P157, DOI 10.3233/JAD-2012-120808; Lonnroos E, 2012, DRUG AGING, V29, P395, DOI 10.2165/11631420-000000000-00000; Lowry E, 2012, J CLIN PHARMACOL, V52, P1584, DOI 10.1177/0091270011421489; Lu CJ, 2003, AM J GERIAT PSYCHIAT, V11, P458, DOI 10.1176/appi.ajgp.11.4.458; Mangoni AA, 2013, AM J GERIAT PSYCHIAT, V21, P785, DOI 10.1016/j.jagp.2013.01.012; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; Onder G, 2013, J GERONTOL A; Panula J, 2009, DRUG AGING, V26, P963, DOI 10.2165/11317660-000000000-00000; Runciman WB, 2003, INT J QUAL HEALTH C, V15, pI49, DOI 10.1093/intqhc/mzg085; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Taipale HT, 2012, J CLIN PSYCHOPHARM, V32, P218, DOI 10.1097/JCP.0b013e3182485802; Tjia J, 2010, J AM GERIATR SOC, V58, P880, DOI 10.1111/j.1532-5415.2010.02819.x; Wilson NM, 2012, DRUG AGING, V29, P157, DOI 10.2165/11598570-000000000-00000; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Zilkens RR, 2009, NEUROEPIDEMIOLOGY, V32, P61, DOI 10.1159/000170908	42	70	71	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83224	10.1371/journal.pone.0083224	http://dx.doi.org/10.1371/journal.pone.0083224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292SL	24454696	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329922500004
J	McNally, A; McNally, M; Galea, R; Thomas, R; Steptoe, RJ				McNally, Alice; McNally, Michael; Galea, Ryan; Thomas, Ranjeny; Steptoe, Raymond J.			Immunogenic, but Not Steady-State, Antigen Presentation Permits Regulatory T-Cells To Control CD8+T-Cell Effector Differentiation by IL-2 Modulation	PLOS ONE			English	Article							DENDRITIC CELLS; PERIPHERAL TOLERANCE; ACTIVATION; BLOCKADE; HELPER; MAINTENANCE; SUPPRESSION; LYMPHOCYTES; HOMEOSTASIS; INDUCTION	Absorption of IL-2 is one proposed mechanism of CD4+CD25+FoxP3+ regulatory T cell (Treg) suppression. Direct in vivo experimental evidence for this has recently been obtained. While modulation of IL-2 bioavailability controls CD8+ T-cell effector differentiation under strongly immunogenic conditions it is not known whether Treg modulate CD8+ T cell responses through this mechanism under steady-state conditions. Here we assess this using a mouse model in which dendritic cells (DC) are manipulated to present cognate antigen to CD8+ T cells either in the steady-state or after activation. Our observations show that Treg exert a check on expansion and effector differentiation of CD8+ T cells under strongly immunogenic conditions associated with TLR ligand activation of DC, and this is mediated by limiting IL-2 availability. In contrast, when DC remain unactivated, depletion of Treg has little apparent effect on effector differentiation or IL-2 homeostasis. We conclude that while modulation of IL-2 homeostasis is an important mechanism through which Treg control CD8+ effector differentiation under immunogenic conditions, this mechanism plays little role in modulating CD8+ T-cell differentiation under steady-state conditions.	[McNally, Alice; McNally, Michael; Galea, Ryan; Thomas, Ranjeny; Steptoe, Raymond J.] Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia	University of Queensland	Steptoe, RJ (corresponding author), Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia.	r.steptoe@uq.edu.au	Thomas, Ranjeny/B-4504-2013; Steptoe, Raymond/B-3843-2011	Thomas, Ranjeny/0000-0002-0518-8386; Steptoe, Raymond/0000-0002-6513-6406	National Health and Medical Research Council [1013066]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (project # 1013066). www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Bertin-Maghit S, 2011, DIABETES, V60, P248, DOI 10.2337/db10-0104; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Cheng LE, 2002, J IMMUNOL, V169, P4990, DOI 10.4049/jimmunol.169.9.4990; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Ertelt JM, 2013, J LEUKOCYTE BIOL, V94, P367, DOI 10.1189/jlb.0313118; Grinberg-Bleyer Y, 2010, J CLIN INVEST, V120, P4558, DOI 10.1172/JCI42945; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hofer T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00268; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holz LE, 2012, J HEPATOL, V57, P830, DOI 10.1016/j.jhep.2012.05.015; Hsieh CS, 2010, J EXP MED, V207, P1819, DOI 10.1084/jem.20101606; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Kastenmuller W, 2011, J IMMUNOL, V187, P3186, DOI 10.4049/jimmunol.1101649; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kornete M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00165; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McNally A, 2011, P NATL ACAD SCI USA, V108, P7529, DOI 10.1073/pnas.1103782108; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Muth S, 2012, P NATL ACAD SCI USA, V109, P9059, DOI 10.1073/pnas.1110620109; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shah JA, 2003, J EXP MED, V198, P281, DOI 10.1084/jem.20030645; Steptoe RJ, 2007, J IMMUNOL, V178, P2094, DOI 10.4049/jimmunol.178.4.2094; Steptoe RJ, 2004, J AUTOIMMUN, V22, P131, DOI 10.1016/j.jaut.2003.12.003; Steptoe RJ, 2002, J IMMUNOL, V168, P5032, DOI 10.4049/jimmunol.168.10.5032; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	41	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85455	10.1371/journal.pone.0085455	http://dx.doi.org/10.1371/journal.pone.0085455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454872	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500054
J	Sakamoto, R; Mori, S; Miller, MI; Okada, T; Togashi, K				Sakamoto, Ryo; Mori, Susumu; Miller, Michael I.; Okada, Tomohisa; Togashi, Kaori			Detection of Time-Varying Structures by Large Deformation Diffeomorphic Metric Mapping to Aid Reading of High-Resolution CT Images of the Lung	PLOS ONE			English	Article							SMALL PULMONARY NODULES; MUTUAL INFORMATION; GROWTH-RATE; REGISTRATION; CHEST; SEGMENTATION; METASTASES; RECIST; OPTIMIZATION; SUBTRACTION	Objectives: To evaluate the accuracy of advanced non-linear registration of serial lung Computed Tomography (CT) images using Large Deformation Diffeomorphic Metric Mapping (LDDMM). Methods: Fifteen cases of lung cancer with serial lung CT images (interval: 62.2 +/- 26.9 days) were used. After affine transformation, three dimensional, non-linear volume registration was conducted using LDDMM with or without cascading elasticity control. Registration accuracy was evaluated by measuring the displacement of landmarks placed on vessel bifurcations for each lung segment. Subtraction images and Jacobian color maps, calculated from the transformation matrix derived from image warping, were generated, which were used to evaluate time-course changes of the tumors. Results: The average displacement of landmarks was 0.02 +/- 0.16 mm and 0.12 +/-.60 mm for proximal and distal landmarks after LDDMM transformation with cascading elasticity control, which was significantly smaller than 3.11 +/- 2.47 mm and 3.99 +/- 3.05 mm, respectively, after affine transformation. Emerged or vanished nodules were visualized on subtraction images, and enlarging or shrinking nodules were displayed on Jacobian maps enabled by highly accurate registration of the nodules using LDDMM. However, some residual misalignments were observed, even with non-linear transformation when substantial changes existed between the image pairs. Conclusions: LDDMM provides accurate registration of serial lung CT images, and temporal subtraction images with Jacobian maps help radiologists to find changes in pulmonary nodules.	[Sakamoto, Ryo; Okada, Tomohisa; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan; [Mori, Susumu] Kennedy Krieger Inst, Dept Radiol, Baltimore, MD 21205 USA; [Mori, Susumu] Kennedy Krieger Inst, FM Kirby Funct Imaging Ctr, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA	Kyoto University; Kennedy Krieger Institute; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Mori, S (corresponding author), Kennedy Krieger Inst, Dept Radiol, Baltimore, MD 21205 USA.	susumu@mri.jhu.edu	Okada, Tomohisa/C-5939-2008	Okada, Tomohisa/0000-0003-2312-5677	National Institutes of Health (NIH) [P41 EB 015909]; JSPS [25670530]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study supported by National Institutes of Health (NIH) through the Grant Number P41 EB 015909 to the co-author Susumu Mori and JSPS Grant-in-Aid for Challenging Exploratory Research Number 25670530 provided to the last author Kaori Togashi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigelman-Aubrey C, 2007, AM J ROENTGENOL, V189, P948, DOI 10.2214/AJR.07.2302; Betke M, 2003, MED IMAGE ANAL, V7, P265, DOI 10.1016/S1361-8415(03)00007-0; Blaffert T, 2004, PROC SPIE, V5370, P1701, DOI 10.1117/12.535345; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Dougherty L, 2003, ACAD RADIOL, V10, P249, DOI 10.1016/S1076-6332(03)80098-3; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Gee J, 2003, ACAD RADIOL, V10, P1147, DOI 10.1016/S1076-6332(03)00329-5; Glaunes J, 2008, INT J COMPUT VISION, V80, P317, DOI 10.1007/s11263-008-0141-9; Gorbunova V, 2012, MED IMAGE ANAL, V16, P786, DOI 10.1016/j.media.2011.11.001; Gorbunova V, 2008, LECT NOTES COMPUT SC, V5242, P863, DOI 10.1007/978-3-540-85990-1_104; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Hung PCK, 2007, IEEE INT ENTERP, P12, DOI 10.1109/EDOCW.2007.24; Keil S, 2008, EUR RADIOL, V18, P2456, DOI 10.1007/s00330-008-1050-6; Keil S, 2010, J VASC INTERV RADIOL, V21, P245, DOI 10.1016/j.jvir.2009.10.024; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kostis WJ, 2003, IEEE T MED IMAGING, V22, P1259, DOI 10.1109/TMI.2003.817785; Lee KW, 2007, AM J ROENTGENOL, V189, P1077, DOI 10.2214/AJR.07.2057; Lester H, 1999, PATTERN RECOGN, V32, P129, DOI 10.1016/S0031-3203(98)00095-8; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Marten K, 2006, EUR RADIOL, V16, P781, DOI 10.1007/s00330-005-0036-x; Mullally W, 2004, MED PHYS, V31, P839, DOI 10.1118/1.1656593; Munden RF, 1997, RADIOLOGY, V202, P105, DOI 10.1148/radiology.202.1.8988198; Murphy K, 2008, LECT NOTES COMPUT SC, V5242, P1006, DOI 10.1007/978-3-540-85990-1_121; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakamoto Y, 2007, AM J ROENTGENOL, V188, P257, DOI 10.2214/AJR.05.0708; Patriarche J, 2004, J DIGIT IMAGING, V17, P158, DOI 10.1007/s10278-004-1010-x; Patriarche JW, 2007, J DIGIT IMAGING, V20, P203, DOI 10.1007/s10278-006-1038-1; Pock T, 2007, LECT NOTES COMPUT SC, V4792, P511; Prasad SR, 2002, RADIOLOGY, V225, P416, DOI 10.1148/radiol.2252011604; Qiu AQ, 2009, NEUROIMAGE, V45, pS51, DOI 10.1016/j.neuroimage.2008.10.039; Rey D, 2002, MED IMAGE ANAL, V6, P163, DOI 10.1016/S1361-8415(02)00056-7; Silva JS, 2011, J APPL CLIN MED PHYS, V12, P362, DOI 10.1120/jacmp.v12i2.3450; Staring M, 2007, MED PHYS, V34, P4098, DOI 10.1118/1.2776236; Staring M, 2009, INVEST RADIOL, V44, P61, DOI 10.1097/RLI.0b013e318197fcb7; Takao H, 2007, BRIT J RADIOL, V80, P85, DOI 10.1259/bjr/29418923; Takashima S, 2003, AM J ROENTGENOL, V180, P1255, DOI 10.2214/ajr.180.5.1801255; Tao C, 2009, AM J ROENTGENOL, V192, P624, DOI 10.2214/AJR.08.1307; Thevenaz P, 2000, IEEE T IMAGE PROCESS, V9, P2083, DOI 10.1109/83.887976; Uchiyama Y, 2003, MED PHYS, V30, P2440, DOI 10.1118/1.1597431; Winer-Muram HT, 2002, RADIOLOGY, V223, P798, DOI 10.1148/radiol.2233011026; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Zhang JY, 2003, NEUROIMAGE, V20, P1639, DOI 10.1016/S1053-8119(03)00410-5; Zhao BS, 2006, INVEST RADIOL, V41, P753, DOI 10.1097/01.rli.0000236907.81400.18; Zhao BS, 2006, J COMPUT ASSIST TOMO, V30, P777, DOI 10.1097/01.rct.0000228164.08968.e8	49	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85580	10.1371/journal.pone.0085580	http://dx.doi.org/10.1371/journal.pone.0085580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454894	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500056
J	Anttonen, M; Pihlajoki, M; Andersson, N; Georges, A; L'Hote, D; Vattulainen, S; Farkkila, A; Unkila-Kallio, L; Veitia, RA; Heikinheimo, M				Anttonen, Mikko; Pihlajoki, Marjut; Andersson, Noora; Georges, Adrien; L'Hote, David; Vattulainen, Sanna; Farkkila, Anniina; Unkila-Kallio, Leila; Veitia, Reiner A.; Heikinheimo, Markku			FOXL2, GATA4, and SMAD3 Co-Operatively Modulate Gene Expression, Cell Viability and Apoptosis in Ovarian Granulosa Cell Tumor Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; SOMATIC-CELLS; ADULT; MUTATION; SIGNALS; LINE; ESTABLISHMENT; ACTIVATION; SURVIVAL; FETAL	Aberrant ovarian granulosa cell proliferation and apoptosis may lead to granulosa cell tumors (GCT), the pathogenesis of which involves transcription factors GATA4, FOXL2, and SMAD3. FOXL2 gene harbors a point mutation (C134W) in a vast majority of GCTs. GATA4 is abundantly expressed in GCTs and its expression correlates with poor prognosis. The TGF-beta mediator SMAD3 promotes GCT cell survival through NF-kappa B activation, and interacts with FOXL2. Here, we find that the expression patterns of these factors overlap in the normal human ovary and 90 GCTs, and positively correlate with each other and with their mutual target gene CCND2, which is a key factor for granulosa cell proliferation. We have explored the molecular interactions of FOXL2, GATA4, and SMAD3 and their roles in the regulation of CCND2 using co-immunoprecipitation, promoter transactivation, and cell viability assays in human GCT cells. We found that not only SMAD3, but also GATA4 physically interact with both wild type and C134W-mutated FOXL2. GATA4 and SMAD3 synergistically induce a 8-fold increase in CCND2 promoter transactivation, which is 50% reduced by both FOXL2 types. We confirmed that wild type FOXL2 significantly decreases cell viability. Interestingly, GATA4 and SMAD3 caused a marked reduction of GCT cell apoptosis induced by wild type FOXL2. Thus, the effects of GATA4 and SMAD3 on both cell viability and apoptosis are distinct from those of wild type FOXL2; a perturbation of this balance due to the oncogenic FOXL2 mutation is likely to contribute to GCT pathogenesis.	[Anttonen, Mikko; Pihlajoki, Marjut; Andersson, Noora; Vattulainen, Sanna; Farkkila, Anniina; Heikinheimo, Markku] Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland; [Anttonen, Mikko; Pihlajoki, Marjut; Andersson, Noora; Vattulainen, Sanna; Farkkila, Anniina; Unkila-Kallio, Leila; Heikinheimo, Markku] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Anttonen, Mikko; Farkkila, Anniina; Unkila-Kallio, Leila] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Georges, Adrien; L'Hote, David; Veitia, Reiner A.] Univ Paris Diderot, UMR CNRS 7592, Inst Jacques Monod, Programme Pathol Mol & Cellulaire, Paris, France; [Heikinheimo, Markku] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; UDICE-French Research Universities; Universite Paris Cite; Washington University (WUSTL)	Anttonen, M (corresponding author), Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland.	mikko.anttonen@helsinki.fi	Georges, Adrien/ABD-6348-2021; Andersson, Noora/AAW-2030-2020; LHOTE, David/AAD-5390-2020; Färkkilä, Anniina/L-3059-2015; L'Hote, David/L-2653-2017	Andersson, Noora/0000-0003-4708-7273; Färkkilä, Anniina/0000-0002-3558-6617; L'Hote, David/0000-0001-5658-5018; Georges, Adrien/0000-0003-4208-2393	Academy of Finland; Helsinki University Central Hospital Research Funds; Sigrid Juselius Foundation; Institut Universitaire de France; La Ligue Nationale Contre le Cancer (Comite' de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); CNRS; Universite' Paris VII	Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Funds; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Institut Universitaire de France; La Ligue Nationale Contre le Cancer (Comite' de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite' Paris VII	Financial support: Academy of Finland, Helsinki University Central Hospital Research Funds, Sigrid Juselius Foundation, Institut Universitaire de France, La Ligue Nationale Contre le Cancer (Comite' de Paris), Groupement d'Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), CNRS and Universite' Paris VII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen M, 2006, J MOL ENDOCRINOL, V36, P557, DOI 10.1677/jme.1.01962; Anttonen M, 2005, J CLIN ENDOCR METAB, V90, P6529, DOI 10.1210/jc.2005-0921; Benayoun BA, 2013, ONCOGENE, V32, P2739, DOI 10.1038/onc.2012.298; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Bilandzic M, 2013, MOL ENDOCRINOL, V27, P466, DOI 10.1210/me.2012-1239; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; D'Angelo E, 2011, MODERN PATHOL, V24, P1360, DOI 10.1038/modpathol.2011.95; Duffin K, 2009, MOL HUM REPROD, V15, P771, DOI 10.1093/molehr/gap065; Farkkila A, 2011, EUR J ENDOCRINOL, V164, P115, DOI 10.1530/EJE-10-0849; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Jamieson S, 2012, ENDOCR REV, V33, P109, DOI 10.1210/er.2011-0014; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Kyronlahti A, 2008, ENDOCRINOLOGY, V149, P5635, DOI 10.1210/en.2008-0148; Kyronlahti A, 2011, BIOL REPROD, V84, P1033, DOI 10.1095/biolreprod.110.086850; Kyronlahti A, 2010, ENDOCR-RELAT CANCER, V17, P709, DOI 10.1677/ERC-10-0041; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Looyenga BD, 2007, MOL ENDOCRINOL, V21, P2440, DOI 10.1210/me.2006-0402; Middlebrook BS, 2009, ENDOCRINOLOGY, V150, P5208, DOI 10.1210/en.2009-0644; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Nonis D, 2013, MOL CELL ENDOCRINOL, V372, P42, DOI 10.1016/j.mce.2013.02.020; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Rosario R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046270; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Suzuki YJ, 2003, J BIOL CHEM, V278, P17525, DOI 10.1074/jbc.M210465200; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Vaskivuo TE, 2001, J CLIN ENDOCR METAB, V86, P3421, DOI 10.1210/jc.86.7.3421; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513	39	43	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85545	10.1371/journal.pone.0085545	http://dx.doi.org/10.1371/journal.pone.0085545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416423	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300086
J	Antwis, RE; Haworth, RL; Engelmoer, DJP; Ogilvy, V; Fidgett, AL; Preziosi, RF				Antwis, Rachael E.; Haworth, Rachel L.; Engelmoer, Daniel J. P.; Ogilvy, Victoria; Fidgett, Andrea L.; Preziosi, Richard F.			Ex situ Diet Influences the Bacterial Community Associated with the Skin of Red-Eyed Tree Frogs (Agalychnis callidryas)	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CUTANEOUS BACTERIA; BATRACHOCHYTRIUM-DENDROBATIDIS; MICROBIAL COMMUNITY; DIVERSITY; GUT; BIOAUGMENTATION; BIOSYNTHESIS; SALAMANDERS; SELECTION	Amphibians support symbiotic bacterial communities on their skin that protect against a range of infectious pathogens, including the amphibian chytrid fungus. The conditions under which amphibians are maintained in captivity (e. g. diet, substrate, enrichment) in ex situ conservation programmes may affect the composition of the bacterial community. In addition, ex situ amphibian populations may support different bacterial communities in comparison to in situ populations of the same species. This could have implications for the suitability of populations intended for reintroduction, as well as the success of probiotic bacterial inoculations intended to provide amphibians with a bacterial community that resists invasion by the chytrid fungus. We aimed to investigate the effect of a carotenoid-enriched diet on the culturable bacterial community associated with captive red-eyed tree frogs (Agalychnis callidryas) and make comparisons to bacteria isolated from a wild population from the Chiquibul Rainforest in Belize. We successfully showed carotenoid availability influences the overall community composition, species richness and abundance of the bacterial community associated with the skin of captive frogs, with A. callidryas fed a carotenoid-enriched diet supporting a greater species richness and abundance of bacteria than those fed a carotenoid-free diet. Our results suggest that availability of carotenoids in the diet of captive frogs is likely to be beneficial for the bacterial community associated with the skin. We also found wild A. callidryas hosted more than double the number of different bacterial species than captive frogs with very little commonality between species. This suggests frogs in captivity may support a reduced and diverged bacterial community in comparison to wild populations of the same species, which could have particular relevance for ex situ conservation projects.	[Antwis, Rachael E.; Haworth, Rachel L.; Engelmoer, Daniel J. P.; Ogilvy, Victoria; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Engelmoer, Daniel J. P.] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Ogilvy, Victoria] FrogLife, Peterborough, Cambs, England; [Fidgett, Andrea L.] Chester Zoo, Chester, Cheshire, England	University of Manchester; Vrije Universiteit Amsterdam	Antwis, RE (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Rachael.Antwis@gmail.com	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655; Antwis, Rachael/0000-0002-8849-8194; Fidgett, Andrea/0000-0001-5036-525X	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [961801] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council studentship to REA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANAS JA, 1988, APPL ENVIRON MICROB, V54, P2305, DOI 10.1128/AEM.54.9.2305-2310.1988; Banning JL, 2008, OECOLOGIA, V156, P423, DOI 10.1007/s00442-008-1002-5; Baruah P., 2012, J RES IBIOL, V2, P114; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boelsma E, 2003, AM J CLIN NUTR, V77, P348, DOI 10.1093/ajcn/77.2.348; Boyen F, 2009, VET MICROBIOL, V135, P187, DOI 10.1016/j.vetmic.2008.12.025; Brizzi R, 2002, J MORPHOL, V254, P328, DOI 10.1002/jmor.10039; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; CARR A H, 1976, Herpetologica, V32, P239; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Dillon RJ, 2005, DIVERSITY LOCUST GUT; Eisenhauer N, 2013, FUNCT ECOL, V27, P282, DOI 10.1111/j.1365-2435.2012.02060.x; Filocamo A, 2012, PHYTOMEDICINE, V19, P707, DOI 10.1016/j.phymed.2012.02.018; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; HIRD DW, 1983, APPL ENVIRON MICROB, V46, P1423, DOI 10.1128/AEM.46.6.1423-1425.1983; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Klaphake E, 2009, EXOTIC ANIMAL PRACTI, V12, P597, DOI [10.1016/j.cvex.2009.06.005, DOI 10.1016/J.CVEX.2009.06.005]; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Kueneman JG, 2014, MOL ECOL, V23, P1238, DOI 10.1111/mec.12510; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Lima AP, 2000, J HERPETOL, V34, P40, DOI 10.2307/1565236; Mahan RD, 2007, J HERPETOL, V41, P16, DOI 10.1670/0022-1511(2007)41[16:DOTGTH]2.0.CO;2; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; Matsui K, 2002, PIGM CELL RES, V15, P265, DOI 10.1034/j.1600-0749.2002.01085.x; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Meyer EA, 2012, DIS AQUAT ORGAN, V101, P235, DOI 10.3354/dao02523; Miller EA, 2001, CONTEMP TOP LAB ANIM, V40, P18; Mendoza GM, 2012, RES VET SCI, V93, P1160, DOI 10.1016/j.rvsc.2012.05.007; Muletz CR, 2012, BIOL CONSERV, V152, P119, DOI 10.1016/j.biocon.2012.03.022; Ogilvy V, 2012, ANIM CONSERV, V15, P480, DOI 10.1111/j.1469-1795.2012.00536.x; Ogilvy V, 2012, ZOO BIOL, V31, P470, DOI 10.1002/zoo.20416; Pasteris SE, 2006, AQUACULTURE, V251, P11, DOI 10.1016/j.aquaculture.2005.05.007; Pasteris SE, 2009, AQUAC RES, V40, P1605, DOI 10.1111/j.1365-2109.2009.02261.x; Pessier AP, 2002, SEMIN AVIAN EXOT PET, V11, P162, DOI 10.1053/saep.2002.123980; SALMOND GPC, 1995, MOL MICROBIOL, V16, P615, DOI 10.1111/j.1365-2958.1995.tb02424.x; Soler JJ, 2009, OPEN ORNITHOLOGY J, V2, P29, DOI DOI 10.1098/8SPB; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Wiggins PJ, 2011, J HERPETOL, V45, P329, DOI 10.1670/10-231.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004	52	75	80	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85563	10.1371/journal.pone.0085563	http://dx.doi.org/10.1371/journal.pone.0085563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416427	Green Published, Green Accepted, gold			2022-12-27	WOS:000329866300088
J	Camara-Leret, R; Paniagua-Zambrana, N; Balslev, H; Macia, MJ				Camara-Leret, Rodrigo; Paniagua-Zambrana, Narel; Balslev, Henrik; Macia, Manuel J.			Ethnobotanical Knowledge Is Vastly Under-Documented in Northwestern South America	PLOS ONE			English	Article							PALM USES; AMAZONIAN ECUADOR; ARECACEAE; FOREST; BIODIVERSITY; MANAGEMENT; DIVERSITY; RESERVE; PERU	A main objective of ethnobotany is to document traditional knowledge about plants before it disappears. However, little is known about the coverage of past ethnobotanical studies and thus about how well the existing literature covers the overall traditional knowledge of different human groups. To bridge this gap, we investigated ethnobotanical data-collecting efforts across four countries (Colombia, Ecuador, Peru, Bolivia), three ecoregions (Amazon, Andes, Choco), and several human groups (including Amerindians, mestizos, and Afro-Americans). We used palms (Arecaceae) as our model group because of their usefulness and pervasiveness in the ethnobotanical literature. We carried out a large number of field interviews (n = 2201) to determine the coverage and quality of palm ethnobotanical data in the existing ethnobotanical literature (n = 255) published over the past 60 years. In our fieldwork in 68 communities, we collected 87,886 use reports and documented 2262 different palm uses and 140 useful palm species. We demonstrate that traditional knowledge on palm uses is vastly under-documented across ecoregions, countries, and human groups. We suggest that the use of standardized data-collecting protocols in wide-ranging ethnobotanical fieldwork is a promising approach for filling critical information gaps. Our work contributes to the Aichi Biodiversity Targets and emphasizes the need for signatory nations to the Convention on Biological Diversity to respond to these information gaps. Given our findings, we hope to stimulate the formulation of clear plans to systematically document ethnobotanical knowledge in northwestern South America and elsewhere before it vanishes.	[Camara-Leret, Rodrigo; Paniagua-Zambrana, Narel; Macia, Manuel J.] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Paniagua-Zambrana, Narel] Univ Mayor San Andres, Herbario Nacl Bolivia, La Paz, Bolivia; [Balslev, Henrik] Aarhus Univ, Dept Biosci, Aarhus, Denmark	Autonomous University of Madrid; Universidad Mayor de San Andres; Aarhus University	Camara-Leret, R (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	rcamaraleret@gmail.com	Paniagua-Zambrana, Narel/AAI-4287-2021; Balslev, Hendrik/AAE-4071-2020; Macia, Manuel J/H-4631-2012; Balslev, Henrik/J-9191-2013; Cámara-Leret, Rodrigo/Z-2747-2019	Macia, Manuel J/0000-0002-4676-612X; Balslev, Henrik/0000-0002-7101-7120; Cámara-Leret, Rodrigo/0000-0001-7705-0602; Paniagua-Zambrana, Narel/0000-0003-0381-634X	European Union [212631]; Russel E. Train Education for Nature Program of the WWF; Anne S. Chatham fellowship of the Garden Club of America; Universidad Autonoma de Madrid	European Union(European Commission); Russel E. Train Education for Nature Program of the WWF; Anne S. Chatham fellowship of the Garden Club of America; Universidad Autonoma de Madrid	This study was funded by the European Union, 7th Framework Programme (contract no. 212631), the Russel E. Train Education for Nature Program of the WWF (to NPZ), the Anne S. Chatham fellowship of the Garden Club of America (to NPZ), and the Universidad Autonoma de Madrid travel grants programme (to RCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque UP, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-72; BALICK MJ, 1979, ECON BOT, V33, P11, DOI 10.1007/BF02858207; Balick MJ, 1990, USEFUL PALMS WORLD S; Balslev H, 2010, ECON BOT, V64, P55, DOI 10.1007/s12231-009-9105-4; Balslev Henrik, 2008, Rev. peru biol., V15, P121; BARFOD A, 1988, Principes, V32, P29; Benz BF, 2000, ECON BOT, V54, P183, DOI 10.1007/BF02907821; Bjorholm S, 2005, GLOBAL ECOL BIOGEOGR, V14, P423, DOI 10.1111/j.1466-822x.2005.00167.x; Borchsenius F., 1998, MANUAL PALMS ECUADOR; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brosi BJ, 2007, CONSERV BIOL, V21, P875, DOI 10.1111/j.1523-1739.2007.00654.x; Byg Anja, 2006, Environment Development and Sustainability, V8, P495, DOI 10.1007/s10668-006-9051-6; Byg Anja, 2004, Journal of Ethnobiology, V24, P255; Caballero R., 1995, ETNOBOTANICA COMUNID; Campos MT, 2003, ECON BOT, V57, P324, DOI 10.1663/0013-0001(2003)057[0324:PVAITE]2.0.CO;2; CLEMENT CR, 1987, ECON BOT, V41, P302, DOI 10.1007/BF02858977; Cook F. E. M., 1995, Economic botany data collection standard.; Couvreur TLP, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-48; de la Torre L, 2009, BIODIVERS CONSERV, V18, P2837, DOI 10.1007/s10531-009-9610-x; Dransfield J., 2008, GENERA PALMARUM THE; Galeano G, 2000, ECON BOT, V54, P358, DOI 10.1007/BF02864787; Galeano G., 2010, PALMAS COLOMBIA GUIA; Henderson A., 1995, PALMS AMAZON; Henderson A., 1997, FIELD GUIDE PALMS AM; JENSEN OH, 1995, ECON BOT, V49, P309, DOI 10.1007/BF02862351; Lewis M., 2013, ETHNOLOGUE LANGUAGES, V17th; Macia M. J., 2012, P BOT 2011 S HON RE, P41; Macia MJ, 2011, BOT REV, V77, P462, DOI 10.1007/s12229-011-9086-8; Macia MJ, 2004, BOT J LINN SOC, V144, P149, DOI 10.1111/j.1095-8339.2003.00248.x; Mikkelsen Caecilie, 2012, INDIGENOUS WORLD 201; Moraes M., 2004, FLORA PALMERAS BOLIV; Paniagua-Zambrana N., 2010, Ecologia en Bolivia, V45, P44; PEDERSEN HB, 1992, SUSTAINABLE HARVEST AND MARKETING OF RAIN FOREST PRODUCTS, P173; PEDERSEN HB, 1994, ECON BOT, V48, P310, DOI 10.1007/BF02862333; PEDERSEN HB, 1990, ECUADOREAN PALMS AGR; PHILLIPS O, 1994, CONSERV BIOL, V8, P225, DOI 10.1046/j.1523-1739.1994.08010225.x; PINEDOVASQUEZ M, 1990, CONSERV BIOL, V4, P405, DOI 10.1111/j.1523-1739.1990.tb00315.x; Pintaud JC, 2008, REV PERUANA BIOL, P5; PLOTKIN MJ, 1984, J ETHNOPHARMACOL, V10, P157, DOI 10.1016/0378-8741(84)90001-1; Ruokolainen K, 2000, BASIC APPL ECOL, V1, P97, DOI 10.1078/1439-1791-00020; Schultes RE, 1974, PRINCIPES, V28, P3; Schultes Richard Evans, 1995, ETHNOBOTANY EVOLUTIO; Alarcon JGS, 2008, ECON BOT, V62, P60, DOI 10.1007/s12231-007-9001-8; Sosnowska J, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-43; Thiers B., 2012, INDEX HERBARIORUM GL; UNEP, 2011, 10 M C PART CONV BIO; V de la Torre L., 2008, ENCICLOPEDIA PLANTAS; Wallace AR, 1853, PALM TREES AMAZON TH; WCSP, 2013, WORLD CHECKL SEL PLA; Zambrana NYP, 2007, BIODIVERS CONSERV, V16, P2771, DOI 10.1007/s10531-007-9218-y	50	41	46	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85794	10.1371/journal.pone.0085794	http://dx.doi.org/10.1371/journal.pone.0085794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416449	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300101
J	Fortner, KB; Grotegut, CA; Ransom, CE; Bentley, RC; Feng, LP; Lan, L; Heine, RP; Seed, PC; Murtha, AP				Fortner, Kimberly B.; Grotegut, Chad A.; Ransom, Carla E.; Bentley, Rex C.; Feng, Liping; Lan, Lan; Heine, R. Phillips; Seed, Patrick C.; Murtha, Amy P.			Bacteria Localization and Chorion Thinning among Preterm Premature Rupture of Membranes	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; LOW-BIRTH-WEIGHT; LOWER UTERINE POLE; STRUCTURAL CHARACTERISTICS; ALTERED MORPHOLOGY; IDENTIFICATION; ASSOCIATION; CERVIX; LABOR; ZONE	Objective: Bacterial colonization of the fetal membranes and its role in pathogenesis of membrane rupture is poorly understood. Prior retrospective work revealed chorion layer thinning in preterm premature rupture of membranes (PPROM) subjects. Our objective was to prospectively examine fetal membrane chorion thinning and to correlate to bacterial presence in PPROM, preterm, and term subjects. Study Design: Paired membrane samples (membrane rupture and membrane distant) were prospectively collected from: PPROM = 14, preterm labor (PTL = 8), preterm no labor (PTNL = 8), term labor (TL = 10), and term no labor (TNL = 8), subjects. Sections were probed with cytokeratin to identify fetal trophoblast layer of the chorion using immunohistochemistry. Fluorescence in situ hybridization was performed using broad range 16 s ribosomal RNA probe. Images were evaluated, chorion and choriodecidua were measured, and bacterial fluorescence scored. Chorion thinning and bacterial presence were compared among and between groups using Student's t-test, linear mixed effect model, and Poisson regression model (SAS Cary, NC). Results: In all groups, the fetal chorion cellular layer was thinner at rupture compared to distant site (147.2 vs. 253.7 mm, p<0.0001). Further, chorion thinning was greatest among PPROM subjects compared to all other groups combined, regardless of site sampled [PPROM(114.9) vs. PTL(246.0) vs. PTNL(200.8) vs. TL(217.9) vs. TNL(246.5)]. Bacteria counts were highest among PPROM subjects compared to all other groups regardless of site sampled or histologic infection [PPROM(31) vs. PTL(9) vs. PTNL(7) vs. TL(7) vs. TNL(6)]. Among all subjects at both sites, bacterial counts were inversely correlated with chorion thinning, even excluding histologic chorioamnionitis (p<0.0001 and p = 0.05). Conclusions: Fetal chorion was uniformly thinner at rupture site compared to distant sites. In PPROM fetal chorion, we demonstrated pronounced global thinning. Although cause or consequence is uncertain, bacterial presence is greatest and inversely correlated with chorion thinning among PPROM subjects.	[Fortner, Kimberly B.; Ransom, Carla E.] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Nashville, TN 37232 USA; [Grotegut, Chad A.; Feng, Liping; Heine, R. Phillips; Murtha, Amy P.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC 27710 USA; [Bentley, Rex C.] Duke Univ, Dept Pathol, Duke Univ Hosp, Durham, NC 27706 USA; [Seed, Patrick C.] Duke Univ, Dept Pediat, Duke Univ Hosp, Div Infect Dis, Durham, NC 27706 USA; [Seed, Patrick C.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Lan, Lan] Duke Univ, Duke Univ Hosp, Dept Biostat, Durham, NC USA	Vanderbilt University; Duke University; Duke University; Duke University; Duke University; Duke University	Murtha, AP (corresponding author), Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC 27710 USA.	amy.murtha@dm.duke.edu	Heine, R. Phillips/AAR-1189-2020		Charles Hammond Foundation; M. Krzyzewski Family	Charles Hammond Foundation; M. Krzyzewski Family	This work was funded by grant from the Charles Hammond Foundation and the M. Krzyzewski Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikat S, 2006, AM J OBSTET GYNECOL, V194, P211, DOI 10.1016/j.ajog.2005.06.083; Avchen RN, 2001, AM J EPIDEMIOL, V154, P895, DOI 10.1093/aje/154.10.895; Cahill RJ, 2005, MOL HUM REPROD, V11, P761, DOI 10.1093/molehr/gah234; Canzoneri BJ FL, 2013, REPROD SCI IN PRESS; Crofts BJ, 1998, BRIT J OPHTHALMOL, V82, P9, DOI 10.1136/bjo.82.1.9; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Khwad M, 2006, J SOC GYNECOL INVEST, V13, P191, DOI 10.1016/j.jsgi.2005.12.010; El Khwad M, 2005, BIOL REPROD, V72, P720, DOI 10.1095/biolreprod.104.033647; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; George RB, 2008, AM J PERINAT, V25, P29, DOI 10.1055/s-2007-1004828; Hamilton BE, 2010, BIRTHS PRELIMINARY D, V58; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jacobsson B, 2005, PEDIATR RES, V57, P473, DOI 10.1203/01.PDR.0000156475.50488.B0; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; KHONG TY, 1986, CELL TISSUE RES, V246, P189; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Kobaly K, 2008, PEDIATRICS, V121, P73, DOI 10.1542/peds.2007-1444; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; MALAK TM, 1994, BRIT J OBSTET GYNAEC, V101, P375, DOI 10.1111/j.1471-0528.1994.tb11908.x; MARTIN J, 2013, NY TIMES BK REV 1103, P15; McLaren J, 1999, HUM REPROD, V14, P237, DOI 10.1093/humrep/14.1.237; McParland PC, 2003, AM J OBSTET GYNECOL, V189, P1481, DOI 10.1067/S0002-9378(03)00585-4; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Moore RM, 2009, BIOL REPROD, V80, P781, DOI 10.1095/biolreprod.108.073205; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P30, DOI 10.1016/S1470-0328(03)00021-1; Murtha A P, 2002, Infect Dis Obstet Gynecol, V10, P93, DOI 10.1155/S106474490200008X; Murtha AP, 2006, AM J OBSTET GYNECOL, V195, P1249, DOI 10.1016/j.ajog.2006.09.002; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Uchide N, 2005, MED SCI MONITOR, V11, pRA7; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/mob.2000.109036; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445	38	51	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83338	10.1371/journal.pone.0083338	http://dx.doi.org/10.1371/journal.pone.0083338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421883	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500043
J	Gladue, DP; Baker-Bransetter, R; Holinka, LG; Fernandez-Sainz, IJ; O'Donnell, V; Fletcher, P; Lu, ZQ; Borca, MV				Gladue, Douglas P.; Baker-Bransetter, Ryan; Holinka, Lauren G.; Fernandez-Sainz, Ignacio J.; O'Donnell, Vivian; Fletcher, Paige; Lu, Zhiqiang; Borca, Manuel V.			Interaction of CSFV E2 Protein with Swine Host Factors as Detected by Yeast Two-Hybrid System	PLOS ONE			English	Article							VIRAL-DIARRHEA-VIRUS; ENVELOPE GLYCOPROTEIN E2; FEVER VIRUS; E-RNS; DENDRITIC CELLS; VIRULENCE DETERMINANT; INFLUENZA-VIRUS; STRAIN BRESCIA; CORE PROTEIN; N-PRO	E2 is one of the envelope glycoproteins of pestiviruses, including classical swine fever virus (CSFV) and bovine viral diarrhea virus (BVDV). E2 is involved in several critical functions, including virus entry into target cells, induction of a protective immune response and virulence in swine. However, there is no information regarding any host binding partners for the E2 proteins. Here, we utilized the yeast two-hybrid system and identified fifty-seven host proteins as positive binding partners which bound E2 from both CSFV and BVDV with the exception of two proteins that were found to be positive for binding only to CSFV E2. Alanine scanning of CSFV E2 demonstrated that the binding sites for these cellular proteins on E2 are likely non-linear binding sites. The possible roles of the identified host proteins are discussed as the results presented here will be important for future studies to elucidate mechanisms of host protein-virus interactions during pestivirus infection. However, due to the limitations of the yeast two hybrid system, the proteins identified is not exhaustive and each interaction identified needs to be confirmed by independent experimental approaches in the context of virus-infected cells before any definitive conclusion can be drawn on relevance for the virus life cycle.	[Gladue, Douglas P.; Baker-Bransetter, Ryan; Holinka, Lauren G.; Fernandez-Sainz, Ignacio J.; O'Donnell, Vivian; Fletcher, Paige; Borca, Manuel V.] ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY USA; [Gladue, Douglas P.; O'Donnell, Vivian] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA; [Lu, Zhiqiang] USDA ARS, Plum Isl Anim Dis Ctr, Dept Homeland Secur, Greenport, NY 11944 USA	United States Department of Agriculture (USDA); University of Connecticut; United States Department of Agriculture (USDA)	Borca, MV (corresponding author), ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY USA.	manuel.borca@ars.usda.gov	Fernandez Sainz, Ignacio/I-3046-2016; Gladue, Douglas/P-6280-2018; O'Donnell, Vivian/ACY-4611-2022	Gladue, Douglas/0000-0002-7894-0233; Borca, Manuel/0000-0002-0888-1178	USDA	USDA(United States Department of Agriculture (USDA))	Funded by the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Becher P, 2003, VIROLOGY, V311, P96, DOI 10.1016/S0042-6822(03)00192-2; Bennett JA, 2012, J VIROL, V86, P6595, DOI 10.1128/JVI.06755-11; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Chen LJ, 2012, RES VET SCI, V93, P529, DOI 10.1016/j.rvsc.2011.06.026; Chen WN, 2012, J VIROL, V86, P13533, DOI 10.1128/JVI.02095-12; Chernyy ES, 2011, BIOCHEMISTRY-MOSCOW+, V76, P958, DOI 10.1134/S0006297911080128; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Feng L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-175; Fernandez-Sainz I, 2010, J VIROL, V84, P1536, DOI 10.1128/JVI.02050-09; Fiebach AR, 2011, J VIROL, V85, P8002, DOI 10.1128/JVI.00330-11; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Garcin P, 2013, J PROTEOMICS, V79, P123, DOI 10.1016/j.jprot.2012.12.010; Gladue DP, 2012, J VIROL, V86, P12080, DOI 10.1128/JVI.01610-12; Gladue DP, 2010, VIROLOGY, V407, P129, DOI 10.1016/j.virol.2010.07.040; Gladue DP, 2010, VIRUS RES, V151, P10, DOI 10.1016/j.virusres.2010.03.007; Gladue DP, 2013, J VIROL; Gross H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042106; Ha SD, 2012, ANTIVIR RES, V93, P175, DOI 10.1016/j.antiviral.2011.11.009; Henke A, 2000, J VIROL, V74, P4284, DOI 10.1128/JVI.74.9.4284-4290.2000; Hong S, 2001, J VIROL, V75, P2526, DOI 10.1128/JVI.75.6.2526-2534.2001; Husser L, 2012, J INTERF CYTOK RES, V32, P221, DOI 10.1089/jir.2011.0068; Hulst M, 2013, ARCH VIROL, V158, P325, DOI 10.1007/s00705-012-1491-8; Hulst MM, 1997, J GEN VIROL, V78, P2779, DOI 10.1099/0022-1317-78-11-2779; Inoue Y, 2011, VIROLOGY, V410, P38, DOI 10.1016/j.virol.2010.10.026; Iourin O, 2013, ACTA CRYSTALLOGR F, V69, P35, DOI 10.1107/S1744309112049184; De Giusti CJ, 2011, NEUROSCI LETT, V501, P163, DOI 10.1016/j.neulet.2011.07.007; Kang K, 2012, MOL BIOL REP, V39, P10515, DOI 10.1007/s11033-012-1936-x; Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11; KONIG M, 1995, J VIROL, V69, P6479; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Li J, 2010, VIRUS RES, V148, P60, DOI 10.1016/j.virusres.2009.12.004; Li Y, 2013, P NATL ACAD SCI USA, V110, P6805, DOI 10.1073/pnas.1300524110; Liang DL, 2003, J GEN VIROL, V84, P1269, DOI 10.1099/vir.0.18557-0; Lindenbach BD, 2007, FIELDS VIROLOGY, P931; Lubinski J, 1999, J EXP MED, V190, P1637, DOI 10.1084/jem.190.11.1637; Maurer K, 2004, J VIROL, V78, P1792, DOI 10.1128/JVI.78.4.1792-1799.2004; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mocquet V, 2012, J VIROL, V86, P7530, DOI 10.1128/JVI.07021-11; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Py B, 2007, APOPTOSIS, V12, P1879, DOI 10.1007/s10495-007-0106-4; Reimann I, 2004, VIROLOGY, V322, P143, DOI 10.1016/j.virol.2004.01.028; Risatti GR, 2007, VIROLOGY, V364, P371, DOI 10.1016/j.virol.2007.02.025; Risatti GR, 2007, J VIROL, V81, P924, DOI 10.1128/JVI.01824-06; Risatti GR, 2006, VIROLOGY, V355, P94, DOI 10.1016/j.virol.2006.07.005; Risatti GR, 2005, J VIROL, V79, P3787, DOI 10.1128/JVI.79.6.3787-3796.2005; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Schmidt T, 2010, FEBS LETT, V584, P4361, DOI 10.1016/j.febslet.2010.09.038; Severino A, 2007, J CELL PHYSIOL, V212, P118, DOI 10.1002/jcp.21011; Shiozaki T, 2011, J GEN VIROL, V92, P315, DOI 10.1099/vir.0.028316-0; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; van Gennip HGP, 2000, VACCINE, V19, P447, DOI 10.1016/S0264-410X(00)00198-5; van Gennip HGP, 2004, J VIROL, V78, P8812, DOI 10.1128/JVI.78.16.8812-8823.2004; van Gennip HGP, 2002, VACCINE, V20, P1544, DOI 10.1016/S0264-410X(01)00497-2; Wang Z, 2004, VIROLOGY, V330, P332, DOI 10.1016/j.virol.2004.09.023; WEILAND E, 1990, J VIROL, V64, P3563, DOI 10.1128/JVI.64.8.3563-3569.1990; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Woodward AM, 2013, J VIROL, V87, P5841, DOI 10.1128/JVI.00166-13; Yoshii H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019352; Zaichick SV, 2013, CELL HOST MICROBE, V13, P193, DOI 10.1016/j.chom.2013.01.009	67	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85324	10.1371/journal.pone.0085324	http://dx.doi.org/10.1371/journal.pone.0085324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416391	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500240
J	Rodkey, EA; Winkler, ML; Bethel, CR; Pagadala, SRR; Buynak, JD; Bonomo, RA; van den Akker, F				Rodkey, Elizabeth A.; Winkler, Marisa L.; Bethel, Christopher R.; Pagadala, Sundar Ram Reddy; Buynak, John D.; Bonomo, Robert A.; van den Akker, Focco			Penam Sulfones and beta-Lactamase Inhibition: SA2-13 and the Importance of the C2 Side Chain Length and Composition	PLOS ONE			English	Article							TRANS-ENAMINE INTERMEDIATE; CLASS-A; CLAVULANIC ACID; CRYSTAL-STRUCTURES; BORONIC ACID; RESISTANCE; STABILIZATION; MUTAGENESIS; COMPLEX; VARIANT	beta-Lactamases are the major reason beta-lactam resistance is seen in Gram-negative bacteria. To combat this resistance mechanism, beta-lactamase inhibitors are currently being developed. Presently, there are only three that are in clinical use (clavulanate, sulbactam and tazobactam). In order to address this important medical need, we explored a new inhibition strategy that takes advantage of a long-lived inhibitory trans-enamine intermediate. SA2-13 was previously synthesized and shown to have a lower k(react) than tazobactam. We investigated here the importance of the carboxyl linker length and composition by synthesizing three analogs of SA2-13 (PSR-4-157, PSR-4-155, and PSR-3-226). All SA2-13 analogs yielded higher turnover numbers and k(react) compared to SA2-13. We next demonstrated using protein crystallography that increasing the linker length by one carbon allowed for better capture of a trans-enamine intermediate; in contrast, this trans-enamine intermediate did not occur when the C2 linker length was decreased by one carbon. If the linker was altered by both shortening it and changing the carboxyl moiety into a neutral amide moiety, the stable trans-enamine intermediate in wt SHV-1 did not form; this intermediate could only be observed when a deacylation deficient E166A variant was studied. We subsequently studied SA2-13 against a relatively recently discovered inhibitor-resistant (IR) variant of SHV-1, SHV K234R. Despite the alteration in the mechanism of resistance due to the K -> R change in this variant, SA2-13 was effective at inhibiting this IR enzyme and formed a trans-enamine inhibitory intermediate similar to the intermediate seen in the wt SHV-1 structure. Taken together, our data reveals that the C2 side chain linker length and composition profoundly affect the formation of the trans-enamine intermediate of penam sulfones. We also show that the design of SA2-13 derivatives offers promise against IR SHV beta-lactamases that possess the K234R substitution.	[Rodkey, Elizabeth A.; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Winkler, Marisa L.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Winkler, Marisa L.; Bethel, Christopher R.; Bonomo, Robert A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Div Res, Cleveland, OH USA; [Pagadala, Sundar Ram Reddy; Buynak, John D.] So Methodist Univ, Dept Chem, Dallas, TX 75275 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Southern Methodist University; Case Western Reserve University; Case Western Reserve University	Bonomo, RA (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	robert.bonomo@va.gov; focco.vandenakker@case.edu			National Institutes of Health (NIH) [R01 AI062968, R01 AI063517]; US Department of Veterans Affairs, Merit Review Program; Cleveland Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517, R01AI062968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs, Merit Review Program(US Department of Veterans Affairs); Cleveland Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the National Institutes of Health (NIH) (R01 AI062968 to FVDA; R01 AI063517 to RAB), US Department of Veterans Affairs, Merit Review Program (to RAB), and Cleveland Geriatric Research Education and Clinical Center (to RAB) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dubois V, 2008, ANTIMICROB AGENTS CH, V52, P3792, DOI 10.1128/AAC.00387-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Helfand MS, 2003, J BIOL CHEM, V278, P52724, DOI 10.1074/jbc.M306059200; Hujer AM, 2001, BBA-PROTEIN STRUCT M, V1547, P37, DOI 10.1016/S0167-4838(01)00164-9; Ke W, 2012, CHEMMEDCHEM, V7, P1002, DOI 10.1002/cmdc.201200006; Ke W, 2012, ANTIMICROB AGENTS CH, V56, P2713, DOI 10.1128/AAC.06099-11; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; LENFANT F, 1991, J BIOL CHEM, V266, P17187; Lin S, 1998, BIOCHEM J, V333, P395, DOI 10.1042/bj3330395; Manageiro V, 2010, ANTIMICROB AGENTS CH, V54, P2271, DOI 10.1128/AAC.01442-09; Mendonca N, 2008, ANTIMICROB AGENTS CH, V52, P1806, DOI 10.1128/AAC.01381-07; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Padayatti PS, 2005, J BIOL CHEM, V280, P34900, DOI 10.1074/jbc.M505333200; Papp-Wallace KM, 2012, BIOCHEM PHARMACOL, V83, P462, DOI 10.1016/j.bcp.2011.11.015; Pattanaik P, 2009, J BIOL CHEM, V284, P945, DOI 10.1074/jbc.M806833200; Sampson JM, 2011, ANTIMICROB AGENTS CH, V55, P2303, DOI 10.1128/AAC.01360-10; SANDERS CC, 1992, CLIN INFECT DIS, V15, P824, DOI 10.1093/clind/15.5.824; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Winkler ML, 2013, J MED CHEM, V56, P1084, DOI 10.1021/jm301490d	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85892	10.1371/journal.pone.0085892	http://dx.doi.org/10.1371/journal.pone.0085892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454944	gold, Green Submitted, Green Published			2022-12-27	WOS:000330236000020
J	Abeln, S; Vendruscolo, M; Dobson, CM; Frenkel, D				Abeln, Sanne; Vendruscolo, Michele; Dobson, Christopher M.; Frenkel, Daan			A Simple Lattice Model That Captures Protein Folding, Aggregation and Amyloid Formation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MONTE-CARLO; ALPHA-SYNUCLEIN; HEAT-CAPACITY; FREE-ENERGY; CONFORMATION; ENERGETICS; ENSEMBLES; SEQUENCES; FIBRILS	The ability of many proteins to convert from their functional soluble state to amyloid fibrils can be attributed to intermolecular beta strand formation. Such amyloid formation is associated with neurodegenerative disorders like Alzheimer's and Parkinson's. Molecular modelling can play a key role in providing insight into the factors that make proteins prone to fibril formation. However, fully atomistic models are computationally too expensive to capture the length and time scales associated with fibril formation. As the ability to form fibrils is the rule rather than the exception, much insight can be gained from the study of coarse-grained models that capture the key generic features associated with amyloid formation. Here we present a simple lattice model that can capture both protein folding and beta strand formation. Unlike standard lattice models, this model explicitly incorporates the formation of hydrogen bonds and the directionality of side chains. The simplicity of our model makes it computationally feasible to investigate the interplay between folding, amorphous aggregation and fibril formation, and maintains the capability of classic lattice models to simulate protein folding with high specificity. In our model, the folded proteins contain structures that resemble naturally occurring beta-sheets, with alternating polar and hydrophobic amino acids. Moreover, fibrils with intermolecular cross-beta strand conformations can be formed spontaneously out of multiple short hydrophobic peptide sequences. Both the formation of hydrogen bonds in folded structures and in fibrils is strongly dependent on the amino acid sequence, indicating that hydrogen-bonding interactions alone are not strong enough to initiate the formation of beta sheets. This result agrees with experimental observations that beta sheet and amyloid formation is strongly sequence dependent, with hydrophobic sequences being more prone to form such structures. Our model should open the way to a systematic study of the interplay between the factors that lead to amyloid formation.	[Abeln, Sanne] Vrije Univ Amsterdam, IBIVU Deptartment Comp Sci, Amsterdam, Netherlands; [Vendruscolo, Michele; Dobson, Christopher M.; Frenkel, Daan] Univ Cambridge, Deptartment Chem, Cambridge, England	Vrije Universiteit Amsterdam; University of Cambridge	Abeln, S (corresponding author), Vrije Univ Amsterdam, IBIVU Deptartment Comp Sci, Amsterdam, Netherlands.	s.abeln@vu.nl	Frenkel, Daan/G-2580-2014; Vendruscolo, Michele/F-5901-2012	Frenkel, Daan/0000-0002-6362-2021; Vendruscolo, Michele/0000-0002-3616-1610	Veni grant from Netherlands Organisation for Scientic Research (NWO); European Molecular Biology Organization (EMBO); Wellcome Trust; ERC [227758]; Wolfson Merit Award of the Royal Society of London; BBSRC [BB/H003843/1] Funding Source: UKRI; EPSRC [EP/I000844/1, EP/I001352/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H003843/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I001352/1, EP/I000844/1] Funding Source: researchfish	Veni grant from Netherlands Organisation for Scientic Research (NWO); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); Wolfson Merit Award of the Royal Society of London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	SA has been supported by a Veni grant on the project 'Understanding toxic protein oligomers through ensemble characteristics' from Netherlands Organisation for Scientic Research (NWO), and a travel-fellowship from the European Molecular Biology Organization (EMBO). MV and CMD acknowledge support from the Wellcome Trust (ref.). DF acknowledges support of ERC Advanced Grant 227758, a Wolfson Merit Award of the Royal Society of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeln S, 2011, BIOPHYS J, V101, P1014, DOI 10.1016/j.bpj.2011.07.032; Abeln S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000241; Auer S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000222; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020853; Combe N, 2007, MOL PHYS; DAVIDSON AR, 1994, P NATL ACAD SCI USA, V91, P2146, DOI 10.1073/pnas.91.6.2146; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; Hoang TX, 2004, P NATL ACAD SCI USA, V101, P7960, DOI 10.1073/pnas.0402525101; Kim S, 2010, BIOPHYS J, V99, P1949, DOI 10.1016/j.bpj.2010.07.008; Li DW, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000238; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li MS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2989981; LYUBARTSEV AP, 1992, J CHEM PHYS, V96, P1776, DOI 10.1063/1.462133; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Matthes D, 2012, J MOL BIOL, V421, P390, DOI 10.1016/j.jmb.2012.02.004; Naganathan AN, 2005, J AM CHEM SOC, V127, P17970, DOI 10.1021/ja055996y; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Ni R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058101; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; PRIVALOV PL, 1989, J MOL BIOL, V205, P737, DOI 10.1016/0022-2836(89)90318-5; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SALI A, 1994, J MOL BIOL, V235, P1614, DOI 10.1006/jmbi.1994.1110; SHAKHNOVICH EI, 1994, PHYS REV LETT, V72, P3907, DOI 10.1103/PhysRevLett.72.3907; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Takeda T, 2009, BIOPHYS J, V96, P442, DOI 10.1016/j.bpj.2008.10.008; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x	34	53	53	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85185	10.1371/journal.pone.0085185	http://dx.doi.org/10.1371/journal.pone.0085185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454816	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100063
J	Handa, S; Halpern, CT; Pettifor, A; Thirumurthy, H				Handa, Sudhanshu; Halpern, Carolyn Tucker; Pettifor, Audrey; Thirumurthy, Harsha			The Government of Kenya's Cash Transfer Program Reduces the Risk of Sexual Debut among Young People Age 15-25	PLOS ONE			English	Article							SOCIAL DESIRABILITY BIAS; HIV-INFECTION; INTERVIEW MODE; BEHAVIOR; SCHOOL; WOMEN; ASSOCIATION; ADOLESCENTS; EDUCATION; GIRLS	The aim of this study is to assess whether the Government of Kenya's Cash Transfer for Orphans and Vulnerable Children (Kenya CT-OVC) can reduce the risk of HIV among young people by postponing sexual debut. The program provides an unconditional transfer of US$20 per month directly to the main caregiver in the household. An evaluation of the program was implemented in 2007-2009 in seven districts. Fourteen Locations were randomly assigned to receive the program and fourteen were assigned to a control arm. A sample of households was enrolled in the evaluation in 2007. We revisited these households in 2011 and collected information on sexual activity among individuals between 15-25 years of age. We used logistic regression, adjusted for the respondent's age, sex and relationship to caregiver, the age, sex and schooling of the caregiver and whether or not the household lived in Nairobi at baseline, to compare rates of sexual debut among young people living in program households with those living in control households who had not yet entered the program. Our results, adjusted for these covariates, show that the program reduced the odds of sexual debut by 31 percent. There were no statistically significant effects on secondary outcomes of behavioral risk such as condom use, number of partners and transactional sex. Since the CT-OVC provides cash to the caregiver and not to the child, and there are no explicit conditions associated with receipt, these impacts are indirect, and may have been achieved by keeping young people in school. Our results suggest that large-scale national social cash transfer programs with poverty alleviation objectives may have potential positive spillover benefits in terms of reducing HIV risk among young people in Eastern and Southern Africa.	[Handa, Sudhanshu] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27514 USA; [Handa, Sudhanshu] Univ N Carolina, Dept Publ Policy, Chapel Hill, NC USA; [Halpern, Carolyn Tucker; Pettifor, Audrey; Thirumurthy, Harsha] Univ N Carolina, Gillings Sch Global Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC USA; [Halpern, Carolyn Tucker] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA; [Pettifor, Audrey] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Thirumurthy, Harsha] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Handa, S (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27514 USA.	shanda@email.unc.edu	Pettifor, Audrey/H-6793-2019	Pettifor, Audrey/0000-0002-3387-0817; Thirumurthy, Harsha/0000-0002-3308-7603	U.S. National Institute of Mental Health [1R01MH093241]; Eunice Kennedy Shriver National Institute of Child Health and Development [R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093241] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was funded by the U.S. National Institute of Mental Health through Grant Number 1R01MH093241 and by Eunice Kennedy Shriver National Institute of Child Health and Development R24 HD050924 to the Carolina Population Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alviar C, 2012, J DEV EFFECT, V4, P38, DOI 10.1080/19439342.2011.653578; Alviar C, 2012, J DEV EFFECT, V4, P9, DOI 10.1080/19439342.2011.653980; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Baird SJ, 2011, LANCET, DOI [10.1016/20140-6736(11)61709-1, DOI 10.1016/20140-6736(11)61709-1]; Beguy D, 2009, J ADOLESCENT HEALTH, V45, P595, DOI 10.1016/j.jadohealth.2009.03.014; Bjorkman-Nyqvist M, 2013, EVALUATING IMPACT SH; Cho H, 2011, J ADOLESCENT HEALTH, V48, P523, DOI 10.1016/j.jadohealth.2010.08.007; de Walque D, 2005, TROP MED INT HEALTH, V10, P993, DOI 10.1111/j.1365-3156.2005.01475.x; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; Eggleston E, 2000, INT FAM PLAN PERSPEC, V26, P79, DOI 10.2307/2648271; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P570, DOI 10.1097/OLQ.0b013e3181a866b8; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Hallfors D, 2011, AM J PUBLIC HEALTH, V101, P1082, DOI 10.2105/AJPH.2010.300042; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Jaya, 2008, American Journal of Public Health, V98, P169, DOI 10.2105/AJPH.2006.099937; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kenya National Bureau of Statistics and ICF Macro, 2010, KEN DEM HLTH SURV 20; Kohler HP, 2012, WORLD BANK ECON REV, V26, P165, DOI 10.1093/wber/lhr041; McCoy SI, 2010, LANCET, V376, P1281, DOI 10.1016/S0140-6736(10)61309-8; Medlin Carol, 2008, 4673 WORLD BANK; Mensch BS, 2008, STUD FAMILY PLANN, V39, P321, DOI 10.1111/j.1728-4465.2008.00178.x; Michelo C, 2006, AIDS, V20, P1031, DOI 10.1097/01.aids.0000222076.91114.95; Palen LA, 2008, J ADOLESCENT HEALTH, V42, P221, DOI 10.1016/j.jadohealth.2007.08.024; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Stockl H, 2013, AM J REPROD IMMUNOL, V69, P27, DOI 10.1111/aji.12043	29	92	92	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85473	10.1371/journal.pone.0085473	http://dx.doi.org/10.1371/journal.pone.0085473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454875	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100092
J	Shinzato, C; Inoue, M; Kusakabe, M				Shinzato, Chuya; Inoue, Mayuri; Kusakabe, Makoto			A Snapshot of a Coral "Holobiont": A Transcriptome Assembly of the Scleractinian Coral, Porites, Captures a Wide Variety of Genes from Both the Host and Symbiotic Zooxanthellae	PLOS ONE			English	Article							AMINO-ACID SYNTHESIS; CLIMATE-CHANGE; ANEMONE AIPTASIA; ALGAL SYMBIONTS; GENOME; DIVERSITY; SEQUENCE; CALCIFICATION; ACIDIFICATION; RESILIENCE	Massive scleractinian corals of the genus Porites are important reef builders in the Indo-Pacific, and they are more resistant to thermal stress than other stony corals, such as the genus Acropora. Because coral health and survival largely depend on the interaction between a coral host and its symbionts, it is important to understand the molecular interactions of an entire "coral holobiont". We simultaneously sequenced transcriptomes of Porites australiensis and its symbionts using the Illumina Hiseq2000 platform. We obtained 14.3 Gbp of sequencing data and assembled it into 74,997 contigs (average: 1,263 bp, N50 size: 2,037 bp). We successfully distinguished contigs originating from the host (Porites) and the symbiont (Symbiodinium) by aligning nucleotide sequences with the decoded Acropora digitifera and Symbiodinium minutum genomes. In contrast to previous coral transcriptome studies, at least 35% of the sequences were found to have originated from the symbionts, indicating that it is possible to analyze both host and symbiont transcriptomes simultaneously. Conserved protein domain and KEGG analyses showed that the dataset contains broad gene repertoires of both Porites and Symbiodinium. Effective utilization of sequence reads revealed that the polymorphism rate in P. australiensis is 1.0% and identified the major symbiotic Symbiodinium as Type C15. Analyses of amino acid biosynthetic pathways suggested that this Porites holobiont is probably able to synthesize most of the common amino acids and that Symbiodinium is potentially able to provide essential amino acids to its host. We believe this to be the first molecular evidence of complementarity in amino acid metabolism between coral hosts and their symbionts. We successfully assembled genes originating from both the host coral and the symbiotic Symbiodinium to create a snapshot of the coral holobiont transcriptome. This dataset will facilitate a deeper understanding of molecular mechanisms of coral symbioses and stress responses.	[Shinzato, Chuya] Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa, Japan; [Inoue, Mayuri; Kusakabe, Makoto] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Okinawa Institute of Science & Technology Graduate University; University of Tokyo	Shinzato, C (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa, Japan.	c.shinzato@oist.jp	Shinzato, Chuya/G-2958-2015	Shinzato, Chuya/0000-0001-7843-3381	Interdisciplinary Collaborative Research Program of the Atmosphere and Ocean Research Institute; University of Tokyo; Canon Foundation; KAKENHI [24241071, 25660172]	Interdisciplinary Collaborative Research Program of the Atmosphere and Ocean Research Institute; University of Tokyo; Canon Foundation(Canon Foundation); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Interdisciplinary Collaborative Research Program of the Atmosphere and Ocean Research Institute, the University of Tokyo and by The Canon Foundation and in part by KAKENHI (24241071 and 25660172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Appeltans W, 2012, WORLD REGISTER MARIN; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; Dubuc TQ, 2012, INTEGR COMP BIOL; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Furst P, 2004, J NUTR, V134, p1558S, DOI 10.1093/jn/134.6.1558S; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOHMAN TC, 1982, J CELL BIOL, V94, P56, DOI 10.1083/jcb.94.1.56; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; Inoue M, 2008, SCI TOTAL ENVIRON, V406, P123, DOI 10.1016/j.scitotenv.2008.07.032; Kawashima T, 2009, GENOME RES, V19, P1393, DOI 10.1101/gr.087072.108; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Lehnert EM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Ohde S, 2004, GEOCHEM J, V38, P613, DOI 10.2343/geochemj.38.613; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Polato NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028634; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHEN GT, 1987, NATURE, V328, P794, DOI 10.1038/328794a0; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Shinzato C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-311; Shoguchi E, 2013, CURR BIOL; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Solomon S., 2007, PHYS SCI BASIS WORKI; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Swanson R, 1998, MAR BIOL, V131, P83, DOI 10.1007/s002270050299; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Weis VM, 2010, MOL ECOL, V19, P1515, DOI 10.1111/j.1365-294X.2010.04575.x; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	63	64	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85182	10.1371/journal.pone.0085182	http://dx.doi.org/10.1371/journal.pone.0085182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454815	Green Published, Green Submitted, gold			2022-12-27	WOS:000330235100062
J	Zaveri, HP; Beck, TF; Hernandez-Garcia, A; Shelly, KE; Montgomery, T; van Haeringen, A; Anderlid, BM; Patel, C; Goel, H; Houge, G; Morrow, BE; Cheung, SW; Lalani, SR; Scott, DA				Zaveri, Hitisha P.; Beck, Tyler F.; Hernandez-Garcia, Andres; Shelly, Katharine E.; Montgomery, Tara; van Haeringen, Arie; Anderlid, Britt-Marie; Patel, Chirag; Goel, Himanshu; Houge, Gunnar; Morrow, Bernice E.; Cheung, Sau Wai; Lalani, Seema R.; Scott, Daryl A.			Identification of Critical Regions and Candidate Genes for Cardiovascular Malformations and Cardiomyopathy Associated with Deletions of Chromosome 1p36	PLOS ONE			English	Article							LEFT-VENTRICULAR NONCOMPACTION; MONOSOMY 1P36; SIGNALING PATHWAY; TERMINAL DELETION; MUTATIONS; MICE; ABNORMALITIES; PERLECAN; DISEASE; BREAKPOINTS	Cardiovascular malformations and cardiomyopathy are among the most common phenotypes caused by deletions of chromosome 1p36 which affect approximately 1 in 5000 newborns. Although these cardiac-related abnormalities are a significant source of morbidity and mortality associated with 1p36 deletions, most of the individual genes that contribute to these conditions have yet to be identified. In this paper, we use a combination of clinical and molecular cytogenetic data to define five critical regions for cardiovascular malformations and two critical regions for cardiomyopathy on chromosome 1p36. Positional candidate genes which may contribute to the development of cardiovascular malformations associated with 1p36 deletions include DVL1, SKI, RERE, PDPN, SPEN, CLCNKA, ECE1, HSPG2, LUZP1, and WASF2. Similarly, haploinsufficiency of PRDM16-a gene which was recently shown to be sufficient to cause the left ventricular noncompaction-SKI, PRKCZ, RERE, UBE4B and MASP2 may contribute to the development of cardiomyopathy. When treating individuals with 1p36 deletions, or providing prognostic information to their families, physicians should take into account that 1p36 deletions which overlie these cardiac critical regions may portend to cardiovascular complications. Since several of these cardiac critical regions contain more than one positional candidate gene-and large terminal and interstitial 1p36 deletions often overlap more than one cardiac critical region-it is likely that haploinsufficiency of two or more genes contributes to the cardiac phenotypes associated with many 1p36 deletions.	[Zaveri, Hitisha P.; Beck, Tyler F.; Hernandez-Garcia, Andres; Shelly, Katharine E.; Cheung, Sau Wai; Lalani, Seema R.; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Montgomery, Tara] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [van Haeringen, Arie] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Anderlid, Britt-Marie] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Anderlid, Britt-Marie] Karolinska Inst, Inst Mol Med & Surg, Stockholm, Sweden; [Patel, Chirag] Birmingham Womens Hosp, Dept Clin Genet, Birmingham, W Midlands, England; [Goel, Himanshu] Univ Newcastle, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [Houge, Gunnar] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Baylor College of Medicine; Baylor College of Medicine; Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Birmingham Women's Hospital; University of Newcastle; University of Bergen; Haukeland University Hospital; Yeshiva University; Albert Einstein College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	dscott@bcm.edu	Patel, Chirag/AAF-4953-2019; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; Lalani, Seema/AAI-5090-2020	Patel, Chirag/0000-0002-6374-5224; HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Beck, Tyler/0000-0002-7373-0640; Morrow, Bernice/0000-0002-8076-4726	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008307] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Boldt ABW, 2011, CLIN IMMUNOL, V140, P63, DOI 10.1016/j.clim.2011.03.008; Bursztejn AC, 2009, AM J MED GENET A, V149A, P2493, DOI 10.1002/ajmg.a.33051; Campeau PM, 2008, AM J MED GENET A, V146A, P3062, DOI 10.1002/ajmg.a.32563; Cappola TP, 2011, P NATL ACAD SCI USA, V108, P2456, DOI 10.1073/pnas.1017494108; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Cremer K, 2008, EUR J MED GENET, V51, P685, DOI 10.1016/j.ejmg.2008.07.006; Douglas YL, 2009, PEDIATR RES, V65, P27, DOI 10.1203/PDR.0b013e31818bc11a; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; El-Hattab AW, 2010, AM J MED GENET A, V152A, P504, DOI 10.1002/ajmg.a.33226; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Hsu CY, 2008, BIOCHEM BIOPH RES CO, V376, P466, DOI 10.1016/j.bbrc.2008.08.170; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057460, 10.1371/journal.pone.0068422]; Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Mahtab EAF, 2009, DEV DYNAM, V238, P183, DOI 10.1002/dvdy.21819; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Nicoulaz A, 2011, AM J MED GENET A, V155A, P1964, DOI 10.1002/ajmg.a.33210; Peddy SB, 2006, PEDIATRICS, V117, P1830, DOI 10.1542/peds.2005-2301; Pizzuti A, 2003, HUM MUTAT, V22, P372, DOI 10.1002/humu.10261; Saito S, 2008, AM J MED GENET A, V146A, P2891, DOI 10.1002/ajmg.a.32556; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Slavotinek A, 1999, J MED GENET, V36, P657; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Wat MJ, 2009, AM J MED GENET A, V149A, P1661, DOI 10.1002/ajmg.a.32896; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	47	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85600	10.1371/journal.pone.0085600	http://dx.doi.org/10.1371/journal.pone.0085600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454898	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100103
J	Zhang, XF; Wei, T; Liu, XM; Liu, C; Lv, Y				Zhang, Xu-Feng; Wei, Tao; Liu, Xue-Min; Liu, Chang; Lv, Yi			Impact of Cigarette Smoking on Outcome of Hepatocellular Carcinoma after Surgery in Patients with Hepatitis B	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; PROSTATE-CANCER; LIVER-DISEASE; ALCOHOL-USE; RISK; RECURRENCE; TOBACCO; INTERVENTION; SINGAPORE; CIRRHOSIS	Background and Objectives: Cigarette smoking is a potential risk factor for hepatocellular carcinoma (HCC) initiation, partially through interaction with hepatitis B virus (HBV). We examined the hypothesis that cigarette smoking might be associated with HBV-related HCC recurrence and patient survival after curative surgery. Patients and Methods: Data of 302 patients with HBV infection who had undergone curative resection for HCC were prospectively collected from 2008 to 2011. Smoking status and smoking quantity (pack-years, PY) were asked at admission. Factors affecting recurrence-free survival (RFS) were examined. RFS and liver-specific mortality (LSM) stratified by risk factors were compared with log-rank test. Results: 109 were current smokers. Current smokers were not different from non-smokers in tumor burden and surgical procedure. Univariate and multivariate analysis identified that heavy smoking (PY >= 20) was the most significant factor associated with HBV-related HCC recurrence after curative surgical resection (p = 0.001), followed by anti-HBV treatment (p < 0.01), current smoking (p = 0.028), surgical margin < 1 cm (p = 0.048) and blood transfusion > 600 ml (p = 0.028). The median RFS in non-smokers, ex-smokers and current smokers was 34 months, 24 months and 26 months, respectively (p = 0.033). Current smokers had significantly worse RFS rate and increased 5-year cumulative LSM than non-smokers (p = 0.024, and p < 0.001, respectively). Heavy smokers had significantly worse RFS than non-and light smokers (0 < PY < 20) (p < 0.001, respectively) and higher cumulative LSM than non-smokers and light smokers (p = 0.003 and 0.001, respectively). Furthermore, in current smokers, continuing smoking postoperatively was strongly associated with poorer RFS and higher LSM than those who quit smoking postoperatively (p = 0.016 and p = 0.003, respectively). Conclusions: Smoking history and quantity appears to be risk factors for HBV-related HCC recurrence and LSM of patients after surgery. For smokers, continued smoking postoperatively might accelerate tumor recurrence and patient death. Therefore, smoking abstinence should be strongly recommended to patients pre- and postoperatively.	[Zhang, Xu-Feng; Wei, Tao; Liu, Xue-Min; Liu, Chang; Lv, Yi] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China	Xi'an Jiaotong University	Lv, Y (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China.	luyi169@126.com	zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022		National Natural Science Foundation [81372582, 81101873]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation (numbers 81372582, 81101873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano J, 2010, GUT, V59, P1159, DOI 10.1136/gut.2008.162453; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; CHEN JG, 2010, ZHONGHUA YU FANG YI, V44, P383; Chen ZM, 2003, INT J CANCER, V107, P106, DOI 10.1002/ijc.11342; Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Giovannucci E, 1999, CANCER EPIDEM BIOMAR, V8, P277; Grosse Y, 2007, LANCET ONCOL, V8, P679, DOI 10.1016/S1470-2045(07)70235-8; Hagiwara M, 2013, J UROLOGY, V189, P2062, DOI 10.1016/j.juro.2013.01.024; Helen A, 1997, J APPL TOXICOL, V17, P289, DOI 10.1002/(SICI)1099-1263(199709)17:5&lt;289::AID-JAT448&gt;3.0.CO;2-9; Hezode C, 2003, GUT, V52, P126, DOI 10.1136/gut.52.1.126; Janjigian YY, 2010, CANCER-AM CANCER SOC, V116, P670, DOI 10.1002/cncr.24813; Joshu CE, 2011, JNCI-J NATL CANCER I, V103, P835, DOI 10.1093/jnci/djr124; Kao JH, 2002, J FORMOS MED ASSOC, V101, P239; Koh WP, 2011, BRIT J CANCER, V105, P1430, DOI 10.1038/bjc.2011.360; Koh WP, 2005, J NUTR, V135, P2473, DOI 10.1093/jn/135.10.2473; Liaw KM, 1998, TOB CONTROL, V7, P141, DOI 10.1136/tc.7.2.141; Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Nagle CM, 2006, CANCER EPIDEM BIOMAR, V15, P2557, DOI 10.1158/1055-9965.EPI-06-0592; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pessione F, 2001, HEPATOLOGY, V34, P121, DOI 10.1053/jhep.2001.25385; Peters MG, 2002, HEPATOLOGY, V36, pS220, DOI 10.1053/jhep.2002.36811; Phipps AI, 2013, J CLIN ONCOL, V31, P2016, DOI 10.1200/JCO.2012.46.2457; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Shih WL, 2012, INT J CANCER, V131, P2612, DOI 10.1002/ijc.27508; Smyth EC, 2012, ANN SURG ONCOL, V19, P2088, DOI 10.1245/s10434-012-2230-9; Tammemagi MC, 2000, ANN EPIDEMIOL, V10, P176, DOI 10.1016/S1047-2797(99)00048-4; Wang LY, 1998, AM J EPIDEMIOL, V147, P315; Yu MC, 2000, CAN J GASTROENTEROL, V14, P703, DOI 10.1155/2000/371801; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330; Zhang XF, 2009, EJSO-EUR J SURG ONC, V35, P622, DOI 10.1016/j.ejso.2008.08.003	36	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85077	10.1371/journal.pone.0085077	http://dx.doi.org/10.1371/journal.pone.0085077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454795	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100054
J	Janssen, BH; Voet, NBM; Nabuurs, CI; Kan, HE; de Rooy, JWJ; Geurts, AC; Padberg, GW; van Engelen, BGM; Heerschap, A				Janssen, Barbara H.; Voet, Nicoline B. M.; Nabuurs, Christine I.; Kan, Hermien E.; de Rooy, Jacky W. J.; Geurts, Alexander C.; Padberg, George W.; van Engelen, Baziel G. M.; Heerschap, Arend			Distinct Disease Phases in Muscles of Facioscapulohumeral Dystrophy Patients Identified by MR Detected Fat Infiltration	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MYOTONIC-DYSTROPHY; SPECTROSCOPY; PHOSPHOCREATINE; QUANTIFICATION; PROGRESSION; PATTERNS; EXERCISE	Facioscapulohumeral muscular dystrophy (FSHD) is an untreatable disease, characterized by asymmetric progressive weakness of skeletal muscle with fatty infiltration. Although the main genetic defect has been uncovered, the downstream mechanisms causing FSHD are not understood. The objective of this study was to determine natural disease state and progression in muscles of FSHD patients and to establish diagnostic biomarkers by quantitative MRI of fat infiltration and phosphorylated metabolites. MRI was performed at 3T with dedicated coils on legs of 41 patients (28 men/13 women, age 34-76 years), of which eleven were re-examined after four months of usual care. Muscular fat fraction was determined with multi spin-echo and T1 weighted MRI, edema by TIRM and phosphorylated metabolites by 3D P-31 MR spectroscopic imaging. Fat fractions were compared to clinical severity, muscle force, age, edema and phosphocreatine (PCr)/ATP. Longitudinal intramuscular fat fraction variation was analyzed by linear regression. Increased intramuscular fat correlated with age (p<0.05), FSHD severity score (p<0.0001), inversely with muscle strength (p<0.0001), and also occurred subclinically. Muscles were nearly dichotomously divided in those with high and with low fat fraction, with only 13% having an intermediate fat fraction. The intramuscular fat fraction along the muscle's length, increased from proximal to distal. This fat gradient was the steepest for intermediate fat infiltrated muscles (0.07 +/- 0.01/cm, p<0.001). Leg muscles in this intermediate phase showed a decreased PCr/ATP (p<0.05) and the fastest increase in fatty infiltration over time (0.18 +/- 0.15/year, p<0.001), which correlated with initial edema (p<0.01), if present. Thus, in the MR assessment of fat infiltration as biomarker for diseased muscles, the intramuscular fat distribution needs to be taken into account. Our results indicate that healthy individual leg muscles become diseased by entering a progressive phase with distal fat infiltration and altered energy metabolite levels. Fat replacement then relatively rapidly spreads over the whole muscle.	[Janssen, Barbara H.; Nabuurs, Christine I.; Kan, Hermien E.; de Rooy, Jacky W. J.; Heerschap, Arend] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Voet, Nicoline B. M.; Geurts, Alexander C.] Radboud Univ Nijmegen, Dept Rehabil, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kan, Hermien E.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Padberg, George W.; van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Janssen, BH (corresponding author), Radboud Univ Nijmegen, Dept Radiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Barbara.Janssen@radboudumc.nl	Kan, Hermien/L-2385-2013; Voet, Nicole/A-1395-2016; Padberg, G.W.A.M./H-8079-2014; Geurts, Alexander/H-8032-2014; Janssen, Barbara/M-9165-2013; van Engelen, Baziel/H-8027-2014; Heerschap, Arend/G-5228-2010	Kan, Hermien/0000-0002-5772-7177; Voet, Nicole/0000-0001-7381-2817; Geurts, Alexander/0000-0001-7478-1119; van Engelen, Baziel/0000-0001-9867-9047; 	Prinses Beatrix Spierfonds [WAR08-15]; ZonMW [89000003]; FSHD Global Research Foundation; FSH Society	Prinses Beatrix Spierfonds; ZonMW(Netherlands Organization for Health Research and Development); FSHD Global Research Foundation; FSH Society	This work was supported by the Prinses Beatrix Spierfonds [WAR08-15] (https://www.prinsesbeatrixspierfonds.nl), ZonMW [89000003 (http://www.zonmw.nl/en/), the FSHD Global Research Foundation (http://www.fshdglobal.org/), and the FSH Society (http://www.fshsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee B, 2010, MAGN RESON IMAGING, V28, P698, DOI 10.1016/j.mri.2010.03.008; BARBIROLI B, 1992, J NEUROL SCI, V109, P188, DOI 10.1016/0022-510X(92)90167-J; Barnes PRJ, 1997, BRAIN, V120, P1699, DOI 10.1093/brain/120.10.1699; Dubowitz V, 2007, MUSCULAR DYSTROPHIES; FELMLEE JP, 1987, RADIOLOGY, V164, P559, DOI 10.1148/radiology.164.2.3602402; Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2; Friedman SD, 2013, MUSCLE NERVE, V31, P155; Friedman SD, 2012, MUSCLE NERVE, V45, P500, DOI 10.1002/mus.22342; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; Gaeta M, 2012, SKELETAL RADIOL, V41, P515, DOI 10.1007/s00256-011-1199-y; Grehl T, 1998, NEUROMUSCULAR DISORD, V8, P480, DOI 10.1016/S0960-8966(98)00066-2; HEERSCHAP A, 1993, MUSCLE NERVE, V16, P367, DOI 10.1002/mus.880160405; Kan HE, 2010, NMR BIOMED, V23, P563, DOI 10.1002/nbm.1494; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; KEMP GJ, 1993, J NEUROL SCI, V116, P201, DOI 10.1016/0022-510X(93)90326-T; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lodi R, 1997, NEUROMUSCULAR DISORD, V7, P505, DOI 10.1016/S0960-8966(97)00108-9; May DA, 2000, RADIOGRAPHICS, V20, pS295, DOI 10.1148/radiographics.20.suppl_1.g00oc18s295; McMahon CJ, 2010, AM J ROENTGENOL, V194, pW284, DOI 10.2214/AJR.10.4247; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Padberg G., 1982, THESIS U LEIDEN LEID; Pandya S, 2008, PHYS THER, V88, P105, DOI 10.2522/ptj.20070104; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Richards M, 2012, HUM GENET, V131, P325, DOI 10.1007/s00439-011-1100-z; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Sookhoo S, 2007, CLIN RADIOL, V62, P160, DOI 10.1016/j.crad.2006.08.012; Statland JM, 2013, NEUROMUSCULAR DISORD, V23, P306, DOI 10.1016/j.nmd.2013.01.008; Statland JM, 2011, CURR OPIN NEUROL, V24, P423, DOI 10.1097/WCO.0b013e32834959af; Takahashi H, 1996, NMR BIOMED, V9, P8, DOI 10.1002/(SICI)1099-1492(199602)9:1<8::AID-NBM387>3.0.CO;2-F; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Taylor D J, 1983, Mol Biol Med, V1, P77; Trenell MI, 2006, ANN NEUROL, V59, P871, DOI 10.1002/ana.20841; van der Kooi EL, 2004, NEUROLOGY, V63, P702, DOI 10.1212/01.WNL.0000134660.30793.1F; van der Maarel SM, 2011, TRENDS MOL MED, V17, P252, DOI 10.1016/j.molmed.2011.01.001; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Voet NBM, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-56; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732	45	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85416	10.1371/journal.pone.0085416	http://dx.doi.org/10.1371/journal.pone.0085416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454861	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800046
J	Jiricny, N; Molin, S; Foster, K; Diggle, SP; Scanlan, PD; Ghoul, M; Johansen, HK; Santorelli, LA; Popat, R; West, SA; Griffin, AS				Jiricny, Natalie; Molin, Soren; Foster, Kevin; Diggle, Stephen P.; Scanlan, Pauline D.; Ghoul, Melanie; Johansen, Helle Krogh; Santorelli, Lorenzo A.; Popat, Roman; West, Stuart A.; Griffin, Ashleigh S.			Loss of Social Behaviours in Populations of Pseudomonas aeruginosa Infecting Lungs of Patients with Cystic Fibrosis	PLOS ONE			English	Article							QUORUM-SENSING HIERARCHY; VIRULENCE; COOPERATION; ADAPTATION; EVOLUTION; AIRWAYS; GENES; LASR; EPIDEMIOLOGY; EXPRESSION	Pseudomonas aeruginosa, is an opportunistic, bacterial pathogen causing persistent and frequently fatal infections of the lung in patients with cystic fibrosis. Isolates from chronic infections differ from laboratory and environmental strains in a range of traits and this is widely interpreted as the result of adaptation to the lung environment. Typically, chronic strains carry mutations in global regulation factors that could effect reduced expression of social traits, raising the possibility that competitive dynamics between cooperative and selfish, cheating strains could also drive changes in P. aeruginosa infections. We compared the expression of cooperative traits -biofilm formation, secretion of exo-products and quorum sensing (QS) in P. aeruginosa isolates that were estimated to have spent different lengths of time in the lung based on clinical information. All three exo-products involved in nutrient acquisition were produced in significantly smaller quantities with increased duration of infection, and patterns across four QS signal molecules were consistent with accumulation over time of mutations in lasR, which are known to disrupt the ability of cells to respond to QS signal. Pyocyanin production, and the proportion of cells in biofilm relative to motile, free-living cells in liquid culture, did not change. Overall, our results confirm that the loss of social behaviour is a consistent trend with time spent in the lung and suggest that social dynamics are potentially relevant to understanding the behaviour of P. aeruginosa in lung infections.	[Jiricny, Natalie; Foster, Kevin; Scanlan, Pauline D.; Ghoul, Melanie; Santorelli, Lorenzo A.; West, Stuart A.; Griffin, Ashleigh S.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Diggle, Stephen P.] Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Johansen, Helle Krogh] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Popat, Roman] Univ Edinburgh, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Oxford; Technical University of Denmark; University of Nottingham; University of Copenhagen; University of Edinburgh	Griffin, AS (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	ashleigh.griffin@zoo.ox.ac.uk	Scanlan, Pauline/AAE-7713-2019; West, Stuart A/M-3608-2014; Griffin, Ashleigh/C-6244-2014	Scanlan, Pauline/0000-0002-6733-9653; West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825; Santorelli, Lorenzo/0000-0002-8392-801X; Foster, Kevin/0000-0003-4687-6633; Molin, Soren/0000-0002-7973-2639	BBSRC; ERC; Royal Society and L'Oreal/UNESCO Fellowship for Women in Science; NERC [NE/J007064/]; NERC [NE/J010642/1, NE/J007064/1] Funding Source: UKRI; Natural Environment Research Council [NE/J007064/1, NE/J010642/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Royal Society and L'Oreal/UNESCO Fellowship for Women in Science(L'Oreal Group); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Work was funded by BBSRC studentship to NJ; ERC to SAW; Royal Society and L'Oreal/UNESCO Fellowship for Women in Science to ASG; NERC grant to SAW and SPD Grant Ref: NE/J007064/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKENBAUER R, 1985, INFECT IMMUN, V49, P132, DOI 10.1128/IAI.49.1.132-140.1985; AYORA S, 1994, MOL GEN GENET, V242, P421, DOI 10.1007/BF00281792; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Bodilis J, 2009, ENVIRON MICROBIOL, V11, P2123, DOI 10.1111/j.1462-2920.2009.01932.x; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Carlsson M, 2011, J CYST FIBROS, V10, P265, DOI 10.1016/j.jcf.2011.03.004; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fletcher MP, 2010, PSEUDOMONAS, VOL 6: MOLECULAR MICROBIOLOGY, INFECTION AND BIODIVERSITY, P29, DOI 10.1007/978-90-481-3909-5_2; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180, DOI 10.1128/IAI.61.4.1180-1184.1993; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hogardt M, 2013, CURR TOP MICROBIOL, V358, P91, DOI 10.1007/82_2011_199; Holloway B., 1975, GENETICS BIOCH PSEUD; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jiricny N, 2010, J EVOLUTION BIOL, V23, P738, DOI 10.1111/j.1420-9101.2010.01939.x; Johansen HK, 2004, PEDIATR PULM, V37, P427, DOI 10.1002/ppul.10457; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Kurachi M, 1958, B I CHEM RES, V36; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lee B, 2011, APMIS, V119, P263, DOI 10.1111/j.1600-0463.2011.02726.x; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Ortori C, 2011, ANAL BIOANAL CHEM, V399, P497; Ortori CA, 2007, ANAL BIOANAL CHEM, V387, P497, DOI 10.1007/s00216-006-0710-0; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Reid DW, 2007, EUR RESPIR J, V30, P286, DOI 10.1183/09031936.00154006; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Rumbaugh KP, 2012, P ROY SOC B-BIOL SCI, V279, P3584, DOI 10.1098/rspb.2012.0843; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Yang L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-184; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	55	50	51	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83124	10.1371/journal.pone.0083124	http://dx.doi.org/10.1371/journal.pone.0083124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454693	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800007
J	Nakashima, R; Imura, Y; Hosono, Y; Seto, M; Murakami, A; Watanabe, K; Handa, T; Mishima, M; Hirakata, M; Takeuchi, T; Fujio, K; Yamamoto, K; Kohsaka, H; Takasaki, Y; Enomoto, N; Suda, T; Chida, K; Hisata, S; Nukiwa, T; Mimori, T				Nakashima, Ran; Imura, Yoshitaka; Hosono, Yuji; Seto, Minae; Murakami, Akihiro; Watanabe, Kizuku; Handa, Tomohiro; Mishima, Michiaki; Hirakata, Michito; Takeuchi, Tsutomu; Fujio, Keishi; Yamamoto, Kazuhiko; Kohsaka, Hitoshi; Takasaki, Yoshinari; Enomoto, Noriyuki; Suda, Takafumi; Chida, Kingo; Hisata, Shu; Nukiwa, Toshihiro; Mimori, Tsuneyo			The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LUNG-DISEASE; ANTISYNTHETASE SYNDROME; REVISED CRITERIA; AUTOANTIBODIES; ANTIBODIES; DERMATOMYOSITIS; CLASSIFICATION; IDENTIFICATION	Objective: Autoantibodies to aminoacyl-tRNA synthetases (ARSs) are useful in the diagnosis of idiopathic inflammatory myopathy (IIM) with interstitial pneumonia (IP). We developed an enzyme-linked immunosorbent assay (ELISA) system using a mixture of recombinant ARS antigens and tested its utility in a multicenter study. Methods: We prepared six recombinant ARSs: GST-Jo-1, His-PL-12, His-EJ and GST-KS expressed in Escherichia coli, and His-PL-7 and His-OJ expressed in Hi-5 cells. After confirming their antigenic activity, with the exception of His-OJ, we developed our ELISA system in which the five recombinant ARSs (without His-OJ) were mixed. Efficiency was confirmed using the sera from 526 Japanese patients with connective tissue disease (CTD) (IIM n = 250, systemic lupus erythematosus n = 91, systemic sclerosis n = 70, rheumatoid arthritis n = 75, Sjo "gren's syndrome n = 27 and other diseases n = 13), 168 with idiopathic interstitial pneumonia (IIP) and 30 healthy controls collected from eight institutes. IIPs were classified into two groups; idiopathic pulmonary fibrosis (IPF) (n = 38) and non-IPF (n = 130). Results were compared with those of RNA immunoprecipitation. Results: Sensitivity and specificity of the ELISA were 97.1% and 99.8%, respectively when compared with the RNA immunoprecipitation assay. Anti-ARS antibodies were detected in 30.8% of IIM, 2.5% of non-myositis CTD, and 10.7% of IIP (5.3% of IPF and 12.3% of non-IPF). Anti-ARS-positive non-IPF patients were younger and more frequently treated with glucocorticoids and/or immunosuppressants than anti-ARS-negative patients. Conclusion: A newly established ELISA detected anti-ARS antibodies as efficiently as RNA immunoprecipitation. This system will enable easier and wider use in the detection of anti-ARS antibodies in patients with IIM and IIP.	[Nakashima, Ran; Imura, Yoshitaka; Hosono, Yuji; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Seto, Minae; Murakami, Akihiro] Med & Biol Labs Co Ltd, Nagoya, Aichi, Japan; [Watanabe, Kizuku; Handa, Tomohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Hirakata, Michito] Keio Univ, Med Educ Ctr, Dept Internal Med, Sch Med, Tokyo, Japan; [Takeuchi, Tsutomu] Keio Univ, Sch Med, Div Rheumatol, Dept Internal Med, Tokyo, Japan; [Fujio, Keishi; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Kohsaka, Hitoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med & Rheumatol, Tokyo, Japan; [Takasaki, Yoshinari] Juntendo Univ, Sch Med, Dept Internal Med & Rheumatol, Tokyo 113, Japan; [Enomoto, Noriyuki; Suda, Takafumi; Chida, Kingo] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan; [Hisata, Shu; Nukiwa, Toshihiro] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan	Kyoto University; Kyoto University; Keio University; Keio University; University of Tokyo; Tokyo Medical & Dental University (TMDU); Juntendo University; Hamamatsu University School of Medicine; Tohoku University	Mimori, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	mimorit@kuhp.kyoto-u.ac.jp	Takeuchi, Tsutomu/L-2327-2013; Takeuchi, Tsutomu/AFM-8316-2022; Hirakata, Michito/B-2474-2015; Yamamoto, Kazuhiko/N-5096-2015; Enomoto, Noriyuki/GLS-0691-2022	Takeuchi, Tsutomu/0000-0003-1111-8218; Enomoto, Noriyuki/0000-0003-3187-4264	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research and for Challenging Exploratory Research from the Japan Society for the Promotion of Science, and grants for intractable diseases from the Ministry of Health, Labour and Welfare in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2013, ANN RHEUM DIS; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Betteridge Z, 2007, RHEUMATOLOGY, V46, P1005, DOI 10.1093/rheumatology/kem045; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Brouwer R, 2001, ANN RHEUM DIS, V60, P116, DOI 10.1136/ard.60.2.116; BUNN CC, 1986, J EXP MED, V163, P1281, DOI 10.1084/jem.163.5.1281; DANG CV, 1988, FASEB J, V2, P2376, DOI 10.1096/fasebj.2.8.2452112; Friedman AW, 1996, SEMIN ARTHRITIS RHEU, V26, P459, DOI 10.1016/S0049-0172(96)80026-6; Ghirardello A, 2006, AUTOIMMUNITY, V39, P217, DOI 10.1080/08916930600622645; Hashish L, 2005, ARTHRITIS RHEUM-US, V52, pS312; Hervier B, 2012, AUTOIMMUN REV, V12, P210, DOI 10.1016/j.autrev.2012.06.006; Hirakata M, 1999, J IMMUNOL, V162, P2315; Hirakata M, 2007, ARTHRITIS RHEUM, V56, P1295, DOI 10.1002/art.22506; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; MATHEWS MB, 1984, J EXP MED, V160, P420, DOI 10.1084/jem.160.2.420; MATHEWS MB, 1983, NATURE, V304, P177, DOI 10.1038/304177a0; Matsushita T, 2007, J RHEUMATOL, V34, P1012; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c; NISHIKAI M, 1980, ARTHRITIS RHEUM, V23, P881, DOI 10.1002/art.1780230802; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Sato T, 2010, ARTHRITIS RHEUM-US, V62, P3730, DOI 10.1002/art.27700; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TARGOFF IN, 1992, ARTHRITIS RHEUM, V35, P821, DOI 10.1002/art.1780350718; TARGOFF IN, 1990, AM J MED, V88, P241, DOI 10.1016/0002-9343(90)90149-8; TARGOFF IN, 1993, J CLIN INVEST, V91, P2556, DOI 10.1172/JCI116493; TARGOFF IN, 1990, J IMMUNOL, V144, P1737; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Watanabe K, 2011, RESP MED, V105, P1238, DOI 10.1016/j.rmed.2011.03.022; Yoshifuji H, 2006, AUTOIMMUNITY, V39, P233, DOI 10.1080/08916930600622884	30	80	83	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85062	10.1371/journal.pone.0085062	http://dx.doi.org/10.1371/journal.pone.0085062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454792	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800021
J	Kim, J; Shapiro, MJ; Bamidele, AO; Gurel, P; Thapa, P; Higgs, HN; Hedin, KE; Shapiro, VS; Billadeau, DD				Kim, Joanna; Shapiro, Michael J.; Bamidele, Adebowale O.; Gurel, Pinar; Thapa, Puspa; Higgs, Henry N.; Hedin, Karen E.; Shapiro, Virginia S.; Billadeau, Daniel D.			Coactosin-Like 1 Antagonizes Cofilin to Promote Lamellipodial Protrusion at the Immune Synapse	PLOS ONE			English	Article							T-CELL-ACTIVATION; ACTIN-DEPOLYMERIZING FACTOR; ALDRICH-SYNDROME PROTEIN; IMMUNOLOGICAL SYNAPSE; BINDING-PROTEIN; TRANSCRIPTIONAL REPRESSOR; CRYSTAL-STRUCTURE; NONMUSCLE CELLS; ADAPTER PROTEIN; DYNAMICS	Actin depolymerizing factor-homology (ADF-H) family proteins regulate actin filament dynamics at multiple cellular locations. Herein, we have investigated the function of the ADF-H family member coactosin-like 1 (COTL1) in the regulation of actin dynamics at the T cell immune synapse (IS). We initially identified COTL1 in a genetic screen to identify novel regulators of T cell activation, and subsequently found that it associates with F-actin and localizes at the IS in response to TCR+CD28 stimulation. Live cell microscopy showed that depletion of COTL1 protein impaired T cell spreading in response to TCR ligation and abrogated lamellipodial protrusion at the T cell - B cell contact site, producing only a band of F-actin. Significantly, re-expression of wild type COTL1, but not a mutant deficient in F-actin binding could rescue these defects. In addition, COTL1 depletion reduced T cell migration. In vitro studies showed that COTL1 and cofilin compete with each other for binding to F-actin, and COTL1 protects F-actin from cofilin-mediated depolymerization. While depletion of cofilin enhanced F-actin assembly and lamellipodial protrusion at the IS, concurrent depletion of both COTL1 and cofilin restored lamellipodia formation. Taken together, our results suggest that COTL1 regulates lamellipodia dynamics in part by protecting F-actin from cofilin-mediated disassembly.	[Kim, Joanna; Billadeau, Daniel D.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Shapiro, Michael J.; Thapa, Puspa; Hedin, Karen E.; Shapiro, Virginia S.; Billadeau, Daniel D.] Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA; [Bamidele, Adebowale O.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA; [Gurel, Pinar; Higgs, Henry N.] Dartmouth Coll, Dept Biochem, Geisel Sch Med Dartmouth, Hanover, NH 03755 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Dartmouth College	Shapiro, VS (corresponding author), Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA.	shapiro.virginia1@mayo.edu; billadeau.daniel@mayo.edu	Bamidele, Adebowale O./AAZ-2453-2020; Kim, Joanna/U-5556-2018	Bamidele, Adebowale O./0000-0002-9547-2195; Kim, Joanna/0000-0001-7877-9446; Higgs, Henry/0000-0002-2917-9644; Hedin, Karen/0000-0003-1010-923X	Mayo Foundation; National Institutes of Health [R01-AI065474, R21 AI104065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065474, R21AI104065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062981, T34GM008078, T32GM008704, T32GM072474] Funding Source: NIH RePORTER	Mayo Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mayo Foundation and National Institutes of Health grants R01-AI065474 (DDB) and R21 AI104065 (VSS and DDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Carrizosa E, 2009, J IMMUNOL, V183, P7352, DOI 10.4049/jimmunol.0900973; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302; Doucet J, 2002, BIOCHEM BIOPH RES CO, V290, P783, DOI 10.1006/bbrc.2001.6236; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gorman JA, 2012, J IMMUNOL, V188, P6135, DOI 10.4049/jimmunol.1103487; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Greene TA, 2003, IMMUNOL RES, V27, P513, DOI 10.1385/IR:27:2-3:513; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Ham H, 2013, J IMMUNOL, V190, P3661, DOI 10.4049/jimmunol.1202792; Hellman M, 2004, FEBS LETT, V576, P91, DOI 10.1016/j.febslet.2004.08.068; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Hou X, 2013, DEV BIOL; Hsu FC, 2011, J EXP MED, V208, P1291, DOI 10.1084/jem.20101874; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Li XM, 2004, PROTEIN SCI, V13, P2845, DOI 10.1110/ps.04937304; Liu L, 2004, J MOL BIOL, V344, P317, DOI 10.1016/j.jmb.2004.09.036; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Provost P, 1999, P NATL ACAD SCI USA, V96, P1881, DOI 10.1073/pnas.96.5.1881; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Provost P, 2001, BIOCHEM J, V359, P255, DOI 10.1042/0264-6021:3590255; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; ROHRIG U, 1995, FEBS LETT, V374, P284, DOI 10.1016/0014-5793(95)01130-7; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Thapa P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2580; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wilkinson Beverley, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010264; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388	51	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85090	10.1371/journal.pone.0085090	http://dx.doi.org/10.1371/journal.pone.0085090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454796	Green Submitted, Green Published, gold			2022-12-27	WOS:000329922500040
J	Brosseau, L; Rahman, P; Toupin-April, K; Poitras, S; King, J; De Angelis, G; Loew, L; Casimiro, L; Paterson, G; McEwan, J				Brosseau, Lucie; Rahman, Prinon; Toupin-April, Karine; Poitras, Stephane; King, Judy; De Angelis, Gino; Loew, Laurianne; Casimiro, Lynn; Paterson, Gail; McEwan, Jessica			A Systematic Critical Appraisal for Non-Pharmacological Management of Osteoarthritis Using the Appraisal of Guidelines Research and Evaluation II Instrument	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; KNEE OSTEOARTHRITIS; REHABILITATION INTERVENTIONS; CARE; HIP; RECOMMENDATIONS; QUALITY; ARTHRITIS; ADULTS; PHYSIOTHERAPY	Clinical practice CPGs (CPGs) have been developed to summarize evidence related to the management of osteoarthritis (OA). CPGs facilitate uptake of evidence-based knowledge by consumers, health professionals, health administrators and policy makers. The objectives of the present review were: 1) to assess the quality of the CPGs on non-pharmacological management of OA; using a standardized and validated instrument - the Appraisal of Guidelines Research and Evaluation (AGREE II) tool - by three pairs of trained appraisers; and 2) to summarize the recommendations based on only high-quality existing CPGs. Scientific literature databases from 2001 to 2013 were systematically searched for the state of evidence, with 17 CPGs for OA being identified. Most CPGs effectively addressed only a minority of AGREE II domains. Scope and purpose was effectively addressed in 10 CPGs on the management of OA, stakeholder involvement in 12 CPGs, rigour of development in 10 CPGs, clarity/presentation in 17 CPGs, editorial independence in 2 CPGs, and applicability in none of the OA CPGs. The overall quality of the included CPGs, according to the 7-point AGREE II scoring system, is 4.8 +/- 0.41 for OA. Therapeutic exercises, patient education, transcutaneous electrical nerve stimulation, acupuncture, orthoses and insoles, heat and cryotherapy, patellar tapping, and weight control are commonly recommended for the non-pharmacological management of OA by the high-quality CPGs. The general clinical management recommendations tended to be similar among high-quality CPGs, although interventions addressed varied. Non-pharmacological management interventions were superficially addressed in more than half of the selected CPGs. For CPGs to be standardized uniform creators should use the AGREE II criteria when developing CPGs. Innovative and effective methods of CPG implementation to users are needed to ultimately enhance the quality of life of arthritic individuals.	[Brosseau, Lucie; Toupin-April, Karine; Poitras, Stephane; King, Judy; De Angelis, Gino; Loew, Laurianne; Casimiro, Lynn] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Rahman, Prinon] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Toupin-April, Karine] Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Toupin-April, Karine] Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada; [Casimiro, Lynn] Montfort Hosp, Dept Acad Affairs, Ottawa, ON, Canada; [Paterson, Gail] Arthrit Soc, Ottawa, ON, Canada; [McEwan, Jessica] Univ Ottawa Lib, Ottawa, ON, Canada	University of Ottawa; Dalhousie University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa	Brosseau, L (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada.	Lucie.Brosseau@uottawa.ca	King, Judy/L-1070-2018	King, Judy/0000-0003-4530-9987; Poitras, Stephane/0000-0002-8049-958X; Loew, Laurianne/0000-0002-7059-8859; De Angelis, Gino/0000-0003-2099-9870; McEwan, Jessica/0000-0002-4802-6539	Canadian Institutes of Health Research's (CIHR) Institute of Musculoskeletal Health and Arthritis Community Outreach Grant [ICS-123828]	Canadian Institutes of Health Research's (CIHR) Institute of Musculoskeletal Health and Arthritis Community Outreach Grant	This project was funded by the Canadian Institutes of Health Research's (CIHR) Institute of Musculoskeletal Health and Arthritis Community Outreach Grant: #ICS-123828. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright J, 2001, PHYS THER, V81, P1675; Albright J, 2001, PHYS THER, V81, P1629; American Academy of Orthopaedic Surgeons, 2008, TREATM OST KNEE NON; Ay S, 2008, INT J REHABIL RES, V31, P159, DOI 10.1097/MRR.0b013e3282fc0f6c; Bekkering GE, 2005, QUAL SAF HEALTH CARE, V14, P107, DOI 10.1136/qshc.2003.009357; Bennell KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4934; Brand C, 2009, GUIDELINE NONSURGICA; Brand CA, 2013, RHEUM DIS CLIN N AM, V39, P123, DOI 10.1016/j.rdc.2012.10.005; Brandt KD, 2004, ANN RHEUM DIS, V63, P117, DOI 10.1136/ard.2002.004606; Brosseau L, 2005, PHYS THER, V85, P907; Brosseau L, 2010, HLTH ED J, V70, P318; Brosseau L, 2011, PHYS THER, V91, P843, DOI 10.2522/ptj.20100104; Brouwers MC, 2010, CMAJ, V182, P472; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Cottrell JED, 2013, INT J NURS KNOWL, V24, P66, DOI 10.1111/j.2047-3095.2013.01231.x; Dehaan MN, 2007, J RHEUMATOL, V34, P2099; Denoeud L, 2005, ANN RHEUM DIS, V64, P70, DOI 10.1136/ard.2003.015263; *EUR LEAG AG RHEUM, 2004, ANN RHEUM DIS, V64, P669; *EUR LEAG AG RHEUM, 2007, ANN RHEUM DIS, V66, P377; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; Glazier RH, 2003, J RHEUMATOL, V30, P1846; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Iwamoto J, 2011, WORLD J ORTHOP, V2, P37, DOI 10.5312/wjo.v2.i5.37; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Jordan KM, 2004, RHEUMATOLOGY, V43, P381, DOI 10.1093/rheumatology/keh045; Kjeken I, 2011, SCAND J OCCUP THER, V18, P265, DOI 10.3109/11038128.2010.514942; Kotlarz H, 2010, J OCCUP ENVIRON MED, V52, P263, DOI 10.1097/JOM.0b013e3181cf00aa; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Li LC, 2004, ARTHRIT RHEUM-ARTHR, V51, P203, DOI 10.1002/art.20244; Loew L, 2012, ARCH PHYS MED REHAB, V93, P1269, DOI 10.1016/j.apmr.2012.01.024; Lutzner J, 2009, NAT REV RHEUMATOL, V5, P309, DOI 10.1038/nrrheum.2009.88; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; Misso ML, 2008, MED J AUSTRALIA, V189, P394, DOI 10.5694/j.1326-5377.2008.tb02086.x; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Pencharz JN, 2002, ARTHRITIS RES, V4, P36, DOI 10.1186/ar381; Peter WFH, 2011, ACTA REUMATOL PORT, V36, P268; Poitras S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2339; Porcheret M, 2007, RHEUMATOLOGY, V46, P638, DOI 10.1093/rheumatology/kel340; Rannou F, 2010, BEST PRACT RES CL RH, V24, P93, DOI 10.1016/j.berh.2009.08.013; Richmond JC, 2013, RHEUM DIS CLIN N AM, V39, P203, DOI 10.1016/j.rdc.2012.10.008; Roddy E, 2005, RHEUMATOLOGY, V44, P67, DOI 10.1093/rheumatology/keh399; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Sakalauskiene G, 2010, MEDICINA-LITHUANIA, V46, P790, DOI 10.3390/medicina46110111; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Toupin KA, 2013, ADDRESSING UNMET NEE, P122; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yan JP, 2013, J EVAL CLIN PRACT, V19, P626, DOI 10.1111/j.1365-2753.2012.01873.x; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	53	62	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e82986	10.1371/journal.pone.0082986	http://dx.doi.org/10.1371/journal.pone.0082986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427268	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200008
J	Lee, MY; Hsiao, PJ; Yang, YH; Lin, KD; Shin, SJ				Lee, Mei-Yueh; Hsiao, Pi-Jung; Yang, Yi-Hsin; Lin, Kun-Der; Shin, Shyi-Jang			The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease	PLOS ONE			English	Article							BLOOD-CELL COUNT; RENAL-INSUFFICIENCY; CARDIOVASCULAR OUTCOMES; INFLAMMATION; PHARMACOKINETICS; DIFFERENTIATION; BIOMARKERS; PREDICTOR; MORTALITY; CORONARY	Objective: Although studies have shown an association between pioglitazone and bladder cancer, the associated factors have not been identified. The aim of this study was to investigate the factors that may link pioglitazone to bladder cancer. Materials and Methods: In total, 34,970 study subjects were identified from the National Health Insurance Research Database in 2003 with follow-up from 2005 to 2009. The demographic characteristics of patients who had used and had never used pioglitazone, including age, sex, diabetes duration, urinary tract disease, nephropathy, bladder cancer, and cumulative dose and duration of pioglitazone therapy, were analyzed using the chi 2 test. Cox proportional hazard regression models were used to determine the independent effects of pioglitazone on bladder cancer and newly developed chronic kidney disease. Results: Among 3,497 ever users and 31,473 never users of pioglitazone, the respective incident cases of bladder cancer were 12 (0.4%) and 72 (0.2%), and for newly developed chronic kidney disease 245 (8.1%) and 663 (2.3%), respectively. Ever use of pioglitazone [1.59(1.32-1.91)], cumulative dose of pioglitazone <10,500 mg [1.69 (1.37-2.01)] and >10,500 mg [1.34 (1.04-1.73)], and duration of therapy <12 months [1.68 (1.36-2.08)] and >12 months [1.39 (1.09-1.76)] were associated with the development of chronic kidney disease. Conclusions: There was no association of pioglitazone use with bladder cancer development, however, there was an association with an increased risk of newly developed chronic kidney disease.	[Lee, Mei-Yueh] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh; Hsiao, Pi-Jung; Lin, Kun-Der; Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh; Hsiao, Pi-Jung; Lin, Kun-Der; Shin, Shyi-Jang] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Grad Inst Med Genet, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ Hosp, Dept Clin Res, Stat Anal Lab, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Shin, SJ (corresponding author), Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan.	sjshin@kmu.edu.tw	Yang, Yi-Hsin/D-6471-2012	Yang, Yi-Hsin/0000-0002-9581-2778; Hsiao, Pi-Jung/0000-0001-5024-9371	Department of Internal Medicine, Kaohsiung Medical University Hospital	Department of Internal Medicine, Kaohsiung Medical University Hospital	This study was funded by the Department of Internal Medicine, Kaohsiung Medical University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Cengiz Kuddusi, 2002, International Urology and Nephrology, V33, P121; Chapelsky MC, 2003, J CLIN PHARMACOL, V43, P252, DOI 10.1177/0091270002250602; Cohen SM, 1998, TOXICOL PATHOL, V26, P121, DOI 10.1177/019262339802600114; COHEN SM, 1995, FOOD CHEM TOXICOL, V33, P715, DOI 10.1016/0278-6915(95)00040-9; Cohen SM, 1999, IARC SCI PUBL, P175; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; de Vinuesa SG, 2006, J AM SOC NEPHROL, V17, pS206, DOI 10.1681/ASN.2006080916; El-Hage J., 2005, INT ATH SOC S PPAR M; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; FRIEDMAN GD, 1991, AM J EPIDEMIOL, V133, P376, DOI 10.1093/oxfordjournals.aje.a115891; GAN SC, 1992, ARCH INTERN MED, V152, P2333, DOI 10.1001/archinte.152.11.2333; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Keller CR, 2007, KIDNEY INT, V71, P239, DOI 10.1038/sj.ki.5002042; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Krepinsky J, 2000, AM J KIDNEY DIS, V35, P500, DOI 10.1016/S0272-6386(00)70204-6; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McGregor DB, 1999, IARC SCI PUBL, P1; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Perkins BA, 2005, J AM SOC NEPHROL, V16, P1404, DOI 10.1681/ASN.2004100854; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Schneider CA, 2008, J AM SOC NEPHROL, V19, P182, DOI 10.1681/ASN.2007060678; Schumacher S, 2001, EUR J CLIN PHARMACOL, V57, P147, DOI 10.1007/s002280100280; Shankar A, 2006, ARCH INTERN MED, V166, P188, DOI 10.1001/archinte.166.2.188; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Takayama S, 1998, JNCI-J NATL CANCER I, V90, P19, DOI 10.1093/jnci/90.1.19; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Varley CL, 2009, CELL DEATH DIFFER, V16, P103, DOI 10.1038/cdd.2008.116; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6; Varley CL, 2008, EXP TOXICOL PATHOL, V60, P435, DOI 10.1016/j.etp.2008.04.009; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998; Yale JF, 2005, J AM SOC NEPHROL, V16, pS7, DOI 10.1681/ASN.2004110974	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85479	10.1371/journal.pone.0085479	http://dx.doi.org/10.1371/journal.pone.0085479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427312	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200053
J	Murray, BD; Kensinger, EA				Murray, Brendan D.; Kensinger, Elizabeth A.			The Route to an Integrative Associative Memory Is Influenced by Emotion	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; IMAGERY QUESTIONNAIRE; PERIRHINAL CORTEX; IMMEDIATE MEMORY; TABOO STROOP; AMYGDALA; RECOGNITION; ATTENTION; AROUSAL; UNITIZATION	Though the hippocampus typically has been implicated in processes related to associative binding, special types of associations - such as those created by integrative mental imagery - may be supported by processes implemented in other medial temporal-lobe or sensory processing regions. Here, we investigated what neural mechanisms underlie the formation and subsequent retrieval of integrated mental images, and whether those mechanisms differ based on the emotionality of the integration (i.e., whether it contains an emotional item or not). Participants viewed pairs of words while undergoing a functional MRI scan. They were instructed to imagine the two items separately from one another ("non-integrative" study) or as a single, integrated mental image ("integrative" study). They provided ratings of how successful they were at generating vivid images that fit the instructions. They were then given a surprise associative recognition test, also while undergoing an fMRI scan. The cuneus showed parametric correspondence to increasing imagery success selectively during encoding and retrieval of emotional integrations, while the parahippocampal gyri and prefrontal cortices showed parametric correspondence during the encoding and retrieval of non-emotional integrations. Connectivity analysis revealed that selectively during negative integration, left amygdala activity was negatively correlated with frontal and hippocampal activity. These data indicate that individuals utilize two different neural routes for forming and retrieving integrations depending on their emotional content, and they suggest a potentially disruptive role for the amygdala on frontal and medial-temporal regions during negative integration.	[Murray, Brendan D.; Kensinger, Elizabeth A.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Boston College	Murray, BD (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	murrayds@bc.edu		Kensinger, Elizabeth/0000-0003-1940-231X	National Institute of Mental Health [MH080833]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080833] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grant MH080833 from the National Institute of Mental Health (awarded to EAK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blajenkova O, 2006, APPL COGNITIVE PSYCH, V20, P239, DOI 10.1002/acp.1182; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; Campos A, 2009, PERCEPT MOTOR SKILL, V108, P798, DOI 10.2466/PMS.108.3.798-802; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303002002003; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fox P.T., 1994, FUNCTIONAL NEUROIMAG, P95; Giovanello KS, 2006, NEUROPSYCHOLOGIA, V44, P1859, DOI 10.1016/j.neuropsychologia.2006.03.004; GRAF P, 1989, J EXP PSYCHOL LEARN, V15, P930, DOI 10.1037/0278-7393.15.5.930; Hadley CB, 2006, J EXP PSYCHOL LEARN, V32, P79, DOI 10.1037/0278-7393.32.1.79; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Haskins AL, 2008, NEURON, V59, P554, DOI 10.1016/j.neuron.2008.07.035; Jacobs WJ, 1998, PSYCHOL PUBLIC POL L, V4, P1110; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Kueera M, 1967, COMPUTATIONAL ANAL P; Libkuman TM, 2004, MEMORY, V12, P237, DOI 10.1080/09658210244000630; MacKay DG, 2005, PSYCHOL SCI, V16, P25, DOI 10.1111/j.0956-7976.2005.00776.x; MacKay DG, 2004, MEM COGNITION, V32, P474, DOI 10.3758/BF03195840; Marks DF, 1995, J MENTAL IMAGERY, V19, P153, DOI DOI 10.1177/0963721414532287; Mather M, 2006, J COGNITIVE NEUROSCI, V18, P614, DOI 10.1162/jocn.2006.18.4.614; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Murray BD, 2012, MEM COGNITION, V40, P1056, DOI 10.3758/s13421-012-0215-3; Nielsen FA, 2002, NEUROIMAGE 2 P 8 ANN; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Payne J. D., 2004, MEMORY EMOTION, P76, DOI [10.1093/acprof:oso/9780195158564.003.0003, DOI 10.1093/ACPROF:OSO/9780195158564.003.0003]; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Quamme JR, 2007, HIPPOCAMPUS, V17, P192, DOI 10.1002/hipo.20257; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Slotnick S.D, 2008, CLUSTER THRESHOLD BE; Staresina BP, 2008, J COGNITIVE NEUROSCI, V20, P1478, DOI 10.1162/jocn.2008.20104; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Staresina BP, 2010, J NEUROSCI, V30, P9890, DOI 10.1523/JNEUROSCI.0826-10.2010; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; WOLLEN KA, 1972, COGNITIVE PSYCHOL, V3, P518, DOI 10.1016/0010-0285(72)90020-5	39	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e82372	10.1371/journal.pone.0082372	http://dx.doi.org/10.1371/journal.pone.0082372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427267	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200007
J	Krishnan, N; Titus, MA; Thapar, R				Krishnan, Nithya; Titus, Mark A.; Thapar, Roopa			The Prolyl Isomerase Pin1 Regulates mRNA Levels of Genes with Short Half-Lives by Targeting Specific RNA Binding Proteins	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; PEPTIDYLPROLYL ISOMERASE; BETA-CATENIN; CELL-CYCLE; IN-VIVO; HUR; PHOSPHORYLATION; INHIBITORS; STABILITY	The peptidyl-prolyl isomerase Pin1 is over-expressed in several cancer tissues is a potential prognostic marker in prostate cancer, and Pin1 ablation can suppress tumorigenesis in breast and prostate cancers. Pin1 can co-operate with activated ErbB2 or Ras to enhance tumorigenesis. It does so by regulating the activity of proteins that are essential for gene expression and cell proliferation. Several targets of Pin1 such as c-Myc, the Androgen Receptor, Estrogen Receptor-alpha, Cyclin D1, Cyclin E, p53, RAF kinase and NCOA3 are deregulated in cancer. At the posttranscriptional level, emerging evidence indicates that Pin1 also regulates mRNA decay of histone mRNAs, GM-CSF, Pth, and TGF beta mRNAs by interacting with the histone mRNA specific protein SLBP, and the ARE-binding proteins AUF1 and KSRP, respectively. To understand how Pin1 may affect mRNA abundance on a genome-wide scale in mammalian cells, we used RNAi along with DNA microarrays to identify genes whose abundance is significantly altered in response to a Pin1 knockdown. Functional scoring of differentially expressed genes showed that Pin1 gene targets control cell adhesion, leukocyte migration, the phosphatidylinositol signaling system and DNA replication. Several mRNAs whose abundance was significantly altered by Pin1 knockdown contained AU-rich element (ARE) sequences in their 3' untranslated regions. We identified HuR and AUF1 as Pin1 interacting ARE-binding proteins in vivo. Pin1 was also found to stabilize all core histone mRNAs in this study, thereby validating our results from a previously published study. Statistical analysis suggests that Pin1 may target the decay of essential mRNAs that are inherently unstable and have short to medium half-lives. Thus, this study shows that an important biological role of Pin1 is to regulate mRNA abundance and stability by interacting with specific RNA-binding proteins that may play a role in cancer progression.	[Krishnan, Nithya; Thapar, Roopa] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14260 USA; [Thapar, Roopa] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Thapar, Roopa] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Titus, Mark A.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rice University; University of Texas System; UTMD Anderson Cancer Center	Thapar, R (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	rthapar@rice.edu	Thapar, Roopa/AAC-3419-2021		NIH [1RO1-GM076660]; Department of Defense (DOD) [W81XWH-10-1-0273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by NIH 1RO1-GM076660 (R. T.) and Department of Defense (DOD) grant W81XWH-10-1-0273 (M. A. T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014656; ALTERMAN RBM, 1984, MOL CELL BIOL, V4, P123, DOI 10.1128/MCB.4.1.123; Anderson P, 2005, NAT IMMUNOL, V6, P1211, DOI 10.1038/ni1205-1211; Avila MA, 2007, GASTROENTEROLOGY, V132, P1180, DOI 10.1053/j.gastro.2007.01.061; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Dominski Z, 1999, MOL CELL BIOL, V19, P3561; Dong LM, 2010, BIOORG MED CHEM LETT, V20, P2210, DOI 10.1016/j.bmcl.2010.02.033; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Duncan KE, 2011, J MED CHEM, V54, P3854, DOI 10.1021/jm200156c; Esnault S, 2008, CRIT REV IMMUNOL, V28, P45, DOI 10.1615/CritRevImmunol.v28.i1.30; Esnault S, 2006, J IMMUNOL, V177, P6999, DOI 10.4049/jimmunol.177.10.6999; Gherzi R, 2010, WIRES RNA, V1, P230, DOI 10.1002/wrna.2; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Guo CX, 2009, BIOORG MED CHEM LETT, V19, P5613, DOI 10.1016/j.bmcl.2009.08.034; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; Jentsch S, 2009, CELL CYCLE, V8, P3800, DOI 10.4161/cc.8.23.9971; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Krishnan N, 2012, MOL CELL BIOL, V32, P4306, DOI 10.1128/MCB.00382-12; Kumar R, 2009, J CLIN INVEST, V119, P2887, DOI 10.1172/JCI40784; La Montagna R, 2012, CELL CYCLE, V11, P3415, DOI 10.4161/cc.21730; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Liu T, 2010, J MED CHEM, V53, P2494, DOI 10.1021/jm901778v; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Moore JD, 2013, BIOORG MED CHEM LETT, V23, P4283, DOI 10.1016/j.bmcl.2013.05.088; Mori T, 2011, BIOCHEM BIOPH RES CO, V406, P439, DOI 10.1016/j.bbrc.2011.02.066; Naveh-Many T, 2010, ENDOCRINOLOGY, V151, P1398, DOI 10.1210/en.2009-1160; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Potter A, 2010, BIOORG MED CHEM LETT, V20, P6483, DOI 10.1016/j.bmcl.2010.09.063; Rajbhandari P, 2013, ONCOGENE; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rudrabhatla P, 2010, J ALZHEIMERS DIS, V19, P389, DOI 10.3233/JAD-2010-1243; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sanchez R, 2002, MOL CELL BIOL, V22, P7093, DOI 10.1128/MCB.22.20.7093-7104.2002; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2012, J BIOL CHEM, V287, P23294, DOI 10.1074/jbc.M111.313684; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Tatara Y, 2009, BIOCHEM BIOPH RES CO, V384, P394, DOI 10.1016/j.bbrc.2009.04.144; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	62	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85427	10.1371/journal.pone.0085427	http://dx.doi.org/10.1371/journal.pone.0085427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416409	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300079
J	Qi, FZ; Huang, MD; Pan, Y; Liu, Y; Liu, JB; Wen, J; Xie, KP; Shen, HB; Ma, HX; Miao, Y; Hu, ZB				Qi, Fuzhen; Huang, Mingde; Pan, Yun; Liu, Yao; Liu, Jibin; Wen, Juan; Xie, Kaipeng; Shen, Hongbing; Ma, Hongxia; Miao, Yi; Hu, Zhibin			A Genetic Variant in the Promoter Region of miR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; LUNG-CANCER; MICRORNA EXPRESSION; CELL-PROLIFERATION; ALPHA-FETOPROTEIN; HUMAN LIVER; CIRRHOSIS; MARKER	Background: MiR-106b-25 cluster, hosted in intron 13 of MCM7, may play integral roles in diverse processes including immune response, tumorigenesis and progression. A single nucleotide polymorphism (SNP), rs999885, is located in the promoter region of MCM7. Our previous study showed that the A to G base change of rs999885 may provide an increased risk for HCC in HBV persistent carriers by altering the expression of the miR-106b-25 cluster. However, it is unknown whether rs999885 is associated with prognosis of intermediate or advanced HBV-related hepatocellular carcinoma (HCC) patients. Methods: The SNP, rs999885, was genotyped by using the TaqMan allelic discrimination Assay in 414 intermediate or advanced HCC patients. Log-rank test and Cox proportional hazard models were used for survival analysis. Results: The variant genotypes of rs999885 were associated with a significantly decreased risk of death for intermediate or advanced HCC [additive model: adjusted hazard ratio (HR) = 0.76,95% confidence intervals (CI) = 0.59-0.97]. Further stepwise regression analysis suggested that rs999885 was an independently protective factor for the prognosis of HCC in the final model (additive model: adjusted HR = 0.72, 95% CI = 0.56-0.91, P = 0.007). Conclusions: These findings indicate that the A to G base change of rs999885 may provide a protective effect on the prognosis of intermediate or advanced HCC in Chinese.	[Qi, Fuzhen] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Hepatopancreatobiliary Surg, Huaian, Jiangsu, Peoples R China; [Huang, Mingde] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Med Oncol, Huaian, Jiangsu, Peoples R China; [Pan, Yun; Liu, Yao; Wen, Juan; Xie, Kaipeng; Shen, Hongbing; Ma, Hongxia; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Epidemiol & Biostat,Canc Ctr, Nanjing, Jiangsu, Peoples R China; [Liu, Jibin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Jiangsu, Peoples R China; [Shen, Hongbing; Ma, Hongxia; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Miao, Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Ma, HX (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Epidemiol & Biostat,Canc Ctr, Nanjing, Jiangsu, Peoples R China.	hongxiama@njmu.edu.cn; miaoyi@njmu.edu.cn; zhibin_hu@njmu.edu.cn			National Natural Science Foundation of China [81372606, 81072344]; National Key Basic Research Program [2013CB911400]; National Science Foundation for Distinguished Young Scholars of China [81225020]; Foundation of Jiangsu Province for Distinguished Young Scholars [BK2012042]; Foundation for the Program for New Century Excellent Talents in University [NCET-10-0178]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions [122031]; Organization Department of the CPC Central Committee; Author of National Excellent Doctoral Dissertation [201081]; Jiangsu Province Clinical Science and Technology Projects [BL2012008]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Foundation of Jiangsu Province for Distinguished Young Scholars; Foundation for the Program for New Century Excellent Talents in University; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions; Organization Department of the CPC Central Committee; Author of National Excellent Doctoral Dissertation; Jiangsu Province Clinical Science and Technology Projects; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This work was funded by the National Natural Science Foundation of China (81372606 and 81072344), Project supported by the National Key Basic Research Program Grant (2013CB911400), the project supported by the National Science Foundation for Distinguished Young Scholars of China (81225020), Foundation of Jiangsu Province for Distinguished Young Scholars(BK2012042), Foundation for the Program for New Century Excellent Talents in University (NCET-10-0178), the Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions (122031), Young tip-top talents support program by the Organization Department of the CPC Central Committee, the Author of National Excellent Doctoral Dissertation (201081), Jiangsu Province Clinical Science and Technology Projects (BL2012008) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braconi C, 2011, SEMIN ONCOL, V38, P752, DOI 10.1053/j.seminoncol.2011.08.001; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; Chen H, 2012, BIOCHEM BIOPH RES CO, V422, P721, DOI 10.1016/j.bbrc.2012.05.066; Chon YE, 2012, INT J CANCER, V131, P2332, DOI 10.1002/ijc.27507; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Rodriguez RG, 2012, REV ESP ENFERM DIG, V104, P298, DOI 10.4321/s1130-01082012000600003; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Hu ZB, 2011, AM J RESP CRIT CARE, V183, P641, DOI 10.1164/rccm.201005-0717OC; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kan T, 2009, CURR OPIN PHARMACOL, V9, P727, DOI 10.1016/j.coph.2009.08.009; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-5; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032230; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Savita U, 2013, BIOCHEM BIOPH RES CO, V434, P841, DOI 10.1016/j.bbrc.2013.04.025; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Slaby O, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-90; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xie K, 2013, CANC EPIDEMIOL; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Zhong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028839	41	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85394	10.1371/journal.pone.0085394	http://dx.doi.org/10.1371/journal.pone.0085394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416400	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500244
J	Dikalova, A; Fagiana, A; Aschner, JL; Aschner, M; Summar, M; Fike, CD				Dikalova, Anna; Fagiana, Angela; Aschner, Judy L.; Aschner, Michael; Summar, Marshall; Fike, Candice D.			Sodium-Coupled Neutral Amino Acid Transporter 1 (SNAT1) Modulates L-Citrulline Transport and Nitric Oxide (NO) Signaling in Piglet Pulmonary Arterial Endothelial Cells	PLOS ONE			English	Article							L-ARGININE THERAPY; SYNTHASE; HYPERTENSION; SYSTEM; LYASE	Rationale: There is evidence that impairments in nitric oxide (NO) signaling contribute to chronic hypoxia-induced pulmonary hypertension. The L-arginine-NO precursor, L-citrulline, has been shown to ameliorate pulmonary hypertension. Sodium-coupled neutral amino acid transporters (SNATs) are involved in the transport of L-citrulline into pulmonary arterial endothelial cells (PAECs). The functional link between the SNATs, L-citrulline, and NO signaling has not yet been explored. Objective: We tested the hypothesis that changes in SNAT1 expression and transport function regulate NO production by modulating eNOS coupling in newborn piglet PAECs. Methods and Results: A silencing RNA (siRNA) technique was used to assess the contribution of SNAT1 to NO production and eNOS coupling (eNOS dimer-to-monomer ratios) in PAECs from newborn piglets cultured under normoxic and hypoxic conditions in the presence and absence of L-citrulline. SNAT1 siRNA reduced basal NO production in normoxic PAECs and prevented L-citrulline-induced elevations in NO production in both normoxic and hypoxic PAECs. SNAT1 siRNA reduced basal eNOS dimer-to-monomer ratios in normoxic PAECs and prevented L-citrulline-induced increases in eNOS dimer-to-monomer ratios in hypoxic PAECs. Conclusions: SNAT1 mediated L-citrulline transport modulates eNOS coupling and thus regulates NO production in hypoxic PAECs from newborn piglets. Strategies that increase SNAT1-mediated transport and supply of L-citrulline may serve as novel therapeutic approaches to enhance NO production in patients with pulmonary vascular disease.	[Dikalova, Anna; Fagiana, Angela; Aschner, Michael; Fike, Candice D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Dikalova, Anna; Fagiana, Angela; Aschner, Michael; Fike, Candice D.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Aschner, Michael] Vanderbilt Ctr Mol Toxicol, Nashville, TN USA; [Summar, Marshall] Childrens Natl Med Ctr, Div Genet & Metab, Washington, DC 20010 USA; [Aschner, Judy L.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Aschner, Judy L.] Childrens Hosp Montefiore, New York, NY USA	Vanderbilt University; Vanderbilt University; Children's National Health System; Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore	Fike, CD (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	Candice.fike@vanderbilt.edu	Fike, Candice/HHN-1602-2022	Summar, Marshall/0000-0001-8920-0110	NIH [HL97566]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL097566, R01HL097566] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by HL97566 to CDF from NIH (www.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan M, 2009, AM J PHYSIOL-LUNG C, V297, pL506, DOI 10.1152/ajplung.00017.2009; Bahri S, 2013, NUTRITION, V29, P479, DOI 10.1016/j.nut.2012.07.002; Boger RH, 2008, CURR OPIN CLIN NUTR, V11, P55, DOI 10.1097/MCO.0b013e3282f2b0c3; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Fike CD, 2012, CARDIOVASC RES, V95, P375, DOI 10.1093/cvr/cvs186; Fike CD, 2004, AM J PHYSIOL-LUNG C, V286, pL1244, DOI 10.1152/ajplung.00345.2003; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Hoet PHM, 2000, AM J PHYSIOL-LUNG C, V278, pL417, DOI 10.1152/ajplung.2000.278.3.L417; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Martasek P, 1998, J BIOL CHEM, V273, P34799, DOI 10.1074/jbc.273.52.34799; Mitani Y, 1997, CIRCULATION, V96, P689; Ou ZJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1131, DOI 10.1152/ajpendo.00107.2010; Sasaki S, 2004, RESP MED, V98, P205, DOI 10.1016/j.rmed.2003.09.013; Schulman SP, 2006, JAMA-J AM MED ASSOC, V295, P58, DOI 10.1001/jama.295.1.58; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; SU YC, 1995, AM J PHYSIOL-LUNG C, V269, pL581, DOI 10.1152/ajplung.1995.269.5.L581; Tonelli AR, 2013, PULM CIRC, V3, P20, DOI 10.4103/2045-8932.109911	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85730	10.1371/journal.pone.0085730	http://dx.doi.org/10.1371/journal.pone.0085730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454923	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100125
J	Lupon, J; de Antonio, M; Vila, J; Penafiel, J; Galan, A; Zamora, E; Urrutia, A; Bayes-Genis, A				Lupon, Josep; de Antonio, Marta; Vila, Joan; Penafiel, Judith; Galan, Amparo; Zamora, Elisabet; Urrutia, Agustin; Bayes-Genis, Antoni			Development of a Novel Heart Failure Risk Tool: The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator)	PLOS ONE			English	Article							PREDICTING MORTALITY; AMBULATORY PATIENTS; TROPONIN-T; SURVIVAL; VALIDATION; BIOMARKERS; DISCRIMINATION; PERFORMANCE; PROGNOSIS; SCORE	Background: A combination of clinical and routine laboratory data with biomarkers reflecting different pathophysiological pathways may help to refine risk stratification in heart failure (HF). A novel calculator (BCN Bio-HF calculator) incorporating N-terminal pro B-type natriuretic peptide (NT-proBNP, a marker of myocardial stretch), high-sensitivity cardiac troponin T (hs-cTnT, a marker of myocyte injury), and high-sensitivity soluble ST2 (ST2), (reflective of myocardial fibrosis and remodeling) was developed. Methods: Model performance was evaluated using discrimination, calibration, and reclassification tools for 1-, 2-, and 3-year mortality. Ten-fold cross-validation with 1000 bootstrapping was used. Results: The BCN Bio-HF calculator was derived from 864 consecutive outpatients (72% men) with mean age 68.2 +/- 12 years (73%/27% New York Heart Association (NYHA) class I-II/III-IV, LVEF 36%, ischemic etiology 52.2%) and followed for a median of 3.4 years (305 deaths). After an initial evaluation of 23 variables, eight independent models were developed. The variables included in these models were age, sex, NYHA functional class, left ventricular ejection fraction, serum sodium, estimated glomerular filtration rate, hemoglobin, loop diuretic dose, beta-blocker, Angiotensin converting enzyme inhibitor/Angiotensin-2 receptor blocker and statin treatments, and hs-cTnT, ST2, and NT-proBNP levels. The calculator may run with the availability of none, one, two, or the three biomarkers. The calculated risk of death was significantly changed by additive biomarker data. The average C-statistic in cross-validation analysis was 0.79. Conclusions: A new HF risk-calculator that incorporates available biomarkers reflecting different pathophysiological pathways better allowed individual prediction of death at 1, 2, and 3 years.	[Lupon, Josep; de Antonio, Marta; Zamora, Elisabet; Urrutia, Agustin; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain; [Lupon, Josep; de Antonio, Marta; Zamora, Elisabet; Urrutia, Agustin; Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain; [Vila, Joan; Penafiel, Judith] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Vila, Joan; Penafiel, Judith] CIBER Epidemiol & Publ Hlth, Barcelona, Spain; [Galan, Amparo] Hosp Badalona Germans Trias & Pujol, Serv Biochem, Badalona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Germans Trias i Pujol	Bayes-Genis, A (corresponding author), Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain.	abayesgenis@gmail.com	de A F, Marta/AAL-3341-2020; Bayes-Genis, Antoni/C-4002-2015; Bayes-Genis, Antonio/AAV-9422-2021	de A F, Marta/0000-0002-4319-797X; Bayes-Genis, Antoni/0000-0002-3044-197X; Bayes-Genis, Antonio/0000-0002-3044-197X; Vila-Domenech, Joan Salvador/0000-0002-0413-9291; Lupon, Josep/0000-0002-5601-9611; Lupon, Josep/0000-0002-3981-3020; Zamora, Elisabet/0000-0001-5317-7481	Roche Diagnostics; Catalan Society of Cardiology	Roche Diagnostics; Catalan Society of Cardiology	ST2 assays were performed by Critical Diagnostics; hs-cTnT and NT-proBNP assays were provided by Roche Diagnostics, which also provided a grant for statistical development and online application of the calculator. Dr. M. de Antonio received a competitive research grant from the Catalan Society of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Bayes-Genis A, 2012, EUR J HEART FAIL, V14, P32, DOI 10.1093/eurjhf/hfr156; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Brophy JM, 2004, AM J MED, V116, P300, DOI 10.1016/j.amjmed.2003.09.035; Collet D, 1995, MODELLING SURVIVAL D, P107; D'Agostino RB, 2004, HANDB STAT, V23, P1; de Antonio M, 2012, AM HEART J, V163, P821, DOI 10.1016/j.ahj.2012.03.004; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Graf E, 1999, STAT MED, V18, P2529; Ketchum ES, 2011, PROG CARDIOVASC DIS, V54, P86, DOI 10.1016/j.pcad.2011.03.003; Ky B, 2012, CIRC-HEART FAIL, V5, P183, DOI 10.1161/CIRCHEARTFAILURE.111.965020; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lupon J, 2013, MAYO CLIN PROC, V88, P234, DOI 10.1016/j.mayocp.2012.09.016; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Pencina MJ, 2012, STAT MED, V31, P101, DOI 10.1002/sim.4348; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Pocock SJ, 2013, EUR HEART J, V34, P1404, DOI 10.1093/eurheartj/ehs337; Refaeilzadeh P., 2009, ENCYCL DATABASE SYST, P532, DOI [10.1007/978-0-387-39940-9, DOI 10.1007/978-0-387-39940-9_565]; Senni M, 2013, INT J CARDIOL, V163, P206, DOI 10.1016/j.ijcard.2011.10.071; Vazquez R, 2009, EUR HEART J, V30, P1088, DOI 10.1093/eurheartj/ehp032; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066	23	74	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85466	10.1371/journal.pone.0085466	http://dx.doi.org/10.1371/journal.pone.0085466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454874	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100091
J	Musumari, PM; Wouters, E; Kayembe, PK; Nzita, MK; Mbikayi, SM; Suguimoto, SP; Techasrivichien, T; Lukhele, BW; El-Saaidi, C; Piot, P; Ono-Kihara, M; Kihara, M				Musumari, Patou Masika; Wouters, Edwin; Kayembe, Patrick Kalambayi; Nzita, Modeste Kiumbu; Mbikayi, Samclide Mutindu; Suguimoto, S. Pilar; Techasrivichien, Teeranee; Lukhele, Bhekumusa Wellington; El-Saaidi, Christina; Piot, Peter; Ono-Kihara, Masako; Kihara, Masahiro			Food Insecurity Is Associated with Increased Risk of Non-Adherence to Antiretroviral Therapy among HIV-Infected Adults in the Democratic Republic of Congo: A Cross-Sectional Study	PLOS ONE			English	Article							MEDICATION ADHERENCE; CARE UTILIZATION; MENTAL-HEALTH; INDIVIDUALS; HIV/AIDS; BARRIERS; ANXIETY; HAART; K6; INSUFFICIENCY	Background: Food insecurity is increasingly reported as an important barrier of patient adherence to antiretroviral therapy (ART) in both resource-poor and rich settings. However, unlike in resource rich-settings, very few quantitative studies to date have investigated the association of food insecurity with patient adherence to ART in Sub-Saharan Africa. The current study examines the association between food insecurity and adherence to ART among HIV-infected adults in the Democratic Republic of Congo (DRC). Methods and Findings: This is a cross-sectional quantitative study of patients receiving ART at three private and one public health facilities in Kinshasa, DRC. Participants were consecutively recruited into the study between April and November 2012. Adherence was measured using a combined method coupling pharmacy refill and self-reported adherence. Food insecurity was the primary predictor, and was assessed using the Household Food Insecurity Access Scale (HFIAS). Of the 898 participants recruited into the study, 512 (57%) were food insecure, and 188 (20.9%) were not adherent to ART. Food insecurity was significantly associated with non-adherence to ART (AOR, 2.06; CI, 1.38-3.09). We also found that perceived harmfulness of ART and psychological distress were associated respectively with increased (AOR, 1.95; CI, 1.15-3.32) and decreased (AOR, 0.31; CI, 0.11-0.83) odds of non-adherence to ART. Conclusion: Food insecurity is prevalent and a significant risk factor for non-adherence to ART among HIV-infected individuals in the DRC. Our findings highlight the urgent need for strategies to improve food access among HIV-infected on ART in order to ensure patient adherence to ART and ultimately the long-term success of HIV treatment in Sub-Saharan Africa.	[Musumari, Patou Masika; Suguimoto, S. Pilar; Techasrivichien, Teeranee; Lukhele, Bhekumusa Wellington; El-Saaidi, Christina; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Wouters, Edwin] Univ Antwerp, Dept Sociol, Res Ctr Longitudinal & Life Course Studies, B-2020 Antwerp, Belgium; [Kayembe, Patrick Kalambayi; Nzita, Modeste Kiumbu] Univ Kinshasa, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Mbikayi, Samclide Mutindu] Ctr Hosp Monkole, Kinshasa, DEM REP CONGO; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England	Kyoto University; University of Antwerp; Universite de Kinshasa; University of London; London School of Hygiene & Tropical Medicine	Musumari, PM (corresponding author), Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.	patoumus@yahoo.fr	Mutindu, Samclide Mbikayi/AAZ-4056-2020; Wouters, Edwin/AAE-1649-2021	Wouters, Edwin/0000-0003-2268-3829; Kayembe Kalambayi, Patrick/0000-0002-5693-2144; Suguimoto, S. Pilar/0000-0002-8447-9172; Lukhele, Bhekumusa Wellington/0000-0001-6429-638X	Department of Global Health and Socio-epidemiology of the Kyoto University School of Public Health	Department of Global Health and Socio-epidemiology of the Kyoto University School of Public Health	This study was sponsored by the Department of Global Health and Socio-epidemiology of the Kyoto University School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LS, 2011, INT J METH PSYCH RES, V20, P215, DOI 10.1002/mpr.351; Anema A, 2011, AIDS CARE, V23, P221, DOI 10.1080/09540121.2010.498908; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balcha Taye T, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P119, DOI 10.1177/1545109710387674; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-13; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Food and Agriculture Organization of the United Nations, 2012, STATE FOOD INS WORLD; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Godin G, 2005, AIDS CARE, V17, P493, DOI 10.1080/09540120412331291715; Godin G, 2003, AIDS PATIENT CARE ST, V17, P325, DOI 10.1089/108729103322231268; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Heaney C.A., 2008, HLTH BEHAV HLTH ED T, V4, P189, DOI DOI 10.1177/109019818501200106; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Institut National de la Statistique et Fonds des Nations Unies pour l'Enfance (National Institut of Statistics and United Nations Children's Fund), 2011, ENQ GRAPP IND MULT R; Jacquet A, 2009, 5 INT AIDS SOC IAS C; Johnston BE, 1998, 12 WORLD AIDS C GEN; *JOINT UN PROGR HI, 2009, AIDS EP UPD; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Kalichman SC, 2011, PREV SCI, V12, P324, DOI 10.1007/s11121-011-0222-9; Kalichman SC, 2010, J URBAN HEALTH, V87, P631, DOI 10.1007/s11524-010-9446-4; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Molassiotis A, 2002, INT J STD AIDS, V13, P301, DOI 10.1258/0956462021925117; Musumari PM, 2013, AIDS CARE, V25, P1271, DOI 10.1080/09540121.2013.764391; Nel A, 2013, AIDS CARE, V25, P948, DOI 10.1080/09540121.2012.748867; Nemes MIB, 2004, AIDS, V18, pS15, DOI 10.1097/00002030-200406003-00004; Nguyen H, 2011, 6 INT C HIV TREATM P; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Peltzer K, 2011, AIDS CARE, V23, P60, DOI 10.1080/09540121.2010.498864; Peretti-Watel P, 2006, SOC SCI MED, V62, P2420, DOI 10.1016/j.socscimed.2005.10.020; Programme National Multisectoriel de lutte contre le VIH/SIDA (National Multi-sectoral Programme on HIV/AIDS), 2012, RAPP ACT RIP VIH SID; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Tsai AC, 2011, J GEN INTERN MED, V26, P1391, DOI 10.1007/s11606-011-1841-3; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; United Nations, 2001, SUBC NUTR 28 SESS NA; Wang EA, 2011, J GEN INTERN MED, V26, P1012, DOI 10.1007/s11606-011-1723-8; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weiser SD, 2013, AIDS, V27; Weiser SD, 2009, 5 INT AIDS SOC IAS C; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; *WORLD BANK, 2009, GLOB EC CRIS HIV PRE; World Food Programme, 2003, PROGR ERA AIDS WFPS; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210; Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4	68	57	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85327	10.1371/journal.pone.0085327	http://dx.doi.org/10.1371/journal.pone.0085327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454841	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000330235100071
J	Rochman, CM; Hentschel, BT; Teh, SJ				Rochman, Chelsea M.; Hentschel, Brian T.; Teh, Swee J.			Long-Term Sorption of Metals Is Similar among Plastic Types: Implications for Plastic Debris in Aquatic Environments	PLOS ONE			English	Article							SAN-DIEGO BAY; RESIN PELLETS; MARINE DEBRIS; TRACE-METALS; ADSORPTION; CONTAMINATION; ACCUMULATION; COMMUNITIES; POLLUTANTS; INGESTION	Concerns regarding plastic debris and its ability to accumulate large concentrations of priority pollutants in the aquatic environment led us to quantify relationships between different types of mass-produced plastic and metals in seawater. At three locations in San Diego Bay, we measured the accumulation of nine targeted metals (aluminum, chromium, manganese, iron, cobalt, nickel, zinc, cadmium and lead) sampling at 1, 3, 6, 9 and 12 months, to five plastic types: polyethylene terephthalate (PET), high-density polyethylene (HDPE), polyvinyl chloride (PVC), low-density polyethylene (LDPE), and polypropylene (PP). Accumulation patterns were not consistent over space and time, and in general all types of plastic tended to accumulate similar concentrations of metals. When we did observe significant differences among concentrations of metals at a single sampling period or location in San Diego Bay, we found that HDPE typically accumulated lesser concentrations of metals than the other four polymers. Furthermore, over the 12-month study period, concentrations of all metals increased over time, and chromium, manganese, cobalt, nickel, zinc and lead did not reach saturation on at least one plastic type during the entire 12-month exposure. This suggests that plastic debris may accumulate greater concentrations of metals the longer it remains at sea. Overall, our work shows that a complex mixture of metals, including those listed as priority pollutants by the US EPA (Cd, Ni, Zn and Pb), can be found on plastic debris composed of various plastic types.	[Rochman, Chelsea M.; Hentschel, Brian T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rochman, Chelsea M.; Hentschel, Brian T.] San Diego State Univ, Coastal Marine Inst, San Diego, CA 92182 USA; [Rochman, Chelsea M.; Teh, Swee J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California Davis	Rochman, CM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	cmrochman@ucdavis.edu			SoCal SETAC; PADI Foundation; SDSU Division of Research Affairs; EPA Superfund Region 9; Aquatic Health Program at the University of California, Davis; National Science Foundation [0548190, 2010101195]	SoCal SETAC; PADI Foundation; SDSU Division of Research Affairs; EPA Superfund Region 9; Aquatic Health Program at the University of California, Davis(University of California System); National Science Foundation(National Science Foundation (NSF))	This material is based on work supported by SoCal SETAC, PADI Foundation, SDSU Division of Research Affairs, EPA Superfund Region 9, The Aquatic Health Program at the University of California, Davis, National Science Foundation Grant No. 0548190, and a National Science Foundation Graduate Research Fellowship (Grant No. 2010101195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artham T, 2009, INT BIODETER BIODEGR, V63, P884, DOI 10.1016/j.ibiod.2009.03.003; Ashton K, 2010, MAR POLLUT BULL, V60, P2050, DOI 10.1016/j.marpolbul.2010.07.014; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Davison P, 2011, MAR ECOL PROG SER, V432, P173, DOI 10.3354/meps09142; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Deheyn DD, 2006, CHEMOSPHERE, V63, P818, DOI 10.1016/j.chemosphere.2005.07.066; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Donohue MJ, 2001, MAR POLLUT BULL, V42, P1301, DOI 10.1016/S0025-326X(01)00139-4; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Fischer AC, 2007, MAR CHEM, V107, P533, DOI 10.1016/j.marchem.2007.08.004; Fotopoulou KN, 2012, MAR ENVIRON RES, V81, P70, DOI 10.1016/j.marenvres.2012.08.010; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hirai H, 2011, MAR POLLUT BULL, V62, P1683, DOI 10.1016/j.marpolbul.2011.06.004; Holmes LA, 2012, ENVIRON POLLUT, V160, P42, DOI 10.1016/j.envpol.2011.08.052; HUTCHINSON TH, 1994, MAR ENVIRON RES, V38, P275, DOI 10.1016/0141-1136(94)90028-0; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Karapanagioti HK, 2008, MAR ENVIRON RES, V65, P283, DOI 10.1016/j.marenvres.2007.11.005; Komoroske LM, 2012, SCI TOTAL ENVIRON, V417, P108, DOI 10.1016/j.scitotenv.2011.12.018; Lancellotti DA, 2004, MAR POLLUT BULL, V48, P303, DOI 10.1016/j.marpolbul.2003.08.005; Lazar B, 2011, MAR POLLUT BULL, V62, P43, DOI 10.1016/j.marpolbul.2010.09.013; Li WJ, 2001, J RADIOANAL NUCL CH, V250, P497; Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038; Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; McKinley AC, 2011, ENVIRON POLLUT, V159, P1499, DOI 10.1016/j.envpol.2011.03.008; Murray F, 2011, MAR POLLUT BULL, V62, P1207, DOI 10.1016/j.marpolbul.2011.03.032; Nakashima E, 2012, ENVIRON SCI TECHNOL, V46, P10099, DOI 10.1021/es301362g; Ogata Y, 2009, MAR POLLUT BULL, V58, P1437, DOI 10.1016/j.marpolbul.2009.06.014; Pascall MA, 2005, J AGR FOOD CHEM, V53, P164, DOI 10.1021/jf048978t; PlasticsEurope, 2010, PLAST FACTS 2010 AN; Quinn GP, 2002, EXPT DESGIN DATA ANA, P260; Rios LM, 2010, J ENVIRON MONITOR, V12, P2226, DOI 10.1039/c0em00239a; ROBERTSON DE, 1968, ANAL CHIM ACTA, V42, P533, DOI 10.1016/S0003-2670(01)80346-9; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P2439, DOI 10.1021/es400748b; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Rusina TP, 2007, CHEMOSPHERE, V68, P1344, DOI 10.1016/j.chemosphere.2007.01.025; Secretariat of the Convention on Biological Diversity and the Scientific and Technical Advisory Panel-GEF, 2012, CBD TECHNICAL SERIES, V67; SPEAR LB, 1995, MAR ENVIRON RES, V40, P123, DOI 10.1016/0141-1136(94)00140-K; Tanaka K, 2013, MAR POLLUT BULL, V69, P219, DOI 10.1016/j.marpolbul.2012.12.010; Tarpley R. J., 1993, Aquatic Mammals, V19, P93; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Tien CJ, 2013, ARCH ENVIRON CON TOX, V64, P605, DOI 10.1007/s00244-012-9856-2; Tien CJ, 2009, CHEMOSPHERE, V76, P1288, DOI 10.1016/j.chemosphere.2009.06.013; Uhrin AV, 2011, MAR POLLUT BULL, V62, P2605, DOI 10.1016/j.marpolbul.2011.10.006; Underwood AJ, 1997, EXPT ECOLOGY; Winer B.J., 1991, STAT PRINCIPLES EXPT; YE S, 1991, Marine Pollution Bulletin, V22, P608, DOI 10.1016/0025-326X(91)90249-R; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	51	294	310	20	235	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85433	10.1371/journal.pone.0085433	http://dx.doi.org/10.1371/journal.pone.0085433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454866	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100084
J	Fujikawa, A; Fujii, T; Mimura, S; Takahashi, R; Sakai, M; Suzuki, S; Kyoto, Y; Uwabe, Y; Maeda, S; Mori, T				Fujikawa, Akira; Fujii, Tatsuya; Mimura, Satoshi; Takahashi, Ryota; Sakai, Masao; Suzuki, Shinya; Kyoto, Yukishige; Uwabe, Yasuhide; Maeda, Shinji; Mori, Toru			Tuberculosis Contact Investigation Using Interferon-Gamma Release Assay with Chest X-Ray and Computed Tomography	PLOS ONE			English	Article							ACTIVE TUBERCULOSIS; PREDICTIVE-VALUE; SKIN-TEST; PULMONARY TUBERCULOSIS; INFECTION; DIAGNOSIS; CT; DISEASE; GOLD	Between September 2009 and January 2010, 6 members of the Japanese Eastern Army, who had completed the same training program, were diagnosed with active tuberculosis (TB) on different occasions. The Ministry of Defense conducted a contact investigation of all members who had come into contact with the infected members. The purpose of this study was to verify the efficacy of the TB screening protocol used in this investigation. A total of 884 subjects underwent interferon-gamma release assay (IGRA) and chest X-ray. The 132 subjects who were IGRA positive or with X-ray findings suggestive of TB subsequently underwent chest computer tomography (CT). Chest CT was performed for 132 subjects. Based on CT findings, 24 (2.7%) subjects were classified into the active TB group, 107 (12.1%) into the latent tuberculosis infection (LTBI) group, and 753 (85.2%) into the non-TB group. The first 2 groups underwent anti-TB therapy, and all 3 groups were followed for 2 years after treatment. Although one subject in the active TB group experienced relapse during the follow-up period, no patient in the LTBI or non-TB groups developed TB. IGRA and chest X-ray, followed by chest CT for those IGRA positive or with suspicious X-ray findings, appears to be an effective means of TB contact screening and infection prevention.	[Fujikawa, Akira; Suzuki, Shinya] Japan Self Def Forces Cent Hosp, Dept Med Educ & Res, Setagaya Ku, Tokyo, Japan; [Fujikawa, Akira; Kyoto, Yukishige] Japan Self Def Forces Cent Hosp, Dept Radiol, Tokyo, Japan; [Fujii, Tatsuya] Kawakita Gen Hosp, Dept Internal Med, Tokyo, Japan; [Mimura, Satoshi; Sakai, Masao; Suzuki, Shinya] Japan Self Def Forces Cent Hosp, Dept Internal Med, Div Resp Med, Tokyo, Japan; [Takahashi, Ryota] Japan Self Def Forces Cent Hosp, Div Infect Dis, Dept Internal Med, Tokyo, Japan; [Uwabe, Yasuhide] Japan Ground Self Def Force Fukuoka Hosp, Dept Internal Med, Kasuga, Fukuoka, Japan; [Maeda, Shinji] Res Inst TB Japan, Dept Mycobacterium Reference & Res, Mol Epidemiol Div, Tokyo, Japan; [Mori, Toru] Res Inst TB Japan, JATA, Tokyo, Japan		Fujikawa, A (corresponding author), Japan Self Def Forces Cent Hosp, Dept Med Educ & Res, Setagaya Ku, Tokyo, Japan.	fujikawa-sdf@umin.ac.jp; hujii@kawakita.or.jp						Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; GREENBAUM M, 1980, AM REV RESPIR DIS, V121, P477, DOI 10.1164/arrd.1980.121.3.477; Higuchi K, 2007, RESPIROLOGY, V12, P88, DOI 10.1111/j.1440-1843.2006.01000.x; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; IM JG, 1993, RADIOLOGY, V186, P653, DOI 10.1148/radiology.186.3.8430169; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; Kipfer B, 2008, SWISS MED WKLY, V138, P267, DOI 2008/17/smw-12051; Kowada A, 2013, EUR J RADIOL, V82, P1353, DOI 10.1016/j.ejrad.2013.02.017; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; LEVY H, 1989, CHEST, V95, P1193, DOI 10.1378/chest.95.6.1193; McCollough CH, 2012, RADIOLOGY, V264, P567, DOI 10.1148/radiol.12112265; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Toyota M, 2001, Kekkaku, V76, P625; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Yoshiyama Takashi, 2008, Kekkaku, V83, P411	21	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85612	10.1371/journal.pone.0085612	http://dx.doi.org/10.1371/journal.pone.0085612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454900	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800052
J	Unelius, CR; Schiebe, C; Bohman, B; Andersson, MN; Schlyter, F				Unelius, C. Rikard; Schiebe, Christian; Bohman, Bjorn; Andersson, Martin N.; Schlyter, Fredrik			Non-Host Volatile Blend Optimization for Forest Protection against the European Spruce Bark Beetle, Ips typographus	PLOS ONE			English	Article							DENDROCTONUS-VALENS COLEOPTERA; AGGREGATION PHEROMONE; PINE-BEETLE; NORWAY SPRUCE; SCOLYTIDAE; VERBENONE; ATTRACTION; PONDEROSAE; TREES; INTERRUPTION	Conifer feeding bark beetles (Coleoptera, Curculionidae, Scolytinae) pose a serious economic threat to forest production. Volatiles released by non-host angiosperm plants (so called non-host volatiles, NHV) have been shown to reduce the risk of attack by many bark beetle species, including the European spruce bark beetle, Ips typographus. However, the most active blend for I. typographus, containing three green leaf volatiles (GLVs) in addition to the key compounds trans-conophthorin (tC) and verbenone, has been considered too expensive for use in large-scale management. To lower the cost and improve the applicability of NHV, we aim to simplify the blend without compromising its anti-attractant potency. Since the key compound tC is expensive in pure form, we also tested a crude version: technical grade trans-conophthorin (T-tC). In another attempt to find a more cost effective substitute for tC, we evaluated a more readily synthesized analog: dehydroconophthorin (DHC). Our results showed that 1-hexanol alone could replace the three-component GLV blend containing 1-hexanol, (3Z)-hexen-1-ol, and (2E)-hexen-1-ol. Furthermore, the release rate of tC could be reduced from 5 mg/day to 0.5 mg/day in a blend with 1-hexanol and (-)-verbenone without compromising the anti-attractant activity. We further show that T-tC was comparable with tC, whereas DHC was a less effective anti-attractant. DHC also elicited weaker physiological responses in the tC-responding olfactory receptor neuron class, providing a likely mechanistic explanation for its weaker anti-attractive effect. Our results suggest a blend consisting of (-)-verbenone, 1-hexanol and technical trans-conophthorin as a cost-efficient anti-attractant for forest protection against I. typographus.	[Unelius, C. Rikard; Schiebe, Christian; Bohman, Bjorn] Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden; [Schiebe, Christian; Andersson, Martin N.; Schlyter, Fredrik] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden	Linnaeus University; Swedish University of Agricultural Sciences	Unelius, CR (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden.	rikard.unelius@lnu.se	Unelius, Carl Rikard/B-3183-2008; Unelius, Carl Rikard/O-7050-2019; Schlyter, Fredrik/F-8567-2015	Unelius, Carl Rikard/0000-0001-7158-6393; Unelius, Carl Rikard/0000-0001-7158-6393; Schlyter, Fredrik/0000-0002-1244-0308; Bohman, Bjorn/0000-0001-7097-5813; Andersson, Martin N/0000-0001-9807-8524	SJFR; Formas [24.0293/98, 2006-1064, 230-2005-1778]; foundation Oscar och Lilli Lamms Minne; Linnaeus University; Swedish University of Agricultural Sciences in Alnarp; Swedish Research Council (VR)	SJFR; Formas(Swedish Research Council Formas); foundation Oscar och Lilli Lamms Minne; Linnaeus University; Swedish University of Agricultural Sciences in Alnarp; Swedish Research Council (VR)(Swedish Research Council)	The studies in Asa were granted by SJFR and Formas (Nr 24.0293/98 and 2006-1064) and by the foundation Oscar och Lilli Lamms Minne. The University of Kalmar (now Linnaeus University) is acknowledged for financial support to RU and BB. The Swedish University of Agricultural Sciences in Alnarp is acknowledged for financial support to CS, FS. MNA was funded by FORMAS project #230-2005-1778 "Semiochemical diversity and insect dynamics'' and by the Swedish Research Council (VR) during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Andersson MN, 2012, CHEM SENSES, V37, P403, DOI 10.1093/chemse/bjs009; Andersson MN, 2011, J CHEM ECOL, V37, P899, DOI 10.1007/s10886-011-9995-3; Andersson MN, 2010, J EXP BIOL, V213, P3332, DOI 10.1242/jeb.044396; Andersson MN, 2009, J INSECT PHYSIOL, V55, P556, DOI 10.1016/j.jinsphys.2009.01.018; ARMITAGE DMA, 1959, J AM CHEM SOC, V81, P2437, DOI 10.1021/ja01519a040; BAKKE A, 1981, Z ANGEW ENTOMOL, V92, P172; BIRGERSSON G, 1988, INSECT BIOCHEM, V18, P761, DOI 10.1016/0020-1790(88)90098-4; Byers JA, 1998, NATURWISSENSCHAFTEN, V85, P557, DOI 10.1007/s001140050551; Byers JA, 2000, NATURWISSENSCHAFTEN, V87, P503, DOI 10.1007/s001140050768; Enander G, 2006, 3206339HK3206339HK; Fettig CJ, 2005, J ECON ENTOMOL, V98, P2041, DOI 10.1603/0022-0493-98.6.2041; Gillette NE, 2009, FOREST ECOL MANAG, V257, P1405, DOI 10.1016/j.foreco.2008.12.017; Gillette NE, 2006, AGR FOREST ENTOMOL, V8, P243, DOI 10.1111/j.1461-9563.2006.00303.x; Gillette NE, 2012, AGR FOREST ENTOMOL, V14, P367, DOI 10.1111/j.1461-9563.2012.00577.x; Hedges LV, 2014, STAT METHODS META AN; Huber DPW, 2001, AGR FOREST ENTOMOL, V3, P225, DOI 10.1046/j.1461-9555.2001.00111.x; HUNT DWA, 1990, J CHEM ECOL, V16, P1385, DOI 10.1007/BF01021034; IRELAND RE, 1980, TETRAHEDRON LETT, V21, P1389, DOI 10.1016/S0040-4039(00)92727-8; Jakus R, 2003, ANZ SCHADL-J PEST SC, V76, P89, DOI 10.1046/j.1439-0280.2003.03020.x; LEUFVEN A, 1987, CAN J BOT, V65, P1038, DOI 10.1139/b87-144; LEUFVEN A, 1984, J CHEM ECOL, V10, P1349, DOI 10.1007/BF00988116; Lindgren BS, 2002, ENVIRON ENTOMOL, V31, P759, DOI 10.1603/0046-225X-31.5.759; MUSTAPARTA H, 1984, J COMP PHYSIOL, V154, P591, DOI 10.1007/BF00610172; PAYNE TL, 1989, J ECON ENTOMOL, V82, P1702, DOI 10.1093/jee/82.6.1702; Rappaport NG, 2001, ENVIRON ENTOMOL, V30, P837, DOI 10.1603/0046-225X-30.5.837; RUDINSKY JA, 1974, ENVIRON ENTOMOL, V3, P90, DOI 10.1093/ee/3.1.90; Schiebe C, 2011, J APPL ENTOMOL, V135, P726, DOI 10.1111/j.1439-0418.2011.01624.x; Schiebe C, 2006, THESIS SWEDEN HOGSKO; Schiebe C, 2012, OECOLOGIA, V170, P183, DOI 10.1007/s00442-012-2298-8; SCHLYTER F, 1987, J CHEM ECOL, V13, P701, DOI 10.1007/BF01020153; SCHLYTER F, 1989, J CHEM ECOL, V15, P2263, DOI 10.1007/BF01014114; Schlyter F, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P113; Schlyter Fredrik, 2012, Psyche (Cambridge), V2012, p10pp, DOI 10.1155/2012/268621; Seo SY, 2009, J AM CHEM SOC, V131, P263, DOI 10.1021/ja8072462; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; Zhang QH, 1999, J CHEM ECOL, V25, P2847, DOI 10.1023/A:1020816011131; Zhang QH, 2000, CHEMOECOLOGY, V10, P69, DOI 10.1007/s000490050010; Zhang QH, 2003, AGRIC FOR ENTOMOL, V5, P145, DOI 10.1046/j.1461-9563.2003.00173.x; Zhang QH, 2003, OIKOS, V101, P299, DOI 10.1034/j.1600-0706.2003.111595.x	42	20	20	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85381	10.1371/journal.pone.0085381	http://dx.doi.org/10.1371/journal.pone.0085381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454855	Green Published, gold, Green Submitted			2022-12-27	WOS:000329925800043
J	Launders, NJ; Nichols, GL; Cartwright, R; Lawrence, J; Jones, J; Hadjichristodoulou, C				Launders, Naomi J.; Nichols, Gordon L.; Cartwright, Rodney; Lawrence, Joanne; Jones, Jane; Hadjichristodoulou, Christos			Self-Reported Stomach Upset in Travellers on Cruise-Based and Land-Based Package Holidays	PLOS ONE			English	Article							PASSENGER BEHAVIORS; DIARRHEA; EPIDEMIOLOGY; SHIPS; INFECTION; ILLNESS	Background: International travellers are at a risk of infectious diseases not seen in their home country. Stomach upsets are common in travellers, including on cruise ships. This study compares the incidence of stomach upsets on land-and cruise-based holidays. Methods: A major British tour operator has administered a Customer Satisfaction Questionnaire (CSQ) to UK resident travellers aged 16 or more on return flights from their holiday abroad over many years. Data extracted from the CSQ was used to measure self-reported stomach upset in returning travellers. Results: From summer 2000 through winter 2008, 6,863,092 questionnaires were completed; 6.6% were from cruise passengers. A higher percentage of land-based holiday-makers (7.2%) reported stomach upset in comparison to 4.8% of cruise passengers (RR = 1.5, p<0.0005). Reported stomach upset on cruises declined over the study period (7.1% in 2000 to 3.1% in 2008, p<0.0005). Over 25% of travellers on land-based holidays to Egypt and the Dominican Republic reported stomach upset. In comparison, the highest proportion of stomach upset in cruise ship travellers were reported following cruises departing from Egypt (14.8%) and Turkey (8.8%). Conclusions: In this large study of self-reported illness both demographic and holiday choice factors were shown to play a part in determining the likelihood of developing stomach upset while abroad. There is a lower cumulative incidence and declining rates of stomach upset in cruise passengers which suggest that the cruise industry has adopted operations (e. g. hygiene standards) that have reduced illness over recent years.	[Launders, Naomi J.; Nichols, Gordon L.] Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, London, England; [Launders, Naomi J.; Nichols, Gordon L.; Hadjichristodoulou, Christos] European Agcy Hlth & Consumers, Publ Hlth Program, EU Shipsan Trainet Project, Luxembourg, Luxembourg; [Cartwright, Rodney] Federat Tour Operators, London, England; [Lawrence, Joanne; Jones, Jane] Publ Hlth England, Travel & Migrant Hlth Sect, London, England; [Nichols, Gordon L.; Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece; [Nichols, Gordon L.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; Public Health England; University of Thessaly; University of East Anglia	Nichols, GL (corresponding author), Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, London, England.	gordon.nichols@ecdc.europa.eu	Nichols, Gordon L./J-1114-2014; Launders, Naomi/GOG-8003-2022	Nichols, Gordon L./0000-0003-0773-9556; Launders, Naomi/0000-0003-4241-938X; Freedman, Joanne/0000-0002-7840-473X; Hadjichristodoulou, Christos/0000-0002-4769-8376	SHIPSAN TRAINET project (EU Project) [2007206]	SHIPSAN TRAINET project (EU Project)	This study was not formally funded and analysis was performed within the SHIPSAN TRAINET project (EU Project No. 2007206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cartwright RY, 2003, J APPL MICROBIOL, V94, p12S, DOI 10.1046/j.1365-2672.94.s1.2.x; Centers for Disease Control and Prevention, 2005, VESS SAN PROGR OP MA; Centers for Disease Control and Prevention, 2011, OUTBR UPD INT CRUIS; Chimonas MAR, 2008, J TRAVEL MED, V15, P177, DOI 10.1111/j.1708-8305.2008.00200.x; Cramer EH, 2006, AM J PREV MED, V30, P252, DOI 10.1016/j.amepre.2005.10.027; Cramer EH, 2008, J ENVIRON HEALTH, V70, P15; de Jong B, 2006, COMP BURDEN SALMONEL; Dupont HL, 2009, ALIMENT PHARM THER, V30, P187, DOI 10.1111/j.1365-2036.2009.04028.x; EU Shipsan Trainet Project, 2012, EUR MAN HYG STAND CO; Evans MR, 2001, J INFECTION, V43, P140, DOI 10.1053/jinf.2001.0876; Greenwood Z, 2008, J TRAVEL MED, V15, P221, DOI 10.1111/j.1708-8305.2008.00203.x; Health Protection Agency, 2010, FOR TRAV ASS ILLN FO; Mouchtouri VA, 2010, INT MARIT HEALTH, V61, P49; Neri AJ, 2008, J TRAVEL MED, V15, P172, DOI 10.1111/j.1708-8305.2008.00199.x; Northey G, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-126; Office for National Statistics, 2010, INT PASS SURV TRAV T; Peake DE, 1999, ANN EMERG MED, V33, P67, DOI 10.1016/S0196-0644(99)70419-1; Pitzurra R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-231; Redman CA, 2006, J TRAVEL MED, V13, P203, DOI 10.1111/j.1708-8305.2006.00046.x; Schultsz C, 2000, J CLIN MICROBIOL, V38, P3550, DOI 10.1128/JCM.38.10.3550-3554.2000; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Soto SM, 2009, CLIN MICROBIOL INFEC, V15, P26, DOI 10.1111/j.1469-0691.2008.02694.x; Steffen R, 2004, J TRAVEL MED, V11, P231, DOI 10.2310/7060.2004.19007; Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008; Tomaszewski R, 2008, INT MARIT HEALTH, V59, P61; Verhoef L, 2008, EMERG INFECT DIS, V14, P238, DOI 10.3201/eid1402.061567; World Health Organization, 2001, COMP FOODB WAT DIS L	27	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83425	10.1371/journal.pone.0083425	http://dx.doi.org/10.1371/journal.pone.0083425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427271	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200011
J	Scott, BM; Matochko, WL; Gierczak, RF; Bhakta, V; Derda, R; Sheffield, WP				Scott, Benjamin M.; Matochko, Wadim L.; Gierczak, Richard F.; Bhakta, Varsha; Derda, Ratmir; Sheffield, William P.			Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; ALPHA(1)-PROTEINASE INHIBITOR; PLASMINOGEN-ACTIVATOR; ALPHA-1-PROTEINASE INHIBITOR; ANTI-THROMBIN; HINGE REGION; SITE LOOP; SPECIFICITY; COMPLEX; ALPHA(1)-ANTITRYPSIN	In spite of the power of phage display technology to identify variant proteins with novel properties in large libraries, it has only been previously applied to one member of the serpin superfamily. Here we describe phage display of human alpha-1 proteinase inhibitor (API) in a T7 bacteriophage system. API M358R fused to the C-terminus of T7 capsid protein 10B was directly shown to form denaturation-resistant complexes with thrombin by electrophoresis and immunoblotting following exposure of intact phages to thrombin. We therefore developed a biopanning protocol in which thrombin-reactive phages were selected using biotinylated anti-thrombin antibodies and streptavidin-coated magnetic beads. A library consisting of displayed API randomized at residues 357 and 358 (P2-P1) yielded predominantly Pro-Arg at these positions after five rounds of thrombin selection; in contrast the same degree of mock selection yielded only non-functional variants. A more diverse library of API M358R randomized at residues 352-356 (P7-P3) was also probed, yielding numerous variants fitting a loose consensus of DLTVS as judged by sequencing of the inserts of plaque-purified phages. The thrombin-selected sequences were transferred en masse into bacterial expression plasmids, and lysates from individual colonies were screening for API-thrombin complexing. The most active candidates from this sixth round of screening contained DITMA and AAFVS at P7-P3 and inhibited thrombin 2.1-fold more rapidly than API M358R with no change in reaction stoichiometry. Deep sequencing using the Ion Torrent platform confirmed that over 800 sequences were significantly enriched in the thrombin-panned versus naive phage display library, including some detected using the combined phage display/bacterial lysate screening approach. Our results show that API joins Plasminogen Activator Inhibitor-1 (PAI-1) as a serpin amenable to phage display and suggest the utility of this approach for the selection of "designer serpins" with novel reactivity and/or specificity.	[Scott, Benjamin M.; Gierczak, Richard F.; Sheffield, William P.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Matochko, Wadim L.; Derda, Ratmir] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada; [Bhakta, Varsha; Sheffield, William P.] Canadian Blood Serv, Hamilton, ON, Canada	McMaster University; University of Alberta; Canadian Blood Services	Sheffield, WP (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	sheffiel@mcmaster.ca		Scott, Benjamin/0000-0003-4782-7139	Heart and Stroke Foundation of Canada (Ontario Provincial Office) [000267]; Canadian Blood Services	Heart and Stroke Foundation of Canada (Ontario Provincial Office); Canadian Blood Services	This work was made possible by Grant-In-Aid 000267 from the Heart and Stroke Foundation of Canada (Ontario Provincial Office) to WPS. RFG received a competitive Graduate Fellowship Program award from Canadian Blood Services in support of his doctoral research at McMaster University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Bhakta V, 2013, J BIOTECHNOL, V168, P373, DOI 10.1016/j.jbiotec.2013.10.011; Bhunia SS, 2011, J CHEM INF MODEL, V51, P1966, DOI 10.1021/ci200185q; Bottomley SP, 2001, PROTEIN SCI, V10, P2518, DOI 10.1110/ps.ps.24101; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; Chaillan-Huntington CE, 1998, J BIOL CHEM, V273, P4569, DOI 10.1074/jbc.273.8.4569; Ciaccia AV, 1997, J BIOL CHEM, V272, P888, DOI 10.1074/jbc.272.2.888; Cunningham MA, 2002, THROMB HAEMOSTASIS, V88, P89; Dan JH, 1997, J BIOL CHEM, V272, P8243, DOI 10.1074/jbc.272.13.8243; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Djie MZ, 1997, J BIOL CHEM, V272, P16268, DOI 10.1074/jbc.272.26.16268; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; Dufour EK, 2005, PROTEIN SCI, V14, P303, DOI 10.1110/ps.04843305; Dufour EK, 2001, J BIOL CHEM, V276, P38971, DOI 10.1074/jbc.M102959200; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Filion ML, 2004, BIOCHEMISTRY-US, V43, P14864, DOI 10.1021/bi048833f; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; GEORGE PM, 1989, BLOOD, V73, P490; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gierczak RF, 2011, J THROMB HAEMOST, V9, P2424, DOI 10.1111/j.1538-7836.2011.04524.x; Han JH, 1998, BIOCHEMISTRY-US, V37, P3203, DOI 10.1021/bi9722195; Harper PL, 1998, THROMB HAEMOSTASIS, V80, P816; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; Hopkins PCR, 2000, J MOL EVOL, V51, P507, DOI 10.1007/s002390010114; HOPKINS PCR, 1995, J BIOL CHEM, V270, P11866, DOI 10.1074/jbc.270.20.11866; HOPKINS PCR, 1995, BIOCHEMISTRY-US, V34, P15872, DOI 10.1021/bi00048a033; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; Matochko WL, 2013, NUCL ACIDS RES; O'Donoghue SI, 2010, NAT METHODS, V7, pS42, DOI [10.1038/NMETH.1427, 10.1038/nmeth.1427]; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PANNEKOEK H, 1993, GENE, V128, P135, DOI 10.1016/0378-1119(93)90164-X; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; RUBIN H, 1994, BIOCHEMISTRY-US, V33, P7627, DOI 10.1021/bi00190a016; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; SCOTT CF, 1986, J CLIN INVEST, V77, P631, DOI 10.1172/JCI112346; Sheffield WP, 2012, THROMB HAEMOSTASIS, V107, P972, DOI 10.1160/TH11-09-0604; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stoop AA, 2000, J MOL BIOL, V301, P1135, DOI 10.1006/jmbi.2000.4035; Stoop AA, 2001, J MOL BIOL, V305, P773, DOI 10.1006/jmbi.2000.4356; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Sutherland JS, 2007, THROMB HAEMOSTASIS, V98, P1014, DOI 10.1160/TH07-03-0197; Sutherland JS, 2006, BIOCHEMISTRY-US, V45, P11444, DOI 10.1021/bi0609624; Sutherland JS, 2006, THROMB RES, V117, P447, DOI 10.1016/j.thromres.2005.03.004; TOLLEFSEN DM, 1982, J BIOL CHEM, V257, P2162; vanMeijer M, 1996, J BIOL CHEM, V271, P7423, DOI 10.1074/jbc.271.13.7423; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790	60	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84491	10.1371/journal.pone.0084491	http://dx.doi.org/10.1371/journal.pone.0084491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427287	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200027
J	Kienesberger, S; Sprenger, H; Wolfgruber, S; Halwachs, B; Thallinger, GG; Perez-Perez, GI; Blaser, MJ; Zechner, EL; Gorkiewicz, G				Kienesberger, Sabine; Sprenger, Hanna; Wolfgruber, Stella; Halwachs, Bettina; Thallinger, Gerhard G.; Perez-Perez, Guillermo I.; Blaser, Martin J.; Zechner, Ellen L.; Gorkiewicz, Gregor			Comparative Genome Analysis of Campylobacter fetus Subspecies Revealed Horizontally Acquired Genetic Elements Important for Virulence and Niche Specificity	PLOS ONE			English	Article							S-LAYER; LIPOPOLYSACCHARIDE; IDENTIFICATION; PATHOGENESIS; SEQUENCE; DIVERSITY; INFECTION; JEJUNI; BIOSYNTHESIS; MECHANISMS	Campylobacter fetus are important animal and human pathogens and the two major subspecies differ strikingly in pathogenicity. C. fetus subsp. venerealis is highly niche-adapted, mainly infecting the genital tract of cattle. C. fetus subsp. fetus has a wider host-range, colonizing the genital-and intestinal-tract of animals and humans. We report the complete genomic sequence of C. fetus subsp. venerealis 84-112 and comparisons to the genome of C. fetus subsp. fetus 82-40. Functional analysis of genes predicted to be involved in C. fetus virulence was performed. The two subspecies are highly syntenic with 92% sequence identity but C. fetus subsp. venerealis has a larger genome and an extra-chromosomal element. Aside from apparent gene transfer agents and hypothetical proteins, the unique genes in both subspecies comprise two known functional groups: lipopolysaccharide production, and type IV secretion machineries. Analyses of lipopolysaccharide-biosynthesis genes in C. fetus isolates showed linkage to particular pathotypes, and mutational inactivation demonstrated their roles in regulating virulence and host range. The comparative analysis presented here broadens knowledge of the genomic basis of C. fetus pathogenesis and host specificity. It further highlights the importance of surface-exposed structures to C. fetus pathogenicity and demonstrates how evolutionary forces optimize the fitness and host-adaptation of these pathogens.	[Kienesberger, Sabine; Sprenger, Hanna; Wolfgruber, Stella; Zechner, Ellen L.] Graz Univ, Inst Mol Biosci, Graz, Austria; [Kienesberger, Sabine; Perez-Perez, Guillermo I.; Blaser, Martin J.] NYU Langone Med Ctr, Dept Med, New York, NY USA; [Perez-Perez, Guillermo I.; Blaser, Martin J.] NYU Langone Med Ctr, Dept Microbiol, New York, NY USA; [Blaser, Martin J.] VA New York Harbor Healthcare Syst, Med Serv, New York, NY USA; [Halwachs, Bettina; Thallinger, Gerhard G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Halwachs, Bettina; Thallinger, Gerhard G.] Austrian Ctr Ind Biotechnol, Core Facil Bioinformat, Graz, Austria; [Kienesberger, Sabine; Sprenger, Hanna; Gorkiewicz, Gregor] Med Univ Graz, Inst Pathol, Graz, Austria	University of Graz; NYU Langone Medical Center; NYU Langone Medical Center; Graz University of Technology; Austrian Centre of Industrial Biotechnology; Medical University of Graz	Kienesberger, S (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	sabine.kienesberger@uni-graz.at; gregor.gorkiewicz@uni-graz.at	Kienesberger, Sabine/AAD-5481-2022; Gorkiewicz, Gregor/ABF-1602-2021; Halwachs, Bettina/AAD-4347-2019; Perez, Guillermo Perez/AAJ-3761-2020	Gorkiewicz, Gregor/0000-0003-1149-4782; Zechner, Ellen L./0000-0003-2035-1898; Kienesberger, Sabine/0000-0003-3190-3678; Halwachs, Bettina/0000-0002-7082-9346; Perez Perez, Guillermo/0000-0002-0131-5798; Thallinger, Gerhard G./0000-0002-2864-5404	Austrian Science Fund FWF [P20479, P24016]; Hygiene Fund Young Scientist grant from the Medical University of Graz; Michael Saperstein Medical Scholars Program, New York School of Medicine; National Institutes of Health [GM63270]; EU-FP7 COST Action SeqAhead, EC Grant [BM1006]; Land Steiermark within the Austrian COMET program FFG Grant [824186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [W 901, P 20479] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Hygiene Fund Young Scientist grant from the Medical University of Graz; Michael Saperstein Medical Scholars Program, New York School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU-FP7 COST Action SeqAhead, EC Grant; Land Steiermark within the Austrian COMET program FFG Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund FWF grants P20479 (GG & ELZ) and P24016 (ELZ), the Hygiene Fund Young Scientist grant from the Medical University of Graz (SK), the Michael Saperstein Medical Scholars Program, New York School of Medicine (SK) and GM63270 from the National Institutes of Health (MJB), and the EU-FP7 COST Action SeqAhead, EC Grant BM1006 (GGT). The Austrian Centre of Industrial Biotechnology (ACIB) contribution was supported by FFG, The Federal Ministry of Economy, Family and Youth (BMWFJ), Federal Ministry for Transport, Innovation and TechnologyBMVIT, ZIT GmbH, Zukunftsstiftung Tirol and Land Steiermark within the Austrian COMET program FFG Grant 824186 (BH, GGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Abril C, 2010, ANTIMICROB AGENTS CH, V54, P3052, DOI 10.1128/AAC.00304-10; Ali A, 2012, GENE; Arce RM, 2012, MOL ORAL MICROBIOL, V27, P373, DOI 10.1111/j.2041-1014.2012.00651.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhatty M, 2013, RES MICROBIOL; BLASER MJ, 1985, J INFECT DIS, V151, P227, DOI 10.1093/infdis/151.2.227; BLASER MJ, 1988, J CLIN INVEST, V81, P1434, DOI 10.1172/JCI113474; Blaser MJ, 1998, CLIN INFECT DIS, V27, P256, DOI 10.1086/514655; Dingle KE, 2010, J CLIN MICROBIOL, V48, P977, DOI 10.1128/JCM.01439-09; DWORKIN J, 1995, J BIOL CHEM, V270, P15093, DOI 10.1074/jbc.270.25.15093; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; GARCIA MM, 1995, J BACTERIOL, V177, P1976, DOI 10.1128/jb.177.8.1976-1980.1995; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gonzalez JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.021; Gorkiewicz G, 2010, J BACTERIOL, V192, P502, DOI 10.1128/JB.00803-09; Grogono-Thomas R, 2003, INFECT IMMUN, V71, P147, DOI 10.1128/IAI.71.1.147-154.2003; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Iraola G, 2013, GENOME ANNOUNC, V1; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Kienesberger S, 2007, APPL ENVIRON MICROB, V73, P4619, DOI 10.1128/AEM.02407-06; Kienesberger S, 2011, J BACTERIOL, V193, P744, DOI 10.1128/JB.00798-10; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Lee CA, 2010, MOL MICROBIOL, V75, P268, DOI 10.1111/j.1365-2958.2009.06985.x; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; Moolhuijzen PM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-86; MORAN AP, 1994, INFECT IMMUN, V62, P3922, DOI 10.1128/IAI.62.9.3922-3929.1994; Nesper J, 2002, INFECT IMMUN, V70, P2419, DOI 10.1128/IAI.70.5.2419-2433.2002; On SLW, 1996, CLIN MICROBIOL REV, V9, P405, DOI 10.1128/CMR.9.3.405; Oppenheimer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032918; PEI ZH, 1990, J CLIN INVEST, V85, P1036, DOI 10.1172/JCI114533; PEREZPEREZ GI, 1986, INFECT IMMUN, V51, P209, DOI 10.1128/IAI.51.1.209-212.1986; Petersen L, 2003, J MOL BIOL, V326, P1361, DOI 10.1016/S0022-2836(03)00034-2; Poele EMT, 2008, ANTON LEEUW INT J G, V94, P127, DOI 10.1007/s10482-008-9255-x; Poulin MB, 2010, J BIOL CHEM, V285, P493, DOI 10.1074/jbc.M109.072157; R Core Team, 2012, R LANG ENV STAT COMP; Stynen APR, 2011, J BACTERIOL, V193, P5871, DOI 10.1128/JB.05854-11; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Senchenkova SN, 1997, EUR J BIOCHEM, V245, P637, DOI 10.1111/j.1432-1033.1997.00637.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Skirrow M.B., 2000, CAMPYLOBACTER, V2nd ed., P69; Thompson SA, 2000, CAMPYLOBACTER, P321; Thompson Stuart A, 2002, Ann Periodontol, V7, P43, DOI 10.1902/annals.2002.7.1.43; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tu ZC, 2005, J INFECT DIS, V191, P2082, DOI 10.1086/430349; Tu ZC, 2005, J CLIN MICROBIOL, V43, P3334, DOI 10.1128/JCM.43.7.3334-3340.2005; Tu ZC, 2003, MOL MICROBIOL, V48, P685, DOI 10.1046/j.1365-2958.2003.03463.x; Tu ZC, 2001, INFECT IMMUN, V69, P2237, DOI 10.1128/IAI.69.4.2237-2244.2001; van Bergen MAP, 2005, REV SCI TECH OIE, V24, P1017, DOI 10.20506/rst.24.3.1629; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; van Bergen MAP, 2005, J MED MICROBIOL, V54, P1217, DOI 10.1099/jmm.0.46186-0	57	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85491	10.1371/journal.pone.0085491	http://dx.doi.org/10.1371/journal.pone.0085491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416416	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300082
J	Chang, RY; Jin, TT; Lu, YH; Liu, GH; Fu, BJ				Chang, Ruiying; Jin, Tiantian; Lu, Yihe; Liu, Guohua; Fu, Bojie			Soil Carbon and Nitrogen Changes following Afforestation of Marginal Cropland across a Precipitation Gradient in Loess Plateau of China	PLOS ONE			English	Article							LOCUST ROBINIA-PSEUDOACACIA; LAND-USE CHANGE; ORGANIC-CARBON; LODGEPOLE PINE; TREE DENSITY; STAND AGE; FOREST; MECHANISMS; ECOSYSTEM; SEQUESTRATION	Cropland afforestation has been widely found to increase soil organic carbon (SOC) and soil total nitrogen (STN); however, the magnitudes of SOC and STN accumulation and regulating factors are less studied in dry, marginal lands, and therein the interaction between soil carbon and nitrogen is not well understood. We examined the changes in SOC and STN in younger (5-9-year-old) and older (25-3-year-old) black locust (Robinia pseudoacacia L., an N-fixing species) plantations that were established on former cropland along a precipitation gradient (380 to 650 mm) in the semi-arid Loess Plateau of China. The SOC and STN stocks of cropland and plantations increased linearly with precipitation increase, respectively, accompanying an increase in the plantation net primary productivity and the soil clay content along the increasing precipitation gradient. The SOC stock of cropland decreased in younger plantations and increased in older plantations after afforestation, and the amount of the initial loss of SOC during the younger plantations' establishment increased with precipitation increasing. By contrast, the STN stock of cropland showed no decrease in the initial afforestation while tending to increase with plantation age, and the changes in STN were not related to precipitation. The changes in STN and SOC showed correlated and were precipitation-dependent following afforestation, displaying a higher relative gain of SOC to STN as precipitation decreased. Our results suggest that the afforestation of marginal cropland in Loess Plateau can have a significant effect on the accumulation of SOC and STN, and that precipitation has a significant effect on SOC accumulation but little effect on STN retention. The limitation effect of soil nitrogen on soil carbon accumulation is more limited in the drier area rather than in the wetter sites.	[Chang, Ruiying] Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Sichuan, Peoples R China; [Chang, Ruiying; Jin, Tiantian; Lu, Yihe; Liu, Guohua; Fu, Bojie] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Jin, Tiantian] China Inst Water Resources & Hydropower Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); China Institute of Water Resources & Hydropower Research	Fu, BJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Fu, Bojie/B-1493-2009	chang, rui ying/0000-0002-0534-4502	National Natural Science Foundation of China [41230745]; Chinese Academy of Sciences [XDA05060000]; International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services"	This research was supported the National Natural Science Foundation of China (41230745), the Chinese Academy of Sciences (No. XDA05060000) and the International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashkin MA, 1998, ECOLOGY, V79, P828, DOI 10.1890/0012-9658(1998)079[0828:CISCFA]2.0.CO;2; Berthrong ST, 2012, ECOL APPL, V22, P76, DOI 10.1890/10-2210.1; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; BORING LR, 1984, FOREST SCI, V30, P528; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Callesen I, 2003, GLOBAL CHANGE BIOL, V9, P358, DOI 10.1046/j.1365-2486.2003.00587.x; Chang RY, 2012, ECOL RES, V27, P827, DOI 10.1007/s11284-012-0958-0; Cheng WX, 2009, SOIL BIOL BIOCHEM, V41, P1795, DOI 10.1016/j.soilbio.2008.04.018; Cheng WX, 2005, ROOTS SOIL MANAGEMEN; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; Dijkstra FA, 2007, SOIL BIOL BIOCHEM, V39, P2264, DOI 10.1016/j.soilbio.2007.03.026; [FAO FAO], 2010, STAT WORLDS FOR 2011; Farrar JF, 2000, NEW PHYTOL, V147, P43, DOI 10.1046/j.1469-8137.2000.00688.x; Feng L.X., 1992, SHAANXI SOILS; Forrester DI, 2013, ECOSYSTEMS, V16, P123, DOI 10.1007/s10021-012-9600-9; Fu BJ, 2009, PROG PHYS GEOG, V33, P793, DOI 10.1177/0309133309350264; Galvez L, 2005, J EXP BOT, V56, P2551, DOI 10.1093/jxb/eri249; Gardenas AI, 2011, SOIL BIOL BIOCHEM, V43, P702, DOI 10.1016/j.soilbio.2010.04.006; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hooker TD, 2003, ECOL APPL, V13, P299, DOI 10.1890/1051-0761(2003)013[0299:FECANA]2.0.CO;2; Jiao JY, 2010, RESTOR ECOL, V20, P240, DOI DOI 10.1111/J.1526-100X.2010.00756.X; JOHNSON DW, 1992, WATER AIR SOIL POLL, V64, P83, DOI 10.1007/BF00477097; Kirkby CA, 2013, SOIL BIOL BIOCHEM, V60, P77, DOI 10.1016/j.soilbio.2013.01.011; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y., 2004, ARCH AGRON SOIL SCI, V50, P115, DOI [10.1080/03650340310001627658, DOI 10.1080/03650340310001627658]; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Li YY, 2005, PEDOSPHERE, V15, P601; Li Z, 2003, INT GEOSCI REMOTE SE, P2275; Litton CM, 2004, ECOL APPL, V14, P460, DOI 10.1890/02-5291; Litton CM, 2003, GLOBAL CHANGE BIOL, V9, P680, DOI 10.1046/j.1365-2486.2003.00626.x; Liu Dong, 2012, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V20, P322, DOI 10.3724/SP.J.1011.2012.00322; Liu SG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002010; [刘雨 LIU Yu], 2007, [干旱地区农业研究, Agricultural Research in the Arid Areas], V25, P220; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; LUGO AE, 1986, PLANT SOIL, V96, P185, DOI 10.1007/BF02374763; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; McCulley RL, 2009, OECOLOGIA, V159, P571, DOI 10.1007/s00442-008-1229-1; McLauchlan K, 2006, ECOSYSTEMS, V9, P1364, DOI 10.1007/s10021-005-0135-1; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Ogle SM, 2005, BIOGEOCHEMISTRY, V72, P87, DOI 10.1007/s10533-004-0360-2; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Peng L, 1995, J NW U NATURAL SCI E, V25, P117; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sun Wen-yi, 2010, Huanjing Kexue, V31, P2740; Tian Q., 1997, J BEIJING FOR UNIV, V19, P104; Wang B, 2012, ENVIRON EARTH SCI, V65, P597, DOI 10.1007/s12665-011-1107-8; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; [王万忠 Wang Wanzhong], 2002, [地理学报, Acta Geographica Sinica], V57, P210; Wang Xiao-li, 2007, Yingyong Shengtai Xuebao, V18, P1281; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Wen Q.Z., 1989, GEOCHEMISTRY CHINESE; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	66	34	40	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85426	10.1371/journal.pone.0085426	http://dx.doi.org/10.1371/journal.pone.0085426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416408	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500248
J	Blednov, YA; Benavidez, JM; Black, M; Leiter, CR; Osterndorff-Kahanek, E; Johnson, D; Borghese, CM; Hanrahan, JR; Johnston, GAR; Chebib, M; Harris, RA				Blednov, Yuri A.; Benavidez, Jillian M.; Black, Mendy; Leiter, Courtney R.; Osterndorff-Kahanek, Elizabeth; Johnson, David; Borghese, Cecilia M.; Hanrahan, Jane R.; Johnston, Graham A. R.; Chebib, Mary; Harris, R. Adron			GABA(A) Receptors Containing rho 1 Subunits Contribute to In Vivo Effects of Ethanol in Mice	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; ALCOHOL-INTOXICATION; BEHAVIORAL-RESPONSES; PERIODIC WITHDRAWAL; ALPHA-1 SUBUNIT; MOUSE RETINA; ION CHANNELS; KNOCKIN MICE; MUTANT MICE; NULL MUTANT	GABA(A) receptors consisting of rho 1, rho 2, or rho 3 subunits in homo-or hetero-pentamers have been studied mainly in retina but are detected in many brain regions. Receptors formed from rho 1 are inhibited by low ethanol concentrations, and family-based association analyses have linked rho subunit genes with alcohol dependence. We determined if genetic deletion of rho 1 in mice altered in vivo ethanol effects. Null mutant male mice showed reduced ethanol consumption and preference in a two-bottle choice test with no differences in preference for saccharin or quinine. Null mutant mice of both sexes demonstrated longer duration of ethanol-induced loss of righting reflex (LORR), and males were more sensitive to ethanol-induced motor sedation. In contrast, rho 1 null mice showed faster recovery from acute motor incoordination produced by ethanol. Null mutant females were less sensitive to ethanol-induced development of conditioned taste aversion. Measurement of mRNA levels in cerebellum showed that deletion of rho 1 did not change expression of rho 2, alpha 2, or alpha 6 GABA(A) receptor subunits. (S)-4-amino-cyclopent-1-enyl butylphosphinic acid ("rho 1" antagonist), when administered to wild type mice, mimicked the changes that ethanol induced in rho 1 null mice (LORR and rotarod tests), but the rho 1 antagonist did not produce these effects in rho 1 null mice. In contrast, (R)-4-amino-cyclopent-1-enyl butylphosphinic acid ("rho 2" antagonist) did not change ethanol actions in wild type but produced effects in mice lacking rho 1 that were opposite of the effects of deleting (or inhibiting) rho 1. These results suggest that rho 1 has a predominant role in two in vivo effects of ethanol, and a role for rho 2 may be revealed when rho 1 is deleted. We also found that ethanol produces similar inhibition of function of recombinant rho 1 and rho 2 receptors. These data indicate that ethanol action on GABA(A) receptors containing rho 1/rho 2 subunits may be important for specific effects of ethanol in vivo.	[Blednov, Yuri A.; Benavidez, Jillian M.; Black, Mendy; Leiter, Courtney R.; Osterndorff-Kahanek, Elizabeth; Johnson, David; Borghese, Cecilia M.; Harris, R. Adron] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Hanrahan, Jane R.; Chebib, Mary] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Johnston, Graham A. R.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia	University of Texas System; University of Texas Austin; University of Sydney; University of Sydney	Harris, RA (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	harris@austin.utexas.edu	Johnston, Graham/AAJ-9569-2021; Johnston, Graham AR/B-9827-2009; Hanrahan, Jane R/A-8155-2010	Johnston, Graham/0000-0001-8872-4078; Hanrahan, Jane R/0000-0001-8205-0260; Borghese, Cecilia/0000-0002-1028-8277	NIH [AA013520, AA06399]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA006399, U01AA013520, R01AA006399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grants AA013520 and AA06399. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G., 2008, V182, P53, DOI 10.1007/978-3-540-74806-9_3; Blednov YA, 2008, GENES BRAIN BEHAV, V7, P1, DOI 10.1111/j.1601-183X.2007.00309.x; Blednov YA, 2013, NEUROPHARMACOLOGY, V67, P46, DOI 10.1016/j.neuropharm.2012.10.016; Blednov YA, 2011, J PHARMACOL EXP THER, V336, P145, DOI 10.1124/jpet.110.171645; Blednov YA, 2003, J PHARMACOL EXP THER, V305, P854, DOI 10.1124/jpet.103.049478; Blednov YA, 2001, PHYSIOL BEHAV, V74, P109, DOI 10.1016/S0031-9384(01)00555-8; Blednov YA, 2012, J PHARMACOL EXP THER, V340, P317, DOI 10.1124/jpet.111.185124; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Borghese CM, 2006, J PHARMACOL EXP THER, V319, P208, DOI 10.1124/jpet.106.104406; CALVO DJ, 1995, NEUROREPORT, V6, P1118, DOI 10.1097/00001756-199505300-00011; Carland JE, 2008, EUR J PHARMACOL, V580, P27, DOI 10.1016/j.ejphar.2007.10.036; Chebib M, 2004, CLIN EXP PHARMACOL P, V31, P800, DOI 10.1111/j.1440-1681.2004.04083.x; Chebib M, 2009, J PHARMACOL EXP THER, V328, P448, DOI 10.1124/jpet.108.146464; Crabbe JC, 2005, NEUROSCI BIOBEHAV R, V28, P785, DOI 10.1016/j.neubiorev.2004.08.002; CRABBE JC, 1991, J PHARMACOL EXP THER, V257, P663; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; CUNNINGHAM CL, 1993, ALCOHOL, V10, P97, DOI 10.1016/0741-8329(93)90087-5; Eggers ED, 2007, J PHYSIOL-LONDON, V582, P569, DOI 10.1113/jphysiol.2007.131763; Findlay GS, 2003, J NEUROSCI, V23, P8051; Flood P, 2000, ANESTHESIOLOGY, V92, P1418, DOI 10.1097/00000542-200005000-00033; Flores-Gracia C, 2010, PSYCHOPHARMACOLOGY, V212, P475, DOI 10.1007/s00213-010-1973-x; Frazao R, 2007, CELL TISSUE RES, V330, P1, DOI 10.1007/s00441-007-0446-y; Fujimura J, 2005, MOL BRAIN RES, V138, P17, DOI 10.1016/j.molbrainres.2005.03.013; Green AS, 2008, ALCOHOL, V42, P1, DOI 10.1016/j.alcohol.2007.10.005; Greka A, 1998, NEUROREPORT, V9, P229, DOI 10.1097/00001756-199801260-00010; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; Harvey VL, 2006, J PHYSIOL-LONDON, V577, P127, DOI 10.1113/jphysiol.2006.112482; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hevers W, 2008, J NEUROSCI, V28, P5383, DOI 10.1523/JNEUROSCI.5443-07.2008; Johnston Graham A. R., 2002, Current Topics in Medicinal Chemistry, V2, P903, DOI 10.2174/1568026023393453; Kirischuk S, 2003, EUR J NEUROSCI, V18, P752, DOI 10.1046/j.1460-9568.2003.02805.x; Kumar RJ, 2008, J MED CHEM, V51, P3825, DOI 10.1021/jm7015842; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Lobo IA, 2008, PHARMACOL BIOCHEM BE, V90, P90, DOI 10.1016/j.pbb.2008.03.006; LUNDQUIST F, 1959, METHOD BIOCHEM ANAL, V7, P217, DOI DOI 10.1002/9780470110232.CH7; Martinez-Delgado G, 2010, CURR NEUROPHARMACOL, V8, P422, DOI 10.2174/157015910793358141; McCall MA, 2002, J NEUROSCI, V22, P4163, DOI 10.1523/JNEUROSCI.22-10-04163.2002; Metten P, 1998, MAMM GENOME, V9, P983, DOI 10.1007/s003359900911; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Milligan CJ, 2004, J NEUROSCI, V24, P7241, DOI 10.1523/JNEUROSCI.1979-04.2004; Ochoa-de la Paz LD, 2008, NEUROSCI RES, V61, P302, DOI 10.1016/j.neures.2008.03.009; Ogurusu T, 1999, RECEPTOR CHANNEL, V6, P463; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Pan Y, 2005, NEUROSCI LETT, V376, P60, DOI 10.1016/j.neulet.2004.11.024; Pan ZH, 2000, EUR J NEUROSCI, V12, P3137, DOI 10.1046/j.1460-9568.2000.00198.x; PINEL JPJ, 1976, PHYSIOL BEHAV, V16, P693, DOI 10.1016/0031-9384(76)90238-9; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Rosas-Arellano A, 2012, J NEUROCHEM, V122, P900, DOI 10.1111/j.1471-4159.2011.07621.x; Rosas-Arellano A, 2011, NEUROSCI LETT, V500, P20, DOI 10.1016/j.neulet.2011.05.235; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; WAYNER MJ, 1972, PHYSIOL BEHAV, V9, P737, DOI 10.1016/0031-9384(72)90043-1; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Xuei XL, 2010, AM J MED GENET B, V153B, P418, DOI 10.1002/ajmg.b.30995; Zheng W, 2003, J BIOL CHEM, V278, P48321, DOI 10.1074/jbc.M307930200	57	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85525	10.1371/journal.pone.0085525	http://dx.doi.org/10.1371/journal.pone.0085525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454882	gold, Green Published, Green Submitted			2022-12-27	WOS:000330236000011
J	Foster, GM; Ambrose, JC; Hue, S; Delpech, VC; Fearnhill, E; Abecasis, AB; Brown, AJL; Geretti, AM				Foster, Geraldine M.; Ambrose, John C.; Hue, Stephane; Delpech, Valerie C.; Fearnhill, Esther; Abecasis, Ana B.; Brown, Andrew J. Leigh; Geretti, Anna Maria		UK HIV Drug Resistance Database	Novel HIV-1 Recombinants Spreading across Multiple Risk Groups in the United Kingdom: The Identification and Phylogeography of Circulating Recombinant Form (CRF) 50_A1D	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUBTYPE-A; DISEASE PROGRESSION; TRANSMISSION; INFECTIONS; EPIDEMIC; PROTEASE; PLASMA; COHORT; UGANDA	Background: An increase in non-B HIV-1 infections among men who have sex with men (MSM) in the United Kingdom (UK) has created opportunities for novel recombinants to arise and become established. We used molecular mapping to characterize the importance of such recombinants to the UK HIV epidemic, in order to gain insights into transmission dynamics that can inform control strategies. Methods and Results: A total of 55,556 pol (reverse transcriptase and protease) sequences in the UK HIV Drug Resistance Database were analyzed using Subtype Classification Using Evolutionary Algorithms (SCUEAL). Overall 72 patients shared the same A1/D recombination breakpoint in pol, comprising predominantly MSM but also heterosexuals and injecting drug users (IDUs). In six MSM, full-length single genome amplification of plasma HIV-1 RNA was performed in order to characterize the A1/D recombinant. Subtypes and recombination breakpoints were identified using sliding window and jumping profile hidden markov model approaches. Global maximum likelihood trees of gag, pol and env genes were drawn using FastTree version 2.1. Five of the six strains showed the same novel A1/D recombinant (8 breakpoints), which has been classified as CRF50_A1D. The sixth strain showed a complex CRF50_A1D/B/U structure. Divergence dates and phylogeographic inferences were determined using Bayesian Evolutionary Analysis using Sampling Trees (BEAST). This estimated that CRF50_A1D emerged in the UK around 1992 in MSM, with subsequent transmissions to heterosexuals and IDUs. Analysis of CRF50_A1D/B/U demonstrated that around the year 2000 CRF50_A1D underwent recombination with a subtype B strain. Conclusions: We report the identification of CRF50_A1D, a novel circulating recombinant that emerged in UK MSM around 1992, with subsequent onward transmission to heterosexuals and IDUs, and more recent recombination with subtype B. These findings highlight the changing dynamics of HIV transmission in the UK and the converging of the two previously distinct MSM and heterosexual epidemics.	[Foster, Geraldine M.; Ambrose, John C.; Geretti, Anna Maria] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Hue, Stephane] UCL, London, England; [Delpech, Valerie C.] Publ Hlth England, London, England; [Fearnhill, Esther] MRC Clin Trials Unit, London, England; [Abecasis, Ana B.] Univ Nova Lisboa, P-1200 Lisbon, Portugal; [Brown, Andrew J. Leigh] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Liverpool; University of London; University College London; Public Health England; Medical Research Council Clinical Trials Unit; Universidade Nova de Lisboa; University of Edinburgh	Geretti, AM (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	geretti@liverpool.ac.uk	Abecasis, Ana/B-6295-2009; Abecasis, Ana/ABF-6657-2020; Leigh Brown, Andrew/F-3802-2010; Brown, Andrew Leigh/ABF-8269-2020	Abecasis, Ana/0000-0002-3903-5265; Abecasis, Ana/0000-0002-3903-5265; Leigh Brown, Andrew/0000-0002-5700-3128; Brown, Andrew Leigh/0000-0002-5700-3128; delpech, valerie/0000-0002-9952-8109; Kellam, Paul/0000-0003-3166-4734; Hue, Stephane/0000-0002-8580-6905; Geretti, Anna Maria/0000-0002-3670-6588	Medical Research Council; Department of Health; Janssen-Cilag Ltd; Bristol-Myers Squibb; Gilead; Pfizer; Roche; MRC [G0900274, MC_UU_12023/15] Funding Source: UKRI; Medical Research Council [MC_UU_12023/15, G0900274] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Janssen-Cilag Ltd; Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Pfizer(Pfizer); Roche(Roche Holding); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Primary funding of the UK HIV Drug Resistance Database is provided by the Medical Research Council; the views expressed in the publication are those of the authors and not necessarily those of the Medical Research Council. The Database was originally established through funding from the Department of Health; additional support has been provided by Janssen-Cilag Ltd, Bristol-Myers Squibb, Gilead, Pfizer, and Roche. The authors declare that no commercial source had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Archer J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000178; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012; Boni J, 1999, J ACQ IMMUN DEF SYND, V22, P174; BRODINE SK, 1995, LANCET, V346, P1198, DOI 10.1016/S0140-6736(95)92901-0; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Health Protection Agency, SEX TRANSM INF MEN W; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kuiken C, 0803719 LAUR LOS AL; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Nadai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001420; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387; Van Laethem K, 2006, J VIROL METHODS, V132, P181, DOI 10.1016/j.jviromet.2005.10.008; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003	23	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83337	10.1371/journal.pone.0083337	http://dx.doi.org/10.1371/journal.pone.0083337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454702	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330235100009
J	Giavi, S; Moretti, M; Bontadina, F; Zambelli, N; Schaub, M				Giavi, Simone; Moretti, Marco; Bontadina, Fabio; Zambelli, Nicola; Schaub, Michael			Seasonal Survival Probabilities Suggest Low Migration Mortality in Migrating Bats	PLOS ONE			English	Article							POPULATION-DYNAMICS; SITE FIDELITY; STOPOVER SITE; LASIONYCTERIS; SONGBIRD; WEATHER; WIND	Migration is adaptive if survival benefits are larger than costs of residency. Many aspects of bat migration ecology such as migratory costs, stopover site use and fidelity are largely unknown. Since many migrating bats are endangered, such information is urgently needed to promote conservation. We selected the migrating Leisler's bat (Nyctalus leisleri) as model species and collected capture-recapture data in southern Switzerland year round during 6 years. We estimated seasonal survival and site fidelity with Cormack-Jolly-Seber models that accounted for the presence of transients fitted with Bayesian methods and assessed differences between sexes and seasons. Activity peaked in autumn and spring, whereas very few individuals were caught during summer. We hypothesize that the study site is a migratory stopover site used during fall and spring migration for most individuals, but there is also evidence for wintering. Additionally, we found strong clues for mating during fall. Summer survival that included two major migratory journeys was identical to winter survival in males and slightly higher in females, suggesting that the migratory journeys did not bear significant costs in terms of survival. Transience probability was in both seasons higher in males than in females. Our results suggest that, similarly to birds, Leisler's bat also use stopover sites during migration with high site fidelity. In contrast to most birds, the stopover site was also used for mating and migratory costs in terms of survival seemed to be low. Transients' analyses highlighted strong individual variation in site use which makes particularly challenging the study and modelling of their populations as well as their conservation.	[Giavi, Simone; Moretti, Marco] Swiss Fed Res Inst WSL, Bellinzona, Ticino, Switzerland; [Bontadina, Fabio] SWILD, Zurich, Switzerland; [Bontadina, Fabio] Swiss Fed Res Inst WSL, Zurich, Switzerland; [Zambelli, Nicola] Museo Cantonale Storia Nat, Lugano, Ticino, Switzerland; [Schaub, Michael] Swiss Ornithol Inst, Sempach, Luzern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Ornithological Institute	Giavi, S (corresponding author), Swiss Fed Res Inst WSL, Bellinzona, Ticino, Switzerland.	sgiavi@hotmail.com		Bontadina, Fabio/0000-0002-0163-2486; Moretti, Marco/0000-0002-5845-3198; Schaub, Michael/0000-0003-2745-0557; Giavi, Simone/0000-0001-8714-5912	Forest Department of the Canton of Ticino; Hochschulstiftung of University of Bern; Pro Natura	Forest Department of the Canton of Ticino; Hochschulstiftung of University of Bern; Pro Natura	This study is part of the SELPI (SELve & PIpistrelli) research program, supported by the Forest Department of the Canton of Ticino and by a grant from the Hochschulstiftung of University of Bern. Pro Natura supported the authors in the purchase of bat boxes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony E.L.P., 1988, P47; Bogdanowicz W, 2004, HDB SAUGETIERE EUROP, P717; Bontadina F, 2009, 1 INT S BAT MIGR BER; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Calvert AM, 2012, OECOLOGIA, V168, P849, DOI 10.1007/s00442-011-2119-5; CANTOS FJ, 1994, J AVIAN BIOL, V25, P131, DOI 10.2307/3677031; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dondini G, 2009, HYSTRIX, V20, P147; Duriez O, 2012, OIKOS, V121, P862, DOI 10.1111/j.1600-0706.2012.20326.x; Dzal Y, 2009, ACTA CHIROPTEROL, V11, P307, DOI 10.3161/150811009X485549; Fleming TH, 2003, BAT ECOLOGY, P156; Hoch S, 2005, 2 WEITERE FERNFUNDE, P288; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; McGuire LP, 2012, J ANIM ECOL, V81, P377, DOI 10.1111/j.1365-2656.2011.01912.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Papadatou E, 2012, ECOGRAPHY, V35, P153, DOI 10.1111/j.1600-0587.2011.07084.x; Papadatou E, 2009, BIOL CONSERV, V142, P280, DOI 10.1016/j.biocon.2008.10.023; Plummer M., 2003, P 3 INT WORKSH DISTR; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; R Core Team, 2012, LANG ENV STAT COMP; Racey P.A., 1988, P31; Reed ET, 1998, CONDOR, V100, P426, DOI 10.2307/1369708; Sanz-Aguilar A, 2012, J ANIM ECOL, V81, P1171, DOI 10.1111/j.1365-2656.2012.01997.x; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Schaub M, 2007, CONSERV BIOL, V21, P945, DOI 10.1111/j.1523-1739.2007.00743.x; SCHORCHT W, 2005, NYCTALUS, V10, P351; Schorcht Wigbert, 2002, Schriftenreihe fuer Landschaftspflege und Naturschutz, V71, P141; Schorcht W, 2009, J ANIM ECOL, V78, P1182, DOI 10.1111/j.1365-2656.2009.01577.x; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SPINEDI F, 2004, DATI STAT SOC, V6, P4; Steffens R, 2004, 40 JAHRE FLEDERMAUSM; Strandberg R, 2010, BIOL LETTERS, V6, P297, DOI 10.1098/rsbl.2009.0785; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; Szentkuti S, 2013, ENDANGER SPECIES RES, V21, P105, DOI 10.3354/esr00496; Taylor PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027054; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Voigt CC, 2012, BIOL CONSERV, V153, P80, DOI 10.1016/j.biocon.2012.04.027; Zambelli N, 2008, PIPISTRELLI SELVE VA; Zambelli N, 2010, NAT TAG SCHWEIZ KOOR	49	13	13	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85628	10.1371/journal.pone.0085628	http://dx.doi.org/10.1371/journal.pone.0085628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454906	Green Submitted, gold, Green Published			2022-12-27	WOS:000330235100109
J	Pulskens, WP; Butter, LM; Teske, GJ; Claessen, N; Dessing, MC; Flavell, RA; Sutterwala, FS; Florquin, S; Leemans, JC				Pulskens, Wilco P.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; Dessing, Mark C.; Flavell, Richard A.; Sutterwala, Fayyaz S.; Florquin, Sandrine; Leemans, Jaklien C.			Nlrp3 Prevents Early Renal Interstitial Edema and Vascular Permeability in Unilateral Ureteral Obstruction	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; TUBULAR DAMAGE; KIDNEY; FIBROSIS; INFLAMMASOME; NEPHROPATHY; APOPTOSIS; PROTEINS; CLAUDINS; INNATE	Progressive renal disease is characterized by tubulo-interstitial injury with ongoing inflammation and fibrosis. The Nlrp3 inflammasome contributes to these pathophysiological processes through its canonical effects in cytokine maturation. Nlrp3 may additionally exert inflammasome-independent effects following tissue injury. Hence, in this study we investigated potential non-canonical effects of Nlrp3 following progressive renal injury by subjecting WT and Nlrp3-deficient (-/-) mice to unilateral ureter obstruction (UUO). Our results revealed a progressive increase of renal Nlrp3 mRNA in WT mice following UUO. The absence of Nlrp3 resulted in enhanced tubular injury and dilatation and an elevated expression of injury biomarker NGAL after UUO. Moreover, interstitial edema was significantly elevated in Nlrp-/- mice. This could be explained by increased intratubular pressure and an enhanced tubular and vascular permeability. In accordance, renal vascular leakage was elevated in Nlrp-/- mice that associated with reduced mRNA expression of intercellular junction components. The decreased epithelial barrier function in Nlrp-/- mice was not associated with increased apoptosis and/or proliferation of renal epithelial cells. Nlrp3 deficiency did not affect renal fibrosis or inflammation. Together, our data reveal a novel non-canonical effect of Nlrp3 in preserving renal integrity and protection against early tubular injury and interstitial edema following progressive renal injury.	[Pulskens, Wilco P.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; Dessing, Mark C.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Yale University; Howard Hughes Medical Institute; University of Iowa	Pulskens, WP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	w.pulskens@fysiol.umcn.nl	Cassel, Suzanne/AAI-3947-2021; Leemans, Jaklien/AAM-4958-2020; Pulskens, Wilco/P-6023-2015; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; Pulskens, Wilco/0000-0001-9697-3189; Florquin, Sandrine/0000-0002-9676-1722	Dutch Kidney Foundation [IP10.20, C10-2350]; Netherlands Organization for Scientific Research [016.126.386-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by a grant from the Dutch Kidney Foundation to W. P. (IP10.20) and L.M.B. (C10-2350), and the Netherlands Organization for Scientific Research to J.C.L. (016.126.386-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Ashworth SL, 2006, NEPHRON PHYSIOL, V103, P91, DOI 10.1159/000090626; Bakker PJ, 2013, KIDNEY INT IN PRESS; Balkovetz DF, 2009, BBA-BIOMEMBRANES, V1788, P858, DOI 10.1016/j.bbamem.2008.07.004; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486; Chevalier RL, 1999, PEDIATR NEPHROL, V13, P612, DOI 10.1007/s004670050756; Chevalier RL, 1996, J UROLOGY, V156, P1474, DOI 10.1016/S0022-5347(01)65633-7; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Dunn KW, 2002, AM J PHYSIOL-CELL PH, V283, pC905, DOI 10.1152/ajpcell.00159.2002; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; GOBE GC, 1987, LAB INVEST, V56, P273; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jones LK, 2009, NEPHROL DIAL TRANSPL, V24, P3024, DOI 10.1093/ndt/gfp214; Kirk A, 2010, NEPHROL DIAL TRANSPL, V25, P2107, DOI 10.1093/ndt/gfq006; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Lichtnekert J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026778; Lorenz G, 2013, NEPHROL DIAL TRANSPL; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Rouschop KMA, 2006, J AM SOC NEPHROL, V17, P746, DOI 10.1681/ASN.2005080808; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanji N, 1998, Int J Urol, V5, P256, DOI 10.1111/j.1442-2042.1998.tb00600.x; Truong LD, 1998, SEMIN NEPHROL, V18, P641; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang J, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/785437; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Yu WM, 2007, AM J PHYSIOL-RENAL, V292, pF1873, DOI 10.1152/ajprenal.00218.2006	46	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85775	10.1371/journal.pone.0085775	http://dx.doi.org/10.1371/journal.pone.0085775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454932	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100133
J	Soraas, A; Sundsfjord, A; Jorgensen, SB; Liestol, K; Jenum, PA				Soraas, Arne; Sundsfjord, Arnfinn; Jorgensen, Silje Bakken; Liestol, Knut; Jenum, Pal A.			High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli	PLOS ONE			English	Article							PERORALLY ADMINISTERED PIVMECILLINAM; NITROFURANTOIN; ANTIBIOTICS; EFFICACY; THERAPY; WOMEN	A population-based study was performed to investigate the efficacy of mecillinam treatment of community-acquired urinary tract infections (CA-UTI) caused by extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. The study was conducted in South-Eastern Norway. Data from patients with CA-UTI caused by ESBL-producing and non-producing (random controls) E. coli were collected through interviews, questionnaires, medical records and the Norwegian Prescription Database. Treatment failure was defined as a new antibiotic prescription appropriate for UTI prescribed within two weeks after the initial antimicrobial therapy. Multivariable logistic regression analysis was performed to identify treatment agents and patient-or bacterial traits associated with treatment failure. A total of 343 patients (mean age 59) were included, of which 158 (46%) were treated with mecillinam. Eighty-one patients (24%, mean age 54) had infections caused by ESBL producing E. coli, and 41 of these patients (51%) received mecillinam as the primary treatment. Mecillinam treatment failure was observed in 18 (44%) of patients infected by ESBL-producing strains and in 16 (14%) of patients with a CA-UTI caused by ESBL non-producing strains. Multivariable analysis showed that ESBL status (odds ratio (OR) 3.2, 95% confidence interval (CI) 1.3-7.8, p = 0.009) and increased MIC of mecillinam (OR 2.0 for each doubling value of MIC, CI 1.4-3.0, p< 0.001) were independently associated with mecillinam treatment failure. This study showed a high rate of mecillinam treatment failure in CA-UTIs caused by ESBL producing E. coli. The high failure rate could not be explained by the increased MIC of mecillinam alone. Further studies addressing the use of mecillinam against ESBL-producing E. coli, with emphasis on optimal dosing and combination therapy with b-lactamase inhibitors, are warranted.	[Soraas, Arne; Jorgensen, Silje Bakken; Jenum, Pal A.] Vestre Viken Hosp Trust, Dept Med Microbiol, Baerum, Norway; [Sundsfjord, Arnfinn] Univ Hosp North Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrobial Resistance, Tromso, Norway; [Sundsfjord, Arnfinn] Univ Tromso, Dept Med Biol, Res Grp Host Microbe Interact, Fac Hlth Sci, Tromso, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Jenum, Pal A.] Univ Oslo, Fac Med, Dept Clin Med, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo; University of Oslo	Soraas, A (corresponding author), Vestre Viken Hosp Trust, Dept Med Microbiol, Baerum, Norway.	arne@meg.no	Sundsfjord, Arnfinn/F-9668-2018	Sundsfjord, Arnfinn/0000-0002-3728-2270; Jorgensen, Silje/0000-0002-3135-1431	South Eastern Norway Health Authority	South Eastern Norway Health Authority	The study were funded by the South Eastern Norway Health Authority. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer S, 2010, ANTIMICROB AGENTS CH, V54, P4006, DOI 10.1128/AAC.01760-09; Berg C, 2011, NORWEGIAN PRESCRIPTI; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bjerrum L, 2002, SCAND J PRIM HEALTH, V20, P97, DOI 10.1080/713796403; Bjerrum L, 2009, SCAND J PRIM HEALTH, V27, P6, DOI 10.1080/02813430802535312; Craig WA, 2003, INFECT DIS CLIN N AM, V17, P479, DOI 10.1016/S0891-5520(03)00065-5; Dewar S, 2014, J ANTIMICROB CHEMOTH, V69, P303, DOI 10.1093/jac/dkt368; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Ferry SA, 2007, SCAND J PRIM HEALTH, V25, P49, DOI 10.1080/02813430601183074; Frimodt-Moller N, 2002, INT J ANTIMICROB AG, V19, P546, DOI 10.1016/S0924-8579(02)00105-X; Garau J, 2008, CLIN MICROBIOL INFEC, V14, P198, DOI 10.1111/j.1469-0691.2007.01852.x; Goettsch WG, 2004, BRIT J CLIN PHARMACO, V58, P184, DOI 10.1111/j.1365-2125.2004.02106.x; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hvidberg H, 2000, ANTIMICROB AGENTS CH, V44, P156, DOI 10.1128/AAC.44.1.156-163.2000; Jensen KS, 2008, 18 EUR C CLIN MICR I; Kahlmeter G, 2012, INT J ANTIMICROB AG, V39, P45, DOI 10.1016/j.ijantimicag.2011.09.013; Kerrn MB, 2004, CLIN MICROBIOL INFEC, V10, P54, DOI 10.1111/j.1469-0691.2004.00737.x; Lampri N, 2012, J ANTIMICROB CHEMOTH, V67, P2424, DOI 10.1093/jac/dks215; Lawrenson RA, 2001, J ANTIMICROB CHEMOTH, V48, P895, DOI 10.1093/jac/48.6.895; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Menday AP, 2000, INT J ANTIMICROB AG, V13, P183, DOI 10.1016/S0924-8579(99)00118-1; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Nicolle LE, 2002, SCAND J INFECT DIS, V34, P487, DOI 10.1080/00365540110080728; Nicolle LE, 2007, SCAND J INFECT DIS, V39, P748, DOI 10.1080/00365540701367801; NORM/NORM-VET, 2010, US ANT AG OCC ANT RE; Raz R, 2000, CLIN INFECT DIS, V30, P152, DOI 10.1086/313596; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; Sougakoff W, 2000, J ANTIMICROB CHEMOTH, V46, P9, DOI 10.1093/jac/46.suppl_1.9; Sullivan A, 2005, ANTIMICROB AGENTS CH, V49, P170, DOI 10.1128/AAC.49.1.170-175.2005; Sullivan A, 2001, J CHEMOTHERAPY, V13, P299, DOI 10.1179/joc.2001.13.3.299; Tarnberg M, 2011, EUR J CLIN MICROBIOL, V30, P981, DOI 10.1007/s10096-011-1183-4; Thomas K, 2006, J ANTIMICROB CHEMOTH, V57, P367, DOI 10.1093/jac/dki451; Titelman E, 2012, MICROB DRUG RESIST, V18, P189, DOI 10.1089/mdr.2011.0161; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; Viera AJ, 2005, FAM MED, V37, P360; Wootton M, 2010, J ANTIMICROB CHEMOTH, V65, P79, DOI 10.1093/jac/dkp404	36	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85889	10.1371/journal.pone.0085889	http://dx.doi.org/10.1371/journal.pone.0085889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454943	Green Published, gold			2022-12-27	WOS:000330235100139
J	Xie, G; Lo, CC; Scholz, M; Chain, PSG				Xie, Gary; Lo, Chien-Chi; Scholz, Matthew; Chain, Patrick S. G.			Recruiting Human Microbiome Shotgun Data to Site-Specific Reference Genomes	PLOS ONE			English	Article							SKIN MICROBIOME; INTESTINAL MICROBIOTA; GUT MICROBIOME; DIVERSITY; COMMUNITY; ECOLOGY; CATALOG; TRACT; CORE	The human body consists of innumerable multifaceted environments that predispose colonization by a number of distinct microbial communities, which play fundamental roles in human health and disease. In addition to community surveys and shotgun metagenomes that seek to explore the composition and diversity of these microbiomes, there are significant efforts to sequence reference microbial genomes from many body sites of healthy adults. To illustrate the utility of reference genomes when studying more complex metagenomes, we present a reference-based analysis of sequence reads generated from 55 shotgun metagenomes, selected from 5 major body sites, including 16 sub-sites. Interestingly, between 13% and 92% (62.3% average) of these shotgun reads were aligned to a then-complete list of 2780 reference genomes, including 1583 references for the human microbiome. However, no reference genome was universally found in all body sites. For any given metagenome, the body site-specific reference genomes, derived from the same body site as the sample, accounted for an average of 58.8% of the mapped reads. While different body sites did differ in abundant genera, proximal or symmetrical body sites were found to be most similar to one another. The extent of variation observed, both between individuals sampled within the same microenvironment, or at the same site within the same individual over time, calls into question comparative studies across individuals even if sampled at the same body site. This study illustrates the high utility of reference genomes and the need for further site-specific reference microbial genome sequencing, even within the already well-sampled human microbiome.	[Xie, Gary; Lo, Chien-Chi; Scholz, Matthew; Chain, Patrick S. G.] Los Alamos Natl Lab, Genome Sci Grp, Los Alamos, NM 87545 USA; [Xie, Gary; Lo, Chien-Chi; Scholz, Matthew; Chain, Patrick S. G.] Joint Genome Inst, Microbial & Metagenome Program, Walnut Creek, CA USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Chain, PSG (corresponding author), Los Alamos Natl Lab, Genome Sci Grp, Los Alamos, NM 87545 USA.	pchain@lanl.gov	Chain, Patrick/O-4140-2019	Chain, Patrick/0000-0003-3949-3634; xie, gary/0000-0002-9176-924X; Scholz, Matthew/0000-0003-3686-1227; Lo, Chien-Chi/0000-0003-3470-1078	National Institutes of Health [Y1-DE-6006-02]; U.S. Department of Energy (Office of Science) Joint Genome Institute [DE-AC02-05CH11231]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (Office of Science) Joint Genome Institute	This study was supported by grants from National Institutes of Health (Y1-DE-6006-02) and U.S. Department of Energy (Office of Science) Joint Genome Institute (DE-AC02-05CH11231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; BRISELDEN AM, 1990, J CLIN MICROBIOL, V28, P2761, DOI 10.1128/JCM.28.12.2761-2764.1990; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Erkel C, 2006, SCIENCE, V313, P370, DOI 10.1126/science.1127062; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Pflughoeft KJ, 2011, ANN REV PATHOLOGY; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yang F, 2011, ISME J; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	34	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84963	10.1371/journal.pone.0084963	http://dx.doi.org/10.1371/journal.pone.0084963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454771	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100044
J	Grau, I; Bohner, G				Grau, Ina; Bohner, Gerd			Anchoring Revisited: The Role of the Comparative Question	PLOS ONE			English	Article							MECHANISMS; KNOWLEDGE; JUDGMENT	When people estimate a numeric value after judging whether it is larger or smaller than a high or low anchor value (comparative question), estimates are biased in the direction of the anchor. One explanation for this anchoring effect is that people selectively access knowledge consistent with the anchor value as part of a positive test strategy. Two studies (total N = 184) supported the alternative explanation that people access knowledge consistent with their own answer to the comparative question. Specifically, anchoring effects emerged when the answer to the comparative question was unexpected (lower than the low anchor or higher than the high anchor). For expected answers (lower than the high anchor or higher than the low anchor), however, anchoring effects were attenuated or reversed. The anchor value itself was almost never reported as an absolute estimate.	[Grau, Ina] Univ Bonn, Dept Social & Legal Psychol, Bonn, Germany; [Bohner, Gerd] Univ Bielefeld, Dept Social Psychol, D-33615 Bielefeld, Germany	University of Bonn; University of Bielefeld	Grau, I (corresponding author), Univ Bonn, Dept Social & Legal Psychol, Bonn, Germany.	igrau@uni-bonn.de	Bohner, Gerd/B-2274-2008	Bohner, Gerd/0000-0002-0564-3625	Deutsche Forschungsgemeinschaft; Bielefeld University Library	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University Library	We acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library.	Chapman GB, 1999, ORGAN BEHAV HUM DEC, V79, P115, DOI 10.1006/obhd.1999.2841; Englich B, 2006, PERS SOC PSYCHOL B, V32, P188, DOI 10.1177/0146167205282152; Englich B, 2008, EUR J SOC PSYCHOL, V38, P896, DOI 10.1002/ejsp.479; Eyssel F, 2006, SWISS J PSYCHOL, V65, P93, DOI 10.1024/1421-0185.65.2.93; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; JACOWITZ KE, 1995, PERS SOC PSYCHOL B, V21, P1161, DOI 10.1177/01461672952111004; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Mussweiler T, 1999, J EXP SOC PSYCHOL, V35, P136, DOI 10.1006/jesp.1998.1364; Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472; Mussweiler T, 2001, EUR J SOC PSYCHOL, V31, P431, DOI 10.1002/ejsp.52; Mussweiler T, 2000, PERS SOC PSYCHOL B, V26, P1142, DOI 10.1177/01461672002611010; Mussweiler T, 2000, J PERS SOC PSYCHOL, V78, P1038, DOI 10.1037//0022-3514.78.6.1038; Mussweiler T, 2004, COGNITIVE ILLUSIONS: A HANDBOOK ON FALLACIES AND BIASES IN THINKING, JUDGEMENT AND MEMORY, P183; PLOUS S, 1989, J APPL SOC PSYCHOL, V19, P67, DOI 10.1111/j.1559-1816.1989.tb01221.x; Strack F, 1997, J PERS SOC PSYCHOL, V73, P437, DOI 10.1037/0022-3514.73.3.437; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wilson TD, 1996, J EXP PSYCHOL GEN, V125, P387, DOI 10.1037/0096-3445.125.4.387; Wong KFE, 2000, ORGAN BEHAV HUM DEC, V82, P314, DOI 10.1006/obhd.2000.2900	18	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e86056	10.1371/journal.pone.0086056	http://dx.doi.org/10.1371/journal.pone.0086056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292TQ	24454953	Green Published, Green Submitted, gold			2022-12-27	WOS:000329925800054
J	Kanemura, H; Go, MJ; Shikamura, M; Nishishita, N; Sakai, N; Kamao, H; Mandai, M; Morinaga, C; Takahashi, M; Kawamata, S				Kanemura, Hoshimi; Go, Masahiro J.; Shikamura, Masayuki; Nishishita, Naoki; Sakai, Noriko; Kamao, Hiroyuki; Mandai, Michiko; Morinaga, Chikako; Takahashi, Masayo; Kawamata, Shin			Tumorigenicity Studies of Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) for the Treatment of Age-Related Macular Degeneration	PLOS ONE			English	Article							SUBRETINAL IMPLANTATION; GENERATION	Basic studies of human pluripotential stem cells have advanced rapidly and stem cell products are now seeing therapeutic applications. However, questions remain regarding the tumorigenic potential of such cells. Here, we report the tumorigenic potential of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of wet-type, age-related macular degeneration (AMD). First, immunodeficient mouse strains (nude, SCID, NOD-SCID and NOG) were tested for HeLa cells' tumor-forming capacity by transplanting various cell doses subcutaneously with or without Matrigel. The 50% Tumor Producing Dose (TPD50 value) is the minimal dose of transplanted cells that generated tumors in 50% of animals. For HeLa cells, the TPD50 was the lowest when cells were embedded in Matrigel and transplanted into NOG mice (TPD50= 10(1.1), n = 75). The TPD50 for undifferentiated iPSCs transplanted subcutaneously to NOG mice in Matrigel was 10(2.12); (n = 30). Based on these experiments, 1610 6 iPSC-derived RPE were transplanted subcutaneously with Matrigel, and no tumor was found during 15 months of monitoring (n = 65). Next, to model clinical application, we assessed the tumor-forming potential of HeLa cells and iPSC 201B7 cells following subretinal transplantation of nude rats. The TPD50 for iPSCs was 10(4.73) (n = 20) and for HeLa cells 10(1.32) (n = 37) respectively. Next, the tumorigenicity of iPSC-derived RPE was tested in the subretinal space of nude rats by transplanting 0.8-1.5x10(4) iPSC-derived RPE in a collagen-lined (1 mmx1 mm) sheet. No tumor was found with iPSC-derived RPE sheets during 6-12 months of monitoring (n = 26). Considering the number of rodents used, the monitoring period, the sensitivity of detecting tumors via subcutaneous and subretinal administration routes and the incidence of tumor formation from the iPSC-derived RPE, we conclude that the tumorigenic potential of the iPSC-derived RPE was negligible.	[Kanemura, Hoshimi; Go, Masahiro J.; Shikamura, Masayuki; Nishishita, Naoki; Kawamata, Shin] Fdn Biomed Res & Innovat, Div Cell Therapy, Kobe, Hyogo, Japan; [Kanemura, Hoshimi; Sakai, Noriko; Kamao, Hiroyuki; Mandai, Michiko; Morinaga, Chikako; Takahashi, Masayo; Kawamata, Shin] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Kamao, Hiroyuki] Kawasaki Med Sch, Dept Ophthalmol, Kurashiki, Okayama, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Kawasaki Medical School	Kawamata, S (corresponding author), Fdn Biomed Res & Innovat, Div Cell Therapy, Kobe, Hyogo, Japan.	kawamata@fbri.org		kawamata, shin/0000-0001-5148-1949; Kamao, Hiroyuki/0000-0002-2194-7063	JST Japan	JST Japan(Japan Science & Technology Agency (JST))	This study was supported by funding from JST research grant "Safety Tests for Pluripotent Stem Cell (2010-2014)'' Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003685; Diniz B, 2013, INVEST OPHTH VIS SCI, V54, P5087, DOI 10.1167/iovs.12-11239; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hu YT, 2012, OPHTHALMIC RES, V48, P186, DOI 10.1159/000338749; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Lewis AM, 2005, REG IMPL NEOPL CELL; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okano Hideyuki, 2009, Genome Inform, V23, P217; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Prockop DJ, 2010, MOL THER, V18, P1249, DOI 10.1038/mt.2010.99; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; WHO, 2010, REC EV AN CELL CULT; World Health Organization, 2008, WHO TECHN REP SER, V878	21	119	125	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85336	10.1371/journal.pone.0085336	http://dx.doi.org/10.1371/journal.pone.0085336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454843	gold, Green Published, Green Submitted			2022-12-27	WOS:000329925800038
J	Nakajima, S; Lan, L; Wei, L; Hsieh, CL; Rapic-Otrin, V; Yasui, A; Levine, AS				Nakajima, Satoshi; Lan, Li; Wei, Leizhen; Hsieh, Ching-Lung; Rapic-Otrin, Vesna; Yasui, Akira; Levine, Arthur S.			Ubiquitin-Specific Protease 5 Is Required for the Efficient Repair of DNA Double-Strand Breaks	PLOS ONE			English	Article							HUMAN-CELLS; DEUBIQUITINATING ENZYMES; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; DAMAGE RESPONSE; PCNA MONOUBIQUITINATION; POLYUBIQUITIN CHAINS; EXCISION-REPAIR; ISOPEPTIDASE-T; GENOME-WIDE	During the DNA damage response (DDR), ubiquitination plays an important role in the recruitment and regulation of repair proteins. However, little is known about elimination of the ubiquitination signal after repair is completed. Here we show that the ubiquitin-specific protease 5 (USP5), a deubiquitinating enzyme, is involved in the elimination of the ubiquitin signal from damaged sites and is required for efficient DNA double-strand break (DSB) repair. Depletion of USP5 sensitizes cells to DNA damaging agents, produces DSBs, causes delayed disappearance of gamma H2AX foci after Bleocin treatment, and influences DSB repair efficiency in the homologous recombination pathway but not in the non-homologous end joining pathway. USP5 co-localizes to DSBs induced by laser micro-irradiation in a RAD18-dependent manner. Importantly, polyubiquitin chains at sites of DNA damage remained for longer periods in USP5-depleted cells. Our results show that disassembly of polyubiquitin chains by USP5 at sites of damage is important for efficient DSB repair.	[Nakajima, Satoshi; Lan, Li; Wei, Leizhen; Hsieh, Ching-Lung; Rapic-Otrin, Vesna; Levine, Arthur S.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Nakajima, Satoshi; Lan, Li; Wei, Leizhen; Hsieh, Ching-Lung; Rapic-Otrin, Vesna; Levine, Arthur S.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome, Sendai, Miyagi 980, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tohoku University	Nakajima, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	san48@pitt.edu; lil64@pitt.edu			UPCI [P30CA047904]; National Institutes of Health [UL1 RR024153, UL1TR000005]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG045545] Funding Source: NIH RePORTER	UPCI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	UPCI shared resources that are supported in part by award P30CA047904 were used for this project. The project described was supported by the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Amerik AY, 1997, EMBO J, V16, P4826; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; HADARI T, 1992, J BIOL CHEM, V267, P719; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Inagaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023155; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Levy-Barda A, 2011, CELL CYCLE, V10, P4300, DOI 10.4161/cc.10.24.18642; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu T, 2010, DNA REPAIR, V9, P1241, DOI 10.1016/j.dnarep.2010.09.016; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tsuji Y, 2008, GENES CELLS, V13, P343, DOI 10.1111/j.1365-2443.2008.01176.x; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032	57	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84899	10.1371/journal.pone.0084899	http://dx.doi.org/10.1371/journal.pone.0084899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454762	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329925800018
J	Yu, Y; Zhu, R; Zeng, ZL; Jia, YW; Wu, ZR; Ren, YL; Chen, B; Ding, ZQ; Cheng, LM				Yu, Yan; Zhu, Rui; Zeng, Zhi-Li; Jia, Yong-Wei; Wu, Zhou-Rui; Ren, Yi-Long; Chen, Bo; Ding, Zu-Quan; Cheng, Li-Ming			The Strain at Bone-Implant Interface Determines the Effect of Spinopelvic Reconstruction following Total Sacrectomy: A Strain Gauge Analysis in Various Spinopelvic Constructs	PLOS ONE			English	Article							PELVIC FIXATION; LUMBOPELVIC RECONSTRUCTION; 4-ROD TECHNIQUE; FINITE-ELEMENT; INSTRUMENTATION; NEOPLASMS; SCREWS; ROD	Purpose: There is still some controversy regarding the optimal biomechanical concept for spinopelvic stabilization following total sacrectomy for malignancy. Strains at specific anatomical sites at pelvis/sacrum and implants interfaces have been poorly investigated. Herein, we compared and analyzed the strains applied at key points at the bone-implant interface in four different spinopelvic constructs following total sacrectomy; consequently, we defined a balanced architecture for spinopelvic fusion in that situation. Methods: Six human cadaveric specimens, from second lumbar vertebra to proximal femur, were used to compare the partial strains at specific sites in a total sacrectomy model. Test constructs included: (1) intact pelvis (control), (2) sacral-rod reconstruction (SRR), (3) bilateral fibular flap reconstruction (BFFR), (4) four-rods reconstruction (FRR), and (5) improved compound reconstruction (ICR). Strains were measured by bonded strain gauges onto the surface of three specific sites (pubic rami, arcuate lines, and posterior spinal rods) under a 500 N axial load. Results: ICR caused lower strains at specific sites and, moreover, on stress distribution and symmetry, compared to the other three constructs. Strains at pubic rami and arcuate lines following BFFR were lower than those following SRR, but higher at the posterior spinal rod construct. The different modes of strain distribution reflected different patient's parameter-related conditions. FRR model showed the highest strains at all sites because of the lack of an anterior bracing frame. Conclusions: The findings of this investigation suggest that both anterior bracing frame and the four-rods load dispersion provide significant load sharing. Additionally, these two constructs decrease the peak strains at bone-implant interface, thus determining the theoretical surgical technique to achieve optimal stress dispersion and balance for spinopelvic reconstruction in early postoperative period following total sacrectomy.	[Yu, Yan; Zhu, Rui; Zeng, Zhi-Li; Jia, Yong-Wei; Wu, Zhou-Rui; Ren, Yi-Long; Cheng, Li-Ming] Tongji Univ, Sch Med, Dept Spine Surg, Tongji Hosp, Shanghai 200092, Peoples R China; [Zhu, Rui] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Chen, Bo; Ding, Zu-Quan] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Chen, Bo] Inst Orthopaed & Traumatol, Shanghai, Peoples R China	Tongji University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tongji University	Cheng, LM (corresponding author), Tongji Univ, Sch Med, Dept Spine Surg, Tongji Hosp, Shanghai 200092, Peoples R China.	chlm.d@163.com	cheng, liming/GMX-4116-2022; Xiao, Hu/GMX-0258-2022	Yu, Yan/0000-0003-1120-7552; Zhu, Rui/0000-0002-9008-9875	Program for New Century Excellent Talents at the University of China [NCET-06-0375]; Program of Shanghai Subject Chief Scientist [12XD1404400]; Youth Foundation of Shanghai Health Bureau [20124Y158]	Program for New Century Excellent Talents at the University of China(Program for New Century Excellent Talents in University (NCET)); Program of Shanghai Subject Chief Scientist; Youth Foundation of Shanghai Health Bureau	This study was supported by the Program for New Century Excellent Talents at the University of China (NCET-06-0375), the Program of Shanghai Subject Chief Scientist (12XD1404400) and the Youth Foundation of Shanghai Health Bureau (20124Y158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng LM, 2011, CLIN BIOMECH, V26, P977, DOI 10.1016/j.clinbiomech.2011.06.003; Dickey ID, 2005, CLIN ORTHOP RELAT R, P42, DOI 10.1097/01.blo.0000180054.76969.41; Ghosh R, 2013, P I MECH ENG H, V227, P162, DOI 10.1177/0954411912461238; Gokaslan ZL, 1997, J NEUROSURG, V87, P781, DOI 10.3171/jns.1997.87.5.0781; Hugate RR, 2006, CLIN ORTHOP RELAT R, P82, DOI 10.1097/01.blo.0000229331.14029.44; Jackson RJ, 2000, J NEUROSURG, V92, P61, DOI 10.3171/spi.2000.92.1.0061; Kawahara N, 2003, SPINE, V28, P1567, DOI 10.1097/00007632-200307150-00017; Kelly BP, 2008, SPINE, V33, pE400, DOI 10.1097/BRS.0b013e31817615c5; King AG, 2000, J PEDIATR ORTHOPED, V20, P667, DOI 10.1097/01241398-200009000-00023; Mindea SA, 2012, SPINE, V37, pE1622, DOI 10.1097/BRS.0b013e31827619d3; Moshirfar A, 2005, J BONE JOINT SURG AM, V87A, P89, DOI 10.2106/JBJS.E.00453; Murakami Hideki, 2002, J Orthop Sci, V7, P658, DOI 10.1007/s007760200117; Nachemson A, 1970, Scand J Rehabil Med Suppl, V1, P1; Peelle MW, 2006, SPINE, V31, P2392, DOI 10.1097/01.brs.0000238973.13294.16; Shen FH, 2006, SPINE, V31, P1395, DOI 10.1097/01.brs.0000219527.64180.95; Spiegel DA, 1999, J BONE JOINT SURG AM, V81A, P848, DOI 10.2106/00004623-199906000-00012; Wood KB, 1996, SPINE, V21, P1185, DOI 10.1097/00007632-199605150-00010; Yu BS, 2010, CLIN BIOMECH, V25, P867, DOI 10.1016/j.clinbiomech.2010.06.012; Yu BS, 2010, EUR SPINE J, V19, P1121, DOI 10.1007/s00586-010-1343-8; Zhou Y, 2013, INT ORTHOP, V37, P653, DOI 10.1007/s00264-012-1756-6; Zhu R, 2012, CLIN BIOMECH, V27, P771, DOI 10.1016/j.clinbiomech.2012.05.008	21	5	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85298	10.1371/journal.pone.0085298	http://dx.doi.org/10.1371/journal.pone.0085298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454839	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800036
J	Chiba, T; Suzuki, E; Yuki, K; Zen, Y; Oshima, M; Miyagi, S; Saraya, A; Koide, S; Motoyama, T; Ogasawara, S; Ooka, Y; Tawada, A; Nakatsura, T; Hayashi, T; Yamashita, T; Kaneko, S; Miyazaki, M; Iwama, A; Yokosuka, O				Chiba, Tetsuhiro; Suzuki, Eiichiro; Yuki, Kaori; Zen, Yoh; Oshima, Motohiko; Miyagi, Satoru; Saraya, Atsunori; Koide, Shuhei; Motoyama, Tenyu; Ogasawara, Sadahisa; Ooka, Yoshihiko; Tawada, Akinobu; Nakatsura, Tetsuya; Hayashi, Takehiro; Yamashita, Taro; Kaneko, Syuichi; Miyazaki, Masaru; Iwama, Atsushi; Yokosuka, Osamu			Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners	PLOS ONE			English	Article							BREAST-CANCER CELLS; STEM-CELLS; SELF-RENEWAL; EXPRESSION; INHIBITION; GLYPICAN-3; APOPTOSIS; MARKER	Tumor-initiating cells (TICs) play a central role in tumor development, metastasis, and recurrence. In the present study, we investigated the effect of disulfiram (DSF), an inhibitor of aldehyde dehydrogenase, toward tumor-initiating hepatocellular carcinoma (HCC) cells. DSF treatment suppressed the anchorage-independent sphere formation of both HCC cells. Flow cytometric analyses showed that DSF but not 5-fluorouracil (5-FU) drastically reduces the number of tumor-initiating HCC cells. The sphere formation assays of epithelial cell adhesion molecule (EpCAM)(+) HCC cells co-treated with p38-specific inhibitor revealed that DSF suppresses self-renewal capability mainly through the activation of reactive oxygen species (ROS)-p38 MAPK pathway. Microarray experiments also revealed the enrichment of the gene set involved in p38 MAPK signaling in EpCAM(+) cells treated with DSF but not 5-FU. In addition, DSF appeared to downregulate Glypican 3 (GPC3) in a manner independent of ROS-p38 MAPK pathway. GPC3 was co-expressed with EpCAM in HCC cell lines and primary HCC cells and GPC3-knockdown reduced the number of EpCAM(+) cells by compromising their self-renewal capability and inducing the apoptosis. These results indicate that DSF impaired the tumorigenicity of tumor-initiating HCC cells through activation of ROS-p38 pathway and in part through the downregulation of GPC3. DSF might be a promising therapeutic agent for the eradication of tumor-initiating HCC cells.	[Chiba, Tetsuhiro; Suzuki, Eiichiro; Yuki, Kaori; Motoyama, Tenyu; Ogasawara, Sadahisa; Ooka, Yoshihiko; Tawada, Akinobu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Chiba, Tetsuhiro; Suzuki, Eiichiro; Yuki, Kaori; Oshima, Motohiko; Miyagi, Satoru; Saraya, Atsunori; Koide, Shuhei; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Zen, Yoh] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Nakatsura, Tetsuya] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Canc Immunotherapy, Kashiwa, Chiba, Japan; [Hayashi, Takehiro; Yamashita, Taro; Kaneko, Syuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan	Chiba University; Chiba University; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; National Cancer Center - Japan; Kanazawa University; Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064; Koide, Shuhei/0000-0001-8599-6115	Global COE program (Global Center for Education and Research in Immune System Regulation and Treatment) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST); Foundation for the Promotion of Cancer Research; Grants-in-Aid for Scientific Research [25460977] Funding Source: KAKEN	Global COE program (Global Center for Education and Research in Immune System Regulation and Treatment) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Foundation for the Promotion of Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants for the Global COE program (Global Center for Education and Research in Immune System Regulation and Treatment) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.jsps.go.jp/j-globalcoe/); grants from Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(http://www.jst.go.jp/kisoken/crest/); and the Foundation for the Promotion of Cancer Research (http://www.fpcr.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cen DZ, 2002, MOL CANCER THER, V1, P197; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dolle L, 2012, HEPATOLOGY, V55, P540, DOI 10.1002/hep.24693; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Liu P, 2012, BRIT J CANCER, V107, P1488, DOI 10.1038/bjc.2012.442; Liu SY, 2012, BIOCHEM BIOPH RES CO, V419, P656, DOI 10.1016/j.bbrc.2012.02.069; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Midorikawa Y, 2003, INT J CANCER, V103, P455, DOI 10.1002/ijc.10856; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Rountree CB, 2012, HEPATOLOGY, V55, P298, DOI 10.1002/hep.24762; Sawada Y, 2012, CLIN CANCER RES, V18, P3686, DOI 10.1158/1078-0432.CCR-11-3044; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki E, 2012, HEPATOL RES, V42, P1100, DOI 10.1111/j.1872-034X.2012.01028.x; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wong DJ, 2008, CANCER RES, V68, P369, DOI 10.1158/0008-5472.CAN-07-0382; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; Zhang HJ, 2010, CANCER RES, V70, P3996, DOI 10.1158/0008-5472.CAN-09-3752	32	54	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84807	10.1371/journal.pone.0084807	http://dx.doi.org/10.1371/journal.pone.0084807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454751	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500022
J	Mendoza, Y; Bello, G; Mewa, JC; Martinez, AA; Gonzalez, C; Garcia-Morales, C; Avila-Rios, S; Reyes-Teran, G; Pascale, JM				Mendoza, Yaxelis; Bello, Gonzalo; Castillo Mewa, Juan; Martinez, Alexander A.; Gonzalez, Claudia; Garcia-Morales, Claudia; Avila-Rios, Santiago; Reyes-Teran, Gustavo; Pascale, Juan M.			Molecular Epidemiology of HIV-1 in Panama: Origin of Non-B Subtypes in Samples Collected from 2007 to 2013	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; CIRCULATING RECOMBINANT FORMS; GENOTYPING SYSTEM; GENETIC DIVERSITY; IDENTIFICATION; SURVEILLANCE; PERFORMANCE; PREVALENCE; INFECTION; SEQUENCES	Phylogenetic studies have suggested that the HIV-1 epidemic in the Americas is mainly dominated by HIV subtype B. However, countries of South America and the Caribbean have recently reported changes in their circulating HIV-1 genetic profiles. The aim of this study was to characterize the molecular profile of the HIV-1 epidemic in Panama by the analysis of 655 polymerase gene (pol) sequences that were obtained from HIV-infected Panamanians diagnosed between 1987 and 2013. Blood samples were collected from recently infected, antiretroviral drug-naive and treatment-experienced subjects since mid-2007 to 2013. Viral RNA from plasma was extracted and sequences of HIV protease and reverse transcriptase genes were obtained. Bootscanning and phylogenetic methods were used for HIV subtyping and to trace the putative origin of non-B subtype strains. Our results showed that HIV-1 infections in Panama are dominated by subtype B (98.9%). The remaining 1.1% is represented by a diverse collection of recombinant variants including: three URFs_BC, one CRF20_BG, and one CRF28/29_BF, in addition to one subtype F1 and one subtype C, none of which were previously reported in Panama. The non-B subtype variants detected in Panama were probably introduced from Brazil (subtype F1 and CRF28/29_BF), Cuba (CRF20_BG), Dominican Republic (URFs_BC) and India (subtype C). Panama is the geographical vertex that connects the North with South America and the Caribbean through trade and cultural relations, which may explain the observed introductions of non-B subtype HIV-1 variants from both the Caribbean and South America into this Central American country.	[Mendoza, Yaxelis; Castillo Mewa, Juan; Martinez, Alexander A.; Gonzalez, Claudia; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, Andhra Pradesh, India; [Mendoza, Yaxelis] Univ Panama, Dept Genet & Mol Biol, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] INDICASAT AIP, Panama City, Panama; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Garcia-Morales, Claudia; Avila-Rios, Santiago; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de Panama; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Fundacao Oswaldo Cruz	Mendoza, Y (corresponding author), Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama.	yaxelis_mendoza@yahoo.com	Avila-Rios, Santiago/AAB-4383-2020; Bentancor, Gonzalo Jose Bello/N-7377-2019; Martínez, Alexander/HHC-2101-2022; Martinez, Alexander A/F-9601-2012; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Martinez, Alexander A/0000-0002-7816-3040; Reyes-Teran, Gustavo/0000-0002-4115-4888; Gonzalez, Claudia/0000-0002-0055-9758	Department of Genomics and Proteomics (ICGES); Ministry of Health (Panama); International Atomic Energy Agency (IAEA) [PAN-6011]; Secretaria Nacional de Ciencia y Tecnologia (SENACYT); Instituto para la Formacion de Recursos Humanos (IFARHU)	Department of Genomics and Proteomics (ICGES); Ministry of Health (Panama); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Secretaria Nacional de Ciencia y Tecnologia (SENACYT); Instituto para la Formacion de Recursos Humanos (IFARHU)	The project was supported in part by Department of Genomics and Proteomics (ICGES) and the Ministry of Health (Panama) and Project PAN-6011 from the International Atomic Energy Agency (IAEA). YM was funded by a fellowship from Secretaria Nacional de Ciencia y Tecnologia (SENACYT) and Instituto para la Formacion de Recursos Humanos (IFARHU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2011, B EST 2010 MIN SAL, P113; [Anonymous], 2012, MOV INT PAS EST PAN; [Anonymous], 2012, B EST 2002 2011 RES; [Anonymous], 2000, GACETA OFICIAL, V23, P964; [Anonymous], 2010, EST PROYECC POBL TOT; Bello G, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/154945; Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; CARR JK, 1998, REFERENCE SEQUENCES; Castillero JR, 2011, DIAGNOSTICO REDES RE; Castillo J, 2011, REV PANAM SALUD PUBL, V30, P649, DOI 10.1590/S1020-49892011001200025; De Mendoza C, 2009, AIDS RES HUM RETROV, V25, P967, DOI 10.1089/aid.2008.0166; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; de Sa DJ, 2008, AIDS RES HUM RETROV, V24, P347, DOI 10.1089/aid.2007.0203; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Gonzalez-Alba JM, 2011, J VIROL, V85, P10755, DOI 10.1128/JVI.00454-11; Guerrero Delgado G A, 1994, Rev Med Panama, V19, P186; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hakre S, 2013, SEX TRANSM INFECT, V89, P156, DOI 10.1136/sextrans-2012-050557; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Holguin A, 2008, J CLIN MICROBIOL, V46, P2918, DOI 10.1128/JCM.02414-07; Kouri V, 2012, J CLIN VIROL, V55, P348, DOI 10.1016/j.jcv.2012.08.019; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Manak M, 2012, AIDS RES HUM RETROV, V28, P594, DOI [10.1089/aid.2011.0271, 10.1089/AID.2011.0271]; Martinez H, 2012, INFORM NACL PROGRESO; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Ministry of Education and Culture, 2009, PRACT GUID MEAS ENH; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; NOWAK MA, 1990, AIDS, V4, P1095, DOI 10.1097/00002030-199011000-00007; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Ratha D, 2011, MIGRATION REMITTANCE; REEVES WC, 1988, AM J TROP MED HYG, V39, P398; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Cavalcanti AMS, 2012, MEM I OSWALDO CRUZ, V107, P450, DOI 10.1590/S0074-02762012000400002; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Sierra M, 2007, JAIDS-J ACQ IMM DEF, V45, P151, DOI 10.1097/QAI.0b013e318046ea47; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor-Castillo L, 2010, REV PANAM SALUD PUBL, V27, P23, DOI 10.1590/S1020-49892010000100004; Teixeira SLM, 2004, J CLIN VIROL, V31, P221, DOI 10.1016/j.jcv.2004.03.016; Teva I, 2012, REV MED CHILE, V140, P50, DOI /S0034-98872012000100007; Thiam M, 2013, J VIROL METHODS, V188, P97, DOI 10.1016/j.jviromet.2012.11.044; Thomson MM, 2005, AIDS REV, V7, P210; Tupinambas U, 2013, MEM I OSWALDO CRUZ, V108, P470, DOI 10.1590/S0074-0276108042013012; United Nations Programme on HIV/AIDS (UNAIDS), 2012, GLOB REP REP GLOB AI	54	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85153	10.1371/journal.pone.0085153	http://dx.doi.org/10.1371/journal.pone.0085153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454808	Green Submitted, gold, Green Published			2022-12-27	WOS:000329922500045
J	Barquero, LA; Davis, N; Cutting, LE				Barquero, Laura A.; Davis, Nicole; Cutting, Laurie E.			Neuroimaging of Reading Intervention: A Systematic Review and Activation Likelihood Estimate Meta-Analysis	PLOS ONE			English	Review							WORD FORM AREA; SENTENCE COMPREHENSION; BRAIN ACTIVATION; EDUCATIONAL INTERVENTIONS; DYSLEXIC-CHILDREN; NEURAL SYSTEMS; LACTATE LEVELS; POOR READERS; FMRI; INSTRUCTION	A growing number of studies examine instructional training and brain activity. The purpose of this paper is to review the literature regarding neuroimaging of reading intervention, with a particular focus on reading difficulties (RD). To locate relevant studies, searches of peer-reviewed literature were conducted using electronic databases to search for studies from the imaging modalities of fMRI and MEG (including MSI) that explored reading intervention. Of the 96 identified studies, 22 met the inclusion criteria for descriptive analysis. A subset of these (8 fMRI experiments with post-intervention data) was subjected to activation likelihood estimate (ALE) meta-analysis to investigate differences in functional activation following reading intervention. Findings from the literature review suggest differences in functional activation of numerous brain regions associated with reading intervention, including bilateral inferior frontal, superior temporal, middle temporal, middle frontal, superior frontal, and postcentral gyri, as well as bilateral occipital cortex, inferior parietal lobules, thalami, and insulae. Findings from the meta-analysis indicate change in functional activation following reading intervention in the left thalamus, right insula/inferior frontal, left inferior frontal, right posterior cingulate, and left middle occipital gyri. Though these findings should be interpreted with caution due to the small number of studies and the disparate methodologies used, this paper is an effort to synthesize across studies and to guide future exploration of neuroimaging and reading intervention.	[Barquero, Laura A.; Davis, Nicole; Cutting, Laurie E.] Vanderbilt Univ, Peabody Coll, Dept Special Educ, Nashville, TN 37203 USA; [Davis, Nicole; Cutting, Laurie E.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37235 USA; [Davis, Nicole; Cutting, Laurie E.] Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA; [Davis, Nicole; Cutting, Laurie E.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Cutting, Laurie E.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University Peabody College; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Barquero, LA (corresponding author), Vanderbilt Univ, Peabody Coll, Dept Special Educ, Nashville, TN 37203 USA.	laura.barquero@vanderbilt.edu			US Department of Education Office of Special Education Program Grant [H325D090077]; National Institute of Neurological Disorders and Strokes through the Neurobiology and Treatment of Reading Disability [NF1 7R01NS049096-05]; Vanderbilt Kennedy Center for Research on Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211, P01HD001994, R01HD067254, R21HD087088, R01HD044073] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD052121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049096] Funding Source: NIH RePORTER	US Department of Education Office of Special Education Program Grant; National Institute of Neurological Disorders and Strokes through the Neurobiology and Treatment of Reading Disability; Vanderbilt Kennedy Center for Research on Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by US Department of Education Office of Special Education Program Grant #H325D090077, the National Institute of Neurological Disorders and Strokes through the Neurobiology and Treatment of Reading Disability in NF1 7R01NS049096-05, and the Vanderbilt Kennedy Center for Research on Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Otaiba S, 2002, REM SPEC EDUC, V23, P300, DOI 10.1177/07419325020230050501; Aylward EH, 2003, NEUROLOGY, V61, P212, DOI 10.1212/01.WNL.0000068363.05974.64; BACH S, NEUROIMAGE, DOI DOI 10.1016/J.NEUR0IMAGE.2011.07.023; Bach S, 2010, NEUROIMAGE, V53, P682, DOI 10.1016/j.neuroimage.2010.06.039; Ben-Shachar M, 2011, J COGNITIVE NEUROSCI, V23, P2387, DOI 10.1162/jocn.2011.21615; Berninger VW, 2008, READ WRIT, V21, P95, DOI 10.1007/s11145-007-9066-x; BLACHMAN BA, 2003, PREVENTING REMEDIATI, P253; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Bus AG, 1999, J EDUC PSYCHOL, V91, P403, DOI 10.1037/0022-0663.91.3.403; Catts HW, 2012, J EDUC PSYCHOL, V104, P166, DOI 10.1037/a0025323; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Church JA, 2008, CEREB CORTEX, V18, P2054, DOI 10.1093/cercor/bhm228; Clements-Stephens AM, 2012, DEV COGN NEUROS-NETH, V2, pS99, DOI 10.1016/j.dcn.2011.06.001; Cohen L, 2000, NEUROPSYCHOLOGIA, V38, P1426, DOI 10.1016/S0028-3932(00)00038-5; Compton DL, 2008, LEARN INDIVID DIFFER, V18, P329, DOI 10.1016/j.lindif.2008.04.003; Compton DL, 2012, J LEARN DISABIL-US, V45, P204, DOI 10.1177/0022219412442151; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Costanzo F, 2012, NEUROPSYCHOLOGIA, V50, P2645, DOI 10.1016/j.neuropsychologia.2012.07.017; Cutting LE, 2006, NEUROIMAGE, V29, P429, DOI 10.1016/j.neuroimage.2005.07.057; Davis N, 2011, DEV NEUROPSYCHOL, V36, P288, DOI 10.1080/87565641.2010.549875; Davis N, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00150; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Farris EA, 2011, NEUROCASE, V17, P425, DOI 10.1080/13554794.2010.532141; Fletcher JM, 2009, J INT NEUROPSYCH SOC, V15, P501, DOI 10.1017/S1355617709090900; FLETCHER JM, 2008, PERSPECTIVES LANGUAG, V34, P27; Foorman BR, 1998, J EDUC PSYCHOL, V90, P37, DOI 10.1037//0022-0663.90.2.235; Frith U, 2001, DEV NEUROPSYCHOL, V20, P555, DOI 10.1207/S15326942DN2002_6; Gebauer D, 2012, BRAIN STRUCT FUNCT, V217, P747, DOI 10.1007/s00429-011-0371-4; Gebauer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038201; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hebb AO, 2013, BRAIN LANG, V126, P99, DOI 10.1016/j.bandl.2012.06.010; Hoeft F, 2007, BEHAV NEUROSCI, V121, P602, DOI 10.1037/0735-7044.121.3.602; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Ihnot C., 2001, READ NATURALLY; KAMEENUI E, 2003, EARLY READING INTERV; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Keller TA, 2009, NEURON, V64, P624, DOI 10.1016/j.neuron.2009.10.018; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Krafnick AJ, 2011, NEUROIMAGE, V57, P733, DOI 10.1016/j.neuroimage.2010.10.062; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; LAIRD AR, 2011, USER MANUAL GINGERAL; LAIRD AR, GINGERALE 2 1 1; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Leach JM, 2003, J EDUC PSYCHOL, V95, P211, DOI 10.1037/0022-0663.95.2.211; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leonard CM, 2008, DEV NEUROPSYCHOL, V33, P663, DOI 10.1080/87565640802418597; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; Lipka O, 2006, J LEARN DISABIL-US, V39, P364, DOI 10.1177/00222194060390040901; Little DM, 2006, BRAIN COGNITION, V60, P233, DOI 10.1016/j.bandc.2005.06.004; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lovio R, 2012, BRAIN RES, V1448, P42, DOI 10.1016/j.brainres.2012.01.071; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lyytinen H, 2007, NORD PSYCHOL, V59, P109, DOI 10.1027/1901-2276.59.2.109; Lyytinen H, 2009, SCAND J PSYCHOL, V50, P668, DOI 10.1111/j.1467-9450.2009.00791.x; Maisog JM, 2008, ANN NY ACAD SCI, V1145, P237, DOI 10.1196/annals.1416.024; Mathes PG, 2005, READ RES QUART, V40, P148, DOI 10.1598/RRQ.40.2.2; MAY P, 2000, HAMBURGER SCHREIBPRO; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McGuinness C, 1996, ANN DYSLEXIA, V46, P73, DOI 10.1007/BF02648172; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Meyler A, 2008, NEUROPSYCHOLOGIA, V46, P2580, DOI 10.1016/j.neuropsychologia.2008.03.012; Miller B, 2011, BEHAV GENET, V41, P1, DOI 10.1007/s10519-010-9439-9; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morgan PL, 2008, LEARN DISABILITY Q, V31, P187, DOI 10.2307/25474651; Nation K, 1997, BRIT J EDUC PSYCHOL, V67, P359, DOI 10.1111/j.2044-8279.1997.tb01250.x; National Reading Panel, 2000, TEACH CHILDR READ EV; Nelson J., 2003, LEARN DISABIL RES PR, V18, P255, DOI [10.1111/1540-5826.00080, DOI 10.1111/1540-5826.00080]; Noble KG, 2005, J DEV BEHAV PEDIATR, V26, P370, DOI 10.1097/00004703-200510000-00006; Odegard TN, 2008, ANN DYSLEXIA, V58, P1, DOI 10.1007/s11881-008-0014-5; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Pugh KR, 2008, J COGNITIVE NEUROSCI, V20, P1146, DOI 10.1162/jocn.2008.20079; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Rezaie R, 2011, DEV NEUROPSYCHOL, V36, P869, DOI 10.1080/87565641.2011.606404; Rezaie R, 2011, J INT NEUROPSYCH SOC, V17, P875, DOI 10.1017/S1355617711000890; Richards TL, 2006, J NEUROLINGUIST, V19, P56, DOI 10.1016/j.jneuroling.2005.07.003; Richards TL, 2000, AM J NEURORADIOL, V21, P916; Richards TL, 2002, AM J NEURORADIOL, V23, P1678; Richards TL, 2001, LEARN DISABILITY Q, V24, P189, DOI 10.2307/1511243; Richards TL, 2008, J NEUROLINGUIST, V21, P294, DOI 10.1016/j.jneuroling.2007.07.002; Richards TL, 2006, DEV NEUROPSYCHOL, V30, P547, DOI 10.1207/s15326942dn3001_3; Richlan F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00120; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rimrodt SL, 2009, CEREB CORTEX, V19, P402, DOI 10.1093/cercor/bhn092; Rumsey M., 2006, TAKE FLIGHT COMPREHE; Saine NL, 2011, CHILD DEV, V82, P1013, DOI 10.1111/j.1467-8624.2011.01580.x; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; Sandak R, 2004, COGN AFFECT BEHAV NE, V4, P67, DOI 10.3758/CABN.4.1.67; Sarkari Shirin, 2002, Semin Pediatr Neurol, V9, P229, DOI 10.1053/spen.2002.35506; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Schlaggar BL, 2009, CURR DIR PSYCHOL SCI, V18, P21, DOI 10.1111/j.1467-8721.2009.01599.x; Shankweiler D., 1999, SCI STUD READ, V3, P69, DOI [10.1207/s1532799xssr0301_4, DOI 10.1207/S1532799XSSR0301_4]; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz BA, 2006, DEV NEUROPSYCHOL, V30, P613, DOI 10.1207/s15326942dn3001_5; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Shaywitz SE, 2008, ANNU REV PSYCHOL, V59, P451, DOI 10.1146/annurev.psych.59.103006.093633; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Simos PG, 2007, NEUROPSYCHOLOGY, V21, P485, DOI 10.1037/0894-4105.21.4.485; Simos PG, 2007, J LEARN DISABIL-US, V40, P37, DOI 10.1177/00222194070400010301; Simos PG, 2005, NEUROPSYCHOLOGY, V19, P787, DOI 10.1037/0894-4105.19.6.787; Simos PG, 2002, NEUROLOGY, V58, P1203, DOI 10.1212/WNL.58.8.1203; Spironelli C, 2010, BRAIN, V133, P3385, DOI 10.1093/brain/awq199; STANOVICH KE, 1986, READ RES QUART, V21, P360, DOI 10.1598/RRQ.21.4.1; Swanson HL, 1999, J LEARN DISABIL-US, V32, P504, DOI 10.1177/002221949903200605; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; Temple E, 2002, CURR OPIN NEUROBIOL, V12, P178, DOI 10.1016/S0959-4388(02)00303-3; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Torgesen JK, 1999, J EDUC PSYCHOL, V91, P579, DOI 10.1037/0022-0663.91.4.579; Torgesen JK., 2000, LEARNING DISABILITIE, V15, P55, DOI [10.1207/sldrp1501_6, 10.1207/SLDRP1501_6, DOI 10.1207/SLDRP1501_6]; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Tran L, 2011, J LEARN DISABIL-US, V44, P283, DOI 10.1177/0022219410378447; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Turkeltaub PE, 2012, BRAIN STIMUL, V5, P201, DOI 10.1016/j.brs.2011.04.002; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; VAUGHN S, 2000, EXCEPT CHILDREN, P67; Vaughn S, 2010, READ WRIT, V23, P931, DOI 10.1007/s11145-009-9183-9; Vaughn S, 2010, SCHOOL PSYCHOL REV, V39, P3; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Vellutino FR, 1996, J EDUC PSYCHOL, V88, P601, DOI 10.1037/0022-0663.88.4.601; Winn W., 2006, Journal of Educational Computing Research, V34, P381, DOI 10.2190/R783-4G36-58V7-5154; Yamada Y, 2011, NEUROIMAGE, V57, P704, DOI 10.1016/j.neuroimage.2010.10.057; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; 2012, MANG VERS 2 6	139	70	73	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83668	10.1371/journal.pone.0083668	http://dx.doi.org/10.1371/journal.pone.0083668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427278	Green Published, Green Submitted, gold			2022-12-27	WOS:000329868200018
J	Suarez-Kurtz, G; Vargens, DD; Santoro, AB; Hutz, MH; de Moraes, ME; Pena, SDJ; Ribeiro-dos-Santos, A; Romano-Silva, MA; Struchiner, CJ				Suarez-Kurtz, Guilherme; Vargens, Daniela D.; Santoro, Ana Beatriz; Hutz, Mara H.; de Moraes, Maria Elisabete; Pena, Sergio D. J.; Ribeiro-dos-Santos, Andrea; Romano-Silva, Marco A.; Struchiner, Claudio Jose			Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population	PLOS ONE			English	Article							GENOTYPE; IMPACT	The influence of self-reported "race/color", geographical origin and genetic ancestry on the distribution of three functional CYP3A5 polymorphisms, their imputed haplotypes and inferred phenotypes was examined in 909 healthy, adult Brazilians, self-identified as White, Brown or Black ("race/color" categories of the Brazilian census). The cohort was genotyped for CYP3A5*3 (rs776746), CYP3A5*6 (rs10264272) and CYP3A5*7 (rs41303343), CYP3A5 haplotypes were imputed and CYP3A5 metabolizer phenotypes were inferred according to the number of defective CYP3A5 alleles. Estimates of the individual proportions of Amerindian, African and European ancestry were available for the entire cohort. Multinomial log-linear regression models were applied to infer the statistical association between the distribution of CYP3A5 alleles, haplotypes and phenotypes (response variables), and self-reported Color, geographical region and ancestry (explanatory variables). We found that Color per se or in combination with geographical region associates significantly with the distribution of CYP3A5 variant alleles and CYP3A5 metabolizer phenotypes, whereas geographical region per se influences the frequency distribution of CYP3A5 variant alleles. The odds of having the default CYP3A5*3 allele and the poor metabolizer phenotype increases continuously with the increase of European ancestry and decrease of African ancestry. The opposite trend is observed in relation to CYP3A5*6, CYP3A5*7, the default CYP3A5*1 allele, and both the extensive and intermediate phenotypes. No significant effect of Amerindian ancestry on the distribution of CYP3A5 alleles or phenotypes was observed. In conclusion, this study strongly supports the notion that the intrinsic heterogeneity of the Brazilian population must be acknowledged in the design and interpretation of pharmacogenomic studies, and dealt with as a continuous variable, rather than proportioned in arbitrary categories that do not capture the diversity of the population. The relevance of this work extrapolates the Brazilian borders, and extends to other admixed peoples of the Americas, with ancestral roots in Europe, Africa and the American continent.	[Suarez-Kurtz, Guilherme; Vargens, Daniela D.; Santoro, Ana Beatriz] Inst Nacl Canc, Programa Farmacol, Rio De Janeiro, RJ, Brazil; [Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [de Moraes, Maria Elisabete] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, CE, Brazil; [Pena, Sergio D. J.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Ribeiro-dos-Santos, Andrea] Univ Fed Para, Lab Genet Humana & Med, Guama, PA, Brazil; [Romano-Silva, Marco A.] Univ Fed Minas Gerais, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil; [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio Grande do Sul; Universidade Federal do Ceara; Universidade Federal de Minas Gerais; Universidade Federal do Para; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Suarez-Kurtz, G (corresponding author), Inst Nacl Canc, Programa Farmacol, Rio De Janeiro, RJ, Brazil.	kurtz@inca.gov.br	Santos, Ândrea Ribeiro dos/B-6061-2013; Romano-Silva, Marco Aurelio/T-8321-2019; Struchiner, Claudio J/M-9360-2013; Hutz, Mara H/I-4070-2012; Suarez-Kurtz, Guilherme/P-4620-2019; Suarez-Kurtz, Guilherme/J-6648-2012; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Romano-Silva, Marco Aurelio/A-1790-2008; Struchiner, Claudio Jose/HGB-9492-2022	Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Struchiner, Claudio J/0000-0003-2114-847X; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Hutz, Mara/0000-0002-9146-1229	Financiadora de Estudos e Projetos (Finep); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Financiadora de Estudos e Projetos (Finep)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was supported by grants from Financiadora de Estudos e Projetos (Finep), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Dandara C, 2005, CANCER LETT, V225, P275, DOI 10.1016/j.canlet.2004.11.004; Ferreira PE, 2008, THER DRUG MONIT, V30, P10, DOI 10.1097/FTD.0b013e31815e93c6; Fox J., 2019, R COMPANION APPL REG, V.; Garsa AA, 2005, BMC MED GENET, V6, DOI 10.1186/1471-23350-6-19; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba J, 2012, PHARMACOGENET GENOM, V22, P555, DOI 10.1097/FPC.0b013e328351d47f; Lee SJ, 2005, PHARMACOGENOMICS, V6, P357, DOI 10.1517/14622416.6.4.357; Mirghani RA, 2006, PHARMACOGENET GENOM, V16, P637, DOI 10.1097/01.fpc.0000230411.89973.1b; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Salzano FM, 2002, EVOLUTION GENETICS L; Santoro A, 2011, PHARMACOGENOMICS, V12, P1293, DOI [10.2217/PGS.11.70, 10.2217/pgs.11.70]; Sortica VD, 2012, BASIC CLIN PHARMACOL, V110, P460, DOI 10.1111/j.1742-7843.2011.00838.x; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Suarez-Kurtz G, 2012, PHARMACOGENOMICS J, V12, P267, DOI 10.1038/tpj.2010.89; Suarez-Kurtz G, 2007, PHARMACOGENOMICS, V8, P1299, DOI 10.2217/14622416.8.10.1299; Suarez-Kurtz G, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00118; Suarez-Kurtz G, 2010, PHARMACOGENOMICS, V11, P1257, DOI [10.2217/pgs.10.89, 10.2217/PGS.10.89]; Venables WN., 2002, MODERN APPL STAT S 4; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	23	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83472	10.1371/journal.pone.0083472	http://dx.doi.org/10.1371/journal.pone.0083472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427273	Green Published, gold, Green Submitted			2022-12-27	WOS:000329868200013
J	Viergever, RF; Karam, G; Reis, A; Ghersi, D				Viergever, Roderik F.; Karam, Ghassan; Reis, Andreas; Ghersi, Davina			The Quality of Registration of Clinical Trials: Still a Problem	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; LOOKING BACK; CLINICALTRIALS.GOV; INTERVENTIONS; EXPLANATION; INFORMATION; DISCLOSURE; AMERICA	Introduction: The benefits of clinical trials registration include improved transparency on clinical trials for healthcare workers and patients, increased accountability of trialists, the potential to address publication bias and selective reporting, and possibilities for research collaboration and prioritization. However, poor quality of information in registered records of trials has been found to undermine these benefits in the past. Trialists' increasing experience with trial registration and recent developments in registration systems may have positively affected data quality. This study was conducted to investigate whether the quality of registration has improved. Methods: We repeated a study from 2009, using the same methods and the same research team. A random sample of 400 records of clinical trials that were registered between 01/01/2012 and 01/01/2013 was taken from the International Clinical Trials Registry Platform (ICTRP) and assessed for the quality of information on 1) contact details, 2) interventions and 3) primary outcomes. Results were compared to the equivalent assessments from our previous study. Results: There was a small and not statistically significant increase from 81.0% to 85.5% in the percentage of records that provided a name of a contact person. There was a significant increase from 68.7% to 74.9% in the number of records that provided either an email address or a telephone number. There was a significant increase from 44.2% to 51.9% in the number of intervention arms that were complete in registering intervention specifics. There was a significant increase from 38.2% to 57.6% in the number of primary outcomes that were specific measures with a meaningful timeframe. Approximately half of all trials continued to be retrospectively registered. Discussion: There have been small but significant improvements in the quality of registration since 2009. Important problems with quality remain and continue to constitute an impediment to the meaningful utilization of registered trial information.	[Viergever, Roderik F.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Viergever, Roderik F.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Karam, Ghassan] World Hlth Org, ICTRP, Dept Eth & Social Determinants Hlth ESD, Geneva, Switzerland; [Reis, Andreas] World Hlth Org, Dept Eth & Social Determinants Hlth ESD, Geneva, Switzerland; [Ghersi, Davina] Univ Sydney, Sydney Med Sch, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia	Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; World Health Organization; University of Sydney	Viergever, RF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	rikviergever@gmail.com	Viergever, Roderik F./I-4847-2019	Viergever, Roderik F./0000-0001-5328-2580; Reis, Andreas/0000-0002-8218-2615	World Health Organization; European Union [285453]	World Health Organization(World Health Organization); European Union(European Commission)	RV received payment to conduct this study from the World Health Organization. AR, GK and DG were personally salaried by their institutions during the period of writing (though no specific salary was set aside or given for the writing of this paper). The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 285453. The research was conducted as part of the OPEN project, which aims to Overcome failure to Publish nEgative fiNdings. [20] Besides this, there was no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. Other than the named authors, no one played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WORLD MED ASS DECL H; [Anonymous], 2008, OFF J EUR UNION C, V168, P3; [Anonymous], 2012, INT STANDARDS CLIN T; Antes G, 2004, JAMA-J AM MED ASSOC, V291, P2432, DOI 10.1001/jama.291.20.2432-c; Antes G, 2004, B WORLD HEALTH ORGAN, V82, P321; Bian ZX, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-64; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Clinical Trial Registration, 2004, STAT INT COMM MED J; ClinicalTrials.gov, 2013, PROT DAT EL DEF; Coombes R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1458; Costa LOP, 2013, MANUAL THER, V18, P1, DOI 10.1016/j.math.2012.10.009; Dekkers OM, 2011, J CLIN EPIDEMIOL, V64, P1034, DOI 10.1016/j.jclinepi.2010.12.008; Drazen JM, 2007, NEW ENGL J MED, V356, P184, DOI 10.1056/NEJMe068291; Drazen JM, 2012, NEW ENGL J MED, V367; European & Developing Countries Clinical Trials Partnership (EDCTP), EDCTP POL HLTH RES E; Gandhi R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-278; Ghersi D, 2008, LANCET, V372, P1531, DOI 10.1016/S0140-6736(08)61635-9; Gill CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001186; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Gopal RK, 2012, CONTEMP CLIN TRIALS, V33, P486, DOI 10.1016/j.cct.2012.02.001; Huic Mirjana, 2011, PLoS One, V6, pe25258, DOI 10.1371/journal.pone.0025258; Huser V, 2013, J AM MED INFORM ASSN, V20, pE169, DOI 10.1136/amiajnl-2012-001501; IFPMA/EFPIA/JPMA/PhRMA, 2009, JOINT POS DISCL CLIN; International Clinical Trials Registry Platform (ICTRP), DAT PROV; International Clinical Trials Registry Platform (ICTRP), REG WHO REG CRIT; International Clinical Trials Registry Platform (ICTRP), TRIAL REG ORG POL; Jones CW, 2012, ANN EMERG MED, V60, P458, DOI 10.1016/j.annemergmed.2012.02.005; Krleza-Jeric K, 2011, REV PANAM SALUD PUBL, V30, P87; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; Laine C, 2007, BRIT MED J, V334, P1177, DOI 10.1136/bmj.39233.510810.80; Li Zheng-Jie, 2012, Zhen Ci Yan Jiu, V37, pcover; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Magee LA, 2011, NEW ENGL J MED, V364, P2169, DOI 10.1056/NEJMc1103910; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moja Lorenzo P, 2009, Trials, V10, P56, DOI 10.1186/1745-6215-10-56; Pandolfini C, 2008, EUR J CLIN PHARMACOL, V64, P611, DOI 10.1007/s00228-007-0458-2; Patrone D, 2010, J MED ETHICS, V36, P431, DOI 10.1136/jme.2010.035378; Pino C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-63; Pinto RZ, 2013, PHYS THER, V93, P299, DOI 10.2522/ptj.20120206; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Reveiz L, 2012, J CLIN EPIDEMIOL, V65, P482, DOI 10.1016/j.jclinepi.2011.09.003; Reveiz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012484; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Scherer M, 2008, BMC HEALTH SERV RES, V8, P18; Scoggins JF, 2009, CONTEMP CLIN TRIALS, V30, P289, DOI 10.1016/j.cct.2009.02.005; Sekeres M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001610; Tharyan Prathap, 2007, Indian J Med Ethics, V4, P168; van Enst WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042812; Viergever RF, PEDIATRICS IN PRESS; Viergever RF, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.22450; Viergever RF, 2013, B WORLD HEALTH ORGAN, V91, P416, DOI 10.2471/BLT.12.114454; Viergever RF, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000221; Viergever RF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-210; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Wallis S, 2012, COMP X2 TESTS SEPARA; Wallis S, 2012, BINOMIAL CONFIDENCE; Wallis S, 2012, WILSON SCORE INTERVA; Wildt S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000309; World Association of Medical Editors (WAME), 2005, REG CLIN TRIALS; You BO, 2012, J CLIN ONCOL, V30, P210, DOI 10.1200/JCO.2011.37.0890; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	66	85	86	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84727	10.1371/journal.pone.0084727	http://dx.doi.org/10.1371/journal.pone.0084727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427293	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000329868200033
J	Pisani, F; Livermore, T; Rose, G; Chubb, JR; Gaspari, M; Saiardi, A				Pisani, Francesca; Livermore, Thomas; Rose, Giuseppina; Chubb, Jonathan Robert; Gaspari, Marco; Saiardi, Adolfo			Analysis of Dictyostelium discoideum Inositol Pyrophosphate Metabolism by Gel Electrophoresis	PLOS ONE			English	Article							PHOSPHOLIPASE-C; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; MYOINOSITOL HEXAKISPHOSPHATE; PHOSPHATES; KINASE; CELLS; IDENTIFICATION; FAMILY; 1,4,5-TRISPHOSPHATE; PHOSPHORYLATION	The social amoeba Dictyostelium discoideum was instrumental in the discovery and early characterization of inositol pyrophosphates, a class of molecules possessing highly-energetic pyrophosphate bonds. Inositol pyrophosphates regulate diverse biological processes and are attracting attention due to their ability to control energy metabolism and insulin signalling. However, inositol pyrophosphate research has been hampered by the lack of simple experimental procedures to study them. The recent development of polyacrylamide gel electrophoresis (PAGE) and simple staining to resolve and detect inositol pyrophosphate species has opened new investigative possibilities. This technology is now commonly applied to study in vitro enzymatic reactions. Here we employ PAGE technology to characterize the D. discoideum inositol pyrophosphate metabolism. Surprisingly, only three major bands are detectable after resolving acidic extract on PAGE. We have demonstrated that these three bands correspond to inositol hexakisphosphate (IP6 or Phytic acid) and its derivative inositol pyrophosphates, IP7 and IP8. Biochemical analyses and genetic evidence were used to establish the genuine inositol phosphate nature of these bands. We also identified IP9 in D. discoideum cells, a molecule so far detected only from in vitro biochemical reactions. Furthermore, we discovered that this amoeba possesses three different inositol pentakisphosphates (IP5) isomers, which are largely metabolised to inositol pyrophosphates. Comparison of PAGE with traditional Sax-HPLC revealed an underestimation of the cellular abundance of inositol pyrophosphates by traditional methods. In fact our study revealed much higher levels of inositol pyrophosphates in D. discoideum in the vegetative state than previously detected. A three-fold increase in IP8 was observed during development of D. discoideum a value lower that previously reported. Analysis of inositol pyrophosphate metabolism using ip6k null amoeba revealed the absence of developmentally-induced synthesis of inositol pyrophosphates, suggesting that the alternative class of enzyme responsible for pyrophosphate synthesis, PP-IP5K, doesn't' play a major role in the IP8 developmental increase.	[Pisani, Francesca; Livermore, Thomas; Chubb, Jonathan Robert; Saiardi, Adolfo] UCL, MRC, Mol Cell Biol Lab, London, England; [Pisani, Francesca; Rose, Giuseppina] Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy; [Gaspari, Marco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Lab Prote & Mass Spectrometry, Catanzaro, Italy	University of London; University College London; University of Calabria; Magna Graecia University of Catanzaro	Saiardi, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, London, England.	dmcbado@ucl.ac.uk	Gaspari, Marco/C-2756-2009; Gaspari, Marco/HGB-2399-2022; Gaspari, Marco/ABE-1539-2020	Gaspari, Marco/0000-0002-5411-8800; Gaspari, Marco/0000-0002-5411-8800; Rose, Giuseppina/0000-0002-4264-4184; Livermore, Tom/0000-0003-0283-4597	Medical Research Council; Medical Research Council [1068476, MC_U122680443, MC_UU_12018/4] Funding Source: researchfish; MRC [MC_U122680443, MC_UU_12018/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council funding of the Cell Biology Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Dove Stephen K., 2009, V462, P59, DOI 10.1007/978-1-60327-115-8_4; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; DRAYER AL, 1994, EMBO J, V13, P1601, DOI 10.1002/j.1460-2075.1994.tb06423.x; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Zhong G, 2007, ANAL BIOANAL CHEM, V387, P1939, DOI 10.1007/s00216-006-1100-3; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; Laussmann T, 2000, EUR J BIOCHEM, V267, P2447, DOI 10.1046/j.1432-1327.2000.01264.x; Laussmann T, 1997, BIOCHEM J, V322, P31, DOI 10.1042/bj3220031; Letcher AJ, 2008, BIOCHEM J, V416, P263, DOI 10.1042/BJ20081417; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Loss O, 2013, MOL BIOL CELL, V24, P2981, DOI 10.1091/mbc.E13-04-0198; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MCCONNELL FM, 1991, BIOCHEM J, V280, P323, DOI 10.1042/bj2800323; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; NEWELL PC, 1988, J CELL SCI, V89, P123; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A., 2012, SUBCELL BIOCH, V59, P413; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; STEPHENS LR, 1990, NATURE, V346, P580, DOI 10.1038/346580a0; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; VANDIJKEN P, 1995, J BIOL CHEM, V270, P29724; VanHaastert PJM, 1995, EXPERIENTIA, V51, P1144; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	37	33	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85533	10.1371/journal.pone.0085533	http://dx.doi.org/10.1371/journal.pone.0085533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416420	Green Published, Green Submitted, gold			2022-12-27	WOS:000329866300084
J	Antonson, P; Matic, M; Portwood, N; Kuiper, RV; Bryzgalova, G; Gao, H; Windahl, SH; Humire, P; Ohlsson, C; Berggren, PO; Gustafsson, JA; Dahlman-Wright, K				Antonson, Per; Matic, Marko; Portwood, Neil; Kuiper, Raoul V.; Bryzgalova, Galyna; Gao, Hui; Windahl, Sara H.; Humire, Patricia; Ohlsson, Claes; Berggren, Per-Olof; Gustafsson, Jan-Ake; Dahlman-Wright, Karin			aP2-Cre-Mediated Inactivation of Estrogen Receptor Alpha Causes Hydrometra	PLOS ONE			English	Article							ER-ALPHA; HORMONE NEURONS; KNOCKOUT MICE; DELETION; MECHANISMS; GENERATION; RESPONSES; FEMALES; REVEALS; BETA	In this study we describe the reproductive phenotypes of a novel mouse model in which Cre-mediated deletion of ER alpha is regulated by the aP2 (fatty acid binding protein 4) promoter. ER alpha-floxed mice were crossed with transgenic mice expressing Cre-recombinase under the control of the aP2 promoter to generate aP2-Cre/ER alpha(flox/flox) mice. As expected, ER alpha mRNA levels were reduced in adipose tissue, but in addition we also detected an 80% reduction of ER alpha levels in the hypothalamus of aP2-Cre/ER alpha(flox/flox) mice. Phenotypic analysis revealed that aP2-Cre/ER alpha(flox/flox) female mice were infertile. In line with this, aP2-Cre/ER alpha(flox/flox) female mice did not cycle and presented 3.8-fold elevated estrogen levels. That elevated estrogen levels were associated with increased estrogen signaling was evidenced by increased mRNA levels of the estrogen-regulated genes lactoferrin and aquaporin 5 in the uterus. Furthermore, aP2-Cre/ER alpha(flox/flox) female mice showed an accumulation of intra-uterine fluid, hydrometra, without overt indications for causative anatomical anomalies. However, the vagina and cervix displayed advanced keratosis with abnormal quantities of accumulating squamous epithelial cells suggesting functional obstruction by keratin plugs. Importantly, treatment of aP2-Cre/ER alpha(flox/flox) mice with the aromatase inhibitor Letrozole caused regression of the hydrometra phenotype linking increased estrogen levels to the observed phenotype. We propose that in aP2-Cre/ER alpha(flox/flox) mice, increased serum estrogen levels cause over-stimulation in the uterus and genital tracts resulting in hydrometra and vaginal obstruction.	[Antonson, Per; Matic, Marko; Gao, Hui; Humire, Patricia; Gustafsson, Jan-Ake; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Novum, Huddinge, Sweden; [Portwood, Neil; Bryzgalova, Galyna; Berggren, Per-Olof] Karolinska Inst, Karolinska Univ Hosp L1, Rolf Luft Ctr Diabet & Endocrinol, Stockholm, Sweden; [Kuiper, Raoul V.] Karolinska Inst, Phenotyping Core Facil, Dept Lab Med, Karolinska Univ Hosp, Huddinge, Sweden; [Windahl, Sara H.; Ohlsson, Claes] Univ Gothenburg, Inst Med, Ctr Bone & Arthrit Res, Sahlgrenska Acad, Gothenburg, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; University of Houston System; University of Houston	Antonson, P (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, Huddinge, Sweden.	per.antonson@ki.se	Ohlsson, Claes/AGP-3544-2022; Gao, Hui/AAF-9770-2019	Ohlsson, Claes/0000-0002-9633-2805; Windahl, Sara/0000-0002-6611-6001; Berggren, Per-Olof/0000-0001-8991-413X; Kuiper, Raoul/0000-0001-5645-2389; Antonson, Per/0000-0001-9335-9941	Swedish Research Council; Cancerfonden [080482, 090678, 100404, 110588, 120435]; Novo Nordisk Foundation; Estrogen signaling in metabolic disease; Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen; Genetic dissection of estrogen signaling in mice; Genetic dissection of estrogen signaling in metabolic disease; Strategic Research Area in Diabetes at the Karolinska Institute (SFO/TM Diabetes); Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen;  [K2009-54X-21122-01-3];  [K2008-54X-20640-01-3];  [K2011-54X-20640-04-6]; Novo Nordisk Fonden [NNF14OC0010513, NNF13OC0005785] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Estrogen signaling in metabolic disease; Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen; Genetic dissection of estrogen signaling in mice; Genetic dissection of estrogen signaling in metabolic disease; Strategic Research Area in Diabetes at the Karolinska Institute (SFO/TM Diabetes); Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen; ; ; ; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work is supported by the Swedish Research Council (http://www.vr.se/; The involvement of estrogen receptor signaling in insulin resistance and type 2 diabetes (project # K2009-54X-21122-01-3), Estrogen signaling in metabolic disease; a functional genomics approach (project # K2008-54X-20640-01-3) and Tissue-specific estrogen signaling - new insights in metabolic disease development (project # K2011-54X-20640-04-6)), Cancerfonden (http://www.cancerfonden.se; grant # 080482, 090678, 100404, 110588 and 120435), Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/; Estrogen signaling in metabolic disease (2006), Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen (2008), Genetic dissection of estrogen signaling in mice (2009), Genetic dissection of estrogen signaling in metabolic disease (2011)), the Strategic Research Area in Diabetes at the Karolinska Institute (http://ki.se/srp-diabetes; SFO/TM Diabetes (2010)), Center for Biosciences (http://ki.se/cb; grant # n/a (2009-2011)), the KI Endomet network (http://researchnetworks.ki.se/converis/; grant details n/a), King Gustaf V and Queen Victoria's Freemason's Foundation; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen (2008, 2009, 2010, 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonson P, 2012, BIOCHEM BIOPH RES CO, V424, P710, DOI 10.1016/j.bbrc.2012.07.016; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4; Chen M, 2009, MOL CELL BIOCHEM, V321, P145, DOI 10.1007/s11010-008-9928-9; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Dupont S, 2000, DEVELOPMENT, V127, P4277; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; GREENMAN DL, 1986, J TOXICOL ENV HEALTH, V19, P531, DOI 10.1080/15287398609530950; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herbison AE, 2001, FRONT NEUROENDOCRIN, V22, P292, DOI 10.1006/frne.2001.0219; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2000, BREAST CANCER RES, V2, P345, DOI 10.1186/bcr79; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Kobayashi M, 2006, GENES CELLS, V11, P1133, DOI 10.1111/j.1365-2443.2006.01009.x; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martens K, 2010, FEBS LETT, V584, P1054, DOI 10.1016/j.febslet.2010.01.061; Matic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057458; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Radovick Sally, 2012, Front Endocrinol (Lausanne), V3, P52, DOI 10.3389/fendo.2012.00052; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Zhang WH, 2000, P NATL ACAD SCI USA, V97, P5936, DOI 10.1073/pnas.97.11.5936	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85581	10.1371/journal.pone.0085581	http://dx.doi.org/10.1371/journal.pone.0085581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416430	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500258
J	Hussain, Z; Al-Sobhi, MM; Al-Zahrani, B				Hussain, Zawar; Al-Sobhi, Mashail M.; Al-Zahrani, Bander			Additive and Subtractive Scrambling in Optional Randomized Response Modeling	PLOS ONE			English	Article								This article considers unbiased estimation of mean, variance and sensitivity level of a sensitive variable via scrambled response modeling. In particular, we focus on estimation of the mean. The idea of using additive and subtractive scrambling has been suggested under a recent scrambled response model. Whether it is estimation of mean, variance or sensitivity level, the proposed scheme of estimation is shown relatively more efficient than that recent model. As far as the estimation of mean is concerned, the proposed estimators perform relatively better than the estimators based on recent additive scrambling models. Relative efficiency comparisons are also made in order to highlight the performance of proposed estimators under suggested scrambling technique.	[Hussain, Zawar] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan; [Al-Sobhi, Mashail M.] Umm Alqura Univ, Dept Math, Mecca, Saudi Arabia; [Al-Zahrani, Bander] King Abdulaziz Univ, Dept Stat, Jeddah 21413, Saudi Arabia	Quaid I Azam University; Umm Al Qura University; King Abdulaziz University	Hussain, Z (corresponding author), Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan.	zhlangah@yahoo.com; mmsobhi@uqu.edu.sa; bmalzahrani@kau.edu.sa	Hussain, Zawar/I-1616-2012; Al-Zahrani, Bander/J-3885-2013	Al-Zahrani, Bander/0000-0002-2496-1290	Institute of Scientific Research and Revival of Islamic Heritage at Umm Al-Qura University [43305030]	Institute of Scientific Research and Revival of Islamic Heritage at Umm Al-Qura University	The work has been funded by the Institute of Scientific Research and Revival of Islamic Heritage at Umm Al-Qura University (grant # 43305030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Lev SK, 2004, METRIKA, V60, P255, DOI 10.1007/s001840300308; Chaudhuri A, 2012, J STAT THEORY PRACT, V6, P376, DOI 10.1080/15598608.2012.673904; EICHHORN BH, 1983, J STAT PLAN INFER, V7, P307, DOI 10.1016/0378-3758(83)90002-2; GREENBERG BG, 1971, J AM STAT ASSOC, V66, P243, DOI 10.2307/2283916; Gupta S, 2002, J STAT PLAN INFER, V100, P239, DOI 10.1016/S0378-3758(01)00137-9; Gupta S., 2004, STATISTICA, V64, P643; Gupta S, 2011, AM J MATH MANAGEMENT, V31, P1; Gupta S., 2006, J STAT THEORY APPL, V5, P226; Gupta S, 2012, COMMUN STAT-THEOR M, V41, P2394, DOI 10.1080/03610926.2011.641654; Gupta S, 2010, J STAT PLAN INFER, V140, P2870, DOI 10.1016/j.jspi.2010.03.010; Huang KC, 2010, METRIKA, V71, P341, DOI 10.1007/s00184-009-0234-7; Hussain Z, 2013, SCI IRAN, V20, P839, DOI 10.1016/j.scient.2013.05.006; Hussain Z, 2007, J STAT RES, V41, P83; Mehta S, 2012, J STAT THEORY PRACT, V6, P417, DOI 10.1080/15598608.2012.695558; Murthy MN, 1967, SAMPLING THEORY METH; Saha A, 2008, J STAT THEORY PRACT, V2, P589, DOI 10.1080/15598608.2008.10411897; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Yan ZZ, 2009, COMMUN STAT-THEOR M, V38, P400, DOI 10.1080/03610920802220785	18	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83557	10.1371/journal.pone.0083557	http://dx.doi.org/10.1371/journal.pone.0083557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421893	Green Published, gold			2022-12-27	WOS:000329862500057
J	Tewari-Singh, N; Jain, AK; Orlicky, DJ; White, CW; Agarwal, R				Tewari-Singh, Neera; Jain, Anil K.; Orlicky, David J.; White, Carl W.; Agarwal, Rajesh			Cutaneous Injury-Related Structural Changes and Their Progression following Topical Nitrogen Mustard Exposure in Hairless and Haired Mice	PLOS ONE			English	Article							SULFUR MUSTARD; SKIN-LESIONS; PIG SKIN; TOXICITY; GAS; TOXICOLOGY; AGENTS; COMPLICATIONS; PROTECTION; FEATURES	To identify effective therapies against sulfur mustard (SM)-induced skin injuries, various animals have been used to assess the cutaneous pathology and related histopathological changes of SM injuries. However, these efforts to establish relevant skin injury endpoints for efficacy studies have been limited mainly due to the restricted assess of SM. Therefore, we employed the SM analog nitrogen mustard (NM), a primary vesicating and bifunctional alkylating agent, to establish relevant endpoints for efficient efficacy studies. Our published studies show that NM (3.2 mg) exposure for 12-120 h in both the hairless SKH-1 and haired C57BL/6 mice caused clinical sequelae of toxicity similar to SM exposure in humans. The NM-induced cutaneous pathology-related structural changes were further analyzed in this study and quantified morphometrically (as percent length or area of epidermis or dermis) of skin sections in mice showing these lesions. H&E stained skin sections of both hairless and haired mice showed that NM (12-120 h) exposure caused epidermal histopathological effects such as increased epidermal thickness, epidermal-dermal separation, necrotic/dead epidermis, epidermal denuding, scab formation, parakeratosis (24-120 h), hyperkeratosis (12-120 h), and acanthosis with hyperplasia (72-120 h). Similar NM exposure in both mice caused dermal changes including necrosis, edema, increase in inflammatory cells, and red blood cell extravasation. These NM-induced cutaneous histopathological features are comparable to the reported lesions from SM exposure in humans and animal models. This study advocates the usefulness of these histopathological parameters observed due to NM exposure in screening and optimization of rescue therapies against NM and SM skin injuries.	[Tewari-Singh, Neera; Jain, Anil K.; Agarwal, Rajesh] Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado Denver, Sch Med, Dept Pathol, Aurora, CO USA; [White, Carl W.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Agarwal, R (corresponding author), Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	Rajesh.Agarwal@ucdenver.edu			Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS) [U54 ES015678]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER	Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Countermeasures Against Chemical Threats (CounterACT) Program, Office of the Director National Institutes of Health (OD) and the National Institute of Environmental Health Sciences (NIEHS), [Grant Number U54 ES015678]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S F, 1947, Mil Surg, V101, P1; Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117; Arroyo CM, 2001, INT J TOXICOL, V20, P281, DOI 10.1080/109158101753253027; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P297, DOI 10.1111/j.1472-8206.2005.00325.x; Benson JM, 2011, WOUND REPAIR REGEN, V19, P348, DOI 10.1111/j.1524-475X.2011.00675.x; Dachir S, 2010, SKIN RES TECHNOL, V16, P114, DOI 10.1111/j.1600-0846.2009.00409.x; Dorandeu F, 2011, HUM EXP TOXICOL, V30, P470, DOI 10.1177/0960327110373615; Emadi SN, 2012, CUTAN OCUL TOXICOL, V31, P214, DOI 10.3109/15569527.2011.641196; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2010, CUTAN OCUL TOXICOL, V29, P269, DOI 10.3109/15569527.2010.511367; Ghasemi H, 2013, CUTAN OCUL TOXICOL, V32, P304, DOI 10.3109/15569527.2013.781615; Graham JS, 2013, CHEM BIOL INTERACT; Hardej D, 2007, TOXICOL IND HEALTH, V23, P209, DOI 10.1177/0748233707083541; Hayden PJ, 2009, TOXICOL IN VITRO; Hess JF, 2007, BIOCHEM BIOPH RES CO, V359, P616, DOI 10.1016/j.bbrc.2007.05.141; Jain AK, 2011, TOXICOLOGY, V282, P129, DOI 10.1016/j.tox.2011.01.021; Joseph LB, 2011, EXP MOL PATHOL, V91, P515, DOI 10.1016/j.yexmp.2011.05.010; Kan RK, 2003, TOXICOL PATHOL, V31, P185, DOI 10.1080/01926230390183661; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P12, DOI 10.1016/j.tox.2009.01.019; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Lomash V, 2011, BURNS, V37, P851, DOI 10.1016/j.burns.2010.12.010; Mol MAE, 2009, TOXICOLOGY, V258, P39, DOI 10.1016/j.tox.2009.01.004; Naraghi ZS, 2005, EUR J DERMATOL, V15, P140; PAPIRMEISTER B, 1985, FUND APPL TOXICOL, V5, pS134, DOI 10.1016/0272-0590(85)90123-X; Petrali JP, 1997, MICROSC RES TECHNIQ, V37, P221, DOI 10.1002/(SICI)1097-0029(19970501)37:3<221::AID-JEMT7>3.0.CO;2-Q; Poursaleh Z, 2012, CUTAN OCUL TOXICOL, V31, P241, DOI 10.3109/15569527.2011.636119; Sabourin CLK, 2002, J BIOCHEM MOL TOXIC, V16, P263, DOI 10.1002/jbt.10050; Shakarjian MP, 2010, TOXICOL SCI, V114, P5, DOI 10.1093/toxsci/kfp253; Sharma M, 2010, INT J TOXICOL, V29, P391, DOI 10.1177/1091581810365730; Smith KJ, 1997, J DERMATOL SCI, V14, P126, DOI 10.1016/S0923-1811(96)00560-9; Smith KJ, 1998, AM J DERMATOPATH, V20, P22, DOI 10.1097/00000372-199802000-00005; Song J, 2010, MODERN PATHOL, V23, P799, DOI 10.1038/modpathol.2010.52; Tewari-Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067557; Tewari-Singh N, 2009, TOXICOL SCI, V108, P194, DOI 10.1093/toxsci/kfn261; Wang GQ, 2007, BURNS, V33, P923, DOI 10.1016/j.burns.2006.11.004; WATSON AP, 1992, ENVIRON HEALTH PERSP, V98, P259, DOI 10.2307/3431280; Wormser U, 2004, TOXICOL APPL PHARM, V200, P40, DOI 10.1016/j.taap.2004.03.013; Wormser U, 2004, ARCH TOXICOL, V78, P156, DOI 10.1007/s00204-003-0523-2; Wormser U, 2002, ARCH TOXICOL, V76, P119, DOI 10.1007/s00204-001-0307-5; WORMSER U, 1991, TRENDS PHARMACOL SCI, V12, P164, DOI 10.1016/0165-6147(91)90534-Y	42	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85402	10.1371/journal.pone.0085402	http://dx.doi.org/10.1371/journal.pone.0085402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416404	Green Published, gold, Green Submitted			2022-12-27	WOS:000329862500246
J	Amado, D; Del Villar, F; Leo, FM; Sanchez-Oliva, D; Sanchez-Miguel, PA; Garcia-Calvo, T				Amado, Diana; Del Villar, Fernando; Miguel Leo, Francisco; Sanchez-Oliva, David; Antonio Sanchez-Miguel, Pedro; Garcia-Calvo, Tomas			Effect of a Multi-Dimensional Intervention Programme on the Motivation of Physical Education Students	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; TRANS-CONTEXTUAL MODEL; AUTONOMY SUPPORT; CREATIVE DANCE; PARTICIPATION; COMPETENCE; NEEDS; RELATEDNESS; TEACHERS; MOVEMENT	This research study purports to verify the effect produced on the motivation of physical education students of a multidimensional programme in dance teaching sessions. This programme incorporates the application of teaching skills directed towards supporting the needs of autonomy, competence and relatedness. A quasi-experimental design was carried out with two natural groups of 4th year Secondary Education students - control and experimental -, delivering 12 dance teaching sessions. A prior training programme was carried out with the teacher in the experimental group to support these needs. An initial and final measurement was taken in both groups and the results revealed that the students from the experimental group showed an increase of the perception of autonomy and, in general, of the level of self-determination towards the curricular content of corporal expression focused on dance in physical education. To this end, we highlight the programme's usefulness in increasing the students' motivation towards this content, which is so complicated for teachers of this area to develop.	[Amado, Diana; Del Villar, Fernando; Miguel Leo, Francisco; Sanchez-Oliva, David; Antonio Sanchez-Miguel, Pedro; Garcia-Calvo, Tomas] Univ Extremadura, Fac Sport Sci, Caceres, Spain	Universidad de Extremadura	Amado, D (corresponding author), Univ Extremadura, Fac Sport Sci, Caceres, Spain.	diamal@unex.es	Leo, Francisco M/H-1492-2017; García-Calvo, Tomás/K-8501-2014; García-Calvo, Tomas/AAN-6825-2021; OLIVA, DAVID SANCHEZ/L-1698-2014; SANCHEZ-OLIVA, DAVID/O-1139-2019	Leo, Francisco M/0000-0003-0971-9188; García-Calvo, Tomás/0000-0002-2550-418X; García-Calvo, Tomas/0000-0002-2550-418X; SANCHEZ-OLIVA, DAVID/0000-0001-9678-963X; Del Villar, Fernando/0000-0001-8724-8006	Ministry of Education, Culture and Sport	Ministry of Education, Culture and Sport	This study has been realized thanks to the financing of the Ministry of Education, Culture and Sport and with the contribution of the Council of Employment, Company and Innovation of the Government of Estremadura across the European funds of Regional Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado D, 2013, DANCE UNDERSTOOD PSY; Amado D, 2012, 2 NAT C DANC INV BAR; Barkoukis V, 2013, EUR J PSYCHOL EDUC, V28, P353, DOI 10.1007/s10212-012-0118-5; Barkoukis V, 2010, BRIT J EDUC PSYCHOL, V80, P647, DOI 10.1348/000709910X487023; Becker KM, 2013, J PHYS EDUC RECREAT, V84, P6, DOI 10.1080/07303084.2013.763665; Brophy J, 1999, EDUC PSYCHOL, V34, P75, DOI 10.1207/s15326985ep3402_1; Chatzisarantis NLD, 2009, PSYCHOL HEALTH, V24, P29, DOI 10.1080/08870440701809533; Chen A, 2001, QUEST, V53, P35, DOI 10.1080/00336297.2001.10491729; Cheon SH., 2010, KOREAN J SPORT PSYCH, V21, P175; Cheon SH, 2012, J SPORT EXERCISE PSY, V34, P365, DOI 10.1123/jsep.34.3.365; Christenson SL, 2012, HANDBOOK OF RESEARCH ON STUDENT ENGAGEMENT, P1, DOI 10.1007/978-1-4614-2018-7; Connell J, 2009, RES DANC EDUC, V10, P115, DOI 10.1080/14647890903019440; Deci E. L., 1985, INTRINSIC MOTIVATION; DECI EL, 1987, J PERS SOC PSYCHOL, V53, P1024, DOI 10.1037/0022-3514.53.6.1024; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Edmunds J, 2008, EUR J SOC PSYCHOL, V38, P375, DOI 10.1002/ejsp.463; Gillet N, 2012, SOC PSYCHOL EDUC, V15, P77, DOI 10.1007/s11218-011-9170-2; Grieser M, 2006, HEALTH EDUC BEHAV, V33, P40, DOI 10.1177/1090198105282416; Hagger MS, 2012, EUR J PSYCHOL EDUC, V27, P195, DOI 10.1007/s10212-011-0082-5; Jang H, 2010, J EDUC PSYCHOL, V102, P588, DOI 10.1037/a0019682; KASSING G., 2003, DANCE TEACHING METHO; Lim BSC, 2009, PSYCHOL SPORT EXERC, V10, P52, DOI 10.1016/j.psychsport.2008.06.003; Lobo YB, 2006, SOC DEV, V15, P501, DOI 10.1111/j.1467-9507.2006.00353.x; Lonsdale C, 2009, PREV MED, V48, P69, DOI 10.1016/j.ypmed.2008.09.013; Mainwaring L.M., 2010, J DANCE ED, V10, P12, DOI [10.1080/15290824.2010.10387153, DOI 10.1080/15290824.2010.10387153]; Murcia JAM, 2010, EUR J PSYCHOL EDUC, V25, P37, DOI 10.1007/s10212-009-0008-7; Murcia JAM, 2008, REV MEX PSICOL, V25, P295; Mosston M., 1986, TEACHING PHYS ED; Ntoumanis N, 2001, BRIT J EDUC PSYCHOL, V71, P225, DOI 10.1348/000709901158497; Ntoumanis N, 2005, J EDUC PSYCHOL, V97, P444, DOI 10.1037/0022-0663.97.3.444; Ntoumanis N, 2009, J EDUC PSYCHOL, V101, P717, DOI 10.1037/a0014696; O'Neill JR, 2011, RES Q EXERCISE SPORT, V82, P373, DOI 10.1080/02701367.2011.10599769; Padilla C, 2003, LANGUAGES EXPRESSION, P217; Pate RR, 2009, BRIT J SPORT MED, V43, P14, DOI 10.1136/bjsm.2008.055517; Ruano K, 2009, CORPORAL EXPRESSION; Sallis JF, 2012, RES Q EXERCISE SPORT, V83, P125, DOI 10.1080/02701367.2012.10599842; Sebire S. J., 2013, Open Journal of Preventive Medicine, V3, P111; Sheldon KM, 2008, BRIT J SOC PSYCHOL, V47, P267, DOI 10.1348/014466607X238797; Shen B, 2009, RES Q EXERCISE SPORT, V80, P44, DOI 10.5641/027013609X13087704027553; Skinner EA, 2002, NEBR S MOT MOT AG LI, P77; Standage M, 2005, BRIT J EDUC PSYCHOL, V75, P411, DOI 10.1348/000709904X22359; Su YL, 2011, EDUC PSYCHOL REV, V23, P159, DOI 10.1007/s10648-010-9142-7; Taylor IM, 2007, J EDUC PSYCHOL, V99, P747, DOI 10.1037/0022-0663.99.4.747; Tessier D, 2008, EUR J PSYCHOL EDUC, V23, P239, DOI 10.1007/BF03172998; Tessier D, 2010, CONTEMP EDUC PSYCHOL, V35, P242, DOI 10.1016/j.cedpsych.2010.05.005; Torrents C, 2011, REV PSICOL DEPORTE, V20, P401; Turner JC, 2004, TEACH COLL REC, V106, P1759, DOI 10.1111/j.1467-9620.2004.00404.x; Vlachopoulos SP, 2006, MEAS PHYS EDUC EXERC, V10, P179, DOI 10.1207/s15327841mpee1003_4; Wallhead TL, 2004, J TEACH PHYS EDUC, V23, P4, DOI 10.1123/jtpe.23.1.4	49	40	40	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85275	10.1371/journal.pone.0085275	http://dx.doi.org/10.1371/journal.pone.0085275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454831	Green Published, gold			2022-12-27	WOS:000330235100068
J	Cori, A; Ayles, H; Beyers, N; Schaap, A; Floyd, S; Sabapathy, K; Eaton, JW; Hauck, K; Smith, P; Griffith, S; Moore, A; Donnell, D; Vermund, SH; Fidler, S; Hayes, R; Fraser, C				Cori, Anne; Ayles, Helen; Beyers, Nulda; Schaap, Ab; Floyd, Sian; Sabapathy, Kalpana; Eaton, Jeffrey W.; Hauck, Katharina; Smith, Peter; Griffith, Sam; Moore, Ayana; Donnell, Deborah; Vermund, Sten H.; Fidler, Sarah; Hayes, Richard; Fraser, Christophe		HPTN 071 PopART Study Team	HPTN 071 (PopART): A Cluster-Randomized Trial of the Population Impact of an HIV Combination Prevention Intervention Including Universal Testing and Treatment: Mathematical Model	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; MALE CIRCUMCISION; SOUTH-AFRICA; FOLLOW-UP; INFECTION; MEN; TRANSMISSION; RISK; EPIDEMIC	Background: The HPTN 052 trial confirmed that antiretroviral therapy (ART) can nearly eliminate HIV transmission from successfully treated HIV-infected individuals within couples. Here, we present the mathematical modeling used to inform the design and monitoring of a new trial aiming to test whether widespread provision of ART is feasible and can substantially reduce population-level HIV incidence. Methods and Findings: The HPTN 071 (PopART) trial is a three-arm cluster-randomized trial of 21 large population clusters in Zambia and South Africa, starting in 2013. A combination prevention package including home-based voluntary testing and counseling, and ART for HIV positive individuals, will be delivered in arms A and B, with ART offered universally in arm A and according to national guidelines in arm B. Arm C will be the control arm. The primary endpoint is the cumulative threeyear HIV incidence. We developed a mathematical model of heterosexual HIV transmission, informed by recent data on HIV-1 natural history. We focused on realistically modeling the intervention package. Parameters were calibrated to data previously collected in these communities and national surveillance data. We predict that, if targets are reached, HIV incidence over three years will drop by.60% in arm A and.25% in arm B, relative to arm C. The considerable uncertainty in the predicted reduction in incidence justifies the need for a trial. The main drivers of this uncertainty are possible community-level behavioral changes associated with the intervention, uptake of testing and treatment, as well as ART retention and adherence. Conclusions: The HPTN 071 (PopART) trial intervention could reduce HIV population-level incidence by.60% over three years. This intervention could serve as a paradigm for national or supra-national implementation. Our analysis highlights the role mathematical modeling can play in trial development and monitoring, and more widely in evaluating the impact of treatment as prevention.	[Cori, Anne; Eaton, Jeffrey W.; Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Ayles, Helen; Schaap, Ab] Univ Zambia, Sch Med, ZAMBART, Lusaka, Zambia; [Ayles, Helen] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Beyers, Nulda] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, ZA-7600 Stellenbosch, South Africa; [Schaap, Ab; Floyd, Sian; Sabapathy, Kalpana; Hayes, Richard] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Hauck, Katharina; Smith, Peter] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England; [Griffith, Sam; Moore, Ayana] FHI 360, Res Triangle Pk, NC USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Vermund, Sten H.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Vermund, Sten H.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Fidler, Sarah] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Imperial College London; University of Zambia; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; FHI 360; Fred Hutchinson Cancer Center; Vanderbilt University; Vanderbilt University; Imperial College London	Fraser, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	c.fraser@imperial.ac.uk	Vermund, Sten/AAD-3592-2020; Cori, Anne/AFL-1641-2022; Fraser, Christophe/A-8109-2008; Hauck, Katharina/ABE-8926-2020	Vermund, Sten/0000-0001-7289-8698; Cori, Anne/0000-0002-8443-9162; Fraser, Christophe/0000-0003-2399-9657; Hauck, Katharina/0000-0003-3138-4169; Shanaube, Kwame/0000-0001-7899-0890; Hargreaves, James/0000-0002-3509-3572; Eaton, Jeffrey/0000-0001-7728-728X; Donnell, Deborah/0000-0002-0587-7480; Hayes, Richard/0000-0002-1729-9892; Ayles, Helen/0000-0003-4108-2842; Smith, Peter/0000-0003-0058-7588; Fidler, Sarah/0000-0003-1676-7583	National Institute of Allergy and Infectious Diseases (NIAID) [UM1-AI068619, UM1AI068617, UM1-AI068613]; U.S. President's Emergency Plan for AIDS Relief (PEPFAR); NIAID; National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation; DAIDS/NIH; Medical Research Council [MR/K010174/1B, MR/K012126/1, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, UM1AI068619, UM1AI068613] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); DAIDS/NIH; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HPTN 071 is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1AI068617, and UM1-AI068613, with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Additional funding is provided through NIAID, the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the International Initiative for Impact Evaluation (3ie) with support from the Bill & Melinda Gates Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIMH, NIDA, PEPFAR, 3ie, or the Bill & Melinda Gates Foundation. The study sponsor (DAIDS/NIH) contributed to the study design and review of the manuscript but had no role in the data collection and analysis or decision to publish. Other study funders contributed to none of the aforementioned activities.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bechange S, 2010, AIDS BEHAV, V14, P816, DOI 10.1007/s10461-008-9481-2; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Boily MC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001250; Coates T, 2013, COMMUNITY LEVEL REDU; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001232; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Gabillard D, 2013, JAIDS-J ACQ IMM DEF, V62, P555, DOI 10.1097/QAI.0b013e3182821821; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guerrero MLF, 2005, CLIN INFECT DIS, V41, P390, DOI 10.1086/431487; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hayes R, 2013, HPTN 071 POPART RATI; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; HIV Modelling Consortium Treatment, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001259; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Kurth AE, 2012, JAIDS-J ACQ IMM DEF, V61, pE65, DOI [10.1097/QAI.0b013e31826a184c., 10.1097/QAI.0b013e31826a184c]; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mehta SD, 2009, AIDS, V23, P1557, DOI 10.1097/QAD.0b013e32832afe95; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Sismanidis C, 2008, CLIN TRIALS, V5, P316, DOI 10.1177/1740774508094747; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Thiebaut R, 2005, AIDS, V19, P53, DOI 10.1097/00002030-200501030-00006; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; UNAIDS/WHO, 2008, EP COUNTR PROF HIV A; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS221, DOI 10.1097/QAI.0b013e318299c3f4; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; Vermund SH, 2010, CLIN INFECT DIS, V50, pS149, DOI 10.1086/651485; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31	47	81	81	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84511	10.1371/journal.pone.0084511	http://dx.doi.org/10.1371/journal.pone.0084511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454728	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100023
J	Higginbotham, S; Wong, WR; Linington, RG; Spadafora, C; Iturrado, L; Arnold, AE				Higginbotham, Sarah; Wong, Weng Ruh; Linington, Roger G.; Spadafora, Carmenza; Iturrado, Liliana; Arnold, A. Elizabeth			Sloth Hair as a Novel Source of Fungi with Potent Anti-Parasitic, Anti-Cancer and Anti-Bacterial Bioactivity	PLOS ONE			English	Article							NATURAL-PRODUCTS; ENDOPHYTES; DIVERSITY; HOST; MICROORGANISMS; BIODIVERSITY; COMMUNITIES; INFECTIONS; ALIGNMENT; ACCURACY	The extraordinary biological diversity of tropical forests harbors a rich chemical diversity with enormous potential as a source of novel bioactive compounds. Of particular interest are new environments for microbial discovery. Sloths - arboreal mammals commonly found in the lowland forests of Panama - carry a wide variety of micro-and macro-organisms on their coarse outer hair. Here we report for the first time the isolation of diverse and bioactive strains of fungi from sloth hair, and their taxonomic placement. Eighty-four isolates of fungi were obtained in culture from the surface of hair that was collected from living three-toed sloths (Bradypus variegatus, Bradypodidae) in Soberania National Park, Republic of Panama. Phylogenetic analyses revealed a diverse group of Ascomycota belonging to 28 distinct operational taxonomic units (OTUs), several of which are divergent from previously known taxa. Seventy-four isolates were cultivated in liquid broth and crude extracts were tested for bioactivity in vitro. We found a broad range of activities against strains of the parasites that cause malaria (Plasmodium falciparum) and Chagas disease (Trypanosoma cruzi), and against the human breast cancer cell line MCF-7. Fifty fungal extracts were tested for antibacterial activity in a new antibiotic profile screen called BioMAP; of these, 20 were active against at least one bacterial strain, and one had an unusual pattern of bioactivity against Gram-negative bacteria that suggests a potentially new mode of action. Together our results reveal the importance of exploring novel environments for bioactive fungi, and demonstrate for the first time the taxonomic composition and bioactivity of fungi from sloth hair.	[Higginbotham, Sarah; Iturrado, Liliana] Smithsonian Trop Res Inst, Panama City, Panama; [Wong, Weng Ruh; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Spadafora, Carmenza] Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama; [Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ USA	Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Santa Cruz; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); University of Arizona	Higginbotham, S (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	higginbothams@si.edu	Spadafora, Carmenza/ABE-8973-2020; Linington, Roger/ABD-5582-2021	Spadafora, Carmenza/0000-0002-3002-9467; Linington, Roger/0000-0003-1818-4971	International Cooperative Biodiversity Groups program (ICBG-Panama) [2 U01 TW006634-06]; College of Agriculture and Life Sciences at the University of Arizona; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	International Cooperative Biodiversity Groups program (ICBG-Panama); College of Agriculture and Life Sciences at the University of Arizona; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the International Cooperative Biodiversity Groups program (ICBG-Panama http://www.icbg.org/, grant number 2 U01 TW006634-06) and the College of Agriculture and Life Sciences at the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; [Anonymous], NEGL TROP DIS; Arabi MIE, 2007, J PLANT PATHOL, V89, P79; Xavier GAA, 2008, BRAZ J MICROBIOL, V39, P508, DOI 10.1590/S1517-838220080003000018; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2009, SYST BIOL, V58, P283, DOI 10.1093/sysbio/syp001; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Ayers S, 2012, J PEPT SCI, V18, P500, DOI 10.1002/psc.2425; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bukovska P, 2010, J MICROBIOL METH, V82, P223, DOI 10.1016/j.mimet.2010.06.007; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Castro JA, 2006, HUM EXP TOXICOL, V25, P471, DOI 10.1191/0960327106het653oa; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dye C, 2013, LANCET, V381, P413, DOI 10.1016/S0140-6736(12)61812-1; ECDC/EMEA, 2009, BACT CHALL TIM REACT; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elewski BE, 2005, J INVEST DERM SYMP P, V10, P190, DOI 10.1111/j.1087-0024.2005.10103.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Figueroa M, 2012, J ANTIBIOT, V65, P559, DOI 10.1038/ja.2012.69; Frisvad JC, 2013, FEMS MICROBIOL LETT, V339, P77, DOI 10.1111/1574-6968.12054; Gilmore DP, 2001, BRAZ J MED BIOL RES, V34, P9, DOI 10.1590/S0100-879X2001000100002; Glenn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032980; GLOER JB, 1995, CAN J BOT, V73, pS1265, DOI 10.1139/b95-387; Goyette JL, 2011, J FIELD ORNITHOL, V82, P279, DOI 10.1111/j.1557-9263.2011.00331.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Higginbotham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073192; Higgins KL, 2011, MYCOLOGIA, V103, P247, DOI 10.3852/09-158; Hoffman MT, 2010, APPL ENVIRON MICROB, V76, P4063, DOI 10.1128/AEM.02928-09; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Iwatsuki M, 2011, J ANTIBIOT, V64, P183, DOI 10.1038/ja.2010.124; Kluger CG, 2008, J TROP ECOL, V24, P351, DOI 10.1017/S0266467408005026; Kunz AN, 2010, CHEMOTHERAPY, V56, P492, DOI 10.1159/000321018; Lee HB, 2005, LETT APPL MICROBIOL, V40, P497, DOI 10.1111/j.1472-765X.2005.01719.x; Liu L, 2009, ORG LETT, V11, P2836, DOI 10.1021/ol901039m; Maddison WP, 2011, MESQUITE MODULAR SYS; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; Miller M.A., 2010, P GAT COMP ENV WORKS; Mohamed Hala F., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P863, DOI 10.1016/S2221-1691(12)60244-5; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Donnell K, 2009, J CLIN MICROBIOL, V47, P3851, DOI 10.1128/JCM.01616-09; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perez-Garcia A, 2006, J PHYTOPATHOL, V154, P190, DOI 10.1111/j.1439-0434.2006.01086.x; Ramsamy Y, 2013, SAMJ S AFR MED J, V103, P371, DOI [10.7196/SAMJ.6459, 10.7196/samj.6459]; Rodrigues A, 2011, FEMS MICROBIOL ECOL, V78, P244, DOI 10.1111/j.1574-6941.2011.01152.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Singh MP, 2007, MAR DRUGS, V5, P71, DOI 10.3390/md20070007; Singh SB, 1996, TETRAHEDRON LETT, V37, P8077, DOI 10.1016/0040-4039(96)01844-8; Smith SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003052; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Suutari M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-86; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wang P, 2011, INT J BIOL SCI, V7, P209, DOI 10.7150/ijbs.7.209; Wong WR, 2012, CHEM BIOL, V19, P1483, DOI 10.1016/j.chembiol.2012.09.014; You JL, 2010, J IND MICROBIOL BIOT, V37, P245, DOI 10.1007/s10295-009-0667-z; Zwickl DJ., 2006, THESIS	65	20	20	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84549	10.1371/journal.pone.0084549	http://dx.doi.org/10.1371/journal.pone.0084549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454729	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100024
J	Khatib, R; Schwalm, JD; Yusuf, S; Haynes, RB; McKee, M; Khan, M; Nieuwlaat, R				Khatib, Rasha; Schwalm, Jon-David; Yusuf, Salim; Haynes, R. Brian; McKee, Martin; Khan, Maheer; Nieuwlaat, Robby			Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies	PLOS ONE			English	Review							BLOOD-PRESSURE CONTROL; PHYSICIAN-RELATED BARRIERS; MEDICATION ADHERENCE; CARDIOVASCULAR RISK; AFRICAN-AMERICANS; REPORTED BARRIERS; GENERAL-PRACTICE; MANAGEMENT; PERCEPTIONS; DETERMINANTS	Background: Although the importance of detecting, treating, and controlling hypertension has been recognized for decades, the majority of patients with hypertension remain uncontrolled. The path from evidence to practice contains many potential barriers, but their role has not been reviewed systematically. This review aimed to synthesize and identify important barriers to hypertension control as reported by patients and healthcare providers. Methods: Electronic databases MEDLINE, EMBASE and Global Health were searched systematically up to February 2013. Two reviewers independently selected eligible studies. Two reviewers categorized barriers based on a theoretical framework of behavior change. The theoretical framework suggests that a change in behavior requires a strong commitment to change [intention], the necessary skills and abilities to adopt the behavior [capability], and an absence of health system and support constraints. Findings: Twenty-five qualitative studies and 44 quantitative studies met the inclusion criteria. In qualitative studies, health system barriers were most commonly discussed in studies of patients and health care providers. Quantitative studies identified disagreement with clinical recommendations as the most common barrier among health care providers. Quantitative studies of patients yielded different results: lack of knowledge was the most common barrier to hypertension awareness. Stress, anxiety and depression were most commonly reported as barriers that hindered or delayed adoption of a healthier lifestyle. In terms of hypertension treatment adherence, patients mostly reported forgetting to take their medication. Finally, priority setting barriers were most commonly reported by patients in terms of following up with their health care providers. Conclusions: This review identified a wide range of barriers facing patients and health care providers pursuing hypertension control, indicating the need for targeted multi-faceted interventions. More methodologically rigorous studies that encompass the range of barriers and that include low-and middle-income countries are required in order to inform policies to improve hypertension control.	[Khatib, Rasha; Schwalm, Jon-David; Yusuf, Salim; Khan, Maheer; Nieuwlaat, Robby] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Khatib, Rasha; Schwalm, Jon-David; Yusuf, Salim; Haynes, R. Brian; Khan, Maheer; Nieuwlaat, Robby] McMaster Univ, Hamilton, ON, Canada; [Schwalm, Jon-David; Yusuf, Salim; Haynes, R. Brian] McMaster Univ, Dept Med, Hamilton, ON, Canada; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	McMaster University; Population Health Research Institute; McMaster University; McMaster University; University of London; London School of Hygiene & Tropical Medicine	Khatib, R (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.	rasha.khatib@phri.ca	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Yusuf, Salim/0000-0003-4776-5601				Ahluwalia JS, 1997, J GEN INTERN MED, V12, P7, DOI 10.1046/j.1525-1497.1997.12107.x; AlGhurair SA, 2012, J CLIN HYPERTENS, V14, P877, DOI 10.1111/j.1751-7176.2012.00699.x; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Anthony H, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-24; Aroian KJ, 2012, J TRANSCULT NURS, V23, P134, DOI 10.1177/1043659611433871; Arrieta MI, 2009, DISASTER MED PUBLIC, V3, P174, DOI 10.1097/DMP.0b013e3181b66ae4; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Barnes DM, 2012, QUAL HEALTH RES, V22, P1685, DOI 10.1177/1049732312458181; Borzecki AM, 2005, AM HEART J, V149, P785, DOI 10.1016/j.ahj.2005.01.047; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Coleman MT, 2000, AM J MED QUAL, V15, P72, DOI 10.1177/106286060001500206; Cornuz J, 2000, FAM PRACT, V17, P535, DOI 10.1093/fampra/17.6.535; Cranney M, 2001, FAM PRACT, V18, P359, DOI 10.1093/fampra/18.4.359; Crosson JC, 2010, J AM BOARD FAM MED, V23, P171, DOI 10.3122/jabfm.2010.02.090125; CUMMINGS KM, 1982, PUBLIC HEALTH REP, V97, P99; Davies P, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-14; Dean SC, 2007, FAM PRACT, V24, P259, DOI 10.1093/fampra/cmm005; Dennis T., 2011, CVD PREVENTION CONTR, V6, P9, DOI DOI 10.1016/J.CVDPC.2010.11.001; Dennison CR, 2007, ETHNIC DIS, V17, P484; Dusing R, 2006, CURR MED RES OPIN, V22, P1545, DOI 10.1185/030079906X120995; Edelman DJ, 2008, J NATL MED ASSOC, V100, P534, DOI 10.1016/S0027-9684(15)31299-2; Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918; Fongwa MN, 2008, VASC HEALTH RISK MAN, V4, P157, DOI 10.2147/vhrm.2008.04.01.157; Ford CD, 2009, ETHNIC DIS, V19, P407; Gee ME, 2012, CAN J CARDIOL, V28, P383, DOI 10.1016/j.cjca.2012.01.014; Gee ME, 2012, AM J CARDIOL, V109, P570, DOI 10.1016/j.amjcard.2011.09.051; Glynn LG, 2010, COCHRANE DATABASE SY, V17; Greer TM, 2010, J HEALTH CARE POOR U, V21, P251, DOI 10.1353/hpu.0.0265; Gregoire JP, 2002, J CLIN EPIDEMIOL, V55, P728, DOI 10.1016/S0895-4356(02)00400-6; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Hassan NB, 2006, J HUM HYPERTENS, V20, P23, DOI 10.1038/sj.jhh.1001930; Heneghan C, 2007, BRIT J GEN PRACT, V57, P948, DOI 10.3399/096016407782604965; Hernandez J, 2012, J AM ACAD NURSE PRAC, V24, P89, DOI 10.1111/j.1745-7599.2011.00663.x; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hill MN, 1999, AM J HYPERTENS, V12, P951, DOI 10.1016/S0895-7061(99)00121-1; Holland N, 2008, DIS MANAGE, V11, P71, DOI 10.1089/dis.2008.1120007; Hong Tantina B, 2006, Psychol Health Med, V11, P20, DOI 10.1080/14786430500228580; Horowitz CR, 2004, J HEALTH CARE POOR U, V15, P631, DOI 10.1353/hpu.2004.0061; Howes F, 2012, AUST FAM PHYSICIAN, V41, P317; Howes F, 2010, AUST FAM PHYSICIAN, V39, P511; Hsu YH, 2010, J TRANSCULT NURS, V21, P297, DOI 10.1177/1043659609360707; Joyner-Grantham J, 2009, AM J MED SCI, V338, P368, DOI 10.1097/MAJ.0b013e3181b473dc; Kasje WN, 2002, INT J QUAL HEALTH C, V14, P509, DOI 10.1093/intqhc/14.6.509; Kmet M, 2004, STANDARD QUALITY ASS; Kobalava ZD, 2007, KARDIOLOGIYA, V47, P38; Krousel-Wood MA, 2009, MED CLIN N AM, V93, P753, DOI 10.1016/j.mcna.2009.02.007; Kusuma YS, 2010, STUD ETHNO-MED, V4, P173, DOI 10.1080/09735070.2010.11886377; 박서연, 2012, [Korean Journal of community Nutrition, 대한지역사회영양학회지], V17, P623; Lin N D, 2006, AMIA Annu Symp Proc, P494; Machado MC, 2012, CIENC SAUDE COLETIVA, V17, P1365, DOI 10.1590/S1413-81232012000500030; Mahabir D, 1997, W INDIAN MED J, V46, P88; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mochari Heidi, 2007, Prev Cardiol, V10, P190, DOI 10.1111/j.1520-037X.2007.06619.x; Murimi MW, 2010, J RURAL HEALTH, V26, P273, DOI 10.1111/j.1748-0361.2010.00289.x; NELSON EC, 1978, MED CARE, V16, P893, DOI 10.1097/00005650-197811000-00001; Nieuwlaat R, 2013, EUR HEART J, V34, P1262, DOI 10.1093/eurheartj/ehs481; Ogedegbe G, 2004, ETHNIC DIS, V14, P3; Oliveria SA, 2002, ARCH INTERN MED, V162, P413, DOI 10.1001/archinte.162.4.413; Oliveria SA, 2005, J GEN INTERN MED, V20, P219, DOI 10.1111/j.1525-1497.2005.30353.x; Parker WA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-503; Peltzer K, 2004, Curationis, V27, P15; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Pham T M, 1999, Fam Med, V31, P647; Reiner Z, 2010, ATHEROSCLEROSIS, V213, P598, DOI 10.1016/j.atherosclerosis.2010.09.014; Roumie CL, 2007, JT COMM J QUAL PATIE, V33, P277, DOI 10.1016/S1553-7250(07)33032-8; Schafheutle EI, 2002, HEALTH SOC CARE COMM, V10, P187, DOI 10.1046/j.1365-2524.2002.00356.x; Serour M, 2007, BRIT J GEN PRACT, V57, P291; SHULMAN NB, 1986, AM J PUBLIC HEALTH, V76, P1105, DOI 10.2105/AJPH.76.9.1105; Swift JA, 2010, J HUM NUTR DIET, V23, P559, DOI 10.1111/j.1365-277X.2010.01116.x; Thorpe JM, 2006, MED CARE, V44, P187, DOI 10.1097/01.mlr.0000196965.54871.d5; Turner BJ, 2009, PHARMACOEPIDEM DR S, V18, P672, DOI 10.1002/pds.1766; van Achterberg T, 2011, HEALTH PROMOT INT, V26, P148, DOI 10.1093/heapro/daq050; Wang LX, 2004, MED PRIN PRACT, V13, P282, DOI 10.1159/000079528; Wee LE, 2012, HYPERTENS RES, V35, P295, DOI 10.1038/hr.2011.187; Wexler R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-23; Wexler R, 2009, J NATL MED ASSOC, V101, P597, DOI 10.1016/S0027-9684(15)30947-0; WHO, 2000, WORLD HLTH REP HLTH; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Youssef R M, 2002, East Mediterr Health J, V8, P579	84	211	216	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84238	10.1371/journal.pone.0084238	http://dx.doi.org/10.1371/journal.pone.0084238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454721	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330235100020
J	Nifong, JC; Nifong, RL; Silliman, BR; Lowers, RH; Guillette, LJ; Ferguson, JM; Welsh, M; Abernathy, K; Marshall, G				Nifong, James C.; Nifong, Rachel L.; Silliman, Brian R.; Lowers, Russell H.; Guillette, Louis J., Jr.; Ferguson, Jake M.; Welsh, Matthew; Abernathy, Kyler; Marshall, Greg			Animal-Borne Imaging Reveals Novel Insights into the Foraging Behaviors and Diel Activity of a Large-Bodied Apex Predator, the American Alligator (Alligator mississippiensis)	PLOS ONE			English	Article							CAIMAN-CROCODILUS; FOOD-HABITS; CROCODYLUS-NILOTICUS; PARAGUAYAN CAIMAN; FISHING BEHAVIOR; SALT-MARSH; WATER; FLORIDA; THERMOREGULATION; COMMUNITIES	Large-bodied, top- and apex predators (e.g., crocodilians, sharks, wolves, killer whales) can exert strong top-down effects within ecological communities through their interactions with prey. Due to inherent difficulties while studying the behavior of these often dangerous predatory species, relatively little is known regarding their feeding behaviors and activity patterns, information that is essential to understanding their role in regulating food web dynamics and ecological processes. Here we use animal-borne imaging systems (Crittercam) to study the foraging behavior and activity patterns of a cryptic, large-bodied predator, the American alligator (Alligator mississippiensis) in two estuaries of coastal Florida, USA. Using retrieved video data we examine the variation in foraging behaviors and activity patterns due to abiotic factors. We found the frequency of prey-attacks (mean = 0.49 prey attacks/hour) as well as the probability of prey-capture success (mean = 0.52 per attack) were significantly affected by time of day. Alligators attempted to capture prey most frequently during the night. Probability of prey-capture success per attack was highest during morning hours and sequentially lower during day, night, and sunset, respectively. Position in the water column also significantly affected prey-capture success, as individuals' experienced two-fold greater success when attacking prey while submerged. These estimates are the first for wild adult American alligators and one of the few examples for any crocodilian species worldwide. More broadly, these results reveal that our understandings of crocodilian foraging behaviors are biased due to previous studies containing limited observations of cryptic and nocturnal foraging interactions. Our results can be used to inform greater understanding regarding the top-down effects of American alligators in estuarine food webs. Additionally, our results highlight the importance and power of using animal-borne imaging when studying the behavior of elusive large-bodied, apex predators, as it provides critical insights into their trophic and behavioral interactions.	[Nifong, James C.; Silliman, Brian R.; Ferguson, Jake M.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Nifong, Rachel L.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Lowers, Russell H.] InoMed Hlth Applicat, Merritt Isl, FL USA; [Guillette, Louis J., Jr.] Med Univ Charleston South Carolina, Dept Obstet & Gynecol, Charleston, SC USA; [Guillette, Louis J., Jr.] Med Univ Charleston South Carolina, Hollings Marine Lab, Charleston, SC USA; [Welsh, Matthew] Guana Tolomato Matanzas Natl Estuarine Res Reserv, Marineland, FL USA; [Abernathy, Kyler; Marshall, Greg] Natl Geog Remote Imaging, Washington, DC USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Geographic Society	Nifong, JC (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	ncboy@ufl.edu	Nifong, James C/D-4137-2015	Nifong, James C/0000-0003-3607-0441; Ferguson, Jake/0000-0002-5034-9089; Silliman, Brian/0000-0001-6360-650X; Nifong, Rachel/0000-0001-8940-3583	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration [NA10NOS4200022]; University of Florida Foundation Inc. [016501]; University of Florida Singer Biology Fund; National Science Foundation [OCE-1030822, 10021501]; Division Of Ocean Sciences [1237140] Funding Source: National Science Foundation	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Florida Foundation Inc.(University of Florida); University of Florida Singer Biology Fund; National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was conducted under an award from the Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration, Award No. NA10NOS4200022 (url: http://www.nerrs.noaa.gov/). This work was supported in-part by the University of Florida Foundation Inc. Alligator Research Fund (016501) (Donors: Delecker Family) (url: https://www.uff.ufl.edu/OnlineGiving/FundDetail.asp?FundCode=016501), University of Florida Singer Biology Fund, and the National Science Foundation, OCE-1030822 (Award No. 10021501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bondavalli C, 1999, ECOSYSTEMS, V2, P49, DOI 10.1007/s100219900057; Brazaitis P., 1987, P373; Bugbee C.D, 2008, THESIS U FLORIDA; CLEUREN J, 1992, J MORPHOL, V212, P141, DOI 10.1002/jmor.1052120205; Coulson R., 1964, BIOCH ALLIGATOR STUD; Craighead F, 1968, FLORIDA NATURALIST, V21; DELANY MF, 1986, J WILDLIFE MANAGE, V50, P348, DOI 10.2307/3801926; DIEFENBACH COD, 1988, COMP BIOCHEM PHYS A, V89, P149; DIEFENBACH CODC, 1975, COMP BIOCHEM PHYS A, V51, P259; DUNSON WA, 1982, COPEIA, P374, DOI 10.2307/1444618; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FISH FE, 1987, COPEIA, P804, DOI 10.2307/1445682; Frazel T.D, 2009, RHETORIC CICEROS VER; Gabrey SW, 2010, HERPETOL CONSERV BIO, V5, P241; GANS C, 1969, COPEIA, P855, DOI 10.2307/1441816; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Jackson J.F., 1974, Journal Herpet, V8, P378, DOI 10.2307/1562912; Keddy PA, 2009, SOUTHEAST NAT, V8, P213, DOI 10.1656/058.008.0202; KUSHLAN JA, 1974, COPEIA, P993; KUSHLAN JA, 1980, COPEIA, P930, DOI 10.2307/1444493; LANG JW, 1979, COPEIA, P48, DOI 10.2307/1443728; Lazzaro X, 2009, J ANIM ECOL, V78, P1307, DOI 10.1111/j.1365-2656.2009.01588.x; Leitch DB, 2012, J EXP BIOL, V215, P4217, DOI 10.1242/jeb.076836; LEWIS LY, 1985, COMP BIOCHEM PHYS A, V80, P441, DOI 10.1016/0300-9629(85)90065-9; Magnusson W. E., 1982, CROCODILES, P389; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; Martin S, 2008, HYDROBIOLOGIA, V595, P587, DOI 10.1007/s10750-007-9030-4; MAZZOTTI FJ, 1984, COMP BIOCHEM PHYS A, V79, P641, DOI 10.1016/0300-9629(84)90462-6; Mazzotti FJ, 2009, ECOL INDIC, V9, pS137, DOI 10.1016/j.ecolind.2008.06.008; MCILHENNY EA, 1935, ALLIGATORS LIFE HIST; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nifong James C., 2013, Herpetological Review, V44, P243; Nifong JC, 2013, J EXP MAR BIOL ECOL, V440, P185, DOI 10.1016/j.jembe.2013.01.002; Nifong JC, 2012, COPEIA, P419, DOI 10.1643/CE-11-177; OLMOS F, 1990, COPEIA, P875, DOI 10.2307/1446458; Palmer ML, 2004, WETLANDS, V24, P115, DOI 10.1672/0277-5212(2004)024[0115:SOEAH]2.0.CO;2; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Platt SG, 2006, HERPETOL J, V16, P281; Pooley A.C., 1989, P76; R Core Development Team, 2011, R LANG ENV STAT COMP; Rosenblatt AE, 2013, OCEANOGRAPHY, V26, P156, DOI 10.5670/oceanog.2013.59; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; Rozas LP, 1998, B MAR SCI, V63, P481; SCHALLER GB, 1982, COPEIA, P66; SMITH EN, 1979, AM ZOOL, V19, P239; Soares D, 2002, NATURE, V417, P241, DOI 10.1038/417241a; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; TAPLIN LE, 1982, J COMP PHYSIOL, V149, P43, DOI 10.1007/BF00735713; Terborgh J., 2010, TROPHIC CASCADES PRE; Thorbjarnarson J, 1990, J HERPETOL, P17; THORBJARNARSON JB, 1993, COPEIA, P1166; U. S. Fish and Wildlife Service, 2013, MERR ISL NAT WILDL R; Wallace KM, 2008, J HERPETOL, V42, P361, DOI 10.1670/07-1071.1; Watanabe YY, 2013, AQUAT BIOL, V18, P1, DOI 10.3354/ab00489; WHITFIELD AK, 1979, COPEIA, P266; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; WOLFE J L, 1987, Northeast Gulf Science, V9, P1; Woodward AR, 1996, PROCEEDINGS OF THE FIFTIETH ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P509; [No title captured]	63	19	23	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83953	10.1371/journal.pone.0083953	http://dx.doi.org/10.1371/journal.pone.0083953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454711	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100013
J	Tang, WM; Pan, JC; Jiang, N; Hu, HY; Mahapatra, T; Yin, YP; Mahapatra, S; Wang, XL; Chen, XS; Lin, N; Zhang, X; Huan, XP; Yang, HT; Fu, GF				Tang, Weiming; Pan, Jicheng; Jiang, Ning; Hu, Hai-Yang; Mahapatra, Tanmay; Yin, Yue-Ping; Mahapatra, Sanchita; Wang, Xiao-Liang; Chen, Xiang-Sheng; Lin, Nan; Zhang, Xun; Huan, Xi-Ping; Yang, Hai-Tao; Fu, Geng-Feng			Correlates of Chlamydia and Gonorrhea Infection among Female Sex Workers: The Untold Story of Jiangsu, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RISK BEHAVIORS; COMMERCIAL SEX; HIV-INFECTIONS; PREVALENCE; SYPHILIS; MEN; INTERVENTIONS; SURVEILLANCE; TRANSMISSION	Objective(s): To estimate the prevalence of sexually transmitted infections (STIs) among female sex workers (FSWs) in the Jiangsu Province, China and measure the association of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections with their potential correlates. Design: A cross-sectional study on a representative sample of FSWs in Yangzhou and Changzhou cities of Jiangsu was conducted. Methods: 185 sex-work venues in Yangzhou and 174 in Changzhou were selected by stratified random sampling. 2972 FSWs (1108 in Yangzhou and 1864 in Changzhou), aged 15 years or more, who agreed to participate and provided blood sample for HIV and syphilis testing were interviewed in these venues. Cervical specimens from 849 randomly chosen participants were then tested for CT and NG. Results: Proportions of young, school-educated, currently married FSWs who were living alone, migrated from other provinces and engaged in unprotected vaginal intercourse in past 3 months (UVI) were relatively high. Prevalence of HIV, syphilis, CT and NG were 0.20%, 4.88%, 14.61% and 5.42% respectively. Younger age, living alone or with persons other than partners/family members, engaging in UVI and having other STIs seemed to be associated with higher risk of CT or NG infection. Being divorced/widowed and working in middle/low-level venues were identified as additional risk factors for NG. Conclusions: Based on a representative sample, this initial effort to identify the correlates of CT/NG infections among FSWs of Jiangsu revealed that focused interventions targeting high-risk FSWs are urgently required for controlling STI epidemics in Yangzhou and Changzhou where substantial number of STI cases were identified.	[Tang, Weiming; Mahapatra, Tanmay; Mahapatra, Sanchita] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Tang, Weiming; Hu, Hai-Yang; Wang, Xiao-Liang; Yang, Hai-Tao; Fu, Geng-Feng] Jiangsu Prov Cent Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Pan, Jicheng] Jiangsu Prov Geriatr Inst, Nanjing, Jiangsu, Peoples R China; [Jiang, Ning; Yin, Yue-Ping; Chen, Xiang-Sheng; Huan, Xi-Ping] China CDC, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; [Lin, Nan] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Zhang, Xun] Univ S Florida, MCM, Dept Mol Pharmacol & Physiol, Tampa, FL USA	University of California System; University of California Los Angeles; Xiamen University; State University System of Florida; University of South Florida	Fu, GF (corresponding author), Jiangsu Prov Cent Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China.	fugf@jscdc.cn	wang, xl/Y-8251-2019; wang, xiao/HGB-7081-2022; Wang, Xin/AAN-8435-2021	wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Tang, Weiming/0000-0002-9026-707X	National Natural Science Foundation [81373125]; "Mega Project" of China National Science Research for the 11th Five-Year Plan [2008ZX10001 -005]; Ministry of Health and the Ministry of Sciences and Technology in China, Jiangsu Provincial Technologies Research Program [BE2009685]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC2011086, 2011087]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); "Mega Project" of China National Science Research for the 11th Five-Year Plan; Ministry of Health and the Ministry of Sciences and Technology in China, Jiangsu Provincial Technologies Research Program; Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by the National Natural Science Foundation (81373125), "Mega Project" of China National Science Research for the 11th Five-Year Plan (2008ZX10001 -005) from the Ministry of Health and the Ministry of Sciences and Technology in China, Jiangsu Provincial Technologies Research Program (BE2009685) and Jiangsu Province's Outstanding Medical Academic Leader Program (RC2011086, 2011087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker M, 2000, WHO REPORT GLOBAL SU, P11; [Anonymous], 2011, 2011 EST HIV AIDS EP; Bruus M., 2003, EPIDATA VERSION 3 CO; Burns FM, 2009, SEX TRANSM INFECT, V85, P75, DOI 10.1136/sti.2007.029546; Chen XS, 2006, SEX TRANSM INFECT, V82, P283, DOI 10.1136/sti.2006.019711; Chen XS, 2013, LANCET INFECT DIS, V13, P13, DOI 10.1016/S1473-3099(12)70298-0; Chen XS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-84; Das A, 2011, INFECT DIS OBSTET GY; Duckett M, 2000, DEV B, V18; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Furstenberg F., 1999, MANAGING MAKE IT URB; Hampton MC, 2012, AIDS BEHAV, P1; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Hong Y, 2011, AIDS CARE, V23, P54, DOI 10.1080/09540121.2011.554526; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Institute S, 1996, SAS SYSTEM WINDOWS; Jin X, 2011, INT J STD AIDS, V22, P80, DOI 10.1258/ijsa.2010.010289; Pando MA, 2006, AM J TROP MED HYG, V74, P233, DOI 10.4269/ajtmh.2006.74.233; Peng ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052731; Pepin J, 2005, SEX TRANSM INFECT, V81, P67, DOI 10.1136/sti.2003.009100; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Safika I, 2011, INT J DRUG POLICY, V22, P49, DOI 10.1016/j.drugpo.2010.09.003; Strathdee SA, 1998, J ACQ IMMUN DEF SYND, V19, P61, DOI 10.1097/00042560-199809010-00010; Thuong NV, 2005, SEX TRANSM INFECT, V81, P477, DOI 10.1136/sti.2005.016097; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang B, 2007, SEX TRANSM DIS, V34, P1, DOI 10.1097/01.olq.0000222668.95038.03; Wang H, 2009, SEX TRANSM INFECT, V85, P290, DOI 10.1136/sti.2008.033100; Weiming Tang HY, 2009, CHIN J EPIDEMIOL, V30, P448; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang H, 2004, PREVENTION SEXUAL ST, P471; YANG H-t, 2009, ACTA U MED NANJING N, V8; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414; Zermiani Monica, 2012, Open AIDS J, V6, P60, DOI 10.2174/1874613601206010060; ZHANG Q-q, 2012, ACTA U MED NANJING N, V4	40	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85985	10.1371/journal.pone.0085985	http://dx.doi.org/10.1371/journal.pone.0085985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454950	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100142
J	Rahman, MM; Khan, SB; Asiri, AM				Rahman, Mohammed M.; Khan, Sher Bahadar; Asiri, Abdullah M.			Fabrication of Smart Chemical Sensors Based on Transition-Doped-Semiconductor Nanostructure Materials with mu-Chips	PLOS ONE			English	Article							THIN-FILM; SENSING PROPERTIES; PHOTO-CATALYST; ZINC-OXIDE; GAS SENSOR; ZNO; NANOPARTICLES; ZNFE2O4; SB2O3; GROWTH	Transition metal doped semiconductor nanostructure materials (Sb2O3 doped ZnO microflowers, MFs) are deposited onto tiny mu-chip (surface area, -0.02217 cm(2)) to fabricate a smart chemical sensor for toxic ethanol in phosphate buffer solution (0.1 M PBS). The fabricated chemi-sensor is also exhibited higher sensitivity, large-dynamic concentration ranges, long-term stability, and improved electrochemical performances towards ethanol. The calibration plot is linear (r(2) = 0.9989) over the large ethanol concentration ranges (0.17 mM to 0.85 M). The sensitivity and detection limit is similar to 5.845 mu Acm(-2)mM(-1) and similar to 0.11 +/- 0.02 mM (signal-to-noise ratio, at a SNR of 3) respectively. Here, doped MFs are prepared by a wet-chemical process using reducing agents in alkaline medium, which characterized by UV/vis., FT-IR, Raman, X-ray photoelectron spectroscopy (XPS), powder X-ray diffraction (XRD), and field-emission scanning electron microscopy (FE-SEM) etc. The fabricated ethanol chemical sensor using Sb2O3-ZnO MFs is simple, reliable, low-sample volume (<70.0 mu L), easy of integration, high sensitivity, and excellent stability for the fabrication of efficient I-V sensors on mu-chips.	[Rahman, Mohammed M.; Khan, Sher Bahadar; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia; [Rahman, Mohammed M.; Khan, Sher Bahadar; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia.	mmrahman@kau.edu.sa	Asiri, Abdullah M./C-3458-2009; Rahman, Mohammed M./H-5823-2012; Khan, Sher Bahadar/H-5833-2012; Khan, Prof. Sher Bahadar/M-7968-2019	Asiri, Abdullah M./0000-0001-7905-3209; Rahman, Mohammed M./0000-0003-2773-1244; Khan, Sher Bahadar/0000-0001-9635-7175; Khan, Prof. Sher Bahadar/0000-0001-9635-7175	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-019-D1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. 130-019-D1433. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah M., 2011, SENSORS TRANSDUCERS, V134, P32; Aguilar-Leyva J, 2007, MATER CHARACT, V58, P740, DOI 10.1016/j.matchar.2006.11.016; Bundesmann C, 2003, APPL PHYS LETT, V83, P1974, DOI 10.1063/1.1609251; Cebriano T, 2012, MATER CHEM PHYS, V135, P1096, DOI 10.1016/j.matchemphys.2012.06.024; Choi KI, 2010, SENSOR ACTUAT B-CHEM, V146, P183, DOI 10.1016/j.snb.2010.02.050; Dale L., 2009, SMALL, V1, P482; DAMEN TC, 1966, PHYS REV, V142, P570, DOI 10.1103/PhysRev.142.570; Das S, 2011, MATER RES BULL, V46, P609, DOI 10.1016/j.materresbull.2010.12.034; De Vicente FS, 2003, J NON-CRYST SOLIDS, V330, P168, DOI 10.1016/j.jnoncrysol.2003.08.047; Di Francesco F, 2005, MICROCHEM J, V79, P405, DOI 10.1016/j.microc.2004.10.008; Faisal M, 2012, APPL SURF SCI, V258, P7515, DOI 10.1016/j.apsusc.2012.04.075; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Faisal M, 2011, MATER LETT, V65, P1400, DOI 10.1016/j.matlet.2011.02.013; Friedrichs S, 2001, CHEM COMMUN, P929, DOI 10.1039/b102348a; Fujii T, 1999, PHYS REV B, V59, P3195, DOI 10.1103/PhysRevB.59.3195; Gibert JP, 2000, POLYM DEGRAD STABIL, V67, P437, DOI 10.1016/S0141-3910(99)00142-1; Gong H, 2006, SENSOR ACTUAT B-CHEM, V115, P247, DOI 10.1016/j.snb.2005.09.008; Guo L, 2000, CHEM PHYS LETT, V318, P49, DOI 10.1016/S0009-2614(99)01461-X; Hagen J, 1999, HETEROGENEOUS CATALY, P83; Han N, 2010, SENSOR ACTUAT B-CHEM, V147, P525, DOI 10.1016/j.snb.2010.03.082; Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471; Hsueh TJ, 2007, SENSOR ACTUAT B-CHEM, V126, P473, DOI 10.1016/j.snb.2007.03.034; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Ingler WB, 2004, J AM CHEM SOC, V126, P10238, DOI 10.1021/ja048461y; Jamal A, 2011, MAT SCI APPL, V2, P676; Khan SB, 2011, TALANTA, V85, P943, DOI 10.1016/j.talanta.2011.05.003; Khan SB, 2011, SCI TOTAL ENVIRON, V409, P2987, DOI 10.1016/j.scitotenv.2011.04.019; Khan SB, 2011, TALANTA, V84, P1005, DOI 10.1016/j.talanta.2011.02.036; Kim GW, 2012, J KOREAN PHYS SOC, V60, P1548, DOI 10.3938/jkps.60.1548; Kumar A, 2007, NANOTECHNOL, V18; Lao YW, 2007, J ELECTROCERAM, V19, P187, DOI 10.1007/s10832-007-9187-2; Lee SR, 2009, BIOSENS BIOELECTRON, V24, P1877, DOI 10.1016/j.bios.2008.09.008; Lee SR, 2009, TRAC-TREND ANAL CHEM, V28, P196, DOI 10.1016/j.trac.2008.11.009; Li YB, 2009, SOLID STATE SCI, V11, P1319, DOI 10.1016/j.solidstatesciences.2009.04.014; Majumder S, 2009, MATER SCI-POLAND, V27, P123; Montenegro A, 2007, J EUR CERAM SOC, V27, P4143, DOI 10.1016/j.jeurceramsoc.2007.02.106; Mori H, 1996, MATER CHEM PHYS, V45, P211, DOI 10.1016/0254-0584(95)01729-1; Ng HT, 2004, NANO LETT, V4, P1247, DOI 10.1021/nl049461z; Nicoletti S, 2003, IEEE SENS J, V3, P454, DOI 10.1109/JSEN.2003.815797; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Pearton SJ, 2004, SEMICOND SCI TECH, V19, pR59, DOI 10.1088/0268-1242/19/10/R01; Pokhrel S, 2008, SENSOR ACTUAT B-CHEM, V133, P78, DOI 10.1016/j.snb.2008.01.054; Rahman MM, 2011, J BIOMED NANOTECHNOL, V7, P351, DOI 10.1166/jbn.2011.1299; Rahman MM, 2009, SENSOR ACTUAT B-CHEM, V137, P327, DOI 10.1016/j.snb.2008.10.060; Rahman MM, 2012, SENSOR ACTUAT B-CHEM, V171, P932, DOI 10.1016/j.snb.2012.06.006; Rahman MM, 2012, TALANTA, V99, P924, DOI 10.1016/j.talanta.2012.07.060; Rahman MM, 2012, ELECTROCHIM ACTA, V75, P164, DOI 10.1016/j.electacta.2012.04.093; Rahman MM, 2012, CHEM ENG J, V192, P122, DOI 10.1016/j.cej.2012.03.045; Rahman MM, 2012, MICROCHIM ACTA, V178, P99, DOI 10.1007/s00604-012-0817-2; Rahman MM, 2011, SUPERLATTICE MICROST, V50, P369, DOI 10.1016/j.spmi.2011.07.016; Rahman MM, 2011, BIOSENS BIOELECTRON, V28, P127, DOI 10.1016/j.bios.2011.07.024; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Rahman MM, 2011, ACS APPL MATER INTER, V3, P1346, DOI 10.1021/am200151f; Rahman MM, 2011, J NANOPART RES, V13, P3789, DOI 10.1007/s11051-011-0301-7; Sahner K, 2005, SENSOR ACTUAT B-CHEM, V108, P102, DOI 10.1016/j.snb.2004.12.104; Shaalan NM, 2011, SENSOR ACTUAT B-CHEM, V153, P11, DOI 10.1016/j.snb.2010.09.070; Soci C, 2007, NANO LETT, V7, P1003, DOI 10.1021/nl070111x; Song P, 2005, SENSOR ACTUAT B-CHEM, V104, P312, DOI 10.1016/j.snb.2004.05.023; Suchea M, 2007, THIN SOLID FILMS, V515, P6562, DOI 10.1016/j.tsf.2006.11.151; Tao BR, 2009, SENSOR ACTUAT B-CHEM, V142, P298, DOI 10.1016/j.snb.2009.08.004; Umar A, 2008, J NANOSCI NANOTECHNO, V8, P3216, DOI 10.1166/jnn.2008.116; Umar A, 2008, CHEM COMMUN, P166, DOI 10.1039/b711215g; Umar A, 2009, ELECTROCHEM COMMUN, V11, P118, DOI 10.1016/j.elecom.2008.10.046; Wang C, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145506; Wang N, 1998, PHYS REV B, V58, P16024, DOI 10.1103/PhysRevB.58.R16024; Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Weng YC, 2004, BIOSENS BIOELECTRON, V20, P41, DOI 10.1016/j.bios.2004.01.027; Weng YC, 2002, SENSOR ACTUAT B-CHEM, V85, P246, DOI 10.1016/S0925-4005(02)00125-9; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Wongrat E, 2009, APPL SURF SCI, V256, P968, DOI 10.1016/j.apsusc.2009.02.046; Yang ZX, 2009, SENSOR ACTUAT B-CHEM, V140, P549, DOI 10.1016/j.snb.2009.04.052; Yao CW, 2007, J PHYS CHEM C, V111, P12274, DOI 10.1021/jp0732763; Ye CH, 2002, CHEM PHYS LETT, V363, P34, DOI 10.1016/S0009-2614(02)01018-7; Zhang CC, 2002, J EUR CERAM SOC, V22, P61, DOI 10.1016/S0955-2219(01)00232-1	76	30	30	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85036	10.1371/journal.pone.0085036	http://dx.doi.org/10.1371/journal.pone.0085036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454785	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500033
J	Johnson, EK; Seidl, A; Tyler, MD				Johnson, Elizabeth K.; Seidl, Amanda; Tyler, Michael D.			The Edge Factor in Early Word Segmentation: Utterance-Level Prosody Enables Word Form Extraction by 6-Month-Olds	PLOS ONE			English	Article							SPEECH SEGMENTATION; INFANTS; BOUNDARIES; LANGUAGE; CUES; STRESS; CONSTRAINTS; VOCABULARY; PREFERENCE; BEGINNINGS	Past research has shown that English learners begin segmenting words from speech by 7.5 months of age. However, more recent research has begun to show that, in some situations, infants may exhibit rudimentary segmentation capabilities at an earlier age. Here, we report on four perceptual experiments and a corpus analysis further investigating the initial emergence of segmentation capabilities. In Experiments 1 and 2, 6-month-olds were familiarized with passages containing target words located either utterance medially or at utterance edges. Only those infants familiarized with passages containing target words aligned with utterance edges exhibited evidence of segmentation. In Experiments 3 and 4, 6-month-olds recognized familiarized words when they were presented in a new acoustically distinct voice (male rather than female), but not when they were presented in a phonologically altered manner (missing the initial segment). Finally, we report corpus analyses examining how often different word types occur at utterance boundaries in different registers. Our findings suggest that edge-aligned words likely play a key role in infants' early segmentation attempts, and also converge with recent reports suggesting that 6-month-olds' have already started building a rudimentary lexicon.	[Johnson, Elizabeth K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Seidl, Amanda] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA; [Tyler, Michael D.] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia; [Tyler, Michael D.] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia	University of Toronto; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Western Sydney University; Western Sydney University	Johnson, EK (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	elizabeth.johnson@utoronto.ca	Tyler, Michael D/B-2399-2013	Tyler, Michael D/0000-0003-1642-7941; Johnson, Elizabeth Kay/0000-0002-9941-9949	NSERC; SSHRC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was funded by NSERC (www.nserc-crsng.gc.ca/index_eng.asp) and SSHRC (http://www.sshrc-crsh.gc.ca/) grants awarded to EKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, PERCEPTION PRODUCTIO; Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Brent MR, 2001, COGNITION, V81, pB33, DOI 10.1016/S0010-0277(01)00122-6; Christophe A, 2004, J MEM LANG, V51, P523, DOI 10.1016/j.jml.2004.07.001; CHRISTOPHE A, 1994, J ACOUST SOC AM, V95, P1570, DOI 10.1121/1.408544; Christophe A, 2001, INFANCY, V2, P385, DOI 10.1207/S15327078IN0203_6; CUTLER A, 1988, J EXP PSYCHOL HUMAN, V14, P113, DOI 10.1037/0096-1523.14.1.113; Cutler A., 1987, Computer Speech and Language, V2, P133, DOI 10.1016/0885-2308(87)90004-0; CUTLER A, 1994, LINGUA, V92, P81, DOI 10.1016/0024-3841(94)90338-7; Cutler Anne, 2012, NATIVE LISTENING LAN; Daland R, 2011, COGNITIVE SCI, V35, P119, DOI 10.1111/j.1551-6709.2010.01160.x; Endress AD, 2010, COGNITIVE PSYCHOL, V61, P177, DOI 10.1016/j.cogpsych.2010.05.001; Endress AD, 2010, J EXP PSYCHOL HUMAN, V36, P235, DOI 10.1037/a0017164; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; Goldsmith J., 2011, HDB PHONOLOGICAL THE, P164; Gout A, 2004, J MEM LANG, V51, P548, DOI 10.1016/j.jml.2004.07.002; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Houston DM, 2000, J EXP PSYCHOL HUMAN, V26, P1570, DOI 10.1037/0096-1523.26.5.1570; Houston DM, 2000, PSYCHON B REV, V7, P504, DOI 10.3758/BF03214363; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Johnson E.K., 2012, STAT LEARNING LANGUA, P55; Johnson EK, 2005, INFANCY, V7, P99, DOI 10.1207/s15327078in0701_8; Johnson EK, 2003, COGNITIVE PSYCHOL, V46, P65, DOI 10.1016/S0010-0285(02)00507-8; Johnson EK, 2012, 2012 INT C INF STUD; Johnson EK, 2003, THESIS J HOPKINS U; Johnson EK, 2008, INFANCY, V13, P440, DOI 10.1080/15250000802329321; Johnson EK, 2008, J ACOUST SOC AM, V123, pEL144, DOI 10.1121/1.2908407; Johnson EK, 2010, DEVELOPMENTAL SCI, V13, P339, DOI 10.1111/j.1467-7687.2009.00886.x; Johnson EK, 2009, DEVELOPMENTAL SCI, V12, P131, DOI 10.1111/j.1467-7687.2008.00740.x; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; Jusczyk PW, 1997, SCIENCE, V277, P1984, DOI 10.1126/science.277.5334.1984; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kidd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036399; KUHL PK, 1979, J ACOUST SOC AM, V66, P1668, DOI 10.1121/1.383639; Lew-Williams C, 2012, COGNITION, V122, P241, DOI 10.1016/j.cognition.2011.10.007; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; Mattys SL, 2001, COGNITION, V78, P91, DOI 10.1016/S0010-0277(00)00109-8; Mattys SL, 2001, J EXP PSYCHOL HUMAN, V27, P644, DOI 10.1037//0096-1523.27.3.644; Nazzi T, 2005, LANG SPEECH, V48, P279, DOI 10.1177/00238309050480030201; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; PHILLIPS JR, 1973, CHILD DEV, V44, P182; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sahni SD, 2010, CHILD DEV, V81, P727, DOI 10.1111/j.1467-8624.2010.01430.x; Schmale R, 2010, INFANCY, V15, P650, DOI 10.1111/j.1532-7078.2010.00032.x; Seidl A, 2008, J CHILD LANG, V35, P1, DOI 10.1017/S0305000907008215; Seidl A, 2006, DEVELOPMENTAL SCI, V9, P565, DOI 10.1111/j.1467-7687.2006.00534.x; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Shi RS, 1998, J CHILD LANG, V25, P169, DOI 10.1017/S0305000997003395; Shi RS, 2006, J ACOUST SOC AM, V119, pEL61, DOI 10.1121/1.2198947; Shukla M, 2007, COGNITIVE PSYCHOL, V54, P1, DOI 10.1016/j.cogpsych.2006.04.002; Shukla M, 2011, P NATL ACAD SCI USA, V108, P6038, DOI 10.1073/pnas.1017617108; Singh L, 2004, J MEM LANG, V51, P173, DOI 10.1016/j.jml.2004.04.004; Singh L, 2008, INFANCY, V13, P57, DOI 10.1080/15250000701779386; Soderstrom M, 2003, J MEM LANG, V49, P249, DOI 10.1016/S0749-596X(03)00024-X; Swingley D, 2005, COGNITIVE PSYCHOL, V50, P86, DOI 10.1016/j.cogpsych.2004.06.001; Swingley D, 2009, PHILOS T R SOC B, V364, P3617, DOI 10.1098/rstb.2009.0107; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Thiessen ED, 2013, FRONT PSYCHOL, V3, P590, DOI [10.3389/fpsyg.2012.00590, DOI 10.3389/FPSYG.2012.00590]; Thiessen ED, 2007, LANG LEARN DEV, V3, P73, DOI 10.1080/15475440709337001; Tincoff R, 1999, PSYCHOL SCI, V10, P172, DOI 10.1111/1467-9280.00127; Tincoff R, 2012, INFANCY, V17, P432, DOI 10.1111/j.1532-7078.2011.00084.x; Tyler MD, 2009, J ACOUST SOC AM, V126, P367, DOI 10.1121/1.3129127; van Heugten M, 2012, J SPEECH LANG HEAR R, V55, P554, DOI 10.1044/1092-4388(2011/10-0347); Weijer van de J, 1998, MAX PLANCK SERIES PS, P9; Yang CD, 2004, TRENDS COGN SCI, V8, P451, DOI 10.1016/j.tics.2004.08.006	70	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83546	10.1371/journal.pone.0083546	http://dx.doi.org/10.1371/journal.pone.0083546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421892	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500055
J	Tettamanti, F; Viblanc, VA				Tettamanti, Federico; Viblanc, Vincent A.			Influences of Mating Group Composition on the Behavioral Time-Budget of Male and Female Alpine Ibex (Capra ibex) during the Rut	PLOS ONE			English	Article							OPERATIONAL SEX-RATIO; PREDATION RISK; GROUP-SIZE; FORAGING BEHAVIOR; SPATIAL-BEHAVIOR; CALVING SUCCESS; BODY CONDITION; AGE; SEGREGATION; VIGILANCE	During the rut, polygynous ungulates gather in mixed groups of individuals of different sex and age. Group social composition, which may vary on a daily basis, is likely to have strong influences on individual's time-budget, with emerging properties at the group-level. To date, few studies have considered the influence of group composition on male and female behavioral time budget in mating groups. Focusing on a wild population of Alpine ibex, we investigated the influence of group composition (adult sex ratio, the proportion of dominant to subordinate males, and group size) on three behavioral axes obtained by Principal Components Analysis, describing male and female group time-budget. For both sexes, the first behavioral axis discerned a trade-off between grazing and standing/vigilance behavior. In females, group vigilance behavior increased with increasingly male-biased sex ratio, whereas in males, the effect of adult sex ratio on standing/vigilance behavior depended on the relative proportion of dominant males in the mating group. The second axis characterized courtship and male-male agonistic behavior in males, and moving and male-directed agonistic behavior in females. Mating group composition did not substantially influence this axis in males. However, moving and male-directed agonistic behavior increased at highly biased sex ratios (quadratic effect) in females. Finally, the third axis highlighted a trade-off between moving and lying behavior in males, and distinguished moving and female-female agonistic behavior from lying behavior in females. For males, those behaviors were influenced by a complex interaction between group size and adult sex ratio, whereas in females, moving and female-female agonistic behaviors increased in a quadratic fashion at highly biased sex ratios, and also increased with increasing group size. Our results reveal complex behavioral trade-offs depending on group composition in the Alpine ibex, and emphasize the importance of social factors in influencing behavioral time-budgets of wild ungulates during the rut.	[Tettamanti, Federico] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Viblanc, Vincent A.] Univ Montpellier 2, Ctr Ecol Fonct & Evolut, Equipe Ecol Comportementale, CNRS,UMR 5175, Montpellier, France	University of Sassari; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Tettamanti, F (corresponding author), Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy.	ftettamanti@bluewin.ch; vincent.viblanc@gmail.com	Viblanc, Vincent Alexandre/A-7455-2014	Viblanc, Vincent Alexandre/0000-0002-4953-659X	University of Sassari; AXA Research Fund	University of Sassari; AXA Research Fund(AXA Research Fund)	Field accommodation was provided by the Swiss National Park (Forschungskommission des Schweizerisches Nationalparks). FT was the recipient of a PhD scholarship from the University of Sassari. VAV was supported by a post-doctoral fellowship from the AXA Research Fund during the time of writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderhalden Walter, 2006, Nationalpark-Forschung in der Schweiz, V93, P171; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Apollonio M, 2013, BEHAV PROCESS, V98, P44, DOI 10.1016/j.beproc.2013.05.001; BERGER J, 1978, BEHAV ECOL SOCIOBIOL, V4, P91, DOI 10.1007/BF00302563; Bergeron P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1299, DOI 10.1007/s00265-010-0944-x; Bon R, 2001, ANIM BEHAV, V62, P495, DOI 10.1006/anbe.2001.1776; BOWYER RT, 1984, J MAMMAL, V65, P410, DOI 10.2307/1381087; Brivio F, 2010, ETHOLOGY, V116, P406, DOI 10.1111/j.1439-0310.2010.01753.x; Bro-Jorgensen J, 2011, EVOL BIOL, V38, P28, DOI 10.1007/s11692-010-9105-4; Cameron EZ, 2005, ANIM BEHAV, V69, P1337, DOI 10.1016/j.anbehav.2004.08.015; CAMERON RD, 1993, CAN J ZOOL, V71, P480, DOI 10.1139/z93-069; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Cote SD, 1997, CAN J ZOOL, V75, P1628, DOI 10.1139/z97-789; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; de Jong K, 2012, BEHAV ECOL, V23, P1170, DOI 10.1093/beheco/ars094; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; GREENBERGCOHEN D, 1994, ETHOLOGY, V98, P210; Grignolio S, 2004, ETHOL ECOL EVOL, V16, P255; Grignolio S, 2007, J MAMMAL, V88, P1488, DOI 10.1644/06-MAMM-A-351R.1; Hamel S, 2008, ANIM BEHAV, V75, P217, DOI 10.1016/j.anbehav.2007.04.028; Hamel S, 2009, OECOLOGIA, V161, P421, DOI 10.1007/s00442-009-1377-y; Holand O, 2006, BEHAV ECOL SOCIOBIOL, V59, P682, DOI 10.1007/s00265-005-0097-5; Isvaran K, 2005, CURR SCI INDIA, V89, P1192; Komers PE, 1999, AM NAT, V153, P431, DOI 10.1086/303185; L'Italien L, 2012, ETHOLOGY, V118, P783, DOI 10.1111/j.1439-0310.2012.02073.x; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Luaps P., 2007, BEITRAGE JAGD WILDFO, V32, P495; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Marshall HH, 2012, ANIM BEHAV, V84, P1295, DOI 10.1016/j.anbehav.2012.09.030; Neuhaus P, 2002, ETHOL ECOL EVOL, V14, P373; Nievergelt B, 1974, COMP RUTTING BEHAV G, P324; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parrini F, 2003, ACTA THERIOL, V48, P411, DOI 10.1007/BF03194179; Parrini Francesca, 2009, Mammalian Species, P1, DOI 10.1644/830.1; Pelletier F, 2006, ANIM BEHAV, V71, P649, DOI 10.1016/j.anbehav.2005.07.008; Pelletier F, 2006, BEHAV ECOL SOCIOBIOL, V60, P645, DOI 10.1007/s00265-006-0208-y; R Development Core Team, 2012, R LANG ENV STAT COMP; RASMUSSEN KLR, 1985, BEHAV ECOL SOCIOBIOL, V17, P161; RATTI P, 1977, Z JAGDWISS, V23, P188, DOI 10.1007/BF01905758; REALE D, 1996, CAN J ZOOL, V74, P1812; Robert K, 2013, J ZOOL, V290, P199, DOI 10.1111/jzo.12027; Roed KH, 2002, MOL ECOL, V11, P1239, DOI 10.1046/j.1365-294X.2002.01509.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Ruckstuhl KE, 2001, BEHAVIOUR, V138, P1033, DOI 10.1163/156853901753286551; Saether BE, 2002, ECOLOGY, V83, P3457, DOI 10.2307/3072094; Saunders FC, 2005, ACTA ETHOL, V8, P103, DOI 10.1007/s10211-005-0006-y; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Shargal D, 2008, THERIOGENOLOGY, V69, P673, DOI 10.1016/j.theriogenology.2007.11.017; Tennenhouse EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P287, DOI 10.1007/s00265-010-1043-8; Testa JW, 1998, J MAMMAL, V79, P1345, DOI 10.2307/1383026; THOULESS CR, 1990, ANIM BEHAV, V40, P105, DOI 10.1016/S0003-3472(05)80669-4; Turner WC, 2005, J ZOOL, V267, P291, DOI 10.1017/S095283690500748X; VALDEZ R, 1991, APPL ANIM BEHAV SCI, V29, P165, DOI 10.1016/0168-1591(91)90244-R; Valle S, 1999, IND ENG CHEM RES, V38, P4389, DOI 10.1021/ie990110i; Viera VM, 2011, ANIM BEHAV, V82, P69, DOI 10.1016/j.anbehav.2011.04.001; Villaret JC, 1995, ETHOLOGY, V101, P291; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; White RG, 1997, J ZOOL, V243, P13, DOI 10.1111/j.1469-7998.1997.tb05752.x; Willisch CS, 2010, BEHAV ECOL, V21, P372, DOI 10.1093/beheco/arp200; Willisch CS, 2009, J MAMMAL, V90, P1421, DOI 10.1644/08-MAMM-A-316R1.1; [No title captured]	65	7	7	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e86004	10.1371/journal.pone.0086004	http://dx.doi.org/10.1371/journal.pone.0086004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416453	Green Published, Green Submitted, gold			2022-12-27	WOS:000329862500268
J	Xuan, CY; Shamonki, JM; Chung, A; DiNome, ML; Chung, M; Sieling, PA; Lee, DJ				Xuan, Caiyun; Shamonki, Jaime M.; Chung, Alice; DiNome, Maggie L.; Chung, Maureen; Sieling, Peter A.; Lee, Delphine J.			Microbial Dysbiosis Is Associated with Human Breast Cancer	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HELICOBACTER-PYLORI; GUT MICROBIOME; CARCINOMA; RISK; INFECTION; ABSENCE; IMMUNITY	Breast cancer affects one in eight women in their lifetime. Though diet, age and genetic predisposition are established risk factors, the majority of breast cancers have unknown etiology. The human microbiota refers to the collection of microbes inhabiting the human body. Imbalance in microbial communities, or microbial dysbiosis, has been implicated in various human diseases including obesity, diabetes, and colon cancer. Therefore, we investigated the potential role of microbiota in breast cancer by next-generation sequencing using breast tumor tissue and paired normal adjacent tissue from the same patient. In a qualitative survey of the breast microbiota DNA, we found that the bacterium Methylobacterium radiotolerans is relatively enriched in tumor tissue, while the bacterium Sphingomonas yanoikuyae is relatively enriched in paired normal tissue. The relative abundances of these two bacterial species were inversely correlated in paired normal breast tissue but not in tumor tissue, indicating that dysbiosis is associated with breast cancer. Furthermore, the total bacterial DNA load was reduced in tumor versus paired normal and healthy breast tissue as determined by quantitative PCR. Interestingly, bacterial DNA load correlated inversely with advanced disease, a finding that could have broad implications in diagnosis and staging of breast cancer. Lastly, we observed lower basal levels of antibacterial response gene expression in tumor versus healthy breast tissue. Taken together, these data indicate that microbial DNA is present in the breast and that bacteria or their components may influence the local immune microenvironment. Our findings suggest a previously unrecognized link between dysbiosis and breast cancer which has potential diagnostic and therapeutic implications.	[Xuan, Caiyun; Sieling, Peter A.; Lee, Delphine J.] John Wayne Canc Inst, Dirks Dougherty Lab Canc Res, Dept Translat Immunol, Santa Monica, CA 90404 USA; [Shamonki, Jaime M.] St Johns Hlth Ctr, Dept Pathol, Santa Monica, CA USA; [Chung, Alice] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [DiNome, Maggie L.; Chung, Maureen] St Johns Hlth Ctr, Margie Petersen Breast Ctr, Santa Monica, CA USA	John Wayne Cancer Institute; Cedars Sinai Medical Center	Lee, DJ (corresponding author), John Wayne Canc Inst, Dirks Dougherty Lab Canc Res, Dept Translat Immunol, Santa Monica, CA 90404 USA.	leedj@jwci.org	Chung, Alice/AAH-5776-2021	DiNome, Maggie/0000-0002-1926-292X	Joseph B. Gould Foundation; Association of Breast and Prostate Cancer Studies (Los Angeles); Fashion Footwear Association of New York Charitable Foundation (New York)	Joseph B. Gould Foundation; Association of Breast and Prostate Cancer Studies (Los Angeles); Fashion Footwear Association of New York Charitable Foundation (New York)	This work was supported by Carolyn Dirks and Brett Dougherty, the Joseph B. Gould Foundation, the Association of Breast and Prostate Cancer Studies (Los Angeles) and the Fashion Footwear Association of New York Charitable Foundation (New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil N, 2008, BRIT J CANCER, V99, P404, DOI 10.1038/sj.bjc.6604503; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; Glaser SL, 1998, INT J CANCER, V75, P555; Gopalkrishna V, 1996, BREAST CANCER RES TR, V39, P197, DOI 10.1007/BF01806186; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Hix LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020702; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kroupis C, 2006, CLIN BIOCHEM, V39, P727, DOI 10.1016/j.clinbiochem.2006.03.005; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin S-Y, 2011, INT J SYST EVOL MICR, V62, P1581; Lindel K, 2007, BREAST, V16, P172, DOI 10.1016/j.breast.2006.09.001; LUQMANI YA, 1995, INT J ONCOL, V6, P899; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2008, J PEDIAT GASTROENTER, V46, pE12; McCall SA, 2001, JNCI-J NATL CANCER I, V93, P148, DOI 10.1093/jnci/93.2.148; Nishio T, 1997, APPL ENVIRON MICROB, V63, P1594, DOI 10.1128/AEM.63.4.1594-1597.1997; Pittet B, 2005, LANCET INFECT DIS, V5, P94, DOI 10.1016/S1473-3099(05)01281-8; Rossini A, 2006, CANCER RES, V66, P6219, DOI 10.1158/0008-5472.CAN-05-4592; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siman JH, 1997, SCAND J GASTROENTERO, V32, P1215, DOI 10.3109/00365529709028150; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827; Xiong T, 2020, SENSOR ACTUAT B-CHEM, V304, DOI [10.1016/j.snb.2019.127310, 10.1126/scitranslmed.3009124]	40	240	255	9	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83744	10.1371/journal.pone.0083744	http://dx.doi.org/10.1371/journal.pone.0083744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421902	gold, Green Submitted, Green Published			2022-12-27	WOS:000329862500069
J	Chen, JQ; Shi, Y; Regan, J; Karuppaiah, K; Ornitz, DM; Long, FX				Chen, Jianquan; Shi, Yu; Regan, Jenna; Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin			Osx-Cre Targets Multiple Cell Types besides Osteoblast Lineage in Postnatal Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-FORMATION; OSTERIX; MOUSE; DIFFERENTIATION; MAINTENANCE; ACTIVATION; HEDGEHOG; ROLES	Osterix (Osx or Sp7) is a zinc-finger-family transcriptional factor essential for osteoblast differentiation in mammals. The Osx-Cre mouse line (also known as Osx1-GFP:: Cre) expresses GFP:: Cre fusion protein from a BAC transgene containing the Osx regulatory sequence. The mouse strain was initially characterized during embryogenesis, and found to target mainly osteoblast-lineage cells. Because the strain has been increasingly used in postnatal studies, it is important to evaluate its targeting specificity in mice after birth. By crossing the Osx-Cre mouse with the R26-mT/mG reporter line and analyzing the progenies at two months of age, we find that Osx-Cre targets not only osteoblasts, osteocytes and hypertrophic chondrocytes as expected, but also stromal cells, adipocytes and perivascular cells in the bone marrow. The targeting of adipocytes and perivascular cells appears to be specific to those residing within the bone marrow, as the same cell types elsewhere are not targeted. Beyond the skeleton, Osx-Cre also targets the olfactory glomerular cells, and a subset of the gastric and intestinal epithelium. Thus, potential contributions from the non-osteoblast-lineage cells should be considered when Osx-Cre is used to study gene functions in postnatal mice.	[Chen, Jianquan; Shi, Yu; Regan, Jenna; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	longf@wudosis.wustl.edu	Shi, Yu/J-5370-2018	Ornitz, David/0000-0003-1592-7629; Chen, Jianping/0000-0001-5685-8581; Regan, Jenna/0000-0002-6698-3340	National Institutes of Health [DK065789, AR055923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work is funded by National Institutes of Health grants DK065789 and AR055923 to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Joeng KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055134; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071318; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maes C, DEV CELL, V19, P329; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Park JS, 2011, BIOCHEM BIOPH RES CO, V407, P842, DOI 10.1016/j.bbrc.2011.03.129; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	26	255	264	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85161	10.1371/journal.pone.0085161	http://dx.doi.org/10.1371/journal.pone.0085161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454809	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100058
J	Wang, HJ; Wang, RZ; Xu, SH; Lakshmana, MK				Wang, Hongjie; Wang, Ruizhi; Xu, Shaohua; Lakshmana, Madepalli K.			RanBP9 Overexpression Accelerates Loss of Pre and Postsynaptic Proteins in the AP Delta E9 Transgenic Mouse Brain	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; SCAFFOLDING PROTEIN; TEMPORAL CORTEX; SYNAPTIC LOSS; HIPPOCAMPUS; SYNAPTOPHYSIN; ABNORMALITIES; DEPOSITION; DENDRITE	There is now compelling evidence that the neurodegenerative process in Alzheimer's disease (AD) begins in synapses. Loss of synaptic proteins and functional synapses in the amyloid precursor protein (APP) transgenic mouse models of AD is well established. However, what is the earliest age at which such loss of synapses occurs, and whether known markers of AD progression accelerate functional deficits is completely unknown. We previously showed that RanBP9 overexpression leads to robustly increased amyloid beta peptide (A beta) generation leading to enhanced amyloid plaque burden in a mouse model of AD. In this study we compared synaptic protein levels among four genotypes of mice, i.e., RanBP9 single transgenic (Ran), AP Delta E9 double transgenic (Dbl), AP Delta E9/RanBP9 triple transgenic (Tpl) and wild-type (WT) controls. We found significant reductions in the levels of synaptic proteins in both cortex and hippocampus of 5-and 6-months-old but not 3-or 4-months- old mice. Specifically, at 5-months of age, rab3A was reduced in the triple transgenic mice only in the cortex by 25% (p<0.05) and gap43 levels were reduced only in the hippocampus by 44% (p<0.01) compared to wild-type (WT) controls. Interestingly, RanBP9 overexpression in the Tpl mice reduced gap43 levels by a further 31% (p<0.05) compared to AP Delta E9 mice. RanBP9 also further decreased the levels of drebrin in the hippocampus by 32% (p<0.01) and chromogranin in the cortex by 24% (p<0.05) compared to APDE9 mice. At 6-months of age, RanBP9 expression in the cortex led to further reduction of rab3A by 30% (p<0.05) and drebrin by 38% (p<0.01) compared to APDE9 mice. RanBP9 also increased Ab oligomers in the cortex at 6 months. Similarly, in the hippocampus, RanBP9 expression further reduced rab3A levels by 36% (p<0.01) and drebrin levels by 33% (p<0.01). Taken together these data suggest that RanBP9 overexpression accelerates loss of synaptic proteins in the mouse brain.	[Wang, Hongjie; Wang, Ruizhi; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port Saint Lucie, FL USA; [Xu, Shaohua] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Torrey Pines Institute for Molecular Studies, Florida; Florida Institute of Technology	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, Neurobiol Sect, Port Saint Lucie, FL USA.	mlakshmana@tpims.org		Xu, Shaohua/0000-0003-1221-6354; Tang, Yamei/0000-0002-6353-6107	National Institutes of Health [1R03AG032064-01, 1R01AG036859-01]; NATIONAL INSTITUTE ON AGING [R03AG032064, R01AG036859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health grant numbers: 1R03AG032064-01, M. K. Lakshmana; 1R01AG036859-01, M. K. Lakshmana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Brasnjevic I, 2013, TRANSL NEUROSCI, V4, P8, DOI 10.2478/s13380-013-0111-8; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Heffernan JM, 1998, EXP NEUROL, V150, P235, DOI 10.1006/exnr.1997.6772; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Lakshmana MK, 2012, FASEB J, V26, P2072, DOI 10.1096/fj.11-196709; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Nistico R, 2012, EUR J NEURODEG DIS, V1, P21; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Palavicini JP, 2013, J ALZHEIMER IN PRESS; Provoda CJ, 2000, J BIOL CHEM, V275, P7004, DOI 10.1074/jbc.275.10.7004; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Roh S-E, 2013, FASEB J; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Sze CI, 2000, J NEUROL SCI, V175, P81, DOI 10.1016/S0022-510X(00)00285-9; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Wang H, 2013, J BIOL CHEM, V7; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	43	59	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85484	10.1371/journal.pone.0085484	http://dx.doi.org/10.1371/journal.pone.0085484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454876	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800047
J	Sun, YY; Chen, LN; Xu, RD; Kong, RQ				Sun, Yuanyuan; Chen, Lina; Xu, Rudan; Kong, Ruiqing			An Image Encryption Algorithm Utilizing Julia Sets and Hilbert Curves	PLOS ONE			English	Article							CRYPTANALYSIS	Image encryption is an important and effective technique to protect image security. In this paper, a novel image encryption algorithm combining Julia sets and Hilbert curves is proposed. The algorithm utilizes Julia sets' parameters to generate a random sequence as the initial keys and gets the final encryption keys by scrambling the initial keys through the Hilbert curve. The final cipher image is obtained by modulo arithmetic and diffuse operation. In this method, it needs only a few parameters for the key generation, which greatly reduces the storage space. Moreover, because of the Julia sets' properties, such as infiniteness and chaotic characteristics, the keys have high sensitivity even to a tiny perturbation. The experimental results indicate that the algorithm has large key space, good statistical property, high sensitivity for the keys, and effective resistance to the chosen-plaintext attack.	[Sun, Yuanyuan; Xu, Rudan; Kong, Ruiqing] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China; [Chen, Lina] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China	Dalian University of Technology; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Sun, YY (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China.	syuan@dlut.edu.cn			National Natural Science Foundation of China [61103147, 61075018, 61070098]; National Key Project of Science and Technology of China [2011ZX05039-003-4]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (No. 61103147, 61075018, 61070098, http://www.nsfc.gov.cn), the National Key Project of Science and Technology of China (No. 2011ZX05039-003-4, http://www.most.gov.cn) and the Fundamental Research Funds for the Central Universities (No. DUT12JB06, http://www.dlut.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Falconer KJ, 2003, FRACTAL MATH FDN APP; Hermassi H, 2010, COMMUN NONLINEAR SCI, V15, P2987, DOI 10.1016/j.cnsns.2009.11.022; Kumar S, 2006, MILCOM 2006, P1, DOI [10.1109/MILCOM.2006.302396, DOI 10.1109/MILCOM.2006.302396]; Li CQ, 2012, NONLINEAR DYNAM, V70, P2383, DOI 10.1007/s11071-012-0626-5; Li CQ, 2011, SIGNAL PROCESS, V91, P949, DOI 10.1016/j.sigpro.2010.09.014; Lin KT, 2012, OPT COMMUN, V285, P2335, DOI 10.1016/j.optcom.2012.01.028; Liu Wen-tao, 2008, Journal of China Academy of Electronics and Information Technology, V3, P580; Lock Abraham Jun Jiang, 2010, Proceedings Second International Conference on Computer Research and Development (ICCRD 2010), P213, DOI 10.1109/ICCRD.2010.40; Rozouvan V, 2009, OPT LASER ENG, V47, P1, DOI 10.1016/j.optlaseng.2008.09.001; Shyu SH, 2007, PATTERN RECOGN, V40, P1014, DOI 10.1016/j.patcog.2006.02.025; Tong XJ, 2009, SIGNAL PROCESS, V89, P480, DOI 10.1016/j.sigpro.2008.09.011; Yuan-yuan Sun, 2010, 2010 International Workshop on Chaos-Fractals Theories and Applications (IWCFTA 2010), P170, DOI 10.1109/IWCFTA.2010.70; Yuen CH, 2012, FRACTALS, V20, P41, DOI 10.1142/S0218348X12500041; Yuen CH, 2011, APPL SOFT COMPUT, V11, P5092, DOI 10.1016/j.asoc.2011.05.050	15	95	96	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84655	10.1371/journal.pone.0084655	http://dx.doi.org/10.1371/journal.pone.0084655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404181	Green Published, gold			2022-12-27	WOS:000329460800060
J	Martin-Serra, A; Figueirido, B; Palmqvist, P				Martin-Serra, Alberto; Figueirido, Borja; Palmqvist, Paul			A Three-Dimensional Analysis of Morphological Evolution and Locomotor Performance of the Carnivoran Forelimb	PLOS ONE			English	Article							FUNCTIONAL TRADE-OFFS; GEOMETRIC MORPHOMETRICS; BODY-SIZE; PREDATORY BEHAVIOR; LIMB MUSCLES; LATE MIOCENE; SKULL SHAPE; MAMMALIA; EXTANT; EXTINCT	In this study, three-dimensional landmark-based methods of geometric morphometrics are used for estimating the influence of phylogeny, allometry and locomotor performance on forelimb shape in living and extinct carnivorans (Mammalia, Carnivora). The main objective is to investigate morphological convergences towards similar locomotor strategies in the shape of the major forelimb bones. Results indicate that both size and phylogeny have strong effects on the anatomy of all forelimb bones. In contrast, bone shape does not correlate in the living taxa with maximum running speed or daily movement distance, two proxies closely related to locomotor performance. A phylomorphospace approach showed that shape variation in forelimb bones mainly relates to changes in bone robustness. This indicates the presence of biomechanical constraints resulting from opposite demands for energetic efficiency in locomotion -which would require a slender forelimb-and resistance to stress -which would be satisfied by a robust forelimb-. Thus, we interpret that the need of maintaining a trade-off between both functional demands would limit shape variability in forelimb bones. Given that different situations can lead to one or another morphological solution, depending on the specific ecology of taxa, the evolution of forelimb morphology represents a remarkable "one-to-many mapping'' case between anatomy and ecology.	[Martin-Serra, Alberto; Figueirido, Borja; Palmqvist, Paul] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain	Universidad de Malaga	Martin-Serra, A (corresponding author), Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain.	almarse@uma.es	Figueirido, Borja/AAV-7882-2020; Martín-Serra, Alberto/C-3460-2015; Figueirido, Borja/G-9665-2015; Palmqvist, Paul/B-5378-2013; Simoes, Nuno/D-9974-2011	Figueirido, Borja/0000-0003-2542-3977; Martín-Serra, Alberto/0000-0003-0221-1103; Figueirido, Borja/0000-0003-2542-3977; Palmqvist, Paul/0000-0002-6630-6956; Castillo Hernandez, Tania/0000-0002-9492-855X; Lopez-Rull, Isabel/0000-0002-3255-0459; Martinez, Ana/0000-0002-0515-1946; Simoes, Nuno/0000-0001-7490-3147; Mascaro, Maite/0000-0003-3614-4383	Spanish Ministry of Education PhD Research Fellowship (FPU); Spanish Ministry of Science and Innovation [CGL2008-04896, CGL2011-30334, CGL2012-37866]; Junta de Andalucia [Hum-7248]	Spanish Ministry of Education PhD Research Fellowship (FPU)(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	This study was supported by the Spanish Ministry of Education PhD Research Fellowship (FPU) to AMS, projects CGL2008-04896, CGL2011-30334 and CGL2012-37866 from the Spanish Ministry of Science and Innovation, and project Hum-7248 from Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; ALBERCH P, 1980, AM ZOOL, V20, P653; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Andersson K, 2005, PALEOBIOLOGY, V31, P56, DOI 10.1666/0094-8373(2005)031<0056:WTPCIT>2.0.CO;2; Andersson K, 2003, P ROY SOC B-BIOL SCI, V270, pS163, DOI 10.1098/rsbl.2003.0070; Andersson K, 2003, THESIS U UPPSALA SWE; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anyonge W, 1996, J ZOOL, V238, P395, DOI 10.1111/j.1469-7998.1996.tb05402.x; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Barone R, 1986, ANATOMIE COMP MAMMIF, V1; Beisiegel Beatriz de Mello, 2005, Mammalian Species, P1, DOI 10.1644/783.1; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1983, J EXP BIOL, V105, P147; BIEWENER AA, 1983, J EXP BIOL, V103, P131; Biewener AA., 2003, ANIMAL LOCOMOTION; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Ercoli MD, 2012, ZOOL J LINN SOC-LOND, V165, P224, DOI 10.1111/j.1096-3642.2011.00793.x; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; Diaz-Uriarte R, 1998, SYST BIOL, V47, P654, DOI 10.1080/106351598260653; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dryden IL, 1998, STAT ANAL SHAPE; Ewer, 1998, CARNIVORES; Fabre AC, 2013, J EVOLUTION BIOL, V26, P1521, DOI 10.1111/jeb.12161; Fabre AC, 2013, BIOL J LINN SOC, V110, P91, DOI 10.1111/bij.12103; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Figueirido B, 2010, J EVOLUTION BIOL, V23, P2579, DOI 10.1111/j.1420-9101.2010.02117.x; Figueirido B, 2013, EVOLUTION, V67, P1975, DOI 10.1111/evo.12059; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; Figueirido B, 2011, PALEOBIOLOGY, V37, P490, DOI 10.1666/09062.1; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; Gidaszewski NA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-110; GONYEA WJ, 1978, ACTA ANAT, V102, P111, DOI 10.1159/000145627; GOSLOW GE, 1981, J EXP BIOL, V94, P15; GUNNELL GF, 1998, EVOLUTION TERTIARY M, V1, P91; Halenar LB, 2011, ANAT REC, V294, P2048, DOI 10.1002/ar.21499; Hanna JB, 2006, AM J PHYS ANTHROPOL, V130, P529, DOI 10.1002/ajpa.20385; Harris MA, 1997, J ZOOL, V241, P381, DOI 10.1111/j.1469-7998.1997.tb01966.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hildebrand M., 1985, P38; Homberger DG, 2004, VERTEBRATE DISSECTIO; Hunt Robert M. Jr, 1998, P196; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Iwaniuk AN, 1999, BEHAV BRAIN RES, V99, P35, DOI 10.1016/S0166-4328(98)00067-9; Janis CM, 2012, J VERTEBR PALEONTOL, V32, P433, DOI 10.1080/02724634.2012.635737; Janis Christine M., 1993, Journal of Mammalian Evolution, V1, P103, DOI 10.1007/BF01041590; Janis CM, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P1, DOI 10.1017/CBO9780511541438; Kardong K., 2006, VERTEBRATES COMP ANA; Kemp TJ, 2005, J EXP BIOL, V208, P3475, DOI 10.1242/jeb.01814; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Klingenberg CP, 2011, MORPHOJ; Koepfli KP, 2007, MOL PHYLOGENET EVOL, V43, P1076, DOI 10.1016/j.ympev.2006.10.003; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Krausman Paul R., 2005, Mammalian Species, P1; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Lee DV, 1999, J EXP BIOL, V202, P3565; MacLeod N, 2001, PALEOBIOLOGY, V27, P226, DOI 10.1666/0094-8373(2001)027<0226:TROPIQ>2.0.CO;2; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin LD, 1998, EVOLUTION TERTIARY M, P228; McLellan B, 1994, BEARS THEIR BIOL MAN, P85; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Meachen-Samuels JA, 2012, PALEOBIOLOGY, V38, P1, DOI 10.1666/10036.1; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Meloro C, 2013, PALEOBIOLOGY, V39, P323, DOI 10.1666/12001; Midford P.E., 2008, PDAP PACKAGE MESQUIT; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Morlo M, 2004, ZOOL J LINN SOC-LOND, V140, P43, DOI 10.1111/j.1096-3642.2004.00087.x; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Osborn HF, 1900, B AM MUS NAT HIST, V13, P269; Pasi BM, 2003, J EVOLUTION BIOL, V16, P324, DOI 10.1046/j.1420-9101.2003.00512.x; Peigne S, 2003, ZOOL SCR, V32, P199, DOI 10.1046/j.1463-6409.2003.00116.x; Polly P. David, 2008, P167, DOI 10.1007/978-1-4020-6997-0_9; Polly PD, 2001, AM NAT, V157, P596, DOI 10.1086/320622; Raichlen DA, 2009, AM J PHYS ANTHROPOL, V138, P395, DOI 10.1002/ajpa.20952; REYNOLDS TR, 1985, AM J PHYS ANTHROPOL, V67, P335, DOI 10.1002/ajpa.1330670406; Rohlf F. James, 2002, VVolume 64, P175; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rothwell T, 2003, AM MUS NOV, V3403; Salesa MJ, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P27, DOI 10.1016/B978-1-4377-7813-7.00003-3; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Samuels JX, 2013, J MORPHOL, V274, P121, DOI 10.1002/jmor.20077; Sanger TJ, 2012, EVOLUTION, V66, P1525, DOI 10.1111/j.1558-5646.2011.01519.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schmitt D, 2002, AM J PHYS ANTHROPOL, V118, P231, DOI 10.1002/ajpa.10048; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Schutz H, 2007, ZOOL J LINN SOC-LOND, V150, P895, DOI 10.1111/j.1096-3642.2007.00303.x; Schwenk K, 2003, KEYWORDS CONCEPTS EV, P52; Singleton M, 2012, EVOL BIOL, V39, P499, DOI 10.1007/s11692-011-9153-4; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Sorkin B, 2008, LETHAIA, V41, P333, DOI 10.1111/j.1502-3931.2007.00091.x; SPOOR CF, 1986, ANAT ANZEIGER, V161, P375; Stein BR, 1997, J ZOOL, V242, P185, DOI 10.1111/j.1469-7998.1997.tb02939.x; STEUDEL K, 1993, J MORPHOL, V217, P55, DOI 10.1002/jmor.1052170105; STRANG KT, 1990, J ZOOL, V221, P343, DOI 10.1111/j.1469-7998.1990.tb04006.x; Taylor M.E., 1989, P382; Turner A., 1997, BIG CATS THEIR FOSSI; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Wallace SC, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P43, DOI 10.1016/B978-1-4377-7813-7.00004-5; Walmsley A, 2012, J MORPHOL, V273, P1424, DOI 10.1002/jmor.20084; Walter RM, 2007, J EXP BIOL, V210, P208, DOI 10.1242/jeb.02645; Wang XM, 1999, B AM MUS NAT HIST, P1; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431; Wilson DE, 2009, HDB MAMMALS WORLD, V1; Wortman, 1894, B AM MUS NAT HIST, V6, P129; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x	126	64	64	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85574	10.1371/journal.pone.0085574	http://dx.doi.org/10.1371/journal.pone.0085574			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	25229639	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100101
J	Adams, J; Light, R				Adams, Jimi; Light, Ryan			Mapping Interdisciplinary Fields: Efficiencies, Gaps and Redundancies in HIV/AIDS Research	PLOS ONE			English	Article								While interdisciplinarity continues to increase in popularity among funders and other scientific organizations, its potential to promote scientific advances remains under-examined. For HIV/AIDS research, we examine the dynamics of disciplinary integration (or lack thereof) providing insight into a field's knowledge base and those questions that remain unresolved. Drawing on the complete histories of two interdisciplinary journals, we construct bibliographic coupling networks based on overlapping citations to identify segregation into research clusters and estimate topic models of research content. We then compare how readily those bibliographic coupling clusters account for the structuring of topics covered within the field as it evolves over two decades. These comparisons challenge one-dimensional and/or cross-sectional approaches to interdisciplinarity. Some topics are increasingly coordinated across disciplinary boundaries (e. g., vaccine development); others remain relatively segmented into disconnected disciplinary domains for the full period (e. g., drug resistance). This divergence indicates heterogeneity in interdisciplinarity and emphasizes the need for critical approaches to studying the organization of science.	[Adams, Jimi] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Light, Ryan] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA	University of Colorado System; University of Colorado Denver; University of Oregon	Adams, J (corresponding author), Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA.	jimi.adams@ucdenver.edu	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; [Anonymous], 1992, ASA P STAT GRAPH SEC; [Anonymous], PREP FUT HIV AIDS AF; [Anonymous], CULTURAL BOUNDARIES; [Anonymous], 2012, AIDS 30 HIST; [Anonymous], SCI SCI SCI2 TOOL; Bettencourt LMA, 2008, SCIENTOMETRICS, V75, P495, DOI 10.1007/s11192-007-1888-4; Bettencourt LMA, 2011, P NATL ACAD SCI USA, V108, P19540, DOI 10.1073/pnas.1102712108; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Crane D., 1972, INVISIBLE COLL DIFFU; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Garfield E, 2001, BIBLIOGRAPHIC COUPLI; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Jacobs J., 2013, DEFENSE DISCIPLINES; Jacobs JA, 2009, ANNU REV SOCIOL, V35, P43, DOI 10.1146/annurev-soc-070308-115954; Klavans R, 2006, J AM SOC INF SCI TEC, V57, P251, DOI 10.1002/asi.20274; Knorr-Cetina K., 1999, EPISTEMIC CULTURES S; Leydesdorff L, 2006, J AM SOC INF SCI TEC, V57, P1616, DOI 10.1002/asi.20335; Manton KG, 2009, P NATL ACAD SCI USA, V106, P10981, DOI 10.1073/pnas.0905104106; Moody James, 2006, AM SOCIOL, V37, P67; National Academy of Sciences, 2005, FAC INT RES; National Institutes of Health, 2007, NIH NEWS; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160; Shwed U, 2010, AM SOCIOL REV, V75, P817, DOI 10.1177/0003122410388488; Small H, 2010, SCIENTOMETRICS, V83, P835, DOI 10.1007/s11192-009-0121-z; Steyvers M, 2007, HDB LATENT SEMANTIC; Wilbur W John, 2002, Pac Symp Biocomput, P386; Yan EJ, 2012, J AM SOC INF SCI TEC, V63, P1313, DOI 10.1002/asi.22680	38	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115092	10.1371/journal.pone.0115092	http://dx.doi.org/10.1371/journal.pone.0115092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506703	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100048
J	Tang, Y; He, H; Cheng, N; Song, YL; Ding, WJ; Zhang, YF; Zhang, WH; Zhang, J; Peng, H; Jiang, H				Tang, Yi; He, Hua; Cheng, Ning; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Wenhao; Zhang, Jie; Peng, Heng; Jiang, Hua			PDGF, NT-3 and IGF-2 in Combination Induced Transdifferentiation of Muscle-Derived Stem Cells into Schwann Cell-Like Cells	PLOS ONE			English	Article							DIFFERENTIATION; REGENERATION	Muscle-derived stem cells (MDSCs) are multipotent stem cells with a remarkable long-term self-renewal and regeneration capacity. Here, we show that postnatal MDSCs could be transdifferentiated into Schwann cell-like cells upon the combined treatment of three neurotrophic factors (PDGF, NT-3 and IGF-2). The transdifferentiation of MDSCs was initially induced by Schwann cell (SC) conditioned medium. MDSCs adopted a spindle-like morphology similar to SCs after the transdifferentiation. Immunocytochemistry and immunoblot showed clearly that the SC markers S100, GFAP and p75 were expressed highly only after the transdifferentiation. Flow cytometry assay showed that the portion of S100 expressed cells was more than 60 percent and over one fourth of the transdifferentiated cells expressed all the three SC markers, indicating an efficient transdifferentiation. We then tested neurotrophic factors in the conditioned medium and found it was PDGF, NT-3 and IGF-2 in combination that conducted the transdifferentiation. Our findings demonstrate that it is possible to use specific neurotrophic factors to transdifferentiate MDSCs into Schwann cell-like cells, which might be therapeutically useful for clinical applications.	[Tang, Yi; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Jie; Jiang, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China; [Tang, Yi] 411 Hosp CPLA, Dept Plast Surg, Shanghai, Peoples R China; [He, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Cheng, Ning] Second Mil Med Univ, Changhai Hosp, Dept Transfus, Shanghai, Peoples R China; [Zhang, Wenhao] Shanghai Jiao Tong Univ, XinHua Hosp, Dept Hematol, Sch Med, Shanghai 200030, Peoples R China; [Peng, Heng] Hong Kong Baptist Univ, Dept Math, Kowloon, Hong Kong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Hong Kong Baptist University	Jiang, H (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China.	lmiao.simm@gmail.com	Peng, Heng/B-7152-2009; Johnson, William/N-1972-2017	Peng, Heng/0000-0001-7807-8527; Johnson, William/0000-0002-3823-4094	National Natural Science Foundation of China [81100950]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81100950. Website http://www.nsfc.gov.cn no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; Cheng HL, 1999, ENDOCRINOLOGY, V140, P4478, DOI 10.1210/en.140.10.4478; Cohen RI, 1999, J EXP BIOL, V202, P461; Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463; Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; GUENARD V, 1992, J NEUROSCI, V12, P3310; Ide C, 1996, NEUROSCI RES, V25, P101; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Keilhoff G, 2000, NEUROREPORT, V11, P3805, DOI 10.1097/00001756-200011270-00042; Keilhoff G, 1999, J NEUROSCI METH, V89, P17, DOI 10.1016/S0165-0270(99)00034-5; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192; Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Zhao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041506	22	62	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e73402	10.1371/journal.pone.0073402	http://dx.doi.org/10.1371/journal.pone.0073402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24637790	Green Submitted, Green Published, gold			2022-12-27	WOS:000329925800001
J	Xie, YH; Chongsuvivatwong, V; Tang, ZZ; McNeil, EB; Tan, Y				Xie, Yi-hong; Chongsuvivatwong, Virasakdi; Tang, Zhenzhu; McNeil, Edward B.; Tan, Yi			Spatio-Temporal Clustering of Hand, Foot, and Mouth Disease at the County Level in Guangxi, China	PLOS ONE			English	Article							ENTEROVIRUS 71; OUTBREAK; EPIDEMIOLOGY; SURVEILLANCE; INFECTION	Background: Amid numerous outbreaks of hand, foot and mouth disease (HFMD) in Asia over the past decade, studies on spatio-temporal clustering are limited. Without this information the distribution of severe cases assumed to be sporadic. We analyzed surveillance data with onset dates between 1 May 2008 to 31 October 2013 with the aim to document the spatio-temporal clustering of HFMD cases and severe cases at the county level. Methods: Purely temporal and purely spatial descriptive analyses were done. These were followed by a space-time scan statistic for the whole study period and by year to detect the high risk clusters based on a discrete Poisson model. Results: The annual incidence rate of HFMD in Guangxi increased whereas the severe cases peaked in 2010 and 2012. EV71 and CoxA16 were alternating viruses. Both HFMD cases and severe cases had a seasonal peak in April to July. The spatio-temporal cluster of HFMD cases were mainly detected in the northeastern, central and southwestern regions, among which three clusters were observed in Nanning, Liuzhou, Guilin city and their neighbouring areas lasting from 1.2 to 2.5 years. The clusters of severe cases were less consistent in location and included around 40-70% of all severe cases in each year. Conclusions: Both HFMD cases and severe cases occur in spatio-temporal clusters. The continuous epidemic in Nanning, Liuzhou, Guilin cities and their neighbouring areas and the clusters of severe cases indicate the need for further intensive surveillance.	[Xie, Yi-hong; Tang, Zhenzhu; Tan, Yi] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Nanning, Guangxi, Peoples R China; [Xie, Yi-hong; Chongsuvivatwong, Virasakdi; McNeil, Edward B.] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand; [Xie, Yi-hong] Minist Publ Hlth, Bur Epidemiol, Int Field Epidemiol Training Program, Bangkok, Thailand	Prince of Songkla University; Ministry of Public Health - Thailand	Chongsuvivatwong, V (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand.	cvirasak@gmail.com	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; McNeil, Edward Braddon/0000-0002-9492-1040				AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [别芹芹 Bie Qinqin], 2010, 地球信息科学学报, V12, P380; BLOMBERG J, 1974, LANCET, V2, P112; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chen Jin, 2008, Int J Health Geogr, V7, P57, DOI 10.1186/1476-072X-7-57; Chinese Center for Disease Control and Prevention and the Office of the World Health Organization in China, 2008, REP HAND FOOT MOUTH; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Infectious Disease Surveillance Centre (IDSC) National Institute of Infectious Diseases (NID) Japan, 2004, INFECT AGENTS SURVEI, V25, P224; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2011, SATSCAN TM USER GUID; Li LL, 2013, PRACTICAL PREVENTIVE, V20, P165; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063447, 10.1371/journal.pone.0076105]; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ma JQ, 2006, DIS SURVEILL, V21, P600; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Ru Wei-Ping, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P448; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shekhar K, 2005, Med J Malaysia, V60, P297; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tango T, 2012, STAT MED, V31, P4207, DOI 10.1002/sim.5478; The Ministry of Health of China, 2010, HAND FOOT MON DIS DI; The Ministry of Health of China, 2008, HAND FOOT MON DIS PR; The Ministry of Health of China, 2009, HAND FOOT MOUTH DIS; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang Ying, 2010, Disease Surveillance, V25, P774; Western Pacific Region WHO, 2013, HAND FOOT MOUTH DIS; Xiao GeXin, 2012, Disease Surveillance, V27, P932; Yu SC, 2012, BIOMED ENVIRON SCI, V25, P645, DOI 10.3967/0895-3988.2012.06.006; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zhu Qi, 2011, Modern Preventive Medicine, V38, P1824	46	65	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88065	10.1371/journal.pone.0088065	http://dx.doi.org/10.1371/journal.pone.0088065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505378	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200108
J	Lunt, H; Draper, N; Marshall, HC; Logan, FJ; Hamlin, MJ; Shearman, JP; Cotter, JD; Kimber, NE; Blackwell, G; Frampton, CMA				Lunt, Helen; Draper, Nick; Marshall, Helen C.; Logan, Florence J.; Hamlin, Michael J.; Shearman, Jeremy P.; Cotter, James D.; Kimber, Nicholas E.; Blackwell, Gavin; Frampton, Christopher M. A.			High Intensity Interval Training in a Real World Setting: A Randomized Controlled Feasibility Study in Overweight Inactive Adults, Measuring Change in Maximal Oxygen Uptake	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; LOW-VOLUME; EXERCISE; ADAPTATIONS; OLDER; RISK; DISEASE; HEALTH; MUSCLE	Background: In research clinic settings, overweight adults undertaking HIIT (high intensity interval training) improve their fitness as effectively as those undertaking conventional walking programs but can do so within a shorter time spent exercising. We undertook a randomized controlled feasibility (pilot) study aimed at extending HIIT into a real world setting by recruiting overweight/obese, inactive adults into a group based activity program, held in a community park. Methods: Participants were allocated into one of three groups. The two interventions, aerobic interval training and maximal volitional interval training, were compared with an active control group undertaking walking based exercise. Supervised group sessions (36 per intervention) were held outdoors. Cardiorespiratory fitness was measured using VO(2)max (maximal oxygen uptake, results expressed in ml/min/kg), before and after the 12 week interventions. Results: On ITT (intention to treat) analyses, baseline (N = 49) and exit (N = 39) VO2 was 25.3+/-4.5 and 25.3+/-3.9, respectively. Participant allocation and baseline/exit VO(2)max by group was as follows: Aerobic interval training N = 16, 24.2+/-4.8/ 25.6+/-4.8; maximal volitional interval training N = 16, 25.0+/-2.8/25.2+/-3.4; walking N = 17, 26.5+/-5.3/25.2+/-3.6. The post intervention change in VO(2)max was +1.01 in the aerobic interval training, 20.06 in the maximal volitional interval training and 21.03 in the walking subgroups. The aerobic interval training subgroup increased VO(2)max compared to walking (p = 0.03). The actual (observed, rather than prescribed) time spent exercising (minutes per week, ITT analysis) was 74 for aerobic interval training, 45 for maximal volitional interval training and 116 for walking (p = 0.001). On descriptive analysis, the walking subgroup had the fewest adverse events. Conclusions: In contrast to earlier studies, the improvement in cardiorespiratory fitness in a cohort of overweight/obese participants undertaking aerobic interval training in a real world setting was modest. The most likely reason for this finding relates to reduced adherence to the exercise program, when moving beyond the research clinic setting.	[Lunt, Helen; Logan, Florence J.] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Draper, Nick; Marshall, Helen C.; Blackwell, Gavin] Univ Canterbury, Christchurch 1, New Zealand; [Hamlin, Michael J.] Lincoln Univ, Lincoln, New Zealand; [Shearman, Jeremy P.; Kimber, Nicholas E.] Christchurch Polytech Inst Technol, Christchurch, New Zealand; [Cotter, James D.] Univ Otago, Dunedin, New Zealand; [Lunt, Helen; Frampton, Christopher M. A.] Univ Otago, Christchurch, New Zealand	University of Canterbury; Christchurch Polytechnic Institute of Technology; University of Otago; University of Otago	Lunt, H (corresponding author), Canterbury Dist Hlth Board, Christchurch, New Zealand.	helen.lunt@cdhb.health.nz	Hamlin, Michael/D-7513-2018	Hamlin, Michael/0000-0001-7941-8554; Kimber, Nick/0000-0002-5323-2767; Lunt, Helen/0000-0003-0069-7402; Marshall, Helen/0000-0002-8271-8969	DHBRF (District Health Board Research Fund), New Zealand; DHBRF	DHBRF (District Health Board Research Fund), New Zealand; DHBRF	The study was funded by the DHBRF (District Health Board Research Fund), New Zealand. The DHBRF is a government funded organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2006, ACMS GUID EX TEST PR; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Courneya KS, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-81; CPMP, 2001, BRIT J CLIN PHARMACO, V52, P223; Edge J, 2013, EXP PHYSIOL, V98, P481, DOI 10.1113/expphysiol.2012.067603; Feinman RD, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-1; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gibala MJ, 2010, J PHYSIOL-LONDON, V588, P3341, DOI 10.1113/jphysiol.2010.196303; Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236; Heydari M, 2012, J OBES, V2012, DOI 10.1155/2012/480467; Korkiakangas EE, 2009, HEALTH PROMOT INT, V24, P416, DOI 10.1093/heapro/dap031; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; LERMAN J, 1976, ARCH PHYS MED REHAB, V57, P355; Linke SE, 2011, ANN BEHAV MED, DOI [10.10007/s12160-011-9279-8, DOI 10.10007/S12160-011-9279-8]; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Murias JM, 2010, J APPL PHYSIOL, V108, P621, DOI 10.1152/japplphysiol.01152.2009; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Whitehurst M, 2012, AM J LIFESTYLE MED, V6, P382, DOI 10.1177/1559827612450262; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Woods K, 2007, SPORTS MED, V37, P1089, DOI 10.2165/00007256-200737120-00006	35	86	87	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83256	10.1371/journal.pone.0083256	http://dx.doi.org/10.1371/journal.pone.0083256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454698	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500006
J	Pane, M; Mazzone, ES; Sormani, MP; Messina, S; Vita, GL; Fanelli, L; Berardinelli, A; Torrente, Y; D'Amico, A; Lanzillotta, V; Viggiano, E; D'Ambrosio, P; Cavallaro, F; Frosini, S; Bello, L; Bonfiglio, S; Scalise, R; De Sanctis, R; Rolle, E; Bianco, F; Van der Haawue, M; Magri, F; Palermo, C; Rossi, F; Donati, MA; Alfonsi, C; Sacchini, M; Arnoldi, MT; Baranello, G; Mongini, T; Pini, A; Battini, R; Pegoraro, E; Previtali, SC; Napolitano, S; Bruno, C; Politano, L; Comi, GP; Bertini, E; Morandi, L; Gualandi, F; Ferlini, A; Goemans, N; Mercuri, E				Pane, Marika; Mazzone, Elena S.; Sormani, Maria Pia; Messina, Sonia; Vita, Gian Luca; Fanelli, Lavinia; Berardinelli, Angela; Torrente, Yvan; D'Amico, Adele; Lanzillotta, Valentina; Viggiano, Emanuela; D'Ambrosio, Paola; Cavallaro, Filippo; Frosini, Silvia; Bello, Luca; Bonfiglio, Serena; Scalise, Roberta; De Sanctis, Roberto; Rolle, Enrica; Bianco, Flaviana; Van der Haawue, Marlene; Magri, Francesca; Palermo, Concetta; Rossi, Francesca; Donati, Maria Alice; Alfonsi, Chiara; Sacchini, Michele; Arnoldi, Maria Teresa; Baranello, Giovanni; Mongini, Tiziana; Pini, Antonella; Battini, Roberta; Pegoraro, Elena; Previtali, Stefano C.; Napolitano, Sara; Bruno, Claudio; Politano, Luisa; Comi, Giacomo P.; Bertini, Enrico; Morandi, Lucia; Gualandi, Francesca; Ferlini, Alessandra; Goemans, Nathalie; Mercuri, Eugenio			6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; RESTORATION; PROTEIN	Objective: In the last few years some of the therapeutical approaches for Duchenne muscular dystrophy (DMD) are specifically targeting distinct groups of mutations, such as deletions eligible for skipping of individual exons. The aim of this observational study was to establish whether patients with distinct groups of mutations have different profiles of changes on the 6 minute walk test (6MWT) over a 12 month period. Methods: The 6MWT was performed in 191 ambulant DMD boys at baseline and 12 months later. The results were analysed using a test for heterogeneity in order to establish possible differences among different types of mutations (deletions, duplications, point mutations) and among subgroups of deletions eligible to skip individual exons. Results: At baseline the 6MWD ranged between 180 and 560,80 metres (mean 378,06, SD 74,13). The 12 month changes ranged between -325 and 175 (mean -10.8 meters, SD 69.2). Although boys with duplications had better results than those with the other types of mutations, the difference was not significant. Similarly, boys eligible for skipping of the exon 44 had better baseline results and less drastic changes than those eligible for skipping exon 45 or 53, but the difference was not significant. Conclusions: even if there are some differences among subgroups, the mean 12 month changes in each subgroup were all within a narrow Range: from the mean of the whole DMD cohort. This information will be of help at the time of designing clinical trials with small numbers of eligible patients.	[Pane, Marika; Mazzone, Elena S.; Fanelli, Lavinia; Scalise, Roberta; De Sanctis, Roberto; Bianco, Flaviana; Palermo, Concetta; Alfonsi, Chiara; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Dept Paediat Neurol, I-00168 Rome, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Biostat Unit, I-16126 Genoa, Italy; [Messina, Sonia; Vita, Gian Luca; Cavallaro, Filippo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, Messina, Italy; [Berardinelli, Angela] C Mondino Fdn, Child Neurol & Psychiat Unit, Pavia, Italy; [Torrente, Yvan; Magri, Francesca; Comi, Giacomo P.] Univ Milan, Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr,Neurosci Sect,Neurol Unit, Milan, Italy; [D'Amico, Adele; Bertini, Enrico] Bambino Gesu Pediat Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Dis, Rome, Italy; [Lanzillotta, Valentina; Bruno, Claudio] G Gaslini Inst Children, Neuromuscular Dis Unit, Genoa, Italy; [Viggiano, Emanuela; D'Ambrosio, Paola; Politano, Luisa] Univ Naples 2, Dipartimento Med Sperimentale, Naples, Italy; [Frosini, Silvia; Battini, Roberta] Univ Pisa, Stella Maris Inst, Dept Dev Neurosci, Pisa, Italy; [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy; [Bonfiglio, Serena; Pini, Antonella] IRCCS Ist Sci Neurol, Child Neurol & Psychiat Unit, Bologna, Italy; [Rolle, Enrica; Mongini, Tiziana] Univ Turin, SG Battista Hosp, Neuromuscular Ctr, Turin, Italy; [Van der Haawue, Marlene; Rossi, Francesca; Goemans, Nathalie] Pediat Neurol KU Gasthuisberg, Louvain, Belgium; [Donati, Maria Alice; Sacchini, Michele] Meyer Hosp, Metab & Neuromuscular Unit, Florence, Italy; [Arnoldi, Maria Teresa; Baranello, Giovanni] Ist Neurol Besta, Dev Neurol Unit, Milan, Italy; [Previtali, Stefano C.; Napolitano, Sara] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Morandi, Lucia] Ist Neurol Besta, Neuromuscular Dis & Immunol Unit, Milan, Italy; [Gualandi, Francesca; Ferlini, Alessandra] Univ Ferrara, Dept Expt & Diagnost Med, Med Genet Sect, I-44100 Ferrara, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Genoa; University of Messina; IRCCS Fondazione Casimiro Mondino; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Campania Vanvitelli; IRCCS Fondazione Stella Maris; University of Pisa; University of Padua; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Neurologico Besta; University of Ferrara	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Dept Paediat Neurol, I-00168 Rome, Italy.	mercuri@rm.unicatt.it	D'Ambrosio, Paola/AAC-6109-2021; pini, antonella/AAB-9171-2020; Viggiano, Emanuela/T-5332-2019; Bertini, Enrico/ABG-1278-2020; Gualandi, Francesca/K-7513-2016; Sormani, Maria Pia/ABH-8756-2020; Berardinelli, angela/AAA-9496-2019; Previtali, Stefano/Z-1962-2019; Comi, Giacomo P/K-5702-2016; d'amico, adele/J-9203-2016; Vita, Gianluca/AAR-4587-2020; Bruno, Claudio/A-3148-2015; Bertini, Enrico/A-2284-2014; Scalise, Roberta/AAC-2345-2022; Arnoldi, Maria Teresa/AAJ-2217-2021; Mazzone, Elena/AAF-4444-2020; Magri, Francesca/K-5739-2016; POLITANO, LUISA/AAK-6885-2020; battini, roberta/P-9095-2017; Mercuri, Eugenio/G-1351-2015	D'Ambrosio, Paola/0000-0002-9204-5622; pini, antonella/0000-0003-3603-5478; Gualandi, Francesca/0000-0001-9551-057X; Previtali, Stefano/0000-0003-2546-4357; Comi, Giacomo P/0000-0002-1383-5248; d'amico, adele/0000-0003-2438-2624; Vita, Gianluca/0000-0003-4190-8042; Bruno, Claudio/0000-0002-3426-2901; Bertini, Enrico/0000-0001-9276-4590; Scalise, Roberta/0000-0002-9141-7842; Arnoldi, Maria Teresa/0000-0002-3920-5869; Magri, Francesca/0000-0001-8974-9453; battini, roberta/0000-0002-7889-1355; SORMANI, MARIA PIA/0000-0001-6892-104X; Viggiano, Emanuela/0000-0002-9864-2620; Messina, Sonia/0000-0001-7994-3391; Bello, Luca/0000-0002-3075-6525; Mercuri, Eugenio/0000-0002-9851-5365; FERLINI, ALESSANDRA/0000-0001-8385-9870; Frosini, Silvia/0000-0001-6169-4382; Napolitano, Sara/0000-0003-2145-7395; berardinelli, angela/0000-0002-4645-8055; Pane, Marika/0000-0002-4851-6124; Rossi, Francesca/0000-0002-1335-5121; MARIA ALICE, DONATI/0000-0003-4769-5025	Telethon Italy; Telethon UILDM Grant [GUP07009, GUP9010]	Telethon Italy(Fondazione Telethon); Telethon UILDM Grant(Fondazione Telethon)	Elena Mazzone is a TREAT NMD research fellow funded by Telethon Italy. These data were collected in the context of the DMD Italian Network, supported by the Telethon UILDM Grant GUP07009 (to E. Mercuri) and GUP9010 (to S. Messina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2012, METHODS MOL BIOL, V867, P97, DOI 10.1007/978-1-61779-767-5_7; Aartsma-Rus A, 2010, ANN NY ACAD SCI, V1214, P199, DOI 10.1111/j.1749-6632.2010.05836.x; Arechavala-Gomeza V, 2012, CURR GENE THER, V12, P152, DOI 10.2174/156652312800840621; Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Flanigan KM, 2012, ANN NEUROL; Foster H, 2012, HUM GENE THER, V23, P676, DOI 10.1089/hum.2012.099; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Henricson E, 2012, PLOS CURR, V4; Kesari A, 2008, HUM MUTAT, V29, P728, DOI 10.1002/humu.20722; Laing Nigel G, 2011, Clin Biochem Rev, V32, P129; Lourbakos A, 2011, NEUROMUSCULAR DISORD, V21, P643, DOI 10.1016/j.nmd.2011.06.766; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Muntoni F, 2010, Neuromuscul Disord, V20, P355, DOI 10.1016/j.nmd.2010.03.005; Muntoni F, 2011, NAT REV DRUG DISCOV, V10, P621, DOI 10.1038/nrd3459; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Ommen GJ, 2008, CURR OPIN MOL THER, V10, P140	26	65	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83400	10.1371/journal.pone.0083400	http://dx.doi.org/10.1371/journal.pone.0083400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421885	Green Published, gold			2022-12-27	WOS:000329862500046
J	Xie, YJ; Stewart, SM; Lam, TH; Viswanath, K; Chan, SS				Xie, Yao Jie; Stewart, Sunita M.; Lam, Tai Hing; Viswanath, Kasisomayajula; Chan, Sophia S.			Television Viewing Time in Hong Kong Adult Population: Associations with Body Mass Index and Obesity	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; SCREEN-TIME; RISK; HEALTH; BEHAVIORS; MEDICINE; CHILDREN; LEISURE	Background: Obesity is increasing dramatically in the Asia-Pacific region particularly China. The population of Hong Kong was exposed to modernization far earlier than the rest of China, reflecting conditions that are likely to be replicated as other Chinese cities undergo rapid change. This study examined the relationship between television viewing and obesity in a Hong Kong sample. Information about the relationship between a key sedentary behavior, TV viewing, and obesity, and its moderation by demographic characteristics may identify sectors of the population at highest risk for excess weight. Methods: Data were from Hong Kong Family and Health Information Trends Survey (2009-2010), a population-based survey on the public's use of media for health information and family communication by telephone interviews with 3,016 Hong Kong adults (age >= 18 years). TV viewing time, body mass index (BMI), physical activity and other lifestyle variables were analyzed. Results: Viewing time was longer in women, increased with age but decreased with education level and vigorous physical activity (all P<0.01). Longer TV viewing time was significantly associated with higher BMI (Coefficients B = 0.17, 95% CI: 0.11, 0.24) after adjusting for age, gender, employment status, marital status, education level, smoking activity and vigorous physical activity. This association was stronger in women than men (Coefficients B: 0.19 versus 0.15) and strongest in those aged 18 to 34 years (Coefficients B = 0.35). Furthermore, an hour increase in daily TV viewing was associated with 10% greater odds of being obese. Conclusions: A significant socioeconomic gradient in television viewing time was observed. TV viewing time positively associated with BMI and obesity. The TV viewing - BMI associations were strongest in women and young adults, suggesting vulnerable groups to target for obesity prevention by decreasing TV viewing.	[Xie, Yao Jie; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Stewart, Sunita M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Ctr Community Based Res,Dept Soc & Behav Sci, Boston, MA 02115 USA; [Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; McNeil, Edward Braddon/0000-0002-9492-1040	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This study was a part of the project "FAMILY: A Jockey Club Initiative for a Harmonious Society," which was funded by The Hong Kong Jockey Club Charities Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Banks E, 2011, PUBLIC HEALTH NUTR, V14, P34, DOI 10.1017/S1368980010000674; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Brown PR, 2001, LEISURE SCI, V23, P131, DOI 10.1080/014904001316896837; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Ching PLYH, 1996, AM J PUBLIC HEALTH, V86, P25, DOI 10.2105/AJPH.86.1.25; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; DURANT RH, 1994, PEDIATRICS, V94, P449; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FitzGerald SJ, 1997, MED SCI SPORT EXER, V29, P910, DOI 10.1097/00005768-199707000-00010; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Griffiths SM, 2010, ASIA-PAC J PUBLIC HE, V22, p110S, DOI 10.1177/1010539510373000; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Huang WY, 2013, J SCI MED SPORT, V16, P509, DOI 10.1016/j.jsams.2012.12.011; Inoue S, 2012, J EPIDEMIOL, V22, P50, DOI 10.2188/jea.JE20110054; King AC, 2008, ANN BEHAV MED, V35, P251, DOI 10.1007/s12160-008-9032-0; Lobstein T, 2005, OBES REV, V6, P203, DOI 10.1111/j.1467-789X.2005.00191.x; Mamun AA, 2012, PUBLIC HEALTH NUTR, V12, P1; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Scully M, 2009, PUBLIC HEALTH NUTR, V12, P105, DOI 10.1017/S1368980008002012; Teychenne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-3; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; Viswanath K SR, 2007, MACROSOCIAL DETERMIN, P275; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; World Health Organization, 2000, AS PAC PERSP RED OB; Xu F, 2008, PUBLIC HEALTH NUTR, V11, P891, DOI 10.1017/S1368980007001280; Zuzanna B, 2008, MCMASTER J COMMUNICA, V5	44	65	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85440	10.1371/journal.pone.0085440	http://dx.doi.org/10.1371/journal.pone.0085440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24505378	gold, Green Submitted, Green Published			2022-12-27	WOS:000329868200050
J	Liu, AQ; Yang, FK; Shen, YJ; Zhang, WZ; Wang, RJ; Zhao, W; Zhang, LX; Ling, H; Cao, JP				Liu, Aiqin; Yang, Fengkun; Shen, Yujuan; Zhang, Weizhe; Wang, Rongjun; Zhao, Wei; Zhang, Longxian; Ling, Hong; Cao, Jianping			Genetic Analysis of the Gdh and Bg Genes of Animal-Derived Giardia duodenalis Isolates in Northeastern China and Evaluation of Zoonotic Transmission Potential	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; DAIRY-CATTLE; IDENTIFICATION; GENOTYPES; CRYPTOSPORIDIUM; LAMBLIA; HUMANS; LOCUS; ASSEMBLAGES	Background: Giardia duodenalis is a common intestinal parasite that infects humans and many other mammals, mainly distributing in some areas with poor sanitation. The proportion of the human giardiasis burden attributable to G. duodenalis of animal origin differs in different geographical areas. In Mainland China, genetic data of the gdh and bg genes of G. duodenalis from animals are only limited in dogs and cats. The aim of the study was to provide information on the genetic characterizations of animal-derived G. duodenalis isolates (from rabbits, sheep and cattle) at both loci in Heilongjiang Province, Northeastern China, and to assess the potential for zoonotic transmission. Methodology/Principal Findings: 61 G. duodenalis isolates from animal feces (dairy and beef cattle, sheep and rabbits) in Heilongjiang Province were characterized at the gdh and bg loci in the present study. The gdh and bg gene sequences of sheep-derived G. duodenalis assemblage AI, and the gdh sequences of rabbit-derived G. duodenalis assemblage B had 100% similarity with those from humans, respectively. Novel subtypes of G. duodenalis were identified, with one and seven subtypes for assemblages A and E at the gdh locus, and two and three subtypes for assemblages B and E at the bg locus, respectively. Three pairs of the same bg sequences of assemblage E were observed in sheep and cattle. Conclusions/Significance: This is the first description of genetic characterizations of the gdh and bg genes of G. duodenalis from rabbits, sheep and cattle in Mainland China. Homology analysis of assemblages AI and B implied the possibility of zoonotic transmission. The novel subtypes of assemblages of G. duodenalis may represent the endemic genetic characteristics of G. duodenalis in Heilongjiang Province, China.	[Liu, Aiqin; Yang, Fengkun; Zhang, Weizhe; Zhao, Wei; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Shen, Yujuan; Cao, Jianping] WHO Collaborating Ctr Malaria Schistosomiasis & F, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ Zhengzhou, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Zhang, WZ (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	zhangweizhe526@163.com; caojp@yahoo.com	Cao, Jianping/AFL-5468-2022; Zhang, Longxian/I-9223-2019; Stojanovski, Kristefer/H-8291-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/R-7799-2019	Cao, Jianping/0000-0002-1974-0047; Zhang, Longxian/0000-0002-5706-131X; Stojanovski, Kristefer/0000-0003-1239-5153; ling, hong/0000-0002-1886-1242; Grant, Robert/0000-0002-0851-7085	Natural Science Foundation of Heilongjiang Province [D200628]; National S & T Major Program for Infectious Disease of China [2012ZX10004-201, 2009ZX10004-201]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065233, U01AI084735, R01AI098472, P30AI027763, UM1AI069496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085598] Funding Source: NIH RePORTER	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); National S & T Major Program for Infectious Disease of China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by grants from the Natural Science Foundation of Heilongjiang Province No. D200628(AL) and the National S & T Major Program for Infectious Disease of China Nos. 2012ZX10004-201 and 2009ZX10004-201(JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, PARASITOL RES, V106, P733, DOI 10.1007/s00436-009-1703-7; Bertrand I, 2005, J CLIN MICROBIOL, V43, P5940, DOI 10.1128/JCM.43.12.5940-5944.2005; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Chen XiaoNing, 2001, Chinese Journal of Parasitic Disease Control, V14, P100; Di Giovanni GD, 2006, INT J ENVIRON HEAL R, V16, P405, DOI 10.1080/09603120601095100; Feng YY, 2008, PARASITOL RES, V103, P87, DOI 10.1007/s00436-008-0932-5; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Gomez-Couso H, 2012, VET PARASITOL, V187, P414, DOI 10.1016/j.vetpar.2012.01.025; Khan SM, 2011, VET PARASITOL, V178, P342, DOI 10.1016/j.vetpar.2011.01.029; Kosuwin R, 2010, GENE, V449, P1, DOI 10.1016/j.gene.2009.09.010; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lasek-Nesselquist E, 2009, J EUKARYOT MICROBIOL, V56, P504, DOI 10.1111/j.1550-7408.2009.00443.x; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lebbad M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/j.vetpar.2009.11.003; Li J, 2012, VET PARASITOL, V188, P368, DOI 10.1016/j.vetpar.2012.04.004; Liu AQ, 2012, PARASITOL RES, V111, P655, DOI 10.1007/s00436-012-2883-0; Lu SQ, 2002, B MED RES, V31, P19; Monis PT, 2009, TRENDS PARASITOL, V25, P93, DOI 10.1016/j.pt.2008.11.006; Mukherjee A. K., 2013, British Microbiology Research Journal, V3, P190; Silva FMPE, 2012, FOLIA PARASIT, V59, P15; PORTER JDH, 1990, AM J PUBLIC HEALTH, V80, P1259, DOI 10.2105/AJPH.80.10.1259; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Robertson LJ, 2007, J INFECTION, V55, P79, DOI 10.1016/j.jinf.2007.02.001; Robertson LJ, 2010, VET PARASITOL, V171, P140, DOI 10.1016/j.vetpar.2010.03.014; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; Ruiz A, 2008, VET PARASITOL, V154, P137, DOI 10.1016/j.vetpar.2008.03.003; Scorza AV, 2012, VET PARASITOL, V189, P182, DOI 10.1016/j.vetpar.2012.04.032; Soares RM, 2011, VET PARASITOL, V180, P344, DOI 10.1016/j.vetpar.2011.03.049; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Stuart JM, 2003, EMERG INFECT DIS, V9, P229; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Gomez-Munoz MT, 2012, RES VET SCI, V93, P836, DOI 10.1016/j.rvsc.2011.12.012; Gomez-Munoz MT, 2009, PARASITOL INT, V58, P297, DOI 10.1016/j.parint.2009.06.005; Trout JM, 2004, VET PARASITOL, V124, P179, DOI 10.1016/j.vetpar.2004.07.010; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Warburton A R, 1994, Commun Dis Rep CDR Rev, V4, pR32; Wen G, 1990, CHIN J PARASIT DIS C, V3, P79; Wielinga CM, 2007, PARASITOLOGY, V134, P1795, DOI 10.1017/S0031182007003071; Yang RC, 2010, INT J PARASITOL, V40, P293, DOI 10.1016/j.ijpara.2009.08.003; Yong TS, 2000, J PARASITOL, V86, P887, DOI 10.1645/0022-3395(2000)086[0887:GOGLIF]2.0.CO;2; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhang WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031262	45	174	181	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95291	10.1371/journal.pone.0095291	http://dx.doi.org/10.1371/journal.pone.0095291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24421901	Green Published, gold			2022-12-27	WOS:000335226500077
J	Zhao, JP; Levy, E; Fraser, WD; Julien, P; Delvin, E; Montoudis, A; Spahis, S; Garofalo, C; Nuyt, AM; Luo, ZC				Zhao, Jin-Ping; Levy, Emile; Fraser, William D.; Julien, Pierre; Delvin, Edgard; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole; Nuyt, Anne Monique; Luo, Zhong-Cheng			Circulating Docosahexaenoic Acid Levels Are Associated with Fetal Insulin Sensitivity	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GESTATIONAL DIABETES-MELLITUS; ALPHA-LINOLENIC ACID; PHOSPHOLIPID-COMPOSITION; DESATURASE ACTIVITIES; ARACHIDONIC-ACID; PREGNANCY; GLUCOSE; SECRETION; OBESITY	Background: Arachidonic acid (AA; C20: 4 n-6) and docosahexaenoic acid (DHA; C22: 6 n-3) are important long-chain polyunsaturated fatty acids (LC-PUFA) in maintaining pancreatic beta-cell structure and function. Newborns of gestational diabetic mothers are more susceptible to the development of type 2 diabetes in adulthood. It is not known whether low circulating AA or DHA is involved in perinatally "programming'' this susceptibility. This study aimed to assess whether circulating concentrations of AA, DHA and other fatty acids are associated with fetal insulin sensitivity or beta-cell function, and whether low circulating concentrations of AA or DHA are involved in compromised fetal insulin sensitivity in gestational diabetic pregnancies. Methods and Principal Findings: In a prospective singleton pregnancy cohort, maternal (32-35 weeks gestation) and cord plasma fatty acids were assessed in relation to surrogate indicators of fetal insulin sensitivity (cord plasma glucose-to-insulin ratio, proinsulin concentration) and beta-cell function (proinsulin-to-insulin ratio) in 108 mother-newborn pairs. Cord plasma DHA levels (in percentage of total fatty acids) were lower comparing newborns of gestational diabetic (n = 24) vs. nondiabetic pregnancies (2.9% vs. 3.5%, P = 0.01). Adjusting for gestational age at blood sampling, lower cord plasma DHA levels were associated with lower fetal insulin sensitivity (lower glucose-to-insulin ratio, r = 0.20, P = 0.036; higher proinsulin concentration, r = 20.37, P<0.0001). The associations remained after adjustment for maternal and newborn characteristics. Cord plasma saturated fatty acids C18:0 and C20:0 were negatively correlated with fetal insulin sensitivity, but their levels were not different between gestational diabetic and non-diabetic pregnancies. Cord plasma AA levels were not correlated with fetal insulin sensitivity. Conclusion: Low circulating DHA levels are associated with compromised fetal insulin sensitivity, and may be involved in perinatally "programming'' the susceptibility to type 2 diabetes in the offspring of gestational diabetic mothers.	[Zhao, Jin-Ping; Fraser, William D.; Luo, Zhong-Cheng] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Levy, Emile; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Julien, Pierre] Laval Univ Hosp Res Ctr, Quebec City, PQ, Canada; [Julien, Pierre] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Nuyt, Anne Monique] Univ Montreal, Dept Pediat, St Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Luo, Zhong-Cheng] Shanghai Jiao Tong Univ, Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp,Sch Med, Shanghai 200030, Peoples R China	Universite de Montreal; Universite de Montreal; Laval University; Laval University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Shanghai Jiao Tong University	Luo, ZC (corresponding author), Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada.	zc_luo@yahoo.com	Julien, Pierre/AGO-7542-2022; Luo, Zhong-Cheng/T-3882-2017	Julien, Pierre/0000-0002-9247-6676; Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR) [79896, 78879]; Quebec Training Network in Perinatal Research (QTNPR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Quebec Training Network in Perinatal Research (QTNPR)	This work was supported by the Canadian Institutes of Health Research (CIHR grant no. 79896 and 78879). J-P Zhao is the recipient of a Postdoctoral Scholarship from Quebec Training Network in Perinatal Research (QTNPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardenheier BH, 2013, DIABETES CARE, V36, P1209, DOI 10.2337/dc12-0901; Baur LA, 1998, METABOLISM, V47, P106, DOI 10.1016/S0026-0495(98)90202-5; Bergeron K, 2007, J LIPID RES, V48, P2396, DOI 10.1194/jlr.M700166-JLR200; Bitsanis D, 2006, LIPIDS, V41, P341, DOI 10.1007/s11745-006-5104-8; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Burdge GC, 2008, PROSTAG LEUKOTR ESS, V78, P73, DOI 10.1016/j.plefa.2007.10.028; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Decsi T, 2000, LIPIDS, V35, P1179, DOI 10.1007/s11745-000-0634-7; Dixon G, 2004, CLIN SCI, V106, P191, DOI 10.1042/CS20030261; FAAS FH, 1983, LIPIDS, V18, P339, DOI 10.1007/BF02534712; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Innis SM, 2003, AM J CLIN NUTR, V77, P473, DOI 10.1093/ajcn/77.2.473; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Konrad RJ, 1996, PANCREAS, V13, P253, DOI 10.1097/00006676-199610000-00007; KONRAD RJ, 1994, BIOCHEMISTRY-US, V33, P13284, DOI 10.1021/bi00249a015; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; LEPAGE G, 1989, J LIPID RES, V30, P1483; Luo ZC, 2010, DIABETES CARE, V33, P2055, DOI 10.2337/dc10-0819; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Makrides M, 2000, AM J CLIN NUTR, V71, p307S, DOI 10.1093/ajcn/71.1.307S; Miller MR, 2012, J CLIN ENDOCR METAB, V97, P3285, DOI 10.1210/jc.2012-1318; Min Y, 2005, DIABETIC MED, V22, P914, DOI 10.1111/j.1464-5491.2005.01556.x; Min Y, 2004, DIABETOLOGIA, V47, P75, DOI 10.1007/s00125-003-1275-5; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; Ortega-Senovilla H, 2009, DIABETES CARE, V32, P120, DOI 10.2337/dc08-0679; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Spahis S, 2008, PROSTAG LEUKOTR ESS, V79, P47, DOI 10.1016/j.plefa.2008.07.005; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Thomas BA, 2005, PROSTAG LEUKOTR ESS, V72, P335, DOI 10.1016/j.plefa.2005.01.001; Wang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059845; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Welch AA, 2010, AM J CLIN NUTR, V92, P1040, DOI 10.3945/ajcn.2010.29457; Whelan J, 2009, PROSTAG LEUKOTR ESS, V81, P133, DOI 10.1016/j.plefa.2009.05.008; Wijendran V, 2000, LIPIDS, V35, P927, DOI 10.1007/S11745-000-0602-2; Zhang G, 2012, J CLIN ENDOCR METAB, V97, pE973, DOI 10.1210/jc.2011-2997	42	252	260	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85054	10.1371/journal.pone.0085054	http://dx.doi.org/10.1371/journal.pone.0085054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	25303175	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500037
J	Yan, YF; Wang, H; Li, DF; Yang, XW; Wang, ZY; Qi, ZZ; Zhang, QW; Cui, BZ; Guo, ZB; Yu, C; Wang, J; Wang, J; Liu, GM; Song, YJ; Li, YR; Cui, YJ; Yang, RF				Yan, Yanfeng; Wang, Hu; Li, Dongfang; Yang, Xianwei; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong; Guo, Zhaobiao; Yu, Chang; Wang, Jun; Wang, Jian; Liu, Guangming; Song, Yajun; Li, Yingrui; Cui, Yujun; Yang, Ruifu			Two-Step Source Tracing Strategy of Yersinia pestis and Its Historical Epidemiology in a Specific Region	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PLAGUE-TRANSMISSION; MAXIMUM-LIKELIHOOD; INSIGHTS; MICROEVOLUTION; EVOLUTION; DYNAMICS; CHINA; DNA; POLYMORPHISMS	Source tracing of pathogens is critical for the control and prevention of infectious diseases. Genome sequencing by high throughput technologies is currently feasible and popular, leading to the burst of deciphered bacterial genome sequences. Utilizing the flooding genomic data for source tracing of pathogens in outbreaks is promising, and challenging as well. Here, we employed Yersinia pestis genomes from a plague outbreak at Xinghai county of China in 2009 as an example, to develop a simple two-step strategy for rapid source tracing of the outbreak. The first step was to define the phylogenetic position of the outbreak strains in a whole species tree, and the next step was to provide a detailed relationship across the outbreak strains and their suspected relatives. Through this strategy, we observed that the Xinghai plague outbreak was caused by Y. pestis that circulated in the local plague focus, where the majority of historical plague epidemics in the Qinghai-Tibet Plateau may originate from. The analytical strategy developed here will be of great help in fighting against the outbreaks of emerging infectious diseases, by pinpointing the source of pathogens rapidly with genomic epidemiological data and microbial forensics information.	[Yan, Yanfeng; Yang, Xianwei; Guo, Zhaobiao; Song, Yajun; Cui, Yujun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Hu; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong] Qinghai Inst Endem Dis Prevent & Control, Xining, Peoples R China; [Yan, Yanfeng; Li, Dongfang; Yu, Chang; Wang, Jun; Wang, Jian; Li, Yingrui; Cui, Yujun; Yang, Ruifu] BGI Shenzhen, Shenzhen, Peoples R China; [Liu, Guangming] Natl Univ Def Technol, Sch Comp Sci, Changsha, Hunan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Beijing Genomics Institute (BGI); National University of Defense Technology - China	Cui, YJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	cuiyujun.new@gmail.com; ruifuyang@gmail.com	Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Song, Yajun/GQQ-0476-2022; Yu, Chang/AAE-8538-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269; Song, Yajun/0000-0002-6628-2747; Wang, Jun/0000-0002-2113-5874; Li, Dongfang/0000-0002-6587-2892; Yang, Xianwei/0000-0003-4388-9674; Wang, Jun/0000-0002-8540-8931	State Key Development Program for Basic Research of China [2009CB522601]; Industry Research Special Foundation of China Ministry of Health [201202021]; National Natural Science Foundation of China [31000015]; National Key Program for Infectious Diseases of China [2012ZX10004215, 2013ZX10004221-002]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Industry Research Special Foundation of China Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This work was supported by the State Key Development Program for Basic Research of China (2009CB522601), the Industry Research Special Foundation of China Ministry of Health (201202021), the National Natural Science Foundation of China (31000015), and the National Key Program for Infectious Diseases of China (2012ZX10004215 and 2013ZX10004221-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P130; Budowle B, 2005, INT J LEGAL MED, V119, P317, DOI 10.1007/s00414-005-0535-y; Colman RE, 2009, EMERG INFECT DIS, V15, P1623, DOI 10.3201/eid1510.090188; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Ji S., 1988, PLAGUE; Kaiser J, 2005, SCIENCE, V308, P31; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li M, 2005, EMERG INFECT DIS, V11, P1494, DOI 10.3201/eid1109.041147; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066567; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Takahashi H, 2004, EMERG INFECT DIS, V10, P117, DOI 10.3201/eid1001.030238; Wang H, 2011, CLIN INFECT DIS, V52, P185, DOI 10.1093/cid/ciq107; Yang R, 2012, J BIOTERR BIODEF S, VS3, DOI [10.4172/2157-2526.S3-007, DOI 10.4172/2157-2526.S3-007]; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	41	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85374	10.1371/journal.pone.0085374	http://dx.doi.org/10.1371/journal.pone.0085374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24866893	Green Submitted, gold, Green Published			2022-12-27	WOS:000329866300074
J	Clutterbuck, S; Adams, J; Nettle, D				Clutterbuck, Stephanie; Adams, Jean; Nettle, Daniel			Childhood Adversity Accelerates Intended Reproductive Timing in Adolescent Girls without Increasing Interest in Infants	PLOS ONE			English	Article							SEX-DIFFERENCES; FATHER ABSENCE; EVOLUTIONARY-THEORY; LIFE-HISTORY; BABY SCHEMA; AGE; RESPONSIVENESS; YOUNG; MENARCHE; BABIES	Women experiencing greater childhood adversity exhibit faster reproductive trajectories. One possible psychological mechanism underlying this phenomenon is an increased interest in infants. Interest in infants is thought to be an adaptation important for successful rearing as it motivates the acquisition of caretaking skills. We investigated the relationships between childhood adversity, intended reproductive timing and interest in infants in a sample of English adolescent girls. Specifically we sought to investigate the relationship between 1) childhood adversity and intended reproductive timing; 2) childhood adversity and interest in infants; and 3) intended reproductive timing and interest in infants. Additionally we explored different methods of measuring interest in infants using self-reported fondness for babies, a forced choice adult versus infant paper-based preference task and a novel computer based attention task using adult and infant stimuli. In total 357 girls aged nine to 14 years participated in the study, which took place in schools. Participants completed the two interest in infants tasks before moving on to a childhood adversity questionnaire. Girls with more childhood adversity reported earlier ideal ages at parenthood. We found some evidence that, contrary to our predictions, girls with less childhood adversity were more interested in infants. There was no relationship between intended reproductive timing and interest in infants. The different measurements for interest in infants were only weakly related, if at all, highlighting the complexity of measuring this construct. Our findings suggest that rather than interest in infants being a mechanism for the effect of childhood adversity on early reproductive timing it might instead be an indicator of future reproductive strategies.	[Clutterbuck, Stephanie; Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Clutterbuck, S (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	p.clutterbuck@ncl.ac.uk	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	North Tyneside Council [001]; Birtch Control Trust of the Galton Institute [001]; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	North Tyneside Council; Birtch Control Trust of the Galton Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was partly funded from two sources: 1. The North Tyneside Council. Grant Number: 001 URL: http://www.northtyneside.gov.uk/, and 2. The Birtch Control Trust of the Galton Institute. Grant Number: 001 URL: http://www.galtoninstitute.org.uk/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber N, 2001, CROSS-CULT RES, V35, P263, DOI 10.1177/106939710103500301; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; BERMAN PW, 1975, SEX ROLES, V1, P311; BERMAN PW, 1978, CHILD DEV, V49, P917, DOI 10.2307/1128272; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; BLAKEMORE JEO, 1981, CHILD DEV, V52, P386; BLAKEMORE JEO, 1985, SEX ROLES, V13, P405, DOI 10.1007/BF00287951; Blell M, 2008, J BIOSOC SCI, V40, P563, DOI 10.1017/S0021932007002696; Bottino MN, 2012, J AFFECT DISORDERS, V142, P219, DOI 10.1016/j.jad.2012.04.030; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; Duchowski A, 2007, EYE TRACKING METHODO, V373; Elliott D. S., 1985, EXPLAINING DELINQUEN; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Ellis BJ, 2009, HUM NATURE-INT BIOS, V20, P204, DOI 10.1007/s12110-009-9063-7; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; FELDMAN SS, 1979, CHILD DEV, V50, P942, DOI 10.2307/1129318; FELDMAN SS, 1978, CHILD DEV, V49, P617, DOI 10.1111/j.1467-8624.1978.tb02361.x; FELDMAN SS, 1977, DEV PSYCHOL, V13, P675, DOI 10.1037/0012-1649.13.6.675; FRODI AM, 1984, SEX ROLES, V10, P639; FRODI AM, 1978, CHILD DEV, V49, P1182, DOI 10.2307/1128758; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Johns SE, 2011, HEALTH PLACE, V17, P122, DOI 10.1016/j.healthplace.2010.09.006; Kiernan KE, 1997, BRIT J SOCIOL, V48, P406, DOI 10.2307/591138; Kim K, 1998, J ADOLESCENCE, V21, P231, DOI 10.1006/jado.1998.0149; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Maestripieri D, 2004, DEVELOPMENTAL SCI, V7, P560, DOI 10.1111/j.1467-7687.2004.00380.x; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Maestripieri D, 2006, DEV REV, V26, P120, DOI 10.1016/j.dr.2006.02.006; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McLennan D., 2011, ENGLISH INDICES DEPR; Mikach SM, 1999, EVOL HUM BEHAV, V20, P141, DOI 10.1016/S1090-5138(98)00045-2; Nettle D., 2010, P R SOC B, V278, P1721, DOI DOI 10.1098/RSPB.2010.1726.PMID:21068037; Nettle D, 2011, PHILOS T R SOC B, V366, P357, DOI 10.1098/rstb.2010.0073; Nettle D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012690; Nettle D, 2010, AM J HUM BIOL, V22, P172, DOI 10.1002/ajhb.20970; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Romans SE, 2003, PSYCHOL MED, V33, P933, DOI 10.1017/S0033291703007530; Russell ST, 2002, J RES ADOLESCENCE, V12, P305, DOI 10.1111/1532-7795.00035; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Seamark CJ, 1997, BRIT J GEN PRACT, V47, P175; Sprengelmeyer R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065844; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Thompson-Booth C, 2014, DEVELOPMENTAL SCI, V17, P35, DOI 10.1111/desc.12090; Wellings K, 1999, REV REPROD, V4, P184, DOI 10.1530/revreprod/4.3.184; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	58	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85013	10.1371/journal.pone.0085013	http://dx.doi.org/10.1371/journal.pone.0085013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	25506703	Green Submitted, Green Published, gold			2022-12-27	WOS:000330236000007
J	Liu, YQ; Luo, BW; Han, FY; Li, XM; Xiong, J; Jiang, M; Yang, XF; Wu, YZ; Zhang, ZR				Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren			Erythropoietin-Derived Nonerythropoietic Peptide Ameliorates Experimental Autoimmune Neuritis by Inflammation Suppression and Tissue Protection	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; PERIPHERAL NERVOUS-SYSTEM; TERTIARY STRUCTURE; CANCER-PATIENTS; CELLS; NEUROPATHIES; RECEPTOR; ANEMIA; ARA290; TRIAL	Experimental autoimmune neuritis (EAN) is an autoantigen-specific T-cell-mediated disease model for human demyelinating inflammatory disease of the peripheral nervous system. Erythropoietin (EPO) has been known to promote EAN recovery but its haematopoiesis stimulating effects may limit its clinic application. Here we investigated the effects and potential mechanisms of an EPO-derived nonerythropoietic peptide, ARA 290, in EAN. Exogenous ARA 290 intervention greatly improved EAN recovery, improved nerve regeneration and remyelination, and suppressed nerve inflammation. Furthermore, haematopoiesis was not induced by ARA 290 during EAN treatment. ARA 290 intervention suppressed lymphocyte proliferation and altered helper T cell differentiation by inducing increase of Foxp3(+)/CD4(+) regulatory T cells and IL-4(+)/CD4(+) Th2 cells and decrease of IFN-gamma(+)/CD4(+) Th1 cells in EAN. In addition, ARA 290 inhibited inflammatory macrophage activation and promoted its phagocytic activity. In vitro, ARA 290 was shown to promote Schwann cell proliferation and inhibit its inflammatory activation. In summary, our data demonstrated that ARA 290 could effectively suppress EAN by attenuating inflammation and exerting direct cell protection, indicating that ARA 290 could be a potent candidate for treatment of autoimmune neuropathies.	[Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren] Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China	Army Medical University	Wu, YZ (corresponding author), Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China.	yuzhangwu@yahoo.com.cn; zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835; Wu, Yuzhang/0000-0002-4049-0214	National Nature Science Foundation of China [31170851]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-035]; SRF for ROCS, SEM	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This investigation was supported by National Nature Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm), No: 31170851, the National Science and Technology Major Projects of New Drugs (2012ZX09103301-035) and the SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bohlius J, 2006, NAT CLIN PRACT ONCOL, V3, P152, DOI 10.1038/ncponc0451; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; CRAGGS RI, 1984, ACTA NEUROPATHOL, V62, P316, DOI 10.1007/BF00687614; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Enders U, 1998, BRAIN, V121, P1257, DOI 10.1093/brain/121.7.1257; Farrell F, 2004, ONCOLOGIST, V9, P18, DOI 10.1634/theoncologist.9-90005-18; Glaspy JA, 2009, ANNU REV MED, V60, P181, DOI 10.1146/annurev.med.60.050307.110718; Heij L, 2012, MOL MED, V18, P1430, DOI 10.2119/molmed.2012.00332; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2002, J ANAT, V200, P331, DOI 10.1046/j.1469-7580.2002.00041.x; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Maurer M, 2002, REV NEUROL-FRANCE, V158, pS7; Mausberg AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026280; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Rosenzweig MQ, 2004, J PAIN SYMPTOM MANAG, V27, P185, DOI 10.1016/j.jpainsymman.2003.06.010; SCHABET M, 1991, J NEUROIMMUNOL, V31, P265, DOI 10.1016/0165-5728(91)90048-C; Shin T, 2012, ANAT CELL BIOL, V45, P215, DOI 10.5115/acb.2012.45.4.215; Soliven B, 2012, J PERIPHER NERV SYST, V17, P28, DOI 10.1111/j.1529-8027.2012.00392.x; Swartjes M, 2011, ANESTHESIOLOGY, V115, P1084, DOI 10.1097/ALN.0b013e31822fcefd; van Rijt WG, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-9; Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381; Xanthos T, 2011, CURR PHARM DESIGN, V17, P1517, DOI 10.2174/138161211796197115; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang Z, 2009, EXP NEUROL, V216, P75, DOI 10.1016/j.expneurol.2008.11.014; ZHANG ZY, 2009, NEUROPATHOL APPL NEU	34	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90942	10.1371/journal.pone.0090942	http://dx.doi.org/10.1371/journal.pone.0090942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603865	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600112
J	Zhang, BB; Shimada, Y; Kuroyanagi, J; Umemoto, N; Nishimura, Y; Tanaka, T				Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio			Quantitative wPhenotyping-Based In Vivo Chemical Screening in a Zebrafish Model of Leukemia Stem Cell Xenotransplantation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KAPPA-B PATHWAY; APOPTOSIS; MECHANISMS; QUIESCENT; CML; PROLIFERATION; XENOGRAFTS; DISCOVERY; IMATINIB	Zebrafish-based chemical screening has recently emerged as a rapid and efficient method to identify important compounds that modulate specific biological processes and to test the therapeutic efficacy in disease models, including cancer. In leukemia, the ablation of leukemia stem cells (LSCs) is necessary to permanently eradicate the leukemia cell population. However, because of the very small number of LSCs in leukemia cell populations, their use in xenotransplantation studies (in vivo) and the difficulties in functionally and pathophysiologically replicating clinical conditions in cell culture experiments (in vitro), the progress of drug discovery for LSC inhibitors has been painfully slow. In this study, we developed a novel phenotype-based in vivo screening method using LSCs xenotransplanted into zebrafish. Aldehyde dehydrogenase-positive (ALDH+) cells were purified from chronic myelogenous leukemia K562 cells tagged with a fluorescent protein (Kusabira-orange) and then implanted in young zebrafish at 48 hours post-fertilization. Twenty-four hours after transplantation, the animals were treated with one of eight different therapeutic agents (imatinib, dasatinib, parthenolide, TDZD-8, arsenic trioxide, niclosamide, salinomycin, and thioridazine). Cancer cell proliferation, and cell migration were determined by high-content imaging. Of the eight compounds that were tested, all except imatinib and dasatinib selectively inhibited ALDH+ cell proliferation in zebrafish. In addition, these anti-LSC agents suppressed tumor cell migration in LSC-xenotransplants. Our approach offers a simple, rapid, and reliable in vivo screening system that facilitates the phenotype-driven discovery of drugs effective in suppressing LSCs.	[Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ Ind Technol Innovat, Dept Om Med, Tsu, Mie, Japan; [Shimada, Yasuhito; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, T (corresponding author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.	tanaka@doc.medic.mie-u.ac.jp	Shimada, Yasuhito/H-2916-2019	Shimada, Yasuhito/0000-0002-4111-8262; Zhang, Bin/0000-0002-7347-0367; Ichino, Noriko/0000-0002-7009-8299; Nishimura, Yuhei/0000-0003-1901-8799	Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the Japan Science and Technology Agency, KAKENHI of Grants-in-Aid for Scientific Research, and the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Angstreich GR, 2005, BRIT J HAEMATOL, V130, P373, DOI 10.1111/j.1365-2141.2005.05606.x; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; Delvecchio C, 2011, ASSAY DRUG DEV TECHN, V9, P354, DOI 10.1089/adt.2010.0346; Fleischman AG, 2012, BLOOD, V119, P3376, DOI 10.1182/blood-2012-02-406751; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Gerber JM, 2011, AM J HEMATOL, V86, P31, DOI 10.1002/ajh.21915; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Heaney NCB, 2007, HEMATOL ONCOL, V25, P66, DOI 10.1002/hon.813; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Koyama-Nasu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053710; Liu L, 2011, MED ONCOL, V28, P835, DOI 10.1007/s12032-010-9529-9; Liu ZB, 2012, BIOCHEM BIOPH RES CO, V427, P223, DOI 10.1016/j.bbrc.2012.09.064; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Miller WH, 2002, CANCER RES, V62, P3893; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nakamura S, 2012, INT J CANCER, V130, P1046, DOI 10.1002/ijc.26065; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Peal DS, 2010, J CARDIOVASC TRANSL, V3, P454, DOI 10.1007/s12265-010-9212-8; Pei SS, 2012, BEST PRACT RES CL HA, V25, P415, DOI 10.1016/j.beha.2012.10.003; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Rice KN, 2010, INT J HEMATOL, V91, P748, DOI 10.1007/s12185-010-0615-8; Rodrigues T, 2002, BRIT J PHARMACOL, V136, P136, DOI 10.1038/sj.bjp.0704672; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Smithen DA, 2013, ORG BIOMOL CHEM, V11, P62, DOI 10.1039/c2ob26535d; Snaar-Jagalska BE, 2009, ZEBRAFISH, V6, P441, DOI 10.1089/zeb.2009.0614; Stuart SA, 2009, CELL CYCLE, V8, P1338, DOI 10.4161/cc.8.9.8209; Szabo AZ, 2013, STEM CELLS, V31, P786, DOI 10.1002/stem.1329; Takeuchi Y, 2004, J NEUROCHEM, V88, P41, DOI 10.1046/j.1471-4159.2003.02129.x; Thomas Xavier, 2012, World J Stem Cells, V4, P44; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang IH, 2008, IEEE ENG MED BIO, P1837, DOI 10.1109/IEMBS.2008.4649537; Yong ASM, 2008, LEUKEMIA, V22, P1721, DOI 10.1038/leu.2008.161; Yuan Lin-Bo, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P191; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1; Zhen XC, 2001, MOL PHARMACOL, V60, P857; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	54	71	73	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85439	10.1371/journal.pone.0085439	http://dx.doi.org/10.1371/journal.pone.0085439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	25036550	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100085
J	Wang, MC; Chien, HF; Tsai, YL; Liu, MC; Liaw, SJ				Wang, Min-Cheng; Chien, Hsiung-Fei; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen			The RNA Chaperone Hfq Is Involved in Stress Tolerance and Virulence in Uropathogenic Proteus mirabilis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; POLYMYXIN-B RESISTANCE; ESCHERICHIA-COLI; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; EPITHELIAL-CELLS; MOUSE MODEL; BACTERIA; MACROPHAGES	Hfq is a bacterial RNA chaperone involved in the riboregulation of diverse genes via small noncoding RNAs. Here, we show that Hfq is critical for the uropathogenic Proteus mirabilis to effectively colonize the bladder and kidneys in a murine urinary tract infection (UTI) model and to establish burned wound infection of the rats. In this regard, we found the hfq mutant induced higher IL-8 and MIF levels of uroepithelial cells and displayed reduced intra-macrophage survival. The loss of hfq affected bacterial abilities to handle H2O2 and osmotic pressures and to grow at 50 degrees C. Relative to wild-type, the hfq mutant had reduced motility, fewer flagella and less hemolysin expression and was less prone to form biofilm and to adhere to and invade uroepithelial cells. The MR/P fimbrial operon was almost switched to the off phase in the hfq mutant. In addition, we found the hfq mutant exhibited an altered outer membrane profile and had higher RpoE expression, which indicates the hfq mutant may encounter increased envelope stress. With the notion of envelope disturbance in the hfq mutant, we found increased membrane permeability and antibiotic susceptibilities in the hfq mutant. Finally, we showed that Hfq positively regulated the RpoS level and tolerance to H2O2 in the stationary phase seemed largely mediated through the Hfq-dependent RpoS expression. Together, our data indicate that Hfq plays a critical role in P. mirabilis to establish UTIs by modulating stress responses, surface structures and virulence factors. This study suggests Hfq may serve as a scaffold molecule for development of novel anti-P. mirabilis drugs and P. mirabilis hfq mutant is a vaccine candidate for preventing UTIs.	[Wang, Min-Cheng; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chien, Hsiung-Fei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Liaw, Shwu-Jen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Liaw, SJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	sjliaw@ntu.edu.tw		LIAW, SHWU-JEN/0000-0002-2666-5284	National Science Council [NSC101-2320-B-002-028]; National Taiwan University Hospital, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC101-2320-B-002-028) and National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 1996, EUR RESPIR J, V9, P1713, DOI 10.1183/09031936.96.09081713; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Caiola MG, 2004, ANN MICROBIOL, V54, P365; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chiang MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022248; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Hamrick TS, 2000, INFECT IMMUN, V68, P125, DOI 10.1128/IAI.68.1.125-132.2000; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jansen AM, 2004, INFECT IMMUN, V72, P7294, DOI 10.1128/IAI.72.12.7294-7305.2004; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P1564, DOI 10.1128/AAC.01219-09; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Li X, 2002, MOL MICROBIOL, V45, P865, DOI 10.1046/j.1365-2958.2002.03067.x; LISSNER CR, 1985, J IMMUNOL, V135, P544; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mobley HLT, 1996, INFECT IMMUN, V64, P5332, DOI 10.1128/IAI.64.12.5332-5340.1996; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nishino K, 2011, J ANTIMICROB CHEMOTH, V66, P291, DOI 10.1093/jac/dkq420; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pearson MM, 2007, J MED MICROBIOL, V56, P1277, DOI 10.1099/jmm.0.47314-0; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; Rocha SPD, 2007, FEMS IMMUNOL MED MIC, V51, P319, DOI 10.1111/j.1574-695X.2007.00308.x; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Roscetto E, 2012, J BACTERIOL, V194, P5864, DOI 10.1128/JB.00746-12; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Van Puyvelde S, 2013, RNA BIOL, V10, P185, DOI 10.4161/rna.23341; Vogel J, 2009, MOL MICROBIOL, V73, P737, DOI 10.1111/j.1365-2958.2009.06806.x; Xiao B, 2009, CURR MICROBIOL, V58, P258, DOI 10.1007/s00284-008-9318-2; Yamada J, 2010, J ANTIMICROB CHEMOTH, V65, P853, DOI 10.1093/jac/dkq067; Zhong M, 2013, J BACTERIOL, V195, P1061, DOI 10.1128/JB.01143-12	52	49	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85626	10.1371/journal.pone.0085626	http://dx.doi.org/10.1371/journal.pone.0085626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454905	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100108
J	Ser, G; Robertson, A; Sheikh, A				Ser, Gloria; Robertson, Ann; Sheikh, Aziz			A Qualitative Exploration of Workarounds Related to the Implementation of National Electronic Health Records in Early Adopter Mental Health Hospitals	PLOS ONE			English	Article							UNINTENDED CONSEQUENCES; INFORMATION-TECHNOLOGY; MEDICAL-RECORDS; SECONDARY CARE; ORDER ENTRY; COMMUNICATION; INTEGRATION; PHYSICIANS; SYSTEMS; ERRORS	Aims: To investigate the perceptions and reported practices of mental health hospital staff using national hospital electronic health records (EHRs) in order to inform future implementations, particularly in acute mental health settings. Methods: Thematic analysis of interviews with a wide range of clinical, information technology (IT), managerial and other staff at two early adopter mental health National Health Service (NHS) hospitals in London, UK, implementing national EHRs. Results: We analysed 33 interviews. We first sought out examples of workarounds, such as delayed data entry, entering data in wrong places and individuals using the EHR while logged in as a colleague, then identified possible reasons for the reported workarounds. Our analysis identified four main categories of factors contributing to workarounds (i.e., operational, cultural, organisational and technical). Operational factors included poor system integration with existing workflows and the system not meeting users' perceived needs. Cultural factors involved users' competence with IT and resistance to change. Organisational factors referred to insufficient organisational resources and training, while technical factors included inadequate local technical infrastructure. Many of these factors, such as integrating the EHR system with day-to-day operational processes, staff training and adequate local IT infrastructure, were likely to apply to system implementations in various settings, but we also identified factors that related particularly to implementing EHRs in mental health hospitals, for example: EHR system incompatibility with IT systems used by mental health-related sectors, notably social services; the EHR system lacking specific, mental health functionalities and options; and clinicians feeling unable to use computers while attending to distressed psychiatric patients. Conclusions: A better conceptual model of reasons for workarounds should help with designing, and supporting the implementation and adoption of, EHRs for use in hospital mental health settings.	[Ser, Gloria; Robertson, Ann; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Otegui, Javier/B-3973-2012	Sheikh, Aziz/0000-0001-7022-3056; Braak, Kyle/0000-0002-3696-3496; Russell, Laura/0000-0002-1920-5298; Otegui, Javier/0000-0002-8997-3559; Bloom, David/0000-0003-1273-1807; Doring, Markus/0000-0001-7757-1889; Desmet, Peter/0000-0002-8442-8025	NHS CFH Evaluation Programme [NHS CFHEP 005]; Commonwealth Fund; private independent foundation based in New York City	NHS CFH Evaluation Programme; Commonwealth Fund; private independent foundation based in New York City	This study involved the secondary analysis of a sub-set of data previously collected in an independent research programme commissioned by NHS. This report draws on a sub-set of data that were gathered in independent research commissioned by the NHS CFH Evaluation Programme (NHS CFHEP 005). It was undertaken as a post-graduate dissertation research project. Aziz Sheikh has a Harkness Fellowship in Health Policy and Practice and is supported by The Commonwealth Fund, a private independent foundation based in New York City. The funders of the initial, commissioned study and The Commonwealth Fund had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2004, INT J EDUC MANAG, DOI DOI 10.1108/09513540410522234; Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burt CW, 2005, HEALTH AFFAIR, V24, P1334, DOI 10.1377/hlthaff.24.5.1334; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; Campbell EM, 2009, J GEN INTERN MED, V24, P21, DOI 10.1007/s11606-008-0857-9; Cresswell KM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-15; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Department of Health, 2007, MENT HLTH ACT; Detmer DE, 2009, QUAL HEALTH CARE, V9, P181; Ferneley EH, 2006, EUR J INFORM SYST, V15, P345, DOI 10.1057/palgrave.ejis.3000629; Forum: Qualitative Social Research, 2005, SEC AN QUAL DAT; GASSER L, 1986, ACM T INFORM SYST, V4, P205, DOI 10.1145/214427.214429; Harrison MI, 2007, J AM MED INFORM ASSN, V14, P542, DOI 10.1197/jamia.M2384; Hayes N., 2000, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V9, P435, DOI 10.1023/A:1008795025075; Heaton J, 2004, REWORKING QUALITATIV; Huckvale C, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038497; Kobayashi M, 2005, CHI LATE BREAKING RE, P1561, DOI DOI 10.1145/1056808.1056966; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; Linder Jeffrey A, 2006, AMIA Annu Symp Proc, P499; Makoul G, 2001, J AM MED INFORM ASSN, V8, P610, DOI 10.1136/jamia.2001.0080610; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Patton M. Q., 1990, QUALITATIVE EVALUATI; Poelmans S., 1999, SIGGROUP Bulletin, V20, P11; Robertson A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4564; Robertson A, 2011, J ROY SOC MED, V104, P434, DOI 10.1258/jrsm.2011.11k039; Rouf E, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-13; Safadi H, 2010, INT C INF SYS P; Saleem JJ, 2009, INT J MED INFORM, V78, P618, DOI 10.1016/j.ijmedinf.2009.04.001; Salomon RM, 2010, J AM MED INFORM ASSN, V17, P54, DOI 10.1197/jamia.M3341; Sartorius N, 2007, LANCET, V370, P810, DOI 10.1016/S0140-6736(07)61245-8; Sheikh A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6054; Sobreperez P, 2008, INT FED INFO PROC, V287, P179; Stewart RF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-3; Stockdale SE, 2011, BMJ QUAL SAF, V20, P941, DOI 10.1136/bmjqs.2010.050450; Strauss A., 1998, BASICS QUALITATIVE R; Ventres W, 2006, ANN FAM MED, V4, P124, DOI 10.1370/afm.425; Vestal K, 2008, NURSE LEAD, V6, P8, DOI 10.1016/j.mnl.2008.06.008; Wachter R., 2008, UNDERSTANDING PATIEN	41	102	104	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e77669	10.1371/journal.pone.0077669	http://dx.doi.org/10.1371/journal.pone.0077669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	25099149	Green Submitted, gold, Green Published			2022-12-27	WOS:000330236000001
J	Liu, AY; Yang, QY; Huang, Y; Bacchetti, P; Anderson, PL; Jin, CS; Goggin, K; Stojanovski, K; Grant, R; Buchbinder, SP; Greenblatt, RM; Gandhi, M				Liu, Albert Y.; Yang, Qiyun; Huang, Yong; Bacchetti, Peter; Anderson, Peter L.; Jin, Chengshi; Goggin, Kathy; Stojanovski, Kristefer; Grant, Robert; Buchbinder, Susan P.; Greenblatt, Ruth M.; Gandhi, Monica			Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; HIV-INFECTION; ANTIRETROVIRAL PROPHYLAXIS; INTERIM GUIDANCE; PREVENTION; PLASMA; NEVIRAPINE; EFAVIRENZ; AXILLARY; HEAD	Background: Pre-exposure prophylaxis (PrEP) trials using tenofovir-based regimens have demonstrated that high levels of adherence are required to evaluate efficacy; the incorporation of objective biomarkers of adherence in trial design has been essential to interpretation, given the inaccuracy of self-report. Antiretroviral measurements in scalp hair have been useful as a marker of long-term exposure in the HIV treatment setting, and hair samples are relatively easy and inexpensive to collect, transport, and store for analysis. To evaluate the relationship between dose and tenofovir concentrations in hair, we examined the dose proportionality of tenofovir in hair in healthy, HIV-uninfected adults. Methods: A phase I, crossover pharmacokinetic study was performed in 24 HIV-negative adults receiving directly-observed oral tenofovir tablets administered 2, 4, and 7 doses/week for 6 weeks, with a >= 3-week break between periods. Small samples of hair were collected after each six-week period and analyzed for tenofovir concentrations. Geometric-mean-ratios compared levels between each pair of dosing conditions. Intensive plasma pharmacokinetic studies were performed during the daily-dosing period to calculate areas-under-the-time-concentration curves (AUCs). Results: Over 90% of doses were observed per protocol. Median tenofovir concentrations in hair increased monotonically with dose. A log-linear relationship was seen between dose and hair levels, with an estimated 76% (95% CI 60-93%) increase in hair level per 2-fold dose increase. Tenofovir plasma AUCs modestly predicted drug concentrations in hair. Conclusions: This study found a strong linear relationship between frequency of dosing and tenofovir levels in scalp hair. The analysis of quantitative drug levels in hair has the potential to improve adherence measurement in the PrEP field and may be helpful in determining exposure thresholds for protection and explaining failures in PrEP trials. Hair measures for adherence monitoring may also facilitate adherence measurement in real-world settings and merit further investigation in upcoming PrEP implementation studies and programs.	[Liu, Albert Y.; Stojanovski, Kristefer; Buchbinder, Susan P.] Bridge HIV, San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Liu, Albert Y.; Buchbinder, Susan P.; Greenblatt, Ruth M.; Gandhi, Monica] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Yang, Qiyun; Huang, Yong] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Bacchetti, Peter; Jin, Chengshi; Buchbinder, Susan P.; Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Anderson, Peter L.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Goggin, Kathy] Univ Missouri, Childrens Mercy Hosp & Clin, Kansas City, MO 64110 USA; [Grant, Robert] Gladstone Inst, San Francisco, CA USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Liu, AY (corresponding author), Bridge HIV, San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA.	albert.liu@sfdph.org	Cao, Jianping/AFL-5468-2022; Zhang, Longxian/I-9223-2019; Stojanovski, Kristefer/H-8291-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/R-7799-2019	Cao, Jianping/0000-0002-1974-0047; Zhang, Longxian/0000-0002-5706-131X; Stojanovski, Kristefer/0000-0003-1239-5153; ling, hong/0000-0002-1886-1242; Grant, Robert/0000-0002-0851-7085	National Institutes of Mental Health [R21MH085598]; National Institutes of Allergy and Infectious Diseases [U01 AI084735, RO1 AI065233, RO1AI098472]; Center for AIDS Research Center [P30 AI027763]; University of California San Francisco Clinical and Translational Science Institute Clinical Research Center Grant [UL1 RR024131, UL1 TR000004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065233, U01AI084735, R01AI098472, P30AI027763, UM1AI069496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085598] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research Center; University of California San Francisco Clinical and Translational Science Institute Clinical Research Center Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Mental Health (grant number R21MH085598 to A. L.), National Institutes of Allergy and Infectious Diseases (grant numbers U01 AI084735 to P. A., RO1 AI065233 to R. G., RO1AI098472 to M. G.), Center for AIDS Research Center (grant number P30 AI027763), and University of California San Francisco Clinical and Translational Science Institute Clinical Research Center Grant (grant numbers UL1 RR024131 and UL1 TR000004). Study drug was supplied by Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli N., 2009, 16 C RETROVIRUSES OP; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bartelink IH, 2013, J CLIN PHARM; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Beumer JH, 2001, INT J CLIN PRACT, V55, P353; Blum MR, 2007, J CLIN PHARMACOL, V47, P751, DOI 10.1177/0091270007300951; Chi BH, 2006, HIV CLIN TRIALS, V7, P263, DOI 10.1310/hct0705-263; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cirimele V, 2000, FORENSIC SCI INT, V107, P289, DOI 10.1016/S0379-0738(99)00172-3; Clevenbergh P, 2002, AIDS, V16, P2311, DOI 10.1097/00002030-200211220-00011; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coetzee B, 2012, FUTURE VIROL, V7, P1135, DOI 10.2217/FVL.12.100; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; Delahunty T, 2006, J CHROMATOGR B, V830, P6, DOI 10.1016/j.jchromb.2005.10.015; Dubuisson JG, 2004, JAIDS-J ACQ IMM DEF, V35, P155, DOI 10.1097/00126334-200402010-00009; Gandhi M, 2013, AIDS RES HU IN PRESS; Gandhi M, 2013, JAIDS-J ACQ IMM DEF, V63, P578, DOI 10.1097/QAI.0b013e31829c48ad; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; Goggin K, 2013, AIDS BEHAV; Goggin K, 2007, PUBLIC HEALTH REP, V122, P472, DOI 10.1177/003335490712200408; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Han EY, 2005, FORENSIC SCI INT, V147, P21, DOI 10.1016/j.forsciint.2004.03.035; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; HENDERSON GL, 1993, FORENSIC SCI INT, V63, P19, DOI 10.1016/0379-0738(93)90256-A; Hendrix CW, 2012, CURR OPIN HIV AIDS, V7, P498, DOI 10.1097/COH.0b013e32835847ae; Jackson A, 2013, JAIDS-J ACQ IMM DEF, V62, P275, DOI 10.1097/QAI.0b013e3182829bd0; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Koenig LJ, 2013, AM J PREV MED, V44, pS91, DOI 10.1016/j.amepre.2012.09.047; L'homme RFA, 2008, CLIN INFECT DIS, V47, P1339, DOI 10.1086/592694; Lagakos SW, 2008, METHODOLOGICAL CHALL; Liu A, 2011, 18 C RETR OPP INF CR; Liu A, 2010, 17 C RETR OPP INF CR; Macalino GE, 2004, CLIN INFECT DIS, V38, pS393, DOI 10.1086/421402; MANGIN P, 1993, FORENSIC SCI INT, V63, P77, DOI 10.1016/0379-0738(93)90261-8; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Nettles RE, 2006, CLIN INFECT DIS, V42, P1189, DOI 10.1086/501458; OFFIDANI C, 1993, FORENSIC SCI INT, V63, P105, DOI 10.1016/0379-0738(93)90264-B; PageShafer K, 1997, AM J EPIDEMIOL, V146, P531, DOI 10.1093/oxfordjournals.aje.a009311; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; PETERSON JL, 2000, AIDS PREVENT MENT H, P217; Podsadecki TJ, 2008, HIV CLIN TRIALS, V9, P238, DOI 10.1310/hct0904-238; Shen M, 2013, FORENSIC SCI INT, V227, P64, DOI 10.1016/j.forsciint.2012.10.028; Shen M, 2012, J FORENSIC SCI, V57, P669, DOI 10.1111/j.1556-4029.2012.02052.x; Smith D, 2011, MMWR, V60; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Wertheimer BZ, 2006, HIV CLIN TRIALS, V7, P59, DOI 10.1310/4CCJ-KT1T-H6PV-NLFC; Yang Q, 2010, AM ASS PHARM SCI AAP	57	174	181	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83736	10.1371/journal.pone.0083736	http://dx.doi.org/10.1371/journal.pone.0083736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421901	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500068
J	Zhou, JH; Wang, YF; Wang, Y; Yin, X; He, YF; Chen, LL; Wang, WW; Liu, T; Di, W				Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen			FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BREAST-CANCER; REPAIR; RESISTANCE; CELLS; CONTRIBUTES; EXPRESSION	Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in ovarian cancers with chemoresistance to cisplatin. Our results indicate that FOXM1 is upregulated in chemoresistant ovarian cancer samples, and defends ovarian cancer cells against cytotoxicity of cisplatin. FOXM1 facilitates DNA repair through regulating direct transcriptional target EXO1 to protect ovarian cancer cells from cisplatin-mediated apoptosis. Attenuating FOXM1 and EXO1 expression by small interfering RNA, augments the chemotherapy efficacy against ovarian cancer. Our findings indicate that targeting FOXM1 and its target gene EXO1 could improve cisplatin effect in ovarian cancer, confirming their role in modulating cisplatin sensitivity.	[Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Focus Construct Subject Shanghai Educ Dept, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Shanghai Hlth Bur Key Disciplines & Specialties F, Shanghai, Peoples R China; [Zhou, Jinhua] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Di, W (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	diwen163@163.com	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	National Natural Science Foundation of China [81272882, 81302275, 81072137]; Shanghai Committee of Science and Technology [12411950200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	In accomplish of this manuscript, the authors have received the support of the National Natural Science Foundation of China (Grant No. 81272882, 81302275, 81072137) and Shanghai Committee of Science and Technology (Grant No. 12411950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chang IY, 2005, BIOCHEM BIOPH RES CO, V327, P225, DOI 10.1016/j.bbrc.2004.12.008; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Eccleston J, 2011, J IMMUNOL, V186, P2336, DOI 10.4049/jimmunol.1003104; Furuta T, 2002, CANCER RES, V62, P4899; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhao R, 2014, MOL CANCER RES, V12, P370, DOI 10.1158/1541-7786.MCR-13-0281; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Ziebarth AJ, 2013, CLIN CANCER RES, V19, P170, DOI 10.1158/1078-0432.CCR-12-1045	40	158	163	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96989	10.1371/journal.pone.0096989	http://dx.doi.org/10.1371/journal.pone.0096989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824601	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200045
J	Zhou, J; Xiao, KF; Wei, BY; Wang, Z; Tian, Y; Tian, YX; Song, QS				Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng			Bioaccumulation of Cry1Ab Protein from an Herbivore Reduces Anti-Oxidant Enzyme Activities in Two Spider Species	PLOS ONE			English	Article							BT RICE; SUPEROXIDE-DISMUTASE; BROWN PLANTHOPPER; FIELD-EVALUATION; TRANSGENIC RICE; GENES; RESISTANCE; DIVERSITY; LINES	Cry proteins are expressed in rice lines for lepidopteran pest control. These proteins can be transferred from transgenic rice plants to non-target arthropods, including planthoppers and then to a predatory spider. Movement of Cry proteins through food webs may reduce fitness of non-target arthropods, although recent publications indicated no serious changes in nontarget populations. Nonetheless, Cry protein intoxication influences gene expression in Cry-sensitive insects. We posed the hypothesis that Cry protein intoxication influences enzyme activities in spiders acting in tri-trophic food webs. Here we report on the outcomes of experiments designed to test our hypothesis with two spider species. We demonstrated that the movement of CryAb protein from Drosophila culture medium into fruit flies maintained on the CryAb containing medium and from the flies to the spiders Ummeliata insecticeps and Pardosa pseudoannulata. We also show that the activities of three key metabolic enzymes, acetylcholine esterase (AchE), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) were significantly influenced in the spiders after feeding on Cry1Ab-containing fruit flies. We infer from these data that Cry proteins originating in transgenic crops impacts non-target arthropods at the physiological and biochemical levels, which may be one mechanism of Cry protein-related reductions in fitness of non-target beneficial predators.	[Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Hunan Agricultural University; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	wangzhispider@hotmail.com; SongQ@missouri.edu	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	Natural Science Foundation of P. R. China [31071943, 31272339]; Scientific Research Fund of Hunan Provincial Education Department [10A054]	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was in part supported by the Natural Science Foundation of P. R. China (No. 31071943). The additional part of the funding of the study has come from Natural Science Foundation of P. R. China (No. 31272339) and Scientific Research Fund of Hunan Provincial Education Department(No. 10A054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir K, 2004, MOL BREEDING, V13, P301, DOI 10.1023/B:MOLB.0000034078.54872.25; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Chen H, 2008, J ECON ENTOMOL, V101, P182, DOI 10.1603/0022-0493(2008)101[182:EOTBTR]2.0.CO;2; Chen Mao, 2003, Acta Phytophylacica Sinica, V30, P365; Chen Mao, 2003, Journal of Zhejiang University (Agriculture and Life Sciences), V29, P29; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; GORUN V, 1978, ANAL BIOCHEM, V86, P324, DOI 10.1016/0003-2697(78)90350-0; Hoefler CD, 2006, J ECON ENTOMOL, V99, P432, DOI 10.1603/0022-0493-99.2.432; Jones AK, 2010, ADV EXP MED BIOL, V683, P25; Li FF, 2007, ENVIRON ENTOMOL, V36, P646, DOI 10.1603/0046-225X(2007)36[646:AAADIB]2.0.CO;2; Liu Li-Jun, 2010, Acta Arachnologica Sinica, V19, P47; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; Missirlis F, 2003, PROCEEDINGS OF THE MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH, EUROPEAN SECTION, P147; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oppert B, 2012, PLOS ONE, V4; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Riaz N, 2006, S AFR J BOT, V72, P217, DOI 10.1016/j.sajb.2005.07.005; Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sogawa K, 2003, CHINESE J RICE SCI, V17, P47; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Ye RJ, 2009, PEST MANAG SCI, V65, P1015, DOI 10.1002/ps.1788; Zaidi MA, 2009, MOL BIOTECHNOL, V43, P232, DOI 10.1007/s12033-009-9201-9	28	158	163	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84724	10.1371/journal.pone.0084724	http://dx.doi.org/10.1371/journal.pone.0084724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24824601	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500016
J	Chen, H; Luo, R; Gong, SZ; Matta, SG; Sharp, BM				Chen, Hao; Luo, Rui; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.			Protection Genes in Nucleus Accumbens Shell Affect Vulnerability to Nicotine Self-Administration across Isogenic Strains of Adolescent Rat	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; AFRICAN-AMERICAN SMOKERS; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMAS; CA2+ SENSOR VILIP-1; HIPPOCAMPAL-NEURONS; NEOSTRIATAL NEURONS; MOLECULAR-GENETICS; SMOKING-CESSATION; EUROPEAN-AMERICAN	Classical genetic studies show the heritability of cigarette smoking is 0.4-0.6, and that multiple genes confer susceptibility and resistance to smoking. Despite recent advances in identifying genes associated with smoking behaviors, the major source of this heritability and its impact on susceptibility and resistance are largely unknown. Operant self-administration (SA) of intravenous nicotine is an established model for smoking behavior. We recently confirmed that genetic factors exert strong control over nicotine intake in isogenic rat strains. Because the processing of afferent dopaminergic signals by nucleus accumbens shell (AcbS) is critical for acquisition and maintenance of motivated behaviors reinforced by nicotine, we hypothesized that differential basal gene expression in AcbS accounts for much of the strain-to-strain variation in nicotine SA. We therefore sequenced the transcriptome of AcbS samples obtained by laser capture microdissection from 10 isogenic adolescent rat strains and compared all RNA transcript levels with behavior. Weighted gene co-expression network analysis, a systems biology method, found 12 modules (i.e., unique sets of genes that covary across all samples) that correlated (p<0.05) with amount of self-administered nicotine; 9 of 12 correlated negatively, implying a protective role. PCR confirmed selected genes from these modules. Chilibot, a literature mining tool, identified 15 genes within 1 module that were nominally associated with cigarette smoking, thereby providing strong support for the analytical approach. This is the first report demonstrating that nicotine intake by adolescent rodents is associated with the expression of specific genes in AcbS of the mesolimbic system, which controls motivated behaviors. These findings provide new insights into genetic mechanisms that predispose or protect against tobacco addiction.	[Chen, Hao; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Luo, Rui] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, H (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu; bsharp@uthsc.edu	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	NIH [RC2 DA 028962]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH grant RC2 DA 028962. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anney RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-46; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Beuten J, 2007, AM J MED GENET B, V144B, P285, DOI 10.1002/ajmg.b.30399; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Brower VG, 2002, BRAIN RES, V930, P12, DOI 10.1016/S0006-8993(01)03375-3; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Buczek Y, 1999, PSYCHOPHARMACOLOGY, V144, P183, DOI 10.1007/s002130050992; Cadoni C, 2009, NEUROPHARMACOLOGY, V57, P496, DOI 10.1016/j.neuropharm.2009.07.033; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044234; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Dao JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1319, DOI 10.1038/npp.2011.8; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gold AB, 2012, NEUROPSYCHOPHARMACOL, V37, P1683, DOI 10.1038/npp.2012.13; Hafkamp HC, 2009, MODERN PATHOL, V22, P686, DOI 10.1038/modpathol.2009.23; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Han SZ, 2010, BIOL PSYCHIAT, V67, P12, DOI 10.1016/j.biopsych.2009.08.028; Iancu OD, 2013, ALCOHOL CLIN EXP RES, V37, P1295, DOI 10.1111/acer.12100; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kalomenidis L, 2001, LUNG, V179, P265, DOI 10.1007/s0040800000067; Kendler KS, 2012, NAT NEUROSCI, V15, P181, DOI 10.1038/nn.3018; Keskitalo-Vuokko K, 2012, NICOTINE TOB RES, V14, P153, DOI 10.1093/ntr/ntr153; Konu O, 2001, BRAIN RES, V909, P194, DOI 10.1016/S0006-8993(01)02685-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Le Foll B, 2012, INT J NEUROPSYCHOPH, V15, P1265, DOI 10.1017/S1461145711001398; Lecca D, 2006, PSYCHOPHARMACOLOGY, V184, P435, DOI 10.1007/s00213-005-0280-4; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu X, 2007, NEUROPSYCHOPHARMACOL, V32, P710, DOI 10.1038/sj.npp.1301129; Ma JZ, 2010, HUM GENET, V127, P503, DOI 10.1007/s00439-010-0787-6; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; O'Dell LE, 2007, J PHARMACOL EXP THER, V320, P180, DOI 10.1124/jpet.106.105270; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Oyang EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024879; Paterson NE, 2005, NEUROPSYCHOPHARMACOL, V30, P119, DOI 10.1038/sj.npp.1300524; Rose JE, 1999, DRUG ALCOHOL DEPEN, V56, P99, DOI 10.1016/S0376-8716(99)00025-3; Rose JE, 1997, PSYCHOPHARMACOLOGY, V130, P28, DOI 10.1007/s002130050209; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Sasaki H, 2012, MOL MED REP, V5, P725, DOI 10.3892/mmr.2011.715; Sato N, 2010, PSYCHIAT GENET, V20, P135, DOI 10.1097/YPG.0b013e32833a21f9; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sharp BM, 2011, GENES BRAIN BEHAV, V10, P778, DOI 10.1111/j.1601-183X.2011.00716.x; Shoaib M, 1997, PSYCHOPHARMACOLOGY, V129, P35, DOI 10.1007/s002130050159; Shoaib M, 1999, PSYCHOPHARMACOLOGY, V143, P318, DOI 10.1007/s002130050954; Slotkin TA, 2007, NEUROPSYCHOPHARMACOL, V32, P1082, DOI 10.1038/sj.npp.1301231; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Valentine JD, 1997, PSYCHOPHARMACOLOGY, V133, P300, DOI 10.1007/s002130050405; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Wei JX, 2012, ADDICT BEHAV, V37, P622, DOI 10.1016/j.addbeh.2012.01.009; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young RJ, 2013, ORAL ONCOL, V49, P576, DOI 10.1016/j.oraloncology.2013.01.006; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	82	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86214	10.1371/journal.pone.0086214	http://dx.doi.org/10.1371/journal.pone.0086214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465966	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100127
J	Chen, HX; Sun, SC; Norenburg, JL; Sundberg, P				Chen, Haixia; Sun, Shichun; Norenburg, Jon L.; Sundberg, Per			Mutation and Selection Cause Codon Usage and Bias in Mitochondrial Genomes of Ribbon Worms (Nemertea)	PLOS ONE			English	Article							AMINO-ACID USAGE; TRANSFER-RNAS; TRANSLATIONAL SELECTION; EFFECTIVE NUMBER; GENE-EXPRESSION; EVOLUTION; PATTERNS; FREQUENCIES; NUCLEOTIDE; ABUNDANCE	The phenomenon of codon usage bias is known to exist in many genomes and it is mainly determined by mutation and selection. To understand the patterns of codon usage in nemertean mitochondrial genomes, we use bioinformatic approaches to analyze the protein-coding sequences of eight nemertean species. Neutrality analysis did not find a significant correlation between GC12 and GC3. ENc-plot showed a few genes on or close to the expected curve, but the majority of points with low-ENc values are below it. ENc-plot suggested that mutational bias plays a major role in shaping codon usage. The Parity Rule 2 plot (PR2) analysis showed that GC and AT were not used proportionally and we propose that codons containing A or U at third position are used preferentially in nemertean species, regardless of whether corresponding tRNAs are encoded in the mitochondrial DNA. Context-dependent analysis indicated that the nucleotide at the second codon position slightly affects synonymous codon choices. These results suggested that mutational and selection forces are probably acting to codon usage bias in nemertean mitochondrial genomes.	[Chen, Haixia; Sundberg, Per] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Sun, Shichun] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Norenburg, Jon L.] Smithsonians Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA	University of Gothenburg; Ocean University of China; Smithsonian Institution; Smithsonian National Museum of Natural History	Chen, HX (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	chen_hai_xia@126.com; per.sundberg@bioenv.gu.se	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	Swedish Research Council; National Natural Science Foundation of China [30970333]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported (to PS) by the Swedish Research Council, and National Natural Science Foundation of China (to SCS, grant no. 30970333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; Chen HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-139; Chen HX, 2011, MOL BIOL REP, V38, P4509, DOI 10.1007/s11033-010-0582-4; Chen HX, 2009, GENE, V442, P8, DOI 10.1016/j.gene.2009.04.015; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Cutter AD, 2006, MOL BIOL EVOL, V23, P2303, DOI 10.1093/molbev/msl097; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Francino HP, 1999, NATURE, V400, P30, DOI 10.1038/21804; Fuglsang A, 2008, GENE, V410, P82, DOI 10.1016/j.gene.2007.12.001; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Ingvarsson PK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-307; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kamatani T, 2007, BIOSYSTEMS, V90, P362, DOI 10.1016/j.biosystems.2006.09.039; Le Thanh Hoa, 2004, Korean Journal of Parasitology, V42, P159, DOI 10.3347/kjp.2004.42.4.159; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Mitreva M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r75; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Podsiadlowski L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-364; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Subramanian S, 2008, GENETICS, V178, P2429, DOI 10.1534/genetics.107.086405; Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Swire J, 2005, J MOL EVOL, V60, P128, DOI 10.1007/s00239-004-0077-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turbeville JM, 2007, MOL PHYLOGENET EVOL, V43, P1056, DOI 10.1016/j.ympev.2006.10.025; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang B, 2010, J INTEGR PLANT BIOL, V52, P1100, DOI 10.1111/j.1744-7909.2010.00998.x; Wang X, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-14; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016147	48	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85631	10.1371/journal.pone.0085631	http://dx.doi.org/10.1371/journal.pone.0085631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24465966	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100110
